PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fecteau, ME; Pitta, DW; Vecchiarelli, B; Indugu, N; Kumar, S; Gallagher, SC; Fyock, TL; Sweeney, RW				Fecteau, Marie-Eve; Pitta, Dipti W.; Vecchiarelli, Bonnie; Indugu, Nagaraju; Kumar, Sanjay; Gallagher, Susan C.; Fyock, Terry L.; Sweeney, Raymond W.			Dysbiosis of the Fecal Microbiota in Cattle Infected with Mycobacterium avium subsp paratuberculosis	PLOS ONE			English	Article							CROHNS-DISEASE; DIVERSITY; PATHOGENESIS; SEQUENCES; BIOASSAY; HERDS	Johne's disease (JD) is a chronic, intestinal infection of cattle, caused by Mycobacterium avium subsp. paratuberculosis (MAP). It results in granulomatous inflammation of the intestinal lining, leading to malabsorption, diarrhea, and weight loss. Crohn's disease (CD), a chronic, inflammatory gastrointestinal disease of humans, has many clinical and pathologic similarities to JD. Dysbiosis of the enteric microbiota has been demonstrated in CD patients. It is speculated that this dysbiosis may contribute to the intestinal inflammation observed in those patients. The purpose of this study was to investigate the diversity patterns of fecal bacterial populations in cattle infected with MAP, compared to those of uninfected control cattle, using phylogenomic analysis. Fecal samples were selected to include samples from 20 MAP-positive cows; 25 MAP-negative herdmates; and 25 MAP-negative cows from a MAP-free herd. The genomic DNA was extracted; PCR amplified sequenced on a 454 Roche platform, and analyzed using QIIME. Approximately 199,077 reads were analyzed from 70 bacterial communities (average of 2,843 reads/sample). The composition of bacterial communities differed between the 3 treatment groups (P < 0.001; Permanova test). Taxonomic assignment of the operational taxonomic units (OTUs) identified 17 bacterial phyla across all samples. Bacteroidetes and Firmicutes constituted more than 95% of the bacterial population in the negative and exposed groups. In the positive group, lineages of Actinobacteria and Proteobacteria increased and those of Bacteroidetes and Firmicutes decreased (P < 0.001). Actinobacteria was highly abundant (30% of the total bacteria) in the positive group compared to exposed and negative groups (0.1-0.2%). Notably, the genus Arthrobacter was found to predominate Actinobacteria in the positive group. This study indicates that MAP-infected cattle have a different composition of their fecal microbiota than MAP-negative cattle.	[Fecteau, Marie-Eve; Pitta, Dipti W.; Vecchiarelli, Bonnie; Indugu, Nagaraju; Kumar, Sanjay; Gallagher, Susan C.; Fyock, Terry L.; Sweeney, Raymond W.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA	University of Pennsylvania	Fecteau, ME (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA.	mfecteau@vet.upenn.edu	Indugu, Nagaraju/AAT-7497-2021	Indugu, Nagaraju/0000-0001-9424-2155; Kumar, Sanjay/0000-0002-0937-918X	University of Pennsylvania	University of Pennsylvania	Support was provided by University of Pennsylvania [http://www.upenn.edu/research/smarts/university_research_foundation/#show1]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2008, INFLAMM BOWEL DIS, V14, P401, DOI 10.1002/ibd.20276; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANTOINE AD, 1964, J BACTERIOL, V88, P1672, DOI 10.1128/JB.88.6.1672-1677.1964; Bates D., 2013, R PACKAGE VERSION 09; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen X, 2014, AM J BIOSCIENCE, V2, P13; Chiodini RJ, 2012, CRIT REV MICROBIOL, V38, P52, DOI 10.3109/1040841X.2011.638273; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Durso LM, 2010, APPL ENVIRON MICROB, V76, P4858, DOI 10.1128/AEM.00207-10; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fecteau ME, 2011, VET CLIN N AM-FOOD A, V27, P547, DOI 10.1016/j.cvfa.2011.07.002; Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6; Fouts DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048289; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hollander M, 1973, NONPARAMETRIC STAT M, P27; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Kittlemann S, 2013, PLOS ONE, V8; Knust B, 2013, JAVMA-J AM VET MED A, V242, P663, DOI 10.2460/javma.242.5.663; Koboziev I, 2014, FREE RADICAL BIO MED, V68, P122, DOI 10.1016/j.freeradbiomed.2013.11.008; Lees Charlie W, 2009, Expert Rev Gastroenterol Hepatol, V3, P513, DOI 10.1586/egh.09.45; Li LL, 2005, P NATL ACAD SCI USA, V102, P12344, DOI 10.1073/pnas.0505662102; Liverani E, 2014, WORLD J GASTROENTERO, V20, P13060, DOI 10.3748/wjg.v20.i36.13060; Lombard JE, 2013, PREV VET MED, V108, P234, DOI 10.1016/j.prevetmed.2012.08.006; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marks DJB, 2010, CLIN REV ALLERG IMMU, V38, P20, DOI 10.1007/s12016-009-8133-2; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Pitta DW, 2014, J ANIM SCI, V92, P4014, DOI 10.2527/jas.2014-7621; Pitta DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111710; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; REICH CV, 1964, J BACTERIOL, V87, P1317, DOI 10.1128/JB.87.6.1317-1320.1964; RUTGEERTS P, 1991, LANCET, V338, P771, DOI 10.1016/0140-6736(91)90663-A; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Scaldaferri F, 2012, GASTROENTEROL CLIN N, V41, P581, DOI 10.1016/j.gtc.2012.06.002; Shin S, 1989, PROCEEDINGS 93RD US, P381; Sweeney RW, 2011, VET CLIN N AM-FOOD A, V27, P537, DOI 10.1016/j.cvfa.2011.07.001; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Team R. c, 2013, R A LANGUAGE AND ENV; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	46	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160353	10.1371/journal.pone.0160353	http://dx.doi.org/10.1371/journal.pone.0160353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494144	gold, Green Published, Green Submitted			2022-12-27	WOS:000381369500032
J	Tao, J; Zhai, Y; Park, H; Han, J; Dong, JH; Xie, M; Gu, T; Lewi, K; Ji, F; Jia, W				Tao, Jiang; Zhai, Yue; Park, Hyun; Han, Junli; Dong, Jianhui; Xie, Ming; Gu, Ting; Lewi, Keidren; Ji, Fang; Jia, William			Circadian Rhythm Regulates Development of Enamel in Mouse Mandibular First Molar	PLOS ONE			English	Article							MELATONIN RECEPTORS; SIGNAL-TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; HARD TISSUES; IN-VITRO; AMELOGENIN; EXPRESSION; DIFFERENTIATION; TOOTH; BONE	Rhythmic incremental growth lines and the presence of melatonin receptors were discovered in tooth enamel, suggesting possible role of circadian rhythm. We therefore hypothesized that circadian rhythm may regulate enamel formation through melatonin receptors. To test this hypothesis, we examined expression of melatonin receptors (MTs) and amelogenin (AMELX), a maker of enamel formation, during tooth germ development in mouse. Using qRT-PCR and immunocytochemistry, we found that mRNA and protein levels of both MTs and AMELX in normal mandibular first molar tooth germs increased gradually after birth, peaked at 3 or 4 day postnatal, and then decreased. Expression of MTs and AMELX by immunocytochemistry was significantly delayed in neonatal mice raised in all-dark or all-light environment as well as the enamel development. Furthermore, development of tooth enamel was also delayed showing significant immature histology in those animals, especially for newborn mice raised in all daylight condition. Interestingly, disruption in circadian rhythm in pregnant mice also resulted in delayed enamel development in their babies. Treatment with melatonin receptor antagonist 4P-PDOT in pregnant mice caused underexpression of MTs and AMELX associated with long-lasting deficiency in baby enamel tissue. Electromicroscopic evidence demonstrated increased necrosis and poor enamel mineralization in ameloblasts. The above results suggest that circadian rhythm is important for normal enamel development at both pre- and postnatal stages. Melatonin receptors were partly responsible for the regulation.	[Tao, Jiang; Zhai, Yue; Park, Hyun; Han, Junli; Dong, Jianhui] Shanghai Jiao Tong Univ, Dept Gen Dent, Peoples Hosp 9, Sch Med,Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Xie, Ming] Shanghai Jiao Tong Univ, Dept Prosthodont, Peoples Hosp 9, Sch Med,Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Gu, Ting] Shanghai Jiao Tong Univ, Dept Oral Pathol, Peoples Hosp 9, Sch Med,Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Lewi, Keidren] Univ Windsor, Dept Med, Sch Med, Cayon, St Kitts & Nevi; [Ji, Fang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Orthodont, Sch Med,Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Jia, William] Univ British Columbia, Brain Res Ctr, Dept Surg, Vancouver, BC V5Z 1M9, Canada	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of British Columbia	Ji, F (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Orthodont, Sch Med,Shanghai Key Lab Stomatol, Shanghai, Peoples R China.; Jia, W (corresponding author), Univ British Columbia, Brain Res Ctr, Dept Surg, Vancouver, BC V5Z 1M9, Canada.	smilefang98@hotmail.com; w.jia@ubc.ca	JIA, WILLIAM/AAE-4322-2020		National Natural Science Foundation of China [81200756, 81500813]; Science and Technology Commission of Shanghai Municipality [10411964500, 11411951800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the No. 81200756 http://www.nsfc.gov.cn/ National Natural Science Foundation of China, No. 10411964500 http://www.stcsm.gov.cn/ Science and Technology Commission of Shanghai Municipality, and No. 81500813 http://www.nsfc.gov.cn/ National Natural Science Foundation of China, No. 11411951800 http://www.stcsm.gov.cn/ Science and Technology Commission of Shanghai Municipality. The funders all participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	BROMAGE TG, 1991, AM J PHYS ANTHROPOL, V86, P205, DOI 10.1002/ajpa.1330860209; Caton J, 2005, ARCH ORAL BIOL, V50, P123, DOI 10.1016/j.archoralbio.2004.11.012; Choi YA, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-35; Coge F, 2009, BRIT J PHARMACOL, V158, P1248, DOI 10.1111/j.1476-5381.2009.00453.x; Dean MC, 2006, P ROY SOC B-BIOL SCI, V273, P2799, DOI 10.1098/rspb.2006.3583; DEAN MC, 1987, J HUM EVOL, V16, P157, DOI 10.1016/0047-2484(87)90074-1; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Ekmekcioglu C, 2001, CHRONOBIOL INT, V18, P973, DOI 10.1081/CBI-100107972; Fong CD, 2000, ORAL SURG ORAL MED O, V90, P218, DOI 10.1067/moe.2000.107052; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Godson C, 1997, ENDOCRINOLOGY, V138, P397, DOI 10.1210/endo.138.1.4824; Gruenbaum-Cohen Y, 2009, J EXP ZOOL PART B, V312B, P445, DOI 10.1002/jez.b.21255; Hardeland R., 2010, OPEN BIOL J, V3, P39, DOI DOI 10.2174/1874196701003010039; Hardeland R, 2011, PROG NEUROBIOL, V93, P350, DOI 10.1016/j.pneurobio.2010.12.004; Hardeland R, 2009, BIOFACTORS, V35, P183, DOI 10.1002/biof.23; Hart P S, 2000, Hum Mutat, V15, P298, DOI 10.1002/(SICI)1098-1004(200003)15:3<298::AID-HUMU20>3.0.CO;2-D; Hu CC, 1997, J DENT RES, V76, P641, DOI 10.1177/00220345970760020401; Hunt AE, 2001, AM J PHYSIOL-CELL PH, V280, pC110, DOI 10.1152/ajpcell.2001.280.1.C110; Iacob S, 2006, EUR J ORAL SCI, V114, P194, DOI 10.1111/j.1600-0722.2006.00287.x; Ishii H, 2009, J PHYSIOL SCI, V59, P37, DOI 10.1007/s12576-008-0003-9; Janones DS, 2005, ARCH ORAL BIOL, V50, P527, DOI 10.1016/j.archoralbio.2004.10.004; Ji F., 2011, DENT HYPOTHESES, V2, P99, DOI [10.5436/j.dehy.2011.2.00034, DOI 10.5436/J.DEHY.2011.2.00034]; Jin XW, 2003, MOL CELL BIOL, V23, P1054, DOI 10.1128/MCB.23.3.1054-1060.2003; Karasek M, 2007, J PHYSIOL PHARMACOL, V58, P105; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; Kumasaka S, 2010, HISTOCHEM CELL BIOL, V133, P577, DOI 10.1007/s00418-010-0698-6; LAU EC, 1992, BIOCHEM BIOPH RES CO, V188, P1253, DOI 10.1016/0006-291X(92)91366-X; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Liu J, 2013, INT J MOL SCI, V14, P10063, DOI 10.3390/ijms140510063; Liu J, 2013, J PINEAL RES, V54, P170, DOI 10.1111/jpi.12002; LYNCH HJ, 1987, ADV PINEAL RES, V2, P181; Matsubara E, 2003, J NEUROCHEM, V85, P1101, DOI 10.1046/j.1471-4159.2003.01654.x; McArthur AJ, 1997, ENDOCRINOLOGY, V138, P627, DOI 10.1210/en.138.2.627; MORGAN PJ, 1994, NEUROCHEM INT, V24, P101, DOI 10.1016/0197-0186(94)90100-7; Mutoh T, 2003, J PHYSIOL-LONDON, V547, P317, DOI 10.1113/jphysiol.2002.028001; Nakade O, 1999, J PINEAL RES, V27, P106, DOI 10.1111/j.1600-079X.1999.tb00603.x; Nebgen DR, 1999, J DENT RES, V78, P1484, DOI 10.1177/00220345990780090201; Oida S, 2002, J DENT RES, V81, P103, DOI 10.1177/154405910208100204; Pandi-Perumal SR, 2006, FEBS J, V273, P2813, DOI 10.1111/j.1742-4658.2006.05322.x; Pandi-Perumal SR, 2008, PROG NEUROBIOL, V85, P335, DOI 10.1016/j.pneurobio.2008.04.001; Rauth Rick J, 2009, J Calif Dent Assoc, V37, P863; Reiter RJ, 1996, TRENDS ENDOCRIN MET, V7, P22, DOI 10.1016/1043-2760(95)00192-1; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; ROSENSTEIN RE, 1991, J NEURAL TRANSM-GEN, V85, P243, DOI 10.1007/BF01244949; Ross AW, 2002, CELL TISSUE RES, V309, P163, DOI 10.1007/s00441-002-0582-3; Roth JA, 1999, J BIOL CHEM, V274, P22041, DOI 10.1074/jbc.274.31.22041; Satomura K, 2007, J PINEAL RES, V42, P231, DOI 10.1111/j.1600-079X.2006.00410.x; Savaskan E, 2001, NEUROSCI LETT, V308, P9, DOI 10.1016/S0304-3940(01)01967-X; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; Shinoda H, 1984, CHEM TODAY, V162, P34; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Smith TM, 2006, J ANAT, V208, P99, DOI 10.1111/j.1469-7580.2006.00499.x; Smith TM, 2003, J HUM EVOL, V44, P283, DOI 10.1016/S0047-2484(03)00006-X; Tachibana R, 2014, INT J MOL SCI, V15, P17304, DOI 10.3390/ijms151017304; Tamura H, 2008, REPROD TOXICOL, V25, P291, DOI 10.1016/j.reprotox.2008.03.005; Thesleff I, 1997, CIBA F SYMP, V205, P3; Thesleff I, 1997, COLD SPRING HARB SYM, V62, P257; Tompkins K, 2006, CONNECT TISSUE RES, V47, P111, DOI 10.1080/03008200600727756; Turgut M, 2005, J PINEAL RES, V39, P392, DOI 10.1111/j.1600-079X.2005.00263.x; von Gall C, 2002, CELL TISSUE RES, V309, P151, DOI 10.1007/s00441-002-0581-4; Ye L, 2006, J DENT RES, V85, P814, DOI 10.1177/154405910608500907	62	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0159946	10.1371/journal.pone.0159946	http://dx.doi.org/10.1371/journal.pone.0159946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494172	Green Published, gold, Green Submitted			2022-12-27	WOS:000381369500015
J	Ashley, SL; Xia, M; Murray, S; O'Dwyer, DN; Grant, E; White, ES; Flaherty, KR; Martinez, FJ; Moore, BB				Ashley, Shanna L.; Xia, Meng; Murray, Susan; O'Dwyer, David N.; Grant, Ethan; White, Eric S.; Flaherty, Kevin R.; Martinez, Fernando J.; Moore, Bethany B.			Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; VASCULAR ENDOTHELIAL GROWTH; REGULATORY T-CELLS; CXCL12/CXCR4 AXIS; LECTIN PATHWAY; LUNG-DISEASES; TUMOR-GROWTH; CATHEPSIN-S; CANCER; COMPLEMENT	Rationale Biomarkers in easily accessible compartments like peripheral blood that can predict disease progression in idiopathic pulmonary fibrosis (IPF) would be clinically useful regarding clinical trial participation or treatment decisions for patients. In this study, we used unbiased proteomics to identify relevant disease progression biomarkers in IPF. Methods Plasma from IPF patients was measured using an 1129 analyte slow off-rate modified aptamer (SOMAmer) array, and patient outcomes were followed over the next 80 weeks. Receiver operating characteristic (ROC) curves evaluated sensitivity and specificity for levels of each biomarker and estimated area under the curve (AUC) when prognostic biomarker thresholds were used to predict disease progression. Both logistic and Cox regression models advised biomarker selection for a composite disease progression index; index biomarkers were weighted via expected progression-free days lost during follow-up with a biomarker on the unfavorable side of the threshold. Results A six-analyte index, scaled 0 to 11, composed of markers of immune function, proteolysis and angiogenesis [high levels of ficolin-2 (FCN2), cathepsin-S (Cath-S), legumain (LGMN) and soluble vascular endothelial growth factor receptor 2 (VEGFsR2), but low levels of inducible T cell costimulator (ICOS) or trypsin 3 (TRY3)] predicted better progression-free survival in IPF with a ROC AUC of 0.91. An index score >= 3 (group >= 2) was strongly associated with IPF progression after adjustment for age, gender, smoking status, immunomodulation, forced vital capacity% predicted and diffusing capacity for carbon monoxide % predicted (HR 16.8, 95% CI 2.2-126.7, P = 0.006). Conclusion This index, derived from the largest proteomic analysis of IPF plasma samples to date, could be useful for clinical decision making in IPF, and the identified analytes suggest biological processes that may promote disease progression.	[Ashley, Shanna L.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Xia, Meng; Murray, Susan] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [O'Dwyer, David N.; White, Eric S.; Flaherty, Kevin R.; Moore, Bethany B.] Univ Michigan, Dept Internal Med, Pulm & Crit Care Med Div, Ann Arbor, MI 48109 USA; [Grant, Ethan] MedImmune, Gaithersburg, MD USA; [Martinez, Fernando J.] Weill Cornell Med Coll, Dept Internal Med, New York, NY USA; [Moore, Bethany B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; AstraZeneca; Medimmune; Cornell University; University of Michigan System; University of Michigan	Moore, BB (corresponding author), Univ Michigan, Dept Internal Med, Pulm & Crit Care Med Div, Ann Arbor, MI 48109 USA.	bmoore@umich.edu	Grant, Ethan/GQP-2720-2022	Murray, Susan/0000-0003-4387-7673; Moore, Bethany/0000-0003-3051-745X	NIH [HL115618]; Michigan CTSA [UL1TR000433, T32AI007413]; UNCF Merck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007413] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan CTSA; UNCF Merck(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants HL115618 (BBM), the Michigan CTSA (UL1TR000433), and T32AI007413 (SLA); and a fellowship from UNCF Merck (SLA).	AbdulHameed MDM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112193; Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Ando M, 2010, LUNG, V188, P247, DOI 10.1007/s00408-009-9223-x; Antoniou KM, 2006, CHEST, V130, P982, DOI 10.1378/chest.130.4.982; Antoniou KM, 2010, CONNECT TISSUE RES, V51, P71, DOI 10.3109/03008200903056150; Atkins CP, 2014, RESP MED, V108, P376, DOI 10.1016/j.rmed.2013.11.007; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Brix K, 2015, PROTOPLASMA, V252, P755, DOI 10.1007/s00709-014-0730-0; Chen KL, 2012, CANCER LETT, V317, P89, DOI 10.1016/j.canlet.2011.11.015; Cosgrove GP, 2004, AM J RESP CRIT CARE, V170, P242, DOI 10.1164/rccm.200308-1151OC; Dancer RCA, 2011, EUR RESPIR J, V38, P1461, DOI 10.1183/09031936.00024711; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Endo Y, 2012, J IMMUNOL, V189, P5860, DOI 10.4049/jimmunol.1200836; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Garantziotis S, 2008, AM J RESP CRIT CARE, V178, P939, DOI 10.1164/rccm.200803-386OC; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hanumegowda C, 2012, CHEST, V142, P200, DOI 10.1378/chest.11-1962; Herazo-Maya JD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005964; Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Kaarteenaho R, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0020-2; Kasabova M, 2014, PROTEOM CLIN APPL, V8, P447, DOI 10.1002/prca.201300047; Kilpatrick DC, 2009, CLIN RESPIR J, V3, P29, DOI 10.1111/j.1752-699X.2008.00105.x; KILPATRICK DC, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/138797; Kim HJ, 2015, RESP MED, V109, P661, DOI 10.1016/j.rmed.2015.02.002; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Knippenberg S, 2015, THORAX, V70, P636, DOI 10.1136/thoraxjnl-2014-206420; Kos J, 2001, BRIT J CANCER, V85, P1193, DOI 10.1054/bjoc.2001.2057; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; Lamszus K, 2003, CLIN CANCER RES, V9, P1399; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Marczynska J, 2014, J IMMUNOL, V193, P2753, DOI 10.4049/jimmunol.1302893; Margaritopoulos GA, 2010, INT J MOL MED, V26, P919, DOI 10.3892/ijmm_00000543; Marsit CJ, 2005, MOL CARCINOGEN, V44, P146, DOI 10.1002/mc.20125; Metzger ML, 2015, CLIN EXP IMMUNOL, V179, P256, DOI 10.1111/cei.12459; Molyneaux PL, 2013, EUR RESPIR REV, V22, P376, DOI 10.1183/09059180.00000713; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Moore BB, 2014, FRONT MED, V1, P1, DOI DOI 10.3389/FMED.2014.00056; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Naik PK, 2012, AM J PHYSIOL-LUNG C, V303, pL1046, DOI 10.1152/ajplung.00139.2012; Naik Payal K, 2010, Expert Rev Respir Med, V4, P759, DOI 10.1586/ers.10.73; Nathan N, 2015, PAEDIATR RESPIR REV, V16, P219, DOI 10.1016/j.prrv.2015.05.002; O'Riordan TG, 2015, CHEST, V148, P1083, DOI 10.1378/chest.14-3218; Osthoff M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0480-6; Pan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035315; Pardo A, 2008, INT J BIOCHEM CELL B, V40, P1141, DOI 10.1016/j.biocel.2007.11.020; Prasad R, 2015, INTRACTABLE RARE DIS, V4, P65, DOI 10.5582/irdr.2015.01009; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Reilkoff RA, 2013, AM J RESP CRIT CARE, V187, P180, DOI 10.1164/rccm.201206-1109OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Schweitzer B, 2002, NAT BIOTECHNOL, V20, P359, DOI 10.1038/nbt0402-359; Shimizu Y, 2010, INT J IMMUNOPATH PH, V23, P449, DOI 10.1177/039463201002300207; Smadja DM, 2014, PATHOL BIOL, V62, P391, DOI 10.1016/j.patbio.2014.07.006; Smadja DM, 2013, ANGIOGENESIS, V16, P147, DOI 10.1007/s10456-012-9306-9; Spagnolo P, 2015, ANN MED, V47, P15, DOI 10.3109/07853890.2014.982165; Sumi M, 2005, J CLIN LAB ANAL, V19, P146, DOI 10.1002/jcla.20069; Tanaka C, 2010, ARTHRITIS RHEUM-US, V62, P1723, DOI 10.1002/art.27428; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Ward C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012543; Weiss Curtis H, 2010, Proc Am Thorac Soc, V7, P77, DOI 10.1513/pats.200906-055JS; Zhang YZ, 2012, CURR OPIN PULM MED, V18, P441, DOI 10.1097/MCP.0b013e328356d03c; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Zielonka TM, 2009, EUR J MED RES, V14, P259, DOI 10.1186/2047-783X-14-S4-259	70	32	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159878	10.1371/journal.pone.0159878	http://dx.doi.org/10.1371/journal.pone.0159878			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490795	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900021
J	Kamigaki, A; Nito, K; Hikino, K; Goto-Yamada, S; Nishimura, M; Nakagawa, T; Mano, S				Kamigaki, Akane; Nito, Kazumasa; Hikino, Kazumi; Goto-Yamada, Shino; Nishimura, Mikio; Nakagawa, Tsuyoshi; Mano, Shoji			Gateway Vectors for Simultaneous Detection of Multiple Protein-Protein Interactions in Plant Cells Using Bimolecular Fluorescence Complementation	PLOS ONE			English	Article							BINARY VECTORS; LIVING CELLS; SIMULTANEOUS VISUALIZATION; PHYSIOLOGICAL CONDITIONS; ARABIDOPSIS-THALIANA; IN-PLANTA; RED; PEROXISOMES; SYSTEM; COMPLEXES	Bimolecular fluorescence complementation (BiFC) is widely used to detect protein-protein interactions, because it is technically simple, convenient, and can be adapted for use with conventional fluorescence microscopy. We previously constructed enhanced yellow fluorescent protein (EYFP)-based Gateway cloning technology-compatible vectors. In the current study, we generated new Gateway cloning technology-compatible vectors to detect BiFC-based multiple protein-protein interactions using N- and C-terminal fragments of enhanced cyan fluorescent protein (ECFP), enhanced green fluorescent protein (EGFP), and monomeric red fluorescent protein (mRFP1). Using a combination of N- and C-terminal fragments from ECFP, EGFP and EYFP, we observed a shift in the emission wavelength, enabling the simultaneous detection of multiple protein-protein interactions. Moreover, we developed these vectors as binary vectors for use in Agrobacterium infiltration and for the generate transgenic plants. We verified that the binary vectors functioned well in tobacco cells. The results demonstrate that the BiFC vectors facilitate the design of various constructions and are convenient for the detection of multiple protein-protein interactions simultaneously in plant cells.	[Kamigaki, Akane; Hikino, Kazumi; Mano, Shoji] Natl Inst Basic Biol, Dept Evolutionary Biol & Biodivers, Okazaki, Aichi, Japan; [Nito, Kazumasa; Goto-Yamada, Shino] Kyoto Univ, Grad Sch Sci, Kyoto, Japan; [Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi, Japan; [Nakagawa, Tsuyoshi] Shimane Univ, Dept Mol & Funct Genom, Interdisciplinary Ctr Sci Res, Org Res, Matsue, Shimane, Japan; [Mano, Shoji] SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan; [Goto-Yamada, Shino] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland; [Nishimura, Mikio] Natl Inst Basic Biol, Res Enhancement Strategy Off, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Shimane University; Graduate University for Advanced Studies - Japan; Jagiellonian University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Mano, S (corresponding author), Natl Inst Basic Biol, Dept Evolutionary Biol & Biodivers, Okazaki, Aichi, Japan.; Mano, S (corresponding author), SOKENDAI Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi, Japan.	mano@nibb.ac.jp		Nishimura, Mikio/0000-0001-7960-9721; Mano, Shoji/0000-0003-1323-3308; Goto-Yamada, Shino/0000-0001-5403-2356	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI] [26440157, 16085101, 22120001]; Japan Agency for Medical Research and development, AMED; Grants-in-Aid for Scientific Research [15J40032] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI](Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI Grant-in-Aid for Scientific Research (C) (grant No. 26440157 to SM), Grant-in-Aid for Scientific Research in Priority Areas (grant No. 16085101 to MN) and Grant-in-Aid for Scientific Research on Innovative Areas (No. 22120001 to MN)], and Research Program on Hepatitis from Japan Agency for Medical Research and development, AMED, to MN. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Arase F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043414; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Citovsky V, 2008, METHODS, V45, P196, DOI 10.1016/j.ymeth.2008.06.007; Diaz I, 2005, PLANT J, V42, P652, DOI 10.1111/j.1365-313X.2005.02402.x; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Fan JY, 2008, BIOCHEM BIOPH RES CO, V367, P47, DOI 10.1016/j.bbrc.2007.12.101; Goto S, 2011, PLANT CELL, V23, P1573, DOI 10.1105/tpc.110.080770; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hynes TR, 2008, METHODS, V45, P207, DOI 10.1016/j.ymeth.2008.06.008; Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Kimura T, 2013, BIOSCI BIOTECH BIOCH, V77, P430, DOI 10.1271/bbb.120877; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Kodama Y, 2009, PLANT MOL BIOL, V70, P211, DOI 10.1007/s11103-009-9467-0; Kwaaitaal M, 2010, PLANT PHYSIOL, V152, P1135, DOI 10.1104/pp.109.151142; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Mano S, 2006, PLANT J, V47, P604, DOI 10.1111/j.1365-313X.2006.02809.x; Mano S, 2011, PLANT CELL PHYSIOL, V52, P2157, DOI 10.1093/pcp/pcr147; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Nakagawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P624, DOI 10.1271/bbb.70678; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Ohad N, 2007, PLANT PHYSIOL, V145, P1090, DOI 10.1104/pp.107.107284; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x; Tanaka Y., 2012, GENETIC ENG BASICS N, P35, DOI DOI 10.5772/32009; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Zamyatnin AA, 2006, PLANT J, V46, P145, DOI 10.1111/j.1365-313X.2006.02674.x	36	13	13	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160717	10.1371/journal.pone.0160717	http://dx.doi.org/10.1371/journal.pone.0160717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490375	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900081
J	Todorova, VK; Makhoul, I; Siegel, ER; Wei, J; Stone, A; Carter, W; Beggs, ML; Owen, A; Klimberg, VS				Todorova, Valentina K.; Makhoul, Issam; Siegel, Eric R.; Wei, Jeanne; Stone, Annjanette; Carter, Weleetka; Beggs, Marjorie L.; Owen, Aaron; Klimberg, V. Suzanne			Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CHRONIC HEART-FAILURE; NEUTROPHIL EXTRACELLULAR TRAPS; LOW-DENSITY GRANULOCYTES; ANTHRACYCLINE CARDIOTOXICITY; INDUCED CARDIOMYOPATHY; RHEUMATOID-ARTHRITIS; PROGNOSTIC VALUE; EXPRESSION; CHEMOTHERAPY	Cardiotoxicity of doxorubicin (DOX) remains an important health concern. DOX cardiotoxicity is cumulative-dose-dependent and begins with the first dose of chemotherapy. No biomarker for presymptomatic detection of DOX cardiotoxicity has been validated. Our hypothesis is that peripheral blood cells (PBC) gene expression induced by the early doses of DOX-based chemotherapy could identify potential biomarkers for presymptomatic cardiotoxicity in cancer patients. PBC gene expression of 33 breast cancer patients was conducted before and after the first cycle of DOX-based chemotherapy. Cardiac function was evaluated before the start of chemotherapy and at its completion. Differentially expressed genes (DEG) of patients who developed DOX-associated cardiotoxicity after the completion of chemotherapy were compared with DEG of patients who did not. Ingenuity database was used for functional analysis of DEG. Sixty-sevens DEG (P<0.05) were identified in PBC of patients with DOX-cardiotoxicity. Most of DEG encode proteins secreted by activated neutrophils. The functional analysis of the DEG showed enrichment for immune-and inflammatory response. This is the first study to identify the PBC transcriptome signature associated with a single dose of DOX-based chemotherapy in cancer patients. We have shown that PBC transcriptome signature associated with one dose of DOX chemotherapy in breast cancer can predict later impairment of cardiac function. This finding may be of value in identifying patients at high or low risk for the development of DOX cardiotoxicity during the initial doses of chemotherapy and thus to avoid the accumulating toxic effects from the subsequent doses during treatment.	[Todorova, Valentina K.; Owen, Aaron; Klimberg, V. Suzanne] Univ Arkansas Med Sci, Dept Surg Breast Surg Oncol, Little Rock, AR 72205 USA; [Makhoul, Issam] Univ Arkansas Med Sci, Dept Hematol Oncol, Little Rock, AR 72205 USA; [Siegel, Eric R.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Wei, Jeanne] Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA; [Stone, Annjanette; Carter, Weleetka] Cent Arkansas Vet Healthcare Syst, Res & Dev Serv, Pharmacogen Anal Lab, Little Rock, AR USA; [Beggs, Marjorie L.] Nephropath, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Todorova, VK (corresponding author), Univ Arkansas Med Sci, Dept Surg Breast Surg Oncol, Little Rock, AR 72205 USA.	vtodorova@uams.edu		Siegel, Eric/0000-0001-9824-6612	Arkansas Breast Cancer Research Program; University of Arkansas for Medical Sciences [1UL1RR029884]; NIH/NIA Claude Pepper Center [P30AG028718]	Arkansas Breast Cancer Research Program; University of Arkansas for Medical Sciences; NIH/NIA Claude Pepper Center	This work was supported by grants to VKT from Arkansas Breast Cancer Research Program and University of Arkansas for Medical Sciences (1UL1RR029884) and NIH/NIA Claude Pepper Center (P30AG028718).	Bagnost T, 2010, CARDIOVASC RES, V87, P569, DOI 10.1093/cvr/cvq081; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonow R., 2012, BRAUNWALDS HEART DIS, DOI DOI 10.1093/eurheartj/ehw249; Bonow RO, 2005, CIRCULATION, V112, P1853, DOI 10.1161/CIRCULATIONAHA.105.170072; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BRISTOW MR, 1978, AM J MED, V65, P823, DOI 10.1016/0002-9343(78)90802-1; Cardinale D, 2010, J AM COLL CARDIOL, V55, P213, DOI 10.1016/j.jacc.2009.03.095; Carmona-Rivera C, 2013, SEMIN IMMUNOPATHOL, V35, P455, DOI 10.1007/s00281-013-0375-7; Christensen HM, 2012, EUR J HEART FAIL, V14, P387, DOI 10.1093/eurjhf/hfs021; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Dodos F, 2008, CLIN RES CARDIOL, V97, P318, DOI 10.1007/s00392-007-0633-6; EHRKE MJ, 1984, CANCER RES, V44, P2497; Floyd JD, 2005, J CLIN ONCOL, V23, P7685, DOI 10.1200/JCO.2005.08.789; Fu J, 2014, ANN ALLERG ASTHMA IM, V113, P635, DOI 10.1016/j.anai.2014.08.024; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Ganz WI, 1996, ONCOLOGY, V53, P461; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Grayson PC, 2015, ARTHRITIS RHEUMATOL, V67, P1922, DOI 10.1002/art.39153; HACBARTH E, 1986, ARTHRITIS RHEUM-US, V29, P1334, DOI 10.1002/art.1780291105; HASKILL JS, 1981, CANCER RES, V41, P3852; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HENDERSON IC, 1989, J CLIN ONCOL, V7, P560, DOI 10.1200/JCO.1989.7.5.560; Iqbal N, 2012, CARDIOVASC DIAGN THE, V2, P147, DOI 10.3978/j.issn.2223-3652.2012.06.03; Jahanyar J, 2007, J SURG RES, V140, P199, DOI 10.1016/j.jss.2007.02.040; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Jungandreas K, 2014, J CARDIOVASC DIS DIA, V2, P140; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; MACKALL CL, 1994, BLOOD, V84, P2221; Marchant DJ, 2012, CIRC RES, V110, P126, DOI 10.1161/CIRCRESAHA.111.243170; McCaffrey TA, 2013, INT J BIOL SCI, V9, P350, DOI 10.7150/ijbs.6058; Mookadam F, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00259; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Pai VB, 2000, DRUG SAFETY, V22, P263, DOI 10.2165/00002018-200022040-00002; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Plana JC, 2014, EUR HEART J-CARD IMG, V15, P1063, DOI 10.1093/ehjci/jeu192; Raber P, 2012, IMMUNOL INVEST, V41, P614, DOI 10.3109/08820139.2012.680634; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sashchenko LP, 2004, J BIOL CHEM, V279, P2117, DOI 10.1074/jbc.M307513200; Schmielau J, 2001, CANCER RES, V61, P4756; Schneider JJ, 2005, J MOL MED, V83, P587, DOI 10.1007/s00109-005-0657-1; Sheen V, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.041; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tan TC, 2012, CURR CARDIOVASC IMAG, V5, P403, DOI 10.1007/s12410-012-9163-3; Theilgaard-Monch K, 2006, BLOOD, V108, P353, DOI 10.1182/blood-2005-09-3890; Todorova VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048398; Vadasz Z, 2014, SEMIN ARTHRITIS RHEU, V43, P767, DOI 10.1016/j.semarthrit.2013.11.010; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Wijayahadi N, 2007, J CHEMOTHERAPY, V19, P716, DOI 10.1179/joc.2007.19.6.716; Yndestad A, 2003, CARDIOVASC RES, V60, P141, DOI 10.1016/S0008-6363(03)00362-6	54	17	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160224	10.1371/journal.pone.0160224	http://dx.doi.org/10.1371/journal.pone.0160224			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490685	gold, Green Submitted, Green Published			2022-12-27	WOS:000381368900038
J	Brohawn, DG; O'Brien, LC; Bennett, JP				Brohawn, David G.; O'Brien, Laura C.; Bennett, James P., Jr.			RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; COEXPRESSION NETWORK; MOTOR-NEURONS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; OXIDATIVE DAMAGE; FACTOR-ALPHA; STEM-CELLS; TNF-ALPHA	ALS is a rapidly progressive, devastating neurodegenerative illness of adults that produces disabling weakness and spasticity arising from death of lower and upper motor neurons. No meaningful therapies exist to slow ALS progression, and molecular insights into pathogenesis and progression are sorely needed. In that context, we used high-depth, next generation RNA sequencing (RNAseq, Illumina) to define gene network abnormalities in RNA samples depleted of rRNA and isolated from cervical spinal cord sections of 7 ALS and 8 CTL samples. We aligned > 50 million 2X150 bp paired-end sequences/sample to the hg19 human genome and applied three different algorithms (Cuffdiff2, DEseq2, EdgeR) for identification of differentially expressed genes (DEG's). Ingenuity Pathways Analysis (IPA) and Weighted Gene Co-expression Network Analysis (WGCNA) identified inflammatory processes as significantly elevated in our ALS samples, with tumor necrosis factor (TNF) found to be a major pathway regulator (IPA) and TNF alpha-induced protein 2 (TNFAIP2) as a major network "hub" gene (WGCNA). Using the oPOSSUM algorithm, we analyzed transcription factors (TF) controlling expression of the nine DEG/hub genes in the ALS samples and identified TF's involved in inflammation (NFkB, REL, NFkB1) and macrophage function (NR1H2::RXRA heterodimer). Transient expression in human iPSC-derived motor neurons of TNFAIP2 (also a DEG identified by all three algorithms) reduced cell viability and induced caspase 3/7 activation. Using high-density RNAseq, multiple algorithms for DEG identification, and an unsupervised gene co-expression network approach, we identified significant elevation of inflammatory processes in ALS spinal cord with TNF as a major regulatory molecule. Overexpression of the DEG TNFAIP2 in human motor neurons, the population most vulnerable to die in ALS, increased cell death and caspase 3/7 activation. We propose that therapies targeted to reduce inflammatory TNF alpha signaling may be helpful in ALS patients.	[Brohawn, David G.; O'Brien, Laura C.; Bennett, James P., Jr.] Virginia Commonwealth Univ, Parkinsons Dis Res Ctr, Richmond, VA 23284 USA; [Brohawn, David G.] Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA USA; [O'Brien, Laura C.; Bennett, James P., Jr.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Bennett, James P., Jr.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23284 USA; [Bennett, James P., Jr.] Neurodegenerat Therapeut Inc, Charlottesville, VA 22902 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Bennett, JP (corresponding author), Virginia Commonwealth Univ, Parkinsons Dis Res Ctr, Richmond, VA 23284 USA.; Bennett, JP (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.; Bennett, JP (corresponding author), Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23284 USA.; Bennett, JP (corresponding author), Neurodegenerat Therapeut Inc, Charlottesville, VA 22902 USA.	aging.mitochondria@gmail.com			ALS Worldwide; MCV Foundation; Neurodegeneration Therapeutics, Inc.	ALS Worldwide; MCV Foundation; Neurodegeneration Therapeutics, Inc.	The work was supported by the following: ALS Worldwide, www.alsworldwide.org; and MCV Foundation, www.mcvfoundation.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JPB is the President and Chief Scientific Officer of Neurodegeneration Therapeutics, Inc., an IRS designated 501(c)3 non-profit, charitable medical research entity. The funders provided support in the form of salaries for authors (DGB, LCO, JPB) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abel O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064899; Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Amoroso MW, 2013, J NEUROSCI, V33, P574, DOI 10.1523/JNEUROSCI.0906-12.2013; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrus PK, 1998, J NEUROCHEM, V71, P2041; Babu GN, 2008, NEUROCHEM RES, V33, P1145, DOI 10.1007/s11064-007-9564-x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brustolim D, 2006, INT IMMUNOPHARMACOL, V6, P903, DOI 10.1016/j.intimp.2005.12.007; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Cereda C, 2008, J NEUROIMMUNOL, V194, P123, DOI 10.1016/j.jneuroim.2007.10.028; Chang YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002849; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Corcia P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052941; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fanning LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057007; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Figueroa-Romero C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052672; Ganesalingam J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007107; Hagl S, 2015, NEUROCHEMISTRY INT; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Han SS, 2002, J BIOCHEM MOL BIOL, V35, P337; Hardiman O, 2007, LANCET NEUROL, V6, P291, DOI 10.1016/S1474-4422(07)70062-5; Hattermann K, 2008, MOL CELL NEUROSCI, V39, P133, DOI 10.1016/j.mcn.2008.03.009; Hausmann M, 2011, J BIOL CHEM, V286, P26533, DOI 10.1074/jbc.M111.265322; Heath PR, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00259; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Hensley K, 2002, J NEUROCHEM, V82, P365, DOI 10.1046/j.1471-4159.2002.00968.x; Higgins CMJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-16; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Ikiz B, 2015, CELL REP, V12, P335, DOI 10.1016/j.celrep.2015.06.019; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Khan S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/379817; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kogelman LJA, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-57; Kong JM, 1998, J NEUROSCI, V18, P3241; Kratz A, 2014, NAT BIOTECHNOL, V32, P882, DOI 10.1038/nbt.3015; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lewis KE, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-55; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Maschietto M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0098-9; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MOHLER KM, 1993, J IMMUNOL, V151, P1548; NAGY D, 1994, J NEUROSCI RES, V38, P336, DOI 10.1002/jnr.490380312; O'Brien LC, 2015, STEM CELLS DEV, V24, P1984, DOI 10.1089/scd.2015.0076; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Poloni M, 2000, NEUROSCI LETT, V287, P211, DOI 10.1016/S0304-3940(00)01177-0; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rusiniak ME, 2000, CANCER RES, V60, P1824; Saito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056587; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Sasaki S, 1996, ACTA NEUROPATHOL, V91, P278, DOI 10.1007/s004010050426; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P10, DOI 10.1097/nen.0b013e31802c396b; Satoh J, 2014, J CENT NERV SYST DIS, V6, P69, DOI [10.4137/JCNSD.S18103, 10.4137/JCNSNSD.S18103]; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stommel EW, 2009, AMYOTROPH LATERAL SC, V10, P393, DOI 10.3109/17482960802709416; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; van Spriel AB, 2004, J IMMUNOL, V172, P2953, DOI 10.4049/jimmunol.172.5.2953; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103207; Zhao WH, 2013, J NEUROIMMUNE PHARM, V8, P888, DOI 10.1007/s11481-013-9489-x; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	96	41	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160520	10.1371/journal.pone.0160520	http://dx.doi.org/10.1371/journal.pone.0160520			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487029	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800083
J	Cleto, SA; Rodrigues, CE; Malaque, CM; Sztajnbok, J; Seguro, AC; Andrade, L				Cleto, Sergio Aparecido; Rodrigues, Camila Eleuterio; Malaque, Ceila Maria; Sztajnbok, Jaques; Seguro, Antonio Carlos; Andrade, Lucia			Hemodiafiltration Decreases Serum Levels of Inflammatory Mediators in Severe Leptospirosis: A Prospective Study	PLOS ONE			English	Article							RENAL-REPLACEMENT THERAPY; CONTINUOUS HEMOFILTRATION; INTENSITY; HEMODIALYSIS; FAILURE	Background Leptospirosis is a health problem worldwide. Its most severe form is a classic model of sepsis, provoking acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI), with associated mortality that remains unacceptably high. We previously demonstrated that early initiation of sustained low-efficiency dialysis (SLED) followed by daily SLED significantly decreases mortality. However, the mode of clearance can also affect dialysis patient outcomes. Therefore, the objective of this study was to compare the effects of SLED with traditional (diffusive) clearance, via hemodialysis, and SLED with convective clearance, via hemodiafiltration (SLEDf), in patients with severe leptospirosis. Methods In this prospective study, conducted in the intensive care unit (ICU) from 2009 through 2012, we compared two groups-SLED (n = 19) and SLEDf (n = 20)-evaluating demographic, clinical, and biochemical parameters, as well as serum levels of interleukins, up to the third day after admission. All patients received dialysis early and daily thereafter. Results During the study period, 138 patients were admitted to our ICU with a diagnosis of leptospirosis; 39 (36 males/3 females) met the criteria for ARDS and AKI. All patients were on mechanical ventilation and were comparable in terms of respiratory parameters. Mortality did not differ between the SLEDf and SLED groups. However, post-admission decreases in the serum levels of interleukin (IL)-17, IL-7, and monocyte chemoattractant protein-1 were significantly greater in the SLEDf group. Direct bilirubin and the arterial oxygen tension/fraction of inspired oxygen ratio were significantly higher in the SLED group. We identified the following risk factors (sensitivities/specificities) for mortality in severe leptospirosis: age >= 55 years (67%/91%); serum urea >= 204 mg/dl (100%/70%); creatinine >= 5.2 mg/dl (100%/58%); Acute Physiology and Chronic Health Evaluation II score >= 39.5 (67%/88%); Sequential Organ Failure Assessment score >= 20.5 (67%/85%); and inspiratory pressure >= 31 mmHg (84%/85%). Conclusions The mode of dialysis clearance might not affect outcomes in severe leptospirosis.	[Cleto, Sergio Aparecido; Malaque, Ceila Maria; Sztajnbok, Jaques] Emilio Ribas Inst Infectol, Intens Care Unit, Sao Paulo, Brazil; [Rodrigues, Camila Eleuterio; Seguro, Antonio Carlos; Andrade, Lucia] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil	Universidade de Sao Paulo	Andrade, L (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	luciacan@usp.br	Rodrigues, Camila/HHN-2048-2022; Sztajnbok, Jaques/AAN-1793-2020; Rodrigues, Camila E/E-9483-2017; Andrade, Lucia C/C-5223-2014; Sztajnbok, Jaques/ABE-7055-2020	Rodrigues, Camila E/0000-0003-0562-0893; Andrade, Lucia C/0000-0002-3078-8957; Sztajnbok, Jaques/0000-0002-3188-8044	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation) [07/55258-1]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development) [306148/2013-7, 302835/2009-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation; Grant no. 07/55258-1). Drs. Seguro and Andrade are recipients of grants from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development; Grant nos. 306148/2013-7 and 302835/2009-1, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation; Grant no. 07/55258-1). Drs. Seguro and Andrade are recipients of grants from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development; Grant nos. 306148/2013-7 and 302835/2009-1, respectively).	Andrade L, 2007, CLIN J AM SOC NEPHRO, V2, P739, DOI 10.2215/CJN.00680207; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Borthwick EMJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008075.pub2; Cole L, 2001, INTENS CARE MED, V27, P978, DOI 10.1007/s001340100963; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; da Silva JB, 2009, MICROB PATHOGENESIS, V47, P87, DOI 10.1016/j.micpath.2009.05.002; De Vriese AS, 1999, INTENS CARE MED, V25, P903, DOI 10.1007/s001340050981; Fialho RN, 2009, HUM IMMUNOL, V70, P915, DOI 10.1016/j.humimm.2009.08.007; GROOTENDORST AF, 1992, INTENS CARE MED, V18, P235, DOI 10.1007/BF01709839; Haase M, 2007, INT J ARTIF ORGANS, V30, P1031, DOI 10.1177/039139880703001202; Hoffmann JN, 2001, WORLD J SURG, V25, P651, DOI 10.1007/s002680020027; Kellum JA, 2002, INTENS CARE MED, V28, P29, DOI 10.1007/s00134-001-1159-4; Kyriakidis I, 2011, CYTOKINE, V54, P117, DOI 10.1016/j.cyto.2011.01.014; Lacerda HG, 2008, T ROY SOC TROP MED H, V102, P1233, DOI 10.1016/j.trstmh.2008.05.010; Marotto PCF, 1999, CLIN INFECT DIS, V29, P1561, DOI 10.1086/313501; Misset B, 1996, INTENS CARE MED, V22, P742, DOI 10.1007/s001340050161; Murugan R, 2015, CLIN J AM SOC NEPHRO, V10, P926, DOI 10.2215/CJN.04560514; Naka T, 2010, CONTRIB NEPHROL, V166, P181, DOI 10.1159/000314871; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Ratanarat R, 2005, CRIT CARE, V9, pR294, DOI 10.1186/cc3529; Rimmele T, 2011, CRIT CARE, V15, DOI 10.1186/cc9411; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Tajiki, 1997, Braz J Infect Dis, V1, P138; Tajiki MH, 1996, CLIN INFECT DIS, V23, P1177, DOI 10.1093/clinids/23.5.1177; TEGLIA OF, 1995, CHEST, V108, P874, DOI 10.1378/chest.108.3.874; Wagenaar JFP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000453	28	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160010	10.1371/journal.pone.0160010	http://dx.doi.org/10.1371/journal.pone.0160010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487001	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800053
J	Teofili, L; Valentini, CG; Di Blasi, R; Orlando, N; Fianchi, L; Zini, G; Sica, S; De Stefano, V; Pagano, L				Teofili, Luciana; Valentini, Caterina Giovanna; Di Blasi, Roberta; Orlando, Nicoletta; Fianchi, Luana; Zini, Gina; Sica, Simona; De Stefano, Valerio; Pagano, Livio			Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia	PLOS ONE			English	Article							RHG-CSF; INFECTIONS; DONORS; EFFICACY; IMMUNOSUPPRESSION; IMMUNOMODULATION; ASSOCIATION; SEPSIS; ADULTS; FEVER	It is still under debate whether granulocyte transfusions (GTs) substantially increase survival in patients with febrile neutropenia. We retrospectively examined data relative to 96 patients with hematological malignancies receiving 491 GTs during 114 infectious episodes (IE). Patients were grouped according to the median doses of granulocytes transfused during the infectious episode (low-dose group: < 1.5-x108 cells/Kg; standard-dose group: 1.53.0x10(8) cells/Kg and high-dose group: > 3.0x10(8) cells/Kg). The impact of clinical, microbiological and GT-related variables on the infection-related mortality (IRM) was investigated. The IRM was not influenced by the number of GTs or by the total amount of granulocytes received, whereas a dose-related effect of the median dose received for IE was detected at univariate analysis (IRM of 18.4% in the standard-dose group, 44.4% in the low-dose group and 48.4% in the high-dose group, p = 0.040) and confirmed at multivariate analysis (OR 3.7, IC 95% 1.5-8.9; 0.004 for patients not receiving standard doses of GTs). Moreover, patients receiving GTs at doses lower or greater than standard had increased risk for subsequent ICU admission and reduced overall survival. The dose-related effect of GTs was confirmed in bacterial but not in fungal infections. Preliminary findings obtained from a subgroup of patients candidate to GTs revealed that levels of inflammatory response mediators increase in a dose-related manner after GTs, providing a possible explanation for the detrimental effect exerted by high-dose transfusions. GTs can constitute a valuable tool to improve the outcome of infections in neutropenic patients, provided that adequate recipient-tailored doses are supplied. Further investigations of the immunomodulatory effects of GTs are recommended.	[Teofili, Luciana; Valentini, Caterina Giovanna; Di Blasi, Roberta; Orlando, Nicoletta; Fianchi, Luana; Zini, Gina; Sica, Simona; De Stefano, Valerio; Pagano, Livio] Catholic Univ, Inst Hematol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Teofili, L (corresponding author), Catholic Univ, Inst Hematol, Rome, Italy.	luciana.teofili@unicatt.it	Valentini, Caterina Giovanna/J-3746-2018; Teofili, Luciana/K-7278-2016; pagano, livio/J-3020-2018; Orlando, Nicoletta N/P-5061-2017; sica, simona/AAC-3679-2020	Valentini, Caterina Giovanna/0000-0002-7022-5366; Teofili, Luciana/0000-0002-7214-1561; pagano, livio/0000-0001-8287-928X; Zini, Gina/0000-0003-0782-294X; Fianchi, Luana/0000-0002-7113-7202; sica, simona/0000-0003-2426-3465	"Centro di ricerca sulle cellule staminali emopoietiche e terapie cellulari" of Universita Cattolica del Sacro Cuore; Grant Linea D1	"Centro di ricerca sulle cellule staminali emopoietiche e terapie cellulari" of Universita Cattolica del Sacro Cuore; Grant Linea D1	The study was funded by "Centro di ricerca sulle cellule staminali emopoietiche e terapie cellulari" of Universita Cattolica del Sacro Cuore, and by Grant Linea D1 to Luciana Teofili and Livio Pagano.	BENSINGER WI, 1993, BLOOD, V81, P1883, DOI 10.1182/blood.V81.7.1883.1883; Blumberg N, 1996, SEMIN HEMATOL, V33, P329; Blumberg N, 2010, TRANSFUSION, V50, P2738, DOI 10.1111/j.1537-2995.2010.02748.x; BRECHER G, 1953, P SOC EXP BIOL MED, V84, P54; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Cata JP, 2013, BRIT J ANAESTH, V110, P690, DOI 10.1093/bja/aet068; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Estcourt LJ, 2015, COCHRANE DB SYST REV, V29; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Freifeld AG, 2011, CLIN INFECT DIS, V52, P427, DOI 10.1093/cid/ciq147; Gea-Banacloche J, 2013, HEMATOL-AM SOC HEMAT, P414, DOI 10.1182/asheducation-2013.1.414; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Italian Ministry of Health's, 2015, QUAL SAF BLOOD BLOOD; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Lannan KL, 2013, BLOOD CELL MOL DIS, V50, P61, DOI 10.1016/j.bcmd.2012.08.009; Legrand M, 2012, CRIT CARE MED, V40, P43, DOI 10.1097/CCM.0b013e31822b50c2; Marfin AA, 2015, J INTENSIVE CARE MED, V30, P79, DOI 10.1177/0885066613498045; Peters C, 1999, BRIT J HAEMATOL, V106, P689, DOI 10.1046/j.1365-2141.1999.01619.x; Price TH, 2000, BLOOD, V95, P3302, DOI 10.1182/blood.V95.11.3302.010k35_3302_3309; Price TH, 2015, BLOOD, V126, P2153, DOI 10.1182/blood-2015-05-645986; Roubinian NH, 2015, TRANSFUSION, V55, P1838, DOI 10.1111/trf.13021; Rutella S, 2003, CYTOTHERAPY, V5, P19, DOI 10.1080/14653240310000047; Rutella S, 1997, BONE MARROW TRANSPL, V20, P355, DOI 10.1038/sj.bmt.1700899; Sachs UJ, 2003, TRANSFUSION, V43, P1683, DOI 10.1111/j.0041-1132.2003.00568.x; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Seidel MG, 2008, BONE MARROW TRANSPL, V42, P679, DOI 10.1038/bmt.2008.237; Seidel MG, 2009, J PEDIAT HEMATOL ONC, V31, P166, DOI 10.1097/MPH.0b013e318196a6f9; Stanworth SJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005339; TALCOTT JA, 1988, ARCH INTERN MED, V148, P2561, DOI 10.1001/archinte.148.12.2561; Vamvakas EC, 1996, J CLIN APHERESIS, V11, P1; WINSTON DJ, 1982, ANN INTERN MED, V97, P509, DOI 10.7326/0003-4819-97-4-509; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	33	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159569	10.1371/journal.pone.0159569	http://dx.doi.org/10.1371/journal.pone.0159569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487075	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800034
J	Yamada, K; Adachi, T; Mibu, A; Nishigami, T; Motoyama, Y; Uematsu, H; Matsuda, Y; Sato, H; Hayashi, K; Cui, RZ; Takao, Y; Shibata, M; Iso, H				Yamada, Keiko; Adachi, Tomonori; Mibu, Akira; Nishigami, Tomohiko; Motoyama, Yasushi; Uematsu, Hironobu; Matsuda, Yoichi; Sato, Hitoaki; Hayashi, Kenichi; Cui, Renzhe; Takao, Yumiko; Shibata, Masahiko; Iso, Hiroyasu			Injustice Experience Questionnaire, Japanese Version: Cross-Cultural Factor-Structure Comparison and Demographics Associated with Perceived Injustice	PLOS ONE			English	Article							PAIN CATASTROPHIZING SCALE; ORGANIZATIONAL JUSTICE; PROSPECTIVE COHORT; SAMPLE-SIZE; VALIDATION; HEALTH; POPULATION; ADAPTATION; DISABILITY; UTILITY	Objective The Injustice Experience Questionnaire (IEQ) assesses injury-related perceived injustice. This study aimed to (1) develop a Japanese version (IEQ-J), (2) examine its factor structure, validity, and reliability, and (3) discover which demographic variable(s) positively contributed to prediction of IEQ-J scores. Methods Data from 71 patients (33 male, 38 female; age = 20+) with injury pain were employed to investigate factor structure by exploratory and confirmatory factor analyses. Concurrent validity was examined by Pearson correlation coefficients among the IEQ-J, Brief Pain Inventory (BPI), and Pain Catastrophizing Scale (PCS). Internal consistency was investigated by Cronbach's alpha, and test-retest reliability was indicated with intra-class correlations (ICCs) in 42 of 71 patients within four weeks. Relations between demographic variables and IEQ-J scores were examined by covariance analysis and linear regression models. Results IEQ-J factor structure differed from the original two-factor model. A three-factor model with Severity/irreparability, Blame/unfairness, and Perceived lack of empathy was extracted. The three-factor model showed goodness-of-fit with the data and sufficient reliability (Cronbach's alpha of 0.90 for total IEQ-J; ICCs = 0.96). Pearson correlation coefficients among IEQ-J, BPI, and PCS ranged from 0.38 to 0.73. Pain duration over a year (regression coefficient, 11.92, 95% CI; 5.95-17.89) and liability for injury on another (regression coefficient, 12.17, 95% CI; 6.38-17.96) predicted IEQ-J total scores. Conclusions This study evidenced the IEQ-J's sound psychometric properties. The three-factor model was the latter distinctive in the Japanese version. Pain duration over a year and injury liability by another statistically significantly increased IEQ-J scores.	[Yamada, Keiko; Cui, Renzhe; Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka, Japan; [Yamada, Keiko; Adachi, Tomonori; Nishigami, Tomohiko; Uematsu, Hironobu; Matsuda, Yoichi; Shibata, Masahiko] Osaka Univ Hosp, Ctr Pain Management, Suita, Osaka, Japan; [Adachi, Tomonori; Mibu, Akira; Shibata, Masahiko] Osaka Univ, Grad Sch Med, Dept Pain Med, Suita, Osaka, Japan; [Mibu, Akira] Tanabe Orthoped, Dept Rehabil, Osaka, Japan; [Nishigami, Tomohiko] Konan Womens Univ, Dept Nursing & Phys Therapy, Kobe, Hyogo, Japan; [Motoyama, Yasushi; Sato, Hitoaki; Takao, Yumiko] Kobe Univ, Grad Sch Med, Div Anesthesiol, Kobe, Hyogo, Japan; [Uematsu, Hironobu; Matsuda, Yoichi] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care Med, Suita, Osaka, Japan; [Hayashi, Kenichi] Keio Univ, Dept Math, Yokohama, Kanagawa, Japan	Osaka University; Osaka University; Osaka University; Kobe University; Osaka University; Keio University	Iso, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka, Japan.	iso@pbhel.med.osaka-u.ac.jp	Adachi, Tomonori/AFV-3638-2022	Adachi, Tomonori/0000-0002-6227-0802	Grants-in-Aid for Scientific Research [15K15950] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ARRINDELL WA, 1985, APPL PSYCH MEAS, V9, P165, DOI 10.1177/014662168500900205; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Boiger M, 2013, PERS SOC PSYCHOL B, V39, P540, DOI 10.1177/0146167213478201; Cho S, 2013, QUAL LIFE RES, V22, P1767, DOI 10.1007/s11136-012-0308-2; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Elovainio M, 2006, J PSYCHOSOM RES, V61, P271, DOI 10.1016/j.jpsychores.2006.02.018; Elovainio M, 2009, PSYCHOSOM MED, V71, P334, DOI 10.1097/PSY.0b013e3181960665; Ferrari R, 2015, CLIN RHEUMATOL, V34, P975, DOI 10.1007/s10067-014-2693-0; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iwaki R, 2012, PAIN MED, V13, P677, DOI 10.1111/j.1526-4637.2012.01353.x; Kennedy L, 2014, J OCCUP REHABIL, V24, P385, DOI 10.1007/s10926-013-9462-9; Kivimaki M, 2003, OCCUP ENVIRON MED, V60, P27, DOI 10.1136/oem.60.1.27; Kondo N, 2012, J EPIDEMIOL, V22, P2, DOI 10.2188/jea.JE20110116; MacCallum RC, 2001, MULTIVAR BEHAV RES, V36, P611, DOI 10.1207/S15327906MBR3604_06; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Monticone M, 2012, QUAL LIFE RES, V21, P1045, DOI 10.1007/s11136-011-0007-4; POLLARD CA, 1984, PERCEPT MOTOR SKILL, V59, P974, DOI 10.2466/pms.1984.59.3.974; Rodero B, 2012, J PSYCHOSOM RES, V73, P86, DOI 10.1016/j.jpsychores.2012.05.011; Ryan K., 1992, ANN ACAD MED, V23, P129; Sehn F, 2012, PAIN MED, V13, P1425, DOI 10.1111/j.1526-4637.2012.01492.x; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan MJL, 2012, CLIN J PAIN, V28, P484, DOI 10.1097/AJP.0b013e3182527d13; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Suren M, 2014, TURK J MED SCI, V44, P104, DOI 10.3906/sag-1206-67; Uki J, 1998, J PAIN SYMPTOM MANAG, V16, P364, DOI 10.1016/S0885-3924(98)00098-0; Xu X, 2015, PAIN PHYSICIAN, P1059; 2002, QUAL LIFE RES LIFE R, V11, P193	29	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160567	10.1371/journal.pone.0160567	http://dx.doi.org/10.1371/journal.pone.0160567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487288	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800087
J	Li, JR; Suzuki, T; Nishimura, H; Kishima, M; Maeda, S; Suzuki, H				Li, Jing-Ru; Suzuki, Takahiro; Nishimura, Hajime; Kishima, Mami; Maeda, Shiori; Suzuki, Harukazu			Asymmetric Regulation of Peripheral Genes by Two Transcriptional Regulatory Networks	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DOPAMINERGIC-NEURONS; DIFFERENTIATION; FIBROBLASTS; CARDIOMYOCYTES; MOUSE	Transcriptional regulatory network (TRN) reconstitution and deconstruction occur simultaneously during reprogramming; however, it remains unclear how the starting and targeting TRNs regulate the induction and suppression of peripheral genes. Here we analyzed the regulation using direct cell reprogramming from human dermal fibroblasts to monocytes as the platform. We simultaneously deconstructed fibroblastic TRN and reconstituted monocytic TRN; monocytic and fibroblastic gene expression were analyzed in comparison with that of fibroblastic TRN deconstruction only or monocytic TRN reconstitution only. Global gene expression analysis showed cross-regulation of TRNs. Detailed analysis revealed that knocking down fibroblastic TRN positively affected half of the upregulated monocytic genes, indicating that intrinsic fibroblastic TRN interfered with the expression of induced genes. In contrast, reconstitution of monocytic TRN showed neutral effects on the majority of fibroblastic gene downregulation. This study provides an explicit example that demonstrates how two networks together regulate gene expression during cell reprogramming processes and contributes to the elaborate exploration of TRNs.	[Li, Jing-Ru; Suzuki, Takahiro; Nishimura, Hajime; Kishima, Mami; Maeda, Shiori; Suzuki, Harukazu] RIKEN Yokohama Inst, Div Genom Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan	RIKEN	Suzuki, H (corresponding author), RIKEN Yokohama Inst, Div Genom Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	harukazu.suzuki@riken.jp	Suzuki, Takahiro/AAW-8509-2020	Suzuki, Takahiro/0000-0002-0972-6911	MEXT for RIKEN Center for Life Science Technologies	MEXT for RIKEN Center for Life Science Technologies	This work was supported by the research grant from MEXT for RIKEN Center for Life Science Technologies.	Batalov I, 2015, BIOMARK INSIGHTS, V10, P71, DOI 10.4137/BMI.S20050; Broccoli V, 2011, J MOL CELL BIOL, V3, P322, DOI 10.1093/jmcb/mjr029; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Coyne JA, 2006, SCIENCE, V313, DOI 10.1126/science.1126454; Cyranoski D, 2014, NATURE, V516, P162, DOI 10.1038/516162a; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laningschror P, 2013, BBA-MOL CELL RES, V1833, P1894, DOI 10.1016/j.bbamcr.2013.03.025; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Lian X, 2014, STEM CELL REP, V3, P323, DOI [10.1016/j.stemcr.2015.07.005, DOI 10.1016/J.STEMCR.2015.07.005]; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lizio M, 2015, FRONT GENET, V6, DOI [10.3389/faene.2015.00331, 10.3389/fgene.2015.00331]; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033474; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tomaru Y, 2014, NUCLEIC ACIDS RES, V42, P8905, DOI 10.1093/nar/gku567; Vierbuchen T, 2012, NATURE, V77, P7, DOI [10.1016/j.wneu.2011.11.002, DOI 10.1016/J.WNEU.2011.11.002]; Willenbring H, 2011, CELL STEM CELL, V9, P89, DOI 10.1016/j.stem.2011.07.009; Yoo J, 2015, BIOMATERIALS, V45, P36, DOI 10.1016/j.biomaterials.2014.12.049; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3	38	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160459	10.1371/journal.pone.0160459	http://dx.doi.org/10.1371/journal.pone.0160459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483142	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110700047
J	Lim, EA; Lee, H; Bae, E; Lim, J; Shin, YK; Choi, SE				Lim, Eun-A; Lee, Haeyoung; Bae, Eunmi; Lim, Jaeok; Shin, Young Kee; Choi, Sang-Eun			Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea	PLOS ONE			English	Article							RANDOMIZED PHASE-II; COST-EFFECTIVENESS ANALYSIS; DOUBLE-BLIND; 2ND-LINE ERLOTINIB; PLUS ERLOTINIB; CISPLATIN PLUS; OPEN-LABEL; TRIAL; CHEMOTHERAPY; GEMCITABINE	Background As targeted therapy becomes increasingly important, diagnostic techniques for identifying targeted biomarkers have also become an emerging issue. The study aims to evaluate the cost-effectiveness of treating patients as guided by epidermal growth factor receptor (EGFR) mutation status compared with a no-testing strategy that is the current clinical practice in South Korea. Methods A cost-utility analysis was conducted to compare an EGFR mutation testing strategy with a no-testing strategy from the Korean healthcare payer's perspective. The study population consisted of patients with stage 3b and 4 lung adenocarcinoma. A decision tree model was employed to select the appropriate treatment regimen according to the results of EGFR mutation testing and a Markov model was constructed to simulate disease progression of advanced non-small cell lung cancer. The length of a Markov cycle was one month, and the time horizon was five years (60 cycles). Results In the base case analysis, the testing strategy was a dominant option. Quality-adjusted lifey-ears gained (QALYs) were 0.556 and 0.635, and total costs were $23,952 USD and $23,334 USD in the no-testing and testing strategy respectively. The sensitivity analyses showed overall robust results. The incremental cost-effectiveness ratios (ICERs) increased when the number of patients to be treated with erlotinib increased, due to the high cost of erlotinib. Conclusion Treating advanced adenocarcinoma based on EGFR mutation status has beneficial effects and saves the cost compared to no testing strategy in South Korea. However, the cost-effectiveness of EGFR mutation testing was heavily affected by the cost-effectiveness of the targeted therapy.	[Lim, Eun-A; Lee, Haeyoung; Bae, Eunmi; Lim, Jaeok; Choi, Sang-Eun] Korea Univ, Coll Pharm, Sejong, South Korea; [Shin, Young Kee] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Korea University; Seoul National University (SNU)	Choi, SE (corresponding author), Korea Univ, Coll Pharm, Sejong, South Korea.	sechoi@korea.ac.kr	Shin, Young Kee/C-8929-2011	Shin, Young Kee/0000-0003-0896-718X	R&D Program for Society of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2013M3C8A1075908]	R&D Program for Society of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by the R&D Program for Society of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (Grant number: 2013M3C8A1075908). Financial support from any other companies was not provided.	Aerts JG, 2013, ANN ONCOL, V24, P2860, DOI 10.1093/annonc/mdt341; [Anonymous], 2016, EGFR RGQ PCR KIT HAN, V3, P29; [Anonymous], 2014, NONSM CELL LUNG CANC, V11, P12; [Anonymous], 2016, ERL 1 LIN TREATM LOC, V3, P29; [Anonymous], 2016, IN VITR DIAGN COMP D, V3, P29; Benlloch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089518; Borget I, 2012, EUR RESPIR J, V39, P172, DOI 10.1183/09031936.00201210; Carlson JJ, 2009, VALUE HEALTH, V12, P20, DOI 10.1111/j.1524-4733.2008.00415.x; 최귀선, 2005, [Health Policy and Mangemnet, 보건행정학회지], V15, P1; Choi YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056011; Doyle S, 2008, LUNG CANCER, V62, P374, DOI 10.1016/j.lungcan.2008.03.019; Ellison G, 2013, J CLIN PATHOL, V66, P79, DOI 10.1136/jclinpath-2012-201194; Fang S, 2014, ONCOTARGETS THER, V7, P1185, DOI 10.2147/OTT.S63665; Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7; Gridelli C, 2007, LANCET ONCOL, V8, P500, DOI 10.1016/S1470-2045(07)70146-8; Groen HJM, 2013, ANN ONCOL, V24, P2382, DOI 10.1093/annonc/mdt212; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Hsu C, 2008, LUNG CANCER, V62, P334, DOI 10.1016/j.lungcan.2008.03.010; IPASS study, 2016, IPASS STUD, V3, P29; Janne PA, 2014, J THORAC ONCOL, V9, P126, DOI 10.1097/JTO.0000000000000037; Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694; Kelly K, 2012, J THORAC ONCOL, V7, P1041, DOI 10.1097/JTO.0b013e31824cc66c; Kim ST, 2012, LUNG CANCER, V75, P82, DOI 10.1016/j.lungcan.2011.05.022; Kim YJ, 2014, J CANCER RES CLIN, V140, P1567, DOI 10.1007/s00432-014-1688-1; Korean Medical Guideline Information Center (KoMGI), 2014, 2010 KOR MED GUID LU, V11, P12; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Lee DH, 2013, EUR J CANCER, V49, P3111, DOI 10.1016/j.ejca.2013.06.035; Lieberthal RD, 2013, PERS MED, V10, P139, DOI [10.2217/PME.13.7, 10.2217/pme.13.7]; Lopez-Rios F, 2013, J CLIN PATHOL, V66, P381, DOI 10.1136/jclinpath-2012-201240; Manegold C, 2012, ANN ONCOL, V23, P72, DOI 10.1093/annonc/mdr030; Mok TSK, 2009, J CLIN ONCOL, V27, P5080, DOI 10.1200/JCO.2008.21.5541; Mylonakis N, 2010, LUNG CANCER, V68, P240, DOI 10.1016/j.lungcan.2009.06.017; Nafees B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-84; Narita Y, 2015, LUNG CANCER, V90, P71, DOI 10.1016/j.lungcan.2015.07.006; Natale RB, 2011, J CLIN ONCOL, V29, P1059, DOI 10.1200/JCO.2010.28.5981; O'Donnell P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-210; Ontario Ministry of Health and Long-Term Care Medical Advisory Secretariat, 2011, EP GROWTH FACT REC M; Paz-Ares LG, 2012, J CLIN ONCOL, V30, P3084, DOI 10.1200/JCO.2011.39.7646; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Riley GF, 2009, MED CARE, V47, pS51, DOI 10.1097/MLR.0b013e31819c95aa; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Scagliotti GV, 2012, J CLIN ONCOL, V30, P2070, DOI 10.1200/JCO.2011.39.2993; Schremser K, 2015, PHARMACOECONOMICS, V33, P1215, DOI 10.1007/s40273-015-0305-8; Schuette WHW, 2013, CLIN LUNG CANCER, V14, P215, DOI 10.1016/j.cllc.2012.10.001; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Spigel DR, 2011, J CLIN ONCOL, V29, P2582, DOI 10.1200/JCO.2010.30.7678; Tabberer M, 2006, VALUE HEALTH, V9, pA298, DOI 10.1016/S1098-3015(10)63502-4; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055917; Westwood M, 2014, HEALTH TECHNOL ASSES, V18, pXVII, DOI [10.3310/hta18320, 10.3310/hta18620]; WHO, 2016, CANCER, V3, P29; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Zhang GZ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-38; Zhang XJ, 2013, RESPIROLOGY, V18, P131, DOI 10.1111/j.1440-1843.2012.02248.x; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	54	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160155	10.1371/journal.pone.0160155	http://dx.doi.org/10.1371/journal.pone.0160155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483001	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110700025
J	Xu, XX; Yin, ZP; Chen, JG; Wang, XQ; Peng, DY; Shangguan, XC				Xu, Xiaoxiang; Yin, Zhongping; Chen, Jiguang; Wang, Xiaoqiang; Peng, Dayong; Shangguan, Xinchen			De Novo Transcriptome Assembly and Annotation of the Leaves and Callus of Cyclocarya Paliurus (Bata1) Iljinskaja	PLOS ONE			English	Article							GENOME-WIDE CLASSIFICATION; LOOP-HELIX PROTEIN; RNA-SEQ; ALKALOID BIOSYNTHESIS; CHEMICAL-COMPOSITION; GENES; ENCODES; RICE; IDENTIFICATION; EXPRESSION	Cyclocarya Paliurus (Bata1) Iljinskaja contains various bioactive secondary metabolites especially in leaves, such as triterpenes, flavonoids, polysaccharides and alkaloids, and its leaves are widely used as an hyperglycemic tea in China. In the present paper, we sequenced the transcriptome of the leaves and callus of Cyclocarya Paliurus using Illumina Hiseq 4000 platform. After sequencing and de novo assembly, a total of 65,654 unigenes were generated with an N50 length of 1,244bp. Among them, 35,041 (53.37%) unigenes were annotated in NCBI Non-Redundant database, 19,453 (29.63%) unigenes were classified into Gene Ontology (GO) database, and 7,259 (11.06%) unigenes were assigned to Clusters of Orthologous Group (COG) categories. Furthermore, 11,697 (17.81%) unigenes were mapped onto 335 pathways in Kyoto Encyclopedia of Genes and Genomes (KEGG), among which 1,312 unigenes were identified to be involved in biosynthesis of secondary metabolites. In addition, a total of 11,247 putative simple sequence repeats (SSRs) were detected. This transcriptome dataset provides a comprehensive sequence resource for gene expression profiling, genetic diversity, evolution and further molecular genetics research on Cyclocarya Paliurus.	[Xu, Xiaoxiang; Yin, Zhongping; Chen, Jiguang; Peng, Dayong; Shangguan, Xinchen] Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Peoples R China; [Xu, Xiaoxiang; Yin, Zhongping; Chen, Jiguang] Jiangxi Agr Univ, Coll Food Sci & Engn, Nanchang 330045, Peoples R China; [Wang, Xiaoqiang] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300000, Peoples R China; [Wang, Xiaoqiang] Nankai Univ, Coll Pharm, Tianjin 300000, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Nankai University; Nankai University	Yin, ZP (corresponding author), Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang 330045, Peoples R China.; Yin, ZP (corresponding author), Jiangxi Agr Univ, Coll Food Sci & Engn, Nanchang 330045, Peoples R China.	yin_zhongping@163.com	Yin, Zhongping/GSJ-1685-2022	Xu, Xiaoxiang/0000-0002-1043-0640	Natural Science Foundation of PR China [31260368, 31460436]	Natural Science Foundation of PR China(National Natural Science Foundation of China (NSFC))	This work was funded by the Natural Science Foundation of PR China (No. 31260368; No. 31460436). ZP Yin received the funding.	[Anonymous], 2015, J Biol Chem, V290, P20104, DOI 10.1074/jbc.A109.026195; Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; [陈金华 CHEN Jin-hua], 2009, [食品工业科技, Science & Technology of Food Industry], P159; Chen J, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S15; Chen Jinhu, 2014, Int J Endocrinol, V2014, P203930, DOI 10.1155/2014/203930; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Fang SZ, 2006, SCI HORTIC-AMSTERDAM, V110, P305, DOI 10.1016/j.scienta.2006.06.031; Fang SZ, 2011, FOOD CHEM, V124, P1382, DOI 10.1016/j.foodchem.2010.07.095; Fukushima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129154; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Guo ChunLan, 2008, Acta Agriculturae Universitatis Jiangxiensis, V30, P275; Guo CL, 2006, ACTA AGR U JIANGXIEN, DOI 10.13836/j.jjau.2006055; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062922; He Y., 2012, PHARM CLIN RES, V20, P187, DOI DOI 10.3969/J.ISSN.1673-7806; Hu DN, 2009, HUBEI AGR SCI, DOI 10.14088/j.cnki.issn0439-8114.2009.06.055; Hu JP, 1996, GENETICS, V142, P1021; Hu LX, 2015, BMC GENOMICS, V16, DOI [10.1186/s12859-015-0583-3, 10.1186/s12864-015-1799-3]; Huang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-648; Ikegami A, 2007, PLANT SCI, V172, P1037, DOI 10.1016/j.plantsci.2007.02.010; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kurihara H, 2003, BIOSCI BIOTECH BIOCH, V67, P877, DOI 10.1271/bbb.67.877; Li Jun, 2006, Zhong Yao Cai, V29, P441; [李俊 Li Jun], 2005, [中药材, Journal of Chinese Medicinal Materials], V28, P1058; Li S, 2011, FITOTERAPIA, V82, P1081, DOI 10.1016/j.fitote.2011.07.002; Li SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132969; Li Tian JAU, 2013, ACTA AGR U JIANGXIEN, DOI 10.13836/j.jjau.2013184; [李婷婷 Li Tingting], 2015, [食品与机械, Food and Machinery], V31, P10; Li X., 2009, J SHIP SCI TECHNOL, V31, P31, DOI DOI 10.13836/J.JJAU.2009176; Liu MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1477-5; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Miao Qian, 2011, Bulletin of Botanical Research, V31, P323; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; [舒任庚 Shu Rengeng], 2006, [中药材, Journal of Chinese Medicinal Materials], V29, P1304; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Spies D, 2015, COMPUT STRUCT BIOTEC, V13, P469, DOI 10.1016/j.csbj.2015.08.004; Sun G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061157; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Todd AT, 2010, PLANT J, V62, P589, DOI 10.1111/j.1365-313X.2010.04186.x; Upadhyay S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-746; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xie JH, 2015, FOOD CHEM, V186, P97, DOI 10.1016/j.foodchem.2014.06.106; Xie JH, 2013, FOOD CHEM, V136, P1453, DOI 10.1016/j.foodchem.2012.09.078; Xie JH, 2010, J SCI FOOD AGR, V90, P1353, DOI 10.1002/jsfa.3935; Xie JH, 2010, FOOD CHEM, V119, P1626, DOI 10.1016/j.foodchem.2009.09.055; [谢明勇 XIE Mingyong], 2008, [食品与生物技术学报, Journal of Food Science and Biotechnology], V27, P113; Xie MY, 2006, EUR FOOD RES TECHNOL, V223, P202, DOI 10.1007/s00217-005-0173-0; Xie MY, 2004, CHINESE J ANAL CHEM, V32, P1053; Yamada Y, 2011, PLANT CELL PHYSIOL, V52, P1131, DOI 10.1093/pcp/pcr062; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Yi Xing, 2002, Zhongguo Zhongyao Zazhi, V27, P43; Yin ZhongPing, 2013, Scientia Silvae Sinicae, V49, P23; Yin ZP, 2013, BIOTECHNOL BIOPROC E, V18, P606, DOI 10.1007/s12257-012-0751-5; Yin ZhongPing, 2010, Acta Agriculturae Universitatis Jiangxiensis, V32, P373; Yin ZP, 2011, JOURNAL OF SHENZHEN, V28, P430; Yuan YX, 2009, PLANTA, V230, P1141, DOI 10.1007/s00425-009-1013-4; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; [张继业 ZHANG Jiye], 2007, [四川农业大学学报, Journal of Sichuan Agricultural University], V25, P82; Zhang J, 2010, FOOD CHEM, V119, P1491, DOI 10.1016/j.foodchem.2009.09.031; Zhang XD, 2015, INT J MOL SCI, V16, P11550, DOI 10.3390/ijms160511550; Zhou SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133312; 张晓琦, 2005, [中国中药杂志, China Journal of Chinese Materia Medica], V30, P791	77	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160279	10.1371/journal.pone.0160279	http://dx.doi.org/10.1371/journal.pone.0160279			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483006	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110700032
J	Hamatani, Y; Ishibashi-Ueda, H; Nagai, T; Sugano, Y; Kanzaki, H; Yasuda, S; Fujita, T; Kobayashi, J; Anzai, T				Hamatani, Yasuhiro; Ishibashi-Ueda, Hatsue; Nagai, Toshiyuki; Sugano, Yasuo; Kanzaki, Hideaki; Yasuda, Satoshi; Fujita, Tomoyuki; Kobayashi, Junjiro; Anzai, Toshihisa			Pathological Investigation of Congenital Bicuspid Aortic Valve Stenosis, Compared with Atherosclerotic Tricuspid Aortic Valve Stenosis and Congenital Bicuspid Aortic Valve Regurgitation	PLOS ONE			English	Article							TENASCIN-C; PROGRESSION; FIBROSIS; CALCIFICATION; INFILTRATION; INFLAMMATION; EXPRESSION; MOUSE	Background Congenital bicuspid aortic valve (CBAV) is the main cause of aortic stenosis (AS) in young adults. However, the histopathological features of AS in patients with CBAV have not been fully investigated. Methods and Results We examined specimens of aortic valve leaflets obtained from patients who had undergone aortic valve re/placement at our institution for severe AS with CBAV (n = 24, CBAV-AS group), severe AS with tricuspid aortic valve (n = 24, TAV-AS group), and severe aortic regurgitation (AR) with CBAV (n = 24, CBAV-AR group). We compared the histopathological features among the three groups. Pathological features were classified using semiquantitative methods (graded on a scale 0 to 3) by experienced pathologists without knowledge of the patients' backgrounds. The severity of inflammation, neovascularization, and calcium and cholesterol deposition did not differ between the CBAV-AS and TAV-AS groups, and these four parameters were less marked in the CBAV-AR group than in the CBAV-AS (all p< 0.01). Meanwhile, the grade of valvular fibrosis was greater in the CBAVAS group, compared with the TAV-AS and CBAV-AR groups (both p< 0.01). In AS patients, thickness of fibrotic lesions was greater on the aortic side than on the ventricular side (both p< 0.01). Meanwhile, thickness of fibrotic lesions was comparable between the aortic and ventricular sides in CBAV-AR patients (p = 0.35). Conclusions Valvular fibrosis, especially on the aortic side, was greater in patients with CBAV-AS than in those without, suggesting a difference in the pathogenesis of AS between CBAV and TAV.	[Hamatani, Yasuhiro; Nagai, Toshiyuki; Sugano, Yasuo; Kanzaki, Hideaki; Yasuda, Satoshi; Anzai, Toshihisa] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Fujita, Tomoyuki; Kobayashi, Junjiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Anzai, T (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Osaka, Japan.	anzai@ncvc.go.jp	Anzai, Toshihisa/J-2179-2015; Tomoyuki, Fujita/AAC-7464-2020	Anzai, Toshihisa/0000-0003-3319-4967; 	Japan Cardiovascular Research Foundation	Japan Cardiovascular Research Foundation	This work was supported by a grant from the Japan Cardiovascular Research Foundation (T.A.).	Aicher D, 2007, ANN THORAC SURG, V83, P1290, DOI 10.1016/j.athoracsur.2006.11.086; Akahori H, 2013, INT J CARDIOL, V167, P514, DOI 10.1016/j.ijcard.2012.01.053; Ankeny RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020969; Chan KL, 2001, AM J CARDIOL, V88, P690, DOI 10.1016/S0002-9149(01)01820-3; Cote N, 2013, PATHOBIOLOGY, V81, P15, DOI 10.1159/000350896; El Accaoui Ramzi N, 2014, Am J Physiol Heart Circ Physiol, V306, pH1302, DOI 10.1152/ajpheart.00392.2013; Fernandes SM, 2007, J AM COLL CARDIOL, V49, P2211, DOI 10.1016/j.jacc.2007.01.090; Furukawa H, 2015, ANN THORAC CARDIOVAS, V21, P314, DOI 10.5761/atcs.ra.15-00130; Goldbarg SH, 2007, J AM COLL CARDIOL, V50, P1205, DOI 10.1016/j.jacc.2007.06.024; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Kennedy JA, 2009, EUR J PHARMACOL, V602, P28, DOI 10.1016/j.ejphar.2008.11.029; Lee TC, 2000, CIRCULATION, V101, P2345, DOI 10.1161/01.CIR.101.20.2345; LINDROOS M, 1994, EUR HEART J, V15, P865; Mazzone A, 2004, J AM COLL CARDIOL, V43, P1670, DOI 10.1016/j.jacc.2003.12.041; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Moreno PR, 2011, J THORAC CARDIOV SUR, V142, P895, DOI 10.1016/j.jtcvs.2011.03.002; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Nishioka T, 2007, J CARDIOVASC PHARM, V49, P261, DOI 10.1097/FJC.0b013e318033dfd4; OLSON LJ, 1984, MAYO CLIN PROC, V59, P835, DOI 10.1016/S0025-6196(12)65618-3; Satta J, 2002, J AM COLL CARDIOL, V39, P96, DOI 10.1016/S0735-1097(01)01705-3; Shimojo N, 2015, HYPERTENSION, V66, P757, DOI 10.1161/HYPERTENSIONAHA.115.06004; Simmons CA, 2005, CIRC RES, V96, P792, DOI 10.1161/01.RES.0000161998.92009.64; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Soini Y, 2003, HUM PATHOL, V34, P756, DOI 10.1016/S0046-8177(03)00245-4; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Wang R, 2014, EXP THER MED, V7, P935, DOI 10.3892/etm.2014.1529; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Warren BA, 1997, PATHOLOGY, V29, P360, DOI 10.1080/00313029700169315; Weiss RM, 2013, CIRC RES, V113, P209, DOI 10.1161/CIRCRESAHA.113.300153; Yokokawa T, 2016, EUR J HEART FAIL, V18, P375, DOI 10.1002/ejhf.464	31	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160208	10.1371/journal.pone.0160208	http://dx.doi.org/10.1371/journal.pone.0160208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479126	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300032
J	Libert, Y; Dubruille, S; Borghgraef, C; Etienne, AM; Merckaert, I; Paesmans, M; Reynaert, C; Roos, M; Slachmuylder, JL; Vandenbossche, S; Bron, D; Razavi, D				Libert, Yves; Dubruille, Stephanie; Borghgraef, Cindy; Etienne, Anne-Marie; Merckaert, Isabelle; Paesmans, Marianne; Reynaert, Christine; Roos, Myriam; Slachmuylder, Jean-Louis; Vandenbossche, Sandrine; Bron, Dominique; Razavi, Darius			Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?	PLOS ONE			English	Article							ELDERLY-PATIENTS; MORTALITY; DEMENTIA; BREAST; MULTIDISCIPLINARY; INTERVENTION; PREVALENCE; PREDICTORS; TIREDNESS; MOBILITY	Introduction Dementia is a known predictor of shorter survival times in older cancer patients. However, no empirical evidence is available to determine how much a cognitive impairment shortens survival in older patients when cancer treatment is initiated. Purpose To longitudinally investigate how much a cognitive impairment detected at the initiation of cancer treatment influences survival of older patients during a two-year follow-up duration and to compare the predictive value of a cognitive impairment on patients survival with the predictive value of other vulnerabilities associated with older age. Methods Three hundred and fifty-seven consecutive patients (>= 65 years old) admitted for breast, prostate, or colorectal cancer surgeries were prospectively recruited. A cognitive impairment was assessed with the Montreal Cognitive Assessment (MoCA<26). Socio-demographic, disease-related, and geriatric vulnerabilities were assessed using validated tools. Univariate and subsequent multivariate Cox proportional hazards models stratified for diagnosis (breast/prostate cancer versus colorectal cancer) and disease status (metastatic versus non-metastatic) were used. Results A cognitive impairment was detected in 46% (n = 163) of patients. Survival was significantly influenced by a cognitive impairment (HR = 6.13; 95% confidence interval [CI] = 2.07-18.09; p = 0.001), a loss in instrumental autonomy (IADL <= 7)(HR = 3.06; 95% CI = 1.31-7.11; p = 0.009) and fatigue (Mob-T<5) (HR = 5.98; 95% CI = 2.47-14.44; p < 0.001). Conclusions During the two years following cancer treatment initiation, older patients with a cognitive impairment were up to six times more likely to die than patients without. Older patients should be screened for cognitive impairments at cancer treatment initiation to enable interventions to reduce morbidity and mortality. Further studies should address processes underlying the relationship between cognitive impairments and an increased risk of dying in older cancer patients.	[Libert, Yves; Dubruille, Stephanie; Borghgraef, Cindy; Merckaert, Isabelle; Slachmuylder, Jean-Louis; Razavi, Darius] Univ Libre Bruxelles, Fac Sci Psychol & Educ, Brussels, Belgium; [Libert, Yves; Dubruille, Stephanie; Borghgraef, Cindy; Merckaert, Isabelle; Paesmans, Marianne; Roos, Myriam; Vandenbossche, Sandrine; Bron, Dominique; Razavi, Darius] Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium; [Etienne, Anne-Marie] Univ Liege, Fac Sci Psychol & Educ, Liege, Belgium; [Reynaert, Christine] Catholic Univ Louvain, Serv Med Psychosomat, Clin Univ Mt Godinne, Yvoir, Belgium	Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles; University of Liege; Universite Catholique Louvain; Universite Catholique Louvain Hospital	Razavi, D (corresponding author), Univ Libre Bruxelles, Fac Sci Psychol & Educ, Brussels, Belgium.; Razavi, D (corresponding author), Univ Libre Bruxelles, Inst Jules Bordet, Brussels, Belgium.	drazavi@ulb.ac.be			National Cancer Plan of Belgium [NKP-24-005]; Centre de Psycho-Oncology (Training and Research Group) of Belgium; Institute Jules Bordet; University Libre de Bruxelles; University Catholique de Louvain; "Fonds National de la Recherche Scientifique - Section Televie" of Belgium	National Cancer Plan of Belgium; Centre de Psycho-Oncology (Training and Research Group) of Belgium; Institute Jules Bordet; University Libre de Bruxelles; University Catholique de Louvain; "Fonds National de la Recherche Scientifique - Section Televie" of Belgium(Fonds de la Recherche Scientifique - FNRS)	This research program was supported by the National Cancer Plan of Belgium 2009-2011; grant number: NKP-24-005 (Cindy Kenis and Pr. Hans Wildfires), the Centre de Psycho-Oncology (Training and Research Group) of Belgium, the Institute Jules Bordet, the University Libre de Bruxelles, the University Catholique de Louvain and by a grant provided by the "Fonds National de la Recherche Scientifique - Section Televie" of Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles TA, 2012, PSYCHO-ONCOLOGY, V21, P1141, DOI 10.1002/pon.3196; Amieva H, 2010, PSYCHOSOM MED, V72, P905, DOI 10.1097/PSY.0b013e3181f5e121; Anstey KJ, 2001, PSYCHOL AGING, V16, P3, DOI 10.1037//0882-7974.16.1.3; Avlund K, 1998, J CLIN EPIDEMIOL, V51, P323, DOI 10.1016/S0895-4356(97)00296-5; Balducci L, 2006, ONCOLOGY-NY, V20, P135; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COPELAND GP, 1991, BRIT J SURG, V78, P356; Dong YH, 2012, INT PSYCHOGERIATR, V24, P1749, DOI 10.1017/S1041610212001068; Dubruille S, 2015, J GERIATR ONCOL, V6, P362, DOI 10.1016/j.jgo.2015.07.006; Dubruille S, 2015, PSYCHO-ONCOLOGY, V24, P294, DOI 10.1002/pon.3636; Etgen T, 2010, AGEING RES REV, V9, P280, DOI 10.1016/j.arr.2010.01.003; Fieo RA, 2013, J AM GERIATR SOC, V61, P429, DOI 10.1111/jgs.12122; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; Guigoz Y, 1996, NUTR REV, V54, pS59; Gussekloo J, 1997, BRIT MED J, V315, P1053, DOI 10.1136/bmj.315.7115.1053; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Lange M, 2014, EUR J CANCER, V50, P2181, DOI 10.1016/j.ejca.2014.05.026; Lange M, 2014, CANCER TREAT REV, V40, P810, DOI 10.1016/j.ctrv.2014.03.003; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Louwman WJ, 2005, EUR J CANCER, V41, P779, DOI 10.1016/j.ejca.2004.12.025; Mandelblatt JS, 2014, J CLIN ONCOL, V32, P2617, DOI 10.1200/JCO.2014.55.1259; McLennan SN, 2011, J GERIATR PSYCH NEUR, V24, P33, DOI 10.1177/0891988710390813; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neuman HB, 2013, CANCER-AM CANCER SOC, V119, P639, DOI 10.1002/cncr.27765; Newman JC, 2015, JAMA INTERN MED, V175, P1459, DOI 10.1001/jamainternmed.2015.2159; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raji MA, 2008, ARCH INTERN MED, V168, P2033, DOI 10.1001/archinte.168.18.2033; RAZAVI D, 1990, BRIT J PSYCHIAT, V156, P79, DOI 10.1192/bjp.156.1.79; Rich MW, 1996, AM J MED, V101, P270, DOI 10.1016/S0002-9343(96)00172-6; Robb C, 2010, CRIT REV ONCOL HEMAT, V74, P218, DOI 10.1016/j.critrevonc.2009.07.002; Sheikh JI, 1986, GERIATRIC DEPRESSION; Stewart S, 1999, LANCET, V354, P1077, DOI 10.1016/S0140-6736(99)03428-5; SWAN GE, 1995, AM J EPIDEMIOL, V141, P32, DOI 10.1093/oxfordjournals.aje.a117342; Tsoi KKF, 2015, JAMA INTERN MED, V175, P1450, DOI 10.1001/jamainternmed.2015.2152; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159734	10.1371/journal.pone.0159734	http://dx.doi.org/10.1371/journal.pone.0159734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27479248	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110300017
J	Tanamai, VW; Seagle, BLL; Yeh, JY; Brady, B; Miller, CB; Sena, S; Dodge, J; Shahabi, S; Samuelson, R; Norwitz, ER; Luo, GY				Tanamai, Vaya W.; Seagle, Brandon-Luke L.; Yeh, Judy Y.; Brady, Bethany; Miller, Corrie B.; Sena, Salvador; Dodge, Jessica; Shahabi, Shohreh; Samuelson, Robert; Norwitz, Errol R.; Luo, Guoyang			Urine Protein/Creatinine Ratios during Labor: A Prospective Observational Study	PLOS ONE			English	Article							PROTEIN CREATININE RATIO; PREECLAMPSIA; WOMEN	Purpose To evaluate the utility of urine protein/creatinine ratio (uPCR) measurements among healthy parturients at term we performed a prospective cohort study at a community teaching hospital. Methods Serial urine samples were collected. Ninety-three women contributed 284 urine samples. uPCRs were determined. Multiple imputation and paired sampled analysis was performed when appropriate. Results Two-thirds (63/93) of women had at least one measured uPCR >= 0.3. One-third (31/93) had a uPCR >= 0.3 at admission, including 39.1%(9/23) of women not in labor. Median (IQR) uPCRs increased during labor and after delivery: latent phase/no labor, 0.15 (0.06-0.32); active phase, 0.29 (0.10-0.58); early postpartum, 0.45 (0.18-1.36) (all p < 0.04). Median uPCRs were significantly < 0.3 in the latent phase and significantly > 0.3 in the immediate postpartum period (p < 0.01). Women who labored before cesarean delivery had the highest early postpartum uPCRs: median (IQR) 1.16 (0.39-1.80). A negative urine dipstick protein result did not exclude uPCR >= 0.3. uPCRs were similar when compared by method of urine collection. Conclusion uPCR >= 0.3 is common among healthy women with uncomplicated pregnancies at term. uPCR increases during labor and is not a reliable measure of pathologic proteinuria at term or during the peripartum period.	[Tanamai, Vaya W.; Seagle, Brandon-Luke L.; Yeh, Judy Y.; Brady, Bethany; Miller, Corrie B.; Samuelson, Robert; Luo, Guoyang] Western Connecticut Hlth Network, Dept Obstet Gynecol & Reprod Sci, Danbury, CT 06810 USA; [Sena, Salvador; Dodge, Jessica] Western Connecticut Hlth Network, Dept Pathol & Lab Med, Danbury, CT USA; [Shahabi, Shohreh] Northwestern Univ, Feinberg Sch Med, Prentice Womens Hosp, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Norwitz, Errol R.] Tufts Med Ctr, Dept Obstet & Gynecol, Boston, MA USA; [Luo, Guoyang] Univ Connecticut, Sch Med, Dept Obstet & Gynecol, Farmington, CT 06269 USA	Northwestern University; Feinberg School of Medicine; Tufts Medical Center; University of Connecticut	Luo, GY (corresponding author), Western Connecticut Hlth Network, Dept Obstet Gynecol & Reprod Sci, Danbury, CT 06810 USA.; Luo, GY (corresponding author), Univ Connecticut, Sch Med, Dept Obstet & Gynecol, Farmington, CT 06269 USA.	luo@uchc.edu			Danbury Hospital Development Fund	Danbury Hospital Development Fund	Funded by the Danbury Hospital Development Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bhide A, 2015, ACTA OBSTET GYN SCAN, V94, P542, DOI 10.1111/aogs.12624; Chen BA, 2008, OBSTET GYNECOL, V112, P606, DOI 10.1097/AOG.0b013e3181827c89; DAVEY DA, 1988, AM J OBSTET GYNECOL, V158, P892, DOI 10.1016/0002-9378(88)90090-7; De Silva DA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-152; Evans W, 2000, J Matern Fetal Med, V9, P233; HIGBY K, 1994, AM J OBSTET GYNECOL, V171, P984, DOI 10.1016/S0002-9378(13)90019-3; Honaker J, 2011, J STAT SOFTW, V45, P1; Kohler M, 2015, ADV EXP MED BIOL, V845, P121, DOI 10.1007/978-94-017-9523-4_12; Lindheimer MD, 2010, OBSTET GYNECOL, V115, P365, DOI 10.1097/AOG.0b013e3181cb9644; Lynch PLM, 1998, CLIN CHEM, V44, P674; MORTON R, 1956, OBSTET GYNECOL, V7, P373; Osmundson SS, 2014, OBSTET GYNECOL, V124, P332, DOI 10.1097/AOG.0000000000000383; Papanna R, 2008, OBSTET GYNECOL, V112, P135, DOI 10.1097/AOG.0b013e3181778cfc; SMITH NA, 2010, AM J OBSTET GYNECOL, V203, pE1, DOI DOI 10.1016/J.AJ0G.2010.06.013; Verdonk K, 2014, BJOG-INT J OBSTET GY, V121, P1660, DOI 10.1111/1471-0528.12803; 2013, OBSTET GYNECOL, V122, P1122, DOI DOI 10.1097/01.AOG	17	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160453	10.1371/journal.pone.0160453	http://dx.doi.org/10.1371/journal.pone.0160453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479123	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300051
J	Job, JR; Myers, K; Naghshineh, K; Gill, SA				Job, Jacob R.; Myers, Kyle; Naghshineh, Koorosh; Gill, Sharon A.			Uncovering Spatial Variation in Acoustic Environments Using Sound Mapping	PLOS ONE			English	Article							ANTHROPOGENIC NOISE; TRAFFIC NOISE; BODY-SIZE; LANDSCAPE; BEHAVIOR; ECOLOGY; COMMUNICATION; PROPAGATION; HABITATS; ANURAN	Animals select and use habitats based on environmental features relevant to their ecology and behavior. For animals that use acoustic communication, the sound environment itself may be a critical feature, yet acoustic characteristics are not commonly measured when describing habitats and as a result, how habitats vary acoustically over space and time is poorly known. Such considerations are timely, given worldwide increases in anthropogenic noise combined with rapidly accumulating evidence that noise hampers the ability of animals to detect and interpret natural sounds. Here, we used microphone arrays to record the sound environment in three terrestrial habitats (forest, prairie, and urban) under ambient conditions and during experimental noise introductions. We mapped sound pressure levels (SPLs) over spatial scales relevant to diverse taxa to explore spatial variation in acoustic habitats and to evaluate the number of microphones needed within arrays to capture this variation under both ambient and noisy conditions. Even at small spatial scales and over relatively short time spans, SPLs varied considerably, especially in forest and urban habitats, suggesting that quantifying and mapping acoustic features could improve habitat descriptions. Subset maps based on input from 4, 8, 12 and 16 microphones differed slightly (< 2 dBA/pixel) from those based on full arrays of 24 microphones under ambient conditions across habitats. Map differences were more pronounced with noise introductions, particularly in forests; maps made from only 4-microphones differed more (> 4 dBA/pixel) from full maps than the remaining subset maps, but maps with input from eight microphones resulted in smaller differences. Thus, acoustic environments varied over small spatial scales and variation could be mapped with input from 4-8 microphones. Mapping sound in different environments will improve understanding of acoustic environments and allow us to explore the influence of spatial variation in sound on animal ecology and behavior.	[Job, Jacob R.; Gill, Sharon A.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Myers, Kyle; Naghshineh, Koorosh] Western Michigan Univ, Dept Mech & Aerosp Engn, Kalamazoo, MI 49008 USA; [Job, Jacob R.] Colorado State Univ, Fish & Wildlife Conservat Biol, Ft Collins, CO 80523 USA; [Myers, Kyle] Penn State Univ, Appl Res Lab, State Coll, PA 16804 USA	Western Michigan University; Western Michigan University; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Job, JR; Gill, SA (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.; Job, JR (corresponding author), Colorado State Univ, Fish & Wildlife Conservat Biol, Ft Collins, CO 80523 USA.	jrjob@rams.colostate.edu; sharon.gill@wmich.edu			National Science Foundation [IOS-1256799]; Western Michigan University Faculty Research and Creative Activities Award; Western Michigan University Graduate Student Research Fund; American Ornithologists' Union Research Award; Direct For Biological Sciences [1257699] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Western Michigan University Faculty Research and Creative Activities Award; Western Michigan University Graduate Student Research Fund; American Ornithologists' Union Research Award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation IOS-1256799 to SAG KN; Western Michigan University Faculty Research and Creative Activities Award to SAG; Western Michigan University Graduate Student Research Fund to JRJ; American Ornithologists' Union Research Award to JRJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio C, 2011, APPL ACOUST, V72, P599, DOI 10.1016/j.apacoust.2010.12.007; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bee MA, 2012, CURR OPIN NEUROBIOL, V22, P301, DOI 10.1016/j.conb.2011.12.014; Biedermann R, 2003, GLOBAL ECOL BIOGEOGR, V12, P381, DOI 10.1046/j.1466-822X.2003.00048.x; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Boersma HF, 1997, J ACOUST SOC AM, V101, P2104, DOI 10.1121/1.418141; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; Chen HL, 2015, BIOL CONSERV, V192, P315, DOI 10.1016/j.biocon.2015.10.003; Coelho J.B., 2005, P FOR AC BUD 2005 4, P1039; de Kluijver H., 2003, Computers, Environment and Urban Systems, V27, P85, DOI 10.1016/S0198-9715(01)00038-2; Dooling RJ, 2013, ANIMAL COMMUNICATION, P229, DOI [10.1007/978-3-642-41494-7_8, DOI 10.1007/978-3-642-41494-7_8]; Dooling RJ, 2007, THE EFFECTS OF HIGHW; Erbe C, 2012, J ACOUST SOC AM, V132, pEL423, DOI 10.1121/1.4758779; Gill SA, 2015, BEHAV ECOL, V26, P328, DOI 10.1093/beheco/aru219; Goutte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078020; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Merchan CI, 2013, SCI TOTAL ENVIRON, V449, P115, DOI 10.1016/j.scitotenv.2013.01.063; Ising H, 2000, NOISE HEALTH, V7, P7; King EA, 2009, APPL ACOUST, V70, P1116, DOI 10.1016/j.apacoust.2009.01.005; Kinsler LE, 1982, FUNDAMENTALS OF ACOU; Lellouch L, 2014, METHODS ECOL EVOL, V5, P495, DOI 10.1111/2041-210X.12178; Lengagne T, 2008, BIOL CONSERV, V141, P2023, DOI 10.1016/j.biocon.2008.05.017; Leonard ML, 2015, ANIM BEHAV, V109, P1, DOI 10.1016/j.anbehav.2015.07.036; Lord H, 1980, NOISE CONTROL FOR EN; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; McClure CJW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2290; McLaughlin KE, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0771; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P704, DOI 10.1111/j.2041-210X.2012.00209.x; Mennitt D, 2014, J ACOUST SOC AM, V135, P2746, DOI 10.1121/1.4870481; Merchant ND, 2015, METHODS ECOL EVOL, V6, P257, DOI 10.1111/2041-210X.12330; Murphy E, 2010, ENVIRON INT, V36, P290, DOI 10.1016/j.envint.2009.11.006; Murray CC, 2015, MAR POLICY, V58, P71, DOI 10.1016/j.marpol.2015.04.003; Pijanowski BC, 2011, BIOSCIENCE, V61, P203, DOI 10.1525/bio.2011.61.3.6; Proppe DS, 2013, GLOBAL CHANGE BIOL, V19, P1075, DOI 10.1111/gcb.12098; R Core Development Team, 2014, R A LANGUAGE AND ENV; Radford AN, 2014, BEHAV ECOL, V25, P1022, DOI [10.1093/beheco/aru029, 10.1093/beheco/art102]; Reichert MS, 2015, ANIM BEHAV, V103, P125, DOI 10.1016/j.anbehav.2015.02.020; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Ripmeester EAP, 2010, BEHAV ECOL SOCIOBIOL, V64, P409, DOI 10.1007/s00265-009-0857-8; Rolland RM, 2012, P ROY SOC LOND B BIO; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Shannon G, 2014, ANIM BEHAV, V94, P135, DOI 10.1016/j.anbehav.2014.06.004; Tarrero AI, 2008, APPL ACOUST, V69, P662, DOI 10.1016/j.apacoust.2007.01.007; Tucker MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1105, DOI 10.1111/geb.12194; TURNER FB, 1969, ECOLOGY, V50, P1076, DOI 10.2307/1936898; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Ware HE, 2015, P NATL ACAD SCI USA, V112, P12105, DOI 10.1073/pnas.1504710112; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; Wells KD, 2007, THE ECOLOGY AND BEHA; Wiens JA, 1989, LANDSCAPE ECOL, V3, P87, DOI 10.1007/BF00131172; Wiley R.H., 2013, ANIMAL COMMUNICATION, P7, DOI [10.1007/978-3-642-41494-7_2, DOI 10.1007/978-3-642-41494-7_2]; Wu CH, 2014, ANIM BEHAV, V90, P47, DOI 10.1016/j.anbehav.2014.01.006; Wu YH, 2013, PRECIS AGRIC, V14, P565, DOI 10.1007/s11119-013-9316-7	56	5	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159883	10.1371/journal.pone.0159883	http://dx.doi.org/10.1371/journal.pone.0159883			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467503	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100068
J	Timmermans, WMC; van Laar, JAM; van der Houwen, TB; Kamphuis, LSJ; Bartol, SJW; Lam, KH; Ouwendijk, RJ; Sparrow, MP; Gibson, PR; van Hagen, PM; van Zelm, MC				Timmermans, Wilhelmina M. C.; van Laar, Jan A. M.; van der Houwen, Tim B.; Kamphuis, Lieke S. J.; Bartol, Sophinus J. W.; Lam, King H.; Ouwendijk, Rob J.; Sparrow, Miles P.; Gibson, Peter R.; van Hagen, P. Martin; van Zelm, Menno C.			B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PERIPHERAL-BLOOD; MURINE MODEL; T-CELLS; IMMUNOGLOBULIN; SARCOIDOSIS; GRANULOMAS; SELECTION; LYMPHOCYTES; POPULATION	Background B-cell depletion can improve a variety of chronic inflammatory diseases, but does not appear beneficial for patients with Crohn's disease. Objective To elucidate the involvement of B cells in Crohn's disease, we here performed an 'in depth' analysis of intestinal and blood B-cells in this chronic inflammatory disease. Methods Patients with Crohn's disease were recruited to study B-cell infiltrates in intestinal biopsies (n = 5), serum immunoglobulin levels and the phenotype and molecular characteristics of blood B-cell subsets (n = 21). The effects of infliximab treatment were studied in 9 patients. Results Granulomatous tissue showed infiltrates of B lymphocytes rather than Ig-secreting plasma cells. Circulating transitional B cells and CD21(low) B cells were elevated. IgM memory B cells were reduced and natural effector cells showed decreased replication histories and somatic hypermutation (SHM) levels. In contrast, IgG and IgA memory B cells were normally present and their Ig gene transcripts carried increased SHM levels. The numbers of transitional and natural effector cells were normal in patients who responded clinically well to infliximab. Conclusions B cells in patients with Crohn's disease showed signs of chronic stimulation with localization to granulomatous tissue and increased molecular maturation of IgA and IgG. Therapy with TNF-alpha-blockers restored the defect in IgM memory B-cell generation and normalized transitional B-cell levels, making these subsets candidate markers for treatment monitoring. Together, these results suggest a chronic, aberrant B-cell response in patients with Crohn's disease, which could be targeted with new therapeutics that specifically regulate B-cell function.	[Timmermans, Wilhelmina M. C.; van Laar, Jan A. M.; van der Houwen, Tim B.; Kamphuis, Lieke S. J.; van Hagen, P. Martin] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Timmermans, Wilhelmina M. C.; van Laar, Jan A. M.; van der Houwen, Tim B.; Kamphuis, Lieke S. J.; Bartol, Sophinus J. W.; van Hagen, P. Martin; van Zelm, Menno C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Lam, King H.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Ouwendijk, Rob J.] Ikazia Hosp, Dept Gastroenterol, Rotterdam, Netherlands; [Sparrow, Miles P.; Gibson, Peter R.] Monash Univ, Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia; [Sparrow, Miles P.; Gibson, Peter R.] Alfred Hlth, Melbourne, Vic, Australia; [van Zelm, Menno C.] Monash Univ, Dept Pathol & Immunol, Melbourne, Vic, Australia	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Ikazia Hospital; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	van Zelm, MC (corresponding author), Erasmus MC, Dept Immunol, Rotterdam, Netherlands.; van Zelm, MC (corresponding author), Monash Univ, Dept Pathol & Immunol, Melbourne, Vic, Australia.	menno.vanzelm@monash.edu	van Zelm, Menno C/O-4404-2015	van Zelm, Menno C/0000-0003-4161-1919				Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Berkowska MA, 2014, LEUKEMIA, V28, P1560, DOI 10.1038/leu.2014.77; Berkowska MA, 2011, BLOOD; Berkowska MA, 2015, J IMMUNOL, V195, P1417, DOI 10.4049/jimmunol.1402708; Berkowska MA, 2014, J ALLERGY CLIN IMMUN, V134, P688, DOI 10.1016/j.jaci.2014.03.036; Blombery P, 2011, J CLIN ONCOL, V29, pE110, DOI 10.1200/JCO.2010.31.8899; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Chen HY, 2010, INT J EXP PATHOL, V91, P472, DOI 10.1111/j.1365-2613.2010.00732.x; CRABBE PA, 1965, LAB INVEST, V14, P235; Di Sabatino A, 2005, AM J GASTROENTEROL, V100, P1788, DOI 10.1111/j.1572-0241.2005.41939.x; Di Sabatino A, 2008, INFLAMM BOWEL DIS, V14, P591, DOI 10.1002/ibd.20374; GEBOES K, 1986, VIRCHOWS ARCH A, V409, P679, DOI 10.1007/BF00713433; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Heresbach D, 2005, GUT, V54, P215, DOI 10.1136/gut.2004.041715; HERMASZEWSKI RA, 1993, Q J MED, V86, P31; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jackson KJL, 2014, IMMUNOL CELL BIOL, V92, P729, DOI 10.1038/icb.2014.44; Janssen CEI, 2012, J ALLERGY CLIN IMMUN, V129, P1076, DOI 10.1016/j.jaci.2012.02.004; Kalina T, 2012, LEUKEMIA, V26, P1986, DOI 10.1038/leu.2012.122; Kamphuis LS, 2013, AM J RESP CRIT CARE, V187, P406, DOI 10.1164/rccm.201206-1024OC; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lee NS, 2011, CLIN VACCINE IMMUNOL, V18, P1306, DOI 10.1128/CVI.05118-11; LENNARDJONES JE, 1968, GASTROENTEROLOGY, V54, P1162; Li Z, 2015, INFLAMM BOWEL DIS, V21, P2787, DOI 10.1097/MIB.0000000000000554; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Neurath MF, 2012, GUT, V61, P1619, DOI 10.1136/gutjnl-2012-302830; Nishida A, 2014, METHODS MOL BIOL, V1190, P227, DOI 10.1007/978-1-4939-1161-5_16; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Papadakis KA, 2003, GASTROENTEROLOGY, V124, P583, DOI 10.1053/gast.2003.50081; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Rakhmanov M, 2010, BLOOD, V116, P3682, DOI 10.1182/blood-2010-05-285585; Rogosnitzky M, 2012, AUTOIMMUN REV, V12, P275, DOI 10.1016/j.autrev.2012.04.006; Saussine A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043588; SIEBER G, 1984, GUT, V25, P1255, DOI 10.1136/gut.25.11.1255; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Sweiss NJ, 2014, EUR RESPIR J, V43, P1525, DOI 10.1183/09031936.00224513; Uduman M, 2011, NUCLEIC ACIDS RES, V39, pW499, DOI 10.1093/nar/gkr413; van Schaik FDM, 2013, GUT, V62, P683, DOI 10.1136/gutjnl-2012-302717; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; van Zelm MC, 2014, IMMUNOL CELL BIOL, V92, P645, DOI 10.1038/icb.2014.48; van Zelm MC, 2014, J ALLERGY CLIN IMMUN, V134, P135, DOI 10.1016/j.jaci.2013.11.015; Verstegen RHJ, 2014, J ALLERGY CLIN IMMUN, V134, P1346, DOI 10.1016/j.jaci.2014.07.015; Wehr C, 2004, CLIN IMMUNOL, V113, P161, DOI 10.1016/j.clim.2004.05.010; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457	51	27	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160103	10.1371/journal.pone.0160103	http://dx.doi.org/10.1371/journal.pone.0160103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27468085	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100112
J	Wu, K; Hoy, MA				Wu, Ke; Hoy, Marjorie A.			The Glutathione-S-Transferase, Cytochrome P450 and Carboxyl/Cholinesterase Gene Superfamilies in Predatory Mite Metaseiulus occidentalis	PLOS ONE			English	Article							INSECTICIDE-RESISTANT STRAIN; GENETICALLY-IMPROVED STRAINS; FUNCTIONAL-CHARACTERIZATION; MOLECULAR EVOLUTION; ACARI PHYTOSEIIDAE; POINT MUTATIONS; BIOLOGICAL-CONTROL; NESBITT ACARINA; DDT RESISTANCE; EXPRESSION	Pesticide-resistant populations of the predatory mite Metaseiulus (= Typhlodromus or Galendromus) occidentalis (Arthropoda: Chelicerata: Acari: Phytoseiidae) have been used in the biological control of pest mites such as phytophagous Tetranychus urticae. However, the pesticide resistance mechanisms inM. occidentalis remain largely unknown. In other arthropods, members of the glutathione-S-transferase (GST), cytochrome P450 (CYP) and carboxyl/cholinesterase (CCE) gene superfamilies are involved in the diverse biological pathways such as the metabolism of xenobiotics (e.g. pesticides) in addition to hormonal and chemosensory processes. In the current study, we report the identification and initial characterization of 123 genes in the GST, CYP and CCE superfamilies in the recently sequenced M. occidentalis genome. The gene count represents a reduction of 35% compared to T. urticae. The distribution of genes in the GST and CCE superfamilies inM. occidentalis differs significantly from those of insects and resembles that of T. urticae. Specifically, we report the presence of the Mu class GSTs, and the J' and J" clade CCEs that, within the Arthropoda, appear unique to Acari. Interestingly, the majority of CCEs in the J' and J" clades contain a catalytic triad, suggesting that they are catalytically active. They likely represent two Acarispecific CCE clades that may participate in detoxification of xenobiotics. The current study of genes in these superfamilies provides preliminary insights into the potential molecular components that may be involved in pesticide metabolism as well as hormonal/chemosensory processes in the agriculturally important M. occidentalis.	[Wu, Ke; Hoy, Marjorie A.] Univ Florida, Dept Entomol & Nematol, POB 11620, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Wu, K (corresponding author), Univ Florida, Dept Entomol & Nematol, POB 11620, Gainesville, FL 32611 USA.	kewu@ufl.edu		Wu, Ke/0000-0002-4438-1517	Davies, Fischer and Eckes Endowment in Biological Control	Davies, Fischer and Eckes Endowment in Biological Control	This research was supported in part by the Davies, Fischer and Eckes Endowment in Biological Control to MAH.	ALDRIDGE WN, 1950, BIOCHEM J, V46, P451, DOI 10.1042/bj0460451; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bajda S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2157-1; Baldwin WS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-169; Bass C, 2013, P NATL ACAD SCI USA, V110, P19460, DOI 10.1073/pnas.1314122110; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Board PG, 1997, BIOCHEM J, V328, P929; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Cassanelli S, 2015, BIOL CONTROL, V90, P75, DOI 10.1016/j.biocontrol.2015.05.015; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Danielson PB, 1997, P NATL ACAD SCI USA, V94, P10797, DOI 10.1073/pnas.94.20.10797; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; David JP, 2006, INSECT BIOCHEM MOLEC, V36, P410, DOI 10.1016/j.ibmb.2006.02.004; Demaeght P, 2013, INSECT BIOCHEM MOLEC, V43, P544, DOI 10.1016/j.ibmb.2013.03.007; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; Enayati AA, 2010, PESTIC BIOCHEM PHYS, V97, P243, DOI 10.1016/j.pestbp.2010.03.003; Feyereisen R., 2005, P1; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; FIELD RP, 1985, ENTOMOL EXP APPL, V38, P113, DOI 10.1007/BF00361921; FIELD RP, 1986, HILGARDIA, V54, P1; FIELD RP, 1978, AUST J ZOOL, V26, P519, DOI 10.1071/ZO9780519; FLAHERTY DL, 1970, HILGARDIA, V40, P267, DOI 10.3733/hilg.v40n10p267; Fournier D, 2005, CHEM-BIOL INTERACT, V157, P257, DOI 10.1016/j.cbi.2005.10.040; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; GOTOH O, 1992, J BIOL CHEM, V267, P83; GRANT DF, 1992, MOL GEN GENET, V234, P169, DOI 10.1007/BF00283836; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Hanna R, 1991, BIOL CONTROL, V1, P51, DOI 10.1016/1049-9644(91)90101-5; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HEADLEY JC, 1987, J ECON ENTOMOL, V80, P555, DOI 10.1093/jee/80.3.555; HOY MA, 1985, ANNU REV ENTOMOL, V30, P345, DOI 10.1146/annurev.en.30.010185.002021; Hoy MA, 2016, GENOME BIOL EVOL, V8, P1762, DOI 10.1093/gbe/evw048; Hoy MA, 2013, EXP APPL ACAROL, V59, P283, DOI 10.1007/s10493-012-9603-4; HOYT SC, 1969, J ECON ENTOMOL, V62, P74, DOI 10.1093/jee/62.1.74; Hu XG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/498957; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Itokawa K, 2011, INSECT BIOCHEM MOLEC, V41, P503, DOI 10.1016/j.ibmb.2011.04.002; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khajehali J, 2010, PEST MANAG SCI, V66, P220, DOI 10.1002/ps.1884; Kwon DH, 2010, INSECT MOL BIOL, V19, P195, DOI 10.1111/j.1365-2583.2009.00958.x; Kwon DH, 2015, PESTIC BIOCHEM PHYS, V121, P97, DOI 10.1016/j.pestbp.2014.12.011; Kwon DH, 2012, INSECT BIOCHEM MOLEC, V42, P212, DOI 10.1016/j.ibmb.2011.12.003; Kwon DH, 2010, PESTIC BIOCHEM PHYS, V96, P36, DOI 10.1016/j.pestbp.2009.08.013; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; Maitra S, 2000, GENE, V248, P147, DOI 10.1016/S0378-1119(00)00129-3; MCMURTRY JA, 1970, HILGARDIA, V40, P331, DOI 10.3733/hilg.v40n11p331; Meng F., 2014, J CHEM, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0093100; Morel F, 2011, DRUG METAB REV, V43, P281, DOI 10.3109/03602532.2011.556122; Mounsey KE, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-43; MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051; MUTERO A, 1994, P NATL ACAD SCI USA, V91, P5922, DOI 10.1073/pnas.91.13.5922; Nelson D.R., 2004, METHODS MOL BIOL, V320, P1; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0474; Nelson David R., 2009, Human Genomics, V4, P59; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Oakeshott JG, 1999, BIOESSAYS, V21, P1031; Pasay C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000354; Pavlidi N, 2015, PESTIC BIOCHEM PHYS, V121, P53, DOI 10.1016/j.pestbp.2015.01.009; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Pomerantz AF, 2015, EXP APPL ACAROL, V65, P17, DOI 10.1007/s10493-014-9852-5; Pridgeon JW, 2003, GENE, V314, P157, DOI 10.1016/S0378-1119(03)00725-X; Ranson H., 2005, P383; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Reddy BPN, 2011, COMPUT BIOL CHEM, V35, P114, DOI 10.1016/j.compbiolchem.2011.03.004; Rewitz KF, 2007, INSECT BIOCHEM MOLEC, V37, P741, DOI 10.1016/j.ibmb.2007.02.012; Riga M, 2015, INSECT BIOCHEM MOLEC, V65, P91, DOI 10.1016/j.ibmb.2015.09.004; Riga M, 2014, INSECT BIOCHEM MOLEC, V46, P43, DOI 10.1016/j.ibmb.2014.01.006; Rogers ME, 1999, J EXP BIOL, V202, P1625; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROUSH RT, 1982, J ECON ENTOMOL, V75, P304, DOI 10.1093/jee/75.2.304; Sabourault C, 2001, INSECT MOL BIOL, V10, P609, DOI 10.1046/j.0962-1075.2001.00303.x; Salman SY, 2015, PESTIC BIOCHEM PHYS, V122, P96, DOI 10.1016/j.pestbp.2014.12.014; Sato ME, 2007, PESTIC BIOCHEM PHYS, V88, P337, DOI 10.1016/j.pestbp.2007.01.010; Scharf ME, 2001, INSECT MOL BIOL, V10, P139, DOI 10.1046/j.1365-2583.2001.00248.x; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Tirello P, 2012, EXP APPL ACAROL, V57, P53, DOI 10.1007/s10493-012-9536-y; Van Leeuwen T, 2016, ANNU REV ENTOMOL, V61, P475, DOI 10.1146/annurev-ento-010715-023907; Van Leeuwen T, 2015, PESTIC BIOCHEM PHYS, V121, P12, DOI 10.1016/j.pestbp.2014.12.009; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Vontas JG, 2002, INSECT MOL BIOL, V11, P329, DOI 10.1046/j.1365-2583.2002.00343.x; Vontas JG, 2000, INSECT MOL BIOL, V9, P655, DOI 10.1046/j.1365-2583.2000.00228.x; Wan H, 2014, PEST MANAG SCI, V70, P1048, DOI 10.1002/ps.3645; Wei SH, 2001, INSECT BIOCHEM MOLEC, V31, P1145, DOI 10.1016/S0965-1748(01)00059-5; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Wu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144291; Wu K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110874; Wu K, 2014, EXP APPL ACAROL, V63, P171, DOI 10.1007/s10493-014-9772-4; Yamamoto K, 2009, PESTIC BIOCHEM PHYS, V94, P30, DOI 10.1016/j.pestbp.2009.02.008; Yan HR, 2012, J INSECT PHYSIOL, V58, P782, DOI 10.1016/j.jinsphys.2012.02.003; Yu QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-553; Yu XL, 2012, COMP BIOCHEM PHYS B, V161, P356, DOI 10.1016/j.cbpb.2011.12.009; Zhang JQ, 2013, CHEMOSPHERE, V93, P1207, DOI 10.1016/j.chemosphere.2013.06.081; Zimmer CT, 2014, INSECT BIOCHEM MOLEC, V45, P18, DOI 10.1016/j.ibmb.2013.11.008	106	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160009	10.1371/journal.pone.0160009	http://dx.doi.org/10.1371/journal.pone.0160009			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467523	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100088
J	Zhang, QM; Morgan, SP; O'Shea, P; Mather, ML				Zhang, Qimei; Morgan, Stephen P.; O'Shea, Paul; Mather, Melissa L.			Ultrasound Induced Fluorescence of Nanoscale Liposome Contrast Agents	PLOS ONE			English	Article							TRANSBILAYER MOVEMENT; PHASE-TRANSITION; IN-VIVO; PYRENE; MICROBUBBLES; VESICLES; PROBES; PHOSPHOLIPIDS	A new imaging contrast agent is reported that provides an increased fluorescent signal upon application of ultrasound (US). Liposomes containing lipids labelled with pyrene were optically excited and the excimer fluorescence emission intensity was detected in the absence and presence of an ultrasound field using an acousto-fluorescence setup. The acousto-fluorescence dynamics of liposomes containing lipids with pyrene labelled on the fatty acid tail group (PyPC) and the head group (PyPE) were compared. An increase in excimer emission intensity following exposure to US was observed for both cases studied. The increased intensity and time constants were found to be different for the PyPC and PyPE systems, and dependent on the applied US pressure and exposure time. The greatest change in fluorescence intensity (130%) and smallest rise time constant (0.33 s) are achieved through the use of PyPC labelled liposomes. The mechanism underlying the observed increase of the excimer emission intensity in PyPC labelled liposomes is proposed to arise from the "wagging" of acyl chains which involves fast response and requires lower US pressure. This is accompanied by increased lipid lateral diffusivity at higher ultrasound pressures, a mechanism that is also active in the PyPE labelled liposomes.	[Zhang, Qimei; Morgan, Stephen P.; Mather, Melissa L.] Univ Nottingham, Adv Opt Grp, Fac Engn, Nottingham, England; [O'Shea, Paul] Univ Nottingham, Sch Life Sci, Cell Biophys Grp, Nottingham, England; [Mather, Melissa L.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England	University of Nottingham; University of Nottingham; Keele University	Mather, ML (corresponding author), Univ Nottingham, Adv Opt Grp, Fac Engn, Nottingham, England.; Mather, ML (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	m.mather@keele.ac.uk		Zhang, Qimei/0000-0001-5811-8034; Mather, Melissa/0000-0002-5551-1321; O'Shea, paul/0000-0001-9313-8313; Morgan, Stephen/0000-0003-4069-3801	China Scholarship Council; Career Acceleration Fellowship from the Engineering and Physical Sciences Research Council [EP/J001953/1]; National Centre for the Replacement, Refinement and Reduction of Animals in Research [NC/L00187X/1]; Engineering and Physical Sciences Research Council [EP/J017566/1]; BBSRC [BB/F004826/1] Funding Source: UKRI; EPSRC [EP/J001953/2, EP/J017566/1, EP/J001953/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F004826/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J001953/2, EP/J001953/1] Funding Source: researchfish; National Centre for the Replacement [NC/L00187X/1] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Career Acceleration Fellowship from the Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Centre for the Replacement	QZ is partially funded by the China Scholarship Council (http://en.csc.edu.cn/). MLM is supported by a Career Acceleration Fellowship from the Engineering and Physical Sciences Research Council (EP/J001953/1, https://www.epsrc.ac.uk/). SPM is supported by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC/L00187X/1, https://www.nc3rs.org.uk/) and PO is supported by the Engineering and Physical Sciences Research Council (EP/J017566/1, https://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102; Benchimol MJ, 2013, SOFT MATTER, V9, P2384, DOI 10.1039/c2sm26900g; Castile JD, 1999, INT J PHARM, V188, P87, DOI 10.1016/S0378-5173(99)00207-0; Cheng BB, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2280997; COMBS CA, 2010, CURRENT PROTOCOLS NE, V50, P1; DAEMS D, 1985, EUR BIOPHYS J BIOPHY, V12, P97, DOI 10.1007/BF00260432; Dayton PA, 2006, MOL IMAGING, V5, P160, DOI 10.2310/7290.2006.00019; Deshpande N, 2010, CLIN RADIOL, V65, P567, DOI 10.1016/j.crad.2010.02.013; Ducros N, 2011, IRBM, V32, P243, DOI 10.1016/j.irbm.2011.04.001; Hillman EMC, 2011, PHILOS T R SOC A, V369, P4620, DOI 10.1098/rsta.2011.0264; Hillman EMC, 2009, LASER PHOTONICS REV, V3, P159, DOI 10.1002/lpor.200810031; Huynh NT, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076008; Immordino ML, 2006, INT J NANOMED, V1, P297; Jiao LJ, 2010, ORG BIOMOL CHEM, V8, P2517, DOI 10.1039/c001068e; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; Johns LD, 2002, J ATHL TRAINING, V37, P293; JOHNSON ID, 1991, ANAL BIOCHEM, V198, P228, DOI 10.1016/0003-2697(91)90418-S; Kobayashi M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364600; Kulkarni PR, 2011, INT J CURR PHARM RES, V3, P10; Lai PX, 2013, LASER PHYS LETT, V10, DOI 10.1088/1612-2011/10/7/075604; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Lehrer S S, 1995, Subcell Biochem, V24, P115; Lin YT, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681378; Liu J, 2004, J AM CHEM SOC, V126, P8376, DOI 10.1021/ja048245p; Liu Y, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.036012; Liu Y, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.085005; Liu Y, 2012, INT J OPT, V2012, DOI 10.1155/2012/260709; Maenpaa K, 2009, SCI TOTAL ENVIRON, V407, P2666, DOI 10.1016/j.scitotenv.2009.01.019; Makrigiorgos GM, 1997, J BIOCHEM BIOPH METH, V35, P23, DOI 10.1016/S0165-022X(97)00020-1; Marks DL, 2008, HISTOCHEM CELL BIOL, V130, P819, DOI 10.1007/s00418-008-0509-5; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Muller P, 2000, CHEM PHYS LIPIDS, V106, P89, DOI 10.1016/S0009-3084(00)00134-1; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; Ozawa T, 2013, ANAL CHEM, V85, P590, DOI 10.1021/ac3031724; Paul S, 2014, COMPUT MECH, V53, P413, DOI 10.1007/s00466-013-0962-4; Pei YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04690; Rao JH, 2007, CURR OPIN BIOTECH, V18, P17, DOI 10.1016/j.copbio.2007.01.003; Richardson ES, 2007, BIOPHYS J, V93, P4100, DOI 10.1529/biophysj.107.104042; SASSAROLI M, 1990, BIOPHYS J, V57, P281, DOI 10.1016/S0006-3495(90)82530-3; Schutt CE, 2014, SMALL, V10, P3316, DOI 10.1002/smll.201302786; Si K, 2012, NAT PHOTONICS, V6, P657, DOI [10.1038/nphoton.2012.205, 10.1038/NPHOTON.2012.205]; Sundararajan V., 2011, COMPUTATIONAL MODELL, P105; Swerdlow AJ, 2010, HLTH EFFECTS EXPOSUR; Traikia M, 2000, EUR BIOPHYS J BIOPHY, V29, P184, DOI 10.1007/s002490000077; Valeur B., 2002, MOL FLUORESCENCE PRI, P94; VAUHKONEN M, 1990, BIOPHYS J, V57, P291, DOI 10.1016/S0006-3495(90)82531-5; Wang YM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1925; Yang J, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4867385; Yuan BH, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737211	49	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159742	10.1371/journal.pone.0159742	http://dx.doi.org/10.1371/journal.pone.0159742			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467748	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000381516100051
J	Maurya, AK; Vinayak, M				Maurya, Akhilendra Kumar; Vinayak, Manjula			PI-103 and Quercetin Attenuate PI3K-AKT Signaling Pathway in T-Cell Lymphoma Exposed to Hydrogen Peroxide	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; LYMPHOBLASTIC-LEUKEMIA CELLS; HUMAN CANCER; ENERGY-METABOLISM; EPITHELIAL-CELLS; IN-VIVO; AKT; ACTIVATION; SURVIVAL; THERAPY	Phosphatidylinositol 3 kinase-protein kinase B (PI3K-AKT) pathway has been considered as major drug target site due to its frequent activation in cancer. AKT regulates the activity of various targets to promote tumorigenesis and metastasis. Accumulation of reactive oxygen species (ROS) has been linked to oxidative stress and regulation of signaling pathways for metabolic adaptation of tumor microenvironment. Hydrogen peroxide (H2O2) in this context is used as ROS source for oxidative stress preconditioning. Antioxidants are commonly considered to be beneficial to reduce detrimental effects of ROS and are recommended as dietary supplements. Quercetin, a ubiquitous bioactive flavonoid is a dietary component which has attracted much of interest due to its potential health-promoting effects. Present study is aimed to analyze PI3K-AKT signaling pathway in H2O2 exposed Dalton's lymphoma ascite (DLA) cells. Further, regulation of PI3K-AKT pathway by quercetin as well as PI-103, an inhibitor of PI3K was analyzed. Exposure of H2O2 (1mM H2O2 for 30min) to DLA cells caused ROS accumulation and resulted in increased phosphorylation of PI3K and downstream proteins PDK1 and AKT (Ser-473 and Thr-308), cell survival factors BAD and ERK1/2, as well as TNFR1. However, level of tumor suppressor PTEN was declined. Both PI-103 & quercetin suppressed the enhanced level of ROS and significantly down-regulated phosphorylation of AKT, PDK1, BAD and level of TNFR1 as well as increased the level of PTEN in H2O2 induced lymphoma cells. The overall result suggests that quercetin and PI3K inhibitor PI-103 attenuate PI3K-AKT pathway in a similar mechanism.	[Maurya, Akhilendra Kumar; Vinayak, Manjula] Banaras Hindu Univ, Ctr Adv Study Zool, Inst Sci, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Vinayak, M (corresponding author), Banaras Hindu Univ, Ctr Adv Study Zool, Inst Sci, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	manjulavinayak@rediffmail.com		Maurya, Akhilendra Kumar/0000-0001-5107-9546	University Grant Commission, India [p-01/653]	University Grant Commission, India(University Grants Commission, India)	The work was supported by grants received by University Grant Commission, India (Grant No. p-01/653). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research was supported by University Grants Commission (UGC), India. MV is thankful to UGC-CAS programme to Department of Zoology for infrastructural facilities; and Interdisciplinary School of Life Sciences (ISLS), BHU, Varanasi, for providing Flow Cytometry (FACS) facility.	Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Bell KA, 2004, J NEUROCHEM, V91, P349, DOI 10.1111/j.1471-4159.2004.02722.x; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Brown Kristin K, 2015, F1000Prime Rep, V7, P13, DOI 10.12703/P7-13; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaisuparat R, 2008, CANCER RES, V68, P8361, DOI 10.1158/0008-5472.CAN-08-0878; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chan CH, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-59; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/pnas.87.12.4458; D'Andrea G, 2015, FITOTERAPIA, V106, P256, DOI 10.1016/j.fitote.2015.09.018; Das L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099583; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dibble CC, 2009, CANCER CELL, V16, P178, DOI 10.1016/j.ccr.2009.08.011; Faes S, 2015, INT J MOL SCI, V16, P21138, DOI 10.3390/ijms160921138; Fang B, 2014, BIOCHEM BIOPH RES CO, V448, P443, DOI 10.1016/j.bbrc.2014.04.123; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fyffe Chanse, 2013, Cancer Manag Res, V5, P271, DOI 10.2147/CMAR.S35026; Gagliardi PA, 2015, BBA-REV CANCER, V1856, P178, DOI 10.1016/j.bbcan.2015.07.003; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Geering B, 2007, BIOCHEM SOC T, V35, P199, DOI 10.1042/BST0350199; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Gu L, 2006, LEUKEMIA, V20, P900, DOI 10.1038/sj.leu.2404160; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Howells CC, 2011, J THEOR BIOL, V271, P114, DOI 10.1016/j.jtbi.2010.11.040; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Ma F, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-31; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Martin-Berenjeno I, 2009, CANCER CELL, V16, P449, DOI 10.1016/j.ccr.2009.11.017; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Maurya AK, 2015, TUMOR BIOL, V36, P8913, DOI 10.1007/s13277-015-3634-5; Maurya AK, 2015, MOL BIOL REP, V42, P1419, DOI 10.1007/s11033-015-3921-7; Maurya AK, 2015, MOL CANCER THER, V14, DOI 10.1158/1538-8514.PI3K14-A07; Maurya AK, 2015, NUTR CANCER, V67, P354, DOI 10.1080/01635581.2015.990574; Mishra S, 2014, NUTR CANCER, V66, P675, DOI 10.1080/01635581.2013.878735; Navarro-Nunez L, 2010, FITOTERAPIA, V81, P75, DOI 10.1016/j.fitote.2009.08.006; Niwa K, 2003, ANTIOXID REDOX SIGN, V5, P713, DOI 10.1089/152308603770380016; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Ozes ON, 1999, NATURE, V401, P82; Pandey SK, 2016, INT J BIOL MACROMOL, V89, P99, DOI 10.1016/j.ijbiomac.2016.04.065; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Park S, 2008, LEUKEMIA, V22, P1698, DOI 10.1038/leu.2008.144; Pronsato L, 2012, J ENDOCRINOL, V212, P371, DOI 10.1530/JOE-11-0234; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rivas MA, 2008, EXP CELL RES, V314, P509, DOI 10.1016/j.yexcr.2007.10.005; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Silva A, 2011, LEUKEMIA, V25, P960, DOI 10.1038/leu.2011.56; Sousa-Lopes A, 2004, FEBS LETT, V578, P152, DOI 10.1016/j.febslet.2004.10.090; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tong LY, 2015, CANCER LETT, V367, P18, DOI 10.1016/j.canlet.2015.07.008; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vogt PK, 2011, CURR TOP MICROBIOL, V347, P79, DOI 10.1007/82_2010_80; Wajant H, 2011, FEBS J, V278, P862, DOI 10.1111/j.1742-4658.2011.08015.x; Weinberg F, 2009, CELL MOL LIFE SCI, V66, P3663, DOI 10.1007/s00018-009-0099-y; Weyhenmeyer B., 2012, Experimental Oncology, V34, P192; Xie ZH, 2003, CANCER RES, V63, P5370; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006	69	35	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160686	10.1371/journal.pone.0160686	http://dx.doi.org/10.1371/journal.pone.0160686			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494022	Green Published, gold, Green Submitted			2022-12-27	WOS:000381369500076
J	Charlon, T; Martinez-Bueno, M; Bossini-Castillo, L; Carmona, FD; Di Cara, A; Wojcik, J; Voloshynovskiy, S; Martin, J; Alarcon-Riquelme, ME				Charlon, Thomas; Martinez-Bueno, Manuel; Bossini-Castillo, Lara; Carmona, F. David; Di Cara, Alessandro; Wojcik, Jerome; Voloshynovskiy, Sviatoslav; Martin, Javier; Alarcon-Riquelme, Marta E.			Single Nucleotide Polymorphism Clustering in Systemic Autoimmune Diseases	PLOS ONE			English	Article							ASSOCIATION	Systemic Autoimmune Diseases, a group of chronic inflammatory conditions, have variable symptoms and difficult diagnosis. In order to reclassify them based on genetic markers rather than clinical criteria, we performed clustering of Single Nucleotide Polymorphisms. However naive approaches tend to group patients primarily by their geographic origin. To reduce this "ancestry signal", we developed SNPClust, a method to select large sources of ancestry-independent genetic variations from all variations detected by Principal Component Analysis. Applied to a Systemic Lupus Erythematosus case control dataset, SNPClust successfully reduced the ancestry signal. Results were compared with association studies between the cases and controls without or with reference population stratification correction methods. SNPClust amplified the disease discriminating signal and the ratio of significant associations outside the HLA locus was greater compared to population stratification correction methods. SNPClust will enable the use of ancestry-independent genetic information in the reclassification of Systemic Autoimmune Diseases. SNPClust is available as an R package and demonstrated on the public Human Genome Diversity Project dataset at https://github.com/ThomasChln/snpclust.	[Charlon, Thomas; Di Cara, Alessandro; Wojcik, Jerome] Quartz Bio, Plan Les Ouates, Geneva, Switzerland; [Charlon, Thomas; Voloshynovskiy, Sviatoslav] Univ Geneva, Stochast Informat Proc, Geneva, Switzerland; [Martinez-Bueno, Manuel; Alarcon-Riquelme, Marta E.] Univ Granada, Ctr Genom & Oncol Res, Pfizer, Andalusian Govt, Granada, Spain; [Bossini-Castillo, Lara; Carmona, F. David; Martin, Javier] Spanish Natl Res Council, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	University of Geneva; Pfizer; University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Wojcik, J (corresponding author), Quartz Bio, Plan Les Ouates, Geneva, Switzerland.	jerome.wojcik@quartz.bio	Martín, Javier/AAV-5209-2021; Carmona, F. David/F-9953-2016; Martin, Javier/B-8141-2008; Alarcón-Riquelme, Marta E./ABF-8163-2020; Bossini-Castillo, Lara/G-1234-2016; Martín, María/HDL-9512-2022	Carmona, F. David/0000-0002-1427-7639; Martin, Javier/0000-0002-2202-0622; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Bossini-Castillo, Lara/0000-0002-5471-5824; Voloshynovskiy, Svyatoslav/0000-0003-0416-9674	Quartz Bio S.A.; EU/EFPIA/Innovative Medicines Initiative Joint Undertaking PREC\SESADS [115565]	Quartz Bio S.A.; EU/EFPIA/Innovative Medicines Initiative Joint Undertaking PREC\SESADS	Quartz Bio S.A. provided support in the form of salaries for TC, ADC, and JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has received support from the EU/EFPIA/Innovative Medicines Initiative Joint Undertaking PREC vertical bar SESADS grant no. 115565.	Bax M, 2011, IMMUNOGENETICS, V63, P459, DOI 10.1007/s00251-011-0528-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentham J, 2015, NAT GENET, V3328, DOI [10.1093/bioinformatics/bts606, DOI 10.1093/BIOINFORMATICS/BTS606]; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Cooper GS, 1999, ENVIRON HEALTH PERSP, V107, P693, DOI 10.2307/3434329; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delgado-Vega A, 2010, CURR OPIN IMMUNOL, V22, P698, DOI 10.1016/j.coi.2010.09.002; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Namjou B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115614; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stram DO, 2004, GENET EPIDEMIOL, V27, P365, DOI 10.1002/gepi.20028; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	17	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160270	10.1371/journal.pone.0160270	http://dx.doi.org/10.1371/journal.pone.0160270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490238	Green Published, gold			2022-12-27	WOS:000381368900044
J	Levinson, RD; Yung, M; Meguro, A; Ashouri, E; Yu, F; Mizuki, N; Ohno, S; Rajalingam, R				Levinson, Ralph D.; Yung, Madeline; Meguro, Akira; Ashouri, Elham; Yu, Fei; Mizuki, Nobuhisa; Ohno, Shigeaki; Rajalingam, Raja			KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease	PLOS ONE			English	Article							MHC CLASS-I; HEMATOPOIETIC-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; COMPLEX CLASS-I; INHIBITORY RECEPTORS; T-CELLS; METASTATIC MELANOMA; BINDING-SITE; HEPATITIS-C; AMINO-ACID	Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells are killer lymphocytes that provide defense against viral infections and tumor transformation. Analogous to that of CTL, interactions of killer-cell immunoglobulin-like receptors (KIR) with specific human leukocyte antigen (HLA) class I ligands calibrate NK cell education and response. Gene families encoding KIRs and HLA ligands are located on different chromosomes, and feature variation in the number and type of genes. The independent segregation of KIR and HLA genes results in variable KIR-HLA interactions in individuals, which may impact disease susceptibility. We tested whether KIR-HLA combinations are associated with Vogt-Koyanagi-Harada (VKH) disease, a bilateral granulomatous panuveitis that has strong association with HLA-DR4. We present a case control study of 196 VKH patients and 209 controls from a highly homogeneous native population of Japan. KIR and HLA class I genes were typed using oligonucleotide hybridization method and analyzed using two-tailed Fisher's exact probabilities. The incidence of Bx-KIR genotypes was decreased in VKH patients (odds ratio [OR] 0.58, P = 0.007), due primarily to a decrease in centromeric B-KIR motif and its associated KIRs 2DS2, 2DL2, 2DS3, and 2DL5B. HLA-B22, implicated in poor immune response, was increased in VKH (OR = 4.25, P = 0.0001). HLA-Bw4, the ligand for KIR3DL1, was decreased in VKH (OR = 0.59, P = 0.01). The KIR-HLA combinations 2DL2 +C1/C2 and 3DL1+Bw4, which function in NK education, were also decreased in VKH (OR = 0.49, P = 0.012; OR = 0.59, P = 0.013). Genotypes missing these two inhibitory KIR-HLA combinations in addition to missing activating KIRs 2DS2 and 2DS3 were more common in VKH (OR = 1.90, P = 0.002). These results suggest that synergistic hyporesponsiveness of NK cells (due to poor NK education along with missing of activating KIRs) and CTL (due to HLA-B22 restriction) fail to mount an effective immune response against viral-infection that may trigger VKH pathogenesis in genetically susceptible individuals, such as HLA-DR4 carriers.	[Levinson, Ralph D.; Yung, Madeline; Yu, Fei] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Ocular Inflammatory Dis Ctr, Los Angeles, CA 90095 USA; [Meguro, Akira; Mizuki, Nobuhisa] Yokohama City Univ, Sch Med, Dept Ophthalmol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa, Japan; [Ashouri, Elham; Rajalingam, Raja] Univ Calif Los Angeles, David Geffen Sch Med, Immunogenet Ctr, Los Angeles, CA 90095 USA; [Ohno, Shigeaki] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Kita Ku, N15W7, Sapporo, Hokkaido, Japan; [Rajalingam, Raja] Univ Calif San Francisco, Dept Surg, Immunogenet & Transplantat Lab, San Francisco, CA 94143 USA; [Ashouri, Elham] Stanford Univ, Dept Struct Biol & Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yokohama City University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Hokkaido University; University of California System; University of California San Francisco; Stanford University	Rajalingam, R (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Immunogenet Ctr, Los Angeles, CA 90095 USA.; Rajalingam, R (corresponding author), Univ Calif San Francisco, Dept Surg, Immunogenet & Transplantat Lab, San Francisco, CA 94143 USA.	Rajalingam.Raja@ucsf.edu	Ashouri, Elham/K-1637-2013	Ashouri, Elham/0000-0002-7310-2847	MacDonald Family Foundation; RPB; UCSF Department of Surgery	MacDonald Family Foundation; RPB(Research to Prevent Blindness (RPB)); UCSF Department of Surgery	Dr. Levinson receives funding from the MacDonald Family Foundation and RPB. This study was partially supported by UCSF Department of Surgery seed grant to Dr. Rajalingam.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Ashouri E, 2009, IMMUNOGENETICS, V61, P483, DOI 10.1007/s00251-009-0378-7; Augusto DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039991; BARBER LD, 1995, CURR BIOL, V5, P179, DOI 10.1016/S0960-9822(95)00039-X; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; COLONNA M, 1992, P NATL ACAD SCI USA, V89, P7983, DOI 10.1073/pnas.89.17.7983; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Crosson JN, 2015, J IMMUNOTHER, V38, P80, DOI 10.1097/CJI.0000000000000066; Dohring C, 1996, J IMMUNOL, V156, P3098; Dorak MT, 2003, J INFECT DIS, V188, P856, DOI 10.1086/378071; DOUGLASS SN, 1976, NEW ENGL J MED, V295, P788; Du ZY, 2007, IMMUNOGENETICS, V59, P1, DOI 10.1007/s00251-006-0168-4; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fusco C, 2010, J NEUROIMMUNOL, V229, P232, DOI 10.1016/j.jneuroim.2010.08.004; GARNIERGERE P, 1992, J HERED, V83, P239, DOI 10.1093/oxfordjournals.jhered.a111204; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hendel H, 1999, J IMMUNOL, V162, P6942; Hilton HG, 2012, J IMMUNOL, V189, P1418, DOI 10.4049/jimmunol.1100431; Hou SP, 2014, NAT GENET, V46, P1007, DOI 10.1038/ng.3061; Hsu KC, 2006, BIOL BLOOD MARROW TR, V12, P828, DOI 10.1016/j.bbmt.2006.04.008; Ikeda N, 2015, TISSUE ANTIGENS, V85, P252, DOI 10.1111/tan.12536; ISLAM SMM, 1994, INVEST OPHTH VIS SCI, V35, P3890; Iwahashi C, 2015, JPN J OPHTHALMOL, V59, P157, DOI 10.1007/s10384-015-0377-1; Kawabata Y, 2009, DIABETOLOGIA, V52, P2513, DOI 10.1007/s00125-009-1539-9; Kikuchi I, 1998, EUR J GASTROEN HEPAT, V10, P859, DOI 10.1097/00042737-199810000-00009; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Klein J, 2000, NEW ENGL J MED, V343, P702, DOI 10.1056/NEJM200009073431006; Klein J, 2000, NEW ENGL J MED, V343, P782, DOI 10.1056/NEJM200009143431106; Kulkarni S, 2008, SEMIN IMMUNOL, V20, P343, DOI 10.1016/j.smim.2008.06.003; Kuzushita N, 1998, HEPATOLOGY, V27, P240, DOI 10.1002/hep.510270136; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lavezzo MM, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0412-4; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Levinson RD, 2008, HUM IMMUNOL, V69, P349, DOI 10.1016/j.humimm.2008.04.005; Levinson RD, 2010, HUM IMMUNOL, V71, P192, DOI 10.1016/j.humimm.2009.11.001; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Minoda Hiroshi, 1999, Nippon Ganka Gakkai Zasshi, V103, P289; Mitsunaga S, 2012, TISSUE ANTIGENS, V80, P16, DOI 10.1111/j.1399-0039.2012.01872.x; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Nakaoka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060793; Ng JYW, 2014, J OPHTHALMIC INFLAMM, V4, DOI 10.1186/s12348-014-0020-1; NUMAGA J, 1991, INVEST OPHTH VIS SCI, V32, P1958; OHNO S, 1981, T OPHTHAL SOC UK, V101, P335; OPELZ G, 1991, LANCET, V338, P461, DOI 10.1016/0140-6736(91)90540-6; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Pende D, 1996, J EXP MED, V184, P505, DOI 10.1084/jem.184.2.505; Rajagopalan S, 2005, J EXP MED, V201, P1025, DOI 10.1084/jem.20050499; Rajalingam Raja, 2011, Korean J Hematol, V46, P216, DOI 10.5045/kjh.2011.46.4.216; Rajalingam Raja, 2013, Methods Mol Biol, V1034, P239, DOI 10.1007/978-1-62703-493-7_12; Rajalingam Raja, 2012, Methods Mol Biol, V882, P391, DOI 10.1007/978-1-61779-842-9_23; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Raulet DH, 2001, ANNU REV IMMUNOL, V19, P291, DOI 10.1146/annurev.immunol.19.1.291; Read RW, 2001, AM J OPHTHALMOL, V131, P647, DOI 10.1016/S0002-9394(01)00925-4; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Sakata VM, 2014, AUTOIMMUN REV, V13, P550, DOI 10.1016/j.autrev.2014.01.023; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Sheereen A, 2011, MOL VIS, V17, P3523; Shi TK, 2014, SCI REP-UK, V4, DOI 10.1038/srep06887; SHINDO Y, 1994, HUM IMMUNOL, V39, P169, DOI 10.1016/0198-8859(94)90257-7; Stringaris K, 2010, BIOL BLOOD MARROW TR, V16, P1257, DOI 10.1016/j.bbmt.2010.03.004; Sugita Sunao, 2007, International Ophthalmology, V27, P87, DOI 10.1007/s10792-006-9020-y; Sugita S, 2006, INVEST OPHTH VIS SCI, V47, P2547, DOI 10.1167/iovs.05-1547; TAGAWA Y, 1976, NEW ENGL J MED, V295, P173; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; USUKU K, 1988, ANN NEUROL, V23, pS143, DOI 10.1002/ana.410230733; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; WATANABE H, 1990, TISSUE ANTIGENS, V36, P69, DOI 10.1111/j.1399-0039.1990.tb01802.x; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Winter CC, 1997, J IMMUNOL, V158, P4026; Wong Ryan K, 2012, Retin Cases Brief Rep, V6, P423, DOI 10.1097/ICB.0b013e31824f7130; YAKURA H, 1976, TISSUE ANTIGENS, V8, P35; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yawata M, 2002, IMMUNOGENETICS, V54, P543, DOI 10.1007/s00251-002-0497-x; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yeh S, 2009, OPHTHALMOLOGY, V116, P981, DOI 10.1016/j.ophtha.2008.12.004; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x	82	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160392	10.1371/journal.pone.0160392	http://dx.doi.org/10.1371/journal.pone.0160392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490240	gold, Green Published			2022-12-27	WOS:000381368900053
J	Toledo, DAM; Roque, NR; Teixeira, L; Milan-Garces, EA; Carneiro, AB; Almeida, MR; Andrade, GFS; Martins, JS; Pinho, RR; Freire-de-Lima, CG; Bozza, PT; D'Avila, H; Melo, RCN				Toledo, Daniel A. M.; Roque, Natalia R.; Teixeira, Livia; Milan-Garces, Erix A.; Carneiro, Alan B.; Almeida, Mariana R.; Andrade, Gustavo F. S.; Martins, Jefferson S.; Pinho, Roberto R.; Freire-de-Lima, Celio G.; Bozza, Patricia T.; D'Avila, Heloisa; Melo, Rossana C. N.			Lipid Body Organelles within the Parasite Trypanosoma cruzi: A Role for Intracellular Arachidonic Acid Metabolism	PLOS ONE			English	Article							ULTRAVIOLET-LASER DESORPTION; RAMAN-SPECTROSCOPY; HUMAN EOSINOPHILS; LIGHT-MICROSCOPY; BRUGIA-MALAYI; FATTY-ACIDS; EXPERIMENTAL-INFECTION; EICOSANOID SYNTHESIS; IMMUNE-RESPONSES; OSMIUM TETROXIDE	Most eukaryotic cells contain varying amounts of cytosolic lipidic inclusions termed lipid bodies (LBs) or lipid droplets (LDs). In mammalian cells, such as macrophages, these lipidrich organelles are formed in response to host-pathogen interaction during infectious diseases and are sites for biosynthesis of arachidonic acid (AA)-derived inflammatory mediators (eicosanoids). Less clear are the functions of LBs in pathogenic lower eukaryotes. In this study, we demonstrated that LBs, visualized by light microscopy with different probes and transmission electron microscopy (TEM), are produced in trypomastigote forms of the parasite Trypanosoma cruzi, the causal agent of Chagas' disease, after both host interaction and exogenous AA stimulation. Quantitative TEM revealed that LBs from amastigotes, the intracellular forms of the parasite, growing in vivo have increased size and electron-density compared to LBs from amastigotes living in vitro. AA-stimulated trypomastigotes released high amounts of prostaglandin E-2 (PGE(2)) and showed PGE(2) synthase expression. Raman spectroscopy demonstrated increased unsaturated lipid content and AA incorporation in stimulated parasites. Moreover, both Raman and MALDI mass spectroscopy revealed increased AA content in LBs purified from AA-stimulated parasites compared to LBs from unstimulated group. By using a specific technique for eicosanoid detection, we immunolocalized PGE(2) within LBs from AA-stimulated trypomastigotes. Altogether, our findings demonstrate that LBs from the parasite Trypanosoma cruzi are not just lipid storage inclusions but dynamic organelles, able to respond to host interaction and inflammatory events and involved in the AA metabolism. Acting as sources of PGE(2), a potent immunomodulatory lipid mediator that inhibits many aspects of innate and adaptive immunity, newly-formed parasite LBs may be implicated with the pathogen survival in its host.	[Toledo, Daniel A. M.; Teixeira, Livia; D'Avila, Heloisa; Melo, Rossana C. N.] Fed Univ Juiz de Fora UFJF, Dept Biol, Lab Cellular Biol, Juiz De Fora, MG, Brazil; [Roque, Natalia R.; Teixeira, Livia; Carneiro, Alan B.; Bozza, Patricia T.] Fiocruz MS, Inst Oswaldo Cruz, Lab Immunopharmacol, Rio De Janeiro, Brazil; [Milan-Garces, Erix A.; Almeida, Mariana R.; Andrade, Gustavo F. S.] Fed Univ Juiz de Fora UFJF, Dept Chem, Lab Plasmon Nanostruct, Mol Spect & Struct Grp, Juiz De Fora, MG, Brazil; [Martins, Jefferson S.; Pinho, Roberto R.] Fed Univ Juiz de Fora UFJF, Dept Phys, Juiz De Fora, MG, Brazil; [Freire-de-Lima, Celio G.] Fed Univ Rio de Janeiro UFRJ, Lab Immunomodulat, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil	Universidade Federal de Juiz de Fora; Fundacao Oswaldo Cruz; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Universidade Federal do Rio de Janeiro	D'Avila, H; Melo, RCN (corresponding author), Fed Univ Juiz de Fora UFJF, Dept Biol, Lab Cellular Biol, Juiz De Fora, MG, Brazil.	davila.bizarro@ufjf.edu.br; rossana.melo@ufjf.edu.br	Milán-Garcés, Erix Alexander/AAH-3212-2019; Melo, Rossana C. N./B-8248-2013; Almeida, Mariana R/F-2982-2018; de Lima, Celio Geraldo Freire/A-9057-2012; Andrade, Gustavo/H-3045-2013; Bozza, Patricia T./AAE-2933-2021; Bozza, Patricia T./AAM-4537-2021; Martins, Jefferson Silva/B-5590-2017	Melo, Rossana C. N./0000-0003-1736-0806; Almeida, Mariana R/0000-0002-2612-068X; Andrade, Gustavo/0000-0003-0718-9400; Bozza, Patricia T./0000-0001-8349-9529; Martins, Jefferson Silva/0000-0003-4499-8549; Teixeira, Livia/0000-0002-6227-3202	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil).	Abdalla GK, 2008, EXP PARASITOL, V118, P514, DOI 10.1016/j.exppara.2007.11.003; ADAMS CWM, 1967, HISTOCHEMISTRY, V9, P68, DOI 10.1007/BF00281808; Araujo-Santos T, 2014, J INFECT DIS, V210, P1951, DOI 10.1093/infdis/jiu299; Bandeira-Melo C, 2011, METHODS MOL BIOL, V689, P163, DOI 10.1007/978-1-60761-950-5_10; Beller M, 2010, FEBS LETT, V584, P2176, DOI 10.1016/j.febslet.2010.03.022; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bozza PT, 2011, PROSTAG LEUKOTR ESS, V85, P205, DOI 10.1016/j.plefa.2011.04.020; Bozza PT, 1996, P NATL ACAD SCI USA, V93, P11091, DOI 10.1073/pnas.93.20.11091; Brasaemle DL, 2006, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB0315S29; Cheng JL, 2009, HISTOCHEM CELL BIOL, V132, P281, DOI 10.1007/s00418-009-0615-z; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V14, P83, DOI 10.1016/0166-6851(85)90108-2; Czamara K, 2015, J RAMAN SPECTROSC, V46, P4, DOI 10.1002/jrs.4607; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; D'Avila H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/478601; D'Avila H, 2011, J INFECT DIS, V204, P951, DOI 10.1093/infdis/jir432; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Dias FF, 2014, MICROSC MICROANAL, V20, P869, DOI 10.1017/S143192761400066X; Dias FF, 2011, MICROSC MICROANAL, V17, P1002, DOI 10.1017/S1431927611012098; Fabrino DL, 2011, J INNATE IMMUN, V3, P71, DOI 10.1159/000320641; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; HAYES TL, 1963, J CELL BIOL, V19, P251, DOI 10.1083/jcb.19.1.251; Herker E, 2012, J BIOL CHEM, V287, P2280, DOI 10.1074/jbc.R111.300202; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; KARAS M, 1987, INT J MASS SPECTROM, V78, P53, DOI 10.1016/0168-1176(87)87041-6; KARAS M, 1985, ANAL CHEM, V57, P2935, DOI 10.1021/ac00291a042; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Kubata BK, 2007, TRENDS PARASITOL, V23, P325, DOI 10.1016/j.pt.2007.05.005; LIU LX, 1992, AM J TROP MED HYG, V46, P520, DOI 10.4269/ajtmh.1992.46.520; LONGWORTH DL, 1988, EXP PARASITOL, V65, P251, DOI 10.1016/0014-4894(88)90129-4; LONGWORTH DL, 1987, MOL BIOCHEM PARASIT, V23, P275, DOI 10.1016/0166-6851(87)90034-X; Luna-Gomes T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090582; Mackey TK, 2014, CLIN MICROBIOL REV, V27, P949, DOI 10.1128/CMR.00045-14; Majzner K, 2014, ANAL CHEM, V86, P6666, DOI 10.1021/ac501395g; Manoharan R, 1996, SPECTROCHIM ACTA A, V52, P215, DOI 10.1016/0584-8539(95)01573-6; Martins JS, 2014, EUR POLYM J, V59, P1, DOI 10.1016/j.eurpo1ymj.2014.07.005; Matthaus C, 2012, ANAL CHEM, V84, P8549, DOI 10.1021/ac3012347; Melo RCN, 2006, INFLAMM RES, V55, P342, DOI 10.1007/s00011-006-5205-0; Melo RCN, 2003, TISSUE CELL, V35, P59, DOI 10.1016/S0040-8166(02)00105-2; Melo RCN, 1999, TISSUE CELL, V31, P281, DOI 10.1054/tice.1999.0040; Melo RCN, 2001, EXP PARASITOL, V97, P15, DOI 10.1006/expr.2000.4576; Melo RCN, 2016, EXP CELL RES, V340, P193, DOI 10.1016/j.yexcr.2015.10.028; Melo RCN, 2014, J LEUKOCYTE BIOL, V96, P703, DOI 10.1189/jlb.3RU0214-110R; Melo RCN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002729; Melo RCN, 2011, J HISTOCHEM CYTOCHEM, V59, P540, DOI 10.1369/0022155411404073; Melo RCN, 2011, METHODS MOL BIOL, V689, P149, DOI 10.1007/978-1-60761-950-5_9; Melo RCN, 2009, LAB INVEST, V89, P769, DOI 10.1038/labinvest.2009.40; Melo RCN, 2009, J CELL MOL MED, V13, P279, DOI 10.1111/j.1582-4934.2008.00388.x; Michelin MA, 2005, EXP PARASITOL, V111, P71, DOI 10.1016/j.exppara.2005.05.001; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Naemat A, 2015, ANALYST, V140, P756, DOI [10.1039/C4AN01810A, 10.1039/c4an01810a]; Nishikawa Y, 2005, CELL MICROBIOL, V7, P849, DOI 10.1111/j.1462-5822.2005.00518.x; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Shibata Y, 2005, J LEUKOCYTE BIOL, V78, P1281, DOI 10.1189/jlb.0605321; Talari ACS, 2015, APPL SPECTROSC REV, V50, P46, DOI 10.1080/05704928.2014.923902; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Toledo DAM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00174; WALKER C, 1983, J IMMUNOL, V130, P1770; WELLER PF, 1991, J CELL BIOL, V113, P137, DOI 10.1083/jcb.113.1.137; WELLER PF, 1985, BLOOD, V65, P1269; WELLER PF, 1991, AM J PATHOL, V138, P141; Yaqoob P, 2003, TRENDS IMMUNOL, V24, P639, DOI 10.1016/j.it.2003.10.002; Yu WG, 1998, AM J PATHOL, V152, P759	63	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160433	10.1371/journal.pone.0160433	http://dx.doi.org/10.1371/journal.pone.0160433			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490663	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900056
J	Leas, EC; Althouse, BM; Dredze, M; Obradovich, N; Fowler, JH; Noar, SM; Allem, JP; Ayers, JW				Leas, Eric C.; Althouse, Benjamin M.; Dredze, Mark; Obradovich, Nick; Fowler, James H.; Noar, Seth M.; Allem, Jon-Patrick; Ayers, John W.			Big Data Sensors of Organic Advocacy: The Case of Leonardo DiCaprio and Climate Change	PLOS ONE			English	Article							INFORMATION-SEEKING; HEALTH; BEHAVIOR; MEDIA; COMMUNICATION; CHALLENGES; PREVENTION; SCIENCE	The strategies that experts have used to share information about social causes have historically been top-down, meaning the most influential messages are believed to come from planned events and campaigns. However, more people are independently engaging with social causes today than ever before, in part because online platforms allow them to instantaneously seek, create, and share information. In some cases this "organic advocacy" may rival or even eclipse top-down strategies. Big data analytics make it possible to rapidly detect public engagement with social causes by analyzing the same platforms from which organic advocacy spreads. To demonstrate this claim we evaluated how Leonardo DiCaprio's 2016 Oscar acceptance speech citing climate change motivated global English language news (Bloomberg Terminal news archives), social media (Twitter postings) and information seeking (Google searches) about climate change. Despite an insignificant increase in traditional news coverage (54%; 95% CI: -144 to 247), tweets including the terms "climate change" or "global warming" reached record highs, increasing 636% (95% CI: 573-699) with more than 250,000 tweets the day DiCaprio spoke. In practical terms the " DiCaprio effect" surpassed the daily average effect of the 2015 Conference of the Parties (COP) and the Earth Day effect by a factor of 3.2 and 5.3, respectively. At the same time, Google searches for "climate change" or "global warming" increased 261% (95% CI, 186-335) and 210% (95% CI 149-272) the day DiCaprio spoke and remained higher for 4 more days, representing 104,190 and 216,490 searches. This increase was 3.8 and 4.3 times larger than the increases observed during COP's daily average or on Earth Day. Searches were closely linked to content from Dicaprio's speech (e.g., "hottest year"), as unmentioned content did not have search increases (e.g., "electric car"). Because these data are freely available in real time our analytical strategy provides substantial lead time for experts to detect and participate in organic advocacy while an issue is salient. Our study demonstrates new opportunities to detect and aid agents of change and advances our understanding of communication in the 21st century media landscape.	[Leas, Eric C.; Fowler, James H.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Althouse, Benjamin M.] Inst Dis Modeling, Bellevue, WA USA; [Althouse, Benjamin M.] Univ Washington, Seattle, WA 98195 USA; [Althouse, Benjamin M.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Althouse, Benjamin M.] New Mexico State Univ, Las Cruces, NM 88003 USA; [Dredze, Mark] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA; [Dredze, Mark] Bloomberg LP, New York, NY USA; [Obradovich, Nick] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Obradovich, Nick; Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA; [Noar, Seth M.] Univ N Carolina, Sch Media & Journalism, Chapel Hill, NC USA; [Noar, Seth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Allem, Jon-Patrick] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Ayers, John W.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; The Santa Fe Institute; New Mexico State University; Johns Hopkins University; Bloomberg L.P.; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; California State University System; San Diego State University	Ayers, JW (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.	ayers.john.w@gmail.com	PAN, ZEQIANG/X-6341-2018; Noar, Seth/AAT-9402-2021	Dredze, Mark/0000-0002-0422-2474; Obradovich, Nick/0000-0003-1127-2231				Allem J- P, 2016, TOB CONTROL; Althouse BM, 2014, AM J PREV MED, V46, P166, DOI 10.1016/j.amepre.2013.10.008; Anderson A, 2011, WIRES CLIM CHANGE, V2, P535, DOI 10.1002/wcc.119; Atkin, 2012, PUBLIC COMMUNICATION; Ayers John W, 2016, JMIR Public Health Surveill, V2, pe16, DOI 10.2196/publichealth.5304; Ayers JW, 2016, JAMA INTERN MED, V176, P552, DOI 10.1001/jamainternmed.2016.0003; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Ayers JW, 2014, JAMA INTERN MED, V174, P146, DOI 10.1001/jamainternmed.2013.11933; Ayers JW, 2014, PREV MED, V58, P81, DOI 10.1016/j.ypmed.2013.11.007; Barnes B, 2016, NY TIMES; Cody EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136092; Cone Communications LLC, 2015, CON COMM EB GLOB CST, V4, P15; Deryugina T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151469; Dredze M, 2016, AM J PREV MED, V50, P550, DOI 10.1016/j.amepre.2015.10.002; Evans DG, 2015, BREAST CANC RES BCR, P17; Fond G, 2015, PSYCHIAT RES, V228, P913, DOI 10.1016/j.psychres.2015.04.022; Frumkin H, 2008, AM J PREV MED, V35, P403, DOI 10.1016/j.amepre.2008.08.019; Hamilton LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138208; Hart PS, 2016, SCI COMMUN, V38, P415, DOI 10.1177/1075547016655357; Hart PS, 2009, ENVIRON COMMUN, V3, P355, DOI 10.1080/17524030903265823; Hmielowski JD, 2013, PUBLIC UNDERST SCI; Hurlstone MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114335; Hyndman R. J., 2007, AUTOMATIC TIME SERIE; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kryvasheyeu Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500779; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lineman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138996; Maibach EW, 2008, AM J PREV MED, V35, P488, DOI 10.1016/j.amepre.2008.08.016; Mccallum ML, 2013, BIODIVERS CONSERV, V22, P1355, DOI 10.1007/s10531-013-0476-6; Moser SC, 2010, WIRES CLIM CHANGE, V1, P31, DOI 10.1002/wcc.11; Newman TP, 2016, TRACKING RELEASE IPC; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; Noar SM, 2015, MED DECIS MAKING, V35, P16, DOI 10.1177/0272989X14556130; Noar Seth M., 2013, Journal of the National Cancer Institute Monographs, P188, DOI 10.1093/jncimonographs/lgt017; Patz JA, 2014, JAMA-J AM MED ASSOC, V312, P1565, DOI 10.1001/jama.2014.13186; Pearce W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094785; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Shadish WR, 2009, ANNU REV PSYCHOL, V60, P607, DOI 10.1146/annurev.psych.60.110707.163544; Stapleton AC, 2015, FREQUENT TANNER SHAR, V5, P15; Thrall AT, 2008, INT J PRESS/POLIT, V13, P362, DOI 10.1177/1940161208319098; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a	42	38	38	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159885	10.1371/journal.pone.0159885	http://dx.doi.org/10.1371/journal.pone.0159885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NS	27482907	Green Published, gold			2022-12-27	WOS:000381110700017
J	van Oostrom, SH; Gijsen, R; Stirbu, I; Korevaar, JC; Schellevis, FG; Picavet, HSJ; Hoeymans, N				van Oostrom, Sandra H.; Gijsen, Ronald; Stirbu, Irina; Korevaar, Joke C.; Schellevis, Francois G.; Picavet, H. Susan J.; Hoeymans, Nancy			Time Trends in Prevalence of Chronic Diseases and Multimorbidity Not Only due to Aging: Data from General Practices and Health Surveys	PLOS ONE			English	Article							CARE UTILIZATION	Introduction Chronic diseases and multimorbidity are common and expected to rise over the coming years. The objective of this study is to examine the time trend in the prevalence of chronic diseases and multimorbidity over the period 2001 till 2011 in the Netherlands, and the extent to which this can be ascribed to the aging of the population. Methods Monitoring study, using two data sources: 1) medical records of patients listed in a nationally representative network of general practices over the period 2002-2011, and 2) national health interview surveys over the period 2001-2011. Regression models were used to study trends in the prevalence-rates over time, with and without standardization for age. Results An increase from 34.9% to 41.8% (p< 0.01) in the prevalence of chronic diseases was observed in the general practice registration over the period 2004-2011 and from 41.0% to 46.6% (p< 0.01) based on self-reported diseases over the period 2001-2011. Multimorbidity increased from 12.7% to 16.2% (p< 0.01) and from 14.3% to 17.5% (p< 0.01), respectively. Aging of the population explained part of these trends: about one-fifth based on general practice data, and one-third for chronic diseases and half of the trend for multimorbidity based on health surveys. Conclusions The prevalence of chronic diseases and multimorbidity increased over the period 2001-2011. Aging of the population only explained part of the increase, implying that other factors such as health care and society-related developments are responsible for a substantial part of this rise.	[van Oostrom, Sandra H.; Picavet, H. Susan J.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Gijsen, Ronald; Hoeymans, Nancy] Natl Inst Publ Hlth & Environm, Ctr Hlth & Soc, Bilthoven, Netherlands; [Stirbu, Irina; Korevaar, Joke C.; Schellevis, Francois G.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Schellevis, Francois G.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam	van Oostrom, SH (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	Sandra.van.oostrom@rivm.nl		Picavet, Susan/0000-0002-6895-165X	Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	Statistical analyses for this study were funded by the Dutch Ministry of Health, Welfare and Sport. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Biermans MCJ, 2008, METHOD INFORM MED, V47, P98, DOI 10.3414/ME0471; De Klerk M., 2011, GEZONDHEID HULPGEBRU; Erdem E, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130118; Erler A, 2011, Z EVIDENZ FORTBILD Q, V105, P571, DOI 10.1016/j.zefq.2011.09.029; European Observatory on Health Systems and Policies, 2002, HEALTH SYSTEMS IN TR; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Freid Virginia M, 2012, NCHS Data Brief, P1; Galenkamp H, 2014, J CLIN EPIDEMIOL, V67, P773, DOI 10.1016/j.jclinepi.2014.02.002; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Hoeymans Nancy, 2013, Ned Tijdschr Geneeskd, V157, pA5994; Hulsegge G, 2014, EUR J PREV CARDIOL, V21, P1134, DOI 10.1177/2047487313485512; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Meinow Bettina, 2006, Eur J Ageing, V3, P98, DOI 10.1007/s10433-006-0027-z; Merkus SL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2407-9; Mollica R.L., 2003, CARE COORDINATION PE; Netherlands Statistics (CBS), 2013, PERM OND LEEFS POLS; Netherlands Statistics (CBS), 2013, GEZ 2010 2011 DAT AR; Netherlands Statistics (CBS), 2014, STATLINE EL DAT STAT; Netherlands Statistics (CBS), 2015, HLTH SURV 2010 ONW; Netherlands Statistics (CBS), 2015, HLTH SURV 1981 1996; NIVEL, 2015, NIVEL PRIM CAR DAT; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Remington Patrick L, 2011, MMWR Suppl, V60, P70; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Swinkels H, 2011, TRENDCIJFERS GEZONDH; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Ward BW, 2010, PREV CHRONIC DIS, V10, pE65, DOI DOI 10.5888/PCD10.120203; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; WHO, 2011, GLOBAL STATUS REPORT; WONCA, 1995, INT GLOSS GEN FAM PR; Wong F. Y, 2011, ANAL METHODEBREUKEN	34	145	149	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160264	10.1371/journal.pone.0160264	http://dx.doi.org/10.1371/journal.pone.0160264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482903	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110700031
J	Adewale, AK; Pazhani, GP; Abiodun, IB; Afolabi, O; Kolawole, OD; Mukhopadhyay, AK; Ramamurthy, T				Adewale, Akinsinde Kehinde; Pazhani, Gururaja Perumal; Abiodun, Iwalokun Bamidele; Afolabi, Oluwadun; Kolawole, Olukoya Daniel; Mukhopadhyay, Asish K.; Ramamurthy, Thanadarayan			Unique Clones of Vibrio cholerae O1 El Tor with Haitian Type ctxB Allele Implicated in the Recent Cholera Epidemics from Nigeria, Africa	PLOS ONE			English	Article							OUTBREAK; STRAINS; VARIANT	Background and Objectives The antimicrobial susceptibility patterns and genetic characteristics of Vibrio cholerae O1, which is responsible for several cholera epidemics in Nigeria, are not reported in detail since 2007. In this study, we screened V. cholerae O1 El Tor biotype isolates from cholera cases and water samples from different states to investigate their phenotypic and genetic attributes with special reference to their clonality. Results All the V. cholerae O1 biotype El Tor isolates isolated during 2007-2013 were susceptible to fluoroquinolones and tetracycline, the drugs currently used in the treatment of cholera cases in Nigeria. Emergence of CT genotype 7 (Haitian type of ctxB allele) was predominantly seen among Ogawa serotype and the CT genotype 1 (classical ctxB allele) was mostly found in Inaba serotype. Overall, V. cholerae O1 from clinical and water samples were found to be closely related as determined by the pulsed-field gel electrophoresis. V. cholerae isolates from Abia, Kano and Bauchi were found to be genetically distinct from the other states of Nigeria. Conclusion Fecal contamination of the water sources may be the possible source of the cholera infection. Combined prevalence of Haitian and classical ctxB alleles were detected in Ogawa and Inaba serotypes, respectively. This study further demonstrated that V. cholerae O1 with the ctxB has been emerged similar to the isolates reported in Haiti. Our findings suggest that the use of fluoroquinolones or tetracycline/doxycycline may help in the effective management of acute cholera in the affected Nigerian states. In addition, strengthening the existing surveillance in the hospitals of all the states and supply of clean drinking water may control cholera outbreaks in the future.	[Adewale, Akinsinde Kehinde] Nigerian Inst Med Res, Div Clin Sci, Lagos, Nigeria; [Pazhani, Gururaja Perumal; Mukhopadhyay, Asish K.; Ramamurthy, Thanadarayan] Natl Inst Cholera & Enter Dis, Div Mol Microbiol, Kolkata, India; [Abiodun, Iwalokun Bamidele] Nigerian Inst Med Res, Mol Biol & Biotechnol Div, Lagos, Nigeria; [Afolabi, Oluwadun] Olabisi Onabanjo Univ, Shagamu, Ogun, Nigeria; [Kolawole, Olukoya Daniel] Danifol Fdn, Lagos, Nigeria; [Pazhani, Gururaja Perumal] Natl Inst Pharmaceut Educ & Res, Kolkata, India; [Ramamurthy, Thanadarayan] Translat Hlth Sci & Technol Inst, Ctr Human Microbial Ecol, Faridabad, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); National Institute of Pharmaceutical Education & Research (NIPER); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Adewale, AK (corresponding author), Nigerian Inst Med Res, Div Clin Sci, Lagos, Nigeria.	kennyadewale2001@yahoo.com	Mukhopadhyay, Asish/ABE-7697-2020	Pazhani, Gururaja Perumal/0000-0001-9500-006X				Adagbada AO, 2012, PAN AFR MED J, V12; Akoachere JFTK, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-421; Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Bhuiyan NA, 2012, EPIDEMIOL INFECT, V140, P510, DOI 10.1017/S0950268811000926; Ceccarelli D, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-130; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Cooper KLF, 2006, FOODBORNE PATHOG DIS, V3, P51, DOI 10.1089/fpd.2006.3.51; Dalhat MM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1167; Dixit SM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-392; Goel AK, 2008, J INFECTION, V57, P280, DOI 10.1016/j.jinf.2008.06.015; Hemant KK, 2008, J CLIN MICROBIOL, V7, P2399; Islam MS, 2011, J CLIN MICROBIOL, V49, P2325, DOI 10.1128/JCM.00432-11; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Mercy N, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.8.2496; Mukhopadhyay AK, 2014, CURR TOP MICROBIOL, V379, P17, DOI 10.1007/82_2014_363; Naha A, 2012, J CLIN MICROBIOL, V50, P1733, DOI 10.1128/JCM.00387-12; Oguntoke O, 2009, Tanzan J Health Res, V11, P189; ONYEMELUKWE GC, 1991, CENT AFR J MED, V37, P186; Oyedeji KS, 2013, J HEALTH POPUL NUTR, V31, P178; Pal BB, 2013, EPIDEMIOL INFECT, V141, P2560, DOI 10.1017/S0950268813000368; Quilici ML, 2010, EMERG INFECT DIS, V16, P1804, DOI 10.3201/eid1611.100568; Saidi SM, 2014, J MED MICROBIOL, V63, P415, DOI 10.1099/jmm.0.068999-0; Thompson CC, 2011, INFECT GENET EVOL, V11, P1951, DOI 10.1016/j.meegid.2011.08.020; Usman A, 2005, Cent Afr J Med, V51, P34; WILSON AMM, 1971, J CLIN PATHOL, V24, P768, DOI 10.1136/jcp.24.8.768-c; World Health Organization, 2014, Weekly Epidemiological Record, V89, P345	26	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159794	10.1371/journal.pone.0159794	http://dx.doi.org/10.1371/journal.pone.0159794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479360	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110300018
J	Aoki-Yoshida, A; Yamada, K; Hachimura, S; Sashihara, T; Ikegami, S; Shimizu, M; Totsuka, M				Aoki-Yoshida, Ayako; Yamada, Kiyoshi; Hachimura, Satoshi; Sashihara, Toshihiro; Ikegami, Shuji; Shimizu, Makoto; Totsuka, Mamoru			Enhancement of Oral Tolerance Induction in DO11.10 Mice by Lactobacillus gasseri OLL2809 via Increase of Effector Regulatory T Cells	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE LPS REGULATION; INTESTINAL BACTERIAL-FLORA; COLLAGEN-INDUCED ARTHRITIS; PROPRIA DENDRITIC CELLS; IMMUNE-RESPONSE; B-CELLS; ANTIBODY-PRODUCTION; PEYERS-PATCHES; TYPE-1 CELLS; II COLLAGEN	Food allergy is a serious problem for infants and young children. Induction of antigen-specific oral tolerance is one therapeutic strategy. Enhancement of oral tolerance induction by diet is a promising strategy to prevent food allergy in infants. Thus, in this study, we evaluate the effect of probiotic Lactobacillus gasseri OLL2809 (LG2809) on oral tolerance induction in a mouse model. The degree of oral tolerance induction was evaluated by measuring the proliferation and level of IL-2 production of splenic CD4(+) T cells from DO11.10 mice fed ovalbumin (OVA) alone or OVA with LG2809. Oral administration of LG2809 significantly decreased the rate of proliferation and IL-2 production by CD4(+) T cells from OVA-fed mice. LG2809 increased a ratio of CD4(+) T-cell population, producing high levels of IL-10 and having strong suppressive activity. Moreover, LG2809 increased a ratio of plasmacytoid dendritic cells (pDCs) among the lamina propria (LP) in small intestine. When used as antigen presenting cells to naive CD4(+) T cells from DO11.10 mice, LP cells from BALB/c mice fed LG2809 induced higher IL-10 production and stronger suppressive activity than those from non-treated mice. These results suggest that oral administration of LG2809 increases the population of pDCs in the LP, resulting in the enhancement of oral tolerance induction by increasing the ratio of effector regulatory T cells. LG2809 could, therefore, act as a potent immunomodulator to prevent food allergies by promoting oral tolerance.	[Aoki-Yoshida, Ayako; Yamada, Kiyoshi; Shimizu, Makoto; Totsuka, Mamoru] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Aoki-Yoshida, Ayako] Natl Agr & Food Res Org, Natl Inst Livestock & Grassland Sci, Tsukuba, Ibaraki, Japan; [Hachimura, Satoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Tokyo, Japan; [Sashihara, Toshihiro; Ikegami, Shuji] Meiji Co Ltd, Div Res & Dev, Odawara, Kanagawa, Japan	University of Tokyo; National Agriculture & Food Research Organization - Japan; University of Tokyo; Meiji Holdings Co., Ltd.	Totsuka, M (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan.	atotuka@mail.ecc.u-tokyo.ac.jp	Aoki, Ayako/GXV-4979-2022	Aoki, Ayako/0000-0003-4535-8586	Japan Society for the Promotion of Science (JSPS) [21380077]; Japan Society for the Promotion of Science	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (B) 21380077 from the Japan Society for the Promotion of Science (JSPS).; This work was supported by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour HM, 2007, INT ARCH ALLERGY IMM, V144, P343, DOI 10.1159/000106461; Ashour HM, 2007, J LEUKOCYTE BIOL, V82, P1033, DOI 10.1189/jlb.0507310; Battaglia M, 2004, ANN NY ACAD SCI, V1029, P142, DOI 10.1196/annals.1309.031; Bhattacharya P, 2014, CLIN IMMUNOL, V153, P187, DOI 10.1016/j.clim.2014.04.014; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; BRADLEY LM, 1992, J IMMUNOL, V148, P324; Buckland Jenny, 2014, Nat Rev Rheumatol, V10, P699, DOI 10.1038/nrrheum.2014.183; Carter NA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3736; Chang JH, 2008, EUR J IMMUNOL, V38, P2727, DOI 10.1002/eji.200838159; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHEN YH, 1995, NATURE, V376, P177, DOI 10.1038/376177a0; Cong Yingzi, 2003, Current Drug Targets - Inflammation and Allergy, V2, P145, DOI 10.2174/1568010033484278; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de LeBlanc AD, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-27; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Diana J, 2009, IMMUNITY, V30, P289, DOI 10.1016/j.immuni.2008.12.017; FAO/WHO, 2002, GUID EV PRO IN PRESS, DOI [10.3168/jds.S0022-0302(06)72557-7, DOI 10.3168/JDS.S0022-0302(06)72557-7]; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Gotoh M, 2009, BIOSCI BIOTECH BIOCH, V73, P1971, DOI 10.1271/bbb.90144; Goubier A, 2008, IMMUNITY, V29, P464, DOI 10.1016/j.immuni.2008.06.017; Hahn EL, 2005, IMMUNOL ALLERGY CLIN, V25, P231, DOI 10.1016/j.iac.2005.02.004; HIRAHARA K, 1995, J IMMUNOL, V154, P6238; Ise W, 2000, FEBS LETT, V465, P28, DOI 10.1016/S0014-5793(99)01716-0; Ise W, 2002, J IMMUNOL, V168, P3242, DOI 10.4049/jimmunol.168.7.3242; Isolauri E, 2002, GUT, V50, P54, DOI 10.1136/gut.50.suppl_3.iii54; Isolauri E, 1998, J PEDIATR-US, V132, P1004, DOI 10.1016/S0022-3476(98)70399-3; Jin JO, 2013, J AUTOIMMUN, V40, P28, DOI 10.1016/j.jaut.2012.07.009; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Lackey DE, 2008, J NUTR, V138, P1512, DOI 10.1093/jn/138.8.1512; LAEGREID A, 1995, J BIOL CHEM, V270, P25418, DOI 10.1074/jbc.270.43.25418; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Li QC, 2014, INT IMMUNOPHARMACOL, V21, P119, DOI 10.1016/j.intimp.2014.04.018; Maeda Y, 2001, IMMUNOBIOLOGY, V204, P442, DOI 10.1078/0171-2985-00054; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; MICHALEK SM, 1982, J IMMUNOL, V128, P1992; Min SY, 2006, ARTHRITIS RHEUM-US, V54, P887, DOI 10.1002/art.21647; Moreau MC, 1996, RES IMMUNOL, V147, P49, DOI 10.1016/0923-2494(96)81548-3; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Park KS, 2009, MOD RHEUMATOL, V19, P581, DOI 10.1007/s10165-009-0210-0; Peng HJ, 2000, SCAND J IMMUNOL, V51, P454; Prioult G, 2003, CLIN DIAGN LAB IMMUN, V10, P787, DOI 10.1128/CDLI.10.5.787-792.2003; Ren ZH, 2008, J NUTR, V138, P544, DOI 10.1093/jn/138.3.544; Sashihara T, 2006, J DAIRY SCI, V89, P2846, DOI 10.3168/jds.S0022-0302(06)72557-7; Sashihara T, 2007, INT J FOOD MICROBIOL, V120, P274, DOI 10.1016/j.ijfoodmicro.2007.09.003; Sashihara Toshihiro, 2008, Allergol Int, V57, P397, DOI 10.2332/allergolint.O-08-541; Shiokawa A, 2009, IMMUNOL LETT, V125, P7, DOI 10.1016/j.imlet.2009.05.002; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; So JS, 2008, MOL IMMUNOL, V46, P172, DOI 10.1016/j.molimm.2008.07.038; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sudo N, 1997, J IMMUNOL, V159, P1739; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun JB, 2008, J IMMUNOL, V181, P8278, DOI 10.4049/jimmunol.181.12.8278; Szeles L, 2009, J IMMUNOL, V182, P2074, DOI 10.4049/jimmunol.0803345; Tanaka K, 2004, HISTOL HISTOPATHOL, V19, P907, DOI 10.14670/HH-19.907; Tang MLK, 2013, PEDIAT ALLERG IMM-UK, V24, P512, DOI 10.1111/pai.12100; Thiruppathi M, 2014, J AUTOIMMUN, V52, P64, DOI 10.1016/j.jaut.2013.12.014; Tsai YT, 2008, INT J FOOD MICROBIOL, V128, P219, DOI 10.1016/j.ijfoodmicro.2008.08.009; Tsuji NM, 2001, IMMUNOLOGY, V103, P458, DOI 10.1046/j.1365-2567.2001.01265.x; Wang X, 2009, J NUTR, V139, P1595, DOI 10.3945/jn.109.109934; WANNEMUEHLER MJ, 1982, J IMMUNOL, V129, P959; Wittmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071338; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Wu L, 2007, IMMUNITY, V26, P741, DOI 10.1016/j.immuni.2007.06.006; Yoshida A, 2011, IMMUNOLOGY, V133, P442, DOI 10.1111/j.1365-2567.2011.03455.x; Yoshida A, 2011, FEMS IMMUNOL MED MIC, V61, P315, DOI 10.1111/j.1574-695X.2010.00777.x; Zeiger RS, 2003, PEDIATRICS, V111, P1662; Zeng HY, 2015, CELL MOL IMMUNOL, V12, P566, DOI 10.1038/cmi.2015.44	70	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0158643	10.1371/journal.pone.0158643	http://dx.doi.org/10.1371/journal.pone.0158643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472281	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300005
J	Cerciello, A; Auriemma, G; Morello, S; Aquino, RP; Del Gaudio, P; Russo, P				Cerciello, Andrea; Auriemma, Giulia; Morello, Silvana; Aquino, Rita P.; Del Gaudio, Pasquale; Russo, Paola			Prednisolone Delivery Platforms: Capsules and Beads Combination for a Right Timing Therapy	PLOS ONE			English	Article							IMMEDIATE-RELEASE PREDNISONE; RHEUMATOID-ARTHRITIS; MORNING STIFFNESS; CIRCADIAN-RHYTHMS; ALGINATE BEADS; DOSAGE FORMS; IN-VITRO; KETOPROFEN; SYSTEMS; DRUG	In this work, a platform of alginate beads loaded with Prednisolone in hypromellose/gellan gum capsules (F6/Cps) able to delay steroidal anti-inflammatory drug (SAID) release as needed for chronotherapy of rheumatoid arthritis is proposed. Rheumatoid arthritis, showing a worsening in symptoms in the morning upon waking, is a pathology that can benefit from chronotherapy. With the aim to maximize prednisolone therapeutic action allowing the right timing of glucocorticoid therapy, different engineered microparticles (gel-beads) were manufactured using prilling (laminar jet break-up) as micro-encapsulation technique and Zn-alginate as gastroresistant carrier. Starting from various feed solutions and process parameters, the effect of the variables on particles size, morphology, solid state properties and drug release was studied. The optimization of operative and prilling/ionotropic gelation variables led to microspheres with almost spherical shape and a narrow dimensional range. The feed solution with the highest alginate (2.5% w/v) amount and drug/polymer ratio (1: 5 w/w) gave rise to the highest encapsulation efficiency (78.5%) as in F6 formulation. As to drug release, F6 exhibited an interesting dissolution profile, releasing about 24% of the drug in simulated gastric fluid followed by a more sustained profile in simulated intestinal fluid. #F6, acting as a gastro-resistant and delayed release formulation, was selected for in vivo studies on male Wistar rats by means of a carrageenan-induced oedema model. Finally, this efficacious formulation was used as core material for the development of a final dosage form: F6/Cps allowed to significantly reduce prednisolone release in simulated gastric fluid (12.6%) and delayed drug release up to about 390 minutes.	[Cerciello, Andrea; Auriemma, Giulia; Morello, Silvana; Aquino, Rita P.; Del Gaudio, Pasquale; Russo, Paola] Univ Salerno, Dept Pharm, Fisciano, Italy; [Cerciello, Andrea] Univ Salerno, PhD Program Drug Discovery & Dev, Fisciano, Italy	University of Salerno; University of Salerno	Russo, P (corresponding author), Univ Salerno, Dept Pharm, Fisciano, Italy.	paorusso@unisa.it	Auriemma, Giulia/P-9709-2016; Morello, Silvana/E-9328-2012; RUSSO, Paola/A-3931-2011; Del Gaudio, Pasquale/B-6833-2011	Auriemma, Giulia/0000-0001-9547-0969; Morello, Silvana/0000-0002-6541-0997; RUSSO, Paola/0000-0002-4362-4388; Del Gaudio, Pasquale/0000-0003-3852-4523; aquino, rita patrizia/0000-0002-9754-4244				Almeida-Prieto S, 2004, J PHARM SCI-US, V93, P621, DOI 10.1002/jps.10572; Alten R, 2015, SCAND J RHEUMATOL, V44, P354, DOI 10.3109/03009742.2015.1038582; Alten R, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000134; Auriemma G, 2013, CARBOHYD POLYM, V92, P367, DOI 10.1016/j.carbpol.2012.09.056; Auriemma G, 2011, INT J PHARMACEUT, V415, P196, DOI 10.1016/j.ijpharm.2011.05.077; Bijlsma JWJ, 2008, LANCET, V371, P183, DOI 10.1016/S0140-6736(08)60114-2; Buttgereit F, 2008, LANCET, V371, P205, DOI 10.1016/S0140-6736(08)60132-4; Buttgereit F, 2015, BULL HOSP JT DIS, V73, P168; Cerciello A, 2016, DRUG DEV IND PHARM, V30, P1; Cerciello A, 2016, J DRUG DELIV SCI TEC, V32, P126, DOI 10.1016/j.jddst.2015.07.017; Cerciello A, 2015, J PHARM SCI-US, V104, P3451, DOI 10.1002/jps.24554; Chakraborty S, 2010, ACTA PHARMACEUT, V60, P255, DOI 10.2478/v10007-010-0026-7; Cicala C, 2007, EUR J PHARMACOL, V577, P156, DOI 10.1016/j.ejphar.2007.08.007; DAVIS M, 1978, BRIT J CLIN PHARMACO, V5, P501, DOI 10.1111/j.1365-2125.1978.tb01664.x; Del Gaudio P, 2005, INT J PHARMACEUT, V302, P1, DOI 10.1016/j.ijpharm.2005.05.041; Del Gaudio P, 2014, EUR J PHARM BIOPHARM, V87, P541, DOI 10.1016/j.ejpb.2014.02.010; Di Colo G, 2006, INT J PHARMACEUT, V310, P154, DOI 10.1016/j.ijpharm.2005.12.002; Gibbs JE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4146; Haus E, 2012, BULL HOSP JT DIS, V70, pS3; Lau ETL, 2012, J MICROENCAPSUL, V29, P706, DOI 10.3109/02652048.2012.686527; MADSBAD S, 1980, GUT, V21, P52, DOI 10.1136/gut.21.1.52; Mazurek S, 2012, J AOAC INT, V95, P744, DOI 10.5740/jaoacint.SGE_Mazurek; Okimoto K, 1998, PHARMACEUT RES, V15, P1562, DOI 10.1023/A:1011955117026; Palanisamy M, 2011, DRUG DEV IND PHARM, V37, P373, DOI 10.3109/03639045.2010.513984; Papageorgiou SK, 2010, CARBOHYD RES, V345, P469, DOI 10.1016/j.carres.2009.12.010; PICKUP ME, 1979, CLIN PHARMACOKINET, V4, P111, DOI 10.2165/00003088-197904020-00004; Skowyra J, 2015, EUR J PHARM SCI, V68, P11, DOI 10.1016/j.ejps.2014.11.009; Spies CM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4687; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; SUGAWARA S, 1994, PHARMACEUT RES, V11, P272, DOI 10.1023/A:1018963626248; Vogt M, 2007, J PHARM SCI-US, V96, P27, DOI 10.1002/jps.20768	31	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160266	10.1371/journal.pone.0160266	http://dx.doi.org/10.1371/journal.pone.0160266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472446	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300039
J	Czolkoss, S; Fritz, C; Holzl, G; Aktas, M				Czolkoss, Simon; Fritz, Christiane; Hoelzl, Georg; Aktas, Meriyem			Two Distinct Cardiolipin Synthases Operate in Agrobacterium tumefaciens	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MITOCHONDRIAL-MEMBRANES; RHODOBACTER-SPHAEROIDES; PHOSPHOLIPID SYNTHASES; ANIONIC PHOSPHOLIPIDS; HIGH SALINITY; BIOSYNTHESIS; PROTEIN; PHOSPHATIDYLETHANOLAMINE	Cardiolipin (CL) is a universal component of energy generating membranes. In most bacteria, it is synthesized via the condensation of two molecules phosphatidylglycerol (PG) by phospholipase D-type cardiolipin synthases (PLD-type Cls). In the plant pathogen and natural genetic engineer Agrobacterium tumefaciens CL comprises up to 15% of all phospholipids in late stationary growth phase. A. tumefaciens harbors two genes, atu1630 (cls1) and atu2486 (cls2), coding for PLD-type Cls. Heterologous expression of either cls1 or cls2 in Escherichia coli resulted in accumulation of CL supporting involvement of their products in CL synthesis. Expression of cls1 and cls2 in A. tumefaciens is constitutive and irrespective of the growth phase. Membrane lipid profiling of A. tumefaciens mutants suggested that Cls2 is required for CL synthesis at early exponential growth whereas both Cls equally contribute to CL production at later growth stages. Contrary to many bacteria, which suffer from CL depletion, A. tumefaciens tolerates large changes in CL content since the CL-deficient cls1/cls2 double mutant showed no apparent defects in growth, stress tolerance, motility, biofilm formation, UV-stress and tumor formation on plants.	[Czolkoss, Simon; Fritz, Christiane; Aktas, Meriyem] Ruhr Univ Bochum, Microbial Biol, Bochum, Germany; [Hoelzl, Georg] Univ Bonn, Inst Mol Physiol & Biotechnol Plants IMBIO, Bonn, Germany	Ruhr University Bochum; University of Bonn	Aktas, M (corresponding author), Ruhr Univ Bochum, Microbial Biol, Bochum, Germany.	meriyem.aktas@rub.de		AKTAS, MERIYEM/0000-0001-6382-5497; Czolkoss, Simon/0000-0003-0361-2996				Vences-Guzman MA, 2013, ENVIRON MICROBIOL, V15, P895, DOI 10.1111/j.1462-2920.2012.02867.x; Bernal P, 2007, ENVIRON MICROBIOL, V9, P1135, DOI 10.1111/j.1462-2920.2006.01236.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buskirk SW, 2014, J BACTERIOL, V196, P107, DOI 10.1128/JB.00298-13; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; CRONAN JE, 1968, J BACTERIOL, V95, P2054, DOI 10.1128/JB.95.6.2054-2061.1968; Dalebroux ZD, 2015, CELL HOST MICROBE, V17, P441, DOI 10.1016/j.chom.2015.03.003; Dalebroux ZD, 2014, P NATL ACAD SCI USA, V111, P1963, DOI 10.1073/pnas.1316901111; DAS PK, 1979, J GEN APPL MICROBIOL, V25, P1, DOI 10.2323/jgam.25.1; Davlieva M, 2013, ANTIMICROB AGENTS CH, V57, P289, DOI 10.1128/AAC.01743-12; Devers EA, 2011, J BACTERIOL, V193, P1377, DOI 10.1128/JB.00768-10; Geske T, 2013, GLYCOBIOLOGY, V23, P69, DOI 10.1093/glycob/cws124; Guo DG, 2000, BBA-MOL CELL BIOL L, V1483, P263, DOI 10.1016/S1388-1981(99)00193-6; HEBER S, 1991, BIOCHIM BIOPHYS ACTA, V1129, P1, DOI 10.1016/0167-4781(91)90206-2; HIRAOKA S, 1993, FEBS LETT, V336, P221, DOI 10.1016/0014-5793(93)80807-7; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Kim KS, 2008, GENE DEV, V22, P3497, DOI 10.1101/gad.1729508; Klusener S, 2009, J BACTERIOL, V191, P365, DOI 10.1128/JB.01183-08; Koonin EV, 1996, TRENDS BIOCHEM SCI, V21, P242, DOI 10.1016/0968-0004(96)30024-8; Koprivnjak T, 2011, J BACTERIOL, V193, P4134, DOI 10.1128/JB.00288-11; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lin TY, 2015, J BACTERIOL, V197, P3446, DOI 10.1128/JB.00420-15; Lobasso S, 2013, FEBS OPEN BIO, V3, P151, DOI 10.1016/j.fob.2013.02.002; Lopez CS, 2006, MICROBIOL-SGM, V152, P605, DOI 10.1099/mic.0.28345-0; MacGilvray ME, 2012, MICROBIOL-SGM, V158, P2133, DOI 10.1099/mic.0.057273-0; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Miller J.H., 1972, EXPT MOL GENETICS; Moser R, 2014, MOL MICROBIOL, V92, P959, DOI 10.1111/mmi.12603; Nichols-Smith S, 2004, BBA-BIOMEMBRANES, V1663, P82, DOI 10.1016/j.bbamem.2004.02.002; Oliver PM, 2014, J BACTERIOL, V196, P3386, DOI 10.1128/JB.01877-14; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Poger D, 2015, J PHYS CHEM B, V119, P5487, DOI 10.1021/acs.jpcb.5b00958; Ponting CP, 1996, PROTEIN SCI, V5, P914; Quigley BR, 2009, BBA-BIOMEMBRANES, V1788, P2107, DOI 10.1016/j.bbamem.2009.03.016; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Romantsov T, 2007, MOL MICROBIOL, V64, P1455, DOI 10.1111/j.1365-2958.2007.05727.x; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Sambrook J., 2001, MOL CLONING LAB MANU; Sandoval-Calderon M, 2009, J BIOL CHEM, V284, P17383, DOI 10.1074/jbc.M109.006072; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; SHIBUYA I, 1985, J BACTERIOL, V161, P473, DOI 10.1128/JB.161.2.473-477.1985; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; TARI A, 1989, BIOCHEMISTRY-US, V28, P7708, DOI 10.1021/bi00445a028; Tian HF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-32; Tsai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-13; Tsai YL, 2009, MICROBIOL-SGM, V155, P3270, DOI 10.1099/mic.0.030676-0; Unsay JD, 2013, LANGMUIR, V29, P15878, DOI 10.1021/la402669z; Wessel M, 2006, MOL MICROBIOL, V62, P906, DOI 10.1111/j.1365-2958.2006.05425.x; ZAMBRYSKI P, 1989, CELL, V56, P193, DOI 10.1016/0092-8674(89)90892-1; Zhang X, 2011, BIOCHEMISTRY-US, V50, P3879, DOI 10.1021/bi101702c	55	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160373	10.1371/journal.pone.0160373	http://dx.doi.org/10.1371/journal.pone.0160373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472399	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300046
J	Zhou, LL; Xu, MG; Yang, YG; Yang, K; Wickett, RR; Andl, T; Millar, SE; Zhang, YH				Zhou, Linli; Xu, Mingang; Yang, Yongguang; Yang, Kun; Wickett, Randall R.; Andl, Thomas; Millar, Sarah E.; Zhang, Yuhang			Activation of beta-Catenin Signaling in CD133-Positive Dermal Papilla Cells Drives Postnatal Hair Growth	PLOS ONE			English	Article							STEM-CELLS; FOLLICLE; EXPRESSION; CD133; CYCLE; RECOMBINATION; INDUCTION	The hair follicle dermal papilla (DP) contains a unique prominin-1/CD133-positive (CD133+) cell subpopulation, which has been shown to possess hair follicle-inducing capability. By assaying for endogenous CD133 expression and performing lineage tracing using CD133-CreER(T2); ZsGreen1 reporter mice, we find that CD133 is expressed in a subpopulation of DP cells during the growth phase of the murine hair cycle (anagen), but is absent at anagen onset. However, how CD133+ DP cells interact with keratinocytes to induce hair regenerative growth remains unclear. Wnt/beta-catenin has long been recognized as a major signaling pathway required for hair follicle morphogenesis, development, and regeneration. Nuclear Wnt/beta-catenin activity is observed in the DP during the hair growth phase. Here we show that induced expression of a stabilized form of beta-catenin in CD133+ DP cells significantly accelerates spontaneous and depilation-induced hair growth. However, hair follicle regression is not affected in these mutants. Further analysis indicates that CD133+ DP-expressed beta-catenin increases proliferation and differentiation of epithelial matrix keratinocytes. Upregulated Wnt/beta-catenin activity in CD133+ DP cells also increases the number of proliferating DP cells in each anagen follicle. Our data demonstrate that beta-catenin signaling potentiates the capability of CD133+ DP cells to promote postnatal hair growth.	[Zhou, Linli; Yang, Kun; Wickett, Randall R.; Zhang, Yuhang] Univ Cincinnati, Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA; [Yang, Yongguang] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc Biol, Cincinnati, OH 45267 USA; [Andl, Thomas] Univ Cent Florida, Burnett Sch Biomed Sci, Orlando, FL 32826 USA; [Millar, Sarah E.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; State University System of Florida; University of Central Florida; University of Pennsylvania; Pennsylvania Medicine	Zhang, YH (corresponding author), Univ Cincinnati, Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA.	yuhang.zhang@uc.edu	Zhang, Yuhang/AAC-8583-2019; Yang, Kun/ABH-2634-2020	Zhang, Yuhang/0000-0002-9738-5343; /0000-0002-6232-6271; Andl, Thomas/0000-0002-5555-468X	NIH [R03 AR062788]; NIAMS [R03 AR062788-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were supported by NIH grant R03 AR062788 (http://www.niams.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Richard J. Gilbertson and the St Jude Children's Research Hospital f for CD133-CreER<SUP>T2</SUP> (Prom1<SUP>C-L</SUP>) mice. This work was supported by NIAMS R03 AR062788-01 (Y.Z.).	Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Charruyer A, 2012, J INVEST DERMATOL, V132, P2522, DOI 10.1038/jid.2012.196; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Choi SA, 2012, CANCER LETT, V324, P221, DOI 10.1016/j.canlet.2012.05.026; Collins CA, 2012, DEV BIOL, V366, P290, DOI 10.1016/j.ydbio.2012.03.016; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Driskell RR, 2012, J INVEST DERMATOL, V132, P1084, DOI 10.1038/jid.2011.428; Enshell-Seijffers D, 2010, P NATL ACAD SCI USA, V107, P21564, DOI 10.1073/pnas.1007326107; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Fusi A, 2011, J INVEST DERMATOL, V131, P487, DOI 10.1038/jid.2010.285; Gay DL, 2015, J INVEST DERMATOL, V135, P45, DOI 10.1038/jid.2014.292; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Iida M, 2007, DEV GROWTH DIFFER, V49, P185, DOI 10.1111/j.1440-169x.2007.00907.x; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kaushal GS, 2015, J INVEST DERMATOL, V135, P2926, DOI 10.1038/jid.2015.319; Kishimoto J, 1999, P NATL ACAD SCI USA, V96, P7336, DOI 10.1073/pnas.96.13.7336; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Morgan BA, 2013, CELL STEM CELL, V13, P638, DOI 10.1016/j.stem.2013.11.012; MuEller-RoEver S, EICHMHMDRENS RES HOS; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nishimura EK, 2011, PIGM CELL MELANOMA R, V24, P401, DOI 10.1111/j.1755-148X.2011.00855.x; Nitahara A, 2006, J INVEST DERMATOL, V126, P1052, DOI 10.1038/sj.jid.5700112; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	32	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160425	10.1371/journal.pone.0160425	http://dx.doi.org/10.1371/journal.pone.0160425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472062	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300051
J	Li, F; Zhou, XF; Zhou, HY; Jia, JB; Li, LW; Zhai, SM; Yan, B				Li, Fei; Zhou, Xiaofei; Zhou, Hongyu; Jia, Jianbo; Li, Liwen; Zhai, Shumei; Yan, Bing			Reducing Both Pgp Overexpression and Drug Efflux with Anti-Cancer Gold-Paclitaxel Nanoconjugates	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; PHOTOTHERMAL ABLATION; CANCER; NANOPARTICLES; DELIVERY; CELLS; NANOCARRIERS; CYCLODEXTRINS; CHEMOTHERAPY	Repeated administrations of anti-cancer drugs to patients often induce drug resistance. P-glycoprotein (Pgp) facilitates an efficient drug efflux, preventing cellular accumulation of drugs and causing multi-drug resistance (MDR). In this study, we developed a gold-paclitaxel nanoconjugate system to overcome MDR. Gold nanoparticles (GNPs) were conjugated with beta-cyclodextrin enclosing paclitaxel (PTX) molecules and PEG molecules. GNP conjugates were effectively endocytosed by both drug-sensitive human lung cancer H460 cells and Pgp-overexpressed drug-resistant H460(PTX) cells. Compared with PTX, PGNPs did not induce the Pgp overexpression in drug-sensitive H460 cells after long-term treatment and also avoided being pumped out of cells by overexpressed Pgp molecules in H460(PTX) with a 17-fold lower EC50 compared to PTX. Fluorescent microscopy and flow cytometry further confirmed that fluorescent labeled PGNPs (f-PGNPs) maintained a high cellular PTX level in both H460 and H460(PTX) cells. These results demonstrated that nano-drug conjugates were able to avoid the development of drug resistance in sensitive cells and evade Pgp-mediated drug resistance and to maintain a high cytotoxicity in drug-resistant cancer cells. These findings exemplify a powerful nanotechnological approach to the long-lasting issue of chemotherapy-induced drug resistance.	[Li, Fei; Zhou, Xiaofei; Zhou, Hongyu; Jia, Jianbo; Li, Liwen; Zhai, Shumei; Yan, Bing] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China	Shandong University	Zhai, SM; Yan, B (corresponding author), Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.	smzhai@sdu.edu.cn; bingyan@yahoo.com	ZHOU, HONGYU/E-7031-2011	Jia, Jianbo/0000-0002-1703-6734	National Natural Science Foundation of China [21137002, 91543204]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB14030401]; Natural Science Foundation of Shandong Province [ZR2014BM026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the National Natural Science Foundation of China (grant numbers: 21137002 and 91543204 to BY) (http://www.nsfc.gov.cn), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant numbers: XDB14030401 to BY) (http://www.cas.cn) and the Natural Science Foundation of Shandong Province (grant numbers: ZR2014BM026 to SZ) (http://www.sdnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykac A, 2014, LANGMUIR, V30, P234, DOI 10.1021/la403454p; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Brewster ME, 2002, PHARMAZIE, V57, P94; Challa R, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060243; CHAUDHARY PM, 1993, J NATL CANCER I, V85, P632, DOI 10.1093/jnci/85.8.632; Chavanpatil MD, 2006, INT J PHARMACEUT, V320, P150, DOI 10.1016/j.ijpharm.2006.03.045; Chen Y, 2015, RSC ADV, V5, P8938, DOI 10.1039/c4ra13135e; Chithrani DB, 2010, RADIAT RES, V173, P719, DOI 10.1667/RR1984.1; Chung TH, 2007, BIOMATERIALS, V28, P2959, DOI 10.1016/j.biomaterials.2007.03.006; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Dong XW, 2010, NANOMEDICINE-UK, V5, P597, DOI [10.2217/nnm.10.35, 10.2217/NNM.10.35]; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Groneberg DA, 2006, CURR DRUG TARGETS, V7, P643, DOI 10.2174/138945006777435245; Gu YJ, 2012, NANOMED-NANOTECHNOL, V8, P204, DOI 10.1016/j.nano.2011.06.005; Guo R, 2010, LANGMUIR, V26, P5428, DOI 10.1021/la903893n; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Heo DN, 2012, BIOMATERIALS, V33, P856, DOI 10.1016/j.biomaterials.2011.09.064; Higgins C F, 1992, ANN REV CELL BIOL; Ho EA, 2007, J CONTROL RELEASE, V117, P20, DOI 10.1016/j.jconrel.2006.10.007; Horcajada P, 2010, NAT MATER, V9, P172, DOI [10.1038/NMAT2608, 10.1038/nmat2608, 10.1038/NMAT260B]; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Jain R, 2009, J CONTROL RELEASE, V138, P90, DOI 10.1016/j.jconrel.2009.05.010; Jiang DH, 2013, CANCER LETT, V335, P404, DOI 10.1016/j.canlet.2013.02.059; Jiao PF, 2011, J AM CHEM SOC, V133, P13918, DOI 10.1021/ja206118a; Khurana V., 2014, RECENT PATENTS NANOM, V4, P57, DOI DOI 10.2174/1877912304999140930143244; Kulkarni SA, 2013, PHARM RES-DORDR, V30, P2512, DOI 10.1007/s11095-012-0958-3; Kumar A, 2013, BIOTECHNOL ADV, V31, P593, DOI 10.1016/j.biotechadv.2012.10.002; Lamendola DE, 2003, CANCER RES, V63, P2200; LEE JS, 1994, MOL PHARMACOL, V46, P627; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li RB, 2010, ACS NANO, V4, P1399, DOI 10.1021/nn9011225; Libutti SK, 2010, CLIN CANCER RES, V16, P6139, DOI 10.1158/1078-0432.CCR-10-0978; Liu XW, 2011, BIOMATERIALS, V32, P144, DOI 10.1016/j.biomaterials.2010.08.096; Lowery AR, 2006, INT J NANOMED, V1, P149, DOI 10.2147/nano.2006.1.2.149; Mellor HR, 2008, PHARMACOLOGY, V81, P275, DOI 10.1159/000115967; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Park C, 2009, J MATER CHEM, V19, P2310, DOI 10.1039/b816209c; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Qiu LP, 2015, NANO LETT, V15, P457, DOI 10.1021/nl503777s; Shanker M, 2010, LUNG CANCER-TARGETS, V1, P23; Sharma AK, 2008, J CONTROL RELEASE, V131, P220, DOI 10.1016/j.jconrel.2008.07.031; Shi Q, 2015, BIOMATERIALS, V67, P169, DOI 10.1016/j.biomaterials.2015.07.023; Shi Y, 2013, INORG CHEM, V52, P9418, DOI 10.1021/ic400989v; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sierpe R, 2015, ACS APPL MATER INTER, V7, P15177, DOI 10.1021/acsami.5b00186; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Vigderman L, 2013, ADV DRUG DELIVER REV, V65, P663, DOI 10.1016/j.addr.2012.05.004; Wang F, 2011, ACS NANO, V5, P3679, DOI 10.1021/nn200007z; Wong HL, 2006, J PHARMACOL EXP THER, V317, P1372, DOI 10.1124/jpet.106.101154; Yergeri M, 2014, NANODRUG DELIVERY RE; Zahreddine H, 2013, FRONT PHARMACOL, V4; Zhang XD, 2012, BIOMATERIALS, V33, P6408, DOI 10.1016/j.biomaterials.2012.05.047; Zhang XQ, 2011, ACS NANO, V5, P6962, DOI 10.1021/nn201446c; Zhou HY, 2008, J MED CHEM, V51, P1242, DOI 10.1021/jm7012024	59	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160042	10.1371/journal.pone.0160042	http://dx.doi.org/10.1371/journal.pone.0160042			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467397	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100097
J	Salehi, Z; Doosti, R; Beheshti, M; Janzamin, E; Sahraian, MA; Izad, M				Salehi, Zahra; Doosti, Rozita; Beheshti, Masoumeh; Janzamin, Ehsan; Sahraian, Mohammad Ali; Izad, Maryam			Differential Frequency of CD8+T Cell Subsets in Multiple Sclerosis Patients with Various Clinical Patterns	PLOS ONE			English	Article							CD8(+) T-CELLS; INTERFERON-GAMMA; CHINESE PATIENTS; IL-21 RECEPTOR; MS PATIENTS; TC17 CELLS; LYMPHOCYTES; AUTOIMMUNE; CYTOKINES; DISEASE	Recent evidence points to a pathogenic role for CD8(+) cytotoxic T (Tc) cells in Multiple sclerosis (MS). Based on cytokine profile, Tc cells can be divided into different subsets: IFN-gamma (Tc1), IL-4 (Tc2), IL-10 (Tc10), IL-17 (Tc17), IL-21 (Tc21), IL-22 (Tc22) and TNF-alpha producing cells. In this study we evaluated the frequency of Tc cell subsets and the serum level of Tc17 differentiation cytokines in MS patients with different clinical patterns. We analyzed Tc cell subsets percentage in peripheral blood of relapsing-remitting (RRMS) (n = 28), secondary-progressive (SPMS) (n = 10) and primary-progressive (PPMS) (n = 4) MS patients in comparison to healthy controls (n = 15) using flow cytometry. Serum level of TGF-beta, IL-6 and IL-23 were measured by ELISA. We showed elevated levels of Tc1 and Tc17 cells in SPMS and RRMS patients in relapse phase, respectively (P = 0.04). Interestingly, the percentage of TNF-alpha producing CD8(+) T cells in relapse and remission phase of RRMS and SPMS patients were higher than controls (P = 0.01, P = 0.004, P = 0.01, respectively) and Tc21 increased in remission phase of RRMS compared to SPMS (P = 0.03). We also found higher frequency of CD8(+) IFN-gamma(+) TNF-alpha(+) IL-17(+) T cells in relapse phase of RRMS compared to remission phase, SPMS patients and controls (P = 0.01, P = 0.004 and P = 0.02, respectively). TGF-beta increased in sera of RRMS patients in remission phase (P = 0.03) and SPMS (P = 0.05) compared to healthy subjects. Increased level of Tc17 and CD8(+) IFN-gamma(+) TNF-alpha(+) IL-17(+) T cells in relapse phase highlights the critical role of IL-17 in RRMS pathogenesis.	[Salehi, Zahra; Izad, Maryam] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran; [Doosti, Rozita; Sahraian, Mohammad Ali; Izad, Maryam] Univ Tehran Med Sci, Inst Neurosci, MS Res Ctr, Tehran, Iran; [Beheshti, Masoumeh] Univ Tehran Med Sci, Sina Hosp, Pathophysiol Lab, Tehran, Iran; [Janzamin, Ehsan] Royan Inst, Dept Stem Cell & Dev Biol, Flow Cytometry Lab, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Izad, M (corresponding author), Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.; Sahraian, MA; Izad, M (corresponding author), Univ Tehran Med Sci, Inst Neurosci, MS Res Ctr, Tehran, Iran.	sahraian1350@yahoo.com; izadm@sina.tums.ac.ir	Salehi, Zahra/AAZ-2534-2020; Izad, Maryam/V-8694-2019; doosti, rozita/N-6273-2019	Salehi, Zahra/0000-0002-0839-2729; doosti, rozita/0000-0001-9811-9154; Sahraian, Mohammad Ali/0000-0002-3224-8807	Tehran University of Medical Sciences & health Services grant [89-04-30-12021]	Tehran University of Medical Sciences & health Services grant	This research has been supported by Tehran University of Medical Sciences & health Services grant 89-04-30-12021.	Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; BAKER D, 1994, EUR J IMMUNOL, V24, P2040, DOI 10.1002/eji.1830240916; Becher B, 1999, ANN NEUROL, V45, P247, DOI 10.1002/1531-8249(199902)45:2<247::AID-ANA16>3.0.CO;2-U; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Brinar Vesna, 2009, Acta Neuropsychiatr, V21 Suppl 2, P15, DOI 10.1017/S0924270800032622; Buckle GJ, 2003, NEUROLOGY, V60, P702, DOI 10.1212/01.WNL.0000048204.89346.30; Chen YC, 2012, J NEUROIMMUNOL, V249, P109, DOI 10.1016/j.jneuroim.2012.04.015; Chen YC, 2012, J NEUROIMMUNOL, V243, P56, DOI 10.1016/j.jneuroim.2011.12.008; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Croce M, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/696578; Etemadifar M, 2014, EUR NEUROL, V72, P370, DOI 10.1159/000365846; Falcone M, 1999, CURR OPIN IMMUNOL, V11, P670, DOI 10.1016/S0952-7915(99)00035-7; Friese MA, 2005, BRAIN, V128, P1747, DOI 10.1093/brain/awh578; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Furlan R, 2000, J NEUROIMMUNOL, V111, P86, DOI 10.1016/S0165-5728(00)00377-5; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Jacques FH, 2015, NEUROLOGY, V84, P963, DOI 10.1212/01.wnl.0000462309.76486.c5; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Killestein J, 2001, MULT SCLER, V7, P145, DOI 10.1191/135245801678438357; Kruglov AA, 2011, J IMMUNOL, V187, P5660, DOI 10.4049/jimmunol.1100663; Laplaud DA, 2004, BRAIN, V127, P981, DOI 10.1093/brain/awh119; Lassmann H, 2004, TRENDS IMMUNOL, V25, P275, DOI 10.1016/j.it.2004.01.007; Lovett-Racke AE, 2011, BBA-MOL BASIS DIS, V1812, P246, DOI 10.1016/j.bbadis.2010.05.012; Martinez-Altarriba MC, 2014, REV MULTIPLE SCLEROS, DOI [10.1016/j.semerg.2014.07.011, DOI 10.1016/J.SEMERG.2014.07.011]; Mehta DS, 2004, IMMUNOL REV, V202, P84, DOI 10.1111/j.0105-2896.2004.00201.x; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Nicoletti F, 1998, CLIN EXP IMMUNOL, V113, P96, DOI 10.1046/j.1365-2249.1998.00604.x; Ochi H, 2001, J NEUROIMMUNOL, V119, P297, DOI 10.1016/S0165-5728(01)00393-9; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pan HF, 2013, CYTOKINE GROWTH F R, V24, P51, DOI 10.1016/j.cytogfr.2012.07.002; Peelen E, 2013, J NEUROIMMUNOL, V258, P77, DOI 10.1016/j.jneuroim.2013.02.014; Perriard G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0335-3; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rollnik JD, 1997, ACTA NEUROL SCAND, V96, P101; Santarlasci V, 2009, EUR J IMMUNOL, V39, P207, DOI 10.1002/eji.200838748; Sepulcre J, 2005, CYTOKINE, V32, P111, DOI 10.1016/j.cyto.2005.08.005; Shajarian M, 2015, IMMUNOL INVEST, V44, P36, DOI 10.3109/08820139.2014.930477; Spolski R, 2010, CRIT REV IMMUNOL, V30, P559, DOI 10.1615/CritRevImmunol.v30.i6.50; Tajima M, 2011, INT IMMUNOL, V23, P751, DOI 10.1093/intimm/dxr086; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Tzartos JS, 2011, AM J PATHOL, V178, P794, DOI 10.1016/j.ajpath.2010.10.043; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351; Vukmanovic-Stejic M, 2000, BLOOD, V95, P231; Wade BJ, 2014, MULT SCLER INT, V2014, DOI 10.1155/2014/124578; Wang HH, 2011, J CLIN NEUROSCI, V18, P1313, DOI 10.1016/j.jocn.2011.01.031; Yen HR, 2009, J IMMUNOL, V183, P7161, DOI 10.4049/jimmunol.0900368; Zang YCQ, 2004, J IMMUNOL, V172, P5120, DOI 10.4049/jimmunol.172.8.5120	56	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159565	10.1371/journal.pone.0159565	http://dx.doi.org/10.1371/journal.pone.0159565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467597	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100040
J	Upadhyay, AK; Sowdhamini, R				Upadhyay, Atul Kumar; Sowdhamini, Ramanathan			Genome-Wide Prediction and Analysis of 3D-Domain Swapped Proteins in the Human Genome from Sequence Information	PLOS ONE			English	Article							AMINO-ACID RESIDUES; CRYSTAL-STRUCTURE; CYSTATIN	3D-domain swapping is one of the mechanisms of protein oligomerization and the proteins exhibiting this phenomenon have many biological functions. These proteins, which undergo domain swapping, have acquired much attention owing to their involvement in human diseases, such as conformational diseases, amyloidosis, serpinopathies, proteionopathies etc. Early realisation of proteins in the whole human genome that retain tendency to domain swap will enable many aspects of disease control management. Predictive models were developed by using machine learning approaches with an average accuracy of 78% (85.6% of sensitivity, 87.5% of specificity and an MCC value of 0.72) to predict putative domain swapping in protein sequences. These models were applied to many complete genomes with special emphasis on the human genome. Nearly 44% of the protein sequences in the human genome were predicted positive for domain swapping. Enrichment analysis was performed on the positively predicted sequences from human genome for their domain distribution, disease association and functional importance based on Gene Ontology (GO). Enrichment analysis was also performed to infer a better understanding of the functional importance of these sequences. Finally, we developed hinge region prediction, in the given putative domain swapped sequence, by using important physicochemical properties of amino acids.	[Upadhyay, Atul Kumar; Sowdhamini, Ramanathan] Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Sowdhamini, R (corresponding author), Natl Ctr Biol Sci TIFR, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	mini@ncbs.res.in	upadhyay, atul kumar/I-3368-2019	upadhyay, atul kumar/0000-0002-9146-8914	NCBS (National Centre for Biological Sciences); TIFR (Tata Institute of Fundamental Research) fellowship	NCBS (National Centre for Biological Sciences); TIFR (Tata Institute of Fundamental Research) fellowship(Tata Institute of Fundamental Research (TIFR))	This work was supported by NCBS (National Centre for Biological Sciences), TIFR (Tata Institute of Fundamental Research) fellowship, both to AKU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AKU is supported by NCBS (National Centre for Biological Sciences), TIER (Tata Institute of Fundamental Research) fellowship. We thank NCBS for infrastructure and other facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; BHASKARAN R, 1988, INT J PEPT PROT RES, V32, P241; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; BURGESS AW, 1974, ISRAEL J CHEM, V12, P239; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CRESTFIELD A M, 1962, Arch Biochem Biophys, VSuppl 1, P217; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donato ADI, 1995, HINTS EVOLUTIONARY D, P1470; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Finn RD, 2013, NUCLEIC ACIDS RES, pD211; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Gordon-Smith DJ, 2001, BIOCHEM BIOPH RES CO, V280, P855, DOI 10.1006/bbrc.2000.4196; Huang K, 2009, HELIX SWAPPING 2 ALP, V7, P539; Janowski R, 2001, HUMAN CYSTATIN C AMY, V8; Jask M, 2001, REVIEW, V48, P807; Joseph AP, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau026; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Khader Shameer, 2010, INSIGHTS PROTEIN SEQ, V4, P33; Kolodziejczyk R, 2010, FEBS J, V277, P1726, DOI 10.1111/j.1742-4658.2010.07596.x; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Liu C, NAT STRUCT MOL BIOL, P49; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; NAGANO K, 1973, J MOL BIOL, V75, P401, DOI 10.1016/0022-2836(73)90030-2; Ogihara NL, 2000, DESIGN 3 DIMENSIONAL; Shameer K, PROTEIN PEPT LETT, P1010; Shameer KD, J CLIN BIOINFORMA, P8; Shameer K, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar042; Shingate, 2012, IDENTIFICATION CONFO, P320; Shingate P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039305; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yang F, 1999, CRYSTAL STRUCTURE CY, P403; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	39	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159627	10.1371/journal.pone.0159627	http://dx.doi.org/10.1371/journal.pone.0159627			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467780	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100042
J	Mercuri, E; Coratti, G; Messina, S; Ricotti, V; Baranello, G; D'Amico, A; Pera, MC; Albamonte, E; Sivo, S; Mazzone, ES; Arnoldi, MT; Fanelli, L; De Sanctis, R; Romeo, DM; Vita, GL; Battini, R; Bertini, E; Muntoni, F; Pane, M				Mercuri, Eugenio; Coratti, Giorgia; Messina, Sonia; Ricotti, Valeria; Baranello, Giovanni; D'Amico, Adele; Pera, Maria Carmela; Albamonte, Emilio; Sivo, Serena; Mazzone, Elena Stacy; Arnoldi, Maria Teresa; Fanelli, Lavinia; De Sanctis, Roberto; Romeo, Domenico M.; Vita, Gian Luca; Battini, Roberta; Bertini, Enrico; Muntoni, Francesco; Pane, Marika			Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy	PLOS ONE			English	Article							6-MINUTE WALK TEST; CHILDREN; MOTOR	The advent of therapeutic approaches for Duchenne muscular dystrophy (DMD) has highlighted the need to identify reliable outcome measures for young boys with DMD. The aim of this study was to develop a revised version of the North Star Ambulatory Assessment (NSAA) suitable for boys between the age of 3 and 5 years by identifying age appropriate items and revising the scoring system accordingly. Using the scale in 171 controls between the age of 2.9 and 4.8 years, we identified items that were appropriate at different age points. An item was defined as age appropriate if it was completed, achieving a full score, by at least 85% of the typically developing boys at that age. At 3 years (+/- 3months) there were only 8 items that were age appropriate, at 3 years and 6 months there were 13 items while by the age of 4 years all 17 items were appropriate. A revised version of the scale was developed with items ordered according to the age when they could be reliably performed. The application of the revised version of the scale to data collected in young DMD boys showed that very few of the DMD boys were able to complete with a full score all the age appropriate items. In conclusion, our study suggests that a revised version of the NSAA can be used in boys from the age of 3 years to obtain information on how young DMD boys acquire new abilities and how this correlates with their peers.	[Mercuri, Eugenio; Coratti, Giorgia; Pera, Maria Carmela; Albamonte, Emilio; Sivo, Serena; Mazzone, Elena Stacy; Fanelli, Lavinia; De Sanctis, Roberto; Romeo, Domenico M.; Pane, Marika] Catholic Univ, Dept Paediat Neurol, Rome, Italy; [Mercuri, Eugenio; Coratti, Giorgia; Pera, Maria Carmela; Albamonte, Emilio; Sivo, Serena; Mazzone, Elena Stacy; Fanelli, Lavinia; De Sanctis, Roberto; Romeo, Domenico M.; Pane, Marika] Nemo Roma Ctr Neuromuscular Disorders, Rome, Italy; [Messina, Sonia; Vita, Gian Luca] Univ Messina, Dept Neurosci, Messina, Italy; [Messina, Sonia; Vita, Gian Luca] Univ Messina, Nemo & Clin Ctr, Psychiat & Anaesthesiol, Messina, Italy; [Ricotti, Valeria; Muntoni, Francesco] UCL, Dubowitz Neuromuscular Ctr, Inst Child Hlth, London, England; [Baranello, Giovanni; Arnoldi, Maria Teresa] Ist Neurol Besta, Dev Neurol Unit, Milan, Italy; [D'Amico, Adele; Bertini, Enrico] Bambino Gesu Pediat Hosp, Unit Neuromuscular & Neurodegenerat Dis, Dept Neurosci, Rome, Italy; [Battini, Roberta] Stella Maris Inst, Dept Dev Neurosci, Pisa, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Messina; University of Messina; University of London; University College London; IRCCS Istituto Neurologico Besta; IRCCS Bambino Gesu; IRCCS Fondazione Stella Maris	Mercuri, E (corresponding author), Catholic Univ, Dept Paediat Neurol, Rome, Italy.; Mercuri, E (corresponding author), Nemo Roma Ctr Neuromuscular Disorders, Rome, Italy.	mercuri@rm.unicatt.it	Romeo, Domenico/AFM-6244-2022; battini, roberta/P-9095-2017; Mazzone, Elena/AAF-4444-2020; Arnoldi, Maria Teresa/AAJ-2217-2021; Vita, Gianluca/AAR-4587-2020; Bertini, Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014; Coratti, Giorgia/AAV-3224-2021; Coratti, Giorgia/Y-6292-2019; Romeo, Domenico M/K-7957-2016; Pera, Maria Carmela/J-6068-2018; Mercuri, Eugenio/G-1351-2015	battini, roberta/0000-0002-7889-1355; Arnoldi, Maria Teresa/0000-0002-3920-5869; Vita, Gianluca/0000-0003-4190-8042; Bertini, Enrico/0000-0001-9276-4590; Coratti, Giorgia/0000-0001-6666-5628; Coratti, Giorgia/0000-0001-6666-5628; Romeo, Domenico M/0000-0002-6229-1208; ALBAMONTE, EMILIO/0000-0002-8465-4460; Pera, Maria Carmela/0000-0001-6777-1721; Mercuri, Eugenio/0000-0002-9851-5365; Pane, Marika/0000-0002-4851-6124	Telethon-Uildm [GUP15011]; Italian Telethon; Great Ormond Street Hospital (GOSH) Children's Charity; GOSH Biomedical Research Centre; Muscular Dystrophy Campaign	Telethon-Uildm(Fondazione Telethon); Italian Telethon(Fondazione Telethon); Great Ormond Street Hospital (GOSH) Children's Charity; GOSH Biomedical Research Centre; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission)	This work was supported by Telethon-Uildm (Award number: GUP15011) http://www.telethon.it/. Elena Mazzone is a TREAT NMD research fellow funded by the Italian Telethon. Francesco Muntoni is supported by the Great Ormond Street Hospital (GOSH) Children's Charity and the GOSH Biomedical Research Centre. The support of the Muscular Dystrophy Campaign to the UK North Star Network is also gratefully acknowledged. The authors have stated that they had no interests which might be perceived as posing conflict or bias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMP BW, 1977, CLIN PEDIATR, V16, P257, DOI 10.1177/000992287701600309; Chieffo D, 2015, PLOS ONE, V14, P10; Connolly AM, 2014, PEDIATR NEUROL, V50, P557, DOI 10.1016/j.pediatrneurol.2014.02.006; Connolly AM, 2013, NEUROMUSCULAR DISORD, V23, P529, DOI 10.1016/j.nmd.2013.04.005; de Lattre C, 2013, ARCH PHYS MED REHAB, V94, P2218, DOI 10.1016/j.apmr.2013.04.001; De Sanctis R, 2015, NEUROMUSCULAR DISORD, V25, P14, DOI 10.1016/j.nmd.2014.09.015; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Griffiths R., 1970, ABILITIES YOUNG CHIL; Guglieri M, 2010, CURR OPIN PHARMACOL, V10, P331, DOI 10.1016/j.coph.2010.03.005; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2009, NEUROMUSCULAR DISORD, V19, P458, DOI 10.1016/j.nmd.2009.06.368; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P451, DOI 10.1016/j.nmd.2013.02.012; PIPER MC, 1992, CAN J PUBLIC HEALTH, V83, pS46; Scott E, 2011, PHYSIOTHER RES INT, V17, P101, DOI DOI 10.1002/PRI.520	17	25	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160195	10.1371/journal.pone.0160195	http://dx.doi.org/10.1371/journal.pone.0160195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494024	gold, Green Submitted, Green Published			2022-12-27	WOS:000381369500022
J	Mansur, RB; Cunha, GR; Asevedo, E; Zugman, A; Zeni-Graiff, M; Rios, AC; Sethi, S; Maurya, PK; Levandowski, ML; Gadelha, A; Pan, PM; Stertz, L; Belangero, SI; Anna, MKS; Teixeira, AL; Mari, JJ; Rohde, LA; Miguel, EC; McIntyre, RS; Grassi-Oliveira, R; Bressan, RA; Brietzke, E				Mansur, Rodrigo B.; Cunha, Graccielle R.; Asevedo, Elson; Zugman, Andre; Zeni-Graiff, Maiara; Rios, Adiel C.; Sethi, Sumit; Maurya, Pawan K.; Levandowski, Mateus L.; Gadelha, Ary; Pan, Pedro M.; Stertz, Laura; Belangero, Sintia I.; Anna, Marcia Kauer-Sant'; Teixeira, Antonio L.; Mari, Jair J.; Rohde, Luis A.; Miguel, Euripedes C.; McIntyre, Roger S.; Grassi-Oliveira, Rodrigo; Bressan, Rodrigo A.; Brietzke, Elisa			Socioeconomic Disadvantage Moderates the Association between Peripheral Biomarkers and Childhood Psychopathology	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; PSYCHIATRIC-DISORDERS; BEHAVIOR-CHECKLIST; OXIDATIVE STRESS; LIFE EVENTS; PERINATAL COMPLICATIONS; INTERNALIZING PROBLEMS; SERUM INTERLEUKIN-6; BRAIN-DEVELOPMENT; LATE-ADOLESCENCE	Background Socioeconomic disadvantage (SED) has been consistently associated with early life mental health problems. SED has been shown to impact multiple biological systems, including the regulation of neurotrophic proteins, immune-inflammatory and oxidative stress markers, which, conversely, have been reported to be relevant to physiological and pathological neurodevelopment This study investigated the relationship between SED, different domains of psychopathology, serum levels of interleukin-6 (IL6), thiobarbituric acid-reactive substance (TBARS) and brain-derived neurotrophic factor (BDNF). We hypothesized that a composite of socioeconomic risk would be associated with psychopathology and altered levels of peripheral biomarkers. In addition, we hypothesized that SED would moderate the associations between mental health problems, IL6, TBARS and BDNF. Methods and Findings Using a cross-sectional design, we measured the serum levels of IL6, TBARS and BDNF in 495 children aged 6 to 12. We also investigated socio-demographic characteristics and mental health problems using the Child Behaviour Checklist (CBCL) DSM-oriented scales. SED was evaluated using a cumulative risk model. Generalized linear models were used to assess associations between SED, biomarkers levels and psychopathology. SED was significantly associated with serum levels of IL6 (RR = 1.026, 95% CI 1.004; 1.049, p = 0.020) and TBARS (RR = 1.077, 95% CI 1.028; 1.127, p = 0.002). The association between SED and BDNF was not statistically significant (RR = 1.031, 95% CI 0.997; 1.066, p = 0.077). SED was also significantly associated with all CBCL DSM-oriented scales (all p < 0.05), whereas serum biomarkers (i.e. IL6, TBARS, BDNF) were associated with specific subscales. Moreover, the associations between serum biomarkers and domains of psychopathology were moderated by SED, with stronger correlations between mental health problems, IL6, TBARS, and BDNF being observed in children with high SED. Conclusions In children, SED is highly associated with mental health problems. Our findings suggest that this association may be moderated via effects on multiple interacting neurobiological systems.	[Mansur, Rodrigo B.; Cunha, Graccielle R.; Asevedo, Elson; Zugman, Andre; Levandowski, Mateus L.; Gadelha, Ary; Pan, Pedro M.; Stertz, Laura; Belangero, Sintia I.; Anna, Marcia Kauer-Sant'; Teixeira, Antonio L.; Mari, Jair J.; Rohde, Luis A.; Miguel, Euripedes C.; Grassi-Oliveira, Rodrigo; Bressan, Rodrigo A.; Brietzke, Elisa] CNPq, Natl Inst Dev Psychiat Children & Adolescents, Sao Paulo, Brazil; [Mansur, Rodrigo B.; Cunha, Graccielle R.; Asevedo, Elson; Zugman, Andre; Zeni-Graiff, Maiara; Rios, Adiel C.; Sethi, Sumit; Maurya, Pawan K.; Gadelha, Ary; Pan, Pedro M.; Belangero, Sintia I.; Mari, Jair J.; Bressan, Rodrigo A.; Brietzke, Elisa] Univ Fed Sao Paulo UNIFESP, Interdisciplinary Lab Clin Neurosci LiNC, Sao Paulo, Brazil; [Mansur, Rodrigo B.; McIntyre, Roger S.] Univ Toronto, Mood Disorders Psychopharmacol Unit MDPU, Univ Hlth Network, Toronto, ON, Canada; [Levandowski, Mateus L.; Grassi-Oliveira, Rodrigo] Pontificia Univ Catolica Rio Grande do Sul, Inst Biomed Res, Porto Alegre, RS, Brazil; [Stertz, Laura; Anna, Marcia Kauer-Sant'; Rohde, Luis A.] Univ Fed Rio Grande do Sul, Dept Psychiat, Porto Alegre, RS, Brazil; [Stertz, Laura] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Ctr Translat Psychiat, Houston, TX 77030 USA; [Teixeira, Antonio L.] Univ Fed Minas Gerais, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil; [Miguel, Euripedes C.] Univ Sao Paulo, Dept Psychiat, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Universidade Federal de Minas Gerais; Universidade de Sao Paulo	Mansur, RB (corresponding author), CNPq, Natl Inst Dev Psychiat Children & Adolescents, Sao Paulo, Brazil.; Mansur, RB (corresponding author), Univ Fed Sao Paulo UNIFESP, Interdisciplinary Lab Clin Neurosci LiNC, Sao Paulo, Brazil.; Mansur, RB (corresponding author), Univ Toronto, Mood Disorders Psychopharmacol Unit MDPU, Univ Hlth Network, Toronto, ON, Canada.	rodrigomansur71@uol.com.br	Levandowski, Mateus L/A-5700-2018; Miguel, Euripedes C/B-2871-2008; Rohde, Luis Augusto P/A-6426-2008; Mansur, Rodrigo/R-5383-2017; Mansur, Rodrigo/N-7131-2019; Brietzke, Elisa/G-9559-2012; McIntyre, Roger/AAU-1000-2020; Zugman, Andre/W-8157-2019; Asevedo, Elson/F-8645-2015; Grassi-Oliveira, R/G-2623-2012; Belangero, Sintia I/A-6818-2009; Pan, Pedro M/I-5167-2013; Stertz, Laura/AAC-7384-2019; de Jesus Mari, Jair/A-7309-2008; Teixeira, Antonio L/N-3315-2014; Bressan, Rodrigo A/E-9178-2010	Rohde, Luis Augusto P/0000-0002-4552-4188; Mansur, Rodrigo/0000-0002-3968-3297; Mansur, Rodrigo/0000-0002-3968-3297; Brietzke, Elisa/0000-0003-2697-1342; McIntyre, Roger/0000-0003-4733-2523; Zugman, Andre/0000-0002-6126-7759; Asevedo, Elson/0000-0002-3109-2695; Grassi-Oliveira, R/0000-0001-9911-5921; Belangero, Sintia I/0000-0002-2419-4351; Pan, Pedro M/0000-0002-1943-6520; Stertz, Laura/0000-0002-1426-6796; de Jesus Mari, Jair/0000-0002-5403-0112; Teixeira, Antonio L/0000-0002-9621-5422; Bressan, Rodrigo A/0000-0002-0868-4449; Gadelha de Alencar Araripe Neto, Ary/0000-0002-0993-8017; Graiff, Maiara/0000-0002-2974-7736; Levandowski, Mateus/0000-0002-6188-620X	National Council for Scientific and Technological Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Sao Paulo Research Foundation (FAPESP)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the following Brazilian government agencies: The National Council for Scientific and Technological Development (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and the Sao Paulo Research Foundation (FAPESP). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Amone-P'Olak K, 2011, J EPIDEMIOL COMMUN H, V65, P57, DOI 10.1136/jech.2009.092569; Amone-P'Olak K, 2009, SOC PSYCH PSYCH EPID, V44, P231, DOI 10.1007/s00127-008-0424-z; Ashford J, 2008, J CHILD PSYCHOL PSYC, V49, P774, DOI 10.1111/j.1469-7610.2008.01889.x; Atzaba-Poria N, 2004, J CHILD PSYCHOL PSYC, V45, P707, DOI 10.1111/j.1469-7610.2004.00265.x; Bannink R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080812; Bellina M, 2013, EUR CHILD ADOLES PSY, V22, P235, DOI 10.1007/s00787-012-0343-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bordin IA, 2013, CAD SAUDE PUBLICA, V29, P13, DOI 10.1590/S0102-311X2013000100004; Brown NC, 2014, PSYCHIAT RES, V218, P61, DOI 10.1016/j.psychres.2014.04.005; Burt SA, 2014, J CHILD PSYCHOL PSYC, V55, P304, DOI 10.1111/jcpp.12173; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Carter AS, 2010, J AM ACAD CHILD PSY, V49, P686, DOI 10.1016/j.jaac.2010.03.018; Cicchetti D, 1999, J CLIN CHILD PSYCHOL, V28, P355, DOI 10.1207/S15374424jccp280308; Coccaro EF, 2016, BIOL PSYCHIAT, V79, P127, DOI 10.1016/j.biopsych.2014.01.014; Copeland WE, 2009, ARCH GEN PSYCHIAT, V66, P764, DOI 10.1001/archgenpsychiatry.2009.85; DODGE KA, 1994, CHILD DEV, V65, P649, DOI 10.2307/1131407; Evans J, 2004, SOC PSYCH PSYCH EPID, V39, P165, DOI 10.1007/s00127-004-0733-9; Fernandes BS, 2014, MOL PSYCHIATR, V19, P749, DOI 10.1038/mp.2013.172; Flouri E, 2007, J AM ACAD CHILD PSY, V46, P1651, DOI 10.1097/chi.0b013e318156a81a; Flouri E, 2010, EUR CHILD ADOLES PSY, V19, P535, DOI 10.1007/s00787-009-0068-x; Garcia-Bueno B, 2008, NEUROSCI BIOBEHAV R, V32, P1136, DOI 10.1016/j.neubiorev.2008.04.001; Gemma C, 2007, FRONTIERS NEUROSCIEN; Gratten J, 2014, NAT NEUROSCI, V17, P782, DOI 10.1038/nn.3708; Guney E, 2015, PSYCHIAT RES, V229, P310, DOI 10.1016/j.psychres.2015.07.003; Gustafsson PE, 2015, EUR J PUBLIC HEALTH, V25, P592, DOI 10.1093/eurpub/cku213; Haddad L, 2015, SCHIZOPHRENIA BULL, V41, P115, DOI 10.1093/schbul/sbu072; Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475; Hanson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080954; Hofstra MB, 2001, BRIT J PSYCHIAT, V179, P203, DOI 10.1192/bjp.179.3.203; Holz NE, 2015, CURR OPIN PSYCHIATR, V28, P365, DOI 10.1097/YCO.0000000000000178; Holz NE, 2015, NEUROPSYCHOPHARMACOL, V40, P996, DOI 10.1038/npp.2014.277; Howes OD, 2014, LANCET, V383, P1677, DOI 10.1016/S0140-6736(13)62036-X; Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405, DOI 10.1080/15374410701444363; John-Henderson NA, 2016, PSYCHOSOM MED, V78, P91, DOI 10.1097/PSY.0000000000000262; Kapi A, 2007, SOC PSYCH PSYCH EPID, V42, P594, DOI 10.1007/s00127-007-0201-4; Khandaker GM, 2014, JAMA PSYCHIAT, V71, P1121, DOI 10.1001/jamapsychiatry.2014.1332; Kofink D, 2013, NEUROSCI BIOBEHAV R, V37, P831, DOI 10.1016/j.neubiorev.2013.03.020; Sistere ML, 2014, PSICOTHEMA, V26, P364, DOI 10.7334/psicothema2013.342; Lahelma E, 2006, SOC SCI MED, V63, P1383, DOI 10.1016/j.socscimed.2006.03.027; Lasky-Su J, 2007, BEHAV GENET, V37, P487, DOI 10.1007/s10519-006-9136-x; Leonard B, 2012, NEUROSCI BIOBEHAV R, V36, P764, DOI 10.1016/j.neubiorev.2011.12.005; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Lin WM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/340936; Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139; Mansur RB, 2016, PSYCHONEUROENDOCRINO, V71, P94, DOI 10.1016/j.psyneuen.2016.05.015; Marsh P, 2003, DEV PSYCHOPATHOL, V15, P451, DOI 10.1017/S0954579403000245; Matthews KA, 2016, PSYCHOSOM MED, V78, P311, DOI 10.1097/PSY.0000000000000283; Miller GE, 2012, BIOL PSYCHIAT, V72, P34, DOI 10.1016/j.biopsych.2012.02.034; Mitchell RHB, 2014, J AM ACAD CHILD PSY, V53, P274, DOI 10.1016/j.jaac.2013.11.013; Modabbernia A, 2013, BIOL PSYCHIAT, V74, P15, DOI 10.1016/j.biopsych.2013.01.007; Nobile M, 2013, EPIDEMIOL PSYCH SCI, V22, P63, DOI 10.1017/S2045796012000145; Oldehinkel AJ, 2004, DEV PSYCHOPATHOL, V16, P421, DOI 10.1017/S0954579404044591; Packard CJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-42; Petresco S, 2014, SOC PSYCH PSYCH EPID, V49, P975, DOI 10.1007/s00127-014-0826-z; Pfaffenseller B, 2013, EXPERT REV NEUROTHER, V13, P827, DOI 10.1586/14737175.2013.811981; Reef J, 2011, SOC PSYCH PSYCH EPID, V46, P1233, DOI 10.1007/s00127-010-0297-9; Reef J, 2010, J AM ACAD CHILD PSY, V49, P1117, DOI 10.1016/j.jaac.2010.08.002; Reijneveld SA, 2005, SOC PSYCH PSYCH EPID, V40, P18, DOI 10.1007/s00127-005-0850-0; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Rowe R, 2006, J ABNORM CHILD PSYCH, V34, P293, DOI 10.1007/s10802-006-9032-0; Salum GA, 2015, INT J METH PSYCH RES, V24, P58, DOI 10.1002/mpr.1459; Schneiders J, 2003, J EPIDEMIOL COMMUN H, V57, P699, DOI 10.1136/jech.57.9.699; Selten JP, 2013, SCHIZOPHRENIA BULL, V39, P1180, DOI 10.1093/schbul/sbt134; Shalev I, 2014, PEDIATRICS, V134, pE1315, DOI 10.1542/peds.2014-1669; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Snelgrove JW, 2015, ACTA OBSTET GYN SCAN, V94, P766, DOI 10.1111/aogs.12648; Stansfeld S, 2008, SOC PSYCH PSYCH EPID, V43, P516, DOI 10.1007/s00127-008-0330-4; Stringhini S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001479; Upthegrove R, 2014, SCHIZOPHR RES, V155, P101, DOI 10.1016/j.schres.2014.03.005; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vendlinski MK, 2011, J CHILD PSYCHOL PSYC, V52, P607, DOI 10.1111/j.1469-7610.2010.02343.x; Versace A, 2014, MOL PSYCHIATR, V19, P200, DOI 10.1038/mp.2012.188; Vilsaint CL, 2013, J PRIM PREV, V34, P261, DOI 10.1007/s10935-013-0305-4; Vos AA, 2014, ACTA OBSTET GYN SCAN, V93, P727, DOI 10.1111/aogs.12430; WILLS ED, 1966, BIOCHEM J, V99, P657, DOI 10.1042/bj0990657	75	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160455	10.1371/journal.pone.0160455	http://dx.doi.org/10.1371/journal.pone.0160455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27489945	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900059
J	Seidelmann, KN; Scherer-Lorenzen, M; Niklaus, PA				Seidelmann, Katrin N.; Scherer-Lorenzen, Michael; Niklaus, Pascal A.			Direct vs. Microclimate-Driven Effects of Tree Species Diversity on Litter Decomposition in Young Subtropical Forest Stands	PLOS ONE			English	Article							PLANT DIVERSITY; BIODIVERSITY; RATES; SOIL; QUALITY; CANOPY; MECHANISMS; CHEMISTRY; DYNAMICS; NITROGEN	Effects of tree species diversity on decomposition can operate via a multitude of mechanism, including alterations of microclimate by the forest canopy. Studying such effects in natural settings is complicated by the fact that topography also affects microclimate and thus decomposition, so that effects of diversity are more difficult to isolate. Here, we quantified decomposition rates of standard litter in young subtropical forest stands, separating effects of canopy tree species richness and topography, and quantifying their direct and micro-climate-mediated components. Our litterbag study was carried out at two experimental sites of a biodiversity-ecosystem functioning field experiment in south-east China (BEF-China). The field sites display strong topographical heterogeneity and were planted with tree communities ranging from monocultures to mixtures of 24 native subtropical tree species. Litter bags filled with senescent leaves of three native tree species were placed from Nov. 2011 to Oct. 2012 on 134 plots along the tree species diversity gradient. Topographic features were measured for all and microclimate in a subset of plots. Stand species richness, topography and microclimate explained important fractions of the variations in litter decomposition rates, with diversity and topographic effects in part mediated by microclimatic changes. Tree stands were 2-3 years old, but nevertheless tree species diversity explained more variation (54.3%) in decomposition than topography (7.7%). Tree species richness slowed litter decomposition, an effect that slightly depended on litter species identity. A large part of the variance in decomposition was explained by tree species composition, with the presence of three tree species playing a significant role. Microclimate explained 31.4% of the variance in decomposition, and was related to lower soil moisture. Within this microclimate effect, species diversity (without composition) explained 8.9% and topography 34.4% of variance. Topography mainly affected diurnal temperature amplitudes by varying incident solar radiation.	[Seidelmann, Katrin N.; Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol, Geobot, Freiburg, Germany; [Niklaus, Pascal A.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland	University of Freiburg; University of Zurich	Seidelmann, KN (corresponding author), Univ Freiburg, Fac Biol, Geobot, Freiburg, Germany.	katrin.seidelmann@biologie.uni-freiburg.de	Niklaus, Pascal A/G-5786-2010; Scherer-Lorenzen, Michael/AGB-4140-2022	Niklaus, Pascal A/0000-0002-2360-1357; Scherer-Lorenzen, Michael/0000-0001-9566-590X	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG FOR 891/2]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This project was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG FOR 891/2), URL: http://www.dfg.de (http://www.dfg.eu). BEF-China is a member of TreeDivNet, a global platform of tree diversity experiments (http://www.treedivnet.ugent.be/). MSL PAN.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Albers D, 2004, SOIL BIOL BIOCHEM, V36, P155, DOI 10.1016/j.soilbio.2003.09.002; ANDERSON JM, 1978, OECOLOGIA, V32, P341, DOI 10.1007/BF00345112; Berg B., 1980, Ecological Bulletins, V32, P373; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Bruelheide H, 2013, SITE PLOTS DIVERSITY; Bruelheide H, 2013, SITE A PLOTS DIVERSI; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Caldeira MC, 2001, ECOL LETT, V4, P439, DOI 10.1046/j.1461-0248.2001.00238.x; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; CHAPMAN K, 1988, AGR ECOSYST ENVIRON, V24, P33, DOI 10.1016/0167-8809(88)90054-0; Cornelissen JHC, 1996, J ECOL, V84, P573, DOI 10.2307/2261479; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; DIX NJ, 1984, SOIL BIOL BIOCHEM, V16, P367, DOI 10.1016/0038-0717(84)90034-8; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; FOGEL R, 1977, CAN J BOT, V55, P1632, DOI 10.1139/b77-190; Freschet GT, 2012, J ECOL, V100, P619, DOI 10.1111/j.1365-2745.2011.01943.x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; GILLON D, 1994, CAN J BOT, V72, P946, DOI 10.1139/b94-120; Gray AN, 2002, CAN J FOREST RES, V32, P332, DOI [10.1139/x01-200, 10.1139/X01-200]; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; HARRISON A F, 1971, Soil Biology and Biochemistry, V3, P167, DOI 10.1016/0038-0717(71)90011-3; Hattenschwiler S, 2005, ECOL STUD-ANAL SYNTH, V176, P149; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Inkilainen ENM, 2013, LANDSCAPE URBAN PLAN, V119, P91, DOI 10.1016/j.landurbplan.2013.07.002; Ishii R, 1997, P ROY SOC B-BIOL SCI, V264, P133, DOI 10.1098/rspb.1997.0020; Jacob M, 2010, OECOLOGIA, V164, P1083, DOI 10.1007/s00442-010-1699-9; Jacob M, 2009, SOIL BIOL BIOCHEM, V41, P2122, DOI 10.1016/j.soilbio.2009.07.024; Keenan Rodney J., 1993, Environmental Reviews, V1, P121, DOI 10.1139/a93-010; Kim HS, 2011, TREE PHYSIOL, V31, P30, DOI 10.1093/treephys/tpq098; Kunert N, 2012, J APPL ECOL, V49, P135, DOI 10.1111/j.1365-2664.2011.02065.x; Li Y, 2014, FOREST ECOL MANAG, V327, P118, DOI 10.1016/j.foreco.2014.04.039; Lin BS, 2010, HORTSCIENCE, V45, P83, DOI 10.21273/HORTSCI.45.1.83; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Peh KSH, 2012, J VEG SCI, V23, P223, DOI 10.1111/j.1654-1103.2011.01352.x; Peng SY, 2018, J GERONTOL B-PSYCHOL, V73, P1123, DOI 10.1093/geronb/gbw105; Perez-Harguindeguy N, 2000, PLANT SOIL, V218, P21, DOI 10.1023/A:1014981715532; Pimentel D, 1998, ECOSYSTEMS, V1, P416, DOI 10.1007/s100219900035; Prescott CE, 2002, TREE PHYSIOL, V22, P1193, DOI 10.1093/treephys/22.15-16.1193; Rosenkranz S, 2012, SOIL BIOL BIOCHEM, V48, P78, DOI 10.1016/j.soilbio.2012.01.008; Sariyildiz T, 2005, SOIL BIOL BIOCHEM, V37, P1695, DOI 10.1016/j.soilbio.2005.02.004; Sariyildiz T, 2008, SCAND J FOREST RES, V23, P330, DOI 10.1080/02827580802275816; Scherer-Lorenzen M, 2008, FUNCT ECOL, V22, P547, DOI 10.1111/j.1365-2435.2008.01389.x; Scherer-Lorenzen M., 2014, FORESTS GLOBAL CHANG, P195, DOI DOI 10.1017/CBO9781107323506.011; Scherer-Lorenzen M, 2007, OIKOS, V116, P2108, DOI 10.1111/j.2007.0030-1299.16065.x; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Song Xin-zhang, 2009, Yingyong Shengtai Xuebao, V20, P537; Spehn EM, 2000, PLANT SOIL, V224, P217, DOI 10.1023/A:1004891807664; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Trogisch S., 2012, THESIS; Xuluc-Tolosa FJ, 2003, FOREST ECOL MANAG, V174, P401, DOI 10.1016/S0378-1127(02)00059-2; Yang XF, 2013, EUR J FOREST RES, V132, P593, DOI 10.1007/s10342-013-0696-z	54	14	18	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160569	10.1371/journal.pone.0160569	http://dx.doi.org/10.1371/journal.pone.0160569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490180	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000381368900070
J	Fu, C; Begum, K; Jordan, PW; He, Y; Overbeek, PA				Fu, Chun; Begum, Khurshida; Jordan, Philip W.; He, Yan; Overbeek, Paul A.			Dearth and Delayed Maturation of Testicular Germ Cells in Fanconi Anemia E Mutant Male Mice	PLOS ONE			English	Article							FANCD2; MOUSE; GENE; HYPERSENSITIVITY; PROLIFERATION; MUTATIONS; DEFECTS; LEADS	After using a self-inactivating lentivirus for non-targeted insertional mutagenesis in mice, we identified a transgenic family with a recessive mutation that resulted in reduced fertility in homozygous transgenic mice. The lentiviral integration site was amplified by inverse PCR. Sequencing revealed that integration had occurred in intron 8 of the mouse Fance gene, which encodes the Fanconi anemia E (Fance) protein. Fanconi anemia (FA) proteins play pivotal roles in cellular responses to DNA damage and Fance acts as a molecular bridge between the FA core complex and Fancd2. To investigate the reduced fertility in the mutant males, we analyzed postnatal development of testicular germ cells. At one week after birth, most tubules in the mutant testes contained few or no germ cells. Over the next 2-3 weeks, germ cells accumulated in a limited number of tubules, so that some tubules contained germ cells around the full periphery of the tubule. Once sufficient numbers of germ cells had accumulated, they began to undergo the later stages of spermatogenesis. Immunoassays revealed that the Fancd2 protein accumulated around the periphery of the nucleus in normal developing spermatocytes, but we did not detect a similar localization of Fancd2 in the Fance mutant testes. Our assays indicate that although Fance mutant males are germ cell deficient at birth, the extant germ cells can proliferate and, if they reach a threshold density, can differentiate into mature sperm. Analogous to previous studies of FA genes in mice, our results show that the Fance protein plays an important, but not absolutely essential, role in the initial developmental expansion of the male germ line.	[Fu, Chun; He, Yan] Cent S Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha 410011, Hunan, Peoples R China; [Begum, Khurshida; Overbeek, Paul A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jordan, Philip W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Central South University; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fu, C (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha 410011, Hunan, Peoples R China.	csxyfc@sina.com		Jordan, Philip/0000-0003-4890-2647; Overbeek, Paul/0000-0001-9784-2084	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117155] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM117155] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agoulnik AI, 2002, HUM MOL GENET, V11, P3047, DOI 10.1093/hmg/11.24.3047; Auerbach Arleen D, 2015, Curr Protoc Hum Genet, V85, DOI 10.1002/0471142905.hg0807s85; Bakker ST, 2013, DIS MODEL MECH, V6, P40, DOI 10.1242/dmm.009795; Bakker ST, 2009, HUM MOL GENET, V18, P3484, DOI 10.1093/hmg/ddp297; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Buisson R, 2015, MOL CELL, V59, P1011, DOI 10.1016/j.molcel.2015.07.029; Fu C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144285; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hopkins J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004413; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Kashiyama K, 2013, AM J HUM GENET, V92, P807, DOI 10.1016/j.ajhg.2013.04.007; Kato Y, 2015, HUM MOL GENET, V24, P5234, DOI 10.1093/hmg/ddv244; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Koomen M, 2002, HUM MOL GENET, V11, P273, DOI 10.1093/hmg/11.3.273; Myers KC, 2011, BRIT J HAEMATOL, V154, P234, DOI 10.1111/j.1365-2141.2011.08721.x; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Polito D, 2014, J BIOL CHEM, V289, P7003, DOI 10.1074/jbc.M113.533976; Risitano AM, 2016, HAEMATOLOGICA, V101, P319, DOI 10.3324/haematol.2015.133520; Sharan SK, 2004, DEVELOPMENT, V131, P131, DOI 10.1242/dev.00888; Singh TR, 2009, BLOOD, V114, P174, DOI 10.1182/blood-2009-02-207811; Sun XF, 2016, CHROMOSOMA, V125, P237, DOI 10.1007/s00412-015-0549-2; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; Tulpule A, 2010, BLOOD, V115, P3453, DOI 10.1182/blood-2009-10-246694; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; van de Vrugt HJ, 2011, DNA REPAIR, V10, P1252, DOI 10.1016/j.dnarep.2011.09.015; Waisfisz Q, 1999, AM J HUM GENET, V64, P1400, DOI 10.1086/302385; Wilson JB, 2001, CARCINOGENESIS, V22, P1939, DOI 10.1093/carcin/22.12.1939; Wong JCY, 2003, HUM MOL GENET, V12, P2063, DOI 10.1093/hmg/ddg219; Wong JCY, 2002, TRENDS MOL MED, V8, P139, DOI 10.1016/S1471-4914(01)02262-6; Wong K, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r72	30	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159800	10.1371/journal.pone.0159800	http://dx.doi.org/10.1371/journal.pone.0159800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486799	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800040
J	Hirakawa, T; Yashiro, M; Doi, Y; Kinoshita, H; Morisaki, T; Fukuoka, T; Hasegawa, T; Kimura, K; Amano, R; Hirakawa, K				Hirakawa, Toshiki; Yashiro, Masakazu; Doi, Yosuke; Kinoshita, Haruhito; Morisaki, Tamami; Fukuoka, Tatsunari; Hasegawa, Tsuyoshi; Kimura, Kenjiro; Amano, Ryosuke; Hirakawa, Kosei			Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR-I; STELLATE CELLS; TGF-BETA; EXPRESSION; RECEPTOR; TUMORS; OVEREXPRESSION; PROGNOSIS; ADENOCARCINOMA	Pancreatic ductal adenocarcinoma (PDAC) is characterized by its hypovascularity, with an extremely poor prognosis because of its highly invasive nature. PDAC proliferates with abundant stromal cells, suggesting that its invasive activity might be controlled by intercellular interactions between cancer cells and fibroblasts. Using four PDAC cell lines and two pancreas cancer-associated fibroblasts (CAFs), the expression of insulin-like growth factor-1 (IGF1) and IGF1 receptor (IGF1R) was evaluated by RT-PCR, FACScan, western blot, or ELISA. Correlation between IGF1R and the hypoxia marker carbonic anhydrase 9 (CA9) was examined by immunohistochemical staining of 120 pancreatic specimens. The effects of CAFs, IGF1, and IGF1R inhibitors on the motility of cancer cells were examined by wound-healing assay or invasion assay under normoxia (20% O-2) and hypoxia (1% O-2). IGF1R expression was significantly higher in RWP-1, MiaPaCa-2, and OCUP-AT cells than in Panc-1 cells. Hypoxia increased the expression level of IGF1R in RWP-1, MiaPaCa-2, and OCUP-AT cells. CA9 expression was correlated with IGF1R expression in pancreatic specimens. CAFs produced IGF1 under hypoxia, but PDAC cells did not. A conditioned medium from CAFs, which expressed alpha SMA, stimulated the migration and invasion ability of MiaPaCa-2, RWP-1, and OCUP-AT cells. The motility of all PDAC cells was greater under hypoxia than under normoxia. The motility-stimulating ability of CAFs was decreased by IGF1R inhibitors. These findings might suggest that pancreas CAFs stimulate the invasion activity of PDAC cells through paracrine IGF1/IGF1R signaling, especially under hypoxia. Therefore the targeting of IGF1R signaling might represent a promising therapeutic approach in IGF1R-dependent PDAC.	[Hirakawa, Toshiki; Yashiro, Masakazu; Doi, Yosuke; Kinoshita, Haruhito; Morisaki, Tamami; Fukuoka, Tatsunari; Hasegawa, Tsuyoshi; Kimura, Kenjiro; Amano, Ryosuke; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Mol Oncol & Therapeut, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Yashiro, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan.; Yashiro, M (corresponding author), Osaka City Univ, Grad Sch Med, Mol Oncol & Therapeut, Osaka, Japan.	m9312510@med.osaka-cu.ac.jp			KAKENHI [22390262, 23390329, 26293307]; Priority Research Fund of Osaka City University	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Priority Research Fund of Osaka City University	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research, Nos. 22390262, 23390329, and 26293307) and Priority Research Fund of Osaka City University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is partially founded by KAKENHI (Grant-in-Aid for Scientific Research, Nos. 22390262, 23390329, and 26293307), and by Priority Research Fund of Osaka City University.	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Bauer TW, 2006, MOL CANCER THER, V5, P1676, DOI 10.1158/1535-7163.MCT-05-0175; Berger AP, 2003, PROSTATE, V57, P57, DOI 10.1002/pros.10279; BERGMANN U, 1995, CANCER RES, V55, P2007; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BRAMHALL SR, 1995, BRIT J SURG, V82, P111, DOI 10.1002/bjs.1800820137; CAMPS JL, 1990, P NATL ACAD SCI USA, V87, P75, DOI 10.1073/pnas.87.1.75; Cho K, 2007, AM J PATHOL, V170, P1964, DOI 10.2353/ajpath.2007.060935; Cleary SP, 2004, J AM COLL SURGEONS, V198, P722, DOI 10.1016/j.jamcollsurg.2004.01.008; Deschoolmeester V, 2010, ONCOLOGIST, V15, P699, DOI 10.1634/theoncologist.2010-0025; Doi Y, 2012, ANN SURG ONCOL, V19, P2733, DOI 10.1245/s10434-011-2181-6; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Hamada S, 2012, BIOCHEM BIOPH RES CO, V421, P349, DOI 10.1016/j.bbrc.2012.04.014; Hirakawa T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-392; Hirakawa T, 2011, ONCOLOGY-BASEL, V81, P192, DOI 10.1159/000333825; Hofmann I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044146; Huang ZQ, 2011, CURR PHARM DESIGN, V17, P2221, DOI 10.2174/138161211796957427; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kato Y, 2010, DIGESTION, V82, P246, DOI 10.1159/000297208; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Kitajima Y, 2008, CANCER SCI, V99, P1341, DOI 10.1111/j.1349-7006.2008.00828.x; KLOPPEL G, 1985, HISTOPATHOLOGY, V9, P841, DOI 10.1111/j.1365-2559.1985.tb02870.x; Komoto M, 2010, CANCER SCI, V101, P468, DOI 10.1111/j.1349-7006.2009.01405.x; Komoto M, 2009, CANCER SCI, V100, P1243, DOI 10.1111/j.1349-7006.2009.01176.x; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Korc M, 2007, AM J SURG, V194, pS84, DOI 10.1016/j.amjsurg.2007.05.004; Li XQ, 2012, CURR PHARM DESIGN, V18, P2404, DOI 10.2174/13816128112092404; Nakamura T, 1997, CANCER RES, V57, P3305; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Saarnio J, 1998, AM J PATHOL, V153, P279, DOI 10.1016/S0002-9440(10)65569-1; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shimizu T, 2012, CLIN CANCER RES, V18, P2316, DOI 10.1158/1078-0432.CCR-11-2381; Sobin Leslie H, 2003, Semin Surg Oncol, V21, P19, DOI 10.1002/ssu.10017; Sohn TA, 2000, J GASTROINTEST SURG, V4, P567, DOI 10.1016/S1091-255X(00)80105-5; Spreafico A, 2013, CLIN CANCER RES, V19, P4149, DOI 10.1158/1078-0432.CCR-12-3140; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Wittman M, 2005, J MED CHEM, V48, P5639, DOI 10.1021/jm050392q; Xu ZH, 2010, AM J PATHOL, V177, P2585, DOI 10.2353/ajpath.2010.090899; Yashiro M, 2005, J SURG RES, V124, P74, DOI 10.1016/j.jss.2004.09.020; YASHIRO M, 1995, BRIT J CANCER, V72, P1200, DOI 10.1038/bjc.1995.486; Yashiro M, 2010, CANCER MICROENVIRON, V3, P127, DOI 10.1007/s12307-010-0036-5; Yasuda K, 2007, ANTICANCER RES, V27, P4071	48	39	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159912	10.1371/journal.pone.0159912	http://dx.doi.org/10.1371/journal.pone.0159912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487118	gold, Green Submitted, Green Published			2022-12-27	WOS:000381367800045
J	Sun, LX; Wang, YY; Zhao, Y; Wang, H; Li, N; Ji, XS				Sun, Li-Xue; Wang, Yi-Ya; Zhao, Yan; Wang, Hui; Li, Ning; Ji, Xiang Shan			Global DNA Methylation Changes in Nile Tilapia Gonads during High Temperature-Induced Masculinization	PLOS ONE			English	Article							INDUCED SEX-DIFFERENTIATION; OREOCHROMIS-NILOTICUS; AROMATASE INHIBITOR; RECEPTOR GPR54; EXPRESSION; GENOME; FISH; GENES; RATIO; TRANSCRIPTION	In some fish species, high or low temperature can switch the sex determination mechanisms and induce fish sex reversal when the gonads are undifferentiated. During this high or low temperature-induced sex reversal, the expressions of many genes are altered. However, genome-wide DNA methylation changes in fish gonads after high or low temperature treatment are unclear. Herein, we compared the global DNA methylation changes in the gonads from control females (CF), control males (CM), high temperature-treated females (TF), and high temperature-induced males (IM) from the F8 family of Nile tilapia (Oreochromis niloticus) using methylated DNA immunoprecipitation sequencing. The DNA methylation level in CF was higher than that in CM for various chromosomes. Both females and males showed an increase in methylation levels on various chromosomes after high-temperature induction. We identified 64,438 (CF/CM), 63,437 (TF/IM), 98,675 (TF/CF), 235,270 (IM/CM) and 119,958 (IM/CF) differentially methylated regions (DMRs) in Nile tilapia gonads, representing approximately 0.70% (CF/CM), 0.69% (TF/IM), 1.07%(TF/CF), 2.56% (IM/CM), and 1.30% (IM/CF) of the length of the genome. A total of 89 and 65 genes that exhibited DMRs in their gene bodies and promoters were mapped to the Nile tilapia genome. Furthermore, more than half of the genes with DMRs in the gene body in CF/CM were also included in the IM/CM, TF/CF, TF/IM, and IM/CF groups. Additionally, many important pathways, including neuroactive ligand-receptor interaction, extracellular matrix-receptor interaction, and biosynthesis of unsaturated fatty acids were identified. This study provided an important foundation to investigate the molecular mechanism of high temperature-induced sex reversal in fish species.	[Sun, Li-Xue; Wang, Yi-Ya; Zhao, Yan; Wang, Hui; Ji, Xiang Shan] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China; [Li, Ning] Shandong Agr Univ, Coll Life Sci, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Ji, XS (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	xsji@sdau.edu.cn	Ji, Xiang Shan/D-5213-2015	Ji, Xiang Shan/0000-0002-3285-7952	National Natural Science Foundation of China [31472270]; Research Award Fund for outstanding young scientists of Shandong Province [2014BSB01303]; earmarked fund for Modern Agro-industry Technology Research System in Shandong Province [SDAIT-13, SDAIT-15-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Award Fund for outstanding young scientists of Shandong Province; earmarked fund for Modern Agro-industry Technology Research System in Shandong Province	This study was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (31472270 to XSJ), the Research Award Fund for outstanding young scientists of Shandong Province (http://jihlx.sdstc.gov.cn/STDPMS/BS/Default.aspx) (2014BSB01303 to YZ), and the earmarked fund for Modern Agro-industry Technology Research System in Shandong Province (SDAIT-13 and SDAIT-15-011 to XSJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (31472270); Research Award Fund for outstanding young scientists of Shandong Province (2014BSB01303); and the earmarked fund for Modern Agro-industry Technology Research System in Shandong Province (SDAIT-13 and SDAIT-15-011).	Abucay JS, 1999, AQUACULTURE, V173, P219, DOI 10.1016/S0044-8486(98)00489-X; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Baras E, 2001, AQUACULTURE, V192, P187, DOI 10.1016/S0044-8486(00)00452-X; Baroiller JF, 2009, COMP BIOCHEM PHYS A, V153, P30, DOI 10.1016/j.cbpa.2008.11.018; BAROILLER JF, 1995, J EXP ZOOL, V273, P216, DOI 10.1002/jez.1402730306; Cao CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058914; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; D'Cotta H, 2001, J EXP ZOOL, V290, P574, DOI 10.1002/jez.1108; D'Cotta H, 2001, MOL REPROD DEV, V59, P265, DOI 10.1002/mrd.1031; Dang Guang-cheng, 2011, Yuye Kexue Jinzhan, V32, P32; DCotta H, 2008, SEX DEV; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Fomitcheva J, 1998, J BIOL CHEM, V273, P22664, DOI 10.1074/jbc.273.35.22664; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Gennotte V, 2015, J EXP ZOOL PART A, V323, P31, DOI 10.1002/jez.1893; Gottsch ML, 2004, ENDOCRINOLOGY, V145, P4073, DOI 10.1210/en.2004-0431; Huang SK, 2012, FASEB J, V26, P3703, DOI 10.1096/fj.11-203323; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lauss M, 2007, PHARMACOGENOMICS, V8, P1063, DOI 10.2217/14622416.8.8.1063; Li CG, 2014, COMP BIOCHEM PHYS B, V177, P36, DOI 10.1016/j.cbpb.2014.08.006; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li M, 2012, BIOL REPROD, V163, P1; Li MH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005678; Li MZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1854; Martinez P, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00340; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nakamoto M, 2006, BIOCHEM BIOPH RES CO, V344, P353, DOI 10.1016/j.bbrc.2006.03.137; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Pandit NP, 2015, GEN COMP ENDOCR, V213, P110, DOI 10.1016/j.ygcen.2015.01.028; Parrott BB, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.111468; Poonlaphdecha S, 2013, GEN COMP ENDOCR, V193, P234, DOI 10.1016/j.ygcen.2013.06.007; Rougeot C, 2008, AQUACULTURE, V276, P205, DOI 10.1016/j.aquaculture.2008.02.001; Shao CW, 2014, GENOME RES, V24, P604, DOI 10.1101/gr.162172.113; Sun LN, 2014, ENDOCRINOLOGY, V155, P1476, DOI 10.1210/en.2013-1959; Tessema M, 2006, AQUACULTURE, V258, P270, DOI 10.1016/j.aquaculture.2006.04.041; Vernetti C.H.M.M., 2013, AFR J BIOTECHNOL, V12, P2129, DOI [10.5897/AJB12.1155, DOI 10.5897/AJB12.1155]; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wessels S, 2007, AQUACULTURE, V272, pS80, DOI 10.1016/j.aquaculture.2007.08.009; Xu N, 2014, MOL ENDOCRINOL, V28, P1329, DOI 10.1210/me.2014-1042; Yang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-10; Zhang X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19738; Zhou LY, 2005, J MOL ENDOCRINOL, V35, P103, DOI 10.1677/jme.1.01801; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	49	103	105	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0158483	10.1371/journal.pone.0158483	http://dx.doi.org/10.1371/journal.pone.0158483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486872	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800011
J	Harper, KL; Eddington, KM; Silvia, PJ				Harper, Kelly L.; Eddington, Kari M.; Silvia, Paul J.			Perfectionism and Effort-Related Cardiac Activity: Do Perfectionists Try Harder?	PLOS ONE			English	Article							SELF-CRITICAL PERFECTIONISM; CARDIOVASCULAR REACTIVITY; AUTONOMIC ACTIVITY; PERFORMANCE; MOTIVATION; CHALLENGE; STRESS; ACHIEVEMENT; DIMENSIONS; DISTRESS	Do perfectionists try harder? Previous research on perfectionism and effort has used self-report items and task performance as indicators of effort. The current study investigated whether individual differences in perfectionism predicted effort-related cardiac activity during a mental effort task. Based on past research that suggests adaptive perfectionism is associated with higher effort, it was hypothesized that self-oriented perfectionism (SOP) would predict increased effort on the task. One hundred and eleven college students completed the Multidimensional Perfectionism Scale (MPS) and a self-paced parity task in which they received a small cash reward (3 cents) for each correct response. Impedance cardiography was used to assess autonomic reactivity, and regression models tested whether SOP and socially prescribed perfectionism (SPP) explained autonomic reactivity. Overall, participants showed both sympathetic (faster pre-ejection period; PEP) and para-sympathetic activation (elevated high-frequency heart rate variability; HRV) during the task, reflecting higher effort and engagement. Contrary to predictions, individual differences in perfectionism did not moderate cardiac reactivity. These findings draw attention to the importance of assessing physiological components of effort and motivation directly rather than inferring them from task performance or self-reported effort.	[Harper, Kelly L.; Eddington, Kari M.; Silvia, Paul J.] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA	University of North Carolina; University of North Carolina Greensboro	Harper, KL (corresponding author), Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.	klharpe2@uncg.edu	Eddington, Kari M/J-6347-2019	Eddington, Kari M/0000-0002-0752-7177	National Institute of Mental Health of the National Institutes of Health [R15MH079374]	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health of the National Institutes of Health under award number R15MH079374. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accordino DB, 2000, PSYCHOL SCHOOLS, V37, P535, DOI 10.1002/1520-6807(200011)37:6<535::AID-PITS6>3.0.CO;2-O; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; Berntson GG, 2004, PSYCHOPHYSIOLOGY, V41, P333, DOI 10.1111/j.1469-8986.2004.00156.x; Besser A., 2008, J RATION-EMOT COGN-B, V26, P206, DOI 10.1007/s10942-007-0067-0; Besser A., 2004, J RATIONAL EMOTIVE C, V22, P297, DOI [10.1023/B:JORE.0000047313.35872.5c, DOI 10.1023/B:JORE.0000047313.35872.5C]; Blascovich J., 2011, SOCIAL PSYCHOPHYSIOL; BREHM JW, 1983, J EXP SOC PSYCHOL, V19, P21, DOI 10.1016/0022-1031(83)90003-3; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Brown EJ, 1999, J SOC CLIN PSYCHOL, V18, P98, DOI 10.1521/jscp.1999.18.1.98; Chang EC, 2006, J SOC CLIN PSYCHOL, V25, P1001, DOI 10.1521/jscp.2006.25.9.1001; Duckworth AL, 2009, J PERS ASSESS, V91, P166, DOI 10.1080/00223890802634290; Dunkley DM, 2003, J PERS SOC PSYCHOL, V84, P234, DOI 10.1037//0022-3514.84.1.234; Dunkley DM, 2000, J COUNS PSYCHOL, V47, P437, DOI 10.1037//0022-0167.47.4.437; Ernst JM, 1999, PSYCHOPHYSIOLOGY, V36, P333, DOI 10.1017/S0048577299981003; Flett GL, 2009, CAN J SCH PSYCHOL, V24, P4, DOI 10.1177/0829573509332457; Frazier BD, 2008, SEX ROLES, V59, P14, DOI 10.1007/s11199-008-9440-4; FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967; Fry PS, 2009, J HEALTH PSYCHOL, V14, P513, DOI 10.1177/1359105309103571; Gendolla G. H., 2012, OXFORD HDB MOTIVATIO, P420, DOI [10.1093/oxfordhb/9780195399820.013.0024, DOI 10.1093/0XF0RDHB/9780195399820.013.0024]; Gendolla GHE, 2008, PSYCHOPHYSIOLOGY, V45, P653, DOI 10.1111/j.1469-8986.2008.00655.x; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; HEWITT PL, 1991, J ABNORM PSYCHOL, V100, P98, DOI 10.1037/0021-843X.100.1.98; HEWITT PL, 1991, J PERS SOC PSYCHOL, V60, P456, DOI 10.1037/0022-3514.60.3.456; Houtveen JH, 2006, INT J PSYCHOPHYSIOL, V59, P97, DOI 10.1016/j.ijpsycho.2005.02.003; Kelsey R.M., 2012, MOTIVATION AFFECTS C, P43, DOI DOI 10.1007/978-1-4613-9564-5_10; Kempke S, 2016, HEALTH PSYCHOL, V35, P298, DOI 10.1037/hea0000299; Kobori O, 2005, COGNITIVE THER RES, V29, P555, DOI 10.1007/s10608-005-2835-4; Kobori O, 2011, J ANXIETY DISORD, V25, P674, DOI 10.1016/j.janxdis.2011.03.001; KOIZUMI K, 1992, J AUTONOM NERV SYST, V41, P19, DOI 10.1016/0165-1838(92)90123-X; KOIZUMI K, 1982, P NATL ACAD SCI-BIOL, V79, P2116, DOI 10.1073/pnas.79.6.2116; Lozano DL, 2007, PSYCHOPHYSIOLOGY, V44, P113, DOI 10.1111/j.1469-8986.2006.00468.x; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; MARTIN LL, 1993, J PERS SOC PSYCHOL, V64, P317, DOI 10.1037/0022-3514.64.3.317; Muraven M, 2003, PERS SOC PSYCHOL B, V29, P894, DOI 10.1177/0146167203029007008; O'Connor RC, 2003, J COUNS PSYCHOL, V50, P362, DOI 10.1037/0022-0167.50.3.362; OBRIST PA, 1987, PSYCHOPHYSIOLOGY, V24, P65, DOI 10.1111/j.1469-8986.1987.tb01864.x; Richter M, 2009, PSYCHOPHYSIOLOGY, V46, P451, DOI 10.1111/j.1469-8986.2009.00795.x; Schachinger H, 2001, PSYCHOSOM MED, V63, P788, DOI 10.1097/00006842-200109000-00012; Segerstrom S. C., 2012, MOTIVATION AFFECTS C, P181; Segerstrom SC, 2007, PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-9280.2007.01888.x; Silvia PJ, 2016, BIOL PSYCHOL, V118, P52, DOI 10.1016/j.biopsycho.2016.04.068; Silvia PJ, 2014, MOTIV EMOTION, V38, P779, DOI 10.1007/s11031-014-9443-0; Silvia PJ, 2013, INT J PSYCHOPHYSIOL, V88, P200, DOI 10.1016/j.ijpsycho.2013.04.007; Silvia PJ, 2013, INT J PSYCHOPHYSIOL, V88, P143, DOI 10.1016/j.ijpsycho.2013.03.007; Stoeber J, 2008, PERS INDIV DIFFER, V45, P323, DOI 10.1016/j.paid.2008.04.021; Stoeber J, 2007, PERS INDIV DIFFER, V43, P2182, DOI 10.1016/j.paid.2007.06.036; Stoeber J, 2015, PERS INDIV DIFFER, V74, P171, DOI 10.1016/j.paid.2014.10.016; Stoeber J, 2010, PERS INDIV DIFFER, V48, P458, DOI 10.1016/j.paid.2009.11.021; Weiner BA, 2012, PERS INDIV DIFFER, V52, P632, DOI 10.1016/j.paid.2011.12.009; WOLFORD G, 1980, MEM COGNITION, V8, P521, DOI 10.3758/BF03213771; Wright R. A., 1996, PSYCHOL ACTION LINKI, P424; Wright RA, 2002, PSYCHOPHYSIOLOGY, V39, P188, DOI 10.1017/S0048577201392090; Wright RA, 2001, ADV EXP SOC PSYCHOL, V33, P255, DOI 10.1016/S0065-2601(01)80007-1; Wright RA, 2008, SOC PERSONAL PSYCHOL, V2, P682, DOI 10.1111/j.1751-9004.2008.00093.x	54	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160340	10.1371/journal.pone.0160340	http://dx.doi.org/10.1371/journal.pone.0160340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NS	27483467	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110700036
J	Makowicz, AM; Tiedemann, R; Steele, RN; Schlupp, I				Makowicz, Amber M.; Tiedemann, Ralph; Steele, Rachel N.; Schlupp, Ingo			Kin Recognition in a Clonal Fish, Poecilia formosa	PLOS ONE			English	Article							TOXIC HYDROGEN-SULFIDE; SEXUAL SELECTION; HYBRID ORIGIN; DISCRIMINATION; BEHAVIOR; COMPETITION; AGGRESSION; CUES; CONSEQUENCES; AVOIDANCE	Relatedness strongly influences social behaviors in a wide variety of species. For most species, the highest typical degree of relatedness is between full siblings with 50% shared genes. However, this is poorly understood in species with unusually high relatedness between individuals: clonal organisms. Although there has been some investigation into clonal invertebrates and yeast, nothing is known about kin selection in clonal vertebrates. We show that a clonal fish, the Amazon molly (Poecilia formosa), can distinguish between different clonal lineages, associating with genetically identical, sister clones, and use multiple sensory modalities. Also, they scale their aggressive behaviors according to the relatedness to other females: they are more aggressive to non-related clones. Our results demonstrate that even in species with very small genetic differences between individuals, kin recognition can be adaptive. Their discriminatory abilities and regulation of costly behaviors provides a powerful example of natural selection in species with limited genetic diversity.	[Makowicz, Amber M.; Steele, Rachel N.; Schlupp, Ingo] Univ Oklahoma, Dept Biol Ecol & Evolutionary Biol, 730 Van Vleet Oval, Norman, OK 73019 USA; [Makowicz, Amber M.] Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Univ Str 10, D-78457 Constance, Germany; [Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Karl Liebknecht Str 24-25, D-14476 Golm, Germany	University of Oklahoma System; University of Oklahoma - Norman; University of Konstanz; University of Potsdam	Makowicz, AM (corresponding author), Univ Oklahoma, Dept Biol Ecol & Evolutionary Biol, 730 Van Vleet Oval, Norman, OK 73019 USA.; Makowicz, AM (corresponding author), Univ Konstanz, Lehrstuhl Zool & Evolut Biol, Dept Biol, Univ Str 10, D-78457 Constance, Germany.	amber.makowicz@uni-konstanz.de	Makowicz, Amber M/Q-6828-2019	Tiedemann, Ralph/0000-0002-2604-6336	Adams Memorial Scholarship; Robberson Research Grant; Graduate Student Senate Research Grant; L.G. Hill Award; Eddie Carol Smith Scholarship; GAANN fellowship; Alexander von Humboldt Foundation Research Award	Adams Memorial Scholarship; Robberson Research Grant; Graduate Student Senate Research Grant; L.G. Hill Award; Eddie Carol Smith Scholarship; GAANN fellowship(US Department of Education); Alexander von Humboldt Foundation Research Award	Funding was provided by an Adams Memorial Scholarship, Robberson Research Grant, Graduate Student Senate Research Grant, L.G. Hill Award, Eddie Carol Smith Scholarship, GAANN fellowship (AMM), and an Alexander von Humboldt Foundation Research Award (IS).	BREED MD, 1988, BEHAV GENET, V18, P439, DOI 10.1007/BF01065513; Cornwallis CK, 2009, J EVOLUTION BIOL, V22, P2445, DOI 10.1111/j.1420-9101.2009.01853.x; Fischer C, 2010, J FISH BIOL, V77, P285, DOI 10.1111/j.1095-8649.2010.02672.x; Gardner Andy, 2010, P308; Gerlach G, 2006, ANIM BEHAV, V71, P1371, DOI 10.1016/j.anbehav.2005.10.010; Giron D, 2004, NATURE, V430, P676, DOI 10.1038/nature02721; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Heubel KU, 2006, J FISH BIOL, V68, P555, DOI 10.1111/j.0022-1112.2006.00941.x; Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kronauer DJC, 2013, BEHAV ECOL, V24, P617, DOI 10.1093/beheco/ars227; Langerhans RB, 2013, EVOL ECOL RES, V15, P633; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lize A, 2014, ISME J, V8, P469, DOI 10.1038/ismej.2013.157; Loughry W. J., 2013, 9 BANDED ARMADILLO; Lynch M, 1999, GENETICS, V152, P1753; Makowicz AM, 2015, ETHOLOGY, V121, P903, DOI 10.1111/eth.12406; Marler CA, 1997, EVOLUTION, V51, P1244, DOI 10.1111/j.1558-5646.1997.tb03971.x; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; McCoy E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1437, DOI 10.1007/s00265-011-1154-x; McLennan DA, 1999, EVOLUTION, V53, P880, DOI 10.1111/j.1558-5646.1999.tb05382.x; Miller DG, 1998, BEHAV ECOL SOCIOBIOL, V43, P95, DOI 10.1007/s002650050471; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; PFENNIG DW, 1993, ANIM BEHAV, V46, P87, DOI 10.1006/anbe.1993.1164; Piyapong C, 2011, HEREDITY, V106, P749, DOI 10.1038/hdy.2010.115; Plath M, 2007, MOL ECOL, V16, P967, DOI 10.1111/j.1365-294X.2006.03212.x; Pravosudova EV, 2001, CONDOR, V103, P821, DOI 10.1650/0010-5422(2001)103[0821:TIOKON]2.0.CO;2; Rajakaruna RS, 2006, CAN J ZOOL, V84, P839, DOI 10.1139/Z06-069; Reding L, 2016, BEHAV ECOL, V27, P411, DOI 10.1093/beheco/arv168; Riesch R, 2012, BIOL J LINN SOC, V106, P598, DOI 10.1111/j.1095-8312.2012.01886.x; Rohlf F.J., 2004, TPS DIG 1 4; Rohlf F.J., 2006, TPSUTIL; Rohlf FJ, 2010, TPSRELW; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Russell ST, 2004, OIKOS, V106, P520; SCHARTL M, 1995, EVOLUTION, V49, P827, DOI 10.1111/j.1558-5646.1995.tb02319.x; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Schlupp Ingo, 2011, P50; Schlupp I, 2009, ADV STUD BEHAV, V39, P153, DOI 10.1016/S0065-3454(09)39005-1; Schwarz S, 2002, COMPUT METH PROG BIO, V67, P55, DOI 10.1016/S0169-2607(00)00150-4; Segoli M, 2009, BEHAV ECOL, V20, P1262, DOI 10.1093/beheco/arp125; Srinivas N, 2012, IEEE T INF FOREN SEC, V7, P1536, DOI 10.1109/TIFS.2012.2206027; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Stock M, 2010, MOL ECOL, V19, P5204, DOI 10.1111/j.1365-294X.2010.04869.x; Strassmann JE, 2001, P NATL ACAD SCI USA, V98, P11839, DOI 10.1073/pnas.221450998; Tiedemann R, 2005, MOL ECOL NOTES, V5, P586, DOI 10.1111/j.1471-8286.2005.00993.x; Tiedemann R, 2011, MOL ECOL, V20, P3237, DOI 10.1111/j.1365-294X.2011.05158.x; Tobler M, 2005, J FISH BIOL, V67, P1072, DOI [10.1111/j.0022-1112.2005.00810.x, 10.1111/j.1095-8649.2005.00810.x]; Tobler M, 2008, EVOLUTION, V62, P2643, DOI 10.1111/j.1558-5646.2008.00466.x; Tobler M, 2010, EVOL ECOL, V24, P39, DOI 10.1007/s10682-008-9288-7; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Winsor GL, 2002, FRESHWATER BIOL, V47, P441, DOI 10.1046/j.1365-2427.2002.00817.x	52	18	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0158442	10.1371/journal.pone.0158442	http://dx.doi.org/10.1371/journal.pone.0158442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483372	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700006
J	Pizzolla, A; Oh, DY; Luong, S; Prickett, SR; Henstridge, DC; Febbraio, MA; O'Hehir, RE; Rolland, JM; Hardy, CL				Pizzolla, Angela; Oh, Ding Yuan; Luong, Suzanne; Prickett, Sara R.; Henstridge, Darren C.; Febbraio, Mark A.; O'Hehir, Robyn E.; Rolland, Jennifer M.; Hardy, Charles L.			High Fat Diet Inhibits Dendritic Cell and T Cell Response to Allergens but Does Not Impair Inhalational Respiratory Tolerance	PLOS ONE			English	Article							PROMOTE AIRWAY TOLERANCE; GUT MICROBIOTA; INDUCED OBESITY; OXIDATIVE STRESS; INCIDENT ASTHMA; ADIPOSE-TISSUE; RECEPTOR GPR43; MICE; INFLAMMATION; CHILDREN	The incidence of obesity has risen to epidemic proportions in recent decades, most commonly attributed to an increasingly sedentary lifestyle, and a 'western' diet high in fat and low in fibre. Although non-allergic asthma is a well-established co-morbidity of obesity, the influence of obesity on allergic asthma is still under debate. Allergic asthma is thought to result from impaired tolerance to airborne antigens, so-called respiratory tolerance. We sought to investigate whether a diet high in fats affects the development of respiratory tolerance. Mice fed a high fat diet (HFD) for 8 weeks showed weight gain, metabolic disease, and alteration in gut microbiota, metabolites and glucose metabolism compared to agematched mice fed normal chow diet (ND). Respiratory tolerance was induced by repeated intranasal (i. n.) administration of ovalbumin (OVA), prior to induction of allergic airway inflammation (AAI) by sensitization with OVA in alum i. p. and subsequent i. n. OVA challenge. Surprisingly, respiratory tolerance was induced equally well in HFD and ND mice, as evidenced by decreased lung eosinophilia and serum OVA-specific IgE production. However, in a pilot study, HFD mice showed a tendency for impaired activation of airway dendritic cells and regulatory T cells compared with ND mice after induction of respiratory tolerance. Moreover, the capacity of lymph node cells to produce IL-5 and IL-13 after AAI was drastically diminished in HFD mice compared to ND mice. These results indicate that HFD does not affect the inflammatory or B cell response to an allergen, but inhibits priming of Th2 cells and possibly dendritic cell and regulatory T cell activation.	[Pizzolla, Angela; Oh, Ding Yuan; Luong, Suzanne; Prickett, Sara R.; O'Hehir, Robyn E.; Rolland, Jennifer M.; Hardy, Charles L.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Pizzolla, Angela; Oh, Ding Yuan; Luong, Suzanne; Prickett, Sara R.; O'Hehir, Robyn E.; Rolland, Jennifer M.; Hardy, Charles L.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic 3004, Australia; [Pizzolla, Angela; Oh, Ding Yuan; Luong, Suzanne; Prickett, Sara R.; O'Hehir, Robyn E.; Rolland, Jennifer M.; Hardy, Charles L.] Monash Univ, Melbourne, Vic 3004, Australia; [Henstridge, Darren C.; Febbraio, Mark A.] Baker IDI, Melbourne, Vic 3004, Australia; [Pizzolla, Angela] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3010, Australia; [Oh, Ding Yuan] Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenza V, 792 Elizabeth St, Melbourne, Vic 3000, Australia; [Febbraio, Mark A.] Garvan Inst Med Res, 384 Victoria St, Darlinghurst, NSW 2010, Australia; [Hardy, Charles L.] Monash Univ, Monash Biomed Imaging, Clayton, Vic 3168, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University; Baker Heart and Diabetes Institute; University of Melbourne; Garvan Institute of Medical Research; Monash University	Pizzolla, A; Hardy, CL (corresponding author), Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia.; Pizzolla, A; Hardy, CL (corresponding author), Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic 3004, Australia.; Pizzolla, A; Hardy, CL (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.	angela.pizzolla@unimelb.edu.au; charles.hardy@monash.edu	Pizzolla, Angela/AAN-1566-2021; O'Hehir, Robyn E/H-3627-2011; Febbraio, Mark/AAE-9632-2019	Pizzolla, Angela/0000-0003-2024-4144; O'Hehir, Robyn E/0000-0002-3489-7595; Oh, Ding Yuan/0000-0003-0695-8490; Febbraio, Mark/0000-0002-9296-4418	National Health and Medical Research Council, Australia (NHMRC), Australia [1027459]	National Health and Medical Research Council, Australia (NHMRC), Australia	This work was funded by the National Health and Medical Research Council, Australia (NHMRC), Australia, grant number 1027459. R.E. O'H. was the recipient with J.M.R. and C.L.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chen Y, 2006, CHEST, V130, P890, DOI 10.1378/chest.130.3.890; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de Vries A, 2009, CLIN EXP ALLERGY, V39, P731, DOI 10.1111/j.1365-2222.2008.03179.x; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fernandes J, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.23; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hardy CL, 2003, AM J RESP CRIT CARE, V167, P1393, DOI 10.1164/rccm.200209-1002OC; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; HOLT PG, 1989, CLIN EXP ALLERGY, V19, P255, DOI 10.1111/j.1365-2222.1989.tb02380.x; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Khare A, 2013, J IMMUNOL, V191, P25, DOI 10.4049/jimmunol.1300193; Kim HY, 2014, NAT MED, V20, P54, DOI 10.1038/nm.3423; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsushita H, 2010, INT IMMUNOL, V22, P739, DOI 10.1093/intimm/dxq062; Pacifico L, 2006, EUR J ENDOCRINOL, V154, P691, DOI 10.1530/eje.1.02138; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peterson CT, 2015, CLIN EXP IMMUNOL, V179, P363, DOI 10.1111/cei.12474; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rastogi D, 2012, CHEST, V141, P895, DOI 10.1378/chest.11-0930; Ronmark E, 2005, EUR RESPIR J, V25, P282, DOI 10.1183/09031936.05.00054304; Ruggiero C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1047, DOI 10.1152/ajpendo.00666.2010; Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849; Sybilski AJ, 2015, PUBLIC HEALTH NUTR, V18, P530, DOI 10.1017/S1368980014000676; Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3; Thorburn AN, 2012, J IMMUNOL, V188, P4611, DOI 10.4049/jimmunol.1101299; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tsitoura DC, 1999, J IMMUNOL, V163, P2592; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Visness CM, 2009, J ALLERGY CLIN IMMUN, V123, P1163, DOI 10.1016/j.jaci.2008.12.1126; VREMEC D, 1992, J EXP MED, V176, P47, DOI 10.1084/jem.176.1.47; Wang PW, 2014, ANTIOXID REDOX SIGN, V20, P2572, DOI 10.1089/ars.2013.5334; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103; Zhao J, 2013, MUCOSAL IMMUNOL, V6, P335, DOI 10.1038/mi.2012.76	49	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160407	10.1371/journal.pone.0160407	http://dx.doi.org/10.1371/journal.pone.0160407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483441	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110700042
J	Wu, WS; Chien, CC; Chen, YC; Chiu, WT				Wu, Wen-Shin; Chien, Chih-Chiang; Chen, Yen-Chou; Chiu, Wen-Ta			Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells	PLOS ONE			English	Article							JNK ACTIVATION; GROWTH; BAX; MITOCHONDRIA; SURVIVAL; THERAPY; PATHWAY; DEATH; ASSAY; PERK	We investigated the anticancer mechanism of evodiamine (EVO) against the viability of human A498 renal cell carcinoma (RCC) cells in vitro and in vivo. The in vitro study showed that EVO decreased the viability of A498 cells with the occurrence of apoptotic characteristics such as hypodiploid cells, DNA ladders, chromatin-condensed cells, and cleaved caspase (Casp)-3/poly(ADP ribose) polymerase (PARP) proteins. Pharmacological studies using chemical inhibitors of mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) indicated that phosphorylation of the c-Jun N-terminal kinase (JNK) protein participated in EVO-induced cell death of A498 cells, and application of the JNK inhibitor, SP600125 (SP), inhibited EVO-induced cleavage of the Casp-3/PARP proteins and chromatin condensation according to Giemsa staining. EVO disruption of the mitochondrial membrane potential (MMP) with increased protein levels of the phosphorylated Bcl-2 protein (p-Bcl-2) was prevented by JNK inhibitors in A498 cells. A structure-activity relationship study showed that a methyl group at position 14 in EVO was important for its apoptotic effects and increased p-Bcl-2 protein in A498 cells. Furthermore, significant increases in the phosphorylated endoplasmic reticular stress protein, protein kinase RNA-like endoplasmic reticulum kinase (p-PERK at Thr980), by EVO were detected in A498 cells, and the PERK inhibitor, GSK2606414, significantly suppressed EVO-induced apoptosis, p-JNK, p-PERK, and cleaved PARP proteins. The in vivo study showed that EVO significantly reduced RCC growth elicited by a subcutaneous injection of A498 cells, and an increased protein level of p-PERK was observed according to an immunohistochemical analysis. Apoptosis by EVO was also demonstrated in other RCC cells such as 786-O, ACHN, and Caki1 cells. This is the first study to demonstrate the anti-RCC effect of EVO via apoptosis in vitro and in vivo, and activation of JNK and PERK to induce Bcl-2 protein phosphorylation, which led to disruption of the MMP.	[Wu, Wen-Shin; Chen, Yen-Chou] Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan; [Wu, Wen-Shin] Taipei Med Univ, Coll Med, Sch Med, Dept Biochem & Mol Cell Biol, Taipei 110, Taiwan; [Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Chien, Chih-Chiang] Chung Hwa Univ Med Technol, Dept Food Nutr, Tainan, Taiwan; [Chen, Yen-Chou] Taipei Med Univ Hosp, Canc Res Ctr, Taipei 110, Taiwan; [Chen, Yen-Chou] Taipei Med Univ Hosp, Orthoped Res Ctr, Taipei 110, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Taipei Municipal Wan Fang Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Clin Med, Taipei 110, Taiwan	Taipei Medical University; Taipei Medical University; Chi Mei Hospital; Chung Hua University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chen, YC (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei 110, Taiwan.; Chen, YC (corresponding author), Taipei Med Univ Hosp, Canc Res Ctr, Taipei 110, Taiwan.; Chen, YC (corresponding author), Taipei Med Univ Hosp, Orthoped Res Ctr, Taipei 110, Taiwan.	yc3270@tmu.edu.tw						Amato RJ, 2000, SEMIN ONCOL, V27, P177; Amin MB, 2002, AM J SURG PATHOL, V26, P281, DOI 10.1097/00000478-200203000-00001; Bukowski RM, 1997, CANCER-AM CANCER SOC, V80, P1198, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H; Chen DYT, 2009, J NATL COMPR CANC NE, V7, P635, DOI 10.6004/jnccn.2009.0044; Chen TC, 2016, PHYTOMEDICINE, V23, P68, DOI 10.1016/j.phymed.2015.12.003; Chien CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099729; Chien CC, 2012, J CELL PHYSIOL, V227, P3128, DOI 10.1002/jcp.23067; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Epstein, 2004, PATHOLOGY GENETICS T, V7; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kan SF, 2007, J CELL BIOCHEM, V101, P44, DOI 10.1002/jcb.21036; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lee TJ, 2006, MOL CANCER THER, V5, P2398, DOI 10.1158/1535-7163.MCT-06-0167; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lorin S, 2010, AUTOPHAGY, V6, P153, DOI 10.4161/auto.6.1.10537; Moch H, 2000, CANCER, V89, P604, DOI 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.3.CO;2-H; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motzer RJ, 2000, J UROLOGY, V163, P408, DOI 10.1016/S0022-5347(05)67889-5; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Namgung U, 2000, THE JOURNAL OF NEURO, P20; Ogasawara M, 2004, BIOL PHARM BULL, V27, P578, DOI 10.1248/bpb.27.578; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang X, 2014, NITRIC OXIDE-BIOL CH, V40, P10, DOI 10.1016/j.niox.2014.05.001; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	42	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160484	10.1371/journal.pone.0160484	http://dx.doi.org/10.1371/journal.pone.0160484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483435	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110700049
J	Quach, CHT; Jung, KH; Lee, JH; Park, JW; Moon, SH; Cho, YS; Choe, YS; Lee, KH				Cung Hoa Thien Quach; Jung, Kyung-Ho; Lee, Jin Hee; Park, Jin Won; Moon, Seung Hwan; Cho, Young Seok; Choe, Yearn Seong; Lee, Kyung-Han			Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel Binding	PLOS ONE			English	Article							INTRACELLULAR PH; MITOCHONDRIAL METABOLISM; CANCER; CELLS; TRANSPORT; ALKALINE; ROLES	To fully understand the glycolytic behavior of cancer cells, it is important to recognize how it is linked to pH dynamics. Here, we evaluated the acute effects of mild acidification and alkalization on cancer cell glucose uptake and glycolytic flux and investigated the role of hexokinase (HK). Cancer cells exposed to buffers with graded pH were measured for F-18-fluorodeoxyglucose (FDG) uptake, lactate production and HK activity. Subcellular localization of HK protein was assessed by western blots and confocal microscopy. The interior of T47D breast cancer cells was mildly alkalized to pH 7.5 by a buffer pH of 7.8, and this was accompanied by rapid increases of FDG uptake and lactate extrusion. This shift toward glycolytic flux led to the prompt recovery of a reversed pH gradient. In contrast, mild acidification rapidly reduced cellular FDG uptake and lactate production. Mild acidification decreased and mild alkalization increased mitochondrial HK translocation and enzyme activity. Cells transfected with specific siRNA against HK-1, HK-2 and voltage-dependent anion channel (VDAC) 1 displayed significant attenuation of pH-induced changes in FDG uptake. Confocal microscopy showed increased co-localization of HK-1 and HK-2 with VDAC1 by alkaline treatment. In isolated mitochondria, acidic pH increased and alkaline pH decreased release of free HK-1 and HK-2 from the mitochondrial pellet into the supernatant. Furthermore, experiments using purified proteins showed that alkaline pH promoted co-immunoprecipitation of HK with VDAC protein. These findings demonstrate that mild alkalization is sufficient to acutely trigger cancer cell glycolytic flux through enhanced activity of HK by promoting its mitochondrial translocation and VDAC binding. This process might serve as a mechanism through which cancer cells trigger the Warburg effect to maintain a dysregulated pH.	[Cung Hoa Thien Quach; Jung, Kyung-Ho; Lee, Jin Hee; Park, Jin Won; Moon, Seung Hwan; Cho, Young Seok; Choe, Yearn Seong; Lee, Kyung-Han] Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea; [Jung, Kyung-Ho; Lee, Jin Hee; Park, Jin Won; Choe, Yearn Seong; Lee, Kyung-Han] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, KH (corresponding author), Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea.; Lee, KH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Sch Med, Seoul, South Korea.	khnm.lee@samsung.com			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2015R1A2A2A01006419]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2015R1A2A2A01006419).	Alfarouk Khalid O, 2014, Oncoscience, V1, P777; Aloj L, 1999, CANC RES; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Franck P, 1996, J BIOTECHNOL, V46, P187, DOI 10.1016/0168-1656(95)00189-1; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gunnink SM, 2014, BIOCHIMIE, V99, P189, DOI 10.1016/j.biochi.2013.12.003; Harguindey S, 2005, BBA-REV CANCER, V1756, P1, DOI 10.1016/j.bbcan.2005.06.004; Harguindey S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-282; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; ISMAILBEIGI F, 1990, AM J PHYSIOL, V258, pC327, DOI 10.1152/ajpcell.1990.258.2.C327; Jadvar H, 2009, J NUCL MED, V50, P1820, DOI 10.2967/jnumed.108.054098; KAMINSKAS E, 1978, BIOCHEM J, V174, P453, DOI 10.1042/bj1740453; Khajah MA, 2015, INT J ONCOL, V46, P1685, DOI 10.3892/ijo.2015.2884; Khajah MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076327; Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P1221, DOI 10.1517/14728222.2013.833607; Lopez-Lazaro M, 2010, MOL MED, V16, P144, DOI 10.2119/molmed.2009.00162; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Mazzio EA, 2012, CANCER SCI, V103, P422, DOI 10.1111/j.1349-7006.2012.02206.x; Miccoli L, 1996, BIOCHEM J, V313, P957, DOI 10.1042/bj3130957; Nagata H, 2011, ONCOL REP, V25, P341, DOI 10.3892/or.2010.1082; Ozkan P, 2002, BBA-GEN SUBJECTS, V1572, P143, DOI 10.1016/S0304-4165(02)00303-3; PAGGI MG, 1991, BIOCHEM BIOPH RES CO, V178, P648, DOI 10.1016/0006-291X(91)90157-3; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Reshkin SJ, 2016, RECENT PAT ANTI-CANC, V8, P85; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Rosano C, 2011, MITOCHONDRION, V11, P513, DOI 10.1016/j.mito.2011.01.012; Scaraffia PY, 2000, J MED ENTOMOL, V37, P689, DOI 10.1603/0022-2585-37.5.689; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; SOLHEIM LP, 1980, BIOCHEMISTRY-US, V19, P6074, DOI 10.1021/bi00567a020; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; WOHLHUETER RM, 1981, J BIOL CHEM, V256, P869	37	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159529	10.1371/journal.pone.0159529	http://dx.doi.org/10.1371/journal.pone.0159529			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479079	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110300014
J	Johnston, D; Earley, B; Cormican, P; Kenny, DA; McCabe, MS; Kelly, AK; McGee, M; Waters, SM				Johnston, D.; Earley, B.; Cormican, P.; Kenny, D. A.; McCabe, M. S.; Kelly, A. K.; McGee, M.; Waters, S. M.			Characterisation of the Whole Blood mRNA Transcriptome in Holstein-Friesian and Jersey Calves in Response to Gradual Weaning	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; INNATE IMMUNE-RESPONSES; ACUTE-PHASE PROTEINS; STAPHYLOCOCCUS-AUREUS; FUNCTIONAL-ANALYSIS; CELLS; CHEMOKINES; RECEPTOR; SEQ; INFECTION	Weaning of dairy calves is an early life husbandry management practice which involves the changeover from a liquid to a solid feed based diet. The objectives of the study were to use RNA-seq technology to examine the effect of (i) breed and (ii) gradual weaning, on the whole blood mRNA transcriptome of artificially reared Holstein-Friesian and Jersey calves. The calves were gradually weaned over 14 days (day (d) -13 to d 0) and mRNA transcription was examined one day before gradual weaning was initiated (d -14), one day after weaning (d 1), and 8 days after weaning (d 8). On d -14, 550 genes were differentially expressed between Holstein-Friesian and Jersey calves, while there were 490 differentially expressed genes (DEG) identified on d 1, and 411 DEG detected eight days after weaning (P < 0.05; FDR < 0.1). No genes were differentially expressed within breed, in response to gradual weaning (P > 0.05). The pathways, gene ontology terms, and biological functions consistently over-represented among the DEG between Holstein-Friesian and Jersey were associated with the immune response and immune cell signalling, specifically chemotaxis. Decreased transcription of several cytokines, chemokines, immunoglobulin-like genes, phagocytosis-promoting receptors and g-protein coupled receptors suggests decreased monocyte, natural killer cell, and T lymphocyte, chemotaxis and activation in Jersey compared to Holstein-Friesian calves. Knowledge of breed-specific immune responses could facilitate health management practices better tailored towards specific disease sensitivities of Holstein-Friesian and Jersey calves. Gradual weaning did not compromise the welfare of artificially-reared dairy calves, evidenced by the lack of alterations in the expression of any genes in response to gradual weaning.	[Johnston, D.; Earley, B.; Cormican, P.; Kenny, D. A.; McCabe, M. S.; Waters, S. M.] TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland; [Johnston, D.; Kelly, A. K.] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Dublin 4, Ireland; [McGee, M.] TEAGASC, Livestock Syst Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland	Teagasc; University College Dublin; Teagasc	Waters, SM (corresponding author), TEAGASC, Anim & Biosci Res Dept, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland.	sinead.waters@teagasc.ie	Kenny, David/B-1653-2013	Kenny, David/0000-0001-9204-098X; Johnston, Dayle/0000-0002-4784-8354; Earley, Bernadette/0000-0002-9772-2813	Department of Agriculture and Food Stimulus Fund [11/S/16]; EU PLF [RMIS 6311, 311825]; Teagasc Walsh Fellowship [WF2013216]	Department of Agriculture and Food Stimulus Fund; EU PLF; Teagasc Walsh Fellowship	This research was made possible by funding, provided by the Department of Agriculture and Food Stimulus Fund 11/S/16 and EU PLF (RMIS 6311) project 311825. DJ was in receipt of a Teagasc Walsh Fellowship funded scholarship (WF2013216).	Admyre C, 2014, IMMUNOLOGY, P144; Anders S, 2014, BIOINFORMATICS; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Ballou M. A., 2013, Professional Animal Scientist, V29, P116; Ballou MA, 2012, J DAIRY SCI, V95, P7319, DOI 10.3168/jds.2012-5970; Bannerman DD, 2008, J DAIRY SCI, V91, P2225, DOI 10.3168/jds.2008-1013; Bannerman DD, 2008, J DAIRY RES, V75, P291, DOI 10.1017/S0022029908003427; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Behrendt JH, 2008, VET PARASITOL, V151, P97, DOI 10.1016/j.vetpar.2007.11.013; Bhuju S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003077; Buitenhuis B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-130; Cetinkaya B, 1997, PREV VET MED, V32, P253, DOI 10.1016/S0167-5877(97)00028-7; Cheung H, 2005, J IMMUNOL, V174, P5351, DOI 10.4049/jimmunol.174.9.5351; CONESA A, 2016, GENOME BIOL, V17, DOI DOI 10.1186/S13059-016-; da Silva LF, 2011, VIRUS RES, V157, P54, DOI 10.1016/j.virusres.2011.02.004; DAFM, 2013, AIM BOVINE STATISTIC; Dhakal K, 2013, J DAIRY SCI, V96, P690, DOI 10.3168/jds.2012-5817; Di Giacomo S, 2015, TRANSBOUND EMERG DIS, V62, P280, DOI 10.1111/tbed.12130; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Floege J, 1998, J AM SOC NEPHROL, V9, P211; Gangur V, 2002, VET IMMUNOL IMMUNOP, V86, P127, DOI 10.1016/S0165-2427(02)00018-1; Gilbert FB, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-40; Griesbeck-Zilch B, 2008, J DAIRY SCI, V91, P2215, DOI 10.3168/jds.2007-0752; Hickey MC, 2003, J ANIM SCI, V81, P2847; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Jakobsen MS, 2000, PREV VET MED, V46, P15, DOI 10.1016/S0167-5877(00)00138-0; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Johnston D, 2015, ANIMAL, V20, P1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasper B, 2007, J IMMUNOL, V179, P2584, DOI 10.4049/jimmunol.179.4.2584; Kim MH, 2011, J VET SCI, V12, P151, DOI 10.4142/jvs.2011.12.2.151; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Lee EY, 2013, AUTOIMMUN REV, V12, P554, DOI 10.1016/j.autrev.2012.10.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RW, 2007, VET PARASITOL, V145, P100, DOI 10.1016/j.vetpar.2006.11.015; Lynch EM, 2010, BMC VET RES, V6, DOI [10.1186/1746-6148-6-39, 10.1186/1746-6148-6-37]; MCEWAN AD, 1970, CLIN CHIM ACTA, V27, P155, DOI 10.1016/0009-8981(70)90390-6; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Ng AP, 2014, P NATL ACAD SCI USA, V111, P5884, DOI 10.1073/pnas.1404354111; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; O'Loughlin A, 2014, RES VET SCI, V97, P458, DOI 10.1016/j.rvsc.2014.06.003; O'Loughlin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-250; O'Loughlin A, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-45; Ohnishi Hiroshi, 2008, Allergol Int, V57, P291, DOI 10.2332/allergolint.08-RAI-0019; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Pareek Ravi, 2005, Journal of Applied Genetics, V46, P171; Peters VA, 2013, BRAIN BEHAV IMMUN, V32, P1, DOI 10.1016/j.bbi.2012.11.006; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russell GC, 2012, VIRUS RES, V169, P246, DOI 10.1016/j.virusres.2012.08.011; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Siveke JT, 1998, J IMMUNOL, V160, P550; Smyth MJ, 1996, J LEUKOCYTE BIOL, V60, P555, DOI 10.1002/jlb.60.5.555; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taubert A, 2006, VET PARASITOL, V142, P214, DOI 10.1016/j.vetpar.2006.07.021; Taubert A, 2009, VET PARASITOL, V164, P141, DOI 10.1016/j.vetpar.2009.06.003; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Tizioto PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131459; van de Wetering D, 2009, INT IMMUNOL, V21, P145, DOI 10.1093/intimm/dxn132; Verschoor CP, 2010, VET IMMUNOL IMMUNOP, V137, P1, DOI 10.1016/j.vetimm.2010.03.026; Villarroel A., 2013, ADV DAIRY RES, V1, P106, DOI 10.4172/2329-888X.1000106; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; Werling D, 2002, VET IMMUNOL IMMUNOP, V87, P225, DOI 10.1016/S0165-2427(02)00086-7; Widdison S, 2011, ANIM GENET, V42, P341, DOI 10.1111/j.1365-2052.2011.02200.x; Widdison S, 2008, MOL IMMUNOL, V45, P740, DOI 10.1016/j.molimm.2007.06.357; Widdison S, 2009, TUBERCULOSIS, V89, P417, DOI 10.1016/j.tube.2009.09.003; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhou T, 2006, CELL MOL IMMUNOL, V3, P279; Zhu PC, 2009, BLOOD, V114, P1205, DOI 10.1182/blood-2008-12-195768	78	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159707	10.1371/journal.pone.0159707	http://dx.doi.org/10.1371/journal.pone.0159707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479136	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300016
J	Ortega, A; Gil-Cayuela, C; Tarazon, E; Garcia-Manzanares, M; Montero, JA; Cinca, J; Portoles, M; Rivera, M; Rosello-Lleti, E				Ortega, Ana; Gil-Cayuela, Carolina; Tarazon, Estefania; Garcia-Manzanares, Maria; Anastasio Montero, Jose; Cinca, Juan; Portoles, Manuel; Rivera, Miguel; Rosello-Lleti, Esther			New Cell Adhesion Molecules in Human Ischemic Cardiomyopathy. PCDHGA3 Implications in Decreased Stroke Volume and Ventricular Dysfunction	PLOS ONE			English	Article							HEART-FAILURE; EXTRACELLULAR-MATRIX; INTERCALATED DISKS; GENE-EXPRESSION; CONNEXIN43; PLAKOGLOBIN; GUIDELINES; MUTATIONS; DIVERSITY; JUNCTIONS	Background Intercalated disks are unique structures in cardiac tissue, in which adherens junctions, desmosomes, and GAP junctions co-localize, thereby facilitating cardiac muscle contraction and function. Protocadherins are involved in these junctions; however, their role in heart physiology is poorly understood. We aimed to analyze the transcriptomic profile of adhesion molecules in patients with ischemic cardiomyopathy (ICM) and relate the changes uncovered with the hemodynamic alterations and functional depression observed in these patients. Methods and Results Twenty-three left ventricular tissue samples from patients diagnosed with ICM (n = 13) undergoing heart transplantation and control donors (CNT, n = 10) were analyzed using RNA sequencing. Forty-two cell adhesion genes involved in cellular junctions were differentially expressed in ICM myocardium. Notably, the levels of protocadherin PCDHGA3 were related with the stroke volume (r = -0.826, P = 0.003), ejection fraction (r = -0.793, P = 0.004) and left ventricular end systolic and diastolic diameters (r = 0.867, P = 0.001; r = 0.781, P = 0.005, respectively). Conclusions Our results support the importance of intercalated disks molecular alterations, closely involved in the contractile function, highlighting its crucial significance and showing gene expression changes not previously described. Specifically, altered PCDHGA3 gene expression was strongly associated with reduced stroke volume and ventricular dysfunction in ICM, suggesting a relevant role in hemodynamic perturbations and cardiac performance for this unexplored protocadherin.	[Ortega, Ana; Gil-Cayuela, Carolina; Tarazon, Estefania; Garcia-Manzanares, Maria; Portoles, Manuel; Rivera, Miguel; Rosello-Lleti, Esther] Hlth Res Inst La Fe, Cardiocirculatory Unit, Valencia, Spain; [Anastasio Montero, Jose] Univ & Polytech La Fe Hosp, Cardiovasc Surg Serv, Valencia, Spain; [Cinca, Juan] Santa Creu & St Pau Hosp, Serv Cardiol, Barcelona, Spain	Hospital Universitari i Politecnic La Fe; Instituto de Investigacion Sanitaria La Fe (IIS La Fe)	Rosello-Lleti, E (corresponding author), Hlth Res Inst La Fe, Cardiocirculatory Unit, Valencia, Spain.	esther_rosello_lleti@hotmail.com	PORTOLES, MANUEL/B-4789-2009; Roselló-Lletí, Esther/B-2695-2017; Ortega, Ana/AAG-5941-2020; Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana AO/D-3027-2017; Gil-Cayuela, Carolina/D-6996-2017; Tarazón, Estefanía/D-6950-2017	PORTOLES, MANUEL/0000-0002-4415-7160; Roselló-Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana AO/0000-0002-9763-0505; Gil-Cayuela, Carolina/0000-0002-1106-7935; Tarazón, Estefanía/0000-0003-3466-2558	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [PI13/00100, PI14/01506]; European Regional Development Fund (FEDER); RETICS [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III"; European Regional Development Fund (FEDER)(European Commission); RETICS	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [PI13/00100; PI14/01506], the European Regional Development Fund (FEDER), and RETICS [12/0042/0003].	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Alcalde M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100560; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bhonsale A, 2015, EUR HEART J, V36, P847, DOI 10.1093/eurheartj/ehu509; Bowen CJ, 2015, DEV BIOL, V407, P145, DOI 10.1016/j.ydbio.2015.07.012; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; dos Santos DO, 2016, EXP MOL PATHOL, V100, P167, DOI 10.1016/j.yexmp.2015.12.009; Dupont E, 2001, J MOL CELL CARDIOL, V33, P359, DOI 10.1006/jmcc.2000.1308; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elliott P, 2010, CIRC-CARDIOVASC GENE, V3, P314, DOI 10.1161/CIRCGENETICS.110.937805; FORBES MS, 1985, TISSUE CELL, V17, P605, DOI 10.1016/0040-8166(85)90001-1; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Guo D, 2010, CIRC RES, V107, P1275, DOI 10.1161/CIRCRESAHA.110.229054; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hesketh GG, 2010, CIRC RES, V106, P1153, DOI 10.1161/CIRCRESAHA.108.182147; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Lorenzon A, 2015, AM J CARDIOL, V116, P1245, DOI 10.1016/j.amjcard.2015.07.037; Lyon RC, 2014, HUM MOL GENET, V23, P1134, DOI 10.1093/hmg/ddt508; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Masuelli L, 2003, CARDIOVASC RES, V60, P376, DOI 10.1016/j.cardiores.2003.08.005; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Molina-Navarro MM, 2013, INT J CARDIOL, V168, P2837, DOI 10.1016/j.ijcard.2013.03.192; Miller S, 2011, NEURO-ONCOLOGY, V13, P866, DOI 10.1093/neuonc/nor070; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Noorman M, 2013, CARDIOVASC PATHOL, V22, P314, DOI 10.1016/j.carpath.2013.04.002; Noorman M, 2013, HEART RHYTHM, V10, P412, DOI 10.1016/j.hrthm.2012.11.018; Ortega A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145518; Pedrosa E, 2008, SCHIZOPHR RES, V102, P210, DOI 10.1016/j.schres.2008.04.013; Pinali C, 2015, BIOPHYS J, V108, P498, DOI 10.1016/j.bpj.2014.12.001; Poelzing S, 2004, AM J PHYSIOL-HEART C, V287, pH1762, DOI 10.1152/ajpheart.00346.2004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosello-Lleti E, 2015, J CELL MOL MED, V19, P442, DOI 10.1111/jcmm.12477; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Soltysinska E, 2009, PFLUG ARCH EUR J PHY, V459, P11, DOI 10.1007/s00424-009-0718-3; Tellez GF, 2015, AM J PHYSIOL-LUNG C, V309, pL725, DOI 10.1152/ajplung.00346.2014; Terry S, 2013, NEOPLASIA, V15, P761, DOI 10.1593/neo.122070; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vite A, 2014, CELL COMMUN ADHES, V21, P169, DOI 10.3109/15419061.2014.908853; Wilson A, 2014, CELL MOL LIFE SCI, V71, P165, DOI 10.1007/s00018-013-1374-5; Yoshida M, 2011, CARDIOVASC RES, V92, P95, DOI 10.1093/cvr/cvr182	45	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160168	10.1371/journal.pone.0160168	http://dx.doi.org/10.1371/journal.pone.0160168			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472518	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300032
J	Przybylla, S; Stindt, J; Kleinschrodt, D; Esch, JSA; Haussinger, D; Keitel, V; Smits, SH; Schmitt, L				Przybylla, Susanne; Stindt, Jan; Kleinschrodt, Diana; Esch, Jan Schulte Am; Haeussinger, Dieter; Keitel, Verena; Smits, Sander H.; Schmitt, Lutz			Analysis of the Bile Salt Export Pump (ABCB11) Interactome Employing Complementary Approaches	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; CANINE KIDNEY-CELLS; APICAL MEMBRANE; ER MEMBRANE; GOLGI-APPARATUS; GENETIC SYSTEM; PROTEIN; EXPRESSION; TRAFFICKING; MUTATIONS	The bile salt export pump (BSEP, ABCB11) plays an essential role in the formation of bile. In hepatocytes, BSEP is localized within the apical (canalicular) membrane and a deficiency of canalicular BSEP function is associated with severe forms of cholestasis. Regulation of correct trafficking to the canalicular membrane and of activity is essential to ensure BSEP functionality and thus normal bile flow. However, little is known about the identity of interaction partners regulating function and localization of BSEP. In our study, interaction partners of BSEP were identified in a complementary approach: Firstly, BSEP interaction partners were co-immunoprecipitated from human liver samples and identified by mass spectrometry (MS). Secondly, a membrane yeast two-hybrid (MYTH) assay was used to determine protein interaction partners using a human liver cDNA library. A selection of interaction partners identified both by MYTH and MS were verified by in vitro interaction studies using purified proteins. By these complementary approaches, a set of ten novel BSEP interaction partners was identified. With the exception of radixin, all other interaction partners were integral or membrane-associated proteins including proteins of the early secretory pathway and the bile acyl-CoA synthetase, the second to last, ER-associated enzyme of bile salt synthesis.	[Przybylla, Susanne; Kleinschrodt, Diana; Smits, Sander H.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany; [Stindt, Jan; Haeussinger, Dieter; Keitel, Verena] Univ Dusseldorf, Univ Hosp, Dept Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Esch, Jan Schulte Am] Univ Dusseldorf, Univ Hosp, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany.	Lutz.Schmitt@hhu.de	Keitel, Verena/AAH-9016-2021; Esch, Jan Schulte am/AAL-9904-2021; Keitel, Verena/AAF-3471-2019	Keitel, Verena/0000-0003-1383-7662; Esch, Jan Schulte am/0000-0002-2101-5012; Stindt, Jan/0000-0002-8760-1989	Deutsche Forschungsgemeinschaft [SFB 974]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Susanne Przybylla, Dieter Haussinger, Verena Keitel and Lutz Schmitt received funding from the Deutsche Forschungsgemeinschaft, grant SFB 974. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjork S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076366; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Cacciagli P, 2013, AM J HUM GENET, V93, P579, DOI 10.1016/j.ajhg.2013.07.023; Chai J, 2015, J HEPATOL, V63, P1440, DOI 10.1016/j.jhep.2015.07.016; Chan W, 2005, J BIOL CHEM, V280, P23741, DOI 10.1074/jbc.M502767200; Clucas J, 2014, J CELL SCI, V127, P267, DOI 10.1242/jcs.133108; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Ellinger P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060620; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fullekrug J, 1997, EUR J CELL BIOL, V74, P31; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hayashi H, 2012, HEPATOLOGY, V55, P1889, DOI 10.1002/hep.25591; Hoque MT, 2009, BIOCHEM BIOPH RES CO, V379, P60, DOI 10.1016/j.bbrc.2008.12.014; Ingraffea J, 2002, EUR J CELL BIOL, V81, P61, DOI 10.1078/0171-9335-00218; Kikuchi S, 2002, NAT GENET, V31, P320, DOI 10.1038/ng905; Kubitz R, 2012, CLIN RES HEPATOL GAS, V36, P536, DOI 10.1016/j.clinre.2012.06.006; Li M, 2010, J BIOL CHEM, V285, P19299, DOI 10.1074/jbc.M109.096081; MAGENDANTZ M, 1995, J BIOL CHEM, V270, P25324, DOI 10.1074/jbc.270.43.25324; Mihalik SJ, 2002, J BIOL CHEM, V277, P24771, DOI 10.1074/jbc.M203295200; Ng CL, 2010, EXP CELL RES, V316, P2113, DOI 10.1016/j.yexcr.2010.04.010; NGOUNOU WA, 2014, CELL MOL LIFE SCI, V71, P205, DOI DOI 10.1007/S00018-013-1333-1; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Ortiz DF, 2004, J BIOL CHEM, V279, P32761, DOI 10.1074/jbc.M404337200; Poschmann G, 2014, J PROTEOME RES, V13, P2339, DOI 10.1021/pr401157k; Poulton CJ, 2011, AM J HUM GENET, V89, P265, DOI 10.1016/j.ajhg.2011.07.006; Sato K, 2003, MOL BIOL CELL, V14, P3605, DOI 10.1091/mbc.E02-12-0777; Shen DW, 2010, J CELL PHYSIOL, V225, P822, DOI 10.1002/jcp.22287; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Small DM, 2003, P NATL ACAD SCI USA, V100, P4, DOI 10.1073/pnas.0237205100; Snider J, 2013, NAT CHEM BIOL; Sommer N, 2013, BBA-MOL CELL RES, V1833, P3104, DOI 10.1016/j.bbamcr.2013.08.018; Soroka CJ, 2014, MOL ASPECTS MED, V37, P3, DOI 10.1016/j.mam.2013.05.001; SPERRY WM, 1950, J BIOL CHEM, V187, P97; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Stindt J, 2013, LIVER INT, V33, P1527, DOI 10.1111/liv.12217; van de Kamp JM, 2015, CLIN GENET, V87, P141, DOI 10.1111/cge.12355; Venot Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146962; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang W, 2006, GASTROENTEROLOGY, V131, P878, DOI 10.1053/j.gastro.2006.06.013; Wlcek K, 2014, BIOCHEM PHARMACOL, V88, P106, DOI 10.1016/j.bcp.2013.12.026; Woo IS, 2011, CANCER LETT, V309, P190, DOI 10.1016/j.canlet.2011.05.031; Yamasaki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05973; Yiu WH, 2004, GENE, V337, P37, DOI 10.1016/j.gene.2004.04.033; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	47	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159778	10.1371/journal.pone.0159778	http://dx.doi.org/10.1371/journal.pone.0159778			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472061	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300019
J	Kwon, JW; Choi, JA; Jee, D				Kwon, Jin-woo; Choi, Jin A.; Jee, Donghyun			Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients	PLOS ONE			English	Article							GELATINASE B/MATRIX METALLOPROTEINASE-9; RETINAL BLOOD-FLOW; TISSUE INHIBITOR; RETINOPATHY; MMP-9; RISK; COMPLICATIONS; DYSREGULATION; POPULATION; ACTIVATION	Purpose To assess the concentrations of matrix metalloproteinase (MMP)-1 and MMP-9 in the aqueous humor of diabetic macular edema (DME) patients. Method The concentrations of MMP-1 and MMP-9 in the aqueous humors of 15 cataract patients and 25 DME patients were compared. DME patients were analyzed according to the diabetic retinopathy (DR) stage, diabetes mellitus (DM) duration, pan-retinal photocoagulation (PRP) treatment, recurrence within 3 months, HbA1C (glycated hemoglobin) level, and axial length. Results The concentrations of MMP-1 and MMP-9 of the DME groups were higher than those of the control group (p = 0.005 and p = 0.002, respectively). There was a significant difference in MMP-1 concentration between the mild non-proliferative diabetic retinopathy (NPDR) group and the proliferative diabetic retinopathy (PDR) group (p = 0.012). MMP-1 concentrations were elevated in PRP-treated patients (p = 0.005). There was a significant difference in MMP-9 concentrations between the mild NPDR group and the PDR group (p < 0.001), and between the moderate and severe NPDR group and the PDR group (p < 0.001). The MMP9 concentrations in PRP treated patients, DM patients with diabetes >= 10 years and recurrent DME within 3months were elevated (p = 0.023, p = 0.011, and p = 0.027, respectively). In correlation analyses, the MMP-1 level showed a significant correlation with age (r =-0.48, p = 0.01,), and the MMP-9 level showed significant correlations with axial length (r =-0.59, p < 0.01) and DM duration (r = 049, p = 0.01). Conclusions Concentrations of MMP-1 and MMP-9 were higher in the DME groups than in the control group. MMP-9 concentrations also differed depending on DR staging, DM duration, PRP treatment, and degree of axial myopia. MMP-9 may be more important than MMP-1 in the induction of DM complications in eyes.	[Kwon, Jin-woo; Choi, Jin A.; Jee, Donghyun] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, St Vincents Hosp, Coll Med, Suwon, South Korea	Catholic University of Korea	Jee, D (corresponding author), Catholic Univ Korea, Dept Ophthalmol & Visual Sci, St Vincents Hosp, Coll Med, Suwon, South Korea.	doj087@mail.harvard.edu		Kwon, Jin-woo/0000-0003-2093-4284				Abu El-Asrar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085857; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; AKIBA J, 1990, OPHTHALMOLOGY, V97, P889; CUNHAVAZ JG, 1978, ARCH OPHTHALMOL-CHIC, V96, P809, DOI 10.1001/archopht.1978.03910050415001; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; Descamps FJ, 2006, EXP EYE RES, V83, P401, DOI 10.1016/j.exer.2006.01.017; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Flaxel C, 2007, RETINA-J RET VIT DIS, V27, P629, DOI 10.1097/01.iae.0000249561.02567.fd; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gharagozlian S, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-7; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; HENDRIKSE F, 1993, KLIN MONATSBL AUGENH, V203, P319, DOI 10.1055/s-2008-1045684; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Jacqueminet S, 2006, CLIN CHIM ACTA, V367, P103, DOI 10.1016/j.cca.2005.11.029; Jia Y, 2014, INVEST OPHTH VIS SCI, V55, P3922, DOI 10.1167/iovs.14-13983; Jin M, 2001, RETINA-J RET VIT DIS, V21, P28, DOI 10.1097/00006982-200102000-00005; Jonas JB, 2012, RETINA-J RET VIT DIS, V32, P2150, DOI 10.1097/IAE.0b013e3182576d07; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Kosano H, 1999, LIFE SCI, V64, P2307, DOI 10.1016/S0024-3205(99)00184-8; Kowluru RA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/635284; Kowluru RA, 2012, EXPERT OPIN INV DRUG, V21, P797, DOI 10.1517/13543784.2012.681043; Kowluru RA, 2010, INVEST OPHTH VIS SCI, V51, P4320, DOI 10.1167/iovs.09-4851; Kramer M, 2012, CLIN EXP OPHTHALMOL, V40, P617, DOI 10.1111/j.1442-9071.2011.02747.x; Lim LS, 2011, INVEST OPHTH VIS SCI, V52, P669, DOI 10.1167/iovs.10-6184; Lim LS, 2010, OPHTHALMOLOGY, V117, P524, DOI 10.1016/j.ophtha.2009.07.044; Lin A, 2015, METHODS MOL BIOL, V1318, P107, DOI 10.1007/978-1-4939-2742-5_11; Man REK, 2013, CLIN EXP OPHTHALMOL, V41, P293, DOI 10.1111/j.1442-9071.2012.02872.x; Mohammad G, 2012, J CELL PHYSIOL, V227, P1052, DOI 10.1002/jcp.22822; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nambi V, 2008, TEX HEART I J, V35, P388; Noda K, 2003, INVEST OPHTH VIS SCI, V44, P2163, DOI 10.1167/iovs.02-0662; Papazoglou D, 2010, EXP CLIN ENDOCR DIAB, V118, P730, DOI 10.1055/s-0030-1249671; PATEL V, 1992, BMJ-BRIT MED J, V305, P678, DOI 10.1136/bmj.305.6855.678; Peeters SA, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0195-2; Quigley M, 1999, ARCH OPHTHALMOL-CHIC, V117, P84; Rohani MG, 2014, J INVEST DERMATOL, V134, P1230, DOI 10.1038/jid.2013.499; Sanchez MC, 2007, EXP EYE RES, V85, P644, DOI 10.1016/j.exer.2007.07.018; Stefansson E, 2006, SURV OPHTHALMOL, V51, P364, DOI 10.1016/j.survophthal.2006.04.005; TAGAWA H, 1986, OPHTHALMOLOGY, V93, P596; TAGAWA H, 1986, OPHTHALMOLOGY, V93, P1188; Thrailkill KM, 2007, DIABETES CARE, V30, P2321, DOI 10.2337/dc07-0162; Thrailkill KM, 2010, ENDOCRINE, V37, P336, DOI 10.1007/s12020-010-9308-6; Toni M, 2013, DIABETOLOGIA, V56, P2743, DOI 10.1007/s00125-013-3052-4; Vandooren J, 2015, BIOCHEM J, V465, P259, DOI 10.1042/BJ20140418; Varma R, 2014, JAMA OPHTHALMOL, V132, P1334, DOI 10.1001/jamaophthalmol.2014.2854; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wells JA, 2015, NEW ENGL J MED, V372, P1193, DOI 10.1056/NEJMoa1414264; Wong TY, 2008, AM J OPHTHALMOL, V146, P656, DOI 10.1016/j.ajo.2008.07.048; Yamamoto N, 2005, OPHTHALMIC RES, V37, P29, DOI 10.1159/000083019; Yildirim N, 2008, J GLAUCOMA, V17, P253, DOI 10.1097/IJG.0b013e31815c3a07; Zeng W, 2011, J DIABETES COMPLICAT, V25, P398, DOI 10.1016/j.jdiacomp.2011.10.002	52	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159720	10.1371/journal.pone.0159720	http://dx.doi.org/10.1371/journal.pone.0159720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467659	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100050
J	Smarr, BL; Zucker, I; Kriegsfeld, LJ				Smarr, Benjamin L.; Zucker, Irving; Kriegsfeld, Lance J.			Detection of Successful and Unsuccessful Pregnancies in Mice within Hours of Pairing through Frequency Analysis of High Temporal Resolution Core Body Temperature Data	PLOS ONE			English	Article							ULTRADIAN RHYTHMS; CIRCADIAN-RHYTHMS; TESTOSTERONE; MODULATION; SECRETION; CORTISOL; HORMONES; STRAINS; NEURONS; PATTERN	Many controllable factors negatively impact fetal development, underscoring the importance of early pregnancy detection and identification of events that reliably predict potential complications. Clinically, core body temperature (CBT) is used to aid family planning and pregnancy detection. However, such temperature data typically are gathered in single, daily measurements. In animal studies, interventions or cell/tissue harvesting at defined stages of fetal development are arduous, requiring timed mating by trained observers. The value of continuous temperature measurements remains largely unexplored, but the advent of small, inexpensive, and increasingly ubiquitous, accurate sensor devices makes continuous measures feasible. Here, using a mouse model, we show that continuous, 1-min resolution CBT measurements reliably allow for the earliest and most accurate detection of pregnancy (100%, within 14 h of initial pairing), without requiring interaction with the animal for data collection. This method also reveals a subset of females that exhibit a pregnancylike response following pairing that persists for a variable number of days. Application of wavelet analysis that permits frequency analysis while preserving temporal resolution, uncovers significant differences in ultradian frequencies of CBT; these rhythms are significantly increased in the 12 h after the day of pairing for pregnancies carried to term compared to apparent pregnancies that failed. High temporal resolution CBT and wavelet analysis permit strikingly early detection and separation of successful pregnancies and pregnancy-like events.	[Smarr, Benjamin L.; Zucker, Irving; Kriegsfeld, Lance J.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kriegsfeld, Lance J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Kriegsfeld, LJ (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.; Kriegsfeld, LJ (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	kriegsfeld@berkeley.edu			National Institute of Child Health and Human Development [F32HD081957]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050470, F32HD081957] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development (www.nichd.nih.gov/Pages/index.aspx), number F32HD081957. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MOUSE BIOMEDICAL RES; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; BUXTON CL, 1948, J CLIN ENDOCRINOL, V8, P544, DOI 10.1210/jcem-8-7-544; Clarke SD, 2012, ENDOCRINOLOGY, V153, P123, DOI 10.1210/en.2011-1634; Deb K, 2006, METH MOLEC MED, V121, P9; DIAMOND M, 1970, SCIENCE, V169, P995, DOI 10.1126/science.169.3949.995; Dowse H, 2010, J EXP BIOL, V213, P1788, DOI 10.1242/jeb.038877; FULKERSON WJ, 1979, J ENDOCRINOL, V81, P135, DOI 10.1677/joe.0.0810135; Heyne GW, 2015, J AM ASSOC LAB ANIM, V54, P368; Leise TL, 2011, J BIOL RHYTHM, V26, P454, DOI 10.1177/0748730411416330; Lilly JM, 2012, IEEE T SIGNAL PROCES, V60, P6036, DOI 10.1109/TSP.2012.2210890; Mader SL, 2009, LAB ANIMAL, V38, P305, DOI 10.1038/laban0909-305; MARRONE BL, 1976, PHYSIOL BEHAV, V17, P419, DOI 10.1016/0031-9384(76)90101-3; Mauvais-Jarvis F, 2011, TRENDS ENDOCRIN MET, V22, P24, DOI 10.1016/j.tem.2010.10.002; MICHAEL SD, 1975, BIOL REPROD, V12, P400, DOI 10.1095/biolreprod12.3.400; Mittelman-Smith MA, 2012, P NATL ACAD SCI USA, V109, P19846, DOI 10.1073/pnas.1211517109; Ono D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12310; Pallares P, 2009, REPROD FERT DEVELOP, V21, P283, DOI 10.1071/RD08124; Qian XX, 2012, ENDOCRINOLOGY, V153, P4346, DOI 10.1210/en.2012-1484; Rance NE, 2013, FRONT NEUROENDOCRIN, V34, P211, DOI 10.1016/j.yfrne.2013.07.003; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Sanchez-Alavez M, 2011, AGE, V33, P89, DOI 10.1007/s11357-010-9164-6; Sanchez-Alavez M, 2010, DIABETES, V59, P43, DOI 10.2337/db09-1128; Smarr BL, 2016, IEEE T AFFECT COMPUT, V7, P220, DOI 10.1109/TAFFC.2015.2511762; Wang ZY, 2014, HORM BEHAV, V66, P228, DOI 10.1016/j.yhbeh.2014.04.014; Weinert D, 2007, PHYSIOL BEHAV, V90, P246, DOI 10.1016/j.physbeh.2006.09.003; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001	28	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160127	10.1371/journal.pone.0160127	http://dx.doi.org/10.1371/journal.pone.0160127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467519	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100118
J	Yong, KJ; Milenic, DE; Baidoo, KE; Brechbiel, MW				Yong, Kwon Joong; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.			Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and Pb-212-Trastuzumab Treatment in a Disseminated i.p. Tumor Model	PLOS ONE			English	Article							DNA-DAMAGE; CYCLE CHECKPOINT; HOMOLOGOUS RECOMBINATION; ALPHA; RADIOIMMUNOTHERAPY; RADIATION; ARREST; REPAIR; PB-212-TCMC-TRASTUZUMAB; POTENTIATION	In pre-clinical studies, combination therapy with gemcitabine and targeted radioimmunotherapy (RIT) using Pb-212-trastuzumab showed tremendous therapeutic potential in the LS-174T tumor xenograft model of disseminated intraperitoneal disease. To better understand the underlying molecular basis for the observed cell killing efficacy, gene expression profiling was performed after a 24 h exposure to Pb-212-trastuzumab upon gemcitabine (Gem) pre-treatment in this model. DNA damage response genes in tumors were quantified using a real time quantitative PCR array (qRT-PCR array) covering 84 genes. The combination of Gem with alpha-radiation resulted in the differential expression of apoptotic genes (BRCA1, CIDEA, GADD45 alpha, GADD45 gamma, IP6K3, PCBP4, RAD21, and p73), cell cycle regulatory genes (BRCA1, CHK1, CHK2, FANCG, GADD45 alpha, GTSE1, PCBP4, MAP2K6, NBN, PCBP4, and SESN1), and damaged DNA binding and repair genes (BRCA1, BTG2, DMC1, ERCC1, EXO1, FANCG, FEN1, MSH2, MSH3, NBN, NTHL1, OGG1, PRKDC, RAD18, RAD21, RAD51B, SEMA4G, p73, UNG, XPC, and XRCC2). Of these genes, the expression of CHK1, GTSE1, EXO1, FANCG, RAD18, UNG and XRCC2 were specific to Gem/Pb-212-trastuzumab administration. In addition, the present study demonstrates that increased stressful growth arrest conditions induced by Gem/Pb-212-trastuzumab could suppress cell proliferation possibly by up-regulating genes involved in apoptosis such as p73, by down-regulating genes involved in cell cycle check point such as CHK1, and in damaged DNA repair such as RAD51 paralogs. These events may be mediated by genes such as BRCA1/MSH2, a member of BARC (BRCA-associated genome surveillance complex). The data suggest that up-regulation of genes involved in apoptosis, perturbation of checkpoint genes, and a failure to correctly perform HR-mediated DSB repair and mismatch-mediated SSB repair may correlate with the previously observed inability to maintain the G2/M arrest, leading to cell death.	[Yong, Kwon Joong; Milenic, Diane E.; Baidoo, Kwamena E.; Brechbiel, Martin W.] NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brechbiel, MW (corresponding author), NCI, Radioimmune & Inorgan Chem Sect, Radiat Oncol Branch, NIH, Bethesda, MD 20892 USA.	martinwb@mail.nih.gov			Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; AREVA Med LLC; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIASC006353] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AREVA Med LLC; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, and AREVA Med LLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research and AREVA Med LLC.	AZURE MT, 1994, RADIAT RES, V140, P276, DOI 10.2307/3578912; Barbet Jacques, 2012, Methods Mol Biol, V907, P681, DOI 10.1007/978-1-61779-974-7_38; Blakely EA, 1998, RADIAT RES, V150, pS126, DOI 10.2307/3579815; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Chang IY, 2008, MOL CANCER RES, V6, P978, DOI 10.1158/1541-7786.MCR-07-0380; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Chauhan V, 2012, INT J HYG ENVIR HEAL, V215, P522, DOI 10.1016/j.ijheh.2012.04.004; Dahle J, 2011, CURR RADIOPHARM, V4, P321, DOI 10.2174/1874471011104040321; Danielsson A, 2013, INT J RADIAT BIOL, V89, P250, DOI 10.3109/09553002.2013.746751; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Franchitto A, 2003, ONCOGENE, V22, P2110, DOI 10.1038/sj.onc.1206254; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Hei TK, 1997, P NATL ACAD SCI USA, V94, P3765, DOI 10.1073/pnas.94.8.3765; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Jia Y, 2013, ONCOGENE, V32, P1943, DOI 10.1038/onc.2012.211; Jurcic JG, 2013, IMMUNOTHERAPY-UK, V5, P383, DOI [10.2217/IMT.13.11, 10.2217/imt.13.11]; Kim YS, 2012, TUMOR BIOL, V33, P573, DOI 10.1007/s13277-011-0286-y; Lawrence TS, 1997, SEMIN ONCOL, V24, pS24; Meredith R, 2014, J NUCL MED, V55, P1636, DOI 10.2967/jnumed.114.143842; Meredith RF, 2014, CANCER BIOTHER RADIO, V29, P12, DOI 10.1089/cbr.2013.1531; Milas L, 1999, CANCER RES, V59, P107; Milenic DE, 2005, CANCER BIOTHER RADIO, V20, P557, DOI 10.1089/cbr.2005.20.557; Milenic DE, 2004, CLIN CANCER RES, V10, P7834, DOI 10.1158/1078-0432.CCR-04-1226; Milenic DE, 2008, CLIN CANCER RES, V14, P5108, DOI 10.1158/1078-0432.CCR-08-0256; Milenic DE, 2007, CLIN CANCER RES, V13, P1926, DOI 10.1158/1078-0432.CCR-06-2300; Navarro-Teulon I, 2013, IMMUNOTHERAPY-UK, V5, P467, DOI [10.2217/IMT.13.34, 10.2217/imt.13.34]; Rossi M, 2004, ANN NY ACAD SCI, V1028, P143, DOI 10.1196/annals.1322.015; Seelan RS, 2002, NEOPLASIA, V4, P195, DOI 10.1038/sj.neo.7900237; Seidl C, 2007, MOL CANCER THER, V6, P2346, DOI 10.1158/1535-7163.MCT-07-0132; Seidl C, 2014, IMMUNOTHERAPY-UK, V6, P431, DOI 10.2217/imt.14.16; Seidl C, 2010, INVEST NEW DRUG, V28, P49, DOI 10.1007/s10637-008-9214-4; SHEWACH DS, 1994, CANCER RES, V54, P3218; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Soyland C, 2000, INT J RADIAT BIOL, V76, P1315, DOI 10.1080/09553000050151583; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Tophkhane C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043564; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Wang Y, 2000, GENE DEV, V14, P927; Yamane K, 2007, CANCER RES, V67, P6286, DOI 10.1158/0008-5472.CAN-06-2205; Yokoyama H, 2004, NUCLEIC ACIDS RES, V32, P2556, DOI 10.1093/nar/gkh578; Yong K, 2011, DALTON T, V40, P6068, DOI 10.1039/c0dt01387k; Yong KJ, 2013, CANCER MED-US, V2, P646, DOI 10.1002/cam4.132; Yong KJ, 2013, INT J RADIAT ONCOL, V85, P1119, DOI 10.1016/j.ijrobp.2012.09.015; Yong KJ, 2012, MOL CANCER THER, V11, P639, DOI 10.1158/1535-7163.MCT-11-0671	46	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159904	10.1371/journal.pone.0159904	http://dx.doi.org/10.1371/journal.pone.0159904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467592	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100070
J	Anderson, CS; DeDiego, ML; Thakar, J; Topham, DJ				Anderson, Christopher S.; DeDiego, Marta L.; Thakar, Juilee; Topham, David J.			Novel Sequence-Based Mapping of Recently Emerging H5NX Influenza Viruses Reveals Pandemic Vaccine Candidates	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; PREDICTING ANTIGENIC VARIANTS; HEMAGGLUTININ; EVOLUTION; H3N2; SELECTION; DISTANCE; EFFICACY; STRAINS; DUCKS	Recently, an avian influenza virus, H5NX subclade 2.3.4.4, emerged and spread to North America. This subclade has frequently reassorted, leading to multiple novel viruses capable of human infection. Four cases of human infections, three leading to death, have already occurred. Existing vaccine strains do not protect against these new viruses, raising a need to identify new vaccine candidate strains. We have developed a novel sequence-based mapping (SBM) tool capable of visualizing complex protein sequence data sets using a single intuitive map. We applied SBM on the complete set of avian H5 viruses in order to better understand hemagglutinin protein variance amongst H5 viruses and identify any patterns associated with this variation. The analysis successfully identified the original reassortments that lead to the emergence of this new subclade of H5 viruses, as well as their known unusual ability to re-assort among neuraminidase subtypes. In addition, our analysis revealed distinct clusters of 2.3.4.4 variants that would not be covered by existing strains in the H5 vaccine stockpile. The results suggest that our method may be useful for pandemic candidate vaccine virus selection.	[Anderson, Christopher S.; DeDiego, Marta L.; Thakar, Juilee; Topham, David J.] Univ Rochester, David Smith Ctr Immunol & Vaccine Biol, New York Influenza Ctr Excellence, Dept Microbiol & Immunol,Med Ctr, Rochester, NY 14642 USA; [Thakar, Juilee] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Topham, DJ (corresponding author), Univ Rochester, David Smith Ctr Immunol & Vaccine Biol, New York Influenza Ctr Excellence, Dept Microbiol & Immunol,Med Ctr, Rochester, NY 14642 USA.	David_Topham@URMC.rochester.edu	Demchuk, Andrew M/E-1103-2012; De Diego, Marta Lopez/B-2307-2017	Demchuk, Andrew M/0000-0002-4930-7789; De Diego, Marta Lopez/0000-0002-7888-7372	New York Influenza Center of Excellence NIH/NIAID/DMID [HHSN272201400005C]	New York Influenza Center of Excellence NIH/NIAID/DMID	Funding for this work was supported by the New York Influenza Center of Excellence NIH/NIAID/DMID, HHSN272201400005C.	Alam S, 2014, J VIROL, V88, P314, DOI 10.1128/JVI.02077-13; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P133; [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P561, DOI DOI 10.1111/IRV.12324/EPDF; Bouwstra R, 2015, EMERG INFECT DIS, V21, P872, DOI 10.3201/eid2105.141839; Cai ZP, 2012, VACCINE, V30, P448, DOI 10.1016/j.vaccine.2011.10.051; Chambers BS, 2014, J VIROL, V88, P10986, DOI 10.1128/JVI.01077-14; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Daly JM, 2013, VACCINE, V31, P6043, DOI 10.1016/j.vaccine.2013.06.070; de Vries E, 2015, EMERG INFECT DIS, V21, P842, DOI 10.3201/eid2105.141927; deJong JC, 1997, NATURE, V389, P554, DOI 10.1038/39218; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gu M, 2011, EMERG INFECT DIS, V17, P1060, DOI [10.3201/eid1706.101406, 10.3201/eid/1706.101406]; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kobayashi Y, 2012, J VIROL, V86, P3446, DOI 10.1128/JVI.06147-11; Koel BF, 2013, SCIENCE, V342, P976, DOI 10.1126/science.1244730; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107; Lees WD, 2010, BIOINFORMATICS, V26, P1403, DOI 10.1093/bioinformatics/btq160; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Liu CG, 2013, VET MICROBIOL, V167, P296, DOI 10.1016/j.vetmic.2013.09.004; Nunez A, 2016, TRANSBOUND EMERG DIS, V63, P5, DOI 10.1111/tbed.12442; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Saito T, 2015, REV MED VIROL, V25, P388, DOI 10.1002/rmv.1857; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Smith DJ, 1997, J THEOR BIOL, V189, P141, DOI 10.1006/jtbi.1997.0495; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki Y, 2015, META GENE, V4, P64, DOI 10.1016/j.mgene.2015.03.003; Swayne DE, 2000, REV SCI TECH OIE, V19, P463; UNDERWOOD PA, 1982, J GEN VIROL, V62, P153, DOI 10.1099/0022-1317-62-1-153; USDA-FSIS, 2015, FSIS COMPL GUID HACC, P1; Verhagen JH, 2015, SCIENCE, DOI [10.1126/science.1259924, DOI 10.1126/SCIENCE.1259924]; World Health Organisation, 2015, CONST WHO ENT FORC 7, P1; Yang ZF, 2015, NEW ENGLAND J, DOI [10.1056/NEJMc1507438, DOI 10.1056/NEJMC1507438]	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160510	10.1371/journal.pone.0160510	http://dx.doi.org/10.1371/journal.pone.0160510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494186	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500051
J	Mendonca, M; Moreira, GMSG; Conceicao, FR; Hust, M; Mendonca, KS; Moreira, AN; Franca, RC; da Silva, WP; Bhunia, AK; Aleixo, JAG				Mendonca, Marcelo; Schmidt Garcia Moreira, Gustavo Marcal; Conceicao, Fabricio Rochedo; Hust, Michael; Mendonca, Karla Sequeira; Moreira, Angela Nunes; Franca, Rodrigo Correa; da Silva, Wladimir Padilha; Bhunia, Arun K.; Aleixo, Jose Antonio G.			Fructose 1,6-Bisphosphate Aldolase, a Novel Immunogenic Surface Protein on Listeria Species	PLOS ONE			English	Article							FRUCTOSE-BISPHOSPHATE ALDOLASES; MONOCLONAL-ANTIBODIES; ESCHERICHIA-COLI; SP NOV.; STREPTOCOCCUS-PNEUMONIAE; CELL-SURFACE; DIFFERENTIAL EXPRESSION; SELECTIVE INHIBITORS; MONOCYTOGENES; IDENTIFICATION	Listeria monocytogenes is a ubiquitous food-borne pathogen, and its presence in food or production facilities highlights the importance of surveillance. Increased understanding of the surface exposed antigens on Listeria would provide potential diagnostic and therapeutic targets. In the present work, using mass spectrometry and genetic cloning, we show that fructose-1,6-bisphosphate aldolase (FBA) class II in Listeria species is the antigen target of the previously described mAb-3F8. Western and dot blot assays confirmed that the mAb-3F8 could distinguish all tested Listeria species from close-related bacteria. Localization studies indicated that FBA is present in every fraction of Listeria cells, including supernatant and the cell wall, setting Listeria spp. as one of the few bacteria described to have this protein on their cell surface. Epitope mapping using ORFeome display and a peptide membrane revealed a 14-amino acid peptide as the potential mAb-3F8 epitope. The target epitope in FBA allowed distinguishing Listeria spp. from closely-related bacteria, and was identified as part of the active site in the dimeric enzyme. However, its function in cell surface seems not to be host cell adhesion-related. Western and dot blot assays further demonstrated that mAb-3F8 together with anti-InlA mAb-2D12 could differentiate pathogenic from non-pathogenic Listeria isolated from artificially contaminated cheese. In summary, we report FBA as a novel immunogenic surface target useful for the detection of Listeria genus.	[Mendonca, Marcelo; Schmidt Garcia Moreira, Gustavo Marcal; Conceicao, Fabricio Rochedo; Moreira, Angela Nunes; Franca, Rodrigo Correa; Aleixo, Jose Antonio G.] Univ Fed Pelotas, Lab Imunol Aplicada, Nucleo Biotecnol, Ctr Desenvolvimento Tecnol, Pelotas, RS, Brazil; [Mendonca, Marcelo; Bhunia, Arun K.] Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, Smith Hall, W Lafayette, IN 47907 USA; [Schmidt Garcia Moreira, Gustavo Marcal; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Abt Biotechnol, Spielmannstr, Braunschweig, Germany; [Mendonca, Karla Sequeira; da Silva, Wladimir Padilha] Univ Fed Pelotas, Lab Microbiol Alimentos, Dept Ciencia & Tecnol Agroind, Fac Agron Eliseu Maciel, Pelotas, RS, Brazil; [Mendonca, Marcelo] Univ Fed Rural Pernambuco, Unidade Acad Garanhuns, Garanhuns, PE, Brazil	Universidade Federal de Pelotas; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Braunschweig University of Technology; Universidade Federal de Pelotas; Universidade Federal Rural de Pernambuco (UFRPE)	Aleixo, JAG (corresponding author), Univ Fed Pelotas, Lab Imunol Aplicada, Nucleo Biotecnol, Ctr Desenvolvimento Tecnol, Pelotas, RS, Brazil.; Bhunia, AK (corresponding author), Purdue Univ, Dept Food Sci, Mol Food Microbiol Lab, Smith Hall, W Lafayette, IN 47907 USA.	bhunia@purdue.edu; biotjaga@gmail.com	Mendonça, Marcelo MM/I-6435-2013; Bhunia, Arun K./K-7639-2012; Moreira, Ângela N/D-1278-2019; Silva, Wladimir P/C-4967-2018	Mendonça, Marcelo MM/0000-0001-7415-457X; Bhunia, Arun K./0000-0003-3640-1554; Moreira, Ângela N/0000-0001-5347-8559; Silva, Wladimir P/0000-0002-4276-2690; Hust, Michael/0000-0003-3418-6045	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil [483673/2013-7, 204693/2014-4]; agricultural Research Service of the U.S. Department of Agriculture [1935-42000-072-02G]; Center for Food Safety and Engineering at Purdue University	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); agricultural Research Service of the U.S. Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Center for Food Safety and Engineering at Purdue University	The authors thank Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) for the scholarship of Marcelo Mendonca and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil for scholarships to Gustavo Moriera and financial support (Project numbers 483673/2013-7, and 204693/2014-4); the agricultural Research Service of the U.S. Department of Agriculture (Project number 1935-42000-072-02G); and the Center for Food Safety and Engineering at Purdue University for hosting Marcelo Mendonca as a visiting scientist for sandwich PhD program and for the financial support to the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) for the scholarship of Marcelo Mendonca and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) from Brazil for scholarships to Gustavo Marcal Schmidt Garcia Moreira and financial support (Project numbers 483673/2013-7, and 204693/2014-4); the agricultural Research Service of the U.S. Department of Agriculture (Project number 1935-42000-072-02G); and the Center for Food Safety and Engineering at Purdue University for hosting Marcelo Mendonca as a visiting scientist for sandwich PhD program and for the financial support to the work.	Chaves EGA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0393-9; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Becker M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0167-3; Bertsch D, 2013, INT J SYST EVOL MICR, V63, P526, DOI 10.1099/ijs.0.036947-0; Besse NG, 2010, INT J FOOD MICROBIOL, V136, P345, DOI 10.1016/j.ijfoodmicro.2009.10.025; BHUNIA AK, 1991, INFECT IMMUN, V59, P3176, DOI 10.1128/IAI.59.9.3176-3184.1991; BHUNIA AK, 1992, APPL ENVIRON MICROB, V58, P1924, DOI 10.1128/AEM.58.6.1924-1929.1992; Bhunia AK, 2008, ADV FOOD NUTR RES, V54, P1, DOI 10.1016/S1043-4526(07)00001-0; Bhunia AK, 2014, FUTURE MICROBIOL, V9, P935, DOI [10.2217/FMB.14.61, 10.2217/fmb.14.61]; Blau K, 2007, J INFECT DIS, V195, P1828, DOI 10.1086/518038; BUTMAN BT, 1988, APPL ENVIRON MICROB, V54, P1564, DOI 10.1128/AEM.54.6.1564-1569.1988; Byrne B, 2009, SENSORS-BASEL, V9, P4407, DOI 10.3390/s90604407; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Connor DO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148986; Daher R, 2010, J MED CHEM, V53, P7836, DOI 10.1021/jm1009814; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; den Bakker HC, 2014, INT J SYST EVOL MICR, V64, P1882, DOI 10.1099/ijs.0.052720-0; Fonvielle M, 2008, CHEM-EUR J, V14, P8521, DOI 10.1002/chem.200800857; Fuchs M, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-68; Gasanov U, 2005, FEMS MICROBIOL REV, V29, P851, DOI 10.1016/j.femsre.2004.12.002; Geng T, 2006, J FOOD PROTECT, V69, P1879, DOI 10.4315/0362-028X-69.8.1879; Goldman SE, 2016, INT J MOL MED, V37, P1127, DOI 10.3892/ijmm.2016.2512; Graves LM, 2010, INT J SYST EVOL MICR, V60, P1280, DOI 10.1099/ijs.0.014118-0; Guillet C, 2010, EMERG INFECT DIS, V16, P136, DOI 10.3201/eid1601.091155; Hain T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/j.ijmm.2007.03.016; Halter EL, 2013, INT J SYST EVOL MICR, V63, P641, DOI 10.1099/ijs.0.036830-0; Heo SA, 2007, J FOOD SCI, V72, pM8, DOI 10.1111/j.1750-3841.2006.00202.x; Hust M, 2006, BIOTECHNIQUES, V41, P335, DOI 10.2144/000112225; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jadhav S, 2012, J MICROBIOL METH, V88, P327, DOI 10.1016/j.mimet.2012.01.002; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Katebi AR, 2015, BIOCHEMISTRY-US, V54, P3543, DOI 10.1021/acs.biochem.5b00042; Kim HC, 2008, APPL ENVIRON MICROB, V74, P4853, DOI 10.1128/AEM.02756-07; Kim KP, 2006, FEMS MICROBIOL LETT, V256, P324, DOI 10.1111/j.1574-6968.2006.00140.x; Kim Seong-Hee, 2005, J Vet Sci, V6, P41; Kugler J, 2008, APPL MICROBIOL BIOT, V80, P447, DOI 10.1007/s00253-008-1576-1; Kugler J, 2013, VIRUSES-BASEL, V5, P2531, DOI 10.3390/v5102531; Kumar G, 2010, COMP IMMUNOL MICROB, V33, P133, DOI 10.1016/j.cimid.2008.08.008; Lathrop AA, 2008, J APPL MICROBIOL, V104, P627, DOI 10.1111/j.1365-2672.2007.03574.x; Lathrop AA, 2014, ANTIB TECHNOL J, V4, P13, DOI [10.2147/anti.s54848, DOI 10.2147/ANTI.S54848]; Leclercq A, 2010, INT J SYST EVOL MICR, V60, P2210, DOI 10.1099/ijs.0.017376-0; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Leonard P, 2004, BIOSENS BIOELECTRON, V19, P1331, DOI 10.1016/j.bios.2003.11.009; Li FQ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-253; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; MARSH JJ, 1992, TRENDS BIOCHEM SCI, V17, P110, DOI 10.1016/0968-0004(92)90247-7; MCLAUCHLIN J, 1988, J CLIN PATHOL, V41, P983, DOI 10.1136/jcp.41.9.983; Mendonca M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-275; Meyer T, 2011, VET MICROBIOL, V147, P162, DOI 10.1016/j.vetmic.2010.06.023; Mishra KK, 2011, GENE, V489, P76, DOI 10.1016/j.gene.2011.08.015; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; Nanduri V, 2007, BIOSENS BIOELECTRON, V23, P248, DOI 10.1016/j.bios.2007.04.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oravcova K, 2008, J APPL MICROBIOL, V104, P429, DOI 10.1111/j.1365-2672.2007.03554.x; Pandiripally VK, 1999, J MED MICROBIOL, V48, P117, DOI 10.1099/00222615-48-2-117; Paoli GC, 2007, J RAPID METH AUT MIC, V15, P77, DOI 10.1111/j.1745-4581.2007.00079.x; Portnoi M, 2006, VACCINE, V24, P1868, DOI 10.1016/j.vaccine.2005.10.053; Ramnath M, 2003, APPL ENVIRON MICROB, V69, P3368, DOI 10.1128/AEM.69.6.3368-3376.2003; Rondot S, 2001, NAT BIOTECHNOL, V19, P75, DOI 10.1038/83567; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar D, 2014, BIOMED MICRODEVICES, V16, P509, DOI 10.1007/s10544-014-9853-5; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Schrodinger L., 2020, PYMOL; Shams F, 2014, BIOCHEM SOC T, V42, P1792, DOI 10.1042/BST20140203; Shank FR, 1996, FOOD CONTROL, V7, P229, DOI 10.1016/S0956-7135(96)00041-2; Shi L, 2015, ANAL BIOANAL CHEM, V407, P529, DOI 10.1007/s00216-014-8276-8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silk BJ, 2012, CLIN INFECT DIS, V54, pS396, DOI 10.1093/cid/cis268; SIRAGUSA GR, 1990, APPL ENVIRON MICROB, V56, P1897, DOI 10.1128/AEM.56.6.1897-1904.1990; Stenz L, 2011, FEMS IMMUNOL MED MIC, V62, P123, DOI 10.1111/j.1574-695X.2011.00812.x; Sun RG, 2000, INFECT IMMUN, V68, P3509, DOI 10.1128/IAI.68.6.3509-3515.2000; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Ueda S, 2013, BIOCONTROL SCI, V18, P157, DOI 10.4265/bio.18.157; Vallim DC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/540204; Wang GQ, 2014, CURR ISSUES MOL BIOL, V16, P15; Weller D, 2015, INT J SYST EVOL MICR, V65, P286, DOI 10.1099/ijs.0.070839-0; Wieckowska-Szakiel M, 2002, INT J FOOD MICROBIOL, V72, P63, DOI 10.1016/S0168-1605(01)00606-7; Yu KY, 2004, CLIN DIAGN LAB IMMUN, V11, P446, DOI 10.1128/CDLI.11.3.446-451.2004	79	13	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160544	10.1371/journal.pone.0160544	http://dx.doi.org/10.1371/journal.pone.0160544			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27489951	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900068
J	Iannetta, M; Zingaropoli, MA; Bellizzi, A; Morreale, M; Pontecorvo, S; D'Abramo, A; Oliva, A; Anzivino, E; Lo Menzo, S; D'Agostino, C; Mastroianni, CM; Millefiorini, E; Pietropaolo, V; Francia, A; Vullo, V; Ciardi, MR				Iannetta, Marco; Zingaropoli, Maria Antonella; Bellizzi, Anna; Morreale, Manuela; Pontecorvo, Simona; D'Abramo, Alessandra; Oliva, Alessandra; Anzivino, Elena; Lo Menzo, Sara; D'Agostino, Claudia; Mastroianni, Claudio Maria; Millefiorini, Enrico; Pietropaolo, Valeria; Francia, Ada; Vullo, Vincenzo; Ciardi, Maria Rosa			Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HUMAN POLYOMAVIRUS; VIRUS-DNA; STEADY-STATE; HUMAN-SERA; PREVALENCE; ANTIBODIES; INFECTION; RISK; PML	The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsing-remitting form of multiple sclerosis (RRMS). Natalizumab therapeutic efficacy is limited by the reactivation of the John Cunningham polyomavirus (JCV) and development of progressive multifocal leukoencephalopathy (PML). To correlate natalizumab-induced phenotypic modifications of peripheral blood T-lymphocytes with JCV reactivation, JCV-specific antibodies (serum), JCV-DNA (blood and urine), CD49d expression and relative abundance of peripheral blood T-lymphocyte subsets were longitudinally assessed in 26 natalizumab-treated RRMS patients. Statistical analyses were performed using GraphPad Prism and R. Natalizumab treatment reduced CD49d expression on memory and effector subsets of peripheral blood T-lymphocytes. Moreover, accumulation of peripheral blood CD8(+) memory and effector cells was observed after 12 and 24 months of treatment. CD4(+) and CD8(+) T-lymphocyte immune-activation was increased after 24 months of treatment. Higher percentages of CD8(+) effectors were observed in subjects with detectable JCV-DNA. Natalizumab reduces CD49d expression on CD8(+) T-lymphocyte memory and effector subsets, limiting their migration to the central nervous system and determining their accumulation in peripheral blood. Impairment of central nervous system immune surveillance and reactivation of latent JCV, can explain the increased risk of PML development in natalizumab-treated RRMS subjects.	[Iannetta, Marco; Zingaropoli, Maria Antonella; Bellizzi, Anna; D'Abramo, Alessandra; Oliva, Alessandra; Anzivino, Elena; Lo Menzo, Sara; D'Agostino, Claudia; Mastroianni, Claudio Maria; Pietropaolo, Valeria; Vullo, Vincenzo; Ciardi, Maria Rosa] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Iannetta, Marco] Inst Cochin, INSERM, U1016, Paris, France; [Bellizzi, Anna] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy; [Morreale, Manuela] Sapienza Univ, Neurol Sect, Neurovasc Diag Unit, Dept Med & Surg Sci & Biotechnol, Rome, Italy; [Morreale, Manuela; Pontecorvo, Simona; Millefiorini, Enrico; Francia, Ada] Sapienza Univ, Multiple Sclerosis Ctr, Dept Neurol & Psychiat, Rome, Italy	Sapienza University Rome; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome	Iannetta, M (corresponding author), Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy.; Iannetta, M (corresponding author), Inst Cochin, INSERM, U1016, Paris, France.	marco.iannetta@uniroma1.it	Iannetta, Marco/M-4619-2019; D'Abramo, Alessandra/AAA-3054-2019; Iannetta, Marco/B-5596-2017; Oliva, Alessandra/C-1708-2019; MASTROIANNI, Claudio Maria/O-9741-2019; millefiorini, enrico/AHD-9424-2022; Pietropaolo, Valeria/J-8339-2018	Iannetta, Marco/0000-0002-6938-8627; D'Abramo, Alessandra/0000-0002-5160-9743; Iannetta, Marco/0000-0002-6938-8627; Oliva, Alessandra/0000-0003-0832-7975; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Pietropaolo, Valeria/0000-0001-5723-8886; Zingaropoli, Maria Antonella/0000-0001-9479-8559; D'Agostino, Caudia/0000-0002-4399-8785; ciardi, maria rosa/0000-0002-0894-6496	Istituto Pasteur-Fondazione Cenci Bolognetti; Sapienza Universita di Roma; Societa Italiana di Malattie Infettive e Tropicali (SIMIT)	Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Sapienza Universita di Roma; Societa Italiana di Malattie Infettive e Tropicali (SIMIT)	The authors received funding from Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza Universita di Roma, and Dr Marco Iannetta received a grant from Societa Italiana di Malattie Infettive e Tropicali (SIMIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWOOD WJ, 1992, VIROLOGY, V190, P716, DOI 10.1016/0042-6822(92)90909-9; Bellizzi A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-298; Beltrami S, 2014, J NEUROVIROL, V20, P137, DOI 10.1007/s13365-013-0222-6; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Bornsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047578; Bozic C, 2011, ANN NEUROL, V70, P713, DOI 10.1002/ana.22606; Chen YP, 2009, NEW ENGL J MED, V361, P1067, DOI 10.1056/NEJMoa0904267; Defer G, 2012, J NEUROL SCI, V314, P138, DOI 10.1016/j.jns.2011.10.005; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Frohman EM, 2014, JAMA NEUROL, V71, P596, DOI 10.1001/jamaneurol.2014.63; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; HEMLER ME, 1990, IMMUNOL REV, V114, P45, DOI 10.1111/j.1600-065X.1990.tb00561.x; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Jing D, 2010, BONE MARROW TRANSPL, V45, P1489, DOI 10.1038/bmt.2009.381; Johnson EM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/197807; Khalili K, 2007, NEUROLOGY, V68, P985, DOI 10.1212/01.wnl.0000257832.38943.2b; Laroni A, 2012, J NEUROIMMUNE PHARM, V7, P665, DOI 10.1007/s11481-012-9366-z; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; Maenetje P, 2010, J IMMUNOL, V184, P4926, DOI 10.4049/jimmunol.0903771; MAJOR EO, 1990, J NEUROSCI RES, V27, P461, DOI 10.1002/jnr.490270405; MAJOR EO, 1992, CLIN MICROBIOL REV, V5, P49, DOI 10.1128/CMR.5.1.49-73.1992; Marshall LJ, 2014, J VIROL, V88, P5177, DOI 10.1128/JVI.03221-13; Monao MCG, 1998, J VIROL, V72, P9918, DOI 10.1128/JVI.72.12.9918-9923.1998; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; PADGETT BL, 1973, J INFECT DIS, V127, P467, DOI 10.1093/infdis/127.4.467; Petrovic A, 2004, BLOOD, V103, P1542, DOI 10.1182/blood-2003-03-0957; Pucci E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007621.pub2; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rudick RA, 2010, ANN NEUROL, V68, P304, DOI 10.1002/ana.22107; Sadiq SA, 2010, J NEUROL, V257, P954, DOI 10.1007/s00415-009-5444-4; Serana F, 2014, J NEUROIMMUNOL, V277, P6, DOI 10.1016/j.jneuroim.2014.10.011; TAGUCHI F, 1982, MICROBIOL IMMUNOL, V26, P1057, DOI 10.1111/j.1348-0421.1982.tb00254.x; TORNATORE C, 1992, ANN NEUROL, V31, P454, DOI 10.1002/ana.410310426; Van Loy T, 2015, J VIROL, V89, P1340, DOI 10.1128/JVI.02565-14; Yaldizli Ozgur, 2009, Ther Adv Neurol Disord, V2, P115, DOI 10.1177/1756285608101861	35	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160277	10.1371/journal.pone.0160277	http://dx.doi.org/10.1371/journal.pone.0160277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486658	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800068
J	Riediger, IN; Hoffmaster, AR; Casanovas-Massana, A; Biondo, AW; Ko, AI; Stoddard, RA				Riediger, Irina N.; Hoffmaster, Alex R.; Casanovas-Massana, Arnau; Biondo, Alexander W.; Ko, Albert I.; Stoddard, Robyn A.			An Optimized Method for Quantification of Pathogenic Leptospira in Environmental Water Samples	PLOS ONE			English	Article							EXTRACTION KITS; OUTBREAK; DNA; HOUSEHOLD; INFECTION; TRANSMISSION; PARTICIPANTS; COMMUNITIES; INTERROGANS; RECOVERY	Leptospirosis is a zoonotic disease usually acquired by contact with water contaminated with urine of infected animals. However, few molecular methods have been used to monitor or quantify pathogenic Leptospira in environmental water samples. Here we optimized a DNA extraction method for the quantification of leptospires using a previously described Taqman-based qPCR method targeting lipL32, a gene unique to and highly conserved in pathogenic Leptospira. QIAamp DNA mini, MO BIO PowerWater DNA and PowerSoil DNA Isolation kits were evaluated to extract DNA from sewage, pond, river and ultrapure water samples spiked with leptospires. Performance of each kit varied with sample type. Sample processing methods were further evaluated and optimized using the PowerSoil DNA kit due to its performance on turbid water samples and reproducibility. Centrifugation speeds, water volumes and use of Escherichia coli as a carrier were compared to improve DNA recovery. All matrices showed a strong linearity in a range of concentrations from 10(6) to 10 degrees leptospires/mL and lower limits of detection ranging from < 1 cell/ml for river water to 36 cells/mL for ultrapure water with E. coli as a carrier. In conclusion, we optimized a method to quantify pathogenic Leptospira in environmental waters (river, pond and sewage) which consists of the concentration of 40 mL samples by centrifugation at 15,000xg for 20 minutes at 4 degrees C, followed by DNA extraction with the PowerSoil DNA Isolation kit. Although the method described herein needs to be validated in environmental studies, it potentially provides the opportunity for effective, timely and sensitive assessment of environmental leptospiral burden.	[Riediger, Irina N.] Cent Lab State Parana, Curitiba, Parana, Brazil; [Hoffmaster, Alex R.; Stoddard, Robyn A.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Casanovas-Massana, Arnau; Ko, Albert I.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Biondo, Alexander W.] Fed Univ State Parana, Dept Vet Med, Curitiba, Parana, Brazil; [Ko, Albert I.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil	Centers for Disease Control & Prevention - USA; Yale University; Universidade Federal do Parana; Fundacao Oswaldo Cruz	Riediger, IN (corresponding author), Cent Lab State Parana, Curitiba, Parana, Brazil.; Casanovas-Massana, A (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	iriediger@yahoo.com.br; arnau.casanovas@yale.edu	BIONDO, ALEXANDER WELKER/AAU-8955-2021; Ko, Albert/P-2343-2015; BIONDO, ALEXANDER WELKER W/E-8823-2018; Casanovas-Massana, Arnau/H-5806-2019	BIONDO, ALEXANDER WELKER/0000-0002-4182-5821; Ko, Albert/0000-0001-9023-2339; BIONDO, ALEXANDER WELKER W/0000-0002-4182-5821; Casanovas-Massana, Arnau/0000-0002-3301-6143	National Institute of Allergy and Infectious Diseases [R01 AI052473, U01 AI088752, R25 TW009338, R01 TW009504, R01 AI121207]; CAPES (Brazilian Ministry of Education) [BEX 066509-6]; FOGARTY INTERNATIONAL CENTER [R01TW009504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI121207] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CAPES (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) (award numbers R01 AI052473, U01 AI088752, R25 TW009338, R01 TW009504 and R01 AI121207 to AIK). INR was supported by a sandwich Ph.D. scholarship (BEX 066509-6) from CAPES (Brazilian Ministry of Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agampodi SB, 2014, EPIDEMIOL INFECT, V142, P843, DOI 10.1017/S0950268813001465; Amilasan AST, 2012, EMERG INFECT DIS, V18, P91, DOI 10.3201/eid1801.101892; Behets J, 2007, J MICROBIOL METH, V68, P137, DOI 10.1016/j.mimet.2006.07.002; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bonot S, 2010, APPL MICROBIOL BIOT, V87, P2303, DOI 10.1007/s00253-010-2686-0; Cosson JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002902; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003819; Costa F, 2014, VECTOR-BORNE ZOONOT, V14, P33, DOI 10.1089/vbz.2013.1378; Dauphin LA, 2009, J MICROBIOL METH, V76, P30, DOI 10.1016/j.mimet.2008.09.004; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Elvang AM, 2001, ENVIRON MICROBIOL, V3, P32, DOI 10.1046/j.1462-2920.2001.00156.x; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Ganoza CA, 2006, PLOS MED, V3, P1329, DOI 10.1371/journal.pmed.0030308; Goarant C, 2009, TROP MED INT HEALTH, V14, P926, DOI 10.1111/j.1365-3156.2009.02310.x; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lloyd KG, 2010, FEMS MICROBIOL ECOL, V72, P143, DOI 10.1111/j.1574-6941.2009.00827.x; Maciel EAP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000154; Mayer-Scholl A, 2014, INT J ENV RES PUB HE, V11, P7562, DOI 10.3390/ijerph110807562; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Munoz-Zanzi C, 2014, INT J ENV RES PUB HE, V11, P6666, DOI 10.3390/ijerph110706666; Munoz-Zanzi C, 2014, AM J TROP MED HYG, V90, P497, DOI 10.4269/ajtmh.13-0334; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Rawlins J, 2014, INT J ENV RES PUB HE, V11, P7953, DOI 10.3390/ijerph110807953; Reis RB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000228; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Smith JKG, 2013, EPIDEMIOL INFECT, V141, P585, DOI 10.1017/S0950268812001021; Stern EJ, 2010, CLIN INFECT DIS, V50, P843, DOI 10.1086/650578; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Tangkanakul W., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P281; Vein J, 2012, CAN J MICROBIOL, V58, P828, DOI [10.1139/W2012-060, 10.1139/w2012-060]; Viau EJ, 2011, J WATER HEALTH, V9, P637, DOI 10.2166/wh.2011.064; Weinberger D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002798; Whitehouse CA, 2007, MOL CELL PROBE, V21, P92, DOI 10.1016/j.mcp.2006.08.003; Wuthiekanun V, 2007, J CLIN MICROBIOL, V45, P1363, DOI 10.1128/JCM.02430-06	41	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160523	10.1371/journal.pone.0160523	http://dx.doi.org/10.1371/journal.pone.0160523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487084	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800084
J	Slofstra, C; Nauta, MH; Holmes, EA; Bockting, CLH				Slofstra, Christien; Nauta, Maaike H.; Holmes, Emily A.; Bockting, Claudi L. H.			Imagery Rescripting: The Impact of Conceptual and Perceptual Changes on Aversive Autobiographical Memories	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIOR THERAPY; MENTAL-IMAGERY; EYE-MOVEMENTS; WORKING-MEMORY; PROLONGED EXPOSURE; EMOTIONALITY; VIVIDNESS; PTSD; METAANALYSIS	Background Imagery rescripting (ImRs) is a process by which aversive autobiographical memories are rendered less unpleasant or emotional. ImRs is thought only to be effective if a change in the meaning-relevant (semantic) content of the mental image is produced, according to a cognitive hypothesis of ImRs. We propose an additional hypothesis: that ImRs can also be effective by the manipulation of perceptual features of the memory, without explicitly targeting meaning-relevant content. Methods In two experiments using a within-subjects design (both N = 48, community samples), both Conceptual-ImRs-focusing on changing meaning-relevant content-and Perceptual-ImRs-focusing on changing perceptual features-were compared to Recall-only of aversive autobiographical image-based memories. An active control condition, Recall + Attentional Breathing (Recall+AB) was added in the first experiment. In the second experiment, a Positive-ImRs condition was added-changing the aversive image into a positive image that was unrelated to the aversive autobiographical memory. Effects on the aversive memory's unpleasantness, vividness and emotionality were investigated. Results In Experiment 1, compared to Recall-only, both Conceptual-ImRs and Perceptual-ImRs led to greater decreases in unpleasantness, and Perceptual-ImRs led to greater decreases in emotionality of memories. In Experiment 2, the effects on unpleasantness were not replicated, and both Conceptual-ImRs and Perceptual-ImRs led to greater decreases in emotionality, compared to Recall-only, as did Positive-ImRs. There were no effects on vividness, and the ImRs conditions did not differ significantly from Recall+AB. Conclusions Results suggest that, in addition to traditional forms of ImRs, targeting the meaning-relevant content of an image during ImRs, relatively simple techniques focusing on perceptual aspects or positive imagery might also yield benefits. Findings require replication and extension to clinical samples.	[Slofstra, Christien; Nauta, Maaike H.; Bockting, Claudi L. H.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Holmes, Emily A.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Holmes, Emily A.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Bockting, Claudi L. H.] Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands	University of Groningen; Karolinska Institutet; Utrecht University	Bockting, CLH (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.; Bockting, CLH (corresponding author), Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands.	c.l.h.bockting@uu.nl	Bockting, Claudi L/K-3768-2019; Holmes, Emily/ABD-4367-2020	Bockting, Claudi L/0000-0002-9220-9244; Holmes, Emily/0000-0001-7319-3112; Nauta, Maaike H./0000-0001-7694-1382	NWO the Netherlands Organisation for Scientific Research [022.003.038]; Medical Research Council (United Kingdom) intramural programme [MC-A060-5PR50]; National Institute for Health Research Oxford Biomedical Research Centre Programme; UK Medical Research Council.	NWO the Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council (United Kingdom) intramural programme; National Institute for Health Research Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); UK Medical Research Council.(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by grant 022.003.038 from NWO (http://www.nwo.nl/) the Netherlands Organisation for Scientific Research, awarded to the Dutch-Flemish Research School Experimental Psychopathology. EAH is supported by the Medical Research Council (http://www.mrc.ac.uk/) (United Kingdom) intramural programme (MC-A060-5PR50) and the National Institute for Health Research (www.nihr.ac.uk) Oxford Biomedical Research Centre Programme. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Funding to pay the Open Access publication charges for this article was also provided by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J, 1997, BRIT J CLIN PSYCHOL, V36, P209, DOI 10.1111/j.2044-8260.1997.tb01408.x; Arntz A., 2014, WORKING EMOTION COGN, P203; Arntz A, 2015, MEMORY, P1; Arntz A., 2012, J EXP PSYCHOPATHOL, V3, P189, DOI [10.5127/jep.024211, DOI 10.5127/JEP.024211]; Arntz A, 2007, J BEHAV THER EXP PSY, V38, P345, DOI 10.1016/j.jbtep.2007.10.006; Arntz A, 2011, COGN BEHAV PRACT, V18, P466, DOI 10.1016/j.cbpra.2011.04.006; Bisson JI, 2007, BRIT J PSYCHIAT, V190, P97, DOI 10.1192/bjp.bp.106.021402; Blackwell SE, 2013, PSYCHIAT RES, V206, P56, DOI 10.1016/j.psychres.2012.09.047; Brewin CR, 2009, BEHAV RES THER, V47, P569, DOI 10.1016/j.brat.2009.03.008; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Cooper MJ, 2011, COGN BEHAV PRACT, V18, P454, DOI 10.1016/j.cbpra.2010.08.003; Dunn BD, 2012, CLIN PSYCHOL PSYCHOT, V19, P326, DOI 10.1002/cpp.1799; Engelhard IM, 2010, BEHAV RES THER, V48, P442, DOI 10.1016/j.brat.2010.01.003; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Grunert BK, 2003, COGN BEHAV PRACT, V10, P333, DOI 10.1016/S1077-7229(03)80051-2; Grunert BK, 2007, J BEHAV THER EXP PSY, V38, P317, DOI 10.1016/j.jbtep.2007.10.005; Hagenaars MA, 2012, J BEHAV THER EXP PSY, V43, P808, DOI 10.1016/j.jbtep.2011.09.005; Hirsch C.R., 2007, PSYCHIATRY, V6, P161, DOI [10.1016/j.mppsy.2007.01.005, DOI 10.1016/J.MPPSY.2007.01.005]; Holmes E., 2003, IMAGINATION COGNITIO, V23, P147, DOI [10.2190/HJG1-7UPH-B3K0-P9H5, DOI 10.2190/HJG1-7UPH-B3K0-P9H5]; Holmes EA, 2005, EMOTION, V5, P489, DOI 10.1037/1528-3542.5.4.489; Holmes EA, 2008, BEHAV RES THER, V46, P976, DOI 10.1016/j.brat.2008.04.009; Holmes EA, 2008, EMOTION, V8, P395, DOI 10.1037/1528-3542.8.3.395; Holmes EA, 2007, J BEHAV THER EXP PSY, V38, P297, DOI 10.1016/j.jbtep.2007.10.007; Holmes EA, 2008, BEHAV RES THER, V46, P1251, DOI 10.1016/j.brat.2008.09.005; Jung K, 2013, PSYCHOTHER PSYCHOSOM, V82, P213, DOI 10.1159/000348450; Lee CW, 2013, J BEHAV THER EXP PSY, V44, P231, DOI 10.1016/j.jbtep.2012.11.001; Leer A, 2014, J BEHAV THER EXP PSY, V45, P396, DOI 10.1016/j.jbtep.2014.04.004; Long ME, 2011, J CLIN PSYCHOL, V67, P1008, DOI 10.1002/jclp.20804; Long ME, 2011, J ANXIETY DISORD, V25, P531, DOI 10.1016/j.janxdis.2010.12.007; Morina N, 2011, J ANXIETY DISORD, V25, P1032, DOI 10.1016/j.janxdis.2011.06.012; Ohanian V, 2002, INT J EAT DISORDER, V31, P352, DOI 10.1002/eat.10044; Raabe S, 2015, J BEHAV THER EXP PSY, V9, P48; Rubin DC, 2008, PSYCHOL REV, V115, P985, DOI 10.1037/a0013397; Seebauer L, 2014, J BEHAV THER EXP PSY, V45, P20, DOI 10.1016/j.jbtep.2013.07.003; Segal Z. V., 2002, MINDFULNESS BASED CO; Shapiro F., 2001, EYE MOVEMENT DESENSI; Sheppes G, 2014, J EXP PSYCHOL GEN, V143, P163, DOI 10.1037/a0030831; Smeets MAM, 2012, MEMORY, V20, P346, DOI 10.1080/09658211.2012.665462; Stopa L, 2011, COGN BEHAV PRACT, V18, P421, DOI 10.1016/j.cbpra.2011.05.001; Tadmor A, 2014, J BEHAV THER EXP PSY; Tsai C, 2014, J BEHAV THER EXP PSY, V45, P15, DOI 10.1016/j.jbtep.2013.07.004; van den Hout M, 2001, BRIT J CLIN PSYCHOL, V40, P121; van den Hout MA, 2012, J EXP PSYCHOPATHOL, V3, P724; van den Hout MA, 2011, J BEHAV THER EXP PSY, V42, P423, DOI 10.1016/j.jbtep.2011.03.004; van den Hout MA, 2011, BEHAV RES THER, V49, P92, DOI 10.1016/j.brat.2010.11.003; Wesslau C, 2014, CLIN PSYCHOL REV, V34, P273, DOI DOI 10.1016/J.CPR.2014.03.001; Wheatley J, 2007, J BEHAV THER EXP PSY, V38, P371, DOI 10.1016/j.jbtep.2007.08.005; Wheatley J, 2011, COGN BEHAV PRACT, V18, P444, DOI 10.1016/j.cbpra.2010.06.004	48	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160235	10.1371/journal.pone.0160235	http://dx.doi.org/10.1371/journal.pone.0160235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486966	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800062
J	Al-Sady, B; Greenstein, RA; El-Samad, HJ; Braun, S; Madhani, HD				Al-Sady, Bassem; Greenstein, Rachel A.; El-Samad, Hana J.; Braun, Sigurd; Madhani, Hiten D.			Sensitive and Quantitative Three-Color Protein Imaging in Fission Yeast Using Spectrally Diverse, Recoded Fluorescent Proteins with Experimentally-Characterized In Vivo Maturation Kinetics	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; CHROMOPHORE MATURATION; NUCLEAR RETENTION; GENE-EXPRESSION; HETEROCHROMATIN; DYNAMICS; VARIANTS; OLIGOMERIZATION; CELLS; COLOR	Schizosaccharomyces pombe is an outstanding model organism for cell biological investigations, yet the range of useful and well-characterized fluorescent proteins (XFPs) is limited. We generated and characterized three recoded fluorescent proteins for 3-color analysis in S. pombe, Super-folder GFP, monomeric Kusabira Orange 2 and E2Crimson. Upon optimization and expression in S. pombe, the three proteins enabled sensitive simultaneous 3-color detection capability. Furthermore, we describe a strategy that combines a pulse-chase approach and mathematical modeling to quantify the maturation kinetics of these proteins in vivo. We observed maturation kinetics in S. pombe that are expected from those described for these proteins in vitro and/or in other cell types, but also unpredicted behaviors. Our studies provide a kinetically-characterized, integrated three-color XFP toolbox for S. pombe.	[Al-Sady, Bassem; Greenstein, Rachel A.] Univ Calif San Francisco, GW Hooper Fdn, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [El-Samad, Hana J.; Madhani, Hiten D.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Greenstein, Rachel A.] Univ Calif San Francisco, TETRAD Grad Program, San Francisco, CA 94143 USA; [Braun, Sigurd] Univ Munich, Biomed Ctr, Dept Physiol Chem, D-82152 Martinsried, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Munich	Al-Sady, B (corresponding author), Univ Calif San Francisco, GW Hooper Fdn, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Madhani, HD (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	bassem.al-sady@ucsf.edu; hitenmadhani@gmail.com		Braun, Sigurd/0000-0001-6399-8574; Al-Sady, Bassem/0000-0002-8996-7941; Madhani, Hiten/0000-0001-7400-6657	National Institutes of Health [GM71801]; European Union Network of Excellence EpiGeneSys [HEALTH-2010-257082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Network of Excellence EpiGeneSys; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a grant from the National Institutes of Health (https://www.nigms.nih.gov/Pages/default.aspx) number GM71801 to HDM and a grant from the European Union Network of Excellence EpiGeneSys (http://www.epigenesys.eu/en/) number HEALTH-2010-257082 to SB.	Ahn J, 2009, J MICROBIOL, V47, P789, DOI 10.1007/s12275-009-0010-4; Al-Sady B, 2013, MOL CELL, V51, P80, DOI 10.1016/j.molcel.2013.06.013; Aliye N, 2015, APPL MICROBIOL BIOT, V99, P1205, DOI 10.1007/s00253-014-5975-1; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Barraud P, 2011, EMBO J, V30, P4223, DOI 10.1038/emboj.2011.300; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bjerling P, 2012, JOVE-J VIS EXP, DOI 10.3791/3454; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Doherty Geoff P, 2010, BMC Res Notes, V3, P303, DOI 10.1186/1756-0500-3-303; Emmerth S, 2010, DEV CELL, V18, P102, DOI 10.1016/j.devcel.2009.11.011; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Johnson M, 2014, CURR BIOL, V24, P1525, DOI 10.1016/j.cub.2014.05.034; Kaida A, 2012, EXP CELL RES, V318, P288, DOI 10.1016/j.yexcr.2011.10.016; Khmelinskii A, 2012, NAT BIOTECHNOL, V30, P708, DOI 10.1038/nbt.2281; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067902; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Scott BL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10270; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Snaith HA, 2010, METHOD CELL BIOL, V97, P147, DOI 10.1016/S0091-679X(10)97009-X; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Warren DT, 2002, J CELL SCI, V115, P1703; Watson AT, 2011, GENE, V484, P76, DOI 10.1016/j.gene.2011.05.028; Watt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001428; Zhang LP, 2006, J AM CHEM SOC, V128, P4766, DOI 10.1021/ja0580439	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159292	10.1371/journal.pone.0159292	http://dx.doi.org/10.1371/journal.pone.0159292			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479698	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300010
J	Wu, CY; Hsu, WL; Wang, CH; Liang, JL; Tsai, MH; Yen, CJ; Li, HW; Chiu, SJ; Chang, CH; Huang, YB; Lin, MW; Yoshioka, T				Wu, Ching-Ying; Hsu, Wen-Li; Wang, Chun-Hsiung; Liang, Jui-Lin; Tsai, Ming-Hsien; Yen, Chia-Jung; Li, Hsiu-Wen; Chiu, Siou-Jin; Chang, Chung-Hsing; Huang, Yaw-Bin; Lin, Ming-Wei; Yoshioka, Tohru			A Novel Strategy for TNF-Alpha Production by 2-APB Induced Downregulated SOCE and Upregulated HSP70 in O. tsutsugamushi-Infected Human Macrophages	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; OPERATED CALCIUM-ENTRY; ORIENTIA-TSUTSUGAMUSHI; 2-AMINOETHOXYDIPHENYL BORATE; ACTIVATION; CELLS; EXPRESSION; INDUCTION; PHENOTYPE; EFFICACY	Orientia (O.) tsutsugamushi-induced scrub typhus is endemic across many regions of Asia and the Western Pacific, where an estimated 1 million cases occur each year; the majority of patients infected with O. tsutsugamushi end up with a cytokine storm from a severe inflammatory response. Previous reports have indicated that blocking tumor necrosis factor (TNF)-alpha reduced cell injury from a cytokine storm. Since TNF-alpha production is known to be associated with intracellular Ca2+ elevation, we examined the effect of store-operated Ca2+ entry (SOCE) inhibitors on TNF-alpha production in O. tsutsugamushi-infected macrophages. We found that 2-aminoethoxydiphenyl borate (2-APB), but not SKF96365, facilitates the suppression of Ca2+ mobilization via the interruption of Orai1 expression in O. tsutsugamushi- infected macrophages. Due to the decrease of Ca2+ elevation, the expression of TNF-alpha and its release from macrophages was repressed by 2-APB. In addition, a novel role of 2-APB was found in macrophages that causes the upregulation of heat shock protein 70 (HSP70) expression associated with ERK activation; upregulated TNF-alpha production in the case of knockdown HSP70 was inhibited with 2-APB treatment. Furthermore, elevated HSP70 formation unexpectedly did not help the cell survival of O. tsutsugamushi-infected macrophages. In conclusion, the parallelism between downregulated Ca2+ mobilization via SOCE and upregulated HSP70 after treatment with 2-APB against TNF-alpha production was found to efficiently attenuate an O. tsutsugamushi-induced severe inflammatory response.	[Wu, Ching-Ying; Yoshioka, Tohru] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Hsu, Wen-Li; Tsai, Ming-Hsien; Yen, Chia-Jung; Yoshioka, Tohru] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung, Taiwan; [Tsai, Ming-Hsien] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Lipid Biosci, Kaohsiung, Taiwan; [Li, Hsiu-Wen] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chang, Chung-Hsing] Kaohsiung Med Univ, Dept Dermatol, Kaohsiung, Taiwan; [Huang, Yaw-Bin] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Huang, Yaw-Bin; Lin, Ming-Wei] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan; [Wu, Ching-Ying] Kaohsiung Municipal Tatung Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Hsu, Wen-Li] Natl Cheng Kung Univ, Inst Basic Med Sci, Coll Med, Tainan, Taiwan; [Wang, Chun-Hsiung] Acad Sinica, Inst Chem, Taipei, Taiwan; [Chiu, Siou-Jin] Acad Sinica, Inst Phys, Taipei, Taiwan; [Liang, Jui-Lin] Chi Mei Med Ctr, Tainan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; National Cheng Kung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Chi Mei Hospital	Yoshioka, T (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.; Yoshioka, T (corresponding author), Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung, Taiwan.; Lin, MW (corresponding author), Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan.	tanukikimo@yahoo.com.tw; yoshitohru@gmail.com		Chang, Chung Hsing/0000-0003-2197-4923; Huang, Yaw-Bin/0000-0002-6024-0108; Wu, Ching-Ying/0000-0002-3645-5117	slow aging program, "Aim for the Top Universities Grant" at Kaohsiung Medical University [KMU-TP104G00, KMU-TP104G01, KMU-TP104G04, KMU-TP104D04]; Ministry of Science and Technology of Taiwan, MOST [104-2314-B-037-003, 104-2314-B-037-060]; Glyen-Po Chen	slow aging program, "Aim for the Top Universities Grant" at Kaohsiung Medical University; Ministry of Science and Technology of Taiwan, MOST; Glyen-Po Chen	This work was supported by the slow aging program, "Aim for the Top Universities Grant" (KMU-TP104G00, KMU-TP104G01, and KMU-TP104G04 [Ming-Wei Lin received] & KMU-TP104D04 [Tohru Yoshioka received]) at Kaohsiung Medical University, and the Ministry of Science and Technology of Taiwan, MOST, 104-2314-B-037-003 (Yaw-Bin Huang received) and 104-2314-B-037-060 (Ching-Ying Wu received). A part of this funding was supported by Glyen-Po Chen (Tohru Yoshioka received).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Burgos RA, 2011, VET IMMUNOL IMMUNOP, V143, P1, DOI 10.1016/j.vetimm.2011.05.037; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; Colton C. K., 2007, V179, P173; Conejeros I, 2012, RES VET SCI, V92, P103, DOI 10.1016/j.rvsc.2010.10.005; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; Goode S, 2006, GUT, V55, P590, DOI 10.1136/gut.2005.085449; Gross C, 2003, J BIOL CHEM, V278, P41173, DOI 10.1074/jbc.M302644200; Hotchkiss R S, 1996, New Horiz, V4, P58; Hsu WL, 2012, CELL CALCIUM, V52, P161, DOI 10.1016/j.ceca.2012.05.007; Hsu WL, 2015, MOLECULES, V20, P20297, DOI 10.3390/molecules201119693; Ikeda M, 2013, BBA-MOL CELL RES, V1833, P2573, DOI 10.1016/j.bbamcr.2013.06.022; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; Keller JM, 2008, COMP BIOCHEM PHYS A, V150, P307, DOI 10.1016/j.cbpa.2008.03.021; Kim HP, 2006, EXPERT OPIN THER TAR, V10, P759, DOI 10.1517/14728222.10.5.759; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Lee BJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-79; Lu HY, 2010, AM J TROP MED HYG, V83, P658, DOI 10.4269/ajtmh.2010.09-0608; Meng XZ, 2002, SHOCK, V17, P345, DOI 10.1097/00024382-200205000-00001; Mitsuhashi M, 2011, INFLAMM RES, V60, P187, DOI 10.1007/s00011-010-0253-x; Moron CG, 2001, MODERN PATHOL, V14, P752, DOI 10.1038/modpathol.3880385; Murdaca G, 2009, INT J IMMUNOPATH PH, V22, P557, DOI 10.1177/039463200902200301; Nambu A, 2006, INT IMMUNOL, V18, P701, DOI 10.1093/intimm/dxl007; Newham P, 2014, INFLAMM RES, V63, P149, DOI 10.1007/s00011-013-0683-3; Rozhkova E, 2010, ANN NY ACAD SCI, V1197, P94, DOI 10.1111/j.1749-6632.2009.05375.x; Sandoval AJ, 2007, J LEUKOCYTE BIOL, V82, P1266, DOI 10.1189/jlb.0307196; Seong SY, 2001, MICROBES INFECT, V3, P11, DOI 10.1016/S1286-4579(00)01352-6; Soong L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003191; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Sun YY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0210-7; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tsai MH, 2016, J INVEST DERMATOL, V136, P1398, DOI 10.1016/j.jid.2015.11.034; Tsay R W, 1998, J Microbiol Immunol Infect, V31, P240; Umemura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089292; Wang CC, 2007, AM J TROP MED HYG, V76, P1148, DOI 10.4269/ajtmh.2007.76.1148; Wang HL, 2008, AM J EMERG MED, V26, P711, DOI 10.1016/j.ajem.2007.10.031; Xia Li-Min, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P207; Ye YX, 2012, INT IMMUNOPHARMACOL, V12, P384, DOI 10.1016/j.intimp.2011.12.011; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059; Zorzi Elisa, 2011, Cancers (Basel), V3, P3921, DOI 10.3390/cancers3043921	45	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159299	10.1371/journal.pone.0159299	http://dx.doi.org/10.1371/journal.pone.0159299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472555	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516300008
J	Camargo-Ayala, PA; Cubides, JR; Nino, CH; Camargo, M; Rodriguez-Celis, CA; Quinones, T; Sanchez-Suarez, L; Patarroyo, ME; Patarroyo, MA				Andrea Camargo-Ayala, Paola; Ricardo Cubides, Juan; Hernando Nino, Carlos; Camargo, Milena; Arturo Rodriguez-Celis, Carlos; Quinones, Teodulo; Sanchez-Suarez, Lizeth; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel			High Plasmodium malariae Prevalence in an Endemic Area of the Colombian Amazon Region	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MIXED INFECTIONS; DIPTERA-CULICIDAE; BRAZILIAN AMAZON; VIVAX; TRANSMISSION; PARASITES; DIAGNOSIS; IDENTIFICATION; POPULATION	Malaria is a worldwide public health problem; parasites from the genus Plasmodium are the aetiological agent for this disease. The parasites are mostly diagnosed by conventional microscopy-based techniques; however, their limitations have led to under-registering the reported prevalence of Plasmodium species. This study has thus been aimed at evaluating the infection and coinfection prevalence of 3 species of Plasmodium spp., in an area of the Colombian Amazon region. Blood samples were taken from 671 symptomatic patients by skin puncture; a nested PCR amplifying the 18S ssRNA region was used on all samples to determine the presence of P. vivax, P. malariae and P. falciparum. Statistical analysis determined infection and coinfection frequency; the association between infection and different factors was established. The results showed that P. vivax was the species having the greatest frequency in the study population (61.4%), followed by P. malariae (43.8%) and P. falciparum (11.8%). The study revealed that 35.8% of the population had coinfection, the P. vivax/P. malariae combination occurring most frequently (28.3%); factors such as age, geographical origin and clinical manifestations were found to be associated with triple-infection. The prevalence reported in this study differed from previous studies in Colombia; the results suggest that diagnosis using conventional techniques could be giving rise to underestimating some Plasmodium spp. species having high circulation rates in Colombia ( particularly in the Colombian Amazon region). The present study's results revealed a high prevalence of P. malariae and mixed infections in the population being studied. The results provide relevant information which should facilitate updating the epidemiological panorama and species' distribution so as to include control, prevention and follow-up measures.	[Andrea Camargo-Ayala, Paola; Ricardo Cubides, Juan; Hernando Nino, Carlos; Camargo, Milena; Quinones, Teodulo; Sanchez-Suarez, Lizeth; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Carrera 50 26-20, Bogota, Colombia; [Elkin Patarroyo, Manuel] Univ Nacl Colombia, Sch Med, Carrera 45 26-85, Bogota, Colombia; [Camargo, Milena; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Carrera 24 63C-69, Bogota, Colombia; [Arturo Rodriguez-Celis, Carlos] Gobernac Amazonas, Calle 10 10-77, Leticia, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Carrera 50 26-20, Bogota, Colombia.; Patarroyo, MA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Carrera 24 63C-69, Bogota, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017	Patarroyo, Manuel A/0000-0002-4751-2500; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Camargo, Milena/0000-0003-0246-0716	government of the Amazonas department [BPIN-266]	government of the Amazonas department	The government of the Amazonas department financed this work through the Colombian General Royalties System (BPIN-266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maktari Mohamed T., 2003, Journal of the Egyptian Society of Parasitology, V33, P361; Alexander N, 2005, AM J TROP MED HYG, V73, P140, DOI 10.4269/ajtmh.2005.73.140; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; [Anonymous], 1991, MALARIA OBSTACLES OP; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; ANTHONY RL, 1992, AM J TROP MED HYG, V47, P346, DOI 10.4269/ajtmh.1992.47.346; Aslan G, 2007, PARASITOL INT, V56, P217, DOI 10.1016/j.parint.2007.03.001; Bharti PK, 2013, TROP MED INT HEALTH, V18, P12, DOI 10.1111/tmi.12005; CABRERA B D, 1977, Acta Tropica, V34, P265; Cavasini M T, 2000, Rev Soc Bras Med Trop, V33, P489, DOI 10.1590/S0037-86822000000500011; Chaparro-Narvaez PE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1323-5; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Ghosh S. K., 1995, Indian Journal of Malariology, V32, P32; Golassa L, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0625-3; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; Gurarie D, 2006, J THEOR BIOL, V240, P185, DOI 10.1016/j.jtbi.2005.09.015; Haworth J, 1988, GLOBAL DISTRIBUTION, P1379; Instituto-Nacional-de-Salud, 2015, B EP SEM SEM; Jiang HY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r33; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Kawamoto F, 1999, PARASITOL TODAY, V15, P422, DOI 10.1016/S0169-4758(99)01511-2; Krishna S, 2015, EMERG INFECT DIS, V21, P1853, DOI 10.3201/eid2110.150678; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; Marrelli MT, 2006, MEM I OSWALDO CRUZ, V101, P817, DOI 10.1590/S0074-02762006000800002; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; PAHO, 2010, GUIA AT CLIN MAL 201; Quinones ML, 2006, MEM I OSWALDO CRUZ, V101, P617, DOI 10.1590/S0074-02762006000600007; Ramani S, 2016, Trop Parasitol, V6, P69, DOI 10.4103/2229-5070.175110; Ramasamy R, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00123; Galardo AKR, 2015, REV SOC BRAS MED TRO, V48, P765, DOI 10.1590/0037-8682-0082-2015; Rodriguez M, 2009, J MED ENTOMOL, V46, P307, DOI 10.1603/033.046.0215; Rodriguez-Morales AJ, 2015, J INFECT PUBLIC HEAL, V8, P603, DOI 10.1016/j.jiph.2015.05.011; Ruiz-Murcia F, 2015, NUEVOS ESCENARIOS CA; Saiki R K, 1992, Biotechnology, V24, P476; Santamaria-Salamanca M, 2010, CLIN MALARIA 2010 CO; Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Vinetz JM, 1998, NEW ENGL J MED, V338, P367, DOI 10.1056/NEJM199802053380605; WARREN MCW, 1975, AM J TROP MED HYG, V24, P749, DOI 10.4269/ajtmh.1975.24.749; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2015, MAL ENT VECT CONTR; WHO TDR FIND, 2012, RES WHO PROD TEST MA, V4; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Zimmerman PA, 2004, TRENDS PARASITOL, V20, P440, DOI 10.1016/j.pt.2004.07.004	53	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159968	10.1371/journal.pone.0159968	http://dx.doi.org/10.1371/journal.pone.0159968			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467587	gold, Green Published			2022-12-27	WOS:000381516100079
J	Badea, M; Floroian, L; Restani, P; Cobzac, SCA; Moga, M				Badea, Mihaela; Floroian, Laura; Restani, Patrizia; Cobzac, Simona Codruta Aurora; Moga, Marius			Ochratoxin A Detection on Antibody-Immobilized on BSA-Functionalized Gold Electrodes	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; ELECTROCHEMICAL IMMUNOSENSOR; IMPEDANCE SPECTROSCOPY; MONOCLONAL-ANTIBODY; SENSITIVE DETECTION; ARRAY BIOSENSOR; IDENTIFICATION; PERFORMANCE; CHALLENGES; SENSORS	Ochratoxin A (OTA)-a toxin produced by Aspergillus carbonarius, Aspergillus ochraceus, and Penicillium verrucosum-is one of the most-abundant food-contaminating mycotoxins. To avoid the risk of OTA consumption for humans and animals, the rapid detection and quantitation of OTA level in different commodities are of great importance. In this work, an impedimetric immunosensor for ochratoxin A (OTA) detection, a common toxic botanical contaminant, was developed via the immobilization of anti-OTA antibody on bovine serum albumin modified gold electrodes. A four-step reaction protocol was tested to modify the gold electrode and obtain the sensing substrate. All the steps of the immunosensor elaboration and also the immunochemical reaction between surface-bound antibody and ochratoxin A were analyzed using cyclic voltammetry and electrochemical impedance spectroscopy. Modification of the impedance due to the specific antigen-antibody reaction at immunosensor surface, was used in order to detect ochratoxin A. Linear proportionality of the charge transfer resistance to the concentration of OTA allows ochratoxin A detection in the range of 2.5-100 ng/mL.	[Badea, Mihaela] Transilvania Univ Brasov, Fundamental Prophylact & Clin Specialties Dept, Brasov, Romania; [Floroian, Laura] Transilvania Univ Brasov, Automat & Informat Technol Dept, Brasov, Romania; [Restani, Patrizia] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Cobzac, Simona Codruta Aurora] Univ Babes Bolyai, Fac Chem & Chem Engn, Cluj Napoca, Romania; [Moga, Marius] Transilvania Univ Brasov, Dept Med & Surg Specialties, Brasov, Romania	Transylvania University of Brasov; Transylvania University of Brasov; University of Milan; Babes Bolyai University from Cluj; Transylvania University of Brasov	Floroian, L (corresponding author), Transilvania Univ Brasov, Automat & Informat Technol Dept, Brasov, Romania.; Restani, P (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	lauraf@unitbv.ro; patrizia.restani@unimi.it	Badea, Mihaela/Z-1490-2018; Cobzac, Simona Codruta/J-9250-2012; MOGA, MARIUS ALEXANDRU/AHC-2310-2022	Badea, Mihaela/0000-0003-4824-2175; Simona, Cobzac/0000-0002-8968-3893; Floroian, Laura/0000-0002-3289-8025	European Community's Seventh Framework Programme [n245199]; structural funds project PRO-DD (POS-CCE) [11/2009, O.2.2.1., ID 123]; project Bursa Univ. Transilvania	European Community's Seventh Framework Programme; structural funds project PRO-DD (POS-CCE); project Bursa Univ. Transilvania	MB, LF, PR, and MM received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n245199. It has been carried out within the PlantLIBRA project (website: www.plantlibra.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The writing of this work has received partial funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 245199. It has been carried out within the PlantLIBRA project (website: www.plantlibra.eu). This report does not necessarily reflect the Commission views or its future policy on these areas. LF, MB hereby acknowledge the structural funds project PRO-DD (POS-CCE, O.2.2.1., ID 123, SMIS 2637, ctr. No 11/2009) for access to the infrastructure used in this work, and also the project Bursa Univ. Transilvania 2016 for funding consumables used for the experiments. We would like to thank to Alina Vasilescu and Alis Vezeanu from International Centre of Biodynamics, Bucharest as well as to Arianna Scollo and Aurora Perini from University of Milan, for assistance with preliminary EIS work.	Adanyi N, 2007, BIOSENS BIOELECTRON, V22, P797, DOI 10.1016/j.bios.2006.02.015; Alarcon SH, 2006, TALANTA, V69, P1031, DOI 10.1016/j.talanta.2005.12.024; Alonso-Lomillo M A, 2009, BIOSENS BIOELECTRON, V10, P1333; Amezqueta S, 2012, FOOD CONTROL, V26, P259, DOI 10.1016/j.foodcont.2012.01.042; Andres E, 2014, BIOCHEM J, V458, P355, DOI 10.1042/BJ20131057; Ansari AA, 2010, BIOELECTROCHEMISTRY, V77, P75, DOI 10.1016/j.bioelechem.2009.06.014; Bard AJ, 2007, ELECTROCHEMICAL METH; Bogomolova A, 2009, ANAL CHEM, V81, P3944, DOI 10.1021/ac9002358; Catanante G, 2016, TALANTA, V153, P138, DOI 10.1016/j.talanta.2016.03.004; Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855; Galarce-Bustos O, 2014, FOOD CONTROL, V46, P102, DOI 10.1016/j.foodcont.2014.05.014; Gaulitz G, 2000, BIOSENSORS ENV MONIT, P150; Hayat A, 2013, TALANTA, V103, P14, DOI 10.1016/j.talanta.2012.09.048; Jiang CM, 2015, FOOD CONTROL, V47, P656, DOI 10.1016/j.foodcont.2014.08.011; Kabak B, 2012, FOOD CONTROL, V28, P1, DOI 10.1016/j.foodcont.2012.04.043; Katz E, 2003, ELECTROANAL, V15, P913, DOI 10.1002/elan.200390114; Kaushik A, 2008, ELECTROCHEM COMMUN, V10, P1364, DOI 10.1016/j.elecom.2008.07.007; Liu GZ, 2012, ELECTROANAL, V24, P1509, DOI 10.1002/elan.201200233; Gerez CL, 2014, FOOD CONTROL, V45, P115, DOI 10.1016/j.foodcont.2014.04.038; Ngundi MM, 2005, ANAL CHEM, V77, P148, DOI 10.1021/ac048957y; Papamichael KI, 2007, SENSOR ACTUAT B-CHEM, V121, P178, DOI 10.1016/j.snb.2006.09.024; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Polonschii C, 2010, TALANTA, V80, P2157, DOI 10.1016/j.talanta.2009.11.023; Prabhakar N, 2011, BIOSENS BIOELECTRON, V26, P4006, DOI 10.1016/j.bios.2011.03.014; Prabu PC, 2013, EXP TOXICOL PATHOL, V65, P277, DOI 10.1016/j.etp.2011.09.003; Radi AE, 2009, BIOSENS BIOELECTRON, V24, P1888, DOI 10.1016/j.bios.2008.09.021; Sapsford KE, 2006, SENSOR ACTUAT B-CHEM, V113, P599, DOI 10.1016/j.snb.2005.07.008; Siddiqui S, 2012, BIOSENS BIOELECTRON, V35, P284, DOI 10.1016/j.bios.2012.03.001; Solanki PR, 2010, NANOSCALE, V2, P2811, DOI 10.1039/c0nr00289e; Suni II, 2008, TRAC-TREND ANAL CHEM, V27, P604, DOI 10.1016/j.trac.2008.03.012; Taleat Z, 2013, ELECTROANAL, V25, P269, DOI 10.1002/elan.201200425; Tsai WC, 2007, ANAL LETT, V40, P1979, DOI 10.1080/00032710701484509; Vidal JC, 2012, ANAL BIOANAL CHEM, V403, P1585, DOI 10.1007/s00216-012-5951-5; Yang JJ, 2015, BIOSENS BIOELECTRON, V64, P13, DOI 10.1016/j.bios.2014.08.025; Yogendrarajah P, 2014, FOOD CONTROL, V46, P26, DOI 10.1016/j.foodcont.2014.04.043; Yu JCC, 2004, SYNTHETIC MET, V143, P253, DOI 10.1016/j.synthmet.2003.12.007; Zamfir LG, 2011, SENSOR ACTUAT B-CHEM, V159, P178, DOI 10.1016/j.snb.2011.06.069; Zhao XB, 2014, FOOD CONTROL, V46, P332, DOI 10.1016/j.foodcont.2014.05.052	38	20	20	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160021	10.1371/journal.pone.0160021	http://dx.doi.org/10.1371/journal.pone.0160021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467684	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100090
J	Silva-Guzman, M; Addo-Quaye, C; Dilkes, BP				Silva-Guzman, Macarena; Addo-Quaye, Charles; Dilkes, Brian P.			Re-Evaluation of Reportedly Metal Tolerant Arabidopsis thaliana Accessions	PLOS ONE			English	Article							HEAVY-METALS; HYPERACCUMULATION; NICKEL; ADAPTATION; PHENOTYPES; GENOME; PLANTS; IRON	Santa Clara, Limeport, and Berkeley are Arabidopsis thaliana accessions previously identified as diversely metal resistant. Yet these same accessions were determined to be genetically indistinguishable from the metal sensitive Col-0. We robustly tested tolerance for Zn, Ni and Cu, and genetic relatedness by growing these accessions under a range of Ni, Zn and Cu concentrations for three durations in multiple replicates. Neither metal resistance nor variance in growth were detected between them and Col-0. We re-sequenced the genomes of these accessions and all stocks available for each accession. In all cases they were nearly indistinguishable from the standard laboratory accession Col-0. As Santa Clara was allegedly collected from the Jasper Ridge serpentine outcrop in California, USA we investigated the possibility of extant A. thaliana populations adapted to serpentine soils. Botanically vouchered Arabidopsis accessions in the Jepson database were overlaid with soil maps of California. This provided no evidence of A. thaliana collections from serpentine sites in California. Thus, our work demonstrates that the Santa Clara, Berkeley and Limeport accessions are not metal tolerant, not genetically distinct from Col-0, and that there are no known serpentine adapted populations or accessions of A. thaliana.	[Silva-Guzman, Macarena; Addo-Quaye, Charles; Dilkes, Brian P.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Dilkes, BP (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	bdilkes@purdue.edu	Addo-Quaye, Charles/J-3694-2016; Dilkes, Brian/C-9293-2012	Addo-Quaye, Charles/0000-0003-0598-5980; Dilkes, Brian/0000-0003-2799-954X	CONICYT Becas Chile [72100511]; Bill and Melinda Gates Foundation [OPP 1052924]	CONICYT Becas Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by a fellowship from CONICYT Becas Chile 72100511 to MS and analysis tools utilized in this project were developed as part of Bill and Melinda Gates Foundation grant OPP 1052924 to BPD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Phillip San Miguel and the Purdue Genomics Facility team are gratefully acknowledged for their exemplary work resequencing the genomes of seven A. thaliana accessions. The Purdue Rosen Center for Academic Computing are here acknowledged to be the best academic compute infrastructure without whom this study would not have been possible. Brian Anacker of UC Davis was gracious enough to provide us with the analysis of botanical data in the Jepson collection and generate the GIS overlay of collections and serpentine soils in Fig 5 and pull the minimum distances described in the text. Conversations about serpentine adaptation with Justen Whitall of Santa Clara University and the gift of intellectual openness are gratefully acknowledged. MS was supported by a fellowship from CONICYT Becas Chile 72100511. Analysis tools utilized in this project were developed as part of Bill and Melinda Gates Foundation grant OPP 1052924.	Agrawal B, 2012, PLANTA, V236, P477, DOI 10.1007/s00425-012-1621-2; Alexander E.B., 2007, SERPENTINE GEOECOLOG; Anastasio AE, 2011, PLANT J, V67, P554, DOI 10.1111/j.1365-313X.2011.04606.x; Baldwin BG, 2002, VASCULAR PLANTS CALI; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Bradshaw HD, 2005, NEW PHYTOL, V167, P81, DOI 10.1111/j.1469-8137.2005.01408.x; Callahan DL, 2007, NEW PHYTOL, V176, P836, DOI 10.1111/j.1469-8137.2007.02216.x; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Freeman JL, 2005, PLANT PHYSIOL, V137, P1082, DOI 10.1104/pp.104.055293; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gao YB, 2015, P NATL ACAD SCI USA, V112, P2275, DOI 10.1073/pnas.1500365112; Ghasemi R, 2009, NEW PHYTOL, V184, P566, DOI 10.1111/j.1469-8137.2009.02993.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hammond JP, 2006, NEW PHYTOL, V170, P239, DOI 10.1111/j.1469-8137.2006.01662.x; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1067, DOI 10.1104/pp.107.4.1067; Hussain I, 2011, J CHEM SOC PAKISTAN, V33, P495; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Lenz HN, 2013, PLANT CELL PHYSIOL, V54, P1118, DOI 10.1093/pcp/pct062; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lochlainn SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017814; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; MURPHY A, 1995, PLANT PHYSIOL, V108, P29, DOI 10.1104/pp.108.1.29; Murphy A, 1997, NEW PHYTOL, V136, P211, DOI 10.1046/j.1469-8137.1997.00738.x; Nishida S, 2011, PLANT CELL PHYSIOL, V52, P1433, DOI 10.1093/pcp/pcr089; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Pollard AJ, 2014, PLANT SCI, V217, P8, DOI 10.1016/j.plantsci.2013.11.011; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Wixon J, 2001, COMP FUNCT GENOM, V2, P91, DOI 10.1002/cfg.75	38	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0130679	10.1371/journal.pone.0130679	http://dx.doi.org/10.1371/journal.pone.0130679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467746	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100001
J	Wang, EY; Guo, DH; Li, CQ; Wei, S; Wang, ZH; Liu, QJ; Zhang, B; Kong, FZ; Feng, L; Sun, DB				Wang, Enyu; Guo, Donghua; Li, Chunqiu; Wei, Shan; Wang, Zhihui; Liu, Qiujin; Zhang, Bei; Kong, Fanzhi; Feng, Li; Sun, Dongbo			Molecular Characterization of the ORF3 and S1 Genes of Porcine Epidemic Diarrhea Virus Non S-INDEL Strains in Seven Regions of China, 2015	PLOS ONE			English	Article							SPIKE GENE; CORONAVIRUS; VARIANT; IDENTIFICATION	In an effort to trace the evolution of porcine epidemic diarrhea virus (PEDV), S1 and ORF3 genes of viruses identified in 41 pig farms from seven regions (North, Northeast, Northwest, Central, East, South West, and South, respectively) of China in 2015 were sequenced and analyzed. Sequence analysis revealed that the 41 ORF3 genes and 29 S1 genes identified in our study exhibited nucleotide homologies of 98.2%-100% and 96.6%-100%, respectively; these two genes exhibited low nucleotide sequence similarities with classical CV777 strain and early Chinese strain LZC. Phylogenetic analysis indicated that the identified PEDV strains belonged to global non S-INDEL strains, and exhibited genetic diversity; S1 gene of the HLJ2015/DP1-1 strain harbored an unique deletion of 12 nucleotides (A(1130)CAACTCCA CTG(1141)); while the Chinese PEDV S-INDEL reference strains included two types of the "CV777" S-INDEL as well as the "US" S-INDEL, and all co-circulated with Chinese non S-INDEL strains. Of 29 identified S1 genes, the SS2 epitope (Y(748)SNIGVCK(755)) was highly conserved, while the SS6 epitope (L(764)QDGQVKI(771)) and pAPN receptor-binding region (aa 490-615) exhibited amino substitutions. Nine possible recombination events were identified between the 29 identifed S1 genes and the 3 S1 reference genes from early Chinese PEDV strains. The complete S genes of selected Chinese PEDV field strains (2011-2015) showed 5.18%-6.07% nucleotide divergence, which is far higher than the divergence observed in early Chinese PEDV strains (3.1%) (P<0.05). Our data provide evidence that PEDV non S-INDEL strains with genetic diversities and potential recombination circulate in seven regions of China in 2015; Chinese PEDV S-INDEL strains exhibit genetic diversity and co-circulate with non S-INDEL strains.	[Wang, Enyu; Guo, Donghua; Li, Chunqiu; Wei, Shan; Wang, Zhihui; Liu, Qiujin; Zhang, Bei; Kong, Fanzhi; Sun, Dongbo] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Peoples R China; [Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Div Swine Infect Dis, Harbin, Peoples R China	Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Sun, DB (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing, Peoples R China.; Feng, L (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, Natl Key Lab Vet Biotechnol, Div Swine Infect Dis, Harbin, Peoples R China.	fl@hvri.ac.cn; dongbosun@126.com	Feng, Li/GQQ-3764-2022		National Natural Science Foundation of China [31472209]; State National Key Laboratory of Veterinary Biotechnology [SKLVBF201506]; Key Science and Technology Program of Heilongjiang Agriculture Reclamation Bureau during the 13th Five-Year Plan Period [HNK135-04-06-03]; Program for New Century Excellent Talents in Heilongjiang Provincial University [1252-NCET-016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State National Key Laboratory of Veterinary Biotechnology; Key Science and Technology Program of Heilongjiang Agriculture Reclamation Bureau during the 13th Five-Year Plan Period; Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET))	This work is supported by the National Natural Science Foundation of China (grant no. 31472209), the State National Key Laboratory of Veterinary Biotechnology (grant no. SKLVBF201506), the Key Science and Technology Program of Heilongjiang Agriculture Reclamation Bureau during the 13th Five-Year Plan Period (HNK135-04-06-03), and the Program for New Century Excellent Talents in Heilongjiang Provincial University (grant no. 1252-NCET-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin H, 2014, PROTEIN SCI, V23, P603, DOI 10.1002/pro.2442; Boniotti MB, 2016, EMERG INFECT DIS, V22, P83, DOI 10.3201/eid2201.150544; Chen FZ, 2015, VIRUSES-BASEL, V7, P5525, DOI 10.3390/v7102891; Chen JF, 2013, VIRUSES-BASEL, V5, P2601, DOI 10.3390/v5102601; Chen Q, 2016, J GEN VIROL; Deng F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030055; Geng YF, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0131886, 10.1371/journal.pone.0137288]; Hao JW, 2014, VIRUS GENES, V49, P58, DOI 10.1007/s11262-014-1055-y; Jarvis MC, 2016, PREV VET MED, V123, P175, DOI 10.1016/j.prevetmed.2015.10.020; Jia AQ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00165-14; Kim SH, 2015, ARCH VIROL, V160, P1055, DOI 10.1007/s00705-015-2353-y; Kim YK, 2016, ARCH VIROL; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Masuda T, 2015, ARCH VIROL, V160, P2565, DOI 10.1007/s00705-015-2522-z; Mesquita JR, 2015, TRANSBOUND EMERG DIS, V62, P586, DOI 10.1111/tbed.12409; Park S, 2014, EMERG INFECT DIS, V20, P2089, DOI 10.3201/eid2012.131642; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; Reguera J, 2014, VIRUS RES, V194, P3, DOI 10.1016/j.virusres.2014.10.005; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stadler J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0454-1; Steinrigl A, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0624-1; Sun DB, 2008, VET MICROBIOL, V131, P73, DOI 10.1016/j.vetmic.2008.02.022; Sun DB, 2016, J VET MED SCI, V78, P355, DOI 10.1292/jvms.15-0446; Sung MH, 2015, INFECT GENET EVOL, V36, P108, DOI 10.1016/j.meegid.2015.09.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Yamamoto R, 2015, RES VET SCI, V103, P103, DOI 10.1016/j.rvsc.2015.09.024; Zhang XB, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0314-4	32	31	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160561	10.1371/journal.pone.0160561	http://dx.doi.org/10.1371/journal.pone.0160561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494026	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500058
J	Canas, MA; Gimenez, R; Fabrega, MJ; Toloza, L; Baldoma, L; Badia, J				Canas, Maria-Alexandra; Gimenez, Rosa; Fabrega, Maria-Jose; Toloza, Lorena; Baldoma, Laura; Badia, Josefa			Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage	PLOS ONE			English	Article							PKC-ZETA; IMMUNE; GUT; MECHANISMS; MODULATION; ENDOSOMES; VIRULENCE; STRAINS; PROTEIN; INDUCE	Interactions between intestinal microbiota and the human host are complex. The gut mucosal surface is covered by a mucin layer that prevents bacteria from accessing the epithelial cells. Thus, the crosstalk between microbiota and the host mainly rely on secreted factors that can go through the mucus layer and reach the epithelium. In this context, vesicles released by commensal strains are seen as key players in signaling processes in the intestinal mucosa. Studies with Gram-negative pathogens showed that outer membrane vesicles (OMVs) are internalized into the host cell by endocytosis, but the entry mechanism for microbiota-derived vesicles is unknown. Escherichia coli strains are found as part of normal human gut microbiota. In this work, we elucidate the pathway that mediate internalization of OMVs from the probiotic E. coli Nissle 1917 (EcN) and the commensal ECOR12 strains in several human intestinal epithelial cell lines. Time course measurement of fluorescence and microscopy analysis performed with rhodamine B-R18-labeled OMVs in the presence of endocytosis inhibitors showed that OMVs from these strains enter epithelial cells via clathrin-mediated endocytosis. Vesicles use the same endocytosis pathway in polarized epithelial monolayers. Internalized OMVs are sorted to lysosomal compartments as shown by their colocalization with clathrin and specific markers of endosomes and lysosomes. OMVs from both strains did not affect cell viability, but reduce proliferation of HT-29 cells. Labeling of 8-oxo-dG adducts in DNA revealed that neither OMVs from EcN nor from ECOR12 promoted oxidative DNA damage. In contrast, flow cytometry analysis of phosphorylated gamma H2AX evidenced that OMVs from the probiotic EcN significantly produced more double strand breaks in DNA than ECOR12 OMVs. The EcN genotoxic effects have been attributed to the synthesis of colibactin. However, it is not known how colibactin is exported and delivered into host cells. Whether colibactin is secreted via OMVs is an open question that needs further study.	[Canas, Maria-Alexandra; Gimenez, Rosa; Fabrega, Maria-Jose; Toloza, Lorena; Baldoma, Laura; Badia, Josefa] Univ Barcelona, Fac Farm, Dept Bioquim & Fisiol, Seccio Bioquim & Biol Mol, Barcelona, Spain; [Canas, Maria-Alexandra; Gimenez, Rosa; Fabrega, Maria-Jose; Baldoma, Laura; Badia, Josefa] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Toloza, Lorena] Univ Talca, Fac Ciencias Salud, Dept Microbiol, Talca, Chile	University of Barcelona; University of Barcelona; Universidad de Talca	Baldoma, L (corresponding author), Univ Barcelona, Fac Farm, Dept Bioquim & Fisiol, Seccio Bioquim & Biol Mol, Barcelona, Spain.; Baldoma, L (corresponding author), Univ Barcelona, Inst Biomed, Barcelona, Spain.	lbaldoma@ub.edu	Pacheco, Maria Alexandra C/B-4509-2019; Baldomà, Laura/G-7301-2015; Giménez, Rosa/V-4777-2017; Badia, Josefa/G-7292-2015	Baldomà, Laura/0000-0002-7678-269X; Giménez, Rosa/0000-0002-4158-7157; Badia, Josefa/0000-0003-0768-5033; Fabrega, Maria Jose/0000-0002-0205-3750	European Commission ERDF funds from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (Ministerio de Economia y Competitividad), Spain [AGL2012-34985]; Ministerio de Economia y Competitividad, Spain [BES-2013-065587]	European Commission ERDF funds from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (Ministerio de Economia y Competitividad), Spain; Ministerio de Economia y Competitividad, Spain	This study was supported by Grant AGL2012-34985 (co-financed with European Commission ERDF funds) from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (Ministerio de Economia y Competitividad), Spain, to L.B. M.J. Fabrega acknowledges her FPI fellowship from the Ministerio de Economia y Competitividad, Spain, with reference BES-2013-065587.	Aguilera L, 2014, PROTEOMICS, V14, P222, DOI 10.1002/pmic.201300328; Bielaszewska M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003797; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Chatterjee D, 2013, J BIOL CHEM, V288, P4299, DOI 10.1074/jbc.M112.408302; Chitcholtan K, 2008, CARCINOGENESIS, V29, P2400, DOI 10.1093/carcin/bgn218; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Eslaminejad Mr Baghaban, 2010, J Dent (Tehran), V7, P185; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Hafez M, 2009, INFECT IMMUN, V77, P2995, DOI 10.1128/IAI.00040-09; Hancock V, 2010, MOL GENET GENOMICS, V284, P437, DOI 10.1007/s00438-010-0578-8; Hering NA, 2014, MUCOSAL IMMUNOL, V7, P369, DOI 10.1038/mi.2013.55; Irving AT, 2014, CELL HOST MICROBE, V15, P623, DOI 10.1016/j.chom.2014.04.001; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Fabrega MJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00705; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kim JH, 2015, SEMIN CELL DEV BIOL, V40, P97, DOI 10.1016/j.semcdb.2015.02.006; Krishnan S, 2015, CURR OPIN BIOTECH, V36, P137, DOI 10.1016/j.copbio.2015.08.015; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kunsmann L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13252; LOWRY OH, 1951, J BIOL CHEM, V193, P265; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Olier M, 2012, GUT MICROBES, V3, P501, DOI 10.4161/gmic.21737; Olofsson A, 2014, MBIO, V5, DOI 10.1128/mBio.00979-14; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Schaar V, 2011, CELL MICROBIOL, V13, P432, DOI 10.1111/j.1462-5822.2010.01546.x; Schertzer JW, 2013, J MOL MICROB BIOTECH, V23, P118, DOI 10.1159/000346770; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267; Trebichavsky I, 2010, NUTR REV, V68, P459, DOI 10.1111/j.1753-4887.2010.00305.x; Turkina MV, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv076; Tyrer PC, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-2; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Vejborg RM, 2010, MOL GENET GENOMICS, V283, P469, DOI 10.1007/s00438-010-0532-9; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	42	58	58	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160374	10.1371/journal.pone.0160374	http://dx.doi.org/10.1371/journal.pone.0160374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487076	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800074
J	Kapasi, AJ; Dittrich, S; Gonzalez, IJ; Rodwell, TC				Kapasi, Anokhi J.; Dittrich, Sabine; Gonzalez, Iveth J.; Rodwell, Timothy C.			Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review	PLOS ONE			English	Review							C-REACTIVE PROTEIN; LOWER RESPIRATORY-TRACT; RAPID DIAGNOSTIC-TESTS; CEREBROSPINAL-FLUID; PROCALCITONIN LEVELS; VIRAL-INFECTIONS; DIFFERENTIAL-DIAGNOSIS; INFLAMMATORY MARKERS; FECAL CALPROTECTIN; PROSPECTIVE COHORT	Background In resource limited settings acute febrile illnesses are often treated empirically due to a lack of reliable, rapid point-of-care diagnostics. This contributes to the indiscriminate use of antimicrobial drugs and poor treatment outcomes. The aim of this comprehensive review was to summarize the diagnostic performance of host biomarkers capable of differentiating bacterial from non-bacterial infections to guide the use of antibiotics. Methods Online databases of published literature were searched from January 2010 through April 2015. English language studies that evaluated the performance of one or more host biomarker in differentiating bacterial from non-bacterial infection in patients were included. Key information extracted included author information, study methods, population, pathogens, clinical information, and biomarker performance data. Study quality was assessed using a combination of validated criteria from the QUADAS and Lijmer checklists. Biomarkers were categorized as hematologic factors, inflammatory molecules, cytokines, cell surface or metabolic markers, other host biomarkers, host transcripts, clinical biometrics, and combinations of markers. Findings Of the 193 citations identified, 59 studies that evaluated over 112 host biomarkers were selected. Most studies involved patient populations from high-income countries, while 19% involved populations from low-and middle-income countries. The most frequently evaluated host biomarkers were C-reactive protein (61%), white blood cell count (44%) and procalcitonin (34%). Study quality scores ranged from 23.1% to 92.3%. There were 9 high performance host biomarkers or combinations, with sensitivity and specificity of >= 85% or either sensitivity or specificity was reported to be 100%. Five host biomarkers were considered weak markers as they lacked statistically significant performance in discriminating between bacterial and non-bacterial infections. Discussion This manuscript provides a summary of host biomarkers to differentiate bacterial from non-bacterial infections in patients with acute febrile illness. Findings provide a basis for prioritizing efforts for further research, assay development and eventual commercialization of rapid point-of-care tests to guide use of antimicrobials. This review also highlights gaps in current knowledge that should be addressed to further improve management of febrile patients.	[Kapasi, Anokhi J.; Dittrich, Sabine; Gonzalez, Iveth J.; Rodwell, Timothy C.] FIND, Campus Biotech Bldg B2 Level 0,9 Chemin Mines, CH-1202 Geneva, Switzerland	Foundation For Innovative New Diagnostics	Rodwell, TC (corresponding author), FIND, Campus Biotech Bldg B2 Level 0,9 Chemin Mines, CH-1202 Geneva, Switzerland.	Timothy.Rodwell@finddx.org			FIND; UK Aid; UK Government; Australian Government	FIND; UK Aid(CGIAR); UK Government; Australian Government(Australian GovernmentCGIAR)	All the manuscript authors were affiliated with and funded by FIND for the implementation of the study, analysis of results and publishing of results. The first author, Dr. Anokhi Kapasi was (and still is) also employed by The Degge Group, Ltd., a private, for-profit company, but Dr. Kapasi was working independently of Degge for this study and publication. The Degge Group did not provide any funding support for this work, and was/is not affiliated with the work or writing of this manuscript in any way. The author affiliations have been updated accordingly in the manuscript, indicating Dr. Kapasi is affiliated with FIND not Degge for the purposes of this work and manuscript. Similarly, Dr. Rodwell, is also employed by University of California, San Diego, but is involved with this work through his affiliation with FIND only. This work was funded by UK Aid, UK Government, and the Australian Government.	Abdelmoez Amal Tohamy, 2014, J Egypt Soc Parasitol, V44, P205; [Anonymous], 2010, GUID TREATM MAL; Bjerk SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056249; Bracken CD, 2014, CLIN ORTHOP RELAT R, V472, P3291, DOI 10.1007/s11999-014-3631-9; Brodska H, 2013, CLIN EXP MED, V13, P165, DOI 10.1007/s10238-012-0191-8; Burdette AJ, 2014, DTIC DOCUMENT; Chalupa P, 2011, INFECTION, V39, P411, DOI 10.1007/s15010-011-0126-4; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Chaudhary N, 2012, J PEDIAT HEMATOL ONC, V34, P617, DOI 10.1097/MPH.0b013e3182677fc6; Chen ZQ, 2012, CLIN CHIM ACTA, V413, P1512, DOI 10.1016/j.cca.2012.06.018; Cid J, 2010, J INFECTION, V60, P313, DOI 10.1016/j.jinf.2010.02.013; Conroy AL, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-35; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847; Cuquemelle E, 2011, INTENS CARE MED, V37, P796, DOI 10.1007/s00134-011-2189-1; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Diez-Padrisa N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013226; Duman M, 2015, AM J EMERG MED, V33, P1436, DOI 10.1016/j.ajem.2015.07.007; Dupuy AM, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-22; Elsing C, 2011, INFECTION, V39, P327, DOI 10.1007/s15010-011-0117-5; Engel MF, 2012, FAM PRACT, V29, P383, DOI 10.1093/fampra/cmr119; Espana PP, 2012, EUR J CLIN MICROBIOL, V31, P3397, DOI 10.1007/s10096-012-1708-5; Falsey AR, 2012, INT J CHRONIC OBSTR, V7, P127, DOI 10.2147/COPD.S29149; Farrar JJ, 2009, MANSONS TROPICAL DIS, V22nd; Galetto-Lacour A, 2010, EXPERT REV ANTI-INFE, V8, P1231, DOI 10.1586/ERI.10.118; Gething PW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000301; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Guiddir T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-276; Guo SY, 2015, AM J MED SCI, V349, P499, DOI 10.1097/MAJ.0000000000000477; Hamilton JL, 2013, AM FAM PHYSICIAN, V87, P254; Haran JP, 2013, AM J EMERG MED, V31, P816, DOI 10.1016/j.ajem.2013.01.030; Haran JP, 2013, AM J EMERG MED, V31, P137, DOI 10.1016/j.ajem.2012.06.026; Hu XR, 2013, P NATL ACAD SCI USA, V110, P12792, DOI 10.1073/pnas.1302968110; Huy NT, 2010, CRIT CARE, V14, DOI 10.1186/cc9268; Ibrahim KA, 2011, J PAK MED ASSOC, V61, P346; Jesse S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010079; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jukic T, 2015, SCAND J CLIN LAB INV, V75, P500, DOI 10.3109/00365513.2015.1057759; Katoh S, 2014, TOHOKU J EXP MED, V232, P263, DOI 10.1620/tjem.232.263; Kawamura M, 2012, J CLIN LAB ANAL, V26, P174, DOI 10.1002/jcla.21507; Koo CY, 2011, EMERG MED J, V28, P715, DOI 10.1136/emj.2010.099531; Kossiva L, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-25; Koya J, 2012, BONE MARROW TRANSPL, V47, P1326, DOI 10.1038/bmt.2012.18; Pinto VLL, 2011, BRAZ J INFECT DIS, V15, P156, DOI 10.1590/S1413-86702011000200011; Laham JL, 2014, PEDIATR EMERG CARE, V30, P11, DOI 10.1097/PEC.0000000000000026; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Linder A, 2011, CRIT CARE MED, V39, P812, DOI 10.1097/CCM.0b013e318206c396; Lubell Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1272-6; Mansour KM, 2011, AM J EMERG MED, V29, P1163, DOI 10.1016/j.ajem.2010.06.024; Markic J, 2015, WIEN KLIN WOCHENSCHR, V127, P942, DOI 10.1007/s00508-015-0831-6; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; McCulloh R.J., 2012, THE J, V1, P165, DOI [10.4172/2324-853X.1000e104, DOI 10.4172/2324-853X.1000E104]; McHugh L, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001916; Mohan A, 2015, INDIAN J MED RES, V141, P271, DOI 10.4103/0971-5916.156551; Mokuda S, 2012, MOD RHEUMATOL, V22, P750, DOI 10.1007/s10165-011-0587-4; Huy NT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050341; Nuutila J, 2013, HUM IMMUNOL, V74, P522, DOI [10.1016/j.humimm.2013.01.011, 10.]; Nuutila J, 2013, J MICROBIOL METH, V92, P64, DOI 10.1016/j.mimet.2012.11.005; Oguz SS, 2011, MYCOSES, V54, P212, DOI 10.1111/j.1439-0507.2009.01802.x; Oved K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120012; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Pfister R, 2014, CRIT CARE, V18, DOI 10.1186/cc13760; Piacentini E, 2011, J CRIT CARE, V26, P201, DOI 10.1016/j.jcrc.2010.07.009; Prilutsky D, 2011, ANAL CHEM, V83, P4258, DOI 10.1021/ac200596f; Pupek M, 2013, ANN CLIN LAB SCI, V43, P257; Rambaud-Althaus C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127674; Rustici MC, 2011, CLIN LAB, V57, P497; Sambursky R, 2015, EUR CLIN RESPIR J, V2, DOI 10.3402/ecrj.v2.28245; Siahanidou T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/375702; Sklavou R, 2012, CLIN BIOCHEM, V45, P1178, DOI 10.1016/j.clinbiochem.2012.07.088; Smith CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5649; Suarez NM, 2015, J INFECT DIS, V212, P213, DOI 10.1093/infdis/jiv047; Sykora J, 2010, ACTA PAEDIATR, V99, P1389, DOI 10.1111/j.1651-2227.2010.01843.x; Tamune H, 2014, AM J EMERG MED, V32, P263, DOI 10.1016/j.ajem.2013.11.030; ten Oever J, 2012, J INFECTION, V65, P490, DOI 10.1016/j.jinf.2012.08.004; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB; Viallon A, 2011, CRIT CARE, V15, DOI 10.1186/cc10254; Weh J, 2013, DIAGN MICR INFEC DIS, V77, P79, DOI 10.1016/j.diagmicrobio.2013.05.005; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Witt RT, 2012, T ROY SOC TROP MED H, V106, P264, DOI 10.1016/j.trstmh.2012.01.001; World Health Organization, 2013, WHO INFORMAL CONSULT; Wu MH, 2013, INFLUENZA OTHER RESP, V7, P349, DOI 10.1111/j.1750-2659.2012.00386.x; Zaas AK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006280; Zhu F, 2015, EUR REV MED PHARMACO, V19, P4300	86	87	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160278	10.1371/journal.pone.0160278	http://dx.doi.org/10.1371/journal.pone.0160278			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486746	gold, Green Submitted, Green Published			2022-12-27	WOS:000381367800069
J	Mildenberger, M; Howe, P; Lachapelle, E; Stokes, L; Marlon, J; Gravelle, T				Mildenberger, Matto; Howe, Peter; Lachapelle, Erick; Stokes, Leah; Marlon, Jennifer; Gravelle, Timothy			The Distribution of Climate Change Public Opinion in Canada	PLOS ONE			English	Article							NONRESPONSE; SEA	While climate scientists have developed high resolution data sets on the distribution of climate risks, we still lack comparable data on the local distribution of public climate change opinions. This paper provides the first effort to estimate local climate and energy opinion variability outside the United States. Using a multi-level regression and post-stratification (MRP) approach, we estimate opinion in federal electoral districts and provinces. We demonstrate that a majority of the Canadian public consistently believes that climate change is happening. Belief in climate change's causes varies geographically, with more people attributing it to human activity in urban as opposed to rural areas. Most prominently, we find majority support for carbon cap and trade policy in every province and district. By contrast, support for carbon taxation is more heterogeneous. Compared to the distribution of US climate opinions, Canadians believe climate change is happening at higher levels. This new opinion data set will support climate policy analysis and climate policy decision making at national, provincial and local levels.	[Mildenberger, Matto; Stokes, Leah] Univ Calif Santa Barbara, Dept Polit Sci, Santa Barbara, CA 93106 USA; [Howe, Peter] Utah State Univ, Dept Environm & Soc, Logan, UT 84322 USA; [Lachapelle, Erick] Univ Montreal, Dept Polit Sci, Montreal, PQ, Canada; [Marlon, Jennifer] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT USA; [Gravelle, Timothy] Univ Essex, Dept Govt, Essex, England	University of California System; University of California Santa Barbara; Utah System of Higher Education; Utah State University; Universite de Montreal; Yale University; University of Essex	Mildenberger, M (corresponding author), Univ Calif Santa Barbara, Dept Polit Sci, Santa Barbara, CA 93106 USA.	mildenberger@polsci.ucsb.edu	Gravelle, Timothy B./I-3077-2019; Lachapelle, Erick/AAI-1449-2021	Gravelle, Timothy B./0000-0002-7091-206X; Marlon, Jennifer/0000-0002-8299-9609; Mildenberger, Matto/0000-0001-5784-435X; Howe, Peter/0000-0002-1555-3746	Social Sciences and Humanities Research Council of Canada [410-2011-2765]; Fonds de Recherche du Quebec - Societe et Culture [2012-NP-162717]; Skoll Global Threats Fund; Energy Foundation; Grantham Foundation for the Protection of the Environment; Ministere des Relations internationales et de la francophonie; Chaire d'etudes politiques et economiques americaines; l'Institut de l'energie Trottier; Sustainable Prosperity; Public Policy Forum; University of California Santa Barbara (UCSB)	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Fonds de Recherche du Quebec - Societe et Culture; Skoll Global Threats Fund; Energy Foundation; Grantham Foundation for the Protection of the Environment; Ministere des Relations internationales et de la francophonie; Chaire d'etudes politiques et economiques americaines; l'Institut de l'energie Trottier; Sustainable Prosperity; Public Policy Forum; University of California Santa Barbara (UCSB)(University of California System)	This research was supported by funding from the Social Sciences and Humanities Research Council of Canada (grant number 410-2011-2765, EL, http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx), the Fonds de Recherche du Quebec - Societe et Culture (grant number 2012-NP-162717, EL, http://www.frqsc.gouv.qc.ca/), the Skoll Global Threats Fund (JM, http://www.skollglobalthreats.org/), the Energy Foundation (JM, http://www.ef.org/), and the Grantham Foundation for the Protection of the Environment (JM, http://www.granthamfoundation.org/). Additionally, funding for individual survey waves was previously provided by the Ministere des Relations internationales et de la francophonie (http://www.mrif.gouv.qc.ca/en/), the Chaire d'etudes politiques et economiques americaines (http:l//cerium.umontreal.ca/recherche/unites-de-recherche/chairedetudes-politiques-et-economiques-americainescepea/), l'Institut de l'energie Trottier (http://www.polymtl.ca/iet/en/), Sustainable Prosperity (http://www.sustainableprosperity.ca/), Canada 2020 (http://canada2020.ca/), and the Public Policy Forum (http://www.ppforum.ca/). The costs of publishing this article as an open-access publication were covered by the University of California Santa Barbara (UCSB) Open Access Fund (http://www.library.ucsb.edu/scholarlycommunication/ucsb-open-access-fund).; Thanks to Christopher Borick, Barry Rabe, and Anthony Leiserowitz for their support of this project, and the collection of its underlying data. Thanks to the Social Sciences and Humanities Research Council of Canada, the Fonds de Recherche du Quebec-Societe et Culture, the Skoll Global Threats Fund, the Energy Foundation, and the Grantham Foundation for the Protection of the Environment for financial support. Funding for individual survey waves was provided by the Ministere des Relations internationales et de la Francophonie, the Public Policy Forum, Sustainable Prosperity, Canada 2020, l'Institut de l'energie Trottier and la Chaire d'etudes politiques et economiques americaines.	Balshi MS, 2009, GLOBAL CHANGE BIOL, V15, P1491, DOI 10.1111/j.1365-2486.2009.01877.x; Bates D, 2012, LME4 LINEAR MIXED EF; Bustinza R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-56; Buttice MK, 2013, POLIT ANAL, V21, P449, DOI 10.1093/pan/mpt017; Camill P, 2005, CLIMATIC CHANGE, V68, P135, DOI 10.1007/s10584-005-4785-y; Environment Canada, 2015, NAT INV REP 1990 201; Environment Canada, 2014, CAN EM TRENDS 2014; Fahimi M., 2014, SURVEY PRACTICE, V7; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Harrison K, 2012, REV POLICY RES, V29, P383, DOI 10.1111/j.1541-1338.2012.00565.x; Houle D, 2015, GLOBAL ENVIRON POLIT, V15, P49, DOI 10.1162/GLEP_a_00311; Howe PD, 2015, NAT CLIM CHANGE, V5, P596, DOI 10.1038/nclimate2583; Kattsov VM, 2005, FUTUTRE CLIMATE CHAN; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Kohut A., 2012, ASSESSING REPRESENTA; Lachapelle E., 2014, PUBLIC OPINION CLIMA; Lachapelle E, 2012, REV POLICY RES, V29, P334, DOI 10.1111/j.1541-1338.2012.00563.x; Lantuit H, 2008, GEOMORPHOLOGY, V95, P84, DOI 10.1016/j.geomorph.2006.07.040; Lax JR, 2009, AM J POLIT SCI, V53, P107, DOI 10.1111/j.1540-5907.2008.00360.x; Levine B, 2015, PUBLIC OPIN QUART, V79, P91, DOI 10.1093/poq/nfu044; Maness H, 2013, NAT GEOSCI, V6, P65, DOI [10.1038/NGEO1642, 10.1038/ngeo1642]; NEB, 2015, EN MARK FACT BOOK 20; Olivier J.G.J., 2014, TRENDS GLOBAL CO2 EM; Pacheco J., 2011, STATE POLIT POLICY Q; Park David K., 2006, PUBLIC OPINION STATE, P209, DOI [10.11126/ stanford/ 9780804753005.003.0011, DOI 10.11126/STANF0RD/9780804753005.003.0011]; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Stokes LC, 2013, ENERG POLICY, V56, P490, DOI 10.1016/j.enpol.2013.01.009; Stroeve JC, 2012, CLIMATIC CHANGE, V110, P1005, DOI 10.1007/s10584-011-0101-1; Swart NC, 2012, NAT CLIM CHANGE, V2, P134, DOI 10.1038/nclimate1421; Warshaw C, 2012, J POLIT, V74, P203, DOI 10.1017/S0022381611001204	31	49	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159774	10.1371/journal.pone.0159774	http://dx.doi.org/10.1371/journal.pone.0159774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486659	Green Published, gold			2022-12-27	WOS:000381367800038
J	Warcoin, E; Baudouin, C; Gard, C; Brignole-Baudouin, F				Warcoin, Elise; Baudouin, Christophe; Gard, Carole; Brignole-Baudouin, Francoise			In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; DRY EYE DISEASE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NERVE GROWTH-FACTOR; NF-KAPPA-B; GENE-EXPRESSION; KERATOCONJUNCTIVITIS SICCA; BENZALKONIUM CHLORIDE; INFLAMMATORY MARKERS; INDUCED APOPTOSIS	Purpose To investigate the pro-inflammatory intracellular mechanisms induced by an in vitro model of dry eye disease (DED) on a Hela-modified conjunctiva-derived cells in hyperosmolarity (HO) stress conditions. This study focused on CCL2 induction and explored the implications of the nuclear factor of activated T-cells 5 (NFAT5) as well as mitogen-activated protein kinases (MAPK) and nuclear factor kappa B (NF kappa B). This work was completed by an analysis of the effects of cyclosporine A (CsA), dexamethasone (Dex) and doxycycline (Dox) on HO-induced CCL2 and NFAT5 induction. Methods A human HeLa-modified conjunctiva-derived cell line was cultured in NaCl-hyperosmolar medium for various exposure times. Cellular viability, CCL2 secretion, NFAT5 and CCL2 gene expression, and intracytoplasmic NFAT5 were assessed using the Cell Titer Blue (R) assay, enzyme-linked immunosorbent assay (ELISA), RT-qPCR and immunostaining, respectively. In selected experiments, inhibitors of MAPKs or NF kappa B, therapeutic agents or NFAT5 siRNAs were added before the hyperosmolar stimulations. Results HO induced CCL2 secretion and expression as well as NFAT5 gene expression and translocation. Adding NFAT5-siRNA before hyperosmolar stimulation led to a complete inhibition of CCL2 induction and to a decrease in cellular viability. p38 MAPK (p38), c-Jun NH2-terminal kinase (JNK) and NF kappa B inhibitors, CsA and Dex induced a partial inhibition of HO-induced CCL2, while Dox and extracellular signal-regulated kinase (ERK) inhibitor did not. Dex also induced a partial inhibition of HO-induced NFAT5 gene expression but not CsA or Dox. Conclusions These in vitro results suggest a potential role of CCL2 in DED and highlight the crucial role of NFAT5 in the pro-inflammatory effect of HO on HeLa-modified conjunctiva-derived cells, a rarely studied cellular type. This inflammatory pathway involving NFAT5 and CCL2 could offer a promising target for developing new therapies to treat DED, warranting further investigations to fully grasp the complete intracellular mechanisms.	[Warcoin, Elise; Baudouin, Christophe; Brignole-Baudouin, Francoise] Univ Paris 06, Sorbonne Univ, INSERM, CNRS,Inst Vis, Paris, France; [Warcoin, Elise] CHNO Quinze Vingts, Serv Pharm, Paris, France; [Baudouin, Christophe] CHNO Quinze Vingts, Serv 3, Paris, France; [Gard, Carole] Horus Pharma, St Laurent Du Var, France; [Brignole-Baudouin, Francoise] Univ Paris 05, Fac Pharm Paris, Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Warcoin, E; Brignole-Baudouin, F (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, CNRS,Inst Vis, Paris, France.; Warcoin, E (corresponding author), CHNO Quinze Vingts, Serv Pharm, Paris, France.; Brignole-Baudouin, F (corresponding author), Univ Paris 05, Fac Pharm Paris, Sorbonne Paris Cite, Paris, France.	elisewarcoin@gmail.com; francoise.brignole-baudouin@parisdescartes.fr		Baudouin, Christophe/0000-0003-1743-6698; BRIGNOLE-BAUDOUIN, FRANCOISE/0000-0002-2006-5384	Horus Pharma	Horus Pharma	Carole Gard is employed by Horus Pharma. Concerning her participation, as a co-author, we had regular scientific meetings with her and she participated in the design of the methods, as well as in the manuscript review. She also contributed to reagents, material and analysis tolls. Horus Pharma provided support in the form of salary for author CG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aramburu J, 2006, BIOCHEM PHARMACOL, V72, P1597, DOI 10.1016/j.bcp.2006.07.002; Barabino S, 2010, EXP EYE RES, V91, P524, DOI 10.1016/j.exer.2010.07.008; Baudouin C, 2007, J FR OPHTALMOL, V30, P239, DOI 10.1016/S0181-5512(07)89584-2; Baudouin C, 2005, J ALLERGY CLIN IMMUN, V116, P614, DOI 10.1016/j.jaci.2005.05.033; BAUDOUIN C, 1992, BRIT J OPHTHALMOL, V76, P545, DOI 10.1136/bjo.76.9.545; Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003; Brasnu E, 2008, MOL VIS, V14, P394; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Capo-Aponte JE, 2007, EXP EYE RES, V84, P361, DOI 10.1016/j.exer.2006.10.011; Cavet ME, 2011, MOL VIS, V17, P533; Cavet ME, 2010, MOL VIS, V16, P1791; Chang EJ, 2008, J CELL PHYSIOL, V216, P69, DOI 10.1002/jcp.21377; Chen LY, 2015, J PROTEOME RES, V14, P3982, DOI 10.1021/acs.jproteome.5b00443; Chen M, 2010, EXP EYE RES, V90, P437, DOI 10.1016/j.exer.2009.12.004; Chen YH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072900, 10.1371/journal.pone.0075805]; Chen Z, 2008, INVEST OPHTH VIS SCI, V49, P539, DOI 10.1167/iovs.07-0569; Clouzeau C, 2012, MOL VIS, V18, P851; Contreras-Ruiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075937; Corrales RM, 2008, CORNEA, V27, P574, DOI 10.1097/ICO.0b013e318165b19e; Deng RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126561; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Djalilian AR, 2006, CORNEA, V25, P709, DOI 10.1097/01.ico.0000208815.02120.90; Duzgun SA, 2000, J CELL BIOCHEM, V76, P567, DOI 10.1002/(SICI)1097-4644(20000315)76:4<567::AID-JCB5>3.0.CO;2-W; FARRIS RL, 1994, ADV EXP MED BIOL, V350, P495; GILBARD JP, 1978, ARCH OPHTHALMOL-CHIC, V96, P677; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Goyal S, 2009, ARCH OPHTHALMOL-CHIC, V127, P882, DOI 10.1001/archophthalmol.2009.125; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hollborn M, 2015, MOL VIS, V21, P360; Hua X, 2015, INVEST OPHTH VIS SCI, V56, P5503, DOI 10.1167/iovs.14-16247; Hua X, 2015, CURR EYE RES, V40, P657, DOI 10.3109/02713683.2014.957776; Kang SS, 2014, INVEST OPHTH VIS SCI, V55, P535, DOI 10.1167/iovs.13-12459; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Kuper C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/513015; Kunert KS, 2002, ARCH OPHTHALMOL-CHIC, V120, P330; Kurtz RM, 1997, INVEST OPHTH VIS SCI, V38, P436; Labbe A, 2013, BRIT J OPHTHALMOL, V97, P1399, DOI 10.1136/bjophthalmol-2013-303838; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee JH, 2008, INVEST OPHTH VIS SCI, V49, P1827, DOI 10.1167/iovs.07-1142; Lee JH, 2011, CORNEA, V30, pS19, DOI 10.1097/ICO.0b013e3182281028; Lemp MA, 2007, OCUL SURF, V5, P75; Li DQ, 2004, INVEST OPHTH VIS SCI, V45, P4302, DOI 10.1167/iovs.04-0299; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; MATSUDA S, 1995, J BIOL CHEM, V270, P12781, DOI 10.1074/jbc.270.21.12781; Matsuo H, 2006, KIDNEY INT, V69, P736, DOI 10.1038/sj.ki.5000131; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Narayanan S, 2006, CORNEA, V25, P1063, DOI 10.1097/01.ico.0000228785.84581.35; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; Pan Z, 2011, INVEST OPHTH VIS SCI, V52, P485, DOI 10.1167/iovs.10-5801; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; RALPH RA, 1975, INVEST OPHTH VISUAL, V14, P299; Ramirez-Miranda A, 2011, MOL VIS, V17, P1652; Raza M, 2006, EXP LUNG RES, V32, P15, DOI 10.1080/01902140600691399; Rinschen MM, 2011, PFLUG ARCH EUR J PHY, V462, P611, DOI 10.1007/s00424-011-0994-6; Roth I, 2010, MOL BIOL CELL, V21, P3459, DOI 10.1091/mbc.E10-02-0133; Stern Michael E, 2004, Ocul Surf, V2, P124; Sullivan BD, 2010, INVEST OPHTH VIS SCI, V51, P6125, DOI 10.1167/iovs.10-5390; Tong L, 2009, GENE EXPRESSION, V14, P265, DOI 10.3727/105221609788681231; Tsubota K, 1999, OPHTHALMOLOGICA, V213, P16, DOI 10.1159/000027387; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P3200, DOI 10.1167/iovs.10-6485; Xiao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115333; Yoon KC, 2007, CORNEA, V26, P431, DOI 10.1097/ICO.0b013e31803dcda2; Zheng QX, 2015, EXP EYE RES, V134, P133, DOI 10.1016/j.exer.2015.02.013; Zhu L, 2009, MOL VIS, V15, P250	74	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159983	10.1371/journal.pone.0159983	http://dx.doi.org/10.1371/journal.pone.0159983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486749	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800049
J	Yoo, A; Nam, KY; Tchah, H; Kim, MJ				Yoo, Aeri; Nam, Ki Yeun; Tchah, Hungwon; Kim, Myoung Joon			Heat Generation and Efficiency of a New Modified Phaco Tip and Sleeve	PLOS ONE			English	Article							ULTRASOUND MODALITIES; CATARACT-SURGERY; PHACOEMULSIFICATION; MICROINCISION; CHATTER	Purpose To compare a modified phacoemulsification tip with the established micro tip, in terms of temperature at the corneal wound, efficiency, and chatter events, using the Centurion (R) Vision system. Methods Eighty porcine eyes were randomized into 4 groups: 1) sleeveless conventional 45D Mini-Flared ABS (R) Kelman tip (1.1-mm incision); 2) sleeveless new modified 45D ABS (R) INTREPID (R) balanced tip(1.1-mm incision); 3) Kelman tip with own sleeve (2.2-mm incision); 4) Balanced tip with modified 4-rib sleeve (2.2-mm incision). Measurements were taken with 2 settings: longitudinal(power 40% and 70%) and torsional mode (power 40% and 100%). Peak temperatures were measured 0, 10, 30, and 60 seconds after continuous ultrasound power. For the efficiency test, porcine lens nuclei were formalin soaked and cut into 2.0 mm(3) cubes. Efficiency and chatter were examined. Results In all longitudinal settings, the sleeveless groups(1 and 2) showed lower temperatures than the sleeved groups(3 and 4) (P = 0.003). In 100% torsional mode, groups 3 and 4 produced significantly different temperatures(37.13 +/- 1.44 and 35.14 +/- 0.54, respectively; P = 0.007). The efficiency, in a 100% power torsional setting, was 13.52 +/- 2.60 sec for group 4, and 44.45 +/- 14.75 sec for group 3 (P<0.001). Conclusions The two different bare tips show no significant differences in thermogenesis. However, the balanced tip with sleeve produces lower temperaturesat100% torsional power and better efficiency than the Kelman tip.	[Yoo, Aeri] Saevit Eye Hosp, Dept Ophthalmol, Goyang, South Korea; [Nam, Ki Yeun] Dongguk Univ, Dept Phys Med & Rehabil, Coll Med, Goyang, South Korea; [Tchah, Hungwon; Kim, Myoung Joon] Univ Ulsan, Dept Ophthalmol, Asan Med Ctr, Coll Med, Seoul, South Korea	Dongguk University; University of Ulsan; Asan Medical Center	Kim, MJ (corresponding author), Univ Ulsan, Dept Ophthalmol, Asan Med Ctr, Coll Med, Seoul, South Korea.	mjmjkim@gmail.com						Alio J, 2005, OPHTHALMOLOGY, V112, P1997, DOI 10.1016/j.ophtha.2005.06.024; Bradley MJ, 2006, AM J OPHTHALMOL, V141, P222, DOI 10.1016/j.ajo.2005.08.018; DeMill DL, 2012, J CATARACT REFR SURG, V38, P1065, DOI 10.1016/j.jcrs.2011.12.040; Gupta I, 2014, J CATARACT REFR SURG, V40, P818, DOI 10.1016/j.jcrs.2013.11.029; Han YK, 2009, J CATARACT REFR SURG, V35, P1799, DOI 10.1016/j.jcrs.2009.04.046; Kurz S, 2006, OPHTHALMOLOGY, V113, P1818, DOI 10.1016/j.ophtha.2006.05.013; Oakey ZB, 2013, J CATARACT REFR SURG, V39, P1248, DOI 10.1016/j.jcrs.2013.01.049; Ronquillo CC, 2014, AM J OPHTHALMOL, V158, P1262, DOI 10.1016/j.ajo.2014.08.034; Zacharias J, 2015, J CATARACT REFR SURG, V41, P208, DOI 10.1016/j.jcrs.2014.11.001	9	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159049	10.1371/journal.pone.0159049	http://dx.doi.org/10.1371/journal.pone.0159049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487206	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800016
J	Li, YF; Zou, Y; Xia, YT; Bai, J; Wang, XW; Jiang, P				Li, Yufeng; Zou, Yao; Xia, Yuting; Bai, Juan; Wang, Xianwei; Jiang, Ping			Proteomic and Transcriptomic Analyses of Swine Pathogen Erysipelothrix rhusiopathiae Reveal Virulence Repertoire	PLOS ONE			English	Article							OCCUPATIONAL PATHOGEN; PROTECTIVE ANTIGEN; CAUSATIVE AGENT; RNA-SEQ; PIGS; STRAINS; OUTBREAKS; PROTEINS; GENES; JAPAN	E. rhusiopathiae is the causative agent of erysipelas in animals and erysipeloid in humans, but its pathogenicity is poorly understood. To identify virulence factors associated with E. rhusiopathiae and screen engineered vaccine candidates, we used proteomics and transcriptomics to compare the highly virulent strain HX130709 with an isogenic avirulent derivative, HX130709a. 1,299 proteins and 1,673 transcribed genes were identified and 1,292 of the proteins could be associated with genes. In a comparison between HX130907 and HX130709a, 168 proteins and 475 genes exhibited differences in regulation level. Among these, levels for 61 proteins and transcripts were positively or negatively correlated. Gene Ontology (GO) analysis suggests that many of the down-regulated proteins in the attenuated strain have catalytic or binding functions. Potential protein-protein interactions suggest that some of the down-regulated proteins may regulate PTS, GMP synthase and ribosomal proteins. Morphological results showed that HX130709 and HX130709a have similar colony and capsule morphology. Growth curves and pyruvate measurements suggest that TCA cycle and saccharide phosphorylation levels were decreased and gluconeogenesis was increased in HX130709a. Our study confirms that SpaA and neuraminidase, but not hyaluronidase and capsule, are associated with virulence in E. rhusiopathiae. We conclude that the virulence of E. rhusiopathiae may be associated with slow reactions of the TCA cycle and down-regulation of selected proteins.	[Li, Yufeng; Zou, Yao; Xia, Yuting; Bai, Juan; Wang, Xianwei; Jiang, Ping] Nanjing Agr Univ, Coll Vet Med, Key Lab Bacteriol, Minist Agr, Nanjing 210095, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Li, YF (corresponding author), Nanjing Agr Univ, Coll Vet Med, Key Lab Bacteriol, Minist Agr, Nanjing 210095, Jiangsu, Peoples R China.	yufengli@njau.edu.cn			public welfare Grants from the Ministry of Agriculture; People's Republic of China [201203039]; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (PAPD)	public welfare Grants from the Ministry of Agriculture; People's Republic of China; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by public welfare Grants from the Ministry of Agriculture, the People's Republic of China (201203039) and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (PAPD).	Bender JS, 2010, CLIN VACCINE IMMUNOL, V17, P1605, DOI 10.1128/CVI.00206-10; Bender JS, 2011, J VET DIAGN INVEST, V23, P139, DOI 10.1177/104063871102300126; Borrathybay E, 2014, JOURNAL OF MICROBIOL; Brooke CJ, 1999, J MED MICROBIOL, V48, P789, DOI 10.1099/00222615-48-9-789; Eamens GJ, 2006, VET MICROBIOL, V115, P329, DOI 10.1016/j.vetmic.2006.02.015; Gaigalat L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-104; GALAN JE, 1990, INFECT IMMUN, V58, P3116; Imada Y, 2004, J CLIN MICROBIOL, V42, P2121, DOI 10.1128/JCM.42.5.2121-2126.2004; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kwok AHY, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-176; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozawa M, 2009, J VET MED SCI, V71, P697, DOI 10.1292/jvms.71.697; REBOLI AC, 1989, CLIN MICROBIOL REV, V2, P354, DOI 10.1128/CMR.2.4.354-359.1989; Shi F, 2012, INFECT IMMUN, V80, P3993, DOI 10.1128/IAI.00635-12; Shimoji Y, 2000, MICROBES INFECT, V2, P965, DOI 10.1016/S1286-4579(00)00397-X; SHIMOJI Y, 1994, INFECT IMMUN, V62, P2806, DOI 10.1128/IAI.62.7.2806-2810.1994; Shimoji Y, 2003, J BACTERIOL, V185, P2739, DOI 10.1128/JB.185.9.2739-2748.2003; Shimoji Y, 2002, J VET MED SCI, V64, P173, DOI 10.1292/jvms.64.173; Takahashi T, 1996, J VET MED SCI, V58, P587, DOI 10.1292/jvms.58.587; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang QN, 2010, VET MICROBIOL, V140, P405, DOI 10.1016/j.vetmic.2009.08.012; Wang QN, 2005, VET MICROBIOL, V107, P265, DOI 10.1016/j.vetmic.2005.01.022; Wood R., 1999, DIS SWINE, P419; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zou Y, 2015, J VET MED SCI, V77, P653, DOI 10.1292/jvms.14-0589	25	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159462	10.1371/journal.pone.0159462	http://dx.doi.org/10.1371/journal.pone.0159462			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479071	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110300013
J	Watanabe, T; Maejima, E; Yoshimura, T; Urayama, M; Yamauchi, A; Owadano, M; Okada, R; Osaki, M; Kanayama, Y; Shinano, T				Watanabe, Toshihiro; Maejima, Eriko; Yoshimura, Tomoko; Urayama, Masaru; Yamauchi, Aiko; Owadano, Masako; Okada, Ryosuke; Osaki, Mitsuru; Kanayama, Yoshinori; Shinano, Takuro			The Ionomic Study of Vegetable Crops	PLOS ONE			English	Article							CADMIUM UPTAKE; LEAF IONOME; PLANT; IRON; CESIUM; ZINC; K+	Soil contains various essential and nonessential elements, all of which can be absorbed by plants. Plant ionomics is the study of the accumulation of these elements (the ionome) in plants. The ionomic profile of a plant is affected by various factors, including species, variety, organ, and environment. In this study, we cultivated various vegetable crop species and cultivars under the same field conditions and analyzed the level of accumulation of each element in the edible and nonedible parts using ionomic techniques. The concentration of each element in the edible parts differed between species, which could be partly explained by differences in the types of edible organs (root, leaf, seed, and fruit). For example, the calcium concentration was lower in seeds and fruit than in other organs because of the higher dependency of calcium accumulation on xylem transfer. The concentration of several essential microelements and nonessential elements in the edible parts also varied greatly between cultivars of the same species, knowledge of which will help in the breeding of vegetables that are biofortified or contain lower concentrations of toxic elements. Comparison of the ionomes of the fruit and leaves of tomato (Solanum lycopersicum) and eggplant (S. melongena) indicated that cadmium and boron had higher levels of accumulation in eggplant fruit, likely because of their effective transport in the phloem. We also found that homologous elements that have been reported to share the same uptake/transport system often showed significant correlation only in a few families and that the slopes of these relationships differed between families. Therefore, these differences in the characteristics of mineral accumulation are likely to affect the ionomic profiles of different families.	[Watanabe, Toshihiro; Maejima, Eriko; Yoshimura, Tomoko; Urayama, Masaru; Yamauchi, Aiko; Owadano, Masako; Okada, Ryosuke; Osaki, Mitsuru] Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan; [Kanayama, Yoshinori] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan; [Shinano, Takuro] NARO Tohoku Agr Res Ctr, Agr Radiat Res Ctr, 50 Aza Harajyukuminami, Fukushima 9602156, Japan	Hokkaido University; Tohoku University	Watanabe, T (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	nabe@chem.agr.hokudai.ac.jp	Shinano, Takuro/AAH-7995-2019; Watanabe, Toshihiro/AAT-6071-2021	Shinano, Takuro/0000-0002-1147-651X; Watanabe, Toshihiro/0000-0003-4466-811X	Japan Society for the Promotion of Science [24580088, 26660019, 16H02534]; Grants-in-Aid for Scientific Research [15H04465, 15K14673] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported financially by Grants-in-Aid for Scientific Research No. 24580088 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-24580088/) (TW), No. 26660019 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-26660019/) (YK, TW) and No. 16H02534 (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT16H02534/) (YK, TW) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported financially by Grants-in-Aid for Scientific Research (No. 24580088 (TW), No. 26660019 (YK, TW), and No. 16H02534 (YK, TW)) from the Japan Society for the Promotion of Science.	[Anonymous], 2012, MINERAL NUTR HIGHER; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Benito B, 2014, J PLANT PHYSIOL, V171, P723, DOI 10.1016/j.jplph.2013.10.014; Chao DY, 2011, PLANT CELL, V23, P1061, DOI 10.1105/tpc.110.079095; Drouet T, 2008, PLANT SOIL, V302, P105, DOI 10.1007/s11104-007-9459-2; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Kaiser Younis, 2015, Journal of Food Processing and Technology, V6, P434; Karley AJ, 2009, CURR OPIN PLANT BIOL, V12, P291, DOI 10.1016/j.pbi.2009.04.013; Liu FJ, 2010, PLANT SOIL, V327, P365, DOI 10.1007/s11104-009-0060-8; Ma JF, 2005, PLANTA, V220, P731, DOI 10.1007/s00425-004-1392-5; Nakanishi H, 2006, SOIL SCI PLANT NUTR, V52, P464, DOI 10.1111/j.1747-0765.2006.00055.x; OESTLING O, 1989, RADIAT PHYS CHEM, V33, P551; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Reese R. A., 2005, SIGNIFICANCE, V2, P134, DOI DOI 10.1111/J.1740-9713.2005.00118.X; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sha ZM, 2012, J AGR FOOD CHEM, V60, P9543, DOI 10.1021/jf3024744; Shakoor N, 2016, PLANT PHYSIOL, V170, P1989, DOI 10.1104/pp.15.01971; Watanabe T, 2007, NEW PHYTOL, V174, P516, DOI 10.1111/j.1469-8137.2007.02078.x; Watanabe T, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1562-x; Watanabe T, 2009, J PLANT NUTR, V32, P1164, DOI 10.1080/01904160902943189; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; White PJ, 2012, NEW PHYTOL, V196, P101, DOI 10.1111/j.1469-8137.2012.04228.x; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Yamaguchi H, 2010, J EXP BOT, V61, P423, DOI 10.1093/jxb/erp313; Yamaguchi N, 2011, ENVIRON EXP BOT, V71, P198, DOI 10.1016/j.envexpbot.2010.12.002	29	26	27	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160273	10.1371/journal.pone.0160273	http://dx.doi.org/10.1371/journal.pone.0160273			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27478901	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110300038
J	Zhou, JW; Yang, YJ; Qiu, XH; Yang, XX; Pan, H; Ban, B; Qiao, ZX; Wang, L; Wang, WB				Zhou, Jiawei; Yang, Yanjie; Qiu, Xiaohui; Yang, Xiuxian; Pan, Hui; Ban, Bo; Qiao, Zhengxue; Wang, Lin; Wang, Wenbo			Relationship between Anxiety and Burnout among Chinese Physicians: A Moderated Mediation Model	PLOS ONE			English	Article							MENTAL-HEALTH; DEPRESSION; DISORDERS; HARDINESS; VIOLENCE; DOCTORS; STAFF	Objective The main goal of this research was to investigate the complex relationships among coping styles, personality, burnout, and anxiety using a moderated mediation analysis. Methods A random cluster sampling procedure was used to select a total of 1274 physicians from two tertiary grade A hospitals in Heilongjiang Province, which is located in northeast China. The Zung Self-Rating Anxiety Scale (SAS), Chinese Maslach Burnout Inventory (CMBI), Chinese version of the EPQ-revised Short Scale, and the Trait Coping Style Questionnaire (TCSQ) were used to gather data. Moderated mediation analysis was used in this study; it was executed using the PROCESS macro so that the mediators and moderator could function together in the same model. Results The prevalence of anxiety symptoms among the physicians was 31%, and there were no differences between the sexes. The results showed that positive and negative coping styles partially mediated the association between burnout and anxiety symptoms in physicians. The mediated effect of positive coping styles was moderated by Eysenck's Psychoticism traits. Conclusions Personality traits moderate the strength of the relationships between burnout and anxiety mediated by positive coping styles; however, personality traits do not moderate the strength of the relationships between burnout and anxiety mediated by negative coping styles.	[Zhou, Jiawei; Yang, Yanjie; Qiu, Xiaohui; Yang, Xiuxian; Qiao, Zhengxue; Wang, Lin; Wang, Wenbo] Harbin Med Univ, Inst Publ Hlth, Dept Med Psychol, Harbin, Peoples R China; [Pan, Hui] Beijing Union Med Coll Hosp, Dept Endocrinol, Beijing, Peoples R China; [Ban, Bo] Jining Med Coll, Affiliated Hosp, Dept Endocrinol, Jining, Peoples R China	Harbin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Jining Medical University	Yang, YJ; Yang, XX (corresponding author), Harbin Med Univ, Inst Publ Hlth, Dept Med Psychol, Harbin, Peoples R China.	yanjie1965@163.com; 125020874@qq.com			National Natural Science Foundation of China [81473054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant No. 81473054 awarded to Professor Yanjie Yang).	Ahmed I, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.06.003; Aiken L. S., 1991, MULTIPLE REGRESSION; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2006, MONOGR SOC RES CHILD, V71, P88; [Anonymous], 2014, LANCET, V383, P1013, DOI 10.1016/S0140-6736(14)60501-8; [Anonymous], 2014, ENCY PSYCHOL RELIG; Bargellini A, 2000, OCCUP ENVIRON MED, V57, P453, DOI 10.1136/oem.57.7.453; Chen KY, 2013, INT J MED SCI, V10, P1471, DOI 10.7150/ijms.6743; [成颢 Cheng Hao], 2012, [中华行为医学与脑科学杂志, Chinese Journal of Behavioral Medicine and Brain Science], V21, P262; COYNE JC, 1981, J ABNORM PSYCHOL, V90, P439, DOI 10.1037/0021-843X.90.5.439; Dempsey M, 2002, AM J ORTHOPSYCHIAT, V72, P102, DOI 10.1037/0002-9432.72.1.102; Ding Y, 2014, MEDIATING EFFECTS BU; Ding YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122128; Dong Zhang XL, 2009, CHINA J HLTH PSYCHOL, V17, P6; FOLKMAN S, 1988, J PERS SOC PSYCHOL, V54, P466, DOI 10.1037/0022-3514.54.3.466; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Jiang Q., 2002, MED PSYCHOL; Jiang Q. J., 1993, CHIN MENT HLTH J, V7, P145; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Leander M, 2014, RESP MED, V108, P1594, DOI 10.1016/j.rmed.2014.09.007; Lei Ni, 2012, CHINESE J IND MED, V25, P338; Li G, 2008, MOD PREV MED, V35, P1490, DOI DOI 10.3969/J.ISSN.1003-8507.2008.08.040; Li JA, 2006, SOC SCI MED, V62, P1066, DOI 10.1016/j.socscimed.2005.07.011; Li Y., 2006, PSYCHOL SCI, V29, P148; Li Y.X., 2005, PSYCHOL EXPLORATION, V25, P70, DOI DOI 10.3969/j.issn.1003-5184.2005.04.015; [李永鑫 LI Yongxin], 2007, [中华护理杂志, Chinese Journal of Nursing], V42, P392; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Mingyi Q., 2000, ACTA PSYCHOL SIN, V32, P317, DOI DOI 10.1007/S11769-000-0010-0; Ning ZS, 2014, CHINESE J CONT NEURO, V14, P117, DOI DOI 10.3969/j.issn.1672-6731.2014.02.009; Ouyang N., 2012, STUDY MENTAL HLTH ST; [庞智辉 Pang Zhihui], 2010, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V18, P654; Ruitenburg MM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-292; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Suls J, 1998, PERS SOC PSYCHOL B, V24, P127, DOI 10.1177/0146167298242002; Sun W, 2012, J OCCUP HEALTH, V54, P1, DOI 10.1539/joh.11-0169-OA; Tieshuang C., 2010, RES OCCUPATIONAL STR; Tyssen R, 2002, HARVARD REV PSYCHIAT, V10, P154, DOI 10.1080/10673220216218; Vollrath M, 1999, ANN INTERDISC J, V29, P367; Wang F, 1998, SICHUAN MENTAL HLTH; Wang Z.Y., 1984, J SHANGHAI PSYCHIAT, V2, P73; WILLIAMS PG, 1992, J BEHAV MED, V15, P237, DOI 10.1007/BF00845354; Winstanley S, 2002, WORK STRESS, V16, P302, DOI 10.1080/0267837021000058650; Yao SK, 2014, J THORAC DIS, V6, pE141, DOI 10.3978/j.issn.2072-1439.2014.06.10; Zhang T, 2006, STUDY RELATIONSHIP L; Zhou JJ., 2013, HOSP MANAGE FORUM, V30, P51; Zhou L, 2011, CHINA J HLTH PSYCHOL; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	48	90	93	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0157013	10.1371/journal.pone.0157013	http://dx.doi.org/10.1371/journal.pone.0157013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27479002	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300003
J	Atim, P; Ochola, E; Ssendagire, S; Rutebemberwa, E				Atim, Pamela; Ochola, Emmanuel; Ssendagire, Stephen; Rutebemberwa, Elizeus			Health Seeking Behaviours among Caretakers of Children with Nodding Syndrome in Pader District - Northern Uganda: A Mixed Methods Study	PLOS ONE			English	Article								Background Nodding syndrome is a neurological disorder which had affected about 3000 children with over 170 deaths in northern Uganda by 2012. With limited data on health seeking, the study aimed to assess the health seeking behavior and associated factors among caretakers of children with nodding syndrome in Pader district. Methods A mixed methods cross sectional study was conducted in July 2013 among 249 caretakers of children with nodding syndrome in three sub-counties of Pader. Respondents were consecutively interviewed using semi-structured questionnaires. Eleven key informants were additionally interviewed. We determined the associations of various factors with health care seeking and obtained adjusted odds ratios and 95% confidence intervals using logistic regression model. Quantitative data was analysed using Stata version 12 while qualitative data was analysed manually and quotes reported. Results Most caretakers, 78.3% (195/249) sought care first from a health facility, 12.9% (32/249) visited traditional healers and 8.8% (22/249) self-medicated. Of those who sought care from a health facility, 50% sought care after a month. Factors associated with improved care seeking included: Time taken to reach care 1-3 hours; adjusted odds ratio = 6.4 (95% CI = 2.96-14.03), time spent in care above five years; adjusted odds ratio = 12.0 (95% CI: 1.24-117.73) and changed care seeking place; adjusted odds ratio = 17.2 (95% CI: 3.64-81.67). Conclusion/Recommendation Caretakers sought care from multiple places. One in five caretakers still sought care outside a formal health facility. Many respondents who sought care first from health facilities went late, at least one month after symptoms onset. Factors associated with health seeking included distance, duration in treatment and not having changing care provider. There is need for massive sensitization of community to enhance prompt care seeking. More research is needed to elucidate the cause, thus finding the treatment for nodding syndrome, to prevent "wandering in hope".	[Atim, Pamela; Ssendagire, Stephen; Rutebemberwa, Elizeus] Makerere Univ, Dept Hlth Policy Planning & Management, Sch Publ Hlth, Kampala, Uganda; [Atim, Pamela; Ochola, Emmanuel] Gulu Univ, Dept Publ Hlth, Fac Med, Gulu, Uganda; [Ochola, Emmanuel] St Marys Hosp Lacor, Dept HIV Res & Documentat, Gulu, Uganda	Makerere University	Ochola, E (corresponding author), Gulu Univ, Dept Publ Hlth, Fac Med, Gulu, Uganda.; Ochola, E (corresponding author), St Marys Hosp Lacor, Dept HIV Res & Documentat, Gulu, Uganda.	ayiga33@hotmail.com		Ochola, Emmanuel/0000-0003-0329-9477; Atim, Pamela/0000-0001-6455-5855; Rutebemberwa, Elizeus/0000-0001-8363-7928	Gulu University, THRiVE (Training Health Researchers into Vocational Excellence) project; Gulu university THRiVE project	Gulu University, THRiVE (Training Health Researchers into Vocational Excellence) project; Gulu university THRiVE project	This work was supported by a study scholarship Gulu University, THRiVE (Training Health Researchers into Vocational Excellence) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge contributions of the following individuals and/or institutions which made this study a success: the research participants for providing the responses, Pader district leaders for granting permission to conduct this study, village health teams for mobilizing research participants, Makerere university for the mentorship and support throughout the development and conduct of this study, and Gulu university THRiVE project for sponsoring the principle investigator's masters program.	Colebunders R, 2015, TROP MED INT HEALTH, V20, P194, DOI 10.1111/tmi.12421; Colebunders R, 2014, INT J INFECT DIS, V27, P74, DOI 10.1016/j.ijid.2014.08.001; Danso-Appiah A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000867; de Savigny D, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-27; Deogratius MA, 2015, HLTH POLICY PLAN, DOI [10.1093/heapol/czv1056, DOI 10.1093/HEAPOL/CZV1056]; Dowell SF, 2013, EMERG INFECT DIS, V19, P1374, DOI 10.3201/eid1909.130401; Foltz Jennifer L., 2013, PLOS ONE, V8, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Idro R, 2013, AFR HEALTH SCI, V13, P219, DOI 10.4314/ahs.v13i2.4; Iyengar PJ, 2014, MMWR-MORBID MORTAL W, V63, P603; Landis JL, 2014, BMJ OPEN, V4; Mitchell KB, 2013, EPILEPSY BEHAV, V26, P22, DOI 10.1016/j.yebeh.2012.10.030; MoH U, 2012, NODDING SYN IN PRESS; Mushi D, 2011, EPILEPSY BEHAV, V20, P338, DOI 10.1016/j.yebeh.2010.11.016; Mwaka AD, 2015, EUR J CANCER CARE, V24, P503, DOI 10.1111/ecc.12211; Mwaka Amos Deogratius, 2015, BMC Res Notes, V8, P386, DOI 10.1186/s13104-015-1323-5; Rutebemberwa E, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-1; Sejvar JJ, 2013, LANCET NEUROL, V12, P166, DOI 10.1016/S1474-4422(12)70321-6; Sinha Abhik, 2012, Indian J Community Med, V37, P25, DOI 10.4103/0970-0218.94018; Tumwesigire S, 2002, AFR HEALTH SCI, V2, P84; Tumwine JK, 2012, AFR HEALTH SCI, V12, P242, DOI 10.4314/ahs.v12i3.1; Winkler AS, 2008, EPILEPSIA, V49, P2008, DOI 10.1111/j.1528-1167.2008.01671.x	21	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159549	10.1371/journal.pone.0159549	http://dx.doi.org/10.1371/journal.pone.0159549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27471850	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300010
J	Kaul, R; O'Brien, MH; Dutra, E; Lima, A; Utreja, A; Yadav, S				Kaul, Raman; O'Brien, Mara H.; Dutra, Eliane; Lima, Alexandro; Utreja, Achint; Yadav, Sumit			The Effect of Altered Loading on Mandibular Condylar Cartilage	PLOS ONE			English	Article							TEMPOROMANDIBULAR-JOINT; COMPRESSIVE FORCES; BONE-FORMATION; II COLLAGENS; GENE; FIBROCARTILAGE; EXPRESSION; STRAINS; DISC	Objective The purpose of this study was to delineate the cellular, mechanical and morphometric effects of altered loading on the mandibular condylar cartilage (MCC) and subchondral bone. We hypothesized that altered loading will induce differentiation of cells by accelerating the lineage progression of the MCC. Materials and Methods Four-week-old male Dkk3 XCol2A1XCol10A1 mice were randomly divided into two groups: (1) Loaded-Altered loading of MCC was induced by forced mouth opening using a custom-made spring; (2) Control-served as an unloaded group. Mice were euthanized and flow cytometery based cell analysis, micro-CT, gene expression analysis, histology and morphometric measurements were done to assess the response. Results Our flow cytometery data showed that altered loading resulted in a significant increase in a number of Col2a1-positive (blue) and Col10a1-positive (red) expressing cells. The gene expression analysis showed significant increase in expression of BMP2, Col10a1 and Sox 9 in the altered loading group. There was a significant increase in the bone volume fraction and trabecular thickness, but a decrease in the trabecular spacing of the subchondral bone with the altered loading. Morphometric measurements revealed increased mandibular length, increased condylar length and increased cartilage width with altered loading. Our histology showed increased mineralization/calcification of the MCC with 5 days of loading. An unexpected observation was an increase in expression of tartrate resistant acid phosphatase activity in the fibrocartilaginous region with loading. Conclusion Altered loading leads to mineralization of fibrocartilage and drives the lineage towards differentiation/maturation.	[Kaul, Raman; O'Brien, Mara H.; Dutra, Eliane; Lima, Alexandro; Yadav, Sumit] Univ Connecticut, Ctr Hlth, Div Orthodont, Farmington, CT 06030 USA; [Utreja, Achint] Indiana Univ Purdue Univ, Div Orthodont, Indianapolis, IN 46202 USA	University of Connecticut; Indiana University System; Indiana University-Purdue University Indianapolis	Yadav, S (corresponding author), Univ Connecticut, Ctr Hlth, Div Orthodont, Farmington, CT 06030 USA.	Yadav_sumit17@yahoo.com	Utreja, Achint/Q-9535-2019	O'Brien, Mara/0000-0002-5646-2541	American Association of Orthodontic Foundation	American Association of Orthodontic Foundation	The study was partially funded by American Association of Orthodontic Foundation and partially by startup funds of Sumit Yadav.	Ahmad M, 2009, ORAL SURG ORAL MED O, V107, P844, DOI 10.1016/j.tripleo.2009.02.023; Beek M, 2000, J BIOMECH, V33, P307, DOI 10.1016/S0021-9290(99)00168-2; BOYD RL, 1990, AM J ORTHOD DENTOFAC, V97, P472, DOI 10.1016/S0889-5406(05)80027-7; CARVALHO RS, 1995, AM J ORTHOD DENTOFAC, V107, P401, DOI 10.1016/S0889-5406(95)70093-5; Chen J, 2012, CELLS TISSUES ORGANS, V195, P232, DOI 10.1159/000325148; Chen J, 2009, OSTEOARTHR CARTILAGE, V17, P354, DOI 10.1016/j.joca.2008.05.021; COPRAY JCVM, 1985, ARCH ORAL BIOL, V30, P299, DOI 10.1016/0003-9969(85)90001-9; COPRAY JCVM, 1985, ARCH ORAL BIOL, V30, P305, DOI 10.1016/0003-9969(85)90002-0; Dyment NA, 2015, OSTEOARTHR CARTILAGE, V23, P996, DOI 10.1016/j.joca.2015.01.017; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219, DOI 10.1177/002215540004800207; Henderson SE, 2015, ARCH ORAL BIOL, V60, P1, DOI 10.1016/j.archoralbio.2014.08.022; Herring S. W., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P391; Herring SW, 2001, CELLS TISSUES ORGANS, V169, P193, DOI 10.1159/000047882; HINTON RJ, 1988, ACTA ANAT, V131, P136; HYLANDER WL, 1975, AM J PHYS ANTHROPOL, V43, P227, DOI 10.1002/ajpa.1330430209; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005; KANTOMAA T, 1994, J DENT RES, V73, P1150, DOI 10.1177/00220345940730060401; Korioth Tom W. P., 1994, Journal of Orofacial Pain, V8, P178; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kuroda S, 2009, OSTEOARTHR CARTILAGE, V17, P1408, DOI 10.1016/j.joca.2009.04.025; Lai A, 2008, SPINE, V33, P2721, DOI 10.1097/BRS.0b013e318180e688; Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205; Liu ZJ, 2000, ARCH ORAL BIOL, V45, P95, DOI 10.1016/S0003-9969(99)00127-2; LUDER HU, 1988, AM J ANAT, V182, P197, DOI 10.1002/aja.1001820302; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; Meng JH, 2005, OSTEOARTHR CARTILAGE, V13, P1115, DOI 10.1016/j.joca.2005.03.010; Mizoguchi I, 1996, ARCH ORAL BIOL, V41, P863, DOI 10.1016/S0003-9969(96)00021-0; Okazaki J, 1996, J ORAL REHABIL, V23, P536, DOI 10.1111/j.1365-2842.1996.tb00892.x; Pirttiniemi P, 2004, EUR J ORTHODONT, V26, P1, DOI 10.1093/ejo/26.1.1; Pirttiniemi P, 1996, ARCH ORAL BIOL, V41, P127, DOI 10.1016/0003-9969(95)00102-6; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; Shelton JC, 2003, CELLS TISSUES ORGANS, V175, P140, DOI 10.1159/000074630; Singh M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838062; Slater JJRH, 1999, J DENT RES, V78, P1815, DOI 10.1177/00220345990780120801; SMITH RJ, 1978, AM J PHYS ANTHROPOL, V49, P341, DOI 10.1002/ajpa.1330490307; Smith RL, 2000, BIORHEOLOGY, V37, P95; Sobue T, 2011, J DENT RES, V90, P512, DOI 10.1177/0022034510390810; Tanaka E, 2006, J DENT RES, V85, P571, DOI 10.1177/154405910608500618; Utreja A, 2016, OSTEOARTHR CARTILAGE, V24, P335, DOI 10.1016/j.joca.2015.08.010; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wang XA, 2006, J BIOMECH, V39, P781, DOI 10.1016/j.jbiomech.2005.02.007; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012; Yang Xu, 2006, J Orthop Surg Res, V1, P15, DOI 10.1186/1749-799X-1-15; Yuan XL, 2014, OSTEOARTHR CARTILAGE, V22, P1077, DOI 10.1016/j.joca.2014.05.023	48	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160121	10.1371/journal.pone.0160121	http://dx.doi.org/10.1371/journal.pone.0160121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472059	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300027
J	Kim, E; Zheng, Z; Jeon, Y; Jin, YX; Hwang, SU; Cai, L; Lee, CK; Kim, NH; Hyun, SH				Kim, Eunhye; Zheng, Zhong; Jeon, Yubyeol; Jin, Yong-Xun; Hwang, Seon-Ung; Cai, Lian; Lee, Chang-Kyu; Kim, Nam-Hyung; Hyun, Sang-Hwan			An Improved System for Generation of Diploid Cloned Porcine Embryos Using Induced Pluripotent Stem Cells Synchronized to Metaphase	PLOS ONE			English	Article							NUCLEAR TRANSFER EMBRYOS; CYCLE SYNCHRONIZATION; FETAL FIBROBLASTS; OOCYTE ACTIVATION; MICE; PIG; MATURATION; CLONING; INACTIVATION; INDUCTION	Pigs provide outstanding models of human genetic diseases due to their striking similarities with human anatomy, physiology and genetics. Although transgenic pigs have been produced using genetically modified somatic cells and nuclear transfer (SCNT), the cloning efficiency was extremely low. Here, we report an improved method to produce diploid cloned embryos from porcine induced pluripotent stem cells (piPSCs), which were synchronized to the G2/M stage using a double blocking method with aphidicolin and nocodazole. The efficiency of this synchronization method on our piPSC lines was first tested. Then, we modified our traditional SCNT protocol to find a workable protocol. In particular, the removal of a 6DMAP treatment post-activation enhanced the extrusion rate of pseudo-second-polar bodies (p2PB) (81.3% vs. 15.8%, based on peak time, 4hpa). Moreover, an immediate activation method yielded significantly more blastocysts than delayed activation (31.3% vs. 16.0%, based on fused embryos). The immunofluorescent results confirmed the effect of the 6DMAP treatment removal, showing remarkable p2PB extrusion during a series of nuclear transfer procedures. The reconstructed embryos from metaphase piPSCs with our modified protocol demonstrated normal morphology at 2-cell, 4-cell and blastocyst stages and a high rate of normal karyotype. This study demonstrated a new and efficient way to produce viable cloned embryos from piPSCs when synchronized to the G2/M phase of the cell cycle, which may lead to opportunities to produce cloned pigs from piPSCs more efficiently.	[Kim, Eunhye; Zheng, Zhong; Jeon, Yubyeol; Hwang, Seon-Ung; Cai, Lian; Hyun, Sang-Hwan] Chungbuk Natl Univ, Lab Vet Embryol & Biotechnol VETEMBIO, Ctr Vet Med, Cheongju, Chungbuk, South Korea; [Kim, Eunhye; Zheng, Zhong; Jeon, Yubyeol; Hwang, Seon-Ung; Cai, Lian; Hyun, Sang-Hwan] Chungbuk Natl Univ, Collage Vet Med, Cheongju, Chungbuk, South Korea; [Kim, Eunhye; Hwang, Seon-Ung; Hyun, Sang-Hwan] Chungbuk Natl Univ, Inst Stem Cell & Regenerat Med, Cheongju, Chungbuk, South Korea; [Jin, Yong-Xun; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci Agr Life & Environm Sci, Cheongju, Chungbuk, South Korea; [Lee, Chang-Kyu] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul, South Korea	Chungbuk National University; Chungbuk National University; Chungbuk National University; Chungbuk National University; Seoul National University (SNU)	Hyun, SH (corresponding author), Chungbuk Natl Univ, Lab Vet Embryol & Biotechnol VETEMBIO, Ctr Vet Med, Cheongju, Chungbuk, South Korea.; Hyun, SH (corresponding author), Chungbuk Natl Univ, Collage Vet Med, Cheongju, Chungbuk, South Korea.; Hyun, SH (corresponding author), Chungbuk Natl Univ, Inst Stem Cell & Regenerat Med, Cheongju, Chungbuk, South Korea.	shhyun@cbu.ac.kr		Zheng, Zhong/0000-0001-5961-2122	Cooperative Research Program for Agriculture Science & Technology Development Rural Development Administration [PJ011288, PJ011077]; Ministry of Trade, Industry & Energy(MOTIE), Korea Institute for Advancement of Technology(KIAT) through the Leading Industry Development for Economic Region [R0004357]; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Advanced Production Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea [115103-02]	Cooperative Research Program for Agriculture Science & Technology Development Rural Development Administration; Ministry of Trade, Industry & Energy(MOTIE), Korea Institute for Advancement of Technology(KIAT) through the Leading Industry Development for Economic Region; Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Advanced Production Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA), Republic of Korea	This work was supported, in part, by a grant from the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ011288, PJ011077)" Rural Development Administration, the "Ministry of Trade, Industry & Energy(MOTIE), Korea Institute for Advancement of Technology(KIAT) through the Leading Industry Development for Economic Region (Project No. R0004357)" and "Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through Advanced Production Technology Development Program, funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (Grant number: 115103-02)", Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Cervera RP, 2010, REPROD DOMEST ANIM, V45, pE12, DOI 10.1111/j.1439-0531.2009.01509.x; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fan NN, 2013, CELL RES, V23, P162, DOI 10.1038/cr.2012.176; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grupen CG, 2002, MOL REPROD DEV, V62, P387, DOI 10.1002/mrd.10126; Hao YH, 2004, BIOL REPROD, V70, P1644, DOI 10.1095/biolreprod.103.026005; Henegariu O, 2001, CYTOMETRY, V43, P101, DOI 10.1002/1097-0320(20010201)43:2<101::AID-CYTO1024>3.0.CO;2-8; Ho YS, 2001, INT J CANCER, V91, P393, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1070&gt;3.0.CO;2-#; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Holker M, 2005, CLONING STEM CELLS, V7, P35, DOI 10.1089/clo.2005.7.35; Im GS, 2007, MOL REPROD DEV, V74, P1158, DOI 10.1002/mrd.20492; Jeong Y S, 2013, INT J DISTRIB SENS N, V2013, DOI DOI 10.1016/J.IJRMMS.2009.03.007; Jin YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086146; Kaufman DG, 2007, ADV ENZYME REGUL, V47, P127, DOI 10.1016/j.advenzreg.2006.12.015; Kim E, 2015, THERIOGENOLOGY; Kobayashi E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-8; Kou ZH, 2010, BIOL REPROD, V83, P238, DOI 10.1095/biolreprod.110.084731; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Kues WA, 2000, BIOL REPROD, V62, P412, DOI 10.1095/biolreprod62.2.412; Kues Wilfried A., 2002, Cloning and Stem Cells, V4, P231, DOI 10.1089/15362300260339511; Lai LX, 2001, BIOL REPROD, V65, P1558, DOI 10.1095/biolreprod65.5.1558; Lawrence Janelle L, 2005, Reprod Biol, V5, P171; Lee GS, 2003, THERIOGENOLOGY, V59, P1949, DOI 10.1016/S0093-691X(02)01294-3; Liu L, 1999, BIOL REPROD, V61, P1, DOI 10.1095/biolreprod61.1.1; Miyoshi K, 2000, Cloning, V2, P175, DOI 10.1089/152045500454735; Miyoshi Kazuchika, 2001, BMC Developmental Biology, V1, P1; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Motlik J, 1998, THERIOGENOLOGY, V49, P461, DOI 10.1016/S0093-691X(97)00418-4; Nanassy L, 2007, THERIOGENOLOGY, V68, P146, DOI 10.1016/j.theriogenology.2007.04.044; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2004, EXP BIOL MED, V229, P1120, DOI 10.1177/153537020422901106; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rodriguez A, 2012, MODULATION PLURIPOTE; Simili M, 1997, MUTAGENESIS, V12, P313, DOI 10.1093/mutage/12.5.313; Song K, 2009, MOL REPROD DEV, V76, P611, DOI 10.1002/mrd.20989; Soto DA, 2016, TRANSGENIC RES, P1; Su GH, 2000, CANCER RES, V60, P3137; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, REPRODUCTION, V122, P49, DOI 10.1530/rep.0.1220049; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yu Y, 2013, J TISSUE ENG REGEN M, V7, P855, DOI 10.1002/term.1476; Yuan Y, 2014, CELL CYCLE, V13, P1265, DOI 10.4161/cc.28176; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou SY, 2010, CELL RES, V20, P850, DOI 10.1038/cr.2010.78	54	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160289	10.1371/journal.pone.0160289	http://dx.doi.org/10.1371/journal.pone.0160289			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472781	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300041
J	Shi, YY; Thomasson, JA; Murray, SC; Pugh, NA; Rooney, WL; Shafian, S; Rajan, N; Rouze, G; Morgan, CLS; Neely, HL; Rana, A; Bagavathiannan, MV; Henrickson, J; Bowden, E; Valasek, J; Olsenholler, J; Bishop, MP; Sheridan, R; Putman, EB; Popescu, S; Burks, T; Cope, D; Ibrahim, A; McCutchen, BF; Baltensperger, DD; Avant, RV; Vidrine, M; Yang, CH				Shi, Yeyin; Thomasson, J. Alex; Murray, Seth C.; Pugh, N. Ace; Rooney, William L.; Shafian, Sanaz; Rajan, Nithya; Rouze, Gregory; Morgan, Cristine L. S.; Neely, Haly L.; Rana, Aman; Bagavathiannan, Muthu V.; Henrickson, James; Bowden, Ezekiel; Valasek, John; Olsenholler, Jeff; Bishop, Michael P.; Sheridan, Ryan; Putman, Eric B.; Popescu, Sorin; Burks, Travis; Cope, Dale; Ibrahim, Amir; McCutchen, Billy F.; Baltensperger, David D.; Avant, Robert V., Jr.; Vidrine, Misty; Yang, Chenghai			Unmanned Aerial Vehicles for High-Throughput Phenotyping and Agronomic Research	PLOS ONE			English	Article							VEGETATION INDEX; LOW-ALTITUDE; IMAGES; YIELD; AGRICULTURE; IMPROVEMENT; BIOMASS; SYSTEMS; WHEAT; SOIL	Advances in automation and data science have led agriculturists to seek real-time, high-quality, high-volume crop data to accelerate crop improvement through breeding and to optimize agronomic practices. Breeders have recently gained massive data-collection capability in genome sequencing of plants. Faster phenotypic trait data collection and analysis relative to genetic data leads to faster and better selections in crop improvement. Furthermore, faster and higher-resolution crop data collection leads to greater capability for scientists and growers to improve precision-agriculture practices on increasingly larger farms; e.g., site-specific application of water and nutrients. Unmanned aerial vehicles (UAVs) have recently gained traction as agricultural data collection systems. Using UAVs for agricultural remote sensing is an innovative technology that differs from traditional remote sensing in more ways than strictly higher-resolution images; it provides many new and unique possibilities, as well as new and unique challenges. Herein we report on processes and lessons learned from year 1-the summer 2015 and winter 2016 growing seasons-of a large multidisciplinary project evaluating UAV images across a range of breeding and agronomic research trials on a large research farm. Included are team and project planning, UAV and sensor selection and integration, and data collection and analysis workflow. The study involved many crops and both breeding plots and agronomic fields. The project's goal was to develop methods for UAVs to collect high-quality, high-volume crop data with fast turnaround time to field scientists. The project included five teams: Administration, Flight Operations, Sensors, Data Management, and Field Research. Four case studies involving multiple crops in breeding and agronomic applications add practical descriptive detail. Lessons learned include critical information on sensors, air vehicles, and configuration parameters for both. As the first and most comprehensive project of its kind to date, these lessons are particularly salient to researchers embarking on agricultural research with UAVs.	[Shi, Yeyin; Thomasson, J. Alex] Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX 77843 USA; [Murray, Seth C.; Pugh, N. Ace; Rooney, William L.; Shafian, Sanaz; Rajan, Nithya; Rouze, Gregory; Morgan, Cristine L. S.; Neely, Haly L.; Rana, Aman; Bagavathiannan, Muthu V.; Ibrahim, Amir; Baltensperger, David D.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Henrickson, James; Bowden, Ezekiel; Valasek, John] Texas A&M Univ, Dept Aerosp Engn, College Stn, TX 77843 USA; [Olsenholler, Jeff; Bishop, Michael P.] Texas A&M Univ, Dept Geog, College Stn, TX 77843 USA; [Sheridan, Ryan; Putman, Eric B.; Popescu, Sorin] Texas A&M Univ, Dept Ecosyst Sci & Management, LASERS Lab, College Stn, TX 77843 USA; [Burks, Travis; Cope, Dale] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Shi, Yeyin; Thomasson, J. Alex; Murray, Seth C.; Rooney, William L.; Shafian, Sanaz; Rajan, Nithya; Morgan, Cristine L. S.; Neely, Haly L.; Rana, Aman; Bagavathiannan, Muthu V.; Popescu, Sorin; Ibrahim, Amir; McCutchen, Billy F.; Baltensperger, David D.; Avant, Robert V., Jr.; Vidrine, Misty] Texas A&M Univ, Texas A&M AgriLife Res, College Stn, TX 77843 USA; [Yang, Chenghai] USDA ARS, Aerial Applicat Technol Res Unit, 3103 F&B Rd, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; United States Department of Agriculture (USDA)	Shi, YY (corresponding author), Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX 77843 USA.; Shi, YY (corresponding author), Texas A&M Univ, Texas A&M AgriLife Res, College Stn, TX 77843 USA.	yeyin.shi@tamu.edu	Popescu, Sorin C/D-5981-2015; Baltensperger, David/AAM-3077-2020; Thomasson, Alex/HHS-2655-2022; Morgan, Cristine`/A-1555-2013	Popescu, Sorin C/0000-0002-8155-8801; Baltensperger, David/0000-0003-4511-5680; Morgan, Cristine`/0000-0001-9836-0669; Miles, Misty/0000-0002-0018-4095; , Yeyin/0000-0003-3964-2855; Neely, Haly/0000-0001-7662-3296; Murray, Seth/0000-0002-2960-8226; Rouze, Gregory/0000-0002-3344-2708	Texas A&M AgriLife Research; Texas Engineering Experiment Station; Texas A&M Center for Geospatial Sciences, Applications and Technology (GEOSAT); Texas A&M Center for Autonomous Vehicles and Sensor Systems (CANVASS); USDA Hatch funds	Texas A&M AgriLife Research; Texas Engineering Experiment Station; Texas A&M Center for Geospatial Sciences, Applications and Technology (GEOSAT); Texas A&M Center for Autonomous Vehicles and Sensor Systems (CANVASS); USDA Hatch funds	This project was supported by Texas A&M AgriLife Research, the Texas Engineering Experiment Station, Texas A&M Center for Geospatial Sciences, Applications and Technology (GEOSAT), and Texas A&M Center for Autonomous Vehicles and Sensor Systems (CANVASS). Field research projects were supported by USDA Hatch funds and other funding to individual investigators.	Anthony D, 2014, INT ROB SYST IROS 20; Bendig J, 2014, REMOTE SENS-BASEL, V6, P10395, DOI 10.3390/rs61110395; Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Brummer EC, 2011, FRONT ECOL ENVIRON, V9, P561, DOI 10.1890/100225; Busemeyer L, 2013, SCI REPORTS, P3; Candiago S, 2015, REMOTE SENS-BASEL, V7, P4026, DOI 10.3390/rs70404026; Chapman SC, 2014, AGRONOMY-BASEL, V4, P279, DOI 10.3390/agronomy4020279; Chen DJ, 2014, PLANT CELL, V26, P4636, DOI 10.1105/tpc.114.129601; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; Farfan IDB, 2013, FIELD CROP RES, V149, P167, DOI 10.1016/j.fcr.2013.04.017; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Ge YF, 2011, FRONT EARTH SCI-PRC, V5, P239, DOI 10.1007/s11707-011-0174-1; Geipel J, 2014, REMOTE SENS-BASEL, V6, P10335, DOI 10.3390/rs61110335; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Gitelson AA, 1996, REMOTE SENS ENVIRON, V58, P289, DOI 10.1016/S0034-4257(96)00072-7; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Grenzdorffer G, 2014, REMOTE SENSING SPATI, V1, P135; Herwitz SR, 2004, COMPUT ELECTRON AGR, V44, P49, DOI 10.1016/j.compag.2004.02.006; Honkavaara E, 2013, REMOTE SENS-BASEL, V5, P5006, DOI 10.3390/rs5105006; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Hunt E. Raymond Jr, 2005, Precision Agriculture, V6, P359, DOI 10.1007/s11119-005-2324-5; Lal R, 2016, J SOIL WATER CONSERV, V71, p20A, DOI 10.2489/jswc.71.1.20A; Li XH, 2012, COMPUT ELECTRON AGR, V83, P32, DOI 10.1016/j.compag.2012.01.010; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; Mirik M, 2011, PLANT DIS, V95, P4, DOI 10.1094/PDIS-04-10-0256; Rajan N, 2014, AGRON J, V106, P1358, DOI 10.2134/agronj13.0532; Ritchie GL, 2010, CROP SCI, V50, P1000, DOI 10.2135/cropsci2009.04.0203; Rooney WL, 2004, ADV AGRON, V83, P37, DOI 10.1016/S0065-2113(04)83002-5; Sankaran S, 2015, EUR J AGRON, V70, P112, DOI 10.1016/j.eja.2015.07.004; Serrano L, 2000, CROP SCI, V40, P723, DOI 10.2135/cropsci2000.403723x; Shanahan JF, 2001, AGRON J, V93, P583, DOI 10.2134/agronj2001.933583x; Stanislav S., 2010, FIELD SCALE ASSESSME; Thorp K. R., 2004, Precision Agriculture, V5, P477, DOI 10.1007/s11119-004-5321-1; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Torres-Sanchez J, 2015, COMPUT ELECTRON AGR, V114, P43, DOI 10.1016/j.compag.2015.03.019; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; White JW, 2012, FIELD CROP RES, V133, P101, DOI 10.1016/j.fcr.2012.04.003; WIEGAND CL, 1990, REMOTE SENS ENVIRON, V33, P1, DOI 10.1016/0034-4257(90)90051-M; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Wu CS, 2004, REMOTE SENS ENVIRON, V93, P480, DOI 10.1016/j.rse.2004.08.003; Yanbo Huang, 2010, International Journal of Agricultural and Biological Engineering, V3, P50, DOI 10.3965/j.issn.1934-6344.2010.01.050-062; Yang CH, 2015, PRECIS AGRIC, V16, P201, DOI 10.1007/s11119-014-9370-9; Yang CH, 2014, REMOTE SENS-BASEL, V6, P5257, DOI 10.3390/rs6065257; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5; Zhao C, 2008, COMPUTER COMPUTING T, V1, P253	46	211	217	12	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159781	10.1371/journal.pone.0159781	http://dx.doi.org/10.1371/journal.pone.0159781			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472222	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300020
J	Tu, CJ; Li, J; Shen, SC; Sheng, QH; Shyr, Y; Qu, J				Tu, Chengjian; Li, Jun; Shen, Shichen; Sheng, Quanhu; Shyr, Yu; Qu, Jun			Performance Investigation of Proteomic Identification by HCD/CID Fragmentations in Combination with High/Low-Resolution Detectors on a Tribrid, High-Field Orbitrap Instrument	PLOS ONE			English	Article							TANDEM MASS-SPECTRA; PEPTIDE IDENTIFICATION; SHOTGUN PROTEOMICS; DATABASE SEARCH; PROTEIN IDENTIFICATION; SEQUENCE DATABASES; SPECTROMETRY; ALGORITHM; VALIDATION; MODEL	The recently-introduced Orbitrap Fusion mass spectrometry permits various types of MS2 acquisition methods. To date, these different MS2 strategies and the optimal data interpretation approach for each have not been adequately evaluated. This study comprehensively investigated the four MS2 strategies: HCD-OT (higher-energy-collisional-dissociation with Orbitrap detection), HCD-IT (HCD with ion trap, IT), CID-IT (collision-induced-dissociation with IT) and CID-OT on Orbitrap Fusion. To achieve extensive comparison and identify the optimal data interpretation method for each technique, several search engines (SEQUEST and Mascot) and post-processing methods (score-based, PeptideProphet, and Percolator) were assessed for all techniques for the analysis of a human cell proteome. It was found that divergent conclusions could be made from the same dataset when different data interpretation approaches were used and therefore requiring a relatively fair comparison among techniques. Percolator was chosen for comparison of techniques because it performs the best among all search engines and MS2 strategies. For the analysis of human cell proteome using individual MS2 strategies, the highest number of identifications was achieved by HCD-OT, followed by HCD-IT and CID-IT. Based on these results, we concluded that a relatively fair platform for data interpretation is necessary to avoid divergent conclusions from the same dataset, and HCD-OT and HCD-IT may be preferable for protein/peptide identification using Orbitrap Fusion.	[Tu, Chengjian; Li, Jun; Shen, Shichen; Qu, Jun] Univ Buffalo State Univ New York, Dept Pharmaceut Sci, Buffalo, NY 14260 USA; [Tu, Chengjian; Li, Jun; Shen, Shichen; Qu, Jun] New York State Ctr Excellence Bioinformat & Life, 701 Ellicott St, Buffalo, NY 14203 USA; [Sheng, Quanhu; Shyr, Yu] Vanderbilt Univ, Sch Med, Ctr Quantitat Sci, Nashville, TN 37212 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Vanderbilt University	Tu, CJ; Qu, J (corresponding author), Univ Buffalo State Univ New York, Dept Pharmaceut Sci, Buffalo, NY 14260 USA.; Tu, CJ; Qu, J (corresponding author), New York State Ctr Excellence Bioinformat & Life, 701 Ellicott St, Buffalo, NY 14203 USA.	ctu3@buffalo.edu; junqu@buffalo.edu	Sheng, Quanhu/B-9543-2009	Sheng, Quanhu/0000-0001-8951-9295; Tu, Chengjian/0000-0001-9589-5609	American Heart Association (AHA) [12SDG9450036]; Center of Protein Therapeutics Industrial Award; NIH [U54HD071594, HL103411]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071594] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103411] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); Center of Protein Therapeutics Industrial Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association (AHA) award 12SDG9450036 (JQ), by a Center of Protein Therapeutics Industrial Award (JQ), by NIH grants U54HD071594 (JQ) and HL103411 (JQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi H, 2008, J PROTEOME RES, V7, P254, DOI 10.1021/pr070542g; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Granholm V, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S3; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Jedrychowski MP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009910; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Klammer AA, 2008, BIOINFORMATICS, V24, pI348, DOI 10.1093/bioinformatics/btn189; McAlister GC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.O111.009456; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Richards AL, 2015, NAT PROTOC, V10, P701, DOI 10.1038/nprot.2015.040; Sadygov RG, 2004, ANAL CHEM, V76, P1664, DOI 10.1021/ac035112y; Second TP, 2009, ANAL CHEM, V81, P7757, DOI 10.1021/ac901278y; Sheng QH, 2012, J PROTEOME RES, V11, P1494, DOI 10.1021/pr200194p; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tu CJ, 2015, J PROTEOME RES, V14, P4662, DOI 10.1021/acs.jproteome.5b00536; Tu CJ, 2013, MOL CELL PROTEOMICS, V12, P3583, DOI 10.1074/mcp.M113.027847; Ulintz PJ, 2006, MOL CELL PROTEOMICS, V5, P497, DOI 10.1074/mcp.M500233-MCP200; Wenger CD, 2013, J PROTEOME RES, V12, P1377, DOI 10.1021/pr301024c	30	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160160	10.1371/journal.pone.0160160	http://dx.doi.org/10.1371/journal.pone.0160160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472422	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300031
J	Enochs, IC; Manzello, DP; Tribollet, A; Valentino, L; Kolodziej, G; Donham, EM; Fitchett, MD; Carlton, R; Price, NN				Enochs, Ian C.; Manzello, Derek P.; Tribollet, Aline; Valentino, Lauren; Kolodziej, Graham; Donham, Emily M.; Fitchett, Mark D.; Carlton, Renee; Price, Nichole N.			Elevated Colonization of Microborers at a Volcanically Acidified Coral Reef	PLOS ONE			English	Article							GREAT-BARRIER-REEF; OCEAN ACIDIFICATION; FRENCH-POLYNESIA; ANTHROPOGENIC CO2; ENDOLITHIC ALGAE; BIOEROSION RATES; PORITES-LOBATA; CLIMATE-CHANGE; SKELETONS; INCREASE	Experiments have demonstrated that ocean acidification (OA) conditions projected to occur by the end of the century will slow the calcification of numerous coral species and accelerate the biological erosion of reef habitats (bioerosion). Microborers, which bore holes less than 100 mu m diameter, are one of the most pervasive agents of bioerosion and are present throughout all calcium carbonate substrates within the reef environment. The response of diverse reef functional groups to OA is known from real-world ecosystems, but to date our understanding of the relationship between ocean pH and carbonate dissolution by microborers is limited to controlled laboratory experiments. Here we examine the settlement of microborers to pure mineral calcium carbonate substrates (calcite) along a natural pH gradient at a volcanically acidified reef at Maug, Commonwealth of the Northern Mariana Islands (CNMI). Colonization of pioneer microborers was higher in the lower pH waters near the vent field. Depth of microborer penetration was highly variable both among and within sites (4.2-195.5 mu m) over the short duration of the study (3 mo.) and no clear relationship to increasing CO2 was observed. Calculated rates of biogenic dissolution, however, were highest at the two sites closer to the vent and were not significantly different from each other. These data represent the first evidence of OA-enhancement of microboring flora colonization in newly available substrates and provide further evidence that microborers, especially bioeroding chlorophytes, respond positively to low pH. The accelerated breakdown and dissolution of reef framework structures with OA will likely lead to declines in structural complexity and integrity, as well as possible loss of essential habitat.	[Enochs, Ian C.; Valentino, Lauren; Kolodziej, Graham; Fitchett, Mark D.; Carlton, Renee] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Cswy, Miami, FL 33149 USA; [Enochs, Ian C.; Manzello, Derek P.; Valentino, Lauren; Kolodziej, Graham; Carlton, Renee] NOAA, AOML, 4301 Rickenbacker Cswy, Miami, FL 33149 USA; [Tribollet, Aline] Univ Paris 06, Sorbonne Univ, Lab IPSL, IRD,CNRS,MNHN,LOCEAN, 32 Ave Henri Varagnat, F-93143 Bondy, France; [Donham, Emily M.] Moss Landing Marine Labs, 8272 Moss Landing Rd, Moss Landing, CA 95039 USA; [Donham, Emily M.; Price, Nichole N.] Bigelow Lab Ocean Sci, 60 Bigelow Dr, East Boothbay, ME 04544 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Moss Landing Marine Laboratories	Enochs, IC (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Cswy, Miami, FL 33149 USA.; Enochs, IC (corresponding author), NOAA, AOML, 4301 Rickenbacker Cswy, Miami, FL 33149 USA.	ienochs@rsmas.miami.edu	Enochs, Ian/B-8051-2014; Kolodziej, Graham/A-3034-2017; Valentino, Lauren/A-3068-2017; Manzello, Derek P/A-8661-2014	Enochs, Ian/0000-0002-8867-0361; Kolodziej, Graham/0000-0001-5483-8923; Valentino, Lauren/0000-0002-8748-9050; Manzello, Derek P/0000-0002-0720-3041; Donham, Emily/0000-0002-5190-0151; Price, Nichole/0000-0001-6773-3215	NOAA's Coral Reef Conservation Program; NOAA's Ocean Acidification Program	NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's Ocean Acidification Program	Financial support was provided by NOAA's Coral Reef Conservation and Ocean Acidification Programs.	Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; ALEXANDERSSON ET, 1975, NATURE, V254, P212, DOI 10.1038/254212b0; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2014, R LANG ENV STAT COMP; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barkley HC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500328; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V106, P41, DOI 10.3354/meps106041; Carreiro-Silva M, 2009, MAR ECOL PROG SER, V392, P1, DOI 10.3354/meps08251; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; DeCarlo TM, 2015, GEOLOGY, V43, P7, DOI 10.1130/G36147.1; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Enochs IC, 2015, NAT CLIM CHANGE, V5, P1083, DOI 10.1038/NCLIMATE2758; Enochs IC, 2015, B MAR SCI, V91, P271, DOI 10.5343/bms.2014.1045; Eyre BD, 2014, NAT CLIM CHANGE, V4, P969, DOI 10.1038/NCLIMATE2380; Fang JKH, 2013, GLOBAL CHANGE BIOL, V19, P3581, DOI 10.1111/gcb.12334; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fine M, 2002, P ROY SOC B-BIOL SCI, V269, P1205, DOI 10.1098/rspb.2002.1983; Garcia-Pichel F, 2010, P NATL ACAD SCI USA, V107, P21749, DOI 10.1073/pnas.1011884108; Gektidis M, 1999, B GEOL SOC DENMARK, V45, P147; Glynn P., 1997, LIFE DEATH CORAL REE, P69, DOI [DOI 10.1007/978-1-4615-5995-5, 10.1007/978-1-4615-5995-5_4]; Godinot C, 2012, BIOGEOSCIENCES, V9, P2377, DOI 10.5194/bg-9-2377-2012; GOLUBIC S, 1981, J SEDIMENT PETROL, V51, P475; Grange JS, 2015, ENVIRON SCI POLLUT R, V22, P13625, DOI 10.1007/s11356-014-4069-z; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Johnson MD, 2012, J EXP MAR BIOL ECOL, V434, P94, DOI 10.1016/j.jembe.2012.08.005; Johnson MD, 2014, PEERJ, V2, DOI 10.7717/peerj.411; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kiene W.E., 1997, P 8 INT COR REEF S P, P897; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KOBLUK DR, 1977, J EXP MAR BIOL ECOL, V27, P107, DOI 10.1016/0022-0981(77)90131-9; Le Grand HM, 2011, CORAL REEFS, V30, P97, DOI 10.1007/s00338-010-0670-x; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P149, DOI 10.3354/meps117149; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Morse J. W., 1990, GEOCHEMISTRY SEDIMEN; NEUMANN AC, 1966, LIMNOL OCEANOGR, V11, P92, DOI 10.4319/lo.1966.11.1.0092; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; PEYROTCLAUSADE M, 1992, CORAL REEFS, V11, P161, DOI 10.1007/BF00255471; Rasband W., 2006, IMAGEJ; Reyes-Nivia C, 2013, GLOBAL CHANGE BIOL, V19, P1919, DOI 10.1111/gcb.12158; RISK MJ, 1978, REV BIOL TROP, V26, P85; Roff G, 2015, GLOBAL CHANGE BIOL, V21, P4415, DOI 10.1111/gcb.13006; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schlichter D, 1997, MAR ECOL-P S Z N I, V18, P299, DOI 10.1111/j.1439-0485.1997.tb00444.x; Schneider J, 1999, EUR J PHYCOL, V34, P417, DOI 10.1017/S0967026299002280; Silbiger NJ, 2014, MAR ECOL PROG SER, V515, P33, DOI 10.3354/meps10999; Tribollet A, 2005, CORAL REEFS, V24, P422, DOI 10.1007/s00338-005-0003-7; Tribollet A, 2002, CORAL REEFS, V21, P424, DOI 10.1007/s00338-002-0267-0; Tribollet A, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003286; Tribollet A, 2008, CURRENT DEVELOPMENTS IN BIOEROSION, P67, DOI 10.1007/978-3-540-77598-0_4; Tribollet A, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P435, DOI 10.1007/978-94-007-0114-4_25; Wisshak M, 2014, HELGOLAND MAR RES, V68, P253, DOI 10.1007/s10152-014-0385-4; Wisshak M, 2011, GEOBIOLOGY, V9, P492, DOI 10.1111/j.1472-4669.2011.00299.x; Wisshak M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045124	57	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159818	10.1371/journal.pone.0159818	http://dx.doi.org/10.1371/journal.pone.0159818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467570	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100059
J	Hines, CDG; Wang, SB; Meng, XJ; Skinner, JM; Heinrichs, JH; Smith, JG; Boddicker, MA				Hines, Catherine D. G.; Wang, Shubing; Meng, Xiangjun; Skinner, Julie M.; Heinrichs, Jon H.; Smith, Jeffrey G.; Boddicker, Melissa A.			MRI as a Novel In Vivo Approach for Assessing Structural Changes of Chlamydia Pathology in a Mouse Model	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; GENITAL-INFECTION; INTRAVAGINAL INOCULATION; TRACHOMATIS INFECTIONS; ANIMAL-MODELS; MURIDARUM; IMMUNITY; VACCINE; MICE; ATHEROSCLEROSIS	Chlamydia trachomatis is among the most prevalent of sexually transmitted diseases. While Chlamydia infection is a reportable event and screening has increased over time, enhanced surveillance has not resulted in a reduction in the rate of infections, and Chlamydia infections frequently recur. The development of a preventative vaccine for Chlamydia may be the only effective approach for reducing infection and the frequency of pathological outcomes. Current vaccine research efforts involve time consuming and/or invasive approaches for assessment of disease state, and MRI presents a clinically translatable method for assessing infection and related pathology both quickly and non-invasively. Longitudinal T2-weighted MRI was performed over 63 days on both control or Chlamydia muridarum challenged mice, either with or without elementary body (EB) immunization, and gross necropsy was performed on day 65. A scoring system was developed to assess the number of regions affected by Chlamydia pathology and was used to document pathology over time and at necropsy. The scoring system documented increasing incidence of pathology in the unimmunized and challenged mice (significantly greater compared to the control and EB immunized-challenged groups) by 21 days post-challenge. No differences between the unchallenged and EB immunized-challenged mice were observed. MRI scores at Day 63 were consistently higher than gross necropsy scores at Day 65, although two of the three groups of mice showed no significant differences between the two techniques. In this work we describe the application of MRI in mice for the potential evaluation of disease pathology and sequelae caused by C. muridarum infection and this technique's potential for evaluation of vaccines for Chlamydia.	[Hines, Catherine D. G.; Meng, Xiangjun] MRL, Dept Translat Imaging Biomarkers, West Point, PA 19486 USA; [Hines, Catherine D. G.; Wang, Shubing; Meng, Xiangjun; Skinner, Julie M.; Boddicker, Melissa A.] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Wang, Shubing] MRL, Dept Biometr Res, Rahway, NJ USA; [Skinner, Julie M.; Boddicker, Melissa A.] MRL, Dept Vaccines Early Discovery, West Point, PA USA; [Heinrichs, Jon H.] Sanofi Pasteur, Global Project Leadership, Swiftwater, PA USA; [Smith, Jeffrey G.] Pfizer, Pharmaceut Sci Analyt Res & Dev, Andover, MA USA	Merck & Company; Sanofi-Aventis; Pfizer	Hines, CDG (corresponding author), MRL, Dept Translat Imaging Biomarkers, West Point, PA 19486 USA.; Hines, CDG (corresponding author), Merck & Co Inc, Kenilworth, NJ 07033 USA.	catherine.hines@merck.com						Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Centers for Disease Control and Prevention, 2012, 2011 SEX TRANSM DIS, V12, P13; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Cong Y, 2007, VACCINE, V25, P3773, DOI 10.1016/j.vaccine.2007.02.010; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Farris CM, 2010, INFECT IMMUN, V78, P4374, DOI 10.1128/IAI.00622-10; Gottlieb SL, 2010, J INFECT DIS, V201, pS85, DOI 10.1086/652392; Hafner L, 2008, MUCOSAL IMMUNOL, V1, P116, DOI 10.1038/mi.2007.19; Hansen J, 2008, J INFECT DIS, V198, P758, DOI 10.1086/590670; Jaffer FA, 2009, ARTERIOSCL THROM VAS, V29, P1017, DOI 10.1161/ATVBAHA.108.165530; Kim MY, 2009, RADIOGRAPHICS, V29, P495, DOI 10.1148/rg.292085070; Liney G., 2006, MRI IN CLINICAL PRAC; Miyairi I, 2010, J INFECT DIS, V201, pS96, DOI 10.1086/652393; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Nahrendorf M, 2009, CIRC-CARDIOVASC IMAG, V2, P56, DOI 10.1161/CIRCIMAGING.108.839092; Niccolai LM, 2007, ARCH PEDIAT ADOL MED, V161, P246, DOI 10.1001/archpedi.161.3.246; Pal S, 2006, VACCINE, V24, P766, DOI 10.1016/j.vaccine.2005.08.074; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; Patel M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/264897; Pinheiro JC, 2004, MIXED EFFECTS MODELS; Rey-Ladino J, 2014, HUM VACC IMMUNOTHER, V10, P2664, DOI 10.4161/hv.29683; Satterwhite C. L., 2011, Morbidity and Mortality Weekly Report, V60, P370; Shao RJ, 2012, FERTIL STERIL, V98, P1175, DOI 10.1016/j.fertnstert.2012.07.1113; Thomassin-Naggara I, 2012, Diagn Interv Imaging, V93, P491, DOI 10.1016/j.diii.2012.04.002; Umutlu L, 2013, EUR RADIOL, V23, P2364, DOI 10.1007/s00330-013-2868-0; Vanrompay D, 2006, DRUGS TODAY, V42, P55; Wiig H, 2011, J PHYSIOL-LONDON, V589, P2945, DOI 10.1113/jphysiol.2011.206136; Wooters MA, 2009, DIAGN MICR INFEC DIS, V63, P140, DOI 10.1016/j.diagmicrobio.2008.10.007; Zhang HB, 2014, INFECT IMMUN, V82, P2688, DOI 10.1128/IAI.00055-14	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160055	10.1371/journal.pone.0160055	http://dx.doi.org/10.1371/journal.pone.0160055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467585	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100099
J	Pal, D; Mukhopadhyay, D; Ramaiah, MJ; Sarma, P; Bhadra, U; Bhadra, MP				Pal, Dhananjaya; Mukhopadhyay, Debasmita; Ramaiah, M. Janaki; Sarma, Pranjal; Bhadra, Utpal; Bhadra, Manika Pal			Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells	PLOS ONE			English	Article							GENETIC PATHWAYS; HISTONE ACETYLTRANSFERASE; BREAST-CANCER; IN-VITRO; P53; EXPRESSION; MICRORNAS; GLIOMAS; INVASION; GAS41	Glioma amplified sequence 41(GAS41) is a potent transcription factor that play a crucial role in cell proliferation and survival. In glioblastoma, the expression of GAS41 at both transcriptional and post transcriptional level needs to be tightly maintained in response to cellular signals. Micro RNAs (miRNA) are small non coding RNA that act as important regulators for modulating the expression of various target genes. Studies have shown that several miRNAs play role in the post-transcriptional regulation of GAS41. Here we identified GAS41 as a novel target for endogenous miR-203 and demonstrate an inverse correlation of miR-203 expression with GAS41 in glioma cell lines (HNGC2 and U87). Over expression of miR-203 negatively regulates GAS41 expression in U87 and HNGC2 cell lines. Moreover, miR-203 restrained miR-10b action by suppressing GAS41. GAS41 is essential for repressing p53 in tumor suppressor pathway during cell proliferation. Enforced expression of GAS41 produced contradictory effect on miR-203 but was able to enhance p53 tumor suppressor pathway associated protein. It was also found that miR-203 maintains the stability of p53 as knock down of p53 expression using siRNA resulted in down regulation of pri-miR and mature miR-203 expression. Conversely reconstitution of miR-203 expression induced apoptosis and inhibited migratory property of glioma cells. Taken together, we show that miR-203 is a key negative regulator of GAS41 and acts as tumor suppressor microRNA in glioma.	[Pal, Dhananjaya; Mukhopadhyay, Debasmita; Ramaiah, M. Janaki; Sarma, Pranjal; Bhadra, Manika Pal] Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Ramaiah, M. Janaki] SASTRA Univ, Sch Chem & Biotechnol, Tirumalaisamudram 613401, Thanjavur, India; [Sarma, Pranjal; Bhadra, Utpal] Ctr Cellular & Mol Biol, CSIR, Funct Genom & Gene Silencing Grp, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Pal, Dhananjaya; Bhadra, Manika Pal] Acad Sci & Innovat Res, Arunasafali Marg, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Shanmugha Arts, Science, Technology & Research Academy (SASTRA); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Academy of Scientific & Innovative Research (AcSIR)	Bhadra, MP (corresponding author), Indian Inst Chem Technol, CSIR, Ctr Chem Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.; Bhadra, MP (corresponding author), Acad Sci & Innovat Res, Arunasafali Marg, New Delhi 110025, India.	manikapb@gmail.com	Sarma, Pranjal/AAE-2582-2020; RAMAIAH, JANAKI/AAL-9074-2020	Sarma, Pranjal/0000-0003-0207-1278; Ramaiah, Janaki/0000-0003-1814-2819	DBT project [GAP 0362]; CSIR Network project [BSC 0121]; CSIR; ICMR	DBT project; CSIR Network project(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); ICMR(Indian Council of Medical Research (ICMR))	The work was supported by DBT project GAP 0362 to MPB and CSIR Network project BSC 0121 to UB. DP and PS thank CSIR and DM thanks ICMR for their fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian K, 2012, FEBS LETT, V586, P804, DOI 10.1016/j.febslet.2012.01.050; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Brandes AA, 2008, CRIT REV ONCOL HEMAT, V67, P139, DOI 10.1016/j.critrevonc.2008.02.005; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Cai Y, 2005, J BIOL CHEM, V280, P13665, DOI 10.1074/jbc.M500001200; Cao Q, 2011, CANCER CELL, V20, P187, DOI 10.1016/j.ccr.2011.06.016; Dontula Ranadheer, 2013, Genes Cancer, V4, P285, DOI 10.1177/1947601913500141; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fischer U, 1997, HUM MOL GENET, V6, P1817, DOI 10.1093/hmg/6.11.1817; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Grier JT, 2006, ONCOLOGIST, V11, P681, DOI 10.1634/theoncologist.11-6-681; Harborth J, 2000, J BIOL CHEM, V275, P31979, DOI 10.1074/jbc.M000994200; Harborth J, 2001, J CELL SCI, V114, P4557; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Iacob Gabriel, 2009, J Med Life, V2, P386; Ju SY, 2014, STEM CELL RES, V12, P86, DOI 10.1016/j.scr.2013.09.011; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Le Masson I, 2003, MOL CELL BIOL, V23, P6086, DOI 10.1128/MCB.23.17.6086-6102.2003; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080475, 10.1371/journal.pone.0070390]; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Loftus JC, 2013, MOL CANCER RES, V11, P865, DOI 10.1158/1541-7786.MCR-13-0008; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Martinez Ramon, 2012, J Signal Transduct, V2012, P519807, DOI 10.1155/2012/519807; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2005, NEUROPATHOLOGY, V25, P1, DOI 10.1111/j.1440-1789.2004.00600.x; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Park JH, 2006, MOL CELL BIOL, V26, P4006, DOI 10.1128/MCB.02185-05; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Shiras A, 2007, STEM CELLS, V25, P1478, DOI 10.1634/stemcells.2006-0585; Sun LH, 2011, BRAIN RES, V1389, P9, DOI 10.1016/j.brainres.2011.03.013; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Vigneswaran K, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.57; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073985; Wang C, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-58; Wick W, 2011, NEURO-ONCOLOGY, V13, P566, DOI 10.1093/neuonc/nor039; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yin JH, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-71; Yuan Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-57; Zimmermann K, 2002, J BIOL CHEM, V277, P18626, DOI 10.1074/jbc.M200572200	56	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159092	10.1371/journal.pone.0159092	http://dx.doi.org/10.1371/journal.pone.0159092			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467502	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100018
J	Rizvi, NF; Weaver, JD; Cram, EJ; Lee-Parsons, CWT				Rizvi, Noreen F.; Weaver, Jessica D.; Cram, Erin J.; Lee-Parsons, Carolyn W. T.			Silencing the Transcriptional Repressor, ZCT1, Illustrates the Tight Regulation of Terpenoid Indole Alkaloid Biosynthesis in Catharanthus roseus Hairy Roots	PLOS ONE			English	Article							TRANSGENIC CELL-LINE; GENE-EXPRESSION; ANTHRANILATE SYNTHASE; JASMONATE; PATHWAY; CULTURES; ACCUMULATION; LIMITATIONS; ELICITOR; PROMOTER	The Catharanthus roseus plant is the source of many valuable terpenoid indole alkaloids (TIAs), including the anticancer compounds vinblastine and vincristine. Transcription factors (TFs) are promising metabolic engineering targets due to their ability to regulate multiple biosynthetic pathway genes. To increase TIA biosynthesis, we elicited the TIA transcriptional activators (ORCAs and other unidentified TFs) with the plant hormone, methyl jasmonate (MJ), while simultaneously silencing the expression of the transcriptional repressor ZCT1. To silence ZCT1, we developed transgenic hairy root cultures of C. roseus that expressed an estrogen-inducible Zct1 hairpin for activating RNA interference. The presence of 17 beta-estradiol (5 mu M) effectively depleted Zct1 in hairy root cultures elicited with MJ dosages that either optimize or inhibit TIA production (250 or 1000 mu M). However, silencing Zct1 was not sufficient to increase TIA production or the expression of the TIA biosynthetic genes (G10h, Tdc, and Str), illustrating the tight regulation of TIA biosynthesis. The repression of the TIA biosynthetic genes at the inhibitory MJ dosage does not appear to be solely regulated by ZCT1. For instance, while Zct1 and Zct2 levels decreased through activating the Zct1 hairpin, Zct3 levels remained elevated. Since ZCT repressors have redundant yet distinct functions, silencing all three ZCTs may be necessary to relieve their repression of alkaloid biosynthesis.	[Rizvi, Noreen F.; Lee-Parsons, Carolyn W. T.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Weaver, Jessica D.; Cram, Erin J.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Lee-Parsons, Carolyn W. T.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University	Lee-Parsons, CWT (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.; Lee-Parsons, CWT (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.	ca.lee@northeastern.edu			National Science Foundation (NSF) CBET Award [1033889]; American Association of University Women (AAUW) Dissertation Fellowship; Div Of Molecular and Cellular Bioscience [1516371] Funding Source: National Science Foundation	National Science Foundation (NSF) CBET Award(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); American Association of University Women (AAUW) Dissertation Fellowship; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (NSF) CBET Award #1033889 to CLP and EJC and by the American Association of University Women (AAUW) Dissertation Fellowship to NFR. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Science Foundation (NSF) CBET Award #1033889 to CLP and EJC and by the American Association of University Women (AAUW) Dissertation Fellowship to NFR. The authors thank Dr. Nam-Hai Chua (The Rockefeller University, New York) for providing the pER8 vector and also thank Kassi Stein and Caroline Webb for their assistance in generating the pER8-Zctlhp and pER8-GFPhp transgenic cultures.	BHADRA R, 1993, BIOTECHNOL BIOENG, V41, P581, DOI 10.1002/bit.260410511; Chatel G, 2003, J EXP BOT, V54, P2587, DOI 10.1093/jxb/erg275; Chebbi M, 2014, J PLANT PHYSIOL, V171, P1510, DOI 10.1016/j.jplph.2014.07.004; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Goklany S, 2013, BIOTECHNOL PROGR, V29, P1367, DOI 10.1002/btpr.1801; Goklany S, 2009, BIOTECHNOL PROGR, V25, P1289, DOI 10.1002/btpr.204; Hong SB, 2006, J BIOTECHNOL, V122, P28, DOI 10.1016/j.jbiotec.2005.08.008; Hughes EH, 2004, METAB ENG, V6, P268, DOI 10.1016/j.ymben.2004.03.002; Hughes EH, 2004, BIOTECHNOL BIOENG, V86, P718, DOI 10.1002/bit.20081; Kellner F, 2015, PLANT J; Lee-Parsons CWT, 2006, PLANT CELL REP, V25, P607, DOI 10.1007/s00299-005-0109-y; Li CY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-155; Memelink J., 2007, Phytochemistry Reviews, V6, P353, DOI 10.1007/s11101-006-9051-z; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Morgan JA, 2000, J BIOTECHNOL, V79, P137, DOI 10.1016/S0168-1656(00)00221-2; Pauw B, 2004, J BIOL CHEM, V279, P52940, DOI 10.1074/jbc.M404391200; Peebles CAM, 2011, METAB ENG, V13, P234, DOI 10.1016/j.ymben.2010.11.005; Peebles CAM, 2009, METAB ENG, V11, P76, DOI 10.1016/j.ymben.2008.09.002; Rizvi NF, 2014, PLANT CELL TISSUE OR, P1; Siberil Y, 2001, PLANT MOL BIOL, V45, P477, DOI 10.1023/A:1010650906695; Suttipanta N, 2011, PLANT PHYSIOL, V157, P2081, DOI 10.1104/pp.111.181834; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; van der Fits L, 2000, PLANT MOL BIOL, V44, P675, DOI 10.1023/A:1026526522555; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; van der Fits L, 2001, PLANT J, V25, P43, DOI 10.1046/j.1365-313x.2001.00932.x; van der Heijden R, 2004, CURR MED CHEM, V11, P607; Van Moerkercke A, 2015, P NATL ACAD SCI USA, V112, P8130, DOI 10.1073/pnas.1504951112; Wang CT, 2010, PLANT CELL REP, V29, P887, DOI 10.1007/s00299-010-0874-0; Whitmer S, 1998, PLANT PHYSIOL, V116, P853, DOI 10.1104/pp.116.2.853; Whitmer S, 2002, PLANT CELL TISS ORG, V69, P85, DOI 10.1023/A:1015090224398; Whitmer S, 2002, J BIOTECHNOL, V96, P193, DOI 10.1016/S0168-1656(02)00027-5; Zhang HT, 2011, PLANT J, V67, P61, DOI 10.1111/j.1365-313X.2011.04575.x; Zhou ML, 2010, APPL MICROBIOL BIOT, V88, P737, DOI 10.1007/s00253-010-2822-x; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	34	22	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159712	10.1371/journal.pone.0159712	http://dx.doi.org/10.1371/journal.pone.0159712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467510	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100048
J	El-Jade, MR; Parcina, M; Schmithausen, RM; Stein, C; Meilaender, A; Hoerauf, A; Molitor, E; Bekeredjian-Ding, I				El-Jade, Mohamed Ramadan; Parcina, Marijo; Schmithausen, Ricarda Maria; Stein, Christoph; Meilaender, Alina; Hoerauf, Achim; Molitor, Ernst; Bekeredjian-Ding, Isabelle			ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; PIPERACILLIN-TAZOBACTAM; PSEUDOMONAS-AERUGINOSA; RAPID DETECTION; BACTEREMIA; THERAPY; AMPC; COMBINATION	Rapid detection and reporting of third generation cephalosporine resistance (3GC-R) and of extended spectrum betalactamases in Enterobacteriaceae (ESBL-E) is a diagnostic and therapeutic priority to avoid inefficacy of the initial antibiotic regimen. In this study we evaluated a commercially available chromogenic screen for 3GC-R as a predictive and/or confirmatory test for ESBL and AmpC activity in clinical and veterinary Enterobacteriaceae isolates. The test was highly reliable in the prediction of cefotaxime and cefpodoxime resistance, but there was no correlation with ceftazidime and piperacillin/tazobactam minimal inhibitory concentrations. All human and porcine ESBL-E tested were detected with exception of one genetically positive but phenotypically negative isolate. By contrast, AmpC detection rates lay below 30%. Notably, exclusion of piperacillin/tazobactam resistant, 3GC susceptible K1+ Klebsiella isolates increased the sensitivity and specificity of the test for ESBL detection. Our data further imply that in regions with low prevalence of AmpC and K1 positive E. coli strains chromogenic testing for 3GC-R can substitute for more time consuming ESBL confirmative testing in E. coli isolates tested positive by Phoenix or VITEK2 ESBL screen. We, therefore, suggest a diagnostic algorithm that distinguishes 3GC-R screening from primary culture and species-dependent confirmatory ESBL testing by beta LACTA (TM) and discuss the implications of MIC distribution results on the choice of antibiotic regimen.	[El-Jade, Mohamed Ramadan; Parcina, Marijo; Schmithausen, Ricarda Maria; Stein, Christoph; Meilaender, Alina; Hoerauf, Achim; Molitor, Ernst; Bekeredjian-Ding, Isabelle] Univ Hosp Bonn, IMMIP, Sigmund Freud Str 25, D-53105 Bonn, Germany; [Schmithausen, Ricarda Maria] Univ Bonn, Inst Anim Sci, Prevent Hlth Management Grp, Katzenburgweg 7-9, D-53115 Bonn, Germany; [Stein, Christoph; Bekeredjian-Ding, Isabelle] Paul Ehrlich Inst, Div Microbiol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany	University of Bonn; University of Bonn; Paul Ehrlich Institute	Bekeredjian-Ding, I (corresponding author), Univ Hosp Bonn, IMMIP, Sigmund Freud Str 25, D-53105 Bonn, Germany.; Bekeredjian-Ding, I (corresponding author), Paul Ehrlich Inst, Div Microbiol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.	isabelle.bekeredjian-ding@pei.de	Bekeredjian-Ding, Isabelle/I-6197-2013; Parcina, Marijo/ABG-4659-2020; Molitor, Ernst/D-3419-2017	Bekeredjian-Ding, Isabelle/0000-0001-6646-5888; Molitor, Ernst/0000-0002-0784-6442				Curello Jennifer, 2014, J Pediatr Pharmacol Ther, V19, P156, DOI 10.5863/1551-6776-19.3.156; Frakking FNJ, 2013, ANTIMICROB AGENTS CH, V57, P3092, DOI 10.1128/AAC.01523-12; Gallah S, 2014, J CLIN MICROBIOL, V52, P3792, DOI 10.1128/JCM.01629-14; Gavin PJ, 2006, ANTIMICROB AGENTS CH, V50, P2244, DOI 10.1128/AAC.00381-05; Hanaki H, 2004, J ANTIMICROB CHEMOTH, V53, P888, DOI 10.1093/jac/dkh166; Hanaki Hideaki, 2007, Journal of Infection and Chemotherapy, V13, P390, DOI 10.1007/s10156-007-0563-2; Harris PNA, 2015, LANCET INFECT DIS, V15, P475, DOI 10.1016/S1473-3099(14)70950-8; Harris PNA, 2015, SEMIN RESP CRIT CARE, V36, P56, DOI 10.1055/s-0034-1398387; Kahlmeter G, 2008, CLIN MICROBIOL INFEC, V14, P169, DOI 10.1111/j.1469-0691.2007.01856.x; Ku NS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/831074; Laurent T, 2013, J CLIN MICROBIOL, V51, P1951, DOI 10.1128/JCM.00524-13; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Lee CH, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.025; Lee NY, 2013, CLIN INFECT DIS, V56, P488, DOI 10.1093/cid/cis916; Levasseur P, 2015, ANTIMICROB AGENTS CH, V59, P1931, DOI 10.1128/AAC.04218-14; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V60, P1375, DOI 10.1093/jac/dkm374; Livermore DM, 2012, J ANTIMICROB CHEMOTH, V67, P1569, DOI 10.1093/jac/dks088; Matsumura Y, 2012, EUR J CLIN MICROBIOL, V31, P1931, DOI 10.1007/s10096-011-1523-4; Morosini MI, 2014, J CLIN MICROBIOL, V52, P1741, DOI 10.1128/JCM.03614-13; Nguyen HM, 2014, J ANTIMICROB CHEMOTH, V69, P871, DOI 10.1093/jac/dkt450; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peterson LR, 2008, CLIN MICROBIOL INFEC, V14, P181, DOI 10.1111/j.1469-0691.2007.01864.x; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Potron A., 2013, EURO SURVEILL, V18; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P37, DOI 10.1086/498519; Rodriguez-Bano J, 2012, CLIN MICROBIOL INFEC, V18, P894, DOI 10.1111/j.1469-0691.2011.03673.x; Rodriguez-Bano J, 2008, EXPERT REV ANTI-INFE, V6, P671, DOI 10.1586/14787210.6.5.671; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V43, P1407, DOI 10.1086/508877; Rodriguez-Bano J, 2015, ANTIMICROB AGENTS CH, V59, P5095, DOI 10.1128/AAC.01333-15; Schmithausen RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138173; Tamma PD, 2015, CLIN INFECT DIS, V60, P1319, DOI 10.1093/cid/civ003; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Vidaillac C, 2009, ANTIMICROB AGENTS CH, V53, P2360, DOI 10.1128/AAC.01452-08; Witte W MM, 2003, PRINCIPLES EPIDEMIOL, V46, P881	36	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160203	10.1371/journal.pone.0160203	http://dx.doi.org/10.1371/journal.pone.0160203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494134	gold, Green Published			2022-12-27	WOS:000381369500023
J	Bacelis, J; Juodakis, J; Sengpiel, V; Zhang, G; Myhre, R; Muglia, LJ; Nilsson, S; Jacobsson, B				Bacelis, Jonas; Juodakis, Julius; Sengpiel, Verena; Zhang, Ge; Myhre, Ronny; Muglia, Louis J.; Nilsson, Staffan; Jacobsson, Bo			Literature-Informed Analysis of a Genome-Wide Association Study of Gestational Age in Norwegian Women and Children Suggests Involvement of Inflammatory Pathways	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; KUSTER-HAUSER-SYNDROME; PRETERM BIRTH; INTERFERON-GAMMA; FETAL MEMBRANES; GENE-EXPRESSION; RECEPTOR 4; RISK; LABOR; POLYMORPHISM	Background Five-to-eighteen percent of pregnancies worldwide end in preterm birth, which is the major cause of neonatal death and morbidity. Approximately 30% of the variation in gestational age at birth can be attributed to genetic factors. Genome-wide association studies (GWAS) have not shown robust evidence of association with genomic loci yet. Methods We separately investigated 1921 Norwegian mothers and 1199 children from pregnancies with spontaneous onset of delivery. Individuals were further divided based on the onset of delivery: initiated by labor or prelabor rupture of membranes. Genetic association with ultrasound- dated gestational age was evaluated using three genetic models and adaptive permutations. The top-ranked loci were tested for enrichment in 12 candidate gene-sets generated by text-mining PubMed abstracts containing pregnancy-related keywords. Results The six GWAS did not reveal significant associations, with the most extreme empirical p = 5.1 x 10(-7). The top loci from maternal GWAS with deliveries initiated by labor showed significant enrichment in 10 PubMed gene-sets, e.g., p = 0.001 and 0.005 for keywords "uterus" and "preterm" respectively. Enrichment signals were mainly caused by infection/inflammation-related genes TLR4, NFKB1, ABCA1, MMP9. Literature-informed analysis of top loci revealed further immunity genes: IL1A, IL1B, CAMP, TREM1, TFRC, NFKBIA, MEFV, IRF8, WNT5A. Conclusion Our analyses support the role of inflammatory pathways in determining pregnancy duration and provide a list of 32 candidate genes for a follow-up work. We observed that the top regions from GWAS in mothers with labor-initiated deliveries significantly more often overlap with pregnancy-related genes than would be expected by chance, suggesting that increased sample size would benefit similar studies.	[Bacelis, Jonas; Sengpiel, Verena] Sahlgrenska Univ, Hosp Ostra, Dept Obstet & Gynecol, Gothenburg, Sweden; [Juodakis, Julius] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Zhang, Ge] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Zhang, Ge] Cincinnati Childrens Hosp Med Ctr, Ctr Prevent Preterm Birth, Perinatal Inst, Cincinnati, OH 45229 USA; [Zhang, Ge; Muglia, Louis J.] March Dimes Prematur Res Ctr Ohio Collaborat, Cincinnati, OH USA; [Myhre, Ronny; Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genet & Bioinformat, Area Hlth Data & Digitalisat, Oslo, Norway; [Nilsson, Staffan] Chalmers Univ Technol, Dept Math Sci, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Norwegian Institute of Public Health (NIPH); Chalmers University of Technology	Bacelis, J (corresponding author), Sahlgrenska Univ, Hosp Ostra, Dept Obstet & Gynecol, Gothenburg, Sweden.	jonas.bacelis@gu.se	Jacobsson, Bo/O-8007-2014	Jacobsson, Bo/0000-0001-5079-2374; Nilsson, Staffan/0000-0003-4748-0446; Bacelis, Jonas/0000-0002-2450-732X; Juodakis, Julius/0000-0001-5600-974X	March of Dimes Foundation [21-FY16-4341]; Swedish Research Council [VR-02559]; Research Council of Norway [FRIMEDBIO-249779]; Jane and Dan Olsson Foundations; Norwegian Ministry of Health [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; Ministry of Education and Research [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; NIH/NIEHS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Swedish Research Council(Swedish Research CouncilEuropean Commission); Research Council of Norway(Research Council of Norway); Jane and Dan Olsson Foundations; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by: research grant No. 21-FY16-4341 (BJ) from the March of Dimes Foundation (http://www.marchofdimes.org); research grant No.VR-02559 (BJ) from the Swedish Research Council (http://www.vr.se); research grant No. FRIMEDBIO-249779 (BJ) from the Research Council of Norway (http://www.forskningsradet.no); research grant (BJ) from the Jane and Dan Olsson Foundations (http://www.jodfoundations.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the families who take part in the on-going MoBa cohort, also, the Norwegian Ministry of Health, the Ministry of Education and Research, NIH/NIEHS and NIH/NINDS for funding it (grant No. 1 UO1 NS 047537-01 and grant No. 2 UO1 NS 047537-06A1).	Alleman BW, 2012, PEDIATR RES, V72, P539, DOI 10.1038/pr.2012.112; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Auger N, 2014, EUR J OBSTET GYN R B, V176, P132, DOI 10.1016/j.ejogrb.2014.02.035; Bae Y, 2007, J HUM HYPERTENS, V21, P159, DOI 10.1038/sj.jhh.1002110; Behrman RE, 2007, PRETERM BIRTH CAUSES; Biason-Lauber A, 2007, HUM REPROD, V22, P224, DOI 10.1093/humrep/del360; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289; Celik E, 2013, EUR J OBSTET GYN R B, V167, P29, DOI 10.1016/j.ejogrb.2012.10.032; Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen YP, 2014, J HYPERTENS, V32, P1833, DOI 10.1097/HJH.0000000000000251; Cheng YH, 2006, BIOL REPROD, V75, P605, DOI 10.1095/biolreprod.106.051912; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Curry AE, 2007, ACTA OBSTET GYN SCAN, V86, P1103, DOI 10.1080/00016340701515423; D'Cruz AA, 2013, PROTEIN SCI, V22, P1, DOI 10.1002/pro.2185; Drew PD, 1995, J NEUROIMMUNOL, V63, P157, DOI 10.1016/0165-5728(95)00140-9; FALETTI A, 1992, PROSTAG LEUKOTR ESS, V47, P29, DOI 10.1016/0952-3278(92)90182-I; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Ferrand PE, 2002, MOL HUM REPROD, V8, P494, DOI 10.1093/molehr/8.5.494; Frew L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103434; Fumagalli M, 2009, GENES IMMUN, V10, P678, DOI 10.1038/gene.2009.59; Gao T, 2008, PRENATAL DIAG, V28, P810, DOI 10.1002/pd.1981; Genc MR, 2002, AM J OBSTET GYNECOL, V187, P157, DOI 10.1067/mob.2002.122407; Goldman-Wohl D, 2002, MOL CELL ENDOCRINOL, V187, P233, DOI 10.1016/S0303-7207(01)00687-6; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Hanna N, 2004, AM J REPROD IMMUNOL, V51, P311, DOI 10.1111/j.1600-0897.2004.00162.x; He WX, 2014, J ENDODONT, V40, P69, DOI 10.1016/j.joen.2013.09.011; Honest H, 2002, BMJ-BRIT MED J, V325, P301, DOI 10.1136/bmj.325.7359.301; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Irgens LM, 1998, SCAND J RHEUMATOL, P105; Kiewisz J, 2011, THERIOGENOLOGY, V76, P687, DOI 10.1016/j.theriogenology.2011.03.022; Korhonen JT, 2013, MICROB PATHOGENESIS, V61-62, P57, DOI 10.1016/j.micpath.2013.05.006; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lappas M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110056; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Li LP, 2010, MOL HUM REPROD, V16, P267, DOI 10.1093/molehr/gap106; Lim R, 2015, J REPROD IMMUNOL, V107, P31, DOI 10.1016/j.jri.2014.10.002; Liu Y, 2015, EUR J OBSTET GYN R B, V190, P11, DOI 10.1016/j.ejogrb.2015.04.003; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Lovvik TS, 2015, BJOG-INT J OBSTET GY, V122, P1295, DOI 10.1111/1471-0528.13339; Lukasse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101682; MacIntyre DA, 2014, FASEB J, V28, P2358, DOI 10.1096/fj.13-247783; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; MARTIN JA, 2014, NCHS DATA BRIEF, V2015, P00001; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Maynard SE, 2010, HYPERTENS PREGNANCY, V29, P330, DOI 10.3109/10641950902968684; McElroy JJ, 2013, HUM GENET, V132, P935, DOI 10.1007/s00439-013-1304-5; Mistry HD, 2011, HYPERTENSION, V58, P497, DOI 10.1161/HYPERTENSIONAHA.111.173740; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Murakami Y, 2009, J HEPATOL, V50, P453, DOI 10.1016/j.jhep.2008.06.010; Myking S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061781; O'Brien M, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-1; Okuhira K, 2010, J BIOL CHEM, V285, P16369, DOI 10.1074/jbc.M109.061424; Osmers R G, 1995, J Obstet Gynaecol (Tokyo 1995), V21, P185; Park CB, 2013, REPRODUCTION, V145, pR55, DOI 10.1530/REP-12-0103; Pawelczyk E, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-66; Pettersson FD, 2012, REPROD SCI, V19, P962, DOI 10.1177/1933719112438970; Philibert P, 2008, J CLIN ENDOCR METAB, V93, P895, DOI 10.1210/jc.2007-2023; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.026; Sata F, 2009, MOL HUM REPROD, V15, P121, DOI 10.1093/molehr/gan078; Shichiri M, 2003, NAT MED, V9, P1166, DOI 10.1038/nm913; Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Soubasi V, 2010, DIABETES METAB, V36, P58, DOI 10.1016/j.diabet.2009.06.010; Steffen KM, 2007, J PERINATOL, V27, P672, DOI 10.1038/sj.jp.7211806; Stehlik C, 2002, J EXP MED, V196, P1605, DOI 10.1084/jem.20021552; Sultan C, 2009, GYNECOL ENDOCRINOL, V25, P8, DOI 10.1080/09513590802288291; Swaminathan G, 2013, PHYSIOL GENOMICS, V45, P1035, DOI 10.1152/physiolgenomics.00112.2013; Tanikawa C, 2012, NAT GENET, V44, P430, DOI 10.1038/ng.1109; Ugocsai P, 2010, INT J BIOCHEM CELL B, V42, P241, DOI 10.1016/j.biocel.2009.10.002; Uzun A, 2013, GENOMICS, V101, P163, DOI 10.1016/j.ygeno.2012.12.005; Verstraelen H, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-55; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Williams PJ, 2012, PREGNANCY HYPERTENS, V2, P123, DOI [10.1016/j.preghy.2012.04.082, 10.1016/j.preghy.2011.12.001]; Wu W, 2015, HUM GENET, V134, P803, DOI 10.1007/s00439-015-1558-1; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Zhang G, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001865; Zhang HP, 2015, GENET EPIDEMIOL, V39, P217, DOI 10.1002/gepi.21887; Zhu Jia-Yu, 2012, Rev Obstet Gynecol, V5, pe137; Zhu YX, 1998, BIOL REPROD, V59, P925, DOI 10.1095/biolreprod59.4.925	92	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160335	10.1371/journal.pone.0160335	http://dx.doi.org/10.1371/journal.pone.0160335			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490719	Green Published, gold			2022-12-27	WOS:000381368900048
J	Gonzalez-Rubio, S; Linares, CI; Aguilar-Melero, P; Rodriguez-Peralvarez, M; Montero-Alvarez, JL; de la Mata, M; Ferrin, G				Gonzalez-Rubio, Sandra; Linares, Clara I.; Aguilar-Melero, Patricia; Rodriguez-Peralvarez, Manuel; Montero-Alvarez, Jose L.; de la Mata, Manuel; Ferrin, Gustavo			AP-1 Inhibition by SR 11302 Protects Human Hepatoma HepG2 Cells from Bile Acid-Induced Cytotoxicity by Restoring the NOS-3 Expression	PLOS ONE			English	Article							OXIDE SYNTHASE PROMOTER; NITRIC-OXIDE; CYCLIN D1; URSODEOXYCHOLIC ACID; OXIDATIVE STRESS; GENE-EXPRESSION; CYCLOSPORINE-A; RETINOIC ACID; ENOS PROMOTER; LIVER	The harmful effects of bile acid accumulation occurring during cholestatic liver diseases have been associated with oxidative stress increase and endothelial nitric oxide synthase (NOS-3) expression decrease in liver cells. We have previously reported that glycochenodeoxycholic acid (GCDCA) down-regulates gene expression by increasing SP1 binding to the NOS-3 promoter in an oxidative stress dependent manner. In the present study, we aimed to investigate the role of transcription factor (TF) AP-1 on the NOS-3 deregulation during GCDCA-induced cholestasis. The cytotoxic response to GCDCA was characterized by 1) the increased expression and activation of TFs cJun and c-Fos; 2) a higher binding capability of these at position -666 of the NOS-3 promoter; 3) a decrease of the transcriptional activity of the promoter and the expression and activity of NOS-3; and 4) the expression increase of cyclin D1. Specific inhibition of AP-1 by the retinoid SR 11302 counteracted the cytotoxic effects induced by GCDCA while promoting NOS-3 expression recovery and cyclin D1 reduction. NOS activity inhibition by L-NAME inhibited the protective effect of SR 11302. Inducible NOS isoform was no detected in this experimental model of cholestasis. Our data provide direct evidence for the involvement of AP-1 in the NOS-3 expression regulation during cholestasis and define a critical role for NOS-3 in regulating the expression of cyclin D1 during the cell damage induced by bile acids. AP-1 appears as a potential therapeutic target in cholestatic liver diseases given its role as a transcriptional repressor of NOS-3.	[Gonzalez-Rubio, Sandra; Linares, Clara I.; Aguilar-Melero, Patricia; Rodriguez-Peralvarez, Manuel; Montero-Alvarez, Jose L.; de la Mata, Manuel; Ferrin, Gustavo] Univ Cordoba, Maimonides Inst Biomed Res Cordoba IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain; [Rodriguez-Peralvarez, Manuel; Montero-Alvarez, Jose L.; de la Mata, Manuel; Ferrin, Gustavo] Inst Salud Carlos III, Biomed Res Ctr Network, Digest & Liver Dis CIBEREHD, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III	Ferrin, G (corresponding author), Univ Cordoba, Maimonides Inst Biomed Res Cordoba IMIBIC, Reina Sofia Univ Hosp, Cordoba, Spain.; Ferrin, G (corresponding author), Inst Salud Carlos III, Biomed Res Ctr Network, Digest & Liver Dis CIBEREHD, Cordoba, Spain.	gustavo.ferrin@imibic.org	aguilar, patricia/L-6986-2014; Rodríguez-perálvarez, Manuel/AGR-2409-2022; Rodríguez-Perálvarez, Manuel/AAO-8616-2021	aguilar, patricia/0000-0003-1396-5445; Rodríguez-perálvarez, Manuel/0000-0002-1795-2919; Ferrin, Gustavo/0000-0002-5744-3289; Linares, Clara Isabel/0000-0002-7621-5089				Bernt C, 2006, BIOCHEM BIOPH RES CO, V340, P800, DOI 10.1016/j.bbrc.2005.12.081; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Biecker E, 2008, LIVER INT, V28, P331, DOI 10.1111/j.1478-3231.2008.01664.x; Castro RE, 2007, AM J PHYSIOL-GASTR L, V293, pG327, DOI 10.1152/ajpgi.00093.2007; Catar R, 2013, KIDNEY INT, V84, P1119, DOI 10.1038/ki.2013.217; Chadalapaka G, 2008, CANCER RES, V68, P5345, DOI 10.1158/0008-5472.CAN-07-6805; Clemens MG, 1999, HEPATOLOGY, V30, P1, DOI 10.1002/hep.510300148; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Fernandez-Alvarez A, 2010, J BIOL CHEM, V285, P11765, DOI 10.1074/jbc.M109.067447; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P8897, DOI 10.1073/pnas.151136298; GALLE PR, 1990, HEPATOLOGY, V12, P486, DOI 10.1002/hep.1840120307; Gonzalez-Rubio S, 2015, BIOCHEM PHARMACOL, V96, P39, DOI 10.1016/j.bcp.2015.04.017; Gonzalez-Rubio S, 2009, CHEM RES TOXICOL, V22, P1984, DOI 10.1021/tx900327t; Han EKH, 1999, APOPTOSIS, V4, P213, DOI 10.1023/A:1009618824145; He H, 2011, HEPATOLOGY, V53, P548, DOI 10.1002/hep.24047; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; Hofmann AF, 2002, LIVER, V22, P14, DOI 10.1034/j.1600-0676.2002.00002.x; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Kim YH, 2008, BIOCHEM PHARMACOL, V75, P1946, DOI 10.1016/j.bcp.2008.02.016; Kleinert H, 1998, BRIT J PHARMACOL, V125, P193, DOI 10.1038/sj.bjp.0702039; Kumar S, 2008, AM J PHYSIOL-LUNG C, V295, pL370, DOI 10.1152/ajplung.90205.2008; Kumar S, 2007, DNA CELL BIOL, V26, P853, DOI 10.1089/dna.2007.0614; Li JJ, 1996, CANCER RES, V56, P483; Lin SY, 2014, J NUTR BIOCHEM, V25, P1183, DOI 10.1016/j.jnutbio.2014.06.003; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Navarro-Antolin J, 2000, J BIOL CHEM, V275, P3075, DOI 10.1074/jbc.275.5.3075; Neumann P, 2004, AM J PHYSIOL-LUNG C, V286, pL452, DOI 10.1152/ajplung.00378.2002; PFAHL M, 1994, VITAM HORM, V49, P327; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Rocky D, 1997, HEPATOLOGY, V25, P2, DOI 10.1002/hep.510250102; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; SPIVEY JR, 1993, J CLIN INVEST, V92, P17, DOI 10.1172/JCI116546; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; Vera-Ramirez L, 2013, BIOFACTORS, V39, P88, DOI 10.1002/biof.1057; Wolf A, 1997, J PHARMACOL EXP THER, V280, P1328; Xing FY, 2006, J CELL BIOCHEM, V98, P872, DOI 10.1002/jcb.20739; Yang HP, 2009, HEPATOLOGY, V49, P860, DOI 10.1002/hep.22720; Yokoo T, 1997, AM J PHYSIOL-RENAL, V273, pF206, DOI 10.1152/ajprenal.1997.273.2.F206; ZHANG R, 1995, J BIOL CHEM, V270, P15320, DOI 10.1074/jbc.270.25.15320	44	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160525	10.1371/journal.pone.0160525	http://dx.doi.org/10.1371/journal.pone.0160525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490694	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900065
J	Hatt, L; Aagaard, MM; Bach, C; Graakjaer, J; Sommer, S; Agerholm, IE; Kolvraa, S; Bojesen, A				Hatt, Lotte; Aagaard, Mads M.; Bach, Cathrine; Graakjaer, Jesper; Sommer, Steffen; Agerholm, Inge E.; Kolvraa, Steen; Bojesen, Anders			Microarray-Based Analysis of Methylation of 1st Trimester Trisomic Placentas from Down Syndrome, Edwards Syndrome and Patau Syndrome	PLOS ONE			English	Article							CELL-FREE DNA; DISCOVERY; DIAGNOSIS; PLASMA	Methylation-based non-invasive prenatal testing of fetal aneuploidies is an alternative method that could possibly improve fetal aneuploidy diagnosis, especially for trisomy 13 (T13) and trisomy 18(T18). Our aim was to study the methylation landscape in placenta DNA from trisomy 13, 18 and 21 pregnancies in an attempt to find trisomy-specific methylation differences better suited for non-invasive prenatal diagnosis. We have conducted high-resolution methylation specific bead chip microarray analyses assessing more than 450,000 CpGs analyzing placentas from 12 T21 pregnancies, 12 T18 pregnancies and 6 T13 pregnancies. We have compared the methylation landscape of the trisomic placentas to the methylation landscape from normal placental DNA and to maternal blood cell DNA. Comparing trisomic placentas to normal placentas we identified 217 and 219 differentially methylated CpGs for CVS T18 and CVS T13, respectively (delta beta>0.2, FDR<0.05), but only three differentially methylated CpGs for T21. However, the methylation differences was only modest (delta beta<0.4), making them less suitable as diagnostic markers. Gene ontology enrichment analysis revealed that the gene set connected to the T18 differentially methylated CpGs was highly enriched for GO terms related to "DNA binding" and "transcription factor binding" coupled to the RNA polymerase II transcription. In the gene set connected to the T13 differentially methylated CpGs we found no significant enrichments.	[Hatt, Lotte; Aagaard, Mads M.; Graakjaer, Jesper; Kolvraa, Steen; Bojesen, Anders] Vejle Hosp, Dept Clin Genet, Kabbeltoft 25, DK-7100 Vejle, Denmark; [Hatt, Lotte; Bach, Cathrine; Sommer, Steffen; Agerholm, Inge E.] Horsens Hosp, Dept Gynecol & Obstet, DK-8700 Horsens, Denmark; [Hatt, Lotte; Kolvraa, Steen; Bojesen, Anders] Univ Southern Denmark, Inst Reg Hlth Serv Res, DK-5000 Odense, Denmark	University of Southern Denmark; Lillebaelt Hospital; Aarhus University; University of Southern Denmark	Hatt, L (corresponding author), Vejle Hosp, Dept Clin Genet, Kabbeltoft 25, DK-7100 Vejle, Denmark.; Hatt, L (corresponding author), Horsens Hosp, Dept Gynecol & Obstet, DK-8700 Horsens, Denmark.; Hatt, L (corresponding author), Univ Southern Denmark, Inst Reg Hlth Serv Res, DK-5000 Odense, Denmark.	lotte@hatt.nu	Bojesen, Anders B/G-6308-2010	Bojesen, Anders/0000-0003-4289-8595	University of Southern Denmark; Jorgen Werner Schous Fond; Det Videnskabelige Fond ved Horsens Sygehus; Familien Hede Nielsens Fond; Aase og Einar Danielsens Fond	University of Southern Denmark; Jorgen Werner Schous Fond; Det Videnskabelige Fond ved Horsens Sygehus; Familien Hede Nielsens Fond; Aase og Einar Danielsens Fond	Funding was provided by the University of Southern Denmark(LH), Jorgen Werner Schous Fond (AB), Det Videnskabelige Fond ved Horsens Sygehus (SS), Familien Hede Nielsens Fond (LH) and Aase og Einar Danielsens Fond (LH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bunce K, 2012, PRENATAL DIAG, V32, P542, DOI 10.1002/pd.3853; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chu TJ, 2009, PRENATAL DIAG, V29, P1020, DOI 10.1002/pd.2335; Eckmann-Scholz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039014; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Gekas J, 2014, APPL CLIN GENET, V7, P127, DOI 10.2147/TACG.S35602; Haghiac M, 2012, OBESITY, V20, P2213, DOI 10.1038/oby.2012.138; Hatt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128918; Jin SN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003515; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Lui YNYN, 2002, CLIN CHEM, V48, P421; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Tong YK, 2010, CLIN CHEM, V56, P90, DOI 10.1373/clinchem.2009.134114; Tsaliki E, 2012, PRENATAL DIAG, V32, P996, DOI 10.1002/pd.3947	15	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160319	10.1371/journal.pone.0160319	http://dx.doi.org/10.1371/journal.pone.0160319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490343	Green Published, gold			2022-12-27	WOS:000381368900045
J	Lacroix, C; Fish, I; Torosyan, H; Parathaman, P; Irwin, JJ; Shoichet, BK; Angers, S				Lacroix, Celine; Fish, Inbar; Torosyan, Hayarpi; Parathaman, Pranavan; Irwin, John J.; Shoichet, Brian K.; Angers, Stephane			Identification of Novel Smoothened Ligands Using Structure-Based Docking	PLOS ONE			English	Article							STRUCTURE-BASED DISCOVERY; BASAL-CELL CARCINOMA; HEDGEHOG PATHWAY INHIBITOR; A(2A) RECEPTOR ANTAGONISTS; PROTEIN-COUPLED RECEPTOR; HIGH-THROUGHPUT; COLLOIDAL AGGREGATION; ADENOSINE RECEPTOR; MOLECULAR DOCKING; CRYSTAL-STRUCTURE	The seven transmembrane protein Smoothened is required for Hedgehog signaling during embryonic development and adult tissue homeostasis. Inappropriate activation of the Hedgehog signalling pathway leads to cancers such as basal cell carcinoma and medulloblastoma, and Smoothened inhibitors are now available clinically to treat these diseases. However, resistance to these inhibitors rapidly develops thereby limiting their efficacy. The determination of Smoothened crystal structures enables structure-based discovery of new ligands with new chemotypes that will be critical to combat resistance. In this study, we docked 3.2 million available, lead-like molecules against Smoothened, looking for those with high physical complementarity to its structure; this represents the first such campaign against the class Frizzled G-protein coupled receptor family. Twenty-one high-ranking compounds were selected for experimental testing, and four, representing three different chemotypes, were identified to antagonize Smoothened with IC50 values better than 50 mu M. A screen for analogs revealed another six molecules, with IC50 values in the low micromolar range. Importantly, one of the most active of the new antagonists continued to be efficacious at the D473H mutant of Smoothened, which confers clinical resistance to the antagonist vismodegib in cancer treatment.	[Lacroix, Celine; Parathaman, Pranavan; Angers, Stephane] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Fish, Inbar; Torosyan, Hayarpi; Irwin, John J.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Fish, Inbar] Tel Aviv Univ, Dept Biochem & Mol Biol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [Angers, Stephane] Univ Toronto, Dept Biochem, Fac Med, Toronto, ON, Canada	University of Toronto; University of California System; University of California San Francisco; Tel Aviv University; University of Toronto	Angers, S (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	bshoichet@gmail.com; stephane.angers@utoronto.ca	Angers, Stephane/E-1432-2014	Angers, Stephane/0000-0001-7241-9044; Torosyan, Hayarpi/0000-0003-1576-0195	US NIH [U01104974]; Canadian Institutes for Health Research [CIHR-342677]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH104974] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by US NIH grants U01104974 (to BS) and by Canadian Institutes for Health Research grant (CIHR-342677) to SA.	Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Bender MH, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-2819; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Bookout Angie L, 2006, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1508s73; Brenk R, 2005, J BIOMOL SCREEN, V10, P667, DOI 10.1177/1087057105281047; Brown N, 2006, MINI-REV MED CHEM, V6, P1217, DOI 10.2174/138955706778742768; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Case D. A., 2015, AMBER 14; Cavasotto CN, 2008, J MED CHEM, V51, P581, DOI 10.1021/jm070759m; Chambers CC, 1996, J PHYS CHEM-US, V100, P16385, DOI 10.1021/jp9610776; Chen D, 2013, J CHEM INF MODEL, V53, P2701, DOI 10.1021/ci4003156; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; Dahlgren MK, 2012, J MED CHEM, V55, P10148, DOI 10.1021/jm301269s; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Doak AK, 2010, J MED CHEM, V53, P4259, DOI 10.1021/jm100254w; Duan D, 2015, ACS CHEM BIOL, V10, P978, DOI 10.1021/cb5009487; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Gallagher K, 1998, BIOPHYS J, V75, P769, DOI 10.1016/S0006-3495(98)77566-6; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GILSON MK, 1987, NATURE, V330, P84, DOI 10.1038/330084a0; Hert J, 2004, ORG BIOMOL CHEM, V2, P3256, DOI 10.1039/b409865j; Hert J, 2008, J CHEM INF MODEL, V48, P755, DOI 10.1021/ci8000259; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2016, J MED CHEM, V59, P4103, DOI 10.1021/acs.jmedchem.5b02008; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kim DJ, 2014, J CLIN ONCOL, V32, P745, DOI 10.1200/JCO.2013.49.9525; Kim J, 2013, CANCER CELL, V23, P23, DOI 10.1016/j.ccr.2012.11.017; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kooistra AJ, 2013, METHOD ENZYMOL, V522, P279, DOI 10.1016/B978-0-12-407865-9.00015-7; Lane JR, 2013, MOL PHARMACOL, V84, P794, DOI 10.1124/mol.113.088054; Langmead CJ, 2012, J MED CHEM, V55, P1904, DOI 10.1021/jm201455y; Li JB, 1998, J PHYS CHEM A, V102, P1820, DOI 10.1021/jp972682r; Lui TTH, 2011, MOL CELL BIOL, V31, P2053, DOI 10.1128/MCB.01094-10; Manetti F, 2010, MOL PHARMACOL, V78, P658, DOI 10.1124/mol.110.065102; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Muchmore SW, 2008, J CHEM INF MODEL, V48, P941, DOI 10.1021/ci7004498; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Mysinger MM, 2012, P NATL ACAD SCI USA, V109, P5517, DOI 10.1073/pnas.1120431109; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Powers RA, 2002, J MED CHEM, V45, P3222, DOI 10.1021/jm020002p; Ramsden NL, 2009, J MED CHEM, V52, P2531, DOI 10.1021/jm801475n; Repasky MP, 2012, J COMPUT AID MOL DES, V26, P787, DOI 10.1007/s10822-012-9575-9; Rodriguez D, 2014, STRUCTURE, V22, P1140, DOI 10.1016/j.str.2014.05.017; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Roughley S, 2012, TOP CURR CHEM, V317, P61, DOI 10.1007/128_2011_181; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sager G, 2012, J MED CHEM, V55, P3049, DOI 10.1021/jm2014666; Sassano MF, 2013, J MED CHEM, V56, P2406, DOI 10.1021/jm301749y; Schmidt D, 2015, ACS CHEM BIOL, V10, P715, DOI 10.1021/cb500577j; Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r; SHARP KA, 1995, BIOPOLYMERS, V36, P227, DOI 10.1002/bip.360360210; SHOICHET BK, 1993, PROTEIN ENG, V6, P723, DOI 10.1093/protein/6.7.723; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; Tosh DK, 2012, J MED CHEM, V55, P4297, DOI 10.1021/jm300095s; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386	75	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160365	10.1371/journal.pone.0160365	http://dx.doi.org/10.1371/journal.pone.0160365			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490099	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900051
J	Cohen, AT; Hamilton, M; Bird, A; Mitchell, SA; Li, S; Horblyuk, R; Batson, S				Cohen, A. T.; Hamilton, M.; Bird, A.; Mitchell, S. A.; Li, S.; Horblyuk, R.; Batson, S.			Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis	PLOS ONE			English	Review							INTENSITY WARFARIN THERAPY; DEEP-VEIN THROMBOSIS; LONG-TERM; SECONDARY PREVENTION; SAFETY OUTCOMES; RISK-FACTORS; 1ST EPISODE; EFFICACY; RECURRENCE; ASPIRIN	Background Historically, warfarin or aspirin have been the recommended therapeutic options for the extended treatment (>3 months) of VTE. Data from Phase III randomised controlled trials (RCTs) are now available for non-VKA oral anticoagulants (NOACs) in this indication. The current systematic review and network meta-analysis (NMA) were conducted to compare the efficacy and safety of anticoagulants for the extended treatment of VTE. Methods Electronic databases (accessed July 2014 and updated April 2016) were systematically searched to identify RCTs evaluating apixaban, aspirin, dabigatran, edoxaban, rivaroxaban, and warfarin for the extended treatment of VTE. Eligible studies included adults with an objectively confirmed deep vein thrombosis, pulmonary embolism or both. A fixed-effect Bayesian NMA was conducted, and results were presented as relative risks (RRs). Sensitivity analyses examining (i) the dataset employed according to the time frame for outcome assessment (ii) the model used for the NMA were conducted. Results Eleven Phase III RCTs (examining apixaban, aspirin, dabigatran, rivaroxaban, warfarin and placebo) were included. The risk of the composite efficacy outcome (VTE and VTE-related death) was statistically significantly lower with the NOACs and warfarin INR 2.0-3.0 compared with aspirin, with no significant differences between the NOACs. Treatment with apixaban (RR 0.23, 95% CrI 0.10, 0.55) or dabigatran (RR 0.55, 95% Crl 0.43, 0.71) was associated with a statistically significantly reduced risk of 'major or clinically relevant non-major bleed' compared with warfarin INR 2.0-3.0. Apixaban also showed a significantly reduced risk compared with dabigatran (RR 0.42, 95% Crl 0.18, 0.97) and rivaroxaban (RR 0.23, 95% Crl 0.09, 0.59). Sensitivity analyses indicate that results were dependent on the dataset, but not on the type of NMA model employed. Conclusions Results from the NMA indicate that NOACs are an effective treatment for prevention of VTE or VTE-related death) in the extended treatment setting. However, bleeding risk differs between potential treatments, with apixaban reporting the most favourable profile compared with other NOACs, warfarin INR 2.0-3.0, and aspirin.	[Cohen, A. T.] Kings Coll London, Guys Hosp, London, England; [Cohen, A. T.] Kings Coll London, St Thomas Hosp, London, England; [Hamilton, M.; Li, S.] BMS, Princeton, NJ USA; [Bird, A.] Pfizer, Walton Oaks, England; [Mitchell, S. A.; Batson, S.] Abacus Int, Bicester, Oxon, England; [Horblyuk, R.] Pfizer, New York, NY USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Pfizer; Pfizer	Batson, S (corresponding author), Abacus Int, Bicester, Oxon, England.	sbatson@teamdrg.com			Bristol Myers Squibb; Pfizer; DRG Abacus	Bristol Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); DRG Abacus	This study was funded by Bristol Myers Squibb and Pfizer. Bristol Myers Squibb provided support in the form of salaries for authors MH and SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer provided support in the form of salaries for authors AB and RH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DRG Abacus provided support in the form of salaries for authors SAM and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2013, HEMATOL-AM SOC HEMAT, P471, DOI 10.1182/asheducation-2013.1.471; Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Alotaibi G, 2014, INT ANGIOL, V33, P301; Amin A, 2016, CLIN APPL THROMB-HEM, V22, P5, DOI 10.1177/1076029615585991; Barnes GD, 2015, VASC MED, V20, P143, DOI 10.1177/1358863X14566429; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Borenstein M., 2009, INTRO METAANALYSIS; Bova C, 2016, THROMB RES, V139, P22, DOI 10.1016/j.thromres.2016.01.005; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Castellucci LA, 2014, JAMA-J AM MED ASSOC, V312, P1122, DOI 10.1001/jama.2014.10538; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Dias S, 2011, 2 NICE DSU; Dobesh PP, 2009, PHARMACOTHERAPY, V29, P943, DOI 10.1592/phco.29.8.943; Fox BD, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7498; Hamilton M, 2015, EUROPEAN HEART J S, V36, P1453; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Kakkos SK, 2014, EUR J VASC ENDOVASC, V48, P565, DOI 10.1016/j.ejvs.2014.05.001; Kang N, 2014, THROMB RES, V133, P1145, DOI 10.1016/j.thromres.2014.03.035; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Mantha S, 2015, J THROMB THROMBOLYS, V39, P155, DOI 10.1007/s11239-014-1102-5; Marik PE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143252; National Institute for Health and Care Excellence, 2009, GUID MAN; Palareti G, 2012, RECURRENT VENOUS THR; Prandoni P, 1997, HAEMATOLOGICA, V82, P423; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rollins BM, 2014, CLIN THER, V36, P1454, DOI 10.1016/j.clinthera.2014.06.033; Ruppert Andras, 2011, J Med Econ, V14, P65, DOI 10.3111/13696998.2010.546465; Sardar P, 2013, DRUGS, V73, P1171, DOI 10.1007/s40265-013-0082-7; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2014, CIRCULATION, V129, P764, DOI 10.1161/CIRCULATIONAHA.113.004450; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Sobieraj DM, 2015, THROMB RES, V135, P888, DOI 10.1016/j.thromres.2015.02.032; Spencer FA, 2008, ARCH INTERN MED, V168, P425, DOI 10.1001/archinternmed.2007.69; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; van der Hulle T, 2014, J THROMB HAEMOST, V12, P320, DOI 10.1111/jth.12485; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; White RH, 2006, THROMB HAEMOSTASIS, V96, P267, DOI 10.1160/TH06-07-0365; Zhu TN, 2009, ARTERIOSCL THROM VAS, V29, P298, DOI 10.1161/ATVBAHA.108.182428; 2012, NEW ENGL J MED, V366, P1287, DOI [DOI 10.1056/NEJMoa1113572, 10.1056/NEJMoa1113572, DOI 10.1056/NEJMOA1113572]	49	39	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160064	10.1371/journal.pone.0160064	http://dx.doi.org/10.1371/journal.pone.0160064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487187	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800056
J	Cooney, L; Sinha, I; Hawcutt, D				Cooney, Lewis; Sinha, Ian; Hawcutt, Daniel			Aminophylline Dosage In Asthma Exacerbations in Children: A Systematic Review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; IV AMINOPHYLLINE; INTRAVENOUS THEOPHYLLINE; EFFICACY; TOXICITY; HETEROGENEITY; SALBUTAMOL; INFUSION; THERAPY; BOLUS	Background Adequate asthma treatment of childhood exacerbations with IV aminophylline depends on appropriate dosage. Recommendations to aim for a target therapeutic range may be inappropriate as serum concentrations correlate poorly with clinical improvement. This review aims to evaluate the evidence for the optimum dosage strategy of intravenous aminophylline in children suffering an exacerbation of asthma. Methods A systematic review comparing dosage regimens of intravenous aminophylline in children suffering an exacerbation of asthma. Primary outcomes were time until resolution of symptoms, mortality and need for mechanical ventilation. Secondary outcomes were date until discharge criteria are met, actual discharge and adverse effects. Data sources CENTRAL, CINAHL, MEDLINE and Web of Science. Search performed in March 2016 Eligibility criteria Studies using intravenous aminophylline in children with an acute exacerbation of asthma which reported the dosage and clinical outcomes. Findings 14 RCTs were included. There is a poor relationship between the dosage administered to children and symptom resolution, length of stay or need for mechanical ventilation. This study is limited due to its use of indirect evidence. Conclusion The currently recommended dosage regimens may not represent the optimum safety and efficacy of intravenous aminophylline. There is a need to develop the evidence base correlating dosage with patient centered clinical outcomes, to improve prescribing practices.	[Cooney, Lewis; Hawcutt, Daniel] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; [Sinha, Ian; Hawcutt, Daniel] Alder Hey Childrens Hosp, Natl Inst Hlth Res, Alder Hey Clin Res Facil, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Hawcutt, D (corresponding author), Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England.; Hawcutt, D (corresponding author), Alder Hey Childrens Hosp, Natl Inst Hlth Res, Alder Hey Clin Res Facil, Liverpool, Merseyside, England.	dhawcutt@liverpool.ac.uk		Hawcutt, Dan/0000-0002-8120-6507	NIHR	NIHR(National Institute for Health Research (NIHR))	DH is part funded by the NIHR alder hey clinical research facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, THORAX, V69, P1; BIEN JP, 1995, CLIN PEDIATR, V34, P475, DOI 10.1177/000992289503400905; CARTER E, 1993, J PEDIATR-US, V122, P470, DOI 10.1016/S0022-3476(05)83443-2; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Cooling David S., 1993, Journal of Emergency Medicine, V11, P415, DOI 10.1016/0736-4679(93)90244-2; Cooney L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153877; D'Avila RS, 2008, RESP MED, V102, P156, DOI 10.1016/j.rmed.2007.07.030; DIGIULIO GA, 1993, J PEDIATR-US, V122, P464, DOI 10.1016/S0022-3476(05)83442-0; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; ELLIS EF, 1985, J ALLERGY CLIN IMMUN, V76, P297, DOI 10.1016/0091-6749(85)90645-1; GLEESON JGA, 1989, EUR J PEDIATR, V148, P577, DOI 10.1007/BF00441563; HAMBLETON G, 1979, ARCH DIS CHILD, V54, P391, DOI 10.1136/adc.54.5.391; Hawcutt DB, 2016, EXPERT REV PRECIS ME, V1, P69, DOI 10.1080/23808993.2016.1138845; Hendeles L, 2006, ANN PHARMACOTHER, V40, P1417, DOI 10.1345/aph.140027; KUBO M, 1986, J PEDIATR-US, V108, P1011, DOI 10.1016/S0022-3476(86)80951-9; Kukreti R, 2009, PHARMACOGENOMICS, V10, P327, DOI 10.2217/14622416.10.3.327; LOUGHNAN PM, 1976, J PEDIATR-US, V88, P874, DOI 10.1016/S0022-3476(76)81136-5; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; Morris I, 2015, THORAX, V70, P88, DOI 10.1136/thoraxjnl-2014-206041; NEEDLEMAN JP, 1995, ARCH PEDIAT ADOL MED, V149, P206, DOI 10.1001/archpedi.1995.02170140088016; Nuhoglu Y, 1998, ANN ALLERG ASTHMA IM, V80, P395, DOI 10.1016/S1081-1206(10)62990-0; Paediatric Formulary Comittee, 2014, BNF CHILDR BNFC 2014; Ream RS, 2001, CHEST, V119, P1480, DOI 10.1378/chest.119.5.1480; Roberts G, 2003, THORAX, V58, P306, DOI 10.1136/thorax.58.4.306; SESSLER CN, 1990, AM J MED, V88, P567, DOI 10.1016/0002-9343(90)90519-J; Singhi S, 2014, ACTA PAEDIATR, V103, P1301, DOI 10.1111/apa.12780; STRAUSS RE, 1994, PEDIATRICS, V93, P205; Tamesis GP, 2007, CURR OPIN ALLERGY CL, V7, P185, DOI 10.1097/ACI.0b013e32807fafe7; Vieira SE, 2000, PULM PHARMACOL THER, V13, P189, DOI 10.1006/pupt.1999.0225; Visser K, 2009, ANN RHEUM DIS, V68, P1094, DOI 10.1136/ard.2008.092668; WEINBERGER MW, 1976, JAMA-J AM MED ASSOC, V235, P2110, DOI 10.1001/jama.235.19.2110; Wheeler Derek S, 2005, Pediatr Crit Care Med, V6, P142, DOI 10.1097/01.PCC.0000154943.24151.58; Yung M, 1998, ARCH DIS CHILD, V79, P405, DOI 10.1136/adc.79.5.405	34	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159965	10.1371/journal.pone.0159965	http://dx.doi.org/10.1371/journal.pone.0159965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483163	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700019
J	Rappaz, B; Sun, KLW; Correia, JP; Wiseman, PW; Kennedy, TE				Rappaz, Benjamin; Sun, Karen Lai Wing; Correia, James P.; Wiseman, Paul W.; Kennedy, Timothy E.			FLIM FRET Visualization of Cdc42 Activation by Netrin-1 in Embryonic Spinal Commissural Neuron Growth Cones	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SNARE-MEDIATED EXOCYTOSIS; COLORECTAL-CANCER; AXON GUIDANCE; CORTICAL-NEURONS; PLASMA-MEMBRANE; RHO GTPASES; CELL INVASIVENESS; RECRUITS DCC; N-WASP	Netrin-1 is an essential extracellular chemoattractant that signals through its receptor DCC to guide commissural axon extension in the embryonic spinal cord. DCC directs the organization of F-actin in growth cones by activating an intracellular protein complex that includes the Rho GTPase Cdc42, a critical regulator of cell polarity and directional migration. To address the spatial distribution of signaling events downstream of netrin-1, we expressed the FRET biosensor Raichu-Cdc42 in cultured embryonic rat spinal commissural neurons. Using FLIM-FRET imaging we detected rapid activation of Cdc42 in neuronal growth cones following application of netrin-1. Investigating the signaling mechanisms that control Cdc42 activation by netrin-1, we demonstrate that netrin-1 rapidly enriches DCC at the leading edge of commissural neuron growth cones and that netrin-1 induced activation of Cdc42 in the growth cone is blocked by inhibiting src family kinase signaling. These findings reveal the activation of Cdc42 in embryonic spinal commissural axon growth cones and support the conclusion that src family kinase activation downstream of DCC is required for Cdc42 activation by netrin-1.	[Rappaz, Benjamin; Sun, Karen Lai Wing; Correia, James P.; Wiseman, Paul W.; Kennedy, Timothy E.] McGill Univ, Program NeuroEngn, Montreal, PQ H3A 2B4, Canada; [Rappaz, Benjamin; Sun, Karen Lai Wing; Correia, James P.; Kennedy, Timothy E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Rappaz, Benjamin; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ H3A 0B8, Canada	McGill University; McGill University; McGill University; McGill University	Kennedy, TE (corresponding author), McGill Univ, Program NeuroEngn, Montreal, PQ H3A 2B4, Canada.; Kennedy, TE (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	timothy.kennedy@mcgill.ca	Rappaz, Benjamin/C-1881-2014	Rappaz, Benjamin/0000-0002-8744-600X	operating grants from the Canadian Institutes of Health Research [114965, 126109]; CREATE training grant from the Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada Discovery Grant [250013-12]	operating grants from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CREATE training grant from the Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by operating grants from the Canadian Institutes of Health Research (114965, 126109: Kennedy), a CREATE training grant from the Natural Sciences and Engineering Research Council of Canada, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (250013-12 Wiseman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Akino T, 2014, CANCER RES, V74, P3716, DOI 10.1158/0008-5472.CAN-13-3116; Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; Bin JM, 2015, CELL REP, V12, P1099, DOI 10.1016/j.celrep.2015.07.028; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bouchard JF, 2008, J NEUROCHEM, V107, P398, DOI 10.1111/j.1471-4159.2008.05609.x; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; CHIEN CB, 1993, NEURON, V11, P237, DOI 10.1016/0896-6273(93)90181-P; Cotrufo T, 2012, EUR J NEUROSCI, V36, P3152, DOI 10.1111/j.1460-9568.2012.08259.x; Cotrufo T, 2011, J NEUROSCI, V31, P14463, DOI 10.1523/JNEUROSCI.3018-11.2011; Dalpe G, 2013, DEVELOPMENT, V140, P4020, DOI 10.1242/dev.095190; Demarco RS, 2012, PLOS GENET, V8, P513, DOI 10.1371/journal.pgen.1002665; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Gadella T. W. J.  Jr., 1994, Bioimaging, V2, P139, DOI 10.1002/1361-6374(199409)2:3<139::AID-BIO4>3.3.CO;2-K; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Goldman JS, 2013, J NEUROSCI, V33, P17278, DOI 10.1523/JNEUROSCI.1085-13.2013; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Gopal AA, 2016, BIOPHYS J, V110, P623, DOI 10.1016/j.bpj.2015.12.022; Grant A, 2012, SCHIZOPHR RES, V137, P26, DOI 10.1016/j.schres.2012.02.023; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; Ide M, 2010, BIOL PSYCHIAT, V68, P25, DOI 10.1016/j.biopsych.2010.02.016; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006; KESHISHIAN H, 1983, DEV BIOL, V96, P89, DOI 10.1016/0012-1606(83)90314-7; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Ma QL, 2008, J BIOL CHEM, V283, P14132, DOI 10.1074/jbc.M708034200; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Matsumoto H, 2010, NEUROSCI RES, V67, P99, DOI 10.1016/j.neures.2010.02.004; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; Moore SW, 2012, J NEUROSCI, V32, P11574, DOI 10.1523/JNEUROSCI.0999-12.2012; Moore Simon W, 2008, Curr Protoc Neurosci, VChapter 3, DOI [10.1002/0471142301.ns0320s43, 10.1002/0471142301.ns0320s45]; Moore SW, 2009, SCIENCE, V325, P166, DOI 10.1126/science.1173851; Moore SW, 2006, J NEUROSCI, V26, P2419, DOI 10.1523/JNEUROSCI.5419-05.2006; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Norris AD, 2014, DEVELOPMENT, V141, P4395, DOI 10.1242/dev.110437; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; Quinn CC, 2008, CURR BIOL, V18, P808, DOI 10.1016/j.cub.2008.04.050; Rama N, 2012, J BIOL CHEM, V287, P30014, DOI 10.1074/jbc.M111.324780; Ren XR, 2008, NEUROSIGNALS, V16, P235, DOI 10.1159/000111566; Ros O, 2015, J NEUROSCI, V35, P5156, DOI 10.1523/JNEUROSCI.0124-14.2015; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shekarabi M, 2005, J NEUROSCI, V25, P3132, DOI 10.1523/JNEUROSCI.1920-04.2005; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Shimizu A, 2013, J BIOL CHEM, V288, P2210, DOI 10.1074/jbc.M112.397398; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Szabelski M, 2009, CHEM PHYS LETT, V471, P153, DOI 10.1016/j.cplett.2009.02.001; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Wetzel- Smith MK, 2014, NAT MED; Winkle CC, 2014, J CELL BIOL, V205, P217, DOI 10.1083/jcb.201311003; Xiao F, 2008, BRAIN RES, V1233, P168, DOI 10.1016/j.brainres.2008.07.101; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Yam PT, 2012, NEURON, V76, P735, DOI 10.1016/j.neuron.2012.09.017; Ylivinkka I, 2013, J CELL SCI, V126, P2459, DOI 10.1242/jcs.120022; Zheng JQ, 1996, J NEUROSCI, V16, P1140; Ziel JW, 2009, NAT CELL BIOL, V11, P183, DOI 10.1038/ncb1825	81	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159405	10.1371/journal.pone.0159405	http://dx.doi.org/10.1371/journal.pone.0159405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482713	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110700009
J	Warhurst, DC; Craig, JC; Raheem, KS				Warhurst, David C.; Craig, John C.; Raheem, K. Saki			Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance	PLOS ONE			English	Article							PH-METRIC LOG; PLASMODIUM-FALCIPARUM; MALARIA; IDENTIFICATION; PIPERAQUINE; SUBSTANCES; DRUGS; WATER	Antimalarial chloroquine (CQ) prevents haematin detoxication when CQ-base concentrates in the acidic digestive vacuole through protonation of its p-aminopyridine (pAP) basic aromatic nitrogen and sidechain diethyl-N. CQ export through the variant vacuolar membrane export channel, PFCRT, causes CQ-resistance in Plasmodium falciparum but 3-methyl CQ (sontochin SC), des-ethyl amodiaquine (DAQ) and bis 4-aminoquinoline piperaquine (PQ) are still active. This is determined by changes in drug accumulation ratios in parasite lipid (LAR) and in vacuolar water (VAR). Higher LAR may facilitate drug binding to and blocking PFCRT and also aid haematin in lipid to bind drug. LAR for CQ is only 8.3; VAR is 143,482. More hydrophobic SC has LAR 143; VAR remains 68,523. Similarly DAQ with a phenol substituent has LAR of 40.8, with VAR 89,366. In PQ, basicity of each pAP is reduced by distal piperazine N, allowing very high LAR of 973,492, retaining VAR of 104,378. In another bis quinoline, dichlorquinazine (DCQ), also active but clinically unsatisfactory, each pAP retains basicity, being insulated by a 2-carbon chain from a proximal nitrogen of the single linking piperazine. While LAR of 15,488 is still high, the lowest estimate of VAR approaches 4.9 million. DCQ may be expected to be very highly lysosomotropic and therefore potentially hepatotoxic. In 11 pAP antimalarials a quadratic relationship between logLAR and logResistance Index (RI) was confirmed, while log (LAR/VAR) vs logRI for 12 was linear. Both might be used to predict the utility of structural modifications.	[Warhurst, David C.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1E 7HT, England; [Warhurst, David C.] London Sch Hyg & Trop Med, Malaria Ctr, London WC1E 7HT, England; [Craig, John C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Raheem, K. Saki] Univ Westminster, Fac Sci & Technol, Dept Life Sci, London W1W 6UV, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; University of Westminster	Warhurst, DC (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Pathogen Mol Biol, London WC1E 7HT, England.; Warhurst, DC (corresponding author), London Sch Hyg & Trop Med, Malaria Ctr, London WC1E 7HT, England.; Raheem, KS (corresponding author), Univ Westminster, Fac Sci & Technol, Dept Life Sci, London W1W 6UV, England.	David.Warhurst@lshtm.ac.uk; S.Raheem@westminster.ac.uk	warhurst, david c/C-3428-2013	Raheem, Saki/0000-0003-1691-4483				[Anonymous], 1963, Rhone-Poulenc. Belg. Pat, Patent No. [626, 239, 626239]; AVDEEF A, 1993, ANAL CHEM, V65, P42, DOI 10.1021/ac00049a010; AVDEEF A, 1993, J PHARM SCI, V82, P183, DOI 10.1002/jps.2600820214; Benazet F, 1965, Ann Soc Belges Med Trop Parasitol Mycol, V45, P459; CHEN L, 1982, CHINESE MED J-PEKING, V95, P281; CHOU AC, 1980, BIOCHEMISTRY-US, V19, P1543, DOI 10.1021/bi00549a600; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Griffin CE, 2012, ANTIMICROB AGENTS CH, V56, P5356, DOI 10.1128/AAC.05667-11; Hansch C., 1995, J AM CHEM SOC; IRVIN JL, 1947, J AM CHEM SOC, V69, P1091, DOI 10.1021/ja01197a034; Kubinyi H, 1979, Prog Drug Res, V23, P97; LEBRAS J, 1983, LANCET, V1, P73; McNamara J V, 1968, Clin Ter, V44, P389; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Pou S, 2012, ANTIMICROB AGENTS CH, V56, P3475, DOI 10.1128/AAC.00100-12; SCHMIDT LH, 1977, ANTIMICROB AGENTS CH, V11, P826, DOI 10.1128/AAC.11.5.826; Schneider J, 1965, Ann Soc Belges Med Trop Parasitol Mycol, V45, P435; TakacsNovak K, 1996, J PHARMACEUT BIOMED, V14, P1405, DOI 10.1016/0731-7085(96)01773-6; VENNERSTROM JL, 1992, J MED CHEM, V35, P2129, DOI 10.1021/jm00089a025; Warhurst DC, 2007, BIOCHEM PHARMACOL, V73, P1910, DOI 10.1016/j.bcp.2007.03.011; Warhurst DC, 2002, LANCET, V360, P1527, DOI 10.1016/S0140-6736(02)11577-7; WARHURST DC, 1966, T ROY SOC TROP MED H, V60, P565, DOI 10.1016/0035-9203(66)90290-2; WARHURST DC, 1967, NATURE, V214, P935, DOI 10.1038/214935a0; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160091	10.1371/journal.pone.0160091	http://dx.doi.org/10.1371/journal.pone.0160091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483471	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000381110700022
J	Yu, FY; Xu, Q; Wu, DD; Lau, ATY; Xu, YM				Yu, Fei-Yuan; Xu, Qian; Wu, Dan-Dan; Lau, Andy T. Y.; Xu, Yan-Ming			The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; MITOCHONDRIAL ROS; SIRT3 EXPRESSION; TUMOR-SUPPRESSOR; GASTRIC-CANCER; LIVER-CANCER; CARCINOGENESIS; METABOLISM; DISEASE; STRESS	Sirtuin-3 (SIRT3) is a major mitochondrial NAD(+)-dependent deacetylase and plays a key role in the progression and development of human cancers. Although the prognostic and clinicopathological features of SIRT3 expression in various cancers have been investigated by different research groups, however, inconsistent and opposing results can be observed. In this study, we therefore performed a meta-analysis to evaluate the significance of SIRT3 expression in various cancers. Systematic literature searching was performed in PubMed, Embase, China National Knowledge Infrastructure, and Wanfang Data up to November 2015. Total effect analyses and subgroup analyses were performed to evaluate the relationship between SIRT3 expression and overall survival, cancer/non-cancer tissues, lymph node metastasis, pathological differentiation, tumor node metastasis (TNM) stage, tumor size, and gender, in various cancer patients. Hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to clarify the risk or hazard association. A total of 14 studies comprising 2165 cancer patients were included to assess the association between SIRT3 immunohistochemical expression and overall survival or clinicopathological characteristics. SIRT3 expression was significantly associated with overall survival in gastric cancer (HR = 0.62, 95% CI = 0.43-0.89, P = 0.009) and hepatocellular carcinoma patients (HR = 0.56, 95% CI = 0.42-0.74, P< 0.0001), cancer/non-cancer tissues in hepatocellular carcinoma patients (OR = 0.04, 95% CI = 0.01-0.16, P< 0.0001), lymph node metastasis in breast cancer patients (OR = 2.20, 95% CI = 1.49-3.26, P< 0.0001), and also pathological differentiation in hepatocellular carcinoma patients (OR = 0.69, 95% CI = 0.48-0.98, P = 0.04) and gastric cancer patients (OR = 0.33, 95% CI = 0.21-0.50, P< 0.00001), by subgroup analyses. Furthermore, SIRT3 expression was significantly associated with pathological differentiation in total effect analysis (OR = 0.46, 95% CI = 0.29-0.74, P = 0.001). No detectable relation between SIRT3 expression and other clinicopathological parameters were found. This meta-analysis indicates that SIRT3 expression level is associated with prognostic and clinical features in specific cancers.	[Yu, Fei-Yuan; Wu, Dan-Dan; Lau, Andy T. Y.; Xu, Yan-Ming] Shantou Univ, Coll Med, Dept Cell Biol & Genet, Lab Canc Biol & Epigenet, Shantou 515041, Guangdong, Peoples R China; [Xu, Qian] Shantou Univ, Coll Med, Dept Pathol, Shantou 515041, Guangdong, Peoples R China	Shantou University; Shantou University	Lau, ATY; Xu, YM (corresponding author), Shantou Univ, Coll Med, Dept Cell Biol & Genet, Lab Canc Biol & Epigenet, Shantou 515041, Guangdong, Peoples R China.	andytylau@stu.edu.cn; amyymxu@stu.edu.cn	Xu, yanming/Q-4931-2019; Lau, Andy Tao Yin/AAX-9980-2021	Lau, Andy Tao Yin/0000-0002-7146-7789; Wu, Dan-Dan/0000-0002-8515-2614	National Natural Science Foundation of China [31271445, 31170785]; Fund for University Talents of Guangdong Province; Guangdong Natural Science Foundation of China [S2012030006289]; Department of Education, Guangdong Government under the Toptier University Development Scheme for Research and Control of Infectious Diseases	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for University Talents of Guangdong Province; Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Department of Education, Guangdong Government under the Toptier University Development Scheme for Research and Control of Infectious Diseases	This work was supported by the grants from the National Natural Science Foundation of China (Nos. 31271445 and 31170785), the Fund for University Talents of Guangdong Province, the Guangdong Natural Science Foundation of China (No. S2012030006289), and the Department of Education, Guangdong Government under the Toptier University Development Scheme for Research and Control of Infectious Diseases.	Alhazzazi Turki Y, 2013, Genes Cancer, V4, P164, DOI 10.1177/1947601913486351; Alhazzazi TY, 2012, THESIS; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14; Cui Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129834; Desouki MM, 2014, LAB INVESTIGATION, V94, p44A; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; George J, 2016, CANCER RES, V76, P2500, DOI 10.1158/0008-5472.CAN-15-2733; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; He SZ, 2014, CELL PHYSIOL BIOCHEM, V34, P2061, DOI 10.1159/000366401; Huang KH, 2014, WORLD J SURG, V38, P910, DOI 10.1007/s00268-013-2359-0; Kang L., 2014, P IEEE C COMP VIS PA, V1, P1; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Liu C, 2014, BIOMED RES INT, V2014; Liu Y., 2012, THESIS; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mushahwar IK, 2004, VIRAL HEPATITIS MOL, Vviii; Park SH, 2011, INT J MOL SCI, V12, P6226, DOI 10.3390/ijms12096226; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Quan YZ, 2015, ONCOTARGET, V6, P26494, DOI 10.18632/oncotarget.4764; Ren JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150961; Satoh Akiko, 2011, Handb Exp Pharmacol, V206, P125, DOI 10.1007/978-3-642-21631-2_7; Stehbens WE, 2004, EXP MOL PATHOL, V77, P121, DOI 10.1016/j.yexmp.2004.04.007; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Venes, 2021, TABERS CYCLOPEDIC ME, V24e; Wang JX, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-297; Yan SM, 2014, MED ONCOLOGY, V31; Yang B, 2014, BIOCHEM BIOPH RES CO, V443, P156, DOI 10.1016/j.bbrc.2013.11.068; Zhang B, 2013, ASIAN PAC J TROP MED, V6, P649, DOI 10.1016/S1995-7645(13)60112-1; Zhang C., 2012, PROPELL EXPLOS PYROT, V37, P235, DOI DOI 10.1161/HYPERTENSI0NAHA.111; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159801	10.1371/journal.pone.0159801	http://dx.doi.org/10.1371/journal.pone.0159801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483432	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110700014
J	Dong, YW; Wang, SQ; Chen, JL; Zhang, QH; Liu, Y; You, CH; Monroig, O; Tocher, DR; Li, YY				Dong, Yewei; Wang, Shuqi; Chen, Junliang; Zhang, Qinghao; Liu, Yang; You, Cuihong; Monroig, Oscar; Tocher, Douglas R.; Li, Yuanyou			Hepatocyte Nuclear Factor 4 alpha (HNF4 alpha) Is a Transcription Factor of Vertebrate Fatty Acyl Desaturase Gene as Identified in Marine Teleost Siganus canaliculatus	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; LC-PUFA BIOSYNTHESIS; FUNCTIONAL-CHARACTERIZATION; NUTRITIONAL REGULATION; ACID SYNTHESIS; EXPRESSION; DELTA-4; PROMOTER; METABOLISM; ACTIVATION	Rabbitfish Siganus canaliculatus was the first marine teleost demonstrated to have the capability of biosynthesizing long-chain polyunsaturated fatty acids (LC-PUFA) from C-18 precursors, and to possess a Delta 4 fatty acyl desaturase (Delta 4 Fad) which was the first report in vertebrates, and is a good model for studying the regulatory mechanisms of LC-PUFA biosynthesis in teleosts. In order to understand regulatory mechanisms of transcription of Delta 4 Fad, the gene promoter was cloned and characterized in the present study. An upstream sequence of 1859 bp from the initiation codon ATG was cloned as the promoter candidate. On the basis of bioinformatic analysis, several binding sites of transcription factors (TF) including GATA binding protein 2 (GATA-2), CCAAT enhancer binding protein (C/EBP), nuclear factor 1 (NF-1), nuclear factor Y (NF-Y), hepatocyte nuclear factor 4 alpha (HNF4 alpha) and sterol regulatory element (SRE), were identified in the promoter by site-directed mutation and functional assays. HNF4 alpha and NF-1 were confirmed to interact with the core promoter of Delta 4 Fad by gel shift assay and mass spectrometry. Moreover, over-expression of HNF4 alpha increased promoter activity in HEK 293T cells and mRNA level of Delta 4 Fad in rabbitfish primary hepatocytes, respectively. The results indicated that HNF4 alpha is a TF of rabbitfish Delta 4 Fad. To our knowledge, this is the first report on promoter structure of a Delta 4 Fad, and also the first demonstration of HNF4 alpha as a TF of vertebrate Fad gene involved in transcription regulation of LC-PUFA biosynthesis.	[Dong, Yewei; Wang, Shuqi; Chen, Junliang; Zhang, Qinghao; Liu, Yang; You, Cuihong; Li, Yuanyou] Shantou Univ, Inst Marine Biol, Shantou 515063, Guangdong, Peoples R China; [Dong, Yewei; Wang, Shuqi; Chen, Junliang; Zhang, Qinghao; Liu, Yang; You, Cuihong; Li, Yuanyou] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou 515063, Guangdong, Peoples R China; [Monroig, Oscar; Tocher, Douglas R.] Univ Stirling, Inst Aquaculture, Sch Nat Sci, Stirling FK9 4LA, Scotland	Shantou University; Shantou University; University of Stirling	Li, YY (corresponding author), Shantou Univ, Inst Marine Biol, Shantou 515063, Guangdong, Peoples R China.; Li, YY (corresponding author), Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou 515063, Guangdong, Peoples R China.	yyli@stu.edu.cn	Tocher, Douglas R/C-5652-2011; Monroig, Oscar/K-9117-2014	Tocher, Douglas R/0000-0002-8603-9410; Monroig, Oscar/0000-0001-8712-0440; Dong, Yewei/0000-0001-9259-953X	Major International Joint Research Project from the National Natural Science Foundation of China (NSFC) [31110103913]; NSFC General Projects [41276179]; Youth Projects [31202011, 31202012]	Major International Joint Research Project from the National Natural Science Foundation of China (NSFC); NSFC General Projects; Youth Projects	This work was financially supported by the Major International Joint Research Project from the National Natural Science Foundation of China (NSFC) (31110103913) and NSFC General Projects (No. 41276179) (http://www.nsfc.gov.cn); both are received by Yuanyou Li. In addition, the study has also been supported by Youth Projects (No. 31202011, 31202012) (http://www.nsfc.gov.cn), received by Shuqi Wang and Cuihong You. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AW, 2006, BIOCHEM J, V399, P285, DOI 10.1042/BJ20060659; Bene H, 2001, BIOCHEM BIOPH RES CO, V284, P1194, DOI 10.1006/bbrc.2001.5102; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Castro LFC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031950; Das UN, 2003, NUTRITION, V19, P62, DOI 10.1016/S0899-9007(02)00852-3; Fonseca-Madrigal J, 2014, J LIPID RES, V55, P1408, DOI 10.1194/jlr.M049791; Geay F, 2012, MAR GENOM, V5, P7, DOI 10.1016/j.margen.2011.08.003; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Kuah MK, 2015, BBA-MOL CELL BIOL L, V1851, P248, DOI 10.1016/j.bbalip.2014.12.012; Li YY, 2008, COMP BIOCHEM PHYS B, V151, P183, DOI 10.1016/j.cbpb.2008.06.013; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Meyer A, 2003, BIOCHEMISTRY-US, V42, P9779, DOI 10.1021/bi034731y; Monroig O, 2012, AQUACULTURE, V350, P63, DOI 10.1016/j.aquaculture.2012.04.017; Morais S, 2012, BBA-MOL CELL BIOL L, V1821, P660, DOI 10.1016/j.bbalip.2011.12.011; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pereira SL, 2004, BIOCHEM J, V384, P357, DOI 10.1042/BJ20040970; Qiu X, 2001, J BIOL CHEM, V276, P31561, DOI 10.1074/jbc.M102971200; Sambrook Joseph D W R, 2001, MOL CLONING; Sargent John R., 2002, P181; Sayanova O, 2011, PHYTOCHEMISTRY, V72, P594, DOI 10.1016/j.phytochem.2011.01.022; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Sprecher H, 1981, PROG LIPID RES, V20, DOI [10.1371/journal.pone.0031950, DOI 10.1371/JOURNAL.PONE.0031950]; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tang CR, 2003, J LIPID RES, V44, P686, DOI 10.1194/jlr.M200195-JLR200; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Tonon T, 2005, FEBS J, V272, P3401, DOI 10.1111/j.1742-4658.2005.04755.x; Tonon T, 2003, FEBS LETT, V553, P440, DOI 10.1016/S0014-5793(03)01078-0; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Xiao YF, 2001, P NATL ACAD SCI USA, V98, P3606, DOI 10.1073/pnas.061003798; Xie D, 2015, AQUACULT NUTR, V21, P541, DOI 10.1111/anu.12178; Xu Y, 2011, WORLD J MICROB BIOT, V27, P2931, DOI 10.1007/s11274-011-0776-5; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Zhang QH, 2014, BBA-MOL CELL BIOL L, V1841, P934, DOI 10.1016/j.bbalip.2014.03.009; Zheng XZ, 2009, COMP BIOCHEM PHYS B, V154, P255, DOI 10.1016/j.cbpb.2009.06.010; Zhu GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096503; Zhu GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084871	44	32	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160361	10.1371/journal.pone.0160361	http://dx.doi.org/10.1371/journal.pone.0160361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472219	Green Published, gold			2022-12-27	WOS:000381516300044
J	Pena-Bello, L; Pertega-Diaz, S; Sangiao-Alvarellos, S; Outeirino-Blanco, E; Eiras-Leal, R; Varela-Rodriguez, B; Juiz-Valina, P; Perez-Fontan, M; Cordido, M; Cordido, F				Pena-Bello, Lara; Pertega-Diaz, Sonia; Sangiao-Alvarellos, Susana; Outeirino-Blanco, Elena; Eiras-Leal, Raquel; Varela-Rodriguez, Barbara; Juiz-Valina, Paula; Perez-Fontan, Miguel; Cordido, Maria; Cordido, Fernando			Circulating Levels of Irisin in Hypopituitary and Normal Subjects	PLOS ONE			English	Article							BODY-COMPOSITION; WEIGHT-LOSS; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; GROWTH-HORMONE; ADIPOSE-TISSUE; OBESE MEN; ADULTS; SERUM; INDIVIDUALS	Context The recently identified myokine irisin conveys some of the benefits of exercise. Hypopituitarism with adult growth hormone deficiency (HP) is a situation characterized by decreased GH secretion and an altered body composition. Objective Our aim was to study the skeletal muscle hormone irisin in HP, and compare the results with a similar group of normal subjects. Participants and Methods Seventeen HP patients and fifty-one normal subjects of similar age and sex were studied. The diagnosis of GH deficiency was confirmed by the presence of pituitary disease and a peak GH secretion below 3 mu g/L after an insulin tolerance test. The patients were adequately treated for all pituitary hormone deficits, except for GH. Fasting serum irisin was measured with an enzyme immunoassay, and HOMA-IR, QUICKI and HOMA-beta were calculated. Results Fasting irisin levels (ng/ml) were similar in normal [208.42 (168.44-249.23)] and HP patients [195.13 (178.44-241.44)]. In the control group there were moderate significant positive correlations between irisin and BMI, waist circumference, leptin, fasting insulin, HOMA-IR, HOMA-beta, triglycerides, and cholesterol. In the control group there were moderate significant negative correlations between irisin and IGF-I and QUICKI. In the hypopituitary group there were moderate significant positive correlations between irisin and body fat and HOMA-beta. Conclusions We found similar irisin levels in GH deficiency hypopituitary patients when compared with normal subjects. The correlation between irisin and adiposity related factors suggests that that in the case of this clinical model, irisin is regulated by adiposity and not by GH.	[Pena-Bello, Lara; Sangiao-Alvarellos, Susana; Varela-Rodriguez, Barbara; Juiz-Valina, Paula; Cordido, Fernando] Univ A Coruna, Dept Med, Fac Hlth Sci, La Coruna, Spain; [Pena-Bello, Lara; Sangiao-Alvarellos, Susana; Varela-Rodriguez, Barbara; Juiz-Valina, Paula; Perez-Fontan, Miguel; Cordido, Maria; Cordido, Fernando] Univ Hosp A Coruna, Inst Invest Biomed INIBIC, La Coruna, Spain; [Pertega-Diaz, Sonia] Univ Hosp A Coruna, Clin Epidemiol & Biostat Unit, La Coruna, Spain; [Outeirino-Blanco, Elena; Eiras-Leal, Raquel; Cordido, Fernando] Univ Hosp A Coruna, Dept Endocrinol, La Coruna, Spain	Universidade da Coruna; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Cordido, F (corresponding author), Univ A Coruna, Dept Med, Fac Hlth Sci, La Coruna, Spain.; Cordido, F (corresponding author), Univ Hosp A Coruna, Inst Invest Biomed INIBIC, La Coruna, Spain.; Cordido, F (corresponding author), Univ Hosp A Coruna, Dept Endocrinol, La Coruna, Spain.	Fernando.Cordido.Carballido@sergas.es	Sangiao-Alvarellos, Susana/J-1758-2016; Cordido, Maria/ABF-8737-2020; Sangiao-Alvarellos, Susana/AAQ-5752-2020; PENA, LARA/ABF-9908-2020; Perez-Fontán, Miguel/ABG-4064-2020; Cordido, Fernando/L-6175-2019; Pértega-Díaz, Sonia/E-4353-2013; Juiz-Valina, Paula/E-7562-2018	Sangiao-Alvarellos, Susana/0000-0003-1207-4667; Cordido, Maria/0000-0003-3549-6360; Sangiao-Alvarellos, Susana/0000-0003-1207-4667; Perez-Fontán, Miguel/0000-0001-7027-2296; Pértega-Díaz, Sonia/0000-0003-3891-3203; Juiz-Valina, Paula/0000-0003-4667-1224; Cordido, Fernando/0000-0003-3528-8174; Varela-Rodriguez, Barbara Maria/0000-0001-5350-4534	FIS del Instituto de Salud Carlos III (FEDER from E.U.) [PI10/00088, PI13/00322]; Xunta de Galicia, Spain [IN845B-2010/187, 10CSA916014PR, CN2012/312]	FIS del Instituto de Salud Carlos III (FEDER from E.U.); Xunta de Galicia, Spain(Xunta de Galicia)	This work was supported in part by FIS del Instituto de Salud Carlos III PI10/00088, PI13/00322 (FEDER from E.U.) and Xunta de Galicia IN845B-2010/187, 10CSA916014PR, CN2012/312, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported in part by: FIS del Instituto de Salud Carlos III PI10/00088, PI13/00322 (FEDER from E.U.) and Xunta de Galicia IN845B-2010/187, 10CSA916014PR, CN2012/312, Spain.	Anastasilakis AD, 2014, J CLIN ENDOCR METAB, V99, P3247, DOI 10.1210/jc.2014-1367; Aydin S, 2014, PEPTIDES, V56, P94, DOI 10.1016/j.peptides.2014.03.021; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Chen JQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/1476-511X-14-2; Chen JQ, 2015, EXP CLIN ENDOCRINOL, DOI [10.1055/s-0035-1565060, DOI 10.1055/S-0035-1565060]; Choi HY, 2014, J CLIN ENDOCR METAB, V99, P2778, DOI 10.1210/jc.2014-1195; Choi YK, 2013, DIABETES RES CLIN PR, V100, P96, DOI 10.1016/j.diabres.2013.01.007; Crujeiras AB, 2015, CLIN ENDOCRINOL, V82, P467, DOI 10.1111/cen.12627; Crujeiras AB, 2014, AM J HUM BIOL, V26, P198, DOI 10.1002/ajhb.22493; DeFronzo RA, 2013, DIABETES CARE, V36, P3607, DOI 10.2337/dc13-0520; Elbornsson M, 2013, EUR J ENDOCRINOL, V168, P745, DOI 10.1530/EJE-12-1083; Gavrieli A, 2016, INT J OBESITY, V40, P1461, DOI 10.1038/ijo.2016.99; Gomes-Santos E, 2014, J CLIN ENDOCR METAB, V99, P3285, DOI 10.1210/jc.2014-2132; Huh JY, 2015, J CLIN ENDOCR METAB, V100, pE453, DOI 10.1210/jc.2014-2416; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Jedrychowski MP, 2015, CELL METAB, V22, P734, DOI 10.1016/j.cmet.2015.08.001; Katznelson L, 2009, PITUITARY, V12, P136, DOI 10.1007/s11102-008-0104-8; Li MY, 2015, J CLIN ENDOCR METAB, V100, P1485, DOI 10.1210/jc.2014-2544; Loffler D, 2015, J CLIN ENDOCR METAB, V100, P1289, DOI 10.1210/jc.2014-2932; Lopez-Legarrea P, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.7; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Moreno M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124100; Newman CB, 2015, PITUITARY, V18, P297, DOI 10.1007/s11102-014-0571-z; Nygaard H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121367; Oliveira CRP, 2012, J CLIN ENDOCR METAB, V97, P1013, DOI 10.1210/jc.2011-2590; Palacios-Gonzalez B, 2015, OBESITY, V23, P729, DOI 10.1002/oby.21029; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Reinehr T, 2015, J CLIN ENDOCR METAB, V100, P2123, DOI 10.1210/jc.2015-1208; Roca-Rivada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060563; Sesti G, 2014, ACTA DIABETOL, V51, P705, DOI 10.1007/s00592-014-0576-0; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Srinivasa S, 2016, GROWTH HORM IGF RES, V26, P36, DOI 10.1016/j.ghir.2015.12.008; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Yan Bing, 2014, PLoS One, V9, pe94235, DOI 10.1371/journal.pone.0094235; Zhang C, 2016, J DIABETES, V8, P56, DOI 10.1111/1753-0407.12256	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160364	10.1371/journal.pone.0160364	http://dx.doi.org/10.1371/journal.pone.0160364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472279	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300045
J	Gilli, F; Chen, X; Pachner, AR; Gimi, B				Gilli, Francesca; Chen, Xi; Pachner, Andrew R.; Gimi, Barjor			High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; SUBSEQUENT DEMYELINATING DISEASE; INTRATHECAL ANTIBODY-PRODUCTION; THEILERS VIRUS-INFECTION; CHRONIC RESTRAINT STRESS; AXONAL INJURY; WHITE-MATTER; MURINE MODEL; MOUSE MODEL	Disease in the spinal cord is a major component of disability in multiple sclerosis, yet current techniques of imaging spinal cord injury are insensitive and nonspecific. This study seeks to remove this major impediment to research in multiple sclerosis and other spinal cord diseases by identifying reliable biomarkers of disability progression using diffusion tensor imaging (DTI), a magnetic resonance imaging technique, to evaluate the spinal cord in a model of multiple sclerosis, i.e. the Theiler's Murine Encephalitis Virus-Induced Demyelinating Disease (TMEV-IDD). Mice with TMEV-IDD with varying levels of clinical disease were imaged using a 9.4T small animal MRI scanner. Axial diffusivity, radial diffusivity, and fractional anisotropy were calculated. Disability was assessed periodically using Rotarod assay and data were expressed as a neurological function index. Correlation was performed between DTI measurements and disability scores. TMEV-IDD mice displayed significant increased neurological deficits over time when compared with controls (p<0.0001). Concurrently, the values of fractional anisotropy and axial diffusivity were both decreased compared to controls (both p<0.0001), while radial diffusivity was increased (p<0.0001). Overall, fractional anisotropy changes were larger in white matter than in grey matter and differences were more pronounced in the ventral region. Lower disability scores were associated with decreased fractional anisotropy values measured in the ventral (r = 0.68; p<0.0001) and ventral-lateral (r = 0.70; p<0.0001) regions of the white matter. These data demonstrate that DTI measures of the spinal cord contribute to strengthening the association between neuroradiological markers and clinical disability, and support the use of DTI measures in spinal cord imaging in MS patients.	[Gilli, Francesca; Pachner, Andrew R.] Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH 03755 USA; [Chen, Xi; Gimi, Barjor] Geisel Sch Med Dartmouth, Dept Radiol, Hanover, NH USA	Dartmouth College; Dartmouth College	Gilli, F (corresponding author), Geisel Sch Med Dartmouth, Dept Neurol, Hanover, NH 03755 USA.	Francesca.Gilli@dartmouth.edu	Chen, Xi/E-7514-2011; Gilli, Francesca/H-4428-2019	Gilli, Francesca/0000-0002-2306-458X	Dartmouth Clinical and Translational Science Institute from National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR001086]; NIH [1S10RR025048-01]	Dartmouth Clinical and Translational Science Institute from National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Dartmouth Clinical and Translational Science Institute, under award number UL1TR001086 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The 9.4T small animal MRI scanner was purchased with NIH grant fund number 1S10RR025048-01.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Begolka WS, 1998, J IMMUNOL, V161, P4437; Bjartmar C, 2003, NEUROTOX RES, V5, P157, DOI 10.1007/BF03033380; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Bruck W, 2005, J NEUROL, V252, pV3, DOI 10.1007/s00415-005-5002-7; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cruz-Orengo L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-170; Fu YH, 2013, BRAIN STRUCT FUNCT, V218, P1337, DOI 10.1007/s00429-012-0462-x; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Gilli F, 2015, J NEUROL SCI, V359, P40, DOI 10.1016/j.jns.2015.10.012; Hesseltine SM, 2006, AM J NEURORADIOL, V27, P1189; Hubbard EA, 2016, J NEUROL SCI, V363, P225, DOI 10.1016/j.jns.2016.02.044; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Li L, 2011, EFFECT FTY720 UNPUB; Li LB, 2006, J NEUROIMMUNOL, V173, P56, DOI 10.1016/j.jneuroim.2005.11.019; Li LB, 2011, J NEUROL SCI, V308, P41, DOI 10.1016/j.jns.2011.06.029; LIPTON HL, 1979, INFECT IMMUN, V26, P369, DOI 10.1128/IAI.26.1.369-374.1979; LIPTON HL, 1975, INFECT IMMUN, V11, P1147, DOI 10.1128/IAI.11.5.1147-1155.1975; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; McCarthy Derrick P, 2012, Methods Mol Biol, V900, P381, DOI 10.1007/978-1-60761-720-4_19; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; McGavern DB, 1999, EXP NEUROL, V158, P171, DOI 10.1006/exnr.1999.7082; Mecha M, 2013, PROG NEUROBIOL, V101, P46, DOI 10.1016/j.pneurobio.2012.11.003; Naismith RT, 2013, NEUROLOGY, V80, P2201, DOI 10.1212/WNL.0b013e318296e8f1; Narayan K, 2005, ANN NEUROL, V57, P813, DOI 10.1002/ana.20486; Oh J, 2015, NEUROLOGY, V84, P720, DOI 10.1212/WNL.0000000000001257; Oh J, 2013, NEUROLOGY, V80, P540, DOI 10.1212/WNL.0b013e31828154c5; Ohgiya Y, 2007, EUR RADIOL, V17, P2499, DOI 10.1007/s00330-007-0672-4; Pachner AR, 2007, J NEUROIMMUNOL, V190, P112, DOI 10.1016/j.jneuroim.2007.09.001; Pachner AR, 2007, J NEUROIMMUNOL, V185, P57, DOI 10.1016/j.jneuroim.2007.01.017; Pachner AR, 2011, CURR OPIN NEUROL, V24, P291, DOI 10.1097/WCO.0b013e328346c226; Pachner AR, 2011, J NEUROIMMUNOL, V232, P35, DOI 10.1016/j.jneuroim.2010.09.026; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; Rush CA, 2015, NAT REV NEUROL, V11, P379, DOI 10.1038/nrneurol.2015.85; Sieve AN, 2006, J NEUROIMMUNOL, V177, P46, DOI 10.1016/j.jneuroim.2006.04.020; Sieve AN, 2004, J NEUROIMMUNOL, V155, P103, DOI 10.1016/j.jneuroim.2004.06.006; Singhi S, 2012, J NEURORADIOLOGY, V39, P142, DOI 10.1016/j.neurad.2011.05.002; Soldan MMP, 2015, J NEUROIMAGING, V25, P595, DOI 10.1111/jon.12250; Tench CR, 2005, J NEUROIMAGING, V15, p94S, DOI 10.1177/1051228405283292; Ulrich R, 2010, J CELL MOL MED, V14, P434, DOI 10.1111/j.1582-4934.2008.00646.x; Underwood CK, 2011, NEUROIMAGE, V55, P455, DOI 10.1016/j.neuroimage.2010.12.044; Valsasina P, 2005, NEUROIMAGE, V26, P822, DOI 10.1016/j.neuroimage.2005.02.033; Valsecchi V, 2013, HEALTH, V5, P1712, DOI DOI 10.4236/HEALTH.2013.510231; Van Hecke W, 2009, J MAGN RESON IMAGING, V30, P25, DOI 10.1002/jmri.21817; Wang XJ, 2013, NMR BIOMED, V26, P1742, DOI 10.1002/nbm.3012; Wilm BJ, 2007, MAGN RESON MED, V57, P625, DOI 10.1002/mrm.21167; Wilm BJ, 2009, NMR BIOMED, V22, P174, DOI 10.1002/nbm.1298	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160071	10.1371/journal.pone.0160071	http://dx.doi.org/10.1371/journal.pone.0160071			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467829	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100102
J	Moewis, P; Duda, GN; Jung, T; Heller, MO; Boeth, H; Kaptein, B; Taylor, WR				Moewis, Philippe; Duda, Georg N.; Jung, Tobias; Heller, Markus O.; Boeth, Heide; Kaptein, Bart; Taylor, William R.			The Restoration of Passive Rotational Tibio-Femoral Laxity after Anterior Cruciate Ligament Reconstruction	PLOS ONE			English	Article							IN-VIVO; KNEE LAXITY; POSTEROLATERAL BUNDLES; MEASUREMENT DEVICE; PART I; MODEL; KINEMATICS; TRANSLATION; RELIABILITY; DEFICIENT	While the anterior cruciate ligament (ACL) is considered one of the most important ligaments for providing knee joint stability, its influence on rotational laxity is not fully understood and its role in resisting rotation at different flexion angles in vivo remains unknown. In this prospective study, we investigated the relationship between in vivo passive axial rotational laxity and knee flexion angle, as well as how they were altered with ACL injury and reconstruction. A rotometer device was developed to assess knee joint rotational laxity under controlled passive testing. An axial torque of +/- 2.5Nm was applied to the knee while synchronised fluoroscopic images of the tibia and femur allowed axial rotation of the bones to be accurately determined. Passive rotational laxity tests were completed in 9 patients with an untreated ACL injury and compared to measurements at 3 and 12 months after anatomical single bundle ACL reconstruction, as well as to the contralateral controls. Significant differences in rotational laxity were found between the injured and the healthy contralateral knees with internal rotation values of 8.7 degrees +/- 4.0 degrees and 3.7 degrees++/- 1.4 degrees (p = 0.003) at 30 degrees of flexion and 9.3 degrees +/- 2.6 degrees and 4.0 degrees +/- 2.0 degrees (p = 0.001) at 90 degrees respectively. After 3 months, the rotational laxity remained similar to the injured condition, and significantly different to the healthy knees. However, after 12 months, a considerable reduction of rotational laxity was observed towards the levels of the contralateral controls. The significantly greater laxity observed at both knee flexion angles after 3 months (but not at 12 months), suggests an initial lack of post-operative rotational stability, possibly due to reduced mechanical properties or fixation stability of the graft tissue. After 12 months, reduced levels of rotational laxity compared with the injured and 3 month conditions, both internally and externally, suggests progressive rotational stability of the reconstruction with time.	[Moewis, Philippe; Duda, Georg N.; Boeth, Heide] Charite, Julius Wolff Inst, Berlin, Germany; [Jung, Tobias] Charite, Knee Surg & Sports Traumatol, Ctr Musculoskeletal Surg, Berlin, Germany; [Heller, Markus O.] Univ Southhampton, Bioengn Res Grp, Southampton, Hants, England; [Kaptein, Bart] Leiden Univ, Med Ctr, Dept Orthopaed Surg, Biomech & Imaging Grp, Leiden, Netherlands; [Taylor, William R.] Swiss Fed Inst Technol, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Southampton; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Moewis, P (corresponding author), Charite, Julius Wolff Inst, Berlin, Germany.	philippe.moewis@charite.de	Kaptein, Bart L./F-6685-2011; Heller, Markus O/F-8437-2010; Duda, Georg N/H-2085-2016; Taylor, William R./F-8692-2010	Kaptein, Bart L./0000-0001-8772-9985; Heller, Markus O/0000-0002-7879-1135; Duda, Georg N/0000-0001-7605-3908; Taylor, William R./0000-0003-4060-4098; Moewis, Philippe/0000-0002-0957-6300	European Union Seventh Framework Programme (FP7) [ICT-2009.5.2MXL 248693]	European Union Seventh Framework Programme (FP7)	The study was supported by the European Union Seventh Framework Programme (FP7/2007-2013 ICT-2009.5.2MXL 248693).	Almquist PO, 2013, J ORTHOP RES, V31, P23, DOI 10.1002/jor.22184; AMIS AA, 1991, J BONE JOINT SURG BR, V73, P260, DOI 10.1302/0301-620X.73B2.2005151; Anderson A F, 2000, Am J Knee Surg, V13, P19; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; Boeth H, 2013, AM J SPORTS MED; Branch TP, 2010, KNEE SURG SPORT TR A, V18, P1379, DOI 10.1007/s00167-009-1010-y; Branch TP, 2010, ARTHROSCOPY, V26, P997, DOI 10.1016/j.arthro.2010.01.019; Bull AMJ, 2002, J BONE JOINT SURG BR, V84B, P1075, DOI 10.1302/0301-620X.84B7.13094; Colombet P, 2012, ORTHOP TRAUMATOL-SUR, V98, pS201, DOI 10.1016/j.otsr.2012.10.005; Cross M, 1996, SPORTS MED ARTHROSC, V4, P313; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Garling EH, 2005, J BIOMECH, V38, P893, DOI 10.1016/j.jbiomech.2004.04.026; Heller MO, 2007, J BIOMECH, V40, pS45, DOI 10.1016/j.jbiomech.2007.03.005; Hemmerich A, 2012, CLIN BIOMECH, V27, P607, DOI 10.1016/j.clinbiomech.2012.01.005; Hoff WA, 1998, CLIN BIOMECH, V13, P455, DOI 10.1016/S0268-0033(98)00009-6; Hoshino Y, 2007, AM J SPORT MED, V35, P1098, DOI 10.1177/0363546507299447; HSIEH HH, 1976, J BONE JOINT SURG AM, V58, P87, DOI 10.2106/00004623-197658010-00016; Imbert P, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-86; Kanamori A, 2002, ARTHROSCOPY, V18, P394, DOI 10.1053/jars.2002.30638; Kapandji IA, 1987, PHYSL JOINTS, V2; Kaptein BL, 2004, P I MECH ENG H, V218, P231, DOI 10.1243/0954411041561036; Koo S, 2008, J BIOMECH, V41, P1269, DOI 10.1016/j.jbiomech.2008.01.013; Kothari A, 2012, KNEE, V19, P648, DOI 10.1016/j.knee.2011.12.001; KUROSAWA H, 1991, CLIN ORTHOP RELAT R, P233; Lacoste C, 2007, KNEE, V14, P289, DOI 10.1016/j.knee.2007.04.009; LIPKE JM, 1981, J BONE JOINT SURG AM, V63, P954, DOI 10.2106/00004623-198163060-00013; List R, 2012, FOOT ANKLE INT, V33, P883, DOI 10.3113/FAI.2012.0883; Lorbach O, 2012, KNEE SURG SPORT TR A, V20, P844, DOI 10.1007/s00167-011-1635-5; Lorbach O, 2010, AM J SPORT MED, V38, P721, DOI 10.1177/0363546509353133; Lorbach O, 2009, KNEE SURG SPORT TR A, V17, P920, DOI 10.1007/s00167-009-0772-6; Lorbach O, 2009, KNEE SURG SPORT TR A, V17, P756, DOI 10.1007/s00167-009-0756-6; Louboutin H, 2009, KNEE, V16, P239, DOI 10.1016/j.knee.2008.11.004; Lubowitz JH, 2008, AM J SPORT MED, V36, P577, DOI 10.1177/0363546507312641; Ma CB, 2000, J ORTHOPAED RES, V18, P176, DOI 10.1002/jor.1100180203; Mannel H, 2004, CLIN BIOMECH, V19, P130, DOI 10.1016/j.clinbiomech.2003.11.007; Mayr HO, 2010, ARTHROSKOPIE, V23, P56, DOI 10.1007/s00142-009-0546-7; Mayr HO, 2016, ARTHROSCOPY, V32, P34, DOI 10.1016/j.arthro.2015.06.029; Mayr HO, 2011, ARTHROSCOPY, V27, P1096, DOI 10.1016/j.arthro.2011.02.034; MCQUADE K J, 1989, Journal of Orthopaedic and Sports Physical Therapy, V11, P146; Moewis P, 2012, MED ENG PHYS, V34, P1427, DOI 10.1016/j.medengphy.2012.01.007; Moewis P, 2014, MED ENG PHYS; Mouton C, 2012, KNEE SURG SPORT TR A, V20, P645, DOI 10.1007/s00167-011-1877-2; Musahl V, 2007, KNEE SURG SPORT TR A, V15, P1009, DOI 10.1007/s00167-007-0317-9; NIELSEN S, 1984, ARCH ORTHOP TRAUM SU, V103, P170, DOI 10.1007/BF00435549; Palmer I, 2007, CLIN ORTHOP RELAT R, P17, DOI 10.1097/BLO.0b013e31802c7915; Pappas E, 2013, KNEE SURG SPORT TR A, V21, P755, DOI 10.1007/s00167-012-1955-0; Park HS, 2008, J ORTHOP RES, V26, P937, DOI 10.1002/jor.20576; REUBEN JD, 1989, AM J SPORT MED, V17, P463, DOI 10.1177/036354658901700403; Sadoghi P, 2011, INT ORTHOP, V35, P127, DOI 10.1007/s00264-010-1037-1; SAPEGA AA, 1990, J BONE JOINT SURG AM, V72A, P259, DOI 10.2106/00004623-199072020-00015; Scott WN, 2006, SURG KNEE; Segawa H, 2001, KNEE, V8, P5, DOI 10.1016/S0968-0160(00)00062-4; Shultz SJ, 2007, J ORTHOP RES, V25, P981, DOI 10.1002/jor.20397; Strobel MJ, 2007, ARTHROSKOPIE; Trojani C, 2011, KNEE SURG SPORT TR A, V19, P196, DOI 10.1007/s00167-010-1201-6; Tsai AG, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-35; WANG CJ, 1974, J BONE JOINT SURG AM, VA 56, P161, DOI 10.2106/00004623-197456010-00017; Wassilew GI, 2010, ARTHROSCOPY, V26, P1096, DOI 10.1016/j.arthro.2009.12.018; Weiler A, 2004, AM J SPORT MED, V32, P881, DOI 10.1177/0363546503261711; Weiler A, 2002, ARTHROSCOPY, V18, P113, DOI 10.1053/jars.2002.30656; Zantop T, 2007, AM J SPORT MED, V35, P223, DOI 10.1177/0363546506294571	61	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159600	10.1371/journal.pone.0159600	http://dx.doi.org/10.1371/journal.pone.0159600			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467744	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100041
J	Gosset, M; Hamy, AS; Mallon, P; Delomenie, M; Mouttet, D; Pierga, JY; Lae, M; Fourquet, A; Rouzier, R; Reyal, F; Feron, JG				Gosset, Marie; Hamy, Anne-Sophie; Mallon, Peter; Delomenie, Myriam; Mouttet, Delphine; Pierga, Jean-Yves; Lae, Marick; Fourquet, Alain; Rouzier, Roman; Reyal, Fabien; Feron, Jean-Guillaume			Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; 20-YEAR FOLLOW-UP; LOCAL RECURRENCE; LOCOREGIONAL RECURRENCES; CONSERVATION THERAPY; RADICAL-MASTECTOMY; RADIATION-THERAPY; REPEAT LUMPECTOMY; CANCER; CHEMOTHERAPY	Background The poor prognosis of patients who experience ipsilateral breast tumor recurrence (IBTR) after breast conserving surgery (BCS) is established. A short time between primary cancer and IBTR is a prognostic factor but no clinically relevant threshold was determined. Classification of IBTR may help tailor treatment strategies. Purpose We determined a specific time frame, which differentiates IBTR into early and late recurrence, and identified prognostic factors for patients with IBTR at time of the recurrence. Methods We analyzed 2209 patients with IBTR after BCS. We applied the optimal cut-points method for survival data to determine the cut-off times to IBTR. A subgroup analysis was performed by hormone receptor (HR) status. Survival analyses were performed using a Cox proportional hazard model to determine clinical features associated with distant-disease-free survival (DDFS) after IBTR. We therefor built decision trees. Results On the 828 metastatic events observed, the majority occurred within the first 3 months after IBTR: 157 in the HR positive group, 98 in the HR negative group. We found different prognostic times to IBTR: 49 months in the HR positive group, 33 in the HR negative group. After multivariate analysis, time to IBTR was the first discriminant prognostic factor in both groups (HR 0.65 CI95%[0.54-0.79] and 0.42 [0.30-0.57] respectively). The other following variables were significantly correlated with the DDFS: the initial number of positive lymph nodes for both groups, the initial tumor size and grade for HR positive tumors. Conclusion A short interval time to IBTR is the strongest factor of poor prognosis and reflects occult distant disease. It would appear that prognosis after IBTR depends more on clinical and histological parameters than on surgical treatment. A prospective trial in a low-risk group of patients to validate the safety of salvage BCS instead of mastectomy in IBTR is needed.	[Gosset, Marie; Hamy, Anne-Sophie; Delomenie, Myriam; Mouttet, Delphine; Rouzier, Roman; Reyal, Fabien; Feron, Jean-Guillaume] Inst Curie, Dept Surg, F-75005 Paris, France; [Mallon, Peter] Belfast City Hosp, Breast Unit, Lisburn Rd, Belfast BT9 7AB, Antrim, North Ireland; [Pierga, Jean-Yves] Inst Curie, Dept Med Oncol, F-75005 Paris, France; [Pierga, Jean-Yves] Paris Descartes Univ, F-75006 Paris, France; [Lae, Marick] Inst Curie, Dept Tumor Biol, F-75005 Paris, France; [Fourquet, Alain] Inst Curie, Dept Radiotherapy, F-75005 Paris, France; [Reyal, Fabien] Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment Lab, F-75005 Paris, France; [Reyal, Fabien] Inst Curie, Immun & Canc UMR932, INSERM, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Belfast City Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite	Reyal, F (corresponding author), Inst Curie, Dept Surg, F-75005 Paris, France.; Reyal, F (corresponding author), Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment Lab, F-75005 Paris, France.; Reyal, F (corresponding author), Inst Curie, Immun & Canc UMR932, INSERM, F-75005 Paris, France.	fabien.reyal@curie.fr	; Rouzier, Roman/G-2953-2018	Gosset, Marie/0000-0001-8291-9843; Rouzier, Roman/0000-0002-8167-6808				Abe O, 2005, LANCET, V366, P2087; Aebi S, 2014, LANCET ONCOL, V15, P156, DOI 10.1016/S1470-2045(13)70589-8; Alpert TE, 2005, INT J RADIAT ONCOL, V63, P845, DOI 10.1016/j.ijrobp.2005.02.035; Anderson SJ, 2009, J CLIN ONCOL, V27, P2466, DOI 10.1200/JCO.2008.19.8424; [Anonymous], 2013, J NATL COMPR CANC NE, V11, pxxxii; ANSINK AC, 1994, GYNECOL ONCOL, V52, P180, DOI 10.1006/gyno.1994.1028; Bouganim N, 2013, BREAST CANCER RES TR, V139, P603, DOI 10.1007/s10549-013-2561-7; Chadha M, 2008, BRACHYTHERAPY, V7, P22, DOI 10.1016/j.brachy.2007.10.006; Chen SL, 2008, AM J SURG, V196, P495, DOI 10.1016/j.amjsurg.2008.06.018; Cheng SH, 2006, J CLIN ONCOL, V24, P4594, DOI 10.1200/JCO.2005.02.5676; Clemons M, 2001, CANCER TREAT REV, V27, P67, DOI 10.1053/ctrv.2000.0204; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Dragun AE, 2013, AM J CLIN ONCOL-CANC, V36, P375, DOI 10.1097/COC.0b013e318248da47; FISHER B, 1991, LANCET, V338, P327, DOI 10.1016/0140-6736(91)90475-5; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Fodor J, 2008, BREAST, V17, P302, DOI 10.1016/j.breast.2007.11.004; Gage I, 1996, CANCER-AM CANCER SOC, V78, P1921, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-#; Galper S, 2005, INT J RADIAT ONCOL, V61, P348, DOI 10.1016/j.ijrobp.2004.06.011; Gentilini O, 2012, ANN SURG ONCOL, V19, P3771, DOI 10.1245/s10434-012-2404-5; Hannoun-Levi JM, 2004, INT J RADIAT ONCOL, V60, P1385, DOI 10.1016/j.ijrobp.2004.05.035; Houssami N, 2010, EUR J CANCER, V46, P3219, DOI 10.1016/j.ejca.2010.07.043; Huang E, 2002, CANCER, V95, P2059, DOI 10.1002/cncr.10952; Ishitobi M, 2011, ONCOLOGY-BASEL, V81, P381, DOI 10.1159/000335265; Ishitobi M, 2011, ANTICANCER RES, V31, P367; Kim HJ, 2015, J BREAST CANCER, V18, P371, DOI 10.4048/jbc.2015.18.4.371; Komoike Y, 2003, ONCOLOGY-BASEL, V64, P1, DOI 10.1159/000066512; Komoike Yoshifumi, 2005, Breast Cancer, V12, P104, DOI 10.2325/jbcs.12.104; Kuerer HM, 2004, CANCER-AM CANCER SOC, V100, P2269, DOI 10.1002/cncr.20257; Kummerow KL, 2015, JAMA SURG, V150, P9, DOI 10.1001/jamasurg.2014.2895; KURTZ JM, 1989, CANCER, V63, P1912, DOI 10.1002/1097-0142(19890515)63:10<1912::AID-CNCR2820631007>3.0.CO;2-Y; KURTZ JM, 1991, EUR J CANCER, V27, P240, DOI 10.1016/0277-5379(91)90505-8; Lee JH, 2015, J BREAST CANCER, V18, P386, DOI 10.4048/jbc.2015.18.4.386; Melvin JC, 2016, BRIT J CANCER, V114, P88, DOI 10.1038/bjc.2015.314; Moarii M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103986; Murthy V, 2013, BREAST J, V19, P571, DOI 10.1111/j.1524-4741.2011.01220.x; Nicholson RM, 2007, BREAST, V16, P396, DOI 10.1016/j.breast.2007.01.009; Nimeus-Malmstrom E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1997; Nishimura Seiichiro, 2005, Breast Cancer, V12, P112, DOI 10.2325/jbcs.12.112; Nottage MK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1531; Nuyten DSA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1614; Panet-Raymond V, 2011, INT J RADIAT ONCOL, V81, P409, DOI 10.1016/j.ijrobp.2010.05.063; Park CC, 2000, J CLIN ONCOL, V18, P1668, DOI 10.1200/JCO.2000.18.8.1668; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Sanghani M, 2010, J CLIN ONCOL, V28, P718, DOI 10.1200/JCO.2009.22.6662; Schlechter BL, 2004, J CLIN ONCOL, V22, P1830, DOI 10.1200/JCO.2004.05.123; Smith TE, 2000, INT J RADIAT ONCOL, V48, P1281, DOI 10.1016/S0360-3016(00)01378-X; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spatuzzi R, 2016, BREAST CARE, V11, P28, DOI 10.1159/000443493; Taghian A, 2004, J CLIN ONCOL, V22, P4247, DOI 10.1200/JCO.2004.01.042; TOTH BA, 1991, PLAST RECONSTR SURG, V87, P1048, DOI 10.1097/00006534-199106000-00006; Trombetta M, 2008, BRACHYTHERAPY, V7, P29, DOI 10.1016/j.brachy.2007.12.001; van der Sangen MJC, 2006, EJSO-EUR J SURG ONC, V32, P34, DOI 10.1016/j.ejso.2005.10.005; VERONESI U, 1995, J NATL CANCER I, V87, P19, DOI 10.1093/jnci/87.1.19; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 1977, World J Surg, V1, P324; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; Vicini FA, 2007, CANCER-AM CANCER SOC, V109, P1264, DOI 10.1002/cncr.22529; Vila J, 2014, J SURG ONCOL; Waeber M, 2003, ANN ONCOL, V14, P1215, DOI 10.1093/annonc/mdg347; Wapnir IL, 2006, J CLIN ONCOL, V24, P2028, DOI 10.1200/JCO.2005.04.3273; Wapnir IL, 2008, ANN SURG ONCOL, V15, P3227, DOI 10.1245/s10434-008-0129-2; Wapnir IL, 2008, CLIN BREAST CANCER, V8, P287, DOI 10.3816/CBC.2008.n.035; Weigelt B, 2012, NAT REV CLIN ONCOL, V9, P58, DOI 10.1038/nrclinonc.2011.125; Yi M, 2011, ANN SURG, V253, P572, DOI 10.1097/SLA.0b013e318208fc2a	65	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0159888	10.1371/journal.pone.0159888	http://dx.doi.org/10.1371/journal.pone.0159888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494111	gold, Green Published			2022-12-27	WOS:000381369500014
J	Scheuer, S; Haase, D; Volk, M				Scheuer, Sebastian; Haase, Dagmar; Volk, Martin			On the Nexus of the Spatial Dynamics of Global Urbanization and the Age of the City	PLOS ONE			English	Article							LAND-USE CHANGE; PERI-URBANIZATION; URBAN; POPULATION; TRENDS; EVOLUTION; GROWTH; COVER; AREA	A number of concepts exist regarding how urbanization can be described as a process. Understanding this process that affects billions of people and its future development in a spatial manner is imperative to address related issues such as human quality of life. In the focus of spatially explicit studies on urbanization is typically a city, a particular urban region, an agglomeration. However, gaps remain in spatially explicit global models. This paper addresses that issue by examining the spatial dynamics of urban areas over time, for a full coverage of the world. The presented model identifies past, present and potential future hotspots of urbanization as a function of an urban area's spatial variation and age, whose relation could be depicted both as a proxy and as a path of urban development.	[Scheuer, Sebastian; Haase, Dagmar] Humboldt Univ, Landscape Ecol Lab, Dept Geog, Berlin, Germany; [Haase, Dagmar; Volk, Martin] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Saxony, Germany	Humboldt University of Berlin; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Scheuer, S (corresponding author), Humboldt Univ, Landscape Ecol Lab, Dept Geog, Berlin, Germany.	sebastian.scheuer@geo.hu-berlin.de	Volk, Martin/F-1172-2010	Volk, Martin/0000-0003-0064-8133				Alonso W., 1964, LOCATION LAND USE GE, DOI [10.4159/harvard.9780674730854, DOI 10.4159/HARVARD.9780674730854]; Amati M, 2006, LANDSCAPE URBAN PLAN, V75, P125, DOI 10.1016/j.landurbplan.2004.12.007; Angel S., 2010, ATLAS URBAN EXPANSIO; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Boone CG, 2014, STRUNGMANN FORUM REP, P313; Burgess E. W., 1925, CITY SUGGESTIONS INV, P47, DOI DOI 10.1007/978-0-387-73412-5_5; Clout HD, 1972, GEOGRAPHY POSTWAR FR; Cohen B, 2004, WORLD DEV, V32, P23, DOI 10.1016/j.worlddev.2003.04.008; Desmet K, 2017, J URBAN ECON, V98, P50, DOI 10.1016/j.jue.2015.03.004; Feng HH, 2014, ADV SPACE RES, V53, P463, DOI 10.1016/j.asr.2013.11.028; Fragkias M., 2013, URBANIZATION BIODIVE, P409, DOI [10.1007/978-94-007-7088-1_21, DOI 10.1007/978-94-007-7088-1_21]; Friedmann J., 1966, REGIONAL DEV POLICY; Giesen K, 2014, EUR ECON REV, V71, P193, DOI 10.1016/j.euroecorev.2014.07.006; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Griffiths P, 2010, REMOTE SENS ENVIRON, V114, P426, DOI 10.1016/j.rse.2009.09.012; Haase D, 2016, ROUT INT HANDB, P50; Haase D, 2014, STRUNGMANN FORUM REP, P299; Haase D, 2014, LANDSCAPE URBAN PLAN, V132, P159, DOI 10.1016/j.landurbplan.2014.09.003; Haase D, 2010, J LAND USE SCI, V5, P123, DOI 10.1080/1747423X.2010.481079; Harris CD, 1945, ANN AM ACAD POLIT SS, V242, P7, DOI 10.1177/000271624524200103; Hoyt H., 1939, STRUCTURE GROWTH RES; Kabisch N, 2011, POPUL SPACE PLACE, V17, P236, DOI 10.1002/psp.600; Kabisch N, 2010, URBAN STUD, V47, P967, DOI 10.1177/0042098009353072; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kazepov Y, 2005, CHANGING CONTEXTS LO; Kiran GS, 2013, INT J REMOTE SENS, V34, P824, DOI 10.1080/01431161.2012.720738; Kontgis C, 2014, APPL GEOGR, V53, P377, DOI 10.1016/j.apgeog.2014.06.029; Liu Wenliang, 2013, P107; Montgomery M., 2008, NEW GLOBAL FRONTIER, P17; Myrdal G., 1958, RICH LANDS POOR ROAD; Portugali J, 2000, SELF ORGANISATION AN; Price SJ, 2006, BIOL CONSERV, V133, P436, DOI 10.1016/j.biocon.2006.07.005; Ravetz J., 2013, PERI URBAN FUTURES S, P13, DOI [10.1007/978-3-642-30529-0_2, DOI 10.1007/978-3-642-30529-0_2]; Rieniets T, 2009, NAT CULT, V4, P231, DOI 10.3167/nc.2009.040302; Sanchez-Vidal M, 2014, REG SCI URBAN ECON, V44, P29, DOI 10.1016/j.regsciurbeco.2013.11.002; Sassen Saskia., 1992, POLIT SCI QUART, V107, P370; Seto K. C, 2013, URBANIZATION BIODIVE, P1, DOI [10.1007/978-94-007-7088-1, DOI 10.1007/978-94-007-7088-1, DOI 10.1007/978-94-007-7088-1_1]; Seto KC, 2014, STRUNGMANN FORUM REP, P1; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2012, P NATL ACAD SCI USA, V109, P7687, DOI 10.1073/pnas.1117622109; Solon J, 2009, LANDSCAPE URBAN PLAN, V93, P250, DOI 10.1016/j.landurbplan.2009.07.012; Taubenbock H, 2014, APPL GEOGR, V47, P137, DOI 10.1016/j.apgeog.2013.12.002; Thapa RB, 2011, GEOJOURNAL LIB, V100, P255, DOI 10.1007/978-94-007-0671-2_15; Thunen J.H. von, 1966, ISOLATED STATE; United Nations, 2014, REV WORLD URB PROSP; Van Den Berg L., 1982, URBAN EUROPE STUDY G; WHITE R, 1993, ENVIRON PLANN A, V25, P1175, DOI 10.1068/a251175; WILSON AG, 1976, ENVIRON PLANN A, V8, P351, DOI 10.1068/a080351; Zhao PJ, 2013, CITIES, V30, P68, DOI 10.1016/j.cities.2011.12.008	53	13	13	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160471	10.1371/journal.pone.0160471	http://dx.doi.org/10.1371/journal.pone.0160471			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490199	gold, Green Submitted, Green Published			2022-12-27	WOS:000381368900061
J	Dyson, ZA; Brown, TL; Farrar, B; Doyle, SR; Tucci, J; Seviour, RJ; Petrovski, S				Dyson, Zoe A.; Brown, Teagan L.; Farrar, Ben; Doyle, Stephen R.; Tucci, Joseph; Seviour, Robert J.; Petrovski, Steve			Locating and Activating Molecular 'Time Bombs': Induction of Mycolata Prophages	PLOS ONE			English	Article							SLUDGE PLANTS; GENOME SEQUENCES; ESCHERICHIA-COLI; SP NOV.; RHODOCOCCUS; PREDICTION; GORDONIA; PHAGES; GENES; BACTERIA	Little is known about the prevalence, functionality and ecological roles of temperate phages for members of the mycolic acid producing bacteria, the Mycolata. While many lytic phages infective for these organisms have been isolated, and assessed for their suitability for use as biological control agents of activated sludge foaming, no studies have investigated how temperate phages might be induced for this purpose. Bioinformatic analysis using the PHAge Search Tool (PHAST) on Mycolata whole genome sequence data in GenBank for members of the genera Gordonia, Mycobacterium, Nocardia, Rhodococcus, and Tsukamurella revealed 83% contained putative prophage DNA sequences. Subsequent prophage inductions using mitomycin C were conducted on 17 Mycolata strains. This led to the isolation and genome characterization of three novel Caudovirales temperate phages, namely GAL1, GMA1, and TPA4, induced from Gordonia alkanivorans, Gordonia malaquae, and Tsukamurella paurometabola, respectively. All possessed highly distinctive dsDNA genome sequences.	[Dyson, Zoe A.; Brown, Teagan L.; Farrar, Ben; Tucci, Joseph] La Trobe Inst Mol Sci, Bendigo, Vic, Australia; [Doyle, Stephen R.] La Trobe Univ, Dept Anim Plant & Soil Sci, Bundoora, Vic, Australia; [Seviour, Robert J.; Petrovski, Steve] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia	La Trobe University; La Trobe University	Petrovski, S (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia.	steve.petrovski@latrobe.edu.au	Brown, Teagan L./AAL-8749-2020; Dyson, Zoe Anne/AAW-4294-2021; Doyle, Stephen/AAS-8224-2021; Doyle, Stephen/GRJ-3949-2022	Dyson, Zoe Anne/0000-0002-8887-3492; Doyle, Stephen/0000-0001-9167-7532; Doyle, Stephen/0000-0001-9167-7532; seviour, robert/0000-0002-1366-0484; Petrovski, Steve/0000-0002-6304-6853; Brown, Teagan L./0000-0001-8885-5668	Australian Postgraduate Award PhD Scholarship	Australian Postgraduate Award PhD Scholarship	ZD was the recipient of an Australian Postgraduate Award PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Dr. Eric Hanssen (Bio21 Institute) for assistance with Transmission Electron Microscopy, and Dr. Daniel Tillett for useful discussions. ZD was the recipient of an Australian Postgraduate Award PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACKALL LL, 1991, WATER RES, V25, P313, DOI 10.1016/0043-1354(91)90011-E; Bose M., 2006, In Silico Biology, V6, P223; Brussow H, 2004, BACTERIOPHAGES BIOL; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Choi W, 2010, P NATL ACAD SCI USA, V107, P10014, DOI 10.1073/pnas.0912615107; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; de los Reyes FL, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P215; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dyson ZA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134512; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; FRAZEE RW, 1993, J BACTERIOL, V175, P6194, DOI 10.1128/JB.175.19.6194-6202.1993; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; HENTHORN KS, 1995, J BACTERIOL, V177, P3185, DOI 10.1128/jb.177.11.3185-3190.1995; KANDA K, 1989, J GEN MICROBIOL, V135, P3035; Kummer C, 1999, INT J SYST BACTERIOL, V49, P1513, DOI 10.1099/00207713-49-4-1513; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9; Lechevalier H, US DEP COMMERCE NATL; Lemire S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002149; Lesnik EA, 2001, NUCLEIC ACIDS RES, V29, P3583, DOI 10.1093/nar/29.17.3583; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Little JW, 2010, J BACTERIOL, V192, P6064, DOI 10.1128/JB.00726-10; Motlagh AM, 2015, WATER RES, V81, P1, DOI 10.1016/j.watres.2015.04.023; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Petrovski S, 2014, ARCH VIROL, V159, P167, DOI 10.1007/s00705-013-1799-z; Petrovski S, 2013, VIRUS GENES, V46, P588, DOI 10.1007/s11262-013-0887-1; Petrovski S, 2013, ARCH VIROL, V158, P601, DOI 10.1007/s00705-012-1530-5; Petrovski S, 2012, APPL ENVIRON MICROB, V78, P42, DOI 10.1128/AEM.05584-11; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P7864, DOI 10.1128/AEM.05692-11; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P3923, DOI 10.1128/AEM.00025-11; Petrovski S, 2011, WATER RES, V45, P2146, DOI 10.1016/j.watres.2010.12.026; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P1389, DOI 10.1128/AEM.01938-10; RAINEY FA, 1995, INT J SYST BACTERIOL, V45, P32, DOI 10.1099/00207713-45-1-32; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; SEVIOUR EM, 1990, WATER RES, V24, P493, DOI 10.1016/0043-1354(90)90234-W; SEVIOUR EM, 1994, WATER RES, V28, P2335, DOI 10.1016/0043-1354(94)90049-3; Soddell JA, 2006, INT J SYST EVOL MICR, V56, P739, DOI 10.1099/ijs.0.63855-0; Summer EJ, 2011, APPL ENVIRON MICROB, V77, P669, DOI 10.1128/AEM.01952-10; Thomas JA, 2002, WATER SCI TECHNOL, V46, P511, DOI 10.2166/wst.2002.0527; Vandenheuvel D, 2015, ANNU REV VIROL, V2, P599, DOI 10.1146/annurev-virology-100114-054915; Verbeken G, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv241; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Withey S, 2005, SCI TOTAL ENVIRON, V339, P1, DOI 10.1016/j.scitotenv.2004.09.021; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	52	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159957	10.1371/journal.pone.0159957	http://dx.doi.org/10.1371/journal.pone.0159957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487243	Green Submitted, gold, Green Published			2022-12-27	WOS:000381367800047
J	Krammer, EM; Ghaddar, K; Andre, B; Prevost, M				Krammer, Eva-Maria; Ghaddar, Kassem; Andre, Bruno; Prevost, Martine			Unveiling the Mechanism of Arginine Transport through AdiC with Molecular Dynamics Simulations: The Guiding Role of Aromatic Residues	PLOS ONE			English	Article							AMINO-ACID ANTIPORTER; NA+/BETAINE SYMPORTER BETP; CYS-LOOP RECEPTOR; ESCHERICHIA-COLI; SUBSTRATE SELECTIVITY; CRYSTAL-STRUCTURE; NEUROTRANSMITTER TRANSPORTERS; MEMBRANE-TRANSPORT; ENTERIC BACTERIA; STRUCTURAL BASIS	Commensal and pathogenic enteric bacteria have developed several systems to adapt to proton leakage into the cytoplasm resulting from extreme acidic conditions. One such system involves arginine uptake followed by export of the decarboxylated product agmatine, carried out by the arginine/agmatine antiporter (AdiC), which thus works as a virtual proton pump. Here, using classical and targeted molecular dynamics, we investigated at the atomic level the mechanism of arginine transport through AdiC of E. coli. Overall, our MD simulation data clearly demonstrate that global rearrangements of several transmembrane segments are necessary but not sufficient for achieving transitions between structural states along the arginine translocation pathway. In particular, local structural changes, namely rotameric conversions of two aromatic residues, are needed to regulate access to both the outward- and inward-facing states. Our simulations have also enabled identification of a few residues, overwhelmingly aromatic, which are essential to guiding arginine in the course of its translocation. Most of them belong to gating elements whose coordinated motions contribute to the alternating access mechanism. Their conservation in all known E. coli acid resistance antiporters suggests that the transport mechanisms of these systems share common features. Last but not least, knowledge of the functional properties of AdiC can advance our understanding of the members of the amino acid-carbocation-polyamine superfamily, notably in eukaryotic cells.	[Krammer, Eva-Maria; Ghaddar, Kassem; Prevost, Martine] ULB, Struct & Fonct Membranes Biol, Brussels, Belgium; [Ghaddar, Kassem; Andre, Bruno] ULB, IBMM, Mol Physiol Cell, Gosselies, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Krammer, EM; Prevost, M (corresponding author), ULB, Struct & Fonct Membranes Biol, Brussels, Belgium.	ekrammer@ulb.ac.be; mprevost@ulb.ac.be	Krammer, Eva-Maria/H-2543-2013	Krammer, Eva-Maria/0000-0002-4821-2550; Prevost, Martine/0000-0003-3144-7828	ARC grant from the Federation Wallonie-Bruxelles [AUWB 2010-15-2]; Federation Wallonie-Bruxelles [1117545]	ARC grant from the Federation Wallonie-Bruxelles; Federation Wallonie-Bruxelles	MP is a senior research associate and EMK is a postdoctoral researcher of the Fonds de la Recherche Scientifique de Belgique (F.R.S-F.R.N.S.), Belgium. This work was supported by an ARC grant (AUWB 2010-15-2) from the Federation Wallonie-Bruxelles. Computational resources were provided by the Consortium des Equipements de Calcul Intensif (CECI) and the F.R.S.-F.N.R.S. under convention 2.5020.11, together with the supercomputing facilities of the Universite catholique de Louvain (CISM/UCL), the Universite de Liege (ULg), ULB, and the Tier-1 supercomputer of the Federation Wallonie-Bruxelles under grant agreement no 1117545.	Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Chang S, 2010, MOL BIOSYST, V6, P2430, DOI 10.1039/c005266c; Cheng MH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003879; Cheng MH, 2013, BIOPHYS J, V105, P630, DOI 10.1016/j.bpj.2013.06.032; Daeffler KNM, 2014, ACS CHEM BIOL, V9, P2283, DOI 10.1021/cb500323d; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Diallinas G, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00207; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Ghaddar K, 2014, MOL CELL BIOL, V34, P4447, DOI 10.1128/MCB.00699-14; Ghaddar K, 2014, J BIOL CHEM, V289, P7232, DOI 10.1074/jbc.M113.525915; Gournas C, 2016, ADV EXP MED BIOL, V892, P69, DOI 10.1007/978-3-319-25304-6_4; Gur M, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4936133; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jung H, 2006, J MEMBRANE BIOL, V213, P119, DOI 10.1007/s00232-006-0880-x; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; Korkmaz F, 2013, BBA-BIOMEMBRANES, V1828, P1181, DOI 10.1016/j.bbamem.2013.01.004; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Li J, 2015, CURR OPIN STRUC BIOL, V31, P96, DOI 10.1016/j.sbi.2015.04.001; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Lu PL, 2013, CELL RES, V23, P635, DOI 10.1038/cr.2013.13; Lummis SCR, 2012, ACS CHEM NEUROSCI, V3, P186, DOI 10.1021/cn200103n; Lund P, 2014, FEMS MICROBIOL REV, V38, P1091, DOI 10.1111/1574-6976.12076; Ma D, 2013, J BIOL CHEM, V288, P15148, DOI 10.1074/jbc.M113.474502; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Moradi M, 2013, P NATL ACAD SCI USA, V110, P18916, DOI 10.1073/pnas.1313202110; Penmatsa A, 2014, J PHYSIOL-LONDON, V592, P863, DOI 10.1113/jphysiol.2013.259051; Perez C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5231; Perez C, 2012, NATURE, V490, P126, DOI 10.1038/nature11403; Perez C, 2011, EMBO J, V30, P1221, DOI 10.1038/emboj.2011.46; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Schulze S, 2010, NATURE, V467, P233, DOI 10.1038/nature09310; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shi YG, 2013, ANNU REV BIOPHYS, V42, P51, DOI 10.1146/annurev-biophys-083012-130429; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Simmons KJ, 2014, EMBO J, V33, P1831, DOI 10.15252/embj.201387557; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Song HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133388; Stolzenberg S, 2015, J BIOL CHEM, V290, P13992, DOI 10.1074/jbc.M114.625343; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; Tsai MF, 2013, P NATL ACAD SCI USA, V110, P5893, DOI 10.1073/pnas.1301442110; Tsai MF, 2013, P NATL ACAD SCI USA, V110, P5898, DOI 10.1073/pnas.1301444110; Tsoulos IG, 2011, COMPUT PHYS COMMUN, V182, P834, DOI 10.1016/j.cpc.2010.11.032; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhao CF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003296; Zomot E, 2011, J BIOL CHEM, V286, P19693, DOI 10.1074/jbc.M110.202085	68	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160219	10.1371/journal.pone.0160219	http://dx.doi.org/10.1371/journal.pone.0160219			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482712	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700030
J	Robinson, N; Zaidi, AD; Rana, M; Prasad, VA; Guan, C; Birbaumer, N; Sitaram, R				Robinson, Neethu; Zaidi, Ali Danish; Rana, Mohit; Prasad, Vinod A.; Guan, Cuntai; Birbaumer, Niels; Sitaram, Ranganatha			Real-Time Subject-Independent Pattern Classification of Overt and Covert Movements from fNIRS Signals	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; MOTOR IMAGERY; STROKE; RECOVERY; PROGRESS	Recently, studies have reported the use of Near Infrared Spectroscopy (NIRS) for developing Brain-Computer Interface (BCI) by applying online pattern classification of brain states from subject-specific fNIRS signals. The purpose of the present study was to develop and test a real-time method for subject-specific and subject-independent classification of multi-channel fNIRS signals using support-vector machines (SVM), so as to determine its feasibility as an online neurofeedback system. Towards this goal, we used left versus right hand movement execution and movement imagery as study paradigms in a series of experiments. In the first two experiments, activations in the motor cortex during movement execution and movement imagery were used to develop subject-dependent models that obtained high classification accuracies thereby indicating the robustness of our classification method. In the third experiment, a generalized classifier-model was developed from the first two experimental data, which was then applied for subject-independent neurofeedback training. Application of this method in new participants showed mean classification accuracy of 63% for movement imagery tasks and 80% for movement execution tasks. These results, and their corresponding offline analysis reported in this study demonstrate that SVM based real-time subject-independent classification of fNIRS signals is feasible. This method has important applications in the field of hemodynamic BCIs, and neuro-rehabilitation where patients can be trained to learn spatio-temporal patterns of healthy brain activity.	[Robinson, Neethu; Prasad, Vinod A.; Guan, Cuntai; Sitaram, Ranganatha] Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore; [Zaidi, Ali Danish; Sitaram, Ranganatha] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Zaidi, Ali Danish; Rana, Mohit; Birbaumer, Niels; Sitaram, Ranganatha] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Guan, Cuntai] ASTAR, Dept Neural & Biomed Technol, Inst Infocomm Res, Singapore, Singapore; [Birbaumer, Niels] Wyss Ctr Bio & Neuroengn, Geneva, Switzerland; [Rana, Mohit; Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Dept Psychiat, Santiago, Chile; [Rana, Mohit; Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Div Neurosci, Sch Engn, Santiago, Chile; [Rana, Mohit; Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sch Biol, Santiago, Chile; [Rana, Mohit; Sitaram, Ranganatha] Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile; [Robinson, Neethu] Birla Inst Technol & Sci Pilani, Pilani, Goa, India	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Birla Institute of Technology & Science Pilani (BITS Pilani)	Sitaram, R (corresponding author), Nanyang Technol Univ, Sch Comp Sci & Engn, Singapore, Singapore.; Zaidi, AD; Sitaram, R (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.; Zaidi, AD; Sitaram, R (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Dept Psychiat, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Div Neurosci, Sch Engn, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sch Biol, Santiago, Chile.; Sitaram, R (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Santiago, Chile.	azaidi@tue.mpg.de; rasitaram@uc.cl	Coish, Elizabeth/AAU-1245-2020; Guan, Cuntai/G-7835-2016	Guan, Cuntai/0000-0002-0872-3276; Zaidi, Ali/0000-0001-8370-1774; Birbaumer, Niels/0000-0002-6786-5127; A. P., Vinod/0000-0001-9408-1275	Deutsche Forschungsgemeinschaft [DFG BI 195/59-1, DFG BI 195/56-1, DFG 195/65-1]; Badenwurttemberg-Singapore Life Sciences Grant; INDIGO research grant from the European Union; CEEDs: Collective Experience of Empathic Data Systems [FP7-ICT-2009-258749]; BETTER: BNCI-driven Robotic Physical Therapies in Stroke Rehabilitation of Gait Disorders [FP7-ICT-2009-247935]; Centre for Integrative Neuroscience (CIN) [PP 2012-16]; INDIGO research grant from the India	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Badenwurttemberg-Singapore Life Sciences Grant; INDIGO research grant from the European Union; CEEDs: Collective Experience of Empathic Data Systems; BETTER: BNCI-driven Robotic Physical Therapies in Stroke Rehabilitation of Gait Disorders; Centre for Integrative Neuroscience (CIN); INDIGO research grant from the India	Funded by Deutsche Forschungsgemeinschaft (DFG BI 195/59-1, DFG BI 195/56-1 and DFG 195/65-1); the Badenwurttemberg-Singapore Life Sciences Grant; the INDIGO research grant from the European Union and India; FP7-ICT-2009-258749 - CEEDs: The Collective Experience of Empathic Data Systems; FP7-ICT-2009-247935 - BETTER: BNCI-driven Robotic Physical Therapies in Stroke Rehabilitation of Gait Disorders; and the Centre for Integrative Neuroscience (CIN) (PP 2012-16).	Abdelnour AF, 2009, NEUROIMAGE, V46, P133, DOI 10.1016/j.neuroimage.2009.01.033; Ang K., 2012, P INT JOINT C NEUR N, V10, P1; Ang KK, 2012, PATTERN RECOGN, V45, P2137, DOI 10.1016/j.patcog.2011.04.018; Birbaumer N, 2013, TRENDS COGN SCI, V17, P295, DOI 10.1016/j.tics.2013.04.009; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Coyle S, 2004, P ANN INT IEEE EMBS, V26, P4540; Daly JJ, 2005, J REHABIL RES DEV, V42, P723, DOI 10.1682/JRRD.2005.02.0048; Daly JJ, 2009, J NEUROL PHYS THER, V33, P203, DOI 10.1097/NPT.0b013e3181c1fc0b; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032234; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Silvoni S, 2011, CLIN EEG NEUROSCI, V42, P245, DOI 10.1177/155005941104200410; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Sitaram R, 2011, NEUROIMAGE, V56, P753, DOI 10.1016/j.neuroimage.2010.08.007; Sulzer J, 2013, NEUROIMAGE, V76, P386, DOI 10.1016/j.neuroimage.2013.03.033; Vapnik V. N., 1998, STAT LEARNING THEORY, V1	17	8	8	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159959	10.1371/journal.pone.0159959	http://dx.doi.org/10.1371/journal.pone.0159959			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467528	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100078
J	Zhang, P; Wang, R; Gao, CS; Jiang, LL; Lv, X; Song, YY; Li, B				Zhang, Peng; Wang, Rui; Gao, Chunshi; Jiang, Lingling; Lv, Xin; Song, Yuanyuan; Li, Bo			Prevalence of Central Obesity among Adults with Normal BMI and Its Association with Metabolic Diseases in Northeast China	PLOS ONE			English	Article							BODY-MASS INDEX; ABDOMINAL OBESITY; RISK; METAANALYSIS; OVERWEIGHT	Objectives The present study aimed to investigate the prevalence of central obesity among adults with normal BMI and its association with metabolic diseases in Jilin Province, China. Methods A population-based cross-sectional study was conducted in 2012 in Jilin Province of China. Information was collected by face to face interview. Descriptive data analysis and 95% confidence intervals (CI) of prevalence/frequency were conducted. Log-binomial regression analyses were used to find the independent factors associated with central obesity and to explore the adjusted association between central obesity and metabolic diseases among adults with normal BMI. Results Among the adult residents with normal BMI in Jilin Province, 55.6% of participants with central obesity self-assessed as normal weight and 27.0% thought their body weight were above normal. 12.7% of central obesity people took methods to lose weight, while 85.3% didn't. Female, older people and non-manual worker had higher risk to be central obesity among adults with normal BMI. Hypertension, diabetes and hyperlipidemia were significantly associated with central obesity among adults with normal BMI, the PRs were 1.337 (1.224-1.461), 1.323 (1.193-1.456) and 1.261 (1.152-1.381) separately when adjusted for gender, age and BMI. Conclusions Hypertension, diabetes and hyperlipidemia were significantly associated with central obesity among adults with normal BMI in Jilin Province, China. The low rates of awareness and control of central obesity among adults with normal BMI should be improved by government and health department.	[Zhang, Peng; Wang, Rui; Gao, Chunshi; Jiang, Lingling; Lv, Xin; Song, Yuanyuan; Li, Bo] Jilin Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Changchun, Jilin, Peoples R China	Jilin University	Li, B (corresponding author), Jilin Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Changchun, Jilin, Peoples R China.	libo2016tougao@sina.com	Li, Bo/AAA-8968-2020; Zhang, Peng/V-8552-2019	Li, Bo/0000-0002-7294-6888; 	Scientific Research Foundation of the Health Bureau of Jilin Province, China [2011Z116]; Scientific Research Foundation of the Health Bureau of Jilin Province, China	Scientific Research Foundation of the Health Bureau of Jilin Province, China; Scientific Research Foundation of the Health Bureau of Jilin Province, China	This study was supported by a competitive grant from the Scientific Research Foundation of the Health Bureau of Jilin Province, China (Grant Number:2011Z116, http://wsjsw.jl.gov.cn/). B.L received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all participants from Jilin Province of China and interviewers from Jilin University. This study was supported by a competitive grant from the Scientific Research Foundation of the Health Bureau of Jilin Province, China.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; [Anonymous], 2007, ZHONGHUA XIN XUE GUA, V35, P390, DOI DOI 10.3760/J.ISSN:0253-3758.2007.05.003; Bhowmik Bishwajit, 2015, BMC Res Notes, V8, P460, DOI 10.1186/s13104-015-1377-4; Cameron AJ, 2008, CIRCULATION, V117, P1624, DOI 10.1161/CIRCULATIONAHA.108.775080; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Jaacks LM, 2013, INT J EPIDEMIOL, V42, P828, DOI 10.1093/ije/dyt052; Kotani K, 1994, INT J OBES RELAT MET, V18, P207; Lee G, 2015, J KOREAN ACAD NURS, V45, P483, DOI 10.4040/jkan.2015.45.4.483; Lisheng L, 2011, CHIN J HYPERTENS, V19, P701; National Health and Family Planning Commission of the People's Republic of China, 2013, CRIT WEIGHT AD; Odum SM, 2013, J ARTHROPLASTY, V28, P148, DOI 10.1016/j.arth.2013.02.036; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Qi L, 2015, INT J ENV RES PUB HE, V12, P13455, DOI 10.3390/ijerph121013455; Qin L, 2010, EUR J EPIDEMIOL, V25, P5, DOI 10.1007/s10654-009-9395-y; Sakashita Y, 2015, J DIABETES INVEST, V6, P527, DOI 10.1111/jdi.12327; Shah SM, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0024-2; Smith SC, 2007, CURR MED RES OPIN, V23, P29, DOI 10.1185/030079906X159489; Su Jian, 2015, Zhonghua Xin Xue Guan Bing Za Zhi, V43, P548; Tao LX, 2014, ENDOCRINE, V46, P485, DOI 10.1007/s12020-013-0067-z; Taylor SA, 2011, INT J PEDIATR OBES, V6, pE307, DOI 10.3109/17477166.2011.575149; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103594; Wang SB, 2015, ASIA-PAC J PUBLIC HE, V27, P394, DOI 10.1177/1010539514551200; Westphal Sydney A, 2008, Clin Cornerstone, V9, P23, DOI 10.1016/S1098-3597(08)60025-3; WHO, 2015, OB OV FACT SHEETS; Zhou XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144179	28	35	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160402	10.1371/journal.pone.0160402	http://dx.doi.org/10.1371/journal.pone.0160402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467819	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100152
J	Sousa, LL; Lopez-Castejon, F; Gilabert, J; Relvas, P; Couto, A; Queiroz, N; Caldas, R; Dias, PS; Dias, H; Faria, M; Ferreira, F; Ferreira, AS; Fortuna, J; Gomes, RJ; Loureiro, B; Martins, R; Madureira, L; Neiva, J; Oliveira, M; Pereira, J; Pinto, J; Py, F; Queiros, H; Silva, D; Sujit, PB; Zolich, A; Johansen, TA; de Sousa, JB; Rajan, K				Sousa, Lara L.; Lopez-Castejon, Francisco; Gilabert, Javier; Relvas, Paulo; Couto, Ana; Queiroz, Nuno; Caldas, Renato; Dias, Paulo Sousa; Dias, Hugo; Faria, Margarida; Ferreira, Filipe; Ferreira, Antonio Sergio; Fortuna, Joao; Gomes, Ricardo Joel; Loureiro, Bruno; Martins, Ricardo; Madureira, Luis; Neiva, Jorge; Oliveira, Marina; Pereira, Joao; Pinto, Jose; Py, Frederic; Queiros, Hugo; Silva, Daniel; Sujit, P. B.; Zolich, Artur; Johansen, Tor Arne; de Sousa, Joao Borges; Rajan, Kanna			Integrated Monitoring of Mola mola Behaviour in Space and Time	PLOS ONE			English	Article							DEPENDENT FORAGING BEHAVIOR; STABLE-ISOTOPES CHALLENGE; AREA-RESTRICTED SEARCH; CENTRAL NORTH PACIFIC; OCEAN SUNFISH; GPS TRACKING; BASKING SHARKS; MOVEMENT PATTERNS; CARETTA-CARETTA; MARINE PREDATOR	Over the last decade, ocean sunfish movements have been monitored worldwide using various satellite tracking methods. This study reports the near-real time monitoring of finescale (< 10 m) behaviour of sunfish. The study was conducted in southern Portugal in May 2014 and involved satellite tags and underwater and surface robotic vehicles to measure both the movements and the contextual environment of the fish. A total of four individuals were tracked using custom-made GPS satellite tags providing geolocation estimates of fine-scale resolution. These accurate positions further informed sunfish areas of restricted search (ARS), which were directly correlated to steep thermal frontal zones. Simultaneously, and for two different occasions, an Autonomous Underwater Vehicle (AUV) videorecorded the path of the tracked fish and detected buoyant particles in the water column. Importantly, the densities of these particles were also directly correlated to steep thermal gradients. Thus, both sunfish foraging behaviour (ARS) and possibly prey densities, were found to be influenced by analogous environmental conditions. In addition, the dynamic structure of the water transited by the tracked individuals was described by a Lagrangian modelling approach. The model informed the distribution of zooplankton in the region, both horizontally and in the water column, and the resultant simulated densities positively correlated with sunfish ARS behaviour estimator (r(s) = 0.184, p < 0.001). The model also revealed that tracked fish opportunistically displace with respect to subsurface current flow. Thus, we show how physical forcing and current structure provide a rationale for a predator's finescale behaviour observed over a two weeks in May 2014.	[Sousa, Lara L.; Couto, Ana; Queiroz, Nuno] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao, P-4485661 Vairao, Portugal; [Lopez-Castejon, Francisco; Gilabert, Javier] Univ Politecn Cartagena UPCT, Dept Chem & Environm Engn, Underwater Vehicles Lab, Alfonso 13,52, E-30203 Cartagena, Spain; [Relvas, Paulo] Univ Algarve, Ctr Marine Sci CCMAR, P-8005139 Faro, Portugal; [Caldas, Renato; Dias, Paulo Sousa; Dias, Hugo; Faria, Margarida; Ferreira, Filipe; Ferreira, Antonio Sergio; Fortuna, Joao; Gomes, Ricardo Joel; Loureiro, Bruno; Martins, Ricardo; Neiva, Jorge; Oliveira, Marina; Pereira, Joao; Pinto, Jose; Py, Frederic; Queiros, Hugo; Silva, Daniel; Sujit, P. B.; de Sousa, Joao Borges; Rajan, Kanna] Univ Porto, Fac Engn, Rua Dr Roberto Frias, P-4200465 Porto, Portugal; [Madureira, Luis] Polo Mar UPTEC, Oceanscan MST, Ave Liberdade, P-4450718 Matosinhos, Portugal; [Zolich, Artur; Johansen, Tor Arne; Rajan, Kanna] Norwegian Univ Sci & Technol, Ctr Autonomous Marine Operat & Syst, Dept Engn Cybernet, Trondheim, Norway; [Sousa, Lara L.] Marine Biol Assoc United Kingdom Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England; [Sujit, P. B.] IIIT Delhi, New Delhi 110020, India	Universidade do Porto; Universidad Politecnica de Cartagena; Universidade do Algarve; Universidade do Porto; Norwegian University of Science & Technology (NTNU); Marine Biological Association United Kingdom; Indraprastha Institute of Information Technology Delhi	Rajan, K (corresponding author), Univ Porto, Fac Engn, Rua Dr Roberto Frias, P-4200465 Porto, Portugal.; Rajan, K (corresponding author), Norwegian Univ Sci & Technol, Ctr Autonomous Marine Operat & Syst, Dept Engn Cybernet, Trondheim, Norway.	Kanna.Rajan@ntnu.no	Relvas, Paulo/B-1257-2008; Sousa, Lara/L-7774-2013; Zolich, Artur/AAI-3801-2021; Queiroz, Nuno/G-3850-2010; pereira, joao/GWN-1007-2022; Fortuna, João/H-6613-2018; Sousa, Joao/E-5040-2017; Oliveira, Beatriz/D-9025-2013	Relvas, Paulo/0000-0002-6404-5895; Sousa, Lara/0000-0002-4392-3572; Zolich, Artur/0000-0001-8800-6156; Queiroz, Nuno/0000-0002-3860-7356; Fortuna, João/0000-0003-4181-8354; Sousa, Joao/0000-0002-2528-4666; Ferreira, Antonio Sergio/0000-0003-3327-9020; Dias, Paulo/0000-0002-6935-7812; Couto, Ana/0000-0003-3050-7219; Pinto, Jose/0000-0003-1224-9391; Lopez-Castejon, Francisco/0000-0002-4196-4100; Oliveira, Marina/0000-0001-7913-6442; PB, sujit/0000-0002-7297-1493; Oliveira, Beatriz/0000-0002-6767-6596	US Office of Naval Research Global (ONRG) under PERSISTS Grant [N62909-14-1-N109]; ONR Grant [N00014-14-1-0536]; FLAD (the Luso American Development Foundation); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [SFRH/BD/68717/2010, IF/01611/2013, PTDC/MAREST/3485/2012]; project 'Marinfo' - North Portugal Regional Operational Programme, under the National Strategic Reference Framework (NSRF) via the European Regional Development Fund (ERDF); Research Council of Norway through the Centres of Excellence funding scheme [223254 - AMOS]; SV2 WaveGlider	US Office of Naval Research Global (ONRG) under PERSISTS Grant(Office of Naval Research); ONR Grant; FLAD (the Luso American Development Foundation); Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); project 'Marinfo' - North Portugal Regional Operational Programme, under the National Strategic Reference Framework (NSRF) via the European Regional Development Fund (ERDF); Research Council of Norway through the Centres of Excellence funding scheme; SV2 WaveGlider	This work was supported by the US Office of Naval Research Global (ONRG) funded under PERSISTS Grant #N62909-14-1-N109. KR and FP are funded by ONR Grant #N00014-14-1-0536 for work on the manuscript. Additional funding from FLAD (the Luso American Development Foundation) is also acknowledged. Support was also received from Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, through a PhD grant to LLS (SFRH/BD/68717/2010); an Investigator Fellowship to NQ (IF/01611/2013), and the SHORE project (Shoreface morphodynamics: an integrated approach) under the contract PTDC/MAREST/3485/2012, for the ADCP data. NQ and JS were also funded through the project 'Marinfo' co-financed by North Portugal Regional Operational Programme (N2020), under the National Strategic Reference Framework (NSRF) via the European Regional Development Fund (ERDF). AZ and TAJ were funded by the Research Council of Norway through the Centres of Excellence funding scheme, grant number 223254 - AMOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Tunipex S.A. for making their facilities available and collaborating for tagging sunfish at sea. The work was funded in part by the US Office of Naval Research Global (ONRG) funded under PERSISTS Grant #N62909-14-1-N109. KR and FP were funded by ONR Grant #N00014-14-1-0536 for work on the manuscript. Additional funding from FLAD (the Luso American Development Foundation) is also acknowledged. We are grateful to Liquid Robotics of Sunnyvale, California in particular to Ryan Carlson, Sotiria Lampoudi, Francois Leroy and their operations personnel, for supporting us with an SV2 WaveGlider. We thank Marine Technologies and Federico Zarghetta for the shipboard VSAT communication system. Thanks to IPMA (Instituto Portugues do Mar e da Atmosfera) and Marinha Portuguesa for logistical support for the experiment. Puertos del Estado facilitated access to ocean data and forecasts used for modelling. Copernicus-Marine environment monitoring service facilitated hydrodynamic modelling outputs of the region. Fundacao para a Ciencia e a Tecnologia (FCT), Portugal, through a PhD grant to LLS (SFRH/BD/68717/2010); an Investigator Fellowship to NQ (IF/01611/2013) and the SHORE project (Shoreface morphodynamics: an integrated approach) under the contract PTDC/MAREST/3485/2012, for the ADCP data. NQ and JS were also funded through the project 'Marinfo' co-financed by North Portugal Regional Operational Programme (N2020), under the National Strategic Reference Framework (NSRF) via the European Regional Development Fund (ERDF). AZ and TAJ were funded by the Research Council of Norway through the Centres of Excellence funding scheme, grant number 223254-AMOS. Lastly, thanks go to High School Jose Regio, in Vila do Conde, Portugal, especially to science teacher Ana Flora Esteves and her students for their enthusiastic engagement prior to, during and after the field experiment.	Torres MA, 2013, ECOL MODEL, V265, P26, DOI 10.1016/j.ecolmodel.2013.05.019; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Belkin IM, 2014, DEEP-SEA RES PT II, V107, P1, DOI 10.1016/j.dsr2.2014.07.009; Bellingham JG, 2007, SCIENCE, V318, P1098, DOI 10.1126/science.1146230; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Cardeira S, 2013, CONT SHELF RES, V52, P133, DOI 10.1016/j.csr.2012.11.011; Cardona L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031329; Cartamil DP, 2004, MAR ECOL PROG SER, V266, P245, DOI 10.3354/meps266245; CAYULA JF, 1992, J ATMOS OCEAN TECH, V9, P67, DOI 10.1175/1520-0426(1992)009<0067:EDAFSI>2.0.CO;2; Chassot E, 2011, ICES J MAR SCI, V68, P651, DOI 10.1093/icesjms/fsq195; Cook TR, 2012, MAR BIOL, V159, P373, DOI 10.1007/s00227-011-1815-3; Criado-Aldeanueva F, 2006, DEEP-SEA RES PT II, V53, P1144, DOI 10.1016/j.dsr2.2006.04.012; DAS J, 2015, THE INTERNATIONAL JO, V34, P1435; Dewar H, 2010, J EXP MAR BIOL ECOL, V393, P32, DOI 10.1016/j.jembe.2010.06.023; Dias PS, 2005, OCEANS 2005 - EUROPE, VOLS 1 AND 2, P963; Domingues CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035794; Drevillon M, 2014, JOURNAL OF OPERATION, V1, P51; Dujon AM, 2014, METHODS ECOL EVOL, V5, P1162, DOI 10.1111/2041-210X.12286; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Frajka-Williams E, 2009, DEEP-SEA RES PT I, V56, P2144, DOI 10.1016/j.dsr.2009.07.008; FRANKS PJS, 1992, MAR ECOL PROG SER, V82, P1, DOI 10.3354/meps082001; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Garcia-Lafuente J, 2006, DEEP-SEA RES PT II, V53, P1182, DOI 10.1016/j.dsr2.2006.04.011; Genin A, 2005, SCIENCE, V308, P860, DOI 10.1126/science.1107834; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Griffa A, 2007, LAGRANGIAN ANALYSIS AND PREDICTION OF COASTAL AND OCEAN DYNAMICS, P1, DOI 10.1017/CBO9780511535901; Guihen D, 2014, LIMNOL OCEANOGR-METH, V12, P373, DOI 10.4319/lom.2014.12.373; Harrod C, 2013, J FISH BIOL, V82, P10, DOI 10.1111/j.1095-8649.2012.03485.x; Hays GC, 2007, J EXP MAR BIOL ECOL, V349, P52, DOI 10.1016/j.jembe.2007.04.016; Hays GC, 2014, CONSERV BIOL, V28, P1636, DOI 10.1111/cobi.12325; Hays GC, 2009, J EXP MAR BIOL ECOL, V370, P134, DOI 10.1016/j.jembe.2008.12.009; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; KaewTraKulPong P, VIDEO BASED SURVEILL, P125; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kuhn Carey E., 2010, Endangered Species Research, V12, P125, DOI 10.3354/esr00297; LEFEVRE J, 1986, ADV MAR BIOL, V23, P163; Lilley MKS, 2011, MAR BIOL, V158, P2429, DOI 10.1007/s00227-011-1744-1; Martin JP, 2009, JOURNAL OF GEOPHYSIC, V114; McKenzie H, 2009, B MATH BIOL, V71, P107, DOI 10.1007/s11538-008-9354-x; McManus MA, 2012, J EXP BIOL, V215, P1008, DOI 10.1242/jeb.059014; Miller P.I., 2011, HDB SATELLITE REMOTE, P229; Moreno A, 2009, J PLANKTON RES, V31, P73, DOI 10.1093/plankt/fbn103; Nakamura I, 2015, JOURNAL OF ANIMAL EC; Nakamura I, 2014, MAR BIOL, V161, P1263, DOI 10.1007/s00227-014-2416-8; Navarro G, 2006, DEEP-SEA RES PT II, V53, P1241, DOI 10.1016/j.dsr2.2006.04.014; Pade NG, 2009, J EXP MAR BIOL ECOL, V370, P64, DOI 10.1016/j.jembe.2008.12.002; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; Piccardi M, 2004, IEEE SYS MAN CYBERN, P3099, DOI 10.1109/ICSMC.2004.1400815; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Pinto Jose, 2015, IFAC - Papers Online, V48, P94, DOI 10.1016/j.ifacol.2015.06.016; PODESTA GP, 1993, CONT SHELF RES, V13, P253, DOI 10.1016/0278-4343(93)90109-B; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Pope EC, 2010, REV FISH BIOL FISHER, V20, P471, DOI 10.1007/s11160-009-9155-9; Queiroz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032374; Rajan K., 2013, MARINE ROBOT AUTONOM, P91, DOI DOI 10.1007/978-1-4614-5659-9_3; Rajan K, 2012, IET CONTR ENG SER, V77, P171, DOI 10.1049/PBCE077E_ch9; Relvas P., 2002, J GEOPHYS RES, V107, P1, DOI DOI 10.1029/2000JC000456; Roberts JJ, 2010, ENVIRON MODELL SOFTW, V25, P1197, DOI 10.1016/j.envsoft.2010.03.029; Ryan JP, 2014, DEEP-SEA RES PT II, V101, P63, DOI 10.1016/j.dsr2.2013.01.017; Ryan JP, 2010, LIMNOL OCEANOGR-METH, V8, P394, DOI 10.4319/lom.2010.8.394; Scales KL, 2014, J APPL ECOL, V51, P1575, DOI 10.1111/1365-2664.12330; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Sibenac M, 2002, OCEANS 02 MTS IEEE; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Simpfendorfer CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016918; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Sims DW, 2009, J EXP MAR BIOL ECOL, V370, P127, DOI 10.1016/j.jembe.2008.12.011; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Sims DW, 2002, J MAR BIOL ASSOC UK, V82, P927, DOI 10.1017/S0025315402006409; Sims DW, 2000, P ROY SOC B-BIOL SCI, V267, P1897, DOI 10.1098/rspb.2000.1227; Sippel T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021087; Smit AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081944; Sommerfeld J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063742; Sousa A, 2012, PROCEEDINGS OF NGCUV; Sousa L.L., 2016, ANIMAL BIOTELEMETRY, V4, P7, DOI [10.1186/s40317-016-0099-2, DOI 10.1186/S40317-016-0099-2]; Southall EJ, 2006, BIOL CONSERV, V132, P33, DOI 10.1016/j.biocon.2006.03.011; Syvaranta J, 2012, J FISH BIOL, V80, P225, DOI 10.1111/j.1095-8649.2011.03163.x; Thys TM, 2015, J EXP MAR BIOL ECOL, V471, P64, DOI 10.1016/j.jembe.2015.05.005; Todd RE, 2009, JOURNAL OF GEOPHYSIC, V114; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Vargas JM, 2003, J MARINE SYST, V38, P205, DOI 10.1016/S0924-7963(02)00240-3; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399	90	20	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160404	10.1371/journal.pone.0160404	http://dx.doi.org/10.1371/journal.pone.0160404			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494028	Green Accepted, Green Published, gold			2022-12-27	WOS:000381369500040
J	Costantini, F; Gori, A; Lopez-Gonzalez, P; Bramanti, L; Rossi, S; Gili, JM; Abbiati, M				Costantini, Federica; Gori, Andrea; Lopez-Gonzalez, Pablo; Bramanti, Lorenzo; Rossi, Sergio; Gili, Josep-Maria; Abbiati, Marco			Limited Genetic Connectivity between Gorgonian Morphotypes along a Depth Gradient	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; EUNICELLA-SINGULARIS; MEDITERRANEAN SEA; POPULATION DIFFERENTIATION; VERTICAL CONNECTIVITY; COMPUTER-PROGRAM; NULL ALLELES; CORAL; MARKERS; CONSERVATION	Gorgonian species show a high morphological variability in relation to the environment in which they live. In coastal areas, parameters such as temperature, light, currents, and food availability vary significantly with depth, potentially affecting morphology of the colonies and the structure of the populations, as well as their connectivity patterns. In tropical seas, the existence of connectivity between shallow and deep populations supported the hypothesis that the deep coral reefs could potentially act as (reproductive) refugia fostering re-colonization of shallow areas after mortality events. Moreover, this hypothesis is not so clear accepted in temperate seas. Eunicella singularis is one of the most common gorgonian species in Northwestern Mediterranean Sea, playing an important role as ecosystem engineer by providing biomass and complexity to the coralligenous habitats. It has a wide bathymetric distribution ranging from about 10 m to 100 m. Two depth-related morphotypes have been identified, differing in colony morphology, sclerite size and shape, and occurrence of symbiotic algae, but not in mitochondrial DNA haplotypes. In the present study the genetic structure of E. singularis populations along a horizontal and bathymetric gradient was assessed using microsatellites and ITS1 sequences. Restricted gene flow was found at 30-40 m depth between the two Eunicella morphotypes. Conversely, no genetic structuring has been found among shallow water populations within a spatial scale of ten kilometers. The break in gene flow between shallow and deep populations contributes to explain the morphological variability observed at different depths. Moreover, the limited vertical connectivity hinted that the refugia hypothesis does not apply to E. singularis. Re-colonization of shallow water populations, occasionally affected by mass mortality events, should then be mainly fueled by larvae from other shallow water populations.	[Costantini, Federica; Abbiati, Marco] Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, CoNISMa, Via S Alberto 163, I-48123 Ravenna, Italy; [Costantini, Federica; Abbiati, Marco] Univ Bologna, CoNISMa, Ctr Interdipartimentale Ric Sci Ambientali CIRSA, Via S Alberto 163, I-48123 Ravenna, Italy; [Gori, Andrea] Univ Barcelona, Fac Biol, Dept Ecol, Av Diagonal 643, E-08028 Barcelona, Spain; [Lopez-Gonzalez, Pablo] Univ Seville, Dept Zool, Fac Biol, Biodiversidad & Ecol Invertebrados Marinos, Av Reina Mercedes 6, E-41012 Seville, Spain; [Bramanti, Lorenzo] Univ Paris 06, Sorbonne Univ, Lab Ecogeochim Environm Benth LECOB, CNRS,Observ Oceanol, F-66650 Banyuls Sur Mer, France; [Rossi, Sergio] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, Cerdanyola Del Valles, Spain; [Gori, Andrea; Gili, Josep-Maria] Inst Ciencies Mar CSIC, Pg Maritim Barceloneta 37-49, Barcelona 08003, Spain; [Abbiati, Marco] CNR, Ist Sci Marine, ISMAR, Bologna, Italy	CoNISMa; University of Bologna; CoNISMa; University of Bologna; University of Barcelona; University of Sevilla; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Costantini, F (corresponding author), Univ Bologna, Dipartimento Sci Biol Geol & Ambientali BiGeA, CoNISMa, Via S Alberto 163, I-48123 Ravenna, Italy.; Costantini, F (corresponding author), Univ Bologna, CoNISMa, Ctr Interdipartimentale Ric Sci Ambientali CIRSA, Via S Alberto 163, I-48123 Ravenna, Italy.	federica.costantini@unibo.it	COSTANTINI, FEDERICA/ABH-9194-2020; Bramanti, Lorenzo/AAH-5094-2021; Gori, Andrea/AAT-4501-2020; Bramanti, Lorenzo/M-5492-2013	COSTANTINI, FEDERICA/0000-0002-8813-1923; Bramanti, Lorenzo/0000-0002-4872-840X; Gori, Andrea/0000-0001-8442-8079; Bramanti, Lorenzo/0000-0002-4872-840X; Abbiati, Marco/0000-0002-2426-4524; Rossi, Sergio/0000-0003-4402-3418	I3P contract of the Consejo Superior de Investigaciones Cientificas [I3P-BPD2005]; Generalitat de Catalunya [2014 SGR - 1356]; Marie Curie International Outgoing Fellowship (ANIMAL FOREST HEALTH) [327845]; CSIC; CNRS; European Union [LIFE07/NAT/E/000732]; PRIN project on 'Coastal bioconstructions: structure, function and management' Italian Ministry of Education, Univeristy and Research [2010Z8HJ5M]	I3P contract of the Consejo Superior de Investigaciones Cientificas; Generalitat de Catalunya(Generalitat de Catalunya); Marie Curie International Outgoing Fellowship (ANIMAL FOREST HEALTH); CSIC; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); PRIN project on 'Coastal bioconstructions: structure, function and management' Italian Ministry of Education, Univeristy and Research	AG was funded by a I3P contract of the Consejo Superior de Investigaciones Cientificas (Ref. I3P-BPD2005). SR wants to thank the support of the Generalitat de Catalunya to MERS (2014 SGR - 1356) and the Marie Curie International Outgoing Fellowship (ANIMAL FOREST HEALTH, project number 327845). The study was funded by a 2003-2004 INTERREG project between Catalonia-Languedoc Rouissillon ''Pirineus Mediterranis: La muntanya que uneix'' of the CSIC and CNRS, of the 2009-2013 European project LIFE+ INDEMARES ''Inventario y designacion de la red natura 2000 en areas marinas del estado espanol'' (LIFE07/NAT/E/000732) of the European Union, and by a PRIN 2010-2011 project (prot. 2010Z8HJ5M) on 'Coastal bioconstructions: structure, function and management' Italian Ministry of Education, Univeristy and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Authors are grateful to L. Terrazzoni for her collaboration in lab work, and to N Viladrich, I Fiorillo and T Garcia for their help during sampling. A Gori was funded by a I3P contract of the Consejo Superior de Investigaciones Cientificas (Ref. I3P-BPD2005). S Rossi wants to thank the support of the Generalitat de Catalunya to MERS (2014 SGR-1356) and the Marie Curie International Outgoing Fellowship (ANIMAL FOREST HEALTH, project number 327845). This work is part of the 2003-2004 INTERREG project between Catalonia-Languedoc Rouissillon "Pirineus Mediterranis: La muntanya que uneix" of the CSIC and CNRS, of the 2009-2013 European project LIFE+ INDEMARES "Inventario y designacion de la red natura 2000 en areas marinas del estado espanol" (LIFE07/NAT/E/000732) of the European Union, and of the PRIN 2010-2011 project (prot. 2010Z8HJ5M) on 'Coastal bioconstructions: structure, function and management' Italian Ministry of Education, Univeristy and Research.	Abdoullaye D, 2010, MOL ECOL RESOUR, V10, P232, DOI 10.1111/j.1755-0998.2009.02796.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Belkhir K, 2004, LAB GENOME POPULATIO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010871; Calderon I, 2006, J EXP MAR BIOL ECOL, V336, P184, DOI 10.1016/j.jembe.2006.05.006; Carlon DB, 2002, EVOLUTION, V56, P2227; CARPINE C, 1975, Bulletin de l'Institut Oceanographique (Monaco), V71, P1; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cornuet JM, 1999, GENETICS, V153, P1989; Costantini F, 2007, MOL ECOL, V16, P5168, DOI 10.1111/j.1365-294X.2007.03579.x; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Forcioli D, 2011, MAR ECOL PROG SER, V439, P57, DOI 10.3354/meps09314; Garrabou J, 2002, J ANIM ECOL, V71, P966, DOI 10.1046/j.1365-2656.2002.00661.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gori A, 2012, CORAL REEFS, V31, P823, DOI 10.1007/s00338-012-0904-1; Gori A, 2012, MAR BIOL, V159, P1485, DOI 10.1007/s00227-012-1928-3; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Gori A, 2011, MAR BIOL, V158, P143, DOI 10.1007/s00227-010-1548-8; Grasshoff M, 1992, COUR FORSCHUNGINSTIT, V149, P135; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Holland LP, 2013, CONSERV GENET RESOUR, V5, P825, DOI 10.1007/s12686-013-9919-3; Holstein DM, 2015, CORAL REEFS, DOI [10.1007/s00338-015-1339-2pone.0003376, DOI 10.1007/S00338-015-1339-2PONE.0003376]; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kendall M., 1977, ADV THEORY STAT, V1; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McFadden CS, 2011, MOL ECOL RESOUR, V11, P19, DOI 10.1111/j.1755-0998.2010.02875.x; Padron M, 2015, EVALUATION OF CONSER; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pey A, 2013, CR BIOL, V336, P331, DOI 10.1016/j.crvi.2013.06.008; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pivotto ID, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140493; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prada C, 2013, P NATL ACAD SCI USA, V110, P3961, DOI 10.1073/pnas.1208931110; Prada C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-47; Pritchard JK, 2000, GENETICS, V155, P945; Quattrini AM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0008; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Rossi S, 2009, INVERTEBR REPROD DEV, V53, P175, DOI 10.1080/07924259.2009.9652304; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Rubio A, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004245; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; Serrano X, 2014, MOL ECOL, V23, P4226, DOI 10.1111/mec.12861; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stevens JR, 2014, ASSESSING GENETIC CO; THEODOR J, 1967, VIE MILIEU A BIOL MA, V18, P291; Theodor J, 1969, VIE MILIEU, V20; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; WEINBERG S, 1979, BIJDR DIERKD, V48, P127, DOI 10.1163/26660644-04802003; Weir B, 1996, GENETIC DATA ANAL, DOI [DOI 10.1111/J.1365-2052.2009.01970.X, 10.1111/j.1365-2052.2009.01970.x]; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x	70	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160678	10.1371/journal.pone.0160678	http://dx.doi.org/10.1371/journal.pone.0160678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490900	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900076
J	Rognon, B; Barrera, C; Monod, M; Valot, B; Roussel, S; Quadroni, M; Jouneau, S; Court-Fortune, I; Caillaud, D; Fellrath, JM; Dalphin, JC; Reboux, G; Millon, L				Rognon, Benedicte; Barrera, Coralie; Monod, Michel; Valot, Benoit; Roussel, Sandrine; Quadroni, Manfredo; Jouneau, Stephane; Court-Fortune, Isabelle; Caillaud, Denis; Fellrath, Jean-Marc; Dalphin, Jean-Charles; Reboux, Gabriel; Millon, Laurence			Identification of Antigenic Proteins from Lichtheimia corymbifera for Farmer's Lung Disease Diagnosis	PLOS ONE			English	Article							HYPERSENSITIVITY PNEUMONITIS; IMMUNOREACTIVE PROTEINS; IGG ANTIBODIES; SERODIAGNOSIS; HAY	The use of recombinant antigens has been shown to improve both the sensitivity and the standardization of the serological diagnosis of Farmer's lung disease (FLD). The aim of this study was to complete the panel of recombinant antigens available for FLD serodiagnosis with antigens of Lichtheimia corymbifera, known to be involved in FLD. L. corymbifera proteins were thus separated by 2D electrophoresis and subjected to western blotting with sera from 7 patients with FLD and 9 healthy exposed controls (HEC). FLD-associated immunoreactive proteins were identified by mass spectrometry based on a protein database specifically created for this study and subsequently produced as recombinant antigens. The ability of recombinant antigens to discriminate patients with FLD from controls was assessed by ELISA performed with sera from FLD patients (n = 41) and controls (n = 43) recruited from five university hospital pneumology departments of France and Switzerland. Forty-one FLD-associated immunoreactive proteins from L. corymbifera were identified. Six of them were produced as recombinant antigens. With a sensitivity and specificity of 81.4 and 77.3% respectively, dihydrolipoyl dehydrogenase was the most effective antigen for discriminating FLD patients from HEC. ELISA performed with the putative proteasome subunit alpha type as an antigen was especially specific (88.6%) and could thus be used for FLD confirmation. The production of recombinant antigens from L. corymbifera represents an additional step towards the development of a standardized ELISA kit for FLD diagnosis.	[Rognon, Benedicte; Barrera, Coralie; Valot, Benoit; Roussel, Sandrine; Dalphin, Jean-Charles; Reboux, Gabriel; Millon, Laurence] Univ Bourgogne Franche Comte, Chronoenvironm UMR6249, Besancon, France; [Rognon, Benedicte; Barrera, Coralie; Valot, Benoit; Roussel, Sandrine; Reboux, Gabriel; Millon, Laurence] Univ Hosp Besancon, Parasitol Mycol Dept, Besancon, France; [Monod, Michel] Univ Hosp, Dept Dermatol, Lausanne, Switzerland; [Quadroni, Manfredo] Univ Lausanne, Ctr Integrat Genom, Prot Anal Facil, Lausanne, Switzerland; [Jouneau, Stephane] Univ Hosp Rennes, Dept Pneumol, Rennes, France; [Jouneau, Stephane] Univ Rennes 1, IRSET, UMR1085, Rennes, France; [Court-Fortune, Isabelle] Univ Hosp North, Dept Pneumol, St Etienne, France; [Caillaud, Denis] Univ Hosp Gabriel Montpied, Dept Pneumol, Clermont Ferrand, France; [Fellrath, Jean-Marc] Pourtales Hosp, Dept Pulm Med, Neuchatel, Switzerland; [Dalphin, Jean-Charles] Univ Hosp Besancon, Dept Resp Dis, Besancon, France	Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; CHU Rennes; Universite de Rennes; CHU Clermont Ferrand; Universite de Franche-Comte; CHU Besancon	Rognon, B (corresponding author), Univ Bourgogne Franche Comte, Chronoenvironm UMR6249, Besancon, France.; Rognon, B (corresponding author), Univ Hosp Besancon, Parasitol Mycol Dept, Besancon, France.	benedicte.rognon@univ-fcomte.fr	Valot, Benoit BV/G-3521-2018; Jouneau, Stephane/K-9956-2015; Millon, laurence/AAK-5980-2020	Reboux, Gabriel/0000-0002-7923-0858; Quadroni, Manfredo/0000-0002-2720-4084	French Ministry of Health (Projet Hospitalier de Recherche Clinique national "SOPHIA") [2009-A00546-51]	French Ministry of Health (Projet Hospitalier de Recherche Clinique national "SOPHIA")	French Ministry of Health (Projet Hospitalier de Recherche Clinique national "SOPHIA" 2009-A00546-51) to LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera C, 2014, PROTEOM CLIN APPL, V8, P971, DOI 10.1002/prca.201400024; Bellanger AP, 2010, MED MYCOL, V48, P981, DOI 10.3109/13693781003713711; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Dalphin J-C, 2009, PNEUMOPATHIES DHYPER, P1008; Erkinjuntti-Pekkanen R, 1999, ALLERGY, V54, P1181, DOI 10.1034/j.1398-9995.1999.00275.x; Fenoglio CM, 2007, EUR RESPIR J, V29, P706, DOI 10.1183/09031936.00001006; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Lacasse Y, 2003, AM J RESP CRIT CARE, V168, P952, DOI 10.1164/rccm.200301-137OC; Lappalainen S, 1998, ANN ALLERG ASTHMA IM, V81, P585, DOI 10.1016/S1081-1206(10)62710-X; Millon L, 2014, CURR PROTEIN PEPT SC, V15, P430, DOI 10.2174/1389203715666140512121733; Millon L, 2012, J ALLERGY CLIN IMMUN, V130, P803, DOI 10.1016/j.jaci.2012.03.039; Reboux G, 2001, AM J RESP CRIT CARE, V163, P1534, DOI 10.1164/ajrccm.163.7.2006077; Reboux G, 2007, J MED MICROBIOL, V56, P1317, DOI 10.1099/jmm.0.46953-0; Rognon B, 2015, J MED MICROBIOL, V64, P359, DOI 10.1099/jmm.0.000037; Roussel S, 2005, MYCOPATHOLOGIA, V160, P273, DOI 10.1007/s11046-005-0155-6; Roussel S, 2004, OCCUP ENVIRON MED, V61; Roussel S, 2011, INT J MED MICROBIOL, V301, P150, DOI 10.1016/j.ijmm.2010.07.002; Schuyler M, 1997, CHEST, V111, P534, DOI 10.1378/chest.111.3.534; Schwartze VU, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004496; Selman M, 2004, CLIN CHEST MED, V25, P531, DOI 10.1016/j.ccm.2004.04.001; Selman Moises, 2010, Proc Am Thorac Soc, V7, P229, DOI 10.1513/pats.200906-041AL	21	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160888	10.1371/journal.pone.0160888	http://dx.doi.org/10.1371/journal.pone.0160888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490813	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900084
J	Setiawan, D; Kotsopoulos, N; Wilschut, JC; Postma, MJ; Connolly, MP				Setiawan, Didik; Kotsopoulos, Nikolaos; Wilschut, Jan C.; Postma, Maarten J.; Connolly, Mark P.			Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach	PLOS ONE			English	Article							CERVICAL-CANCER PREVENTION; HUMAN-PAPILLOMAVIRUS VACCINATION; COST-EFFECTIVENESS; AS04-ADJUVANTED VACCINE; QUADRIVALENT VACCINE; THAILAND; HEALTH; TRIAL; STRATEGIES; MORTALITY	Background Cervical cancer poses a substantial burden in terms of morbidity, mortality, and economic losses, especially in low/middle-income countries. HPV vaccination and/or cervical cancer screening among females may reduce the burden of HPV-related diseases, including cervical cancer. However, limited funds may impede the implementation of population-based programmes. Governmental investments in the prevention of infectious disease may have broader economic and fiscal benefits, which are not accounted in conventional economic analyses. This study estimates the broader economic and fiscal impacts of implementing HPV vaccination and/or cervical cancer screening in Indonesia from the perspective of the government. Methods A government-perspective quantitative analytic framework was applied to assess the Net Present Value (NPV) of investment on cervical cancer prevention strategies including HPV vaccination, cervical screening and its combination in Indonesia. All monetary values were presented in International Dollars (I$). Results Based on a cohort of 10,000,000 Indonesian 12-year-old females, it was estimated that HPV vaccination and/or cervical cancer screening result in a positive NPV for the Indonesian government. The combination of cervical screening and HPV vaccination generated a substantial reduction of cervical cancer incidence and HPV-related mortality of 87,862 and 19,359, respectively. It was estimated that HPV vaccination in combination with cervical screening is the most favorable option for cervical cancer prevention (NPV I $2.031.786.000), followed by HPV vaccination alone (NPV I$1.860.783.000) and cervical screening alone (NPV I$375.244.000). Conclusion In addition to clinical benefits, investing in HPV vaccination and cervical screening may yield considerable fiscal benefits for the Indonesian governments due to lifelong benefits resulting from reduction of cervical cancer-related morbidity and mortality.	[Setiawan, Didik; Kotsopoulos, Nikolaos; Postma, Maarten J.; Connolly, Mark P.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Setiawan, Didik] Univ Muhammadiyah Purwokerto, Fac Pharm, Purwokerto, Indonesia; [Kotsopoulos, Nikolaos; Connolly, Mark P.] Global Market Access Solut GMAS, St Prex, Switzerland; [Wilschut, Jan C.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & HealthcaRE SHARE, Groningen, Netherlands	University of Groningen; Universitas Muhammadiyah Purwokerto; University of Groningen; University of Groningen	Setiawan, D (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.; Setiawan, D (corresponding author), Univ Muhammadiyah Purwokerto, Fac Pharm, Purwokerto, Indonesia.	d.didiksetiawan@gmail.com		Postma, Maarten/0000-0002-6306-3653; Setiawan, Didik/0000-0001-9104-548X; KOTSOPOULOS, NIKOLAOS/0000-0002-8248-7697	Directorate General of Higher Education (DIKTI) Scholarship, Ministry of National Education, Indonesia; Global Market Access Solutions	Directorate General of Higher Education (DIKTI) Scholarship, Ministry of National Education, Indonesia; Global Market Access Solutions	The first author, Didik Setiawan, was supported by the funding from Directorate General of Higher Education (DIKTI) Scholarship, Ministry of National Education, Indonesia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Global Market Access Solutions provided support in the form of salaries for authors NK and MPC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Badan Pusat Statistik, 2014, PEND BER 15 TAH KE A; Badan Pusat Statistik, 2014, RAT RAT PENG KAP SEB; Badan Pusat Statistik, 2014, PROD DOM BRUT KAP PR; Badan Pusat Statistik, 2014, PEND IND MEN PROV 19; Badan Pusat STatistik, 2014, NAT INC IND 2010 201, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Badan Pusat Statistik, 2011, RAT RAT PENG KAP SEB; Badan Pusat Statistik, 2014, ANGK HAR HID PEND BE; Badan Pusat Statistik, 2014, JUML PEG NEG SIP MEN; BPJS Ketenagakerjaan, 2014, LAP TAH 2013; Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Connolly MP, 2012, PHARMACOECONOMICS, V30, P681, DOI 10.2165/11597750-000000000-00000; Coupe VMH, 2009, INT J CANCER, V124, P970, DOI 10.1002/ijc.24000; Deerasamee S, 2007, ASIAN PAC J CANCER P, V8, P547; Denny L, 2015, INT J GYNECOL OBSTET, V131, pS28, DOI 10.1016/j.ijgo.2015.02.009; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Dewan Jaminan Sosial Nasional, 2014, JAM SOS BID KET 2013; Diaz M, 2008, BRIT J CANCER, V99, P230, DOI 10.1038/sj.bjc.6604462; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Direktorat Jenderal Pajak, 2013, PAJ PERT NIL; Domingo EJ, 2008, VACCINE, V26, pM71, DOI 10.1016/j.vaccine.2008.05.039; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; HAUSEN HZ, 1989, CANCER RES, V49, P4677; Jit M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0446-9; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Kim JJ, 2008, VACCINE, V26, P4015, DOI 10.1016/j.vaccine.2008.05.038; Kotsopoulos N, 2013, VACCINE, V31, P5430, DOI 10.1016/j.vaccine.2013.09.002; Kotsopoulos N, 2013, J MENT HEALTH POLICY, V16, P27; KPMG, 2011, AS PAC IND TAX COUNT; Lee VJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-203; Lorenz MO, 1905, METHODS MEASURING CO, P209; Mandelblatt JS, 2002, JNCI-J NATL CANCER I, V94, P1469, DOI 10.1093/jnci/94.19.1469; Manurung S, 2013, KOMPLEKSITAS KEPATUH; Marty R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-10; Menteri Keuangan Republik Indonesia, 2012, PEN BES PENGH TID KE, P1; Palmer S, 1999, BRIT MED J, V318, P1136, DOI 10.1136/bmj.318.7191.1136; Praditsitthikorn N, 2011, PHARMACOECONOMICS, V29, P781, DOI 10.2165/11586560-000000000-00000; Presiden Republik Indonesia, 1992, DAN PENS, P1; Presiden Republik Indonesia, 1993, PEN PROGR JAM SOS TE, P1; Presiden Republik Indonesia, 2004, SIST JAM SOS NAS; Rogoza RM, 2008, VACCINE, V26, pF46, DOI 10.1016/j.vaccine.2008.02.039; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Setiawan Didik, 2016, Value Health Reg Issues, V9, P84, DOI 10.1016/j.vhri.2015.10.010; Setiawan D, 2015, EXPERT REV VACCINES, V14, P589, DOI 10.1586/14760584.2014.990386; The Organisation for Economic Co-operation and Development, 2013, PROD LONG TERM GROWT, P167; Triami Media BV, 2014, INFL IND 2014; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Westra TA, 2012, VALUE HEALTH, V15, P562, DOI 10.1016/j.jval.2012.01.005; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; WHO, 2013, COMP CERV CANC PREV; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	51	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160707	10.1371/journal.pone.0160707	http://dx.doi.org/10.1371/journal.pone.0160707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490258	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900080
J	Hung, YL; Jiang, I; Lee, YZ; Wen, CK; Sue, SC				Hung, Yi-Lin; Jiang, Ingjye; Lee, Yi-Zong; Wen, Chi-Kuang; Sue, Shih-Che			NMR Study Reveals the Receiver Domain of Arabidopsis ETHYLENE RESPONSE1 Ethylene Receptor as an Atypical Type Response Regulator	PLOS ONE			English	Article							HISTIDINE KINASE-ACTIVITY; HIGH-RESOLUTION NMR; CRYSTAL-STRUCTURE; MIMICS PHOSPHORYLATION; MOLECULAR RECOGNITION; SIGNAL-TRANSDUCTION; BACKBONE DYNAMICS; ACTIVATED CHEY; ETR1; PROTEIN	The gaseous plant hormone ethylene, recognized by plant ethylene receptors, plays a pivotal role in various aspects of plant growth and development. ETHYLENE RESPONSE1 (ETR1) is an ethylene receptor isolated from Arabidopsis and has a structure characteristic of prokaryotic two-component histidine kinase (HK) and receiver domain (RD), where the RD structurally resembles bacteria response regulators (RRs). The ETR1 HK domain has autophosphorylation activity, and little is known if the HK can transfer the phosphoryl group to the RD for receptor signaling. Unveiling the correlation of the receptor structure and phosphorylation status would advance the studies towards the underlying mechanisms of ETR1 receptor signaling. In this study, using the nuclear magnetic resonance technique, our data suggested that the ETR1-RD is monomeric in solution and the rigid structure of the RD prevents the conserved aspartate residue phosphorylation. Comparing the backbone dynamics with other RRs, we propose that backbone flexibility is critical to the RR phosphorylation. Besides the limited flexibility, ETR1-RD has a unique. loop conformation of opposite orientation, which makes ETR1-RD unfavorable for phosphorylation. These two features explain why ETR1-RD cannot be phosphorylated and is classified as an atypical type RR. As a control, phosphorylation of the ETR1-RD was also impaired when the sequence was swapped to the fragment of the bacterial typical type RR, CheY. Here, we suggest a molecule insight that the ETR1-RD already exists as an active formation and executes its function through binding with the downstream factors without phosphorylation.	[Hung, Yi-Lin; Jiang, Ingjye; Lee, Yi-Zong; Sue, Shih-Che] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Hung, Yi-Lin] Natl Tsing Hua Univ, Instrumentat Ctr, Hsinchu, Taiwan; [Wen, Chi-Kuang] Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Natl Key Lab Plant Mol Genet, Inst Plant Physiol & Ecol,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Sue, Shih-Che] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Tsing Hua University	Sue, SC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.; Sue, SC (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan.	scsue@life.nthu.edu.tw	Wen, Chi-Kuang/AAI-4308-2020		Ministry of Science and Technology (MOST), Taiwan [102-2113-M-007-014, 103-2113-M-007-016]; National Tsing Hua University [105N527CE1, 105N183DE1]	Ministry of Science and Technology (MOST), Taiwan; National Tsing Hua University	This work was supported by Ministry of Science and Technology (MOST), Taiwan (102-2113-M-007-014 and 103-2113-M-007-016) and National Tsing Hua University (105N527CE1, 105N183DE1).	Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07; Bakshi A, 2015, PLANT PHYSIOL, V169, P219, DOI 10.1104/pp.15.00626; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2008, PLANT SCI, V175, P8, DOI 10.1016/j.plantsci.2007.12.001; Bleecker AB, 1998, PHILOS T ROY SOC B, V353, P1405, DOI 10.1098/rstb.1998.0295; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Chang C, 1998, PLANT PHYSIOL, V117, P723, DOI 10.1104/pp.117.3.723; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Cho HS, 2000, J MOL BIOL, V297, P543, DOI 10.1006/jmbi.2000.3595; Cho YH, 2007, PLANT PHYSIOL, V143, P612, DOI 10.1104/pp.106.091504; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; Feher VA, 1997, BIOCHEMISTRY-US, V36, P10015, DOI 10.1021/bi970816l; FEHER VA, 1995, PROTEIN SCI, V4, P1801, DOI 10.1002/pro.5560040915; Foussard M, 2001, MICROBES INFECT, V3, P417, DOI 10.1016/S1286-4579(01)01390-9; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gao TY, 2007, PROTEIN SCI, V16, P465, DOI 10.1110/ps.062532007; Goddard T, 2004, SPARKY 3, V14, P15; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hastings CA, 2003, BIOCHEMISTRY-US, V42, P9081, DOI 10.1021/bi0273866; Hong E, 2007, J BIOL CHEM, V282, P20667, DOI 10.1074/jbc.M609104200; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Hung YL, 2015, BIOMOL NMR ASSIGN, V9, P119, DOI 10.1007/s12104-014-9556-0; Im YJ, 2002, PROTEIN SCI, V11, P614, DOI 10.1110/ps.39102; Jeong KW, 2013, MOL CELLS, V35, P158, DOI 10.1007/s10059-013-2303-z; Kim H, 2011, PLANT PHYSIOL, V156, P417, DOI 10.1104/pp.110.170621; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; Luo SC, 2010, J STRUCT BIOL, V172, P319, DOI 10.1016/j.jsb.2010.06.007; Mayerhofer H, 2015, J BIOL CHEM, V290, P2644, DOI 10.1074/jbc.M114.587667; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; Ocasio VJ, 2015, BIOCHEMISTRY-US, V54, P1353, DOI 10.1021/bi501143b; Pekarova B, 2011, PLANT J, V67, P827, DOI 10.1111/j.1365-313X.2011.04637.x; Qiu LP, 2012, PLANT PHYSIOL, V159, P1263, DOI 10.1104/pp.112.193979; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Rombel I, 1999, J BACTERIOL, V181, P4628, DOI 10.1128/JB.181.15.4628-4638.1999; Sheftic SR, 2012, BIOCHEMISTRY-US, V51, P6932, DOI 10.1021/bi300922z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Tzeng YL, 1997, J MOL BIOL, V272, P200, DOI 10.1006/jmbi.1997.1226; Varughese KI, 2006, J BACTERIOL, V188, P4970, DOI 10.1128/JB.00160-06; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Wemmer DE, 2005, J BACTERIOL, V187, P8229, DOI 10.1128/JB.187.24.8229-8230.2005; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Xu CY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004956; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103	53	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160598	10.1371/journal.pone.0160598	http://dx.doi.org/10.1371/journal.pone.0160598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486797	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800090
J	Kagy, VD; Muniz, LTB; Michels, AC; Luiz, ST; Alanis, LRA; Brancher, JA; Gregio, AMT; Ignacio, SA; Camargo, ES; Machado, MAN; Johann, ACBR				Kagy, Viviane da Silva; Bittencourt Muniz, Luciana Trevisan; Michels, Arieli Carini; Luiz, Suelen Teixeira; Azevedo Alanis, Luciana Reis; Brancher, Joao Armando; Trindade Gregio, Ana Maria; Ignacio, Sergio Aparecido; Camargo, Elisa Souza; Naval Machado, Maria Angela; Batista Rodrigues Johann, Aline Cristina			Effect of the Chronic Use of Lithium Carbonate on Induced Tooth Movement in Wistar Rats	PLOS ONE			English	Article							ROOT RESORPTION; ALVEOLAR BONE; THERAPY; DISORDERS; TOXICITY; ACTIVATION; MECHANISM; TISSUE; ERRORS; SERUM	Patients who seek dental treatment may have bipolar disorder, and lithium carbonate (LC) is the drug of choice used in the treatment of this disorder. Taking into consideration the controversial results found in the literature, and the possible influence of LC on induced tooth movement, the objective was to evaluate tooth movement induced in rats after administration of lithium carbonate. One hundred and ninety-two rats were divided into 3 groups. In the L group, the animals received daily 60mg/kg of LC, they were not subjected to orthodontic movement, and they were euthanized after 33, 37, 44 or 51 days. In the LM group, the LC was administered for 30 days and during the subsequent 3, 7, 14 and 21 days, corresponding to the period of induced tooth movement, and they received a spring that produced a 30cN force. In the SM group, saline solution was applied. Measurements were made of tooth displacement, the numbers of osteoclasts and serum lithium phosphate (PO4), alkaline phosphatase (ALP) and creatinine levels. The tooth displacement was lower in the LM group compared to the SM group at 44 days. A tendency toward reduction in the number of osteoclasts was observed in the LM group compared to the SM group at 44 days. The average lithium were higher in the L and LM groups compared to the SM group. The opposite was observed for the PO4 group. A higher value for the ALP was found in the L group. The average creatinine level was lower in the LM group. LC inhibited tooth movement for 14 days, possibly due to the reduction in the number of osteoclasts.	[Kagy, Viviane da Silva; Bittencourt Muniz, Luciana Trevisan; Michels, Arieli Carini; Luiz, Suelen Teixeira; Azevedo Alanis, Luciana Reis; Brancher, Joao Armando; Trindade Gregio, Ana Maria; Ignacio, Sergio Aparecido; Camargo, Elisa Souza; Batista Rodrigues Johann, Aline Cristina] Pontificia Univ Catolica Parana, Dept Sch Hlth & Biosci, Curitiba, PR, Brazil; [Naval Machado, Maria Angela] Univ Fed Parana, Sch Dent, Dept Stomatol, Curitiba, PR, Brazil	Pontificia Universidade Catolica do Parana; Universidade Federal do Parana	Johann, ACBR (corresponding author), Pontificia Univ Catolica Parana, Dept Sch Hlth & Biosci, Curitiba, PR, Brazil.	alinecristinabatista@yahoo.com.br	Johann, Aline C B R/G-7190-2012; Brancher, João Armando/C-7758-2014; Azevedo-Alanis, Luciana R/G-9150-2012; Machado, Maria/ABH-7992-2020; Muniz, Luciana/Y-2102-2019; Brancher, João Armando/AAQ-4858-2020; Camargo, Elisa/P-7077-2016	Johann, Aline C B R/0000-0002-1678-9363; Brancher, João Armando/0000-0002-8914-702X; Azevedo-Alanis, Luciana R/0000-0001-8809-3579; Brancher, João Armando/0000-0002-8914-702X; Camargo, Elisa/0000-0002-7382-1526; Teixeira Luiz, Suelen/0000-0001-5675-8134; Gregio Hardy, Ana Maria/0000-0003-0445-8206; Machado, Maria Angela Naval/0000-0002-2752-1979; Michels, Arieli Carini/0000-0001-9099-0893				Allagui MS, 2005, CR BIOL, V328, P900, DOI 10.1016/j.crvi.2005.08.005; ALTAMURA AC, 1977, EUR J CLIN PHARMACOL, V12, P59, DOI 10.1007/BF00561406; ANDERSSON KE, 1986, ACTA PHARMACOL TOX, V59, P27; Arioka M, 2014, BIOCHEM PHARMACOL, V90, P397, DOI 10.1016/j.bcp.2014.06.011; Baloul SS, 2011, AM J ORTHOD DENTOFAC, V139, pS83, DOI 10.1016/j.ajodo.2010.09.026; BARAN DT, 1978, J CLIN INVEST, V61, P1691, DOI 10.1172/JCI109090; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Close H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090169; Cohen O, 1998, HORM METAB RES, V30, P594, DOI 10.1055/s-2007-978939; DAVIES NL, 1991, J S AFR VET ASSOC, V62, P140; Dibart S, 2014, EUR J ORTHODONT, V36, P457, DOI 10.1093/ejo/cjt079; Diravidamani K, 2012, J PHARM BIOALLIED SC, V4, pS299, DOI 10.4103/0975-7406.100278; Ekizer A, 2015, LASER MED SCI, V30, P779, DOI 10.1007/s10103-013-1405-3; Frigotto GCF, 2015, AM J ORTHOD DENTOFAC, V148, P450, DOI 10.1016/j.ajodo.2015.04.031; Galvao MJ, 2011, EUR J HISTOCHEM, V55, P1, DOI 10.4081/ejh.2011.e1; Giglio JA, 2010, QUINTESSENCE INT, V41, P433; Gonzales C, 2009, ANGLE ORTHOD, V79, P715, DOI 10.2319/072108-381.1; Grande I., 2015, LANCET, DOI [10.1016/S0140-6736(15)00241-X, DOI 10.1016/S0140-6736(15)00241-X.]; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hillert M, 2012, NEUROSCI LETT, V521, P62, DOI 10.1016/j.neulet.2012.05.060; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Jensen HV, 1996, J AFFECT DISORDERS, V36, P89, DOI 10.1016/0165-0327(95)00052-6; KEELING SD, 1993, AM J ORTHOD DENTOFAC, V103, P320, DOI 10.1016/0889-5406(93)70012-D; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lepkifker E, 2007, DEPRESS ANXIETY, V24, P571, DOI 10.1002/da.20273; Leslie Will, ORTHODONTICS CURRENT; Lewicki M, 2006, EXP TOXICOL PATHOL, V58, P197, DOI 10.1016/j.etp.2006.06.003; Mak TWL, 1998, J CLIN ENDOCR METAB, V83, P3857, DOI 10.1210/jc.83.11.3857; Marquezan M, 2010, PHOTOMED LASER SURG, V28, P757, DOI 10.1089/pho.2009.2694; McCormack SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102387; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Meikle MC, 2006, EUR J ORTHODONT, V28, P221, DOI 10.1093/ejo/cj1001; MIDTGARD J, 1974, ANGLE ORTHOD, V44, P56; Milne TJ, 2009, EUR J ORTHODONT, V31, P221, DOI 10.1093/ejo/cjp032; Moe SM, 2008, PRIMARY CARE, V35, P215, DOI 10.1016/j.pop.2008.01.007; Ng F, 2009, BIPOLAR DISORD, V11, P559, DOI 10.1111/j.1399-5618.2009.00737.x; Patel BD, 2013, PSYCHIAT QUART, V84, P407, DOI 10.1007/s11126-013-9253-7; Paton C, 2013, BIPOLAR DISORD, V15, P865, DOI 10.1111/bdi.12128; Pearson GS, 2012, J CHILD ADOL PS NURS, V25, P232, DOI 10.1111/jcap.12008; Prigent A, 2008, SEMIN NUCL MED, V38, P32, DOI 10.1053/j.semnuclmed.2007.09.003; Retamoso LB, 2009, MICRON, V40, P827, DOI 10.1016/j.micron.2009.07.003; Ribeiro Jucienne Salgado, 2013, Braz. Dent. J., V24, P503, DOI 10.1590/0103-6440201302286; Sharma SD, 2005, BIOL PHARM BULL, V28, P834, DOI 10.1248/bpb.28.834; Shoji S, 2010, CALCIFIED TISSUE INT, V87, P181, DOI 10.1007/s00223-010-9384-x; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Tamura M, 2011, INT J BIOCHEM CELL B, V43, P760, DOI 10.1016/j.biocel.2011.01.021; Tang GH, 2011, J DENT RES, V90, P336, DOI 10.1177/0022034510389180; Teng GYY, 2014, J ORAL MAXIL SURG, V72, P19, DOI 10.1016/j.joms.2013.09.012; Tucker MJ, 1997, DISEASES OF THE WIST; Wang Y, 2014, EXP THER MED, V7, P468, DOI 10.3892/etm.2013.1410; Zamani A, 2009, BONE, V44, P331, DOI 10.1016/j.bone.2008.10.001; Zhang MY, 2009, CELL SIGNAL, V21, P559, DOI 10.1016/j.cellsig.2008.12.010	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160400	10.1371/journal.pone.0160400	http://dx.doi.org/10.1371/journal.pone.0160400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487121	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800075
J	Reid, LB; Cunnington, R; Boyd, RN; Rose, SE				Reid, Lee B.; Cunnington, Ross; Boyd, Roslyn N.; Rose, Stephen E.			Surface-Based fMRI-Driven Diffusion Tractography in the Presence of Significant Brain Pathology: A Study Linking Structure and Function in Cerebral Palsy	PLOS ONE			English	Article							HEMODYNAMIC-RESPONSE FUNCTION; CONGENITAL HEMIPARESIS; CHILDREN; MATTER; IMAGES; REGISTRATION; MOVEMENT; ACCURATE; DENSITY; ROBUST	Diffusion MRI (dMRI) tractography analyses are difficult to perform in the presence of brain pathology. Automated methods that rely on cortical parcellation for structural connectivity studies often fail, while manually defining regions is extremely time consuming and can introduce human error. Both methods also make assumptions about structure-function relationships that may not hold after cortical reorganisation. Seeding tractography with functional- MRI (fMRI) activation is an emerging method that reduces these confounds, but inherent smoothing of fMRI signal may result in the inclusion of irrelevant pathways. This paper describes a novel fMRI-seeded dMRI-analysis pipeline based on surface-meshes that reduces these issues and utilises machine-learning to generate task specific white matter pathways, minimising the requirement for manually-drawn ROIs. We directly compared this new strategy to a standard voxelwise fMRI-dMRI approach, by investigating correlations between clinical scores and dMRI metrics of thalamocortical and corticomotor tracts in 31 children with unilateral cerebral palsy. The surface-based approach successfully processed more participants (87%) than the voxel-based approach (65%), and provided significantly more-coherent tractography. Significant correlations between dMRI metrics and five clinical scores of function were found for the more superior regions of these tracts. These significant correlations were stronger and more frequently found with the surface-based method (15/20 investigated were significant; R-2 = 0.43-0.73) than the voxelwise analysis (2 sig. correlations; 0.38 & 0.49). More restricted fMRI signal, better-constrained tractography, and the novel track-classification method all appeared to contribute toward these differences.	[Reid, Lee B.; Rose, Stephen E.] CSIRO, Australian E Hlth Res Ctr, Brisbane, Qld, Australia; [Cunnington, Ross] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Cunnington, Ross] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Reid, Lee B.; Boyd, Roslyn N.] Univ Queensland, Sch Med, Childrens Hlth Res Ctr, Queensland Cerebral Palsy & Rehabil Res Ctr, Level 6, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of Queensland; University of Queensland	Rose, SE (corresponding author), CSIRO, Australian E Hlth Res Ctr, Brisbane, Qld, Australia.	stephen.rose@csiro.au	Boyd, Roslyn N/A-4498-2011; Rose, Stephen/C-8044-2009	Boyd, Roslyn N/0000-0002-4919-5975; 	Foundation for Children Grant; Smart Futures Co-Investment Program	Foundation for Children Grant; Smart Futures Co-Investment Program	This work was supported by the Foundation for Children Grant (RNB), Smart Futures Co-Investment Program Grant (RNB). R. Boyd is an NHMRC Research Fellow (#1037220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade A, 2001, HUM BRAIN MAPP, V12, P79, DOI 10.1002/1097-0193(200102)12:2<79::AID-HBM1005>3.0.CO;2-I; Anticevic A, 2008, NEUROIMAGE, V41, P835, DOI 10.1016/j.neuroimage.2008.02.052; Arnfield E, 2013, RES DEV DISABIL, V34, P2234, DOI 10.1016/j.ridd.2013.03.031; Barnea-Goraly N, 2014, PEDIATR RADIOL, V44, P181, DOI 10.1007/s00247-013-2798-7; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Bonakdarpour B, 2007, NEUROIMAGE, V36, P322, DOI 10.1016/j.neuroimage.2007.02.035; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Boyd R. N., 2013, BMJ OPEN, P3, DOI [DOI 10.1136/BMJOPEN-2013-002853, 10.1136/bmjopen-2013-002853]; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Fisher A. G., 2010, ASSESSMENT MOTOR PRO, V1; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jo HJ, 2008, NEUROIMAGE, V40, P1077, DOI 10.1016/j.neuroimage.2007.12.036; Jo HJ, 2007, NEUROIMAGE, V34, P550, DOI 10.1016/j.neuroimage.2006.09.047; JOHNSON LM, 1994, DEV MED CHILD NEUROL, V36, P965; Juenger H, 2007, NEUROPEDIATRICS, V38, P130, DOI 10.1055/s-2007-985904; Krageloh-Mann I, 2007, DEV MED CHILD NEUROL, V49, P144; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; Oosterhof NN, 2011, NEUROIMAGE, V56, P593, DOI 10.1016/j.neuroimage.2010.04.270; Pannek K, 2014, NEUROIMAGE-CLIN, V5, P84, DOI 10.1016/j.nicl.2014.05.018; Pannek K, 2012, PEDIATR RADIOL, V42, P1169, DOI 10.1007/s00247-012-2427-x; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reid LB, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2643491; Reid LB, 2015, NAT REV NEUROL, V11, P390, DOI 10.1038/nrneurol.2015.97; Rose S, 2011, BRAIN CONNECT, V1, P309, DOI 10.1089/brain.2011.0034; Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028; Scheck SM, 2014, DEV MED CHILD NEUROL, V56, P968, DOI 10.1111/dmcn.12461; Scheck SM, 2012, DEV MED CHILD NEUROL, V54, P684, DOI 10.1111/j.1469-8749.2012.04332.x; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Sochen N, 2003, PROC NINTH IEEE INT, DOI [10.1109/ICCV.2003.1238434, DOI 10.1109/ICCV.2003.1238434]; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Towsley K, 2011, EUR J PAEDIATR NEURO, V15, P29, DOI 10.1016/j.ejpn.2010.07.005; Tsao H, 2014, RES DEV DISABIL, V35, P250, DOI 10.1016/j.ridd.2013.11.001; Van de Winckel A, 2013, RES DEV DISABIL, V34, P183, DOI 10.1016/j.ridd.2012.07.030; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhu DJ, 2014, NEUROIMAGE, V102, P184, DOI 10.1016/j.neuroimage.2013.09.071	43	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159540	10.1371/journal.pone.0159540	http://dx.doi.org/10.1371/journal.pone.0159540			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487011	gold, Green Submitted, Green Published			2022-12-27	WOS:000381367800033
J	Zhou, JL; Zhu, L; Chen, H; Cui, BK				Zhou, Jun-Liang; Zhu, Lin; Chen, Hong; Cui, Bao-Kai			Taxonomy and Phylogeny of Polyporus Group Melanopus (Polyporales, Basidiomycota) from China	PLOS ONE			English	Article							SP-NOV POLYPORALES; RIBOSOMAL DNA; MEDICINAL MUSHROOMS; SEQUENCES; INFERENCE; LENTINUS; INOCYBE; NUCLEAR; FUNGI; GENUS	Melanopus is a morphological group of Polyporus which contains species with a black cuticle on the stipe. In this article, taxonomic and phylogenetic studies on Melanopus group were carried out on the basis of morphological characters and phylogenetic evidence of DNA sequences of multiple loci including the internal transcribed spacer (ITS) regions, the large subunit nuclear ribosomal RNA gene (nLSU), the small subunit nuclear ribosomal RNA gene (nSSU), the small subunit mitochondrial rRNA gene sequences (mtSSU), the translation elongation factor 1-alpha gene (EF1-alpha), the largest subunit of RNA polymerase II (RPB1), the second largest subunit of RNA polymerase II (RPB2), and beta-tubulin gene sequences (beta-tubulin). The phylogenetic result confirmed that the previously so-called Melanopus group is not a monophyletic assemblage, and species in this group distribute into two distinct clades: the Picipes clade and the Squamosus clade. Four new species of Picipes are described, and nine new combinations are proposed. A key to species of Picipes is provided.	[Zhou, Jun-Liang; Zhu, Lin; Chen, Hong; Cui, Bao-Kai] Beijing Forestry Univ, Inst Microbiol, Beijing 100083, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Cui, BK (corresponding author), Beijing Forestry Univ, Inst Microbiol, Beijing 100083, Peoples R China.	cuibaokai@yahoo.com	Cui, Bao-Kai/P-8328-2014	Cui, Bao-Kai/0000-0003-3059-9344	National Natural Science Foundation of China [31422001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was financed by the National Natural Science Foundation of China (Project No. 31422001).	[Anonymous], 1933, REVISION NIEDERLANDI; [Anonymous], 2001, THE MYCOTA VII PART; [Anonymous], 1916, TORREYA; [Anonymous], 2016, FUNGAL DIVERS; [Anonymous], 1899, B TORREY BOT CLUB; [Anonymous], 1980, WESTFALISCHE PILZBRI; [Anonymous], 1983, KEW B ADD SER; Binder M, 2005, SYST BIODIVERS, V3, P113, DOI 10.1017/S1477200005001623; Binder M, 2013, MYCOLOGIA, V105, P1350, DOI 10.3852/13-003; Binder M, 2010, MYCOLOGIA, V102, P865, DOI 10.3852/09-288; Chen JJ, 2015, FUNGAL DIVERS, V71, P185, DOI 10.1007/s13225-014-0317-2; Corner E. J. H., 1984, NOVA HEDWIGIA S, V78, P1; Dai YC, 1996, ANN BOT FENN, V33, P153; Dai YC, 2014, FUNGAL DIVERS, V64, P133, DOI 10.1007/s13225-013-0248-3; Dai YC, 2009, ANN BOT FENN, V46, P54, DOI 10.5735/085.046.0105; Dai YuCheng, 1999, Fungal Science, V14, P67; De AB, 1996, MYCOTAXON, V60, P143; Dodge B. O., 1916, MYCOLOGIA, V8, P5, DOI DOI 10.2307/3753323; DONK M. A., 1960, Persoonia, V1, P173; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; HIBBETT DS, 1995, CAN J BOT, V73, pS853, DOI 10.1139/b95-331; Hibbett DS, 1996, MOL BIOL EVOL, V13, P903, DOI 10.1093/oxfordjournals.molbev.a025658; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; HIBBETT DS, 1993, SYST BOT, V18, P409, DOI 10.2307/2419417; Ko KS, 2002, MYCOTAXON, V82, P315; Kruger D, 2006, MYCOL PROG, V5, P185, DOI 10.1007/s11557-006-0512-y; Kruger D., 2004, Feddes Repertorium, V115, P530, DOI 10.1002/fedr.200311052; Kruger D., 2002, THESIS; Li HJ, 2014, PERSOONIA, V32, P170, DOI 10.3767/003158514X681828; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Matheny PB, 2005, MOL PHYLOGENET EVOL, V35, P1, DOI 10.1016/j.ympev.2004.11.014; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; Nunez M, 1995, POLYPORUS BASIDIOMYC; NYLANDER JAA, 2004, MRMODELTEST2 2; Patouillard NT, 1887, HYMENOMYCETES DEUROP; Petersen J.H., 1996, FORENINGEN SVAMPEKUN; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; RYVARDEN L., 1994, SYNOPSIS FUNGORUM, V7, P394; Seelan JSS, 2015, MYCOLOGIA, V107, P460, DOI 10.3852/14-084; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Singer R, 1975, AGARICALES MODERN TA; Sotome Kozue, 2007, Mycoscience, V48, P42, DOI 10.1007/s10267-006-0328-2; Sotome K, 2008, MYCOLOGIA, V100, P603, DOI 10.3852/07-191R; Sotome K, 2013, FUNGAL DIVERS, V58, P245, DOI 10.1007/s13225-012-0213-6; Sotome K, 2009, MYCOSCIENCE, V50, P415, DOI 10.1007/s10267-009-0506-0; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xue HJ, 2014, MYCOL PROG, V13, P811, DOI 10.1007/s11557-014-0964-4; Xue HJ, 2012, MYCOTAXON, V122, P433, DOI 10.5248/122.433; Zhao CL, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1062-y; Zhao CL, 2014, MYCOL PROG, V13, P771, DOI 10.1007/s11557-014-0960-8; Zhao CL, 2013, FUNGAL DIVERS, V58, P47, DOI 10.1007/s13225-012-0177-6; Zmitrovich IV, 2016, INT J MED MUSHROOMS, V18, P23, DOI 10.1615/IntJMedMushrooms.v18.i1.40; Zmitrovich IV, 2010, INT J MED MUSHROOMS, V12, P87, DOI 10.1615/IntJMedMushr.v12.i1.80	57	37	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159495	10.1371/journal.pone.0159495	http://dx.doi.org/10.1371/journal.pone.0159495			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486931	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800032
J	Binz, N; Rakoczy, EP; Rahman, ISA; Vagaja, NN; Lai, CM				Binz, Nicolette; Rakoczy, Elizabeth P.; Rahman, Ireni S. Ali; Vagaja, Nermina N.; Lai, Chooi-May			Biomarkers for Diabetic Retinopathy - Could Endothelin 2 Be Part of the Answer?	PLOS ONE			English	Article							RETINAL NEOVASCULARIZATION; GENE-EXPRESSION; GROWTH-FACTOR; MOUSE MODEL; PLASMA ENDOTHELIN-1; TRANSGENIC MICE; DISEASE; COMPLICATIONS; STRESS; DAMAGE	Purpose The endothelins are a family of three highly conserved and homologous vasoactive peptides that are expressed across all organ systems. Endothelin (Edn) dysregulation has been implicated in a number of pathophysiologies, including diabetes and diabetes-related complications. Here we examined Edn2 and endothelin receptor B (Endrb) expression in retinae of diabetic mouse models and measured serum Edn2 to assess its biomarker potential. Materials and Methods Edn2 and Ednrb mRNA and Edn2 protein expression were assessed in young (8wk) and mature (24wk) C57Bl/6 (wild type; wt), Kimba (model of retinal neovascularisation, RNV), Akita (Type 1 diabetes; T1D) and Akimba mice (T1D plus RNV) by qRT-PCR and immunohistochemistry. Edn2 protein concentration in serum was measured using ELISA. Results Fold-changes in Edn2 and Ednrb mRNA were seen only in young Kimba (Edn2:5.3; Ednrb: 6.0) and young Akimba (Edn2: 7.9, Ednrb: 8.8) and in mature Kimba (Edn2:9.2, Ednrb:11.2) and mature Akimba (Edn2: 14.0, Ednrb: 17.5) mice. Co-localisation of Edn2 with Muller-cellspecific glutamine synthetase demonstrated Muller cells and photoreceptors as the major cell types for Edn2 expression in all animal models. Edn2 serum concentrations in young Kimba, Akita and Akimba mice were not elevated compared to wt. However, in mature mice, Edn2 serum concentration was increased in Akimba (6.9pg/mg total serum protein) compared to wt, Kimba and Akita mice (3.9, 4.6, and 3.8pg/mg total serum protein, respectively; p<0.05). Conclusions These results demonstrated that long-term hyperglycaemia in conjunction with VEGF-driven RNV increased Edn2 serum concentration suggesting Edn2 might be a candidate biomarker for vascular changes in diabetic retinopathy.	[Binz, Nicolette; Rakoczy, Elizabeth P.; Lai, Chooi-May] Lions Eye Inst, Mol Ophthalmol, Nedlands, WA 6009, Australia; [Rakoczy, Elizabeth P.; Rahman, Ireni S. Ali; Vagaja, Nermina N.; Lai, Chooi-May] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA 6009, Australia	Lions Eye Institute; University of Western Australia; University of Western Australia	Rakoczy, EP (corresponding author), Lions Eye Inst, Mol Ophthalmol, Nedlands, WA 6009, Australia.; Rakoczy, EP (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA 6009, Australia.	elizabeth.rakoczy@uwa.edu.au	Lai, Chooi-May/H-5224-2014		Juvenile Diabetes Research Foundation (USA); National Health and Medical Research Council (Australia); WestPac grant-in-aid (Australia); Lions Save-Sight Foundation of Western Australia through the foundation's Brian King Postdoctoral Research Fellowship; Ministry of Education's, Brunei Darussalam, Postgraduate Research Scholarship	Juvenile Diabetes Research Foundation (USA)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); WestPac grant-in-aid (Australia); Lions Save-Sight Foundation of Western Australia through the foundation's Brian King Postdoctoral Research Fellowship; Ministry of Education's, Brunei Darussalam, Postgraduate Research Scholarship	This work was funded by the Juvenile Diabetes Research Foundation (USA), National Health and Medical Research Council (Australia) and WestPac grant-in-aid (Australia). N. Binz received financial support from the Lions Save-Sight Foundation of Western Australia through the foundation's Brian King Postdoctoral Research Fellowship. I. Ali Rahman was the recipient of the Ministry of Education's, Brunei Darussalam, Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 2005, INVEST OPHTH VIS SCI, V46, P2210, DOI 10.1167/iovs.04-1340; Barr TP, 2011, PHARMACOL RES, V63, P532, DOI 10.1016/j.phrs.2011.02.002; Beisswenger PJ, 2012, AMINO ACIDS, V42, P1171, DOI 10.1007/s00726-010-0784-z; Binz N, 2013, CLIN EXP OPHTHALMOL, V41, P251, DOI 10.1111/j.1442-9071.2012.02845.x; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Chang I, 2013, J CLIN INVEST, V123, P2643, DOI 10.1172/JCI66735; Cheng Christiana L, 2013, Mol Vis, V19, P955; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Ergul A, 2011, PHARMACOL RES, V63, P477, DOI 10.1016/j.phrs.2011.01.012; Giuliari GP, 2012, CURR DIABETES REV, V8, P32, DOI 10.2174/157339912798829188; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; HAAK T, 1992, AM J HYPERTENS, V5, P161, DOI 10.1093/ajh/5.3.161; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Jardeleza MSR, 2009, SEMIN OPHTHALMOL, V24, P87, DOI 10.1080/08820530902800330; Khimji A, 2011, PHARMACOL RES, V63, P512, DOI 10.1016/j.phrs.2011.03.005; Lai CM, 2005, BRIT J OPHTHALMOL, V89, P911, DOI 10.1136/bjo.2004.059089; Laurenti O, 1997, EXP CLIN ENDOCR DIAB, V105, P40, DOI 10.1055/s-0029-1211795; Letizia C, 1997, HORM METAB RES, V29, P247, DOI 10.1055/s-2007-979030; Li ZZ, 2010, J INT MED RES, V38, P95, DOI 10.1177/147323001003800111; Ling L, 2013, BRIT J PHARMACOL, V168, P283, DOI 10.1111/j.1476-5381.2011.01786.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcovecchio ML, 2011, PEDIATR NEPHROL, V26, P365, DOI 10.1007/s00467-010-1624-9; McLenachan S, 2013, CLIN EXP OPHTHALMOL, V41, P582, DOI 10.1111/ceo.12084; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Natoli R, 2008, MOL VIS, V14, P1983; Palmer J, 2011, PHARMACOL RES, V63, P525, DOI 10.1016/j.phrs.2010.12.008; Rakoczy EP, 2010, AM J PATHOL, V177, P2659, DOI 10.2353/ajpath.2010.090883; Rattner A, 2005, J NEUROSCI, V25, P4540, DOI 10.1523/JNEUROSCI.0492-05.2005; Rodriguez-Pascual F, 2011, PHARMACOL RES, V63, P463, DOI 10.1016/j.phrs.2011.01.014; Roldan-Pallares M, 2007, RETINA-J RET VIT DIS, V27, P222, DOI 10.1097/01.iae.0000231376.76601.40; Salam A, 2011, ACTA OPHTHALMOL, V89, P405, DOI 10.1111/j.1755-3768.2010.02079.x; Schmidinger G, 2011, ACTA OPHTHALMOL, V89, P76, DOI 10.1111/j.1755-3768.2009.01622.x; Shen WY, 2006, DIABETOLOGIA, V49, P1690, DOI 10.1007/s00125-006-0274-8; Shen WY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-137; Shen WY, 2006, ADV EXP MED BIOL, V572, P187; Swiderski RE, 2007, INVEST OPHTH VIS SCI, V48, P3329, DOI 10.1167/iovs.06-1477; TAKAHASHI K, 1990, DIABETOLOGIA, V33, P306, DOI 10.1007/BF00403325; Tsui JC, 2011, PHARMACOL RES, V63, P473, DOI 10.1016/j.phrs.2011.02.012; van Eeden PE, 2006, INVEST OPHTH VIS SCI, V47, P4638, DOI 10.1167/iovs.06-0251; Wang R, 2011, PHARMACOL RES, V63, P519, DOI 10.1016/j.phrs.2011.01.002; Wisniewska-Kruk J, 2014, EXP EYE RES, V122, P123, DOI 10.1016/j.exer.2014.03.005; Wollesen F, 1999, CLIN SCI, V97, P149, DOI 10.1042/cs0970149; Yam Jason C. S., 2007, Hong Kong Medical Journal, V13, P46; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zacks DN, 2006, INVEST OPHTH VIS SCI, V47, P1691, DOI 10.1167/iovs.05-1209; Zhan SX, 2011, EXP CELL RES, V317, P1040, DOI 10.1016/j.yexcr.2010.12.026	48	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160442	10.1371/journal.pone.0160442	http://dx.doi.org/10.1371/journal.pone.0160442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482904	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700045
J	Chen, YE; Kao, SS; Chung, RH				Chen, Ying-Erh; Kao, Sung-Shuo; Chung, Ren-Hua			Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; NEWLY-DIAGNOSED PATIENTS; GERMLINE MUTATIONS; ECONOMIC-EVALUATION; CARCINOMA; MORTALITY; FAMILIES; GERMANY	Patients with Lynch syndrome (LS) have a significantly increased risk of developing colorectal cancer (CRC) and other cancers. Genetic screening for LS among patients with newly diagnosed CRC aims to identify mutations in the disease-causing genes (i.e., the DNA mismatch repair genes) in the patients, to offer genetic testing for relatives of the patients with the mutations, and then to provide early prevention for the relatives with the mutations. Several genetic tests are available for LS, such as DNA sequencing for MMR genes and tumor testing using microsatellite instability and immunohistochemical analyses. Cost-effectiveness analyses of different genetic testing strategies for LS have been performed in several studies from different countries such as the US and Germany. However, a cost-effectiveness analysis for the testing has not yet been performed in Taiwan. In this study, we evaluated the cost-effectiveness of four genetic testing strategies for LS described in previous studies, while population-specific parameters, such as the mutation rates of the DNA mismatch repair genes and treatment costs for CRC in Taiwan, were used. The incremental cost-effectiveness ratios based on discounted life years gained due to genetic screening were calculated for the strategies relative to no screening and to the previous strategy. Using the World Health Organization standard, which was defined based on Taiwan's Gross Domestic Product per capita, the strategy based on immunohistochemistry as a genetic test followed by BRAF mutation testing was considered to be highly cost-effective relative to no screening. Our probabilistic sensitivity analysis results also suggest that the strategy has a probability of 0.939 of being cost-effective relative to no screening based on the commonly used threshold of $50,000 to determine cost-effectiveness. To the best of our knowledge, this is the first cost-effectiveness analysis for evaluating different genetic testing strategies for LS in Taiwan. The results will be informative for the government when considering offering screening for LS in patients newly diagnosed with CRC.	[Chen, Ying-Erh] Tamkang Univ, Dept Insurance, New Taipei 251, Taiwan; [Kao, Sung-Shuo] Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung 813, Taiwan; [Chung, Ren-Hua] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan 350, Taiwan	Tamkang University; Kaohsiung Veterans General Hospital; National Health Research Institutes - Taiwan	Chen, YE (corresponding author), Tamkang Univ, Dept Insurance, New Taipei 251, Taiwan.	yingerh@gmail.com	Chung, Ren-Hua/AAB-8364-2019		National Health Research Institutes in Taiwan [PH-105-PP-10, PH-104-PP-10]	National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	This work was funded by a grant (PH-105-PP-10) from the National Health Research Institutes (http://www.nhri.org.tw) in Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the National Health Research Institutes (PH-104-PP-10) in Taiwan.	Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Bonadona V, 2011, JAMA-J AM MED ASSOC, V305, P2304, DOI 10.1001/jama.2011.743; Bonis Peter A, 2007, Evid Rep Technol Assess (Full Rep), P1; Chang SC, 2010, SURGERY, V147, P720, DOI 10.1016/j.surg.2009.10.069; Chen PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133755; Chen SN, 2006, JAMA-J AM MED ASSOC, V296, P1479, DOI 10.1001/jama.296.12.1479; Chiu HM, 2015, CANCER-AM CANCER SOC, V121, P3221, DOI 10.1002/cncr.29462; Grosse SD, 2015, GENET MED, V17, P510, DOI 10.1038/gim.2015.53; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Ladabaum U, 2011, ANN INTERN MED, V155, P69, DOI 10.7326/0003-4819-155-2-201107190-00002; Moreira L, 2012, JAMA-J AM MED ASSOC, V308, P1555, DOI 10.1001/jama.2012.13088; Mvundura M, 2010, GENET MED, V12, P93, DOI 10.1097/GIM.0b013e3181cd666c; Ni S, 2012, GERM LINE MUTATIONS; Palomaki GE, 2009, GENET MED, V11, P42, DOI 10.1097/GIM.0b013e31818fa2db; Parry S, 2011, GUT, V60, P950, DOI 10.1136/gut.2010.228056; Ramsey SD, 2001, ANN INTERN MED, V135, P577, DOI 10.7326/0003-4819-135-8_Part_1-200110160-00008; Reyes CM, 2002, CANCER, V95, P1848, DOI 10.1002/cncr.10910; Schneider R, 2011, DEUT MED WOCHENSCHR, V136, P17, DOI 10.1055/s-0030-1269434; Severin F, 2015, GENET MED, V17, P765, DOI 10.1038/gim.2014.190; Sheng Jian Qiu, 2006, Chin J Dig Dis, V7, P197, DOI 10.1111/j.1443-9573.2006.00269.x; Sheng X, 2010, WORLD J GASTROENTERO, V16, P3847, DOI 10.3748/wjg.v16.i30.3847; Shia J, 2005, AM J SURG PATHOL, V29, P96, DOI 10.1097/01.pas.0000146009.85309.3b; Snowsill T, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI [10.3310/hta19020, 10.3310/hta18580]; Stupart DA, 2009, FAM CANCER, V8, P519, DOI 10.1007/s10689-009-9281-5; Wang VW, 2012, FAM CANCER, V11, P279, DOI 10.1007/s10689-012-9513-y; Yan SY, 2007, WORLD J GASTROENTERO, V13, P5021, DOI 10.3748/wjg.v13.i37.5021	26	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160599	10.1371/journal.pone.0160599	http://dx.doi.org/10.1371/journal.pone.0160599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482709	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700058
J	Tsukada, M; Nakashima, T; Kamachi, T; Niwano, Y				Tsukada, Mana; Nakashima, Takuji; Kamachi, Toshiaki; Niwano, Yoshimi			Prooxidative Potential of Photo-Irradiated Aqueous Extracts of Grape Pomace, a Recyclable Resource from Winemaking Process (vol 11, e0158197, 2016)	PLOS ONE			English	Correction													Nakashima, Takuji/AAK-1075-2021; Nakashima, Takuji/Q-4166-2019; nakashima, takuji/Q-1742-2019	Nakashima, Takuji/0000-0001-6324-0472; 				Tsukada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158197	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160794	10.1371/journal.pone.0160794	http://dx.doi.org/10.1371/journal.pone.0160794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483172	gold, Green Published			2022-12-27	WOS:000381110700061
J	Del Viva, MM; Punzi, G; Shevell, SK				Del Viva, Maria M.; Punzi, Giovanni; Shevell, Steven K.			Chromatic Information and Feature Detection in Fast Visual Analysis	PLOS ONE			English	Article							NATURAL SCENES; COLOR; PERCEPTION; ATTENTION; STIMULI; CATEGORIZATION; SENSITIVITY; RECOGNITION; LUMINANCE; SYSTEM	The visual system is able to recognize a scene based on a sketch made of very simple features. This ability is likely crucial for survival, when fast image recognition is necessary, and it is believed that a primal sketch is extracted very early in the visual processing. Such highly simplified representations can be sufficient for accurate object discrimination, but an open question is the role played by color in this process. Rich color information is available in natural scenes, yet artist's sketches are usually monochromatic; and, black-and-white movies provide compelling representations of real world scenes. Also, the contrast sensitivity of color is low at fine spatial scales. We approach the question from the perspective of optimal information processing by a system endowed with limited computational resources. We show that when such limitations are taken into account, the intrinsic statistical properties of natural scenes imply that the most effective strategy is to ignore fine-scale color features and devote most of the bandwidth to gray-scale information. We find confirmation of these information-based predictions from psychophysics measurements of fast-viewing discrimination of natural scenes. We conclude that the lack of colored features in our visual representation, and our overall low sensitivity to high-frequency color components, are a consequence of an adaptation process, optimizing the size and power consumption of our brain for the visual world we live in.	[Del Viva, Maria M.] Univ Florence, NEUROFARBA Dipartimento Neurosci, Area Farmaco & Salute Bambino, Psicol,Sez Psicol, Via San Salvi,12 Complesso San Salvi, I-50135 Florence, Italy; [Del Viva, Maria M.; Shevell, Steven K.] Univ Chicago, Inst Mind & Biol, 940 East 57th St, Chicago, IL 60637 USA; [Punzi, Giovanni] Univ Pisa, Dipartimento Fis E Fermi, Via Buonarroti 2, I-56127 Pisa, Italy; [Punzi, Giovanni] Ist Nazl Fis Nucl, I-56127 Pisa, Italy; [Punzi, Giovanni] Fermi Natl Lab, Batavia, IL 60510 USA; [Shevell, Steven K.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA	University of Florence; University of Chicago; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; University of Chicago	Del Viva, MM (corresponding author), Univ Florence, NEUROFARBA Dipartimento Neurosci, Area Farmaco & Salute Bambino, Psicol,Sez Psicol, Via San Salvi,12 Complesso San Salvi, I-50135 Florence, Italy.; Del Viva, MM (corresponding author), Univ Chicago, Inst Mind & Biol, 940 East 57th St, Chicago, IL 60637 USA.	Michela@in.cnr.it		DEL VIVA, MARIA/0000-0001-6332-4959	Italian Ministry of Research Grant; MIUR-PRIN [2007WMC8ZY_001, 20083N7YWS_004]; University of Chicago	Italian Ministry of Research Grant; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Chicago(University of Chicago)	This work was supported by an Italian Ministry of Research Grant, MIUR-PRIN # 2007WMC8ZY_001 (http://www.istruzione.it), MIUR-PRIN # 20083N7YWS_004 (http://www.istruzione.it), and University of Chicago: Support for research on rapid recognition of meaningful patterns (http://imb.uchicago.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bodelon C, 2007, J NEUROSCI, V27, P725, DOI 10.1523/JNEUROSCI.3860-06.2007; Boynton R M, 1979, HUMAN COLOUR VISION; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; Dacey D, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P281; Delorme A, 2000, VISION RES, V40, P2187, DOI 10.1016/S0042-6989(00)00083-3; Echeverri E, 2006, IEEE T INF TECHNOL B, V10, P803, DOI 10.1109/TITB.2006.879585; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; HARE RD, 1973, PSYCHOPHYSIOLOGY, V10, P453, DOI 10.1111/j.1469-8986.1973.tb00532.x; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Koene AR, 2007, J VISION, V7, DOI 10.1167/7.7.6; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Moller P, 1996, P NATL ACAD SCI USA, V93, P7421, DOI 10.1073/pnas.93.14.7421; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Oliva A, 1997, COGNITIVE PSYCHOL, V34, P72, DOI 10.1006/cogp.1997.0667; Olmos A, 2004, PERCEPTION, V33, P1463, DOI 10.1068/p5321; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parraga CA, 1998, J OPT SOC AM A, V15, P563, DOI 10.1364/JOSAA.15.000563; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Torralba A, 2003, J OPT SOC AM A, V20, P1407, DOI 10.1364/JOSAA.20.001407	30	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159898	10.1371/journal.pone.0159898	http://dx.doi.org/10.1371/journal.pone.0159898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27478891	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110300020
J	Fang, CL; Huang, H; Xu, ZJ				Fang, Chuling; Huang, Hui; Xu, Zuojun			Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis	PLOS ONE			English	Article							QUANTIFERON-TB GOLD; HEAT-SHOCK PROTEINS; TUBERCULOSIS INFECTION; PULMONARY SARCOIDOSIS; SYSTEMIC SARCOIDOSIS; IMMUNE-RESPONSES; ANTIGENS; BLOOD; DIFFERENTIATION; IDENTIFICATION	Background Sarcoidosis is a granulomatous disease, the etiology of which is currently unknown. The role of mycobacteria in the etiology of sarcoidosis has been extensively investigated. In this meta-analysis, we assessed the immunological evidence of the possible role of mycobacteria in the pathogenesis and development of sarcoidosis. Methods We performed a systematic search of relevant articles from PubMed, Embase and Cochrane Library databases published between January 1990 and October 2015. Data extracted from the articles were analyzed with Review Manager 5.3 (Cochrane Collaboration, Oxford, UK). Results In this meta-analysis, 13 case-control studies (733 participants) were considered eligible according to our criteria. Methodological quality was assessed using the Newcastle-Ottawa Scale (NOS). The positivity incidence of the immune response (either the cell-mediated response or humoral response) in sarcoidosis patients was significantly higher than that in controls, as determined using fixed-effects model. The odds ratio (OR) of the positivity incidence of T-cell response in the patients with sarcoidosis versus the controls with PPD-or unknown PPD status was 5.54 (95% CI 3.56-8.61); the ORs were 16.70 (95% CI 8.19-34.08) and 1.48 (95% CI 0.74-2.96) for the two subgroups with PPD-controls and unknown PPD status respectively. However, the OR of the positivity incidence in patients with sarcoidosis versus PPD+ controls (latent tuberculosis infection; LTBI) was 0.26 (95% 0.10-0.66). Regarding the humoral response, pooled analysis of the positivity incidence revealed an OR (95% CI) of 20.43 (5.53-75.53) for the patients with sarcoidosis versus controls; the ORs were 11.93 (95% CI 2.15-66.27) and 41.97 (95% CI 5.24-336.15) in two subgroups of controls with PPD- and unknown PPD statuses respectively. Data on heterogeneity and evidence of publication bias were examined. Conclusions This meta-analysis confirmed the existence of an association between mycobacteria (especially M. tuberculosis) and sarcoidosis. The current available evidence indicates that some insoluble mycobacterial antigens that preferentially within the body are involved in the pathogenesis of sarcoidosis rather than the whole mycobacteria and that they elicit a type IV immune response.	[Xu, Zuojun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, ZJ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China.	xuzj@hotmail.com			National Natural Science Foundation of China [81170055]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Fiveyear Plan Period [2012BAI05B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program during the Twelfth Fiveyear Plan Period	This work was supported by the National Natural Science Foundation of China (No. 81170055); and Key Projects in the National Science & Technology Pillar Program during the Twelfth Fiveyear Plan Period (2012BAI05B02), URL: http://www.letpub.com.cn/?page=grant&name=&person=%E5%BE%90%E4%BD%9C%E5%86%9B&no=&company=&addcomment_s1=662&addcomment_s2=0&addcomment_s3=0&money1=&money2=&startTime=2011&endTime=2015&subcategory=&searchsubmit=true&submit.x=59&submit.y=13#fundlisttable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, PHYTOMEDICINE, V17, P23, DOI 10.1016/j.phymed.2009.10.019; Agarwal R, 2012, INDIAN J MED RES, V135, P920; Ahmadzai H, 2012, RESP MED, V106, P701, DOI 10.1016/j.rmed.2012.01.012; Almenoff PL, 1996, THORAX, V51, P530, DOI 10.1136/thx.51.5.530; Ang SC, 1996, HISTOL HISTOPATHOL, V11, P125; Brown ST, 2003, CHEST, V123, P413, DOI 10.1378/chest.123.2.413; Brownell I, 2011, AM J RESP CELL MOL, V45, P899, DOI 10.1165/rcmb.2010-0433TR; Carlisle J, 2007, CLIN EXP IMMUNOL, V2007, P150; Ding Xiao-Lan, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P20; Drake WP, 2007, INFECT IMMUN, V75, P527, DOI 10.1128/IAI.00732-06; Drake WP, 2002, EMERG INFECT DIS, V8, P1334, DOI 10.3201/eid0811.020318; Dubaniewicz A, 2006, J CLIN MICROBIOL, V44, P3448, DOI 10.1128/JCM.01433-06; Dubaniewicz A, 2010, AUTOIMMUN REV, V9, P419, DOI 10.1016/j.autrev.2009.11.015; Eishi Y, 2002, J CLIN MICROBIOL, V2002, P40; ElZaatari FAK, 1996, J CLIN MICROBIOL, V34, P2240, DOI 10.1128/JCM.34.9.2240-2245.1996; Gupta D, 2011, SARCOIDOSIS VASC DIF, V28, P95; Gupta D, 2007, EUR RESPIR J, V2007, P30; Gupta D, 2012, CURR OPIN PULM MED, V18, P506, DOI 10.1097/MCP.0b013e3283560809; Hajizadeh R, 2007, J CLIN IMMUNOL, V27, P445, DOI 10.1007/s10875-007-9080-4; Horster R, 2009, CLIN RESPIR J, V3, P229, DOI 10.1111/j.1752-699X.2009.00136.x; Hofland RW, 2014, SARCOIDOSIS VASC DIF, V31, P142; Hofman V, 2003, ANN PATHOL, V23, P206; Inui N, 2008, RESP MED, V102, P313, DOI 10.1016/j.rmed.2007.09.013; Li N, 1999, J CUTAN PATHOL, V26, P271, DOI 10.1111/j.1600-0560.1999.tb01844.x; Li Qiu-hong, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P686; Litvinov V I, 1997, Probl Tuberk, P36; Luk A, 2010, CAN J CARDIOL, V26, pE273, DOI 10.1016/S0828-282X(10)70424-4; Milman N, 2004, SARCOIDOSIS VASC DIF, V21, P25; Moller D R, 1998, Semin Respir Infect, V13, P174; Mootha VK, 2010, J INFECTION, V60, P501, DOI 10.1016/j.jinf.2010.03.010; Oswald-Richter KA, 2012, J CLIN IMMUNOL, V32, P1129, DOI 10.1007/s10875-012-9700-5; Oswald-Richter KA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-161; Oswald-Richter KA, 2009, INFECT IMMUN, V77, P3740, DOI 10.1128/IAI.00142-09; Piotrowski WJ, 2014, AM J CASE REP, V15, P216, DOI 10.12659/AJCR.890014; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; SCADDING JG, 1960, BRIT MED J, V2, P1617, DOI 10.1136/bmj.2.5213.1617; Song ZM, 2005, J EXP MED, V201, P755, DOI 10.1084/jem.20040429; van Enschot JWT, 2013, RESPIR MED CASE REP, V9, P11, DOI 10.1016/j.rmcr.2013.03.006; Yasuhara T, 2005, ACTA OPHTHALMOL SCAN, V83, P364, DOI 10.1111/j.1600-0420.2005.00449.x; Zhou Y, 2008, SARCOIDOSIS VASC DIF, V25, P93	40	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0154716	10.1371/journal.pone.0154716	http://dx.doi.org/10.1371/journal.pone.0154716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479700	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300001
J	Guerrero, S; Dujardin, G; Cabrera-Andrade, A; Paz-y-Mino, C; Indacochea, A; Ingles-Ferrandiz, M; Nadimpalli, HP; Collu, N; Dublanche, Y; De Mingo, I; Camargo, D				Guerrero, Santiago; Dujardin, Gwendal; Cabrera-Andrade, Alejandro; Paz-y-Mino, Cesar; Indacochea, Alberto; Ingles-Ferrandiz, Marta; Priyanka Nadimpalli, Hima; Collu, Nicola; Dublanche, Yann; De Mingo, Ismael; Camargo, David			Analysis and Implementation of an Electronic Laboratory Notebook in a Biomedical Research Institute	PLOS ONE			English	Article							CLOUD; CHALLENGES; CHEMISTRY; SECURITY; LAB	Electronic laboratory notebooks (ELNs) will probably replace paper laboratory notebooks (PLNs) in academic research due to their advantages in data recording, sharing and security. Despite several reports describing technical characteristics of ELNs and their advantages over PLNs, no study has directly tested ELN performance among researchers. In addition, the usage of tablet-based devices or wearable technology as ELN complements has never been explored in the field. To implement an ELN in our biomedical research institute, here we first present a technical comparison of six ELNs using 42 parameters. Based on this, we chose two ELNs, which were tested by 28 scientists for a 3-month period and by 80 students via hands-on practical exercises. Second, we provide two survey-based studies aimed to compare these two ELNs (PerkinElmer Elements and Microsoft OneNote) and to analyze the use of tablet-based devices. We finally explore the advantages of using wearable technology as ELNs tools. Among the ELNs tested, we found that OneNote presents almost all parameters evaluated (39/42) and both surveyed groups preferred OneNote as an ELN solution. In addition, 80% of the surveyed scientists reported that tablet-based devices improved the use of ELNs in different respects. We also describe the advantages of using OneNote application for Apple Watch as an ELN wearable complement. This work defines essential features of ELNs that could be used to improve ELN implementation and software development.	[Guerrero, Santiago; Dujardin, Gwendal; Indacochea, Alberto; Ingles-Ferrandiz, Marta; Priyanka Nadimpalli, Hima] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Stem Cells & Canc Programme, Gene Regulat, Barcelona, Spain; [Collu, Nicola; Dublanche, Yann; De Mingo, Ismael; Camargo, David] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Informat & Commun Technol Dept, Barcelona, Spain; [Cabrera-Andrade, Alejandro; Paz-y-Mino, Cesar] Amer Univ, Fac Ciencias Salud, Inst Invest Biomed, Quito, Ecuador; [Guerrero, Santiago; Dujardin, Gwendal; Indacochea, Alberto; Ingles-Ferrandiz, Marta; Priyanka Nadimpalli, Hima; Collu, Nicola; Dublanche, Yann; De Mingo, Ismael; Camargo, David] UPF, Barcelona, Spain; [Indacochea, Alberto] Univ Barcelona, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universidad de Las Americas - Ecuador; Pompeu Fabra University; University of Barcelona	Guerrero, S (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Stem Cells & Canc Programme, Gene Regulat, Barcelona, Spain.; Camargo, D (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Informat & Commun Technol Dept, Barcelona, Spain.; Guerrero, S; Camargo, D (corresponding author), UPF, Barcelona, Spain.	santiago.guerrero@crg.eu; david.camargo@crg.eu	Guerrero, Santiago/M-4500-2019; Guerrero, Santiago/H-7382-2015; Cabrera, Alejandro/AAD-8355-2020; Dujardin, Gwendal/K-7464-2015	Guerrero, Santiago/0000-0003-3473-7214; Guerrero, Santiago/0000-0003-3473-7214; Dujardin, Gwendal/0000-0003-4320-6351; Paz-y-Mino, Cesar/0000-0002-6693-7344; Cabrera-Andrade, Alejandro/0000-0001-9702-6618; Ingles-Ferrandiz, Marta/0000-0003-1531-7791	Spanish Ministry of Economy and Competitiveness; Catalan Government through the Economy and Knowledge Department; Catalan Government through the Health Department; La Caixa; Fundacio la Marato de TV3; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie grant [661051]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Catalan Government through the Economy and Knowledge Department; Catalan Government through the Health Department; La Caixa(La Caixa Foundation); Fundacio la Marato de TV3; European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie grant	This work was supported by the Spanish Ministry of Economy and Competitiveness and the Catalan Government through the Economy and Knowledge Department and the Health Department. This work was also supported by doctoral fellowships from the Spanish Ministry of Economy and Competitiveness and "La Caixa" to MIF and HPN, respectively. SG was supported by a post-doctoral fellowship from "Fundacio la Marato de TV3". GD has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 661051.	Ali M, 2015, INFORM SCIENCES, V305, P357, DOI 10.1016/j.ins.2015.01.025; Barber CG, 2009, DRUG DISCOV TODAY, V14, P845, DOI 10.1016/j.drudis.2009.06.015; Bird CL, 2013, CHEM SOC REV, V42, P8157, DOI 10.1039/c3cs60122f; Cloud Security Alliance, 2016, TREACH 12 CLOUD COMP; Crouzier T, 2014, TRENDS BIOCHEM SCI, V39, P344, DOI 10.1016/j.tibs.2014.06.004; Day AE, 2015, J CHEM INF MODEL, V55, P501, DOI 10.1021/ci5005948; Gerard Oleksik NM-F, 2014, P ACM C COMP SUPP CO, P120, DOI [10.1145/2531602.2531709, DOI 10.1145/2531602.2531709]; Giardino C, 2014, LECT NOTES BUS INF P, V182, P27; Giles J, 2012, NATURE, V481, P430, DOI 10.1038/481430a; Herrmann B.L., 2015, COMPASS; Machina HK, 2013, JALA-J LAB AUTOM, V18, P264, DOI 10.1177/2211068213484471; Milsted AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067460; Rubacha M, 2011, JALA-J LAB AUTOM, V16, P90, DOI 10.1016/j.jala.2009.01.002; Subashini S, 2011, J NETW COMPUT APPL, V34, P1, DOI 10.1016/j.jnca.2010.07.006; Voegele C, 2013, BIOINFORMATICS, V29, P1710, DOI 10.1093/bioinformatics/btt253; Walsh E, 2013, JALA-J LAB AUTOM, V18, P229, DOI 10.1177/2211068212471834	16	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160428	10.1371/journal.pone.0160428	http://dx.doi.org/10.1371/journal.pone.0160428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479083	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110300050
J	Nogara, L; Naber, N; Pate, E; Canton, M; Reggiani, C; Cooke, R				Nogara, Leonardo; Naber, Nariman; Pate, Edward; Canton, Marcella; Reggiani, Carlo; Cooke, Roger			Spectroscopic Studies of the Super Relaxed State of Skeletal Muscle	PLOS ONE			English	Article							REGULATORY LIGHT-CHAIN; VERTEBRATE STRIATED-MUSCLE; MYOSIN ATP TURNOVER; SMOOTH-MUSCLE; TARANTULA MUSCLE; CARDIAC-MUSCLE; STRUCTURAL-CHANGES; ORDER TRANSITION; THICK FILAMENTS; CATION-BINDING	In the super-relaxed state of myosin, ATPase activity is strongly inhibited by binding of the myosin heads to the core of the thick filament in a structure known as the interacting-heads motif. In the disordered relaxed state myosin heads are not bound to the core of the thick filament and have an ATPase rate that is 10 fold greater. In the interacting-heads motif the two regulatory light chains appear to bind to each other. We have made single cysteine mutants of the regulatory light chain, placed both paramagnetic and fluorescent probes on them, and exchanged them into skinned skeletal muscle fibers. Many of the labeled light chains tended to disrupt the stability of the super-relaxed state, and showed spectral changes in the transition from the disordered relaxed state to the super-relaxed state. These data support the putative interface between the two regulatory light chains identified by cryo electron microscopy and show that both the divalent cation bound to the regulatory light chain and the N-terminus of the regulatory light chain play a role in the stability of the super-relaxed state. One probe showed a shift to shorter wavelengths in the super-relaxed state such that a ratio of intensities at 440nm to that at 520nm provided a measure of the population of the super-relaxed state amenable for high throughput screens for finding potential pharmaceuticals. The results provide a proof of concept that small molecules that bind to this region can destabilize the super-relaxed state and provide a method to search for small molecules that do so leading to a potentially effective treatment for Type 2 diabetes and obesity.	[Nogara, Leonardo; Canton, Marcella; Reggiani, Carlo] Univ Padua, Dipartimento Sci Biomed, Padua, Italy; [Naber, Nariman; Cooke, Roger] Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA; [Pate, Edward] Washington State Univ, Voiland Sch Bioengn, Pullman, WA 99164 USA	University of Padua; University of California System; University of California San Francisco; Washington State University	Nogara, L (corresponding author), Univ Padua, Dipartimento Sci Biomed, Padua, Italy.	leonardo.nogara@unipd.it	Nogara, Leonardo/AAL-4127-2021	Nogara, Leonardo/0000-0002-7009-8707; canton, marcella/0000-0002-8967-4049	NIH [AR062279]; Fondazione Cassa di Risparmio di Padova e Rovigo; Fondazione Ing. Aldo Gini	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); Fondazione Ing. Aldo Gini	This research was supported by a grant from the NIH AR062279 to EP and RC, and by a grant from Fondazione Cassa di Risparmio di Padova e Rovigo to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data for this study were acquired at the Nikon Imaging Center at UCSF/QB3. The authors would like to thank Dr. Kurt Thorn and Ms. Delaine Larson for their generous help in using the microscopes. Troponin C was a gift from Dr. Dong, WSU; the mouse sequence was a gift from Prof. Di Lisa, Univ. of Padova. The authors would also like to thank the many members of the laboratory of Dr. Geeta Narlikar, UCSF, and Prof. Bergantino, Univ. of Padova, for their help with the molecular biology. The authors would like to thank Kenny Ang and Michelle Arkins, Small Molecule Discovery Center UCSF, for their advices on the screen. LN would like to thank Fondazione Cassa di Risparmio di Padova e Rovigo and Fondazione Ing. Aldo Gini for their support. The authors would like to dedicate this paper to the memory of Ed Pate, who recently passed away.	Alamo L, 2016, J MOL BIOL, V428, P1142, DOI 10.1016/j.jmb.2016.01.027; Alamo L, 2015, MOL BIOSYST, V11, P2180, DOI 10.1039/c5mb00163c; Alamo L, 2008, J MOL BIOL, V384, P780, DOI 10.1016/j.jmb.2008.10.013; BAGSHAW CR, 1977, FEBS LETT, V81, P386, DOI 10.1016/0014-5793(77)80560-7; Baumann BAJ, 2012, J MOL BIOL, V415, P274, DOI 10.1016/j.jmb.2011.10.047; Brito R, 2011, J MOL BIOL, V414, P44, DOI 10.1016/j.jmb.2011.09.017; Cooke Roger, 2011, Biophys Rev, V3, P33; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; CREMO CR, 1990, BIOCHEMISTRY-US, V29, P3309, DOI 10.1021/bi00465a023; CROSS RA, 1988, J MOL BIOL, V203, P173, DOI 10.1016/0022-2836(88)90100-3; Diffee GM, 1996, BIOPHYS J, V71, P341, DOI 10.1016/S0006-3495(96)79231-7; DIFFEE GM, 1995, BIOPHYS J, V68, P1443, DOI 10.1016/S0006-3495(95)80317-6; Espinoza-Fonseca LM, 2007, BIOPHYS J, V93, P2083, DOI 10.1529/biophysj.106.095802; Espinoza-Fonseca LM, 2015, MOL BIOSYST, V11, P2167, DOI 10.1039/c5mb00162e; Espinoza-Fonseca LM, 2014, MOL BIOSYST, V10, P2693, DOI 10.1039/c4mb00364k; FERENCZI MA, 1978, BIOCHEM J, V171, P165, DOI 10.1042/bj1710165; Fusi L, 2015, BIOPHYS J, V109, P783, DOI 10.1016/j.bpj.2015.06.038; Greenberg MJ, 2009, J MOL CELL CARDIOL, V46, P108, DOI 10.1016/j.yjmcc.2008.09.126; HASELGROVE JC, 1975, J MOL BIOL, V92, P113, DOI 10.1016/0022-2836(75)90094-7; Hooijman P, 2011, BIOPHYS J, V100, P1969, DOI 10.1016/j.bpj.2011.02.061; HUXLEY HE, 1983, ANNU REV BIOPHYS BIO, V12, P381, DOI 10.1146/annurev.bb.12.060183.002121; IKEBE M, 1994, J BIOL CHEM, V269, P28173; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kampourakis T, 2015, J MOL CELL CARDIOL, V85, P199, DOI 10.1016/j.yjmcc.2015.06.002; Kampourakis T, 2015, BIOPHYS J, V108, P304, DOI 10.1016/j.bpj.2014.11.049; Karatzaferi C, 2008, AM J PHYSIOL-REG I, V294, pR948, DOI 10.1152/ajpregu.00541.2007; Kast D, 2010, P NATL ACAD SCI USA, V107, P8207, DOI 10.1073/pnas.1001941107; Mazhari SM, 2004, J BIOL CHEM, V279, P39905, DOI 10.1074/jbc.M407062200; MYBURGH KH, 1995, J GEN PHYSIOL, V106, P957, DOI 10.1085/jgp.106.5.957; Naber N, 2011, J MOL BIOL, V411, P943, DOI 10.1016/j.jmb.2011.06.051; Nelson WD, 2005, P NATL ACAD SCI USA, V102, P4000, DOI 10.1073/pnas.0401664102; Pinto A, 2012, J STRUCT BIOL, V180, P469, DOI 10.1016/j.jsb.2012.08.010; Reconditi M, 2014, J PHYSIOL-LONDON, V592, P1119, DOI 10.1113/jphysiol.2013.267849; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; Sulbaran G, 2015, P NATL ACAD SCI USA, V112, pE5660, DOI 10.1073/pnas.1513439112; Sulbaran G, 2013, BIOPHYS J, V105, P2114, DOI 10.1016/j.bpj.2013.09.001; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; TAYLOR EW, 1979, CRC CR REV BIOCH MOL, V6, P103, DOI 10.3109/10409237909102562; VIBERT P, 1985, J CELL BIOL, V101, P830, DOI 10.1083/jcb.101.3.830; Wendt T, 1999, J CELL BIOL, V147, P1385, DOI 10.1083/jcb.147.7.1385; Wilson C, 2014, BIOPHYS J, V107, P1637, DOI 10.1016/j.bpj.2014.07.075; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Woodhead JL, 2013, P NATL ACAD SCI USA, V110, P8561, DOI 10.1073/pnas.1218462110; WOODWARD SKA, 1991, BIOCHEMISTRY-US, V30, P422, DOI 10.1021/bi00216a017; Xu S, 2003, BIOCHEMISTRY-US, V42, P390, DOI 10.1021/bi026085t; Zhao FQ, 2009, J MOL BIOL, V385, P423, DOI 10.1016/j.jmb.2008.10.038; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	47	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160100	10.1371/journal.pone.0160100	http://dx.doi.org/10.1371/journal.pone.0160100			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479128	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300024
J	Xie, GY; Zhao, XC; Ma, BW; Guo, P; Li, GP; Feng, HQ; Wu, GL				Xie, Gui-Ying; Zhao, Xin-Cheng; Ma, Bai-Wei; Guo, Pei; Li, Guo-Ping; Feng, Hong-Qiang; Wu, Guo-Liang			Central Projection of Antennal Sensory Neurons in the Central Nervous System of the Mirid Bug Apolygus lucorum (Meyer-Dur)	PLOS ONE			English	Article							GUSTATORY RECEPTOR NEURONS; HEMIPTERA-MIRIDAE; BT COTTON; INSECT; LOBE; ORGANIZATION; HETEROPTERA; AFFERENTS; GLOMERULI; PATHWAYS	The mirid bug Apolygus lucorum (Meyer-Dur), a polyphagous pest, is dependent on olfactory cues to locate various host plant species and mates. In this study, we traced the projection pathway of the antennal sensory neurons and visualized their projection patterns in the central nervous system of A. lucorum through confocal microscopy and digital reconstructions. We also examined the glomerular organization of the primary olfactory center of the brain, the antennal lobe, and created a three-dimensional model of the glomeruli. We found that the axons of the sensory neurons project into the brain via the ipsilateral antennal nerve, and descend further into the gnathal ganglion, prothoracic ganglion, mesothoracic ganglion, and metathoracic ganglion, and reach as far as to the abdominal ganglion. Such a projection pattern indicates that antennal sensory neurons of A. lucorum may be potentially directly connected to motor neurons. The antennal lobe, however, is the major target area of antennal sensory neurons. The antennal lobe is composed of a large number of glomeruli, i. e. 70-80 glomeruli in one AL of A. lucorum. The results of this study which provide information about the basic anatomical arrangement of the brain olfactory center of A. lucorum, are important for further investigations of chemosensory encoding mechanisms of the mirid bug.	[Xie, Gui-Ying] Henan Agr Univ, Dept Pesticide, Coll Plant Protect, Zhengzhou 450002, Peoples R China; [Zhao, Xin-Cheng; Ma, Bai-Wei; Guo, Pei] Henan Agr Univ, Dept Entomol, Coll Plant Protect, Zhengzhou 450002, Peoples R China; [Li, Guo-Ping; Feng, Hong-Qiang] Henan Acad Agr Sci, Inst Plant Protect, Int Joint Res Lab Crop Protect Henan,Henan Key La, Key Lab Integrated Pest Management Crops Southern, Zhengzhou 450002, Peoples R China; [Wu, Guo-Liang] Henan Agr Univ, Dept Pomol, Coll Hort, Zhengzhou 450002, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Academy of Agricultural Sciences; Henan Agricultural University	Zhao, XC (corresponding author), Henan Agr Univ, Dept Entomol, Coll Plant Protect, Zhengzhou 450002, Peoples R China.; Wu, GL (corresponding author), Henan Agr Univ, Dept Pomol, Coll Hort, Zhengzhou 450002, Peoples R China.	xincheng@henau.edu.cn; walnut-wu@126.com			Special Fund for Agro-scientific Researches of the Public Interests [201203036]; National Natural Science Foundation of China [31471830]	Special Fund for Agro-scientific Researches of the Public Interests; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Special Fund for Agro-scientific Researches of the Public Interests (http://www.kjs.moa.gov.cn/xiangmu/), Grant number: 201203036, to XCZ; and National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Grant number: 31471830, to XCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2007, J COMP NEUROL, V502, P1030, DOI 10.1002/cne.21341; Barrozo RB, 2009, ARTHROPOD STRUCT DEV, V38, P101, DOI 10.1016/j.asd.2008.08.004; Berg BG, 2002, J COMP NEUROL, V446, P123, DOI 10.1002/cne.10180; Chen Zhan-Ce, 2010, Acta Entomologica Sinica, V53, P47; Crespo JG, 2012, ARTHROPOD STRUCT DEV, V41, P227, DOI 10.1016/j.asd.2012.02.008; Feng HQ, 2012, ENVIRON ENTOMOL, V41, P1606, DOI 10.1603/EN12099; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800; INSAUSTI TC, 1994, J MORPHOL, V221, P343, DOI 10.1002/jmor.1052210308; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Ji Ping, 2013, Acta Entomologica Sinica, V56, P575; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Kamikouchi A, 2006, J COMP NEUROL, V499, P317, DOI 10.1002/cne.21075; Kollmann M, 2011, CELL TISSUE RES, V343, P343, DOI 10.1007/s00441-010-1099-9; Kristoffersen L, 2008, CHEM SENSES, V33, P771, DOI 10.1093/chemse/bjn044; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu Yan-Hui, 2012, Chinese Journal of Applied Entomology, V49, P578; Lu Yan-Hui, 2007, Acta Entomologica Sinica, V50, P863; Lu YH, 2011, APPL ENTOMOL ZOOL, V46, P421, DOI 10.1007/s13355-011-0058-6; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; NASSEL DR, 1984, J MORPHOL, V180, P159, DOI 10.1002/jmor.1051800206; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; Nishino H, 2009, J COMP NEUROL, V515, P161, DOI 10.1002/cne.22064; Oland LA, 2008, J COMP NEUROL, V509, P526, DOI 10.1002/cne.21762; Pan HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep14805; Pan HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117153; Popescu A, 2013, J COMP PHYSIOL A, V199, P403, DOI 10.1007/s00359-013-0803-0; Rebora M, 2013, ZOOLOGY, V116, P205, DOI 10.1016/j.zool.2013.04.001; ROSPARS JP, 1988, INT J INSECT MORPHOL, V17, P243, DOI 10.1016/0020-7322(88)90041-4; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; WIGGLESWORTH VB, 1959, Q J MICROSC SCI, V100, P299; Xie Gui-Ying, 2016, Acta Entomologica Sinica, V59, P446, DOI 10.16380/j.kcxb.2016.04.010; Yan SW, 2015, J INSECT PHYSIOL, V79, P36, DOI 10.1016/j.jinsphys.2015.06.002; Yang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127051; Yoritsune A, 2012, INVERTEBR NEUROSCI, V12, P103, DOI 10.1007/s10158-012-0137-6; Zhang T., 2011, THESIS; Zhao XC, 2016, J COMP NEUROL, V524, P2993, DOI 10.1002/cne.24003; Zhao Xin-Cheng, 2015, Acta Entomologica Sinica, V58, P190; Zhou YL, 2014, J INSECT PHYSIOL, V60, P31, DOI 10.1016/j.jinsphys.2013.10.006	42	4	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160161	10.1371/journal.pone.0160161	http://dx.doi.org/10.1371/journal.pone.0160161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27478892	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300029
J	Ballesteros-Mejia, L; Lima, NE; Lima-Ribeiro, MS; Collevatti, RG				Ballesteros-Mejia, Liliana; Lima, Natacia E.; Lima-Ribeiro, Matheus S.; Collevatti, Rosane G.			Pollination Mode and Mating System Explain Patterns in Genetic Differentiation in Neotropical Plants	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; LINEAR MIXED MODELS; PHYLOGENETIC SIGNAL; RELATIVE RATES; DIVERSITY; CHLOROPLAST; POPULATIONS; EVOLUTION; NUCLEAR; POLLEN	We studied genetic diversity and differentiation patterns in Neotropical plants to address effects of life history traits (LHT) and ecological attributes based on an exhaustive literature survey. We used generalized linear mixed models (GLMMs) to test the effects as fixed and random factors of growth form, pollination and dispersal modes, mating and breeding systems, geographical range and habitat on patterns of genetic diversity (HS, HeS, p and h), inbreeding coefficient (FIS), allelic richness (AR) and differentiation among populations (FST) for both nuclear and chloroplast genomes. In addition, we used phylogenetic generalized least squares (pGLS) to account for phylogenetic independence on predictor variables and verify the robustness of the results from significant GLMMs. In general, GLMM revealed more significant relationships among LHTs and genetic patterns than pGLS. After accounting for phylogenetic independence (i.e., using pGLS), FST for nuclear microsatellites was significantly related to pollination mode, mating system and habitat. Plants specifically with outcrossing mating system had lower FST. Moreover, AR was significantly related to pollination mode and geographical range and HeS for nuclear dominant markers was significantly related to habitat. Our findings showed that different results might be retrieved when phylogenetic non-independence is taken into account and that LHTs and ecological attributes affect substantially the genetic pattern in Neotropical plants, hence may drive key evolutionary processes in plants.	[Ballesteros-Mejia, Liliana; Lima, Natacia E.; Collevatti, Rosane G.] Univ Fed Goias, Inst Ciencias Biol, Lab Genet & Biodiversidade, CxP 131, BR-74001970 Goiania, Go, Brazil; [Lima-Ribeiro, Matheus S.] Univ Fed Goias, Lab Macroecol, CxP 03, BR-75801615 Jatai, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias	Collevatti, RG (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Lab Genet & Biodiversidade, CxP 131, BR-74001970 Goiania, Go, Brazil.	rosanegc68@hotmail.com	Collevatti, Rosane/D-8673-2013; LIMA-RIBEIRO, MATHEUS S./H-9503-2014; Ballesteros-Mejia, Liliana/AAC-4971-2019	Collevatti, Rosane/0000-0002-3733-7059; LIMA-RIBEIRO, MATHEUS S./0000-0002-3322-1702; Ballesteros-Mejia, Liliana/0000-0003-2790-8652	Conselho Nacional de Pesquisa (CNPq) [563624/2010-8]; network Rede Cerrado CNPq/PPBio project [457406/2012-7]; Conselho de Aperfeicoamento de Pessoal em Ensino (CAPES) [88881.030318/2013-01]; research network GENPAC (Geographical Genetics and Regional Planning for natural resources in Brazilian Cerrado, CNPq/MCT/CAPES/FAPEG project) [563624/2010-8]; network Rede Cerrado CNPq/PPBio [457406/2012-7]; CAPES Ciencias sem Fronteira [88881.030318/2013-01]; CNPq; CAPES	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); network Rede Cerrado CNPq/PPBio project; Conselho de Aperfeicoamento de Pessoal em Ensino (CAPES); research network GENPAC (Geographical Genetics and Regional Planning for natural resources in Brazilian Cerrado, CNPq/MCT/CAPES/FAPEG project); network Rede Cerrado CNPq/PPBio; CAPES Ciencias sem Fronteira(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	RGC received grants from the following sources: Conselho Nacional de Pesquisa (CNPq) supported the research network GENPAC (Geographical Genetics and Regional Planning for natural resources in Brazilian Cerrado, project no. 563624/2010-8), and the network Rede Cerrado CNPq/PPBio project no. 457406/2012-7. LBM received a fellowship from Conselho de Aperfeicoamento de Pessoal em Ensino (CAPES) Project Ciencias sem Fronteira CSF-PAJT/CAPES no. 88881.030318/2013-01.; This work was supported by the research network GENPAC (Geographical Genetics and Regional Planning for natural resources in Brazilian Cerrado, CNPq/MCT/CAPES/FAPEG project no. 563624/2010-8), and the network Rede Cerrado CNPq/PPBio (project no. 457406/2012-7). LBM receives a fellowship from CAPES Ciencias sem Fronteira (project CSF-PAJT/CAPES no. 88881.030318/2013-01). RGC have continuously been supported by CNPq and CAPES grants and scholarships whose assistance we gratefully acknowledge.	Abouheif E, 1999, EVOL ECOL RES, V1, P895; Ackerly DD, 2000, EVOLUTION, V54, P1480, DOI 10.1111/j.0014-3820.2000.tb00694.x; Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Aguinagalde I, 2005, J BIOGEOGR, V32, P329, DOI 10.1111/j.1365-2699.2004.01178.x; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; BAWA KS, 1980, ANNU REV ECOL SYST, V11, P15, DOI 10.1146/annurev.es.11.110180.000311; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cant ET, 2005, P ROY SOC B-BIOL SCI, V272, P785, DOI 10.1098/rspb.2004.3002; Chave J, 2013, ECOL LETT, V16, P4, DOI 10.1111/ele.12048; Collevatti RG, 2003, MOL ECOL, V12, P105, DOI 10.1046/j.1365-294X.2003.01701.x; Cox C.B., 1985, BIOGEOGRAPHY ECOLOGI; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Diniz-Filho J.A.F., 2013, FRONT BIOGEOGR, V5, P195, DOI [10.21425/F5FBG18886, DOI 10.21425/F5FBG18886]; DONOGHUE MJ, 1989, EVOLUTION, V43, P1137, DOI [10.2307/2409353, 10.1111/j.1558-5646.1989.tb02565.x]; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gottsberger Gerhard, 1999, Plant Species Biology, V14, P143, DOI 10.1046/j.1442-1984.1999.00018.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hamilton MB, 2002, GENETICS, V162, P1897; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hamrick James L., 1996, P203; HAMRICK JL, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P75; HAMRICK JL, 1979, ANNU REV ECOL SYST, V10, P173, DOI 10.1146/annurev.es.10.110179.001133; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HEINRICH B, 1975, ANNU REV ECOL SYST, V6, P139, DOI 10.1146/annurev.es.06.110175.001035; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Horn HS, 2001, ECOL RES, V16, P877, DOI 10.1046/j.1440-1703.2001.00456.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jombart T, 2010, BIOINFORMATICS, V26, P1907, DOI 10.1093/bioinformatics/btq292; JORDANO P, 1995, AM NAT, V145, P163, DOI 10.1086/285735; Lawton JH, 1996, OIKOS, V75, P145, DOI 10.2307/3546237; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Margalef R, 1998, OUR BIOSPHERE EXCELL; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Orme D., 2013, CAPER PACKAGE COMP A, P1; Pavoine S, 2008, THEOR POPUL BIOL, V73, P79, DOI 10.1016/j.tpb.2007.10.001; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Ward M, 2005, HEREDITY, V95, P246, DOI 10.1038/sj.hdy.6800712; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x	55	27	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0158660	10.1371/journal.pone.0158660	http://dx.doi.org/10.1371/journal.pone.0158660			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472384	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300006
J	Loc-Carrillo, C; Wang, C; Canden, A; Burr, M; Agarwal, J				Loc-Carrillo, Catherine; Wang, Caroline; Canden, Ahranee; Burr, Michael; Agarwal, Jayant			Local Intramedullary Delivery of Vancomycin Can Prevent the Development of Long Bone Staphylococcus aureus Infection	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; RAT MODEL; IN-VITRO; CHRONIC OSTEOMYELITIS; JOINT INFECTIONS; OPEN FRACTURES; PROPHYLAXIS; PHARMACOKINETICS; EPIDEMIOLOGY; ANTIBIOTICS	Current treatments for methicillin-resistant Staphylococcus aureus (MRSA) infections require intravenously delivered vancomycin; however, systemically delivered vancomycin has its problems. To determine the feasibility and safety of locally delivering vancomycin hydrochloride (similar to 25 mg/Kg) to the medullary canal of long bones, we conducted a pharmacokinetics study using a rat tibia model. We found that administering the vancomycin intraosseously resulted in very low concentrations of vancomycin in the blood plasma and the muscle surrounding the tibia, reducing the risk for systemic toxicity, which is often seen with traditional intravenous administration of vancomycin. Additionally, we were able to inhibit the development of osteomyelitis in the tibia if the treatment was administered locally at the same time as a bacterial inoculum (i.e., Log(10) 7.82 CFU/mL or 6.62x10(7) CFU/mL), when compared to an untreated group. These findings suggest that local intramedullary vancomycin delivery can achieve sufficiently high local concentrations to prevent development of osteomyelitis while minimizing systemic toxicity.	[Loc-Carrillo, Catherine; Wang, Caroline; Canden, Ahranee; Agarwal, Jayant] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA; [Loc-Carrillo, Catherine; Agarwal, Jayant] Univ Utah, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Salt Lake City, UT 84112 USA; [Burr, Michael] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Moran Eye Ctr, Salt Lake City, UT USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Loc-Carrillo, C (corresponding author), VA Salt Lake City Hlth Care Syst, Salt Lake City, UT 84148 USA.; Loc-Carrillo, C (corresponding author), Univ Utah, Sch Med, Dept Surg, Div Plast & Reconstruct Surg, Salt Lake City, UT 84112 USA.	c.loc.carrillo@hsc.utah.edu	Loc-Carrillo, Catherine/B-5461-2014	Loc-Carrillo, Catherine/0000-0002-7265-1203; Wang-Crocker, Caroline/0000-0002-4233-1110	University of Utah Research Foundation	University of Utah Research Foundation	This work was supported by the University of Utah Research Foundation to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866; Ball AP, 2004, J CHEMOTHERAPY, V16, P419, DOI 10.1179/joc.2004.16.5.419; Bhattacharya R, 2013, MAT SCI ENG C-MATER, V33, P3986, DOI 10.1016/j.msec.2013.05.036; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; Crawford T, 2012, CLIN INFECT DIS; Darley ESR, 2004, J ANTIMICROB CHEMOTH, V53, P928, DOI 10.1093/jac/dkh191; De Smet E, 2006, EUR J ORAL SCI, V114, P232, DOI 10.1111/j.1600-0722.2006.00355.x; DWORKIN R, 1990, ANTIMICROB AGENTS CH, V34, P1014, DOI 10.1128/AAC.34.6.1014; Edin ML, 1996, CLIN ORTHOP RELAT R, P245; EVANS RS, 1990, DICP ANN PHARMAC, V24, P351, DOI 10.1177/106002809002400401; Folsch C, 2015, INT ORTHOP, V39, P981, DOI 10.1007/s00264-014-2582-9; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; GERHART TN, 1988, J ORTHOPAED RES, V6, P585, DOI 10.1002/jor.1100060417; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; Hanssen AD, 1999, CLIN ORTHOP RELAT R, P124; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Kavanagh KT, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-18; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Lucke M, 2005, BONE, V36, P770, DOI 10.1016/j.bone.2005.01.008; MARRE R, 1984, J ANTIMICROB CHEMOTH, V14, P253, DOI 10.1093/jac/14.3.253; MATZKE GR, 1986, CLIN PHARMACOKINET, V11, P257, DOI 10.2165/00003088-198611040-00001; McHugh SM, 2011, J ANTIMICROB CHEMOTH, V66, P693, DOI 10.1093/jac/dkr009; McKinnon PS, 2004, EUR J CLIN MICROBIOL, V23, P271, DOI 10.1007/s10096-004-1107-7; McNamara DR, 2005, J AM ACAD ORTHOP SUR, V13, P89, DOI 10.5435/00124635-200503000-00001; O'Neill KR, 2011, SPINE J, V11, P641, DOI 10.1016/j.spinee.2011.04.025; Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11; Pritchard L, 2010, AM J MED, V123, P1143, DOI 10.1016/j.amjmed.2010.07.025; Quintiliani R, 2004, INFECT MED, V21, P219; Rodvold KA, 2001, PHARMACOTHERAPY, V21, p319S, DOI 10.1592/phco.21.18.319S.33904; Rubinstein E, 2014, FRONTIERS PUBLIC HLT, V2; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068; Solberg BD, 1999, J ORTHOP TRAUMA, V13, P102, DOI 10.1097/00005131-199902000-00006; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033; Yoeruek E, 2008, J CATARACT REFR SURG, V34, P2139, DOI 10.1016/j.jcrs.2008.08.022; Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d	43	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160187	10.1371/journal.pone.0160187	http://dx.doi.org/10.1371/journal.pone.0160187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472197	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300036
J	Wood, JM; Black, AA; Mallon, K; Thomas, R; Owsley, C				Wood, Joanne M.; Black, Alex A.; Mallon, Kerry; Thomas, Ravi; Owsley, Cynthia			Glaucoma and Driving: On-Road Driving Characteristics	PLOS ONE			English	Article							VISUAL-FIELD LOSS; MOTOR-VEHICLE COLLISIONS; OPEN-ANGLE GLAUCOMA; OLDER DRIVERS; RISK-FACTORS; PERFORMANCE; IMPAIRMENT; CRASHES; ADULTS; INVOLVEMENT	Purpose To comprehensively investigate the types of driving errors and locations that are most problematic for older drivers with glaucoma compared to those without glaucoma using a standardized on-road assessment. Methods Participants included 75 drivers with glaucoma (mean = 73.2+/-6.0 years) with mild to moderate field loss (better-eye MD = -1.21 dB; worse-eye MD = -7.75 dB) and 70 age-matched controls without glaucoma (mean = 72.6 +/- 5.0 years). On-road driving performance was assessed in a dual-brake vehicle by an occupational therapist using a standardized scoring system which assessed the types of driving errors and the locations where they were made and the number of critical errors that required an instructor intervention. Driving safety was rated on a 10-point scale. Self-reported driving ability and difficulties were recorded using the Driving Habits Questionnaire. Results Drivers with glaucoma were rated as significantly less safe, made more driving errors, and had almost double the rate of critical errors than those without glaucoma. Driving errors involved lane positioning and planning/approach, and were significantly more likely to occur at traffic lights and yield/give-way intersections. There were few between group differences in self-reported driving ability. Conclusions Older drivers with glaucoma with even mild to moderate field loss exhibit impairments in driving ability, particularly during complex driving situations that involve tactical problems with lane-position, planning ahead and observation. These results, together with the fact that these drivers self-report their driving to be relatively good, reinforce the need for evidence-based on-road assessments for evaluating driving fitness.	[Wood, Joanne M.; Black, Alex A.; Mallon, Kerry] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia; [Thomas, Ravi] Queensland Eye Inst, Brisbane, Qld, Australia; [Thomas, Ravi] Univ Queensland, Brisbane, Qld, Australia; [Owsley, Cynthia] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA	Queensland University of Technology (QUT); Queensland Eye Institute; University of Queensland; University of Alabama System; University of Alabama Birmingham	Wood, JM (corresponding author), Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld, Australia.	j.wood@qut.edu.au	Thomas, Ravi/A-3377-2011; Black, Alex/I-9727-2012	Thomas, Ravi/0000-0003-0341-341X; Black, Alex/0000-0002-8671-5167	National Health and Medical Research Council [1008451]; National Institutes of Health [R01EY18966, P30AG22838]; Research to Prevent Blindness; EyeSight Foundation of Alabama; NATIONAL EYE INSTITUTE [R01EY018966] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); EyeSight Foundation of Alabama; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Health and Medical Research Council 1008451. The sponsor or funding organization had no role in the design or conduct of this research. CO's participation was made possible by National Institutes of Health grants R01EY18966 and P30AG22838, Research to Prevent Blindness, and the EyeSight Foundation of Alabama.	BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bechetoille A, 2008, ACTA OPHTHALMOL, V86, P71, DOI 10.1111/j.1600-0420.2007.00999.x; Bhorade AM, 2016, AM J OPHTHALMOL, V166, P43, DOI 10.1016/j.ajo.2016.02.031; Black AA, 2008, OPTOMETRY VISION SCI, V85, P489, DOI 10.1097/OPX.0b013e31817882db; Black AA, 2011, OPTOMETRY VISION SCI, V88, P1275, DOI 10.1097/OPX.0b013e31822f4d6a; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Chen HQ, 2012, TRAFFIC INJ PREV, V13, P300, DOI 10.1080/15389588.2011.653841; Chu BS, 2009, EYE CONTACT LENS, V35, P133, DOI 10.1097/ICL.0b013e3181a1435e; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; ELLIOTT DB, 1991, CLIN VISION SCI, V6, P471; Fan-Paul NI, 2002, SURV OPHTHALMOL, V47, P533, DOI 10.1016/S0039-6257(02)00350-8; FOLEY DJ, 1995, J AM GERIATR SOC, V43, P776, DOI 10.1111/j.1532-5415.1995.tb07049.x; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Glen FC, 2015, BRIT J OPHTHALMOL, V99, P613, DOI 10.1136/bjophthalmol-2014-305932; Hakamies-Blomqvist L, 1998, ACCIDENT ANAL PREV, V30, P305, DOI 10.1016/S0001-4575(97)00106-1; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Hu PS, 1998, ACCIDENT ANAL PREV, V30, P569, DOI 10.1016/S0001-4575(98)00019-0; Huisingh C, 2015, INVEST OPHTH VIS SCI, V56, P132, DOI 10.1167/iovs.14-15194; Janz NK, 2009, INVEST OPHTH VIS SCI, V50, P1718, DOI 10.1167/iovs.08-2575; Kasneci E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087470; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P203, DOI 10.1167/iovs.08-2496; Kubler TC, 2015, OPTOMETRY VISION SCI, V92, P1037, DOI 10.1097/OPX.0000000000000702; Kunimatsu-Sanuki S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006379; Kwon M, 2016, OPHTHALMOLOGY, V123, P109, DOI 10.1016/j.ophtha.2015.08.043; MCCLOSKEY LW, 1994, AGE AGEING, V23, P267, DOI 10.1093/ageing/23.4.267; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; Owsley C, 2002, JAMA-J AM MED ASSOC, V288, P841, DOI 10.1001/jama.288.7.841; Parker WT, 2011, CURR EYE RES, V36, P270, DOI 10.3109/02713683.2010.548893; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramrattan RS, 2001, ARCH OPHTHALMOL-CHIC, V119, P1788, DOI 10.1001/archopht.119.12.1788; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; Scilley K, 2002, OPHTHALMOLOGY, V109, P1235, DOI 10.1016/S0161-6420(02)01060-6; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Tanabe S, 2011, INVEST OPHTH VIS SCI, V52, P4177, DOI 10.1167/iovs.10-6264; Vega RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077294; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; Wood JM, 2005, J NEUROL NEUROSUR PS, V76, P176, DOI 10.1136/jnnp.2004.047118; Wood JM, 2001, OPTOMETRY VISION SCI, V78, P343, DOI 10.1097/00006324-200105000-00018; Wood JM, 2008, J AM GERIATR SOC, V56, P986, DOI 10.1111/j.1532-5415.2008.01709.x; Wood JM, 2013, J GERONTOL A-BIOL, V68, P559, DOI 10.1093/gerona/gls150; Wood JM, 2011, INVEST OPHTH VIS SCI, V52, P1220, DOI 10.1167/iovs.10-6296; Wood JM, 2009, J AM GERIATR SOC, V57, P2062, DOI 10.1111/j.1532-5415.2009.02498.x	50	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0158318	10.1371/journal.pone.0158318	http://dx.doi.org/10.1371/journal.pone.0158318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27472221	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516300004
J	Harks, I; Jockel-Schneider, Y; Schlagenhauf, U; May, TW; Gravemeier, M; Prior, K; Petersilka, G; Ehmke, B				Harks, Inga; Jockel-Schneider, Yvonne; Schlagenhauf, Ulrich; May, Theodor W.; Gravemeier, Martina; Prior, Karola; Petersilka, Gregor; Ehmke, Benjamin			Impact of the Daily Use of a Microcrystal Hydroxyapatite Dentifrice on De Novo Plaque Formation and Clinical/Microbiological Parameters of Periodontal Health. A Randomized Trial	PLOS ONE			English	Article							ORAL HYGIENE; TOOTHPASTE; EFFICACY; FLUORIDE	Aim This 12-week prospective, randomized, double-blind, two-center trial evaluated the impact of a microcrystalline zinc hydroxyapatite (mHA) dentifrice on plaque formation rate (PFR) in chronic periodontitis patients. We hypothesized that mHA precipitates cause delayed plaque development when compared to a fluoridated control (AmF/SnF2), and therefore would improve periodontal health. Material & Methods At baseline and after 4 and 12 weeks, PFR and other clinical and microbiological parameters were recorded. Seventy periodontitis patients received a mHA or AmF/SnF2 dentifrice as daily oral care without hygiene instructions. Four weeks after baseline, participants received full mouth debridement and continued using the dentifrices for another 8 weeks. Results Primary outcome PFR did not change statistically significantly from baseline to weeks 4 and 12, neither in mHA (n = 33; 51.7 +/- 17.2% vs. 48.5 +/- 16.65% vs. 48.4 +/- 19.9%) nor in AmF/SnF2-group (n = 34; 52.3 +/- 17.5% vs. 52.5 +/- 21.3% vs. 46.1 +/- 21.8%). Secondary clinical parameters such as plaque control record, gingival index, bleeding on probing, and pocket probing depth improved, but between-group differences were not statistically significant. Microbiological analyses showed similar slight decreases in colony-forming units in both groups. Conclusion In patients with mild-to-moderate periodontitis, periodontal therapy and use of a mHA-or AmF/SnF2 dentifrice without instructions induced comparable improvements in periodontal health but did not significantly reduce the PFR.	[Harks, Inga; Gravemeier, Martina; Prior, Karola; Petersilka, Gregor; Ehmke, Benjamin] Univ Hosp Muenster, Dept Periodontol, Munster, Germany; [Jockel-Schneider, Yvonne; Schlagenhauf, Ulrich] Univ Hosp Wuerzburg, Dept Periodontol, Wurzburg, Germany; [May, Theodor W.] Soc Biometry & Psychometry, Bielefeld, Germany	University of Munster; University of Wurzburg	Ehmke, B (corresponding author), Univ Hosp Muenster, Dept Periodontol, Munster, Germany.	ehmke@uni-muenster.de	Jockel-Schneider, Yvonne/GQA-6206-2022	Jockel-Schneider, Yvonne/0000-0002-5646-3691; Petersilka, Gregor/0000-0001-8347-644X	Dr. Kurt Wolff GmbH & CO. KG, Johanneswerkstr, Bielefeld, Germany	Dr. Kurt Wolff GmbH & CO. KG, Johanneswerkstr, Bielefeld, Germany	The authors declare that all study affairs have been exclusively funded by Dr. Kurt Wolff GmbH & CO. KG, Johanneswerkstr. 34 - 36, 33611 Bielefeld, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson P, 1991, RISK MARKERS ORAL DI, VI, P158; BAELUM V, 1986, J PERIODONTAL RES, V21, P221, DOI 10.1111/j.1600-0765.1986.tb01454.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; DAVIS WB, 1980, COMMUNITY DENT ORAL, V8, P237, DOI 10.1111/j.1600-0528.1980.tb01295.x; Duckworth RM, 2013, MONOGR ORAL SCI, V23, P125, DOI 10.1159/000350590; Flemmig T F, 1999, Ann Periodontol, V4, P32, DOI 10.1902/annals.1999.4.1.32; Forward G C, 1991, Int Dent J, V41, P164; Hannig C, 2013, CLIN ORAL INVEST, V17, P805, DOI 10.1007/s00784-012-0781-6; HUTTEMANN RW, 1987, DEUT ZAHNAERZTL Z, V42, P486; Junemann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041606; Kalsbeek H, 2000, COMMUNITY DENT ORAL, V28, P112, DOI 10.1034/j.1600-0528.2000.028002112.x; Kleinfelder JW, 2000, J CLIN PERIODONTOL, V27, P846, DOI 10.1034/j.1600-051x.2000.027011846.x; LANG NP, 1990, J CLIN PERIODONTOL, V17, P714, DOI 10.1111/j.1600-051X.1990.tb01059.x; Lelli M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00333; LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610; LOE H, 1979, J CLIN PERIODONTOL, V6, P32, DOI 10.1111/j.1600-051X.1979.tb02116.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Orsini G, 2010, J CLIN PERIODONTOL, V37, P510, DOI 10.1111/j.1600-051X.2010.01558.x; PEARSON ES, 1951, BIOMETRIKA, V38, P112, DOI 10.1093/biomet/38.1-2.112; Pradeep AR, 2012, CONTEMP CLIN DENT, V3, P265, DOI 10.4103/0976-237X.103616; Sanz M, 2013, MONOGR ORAL SCI, V23, P27, DOI 10.1159/000350465; Wright JT, 2014, J AM DENT ASSOC, V145, P182, DOI 10.14219/jada.2013.37	22	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160142	10.1371/journal.pone.0160142	http://dx.doi.org/10.1371/journal.pone.0160142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467683	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100120
J	Liu, LJ; Brown, SL; Ewing, JR; Ala, BD; Schneider, KM; Schlesinger, M				Liu, Long Jian; Brown, Stephen L.; Ewing, James R.; Ala, Brigitte D.; Schneider, Kenneth M.; Schlesinger, Mordechay			Estimation of Tumor Interstitial Fluid Pressure (TIFP) Noninvasively	PLOS ONE			English	Article							TRANSPORT; METASTASIS; MACROMOLECULES; CONVECTION; DIFFUSION	Tumor interstitial fluid pressure (TIFP), is a physiological parameter with demonstrated predictive value for a tumor's aggressiveness, drug delivery, as well as response to treatments such as radiotherapy and chemotherapy. Despite its utility, measurement of TIFP has been limited by the need for invasive procedures. In this work, the theoretical basis for approaching the absolute value of TIFP and the experimental method for noninvasively measuring TIFP are presented. Given specific boundary and continuity conditions, we convert theoretical variables into measurable variables by applying MRI technology. The work shows that TIFP in the central region of the tumor can be estimated by an analysis of the variation of tissue fluid motion in the tumor rim and surrounding tissue. It is determined from three noninvasive measurable parameters: i) an estimate of the velocity of the tumor interstitial fluid at the tumor surface, which is maximal, ii) a measurement of the distance from the tumor surface to where the tumor exudates are absorbed (or normalized), and iii) an estimate of the hydraulic conductivity of the interstitium through which the tumor exudate travels. We experimentally show that the fluid flow within the tumor rim is not uniform, even for a round shaped tumor, and demonstrate the procedures for the noninvasive measurement of TIFP.	[Liu, Long Jian; Brown, Stephen L.; Schlesinger, Mordechay] Univ Windsor, Dept Phys, Windsor, ON, Canada; [Brown, Stephen L.; Ewing, James R.] Henry Ford Hosp, Dept Radiat Oncol, Detroit, MI 48202 USA; [Ewing, James R.] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Ala, Brigitte D.] Windsor Reg Hosp, Dept Radiol, Windsor, ON, Canada; [Schneider, Kenneth M.] Windsor Reg Hosp, Dept Radiat Oncol, Windsor, ON, Canada	University of Windsor; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Liu, LJ (corresponding author), Univ Windsor, Dept Phys, Windsor, ON, Canada.	liu111k@uwindsor.ca		Liu, Longjian/0000-0002-0493-9272	Seeds 4 Hope through Windsor Essex County Cancer Centre Foundation	Seeds 4 Hope through Windsor Essex County Cancer Centre Foundation	The work was funded by a grant from Seeds 4 Hope, a program that provides seed money to foster local cancer research projects through the Windsor Essex County Cancer Centre Foundation, http://windsorcancerfoundation.org/seeds-4-hope/.; The work was funded by a grant from Seeds 4 Hope, a program that provides seed money to foster local cancer research projects through the Windsor Essex County Cancer Centre Foundation.	Ali JH, 2004, TECHNOL CANCER RES T, V3, P491, DOI 10.1177/153303460400300510; BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bert J.L., 1970, SURFACE CHEM BIOL SY, P287; Boron W. F., 2003, MED PHYSL CELLULAR M; Boucher Y, 1998, BRIT J CANCER, V78, P1442, DOI 10.1038/bjc.1998.705; BOUCHER Y, 1990, CANCER RES, V50, P4478; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Curry FE, 1984, HDB PHYSL CARDIOVASC, P309; Ferretti S, 2009, NEOPLASIA, V11, P874, DOI 10.1593/neo.09554; Hassid Y, 2006, CANCER RES, V66, P4159, DOI 10.1158/0008-5472.CAN-05-3289; Hompland T, 2012, CANCER RES, V72, P4899, DOI 10.1158/0008-5472.CAN-12-0903; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; JAIN RK, 1987, CANCER RES, V47, P3039; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Liu LD, 2011, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2011-2; Lunt SJ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-2; Markl M., 2005, VELOCITY ENCODING FL; Phipps C, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/843765; Rofstad EK, 2010, CLIN CANCER RES, V16, P936, DOI 10.1158/1078-0432.CCR-09-2718; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Sarntinoranont M, 2003, ANN BIOMED ENG, V31, P327, DOI 10.1114/1.1554923; Sherwood L., 2012, HUMAN PHYSL CELLS SY; Soltani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020344; Starling E H, 1896, J Physiol, V19, P312; Stohrer M, 2000, CANCER RES, V60, P4251; Sven K, 2007, ADV PHYSIOL EDUC, V31, P116, DOI 10.1152/advan.00084.2006; SWABB EA, 1974, CANCER RES, V34, P2814; Walker-Samuel S, 2011, P BRIT CHAPT INT SOC; Yeo SG, 2009, CLIN CANCER RES, V15, P6201, DOI 10.1158/1078-0432.CCR-09-0560	32	22	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0140892	10.1371/journal.pone.0140892	http://dx.doi.org/10.1371/journal.pone.0140892			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467886	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100002
J	Schulz, A; Buttner, R; Toledo, A; Baader, SL; von Maltzahn, J; Irintchev, A; Bauer, R; Morrison, H				Schulz, Alexander; Buettner, Robert; Toledo, Andrea; Baader, Stephan L.; von Maltzahn, Julia; Irintchev, Andrey; Bauer, Reinhard; Morrison, Helen			Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration	PLOS ONE			English	Article							AXONAL REGENERATION; SKELETAL-MUSCLE; MERLIN; EXPRESSION; GROWTH; PAIN; MICE; NEUROFILAMENTS; INHIBITION; PROTEIN	In contrast to axons of the central nervous system (CNS), axons of the peripheral nervous system (PNS) show better, but still incomplete and often slow regeneration following injury. The tumor suppressor protein merlin, mutated in the hereditary tumor syndrome Neurofibromatosis type 2 (NF2), has recently been shown to have RhoA regulatory functions in PNS neurons in addition to its well-characterized, growth-inhibitory activity in Schwann cells. Here we report that the conditional knockout of merlin in PNS neurons leads to impaired functional recovery of mice following sciatic nerve crush injury, in a gene-dosage dependent manner. Gross anatomical or electrophysiological alterations of sciatic nerves could not be detected. However, correlating with attenuated RhoA activation due to merlin deletion, ultra structural analysis of nerve samples indicated enhanced sprouting of axons with reduced caliber size and increased myelination compared to wildtype animals. We conclude that deletion of the tumor suppressor merlin in the neuronal compartment of peripheral nerves results in compromised functional regeneration after injury. This mechanism could explain the clinical observation that NF2 patients suffer from higher incidences of slowly recovering facial nerve paralysis after vestibular schwannoma surgery.	[Schulz, Alexander; Buettner, Robert; von Maltzahn, Julia; Morrison, Helen] Fritz Lipmann Inst, Leibniz Inst Aging, D-07745 Jena, Germany; [Toledo, Andrea; Baader, Stephan L.] Univ Bonn, Inst Anat Anat & Cell Biol, D-53115 Bonn, Germany; [Irintchev, Andrey] Univ Jena, Jena Univ Hosp, Dept Otorhinolaryngol, D-07747 Jena, Germany; [Bauer, Reinhard] Univ Jena, Inst Mol Cell Biol, D-07747 Jena, Germany; [Bauer, Reinhard] Univ Jena, Jena Univ Hosp, Ctr Sepsis Control & Care CSCC, D-07747 Jena, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Bonn; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Morrison, H (corresponding author), Fritz Lipmann Inst, Leibniz Inst Aging, D-07745 Jena, Germany.	Helen.Morrison@leibniz-fli.de	von Maltzahn, Julia/A-6689-2017; Irintchev, Andrey/A-2465-2011; von Maltzahn, Julia/AFP-2284-2022; Morrison, Helen/B-3984-2017; Morrison, Helen/F-9748-2014	von Maltzahn, Julia/0000-0001-7674-1487; Irintchev, Andrey/0000-0002-4637-1259; von Maltzahn, Julia/0000-0001-7674-1487; Morrison, Helen/0000-0003-4938-1409; Morrison, Helen/0000-0003-4938-1409; Toledo, Andrea/0000-0002-8310-8636; Schulz, Alexander/0000-0003-1604-4596; Buttner, Robert/0000-0002-4337-4251	Children's Tumor Foundation (Drug Discovery Award) [2015-05-010]; Alexander von Humboldt foundation; German Research Foundation (DFG) [MA-3975/2-1]; DFG [SFB 604, MO 1421/2-1, RTG1715, Krebshilfe 107089]	Children's Tumor Foundation (Drug Discovery Award); Alexander von Humboldt foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by SFB 604, DFG MO 1421/2-1, RTG1715 and Krebshilfe 107089 (H.M.), by the Children's Tumor Foundation (Drug Discovery Award 2015-05-010) to A.S., by the Alexander von Humboldt foundation (A.T.) and by a grant from the German Research Foundation (DFG, MA-3975/2-1) to J.v.M.	Akyuaz N, 2013, EXP NEUROL, V247, P517, DOI 10.1016/j.expneurol.2013.01.025; Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Bauder AR, 2012, JOVE-J VIS EXP, DOI 10.3791/3606; Bradman MJG, 2015, J NEUROSCI METH, V255, P92, DOI 10.1016/j.jneumeth.2015.08.010; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; Cooper J, 2014, FEBS LETT, V588, P2743, DOI 10.1016/j.febslet.2014.04.001; Dergham P, 2002, J NEUROSCI, V22, P6570; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Fey A, 2010, J NEUROTRAUM, V27, P815, DOI 10.1089/neu.2009.1217; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Grant GA, 2002, J NEUROSURG, V97, P93, DOI 10.3171/jns.2002.97.1.0093; Hiraga A, 2006, J PERIPHER NERV SYST, V11, P217, DOI 10.1111/j.1529-8027.2006.00091.x; Hirasawa M, 2001, NEUROSCI RES, V40, P125, DOI 10.1016/S0168-0102(01)00216-4; Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Malin SA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-21; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Morrison H, 2007, CANCER RES, V67, P520, DOI 10.1158/0008-5472.CAN-06-1608; Rao MV, 1998, J CELL BIOL, V143, P171, DOI 10.1083/jcb.143.1.171; RAYNOR EM, 1995, MUSCLE NERVE, V18, P402, DOI 10.1002/mus.880180406; Ren AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5984; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Schulz A, 2014, JOVE-J VIS EXP, DOI 10.3791/51181; Schulz A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0082-1; Schulz A, 2014, BRAIN, V137, P420, DOI 10.1093/brain/awt327; Schulz A, 2013, NAT NEUROSCI, V16, P426, DOI 10.1038/nn.3348; Schulz A, 2010, J NEUROSCI, V30, P10177, DOI 10.1523/JNEUROSCI.0840-10.2010; von Maltzahn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3869; von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110; Zhao J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-77; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159718	10.1371/journal.pone.0159718	http://dx.doi.org/10.1371/journal.pone.0159718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467574	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516100049
J	Sharma, A; Conteh, S; Langhorne, J; Duffy, PE				Sharma, Ankur; Conteh, Solomon; Langhorne, Jean; Duffy, Patrick E.			Heterologous Infection of Pregnant Mice Induces Low Birth Weight and Modifies Offspring Susceptibility to Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; NECROSIS-FACTOR-ALPHA; MOSQUITO TRANSMISSION; CHONDROITIN-SULFATE; PLACENTAL MALARIA; IMMUNE-RESPONSES; IFN-GAMMA; CHABAUDI; BERGHEI; PATHOGENESIS	Pregnancy malaria (PM) is associated with poor pregnancy outcomes, and can arise due to relapse, recrudescence or a re-infection with heterologous parasites. We have used the Plasmodium chabaudi model of pregnancy malaria in C57BL/6 mice to examine recrudescence and heterologous infection using CB and AS parasite strains. After an initial course of patent parasitemia and first recrudescence, CB but not AS parasites were observed to recrudesce again in most animals that became pregnant. Pregnancy exacerbated heterologous CB infection of AS-experienced mice, leading to mortality and impaired post-natal growth of pups. Parasites were detected in placental blood without evidence of sequestration, unlike P. falciparum but similar to other malaria species that infect pregnant women. Inflammatory cytokine levels were elevated in pregnant females during malaria, and associated with intensity of infection and with poor outcomes. Pups born to dams during heterologous infection were more resistant to malaria infections at 6-7 weeks of age, compared to pups born to malaria-experienced but uninfected dams or to malaria-naive dams. In summary, our mouse model reproduces several features of human PM, including recrudescences, heterologous infections, poor pregnancy outcomes associated with inflammatory cytokines, and modulation of offspring susceptibility to malaria. This model should be further studied to explore mechanisms underlying PM pathogenesis.	[Sharma, Ankur; Conteh, Solomon; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA; [Langhorne, Jean] Francis Crick Inst, Mill Hill Lab, London, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Francis Crick Institute	Duffy, PE (corresponding author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD 20852 USA.	patrick.duffy@nih.gov		Langhorne, Jean/0000-0002-2257-9733	Division of Intramural Research, NIAID/NIH; Francis Crick Institute; UK Medical Research Council [U117584248]; Cancer Research UK; Wellcome Trust [WT104777MA]; The Francis Crick Institute [10101] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001134] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Francis Crick Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Division of Intramural Research, NIAID/NIH. JL is supported by the Francis Crick Institute, which receives its core funding from the UK Medical Research Council (U117584248), Cancer Research UK, and the Wellcome Trust (WT104777MA).	Abrams ET, 2004, AM J REPROD IMMUNOL, V52, P174, DOI 10.1111/j.1600-0897.2004.00186.x; Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; AUSTGULEN R, 1994, EUR J OBSTET GYN R B, V57, P149, DOI 10.1016/0028-2243(94)90291-7; Beeson JG, 2002, CELL MOL LIFE SCI, V59, P258, DOI 10.1007/s00018-002-8421-y; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P1; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; BRAY RS, 1979, T ROY SOC TROP MED H, V73, P427, DOI 10.1016/0035-9203(79)90170-6; BRUCECHWATT LJ, 1954, NATURE, V173, P353, DOI 10.1038/173353a0; Brugat T, 2014, CELL MICROBIOL, V16, P687, DOI 10.1111/cmi.12212; CARTER R, 1975, ANN TROP MED PARASIT, V69, P187, DOI 10.1080/00034983.1975.11687000; Chatterjee P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00253; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Crocker IP, 2004, PLACENTA, V25, P273, DOI 10.1016/j.placenta.2003.09.010; Cunningham D, 2010, MOL BIOCHEM PARASIT, V170, P65, DOI 10.1016/j.molbiopara.2009.12.010; De Roode JC, 2003, PARASITOLOGY, V127, P411, DOI 10.1017/S0031182003004001; Doritchamou J, 2012, J INFECT DIS, V206, P1911, DOI 10.1093/infdis/jis629; Duffy PE, 2007, PARASITOLOGY, V134, P1877, DOI 10.1017/S0031182007000170; Duffy PE, 2011, MEM I OSWALDO CRUZ, V106, P64, DOI 10.1590/S0074-02762011000900008; Duffy PE, 2003, CURR OPIN MICROBIOL, V6, P371, DOI 10.1016/S1369-5274(03)00090-0; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 2006, EXP PARASITOL, V113, P36, DOI 10.1016/j.exppara.2005.12.003; GILKS CF, 1990, PARASITE IMMUNOL, V12, P45, DOI 10.1111/j.1365-3024.1990.tb00935.x; HIOKI A, 1990, J PROTOZOOL, V37, P163, DOI 10.1111/j.1550-7408.1990.tb01121.x; Ibitokou S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049621; Jacobs P, 1996, INFECT IMMUN, V64, P535, DOI 10.1128/IAI.64.2.535-541.1996; Janssen CS, 2002, P ROY SOC B-BIOL SCI, V269, P431, DOI 10.1098/rspb.2001.1903; Lawton J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-125; Mackinnon MJ, 2005, INT J PARASITOL, V35, P145, DOI 10.1016/j.ijpara.2004.11.011; Mackinnon MJ, 2002, EXP PARASITOL, V101, P121, DOI 10.1016/S0014-4894(02)00103-0; Marinho CRF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005630; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; MENON R., 1972, Medical Journal of Malaysia, V27, P115; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Moya-Alvarez V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-271; Neres R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001608; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; ODUOLA AMJ, 1982, J PROTOZOOL, V29, P77, DOI 10.1111/j.1550-7408.1982.tb02883.x; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; PALMER TT, 1978, J PARASITOL, V64, P493, DOI 10.2307/3279791; Poovassery J, 2006, INFECT IMMUN, V74, P2839, DOI 10.1128/IAI.74.5.2839-2848.2006; Poovassery J, 2009, INFECT IMMUN, V77, P4998, DOI 10.1128/IAI.00617-09; Poovassery JS, 2009, J IMMUNOL, V183, P5342, DOI 10.4049/jimmunol.0901669; Requena P, 2015, J IMMUNOL, V194, P3275, DOI 10.4049/jimmunol.1401038; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; Roberts CT, 2003, PLACENTA, V24, pS94, DOI 10.1053/plac.2002.0949; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Rusterholz C, 2007, SEMIN IMMUNOPATHOL, V29, P151, DOI 10.1007/s00281-007-0071-6; Sacks G, 1999, IMMUNOL TODAY, V20, P114, DOI 10.1016/S0167-5699(98)01393-0; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Sarr D, 2012, PARASITE IMMUNOL, V34, P224, DOI 10.1111/j.1365-3024.2012.01355.x; Schmid-Hempel P, 2007, PLOS PATHOG, V3, P1372, DOI 10.1371/journal.ppat.0030147; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Spence PJ, 2013, NATURE, V498, P228, DOI 10.1038/nature12231; Spence PJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-407; Staszewski V, 2012, P ROY SOC B-BIOL SCI, V279, P2487, DOI 10.1098/rspb.2011.1563; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Thakar J, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-35; VANZON AAJC, 1980, TROPENMED PARASITOL, V31, P402; VANZON AAJC, 1980, INFECT IMMUN, V28, P630; WATKINSON M, 1983, BMJ-BRIT MED J, V287, P251, DOI 10.1136/bmj.287.6387.251	65	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160120	10.1371/journal.pone.0160120	http://dx.doi.org/10.1371/journal.pone.0160120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467392	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100117
J	Spalinger, MR; Zeitz, J; Biedermann, L; Rossel, JB; Sulz, MC; Frei, P; Scharl, S; Vavricka, SR; Fried, M; Rogler, G; Scharl, M				Spalinger, Marianne R.; Zeitz, Jonas; Biedermann, Luc; Rossel, Jean-Benoit; Sulz, Michael C.; Frei, Pascal; Scharl, Sylvie; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael		Swiss IBD Cohort Study Grp	Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; 1,25-DIHYDROXYVITAMIN D-3; IMMUNE-SYSTEM; PTPN22; VARIANT; POPULATION; SUSCEPTIBILITY	Background Protein tyrosine phosphatase non-receptor type 22 (PTPN22) plays an important role in immune cell function and intestinal homeostasis. The single nucleotide polymorphism (SNP) rs2476601 within the PTPN22 gene locus results in aberrant function of PTPN22 protein and protects from Crohn's disease (CD). Here, we investigated associations of PTPN22 SNP rs2476601 in inflammatory bowel disease (IBD) patients in the Swiss IBD Cohort Study (SIBDCS). Methods 2'028 SIBDCS patients (1173 CD and 855 ulcerative colitis (UC) patients) were included. The clinical characteristics were analysed for an association with the presence of the PTPN22 SNP rs2476601 genotypes 'homozygous variant' (AA), 'heterozygous' (GA) and 'homozygous wild-type' (GG). Results 13 patients (0.6%) were homozygous variant (AA) for the PTPN22 polymorphism, 269 (13.3%) heterozygous variant (GA) and 1'746 (86.1%) homozygous wild-type (GG). In CD, AA and GA genotypes were associated with less use of steroids and antibiotics, and reduced prevalence of vitamin D and calcium deficiency. In UC the AA and GA genotype was associated with increased use of azathioprine and anti-TNF antibodies, but significantly less patients with the PTPN22 variant featured malabsorption syndrome (p = 0.026). Conclusion Our study for the first time addressed how presence of SNP rs2476601 within the PTPN22 gene affects clinical characteristics in IBD-patients. Several factors that correlate with more severe disease were found to be less common in CD patients carrying the A-allele, pointing towards a protective role for this variant in affected CD patients. In UC patients however, we found the opposite trend, suggesting a disease-promoting effect of the A-allele.	[Spalinger, Marianne R.; Zeitz, Jonas; Biedermann, Luc; Frei, Pascal; Scharl, Sylvie; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Rossel, Jean-Benoit] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Sulz, Michael C.] Kantonsspital St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland; [Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Lausanne; Kantonsspital St. Gallen; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Scharl, M (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland.	michael.scharl@usz.ch	Biedermann, Luc/J-2654-2017	Rossel, Jean-Benoit/0000-0001-5803-3233; Scharl, Michael/0000-0002-6729-1469	Swiss National Science Foundation [314730-146204, CRSII3_154488/1, 3347CO-108792]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by research grants from the Swiss National Science Foundation to MS [Grants No. 314730-146204, No. CRSII3_154488/1] and to GR for the Swiss IBD Cohort [Grant No. 3347CO-108792]. The funding institutions had no role in study design and data interpretation.	Abraham C, 2011, GASTROENTEROLOGY, V140, P1729, DOI 10.1053/j.gastro.2011.02.012; Ardesia M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470805; Arimura Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000966; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang HH, 2013, J IMMUNOL, V191, P2134, DOI 10.4049/jimmunol.1203363; Chen J, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-6; Connelly TM, 2015, DIS COLON RECTUM, V58, P321, DOI 10.1097/DCR.0000000000000274; Dai XZ, 2013, J CLIN INVEST, V123, P2024, DOI 10.1172/JCI66963; de Souza H, 2015, NAT REV GASTROENTERO; Diaz-Gallo LM, 2011, INFLAMM BOWEL DIS, V17, P2287, DOI 10.1002/ibd.21630; Dieude P, 2008, ANN RHEUM DIS, V67, P900, DOI 10.1136/ard.2007.077180; Eliopoulos E, 2011, LUPUS, V20, P501, DOI 10.1177/0961203310392423; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Forbes A, 2011, JPEN-PARENTER ENTER, V35, P571, DOI 10.1177/0148607111413599; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kotlarz D, 2012, GASTROENTEROLOGY, V143, P347, DOI 10.1053/j.gastro.2012.04.045; Li YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9442; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Maine CJ, 2014, J IMMUNOL, V192, P1415, DOI 10.4049/jimmunol.1302418; Maine CJ, 2012, J IMMUNOL, V188, P5267, DOI 10.4049/jimmunol.1200150; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Massironi S, 2013, CLIN NUTR, V32, P904, DOI 10.1016/j.clnu.2013.03.020; Michou L, 2007, P NATL ACAD SCI USA, V104, P1649, DOI 10.1073/pnas.0610250104; Moez P, 2012, RHEUMATOL INT, V32, P2753, DOI 10.1007/s00296-011-2063-z; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Nguyen GC, 2008, INFLAMM BOWEL DIS, V14, P1105, DOI 10.1002/ibd.20429; Nowak JK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04768; Pittet V, 2009, INT J EPIDEMIOL, V38, P922, DOI 10.1093/ije/dyn180; Ramirez M, 2012, CLIN EXP RHEUMATOL, V30, P520; Russell RK, 2005, INFLAMM BOWEL DIS, V11, P955, DOI 10.1097/01.MIB.0000183423.38037.f3; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Spalinger MR, 2015, INFLAMM BOWEL DIS, V21, P645, DOI 10.1097/MIB.0000000000000297; Spalinger MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072384; Spalinger MR, 2013, GASTROENTEROLOGY, V144, P978, DOI 10.1053/j.gastro.2013.01.048; Spalinger MR, 2016, J CLIN INVESTIGATION, V126; Torki M, 2015, DIGEST DIS SCI, V60, P3085, DOI 10.1007/s10620-015-3727-4; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Vang T, 2012, NAT CHEM BIOL, V8, P437, DOI [10.1038/NCHEMBIO.916, 10.1038/nchembio.916]; Wang TT, 2010, J BIOL CHEM, V285, P2237, DOI 10.1074/jbc.C109.071225; Wang YY, 2015, ARTHRITIS RHEUMATOL, V67, P2403, DOI 10.1002/art.39211; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; Weisshof R, 2015, CURR OPIN CLIN NUTR, V18, P576, DOI 10.1097/MCO.0000000000000226; Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhebrun D, 2011, AGING-US, V3, P368, DOI 10.18632/aging.100305	53	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160215	10.1371/journal.pone.0160215	http://dx.doi.org/10.1371/journal.pone.0160215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467733	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100131
J	Vahidy, F; Nguyen, C; Albright, KC; Boehme, AK; Mir, O; Sands, KA; Savitz, SI				Vahidy, Farhaan; Nguyen, Claude; Albright, Karen C.; Boehme, Amelia K.; Mir, Osman; Sands, Kara A.; Savitz, Sean I.			Transferring Patients with Intracerebral Hemorrhage Does Not Increase In-Hospital Mortality	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; STROKE; IMPACT; OUTCOMES; ASSOCIATION; PREVENTION; GUIDELINES; ADMISSION; STATEMENT; ACCESS	Introduction Comprehensive stroke centers (CSCs) accept transferred patients from referring hospitals in a given regional area. The transfer process itself has not been studied as a potential factor that may impact outcome. We compared in-hospital mortality and severe disability or death at CSCs between transferred and directly admitted intracerebral hemorrhage (ICH) patients of matched severity. Materials and Methods We retrospectively reviewed all primary ICH patients from a prospectively-collected stroke registry and electronic medical records, at two tertiary care sites. Patients meeting inclusion criteria were divided into two groups: patients transferred in for a higher level of care and direct presenters. We used propensity scores (PS) to match 175 transfer patients to 175 direct presenters. These patients were taken from a pool of 530 eligible patients, 291 (54.9%) of whom were transferred in for a higher level of care. Severe disability or death was defined as a modified Rankin Scale (mRS) sore of 4-6. Mortality and morbidity were compared between the 2 groups using Pearson chi-squared test and Student t test. We fit logistic regression models to estimate odds ratios (OR) and 95% confidence intervals (CI) for association between transfer status and in-hospital mortality and severe disability or death in full and PS-matched patients. Results There were no significant differences in the PS-matched transfer and direct presentation groups. Patients transferred to a regional center were not at higher odds of in-hospital mortality (OR: 0.93, 95% CI: 0.50-1.71) and severe disability or death (OR: 0.77, 95% CI: 0.39-1.50), than direct presenters, even after adjustment for PS, age, baseline NIHSS score, and glucose on admission. Conclusion Our observation suggests that transfer patients of similar disease burden are not at higher risk of in-hospital mortality than direct presenters.	[Vahidy, Farhaan; Nguyen, Claude; Mir, Osman; Savitz, Sean I.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, Houston, TX USA; [Albright, Karen C.] Birmingham VA Med Ctr, Geriatr Res Educ & Clin Ctr, Birmingham, AL USA; [Albright, Karen C.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Boehme, Amelia K.] Columbia Univ, Gertrude H Sergievsky Ctr, Dept Neurol, New York, NY 10027 USA; [Sands, Kara A.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA	University of Texas System; University of Texas Health Science Center Houston; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; Columbia University; University of Alabama System; University of Alabama Birmingham	Vahidy, F (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurol, Houston, TX USA.	farhaan.vahidy@uth.tmc.edu	Vahidy, Farhaan/AAC-1049-2019	Vahidy, Farhaan/0000-0002-3464-2111; Mir, Osman/0000-0002-0226-3299; Boehme, Amelia/0000-0001-7408-1075; Albright, Karen/0000-0002-9035-7067	National Institutes of Health Training Grant [5 T32 NS007412-12]; NINDS [T32 NS007153 31]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007412, T32NS007153] Funding Source: NIH RePORTER	National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Financial support for this study was provided in part by National Institutes of Health Training Grant 5 T32 NS007412-12. Dr. Boehme is supported by NINDS T32 NS007153 31. The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing and publishing the report.; The authors acknowledge technical and infrastructural research supported provided by the Center for Clinical Research and Evidence Based Medicine at the McGovern Medical School at University of Texas in Houston for this work. This work was supported by National Institutes of Health Training Grant 5 T32 NS007412-12. Dr. Boehme is supported by NINDS T32 NS007153 31.	Adeoye O, 2011, AM J EMERG MED, V29, P391, DOI 10.1016/j.ajem.2009.10.016; Adil MM, 2014, STROKE S1, V45; Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Albright KC, 2013, STROKE, V44, P1117, DOI 10.1161/STROKEAHA.111.666156; Albright KC, 2010, ARCH NEUROL-CHICAGO, V67, P1210, DOI 10.1001/archneurol.2010.250; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Bardach NS, 2002, STROKE, V33, P1851, DOI 10.1161/01.STR.0000019126.43079.7B; BRODERICK J, 1994, NEUROSURGERY, V34, P882, DOI 10.1227/00006123-199405000-00015; Centers for Medicare and Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P50041; Dennis MS, 2003, CEREBROVASC DIS, V16, P9, DOI 10.1159/000069935; Diringer MN, 2001, CRIT CARE MED, V29, P635, DOI 10.1097/00003246-200103000-00031; Flaherty ML, 2006, NEUROLOGY, V66, P1182, DOI 10.1212/01.wnl.0000208400.08722.7c; Fogelholm R, 2005, J NEUROL NEUROSUR PS, V76, P1534, DOI 10.1136/jnnp.2004.055145; Fonarow GC, 2014, STROKE, V45, P1589, DOI 10.1161/STR.0000000000000014; Glance LG, 2006, CRIT CARE MED, V34, P1925, DOI 10.1097/01.CCM.0000226415.93237.84; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Holmes W, 2010, USING PROPENSITY SCO; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Kodankandath T, 2016, NEUROLOGY S, V86, pP5; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Mirski MA, 2001, J NEUROSURG ANESTH, V13, P83, DOI 10.1097/00008506-200104000-00004; Naval NS, 2010, NEUROCRIT CARE, V12, P149, DOI 10.1007/s12028-009-9302-0; Parsons L., 2004, 26 ANN SAS US GROUP, V26, P214; Quigley DD, 2003, USING MULTIVARIATE M; Rahbar MH, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-61; Reeves MJ, 2011, PREV CHRONIC DIS, V8; Rockson SG, 2004, J AM COLL CARDIOL, V43, P929, DOI 10.1016/j.jacc.2003.11.028; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Savitz SI, 2007, STROKE, V38, P3205, DOI 10.1161/STROKEAHA.107.489351; Services CfM, MEAS METH 2016; States FGotU, 2016, HOSP INP PROSP PAYM; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Tadevosyan A, 2016, STROKE, V47; Vahidy F, 2016, STROKE, V47, pAWMP31; Ward MJ, 2012, NEUROCRIT CARE, V16, P232, DOI 10.1007/s12028-011-9644-2; WHISNANT J P, 1990, Stroke, V21, P637	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159174	10.1371/journal.pone.0159174	http://dx.doi.org/10.1371/journal.pone.0159174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467594	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100020
J	Heegaard, NHH; Carlsen, AL; Lilje, B; Ng, KL; Ronne, ME; Jorgensen, HL; Sennels, H; Fahrenkrug, J				Heegaard, Niels H. H.; Carlsen, Anting Liu; Lilje, Berit; Ng, Kim Lee; Ronne, Mette E.; Jorgensen, Henrik L.; Sennels, Henriette; Fahrenkrug, Jan			Diurnal Variations of Human Circulating Cell-Free Micro-RNA	PLOS ONE			English	Article							CIRCADIAN-CLOCK; POSTTRANSCRIPTIONAL REGULATION; PINEAL-GLAND; GENE; EXPRESSION; MAMMALS; RHYTHM; TRANSCRIPTS; DISEASE; BIOLOGY	A 24-hour light and dark cycle-dependent rhythmicity pervades physiological processes in virtually all living organisms including humans. These regular oscillations are caused by external cues to endogenous, independent biological time-keeping systems (clocks). The rhythm is reflected by gene expression that varies in a circadian and specific fashion in different organs and tissues and is regulated largely by dynamic epigenetic and post-transcriptional mechanisms. This leads to well-documented oscillations of specific electrolytes, hormones, metabolites, and plasma proteins in blood samples. An emerging, important class of gene regulators is short single-stranded RNA (micro-RNA, miRNA) that interferes post-transcriptionally with gene expression and thus may play a role in the circadian variation of gene expression. MiRNAs are promising biomarkers by virtue of their disease-specific tissue expression and because of their presence as stable entities in the circulation. However, no studies have addressed the putative circadian rhythmicity of circulating, cell-free miRNAs. This question is important both for using miRNAs as biological markers and for clues to miRNA function in the regulation of circadian gene expression. Here, we investigate 92 miRNAs in plasma samples from 24 young male, healthy volunteers repeatedly sampled 9 times during a 24-hour stay in a regulated environment. We demonstrate that a third (26/79) of the measurable plasma miRNAs (using RT-qPCR on a microfluidic system) exhibit a rhythmic behavior and are distributed in two main phase patterns. Some of these miRNAs weakly target known clock genes and many have strong targets in intracellular MAPK signaling pathways. These novel findings highlight the importance of considering bio-oscillations in miRNA biomarker studies and suggest the further study of a set of specific circulating miRNAs in the regulation and functioning of biological clocks.	[Heegaard, Niels H. H.; Carlsen, Anting Liu; Ronne, Mette E.] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen, Denmark; [Heegaard, Niels H. H.] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark; [Carlsen, Anting Liu] Statens Serum Inst, Dept Congenital Disorders, Copenhagen, Denmark; [Lilje, Berit; Ng, Kim Lee] Statens Serum Inst, Dept Microbiol & Infect Control, Copenhagen, Denmark; [Jorgensen, Henrik L.; Fahrenkrug, Jan] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, DK-1168 Copenhagen, Denmark; [Sennels, Henriette] Univ Copenhagen, Rigshosp Glostrup, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark	Statens Serum Institut; University of Southern Denmark; Odense University Hospital; Statens Serum Institut; Statens Serum Institut; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Heegaard, NHH (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen, Denmark.; Heegaard, NHH (corresponding author), Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Odense, Denmark.	nhe@ssi.dk	Jorgensen, Henrik/ABI-8236-2020	Jorgensen, Henrik Lovendahl/0000-0001-6374-761X; Ronne, Mette Errebo/0000-0002-7892-4655; Ng, Kim/0000-0002-2679-8845	Danish Biotechnology Center of Cellular Communication	Danish Biotechnology Center of Cellular Communication	The study was supported by the Danish Biotechnology Center of Cellular Communication.; The skillful technical assistance of Anita Hansen is gratefully acknowledged. The study was supported by the Danish Biotechnology Center of Cellular Communication.	Altman BJ, 2015, CELL METAB, V10; Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Azzi A, 2014, NAT NEUROSCI, V17, P377, DOI 10.1038/nn.3651; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Born J, 1997, J IMMUNOL, V158, P4454; Chen RM, 2013, CURR BIOL, V23, P1959, DOI 10.1016/j.cub.2013.08.005; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Clokie SJH, 2012, J BIOL CHEM, V287, P25312, DOI 10.1074/jbc.M112.356733; Coon SL, 2012, P NATL ACAD SCI USA, V109, P13319, DOI 10.1073/pnas.1207748109; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; Felicetti F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0811-2; Figueredo DD, 2015, BLOOD CELL MOL DIS, V54, P364, DOI 10.1016/j.bcmd.2015.01.004; Figueredo DD, 2013, J BIOL RHYTHM, V28, P107, DOI 10.1177/0748730413476827; Fogg PCM, 2014, J BIOL CHEM, V289, P34341, DOI 10.1074/jbc.M114.606392; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Jakobsen JS, 2013, GENOME RES, V23, P592, DOI 10.1101/gr.146399.112; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kojima S, 2015, BIOCHEMISTRY-US, V54, P124, DOI 10.1021/bi500707c; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Lim C, 2013, NAT NEUROSCI, V16, P1544, DOI 10.1038/nn.3543; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MacLellan SA, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-27; Marabita F, 2015, BRIEF BIOINFORM, P1; de Paz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123693; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510; O'Neill JS, 2007, CURR BIOL, V17, pR760, DOI 10.1016/j.cub.2007.07.001; Ogawa S, 2007, BRAIN RES, V1168, P112, DOI 10.1016/j.brainres.2007.06.074; Pegoraro M, 2008, J GENET, V87, P505, DOI 10.1007/s12041-008-0073-8; Ratajczak MZ, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0087-4; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Robles MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004047; Saito T, 2013, CIRCULATION, V127, P104, DOI 10.1161/CIRCULATIONAHA.112.135608; Saus E, 2010, HUM MOL GENET, V19, P4017, DOI 10.1093/hmg/ddq316; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Sennels HP, 2011, SCAND J CLIN LAB INV, V71, P532, DOI 10.3109/00365513.2011.602422; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Takahashi H, 2003, MOL BRAIN RES, V110, P1, DOI 10.1016/S0169-328X(02)00543-0; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Wang HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep21598; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Weigl Y, 2013, J EXP BIOL, V216, P2276, DOI 10.1242/jeb.081729; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wu JH, 2011, CANCER RES, V71, P2622, DOI 10.1158/0008-5472.CAN-10-3837; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yan YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080029; Zak DE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r48; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	55	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160577	10.1371/journal.pone.0160577	http://dx.doi.org/10.1371/journal.pone.0160577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494182	Green Submitted, Green Published, gold			2022-12-27	WOS:000381369500060
J	Shimmon, G; Wood, BA; Morris, A; Mioulet, V; Grazioli, S; Brocchi, E; Berryman, S; Tuthill, T; King, DP; Burman, A; Jackson, T				Shimmon, Gareth; Wood, Britta A.; Morris, Alison; Mioulet, Valerie; Grazioli, Santina; Brocchi, Emiliana; Berryman, Stephen; Tuthill, Toby; King, Donald P.; Burman, Alison; Jackson, Terry			Truncated Bovine Integrin Alpha-v/Beta-6 as a Universal Capture Ligand for FMD Diagnosis	PLOS ONE			English	Article							FOOT-AND-MOUTH; LINKED-IMMUNOSORBENT-ASSAY; DISEASE VIRUS-PARTICLES; IMPROVED VACCINES; STRUCTURAL BASIS; ANTIGENIC SITES; RECEPTOR; INTEGRIN-ALPHA-V-BETA-6; ALPHA(V)BETA(3); IDENTIFICATION	Foot-and-mouth disease (FMD) is endemic in many regions of the world and is one of the most prevalent epizootic animal diseases. FMD affects livestock, such as cattle, sheep, goats and pigs, and causes enormous economic losses due to reduced productivity and trade restrictions. Preparedness and early diagnosis are essential for effective control of FMD. Many diagnostic assays are dependent on raising high-affinity, anti-FMD virus (FMDV) serotype-specific antibodies in small animals (rabbits and guinea pigs) that give broad virus coverage. Here we show that soluble, truncated forms of bovine alpha v beta 6 bind FMDV in an authentic RGD and divalent cation dependent interaction and can be used as the trapping reagent in a FMDV sandwich ELISA. In addition, inclusion of FLAG or His tags facilitates simple purification without the loss of virus binding. We also provide evidence that when combined with a guinea pig polyclonal serum, or serotype-specific monoclonal antibodies, the integrin can be used to detect viruses representative of all FMDV serotypes. We also show that recombinant FMDV empty capsids, with stabilising disulphide bonds, can serve as an antigen in the ELISA and can therefore replace inactivated virus antigen as a positive control for the assay. Our results demonstrate the potential use of bovine alpha v beta 6 and FMDV empty capsids in FMD diagnostic assays.	[Shimmon, Gareth; Wood, Britta A.; Morris, Alison; Mioulet, Valerie; Berryman, Stephen; Tuthill, Toby; King, Donald P.; Burman, Alison; Jackson, Terry] Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England; [Grazioli, Santina; Brocchi, Emiliana] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Via Bianchi 9, Brescia, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; IZS Lombardia e Emilia	Jackson, T (corresponding author), Pirbright Inst, Ash Rd, Pirbright GU24 0NF, Surrey, England.	terry.jackson@pirbright.ac.uk	Brocchi, Emiliana/G-1810-2019	Brocchi, Emiliana/0000-0003-1864-080X; King, Donald/0000-0002-6959-2708	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001716]; United Kingdom Department for Environment, Food and Rural Affairs [SE1127, SE1128]; BBSRC [BB/J005479/1, BBS/E/I/00001980, BBS/E/I/00001716] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J005479/1, BBS/E/I/00001980] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, project BBS/E/I/00001716 to TJ, http://www.bbsrc.ac.uk/, and the United Kingdom Department for Environment, Food and Rural Affairs, projects SE1127 and SE1128 to DPK, https://www.gov.uk/government/organisations/department-for-environment-food-rural-affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; Caridi F, 2015, J VIROL, V89, P5633, DOI 10.1128/JVI.03358-14; CROWTHER JR, 1993, J GEN VIROL, V74, P1547, DOI 10.1099/0022-1317-74-8-1547; DiCara D, 2008, J VIROL, V82, P1537, DOI 10.1128/JVI.01480-07; Domingo E, 2003, VIRUS RES, V91, P47, DOI 10.1016/S0168-1702(02)00259-9; Duque H, 2004, J VIROL, V78, P9773, DOI 10.1128/JVI.78.18.9773-9781.2004; Duque H, 2003, J VIROL, V77, P2500, DOI 10.1128/JVI.77.4.2500-2511.2003; Ellard FM, 1999, J GEN VIROL, V80, P1911, DOI 10.1099/0022-1317-80-8-1911; Ferris NP, 2011, J VIROL METHODS, V175, P253, DOI 10.1016/j.jviromet.2011.05.026; FERRIS NP, 1988, VET MICROBIOL, V16, P201, DOI 10.1016/0378-1135(88)90024-7; Ferris NP, 2005, J VIROL METHODS, V127, P69, DOI 10.1016/j.jviromet.2005.02.014; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; KITSON JDA, 1990, VIROLOGY, V179, P26, DOI 10.1016/0042-6822(90)90269-W; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mateo R, 2008, J VIROL, V82, P12232, DOI 10.1128/JVI.01553-08; MCCULLOUGH KC, 1987, VIROLOGY, V157, P516, DOI 10.1016/0042-6822(87)90294-7; Porta C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003255; Porta C, 2013, J VIROL METHODS, V187, P406, DOI 10.1016/j.jviromet.2012.11.011; Rincon V, 2014, STRUCTURE, V22, P1560, DOI 10.1016/j.str.2014.08.019; Rodriguez LL, 2011, EXPERT REV VACCINES, V10, P377, DOI [10.1586/erv.11.4, 10.1586/ERV.11.4]; ROEDER PL, 1987, RES VET SCI, V43, P225, DOI 10.1016/S0034-5288(18)30778-1; XIE QC, 1987, J GEN VIROL, V68, P1637, DOI 10.1099/0022-1317-68-6-1637	28	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160696	10.1371/journal.pone.0160696	http://dx.doi.org/10.1371/journal.pone.0160696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494135	Green Submitted, gold, Green Published			2022-12-27	WOS:000381369500077
J	Damasceno, KA; Ferreira, E; Estrela-Lima, A; Gamba, CD; Miranda, FF; Alves, MR; Rocha, RM; de Barros, ALB; Cassali, GD				Damasceno, Karine Araujo; Ferreira, Enio; Estrela-Lima, Alessandra; Gamba, Conrado de Oliveira; Miranda, Fernanda Freitas; Alves, Mariana Rezende; Rocha, Rafael Malagoli; Branco de Barros, Andre Luis; Cassali, Geovanni Dantas			HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER; IN-SITU; DUCTAL CARCINOMA; MIXED TUMORS; HYALURONAN; COMPONENTS; CELLS; GENE; OVEREXPRESSION	Versican expression promotes tumor growth by destabilizing focal cell contacts, thus impeding cell adhesion and facilitating cell migration. It not only presents or recruits molecules to the cell surface, but also modulates gene expression levels and coordinates complex signal pathways. Previously, we suggested that the interaction between versican and human epidermal growth factor receptors may be directly associated with tumor aggressiveness. Thus, the expression of EGFR and HER-2 in these neoplasms may contribute to a better understanding of the progression mechanisms in malignant mammary tumors. The purpose of this study was to correlate the gene and protein expressions of EGFR and HER2 by RNA In Situ Hybridization (ISH) and immunohistochemistry (IHC), respectively, and their relationship with the versican expression in carcinomas in mixed tumors and carcinosarcomas of the canine mammary gland. The results revealed that EGFR mRNA expression showed a significant difference between in situ and invasive carcinomatous areas in low and high versican expression groups. Identical results were observed in HER-2 mRNA expression. In immunohistochemistry analysis, neoplasms with low versican expression showed greater EGFR immunostaining in the in situ areas than in invasive areas, even as the group presenting high versican expression displayed greater EGFR and HER-2 staining in in situ areas. Significant EGFR and HER-2 mRNA and protein expressions in in situ carcinomatous sites relative to invasive areas suggest that these molecules play a role during the early stages of tumor progression.	[Damasceno, Karine Araujo; Ferreira, Enio; Gamba, Conrado de Oliveira; Miranda, Fernanda Freitas; Cassali, Geovanni Dantas] Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil; [Damasceno, Karine Araujo] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Lab Expt Pathol, Salvador, BA, Brazil; [Estrela-Lima, Alessandra] Univ Fed Bahia, Dept Pathol & Clin, Sch Vet Med & Zootechny, Salvador, BA, Brazil; [Alves, Mariana Rezende; Rocha, Rafael Malagoli] AC Camargo Canc Ctr, Int Ctr Res Canc CIPE, Sao Paulo, Brazil; [Branco de Barros, Andre Luis] Univ Fed Minas Gerais, Sch Pharm, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; A.C.Camargo Cancer Center; Universidade Federal de Minas Gerais	Cassali, GD (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.	cassalig@icb.ufmg.br	de Barros, Andre Luis/O-2615-2017; DAMASCENO, KARINE/AAO-3340-2021; Estrela-Lima, Alessandra/AAL-2745-2021; DAMASCENO, KARINE ARAÚJO/AAV-6002-2021; Ferreira, Enio/AAC-8167-2022	de Barros, Andre Luis/0000-0002-7641-6585; Estrela-Lima, Alessandra/0000-0002-9879-7999; DAMASCENO, KARINE ARAÚJO/0000-0003-2087-1690; Ferreira, Enio/0000-0002-1835-0303	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento e Pesquisa (CNPq); Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento e Pesquisa (CNPq) and Fundacao de amparo a pesquisa do Estado de Minas Gerais (FAPEMIG).	Aguiar FN, 2013, REV BRAS GINECOL OBS, V35, P97, DOI 10.1590/S0100-72032013000300002; Alba J, 2012, HISTOL HISTOPATHOL, V27, P1021, DOI 10.14670/HH-27.1021; Alves MR, 2014, VIRCHOWS ARCH, V465, P321, DOI 10.1007/s00428-014-1629-z; Appert-Collin A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00283; Bertagnolli AC, 2011, AUST VET J, V89, P312, DOI 10.1111/j.1751-0813.2011.00803.x; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Cassali G. D., 2014, Brazilian Journal of Veterinary Pathology, V7, P38; Damasceno KA, 2016, HISTOL HISTOPATHOL, V31, P675, DOI 10.14670/HH-11-705; Damasceno KA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-195; Dantas Cassali Geovanni, 2012, Vet Med Int, V2012, P274608, DOI 10.1155/2012/274608; Du WW, 2013, HISTOL HISTOPATHOL, V28, P701, DOI 10.14670/HH-28.701; Elston CW., 1998, BREAST, P365; Erdelyi I, 2005, HISTOCHEM CELL BIOL, V124, P139, DOI 10.1007/s00418-005-0007-y; Ferreira E, 2014, ARQ BRAS MED VET ZOO, V66, P609, DOI 10.1590/1678-41626212; Genelhu MCLS, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-218; Gorter A, 2010, MODERN PATHOL, V23, P1605, DOI 10.1038/modpathol.2010.154; Hernandez D, 2011, J BIOL CHEM, V286, P1475, DOI 10.1074/jbc.M110.127522; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Kamdje AHN, 2014, CELL SIGNAL, V26, P2843, DOI 10.1016/j.cellsig.2014.07.034; Kischel P, 2010, INT J CANCER, V126, P640, DOI 10.1002/ijc.24812; Latta EK, 2002, MODERN PATHOL, V15, P1318, DOI 10.1097/01.MP.0000038462.62634.B1; Lavalle GE, 2009, VET PATHOL, V46, P1275, DOI 10.1354/vp.08-VP-0226-C-FL; Lee HC, 2015, ONCOTARGET, V6, P42976, DOI 10.18632/oncotarget.5621; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; MISDORP W, 1973, VET PATHOL, V10, P241, DOI 10.1177/030098587301000307; Misdorp W., 1999, WHO INTERNATIONAL HI, V7, P1; Owen L.N, 1980, WHO CLASSIFICATION T, P3; Ozturk M, 1998, ANAL CELL PATHOL, V16, P201; Reis JS, 2005, BREAST CANCER RES, V7, pR1028, DOI 10.1186/bcr1341; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Sassi F, 2008, J VET DIAGN INVEST, V20, P766, DOI 10.1177/104063870802000608; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Skandalis SS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-314; Suwiwat S, 2004, CLIN CANCER RES, V10, P2491, DOI 10.1158/1078-0432.CCR-03-0146; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Viale G, 2016, BREAST CANCER RES TR, V155, P463, DOI 10.1007/s10549-016-3690-6; Ween MP, 2011, INT J MOL SCI, V12, P1009, DOI 10.3390/ijms12021009; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wu YJ, 2004, J CELL SCI, V117, P2227, DOI 10.1242/jcs.01057; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751	42	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160419	10.1371/journal.pone.0160419	http://dx.doi.org/10.1371/journal.pone.0160419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490467	gold, Green Submitted, Green Published			2022-12-27	WOS:000381368900055
J	Montezuma-Rusca, JM; Powers, JH; Follmann, D; Wang, J; Sullivan, B; Williamson, PR				Montezuma-Rusca, Jairo M.; Powers, John H.; Follmann, Dean; Wang, Jing; Sullivan, Brigit; Williamson, Peter R.			Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence	PLOS ONE			English	Review							LIPOSOMAL AMPHOTERICIN-B; HIGH-DOSE FLUCONAZOLE; RANDOMIZED-TRIAL; PLUS FLUCYTOSINE; AIDS PATIENTS; HIV; COMBINATION; THERAPY; ASSOCIATION; BIOMARKERS	Background Cryptococcal meningitis ( CM) is a leading cause of HIV-associated mortality. In clinical trials evaluating treatments for CM, biomarkers of early fungicidal activity (EFA) in cerebrospinal fluid (CSF) have been proposed as candidate surrogate endpoints for all-cause mortality (ACM). However, there has been no systematic evaluation of the group-level or trial-level evidence for EFA as a candidate surrogate endpoint for ACM. Methods We conducted a systematic review of randomized trials in treatment of CM to evaluate available evidence for EFA measured as culture negativity at 2 weeks/10 weeks and slope of EFA as candidate surrogate endpoints for ACM. We performed sensitivity analysis on superiority trials and high quality trials as determined by Cochrane measures of trial bias. Results Twenty-seven trials including 2854 patients met inclusion criteria. Mean ACM was 15.8% at 2 weeks and 27.0% at 10 weeks with no overall significant difference between test and control groups. There was a statistically significant group-level correlation between average EFA and ACM at 10 weeks but not at 2 weeks. There was also no statistically significant group-level correlation between CFU culture negativity at 2weeks/10weeks or average EFA slope at 10 weeks. A statistically significant trial-level correlation was identified between EFA slope and ACM at 2 weeks, but is likely misleading, as there was no treatment effect on ACM. Conclusions Mortality remains high in short time periods in CM clinical trials. Using published data and Institute of Medicine criteria, evidence for use of EFA as a surrogate endpoint for ACM is insufficient and could provide misleading results from clinical trials. ACM should be used as a primary endpoint evaluating treatments for cryptococcal meningitis.	[Montezuma-Rusca, Jairo M.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Powers, John H.; Wang, Jing] Leidos Biomed Res Inc, Clin Res Directorate, Clin Monitoring Res Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Follmann, Dean] NIAID, Math Statisticians, Biostat Res Branch, NIH, Bethesda, MD 20892 USA; [Sullivan, Brigit] NIH, Natl Inst Hlth Lib, Off Res Serv, Bethesda, MD 20892 USA; [Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Williamson, PR (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	williamsonpr@mail.nih.gov		Powers III, John H/0000-0002-5150-5119	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Institutes of Allergy and Infectious Diseases [NIH AI001123, AI001124-PRW]; Leidos Biomedical Research under the FFRDC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001124] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Institutes of Allergy and Infectious Diseases; Leidos Biomedical Research under the FFRDC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JHP works for Leidos Biomedical Research under the FFRDC contract and receives compensation in the form of salary. Leidos Biomedical Research is a FFRDC (Federally Funded Research and Development Contractor) to NIH and is a fully separate subsidiary of corporate Leidos Inc. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health (Contract No. HHSN261200800001E). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. This project was also supported by the Intramural Research Program of the NIH, National Institutes of Allergy and Infectious Diseases (NIH AI001123, AI001124-PRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams P, 2016, NEWSWEEK; Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Bicanic T, 2008, CLIN INFECT DIS, V47, P123, DOI 10.1086/588792; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bisson GP, 2013, CLIN INFECT DIS, V56, P1165, DOI 10.1093/cid/cit019; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Buyse M, 2008, STAT METHODS MED RES, V17, P467, DOI 10.1177/0962280207081864; Casadevall A, 2014, NATURE, V516, P165, DOI 10.1038/516165a; Chotmongkol Verajit, 1997, Journal of the Medical Association of Thailand, V80, P416; Chotmongkol Verajit, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P170; Cohn DL, 1999, CLIN INFECT DIS, V29, P125, DOI 10.1086/520141; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; DEGANS J, 1992, AIDS, V6, P185, DOI 10.1097/00002030-199202000-00007; DISMUKES WE, 1987, NEW ENGL J MED, V317, P334, DOI 10.1056/NEJM198708063170602; Evans SR, 2015, CLIN INFECT DIS, V61, P800, DOI 10.1093/cid/civ495; Fay MP, 2001, BIOMETRICS, V57, P1198, DOI 10.1111/j.0006-341X.2001.01198.x; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Hamill RJ, 2010, CLIN INFECT DIS, V51, P225, DOI 10.1086/653606; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Institute of Medicine, 2010, EVALUATION OF BIOMAR; Jackson AT, 2012, AIDS, V26, P1363, DOI 10.1097/QAD.0b013e328354b419; Jadhav MP, 2010, J POSTGRAD MED, V56, P14, DOI 10.4103/0022-3859.65276; Jarvis JN, 2012, AIDS, V26, P1105, DOI 10.1097/QAD.0b013e3283536a93; Kim S, 2000, AIDS RES HUM RETROV, V16, P645, DOI 10.1089/088922200308873; Korn EL, 2016, ANN ONCOL, V27, P10, DOI 10.1093/annonc/mdv507; LARSEN RA, 1990, ANN INTERN MED, V113, P183, DOI 10.7326/0003-4819-113-3-183; Lassere MN, 2008, STAT METHODS MED RES, V17, P303, DOI 10.1177/0962280207082719; Leenders ACAP, 1997, AIDS, V11, P1463, DOI 10.1097/00002030-199712000-00010; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Mayanja-Kizza H, 1998, CLIN INFECT DIS, V26, P1362, DOI 10.1086/516372; Montezuma-Rusca Jairo Mauricio, 2014, Curr Treat Options Infect Dis, V6, P326; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Pappas PG, 2004, J INFECT DIS, V189, P2185, DOI 10.1086/420829; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Pyrgos V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056269; Rhein J BD, 2012, NEUROBEHAVIORAL HIV, V2012, P45; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Sharkey PK, 1996, CLIN INFECT DIS, V22, P315, DOI 10.1093/clinids/22.2.315; Tansuphaswadikul Somsit, 2006, Journal of the Medical Association of Thailand, V89, P1677; Techapornroong M, 2007, SCAND J INFECT DIS, V39, P896, DOI 10.1080/00365540701383147; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103	48	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159727	10.1371/journal.pone.0159727	http://dx.doi.org/10.1371/journal.pone.0159727			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490100	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900015
J	Vilela, BS; Vasques, ACJ; Cassani, RSL; Forti, ACE; Pareja, JC; Tambascia, MA; Geloneze, B				Vilela, Brunna Sullara; Junqueira Vasques, Ana Carolina; Lara Cassani, Roberta Soares; Costa e Forti, Adriana; Pareja, Jose Carlos; Tambascia, Marcos Antonio; Geloneze, Bruno		BRAMS Investigators	The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS)	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; PLASMA; SENSITIVITY; POPULATION; PREDICTOR	Background The major adverse consequences of obesity are associated with the development of insulin resistance (IR) and adiposopathy. The Homeostasis Model Assessment-Adiponectin (HOMA-AD) was proposed as a modified version of the HOMA1-IR, which incorporates adiponectin in the denominator of the index. Objectives To evaluate the performance of the HOMA-AD index compared with the HOMA1-IR index as a surrogate marker of IR in women, and to establish the cutoff value of the HOMA-AD. Subjects/Methods The Brazilian Metabolic Syndrome Study (BRAMS) is a cross-sectional multicenter survey. The data from 1,061 subjects met the desired criteria: 18-65 years old, BMI: 18.5-49.9 Kg/m(2) and without diabetes. The IR was assessed by the indexes HOMA1-IR and HOMA-AD (total sample) and by the hyperglycemic clamp(n = 49). Metabolic syndrome was defined using the IDF criteria. Results For the IR assessed by the clamp, the HOMA-AD demonstrated a stronger coefficient of correlation (r = -0.64) compared with the HOMA1-IR (r = -0.56); p < 0.0001. In the ROC analysis, compared with the HOMA1-IR, the HOMA-AD showed higher values of the AUC for the identification of IR based on the clamp test (AUC: 0.844 vs. AUC: 0.804) and on the metabolic syndrome (AUC: 0.703 vs. AUC: 0.689), respectively; p < 0.001 for all. However, the pairwise comparison did not show evidence of superiority for the HOMA-AD in comparison with the HOMA1-IR in the diagnosis of IR and metabolic syndrome (p > 0.05). The optimal cutoff identified for the HOMA-AD for the diagnosis of IR was 0.95. Conclusions The HOMA-AD index was demonstrated to be a useful surrogate marker for detecting IR among adult women and presented a similar performance compared with the HOMA1-IR index. These results may assist physicians and researchers in determining which method to use to evaluate IR in light of the available facilities.	[Vilela, Brunna Sullara; Junqueira Vasques, Ana Carolina; Lara Cassani, Roberta Soares; Pareja, Jose Carlos; Geloneze, Bruno] Univ Estadual Campinas, Gastroctr, LIMED, Campinas, SP, Brazil; [Junqueira Vasques, Ana Carolina] Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil; [Costa e Forti, Adriana] Univ Fed Ceara, Dept Endocrinol, Fortaleza, Ceara, Brazil; [Tambascia, Marcos Antonio] Univ Estadual Campinas, Dept Endocrinol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal do Ceara; Universidade Estadual de Campinas	Geloneze, B (corresponding author), Univ Estadual Campinas, Gastroctr, LIMED, Campinas, SP, Brazil.	bgeloneze@terra.com.br	Geloneze, Bruno/F-4231-2010; LIMA, MARCELO MIRANDA DE OLIVEIRA/AAT-5828-2020	Geloneze, Bruno/0000-0002-0557-4578; LIMA, MARCELO MIRANDA DE OLIVEIRA/0000-0002-0911-7585; Vasques, Ana Carolina Junqueira/0000-0001-9222-1107; Vilela, Brunna/0000-0002-4096-8337	National Counsel of Technological and Scientific Development (CNPq) [563664/2010-0]; Sao Paulo Research Foundation - FAPESP [2013/06195-8]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the National Counsel of Technological and Scientific Development (CNPq), process n. 563664/2010-0 and the Sao Paulo Research Foundation - FAPESP, grant n. 2013/06195-8 (http://www.bv.fapesp.br/pt/pesquisa/?sort=-data_inicio&q2=%28id_pesquisador_exact%3A669412%29+AND+%28%28bolsa_exact%3A%22Bolsas+no+Brasil%22+AND+situacao_exact%3A%22Conclu%C3%ADdos%22%29%29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2014, DIABETES CARE, V37; Bays HE, 2009, AM J MED S, V122, P015; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Geloneze B, 2006, DIABETES RES CLIN PR, V72, P219, DOI 10.1016/j.diabres.2005.10.017; Geloneze B, 2009, ARQ BRAS ENDOCRINOL, V53, P281, DOI 10.1590/S0004-27302009000200020; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hung AM, 2011, CLIN J AM SOC NEPHRO, V6, P767, DOI 10.2215/CJN.08070910; Vasques ACJ, 2013, METABOLISM, V62, P1032, DOI 10.1016/j.metabol.2013.01.022; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Makni E, 2012, ANN ENDOCRINOL-PARIS, V73, P26, DOI 10.1016/j.ando.2011.12.002; Matsuhisa M, 2007, DIABETES RES CLIN PR, V77, P151, DOI 10.1016/j.diabres.2006.10.005; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menzaghi C, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0130-y; Michalczuk Matheus Truccolo, 2012, Int J Hepatol, V2012, P576584, DOI 10.1155/2012/576584; MITRAKOU A, 1992, J CLIN ENDOCR METAB, V75, P379, DOI 10.1210/jc.75.2.379; Pittas AG, 2004, J CLIN ENDOCR METAB, V89, P447, DOI 10.1210/jc.2003-031005; Seino Y, 2009, METABOLISM, V58, P355, DOI 10.1016/j.metabol.2008.10.008; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yadav A, 2013, CLIN CHIM ACTA, V417, P80, DOI 10.1016/j.cca.2012.12.007	21	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0158751	10.1371/journal.pone.0158751	http://dx.doi.org/10.1371/journal.pone.0158751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490249	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900008
J	Gao, Y; Jiang, LH; Wang, H; Yu, CS; Wang, WJ; Liu, SF; Gao, CL; Tong, XG; Wang, JH; Jin, Y; Wu, JL				Gao, Yuan; Jiang, Lihong; Wang, Hui; Yu, Changshen; Wang, Wanjun; Liu, Shoufeng; Gao, Chunlin; Tong, Xiaoguang; Wang, Jinhuan; Jin, Yi; Wu, Jialing			Association between Elevated Hemoglobin A1c Levels and the Outcomes of Patients with Small-Artery Occlusion: A Hospital-Based Study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; GLYCATED HEMOGLOBIN; DIABETES-MELLITUS; LACUNAR STROKE; GLUCOSE LEVEL; RISK-FACTORS; HYPERGLYCEMIA; SUBTYPES; MANAGEMENT; PREDICTOR	Introduction Abnormal glucose metabolism is an independent risk factor for poor outcome following acute ischemic stroke. However, the relationship between initial hemoglobin A1c level and functional outcome (defined by modified Rankin Scale scores) following small-artery occlusion, a subtype of ischemic stroke, is unknown. The aim of the present study was to evaluate this association among patients diagnosed with small-artery occlusion. Materials and Methods Data on 793 patients diagnosed with small-artery occlusion from October 25, 2012 to June 30, 2015 were collected from the stroke registry of the Department of Neurorehabilitation of HuanHu Hospital. Hemoglobin A1c values at admission were classified into three groups according to tertiles (<5.9,5.9to<6.7, and >= 6.7). We used receiver operating characteristics curves to investigate the predictive value of hemoglobin A1c and examined the relationship between hemoglobin A1c levels at admission and modified Rankin Scale scores using univariate and multivariate analyses. Results The area under the curve was 0.570 (95%CI, 0.509-0.631; P = 0.023). Patients in the highest HbA1c stratification (>= 6.7) had a significantly higher risk of an unfavorable outcome than patients in the lowest stratification (<5.9; adjusted odds ratio, 2.099; 95%CI, 1.160-3.798; P = 0.014). However, a significant association was not seen in the middle stratification (5.9 to <6.7; P = 0.115). Conclusions Elevated hemoglobin A1c level on admission was adversely associated with functional outcomes 3 months after stroke onset among patients presenting with small-artery occlusion.	[Gao, Yuan; Jiang, Lihong; Wang, Hui; Yu, Changshen; Wang, Wanjun; Liu, Shoufeng; Gao, Chunlin; Wu, Jialing] Tianjin Huanhu Hosp, Dept Neurol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China; [Tong, Xiaoguang; Wang, Jinhuan] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China; [Jin, Yi] Tianjin Huanhu Hosp, Dept Nursing, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China		Wu, JL (corresponding author), Tianjin Huanhu Hosp, Dept Neurol, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China.; Jin, Y (corresponding author), Tianjin Huanhu Hosp, Dept Nursing, Tianjin Key Lab Cerebrovasc & Neurodegenerat Dis, Tianjin, Peoples R China.	jinyi6196@163.com; wywjl2009@hotmail.com			Tianjin Public Health Bureau [2013KG122]; General Administration of Sport of China [2015B098]; Tianjin Municipal Science and Technology Commission [13JCYBJC23200, 13ZCZDSY01600]	Tianjin Public Health Bureau; General Administration of Sport of China; Tianjin Municipal Science and Technology Commission	This study was generously supported by grants from Tianjin Public Health Bureau (2013KG122) to J.W. (http://www.tjwsj.gov.cn), General Administration of Sport of China (2015B098) to J.W. (http://www.sport.gov.cn), and Tianjin Municipal Science and Technology Commission (13JCYBJC23200) to J.W. (http://www.tstc.gov.cn) and (13ZCZDSY01600) to X.T. (http://www.tstc.gov.cn).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Baird TA, 2002, J CLIN NEUROSCI, V9, P618, DOI 10.1054/jocn.2002.1081; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Bezerra DC, 2012, NEUROLOGY, V78, P102, DOI 10.1212/WNL.0b013e31823efc42; Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Fang Y, 2013, DIABETES VASC DIS RE, V10, P216, DOI 10.1177/1479164112459663; Garg R, 2006, STROKE, V37, P267, DOI 10.1161/01.STR.0000195175.29487.30; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Heo SH, 2010, CLIN NEUROL NEUROSUR, V112, P98, DOI 10.1016/j.clineuro.2009.08.024; Hjalmarsson C, 2014, STROKE RES TREAT, V2014, DOI 10.1155/2014/694569; Hu GC, 2012, EUR J NEUROL, V19, P884, DOI 10.1111/j.1468-1331.2011.03647.x; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jia Q, 2014, STROKE, V45, P1498, DOI 10.1161/STROKEAHA.113.002977; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Krishnamurti U, 2001, CLIN CHEM, V47, P1157; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Park JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044865; Roquer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109960; Shimoyama T, 2014, EUR J NEUROL, V21, P402, DOI 10.1111/ene.12280; Stead LG, 2009, NEUROCRIT CARE, V10, P181, DOI 10.1007/s12028-008-9080-0; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; WHO Task Force on Stroke and other Cerebrovascular Disorders, 1989, STROKE, V20, P1407, DOI DOI 10.1161/01.STR.20.10.1407; Wilterdink JL, 2001, STROKE, V32, P2836, DOI 10.1161/hs1201.099384; Wu SL, 2014, NEUROL RES, V36, P444, DOI 10.1179/1743132814Y.0000000355; Wu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080690; Zhou Heng, 2004, Zhonghua Nei Ke Za Zhi, V43, P495; Zsuga J, 2012, NEUROL RES, V34, P72, DOI 10.1179/1743132811Y.0000000062	31	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160223	10.1371/journal.pone.0160223	http://dx.doi.org/10.1371/journal.pone.0160223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486868	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800061
J	MacAulay, RK; Allaire, T; Brouillette, R; Foil, H; Bruce-Keller, AJ; Keller, JN				MacAulay, Rebecca K.; Allaire, Ted; Brouillette, Robert; Foil, Heather; Bruce-Keller, Annadora J.; Keller, Jeffrey N.			Apolipoprotein E Genotype Linked to Spatial Gait Characteristics: Predictors of Cognitive Dual Task Gait Change	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OLDER-ADULTS; DECLINE; BRAIN; DYSFUNCTION; RISK; DISABILITY; DISORDERS; DEMENTIA	Background Developing measures to detect preclinical Alzheimer's Disease is vital, as prodromal stage interventions may prove more efficacious in altering the disease's trajectory. Gait changes may serve as a useful clinical heuristic that precedes cognitive decline. This study provides the first systematic investigation of gait characteristics relationship with relevant demographic, physical, genetic (Apolipoprotein E genotype), and health risk factors in non-demented older adults during a cognitive-load dual task walking condition. Methods The GAITRite system provided objective measurement of gait characteristics in APOE-e4 "carriers" (n = 75) and "non-carriers" (n = 224). Analyses examined stride length and step time gait characteristics during simple and dual-task (spelling five-letter words backwards) conditions in relation to demographic, physical, genetic, and health risk factors. Results Slower step time and shorter stride length associated with older age, greater health risk, and worse physical performance (ps < .05). Men and women differed in height, gait characteristics, health risk factors and global cognition (ps < .05). APOE-e4 associated with a higher likelihood of hypercholesterolemia and overall illness index scores (ps < .05). No genotype-sex interactions on gait were found. APOE-e4 was linked to shorter stride length and greater dual-task related disturbances in stride length. Conclusions Stride length has been linked to heightened fall risk, attention decrements and structural brain changes in older adults. Our results indicate that stride length is a useful behavioral marker of cognitive change that is associated with genetic risk for AD. Sex disparities in motor decline may be a function of health risk factors.	[MacAulay, Rebecca K.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [MacAulay, Rebecca K.; Allaire, Ted; Brouillette, Robert; Foil, Heather; Bruce-Keller, Annadora J.; Keller, Jeffrey N.] Pennington Biomed Res Ctr LSU, Inst Dementia Res & Prevent, Baton Rouge, LA 70808 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	MacAulay, RK (corresponding author), Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA.; MacAulay, RK (corresponding author), Pennington Biomed Res Ctr LSU, Inst Dementia Res & Prevent, Baton Rouge, LA 70808 USA.	rkmacaulay@gmail.com	Bruce-Keller, Annadora/N-1954-2017; Allaire, Ted/V-1878-2019; Keller, Jeffrey N/N-1975-2017	MacAulay, Rebecca/0000-0002-7985-998X; keller, jeffrey/0000-0002-9892-7423	Institute for Dementia Research and Prevention	Institute for Dementia Research and Prevention	The funding sources for this study are the Hibernia National Bank/Edward G Schlieder Chair and supporters of the Institute for Dementia Research and Prevention (PI: Jeffrey N. Keller). The funders of this manuscript had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the community supporters and participants of the Institute for Dementia Research and Prevention.	Albers MW, 2015, ALZHEIMERS DEMENT, V11, P70, DOI 10.1016/j.jalz.2014.04.514; Allali G, 2007, GAIT POSTURE, V26, P572, DOI 10.1016/j.gaitpost.2006.12.011; Allali G, 2016, J GERONTOL A-BIOL, V71, P378, DOI 10.1093/gerona/glv092; Andersen MM, 2015, J GERONTOL A-BIOL, V70, P545, DOI 10.1093/gerona/glu085; Annweiler C, 2012, PANMINERVA MED, V54, P189; Annweiler C, 2013, BRAIN, V136, P859, DOI 10.1093/brain/aws373; Annweiler C, 2012, AM J ALZHEIMERS DIS, V27, P371, DOI 10.1177/1533317512454710; [Anonymous], GAITRITE ELECT WALKW; Beauchet O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099318; Beauchet Olivier, 2008, Neuropsychiatr Dis Treat, V4, P155; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Bolandzadeh N, 2014, NEUROIMAGE, V99, P7, DOI 10.1016/j.neuroimage.2014.05.017; Buchman AS, 2009, ALZ DIS ASSOC DIS, V23, P63, DOI 10.1097/WAD.0b013e31818877b5; Callisaya ML, 2015, J GERONTOL A-BIOL, V70, P358, DOI 10.1093/gerona/glu148; Callisaya ML, 2013, J AM GERIATR SOC, V61, P1074, DOI 10.1111/jgs.12331; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hausdorff JM, 2008, J GERONTOL A-BIOL, V63, P1335, DOI 10.1093/gerona/63.12.1335; Hollman JH, 2007, GAIT POSTURE, V26, P113, DOI 10.1016/j.gaitpost.2006.08.005; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; MacAulay RK, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00034; MacAulay RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099436; Mufson Elliott J., 2000, Journal of Comparative Neurology, V427, P19, DOI 10.1002/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A; Rosso AL, 2015, J GERONTOL A-BIOL, V70, P317, DOI 10.1093/gerona/glu176; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sheridan PL, 2007, DEMENT GERIATR COGN, V24, P125, DOI 10.1159/000105126; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Verghese J, 2013, J GERONTOL A-BIOL, V68, P1395, DOI 10.1093/gerona/glt115; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wirths O, 2008, GENES BRAIN BEHAV, V7, P1, DOI 10.1111/j.1601-183X.2007.00373.x; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zimmerman ME, 2009, BRAIN RES, V1291, P73, DOI 10.1016/j.brainres.2009.07.043	33	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0156732	10.1371/journal.pone.0156732	http://dx.doi.org/10.1371/journal.pone.0156732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486898	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800002
J	Mokryn, O; Wagner, A; Blattner, M; Ruppin, E; Shavitt, Y				Mokryn, Osnat; Wagner, Allon; Blattner, Marcel; Ruppin, Eytan; Shavitt, Yuval			The Role of Temporal Trends in Growing Networks	PLOS ONE			English	Article							PREFERENTIAL ATTACHMENT; COMMUNITY STRUCTURE; ADVANTAGE; EMERGENCE; EVOLUTION	The rich get richer principle, manifested by the Preferential attachment (PA) mechanism, is widely considered one of the major factors in the growth of real-world networks. PA stipulates that popular nodes are bound to be more attractive than less popular nodes; for example, highly cited papers are more likely to garner further citations. However, it overlooks the transient nature of popularity, which is often governed by trends. Here, we show that in a wide range of real-world networks the recent popularity of a node, i.e., the extent by which it accumulated links recently, significantly influences its attractiveness and ability to accumulate further links. We proceed to model this observation with a natural extension to PA, named Trending Preferential Attachment (TPA), in which edges become less influential as they age. TPA quantitatively parametrizes a fundamental network property, namely the network's tendency to trends. Through TPA, we find that real-world networks tend to be moderately to highly trendy. Networks are characterized by different susceptibilities to trends, which determine their structure to a large extent. Trendy networks display complex structural traits, such as modular community structure and degree-assortativity, occurring regularly in real-world networks. In summary, this work addresses an inherent trait of complex networks, which greatly affects their growth and structure, and develops a unified model to address its interaction with preferential attachment.	[Mokryn, Osnat] Univ Haifa, Informat & Knowledge Management Dept, Haifa, Israel; [Wagner, Allon; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Wagner, Allon; Blattner, Marcel] Univ Appl Sci FFHS, Lab Web Sci, Zurich, Switzerland; [Wagner, Allon; Blattner, Marcel] Tamedia Zurich, Tamedia Digital Analyt, Zurich, Switzerland; [Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Shavitt, Yuval] Tel Aviv Univ, Sch Elect Engn, Tel Aviv, Israel	University of Haifa; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Mokryn, O (corresponding author), Univ Haifa, Informat & Knowledge Management Dept, Haifa, Israel.	ossimo@gmail.com	Shavitt, Yuval/GPW-8557-2022; Ruppin, Eytan/R-9698-2017; Shavitt, Yuval/S-5968-2019	Ruppin, Eytan/0000-0002-7862-3940; Shavitt, Yuval/0000-0002-0701-2405; Mokryn, Osnat/0000-0002-1241-9015; Wagner, Allon/0000-0001-5095-6009	Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Edmond J. Safra Center for Bioinformatics at Tel Aviv University	AW was supported by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. All other authors received no specific funding for this work.; The authors thank Daniel ben-Avraham, Alex Resnik, Moshe Mazuz, Amir Shavitt, Raphy Zarecki, and Isaac Meilijson for their assistance in various phases of this manuscript. AW was supported by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University.	ACKLEY DH, 1985, COGNITIVE SCI, V9, P147; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bianconi G, 2001, EUROPHYS LETT, V54, P436, DOI 10.1209/epl/i2001-00260-6; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Cusumano MA, 2010, COMMUN ACM, V53, P22, DOI 10.1145/1831407.1831418; DENISON EDWARD F., 1985, TRENDS AM EC GROWTH; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Eom YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024926; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gruger W., 2012, BILLBOARDBIZ     DEC; Kampf M, 2012, PHYSICA A, V391, P6101, DOI 10.1016/j.physa.2012.07.004; Lehmann S., 2005, Computational & Mathematical Organization Theory, V11, P161, DOI 10.1007/s10588-005-3942-1; Lehoucq R.B., 1998, ARPACK USERS GUIDE S, V6; Mathioudakis M., 2010, P 2010 ACM SIGMOD IN, P1155, DOI DOI 10.1145/1807167.1807306; Medo M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.238701; Mokryn O, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P1089, DOI 10.1145/2740908.2744716; Newman M., 2013, ARXIV13108220; Newman M., 2011, STRUCTURE DYNAMICS N; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/68001; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; PRICE DJD, 1976, J AM SOC INFORM SCI, V27, P292, DOI 10.1002/asi.4630270505; Redner, 2004, PHYSICS0407137 ARXIV; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Shavitt Y, 2012, P 4 ANN WORKSH SIMPL, P13; Sitaram A., 2011, ICWSM, P434; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang MY, 2008, PHYSICA A, V387, P4692, DOI 10.1016/j.physa.2008.03.017; Wang MY, 2009, PHYSICA A, V388, P4273, DOI 10.1016/j.physa.2009.05.008; Wu Y, 2014, J INFORMETR, V8, P650, DOI 10.1016/j.joi.2014.06.002; Zink M, 2009, COMPUT NETW, V53, P501, DOI 10.1016/j.comnet.2008.09.022	39	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0156505	10.1371/journal.pone.0156505	http://dx.doi.org/10.1371/journal.pone.0156505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486847	Green Submitted, gold, Green Published			2022-12-27	WOS:000381367800001
J	Shrestha, SS; Thompson, TJ; Kirtland, KA; Gregg, EW; Beckles, GL; Luman, ET; Barker, LE; Geiss, LS				Shrestha, Sundar S.; Thompson, Theodore J.; Kirtland, Karen A.; Gregg, Edward W.; Beckles, Gloria L.; Luman, Elizabeth T.; Barker, Lawrence E.; Geiss, Linda S.			Changes in Disparity in County-Level Diagnosed Diabetes Prevalence and Incidence in the United States, between 2004 and 2012	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; EMPIRICAL-EVIDENCE; RISK-FACTORS; LIFE-STYLE; US; CONVERGENCE; POPULATION; OBESITY; ADULTS; TRENDS	Background In recent decades, the United States experienced increasing prevalence and incidence of diabetes, accompanied by large disparities in county-level diabetes prevalence and incidence. However, whether these disparities are widening, narrowing, or staying the same has not been studied. We examined changes in disparity among U.S. counties in diagnosed diabetes prevalence and incidence between 2004 and 2012. Methods We used 2004 and 2012 county-level diabetes (type 1 and type 2) prevalence and incidence data, along with demographic, socio-economic, and risk factor data from various sources. To determine whether disparities widened or narrowed over the time period, we used a regression-based beta-convergence approach, accounting for spatial autocorrelation. We calculated diabetes prevalence/incidence percentage point (ppt) changes between 2004 and 2012 and modeled these changes as a function of baseline diabetes prevalence/incidence in 2004. Covariates included county-level demographic and, socio-economic data, and known type 2 diabetes risk factors (obesity and leisure-time physical inactivity). Results For each county-level ppt increase in diabetes prevalence in 2004 there was an annual average increase of 0.02 ppt (p<0.001) in diabetes prevalence between 2004 and 2012, indicating a widening of disparities. However, after accounting for covariates, diabetes prevalence decreased by an annual average of 0.04 ppt (p<0.001). In contrast, changes in diabetes incidence decreased by an average of 0.04 ppt (unadjusted) and 0.09 ppt (adjusted) for each ppt increase in diabetes incidence in 2004, indicating a narrowing of county-level disparities. Conclusions County-level disparities in diagnosed diabetes prevalence in the United States widened between 2004 and 2012, while disparities in incidence narrowed. Accounting for demographic and, socio-economic characteristics and risk factors for type 2 diabetes narrowed the disparities, suggesting that these factors are strongly associated with changes in disparities. Public health interventions that target modifiable risk factors, such as obesity and physical inactivity, in high burden counties might further reduce disparities in incidence and, over time, in prevalence.	[Shrestha, Sundar S.; Thompson, Theodore J.; Kirtland, Karen A.; Gregg, Edward W.; Beckles, Gloria L.; Luman, Elizabeth T.; Barker, Lawrence E.; Geiss, Linda S.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Shrestha, SS (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA.	gqm2@cdc.gov		Gregg, Edward/0000-0003-2381-6822				Albright Ann, 2012, Diabetes Care Educ Newsl, V33, P4; Ali MK, 2012, HEALTH AFFAIR, V31, P67, DOI 10.1377/hlthaff.2011.1009; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., EXPLORING SPATIAL DA; Anselin L., 1998, SPATIAL ECONOMETRICS; Barker L, 2011, OPEN DIABETES J, V4, P123; Barker Lawrence E, 2013, J Data Sci, V11, P269; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Bernard AB, 1996, J ECONOMETRICS, V71, P161, DOI 10.1016/0304-4076(94)01699-2; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Cadwell BL., 2005, J DATA SCI, V8, P173; Center for Disease Control and Prevention, 2013, CRUD AG ADJ PERC CIV; Centers for Disease Control and Prevention, 2013, LEIS TIM PHYS IN PRE; Centers for Disease Control and Prevention, 2014, NATIONAL DIABETES ST; Centers for Disease Control and Prevention, 2013, DIAGN DIAB INC; Centers for Disease Control and Prevention, 2013, DIAGN DIAB PREV; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, 2013, OB PREV; Centers for Disease Control and Prevention, 2013, CRUD AG ADJ INC DIAG; Cleal B, 2014, DIABETIC MED, V31, P1559, DOI 10.1111/dme.12493; Gachter M, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-34; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Green C, 2003, SOC SCI MED, V57, P551, DOI 10.1016/S0277-9536(02)00380-5; Gregg E. W., 2009, Morbidity and Mortality Weekly Report, V58, P1259; Gregg EW, 2014, LANCET DIABETES ENDO, V2, P867, DOI 10.1016/S2213-8587(14)70161-5; Gregg EW, 2012, DIABETES CARE, V35, P1252, DOI 10.2337/dc11-1162; Jiang LH, 2013, DIABETES CARE, V36, P2027, DOI 10.2337/dc12-1250; Joseph J, 2010, SCAND J PUBLIC HEALT, V38, P768, DOI 10.1177/1403494810380299; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Leiter AM, 2012, EUR J HEALTH ECON, V13, P7, DOI 10.1007/s10198-010-0265-z; Liese AD, 2010, HEALTH PLACE, V16, P547, DOI 10.1016/j.healthplace.2009.12.015; Link CL, 2009, ETHNIC DIS, V19, P288; Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167; Pan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071474; Panopoulou E, 2013, HEALTH ECON, V22, P451, DOI 10.1002/hec.2816; Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410; Shrestha SS, 2012, OPEN DIABETES J, V5, P29, DOI DOI 10.2174/1876524601205010029; U. S. Census Bureau, 2013, SMALL AR INC POV EST; U. S. Department of Health and Human Services, 2010, ODPHP PUBL; United States Census Bureau, 2011, POPULATION ESTIMATES; United States Department of Agriculture, 2014, 2004 COUNT TYP COD; Wang ZJ, 2009, HEALTH ECON, V18, P55, DOI 10.1002/hec.1343; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4	45	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159876	10.1371/journal.pone.0159876	http://dx.doi.org/10.1371/journal.pone.0159876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487006	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800043
J	Singh, S; Doyle, P; Campbell, OM; Mathew, M; Murthy, GVS				Singh, Samiksha; Doyle, Pat; Campbell, Oona M.; Mathew, Manu; Murthy, G. V. S.			Referrals between Public Sector Health Institutions for Women with Obstetric High Risk, Complications, or Emergencies in India - A Systematic Review	PLOS ONE			English	Review							MATERNAL MORTALITY; UTTAR-PRADESH; CARE; COMMUNITY; DISTRICT; PREGNANCY; DEATH; DELIVERIES; FACILITIES; MORBIDITY	Emergency obstetric care (EmOC) within primary health care systems requires a linked referral system to be effective in reducing maternal death. This systematic review aimed to summarize evidence on the proportion of referrals between institutions during pregnancy and delivery, and the factors affecting referrals, in India. We searched 6 electronic databases, reviewed four regional databases and repositories, and relevant program reports from India published between 1994 and 2013. All types of study or reports (except editorials, comments and letters) which reported on institution-referrals (out-referral or in-referral) for obstetric care were included. Results were synthesized on the proportion and the reasons for referral, and factors affecting referrals. Of the 11,346 articles identified by the search, we included 232 articles in the full text review and extracted data from 16 studies that met our inclusion criteria Of the 16, one was RCT, seven intervention cohort (without controls), six cross-sectional, and three qualitative studies. Bias and quality of studies were reported. Between 25% and 52% of all pregnancies were referred from Sub-centres for antenatal high-risk, 14% to 36% from nurse run delivery or basic EmOC centres for complications or emergencies, and 2 to 7% were referred from doctor run basic EmOC centres for specialist care at comprehensive EmOC centres. Problems identified with referrals from peripheral health centres included low skills and confidence of staff, reluctance to induce labour, confusion over the clinical criteria for referral, non-uniform standards of care at referral institutions, a tendency to by-pass middle level institutions, a lack of referral communication and supervision, and poor compliance. The high proportion of referrals from peripheral health centers reflects the lack of appropriate clinical guidelines, processes, and skills for obstetric care and referral in India. This, combined with inadequate referral communication and low compliance, is likely to contribute to gaps and delays in the provision of emergency obstetric care.	[Singh, Samiksha; Murthy, G. V. S.] Publ Hlth Fdn India, Indian Inst Publ Hlth Hyderabad, Hyderabad, Telangana, India; [Doyle, Pat] London Sch Hyg & Trop Med, Fac EPH, Dept Noncommunicable Dis Epidemiol, London, England; [Campbell, Oona M.] London Sch Hyg & Trop Med, Fac EPH, Dept Infect Dis Epidemiol, London, England	Public Health Foundation of India; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Singh, S (corresponding author), Publ Hlth Fdn India, Indian Inst Publ Hlth Hyderabad, Hyderabad, Telangana, India.	samiksha.singh@iiphh.org		Campbell, Oona/0000-0002-9311-0115	Wellcome Trust Capacity Strengthening Strategic Award	Wellcome Trust Capacity Strengthening Strategic Award(Wellcome Trust)	This work was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C., 1998, HLTH DIMENSIONS SEX; Alehagen SA, 2012, RURAL REMOTE HEALTH, V12; Banerjee SK, 2012, INT J GYNECOL OBSTET, V118, pS113, DOI 10.1016/S0020-7292(12)60009-5; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Barnett Sarah, 2008, BMC Pregnancy Childbirth, V8, P6, DOI 10.1186/1471-2393-8-6; Barua A, 2003, REPROD HEALTH MATTER, V11, P140, DOI 10.1016/S0968-8080(03)02162-1; Biswas A B, 2004, Indian J Public Health, V48, P21; Biswas AB, 2005, J HEALTH POPUL NUTR, V23, P266; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chaturvedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096773; Das V, 2010, INT J GYNECOL OBSTET, V109, P72, DOI 10.1016/j.ijgo.2009.11.003; David KV, 2012, NATL MED J INDIA, V25, P323; Department of Public Health & Family Welfare, 2010, INN SHEM PROGR INT N; Fauveau V, 2006, INT J GYNECOL OBSTET, V93, P308, DOI 10.1016/j.ijgo.2006.01.031; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; George A, 2007, REPROD HEALTH MATTER, V15, P91, DOI 10.1016/S0968-8080(07)30318-2; Gupta M, 2009, THESIS; Hitesh J, 1996, J FAM WELFARE, V42, P24; Hussein J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001264; Interagency group for safe motherhood, 1997, SAF MOTH ACT AG PRIO; Iyengar K, 2009, REPROD HEALTH MATTER, V17, P9, DOI 10.1016/S0968-8080(09)33459-X; Jahn A, 1998, TROP MED INT HEALTH, V3, P926, DOI 10.1046/j.1365-3156.1998.00323.x; Jahn A, 2001, SAFE MOTHERHOOD STRA; Johnston HB, 2003, INT FAM PLAN PERSPEC, V29, P182, DOI 10.2307/3181047; Kaul Virochana, 2006, Indian J Med Sci, V60, P233; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kongnyuy EJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-190; Kowalewski M., 1998, CURARE, VSB15, P195; Kumutha J, 2015, SEMIN FETAL NEONAT M, V20, P326, DOI 10.1016/j.siny.2015.07.003; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Maitra K, 1995, Indian Pediatr, V32, P67; McCord C, 2001, INT J GYNECOL OBSTET, V75, P297, DOI 10.1016/S0020-7292(01)00526-4; McDonagh M, 1996, HEALTH POLICY PLANN, V11, P1, DOI 10.1093/heapol/11.1.1; MOHFW, 2014, RUR HLTH STAT IND 20; MOHFW, 2006, JAN SUR YOJ REV GUID; MOHFW, 2008, DIR INN IMPL HLTH SE; More NS, 2011, GLOB PUBLIC HEALTH, V6, P746, DOI 10.1080/17441692.2010.520725; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; NHSRC, 2011, PROGR EV JAN SUR YOJ; [NUHM MOHFW], 2013, NUHM IMPL FRAM; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Pasha O, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-215; Pasha O, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-82; Pembe AB, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-326; Raj SS, 2015, INT J HEALTH POLICY, V4, P99, DOI 10.15171/ijhpm.2015.14; Randive B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067452; Registrar General of India, 2014, SRS MAT MORT RAT B 2; Sharma K, 2011, INDIAN J MATERNAL CH, V13, P1; Singh S, 2015, MATERN CHILD HLTH J, V19, P1447, DOI 10.1007/s10995-015-1678-1; Strand R T, 2009, Afr J Reprod Health, V13, P75; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; UNFPA, 2011, CONC ASS JAN SUR YOJ; UNICEF, 2008, MAT PER DEATH INQ RE; UNICEF WHO UN Population Fund, 1997, GUID MON AV US OBST; Vanneste AM, 2000, HEALTH POLICY PLANN, V15, P1, DOI 10.1093/heapol/15.1.1; Vijayashree HY, 2012, BMC P S5, V6, P15, DOI [10.1186/1753-6561-6-S5-P15, DOI 10.1186/1753-6561-6-S5-P15]; Vora KS, 2009, J HEALTH POPUL NUTR, V27, P184, DOI 10.3329/jhpn.v27i2.3363; WHO, 1994, MOTH BAB PACK IMPL S; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	59	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159793	10.1371/journal.pone.0159793	http://dx.doi.org/10.1371/journal.pone.0159793			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486745	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000381367800039
J	Weston, KL; Azevedo, LB; Bock, S; Weston, M; George, KP; Batterham, AM				Weston, Kathryn L.; Azevedo, Liane B.; Bock, Susan; Weston, Matthew; George, Keith P.; Batterham, Alan M.			Effect of Novel, School-Based High-Intensity Interval Training (HIT) on Cardiometabolic Health in Adolescents: Project FFAB (Fun Fast Activity Blasts) - An Exploratory Controlled Before-And-After Trial	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; PHYSICAL-ACTIVITY; LOW-VOLUME; METABOLIC SYNDROME; LIPID-LEVELS; EXERCISE; FITNESS; INTERVENTIONS; CHILDREN; METAANALYSIS	Background Low-volume high-intensity interval training holds promise for cardiometabolic health promotion in adolescents, but sustainable interventions must be practical and engaging. We examined the effect of a school-based multi-activity low-volume high-intensity interval training intervention on adolescents' cardiometabolic health. Methods In an exploratory controlled before-and-after design, 101 adolescents (mean age +/- standard deviation [SD] 14.0 +/- 0.3 years) were recruited from four schools; two were designated as intervention sites (n = 41), and two as control (n = 60). The intervention comprised 4 to 7 repetitions of 45 s maximal effort exercise (basketball, boxing, dance and soccer drills) interspersed with 90-s rest, thrice weekly for 10 weeks. Outcomes were non-fasting blood lipids and glucose, waist circumference, high sensitivity C-reactive protein, resting blood pressure, physical activity, twenty-metre shuttle-run test performance and carotid artery intimamedia thickness. The difference in the change from baseline (intervention minus control) was estimated for each outcome. Using magnitude-based inferences, we calculated the probability that the true population effect was beneficial, trivial, and harmful against a threshold for the minimum clinically important difference of 0.2 between-subject SDs. Results and Discussion Mean (+/- SD) attendance for the intervention (expressed as percentage of available intervention sessions [n = 30]) was 77 +/- 13%. Post-intervention, there were likely beneficial effects for triglycerides (-26%; 90% confidence interval -46% to 0%), waist circumference (-3.9 cm; -6.1 cm to -1.6 cm) and moderate-to-vigorous physical activity (+16 min; -5 to 38 min), and a possibly beneficial effect for twenty-metre shuttle-run test performance (+5 shuttles; -1 to 11 shuttles) in intervention participants (vs controls). The role of elevated triglycerides and waist circumference in cardiovascular disease and metabolic syndrome development underlines the importance of our findings. We also demonstrated that school-based low-volume high-intensity interval training can be delivered as intended, thus representing a novel and scalable means of improving aspects of adolescents' cardiometabolic health.	[Weston, Kathryn L.; Azevedo, Liane B.; Batterham, Alan M.] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England; [Bock, Susan] Univ Durham, Sch Appl Social Sci, Durham, England; [Weston, Matthew] Univ Teesside, Sch Social Sci Business & Law, Middlesbrough, Cleveland, England; [George, Keith P.] Liverpool John Moores Univ, Res Inst Sport & Exercise Sci, Liverpool, Merseyside, England	University of Teesside; Durham University; University of Teesside; Liverpool John Moores University	Weston, KL (corresponding author), Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England.	k.weston@tees.ac.uk	Weston, Kathryn/AAB-3155-2020; Azevedo, Liane B/Q-4012-2016	Weston, Kathryn/0000-0001-5918-6389; Azevedo, Liane B/0000-0001-9966-9414; BATTERHAM, ALAN/0000-0002-7865-7227; Weston, Matthew/0000-0002-9531-3004	Fuse, the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research United Kingdom; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under United Kingdom Clinical Research Collaboration; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	Fuse, the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research United Kingdom(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under United Kingdom Clinical Research Collaboration; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was undertaken as part of a PhD studentship funded by Fuse, the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research United Kingdom, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, under the auspices of the United Kingdom Clinical Research Collaboration, is gratefully acknowledged.; The work was undertaken as part of a PhD studentship funded by Fuse, the Centre for Translational Research in Public Health, a UKCRC Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged.	Allison P. D., 2001, MISSING DATA SAGE U; Andersen Lars Bo, 2004, Int J Behav Nutr Phys Act, V1, P6, DOI 10.1186/1479-5868-1-6; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Biddle SJH, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0254-9; Boddy LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045755; Bond B, 2015, AM J PHYSIOL-HEART C, V309, pH1039, DOI 10.1152/ajpheart.00360.2015; Bond B, 2015, METABOLISM, V64, P1068, DOI 10.1016/j.metabol.2015.05.016; Buchan DS, 2011, SCAND J MED SCI SPOR, V21, pE341, DOI 10.1111/j.1600-0838.2011.01303.x; Buchan Duncan S, 2013, BMC Public Health, V13, P498, DOI 10.1186/1471-2458-13-498; Buchheit M, 2012, SPORTS MED, V42, P169, DOI 10.2165/11598230-000000000-00000; Carson V, 2014, INT J OBESITY, V38, P16, DOI 10.1038/ijo.2013.135; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Costigan S A, 2015, Prev Med Rep, V2, P973, DOI 10.1016/j.pmedr.2015.11.001; Costigan SA, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094490; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Craig R, 2009, HEALTH SURVEY FOR EN; Department for Communities and Local Government, 2011, ENGLISH INDICES DEPR; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Freese EC, 2011, J APPL PHYSIOL, V111, P1584, DOI 10.1152/japplphysiol.00416.2011; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Griffiths C, 2013, PUBLIC HEALTH, V127, P1090, DOI 10.1016/j.puhe.2013.09.020; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Hopkins WG, 2016, SPORTS MED, V46, P1563, DOI 10.1007/s40279-016-0517-x; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Krishnaveni R, 2015, J CLIN DIAGN RES, V9, pBC01, DOI 10.7860/JCDR/2015/16850.6870; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Lim JS, 2009, PEDIATR INT, V51, P263, DOI 10.1111/j.1442-200X.2008.02698.x; Little JP, 2011, J APPL PHYSIOL, V111, P1554, DOI 10.1152/japplphysiol.00921.2011; Logan GRM, 2014, SPORTS MED, V44, P1071, DOI 10.1007/s40279-014-0187-5; Logan GRM, 2016, MED SCI SPORT EXER, V48, P481, DOI 10.1249/MSS.0000000000000799; Martin R, 2015, BIOL SPORT, V32, P307, DOI 10.5604/20831862.1173644; McCarthy HD, 2001, EUR J CLIN NUTR, V55, P902, DOI 10.1038/sj.ejcn.1601240; McMurray RG, 2010, AM J LIFESTYLE MED, V4, P176, DOI 10.1177/1559827609351234; Milanovic Z, 2015, SPORTS MED, V45, P1339, DOI 10.1007/s40279-015-0361-4; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Murphy A, 2015, CLIN PEDIATR, V54, P87, DOI 10.1177/0009922814528038; Parikh P, 2009, AM J HEALTH PROMOT, V23, P279, DOI 10.4278/ajhp.071221140; Racil G, 2013, EUR J APPL PHYSIOL, V113, P2531, DOI 10.1007/s00421-013-2689-5; Ramsbottom R, 1988, Br J Sports Med, V22, P141; Rubin DB., 2004, MULTIPLE IMPUTATION; Ryley A, 2013, HLTH SURVEY ENGLAND, V1; Scholes S., 2012, HLTH SURV ENGL, V1, P1; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Shemesh T, 2006, CLIN CHIM ACTA, V367, P69, DOI 10.1016/j.cca.2005.11.014; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Taylor K.L., 2014, THESIS; Taylor KL, 2014, PLOS ONE, V10, DOI [10.1371/joural.pone.0125166268, 10.1111/j.1442-200X.2008.02698,x, DOI 10.1371/JOURNAL.PONE.0125166268.]; Thackray AE, 2013, MED SCI SPORT EXER, V45, P1277, DOI 10.1249/MSS.0b013e31828452c1; Treuth MS, 2003, MED SCI SPORT EXER, V35, P532, DOI 10.1249/01.MSS.0000053702.03884.3F; Trombold JR, 2013, J APPL PHYSIOL, V114, P792, DOI 10.1152/japplphysiol.01028.2012; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; Weston M, 2014, SPORTS MED, V44, P1005, DOI 10.1007/s40279-014-0180-z; Whyte LJ, 2010, METABOLISM, V59, P1421, DOI 10.1016/j.metabol.2010.01.002; Young DR, 2006, HEALTH EDUC BEHAV, V33, P97, DOI 10.1177/1090198105282444; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	62	47	50	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159116	10.1371/journal.pone.0159116	http://dx.doi.org/10.1371/journal.pone.0159116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486660	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000381367800018
J	Kawagoe, N; Kano, O; Kijima, S; Tanaka, H; Takayanagi, M; Urita, Y				Kawagoe, Naoyuki; Kano, Osamu; Kijima, Sho; Tanaka, Hideki; Takayanagi, Masaaki; Urita, Yoshihisa			Investigation of Metabolism of Exogenous Glucose at the Early Stage and Onset of Diabetes Mellitus in Otsuka Long-Evans Tokushima Fatty Rats Using [1, 2, 3-C-13] Glucose Breath Tests	PLOS ONE			English	Article							GLUCONEOGENESIS; HYPERPHAGIA; OBESITY	This study aimed to evaluate changes in glucose metabolism at the early stage and onset of diabetes in Otsuka Long-Evans Tokushima Fatty ( OLETF) rats. Specifically, after the oral administration of [1, 2, 3-C-13] glucose, the levels of exhaled (CO2)-C-13, which most likely originated from pyruvate decarboxylation and tricarboxylic acid, were measured. Eight OLETF rats and eight control rats ( Long-Evans Tokushima Otsuka [LETO]) were administered C-13-glucose. Three types of C-13-glucose breath tests were performed thrice in each period at 2-week intervals. [3-C-13] glucose results in a C-13 isotope at position 1 in the pyruvate molecule, which provides (CO2)-C-13. The C-13 at carbons 1 and 2 of glucose is converted to C-13 at carbons 2 and 1 of acetate, respectively, which produce (CO2)-C-13. Based on metabolic differences of the labeled sites, glucose metabolism was evaluated using the results of three breath tests. The increase in (CO2)-C-13 excretion in OLETF rats was delayed in all three breath tests compared to that in control rats, suggesting that OLETF rats had a lower glucose metabolism than control rats. In addition, overall glucose metabolism increased with age in both groups. The utilization of [2-C-13] glucose was suppressed in OLETF rats at 6-12 weeks of age, but they showed higher [3-C-13] glucose oxidation than control rats at 22-25 weeks of age. In the [1-C-13] glucose breath test, no significant differences in the area under the curve until 180 minutes (AUC(180)) were observed between OLETF and LETO rats of any age. Glucose metabolism kinetics were different between the age groups and two groups of rats; however, these differences were not significant based on the overall AUC(180) of [1-C-13] glucose. We conclude that breath (CO2)-C-13 excretion is reduced in OLETF rats at the primary stage of prediabetes, indicating differences in glucose oxidation kinetics between OLETF and LETO rats.	[Kawagoe, Naoyuki; Kijima, Sho; Tanaka, Hideki; Urita, Yoshihisa] Toho Univ, Omori Hosp, Sch Med, Dept Gen Med & Emergency Care,Ota Ku, Tokyo, Japan; [Kawagoe, Naoyuki; Kijima, Sho; Tanaka, Hideki] Toho Univ, Grad Sch Med, Dept Gen Med & Emergency Care, Ota Ku, Tokyo, Japan; [Kano, Osamu] Toho Univ, Dept Neurol, Sch Med, Omori Hosp,Ota Ku, Tokyo, Japan; [Takayanagi, Masaaki] Toho Univ, Sch Med, Dept Anat, Ota Ku, Tokyo, Japan		Kawagoe, N (corresponding author), Toho Univ, Omori Hosp, Sch Med, Dept Gen Med & Emergency Care,Ota Ku, Tokyo, Japan.; Kawagoe, N (corresponding author), Toho Univ, Grad Sch Med, Dept Gen Med & Emergency Care, Ota Ku, Tokyo, Japan.	naoyuki.kawagoe@med.toho-u.ac.jp		Kawagoe, Naoyuki/0000-0001-8644-8583				Bi S, 2005, ENDOCRINOLOGY, V146, P1676, DOI 10.1210/en.2004-1441; Bi S, 2001, AM J PHYSIOL-REG I, V281, pR254, DOI 10.1152/ajpregu.2001.281.1.R254; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; FUNAKOSHI A, 1994, BIOCHEM BIOPH RES CO, V199, P482, DOI 10.1006/bbrc.1994.1254; Ghosh C, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/3/036001; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; LACROIX M, 1973, SCIENCE, V181, P444, DOI 10.1126/science.181.4098.445; Moran TH, 1992, AM J PHYSIOL, V272, pR46; ORahilly S, 1997, BRIT MED J, V314, P955, DOI 10.1136/bmj.314.7085.955; RUDERMAN NB, 1968, AM J PHYSIOL, V214, P1346, DOI 10.1152/ajplegacy.1968.214.6.1346; Ruzzin J, 2003, J APPL PHYSIOL, V95, P477, DOI 10.1152/japplphysiol.00095.2003; Salas-Fernandez A, 2015, CLIN CHEM LAB MED, V53, P133, DOI 10.1515/cclm-2014-0412; Tajima N, 2015, DIABETOL INT, V6, P151, DOI 10.1007/s13340-015-0206-2; Uchida M, 2005, J PHARMACOL SCI, V98, P388, DOI 10.1254/jphs.FP0050153; Urita Y, 2002, J GASTROENTEROL, V37, P442, DOI 10.1007/s005350200064	16	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160177	10.1371/journal.pone.0160177	http://dx.doi.org/10.1371/journal.pone.0160177			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483133	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700026
J	Lunn, J; Donovan, T; Litchfield, D; Lewis, C; Davies, R; Crawford, T				Lunn, Judith; Donovan, Tim; Litchfield, Damien; Lewis, Charlie; Davies, Robert; Crawford, Trevor			Saccadic Eye Movement Abnormalities in Children with Epilepsy	PLOS ONE			English	Article							INHIBITORY CONTROL; REACTION-TIME; LATER MODEL; TASK; PERFORMANCE; VOLUNTARY; ATTENTION; ANTISACCADES; DEFINITION; MATURATION	Childhood onset epilepsy is associated with disrupted developmental integration of sensorimotor and cognitive functions that contribute to persistent neurobehavioural comorbidities. The role of epilepsy and its treatment on the development of functional integration of motor and cognitive domains is unclear. Oculomotor tasks can probe neurophysiological and neurocognitive mechanisms vulnerable to developmental disruptions by epilepsy-related factors. The study involved 26 patients and 48 typically developing children aged 8-18 years old who performed a prosaccade and an antisaccade task. Analyses compared medicated chronic epilepsy patients and unmedicated controlled epilepsy patients to healthy control children on saccade latency, accuracy and dynamics, errors and correction rate, and express saccades. Patients with medicated chronic epilepsy had impaired and more variable processing speed, reduced accuracy, increased peak velocity and a greater number of inhibitory errors, younger unmedicated patients also showed deficits in error monitoring. Deficits were related to reported behavioural problems in patients. Epilepsy factors were significant predictors of oculomotor functions. An earlier age at onset predicted reduced latency of prosaccades and increased express saccades, and the typical relationship between express saccades and inhibitory errors was absent in chronic patients, indicating a persistent reduction in tonic cortical inhibition and aberrant cortical connectivity. In contrast, onset in later childhood predicted altered antisaccade dynamics indicating disrupted neurotransmission in frontoparietal and oculomotor networks with greater demand on inhibitory control. The observed saccadic abnormalities are consistent with a dysmaturation of subcortical-cortical functional connectivity and aberrant neurotransmission. Eye movements could be used to monitor the impact of epilepsy on neurocognitive development and help assess the risk for poor neurobehavioural outcomes.	[Lunn, Judith; Lewis, Charlie; Davies, Robert; Crawford, Trevor] Univ Lancaster, Dept Psychol, Lancaster, England; [Donovan, Tim] Univ Cumbria, Ctr Med Imaging, Lancaster, England; [Litchfield, Damien] Edge Hill Univ, Dept Psychol, Ormskirk, England	Lancaster University; University of Cumbria; Edge Hill University	Lunn, J (corresponding author), Univ Lancaster, Dept Psychol, Lancaster, England.	j.lunn1@lancaster.ac.uk	Donovan, Tim/AAF-3563-2019; Crawford, Trevor J/N-4237-2015	Crawford, Trevor J/0000-0001-5928-7307; Litchfield, Damien/0000-0001-7760-293X; Davies, Robert Aye Imanol/0000-0002-7783-9782; Donovan, Tim/0000-0003-4112-861X; Lewis, Charlie/0000-0001-9883-7893	Interdisciplinary Medical Research Council (MRC); Economic and Social Research Council (ESRC) PhD Studentship [ES/F010141/1]; Department of Child Neurology, Preston; Paediatrics, Royal Blackburn Hospital, East Lancashire NHS Health Care Trust; Lancashire Care NHS Foundation Trust	Interdisciplinary Medical Research Council (MRC); Economic and Social Research Council (ESRC) PhD Studentship; Department of Child Neurology, Preston; Paediatrics, Royal Blackburn Hospital, East Lancashire NHS Health Care Trust; Lancashire Care NHS Foundation Trust	This work was supported by an Interdisciplinary Medical Research Council (MRC) and Economic and Social Research Council (ESRC) PhD Studentship awarded to Judith Lunn (award number ES/F010141/1). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge the involvement and support of the Department of Child Neurology, Preston, Lancashire Care NHS Foundation Trust and Paediatrics, Royal Blackburn Hospital, East Lancashire NHS Health Care Trust.	Achenbach T. M., 2001, MANUAL ACHENBACH SYS; Antoniades C, 2013, VISION RES, V84, P1, DOI 10.1016/j.visres.2013.02.007; Asato MR, 2011, EPILEPSIA, V52, P377, DOI 10.1111/j.1528-1167.2010.02787.x; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Bedi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068613; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BRUHN P, 1977, CORTEX, V13, P373, DOI 10.1016/S0010-9452(77)80018-X; Bucci MP, 2012, EXP BRAIN RES, V222, P21, DOI 10.1007/s00221-012-3192-7; Chandna A, 2012, CEPHALALGIA; Di Stasi LL, 2013, NEUROSCI BIOBEHAV R, V37, P968, DOI 10.1016/j.neubiorev.2013.03.011; Eddy Clare M, 2011, Ther Adv Neurol Disord, V4, P385, DOI 10.1177/1756285611417920; Everling S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0068; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Grefkes C, 2010, CEREB CORTEX, V20, P783, DOI 10.1093/cercor/bhp144; Halliday J, 2010, PERCEPTION, V39, P41, DOI 10.1068/p6547; Heath M, 2010, EXP BRAIN RES, V203, P743, DOI 10.1007/s00221-010-2290-7; Helmstaedter C, 2008, EPILEPSY BEHAV, V13, P642, DOI 10.1016/j.yebeh.2008.07.012; Hermann B, 2008, LANCET NEUROL, V7, P151, DOI 10.1016/S1474-4422(08)70018-8; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Kellermann TS, 2015, CORTEX, V66, P1, DOI 10.1016/j.cortex.2015.02.001; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Lo CN, 2008, EPILEPSY RES, V78, P93, DOI 10.1016/j.eplepsyres.2007.11.004; Luna B, 2004, CHILD DEV, V75, P1357, DOI 10.1111/j.1467-8624.2004.00745.x; Lunn J, 2015, EPILEPSY BEHAV, V43, P109, DOI 10.1016/j.yebeh.2014.11.010; Marino RA, 2015, J NEUROPHYSIOL, V114, P879, DOI 10.1152/jn.00047.2015; Michel F, 2009, DEVELOPMENTAL SCI, V12, P272, DOI 10.1111/j.1467-7687.2008.00759.x; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 2003, J NEUROPHYSIOL, V90, P503, DOI 10.1152/jn.00192.2003; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Noorani I, 2013, EUR J NEUROSCI, V37, P330, DOI 10.1111/ejn.12025; Noorani I, 2016, NEUROSCI BIOBEHAV R, V64, P229, DOI 10.1016/j.neubiorev.2016.02.018; Optican LM, 2008, PROG BRAIN RES, V171, P115, DOI 10.1016/S0079-6123(08)00615-8; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Shaikh AG, 2012, EXPERT REV OPHTHALMO, V7, P481, DOI 10.1586/EOP.12.55; Triplett RL, 2014, EPILEPSIA, V55, P1667, DOI 10.1111/epi.12768; Van Horn M. R., 2011, OXFORD HDB EYE MOVEM, P151; Velanova K, 2008, CEREB CORTEX, V18, P2505, DOI 10.1093/cercor/bhn012; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Vollmar C, 2011, BRAIN, V134, P1710, DOI 10.1093/brain/awr098; Yoong M, 2015, QUANT IMAGING MED SU, V5, P225, DOI 10.3978/j.issn.2223-4292.2015.01.06	45	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160508	10.1371/journal.pone.0160508	http://dx.doi.org/10.1371/journal.pone.0160508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483011	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000381110700053
J	Stautz, K; Pechey, R; Couturier, DL; Deary, IJ; Marteau, TM				Stautz, Kaidy; Pechey, Rachel; Couturier, Dominique-Laurent; Deary, Ian J.; Marteau, Theresa M.			Do Executive Function and Impulsivity Predict Adolescent Health Behaviour after Accounting for Intelligence? Findings from the ALSPAC Cohort	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; SUBSTANCE-USE; SOCIOECONOMIC POSITION; PERSONALITY-TRAITS; CHILDHOOD IQ; SELF-CONTROL; ALCOHOL-USE; FOOD-INTAKE; RISK; MORTALITY	Objective Executive function, impulsivity, and intelligence are correlated markers of cognitive resource that predict health-related behaviours. It is unknown whether executive function and impulsivity are unique predictors of these behaviours after accounting for intelligence. Methods Data from 6069 participants from the Avon Longitudinal Study of Parents and Children were analysed to investigate whether components of executive function (selective attention, attentional control, working memory, and response inhibition) and impulsivity (parent-rated) measured between ages 8 and 10, predicted having ever drunk alcohol, having ever smoked, fruit and vegetable consumption, physical activity, and overweight at age 13, after accounting for intelligence at age 8 and childhood socioeconomic characteristics. Results Higher intelligence predicted having drunk alcohol, not smoking, greater fruit and vegetable consumption, and not being overweight. After accounting for intelligence, impulsivity predicted alcohol use (odds ratio = 1.10; 99% confidence interval = 1.02, 1.19) and smoking (1.22; 1.11, 1.34). Working memory predicted not being overweight (0.90; 0.81, 0.99). Conclusions After accounting for intelligence, executive function predicts overweight status but not health-related behaviours in early adolescence, whilst impulsivity predicts the onset of alcohol and cigarette use, all with small effects. This suggests overlap between executive function and intelligence as predictors of health behaviour in this cohort, with trait impulsivity accounting for additional variance.	[Stautz, Kaidy; Pechey, Rachel; Couturier, Dominique-Laurent; Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England; [Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Cambridge; University of Edinburgh	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England.	tm388@cam.ac.uk	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X; Marteau, Theresa/0000-0003-3025-1129; Pechey, Rachel/0000-0002-6558-388X; Couturier, Dominique-Laurent/0000-0001-5774-5036; Stautz, Kaidy/0000-0001-9279-7042	Department of Health Policy Research Program (Policy Research Unit in Behaviour and Health) [PR-UN-0409-10109]; National Institute for Health Research School for Public Health Research [SYAG/019- Task 4 - RG67185]; Medical Research Council [MR/K026992/1, MC_PC_15018] Funding Source: researchfish	Department of Health Policy Research Program (Policy Research Unit in Behaviour and Health); National Institute for Health Research School for Public Health Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was jointly funded by the Department of Health Policy Research Program (Policy Research Unit in Behaviour and Health [PR-UN-0409-10109]), and by the National Institute for Health Research School for Public Health Research [SYAG/019- Task 4 - RG67185]. The funders had no role in the study design, analysis, decision to publish, or preparation of the manuscript.	Allom V, 2014, APPETITE, V80, P123, DOI 10.1016/j.appet.2014.05.007; Aytaclar S, 1999, J AM ACAD CHILD PSY, V38, P172, DOI 10.1097/00004583-199902000-00016; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P241, DOI 10.1136/jech.2006.048215; Batty GD, 2007, PEDIATRICS, V119, pE38, DOI 10.1542/peds.2006-1831; Batty GD, 2008, AM J PUBLIC HEALTH, V98, P2237, DOI 10.2105/AJPH.2007.109488; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Bickel WK, 2012, PSYCHOPHARMACOLOGY, V221, P361, DOI 10.1007/s00213-012-2689-x; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brega AG, 2008, AGE AGEING, V37, P521, DOI 10.1093/ageing/afn121; BrooksGunn J, 1996, CHILD DEV, V67, P396; Brydges CR, 2012, INTELLIGENCE, V40, P458, DOI 10.1016/j.intell.2012.05.006; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Centers for Disease Control and Prevention, CLIN GROWTH CHARTS B; Chandola T, 2006, INT J OBESITY, V30, P1422, DOI 10.1038/sj.ijo.0803279; Chuderski A, 2012, INTELLIGENCE, V40, P278, DOI 10.1016/j.intell.2012.02.010; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Davison AC, 1997, BOOTSTRAP METHODS TH; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Deckel AW, 1996, ALCOHOL CLIN EXP RES, V20, P1173, DOI 10.1111/j.1530-0277.1996.tb01107.x; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Duckworth AL, 2011, J RES PERS, V45, P259, DOI 10.1016/j.jrp.2011.02.004; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fernie G, 2013, ADDICTION, V108, P1916, DOI 10.1111/add.12283; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hall PA, 2014, J BEHAV MED, V37, P1057, DOI 10.1007/s10865-013-9535-4; Hall PA, 2009, PSYCHOSOM MED, V71, P196, DOI 10.1097/PSY.0b013e318190d7f0; Hayward MD, 2000, AM SOCIOL REV, V65, P910, DOI 10.2307/2657519; Johnson JK, 2007, J GERONTOL A-BIOL, V62, P1134, DOI 10.1093/gerona/62.10.1134; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kanazawa S, 2010, REV GEN PSYCHOL, V14, P382, DOI 10.1037/a0021526; Khan NA, 2015, APPETITE, V93, P51, DOI 10.1016/j.appet.2015.04.012; Kubicka L, 2001, ADDICTION, V96, P1615, DOI 10.1046/j.1360-0443.2001.961116158.x; Kuntsi J, 2001, BRIT J DEV PSYCHOL, V19, P339, DOI 10.1348/026151001166137; Latvala A, 2014, ALCOHOL CLIN EXP RES, V38, P457, DOI 10.1111/acer.12254; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Liang WB, 2015, INT J DRUG POLICY, V26, P131, DOI 10.1016/j.drugpo.2014.07.001; Logan Gordon D., 1994, P189; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; Melotti R, 2011, PEDIATRICS, V127, pE948, DOI 10.1542/peds.2009-3450; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Nigg JT, 2006, J AM ACAD CHILD PSY, V45, P468, DOI 10.1097/01.chi.0000199028.76452.a9; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Parada M, 2012, ADDICT BEHAV, V37, P167, DOI 10.1016/j.addbeh.2011.09.015; Paul SL, 2008, ADDICTION, V103, P846, DOI 10.1111/j.1360-0443.2008.02196.x; Pedersen SL, 2012, ALCOHOL CLIN EXP RES, V36, P1794, DOI 10.1111/j.1530-0277.2012.01797.x; Peeters M, 2015, DEV COGN NEUROS-NETH, V16, P139, DOI 10.1016/j.dcn.2015.04.003; Rao N, 2014, EARLY CHILDHOOD DEV; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Reinert KRS, 2013, J OBES, V2013, DOI 10.1155/2013/820956; Riggs N, 2010, CHILD NEUROPSYCHOL, V16, P279, DOI 10.1080/09297041003601488; Russo PM, 2008, INT J PSYCHOPHYSIOL, V69, P112, DOI 10.1016/j.ijpsycho.2008.03.008; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sharma L, 2014, PSYCHOL BULL, V140, P374, DOI 10.1037/a0034418; Stautz K, 2013, CLIN PSYCHOL REV, V33, P574, DOI 10.1016/j.cpr.2013.03.003; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Vigil-Colet A, 2005, SPAN J PSYCHOL, V8, P199, DOI 10.1017/S1138741600005072; Wechsler D., 1991, WISC 3 WECHSLER INTE	69	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160512	10.1371/journal.pone.0160512	http://dx.doi.org/10.1371/journal.pone.0160512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27479488	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300054
J	Asano, Y; Kashiwagi, S; Onoda, N; Noda, S; Kawajiri, H; Takashima, T; Ohsawa, M; Kitagawa, S; Hirakawa, K				Asano, Yuka; Kashiwagi, Shinichiro; Onoda, Naoyoshi; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Ohsawa, Masahiko; Kitagawa, Seiichi; Hirakawa, Kosei			Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer	PLOS ONE			English	Article							CELL GROWTH-FACTOR; FACTOR THYMIDINE PHOSPHORYLASE; PREOPERATIVE CHEMOTHERAPY; COLORECTAL-CANCER; PROGNOSTIC MARKER; OVARIAN-CANCER; EXPRESSION; NEUTROPHIL; CYCLOPHOSPHAMIDE; LOCALIZATION	Background The peripheral blood platelet-lymphocyte ratio (PLR) has been proposed as an indicator for evaluating systemic inflammatory responses in cancer-bearing patients. While some reports suggest a correlation between PLR and prognosis, few studies have examined the relationship between PLR and sensitivity to chemotherapy. We conducted a study on whether PLR could serve as a predictor of the therapeutic effects of neoadjuvant chemotherapy (NAC). Methods PLR was evaluated in 177 breast cancer patients treated with the NAC 5-fluorouracil, epirubicin and cyclophosphamide, followed by weekly paclitaxel and subsequent curative surgery. The correlation between PLR and prognosis, and between PLR and the efficacy of NAC, were evaluated retrospectively. Results The low PLR group had significantly more patients > 56 years old (p = 0.001) and postmenopausal women (p = 0.001) than the high PLR group. The low PLR group also had a higher pathologic complete response (pCR) rate (p = 0.019). On examining the correlation with prognosis, the low-PLR group was found to have significantly longer disease-free survival (p = 0.004) and overall survival (p = 0.032) than the high PLR group. Multivariate analysis also revealed that lymph node metastasis (p = 0.043, hazard ratio = 4.40) and a high PLR (p = 0.005, hazard ratio = 2.84) were independent, unfavorable prognostic factors. Conclusions For patients with breast cancer treated with NAC, a low PLR indicated high chemotherapy sensitivity, suggesting that PLR could serve as a predictive marker of the therapeutic effect of NAC.	[Asano, Yuka; Kashiwagi, Shinichiro; Onoda, Naoyoshi; Noda, Satoru; Kawajiri, Hidemi; Takashima, Tsutomu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan; [Ohsawa, Masahiko] Osaka City Univ, Grad Sch Med, Dept Diagnost Pathol, Osaka, Japan; [Kitagawa, Seiichi] Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Kashiwagi, S (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan.	spqv9ke9@view.ocn.ne.jp	Kashiwagi, Shinichiro/AAE-5243-2020; Kashiwagi, Shinichiro/AAC-7070-2019	Kashiwagi, Shinichiro/0000-0002-0460-9599; Kashiwagi, Shinichiro/0000-0002-0460-9599				Aliustaoglu M, 2010, MED ONCOL, V27, P1060, DOI 10.1007/s12032-009-9335-4; Asano Y, 2016, BRIT J CANCER, V114, P14, DOI 10.1038/bjc.2015.434; Asher V, 2011, CLIN TRANSL ONCOL, V13, P499, DOI 10.1007/s12094-011-0687-9; Azab B, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0432-4; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; Buzdar AU, 2007, CLIN CANCER RES, V13, P228, DOI 10.1158/1078-0432.CCR-06-1345; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112581; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; HELDIN CH, 1979, P NATL ACAD SCI USA, V76, P3722, DOI 10.1073/pnas.76.8.3722; HELDIN CH, 1984, CELL, V37, P9, DOI 10.1016/0092-8674(84)90296-4; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN NE, 1993, BRIT J CANCER, V68, P708, DOI 10.1038/bjc.1993.414; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; Kemal Y, 2014, ASIAN PAC J CANCER P, V15, P2651, DOI 10.7314/APJCP.2014.15.6.2651; Krenn-Pilko S, 2014, BRIT J CANCER, V110, P2524, DOI 10.1038/bjc.2014.163; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Malietzis G, 2014, ANN SURG ONCOL, V21, P3938, DOI 10.1245/s10434-014-3815-2; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mayer EL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1755; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; MIYAZONO K, 1987, J BIOL CHEM, V262, P4098; MIYAZONO K, 1990, ANN NY ACAD SCI, V593, P51, DOI 10.1111/j.1749-6632.1990.tb16099.x; Noh H, 2013, J BREAST CANCER, V16, P55, DOI 10.4048/jbc.2013.16.1.55; Raungkaewmanee S, 2012, J GYNECOL ONCOL, V23, P265, DOI 10.3802/jgo.2012.23.4.265; ROSS R, 1990, SCIENCE, V248, P1009, DOI 10.1126/science.2343305; Sachelarie I, 2006, ONCOLOGIST, V11, P574, DOI 10.1634/theoncologist.11-6-574; Seretis C, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/653608; Singletary SE, 2003, CANCER, V98, P2740, DOI 10.1002/cncr.11865; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; SPORN MB, 1989, JAMA-J AM MED ASSOC, V262, P938, DOI 10.1001/jama.262.7.938; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; TOI M, 1995, INT J CANCER, V64, P79, DOI 10.1002/ijc.2910640202; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96	38	44	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0153459	10.1371/journal.pone.0153459	http://dx.doi.org/10.1371/journal.pone.0153459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472762	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300001
J	Cloarec, R; Bauer, S; Luche, H; Buhler, E; Pallesi-Pocachard, E; Salmi, M; Courtens, S; Massacrier, A; Grenot, P; Teissier, N; Watrin, F; Schaller, F; Adle-Biassette, H; Gressens, P; Malissen, M; Stamminger, T; Streblow, DN; Bruneau, N; Szepetowski, P				Cloarec, Robin; Bauer, Sylvian; Luche, Herve; Buhler, Emmanuelle; Pallesi-Pocachard, Emilie; Salmi, Manal; Courtens, Sandra; Massacrier, Annick; Grenot, Pierre; Teissier, Natacha; Watrin, Francoise; Schaller, Fabienne; Adle-Biassette, Homa; Gressens, Pierre; Malissen, Marie; Stamminger, Thomas; Streblow, Daniel N.; Bruneau, Nadine; Szepetowski, Pierre			Cytomegalovirus Infection of the Rat Developing Brain In Utero Prominently Targets Immune Cells and Promotes Early Microglial Activation	PLOS ONE			English	Article							VIRUS; DISSEMINATION; MONOCYTES; MIGRATION; MACROPHAGES; EXPRESSION; STRATEGY; DISEASE; ROLES	Background Congenital cytomegalovirus infections are a leading cause of neurodevelopmental disorders in human and represent a major health care and socio-economical burden. In contrast with this medical importance, the pathophysiological events remain poorly known. Murine models of brain cytomegalovirus infection, mostly neonatal, have brought recent insights into the possible pathogenesis, with convergent evidence for the alteration and possible involvement of brain immune cells. Objectives and Methods In order to confirm and expand those findings, particularly concerning the early developmental stages following infection of the fetal brain, we have created a model of in utero cytomegalovirus infection in the developing rat brain. Rat cytomegalovirus was injected intraventricularly at embryonic day 15 (E15) and the brains analyzed at various stages until the first postnatal day, using a combination of gene expression analysis, immunohistochemistry and multicolor flow cytometry experiments. Results Rat cytomegalovirus infection was increasingly seen in various brain areas including the choroid plexi and the ventricular and subventricular areas and was prominently detected in CD45(low/int), CD11b(+) microglial cells, in CD45(high), CD11b(+) cells of the myeloid lineage including macrophages, and in CD45(+), CD11b(-) lymphocytes and non-B non-T cells. In parallel, rat cytomegalovirus infection of the developing rat brain rapidly triggered a cascade of pathophysiological events comprising: chemokines upregulation, including CCL2-4, 7 and 12; infiltration by peripheral cells including B-cells and monocytes at E17 and P1, and T-cells at P1; and microglia activation at E17 and P1. Conclusion In line with previous findings in neonatal murine models and in human specimen, our study further suggests that neuroimmune alterations might play critical roles in the early stages following cytomegalovirus infection of the brain in utero. Further studies are now needed to determine which role, whether favorable or detrimental, those putative double-edge swords events actually play.	[Cloarec, Robin; Bauer, Sylvian; Buhler, Emmanuelle; Pallesi-Pocachard, Emilie; Salmi, Manal; Courtens, Sandra; Massacrier, Annick; Watrin, Francoise; Schaller, Fabienne; Bruneau, Nadine; Szepetowski, Pierre] INSERM U901, Marseille, France; [Cloarec, Robin; Bauer, Sylvian; Buhler, Emmanuelle; Pallesi-Pocachard, Emilie; Salmi, Manal; Courtens, Sandra; Massacrier, Annick; Watrin, Francoise; Schaller, Fabienne; Bruneau, Nadine; Szepetowski, Pierre] Mediterranean Inst Neurobiol INMED, Marseille, France; [Cloarec, Robin; Bauer, Sylvian; Buhler, Emmanuelle; Pallesi-Pocachard, Emilie; Salmi, Manal; Courtens, Sandra; Massacrier, Annick; Watrin, Francoise; Schaller, Fabienne; Bruneau, Nadine; Szepetowski, Pierre] Aix Marseille Univ, UMR S901, Marseille, France; [Luche, Herve; Grenot, Pierre; Malissen, Marie] UM2 Aix Marseille Univ, PHENOMIN, CIPHE Ctr Immunophenom, Marseille, France; [Luche, Herve; Malissen, Marie] INSERM US012, Marseille, France; [Luche, Herve; Grenot, Pierre; Malissen, Marie] CNRS UMS3367, Marseille, France; [Buhler, Emmanuelle; Schaller, Fabienne] INMED, PPGI Platform, Marseille, France; [Pallesi-Pocachard, Emilie] INMED, PBMC Platform, Marseille, France; [Teissier, Natacha; Adle-Biassette, Homa; Gressens, Pierre] INSERM, U1141, Paris, France; [Teissier, Natacha; Adle-Biassette, Homa; Gressens, Pierre] Paris Diderot Univ, Sorbonne Paris Cite, Paris, France; [Teissier, Natacha; Adle-Biassette, Homa; Gressens, Pierre] PremUP, Paris, France; [Stamminger, Thomas] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany; [Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Erlangen Nuremberg; Oregon Health & Science University	Bruneau, N; Szepetowski, P (corresponding author), INSERM U901, Marseille, France.; Bruneau, N; Szepetowski, P (corresponding author), Mediterranean Inst Neurobiol INMED, Marseille, France.; Bruneau, N; Szepetowski, P (corresponding author), Aix Marseille Univ, UMR S901, Marseille, France.	nadine.bruneau@inserm.fr; pierre.szepetowski@inserm.fr	Adle-Biassette, Homa/AAG-2751-2019; Cloarec, Robin/GPS-8888-2022; watrin, francoise/P-5380-2016; Teissier, Natacha/AAC-2435-2019; Pallesi-Pocachard, Emilie/M-7290-2016; LUCHE, Herve/GLT-1401-2022; gressens, pierre/M-7557-2017; Bruneau, Nadine/O-2100-2016; Teissier, Natacha/ABD-5672-2020	watrin, francoise/0000-0003-2087-412X; gressens, pierre/0000-0002-0909-4221; Bruneau, Nadine/0000-0002-1523-3128; Malissen, Marie/0000-0003-2331-1445; LUCHE, Herve/0000-0003-4309-8338; Stamminger, Thomas/0000-0001-9878-3119; Salmi, Manal/0000-0003-0218-7342; GRENOT, PIERRE/0000-0003-3991-753X; Sylvian, Bauer/0000-0002-0667-3412	INSERM (Institut National de la Sante et de la Recherche Medicale); ANR (Agence Nationale de la Recherche) [ANR-2010-BLAN-1405 01]; FRM (Fondation pour la Recherche Medicale) [FDT20140930813]; PACA (Provence-Alpes-Cote d'Azur) Regional Council; INSERM/PACA (Institut National de la Sante et de la Recherche Medicale/Provence-Alpes-Cote d'Azur) PhD fellowship; Deutsche Forschungsgemeinschaft [SFB796]	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); PACA (Provence-Alpes-Cote d'Azur) Regional Council(Region Provence-Alpes-Cote d'Azur); INSERM/PACA (Institut National de la Sante et de la Recherche Medicale/Provence-Alpes-Cote d'Azur) PhD fellowship(Region Provence-Alpes-Cote d'Azur); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by INSERM (Institut National de la Sante et de la Recherche Medicale), by ANR (Agence Nationale de la Recherche) grant EPILAND (ANR-2010-BLAN-1405 01), by FRM (Fondation pour la Recherche Medicale) grant ("Physiology and pathology of brain development", call 2012), and by the PACA (Provence-Alpes-Cote d'Azur) Regional Council. RC was a recipient of an INSERM/PACA (Institut National de la Sante et de la Recherche Medicale/Provence-Alpes-Cote d'Azur) PhD fellowship and a recipient of a FRM (Fondation pour la Recherche Medicale) PhD fellowship (FDT20140930813). TS was supported by the Deutsche Forschungsgemeinschaft (SFB796).	Bantug GRB, 2008, J IMMUNOL, V181, P2111, DOI 10.4049/jimmunol.181.3.2111; Ben-Ari Y, 2015, NAT REV NEUROSCI, V16, P498, DOI 10.1038/nrn3956; Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Cekinovic D, 2014, METHODS MOL BIOL, V1119, P289, DOI 10.1007/978-1-62703-788-4_16; Chan G, 2012, J LEUKOCYTE BIOL, V92, P743, DOI 10.1189/jlb.0112040; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Cheeran MCJ, 2004, J NEUROVIROL, V10, P152, DOI 10.1080/13550280490441130; Cheeran MCJ, 2001, J NEUROVIROL, V7, P135; Chugh D, 2015, PLOS ONE, V10, DOI [10.1371/ journal. pone. 0132366, DOI 10.1371/J0URNAL.P0NE.0132366]; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cunningham RL, 2013, HORM BEHAV, V64, P350, DOI 10.1016/j.yhbeh.2012.12.009; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Feuer R, 2003, AM J PATHOL, V163, P1379, DOI 10.1016/S0002-9440(10)63496-7; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; Harry GJ, 2012, NEUROTOXICOLOGY, V33, P191, DOI 10.1016/j.neuro.2012.01.012; Jones CCB, 2009, VIROLOGY, V388, P78, DOI 10.1016/j.virol.2009.02.050; Kawasaki H, 2015, AM J PATHOL, V185, P1304, DOI 10.1016/j.ajpath.2015.01.032; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Koontz T, 2008, J EXP MED, V205, P423, DOI 10.1084/jem.20071489; Kosmac K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003200; Kosugi I, 2002, AM J PATHOL, V161, P919, DOI 10.1016/S0002-9440(10)64252-6; Lazarini F, 2012, J NEUROSCI, V32, P3652, DOI 10.1523/JNEUROSCI.6394-11.2012; Malmevik J, 2014, BRAIN RES, V1586, P12, DOI 10.1016/j.brainres.2014.08.017; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Marques CP, 2004, GLIA, V47, P358, DOI 10.1002/glia.20045; Mutnal MB, 2014, J IMMUNOL, V193, P6070, DOI 10.4049/jimmunol.1400654; Nutile-McMenemy N, 2007, J NEUROCHEM, V103, P2035, DOI 10.1111/j.1471-4159.2007.04889.x; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Sakao-Suzuki M, 2014, ANN CLIN TRANSL NEUR, V1, P570, DOI 10.1002/acn3.88; Salmi M, 2013, BRAIN, V136, P2457, DOI 10.1093/brain/awt161; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwerk C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00080; Shinmura Y, 1997, ACTA NEUROPATHOL, V93, P551, DOI 10.1007/s004010050651; Slavuljica I, 2015, CELL MOL IMMUNOL, V12, P180, DOI 10.1038/cmi.2014.51; Smith MS, 2004, J VIROL, V78, P4444, DOI 10.1128/JVI.78.9.4444-4453.2004; Tabor-Godwin JM, 2010, J NEUROSCI, V30, P8676, DOI 10.1523/JNEUROSCI.1860-10.2010; Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038; Teissier N, 2011, ACTA NEUROPATHOL, V122, P763, DOI 10.1007/s00401-011-0895-y; van den Pol AN, 2007, J VIROL, V81, P332, DOI 10.1128/JVI.01592-06; Vomaske J, 2012, J VIROL, V86, P11833, DOI 10.1128/JVI.00452-12; Wang D, 2014, CURR OPIN VIROL, V6, P13, DOI 10.1016/j.coviro.2014.02.004; Zusso M, 2012, J NEUROSCI, V32, P11285, DOI 10.1523/JNEUROSCI.6182-11.2012	46	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160176	10.1371/journal.pone.0160176	http://dx.doi.org/10.1371/journal.pone.0160176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472761	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300033
J	Skaug, EA; Nes, B; Aspenes, ST; Ellingsen, O				Skaug, Eli-Anne; Nes, Bjarne; Aspenes, Stian Thoresen; Ellingsen, Oyvind			Non-Smoking Tobacco Affects Endothelial Function in Healthy Men in One of the Largest Health Studies Ever Performed; The Nord-Trondelag Health Study in Norway; HUNT3	PLOS ONE			English	Article							SWEDISH MOIST SNUFF; CARDIOVASCULAR RISK-FACTORS; PEAK OXYGEN-UPTAKE; SMOKELESS TOBACCO; MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; PHYSICAL-ACTIVITY; SOCIOECONOMIC-FACTORS; ADIPOSE PATIENTS; BLOOD-PRESSURE	Background Oral tobacco (snuff) is taking a large market share in Scandinavia, especially with young users. However, long-term health effects are unknown. Small studies show association between snuff and reduced endothelial function, representing an early stage of vascular injury that often precedes manifest cardiovascular disease by several years. We therefore determined the associations between snuff and endothelial function in a large sample of healthy Norwegian men. Methods and Design In the Fitness substudy of the Nord-Trondelag Health Study (HUNT3), endothelial function was measured by flow-mediated dilation (FMD). Aerobic fitness was measured by peak oxygen uptake (VO2peak). A cross-sectional design including 1 592 self-reported healthy men compared these observations with records of present tobacco use, standard cardiovascular risk factors, and socioeconomic status, using general linear models. Results FMD was lower in snuff users (FMD: 4.12%, 3.63, 4.61) compared to non-users (FMD: 4.52%, 4.27, 4.78) after adjustment for age (difference: -0.57%, -1.12, -0.01). After further adjustment for potential confounders, FMD still tended to be lower in snuff users than in non-users (difference: -0.53%, -1.09, 0.02). This difference was even more pronounced in the inactive snuff users (-0.83%, -1.59, -0.06) and in the low fit snuff users (-0.74%, CI -0.55, 0.079). Conclusions Oral tobacco is associated with a tendency towards reduced endothelial function, indicating vascular changes that precede cardiovascular disease. The strongest associations were found in men with low physical activity or reduced aerobic fitness.	[Skaug, Eli-Anne; Nes, Bjarne; Aspenes, Stian Thoresen; Ellingsen, Oyvind] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway; [Ellingsen, Oyvind] St Olavs Hosp, Dept Cardiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Skaug, EA (corresponding author), Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, Trondheim, Norway.	eli-anne.skaug@ntnu.no	Nes, Bjarne Martens/I-2903-2016	Nes, Bjarne Martens/0000-0002-9958-8179; Skaug, Eli-Anne/0000-0001-8472-3916	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated	The study was supported by grants from the K.G. Jebsen Foundation, the Norwegian Council on Cardiovascular Disease and Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; and Roche Norway Incorporated. There are no disclosures to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000762; ANDERSON TJ, 1995, NEW ENGL J MED, V332, P488, DOI 10.1056/NEJM199502233320802; Arefalk G, EUROPEAN J CARDIOVAS; Arefalk G, 2012, EUR J PREV CARDIOL, V19, P1120, DOI 10.1177/1741826711420003; Ashor AW, 2014, SPORTS MED; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1675, DOI 10.1249/MSS.0b013e318216ea50; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; Asselbergs FW, 2005, VASC PHARMACOL, V42, P125, DOI 10.1016/j.vph.2005.01.009; Beck EB, 2010, EUR HEART J, V31, P783; BENOWITZ NL, 1988, CLIN PHARMACOL THER, V44, P23, DOI 10.1038/clpt.1988.107; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; Bolduc V, 2013, AM J PHYSIOL-HEART C, V305, pH620, DOI 10.1152/ajpheart.00624.2012; Bolinder G, 1997, ATHEROSCLEROSIS, V132, P95, DOI 10.1016/S0021-9150(97)00075-0; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Critchley JA, 2004, EUR J CARDIOV PREV R, V11, P101, DOI 10.1097/01.hjr.0000114971.39211.d7; ENVIRON International Corporation, 2010, REV SCI LIT SNUS SWE; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Fant RV, 1999, TOB CONTROL, V8, P387, DOI 10.1136/tc.8.4.387; Furie MB, 2000, IMMUNOPHARMACOLOGY, V47, P13, DOI 10.1016/S0162-3109(99)00181-2; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Gokce N, 2002, CIRCULATION, V105, P1567, DOI 10.1161/01.CIR.0000012543.55874.47; Golbidi S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/789607; Granberry MC, 2003, PHARMACOTHERAPY, V23, P974, DOI 10.1592/phco.23.8.974.32871; Guarino F, J BIOL REGUL HOMEOST, V25, P259; Haglund B, 2007, SCAND J PUBLIC HEALT, V35, P618, DOI 10.1080/14034940701436949; Helath NIoP, 2014, HLTH RISKS SCAND SNU; Hergens MP, 2007, J INTERN MED, V262, P351, DOI 10.1111/j.1365-2796.2007.01816.x; Hergens MP, 2005, EPIDEMIOLOGY, V16, P12, DOI 10.1097/01.ede.0000147108.92895.ba; Hoellriegel R, 2011, EUR HEART J, V32, P685; HUHTASAARI F, 1992, BRIT MED J, V305, P1252, DOI 10.1136/bmj.305.6864.1252; Huhtasaari F, 1999, J AM COLL CARDIOL, V34, P1784, DOI 10.1016/S0735-1097(99)00409-X; HUNT research center NUoSaT NTNU, 2007, HUNT3 QUEST 1 NT3BLQ; HUNT research center NUoSaT NTNU, 2007, INVITASJON TIL HUNT3; HUNT research center NUoSaT NTNU, 2016, ACC HUNT DAT SAMPL R; Jenum Anne Karen, 2007, Tidsskr Nor Laegeforen, V127, P2532; Kallio K, 2007, CIRCULATION, V115, P3205, DOI 10.1161/CIRCULATIONAHA.106.674804; Krokstad S., 2012, INT J EPIDEMIOL; Kuvin JT, 2001, J AM COLL CARDIOL, V38, P1843, DOI 10.1016/S0735-1097(01)01657-6; Laclaustra M, 2008, INT J CARDIOL, V125, P376, DOI 10.1016/j.ijcard.2007.03.001; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Laytragoon-Lewin N, 2011, ANTICANCER RES, V31, P1527; Luo J, 2007, LANCET, V369, P2015, DOI 10.1016/S0140-6736(07)60678-3; Marshall IJ, 2015, LANCET NEUROL, V14, P1206, DOI 10.1016/S1474-4422(15)00200-8; Martin JS, 2010, EXP BIOL MED, V235, P1263, DOI 10.1258/ebm.2010.009376; Moyna NM, 2004, ACTA PHYSIOL SCAND, V180, P113, DOI 10.1111/j.0001-6772.2003.01253.x; Norberg M, 2006, SCAND J PUBLIC HEALT, V34, P576, DOI 10.1080/14034940600665143; Nordahl Helene, 2014, Dan Med J, V61, pB4943; Norway S, 2015, SMOKING HABITS 2014; Notarius CF, 2012, MED SCI SPORT EXER, V44, P232, DOI 10.1249/MSS.0b013e31822a68a5; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Peretz Alon, 2007, BMC Cardiovasc Disord, V7, P11, DOI 10.1186/1471-2261-7-11; Pollitt RA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-7; Rohani M, 2004, J INTERN MED, V255, P379, DOI 10.1046/j.1365-2796.2003.01279.x; Siasos G, 2012, CIRCULATION, V125, pE806; SIEGEL D, 1992, AM J PUBLIC HEALTH, V82, P417, DOI 10.2105/AJPH.82.3.417; Skaug EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101371; Skaug EA, 2013, EUR J PREV CARDIOL, V20, P531, DOI 10.1177/2047487312444234; Solbraa AK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-569; Sundstrom D, 2012, CLIN PHYSIOL FUNCT I, V32, P106, DOI 10.1111/j.1475-097X.2011.01062.x; Suzuki H, 1996, J APPL PHYSIOL, V81, P225, DOI 10.1152/jappl.1996.81.1.225; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Tyroler HA, 1999, PREV MED, V29, pS36, DOI 10.1006/pmed.1998.0441; Wallenfeldt K, 2001, J INTERN MED, V250, P492, DOI 10.1046/j.1365-2796.2001.00917.x; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Wikstrom AK, 2010, BJOG-INT J OBSTET GY, V117, P1005, DOI 10.1111/j.1471-0528.2010.02575.x; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; Winkelmann BR, 2009, BIOMARK MED, V3, P617, DOI [10.2217/BMM.09.51, 10.2217/bmm.09.51]; Wolk R, 2005, J AM COLL CARDIOL, V45, P910, DOI 10.1016/j.jacc.2004.11.056; World Health Organisation (WHO), 2015, PHYS ACT AD REC LEV; Yatsuya H, 2010, AM J EPIDEMIOL, V172, P600, DOI 10.1093/aje/kwq191; ZEIHER AM, 1995, CIRCULATION, V92, P1094, DOI 10.1161/01.CIR.92.5.1094	73	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160205	10.1371/journal.pone.0160205	http://dx.doi.org/10.1371/journal.pone.0160205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490361	gold, Green Published			2022-12-27	WOS:000381368900036
J	Spyreas, G				Spyreas, Greg			Scale and Sampling Effects on Floristic Quality	PLOS ONE			English	Article							TALLGRASS-PRAIRIE-PRESERVE; ASSESSMENT INDEX; CENTRAL PENNSYLVANIA; WETLAND CONDITION; BIOTIC INTEGRITY; CONSERVATION; INDICATORS; METRICS; PERFORMANCE; DIVERSITY	Floristic Quality Assessment (FQA) is increasingly influential for making land management decisions, for directing conservation policy, and for research. But, the basic ecological properties and limitations of its metrics are ill defined and not well understood-especially those related to sample methods and scale. Nested plot data from a remnant tallgrass prairie sampled annually over a 12-year period, were used to investigate FQA properties associated with species detection rates, species misidentification rates, sample year, and sample grain/area. Plot size had no apparent effect on Mean C (an area's average Floristic Quality level), nor did species detection levels above 65% detection. Simulated species misidentifications only affected Mean C values at greater than 10% in large plots, when the replaced species were randomly drawn from the broader county-wide species pool. Finally, FQA values were stable over the 12-year study, meaning that there was no evidence that the metrics exhibit year effects. The FQA metric Mean C is demonstrated to be robust to varied sample methodologies related to sample intensity (plot size, species detection rate), as well as sample year. These results will make FQA measures even more appealing for informing land-use decisions, policy, and research for two reasons: 1) The sampling effort needed to generate accurate and consistent site assessments with FQA measures is shown to be far lower than what has previously been assumed, and 2) the stable properties and consistent performance of metrics with respect to sample methods will allow for a remarkable level of comparability of FQA values from different sites and datasets compared to other commonly used ecological metrics.	[Spyreas, Greg] Illinois Nat Hist Survey, Champaign, IL 61820 USA	Illinois Natural History Survey	Spyreas, G (corresponding author), Illinois Nat Hist Survey, Champaign, IL 61820 USA.	spyreas@Illinois.edu						Ahrends A, 2011, BIOL CONSERV, V144, P131, DOI 10.1016/j.biocon.2010.08.008; Bauer JT, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00480.1; Bernthal T.W., 2003, DEV FLORISTIC QUALIT; Bourdaghs M, 2006, WETLANDS, V26, P718, DOI 10.1672/0277-5212(2006)26[718:PAPOTF]2.0.CO;2; Brandon A, 2003, NAT AREA J, V23, P254; Brudvig LA, 2007, CONSERV BIOL, V21, P864, DOI 10.1111/j.1523-1739.2006.00619.x; Chamberlain SJ, 2016, ECOL INDIC, V60, P1142, DOI 10.1016/j.ecolind.2015.09.004; Chen GK, 2009, J ECOL, V97, P1383, DOI 10.1111/j.1365-2745.2009.01560.x; Cohen MJ, 2004, ECOL APPL, V14, P784, DOI 10.1890/02-5378; Conn PB, 2013, ECOLOGY, V94, P2607, DOI 10.1890/12-2124.1; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; DIETVORST P, 1982, VEGETATIO, V50, P77, DOI 10.1007/BF00055205; Euliss NH, 2011, WETLANDS, V31, P713, DOI 10.1007/s13157-011-0187-2; Fleishman E, 2006, ECOL INDIC, V6, P543, DOI 10.1016/j.ecolind.2005.07.005; Francis CM, 2000, NAT AREA J, V20, P66; FREEMAN CC, 2002, KANSAS FLORISTIC QUA; Gertner G, 1988, ESTIMATION FOREST DI, P199; Hamilton RG, 2007, TALL TIMB FIRE ECOL, P163; Hargiss CLM, 2007, ECOLOGICAL INDICATOR, V8, P303; Hernandez EC, 2015, ECOL INDIC, V52, P558, DOI 10.1016/j.ecolind.2015.01.013; Jessop J, 2015, BIOL CONSERV, V191, P341, DOI 10.1016/j.biocon.2015.07.006; LADD D, 1993, MISSOURI FLORISTIC Q; Ladd D, 2015, PHYTONEURON, V12, P1; LEPS J, 1992, J VEG SCI, V3, P119, DOI 10.2307/3236006; Lopez RD, 2002, ECOL APPL, V12, P487, DOI 10.1890/1051-0761(2002)012[0487:TTFQAI]2.0.CO;2; Mack JJ, 2008, AQUAT ECOSYST HEALTH, V11, P91, DOI 10.1080/14634980701880823; Magurran AE, 2011, BIOL DIVERSITY; Masters LA, 1994, ERIGENIA, V13, P141; Matthews JW, 2008, ENVIRON MANAGE, V41, P130, DOI 10.1007/s00267-007-9002-5; Matthews JW, 2015, ECOL INDIC, V52, P1, DOI 10.1016/j.ecolind.2014.11.017; Matthews JW, 2009, ECOL APPL, V19, P2093, DOI 10.1890/08-1371.1; Matthews JW, 2003, NAT AREA J, V23, P53, DOI 10.1038/nature01736; McGlinn D. J., 2010, ECOLOGY, V91, P1872, DOI DOI 10.1890/09-2017.1; Miller SJ, 2006, ECOL INDIC, V6, P313, DOI 10.1016/j.ecolind.2005.03.012; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; Morrison LW, 2016, J PLANT ECOL, V9, P367, DOI 10.1093/jpe/rtv077; Mueller-Dombois D., 1974, AIMS METHODS VEGETAT; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; NILSSON IN, 1985, J ECOL, V73, P65, DOI 10.2307/2259768; Palmer MW, 2007, CASTANEA, V72, P235, DOI 10.2179/06-29.1; Panzer R, 1998, CONSERV BIOL, V12, P693, DOI 10.1046/j.1523-1739.1998.97051.x; Peng Wanting, 2014, Biodiversity Science, V22, P564, DOI 10.3724/SP.J.1003.2014.14078; Rooney TP, 2002, NAT AREA J, V22, P340; Rothrock Paul E., 2005, Proceedings of the Indiana Academy of Science, V114, P9; Sandel B, 2015, ECOGRAPHY, V38, P358, DOI 10.1111/ecog.01034; Scott WA, 2003, PLANT ECOL, V165, P101, DOI 10.1023/A:1021441331839; Smart AJ, 2011, GREAT PLAINS RES FAL, P181; Spyreas G., 2014, EXAMINATION TEMPORAL; Spyreas G, 2006, ECOL APPL, V16, P1351, DOI 10.1890/1051-0761(2006)016[1351:FCVNUF]2.0.CO;2; Spyreas G, 2012, J APPL ECOL, V49, P339, DOI 10.1111/j.1365-2664.2011.02100.x; Spyreas G, 2010, BIOL INVASIONS, V12, P1253, DOI 10.1007/s10530-009-9544-y; T'ulbure MG, 2007, J GREAT LAKES RES, V33, P269, DOI 10.3394/0380-1330(2007)33[269:RIOAGL]2.0.CO;2; TAFT JB, 1997, ERIGENIA, V15, P1; Taft JB, 2006, BIOL CONSERV, V131, P42, DOI 10.1016/j.biocon.2006.02.006; U.S.E.P.A, 2010, DRAFT EC IND 2011 NA; Wilcox DA, 2002, WETLANDS, V22, P588, DOI 10.1672/0277-5212(2002)022[0588:HVATAO]2.0.CO;2; Wilson MJ, 2012, ECOL INDIC, V20, P187, DOI 10.1016/j.ecolind.2012.02.009; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	58	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160693	10.1371/journal.pone.0160693	http://dx.doi.org/10.1371/journal.pone.0160693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27489959	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900077
J	Vleurinck, C; Raub, S; Sturgill, D; Oliver, B; Beye, M				Vleurinck, Christina; Raub, Stephan; Sturgill, David; Oliver, Brian; Beye, Martin			Linking Genes and Brain Development of Honeybee Workers: A Whole-Transcriptome Approach	PLOS ONE			English	Article							COLONY INTEGRATION; BEE; BEHAVIOR; DIFFERENTIATION; VISUALIZATION; EXPRESSION; QUEEN	Honeybees live in complex societies whose capabilities far exceed those of the sum of their single members. This social synergism is achieved mainly by the worker bees, which form a female caste. The worker bees display diverse collaborative behaviors and engage in different behavioral tasks, which are controlled by the central nervous system (CNS). The development of the worker brain is determined by the female sex and the worker caste determination signal. Here, we report on genes that are controlled by sex or by caste during differentiation of the worker's pupal brain. We sequenced and compared transcriptomes from the pupal brains of honeybee workers, queens and drones. We detected 333 genes that are differently expressed and 519 genes that are differentially spliced between the sexes, and 1760 genes that are differentially expressed and 692 genes that are differentially spliced between castes. We further found that 403 genes are differentially regulated by both the sex and caste signals, providing evidence of the integration of both signals through differential gene regulation. In this gene set, we found that the molecular processes of restructuring the cell shape and cell-to-cell signaling are overrepresented. Our approach identified candidate genes that may be involved in brain differentiation that ensures the various social worker behaviors.	[Vleurinck, Christina; Beye, Martin] Univ Dusseldorf, Inst Evolutionary Genet, Dusseldorf, Germany; [Raub, Stephan] Univ Dusseldorf, Ctr Informat & Media Technol, Dusseldorf, Germany; [Sturgill, David; Oliver, Brian] NIDDK, Lab Cellular & Dev Biol, Bethesda, MD 20892 USA; [Sturgill, David] NCI, Lab Receptor Biol & Gene Express, Bethesda, MD 20892 USA	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Beye, M (corresponding author), Univ Dusseldorf, Inst Evolutionary Genet, Dusseldorf, Germany.	martin.beye@hhu.de		Sturgill, David/0000-0002-7902-3605	Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015600] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/). MB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Arthur BI, 1998, CURR BIOL, V8, P1187, DOI 10.1016/S0960-9822(07)00491-5; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Chen X, 2012, INSECT BIOCHEM MOLEC, V42, P665, DOI 10.1016/j.ibmb.2012.05.004; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Haydak MH, 1943, J ECON ENTOMOL, V36, P778, DOI 10.1093/jee/36.5.778; Holldobler B., 2009, SUPERORGANISM; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li-Byarlay H, 2013, P NATL ACAD SCI USA, V110, P12750, DOI 10.1073/pnas.1310735110; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Ramirez SR, 2010, MOL PHYLOGENET EVOL, V56, P519, DOI 10.1016/j.ympev.2010.04.026; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Schulte C, 2014, P NATL ACAD SCI USA, V111, P9003, DOI 10.1073/pnas.1402341111; Seeley T., 1995, WISDOM HIVE SOCIAL P; Sturgill D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-320; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Technau G.M., 2008, BRAIN DEV DROSOPHILA; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Winston M.L., 1991, BIOL HONEY BEE; WINSTON ML, 1985, CAN J ZOOL, V63, P777, DOI 10.1139/z85-113; Winston ML, 1996, SCIENCE, V272, P967, DOI 10.1126/science.272.5264.967	37	17	17	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0157980	10.1371/journal.pone.0157980	http://dx.doi.org/10.1371/journal.pone.0157980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490820	Green Submitted, gold, Green Published			2022-12-27	WOS:000381368900003
J	Kraim-Leleu, M; Lesage, FX; Drame, M; Lebargy, F; Deschamps, F				Kraim-Leleu, Marie; Lesage, Francois-Xavier; Drame, Moustapha; Lebargy, Francois; Deschamps, Frederic			Occupational Risk Factors for COPD: A Case-Control Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EXPOSURE; EPIDEMIOLOGY; ASSOCIATION; BURDEN; DEFINITION; PREVALENCE	Objectives The aim of this research was to examine the occupational risk factors for Chronic Obstructive Pulmonary Diseases (COPD) in a range of occupations. Methods Eleven occupations involving different types of exposure were observed in this multicenter case-control study. Controls and cases were matched for sex, age and smoking. Multiple logistic regression analyses were used to estimate odds ratios (ORs). Results A total of 1,519 participants were initially recruited between September 2004 and September 2012. After matching, 547 pairs were obtained. The mean age was 56.3 +/- 10.4 years. Smelter workers were the only ones with an increased risk of COPD in this study (OR = 7.6, p < 0.0001, 95% CI [4.5, 12.9]). Physical activity was protective (OR = 0.7), while living in the city was a risk (OR = 1.6). The main used metals were cast iron, aluminum and alloys. Molds and cores were mainly made from sand and synthetic resins. Machine maintenance (65.2%), molding (49.6%), finishing (41.1%) and casting (41.0%) were the most common activities. Almost all workers (95.1%) cleaned the floors and machines with a brush or compressed air. Conclusions This study demonstrates the importance of occupational factors in the genesis of COPD, especially among smelter workers. As with the fight against smoking-related disease, the removal or substitution of recognized hazardous agents is the best way of preventing the onset of COPD. This is why it is essential to continue research on its occupational risk factors.	[Kraim-Leleu, Marie; Deschamps, Frederic] Univ Reims, Dept Occupat Hlth, Fac Med, Reims, France; [Lesage, Francois-Xavier] Univ Montpellier, Dept Occupat Hlth, Fac Med, Montpellier, France; [Lesage, Francois-Xavier] Univ Montpellier, Dept Psychology, Epsylon EA 4556, Montpellier, France; [Drame, Moustapha] Univ Reims, Dept Publ Hlth & Clin Res, Fac Med, Reims, France; [Lebargy, Francois] Univ Reims, Dept Resp Med, Fac Med, Reims, France	Universite de Reims Champagne-Ardenne; Universite de Montpellier; Universite de Montpellier; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Lesage, FX (corresponding author), Univ Montpellier, Dept Occupat Hlth, Fac Med, Montpellier, France.; Lesage, FX (corresponding author), Univ Montpellier, Dept Psychology, Epsylon EA 4556, Montpellier, France.	fx-lesage@chu-montpellier.fr	Dramé, Moustapha/E-6888-2017; Dramé, Moustapha/AAK-4797-2020	Dramé, Moustapha/0000-0002-6662-8832; 				Ameille J, 2006, REV MAL RESPIR, V23; American Thoracic Society/European Respiratory Society Task Force, 2004, STAND DIAGN MAN PAT; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Bergdahl IA, 2004, EUR RESPIR J, V23, P402, DOI 10.1183/09031936.04.00034304; Blanc RD, 2007, INT J TUBERC LUNG D, V11, P251; Blanc PD, 2009, EUR RESPIR J, V33, P298, DOI 10.1183/09031936.00118808; Blanc PD, 2009, THORAX, V64, P6, DOI 10.1136/thx.2008.099390; Blanc PD, 2012, J ASTHMA, V49, P2, DOI 10.3109/02770903.2011.611957; Blanc PD, 2009, J OCCUP ENVIRON MED, V51, P804, DOI 10.1097/JOM.0b013e3181a7dd4e; Blanc PD, 2004, OCCUP ENVIRON MED, V61, P661, DOI 10.1136/oem.2003.010058; Boschetto P, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-11; BURGE PS, 1994, EUR RESPIR J, V7, P1032; Caillaud D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-302; Devereux G, 2006, BRIT MED J, V332, P1142, DOI 10.1136/bmj.332.7550.1142; Diaz-Guzman E, 2012, CLIN CHEST MED, V33, P625, DOI 10.1016/j.ccm.2012.07.004; Fishwick David, 2010, Chron Respir Dis, V7, P113, DOI 10.1177/1479972309354690; Giraud V, 2008, PRESSE MED, V37, P377, DOI 10.1016/j.lpm.2007.10.012; Govender N, 2011, THORAX, V66, P597, DOI 10.1136/thx.2010.149468; Hendrick DJ, 1996, THORAX, V51, P947, DOI 10.1136/thx.51.9.947; Katajisto M, 2012, INT J CHRONIC OBSTR, V7, P743, DOI 10.2147/COPD.S35497; Lam KBH, 2012, RESP MED, V106, P1421, DOI 10.1016/j.rmed.2012.05.009; Lamprecht B, 2007, AM J IND MED, V50, P421, DOI 10.1002/ajim.20470; Le Moual N, 2000, OCCUP ENVIRON MED, V57, P126, DOI 10.1136/oem.57.2.126; Meldrum M, 2005, OCCUP ENVIRON MED, V62, P212, DOI 10.1136/oem.2004.015511; Melville AM, 2010, EUR RESPIR J, V36, P488, DOI 10.1183/09031936.00038309; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Rodriguez E, 2008, CHEST, V134, P1237, DOI 10.1378/chest.08-0622; Rushton Lesley, 2007, Reviews on Environmental Health, V22, P195; Salvi SS, 2012, PRIM CARE RESP J, V21, P249, DOI 10.4104/pcrj.2012.00082; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sunyer J, 2006, OCCUP ENVIRON MED, V63, P836, DOI 10.1136/oem.2006.027995; Teschke K, 2002, OCCUP ENVIRON MED, V59, P575, DOI 10.1136/oem.59.9.575; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507; Weinmann S, 2008, J OCCUP ENVIRON MED, V50, P561, DOI 10.1097/JOM.0b013e3181651556	37	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0158719	10.1371/journal.pone.0158719	http://dx.doi.org/10.1371/journal.pone.0158719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487078	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800014
J	Murphy, JC; Jowers, MJ; Lehtinen, RM; Charles, SP; Colli, GR; Peres, AK; Hendry, CR; Pyron, RA				Murphy, John C.; Jowers, Michael J.; Lehtinen, Richard M.; Charles, Stevland P.; Colli, Guarino R.; Peres, Ayrton K., Jr.; Hendry, Catriona R.; Pyron, R. Alexander			Cryptic, Sympatric Diversity in Tegu Lizards of the Tupinambis teguixin Group (Squamata, Sauria, Teiidae) and the Description of Three New Species	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SELECTION	Tegus of the genera Tupinambis and Salvator are the largest Neotropical lizards and the most exploited clade of Neotropical reptiles. For three decades more than 34 million tegu skins were in trade, about 1.02 million per year. The genus Tupinambis is distributed in South America east of the Andes, and currently contains four recognized species, three of which are found only in Brazil. However, the type species of the genus, T. teguixin, is known from Bolivia, Brazil, Colombia, Ecuador, French Guyana, Guyana, Peru, Suriname, Trinidad and Tobago, and Venezuela ( including the Isla de Margarita). Here we present molecular and morphological evidence that this species is genetically divergent across its range and identify four distinct clades some of which are sympatric. The occurrence of cryptic sympatric species undoubtedly exacerbated the nomenclatural problems of the past. We discuss the species supported by molecular and morphological evidence and increase the number of species in the genus Tupinambis to seven. The four members of the T. teguixin group continue to be confused with Salvator merianae, despite having a distinctly different morphology and reproductive mode. All members of the genus Tupinambis are CITES Appendix II. Yet, they continue to be heavily exploited, under studied, and confused in the minds of the public, conservationists, and scientists.	[Murphy, John C.] Field Museum Nat Hist, Sci & Educ, 1400 S Lake Shore Dr, Chicago, IL 60605 USA; [Jowers, Michael J.] Natl Inst Ecol, 1210 Geumgang Ro, Maseo Myeon 33657, South Korea; [Jowers, Michael J.] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Campus Agr Vairao,Rua Padre Armando Quintas 7, P-4485661 Vairao, Portugal; [Lehtinen, Richard M.] Coll Wooster, Dept Biol, 931 Coll Mall, Wooster, OH 44691 USA; [Charles, Stevland P.] Howard Univ, Dept Biol, Washington, DC 20059 USA; [Colli, Guarino R.; Peres, Ayrton K., Jr.] Univ Brasilia, Dept Zool, BR-70910900 Brasilia, DF, Brazil; [Hendry, Catriona R.; Pyron, R. Alexander] George Washington Univ, Dept Biol, 2023 G St NW, Washington, DC 20052 USA	Field Museum of Natural History (Chicago); National Institute of Ecology; Universidade do Porto; College of Wooster; Howard University; Universidade de Brasilia; George Washington University	Murphy, JC (corresponding author), Field Museum Nat Hist, Sci & Educ, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	serpentresearch@gmail.com	Colli, Guarino Rinaldi/A-5368-2008; Jowers, Michael/AAT-8514-2021; Pyron, Robert/F-1681-2014; Murphy, John C/T-6175-2018	Colli, Guarino Rinaldi/0000-0002-2628-5652; Jowers, Michael J/0000-0001-8935-5913; Pyron, Robert/0000-0003-2524-1794; Murphy, John C/0000-0001-9252-6103	George Washington University; National Science Foundation [DBI-0905765, DEB-1441719]	George Washington University; National Science Foundation(National Science Foundation (NSF))	George Washington University and the National Science Foundation funded part of this project (DBI-0905765, DEB-1441719) to R. Alex Pyron. But, no funding for this project was received by the other authors.	AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; Balsai M., 1998, REPTILES, V6, P52; Bauer AM, 2013, ZOOSYST EVOL, V89, P167, DOI 10.1002/zoos.201300005; Beebe W., 1944, ZOOLOGICA PART 2, V2, P195; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boehme Wolfgang, 2010, Bonn Zoological Bulletin, V59, P79; Boos HEA, 1975, J TRINIDAD TOBAGO FI, V16-21, P47; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Costa Henrique Caldeira, 2008, Check List, V4, P267; da Silva MB, 2013, ZOOKEYS, P61, DOI 10.3897/zookeys.361.5738; de Queiroz K, 1998, ENDLESS FORMS, P57; Deng H., 2013, ARXIV13060237, V1306.0237, P1; Deng HT, 2012, IEEE IJCNN; Deng HT, 2013, PATTERN RECOGN, V46, P3483, DOI 10.1016/j.patcog.2013.05.018; Donso-Barrios R, 1970, B US NATL MUSEUM; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duellman W.E., 2005, CUSCO AMAZONICO; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FITZGERALD LA, 1994, AM ZOOL, V34, P371; FITZGERALD LA, 1993, J HERPETOL, V27, P70, DOI 10.2307/1564908; Fitzgerald LA, 1999, COPEIA, P894, DOI 10.2307/1447965; Fitzgerald LA, 2012, REPTILE BIODIVERSITY: STANDARD METHODS FOR INVENTORY AND MONITORING, P323; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Giugliano LG, 2007, MOL PHYLOGENET EVOL, V45, P168, DOI 10.1016/j.ympev.2007.05.017; Goeldi EA, 1897, ZOOL JB SYST, V10, P640; Gols-Ripoll A, 2015, REV BIOL TROP, V63, P1235, DOI 10.15517/rbt.v63i4.17962; Green B, 1997, COPEIA, P200; Hagmann G., 1907, ZOO JB JEENA F, V24, P307; Harvey MB, 2012, ZOOTAXA, P1; Herrera EA, 2000, J HERPETOL, V34, P598, DOI 10.2307/1565277; Hill K, 2000, BIOL RESOURCE MANAGE, P79; HOOGMOED M S, 1983, Spixiana Supplement, P319; HOOGMOED M S, 1975, Zoologische Mededelingen (Leiden), V49, P141; Hoogmoed MS, 1973, BIOGEOGRAPHIA; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inger RF, 2009, ZOOL J LINN SOC-LOND, V155, P123, DOI 10.1111/j.1096-3642.2008.00440.x; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; KING D, 1994, COPEIA, P806; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Krieg H., 1925, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V3, P441, DOI 10.1007/BF00408150; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langstroth Robert P., 2005, Kempffiana, V1, P101; Manzani Paulo Roberto, 2002, Arquivos do Museu Nacional Rio de Janeiro, V60, P295; Muller P., 1968, HERPETOFAUNA INSEL S; Palumbi S, 1991, SIMPLE FOOLS GUIDE P, P96822; Pernas T, 2012, SOUTHEAST NAT, V11, P765, DOI 10.1656/058.011.0414; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; PRESCH W, 1973, COPEIA, P740; Prudente ALC, 2013, CHECKLIST, V9; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2009, ZOOTAXA, P22, DOI 10.11646/zootaxa.2241.1.2; Reese AM, 1922, COPEIA, P69; Rumiz Dl, 2012, THE CUTTING EDGE, P333; Schneider L, 2011, CHELONIAN CONSERV BI, V10, P206, DOI 10.2744/1071-8443-10.2.206; Seba A, ARTIFICIOSISSIMIS EX; STATON M A, 1977, Journal of Herpetology, V11, P17, DOI 10.2307/1563286; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Sy EY, 2015, J NATURE STUDIES, V14, P66; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vanzolini PE, 1981, INTRO SCI POLITICAL; Werneck FP, 2006, J BIOGEOGR, V33, P1983, DOI 10.1111/j.1365-2699.2006.01553.x	62	27	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0158542	10.1371/journal.pone.0158542	http://dx.doi.org/10.1371/journal.pone.0158542			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487019	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800013
J	Nashine, S; Chwa, M; Kazemian, M; Thaker, K; Lu, S; Nesburn, A; Kuppermann, BD; Kenney, MC				Nashine, Sonali; Chwa, Marilyn; Kazemian, Mina; Thaker, Kunal; Lu, Stephanie; Nesburn, Anthony; Kuppermann, Baruch D.; Kenney, M. Cristina			Differential Expression of Complement Markers in Normal and AMD Transmitochondrial Cybrids	PLOS ONE			English	Article							MITOCHONDRIAL-NUCLEAR INTERACTIONS; H-RELATED PROTEIN; RETINAL-PIGMENT EPITHELIUM; C-REACTIVE PROTEIN; MACULAR DEGENERATION; DNA VARIANTS; CHOROIDAL NEOVASCULARIZATION; FUNCTIONAL-PROPERTIES; CELLS; RISK	Purpose Variations in mitochondrial DNA (mtDNA) and abnormalities in the complement pathways have been implicated in the pathogenesis of age-related macular degeneration (AMD). This study was designed to determine the effects of mtDNA from AMD subjects on the complement pathway. Methods Transmitochondrial cybrids were prepared by fusing platelets from AMD and age-matched Normal subjects with Rho0 (lacking mtDNA) human ARPE-19 cells. Quantitative PCR and Western blotting were performed to examine gene and protein expression profiles, respectively, of complement markers in these cybrids. Bioenergetic profiles of Normal and AMD cybrids were examined using the Seahorse XF24 flux analyzer. Results Significant decreases in the gene and protein expression of complement inhibitors, along with significantly higher levels of complement activators, were found in AMD cybrids compared to Older-Normal cybrids. Seahorse flux data demonstrated that the bioenergetic profiles for Older-Normal and Older-AMD cybrid samples were similar to each other but were lower compared to Young-Normal cybrid samples. Conclusion In summary, since all cybrids had identical nuclei and differed only in mtDNA content, the observed changes in components of complement pathways can be attributed to mtDNA variations in the AMD subjects, suggesting that mitochondrial genome and retrograde signaling play critical roles in this disease. Furthermore, the similar bioenergetic profiles of AMD and Older-Normal cybrids indicate that the signaling between mitochondria and nuclei are probably not via a respiratory pathway.	[Nashine, Sonali; Chwa, Marilyn; Thaker, Kunal; Lu, Stephanie; Nesburn, Anthony; Kuppermann, Baruch D.; Kenney, M. Cristina] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA; [Kazemian, Mina] Touro Univ Nevada, Coll Osteopath Med, Henderson, NV USA; [Lu, Stephanie] Long Beach Hosp, VA Med Ctr, Long Beach, CA USA; [Nesburn, Anthony] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Kenney, M. Cristina] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	University of California System; University of California Irvine; Cedars Sinai Medical Center; University of California System; University of California Irvine	Kenney, MC (corresponding author), Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA.; Kenney, MC (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA.	mkenney@uci.edu	NASHINE, SONALI/AAG-1474-2020		Arnold and Mabel Beckman Foundation; Discovery Eye Foundation; Guenther Foundation; Beckman Initiative for Macular Research; Polly and Michael Smith Foundation; Max Factor Family Foundation; Iris and B. Gerald Cantor Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; Discovery Eye Foundation; Guenther Foundation; Beckman Initiative for Macular Research; Polly and Michael Smith Foundation; Max Factor Family Foundation; Iris and B. Gerald Cantor Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Arnold and Mabel Beckman Foundation, Discovery Eye Foundation, Guenther Foundation, Beckman Initiative for Macular Research, Polly and Michael Smith Foundation, Max Factor Family Foundation, Iris and B. Gerald Cantor Foundation and SRN is a Arnold and Mabel Beckman Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2011, MIDDLE EAST AFR J OP, V18, P17, DOI 10.4103/0974-9233.75880; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Atilano SR, 2015, HUM MOL GENET, V24, P4491, DOI 10.1093/hmg/ddv173; Awh CC, 2013, OPHTHALMOLOGY, V120, P2317, DOI 10.1016/j.ophtha.2013.07.039; Ballinger SW, 2013, BIOCHEM SOC T, V41, P111, DOI 10.1042/BST20120227; Bandyopadhyay M, 2012, INVEST OPHTH VIS SCI, V53, P1953, DOI 10.1167/iovs.11-8638; Barot M, 2011, CURR EYE RES, V36, P1069, DOI 10.3109/02713683.2011.607536; Bellizzi D, 2013, DNA RES, V20, P537, DOI 10.1093/dnares/dst029; Bellizzi D, 2012, EPIGENOMICS-UK, V4, P17, DOI [10.2217/EPI.11.109, 10.2217/epi.11.109]; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Blenkinsop TA, 2015, INVEST OPHTH VIS SCI, V56, P7085, DOI 10.1167/iovs.14-16246; Bradley DT, 2011, EYE, V25, P683, DOI 10.1038/eye.2011.37; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Capt C., 2015, MITOCHONDR DNA, V00, P1; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Correia RL, 2011, MITOCHONDRION, V11, P48, DOI 10.1016/j.mito.2010.07.001; Dey R, 2000, J BIOL CHEM, V275, P31520, DOI 10.1074/jbc.M004053200; Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Gemenetzi M, 2016, EYE, V30, P1, DOI 10.1038/eye.2015.203; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; He Y, 2010, ADV EXP MED BIOL, V664, P165, DOI 10.1007/978-1-4419-1399-9_20; Hebecker M, 2012, J BIOL CHEM, V287, P19528, DOI 10.1074/jbc.M112.364471; Hebecker M, 2010, MOL IMMUNOL, V47, P1347, DOI 10.1016/j.molimm.2009.12.005; Hellwage J, 1999, FEBS LETT, V462, P345, DOI 10.1016/S0014-5793(99)01554-9; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Kam JH, 2013, AM J PATHOL, V183, P480, DOI 10.1016/j.ajpath.2013.04.008; Karunadharma PP, 2010, INVEST OPHTH VIS SCI, V51, P5470, DOI 10.1167/iovs.10-5429; Kenney MC, 2014, HUM MOL GENET, V23, P3537, DOI 10.1093/hmg/ddu065; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339; Kenney MC, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-4; Klein R, 2013, JAMA OPHTHALMOL, V131, P383, DOI 10.1001/jamaophthalmol.2013.713; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Losse J, 2010, J IMMUNOL, V184, P912, DOI 10.4049/jimmunol.0901702; Lyzogubov V, 2014, AM J PATHOL, V184, P2537, DOI 10.1016/j.ajpath.2014.06.001; Ma KN, 2010, INVEST OPHTH VIS SCI, V51, P6776, DOI 10.1167/iovs.10-5887; Malik D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099003; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Men J, 2012, J MOL NEUROSCI, V47, P144, DOI 10.1007/s12031-011-9701-5; Mihlan M, 2009, MOL IMMUNOL, V46, P335, DOI 10.1016/j.molimm.2008.10.029; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Persson BD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001122; Ratnapriya R, 2013, CLIN GENET, V84, P160, DOI 10.1111/cge.12206; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Rohrer B, 2016, ADV EXP MED BIOL, V854, P793, DOI 10.1007/978-3-319-17121-0_106; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; SEYA T, 1989, BIOCHEM J, V264, P581, DOI 10.1042/bj2640581; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Skerka C, 2013, MOL IMMUNOL, V56, P170, DOI 10.1016/j.molimm.2013.06.001; Smailhodzic D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112682; Stelmashook EV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P391, DOI 10.1134/S0006297914050022; Tawadrous H, 2010, PEDIATR NEPHROL, V25, P947, DOI 10.1007/s00467-009-1415-3; Terluk MR, 2015, J NEUROSCI, V35, P7304, DOI 10.1523/JNEUROSCI.0190-15.2015; Thakkinstian A, 2012, AM J EPIDEMIOL, V176, P361, DOI 10.1093/aje/kws031; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Udar N, 2009, INVEST OPHTH VIS SCI, V50, P2966, DOI 10.1167/iovs.08-2646; Ufret-Vincenty RL, 2010, INVEST OPHTH VIS SCI, V51, P5878, DOI 10.1167/iovs.09-4457; Williams P, 2003, J BIOL CHEM, V278, P10691, DOI 10.1074/jbc.M212561200; Wolff JN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0443; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002; Zhang FF, 2013, GENOME BIOL EVOL, V5, P1781, DOI 10.1093/gbe/evt129; Zhao J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002079	75	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159828	10.1371/journal.pone.0159828	http://dx.doi.org/10.1371/journal.pone.0159828			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486856	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800041
J	King, P; Pham, LK; Waltz, S; Sphar, D; Yamamoto, RT; Conrad, D; Taplitz, R; Torriani, F; Forsyth, RA				King, Paula; Pham, Long K.; Waltz, Shannon; Sphar, Dan; Yamamoto, Robert T.; Conrad, Douglas; Taplitz, Randy; Torriani, Francesca; Forsyth, R. Allyn			Longitudinal Metagenomic Analysis of Hospital Air Identifies Clinically Relevant Microbes	PLOS ONE			English	Article							MICROORGANISMS; ENVIRONMENT; DIVERSITY; GENOME; MICROBIOLOGY; TRANSMISSION; RESISTANCE; OUTBREAK; REVEALS	We describe the sampling of sixty-three uncultured hospital air samples collected over a six-month period and analysis using shotgun metagenomic sequencing. Our primary goals were to determine the longitudinal metagenomic variability of this environment, identify and characterize genomes of potential pathogens and determine whether they are atypical to the hospital airborne metagenome. Air samples were collected from eight locations which included patient wards, the main lobby and outside. The resulting DNA libraries produced 972 million sequences representing 51 gigabases. Hierarchical clustering of samples by the most abundant 50 microbial orders generated three major nodes which primarily clustered by type of location. Because the indoor locations were longitudinally consistent, episodic relative increases in microbial genomic signatures related to the opportunistic pathogens Aspergillus, Penicillium and Stenotrophomonas were identified as outliers at specific locations. Further analysis of microbial reads specific for Stenotrophomonas maltophilia indicated homology to a sequenced multi-drug resistant clinical strain and we observed broad sequence coverage of resistance genes. We demonstrate that a shotgun metagenomic sequencing approach can be used to characterize the resistance determinants of pathogen genomes that are uncharacteristic for an otherwise consistent hospital air microbial metagenomic profile.	[King, Paula; Pham, Long K.; Waltz, Shannon; Sphar, Dan; Forsyth, R. Allyn] FLIR Syst Inc, La Jolla, CA 92037 USA; [King, Paula; Forsyth, R. Allyn] Singlera Genom Inc, La Jolla, CA 92037 USA; [Forsyth, R. Allyn] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Yamamoto, Robert T.] Zova Syst LLC, San Diego, CA USA; [Conrad, Douglas] UC San Diego Hlth Syst, Div Pulm Med, Dept Med, San Diego, CA USA; [Taplitz, Randy; Torriani, Francesca] UC San Diego Hlth Syst, Div Infect Dis, Dept Med, San Diego, CA USA; [Taplitz, Randy; Torriani, Francesca] UC San Diego Hlth Syst, Infect Prevent & Clin Epidemiol Unit, San Diego, CA USA	California State University System; San Diego State University	Forsyth, RA (corresponding author), FLIR Syst Inc, La Jolla, CA 92037 USA.; Forsyth, RA (corresponding author), Singlera Genom Inc, La Jolla, CA 92037 USA.; Forsyth, RA (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	rforsyth@mail.sdsu.edu	Torriani, Francesca/HGE-5175-2022	King, Paula/0000-0002-3876-2655	Department of Homeland Security (DHS), Science and Technology Directorate (ST) [HSHQDC-10-C-00019]; FLIR Systems, Inc.; Singlera Genomics Inc.; Zova Systems, LLC	Department of Homeland Security (DHS), Science and Technology Directorate (ST)(United States Department of Homeland Security (DHS)); FLIR Systems, Inc.; Singlera Genomics Inc.; Zova Systems, LLC	Funding for this research was provided in full through contract HSHQDC-10-C-00019 to FLIR Systems, Inc., by the Department of Homeland Security (DHS), Science and Technology Directorate (S&T), http://www.dhs.gov/science-and-technology. DHS S&T reviewed and approved the manuscript for publication. DHS S&T had no additional roles in the study design, data collection and analysis or preparation of the manuscript. FLIR Systems, Inc., Singlera Genomics Inc. and Zova Systems, LLC, provided support in the form of salaries for authors PK, LKP, SW, DS, RTY, and RAF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afshinnekoo E, 2015, CELL SYST, V1, P97, DOI 10.1016/j.cels.2015.07.006; Alburty DS, 2013, M AM ASS AER RES POR; Amato P, 2007, FEMS MICROBIOL ECOL, V59, P242, DOI 10.1111/j.1574-6941.2006.00199.x; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Barnes HE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109061; Barrett LW, 1998, AM IND HYG ASSOC J, V59, P532, DOI 10.1080/15428119891010703; Beggs C, 2015, INDOOR AIR, V25, P462, DOI 10.1111/ina.12170; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Caggiano G, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0595-z; Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; de Abreu PM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-118; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096; Fernstrom A, 2013, J PATHOG, V2013, DOI [10.1155/013/493960, 10.1155/2013/493960]; Gibbons HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017836; Hahn T, 2002, INFECT CONT HOSP EP, V23, P525, DOI 10.1086/502101; Halachev MR, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0070-x; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Hasan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097699; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Jalali S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128711; Jiang WJ, 2015, NAT PROTOC, V10, P768, DOI 10.1038/nprot.2015.046; Katra I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05265; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Kievet O, 1999, ELECTRET FILTERS PRO; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Layshock JA, 2012, BIOSECUR BIOTERROR, V10, P299, DOI 10.1089/bsp.2012.0026; Leung MHY, 2014, APPL ENVIRON MICROB, V80, P6760, DOI 10.1128/AEM.02244-14; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Liu GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146064; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Matouskova I, 2014, INT J ENV RES PUB HE, V11, P9480, DOI 10.3390/ijerph110909480; Oberauner L, 2013, SCI REP-UK, V3, DOI 10.1038/srep01413; Ortiz G, 2009, CURR MICROBIOL, V59, P53, DOI 10.1007/s00284-009-9398-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Robertson CE, 2013, APPL ENVIRON MICROB, V79, P3485, DOI 10.1128/AEM.00331-13; Romay RJ, 1998, AEROSOL SCI TECH, V28, P224; Sanchez MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00658; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Sghaier H, 2016, ISME J, V10, P21, DOI 10.1038/ismej.2015.108; Sharon I, 2013, SCIENCE, V342, P1057, DOI 10.1126/science.1247023; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Smith DJ, 2012, MICROB ECOL, V64, P973, DOI 10.1007/s00248-012-0088-9; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Verde SC, 2015, RES MICROBIOL, V166, P557, DOI 10.1016/j.resmic.2015.03.004; Weber DJ, 1999, AM J INFECT CONTROL, V27, P59, DOI 10.1016/S0196-6553(99)70077-5; Yooseph S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081862	54	19	19	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160124	10.1371/journal.pone.0160124	http://dx.doi.org/10.1371/journal.pone.0160124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482891	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700024
J	Brown, CJ; Quates, CJ; Mirabzadeh, CA; Miller, CR; Wichman, HA; Miura, TA; Ytreberg, FM				Brown, Celeste J.; Quates, Caleb J.; Mirabzadeh, Christopher A.; Miller, Craig R.; Wichman, Holly A.; Miura, Tanya A.; Ytreberg, F. Marty			New Perspectives on Ebola Virus Evolution	PLOS ONE			English	Article							MOLECULAR EVOLUTION; ZAIRE EBOLAVIRUS; DC-SIGN; GLYCOPROTEIN; TRANSMISSION; PREDICTION; INFECTION; OUTBREAK; ANTIBODY; GENOME	Since the recent devastating outbreak of Ebola virus disease in western Africa, there has been significant effort to understand the evolution of the deadly virus that caused the outbreak. There has been a considerable investment in sequencing Ebola virus (EBOV) isolates, and the results paint an important picture of how the virus has spread in western Africa. EBOV evolution cannot be understood outside the context of previous outbreaks, however. We have focused this study on the evolution of the EBOV glycoprotein gene (GP) because one of its products, the spike glycoprotein (GP(1,2)), is central to the host immune response and because it contains a large amount of the phylogenetic signal for this virus. We inferred the maximum likelihood phylogeny of 96 nonredundant GP gene sequences representing each of the outbreaks since 1976 up to the end of 2014. We tested for positive selection and considered the placement of adaptive amino acid substitutions along the phylogeny and within the protein structure of GP(1,2). We conclude that: 1) the common practice of rooting the phylogeny of EBOV between the first known outbreak in 1976 and the next outbreak in 1995 provides a misleading view of EBOV evolution that ignores the fact that there is a non-human EBOV host between outbreaks; 2) the N-terminus of GP(1) may be constrained from evolving in response to the host immune system by the highly expressed, secreted glycoprotein, which is encoded by the same region of the GP gene; 3) although the mucin-like domain of GP(1) is essential for EBOV in vivo, it evolves rapidly without losing its twin functions: providing O-linked glycosylation sites and a flexible surface.	[Brown, Celeste J.; Miller, Craig R.; Wichman, Holly A.; Miura, Tanya A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Brown, Celeste J.; Miller, Craig R.; Wichman, Holly A.; Ytreberg, F. Marty] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA; [Brown, Celeste J.; Quates, Caleb J.; Mirabzadeh, Christopher A.; Miller, Craig R.; Wichman, Holly A.; Miura, Tanya A.; Ytreberg, F. Marty] Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA; [Quates, Caleb J.; Mirabzadeh, Christopher A.; Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Brown, CJ (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.; Brown, CJ (corresponding author), Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83843 USA.; Brown, CJ (corresponding author), Univ Idaho, Ctr Modeling Complex Interact, Moscow, ID 83843 USA.	celesteb@uidaho.edu	Miller, Craig/GWQ-5012-2022		National Science Foundation [DEB1521049]; Center for Modeling Complex Interactions; National Institutes of Health [P20 GM104420, P30 GM103324]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104420] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Center for Modeling Complex Interactions; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by DEB1521049 (to FMY) from the National Science Foundation (www.nsf.gov) and the Center for Modeling Complex Interactions, which is sponsored by P20 GM104420 (to HAW) from the National Institutes of Health (www.nih.gov). Computer resources were provided by the Institute for Bioinformatics and Evolutionary Studies Computational Resources Core, which is sponsored by P30 GM103324 from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Becquart P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096360; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; de La Vega MA, 2015, VIRAL IMMUNOL, V28, P3, DOI 10.1089/vim.2014.0068; Dudas Gytis, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.84eefe5ce43ec9dc0bf0670f7b8b417d; Falzarano D, 2006, CHEMBIOCHEM, V7, P1605, DOI 10.1002/cbic.200600223; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Grard G, 2011, J INFECT DIS, V204, pS776, DOI 10.1093/infdis/jir364; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jun SR, 2015, FEMS MICROBIOL REV, V39, P764, DOI 10.1093/femsre/fuv031; Khan T, 2015, GENOME BIOL EVOL, V7, P1815, DOI 10.1093/gbe/evv105; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Lam TTY, 2015, J VIROL, V89, P10130, DOI 10.1128/JVI.01226-15; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Lee JE, 2009, FUTURE VIROL, V4, P621, DOI 10.2217/FVL.09.56; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Li YH, 2014, EPIDEMIOL INFECT, V142, P1138, DOI 10.1017/S0950268813002215; Liu SQ, 2015, INFECT GENET EVOL, V32, P51, DOI 10.1016/j.meegid.2015.02.024; Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Olabode AS, 2015, VIROLOGY, V482, P202, DOI 10.1016/j.virol.2015.03.029; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Rawling J, 2007, METHODS MOL BIOL GLY; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; SANCHEZ A, 1993, VIRUS RES, V29, P215, DOI 10.1016/0168-1702(93)90063-S; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tran EEH, 2014, J VIROL, V88, P10958, DOI 10.1128/JVI.00870-14; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437; Walsh PD, 2005, PLOS BIOL, V3, P1946, DOI 10.1371/journal.pbio.0030371; Wittmann TJ, 2007, P NATL ACAD SCI USA, V104, P17123, DOI 10.1073/pnas.0704076104; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	52	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160410	10.1371/journal.pone.0160410	http://dx.doi.org/10.1371/journal.pone.0160410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479005	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300048
J	Cho, MS; Kim, J; Kim, JH; Kim, M; Lee, JH; Hwang, YM; Jo, U; Nam, G; Choi, KJ; Kim, YH				Cho, Min Soo; Kim, Jun; Kim, Ju Hyeon; Kim, Minsu; Lee, Ji Hyun; Hwang, You Mi; Jo, Uk; Nam, Gibyoung; Choi, Kee-Joon; Kim, You-Ho			Clinical, Echocardiographic, and Electrocardiographic Predictors of Persistent Atrial Fibrillation after Dual-Chamber Pacemaker Implantation: An Integrated Scoring Model Approach	PLOS ONE			English	Article							CANADIAN TRIAL; PROGRESSION; ASSOCIATION; BRADYCARDIA; RECIPIENTS	Persistent atrial fibrillation (PeAF) predictors after dual-chamber pacemaker (PM) implantation remain unclear. We sought to determine these predictors and establish an integrated scoring model. Data were retrospectively reviewed for 649 patients (63.8 +/- 12.3 years, 48.6% male, mean CHA(2)DS(2)-VASC score 2.7 +/- 2.0) undergoing dual-chamber PM implantation. PeAF was defined as documented AF on two consecutive electrocardiograms acquired >= 7 days apart. During a 7.1-year median follow-up (interquartile range 4.5-10.1 years), 67 (10.3%) patients had PeAF. Multivariable analysis showed the following independent predictors of future PeAF: ischemic stroke or transient ischemic accident history (hazard ratio [HR] 2.03, 95% confidence interval [CI] 1.03-3.50, p = 0.040), atrial fibrillation/ flutter history (HR 1.80, 95% CI 1.01-3.20, p = 0.046), sinus node disease (HR 2.24, 95% CI 1.16-4.35, p = 0.016), left atrial enlargement (>45 mm, HR 2.14, 95% CI 1.26-3.63, p = 0.005), and time in automatic mode switching > 1% at first follow-up interrogation (HR 2.58, 95% CI 1.51-4.42, p < 0.001). An integrated scoring model combining these predictors showed good discrimination performance at the seven-year follow-up. (C-statistic 0.716, 95% CI 0.629-0.802, p < 0.001). Significantly greater seven-year PeAF incidences were seen in patients with higher scores (2-5) than in those with lower scores (0-1) (22.8% +/- 3.8% vs. 5.3% +/- 1.7%, p < 0.001). In conclusion, an integrated scoring model combining clinical, echocardiographic, and electrocardiographic characteristics is useful for predicting future PeAF in patients with a dual-chamber PM.	[Cho, Min Soo; Kim, Jun; Kim, Ju Hyeon; Kim, Minsu; Lee, Ji Hyun; Hwang, You Mi; Jo, Uk; Nam, Gibyoung; Choi, Kee-Joon; Kim, You-Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Heart, Seoul, South Korea	University of Ulsan; Asan Medical Center	Kim, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Inst Heart, Seoul, South Korea.	mdjunkim@gmail.com	Hwang, YouMi/GVS-5432-2022; Hwang, Youmi/GXG-2427-2022	Hwang, YouMi/0000-0001-8385-6485; 				Al-Khatib SM, 2000, AM HEART J, V140, P142, DOI 10.1067/mhj.2000.107547; Boriani G, 2014, EUR HEART J, V35, P2352, DOI 10.1093/eurheartj/ehu165; BRANDT J, 1990, PACE, V13, P417, DOI 10.1111/j.1540-8159.1990.tb02056.x; Capucci A, 2005, J AM COLL CARDIOL, V46, P1913, DOI 10.1016/j.jacc.2005.07.044; de Voogt WG, 2006, EUROPACE, V8, P950, DOI 10.1093/europace/eul112; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; Gillis AM, 2002, J CARDIOVASC ELECTR, V13, P542, DOI 10.1046/j.1540-8167.2002.00542.x; Glotzer TV, 2003, CIRCULATION, V107, P1614, DOI 10.1161/01.CIR.0000057981.70380.45; Healey JS, 2013, CAN J CARDIOL, V29, P224, DOI 10.1016/j.cjca.2012.08.019; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Kerr CR, 2005, AM HEART J, V149, P489, DOI 10.1016/j.ahj.2004.09.053; Kerr CR, 2004, CIRCULATION, V109, P357, DOI 10.1161/01.CIR.0000109490.72104.EE; Kosmala W, 2015, CIRCULATION CARDIOVA, V8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Mattioli AV, 1998, EUR HEART J, V19, P282, DOI 10.1053/euhj.1997.0616; Nagarakanti R, 2011, J INTERV CARD ELECTR, V32, P7, DOI 10.1007/s10840-011-9601-1; Orlov MV, 2007, PACE, V30, P404, DOI 10.1111/j.1540-8159.2007.00682.x; Padeletti L, 2008, AM HEART J, V156, P520, DOI 10.1016/j.ahj.2008.04.013; Passman RS, 2004, J CARDIOVASC ELECTR, V15, P773, DOI 10.1046/j.1540-8167.2004.03537.x; Petrac D, 2012, PACE, V35, P695, DOI 10.1111/j.1540-8159.2012.03376.x; Ricci RP, 2015, HEART RHYTHM, V12, P2239, DOI 10.1016/j.hrthm.2015.06.041; Saksena S, 2007, AM HEART J, V154, P884, DOI 10.1016/j.ahj.2007.06.045; Sanders P, 2004, CIRCULATION, V109, P1514, DOI 10.1161/01.CIR.0000121734.47409.AA; Skanes AC, 2001, J AM COLL CARDIOL, V38, P167, DOI 10.1016/S0735-1097(01)01326-2; Stambler BS, 2003, PACE, V26, P2000, DOI 10.1046/j.1460-9592.2003.00309.x; Sweeney MO, 2007, NEW ENGL J MED, V357, P1000, DOI 10.1056/NEJMoa071880	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160422	10.1371/journal.pone.0160422	http://dx.doi.org/10.1371/journal.pone.0160422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479069	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110300049
J	Argaud, S; Delplanque, S; Houvenaghel, JF; Auffret, M; Duprez, J; Verin, M; Grandjean, D; Sauleau, P				Argaud, Soizic; Delplanque, Sylvain; Houvenaghel, Jean-Francois; Auffret, Manon; Duprez, Joan; Verin, Marc; Grandjean, Didier; Sauleau, Paul			Does Facial Amimia Impact the Recognition of Facial Emotions? An EMG Study in Parkinson's Disease	PLOS ONE			English	Article							EXPRESSION RECOGNITION; MIMICRY; FACE; IMPRESSIONS; PERFORMANCE; PERCEPTION; STIMULI; PEOPLE; MODELS	According to embodied simulation theory, understanding other people's emotions is fostered by facial mimicry. However, studies assessing the effect of facial mimicry on the recognition of emotion are still controversial. In Parkinson's disease (PD), one of the most distinctive clinical features is facial amimia, a reduction in facial expressiveness, but patients also show emotional disturbances. The present study used the pathological model of PD to examine the role of facial mimicry on emotion recognition by investigating EMG responses in PD patients during a facial emotion recognition task (anger, joy, neutral). Our results evidenced a significant decrease in facial mimicry for joy in PD, essentially linked to the absence of reaction of the zygomaticus major and the orbicularis oculi muscles in response to happy avatars, whereas facial mimicry for expressions of anger was relatively preserved. We also confirmed that PD patients were less accurate in recognizing positive and neutral facial expressions and highlighted a beneficial effect of facial mimicry on the recognition of emotion. We thus provide additional arguments for embodied simulation theory suggesting that facial mimicry is a potential lever for therapeutic actions in PD even if it seems not to be necessarily required in recognizing emotion as such.	[Argaud, Soizic; Houvenaghel, Jean-Francois; Auffret, Manon; Duprez, Joan; Verin, Marc; Sauleau, Paul] Univ Rennes 1, Behav & Basal Ganglia Res Unit EA4712, Rennes, France; [Argaud, Soizic; Grandjean, Didier] Univ Geneva, Dept Psychol & Educ Sci, Neurosci Emot & Affect Dynam Lab, Geneva, Switzerland; [Delplanque, Sylvain; Grandjean, Didier] Univ Geneva, Swiss Ctr Affect Sci, Campus Biotech, Geneva, Switzerland; [Houvenaghel, Jean-Francois; Verin, Marc] Rennes Univ Hosp, Dept Neurol, Rennes, France; [Sauleau, Paul] Rennes Univ Hosp, Dept Neurophysiol, Rennes, France	Universite de Rennes; University of Geneva; University of Geneva; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes	Argaud, S (corresponding author), Univ Rennes 1, Behav & Basal Ganglia Res Unit EA4712, Rennes, France.; Argaud, S (corresponding author), Univ Geneva, Dept Psychol & Educ Sci, Neurosci Emot & Affect Dynam Lab, Geneva, Switzerland.	argaud.soizic@gmail.com	Verin, Marc/ABC-6924-2020; Duprez, Joan/X-8320-2019; Sauleau, Paul/ABC-4459-2020; Auffret, Manon/J-1832-2019	Duprez, Joan/0000-0002-8176-5114; Auffret, Manon/0000-0002-7003-4084; Delplanque, Sylvain/0000-0002-9025-4754; Grandjean, Didier/0000-0001-6125-4520; Houvenaghel, Jean-Francois/0000-0001-5424-2759	Belgian pharmaceutical company UCB Pharma; national association of PD patients France Parkinson; National Center of Competence in Research (NCCR Affective Sciences) [51NF40-104897]	Belgian pharmaceutical company UCB Pharma(UCB Pharma SA); national association of PD patients France Parkinson; National Center of Competence in Research (NCCR Affective Sciences)	This work was supported by the Belgian pharmaceutical company UCB Pharma; the national association of PD patients France Parkinson; and the National Center of Competence in Research "Affective Sciences - Emotions in Individual Behaviour and Social Processes" (NCCR Affective Sciences) [51NF40-104897 to DG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1998, NEUROPSYCHOLOGY, V12, P253, DOI 10.1037/0894-4105.12.2.253; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Alonso-Recio L, 2014, J NEUROPSYCHOL, V8, P269, DOI 10.1111/jnp.12029; Anders S, 2012, BRAIN, V135, P1128, DOI 10.1093/brain/aws040; Ariatti A, 2008, NEUROL SCI, V29, P219, DOI 10.1007/s10072-008-0971-9; Assogna F, 2008, EUR NEUROPSYCHOPHARM, V18, P835, DOI 10.1016/j.euroneuro.2008.07.004; Bailey PE, 2009, PSYCHOL AGING, V24, P224, DOI 10.1037/a0014112; Benke T, 1998, BRAIN COGNITION, V38, P36, DOI 10.1006/brcg.1998.1013; Benton AL, 1994, CONTRIBUTIONS TO NEU; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Blairy S, 1999, J NONVERBAL BEHAV, V23, P5, DOI 10.1023/A:1021370825283; Bogart K. R., 2014, HDB SPRACH KOMMUNIKA, V2, P1969; Bogart KR, 2012, REHABIL PSYCHOL, V57, P43, DOI 10.1037/a0026904; Bogart KR, 2010, SOC NEUROSCI-UK, V5, P241, DOI 10.1080/17470910903395692; Bologna M, 2013, J NEUROL NEUROSUR PS, V84, P681, DOI 10.1136/jnnp-2012-303993; CAEKEBEKE JFV, 1991, J NEUROL NEUROSUR PS, V54, P145, DOI 10.1136/jnnp.54.2.145; Darwin C., 2001, THE EXPRESSION OF TH; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Douglas B, IME4 LINEAR MIXED EF; Dujardin K, 2004, NEUROPSYCHOLOGIA, V42, P239, DOI 10.1016/S0028-3932(03)00154-4; Dujardin K, 2013, MOVEMENT DISORD, V28, P2014, DOI 10.1002/mds.25584; Ekman P., 2002, FACIAL ACTION CODING; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Fox J, 2010, AN R COMPANION TO AP; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gallese V., 2005, PHENOMENOLOGY COGNIT, V4, P23, DOI [10.1007/s11097-005-4737-z, DOI 10.1007/S11097-005-4737-Z]; Goldman AI, 2005, COGNITION, V94, P193, DOI 10.1016/j.cognition.2004.01.005; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Hemmesch AR, 2009, PSYCHOL AGING, V24, P542, DOI 10.1037/a0016105; Herrera E, 2011, J NEUROL SCI, V310, P237, DOI 10.1016/j.jns.2011.06.034; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2001, EMOTIONS QUALIA CONS, P397; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hess U, 2010, BIOL PSYCHOL, V84, P514, DOI 10.1016/j.biopsycho.2009.11.001; Hoehn MM, 2001, NEUROLOGY, V57, pS11; JACOBS DH, 1995, NEUROLOGY, V45, P1696, DOI 10.1212/WNL.45.9.1696; Kan Y, 2002, CORTEX, V38, P623, DOI 10.1016/S0010-9452(08)70026-1; Korb S, 2015, CORTEX, V70, P101, DOI 10.1016/j.cortex.2015.06.025; Korb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099194; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Krumhuber EG, 2012, EMOTION, V12, P351, DOI 10.1037/a0026632; Kunecke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084053; Lawrence AD, 2002, NEUROREPORT, V13, P881, DOI 10.1097/00001756-200205070-00029; Lawrence AD, 2007, NEUROPSYCHOLOGIA, V45, P65, DOI 10.1016/j.neuropsychologia.2006.04.016; MADELEY P, 1995, BEHAV NEUROL, V8, P115, DOI 10.3233/BEN-1995-8207; Mallol R, 2007, BRAIN RES, V1147, P265, DOI 10.1016/j.brainres.2007.02.046; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Mattis S, 1988, DEMENTIA RATING SCAL; McIntosh LG, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00349; Mermillod Martial, 2011, ISRN Neurol, V2011, P306918, DOI 10.5402/2011/306918; Molenberghs P, 2012, NEUROSCI BIOBEHAV R, V36, P341, DOI 10.1016/j.neubiorev.2011.07.004; Neal DT, 2011, SOC PSYCHOL PERS SCI, V2, P673, DOI 10.1177/1948550611406138; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Pell MD, 2005, COGNITIVE BRAIN RES, V23, P327, DOI 10.1016/j.cogbrainres.2004.11.004; PENTLAND B, 1988, BRIT J DISORD COMMUN, V23, P31; Peron J, 2013, NEUROSCI BIOBEHAV R, V37, P358, DOI 10.1016/j.neubiorev.2013.01.001; Peron J, 2012, MOVEMENT DISORD, V27, P186, DOI 10.1002/mds.24025; Pistoia F, 2010, J NEUROSCI, V30, P7838, DOI 10.1523/JNEUROSCI.6300-09.2010; Ponari M, 2012, EMOTION, V12, P1398, DOI 10.1037/a0028588; R Core Team, 2014, R A LANGUAGE AND ENV; Ricciardi L, 2015, J NEUROL SCI, V358, P125, DOI 10.1016/j.jns.2015.08.1516; Roesch EB, 2011, J NONVERBAL BEHAV, V35, P1, DOI 10.1007/s10919-010-0095-9; Rosario-Martinez H.D., 2013, PHIA POST HOC INTERA; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Salgado-Pineda P, 2005, CLIN NEUROPHARMACOL, V28, P228, DOI 10.1097/01.wnf.0000185824.57690.f0; Sato W, 2008, INT J PSYCHOPHYSIOL, V70, P70, DOI 10.1016/j.ijpsycho.2008.06.001; Sato W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057889; Schrag A, 2006, PARKINSONISM RELAT D, V12, P35, DOI 10.1016/j.parkreldis.2005.06.011; Spielberger CD., 2010, STATE TRAIT ANXIETY; Sprengelmeyer R, 2003, NEUROPSYCHOLOGIA, V41, P1047, DOI 10.1016/S0028-3932(02)00295-6; Stel M, 2008, PSYCHOL SCI, V19, P984, DOI 10.1111/j.1467-9280.2008.02188.x; Tessitore A, 2002, J NEUROSCI, V22, P9099, DOI 10.1523/jneurosci.22-20-09099.2002; Tickle-Degnen L, 2004, SOC SCI MED, V58, P603, DOI 10.1016/S0277-9536(03)00213-2; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Warrington EK, 1991, THE VISUAL OBJECT AN; Wechsler D., 2012, WAIS 4 KASIKIRJA; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x	82	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160329	10.1371/journal.pone.0160329	http://dx.doi.org/10.1371/journal.pone.0160329			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IL	27467393	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100147
J	Kikuchi, M; Shimada, M; Matsuzaka, T; Ishii, K; Nakagawa, Y; Takayanagi, M; Yamada, N; Shimano, H				Kikuchi, Manami; Shimada, Masako; Matsuzaka, Takashi; Ishii, Kiyoaki; Nakagawa, Yoshimi; Takayanagi, Misa; Yamada, Nobuhiro; Shimano, Hitoshi			Crucial Role of Elovl6 in Chondrocyte Growth and Differentiation during Growth Plate Development in Mice	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; METABOLIC SYNDROME; TARGETED DELETION; BONE-GROWTH; ELONGASE; IDENTIFICATION; HYPERTROPHY; HEDGEHOG; CALPAIN	ELOVL family member 6, elongation of very long chain fatty acids (Elovl6) is a microsomal enzyme, which regulates the elongation of C12-16 saturated and monounsaturated fatty acids. Elovl6 has been shown to be associated with various pathophysiologies including insulin resistance, atherosclerosis, and non-alcoholic steatohepatitis. To investigate a potential role of Elovl6 during bone development, we here examined a skeletal phenotype of Elovl6 knockout (Elovl6(-/-)) mice. The Elovl6(-/-) skeleton was smaller than that of controls, but exhibited no obvious patterning defects. Histological analysis revealed a reduced length of proliferating and an elongated length of hypertrophic chondrocyte layer, and decreased trabecular bone in Elovl6(-/-) mice compared with controls. These results were presumably due to a modest decrease in chondrocyte proliferation and accelerated differentiation of cells of the chondrocyte lineage. Consistent with the increased length of the hypertrophic chondrocyte layer in Elovl6(-/-) mice, Collagen10 alpha 1 was identified as one of the most affected genes by ablation of Elovl6 in chondrocytes. Furthermore, this elevated expression of Collagen10 alpha 1 of Elovl6-null chondrocytes was likely associated with increased levels of Foxa2/ a3 and Mef2c mRNA expression. Relative increases in protein levels of nuclear Foxa2 and cytoplasmic histone deacethylase 4/5/7 were also observed in Elovl6 knockdown cells of the chondrocyte lineage. Collectively, our data suggest that Elovl6 plays a critical role for proper development of embryonic growth plate.	[Kikuchi, Manami; Shimada, Masako; Matsuzaka, Takashi; Ishii, Kiyoaki; Nakagawa, Yoshimi; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Fac Med, Dept Internal Med Endocrinol & Metab, Ibaraki, Japan; [Shimada, Masako; Takayanagi, Misa] Sagami Womens Univ, Grad Sch Nutr Sci, Kanagawa, Japan; [Nakagawa, Yoshimi; Shimano, Hitoshi] Univ Tsukuba, Int Inst Integrat Sleep Med, Ibaraki, Japan; [Shimano, Hitoshi] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	University of Tsukuba; University of Tsukuba	Shimada, M (corresponding author), Univ Tsukuba, Fac Med, Dept Internal Med Endocrinol & Metab, Ibaraki, Japan.; Shimada, M (corresponding author), Sagami Womens Univ, Grad Sch Nutr Sci, Kanagawa, Japan.	shimada_masako@isc.sagami-wu.ac.jp	Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Shimano, Hitoshi/0000-0002-5562-5572; Ishii, Kiyo-aki/0000-0001-9846-5575	JSPS Kaken Houga [26560393]; AMED-CREST	JSPS Kaken Houga; AMED-CREST	This work is supported by JSPS Kaken Houga #26560393 to MS and AMED-CREST to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, CARING; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Ingham PW, 2001, SCIENCE, V294, P1879, DOI 10.1126/science.1064115; Ionescu A, 2012, DEV CELL, V22, P927, DOI 10.1016/j.devcel.2012.03.011; Kashiwagi A, 2011, BIOCHEM BIOPH RES CO, V409, P235, DOI 10.1016/j.bbrc.2011.04.134; Kashiwagi A, 2010, MOL CELL BIOL, V30, P2799, DOI 10.1128/MCB.00157-10; Koren N, 2014, J NUTR BIOCHEM, V25, P623, DOI 10.1016/j.jnutbio.2014.01.012; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kronenberg HM, 2006, ANN NY ACAD SCI, V1068, P1, DOI 10.1196/annals.1346.002; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Liu Y, 2013, BRAZ J MED BIOL RES, V46, P623, DOI 10.1590/1414-431X20133103; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Matsuzaka T, 2002, J LIPID RES, V43, P911; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Morcillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021198; Muka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129116; Narita T, 2005, DEV DYNAM, V233, P282, DOI 10.1002/dvdy.20321; Pearce LC, 2003, CARING, V22, P30; Pearce LC, 2003, CARING, V22, P2; Pearce Linda C, 2003, Caring, V22, P24; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Saito R, 2011, ARTERIOSCL THROM VAS, V31, P1973, DOI 10.1161/ATVBAHA.110.221663; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimada M, 2008, J BIOL CHEM, V283, P21002, DOI 10.1074/jbc.M710354200; Wang J, 1999, FASEB J, V13, P1985, DOI 10.1096/fasebj.13.14.1985; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Zhuo Q, 2012, NAT REV RHEUMATOL, V8, P729, DOI 10.1038/nrrheum.2012.135	33	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159375	10.1371/journal.pone.0159375	http://dx.doi.org/10.1371/journal.pone.0159375			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467521	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100028
J	Li, ZC; Wang, Y; Liu, Z				Li, Zhencai; Wang, Yang; Liu, Zhen			Unscented Kalman Filter-Trained Neural Networks for Slip Model Prediction	PLOS ONE			English	Article							ROBOTS	The purpose of this work is to investigate the accurate trajectory tracking control of a wheeled mobile robot (WMR) based on the slip model prediction. Generally, a nonholonomic WMR may increase the slippage risk, when traveling on outdoor unstructured terrain (such as longitudinal and lateral slippage of wheels). In order to control a WMR stably and accurately under the effect of slippage, an unscented Kalman filter and neural networks (NNs) are applied to estimate the slip model in real time. This method exploits the model approximating capabilities of nonlinear state-space NN, and the unscented Kalman filter is used to train NN's weights online. The slip parameters can be estimated and used to predict the time series of deviation velocity, which can be used to compensate control inputs of a WMR. The results of numerical simulation show that the desired trajectory tracking control can be performed by predicting the nonlinear slip model.	[Li, Zhencai; Wang, Yang; Liu, Zhen] Harbin Inst Technol, State Key Lab Robot & Syst, Harbin 150001, Peoples R China	Harbin Institute of Technology	Li, ZC; Liu, Z (corresponding author), Harbin Inst Technol, State Key Lab Robot & Syst, Harbin 150001, Peoples R China.	lizc_hit@163.com; liuzhen_hit@163.com			111 Project [B07018]; Self-Planned Task of State Key Laboratory of Robotics and System (HIT) [SKLRS20140MS09]	111 Project(Ministry of Education, China - 111 Project); Self-Planned Task of State Key Laboratory of Robotics and System (HIT)	111 Project, No. B07018; Self-Planned Task of State Key Laboratory of Robotics and System (HIT), SKLRS20140MS09.; This work was supported by the part of Self-Planned Task of State Key Laboratory of Robotics and System (HIT) (NO. SKLRS20140MS09); and the "111 Project" (Grant No. B07018).	Ahmed R, 2016, NEURAL COMPUT APPL, V27, P537, DOI 10.1007/s00521-015-1875-2; Ding LA, 2010, IEEE INT C INT ROBOT, P4958, DOI 10.1109/IROS.2010.5652250; Endo D, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P2877; Gao HB, 2013, INT J ROBOT AUTOM, V28, P371, DOI 10.2316/Journal.206.2013.4.206-3883; Haykin S., 2009, NEURAL NETWORKS LEAR; Jung JR, 2011, EXPERT SYST APPL, V38, P504, DOI 10.1016/j.eswa.2010.06.092; Kosic D, 2015, NEURAL NETWORKS, V63, P79, DOI 10.1016/j.neunet.2014.11.008; Li ZJ, 2012, IEEE T CONTR SYST T, V20, P1583, DOI 10.1109/TCST.2011.2168224; Li ZJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008443; Low C B, 2007, IEEE INT C ROB AUT; Mariani S, 2007, NONLINEAR DYNAM, V49, P131, DOI 10.1007/s11071-006-9118-9; Moreland S., 2012, P INT C FIELD SERV R; Ray LR, 2009, J TERRAMECHANICS, V46, P75, DOI 10.1016/j.jterra.2008.03.003; Sarkka S, 2007, IEEE T AUTOMAT CONTR, V52, P1631, DOI 10.1109/TAC.2007.904453; Ward CC, 2008, IEEE T ROBOT, V24, P821, DOI 10.1109/TRO.2008.924945; Wong JY., 2001, THEORY GROUND VEHICL; Xi YH, 2014, NEURAL COMPUT APPL, V25, P807, DOI 10.1007/s00521-014-1551-y; Yi JG, 2009, IEEE T ROBOT, V25, P1087, DOI 10.1109/TRO.2009.2026506; Zhan RH, 2006, IEEE SIGNAL PROC LET, V13, P445, DOI 10.1109/LSP.2006.871854	20	5	5	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0158492	10.1371/journal.pone.0158492	http://dx.doi.org/10.1371/journal.pone.0158492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467703	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516100010
J	Ventress, JK; Partridge, LJ; Read, RC; Cozens, D; MacNeil, S; Monk, PN				Ventress, Jennifer K.; Partridge, Lynda J.; Read, Robert C.; Cozens, Daniel; MacNeil, Sheila; Monk, Peter N.			Peptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes	PLOS ONE			English	Article							ADHESION	Staphylococcus aureus is one of the primary causative agents of skin and wound infections. As bacterial adherence is essential for infection, blocking this step can reduce invasion of host tissues by pathogens. An anti-adhesion therapy, based on a host membrane protein family, the tetraspanins, has been developed that can inhibit the adhesion of S. aureus to human cells. Synthetic peptides derived from a keratinocyte-expressed tetraspanin, CD9, were tested for anti-adhesive properties and at low nanomolar concentrations were shown to inhibit bacterial adhesion to cultured keratinocytes and to be effective in a tissue engineered model of human skin infection. These potential therapeutics had no effect on keratinocyte viability, migration or proliferation, indicating that they could be a valuable addition to current treatments for skin infection.	[Ventress, Jennifer K.; Cozens, Daniel; Monk, Peter N.] Univ Sheffield, Sch Med, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Partridge, Lynda J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield, S Yorkshire, England; [Read, Robert C.] Univ Southampton, Clin & Expt Med, Southampton, Hants, England; [MacNeil, Sheila] Univ Sheffield, Mat Sci & Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Southampton; University of Sheffield	Monk, PN (corresponding author), Univ Sheffield, Sch Med, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England.	p.monk@sheffield.ac.uk	Monk, Peter/C-6155-2008	Monk, Peter/0000-0003-4637-3059; Read, Robert/0000-0002-4297-6728	AgeUK Molly Burton Scholarship [370]	AgeUK Molly Burton Scholarship	AgeUK Molly Burton Scholarship 370 http://www.ageuk.org.uk/professional-resources-home/research/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Cozens D, 2012, EXPERT REV ANTI-INFE, V10, P1457, DOI [10.1586/ERI.12.145, 10.1586/eri.12.145]; Green LR, 2011, INFECT IMMUN, V79, P2241, DOI 10.1128/IAI.01354-10; Hassuna N, 2009, BIODRUGS, V23, P341, DOI 10.2165/11315650-000000000-00000; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Jiang X, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/489095; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Little MC, 1996, BRIT J DERMATOL, V134, P199; Monk Peter N., 2012, Infectious Disorders - Drug Targets, V12, P4; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shepherd J, 2009, TISSUE ENG PART C-ME, V15, P475, DOI 10.1089/ten.tec.2008.0614; Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14; Zhou G, 2001, J CELL SCI, V114, P4095; Zumaquero E, 2010, EXP CELL RES, V316, P2692, DOI 10.1016/j.yexcr.2010.05.032	16	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160387	10.1371/journal.pone.0160387	http://dx.doi.org/10.1371/journal.pone.0160387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467693	Green Published, Green Accepted, gold			2022-12-27	WOS:000381516100150
J	Leung, DTM; Lim, PL; Cheung, TH; Wong, RRY; Yim, SF; Ng, MHL; Tam, FCH; Chung, TKH; Wong, YF				Leung, Danny T. M.; Lim, Pak-Leong; Cheung, Tak-Hong; Wong, Raymond R. Y.; Yim, So-Fan; Ng, Margaret H. L.; Tam, Frankie C. H.; Chung, Tony K. H.; Wong, Yick-Fu			Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients	PLOS ONE			English	Article							BREAST-CANCER; PLASMA OSTEOPONTIN; TUMOR-GROWTH; HEPATOCELLULAR-CARCINOMA; BONE SIALOPROTEIN; DENDRITIC CELLS; EXPRESSION; METASTASIS; SURVIVAL; BINDING	We investigated whether circulating osteopontin (OPN) could be used as a biomarker for cervical cancer. We employed a monoclonal antibody (mAb 659) specific for the unique and intact thrombin-sensitive site in OPN using an inhibition ELISA. We found significantly higher levels of OPN in 33 cervical cancer patients in both the plasma (mean +/- SD, 612 +/- 106 ng/mL) and serum(424 +/- 121 ng/mL) compared to healthy subjects [409 +/- 56 ng/mL, from 31 plasma samples (P < 0.0001), and 314 +/- 98 ng/mL, from 32 serum samples (P = 0.0002), respectively]. Similar results were obtained when the plasma from a bigger group (147 individuals) of cervical cancer patients (560 +/- 211 ng/mL) were compared with the same plasma samples of the healthy individuals (P = 0.0014). More significantly, the OPN level was highest in stage III-IV disease (614 +/- 210 ng/mL, from 52 individuals; P = 0.0001) and least and nondiscriminatory in stage I (473 +/- 110 ng/mL, from 40 individuals; P = 0.5318). No such discrimination was found when a mAb of a different specificity (mAb 446) was used in a similar inhibition ELISA to compare the two groups in the first study; a commercial capture ELISA also failed. The possibility that the target epitope recognized by the antibody probe in these assays was absent from the circulating OPN due to protein truncation was supported by gel fractionation of the OPN found in patients' plasma: 60-64 kDa fragments were found instead of the presumably full-length OPN (68 kDa) seen in healthy people. How these fragments are generated and what possible role they play in cancer biology remain interesting questions.	[Leung, Danny T. M.; Lim, Pak-Leong; Tam, Frankie C. H.] Chinese Univ Hong Kong, Clin Immunol Unit, Hong Kong, Hong Kong, Peoples R China; [Lim, Pak-Leong; Tam, Frankie C. H.] IgGENE, Fo Tan, Hong Kong, Peoples R China; [Cheung, Tak-Hong; Wong, Raymond R. Y.; Yim, So-Fan; Chung, Tony K. H.; Wong, Yick-Fu] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wong, Yick-Fu] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynaecol & Reprod Biol, Boston, MA USA; [Ng, Margaret H. L.] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Chinese University of Hong Kong	Lim, PL (corresponding author), Chinese Univ Hong Kong, Clin Immunol Unit, Hong Kong, Hong Kong, Peoples R China.; Lim, PL (corresponding author), IgGENE, Fo Tan, Hong Kong, Peoples R China.; Chung, TKH (corresponding author), Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.	pllim@iggene.com; tonychung@cuhk.edu.hk; tonychung@cuhk.edu.hk		CHUNG, Tony/0000-0002-6362-8546	Chinese University of Hong Kong Direct Grants; Chinese University of Hong Kong	Chinese University of Hong Kong Direct Grants; Chinese University of Hong Kong(Chinese University of Hong Kong)	Funded by The Chinese University of Hong Kong Direct Grants awarded to YFW.; We thank Mr. Man-Hin Leung for technical assistance. This work was supported in part by a Direct Grant from the Chinese University of Hong Kong to YFW.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; Anborgh PH, 2009, CLIN CHEM, V55, P895, DOI 10.1373/clinchem.2008.117465; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chambers AF, 1996, LUNG CANCER-J IASLC, V15, P311, DOI 10.1016/0169-5002(95)00595-1; Cho H, 2008, J CANCER RES CLIN, V134, P909, DOI 10.1007/s00432-007-0351-5; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Coppola D, 2004, CLIN CANCER RES, V10, P184, DOI 10.1158/1078-0432.CCR-1405-2; Courter D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009633; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Fedarko NS, 2000, J BIOL CHEM, V275, P16666, DOI 10.1074/jbc.M001123200; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P15326, DOI 10.1073/pnas.0903704106; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Le QT, 2003, CLIN CANCER RES, V9, P59; Leung DTM, 2006, J VIROL, V80, P8920, DOI 10.1128/JVI.00649-06; Leung DTM, 2004, J INFECT DIS, V190, P379, DOI 10.1086/422040; Lim AM, 2012, CLIN CANCER RES, V18, P301, DOI 10.1158/1078-0432.CCR-11-2295; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; Ng L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126219; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970; Sakaguchi H, 2007, CANCER LETT, V247, P98, DOI 10.1016/j.canlet.2006.03.026; Shinohara ML, 2007, NAT MED, V13, P536, DOI 10.1038/nm0507-536; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Song JY, 2009, AUST NZ J OBSTET GYN, V49, P434, DOI 10.1111/j.1479-828X.2009.01027.x; Sun BS, 2008, HEPATOLOGY, V48, P1834, DOI 10.1002/hep.22531; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; Teramoto H, 2005, ONCOGENE, V24, P489, DOI 10.1038/sj.onc.1208209; Thoms JW, 2012, BRIT J CANCER, V107, P840, DOI 10.1038/bjc.2012.345; Tiniakos DG, 1998, HUM PATHOL, V29, P1250, DOI 10.1016/S0046-8177(98)90253-2; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Wai PY, 2008, CANCER METAST REV, V27, P103, DOI 10.1007/s10555-007-9104-9; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Wong YF, 2006, INT J CANCER, V118, P2461, DOI 10.1002/ijc.21660; Wun HL, 2001, INT IMMUNOL, V13, P1099, DOI 10.1093/intimm/13.9.1099; Yan MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024743; Yumoto K, 2002, P NATL ACAD SCI USA, V99, P4556, DOI 10.1073/pnas.052523599	46	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160412	10.1371/journal.pone.0160412	http://dx.doi.org/10.1371/journal.pone.0160412			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494141	gold, Green Submitted, Green Published			2022-12-27	WOS:000381369500041
J	Jay, JJ; Brouwer, C				Jay, Jeremy J.; Brouwer, Cory			Lollipops in the Clinic: Information Dense Mutation Plots for Precision Medicine	PLOS ONE			English	Article							CANCER	Introduction Concise visualization is critical to present large amounts of information in a minimal space that can be interpreted quickly. Clinical applications in precision medicine present an important use case due to the time dependent nature of the interpretations, although visualization is increasingly necessary across the life sciences. In this paper we describe the Lollipops software for the presentation of panel or exome sequencing results. Source code and binaries are freely available at https://github.com/pbnjay/lollipops. Although other software and web resources exist to produce lollipop diagrams, these packages are less suited to clinical applications. The demands of precision medicine require the ability to easily fit into a workflow and incorporate external information without manual intervention. Results The Lollipops software provides a simple command line interface that only requires an official gene symbol and mutation list making it easily scriptable. External information is integrated using the publicly available Uniprot and Pfam resources. Heuristics are used to select the most informative components and condense them for a concise plot. The output is a flexible Scalable Vector Graphic (SVG) diagram that can be displayed in a web page or graphic illustration tool. Conclusion The Lollipops software creates information-dense, publication-quality mutation plots for automated pipelines and high-throughput workflows in precision medicine. The automatic data integration enables clinical data security, and visualization heuristics concisely present knowledge with minimal user configuration.	[Jay, Jeremy J.; Brouwer, Cory] Bioinformat Serv Div, North Carolina Res Campus, Kannapolis, NC 28081 USA; [Jay, Jeremy J.; Brouwer, Cory] Univ N Carolina, Bioinformat & Genom Dept, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Jay, JJ (corresponding author), Bioinformat Serv Div, North Carolina Res Campus, Kannapolis, NC 28081 USA.; Jay, JJ (corresponding author), Univ N Carolina, Bioinformat & Genom Dept, Charlotte, NC 28223 USA.	jeremy.jay@uncc.edu	Jay, Jeremy/AAV-5143-2020	Jay, Jeremy/0000-0002-5761-7533				Aksoy BA, 2014, BIOINFORMATICS, V30, P2051, DOI 10.1093/bioinformatics/btu164; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bauer DT, 2010, J AM MED INFORM ASSN, V17, P416, DOI 10.1136/jamia.2009.000505; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Hawkins Robert C, 2007, Clin Biochem Rev, V28, P179; Ou J, 2016, TRACKVIEWER BIOCONDU; Schroeder MP, 2015, MUTS NEEDLE PLOT MUT; Turner Tychele, 2013, J Clin Bioinforma, V3, P14, DOI 10.1186/2043-9113-3-14	10	72	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160519	10.1371/journal.pone.0160519	http://dx.doi.org/10.1371/journal.pone.0160519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490490	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900064
J	Jeong, YC; Hwang, YH				Jeong, Yun Cheol; Hwang, Young Hoon			Etiology and Features of Eyes with Rubeosis Iridis among Korean Patients: A Population-Based Single Center Study	PLOS ONE			English	Article							OCULAR ISCHEMIC SYNDROME; RETINAL VEIN OCCLUSION; NEOVASCULAR GLAUCOMA; PREVALENCE	Purpose To estimate the etiology and features of the eyes with rubeosis iridis among Korean patients. Materials and Methods This study is a retrospective review of 533 Korean patients with rubeosis iridis who visited an eye hospital in Seoul, Korea. We defined rubeosis iridis as visible blood vessels on the iris surface detected during a slit-lamp examination. All cases were reviewed for age at the time of diagnosis, medical history, the most likely cause of rubeosis iridis, visual acuity, and intraocular pressure. Results The most commonly observed cause of rubeosis iridis was diabetic retinopathy (DR; n = 337, 63.2%), followed by retinal vein occlusion (RVO; n = 101, 18.9%), ocular ischemic syndrome (OIS; n = 24, 4.5%), retinal detachment (n = 17, 3.2%), and uveitis (n = 15, 2.8%). The cause was classified as miscellaneous in 18 cases (3.4%); in 21 eyes (3.9%), the cause was not clear. Age at the time of rubeosis iridis diagnosis was lower in patients with DR (56.5 years) than in those with RVO (61.0 years) and OIS (64.8 years; P < 0.01). Intraocular pressure of the eyes with DR (37.3 mmHg) and RVO (39.5 mmHg) was higher than that of the eyes with OIS (25.8 mmHg; P < 0.01). Conclusion In our population-based single center study, DR was the leading cause of rubeosis iridis followed by RVO and OIS among Korean patients. The clinical characteristics of the eyes with rubeosis iridis differed according to etiology. This finding may be useful when assessing eyes with rubeosis iridis.	[Jeong, Yun Cheol; Hwang, Young Hoon] Konyang Univ, Dept Ophthalmol, Kims Eye Hosp, Myung Gok Eye Res Inst, Seoul, South Korea	Konyang University	Hwang, YH (corresponding author), Konyang Univ, Dept Ophthalmol, Kims Eye Hosp, Myung Gok Eye Res Inst, Seoul, South Korea.	brainh@hanmail.net						Al-Shamsi HN, 2009, MIDDLE EAST AFR J OP, V16, P15, DOI 10.4103/0974-9233.48860; Allingham R, 2011, SHIELDS TXB GLAUCOMA, P294; Ashaye A O, 2006, East Afr Med J, V83, P559; Ashaye A, 2013, INVEST OPHTH VIS SCI, V54, P7410, DOI 10.1167/iovs.13-12698; BROWN GC, 1984, OPHTHALMOLOGY, V91, P315; BROWN GC, 1988, INT OPHTHALMOL, V11, P239, DOI 10.1007/BF00131023; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; GARTNER S, 1978, SURV OPHTHALMOL, V22, P291, DOI 10.1016/0039-6257(78)90175-3; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P488; HOSKINS HD, 1974, T AM ACAD OPHTHALMOL, V78, pO330; Ichhpujani P, 2007, CAN J OPHTHALMOL, V42, P812, DOI 10.3129/i07-160; JOHN T, 1983, OPHTHALMOLOGY, V90, P721; Kiddee Weerawat, 2012, J Med Assoc Thai, V95 Suppl 4, pS36; Landers J, 2012, BRIT J OPHTHALMOL, V96, P162, DOI 10.1136/bjo.2010.196642; Liao N, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0190-8; MADSEN PH, 1971, BRIT J OPHTHALMOL, V55, P444, DOI 10.1136/bjo.55.7.444; MAGARGAL LE, 1982, OPHTHALMOLOGY, V89, P1241; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P4621, DOI 10.1167/iovs.13-11950; NOMURA T, 1983, JPN J OPHTHALMOL, V27, P193; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; SCHULZE RR, 1967, AM J OPHTHALMOL, V63, P487, DOI 10.1016/0002-9394(67)90249-8; Sivak-Callcott JA, 2001, OPHTHALMOLOGY, V108, P1767, DOI 10.1016/S0161-6420(01)00775-8; Sivaprasad S, 2012, SURV OPHTHALMOL, V57, P347, DOI 10.1016/j.survophthal.2012.01.004; Terelak-Borys B, 2012, MED SCI MONITOR, V18, pRA138, DOI 10.12659/MSM.883260	24	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160662	10.1371/journal.pone.0160662	http://dx.doi.org/10.1371/journal.pone.0160662			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490797	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900075
J	Niehage, C; Karbanova, J; Steenblock, C; Corbeil, D; Hoflack, B				Niehage, Christian; Karbanova, Jana; Steenblock, Charlotte; Corbeil, Denis; Hoflack, Bernard			Cell Surface Proteome of Dental Pulp Stem Cells Identified by Label-Free Mass Spectrometry	PLOS ONE			English	Article							MARROW STROMAL CELLS; LONG-TERM CULTURE; BONE-MARROW; QUANTITATIVE PROTEOMICS; SPONTANEOUS DIFFERENTIATION; MALIGNANT-TRANSFORMATION; IN-VITRO; QUANTIFICATION; ABUNDANCE; PROTEINS	Multipotent mesenchymal stromal cells (MSCs) are promising tools for regenerative medicine. They can be isolated from different sources based on their plastic-adherence property. The identification of reliable cell surface markers thus becomes the Holy Grail for their prospective isolation. Here, we determine the cell surface proteomes of human dental pulp-derived MSCs isolated from single donors after culture expansion in low (2%) or high (10%) serum-containing media. Cell surface proteins were tagged on intact cells using cell impermeable, cleavable sulfo-NHS-SS-biotin, which allows their enrichment by streptavidin pull-down. For the proteomic analyses, we first compared label-free methods to analyze cell surface proteomes i.e. composition, enrichment and proteomic differences, and we developed a new mathematical model to determine cell surface protein enrichment using a combinatorial gene ontology query. Using this workflow, we identified 101 cluster of differentiation (CD) markers and 286 non-CD cell surface proteins. Based on this proteome profiling, we identified 14 cell surface proteins, which varied consistently in abundance when cells were cultured under low or high serum conditions. Collectively, our analytical methods provide a basis for identifying the cell surface proteome of dental pulp stem cells isolated from single donors and its evolution during culture or differentiation. Our data provide a comprehensive cell surface proteome for the precise identification of dental pulp-derived MSC populations and their isolation for potential therapeutic intervention.	[Niehage, Christian; Karbanova, Jana; Steenblock, Charlotte; Corbeil, Denis; Hoflack, Bernard] Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany; [Steenblock, Charlotte; Corbeil, Denis] Tech Univ Dresden, Dept Internal Med 3, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Hoflack, B (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Dresden, Germany.	bernard.hoflack@biotec.tu-dresden.de	Steenblock, Charlotte/C-9038-2018; HOFLACK, Bernard/AAZ-6668-2020; Corbeil, Denis/L-2340-2019; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/A-6519-2010	Corbeil, Denis/0000-0003-1181-3659; Karbanova, Jana/0000-0001-7687-0983; Steenblock, Charlotte/0000-0002-9635-4860	Deutsche Forschungsgemeinschaft [TRR 13/2-08, TRR13/2-2013, HO 2584/2-1, HO 2584/1-1, HO 2584/6-1, HO 2584/8-1, SFB 655, TRR83, CO298/5-1]; Technische Universitat Dresden; Sachsisches Staatsministerium fur Wissenschaft und Kunst	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Dresden; Sachsisches Staatsministerium fur Wissenschaft und Kunst	BH was supported in part by grants from Deutsche Forschungsgemeinschaft (http://www.dfg.de) (TRR 13/2-08, TRR13/2-2013, HO 2584/2-1, HO 2584/1-1, HO 2584/6-1, HO 2584/8-1) and Technische Universitat Dresden (Support-the-best). DC was supported by grants from Deutsche Forschungsgemeinschaft (SFB 655 B3; TRR83 TP6; CO298/5-1). Sachsisches Staatsministerium fur Wissenschaft und Kunst (http://www.smwk.sachsen.de) supported JK and DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Atari M, 2012, J CELL SCI, V125, P3343, DOI 10.1242/jcs.096537; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crop M, 2009, TRANSPL INT, V22, P365, DOI 10.1111/j.1432-2277.2008.00786.x; Dayon L, 2008, ANAL CHEM, V80, P2921, DOI 10.1021/ac702422x; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83; Gou SM, 2010, CELLS TISSUES ORGANS, V191, P185, DOI 10.1159/000240246; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Hofmann Andreas, 2013, Methods Mol Biol, V951, P33, DOI 10.1007/978-1-62703-146-2_3; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jeong JA, 2007, PROTEOMICS, V7, P4181, DOI 10.1002/pmic.200700502; Karbanova J, 2011, CELLS TISSUES ORGANS, V193, P344, DOI 10.1159/000321160; Kawashima N, 2012, ARCH ORAL BIOL, V57, P1439, DOI 10.1016/j.archoralbio.2012.08.010; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kudlicki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032339; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Mareddy S, 2009, J CELL BIOCHEM, V106, P776, DOI 10.1002/jcb.22088; Megger DA, 2013, BBA-PROTEINS PROTEOM, V1834, P1581, DOI 10.1016/j.bbapap.2013.04.001; Mindaye ST, 2013, J PROTEOMICS, V78, P1, DOI 10.1016/j.jprot.2012.10.028; Niehage C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020399; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pisciotta A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0065-x; Potdar PD, 2015, WORLD J STEM CELLS, V7, P839, DOI 10.4252/wjsc.v7.i5.839; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Saito MT, 2015, WORLD J STEM CELLS, V7, P399, DOI 10.4252/wjsc.v7.i2.399; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Suchanek Jakub, 2007, Acta Medica (Hradec Kralove), V50, P195; Tirino Virginia, 2012, Methods Mol Biol, V879, P443, DOI 10.1007/978-1-61779-815-3_26; Tseng PY, 2007, J VET MED SCI, V69, P95, DOI 10.1292/jvms.69.95; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Yu JH, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-32	52	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159824	10.1371/journal.pone.0159824	http://dx.doi.org/10.1371/journal.pone.0159824			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490675	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900020
J	Yoshida, M; Taguchi, A; Kawana, K; Adachi, K; Kawata, A; Ogishima, J; Nakamura, H; Fujimoto, A; Sato, M; Inoue, T; Nishida, H; Furuya, H; Tomio, K; Arimoto, T; Koga, K; Wada-Hiraike, O; Oda, K; Nagamatsu, T; Kiyono, T; Osuga, Y; Fujii, T				Yoshida, Mitsuyo; Taguchi, Ayumi; Kawana, Kei; Adachi, Katsuyuki; Kawata, Akira; Ogishima, Juri; Nakamura, Hiroe; Fujimoto, Asaha; Sato, Masakazu; Inoue, Tomoko; Nishida, Haruka; Furuya, Hitomi; Tomio, Kensuke; Arimoto, Takahide; Koga, Kaori; Wada-Hiraike, Osamu; Oda, Katsutoshi; Nagamatsu, Takeshi; Kiyono, Tohru; Osuga, Yutaka; Fujii, Tomoyuki			Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis	PLOS ONE			English	Article							ANGIOGENESIS; CHEMOTHERAPY; MACROPHAGES; CARCINOMA; ONCOGENES; PATHWAY; CELLS	The most common properties of oncogenes are cell proliferation and the prevention of apoptosis in malignant cells, which, as a consequence, induce tumor formation and dissemination. However, the effects of oncogenes on the tumor microenvironment (TME) have not yet been examined in detail. The accumulation of ascites accompanied by chronic inflammation and elevated concentrations of VEGF is a hallmark of the progression of ovarian cancer. We herein demonstrated the mechanisms by which oncogenes contribute to modulating the ovarian cancer microenvironment. c-MYC and KRAS were transduced into the mouse ovarian cancer cell line ID8. ID8, ID8-c-MYC, or ID8-KRAS cells were then injected into the peritoneal cavities of C57/BL6 mice and the production of ascites was assessed. ID8-c-MYC and ID8-KRAS both markedly accelerated ovarian cancer progression in vivo, whereas no significant differences were observed in proliferative activity in vitro. ID8-KRAS in particular induced the production of ascites, which accumulated between approximately two to three weeks after the injection, more rapidly than ID8 and ID8-c-MYC (between nine and ten weeks and between six and seven weeks, respectively). VEGF concentrations in ascites significantly increased in c-MYC-induced ovarian cancer, whereas the concentrations of inflammatory cytokines in ascites were significantly high in KRAS-induced ovarian cancer and were accompanied by an increased number of neutrophils in ascites. A cytokine array revealed that KRAS markedly induced the expression of granulocyte macrophage colony-stimulating factor (GM-CSF) in ID8 cells. These results suggest that oncogenes promote cancer progression by modulating the TME in favor of cancer progression.	[Yoshida, Mitsuyo; Taguchi, Ayumi; Kawana, Kei; Adachi, Katsuyuki; Kawata, Akira; Ogishima, Juri; Nakamura, Hiroe; Fujimoto, Asaha; Sato, Masakazu; Inoue, Tomoko; Nishida, Haruka; Furuya, Hitomi; Tomio, Kensuke; Arimoto, Takahide; Koga, Kaori; Wada-Hiraike, Osamu; Oda, Katsutoshi; Nagamatsu, Takeshi; Osuga, Yutaka; Fujii, Tomoyuki] Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Kiyono, Tohru] Natl Canc Ctr, Div Virol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan	University of Tokyo; National Cancer Center - Japan	Kawana, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kkawana-tky@umin.org	Koga, Kaori/ABA-5601-2020; Nagamatsu, Takeshi/AAH-1402-2019; Nagamatsu, Takeshi/AAC-5201-2021	Koga, Kaori/0000-0002-5057-4120; Nagamatsu, Takeshi/0000-0003-1480-5785; Wada-Hiraike, Osamu/0000-0002-3458-6711	JSPS KAKENHI Grant [26293357, 15H06172, 26870148]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant number 26293357 (15H06172 and 26870148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill F, 2001, LANCET, P357; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Chandler RL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7118; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Dijkgraaf EM, 2013, CANCER RES, V73, P2480, DOI 10.1158/0008-5472.CAN-12-3542; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Fossati G, 1998, INT J MOL MED, V1, P943; Harries M, 2002, LANCET ONCOL, V3, P537, DOI 10.1016/S1470-2045(02)00847-1; Huang ZH, 2011, CANCER RES, V71, P2582, DOI 10.1158/0008-5472.CAN-10-3032; Itamochi H, 2012, INT J CLIN ONCOL, V17, P430, DOI 10.1007/s10147-012-0459-8; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546; Liang B., 2013, SCAND J CLIN LAB INV; Lo CW, 2011, CANCER RES, V71, P424, DOI 10.1158/0008-5472.CAN-10-1496; Nagasaki T, 2014, BRIT J CANCER, V110, P469, DOI 10.1038/bjc.2013.748; Nelson BH, 2015, CURR OPIN IMMUNOL, V33, P93, DOI 10.1016/j.coi.2015.02.004; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sahin N, 2015, ARCH GYNECOL OBSTET; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schmid BC, 2014, MATURITAS, V77, P128, DOI 10.1016/j.maturitas.2013.11.009; Shoji T, 2014, CANCER CHEMOTH PHARM, V73, P895, DOI 10.1007/s00280-014-2418-8; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Taguchi A, 2014, J OBSTET GYNAECOL RE, V40, P770, DOI 10.1111/jog.12252; Taguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089605; Taguchi S, 2015, INT J UROL, V22, P638, DOI 10.1111/iju.12766; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124	32	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160330	10.1371/journal.pone.0160330	http://dx.doi.org/10.1371/journal.pone.0160330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483433	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700035
J	Deforche, L; Tersteeg, C; Roose, E; Vandenbulcke, A; Vandeputte, N; Pareyn, I; De Cock, E; Rottensteiner, H; Deckmyn, H; De Meyer, SF; Vanhoorelbeke, K				Deforche, Louis; Tersteeg, Claudia; Roose, Elien; Vandenbulcke, Aline; Vandeputte, Nele; Pareyn, Inge; De Cock, Elien; Rottensteiner, Hanspeter; Deckmyn, Hans; De Meyer, Simon F.; Vanhoorelbeke, Karen			Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; UPSHAW-SCHULMAN SYNDROME; MYOCARDIAL-INFARCTION; VONWILLEBRAND-FACTOR; ISCHEMIC-STROKE; IN-VIVO; DEFICIENCY; MICE; VWF	Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy linked to a deficiency in the metalloprotease ADAMTS13. In the current study, a novel mouse model for acquired TTP was generated to facilitate development and validation of new therapies for this disease. Therefore, a large panel (n = 19) of novel anti-mouse ADAMTS13 (mADAMTS13) monoclonal antibodies (mAbs) of mouse origin was generated. Inhibitory anti-mADAMTS13 mAbs were identified using the FRETS-VWF73 assay. Four mAbs strongly inhibited mADAMTS13 activity in vitro (similar to 68-90% inhibition). Injecting a combination of 2 inhibitory mAbs (13B4 and 14H7, 1.25 mg/kg each) in Adamts13(+/+) mice resulted in full inhibition of plasma ADAMTS13 activity (96 +/- 4% inhibition, day 1 post injection), leading to the appearance of ultra-large von Willebrand factor (UL-VWF) multimers. Interestingly, the inhibitory anti-mADAMTS13 mAbs 13B4 and 14H7 were ideally suited to induce long-term ADAMTS13 deficiency in Adamts13(+/+) mice. A single bolus injection resulted in full ex vivo inhibition for more than 7 days. As expected, the mice with the acquired ADAMTS13 deficiency did not spontaneously develop TTP, despite the accumulation of UL-VWF multimers. In line with the Adamts13(-/-) mice, TTP-like symptoms could only be induced when an additional trigger (rVWF) was administered. On the other hand, the availability of our panel of anti-mADAMTS13 mAbs allowed us to further develop a sensitive ELISA to detect ADAMTS13 in mouse plasma. In conclusion, a novel acquired TTP mouse model was generated through the development of inhibitory anti-mADAMTS13 mAbs. Consequently, this model provides new opportunities for the development and validation of novel treatments for patients with TTP. In addition, these newly developed inhibitory anti-mADAMTS13 mAbs are of great value to specifically study the role of ADAMTS13 in mouse models of thrombo-inflammatory disease.	[Deforche, Louis; Tersteeg, Claudia; Roose, Elien; Vandenbulcke, Aline; Vandeputte, Nele; Pareyn, Inge; De Cock, Elien; Deckmyn, Hans; De Meyer, Simon F.; Vanhoorelbeke, Karen] KU Leuven Campus Kulak Kortrijk, IRF Life Sci, Lab Thrombosis Res, Kortrijk, Belgium; [Rottensteiner, Hanspeter] Baxalta Innovat GmbH, Vienna, Austria	KU Leuven; Baxalta Innovations GmbH	Vanhoorelbeke, K (corresponding author), KU Leuven Campus Kulak Kortrijk, IRF Life Sci, Lab Thrombosis Res, Kortrijk, Belgium.	Karen.Vanhoorelbeke@kuleuven-kulak.be	Deckmyn, Hans/N-8932-2019; Deckmyn, Hans/L-9434-2015; Tersteeg, Claudia/V-3758-2018; Roose, Elien/AAG-2946-2021	Deckmyn, Hans/0000-0003-3952-5501; Deckmyn, Hans/0000-0003-3952-5501; Tersteeg, Claudia/0000-0002-6380-6349; De Meyer, Simon/0000-0002-1807-5882; Roose, Elien/0000-0002-9078-9070; Vanhoorelbeke, Karen/0000-0003-2288-8277	Agency for Innovation by Science and Technology (IWT), Flanders, Belgium [111507]; Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek, FWO), Belgium [12N0715N]; Programmafinanciering KU Leuven [PF10/014]; 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' of the Flemish government (FWO) [G.0584.11]; 'Onderzoekstoelage' of the KU Leuven (OT) [OT/14/071]	Agency for Innovation by Science and Technology (IWT), Flanders, Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek, FWO), Belgium; Programmafinanciering KU Leuven(KU Leuven); 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' of the Flemish government (FWO)(FWO); 'Onderzoekstoelage' of the KU Leuven (OT)	Louis Deforche is supported by a PhD grant from the Agency for Innovation by Science and Technology (IWT, www.iwt.be), Flanders, Belgium (111507). Claudia Tersteeg is a Postdoctoral Fellow supported by the Research Foundation-Flanders (Fonds voor Wetenschappelijk Onderzoek, FWO, www.fwo.be), Belgium (12N0715N). This work was supported by research grants 'Programmafinanciering KU Leuven' (PF10/014), the 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen' of the Flemish government (FWO grant G.0584.11) and the 'Onderzoekstoelage' of the KU Leuven (OT grant OT/14/071). Hanspeter Rottensteiner is an employee of Baxalta Innovations and only provided recombinant VWF for our study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders provided support in the form of salaries for authors [LD, CT] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson HM, 2012, BLOOD, V119, P1555, DOI 10.1182/blood-2011-09-380618; Aref S, 2013, HEMATOLOGY, V18, P237, DOI 10.1179/1607845412Y.0000000070; Banno F, 2004, J BIOL CHEM, V279, P30896, DOI 10.1074/jbc.M314184200; Banno F, 2006, BLOOD, V107, P3161, DOI 10.1182/blood-2005-07-2765; Blombery P, 2014, J BLOOD MED, V5, P15, DOI 10.2147/JBM.S46458; Callewaert F, 2012, BLOOD, V120, P3603, DOI 10.1182/blood-2012-04-420943; De Cock E, 2015, J THROMB HAEMOST, V13, P283, DOI 10.1111/jth.12804; De Maeyer B, 2010, J THROMB HAEMOST, V8, P2305, DOI 10.1111/j.1538-7836.2010.04008.x; De Meyer SF, 2008, ARTERIOSCL THROM VAS, V28, P1621, DOI 10.1161/ATVBAHA.108.168369; De Meyer SF, 2012, BLOOD, V120, P5217, DOI 10.1182/blood-2012-06-439935; Deforche L, 2015, J THROMB HAEMOST; DENT JA, 1991, J CLIN INVEST, V88, P774, DOI 10.1172/JCI115376; Falter T, 2014, HAMOSTASEOLOGIE, V34, P244, DOI 10.5482/HAMO-14-03-0023; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; Feys HB, 2012, BLOOD, V120, P3611, DOI 10.1182/blood-2012-04-421248; Feys HB, 2010, BLOOD, V116, P2005, DOI 10.1182/blood-2010-04-280479; Fujimura Y, 2009, BRIT J HAEMATOL, V144, P742, DOI 10.1111/j.1365-2141.2008.07515.x; Furlan M, 1998, BLOOD, V91, P2839, DOI 10.1182/blood.V91.8.2839.2839_2839_2846; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gandhi C, 2012, BLOOD, V119, P2385, DOI 10.1182/blood-2011-09-376202; Hanson E, 2009, J THROMB HAEMOST, V7, P2147, DOI 10.1111/j.1538-7836.2009.03617.x; Holz JB, 2012, TRANSFUS APHER SCI, V46, P343, DOI 10.1016/j.transci.2012.03.027; Jubelirer SJ, W V MED J, V111, P10; Kaikita K, 2006, J THROMB HAEMOST, V4, P2490, DOI 10.1111/j.1538-7836.2006.02161.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Larkin D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000349; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lotta LA, 2010, HUM MUTAT, V31, P11, DOI 10.1002/humu.21143; Matsukawa M, 2007, AM J CARDIOL, V100, P760, DOI 10.1016/j.amjcard.2007.03.095; Morioka M, 2014, BLOOD TRANSFUS-ITALY, V12, pS153, DOI 10.2450/2013.0307-12; MOSCHCOWITZ E, 1952, AM J MED, V13, P567, DOI 10.1016/0002-9343(52)90022-3; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Pickens B, 2015, BLOOD, V125, P3326, DOI 10.1182/blood-2014-07-587139; RUGGERI ZM, 1981, BLOOD, V57, P1140; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Schiviz A, 2012, BLOOD, V119, P6128, DOI 10.1182/blood-2011-09-380535; Scully M, 2008, BRIT J HAEMATOL, V142, P819, DOI 10.1111/j.1365-2141.2008.07276.x; Stepanian A, 2011, ARTERIOSCL THROM VAS, V31, P1703, DOI 10.1161/ATVBAHA.111.223610; Tersteeg C, 2015, ARTERIOSCL THROM VAS, V35, P2336, DOI 10.1161/ATVBAHA.115.306014; Thomas MR, 2015, EBIOMEDICINE; Tsai HM, 2012, ASAIO J, V58, P163, DOI 10.1097/MAT.0b013e31824363e7; Tsai HM, 2010, INT J HEMATOL, V91, P1, DOI 10.1007/s12185-009-0476-1; Tsai HM, 2003, ARTERIOSCL THROM VAS, V23, P388, DOI 10.1161/01.ATV.0000058401.34021.D4; Vanhoorelbeke K, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12255; Widemann A, 2014, J THROMB HAEMOST, V12, P1601, DOI 10.1111/jth.12681	46	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160388	10.1371/journal.pone.0160388	http://dx.doi.org/10.1371/journal.pone.0160388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479501	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110300046
J	Matos, M; Marefati, A; Gutierrez, G; Wahlgren, M; Rayner, M				Matos, Maria; Marefati, Ali; Gutierrez, Gemma; Wahlgren, Marie; Rayner, Marilyn			Comparative Emulsifying Properties of Octenyl Succinic Anhydride (OSA)-Modified Starch: Granular Form vs Dissolved State	PLOS ONE			English	Article							PICKERING-TYPE EMULSIONS; PARTICLES; FOOD; RETROGRADATION; EMULSIFICATION; RESVERATROL; GELATINIZATION; STABILIZATION; NANOPARTICLES; AMYLOPECTIN	The emulsifying ability of OSA-modified and native starch in the granular form, in the dissolved state and a combination of both was compared. This study aims to understand mixed systems of particles and dissolved starch with respect to what species dominates at droplet interfaces and how stability is affected by addition of one of the species to already formed emulsions. It was possible to create emulsions with OSA-modified starch isolated from Quinoa as sole emulsifier. Similar droplet sizes were obtained with emulsions prepared at 7% (w/w) oil content using OSA-modified starch in the granular form or molecularly dissolved but large differences were observed regarding stability. Pickering emulsions kept their droplet size constant after one month while emulsions formulated with OSA-modified starch dissolved exhibited coalescence. All emulsions stabilized combining OSA-modified starch in granular form and in solution showed larger mean droplet sizes with no significant differences with respect to the order of addition. These emulsions were unstable due to coalescence regarding presence of free oil. Similar results were obtained when emulsions were prepared by combining OSA-modified granules with native starch in solution. The degree of surface coverage of starch granules was much lower in presence of starch in solution which indicates that OSA-starch is more surface active in the dissolved state than in granular form, although it led to unstable systems compared to starch granule stabilized Pickering emulsions, which demonstrated to be extremely stable.	[Matos, Maria; Marefati, Ali; Wahlgren, Marie; Rayner, Marilyn] Lund Univ, Dept Food Technol Engn & Nutr, POB 124, SE-22100 Lund, Sweden; [Matos, Maria; Gutierrez, Gemma] Univ Oviedo, Dept Chem & Environm Engn, Julian Claveria 8, E-33006 Oviedo, Spain	Lund University; University of Oviedo	Rayner, M (corresponding author), Lund Univ, Dept Food Technol Engn & Nutr, POB 124, SE-22100 Lund, Sweden.	marilyn.rayner@food.lth.se	Rayner, Marilyn D/B-2679-2017; MAREFATI, ALI/AAC-1876-2019	Rayner, Marilyn D/0000-0001-6338-7124; MAREFATI, ALI/0000-0002-6288-7052; Gutierrez, Gemma/0000-0003-2700-4944; Wahlgren, Marie/0000-0002-1705-3964; Maria, Matos/0000-0002-6980-0554	Crafoord Foundation [20140816]; Vinnova-the Swedish Innovation Agency [2014-0587]; Department of Food Technology, Engineering, and Nutrition of Lund University	Crafoord Foundation; Vinnova-the Swedish Innovation Agency(Vinnova); Department of Food Technology, Engineering, and Nutrition of Lund University	The study was supported by the Crafoord Foundation through the call Research Grants 2014 (Ref. 20140816) to MM, MW, and MR; Vinnova-the Swedish Innovation Agency through the Planning Grant Fall 2014 Marie Curie Incoming (Ref. 2014-0587) to MM, MW, and MR; and Department of Food Technology, Engineering, and Nutrition of Lund University to MM and MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle T, 1997, STARCH-STARKE, V49, P215, DOI 10.1002/star.19970490602; Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; Chevalier Y, 2013, COLLOID SURFACE A, V439, P23, DOI 10.1016/j.colsurfa.2013.02.054; Dickinson E, 2012, TRENDS FOOD SCI TECH, V24, P4, DOI 10.1016/j.tifs.2011.09.006; FEIGIN RI, 1980, J COLLOID INTERF SCI, V75, P525, DOI 10.1016/0021-9797(80)90475-0; Fredriksson H, 1998, CARBOHYD POLYM, V35, P119, DOI 10.1016/S0144-8617(97)00247-6; GUDMUNDSSON M, 1994, THERMOCHIM ACTA, V246, P329, DOI 10.1016/0040-6031(94)80100-2; Huck-Iriarta C, 2001, PROCEDIA FOOD SCI, V1, P116; Kargar M, 2012, J COLLOID INTERF SCI, V366, P209, DOI 10.1016/j.jcis.2011.09.073; KLEIN J, 1984, NATURE, V308, P836, DOI 10.1038/308836a0; Li C, 2012, STARCH-STARKE, V64, P497, DOI 10.1002/star.201100178; Marefati A, 2015, FOOD HYDROCOLLOID, V51, P261, DOI 10.1016/j.foodhyd.2015.04.022; Marefati A, 2013, COLLOID SURFACE A, V436, P512, DOI 10.1016/j.colsurfa.2013.07.015; Marku D, 2012, INT J PHARMACEUT, V428, P1, DOI 10.1016/j.ijpharm.2012.01.031; Matos M, 2015, J FOOD ENG, V166, P212, DOI 10.1016/j.jfoodeng.2015.06.002; Matos M, 2015, FOOD HYDROCOLLOID, V49, P156, DOI 10.1016/j.foodhyd.2015.03.021; Matos M, 2014, COLLOID SURFACE A, V442, P69, DOI 10.1016/j.colsurfa.2013.05.065; Matos M, 2013, COLLOID SURFACE A, V423, P147, DOI 10.1016/j.colsurfa.2013.01.060; Matos M, 2012, TRIBOL T, V55, P685, DOI 10.1080/10402004.2012.694580; Nilsson L, 2007, J AGR FOOD CHEM, V55, P1469, DOI 10.1021/jf062087z; Nilsson L, 2006, LANGMUIR, V22, P8770, DOI 10.1021/la060870f; Ortega-Ojeda FE, 2001, STARCH-STARKE, V53, P520, DOI 10.1002/1521-379X(200110)53:10<520::AID-STAR520>3.0.CO;2-D; Pando D, 2013, J FOOD ENG, V117, P227, DOI 10.1016/j.jfoodeng.2013.02.020; Perez-Rea D, 2015, ANAL BIOANAL CHEM, P8894; Perez-Rea D, 2015, ANAL BIOANAL CHEM, V407, P4315, DOI 10.1007/s00216-015-8611-8; Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001; Ramsden W, 1903, P R SOC LONDON, V72, P156, DOI 10.1098/rspl.1903.0034; Rayner M, 2014, COLLOID SURFACE A, V458, P48, DOI 10.1016/j.colsurfa.2014.03.053; Rayner M, 2012, FARADAY DISCUSS, V158, P139, DOI 10.1039/c2fd20038d; Rayner M, 2012, J SCI FOOD AGR, V92, P1841, DOI 10.1002/jsfa.5610; Stainsby G., 1897, ADV FOOD EMULSIONS F; Timgren A, 2013, FOOD SCI NUTR, V1, P157, DOI 10.1002/fsn3.17; Timgren A, 2011, PROC FOOD SCI, V1, P95, DOI 10.1016/j.profoo.2011.09.016; Vorwerg W, 2002, CARBOHYD POLYM, V47, P181, DOI 10.1016/S0144-8617(01)00164-3; Wahlgren M, 2013, CURR PHARM BIOTECHNO, V14, P1222	36	34	36	5	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160140	10.1371/journal.pone.0160140	http://dx.doi.org/10.1371/journal.pone.0160140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479315	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110300026
J	Esterman, M; Grosso, M; Liu, GY; Mitko, A; Morris, R; DeGutis, J				Esterman, Michael; Grosso, Mallory; Liu, Guanyu; Mitko, Alex; Morris, Rachael; DeGutis, Joseph			Anticipation of Monetary Reward Can Attenuate the Vigilance Decrement	PLOS ONE			English	Article							SUSTAINED ATTENTION; DEFAULT NETWORK; STRENGTH MODEL; EGO DEPLETION; SELF-CONTROL; ABSENT MIND; MEMORY LOAD; TASK; RESOURCE; PERFORMANCE	Motivation and reward can have differential effects on separate aspects of sustained attention. We previously demonstrated that continuous reward/punishment throughout a sustained attention task improves overall performance, but not vigilance decrements. One interpretation of these findings is that vigilance decrements are due to resource depletion, which is not overcome by increasing overall motivation. However, an alternative explanation is that as one performs a continuously rewarded task there are less potential gains/losses as the task progresses, which could decrease motivation over time, producing a vigilance decrement. This would predict that keeping future gains/losses consistent throughout the task would reduce the vigilance decrement. In the current study, we examined this possibility by comparing two versions (continuous-small loss vs. anticipate-large loss) of a 10-minute gradual onset continuous performance task (gradCPT), a challenging go/no-go sustained attention task. Participants began each task with the potential to keep $ 18. In the continuous-small-loss version, small monetary losses were accrued continuously throughout the task for each error. However, in the anticipate-large-loss version, participants lost all $ 18 if they erroneously responded to one target that always appeared toward the end of the vigil. Typical vigilance decrements were observed in the continuous-small-loss condition. In the anticipate-large-loss condition, vigilance decrements were reduced, particularly when the anticipate-large loss condition was completed second. This suggests that the looming possibility of a large loss can attenuate the vigilance decrement and that this attenuation may occur most consistently after sufficient task experience. We discuss these results in the context of current theories of sustained attention.	[Esterman, Michael; Grosso, Mallory; Liu, Guanyu; Mitko, Alex; DeGutis, Joseph] VA Boston Healthcare Syst, Boston Attent & Learning Lab, Boston, MA 02130 USA; [Esterman, Michael; DeGutis, Joseph] Boston Div VA Healthcare Syst, GRECC, Boston, MA 02130 USA; [Esterman, Michael] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Esterman, Michael; DeGutis, Joseph] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Morris, Rachael] Univ Kent, Sch Psychol, Canterbury, Kent, England	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Geriatric Research Education & Clinical Center; Boston University; Harvard University; Harvard Medical School; University of Kent	Esterman, M (corresponding author), VA Boston Healthcare Syst, Boston Attent & Learning Lab, Boston, MA 02130 USA.; Esterman, M (corresponding author), Boston Div VA Healthcare Syst, GRECC, Boston, MA 02130 USA.; Esterman, M (corresponding author), Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA.; Esterman, M (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.	esterman@bu.edu			VA Clinical Science R&D Career Development Award [1IK2CX000706-01A2]; Veterans Affairs [IK2CX000706] Funding Source: NIH RePORTER	VA Clinical Science R&D Career Development Award; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by a VA Clinical Science R&D Career Development Award to Michael Esterman (1IK2CX000706-01A2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga A, 2011, COGNITION, V118, P439, DOI 10.1016/j.cognition.2010.12.007; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Caggiano DM, 2004, PSYCHON B REV, V11, P932, DOI 10.3758/BF03196724; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; DeGutis JM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00060; Edkins GD, 1997, ACCIDENT ANAL PREV, V29, P533, DOI 10.1016/S0001-4575(97)00033-X; Esterman M, 2014, J EXP PSYCHOL GEN, V143, P2287, DOI 10.1037/xge0000019; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Fortenbaugh FC, 2015, PSYCHOL SCI, V26, P1497, DOI 10.1177/0956797615594896; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Graham Thomas J, 2015, OBESITY SCIENCE PRAC, V1, P131; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hancock PA, 2013, AM PSYCHOL, V68, P97, DOI 10.1037/a0030214; Head J, 2012, CONSCIOUS COGN, V21, P1617, DOI 10.1016/j.concog.2012.08.009; Helton WS, 2008, ACTA PSYCHOL, V129, P18, DOI 10.1016/j.actpsy.2008.04.002; Helton WS, 2012, EXP BRAIN RES, V219, P37, DOI 10.1007/s00221-012-3065-0; Helton WS, 2011, EXP BRAIN RES, V212, P429, DOI 10.1007/s00221-011-2749-1; Helton WS, 2011, HUM FACTORS, V53, P132, DOI 10.1177/0018720811401385; Hopstaken JF, 2015, BIOL PSYCHOL, V110, P100, DOI 10.1016/j.biopsycho.2015.06.013; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Morgan K, 2014, BRIT J PSYCHOL, V105, P214, DOI 10.1111/bjop.12025; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; PARASURAMAN R, 1979, SCIENCE, V205, P924, DOI 10.1126/science.472714; Parasuraman R., 1987, REC RES PSY, P11, DOI 10.1007/978-1-4612-4756-2_2; Parasuraman R, 2009, J EXP PSYCHOL-APPL, V15, P275, DOI 10.1037/a0017132; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Robertson IH, 2003, PSYCHOLOGIST, V16, P476; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rosenberg M, 2013, ATTEN PERCEPT PSYCHO, V75, P426, DOI 10.3758/s13414-012-0413-x; Seli P, 2016, PSYCHOL SCI, V27, P685, DOI 10.1177/0956797616634068; Shaw TH, 2013, BRAIN COGNITION, V82, P265, DOI 10.1016/j.bandc.2013.05.003; SIPOWICZ RR, 1962, J EXP PSYCHOL, V64, P58, DOI 10.1037/h0041816; Smallwood J, 2015, THE HANDBOOK OF ATTE; Smit AS, 2004, ACTA PSYCHOL, V115, P35, DOI 10.1016/j.actpsy.2003.11.001; Thomson DR, 2015, PERSPECT PSYCHOL SCI, V10, P82, DOI 10.1177/1745691614556681; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727	49	24	24	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159741	10.1371/journal.pone.0159741	http://dx.doi.org/10.1371/journal.pone.0159741			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27472785	Green Published, gold			2022-12-27	WOS:000381516300017
J	Stenroos, M; Nummenmaa, A				Stenroos, Matti; Nummenmaa, Aapo			Incorporating and Compensating Cerebrospinal Fluid in Surface-Based Forward Models of Magneto- and Electroencephalography	PLOS ONE			English	Article							VOLUME CONDUCTOR; HEAD MODELS; EEG; ROBUST; SKULL; FIELD	MEG/EEG source imaging is usually done using a three-shell (3-S) or a simpler head model. Such models omit cerebrospinal fluid (CSF) that strongly affects the volume currents. We present a four-compartment (4-C) boundary-element (BEM) model that incorporates the CSF and is computationally efficient and straightforward to build using freely available software. We propose a way for compensating the omission of CSF by decreasing the skull conductivity of the 3-S model, and study the robustness of the 4-C and 3-S models to errors in skull conductivity. We generated dense boundary meshes using MRI datasets and automated Sim NIBS pipeline. Then, we built a dense 4-C reference model using Galerkin BEM, and 4-C and 3-S test models using coarser meshes and both Galerkin and collocation BEMs. We compared field topographies of cortical sources, applying various skull conductivities and fitting conductivities that minimized the relative error in 4-C and 3-S models. When the CSF was left out from the EEG model, our compensated, unbiased approach improved the accuracy of the 3-S model considerably compared to the conventional approach, where CSF is neglected without any compensation (mean relative error < 20% vs. > 40%). The error due to the omission of CSF was of the same order in MEG and compensated EEG. EEG has, however, large overall error due to uncertain skull conductivity. Our results show that a realistic 4-C MEG/EEG model can be implemented using standard tools and basic BEM, without excessive workload or computational burden. If the CSF is omitted, compensated skull conductivity should be used in EEG.	[Stenroos, Matti] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, POB 12200, FI-00076 Aalto, Finland; [Nummenmaa, Aapo] Harvard Med Sch, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02129 USA	Aalto University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Stenroos, M (corresponding author), Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, POB 12200, FI-00076 Aalto, Finland.	matti.stenroos@aalto.fi	Stenroos, Matti/S-8360-2019		National Institutes of Health under National Institute of Biomedical Imaging and Bioengineering [R00EB015445]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R00EB015445] Funding Source: NIH RePORTER	National Institutes of Health under National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	AN received funding from the National Institutes of Health under National Institute of Biomedical Imaging and Bioengineering (http://www.nibib.nih.gov/) award number R00EB015445. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar ZA, 2013, BRAIN TOPOGR, V26, P378, DOI 10.1007/s10548-012-0274-6; Akhtari M, 2010, BRAIN TOPOGR, V23, P292, DOI 10.1007/s10548-010-0144-z; Attene M, 2010, VISUAL COMPUT, V26, P1393, DOI 10.1007/s00371-010-0416-3; BARNARD ACL, 1967, BIOPHYS J, V7, P443, DOI 10.1016/S0006-3495(67)86598-6; Baumann SB, 1997, IEEE T BIO-MED ENG, V44, P220, DOI 10.1109/10.554770; Dabek J., 2015, NEUROIMAGE; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; DEMUNCK JC, 1992, IEEE T BIO-MED ENG, V39, P986, DOI 10.1109/10.256433; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; GEDDES LA, 1967, MED BIOL ENG, V5, P271, DOI 10.1007/BF02474537; GESELOWT.DB, 1970, IEEE T MAGN, VMAG6, P346, DOI 10.1109/TMAG.1970.1066765; Guellmar D, 2006, IEEE T BIO-MED ENG, V53, P1841, DOI 10.1109/TBME.2006.876641; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; HELLER L, 1992, BIOPHYS J, V63, P129, DOI 10.1016/S0006-3495(92)81587-4; Janssen AM, 2013, PHYS MED BIOL, V58, P4881, DOI 10.1088/0031-9155/58/14/4881; Jenkinson M, 2005, 11 ANN M ORG HUM BRA, P167; Keil B, 2013, MAGN RESON MED, V70, P248, DOI 10.1002/mrm.24427; Lanfer B., 2014, THESIS; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nummenmaa A, 2013, CLIN NEUROPHYSIOL, V124, P1995, DOI 10.1016/j.clinph.2013.04.019; Opitz A, 2015, NEUROIMAGE, V109, P140, DOI 10.1016/j.neuroimage.2015.01.033; PLONSEY R, 1967, B MATH BIOPHYS, V29, P657, DOI 10.1007/BF02476917; Ramon C, 2004, BRAIN TOPOGR, V16, P245; Ramon Ceon, 2006, Biomed Eng Online, V5, P55, DOI 10.1186/1475-925X-5-55; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; SimBio Development Group, 2010, J NEUROSCI METH, V190, P258, DOI [10.1016/j.jneumeth.2010.04.031, DOI 10.1016/J.JNEUMETH.2010.04.031]; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stenroos M, 2007, COMPUT METH PROG BIO, V88, P256, DOI 10.1016/j.cmpb.2007.09.004; Stenroos M, 2012, PHYS MED BIOL, V57, P3517, DOI 10.1088/0031-9155/57/11/3517; Stenroos M., 2012, INT J BIOELECTROMAGN, V14, P29; Stenroos M, 2014, NEUROIMAGE, V94, P337, DOI 10.1016/j.neuroimage.2014.01.006; Stenroos M, 2013, NEUROIMAGE, V81, P265, DOI 10.1016/j.neuroimage.2013.04.086; Strobbe G, 2014, NEUROIMAGE, V93, P11, DOI 10.1016/j.neuroimage.2014.02.022; von Ellenrieder N, 2009, MED BIOL ENG COMPUT, V47, P1083, DOI 10.1007/s11517-009-0529-x; Vorwerk J, 2014, NEUROIMAGE, V100, P590, DOI 10.1016/j.neuroimage.2014.06.040; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Ziegler E, 2014, NEUROIMAGE, V103, P542, DOI 10.1016/j.neuroimage.2014.08.056	42	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159595	10.1371/journal.pone.0159595	http://dx.doi.org/10.1371/journal.pone.0159595			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472278	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300013
J	Garcia-Ramos, A; Stirn, I; Padial, P; Arguelles-Cienfuegos, J; De la Fuente, B; Calderon, C; Bonitch-Gongora, J; Tomazin, K; Strumbelj, B; Strojnik, V; Feriche, B				Garcia-Ramos, Amador; Stirn, Igor; Padial, Paulino; Arguelles-Cienfuegos, Javier; De la Fuente, Blanca; Calderon, Carmen; Bonitch-Gongora, Juan; Tomazin, Katja; Strumbelj, Boro; Strojnik, Vojko; Feriche, Belen			The Effect of an Altitude Training Camp on Swimming Start Time and Loaded Squat Jump Performance	PLOS ONE			English	Article							SKELETAL-MUSCLE ADAPTATIONS; SEA-LEVEL PERFORMANCE; CHRONIC HYPOXIA; EXERCISE; STRENGTH; ENDURANCE; SWIMMERS; EXPOSURE; POWER	This study evaluated the influence of an altitude training (AT) camp on swimming start time and loaded squat jump performance. To accomplish this goal, 13 international swimmers (8 women, 5 men) were allocated to both the control (Sea Level Training, SLT) and experimental conditions (AT, 2320 m above sea level) that were separated by a one year period. All tests (15 m freestyle swimming start and loaded squat jumps with additional loads of 25%, 50%, 75%, and 100% of swimmers' body weight) were performed before and after a concurrent 3-week strength and endurance training program prescribed by the national coach. Following the SLT camp, significant impairments in swimming start times to 10 (+3.1%) and 15 m (+4.0%) were observed (P < 0.05), whereas no significant changes for the same distances were detected following the AT camp (-0.89%; P > 0.05). Trivial changes in peak velocity were obtained during the loaded squat jump after both training periods (effect sizes: < 0.20). Based on these results we can conclude that a traditional training high-living high strategy concurrent training of 3 weeks does not adversely affect swimming start time and loaded squat jump performance in high level swimmers, but further studies are necessary to assess the effectiveness of power-oriented resistance training in the development of explosive actions.	[Garcia-Ramos, Amador; Padial, Paulino; Bonitch-Gongora, Juan; Feriche, Belen] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Stirn, Igor; Tomazin, Katja; Strumbelj, Boro; Strojnik, Vojko] Univ Ljubljana, Fac Sport, Dept Kinesiol, Ljubljana, Slovenia; [Arguelles-Cienfuegos, Javier; De la Fuente, Blanca; Calderon, Carmen] Spanish Sport Council, High Performance Ctr Sierra Nevada, Granada, Spain	University of Granada; University of Ljubljana	Feriche, B (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.	mbelen@ugr.es	Feriche, Belén/K-2783-2012; Bonitch-Góngora, Juan/AAG-5406-2020; Bonitch-Góngora, Juan/P-8233-2019; Ramos, Amador Garcia/S-6982-2016; De la Fuente Caynzos, Blanca/ABF-9921-2021	Feriche, Belén/0000-0002-3933-6041; Bonitch-Góngora, Juan/0000-0003-0083-0138; Ramos, Amador Garcia/0000-0003-0608-8755; 	Spanish Ministry of Science and Innovation [DEP2012-35774]; Ministry of Education, Culture and Sport [FPU12/00360]; Ferrovial S.A.	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Education, Culture and Sport; Ferrovial S.A.	This study was supported by the Spanish Ministry of Science and Innovation (DEP2012-35774), Ministry of Education, Culture and Sport (Predoctoral Grant FPU12/00360), and Ferrovial S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeberli I, 2013, EUR J NUTR, V52, P625, DOI 10.1007/s00394-012-0366-9; [Anonymous], 2014, THE J; [Anonymous], 2006, ARCH MED DEPORT; Barlow H, 2014, HUM MOVEMENT SCI, V34, P178, DOI 10.1016/j.humov.2014.02.002; Bonetti DL, 2009, SPORTS MED, V39, P107, DOI 10.2165/00007256-200939020-00002; BORG G, 1985, EUR J APPL PHYSIOL O, V54, P343, DOI 10.1007/BF02337176; Etheridge T, 2011, AM J PHYSIOL-ENDOC M, V301, pE697, DOI 10.1152/ajpendo.00276.2011; Felici F, 2001, EUR J APPL PHYSIOL, V85, P507, DOI 10.1007/s004210100488; Feriche B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114072; FERRETTI G, 1990, INT J SPORTS MED, V11, pS31, DOI 10.1055/s-2007-1024851; Francaux M., 2013, CELL MOL EXERC PHYSL, V2, pE5; Fulco CS, 2002, AVIAT SPACE ENVIR MD, V73, P758; Garcia-Ramos A, 2016, J STRENGTH COND RES, V30, P1638, DOI 10.1519/JSC.0000000000001242; Garcia-Ramos A, 2015, EUR J SPORT SCI, V15, P687, DOI 10.1080/17461391.2015.1063699; Garcia-Ramos A, 2015, J SPORT SCI MED, V14, P256; Govus AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135120; Hainsworth R, 2007, CLIN AUTON RES, V17, P13, DOI 10.1007/s10286-006-0395-7; Hakkinen K, 2003, EUR J APPL PHYSIOL, V89, P42, DOI 10.1007/s00421-002-0751-9; Hamlin MJ, 2015, INT J SPORT PHYSIOL, V10, P881, DOI 10.1123/ijspp.2014-0261; Hopkins W.G., 2000, SPORTSCIENCE, P1; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Mason B., 2000, P 18 S BIOM SPORTS A, P75; Melissa L, 1997, MED SCI SPORT EXER, V29, P238, DOI 10.1097/00005768-199702000-00012; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; NARICI MV, 1995, EUR J APPL PHYSIOL O, V70, P213, DOI 10.1007/BF00238566; PERONNET F, 1991, J APPL PHYSIOL, V70, P399, DOI 10.1152/jappl.1991.70.1.399; Raguso CA, 2004, CURR OPIN CLIN NUTR, V7, P411, DOI 10.1097/01.mco.0000134372.78438.09; Rodriguez FA, 2015, MED SCI SPORT EXER, V47, P1965, DOI 10.1249/MSS.0000000000000626; Ronnestad BR, 2012, EUR J APPL PHYSIOL, V112, P1457, DOI 10.1007/s00421-011-2112-z; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Schoenfeld BJ, 2013, SPORTS MED, V43, P179, DOI 10.1007/s40279-013-0017-1; Scott BR, 2014, SPORTS MED, V44, P1037, DOI 10.1007/s40279-014-0177-7; Tor E, 2015, J SPORT SCI, V33, P1313, DOI 10.1080/02640414.2014.990486; West DJ, 2011, J STRENGTH COND RES, V25, P950, DOI 10.1519/JSC.0b013e3181c8656f; Wilber RL, 2007, MED SCI SPORT EXER, V39, P1590, DOI 10.1249/mss.0b013e3180de49bd	35	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160401	10.1371/journal.pone.0160401	http://dx.doi.org/10.1371/journal.pone.0160401			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467760	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100151
J	O'Meara, MJ; Ballouz, S; Shoichet, BK; Gillis, J				O'Meara, Matthew J.; Ballouz, Sara; Shoichet, Brian K.; Gillis, Jesse			Ligand Similarity Complements Sequence, Physical Interaction, and Co-Expression for Gene Function Prediction	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; TARGET IDENTIFICATION; DRUGGABLE GENOME; NETWORK; INFORMATICS; REPOSITORY; CHEMISTRY; EVOLUTION; KINOME; SPACE	The expansion of protein-ligand annotation databases has enabled large-scale networking of proteins by ligand similarity. These ligand-based protein networks, which implicitly predict the ability of neighboring proteins to bind related ligands, may complement biologically-oriented gene networks, which are used to predict functional or disease relevance. To quantify the degree to which such ligand-based protein associations might complement functional genomic associations, including sequence similarity, physical protein-protein interactions, co-expression, and disease gene annotations, we calculated a network based on the Similarity Ensemble Approach (SEA: sea.docking.org), where protein neighbors reflect the similarity of their ligands. We also measured the similarity with functional genomic networks over a common set of 1,131 genes, and found that the networks had only small overlaps, which were significant only due to the large scale of the data. Consistent with the view that the networks contain different information, combining them substantially improved Molecular Function prediction within GO (from AUROC similar to 0.63-0.75 for the individual data modalities to AUROC similar to 0.8 in the aggregate). We investigated the boost in guilt-by-association gene function prediction when the networks are combined and describe underlying properties that can be further exploited.	[O'Meara, Matthew J.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Ballouz, Sara; Gillis, Jesse] Stanley Inst Cognit Genom, Cold Spring Harbor Lab, 500 Sunnyside Blvd, Woodbury, NY 11797 USA	University of California System; University of California San Francisco; Cold Spring Harbor Laboratory	Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.; Gillis, J (corresponding author), Stanley Inst Cognit Genom, Cold Spring Harbor Lab, 500 Sunnyside Blvd, Woodbury, NY 11797 USA.	shoichet@cgl.ucsf.edu; jgillis@cshl.edu	Ballouz, Sara/L-2196-2019	Ballouz, Sara/0000-0003-4701-3020; Gillis, Jesse/0000-0002-0936-9774; O'Meara, Matthew/0000-0002-3128-5331	National Institute of General Medical Sciences [GM71896]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM114961, R01GM071896] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institute of General Medical Sciences (http://www.nigms.nih.gov/) GM71896 (to BKS and J. Irwin), and a grant from T. and V. Stanley (to JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Altenhoff AM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002514; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ballouz S, 2015, BIOINFORMATICS, V31, P2123, DOI 10.1093/bioinformatics/btv118; Ballouz S, 2016, EGAD EXTENDING GUILT; Bender A, 2004, ORG BIOMOL CHEM, V2, P3204, DOI 10.1039/b409813g; Bender A, 2009, J CHEM INF MODEL, V49, P108, DOI 10.1021/ci800249s; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Garcia-Serna R, 2015, CHEM RES TOXICOL, V28, P1875, DOI 10.1021/acs.chemrestox.5b00260; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Gillis J, 2014, J PROTEOMICS, V100, P44, DOI 10.1016/j.jprot.2014.01.020; Gillis J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002444; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Gregori-Puigjane E, 2012, P NATL ACAD SCI USA, V109, P11178, DOI 10.1073/pnas.1204524109; HAND DJ, 2006, CLASSIFIER TECHNOLOG, P1, DOI DOI 10.1214/088342306000000060; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jiang Y, 2016, ARXIV 160100891V1 Q; Jiang YX, 2014, BIOINFORMATICS, V30, pI609, DOI 10.1093/bioinformatics/btu472; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khoury-Haddad H, 2015, CELL CYCLE, V14, P950, DOI 10.1080/15384101.2015.1014147; Laggner C, 2012, NAT CHEM BIOL, V8, P144, DOI 10.1038/nchembio.732; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lemieux GA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001712; Maietta P, 2014, NUCLEIC ACIDS RES, V42, pD267, DOI 10.1093/nar/gkt1127; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Mistry M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-327; Montojo J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00123; Myers CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-187; Olah M., 2007, CHEM BIOL SMALL MOL, P760; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Powers D. M. W., 2012, 2012 IEEE International Conference on Information Science and Technology, P567, DOI 10.1109/ICIST.2012.6221710; Rask-Andersen M, 2014, ANNU REV PHARMACOL, V54, P9, DOI 10.1146/annurev-pharmtox-011613-135943; Rentzsch R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S5; Reschly EJ, 2008, J STEROID BIOCHEM, V110, P83, DOI 10.1016/j.jsbmb.2008.02.007; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Team RC, R A LANGUAGE AND ENV; Verleyen W, 2016, BIOINFORMATICS, V32, P1065, DOI 10.1093/bioinformatics/btv734; Verleyen W, 2015, BIOINFORMATICS, V31, P745, DOI 10.1093/bioinformatics/btu715; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zoubarev A, 2012, BIOINFORMATICS, V28, P2272, DOI 10.1093/bioinformatics/bts430	59	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160098	10.1371/journal.pone.0160098	http://dx.doi.org/10.1371/journal.pone.0160098			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467773	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000381516100110
J	Park, CS; Kim, T; Hong, SH; Shin, KC; Kim, KR; Oh, DK				Park, Chul-Soon; Kim, Taeyong; Hong, Seung-Hye; Shin, Kyung-Chul; Kim, Kyoung-Rok; Oh, Deok-Kun			D-Allulose Production from D-Fructose by Permeabilized Recombinant Cells of Corynebacterium glutamicum Cells Expressing D-Allulose 3-Epimerase Flavonifractor plautii	PLOS ONE			English	Article							D-PSICOSE 3-EPIMERASE; CLOSTRIDIUM-CELLULOLYTICUM H10; ALPHA-LINOLENIC ACID; ESCHERICHIA-COLI; AGROBACTERIUM-TUMEFACIENS; 10-HYDROXY-12,15(Z,Z)-OCTADECADIENOIC ACID; CRYSTAL-STRUCTURES; HEALTH-BENEFITS; D-TAGATOSE; ENERGY	A D-allulose 3-epimerase from Flavonifractor plautii was cloned and expressed in Escherichia coli and Corynebacterium glutamicum. The maximum activity of the enzyme purified from recombinant E. coli cells was observed at pH 7.0, 65 degrees C, and 1 mM Co2+ with a half-life of 40 min at 65 degrees C, K-m of 162 mM, and k(cat) of 25280 1/s. For increased D-allulose production, recombinant C. glutamicum cells were permeabilized via combined treatments with 20 mg/L penicillin and 10% (v/v) toluene. Under optimized conditions, 10 g/L permeabilized cells produced 235 g/L D-allulose from 750 g/L D-fructose after 40 min, with a conversion rate of 31% (w/w) and volumetric productivity of 353 g/L/h, which were 1.4- and 2.1-fold higher than those obtained for nonpermeabilized cells, respectively.	[Park, Chul-Soon; Hong, Seung-Hye; Shin, Kyung-Chul; Kim, Kyoung-Rok; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea; [Kim, Taeyong] Sejong Univ, Dept Food Sci & Technol, Seoul 05006, South Korea	Konkuk University; Sejong University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea.	deokkun@konkuk.ac.kr	Shin, Kyung-Chul/E-9681-2017	Shin, Kyung-Chul/0000-0002-1527-0164	Next-Generation BioGreen 21 Program [PJ01113701]; Rural Development Administration, Republic of Korea	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ01113701), Rural Development Administration, Republic of Korea.	Ahmed Y. M., 2013, African Journal of Microbiology Research, V7, P2071; An JU, 2013, APPL ENVIRON MICROB, V79, P2636, DOI 10.1128/AEM.02602-12; Bayan N, 2003, J BIOTECHNOL, V104, P55, DOI 10.1016/S0168-1656(03)00163-9; Binkley W. W., 1963, INT SUGAR J, V65, P105; Burdock GA, 2004, TOXICOL LETT, V150, P3, DOI 10.1016/j.toxlet.2003.07.004; Chan HC, 2012, PROTEIN CELL, V3, P123, DOI 10.1007/s13238-012-2026-5; Chen RRZ, 2007, APPL MICROBIOL BIOT, V74, P730, DOI 10.1007/s00253-006-0811-x; Choi HY, 2015, BIOTECHNOL LETT, V37, P2271, DOI 10.1007/s10529-015-1913-2; Chung MY, 2012, J AGR FOOD CHEM, V60, P863, DOI 10.1021/jf204050w; De Leon A, 2003, PROCESS BIOCHEM, V39, P301, DOI 10.1016/S0032-9592(03)00079-7; He WW, 2016, J AGR FOOD CHEM, V64, P3243, DOI 10.1021/acs.jafc.6b00278; Jia M, 2014, APPL MICROBIOL BIOT, V98, P717, DOI 10.1007/s00253-013-4924-8; Kim HJ, 2006, APPL ENVIRON MICROB, V72, P981, DOI 10.1128/AEM.72.2.981-985.2006; Kim K, 2006, J MOL BIOL, V361, P920, DOI 10.1016/j.jmb.2006.06.069; Kim SH, 2010, ENZYME MICROB TECH, V46, P366, DOI 10.1016/j.enzmictec.2009.12.012; LEVIN GV, 1995, AM J CLIN NUTR, V62, P1161; Livesey G, 1996, J NUTR, V126, P1601, DOI 10.1093/jn/126.6.1601; Matsuo T, 2002, J NUTR SCI VITAMINOL, V48, P77, DOI 10.3177/jnsv.48.77; Miller B.S., 1960, J SCI FOOD AGR, V11, P344, DOI DOI 10.1002/JSFA.2740110609; Mu WM, 2013, BIOTECHNOL LETT, V35, P1481, DOI 10.1007/s10529-013-1230-6; Mu WM, 2011, J AGR FOOD CHEM, V59, P7785, DOI 10.1021/jf201356q; Oh DK, 2007, WORLD J MICROB BIOT, V23, P559, DOI 10.1007/s11274-006-9265-7; Oh HJ, 2013, BIOTECHNOL LETT, V35, P1487, DOI 10.1007/s10529-013-1231-5; Park CS, 2016, J BIOSCI BIOENG, V121, P186, DOI 10.1016/j.jbiosc.2015.06.010; PARK YM, 1994, BIOTECHNOL LETT, V16, P345, DOI 10.1007/BF00245048; Shyamkumar Rajaram, 2014, Avicenna Journal of Medical Biotechnology, V6, P163; Yoshida H, 2007, J MOL BIOL, V374, P443, DOI 10.1016/j.jmb.2007.09.033; Zhang L., 2009, FRONT CHEM ENG CHINA, V3, P393, DOI [DOI 10.1007/s11705-009-0252-z, DOI 10.1007/S11705-009-0252-Z]; Zhang LT, 2009, BIOTECHNOL LETT, V31, P857, DOI 10.1007/s10529-009-9942-3; Zhang W, 2015, INT J ANTENN PROPAG, V2015, P1, DOI DOI 10.1145/2820783.2820823.10; Zhang WL, 2015, J MOL CATAL B-ENZYM, V120, P68, DOI 10.1016/j.molcatb.2015.05.018; Zhang WL, 2013, J AGR FOOD CHEM, V61, P11468, DOI 10.1021/jf4035817; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062987; Zhu YM, 2012, BIOTECHNOL LETT, V34, P1901, DOI 10.1007/s10529-012-0986-4	35	42	49	8	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160044	10.1371/journal.pone.0160044	http://dx.doi.org/10.1371/journal.pone.0160044			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467527	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100098
J	Samelko, L; Landgraeber, S; McAllister, K; Jacobs, J; Hallab, NJ				Samelko, Lauryn; Landgraeber, Stefan; McAllister, Kyron; Jacobs, Joshua; Hallab, Nadim James			Cobalt Alloy Implant Debris Induces Inflammation and Bone Loss Primarily through Danger Signaling, Not TLR4 Activation: Implications for DAMP-ening Implant Related Inflammation	PLOS ONE			English	Article							PERIPHERAL-BLOOD MONOCYTES; NALP3 INFLAMMASOME; PERIPROSTHETIC OSTEOLYSIS; WEAR PARTICLES; RECEPTOR 4; IN-VITRO; EXPRESSION; RELEASE; IONS; STIMULATION	Cobalt alloy debris has been implicated as causative in the early failure of some designs of current total joint implants. The ability of implant debris to cause excessive inflammation via danger signaling (NLRP3 inflammasome) vs. pathogen associated pattern recognition receptors (e.g. Toll-like receptors; TLRs) remains controversial. Recently, specific non-conserved histidines on human TLR4 have been shown activated by cobalt and nickel ions in solution. However, whether this TLR activation is directly or indirectly an effect of metals or secondary endogenous alarmins (danger-associated molecular patterns, DAMPs) elicited by danger signaling, remains unknown and contentious. Our study indicates that in both a human macrophage cell line (THP-1) and primary human macrophages, as well as an in vivo murine model of inflammatory osteolysis, that Cobalt-alloy particle induced NLRP3 inflammasome danger signaling inflammatory responses were highly dominant relative to TLR4 activation, as measured respectively by IL-1 beta or TNF-alpha, IL-6, IL-10, tissue histology and quantitative bone loss measurement. Despite the lack of metal binding histidines H456 and H458 in murine TLR4, murine calvaria challenge with Cobalt alloy particles induced significant macrophage driven in vivo inflammation and bone loss inflammatory osteolysis, whereas LPS calvaria challenge alone did not. Additionally, no significant increase (p<0.05) in inflammation and inflammatory bone loss by LPS co-challenge with Cobalt vs. Cobalt alone was evident, even at high levels of LPS (i.e. levels commiserate with hematogenous levels in fatal sepsis, >500pg/mL). Therefore, not only do the results of this investigation support Cobalt alloy danger signaling induced inflammation, but under normal homeostasis low levels of hematogenous PAMPs (<2pg/mL) from Gram-negative bacteria, seem to have negligible contribution to the danger signaling responses elicited by Cobalt alloy metal implant debris. This suggests the unique nature of Cobalt alloy particle bioreactivity is strong enough to illicit danger signaling that secondarily activate concomitant TLR activation, and may in part explain Cobalt particulate associated inflammatory and toxicity-like reactions of specific orthopedic implants.	[Samelko, Lauryn; McAllister, Kyron; Jacobs, Joshua; Hallab, Nadim James] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Samelko, Lauryn] Rush Univ, Med Ctr, Dept Immunol, Chicago, IL 60612 USA; [Landgraeber, Stefan] Univ Duisburg Essen, Univ Hosp Essen, Dept Orthopaed, Hufelandstr 55, D-45122 Essen, Germany	Rush University; Rush University; University of Duisburg Essen	Hallab, NJ (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	nhallab@rush.edu	Jacobs, Joshua/AGG-8284-2022	Jacobs, Joshua/0000-0003-3902-7334	National Institutes of Health [AR060782]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding was provided by National Institutes of Health, grant number AR060782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number AR060782. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bauernfeind F, 2013, EMBO MOL MED, V5, P814, DOI 10.1002/emmm.201201771; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bi YM, 2002, J ORTHOP RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bosker BH, 2015, ARCH ORTHOP TRAUM SU, V135, P417, DOI 10.1007/s00402-015-2165-2; Burton L, 2013, J ORTHOP RES, V31, P73, DOI 10.1002/jor.22190; Caicedo M, 2008, J BIOMED MATER RES A, V86A, P905, DOI 10.1002/jbm.a.31789; Caicedo MS, 2013, J ORTHOP RES, V31, P1633, DOI 10.1002/jor.22411; Caicedo MS, 2010, J BIOMED MATER RES A, V93A, P1312, DOI 10.1002/jbm.a.32627; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Dalal A, 2012, J BIOMED MATER RES A, V100A, P2147, DOI 10.1002/jbm.a.34122; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035; Gordon A, 2008, ARTHRITIS RHEUM-US, V58, P3157, DOI 10.1002/art.23863; Gordon A, 2010, J ORTHOP RES, V28, P1127, DOI 10.1002/jor.21135; Green JM, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0325-3; Greenfield EM, 2010, J BIOL CHEM, V285, P32378, DOI 10.1074/jbc.M110.136895; Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150; Grutz G, 2005, J LEUKOCYTE BIOL, V77, P3, DOI 10.1189/jlb.0904484; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gurung P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14488; Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182; Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106; Hallab NJ, 2011, J BIOMED MAT RES B; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P99, DOI 10.2106/JBJS.F.00102; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Lahdeoja T, 2010, J ORTHOP RES, V28, P184, DOI 10.1002/jor.20979; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lawrence H, 2014, BONE JOINT J, V96B, P1172, DOI 10.1302/0301-620X.96B9.33476; Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2; Madl AK, 2015, NANOMEDICINE; Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2; Mishra KP, 2014, INDIAN J CLIN BIOCHE, V29, P133, DOI 10.1007/s12291-013-0345-9; Oblak A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120583; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Paladini F, 2011, TOXICOL SCI, V119, P257, DOI 10.1093/toxsci/kfq328; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Pearl JI, 2011, BIOMATERIALS, V32, P5535, DOI 10.1016/j.biomaterials.2011.04.046; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155; Samelko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067127; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Sloane JA, 2010, NEUROMOL MED, V12, P149, DOI 10.1007/s12017-009-8094-x; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Tamaki Y, 2011, J RHEUMATOL, V38, P810, DOI 10.3899/jrheum.100732; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tyson-Capper AJ, 2013, ANN RHEUM DIS, V72, P460, DOI 10.1136/annrheumdis-2012-202468; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793	56	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160141	10.1371/journal.pone.0160141	http://dx.doi.org/10.1371/journal.pone.0160141			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467577	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100119
J	Toscano-Zapien, AL; Velazquez-Lopez, D; Velazquez-Martinez, DN				Toscano-Zapien, Anna L.; Velazquez-Lopez, Daniel; Velazquez-Martinez, David N.			Attentional Mechanisms during the Performance of a Subsecond Timing Task	PLOS ONE			English	Article							PUPILLARY RESPONSES; VISUAL-ATTENTION; TIME PERCEPTION; INTERNAL CLOCK; EYE-MOVEMENTS; INTERVAL; MODEL; SYSTEM; DISCRIMINATION; REPRESENTATION	There is evidence that timing processes in the suprasecond scale are modulated by attentional mechanisms; in addition, some studies have shown that attentional mechanisms also affect timing in the subsecond scale. Our aim was to study eye movements and pupil diameter during a temporal bisection task in the subsecond range. Subjects were trained to discriminate anchor intervals of 200 or 800 msec, and were then confronted with intermediate durations. Eye movements revealed that subjects used different cognitive strategies during the bisection timing task. When the stimulus to be timed appeared randomly at a central or 4 peripheral positions on a screen, some subjects choose to maintain their gaze toward the central area while other followed the peripheral placement of the stimulus; some others subjects used both strategies. The time of subjective equality did not differ between subjects who employed different attentional mechanisms. However, differences emerged in the timing variance and attentional indexes (time taken to initial fixation, latency to respond, pupil dilatation and duration and number of fixations to stimulus areas). Timing in the subsecond range seems invariant despite the use of different attentional strategies. Future research should determine whether the selection of attentional mechanisms is related to particular timing tasks or instructions or whether it represents idiosyncratic cognitive "styles".	[Toscano-Zapien, Anna L.; Velazquez-Martinez, David N.] Univ Nacl Autonoma Mexico, Fac Psicol, Dept Psicofisiol, Mexico City 04510, DF, Mexico; [Velazquez-Lopez, Daniel] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Matemat, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Velazquez-Martinez, DN (corresponding author), Univ Nacl Autonoma Mexico, Fac Psicol, Dept Psicofisiol, Mexico City 04510, DF, Mexico.	velazque@unam.mx		Velazquez-Martinez, David/0000-0002-0823-3058	Consejo Nacional de Cienccia y Tecnologia [129337]	Consejo Nacional de Cienccia y Tecnologia	This study was supported by Consejo Nacional de Cienccia y Tecnologia, grant 129337 (http://www.conacyt.mx/), DNVM.	Alards-Tomalin D, 2014, J EXP PSYCHOL LEARN, V40, P555, DOI 10.1037/a0035031; Allan LG, 2002, Q J EXP PSYCHOL-B, V55, P43, DOI 10.1080/02724990143000162; ALLAN LG, 1992, AM J PSYCHOL, V105, P140, DOI 10.2307/1422989; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bartels M., 2012, P S EYE TRACK RES AP, P161, DOI [10.1145/2168556.2168582, DOI 10.1145/2168556.2168582]; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; Block RA, 1996, TIME AND MIND, P171; BLOCK RA, 1992, NATO ADV SCI INST SE, V66, P141; Block RA, 2014, ACTA PSYCHOL, V149, P129, DOI 10.1016/j.actpsy.2013.11.003; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; Brown SW, 2008, PERCEPTION, V37, P712, DOI 10.1068/p5698; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Brown SW, 2002, J EXP PSYCHOL HUMAN, V28, P600, DOI 10.1037//0096-1523.28.3.600; BROWN SW, 1990, ACTA PSYCHOL, V75, P103, DOI 10.1016/0001-6918(90)90081-P; BROWN SW, 1992, PERCEPTION, V21, P545, DOI 10.1068/p210545; Buhusi CV, 2014, BEHAV PROCESS, V101, P72, DOI 10.1016/j.beproc.2013.09.003; Burle B, 2001, J EXP PSYCHOL HUMAN, V27, P195, DOI 10.1037/0096-1523.27.1.195; Cao Y, 2015, NEURON, V87, P1248, DOI 10.1016/j.neuron.2015.09.002; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; Conti R, 2001, J PERS, V69, P1, DOI 10.1111/1467-6494.00134; Coskun F, 2015, Q J EXP PSYCHOL, V68, P381, DOI 10.1080/17470218.2014.944921; Fabbri M, 2012, ACTA PSYCHOL, V139, P111, DOI 10.1016/j.actpsy.2011.09.006; Ferrara A, 1997, Q J EXP PSYCHOL-B, V50, P217; Garcia-Perez MA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00415; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gros A, 2015, FRONT BEHAV NEUROSCI, V9, P1, DOI 10.3389/fnbeh.2015.00143; Harrington DL, 1998, J NEUROSCI, V18, P1085; Hellstrom A, 2004, ACTA PSYCHOL, V116, P1, DOI 10.1016/j.actpsy.2003.11.003; Henderson J. M., 1998, EYE GUIDANCE READING, P269, DOI [10.1016/B978-008043361-5/50013-4, DOI 10.1016/B978-008043361-5/50013-4, 10.1016/b978-008043361-5/50013-4]; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM, 1997, PERCEPT PSYCHOPHYS, V59, P323, DOI 10.3758/BF03211901; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Henderson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064937; Henderson JM, 2009, PSYCHON B REV, V16, P850, DOI 10.3758/PBR.16.5.850; Hertzum M, 2015, HUM FACTORS, V57, P101, DOI 10.1177/0018720814540208; Hertzum M, 2013, INT J HUM-COMPUT INT, V29, P26, DOI 10.1080/10447318.2012.676538; Hertzum M, 2009, BEHAV INFORM TECHNOL, V28, P165, DOI 10.1080/01449290701773842; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; HO MY, 1995, PSYCHOPHARMACOLOGY, V120, P213, DOI 10.1007/BF02246196; Holmes KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058381; Howells FM, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-39; INHOFF AW, 1989, Q J EXP PSYCHOL-A, V41, P63, DOI 10.1080/14640748908402353; Itti L, 2006, VIS COGN, V14, P959, DOI 10.1080/13506280500195672; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Kahneman D., 1973, ATTENTION EFFORT; Kammerer Y, 2013, P 35 ANN C COGN SCI; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; KILLEEN PR, 1988, PSYCHOL REV, V95, P274, DOI 10.1037/0033-295X.95.2.274; Klingner J, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P69, DOI 10.1145/1344471.1344489; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Lake JI, 2014, ACTA PSYCHOL, V149, P169, DOI 10.1016/j.actpsy.2014.03.010; Lejeune H, 1998, BEHAV PROCESS, V44, P127, DOI 10.1016/S0376-6357(98)00045-X; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; Machado A, 2003, BEHAV PROCESS, V62, P157, DOI 10.1016/S0376-6357(03)00023-8; Malcolm GL, 2010, J VISION, V10, DOI 10.1167/10.2.4; Mangels JA, 1998, BRAIN RES COGN BRAIN, V7, P39; MCCLAIN L, 1983, PERCEPT PSYCHOPHYS, V34, P185, DOI 10.3758/BF03211347; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meck WH, 1996, BRAIN RES COGN BRAIN, V6, P233; Meck WH, 1984, ANN NY ACAD SCI, V423, P541; Moresi S, 2008, INT J PSYCHOPHYSIOL, V67, P124, DOI 10.1016/j.ijpsycho.2007.10.011; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Neider MB, 2006, VISION RES, V46, P614, DOI 10.1016/j.visres.2005.08.025; Nuthmann A, 2010, PSYCHOL REV, V117, P382, DOI 10.1037/a0018924; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Penney TB, 2014, ACTA PSYCHOL, V147, P97, DOI 10.1016/j.actpsy.2013.07.017; POLLATSEK A, 1990, J EXP PSYCHOL HUMAN, V16, P199, DOI 10.1037/0096-1523.16.1.199; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Schirmer A, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00058; Siegle GJ, 2008, PSYCHOPHYSIOLOGY, V45, P679, DOI 10.1111/j.1469-8986.2008.00681.x; Suarez I, 2013, COGN NEUROPSYCHOL, V30, P195, DOI 10.1080/02643294.2013.842548; THOMAS EAC, 1975, PERCEPT PSYCHOPHYS, V17, P363, DOI 10.3758/BF03199347; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; Valera EM, 2010, BIOL PSYCHIAT, V68, P359, DOI 10.1016/j.biopsych.2010.05.012; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; van Diepen PMJ, 2003, VIS COGN, V10, P79, DOI 10.1080/13506280143000023; Verney SP, 2004, INT J PSYCHOPHYSIOL, V52, P23, DOI 10.1016/j.ijpsycho.2003.12.003; Vicario CM, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00065; Wadlinger HA, 2008, EMOTION, V8, P121, DOI 10.1037/1528-3542.8.1.121; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P129; Weinbach N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00236; Werthmann J, 2014, EAT BEHAV, V15, P230, DOI 10.1016/j.eatbeh.2014.02.001; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wilson TW, 2013, NEUROPSYCHOLOGY, V27, P654, DOI 10.1037/a0034032; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Zakay D, 2004, ACTA NEUROBIOL EXP, V64, P319; Zakay D, 2004, APPL COGNITIVE PSYCH, V18, P931, DOI 10.1002/acp.1058; Zakay D, 1997, CURR DIR PSYCHOL SCI, V6, P12, DOI 10.1111/1467-8721.ep11512604; Zakay D, 2000, BEHAV PROCESS, V52, P63, DOI 10.1016/S0376-6357(00)00141-8; Zakay D., 1995, TIME DYNAMIC CONTROL, P167	100	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0158508	10.1371/journal.pone.0158508	http://dx.doi.org/10.1371/journal.pone.0158508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IL	27467762	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100011
J	Naito, W; Uesaka, M; Yamada, C; Kurosawa, T; Yasutaka, T; Ishii, H				Naito, Wataru; Uesaka, Motoki; Yamada, Chie; Kurosawa, Tadahiro; Yasutaka, Tetsuo; Ishii, Hideki			Relationship between Individual External Doses, Ambient Dose Rates and Individuals' Activity-Patterns in Affected Areas in Fukushima following the Fukushima Daiichi Nuclear Power Plant Accident	PLOS ONE			English	Article								The accident at Fukushima Daiichi Nuclear Power Plant on March 11, 2011, released radioactive material into the atmosphere and contaminated the land in Fukushima and several neighboring prefectures. Five years after the nuclear disaster, the radiation levels have greatly decreased due to physical decay, weathering, and decontamination operations in Fukushima. The populations of 12 communities were forced to evacuate after the accident; as of March 2016, the evacuation order has been lifted in only a limited area, and permanent habitation is still prohibited in most of the areas. In order for the government to lift the evacuation order and for individuals to return to their original residential areas, it is important to assess current and future realistic individual external doses. Here, we used personal dosimeters along with the Global Positioning System and Geographic Information System to understand realistic individual external doses and to relate individual external doses, ambient doses, and activity-patterns of individuals in the affected areas in Fukushima. The results showed that the additional individual external doses were well correlated to the additional ambient doses based on the airborne monitoring survey. The results of linear regression analysis suggested that the additional individual external doses were on average about one-fifth that of the additional ambient doses. The reduction factors, which are defined as the ratios of the additional individual external doses to the additional ambient doses, were calculated to be on average 0.14 and 0.32 for time spent at home and outdoors, respectively. Analysis of the contribution of various activity patterns to the total individual external dose demonstrated good agreement with the average fraction of time spent daily in each activity, but the contribution due to being outdoors varied widely. These results are a valuable contribution to understanding realistic individual external doses and the corresponding airborne monitoring-based ambient doses and time-activity patterns of individuals. Moreover, the results provide important information for predicting future cumulative doses after the return of residents to evacuation order areas in Fukushima.	[Naito, Wataru; Uesaka, Motoki; Yamada, Chie] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan; [Kurosawa, Tadahiro] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan; [Yasutaka, Tetsuo] Natl Inst Adv Ind Sci & Technol, Inst Georesources & Environm, Tsukuba, Ibaraki, Japan; [Ishii, Hideki] Fukushima Univ, Fukushima Future Ctr Reg Revitalizat, Fukushima, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Metrology Institute of Japan; National Institute of Advanced Industrial Science & Technology (AIST); Fukushima University	Naito, W (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan.	w-naito@aist.go.jp	Naito, Wataru/M-1928-2018; Yasutaka, Tetsuo/N-6727-2016; Kurosawa, Tadahiro/L-6242-2018; Hayano, Ryugo/F-7889-2012	Naito, Wataru/0000-0003-2064-7170; Yasutaka, Tetsuo/0000-0001-6000-663X; Kurosawa, Tadahiro/0000-0002-7909-2758; Hayano, Ryugo/0000-0002-1214-7806; Ishii, Hideki/0000-0003-4348-0123	JSPS KAKENHI [15H02854, 26241023]; Grants-in-Aid for Scientific Research [26241023] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant number 15H02854 (WN), 26241023 (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2016, J RADIOL PROT, V36, P49, DOI 10.1088/0952-4746/36/1/49; Agency Reconstruction, 2016, CURR STAT REC CHALL; Date-City, 2013, MEAS EXT EXP DOS 201; Hayano R., 2014, FBNEWS, V447, P1; Hirayama Hideo, 2013, Radioisotopes, V62, P335; [Japan Atomic Energy Agency National Institute of Radiological Sciences], 2014, RES CHAR PERS DOS AC; [Ministry of Environment Fukushima-city Koriyama-city Souma-city Date-city Agency Reconstruction], 2014, INT REP EFF GOV 4 CI; Ministry of Internal Affairs and Communications, 2012, SURV TIM US LEIS ACT; Ministry of the Environment, 2011, VIEW ADD ANN DOS 1 M; Naito W, 2015, RADIAT PROT DOSIM, V163, P353, DOI 10.1093/rpd/ncu201; National Diet of Japan Fukushima Nuclear Accident Independent Investigation Commission, 2012, OFF REP FUK NUCL ACC; Nihonmatsu-City, 2012, RES RAD EXP DOS SURV; Nomura S, 2015, ENVIRON SCI TECHNOL, V49, P1009, DOI 10.1021/es503504y; Nuclear Regulation Authority, 2013, MON AIR DOS RAT SER; Nuclear Regulation Authority, 2013, PRACT MEAS EV RET TH; Nuclear Regulation Authority, 2016, EXT SIT DISTR MAP RA; Takahara S, 2014, HEALTH PHYS, V107, P326, DOI 10.1097/HP.0000000000000120; Working Group on the Concept of Dose under the Division of Radiation Science and Technology, 2013, 2 DIV RAD SCI TECHN; Yoshida-Ohuchi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07541	19	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0158879	10.1371/journal.pone.0158879	http://dx.doi.org/10.1371/journal.pone.0158879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494021	Green Submitted, Green Published, gold			2022-12-27	WOS:000381369500004
J	Acosta-Jurado, S; Navarro-Gomez, P; Murdoch, PD; Crespo-Rivas, JC; Jie, S; Cuesta-Berrio, L; Ruiz-Sainz, JE; Rodriguez-Carvajal, MA; Vinardell, JM				Acosta-Jurado, Sebastian; Navarro-Gomez, Pilar; del Socorro Murdoch, Piedad; Crespo-Rivas, Juan-Carlos; Jie, Shi; Cuesta-Berrio, Lidia; Ruiz-Sainz, Jose-Enrique; Rodriguez-Carvajal, Miguel-Angel; Vinardell, Jose-Maria			Exopolysaccharide Production by Sinorhizobium fredii HH103 Is Repressed by Genistein in a NodD1-Dependent Manner	PLOS ONE			English	Article							LEGUMINOSARUM BV TRIFOLII; CELL-SURFACE COMPONENTS; FAST-GROWING RHIZOBIA; SYMBIOTIC PROPERTIES; BIOFILM FORMATION; GENE-EXPRESSION; NODULATION; MELILOTI; SIGNALS; POLYSACCHARIDES	In the rhizobia-legume symbiotic interaction, bacterial surface polysaccharides, such as exopolysaccharide (EPS), lipopolysaccharide (LPS), K-antigen polysaccharide (KPS) or cyclic glucans (CG), appear to play crucial roles either acting as signals required for the progression of the interaction and/or preventing host defence mechanisms. The symbiotic significance of each of these polysaccharides varies depending on the specific rhizobialegume couple. In this work we show that the production of exopolysaccharide by Sinorhizobium fredii HH103, but not by other S. fredii strains such as USDA257 or NGR234, is repressed by nod gene inducing flavonoids such as genistein and that this repression is dependent on the presence of a functional NodD1 protein. In agreement with the importance of EPS for bacterial biofilms, this reduced EPS production upon treatment with flavonoids correlates with decreased biofilm formation ability. By using quantitative RT-PCR analysis we show that expression of the exoY2 and exoK genes is repressed in late stationary cultures of S. fredii HH103 upon treatment with genistein. Results presented in this work show that in S. fredii HH103 EPS production is regulated just in the opposite way than other bacterial signals such as Nod factors and type 3 secreted effectors: it is repressed by flavonoids and NodD1 and enhanced by the nod repressor NolR. These results are in agreement with our previous observations showing that lack of EPS production by S. fredii HH103 is not only non-detrimental but even beneficial for symbiosis with soybean.	[Acosta-Jurado, Sebastian; Navarro-Gomez, Pilar; Crespo-Rivas, Juan-Carlos; Jie, Shi; Ruiz-Sainz, Jose-Enrique; Vinardell, Jose-Maria] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [del Socorro Murdoch, Piedad] Univ Seville, Fac Biol, Dept Bioquim Vegetal & Biol Mol, Seville, Spain; [Cuesta-Berrio, Lidia; Rodriguez-Carvajal, Miguel-Angel] Univ Seville, Fac Quim, Dept Quim Organ, Seville, Spain; [Jie, Shi] Heilongjiang Acad Sci, Daqing Branch, Daqing, Peoples R China	University of Sevilla; University of Sevilla; University of Sevilla	Vinardell, JM (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	jvinar@us.es	Carvajal, Miguel Ángel Rodríguez/F-2577-2012; Vinardell, José M/H-5355-2013; Navarro-Gómez, Pilar/AAB-5760-2019; Jurado, Sebastián Acosta/ABH-3676-2020; Murdoch, Piedad del Socorro/K-7571-2014	Carvajal, Miguel Ángel Rodríguez/0000-0002-2131-6448; Vinardell, José M/0000-0002-7105-5389; Navarro-Gómez, Pilar/0000-0001-9573-4338; Murdoch, Piedad del Socorro/0000-0002-5703-352X; Acosta Jurado, Sebastian/0000-0002-5505-2508	Spanish Ministry of Science and Innovation [BIO2011-30229-C02-01]; Andalusia Government (Junta de Andalucia) [P11-CVI-7500]; VPPI from the University of Seville; European Regional Development Fund (FEDER)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Andalusia Government (Junta de Andalucia)(Junta de Andalucia); VPPI from the University of Seville; European Regional Development Fund (FEDER)(European Commission)	This work was supported by grants from the Spanish Ministry of Science and Innovation (http://www.idi.mineco.gob.es/portal/site/MICINN/) (project BIO2011-30229-C02-01) and the Andalusia Government (http://www.juntadeandalucia.es/organismos/economiayconocimiento.html) (project P11-CVI-7500 of Junta de Andalucia). SAJ and PNG are recipients of PhD grants from the VPPI from the University of Seville (https://investigacion.us.es/secretariado-investigacion/plan-propio). The authors also acknowledge the European Regional Development Fund (FEDER) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Grau AM, 2012, APPL ENVIRON MICROB, V78, P1644, DOI 10.1128/AEM.07117-11; APPELBAUM ER, 1988, J BACTERIOL, V170, P12, DOI 10.1128/jb.170.1.12-20.1988; Ardissone S, 2011, MOL PLANT MICROBE IN, V24, P1513, DOI 10.1094/MPMI-05-11-0143; Barnett MJ, 2015, J BACTERIOL, V197, P1792, DOI 10.1128/JB.02626-14; Barnett MJ, 1998, GENETICS, V148, P19; BECKER A, 1995, GENE, V162, P37, DOI 10.1016/0378-1119(95)00313-U; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; Crespo-Rivas JC, 2009, MOL PLANT MICROBE IN, V22, P575, DOI 10.1094/MPMI-22-5-0575; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; DUNN MF, 1992, FEMS MICROBIOL LETT, V97, P107; Dusha I, 1999, MOL PLANT MICROBE IN, V12, P755, DOI 10.1094/MPMI.1999.12.9.755; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Fujishige NA, 2008, MOL MICROBIOL, V67, P504, DOI 10.1111/j.1365-2958.2007.06064.x; Gil-Serrano AM, 1999, BIOCHEM J, V342, P527, DOI 10.1042/0264-6021:3420527; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Hidalgo A, 2010, MICROBIOL-SGM, V156, P3398, DOI 10.1099/mic.0.042499-0; Quelas JI, 2010, MOL PLANT MICROBE IN, V23, P1592, DOI 10.1094/MPMI-05-10-0122; Janczarek M, 2015, APPL SOIL ECOL, V85, P94, DOI 10.1016/j.apsoil.2014.08.010; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Janczarek M, 2011, INT J MOL SCI, V12, P4132, DOI 10.3390/ijms12064132; Jiao J, 2016, MOL PLANT MICROBE IN, V29, P352, DOI 10.1094/MPMI-01-16-0019-R; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; KELLER M, 1995, MOL PLANT MICROBE IN, V8, P267, DOI 10.1094/MPMI-8-0267; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; KEYSER HH, 1982, SCIENCE, V215, P1631, DOI 10.1126/science.215.4540.1631; KONDOROSI E, 1989, EMBO J, V8, P1331, DOI 10.1002/j.1460-2075.1989.tb03513.x; Lopez-Baena FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050755; Lopez-Baena FJ, 2008, MICROBIOL-SGM, V154, P1825, DOI 10.1099/mic.0.2007/016337-0; Machado D, 2003, CURR MICROBIOL, V47, P134, DOI 10.1007/s00284-002-3972-6; Machado D, 1998, MOL PLANT MICROBE IN, V11, P375, DOI 10.1094/MPMI.1998.11.5.375; Madinabeitia N, 2002, MOL PLANT MICROBE IN, V15, P150, DOI 10.1094/MPMI.2002.15.2.150; Margaret I, 2011, J BIOTECHNOL, V155, P11, DOI 10.1016/j.jbiotec.2011.03.016; Margaret-Oliver I, 2012, ARCH MICROBIOL, V194, P87, DOI 10.1007/s00203-011-0729-2; MEADE HM, 1977, P NATL ACAD SCI USA, V74, P2076, DOI 10.1073/pnas.74.5.2076; MIMMACK ML, 1994, MICROBIOL-UK, V140, P1223, DOI 10.1099/13500872-140-5-1223; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Parada M, 2006, MOL PLANT MICROBE IN, V19, P43, DOI 10.1094/MPMI-19-0043; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; Rachwal K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2332-4; Rodriguez-Navarro DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115391; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; Simsek S, 2009, CARBOHYD RES, V344, P1947, DOI 10.1016/j.carres.2009.07.006; Staehelin C, 2015, BIOCHEM J, V470, P263, DOI 10.1042/BJ20150518; Suzaki T, 2015, INT REV CEL MOL BIO, V316, P111, DOI 10.1016/bs.ircmb.2015.01.004; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vinardell JM, 2004, ARCH MICROBIOL, V181, P144, DOI 10.1007/s00203-003-0635-3; Vinardell JM, 2015, MOL PLANT MICROBE IN, V28, P811, DOI 10.1094/MPMI-12-14-0397-FI; Vincent JM, 1970, MANUAL PRACTICAL STU, P144; Weidner S, 2012, J BACTERIOL, V194, P1617, DOI 10.1128/JB.06729-11	53	19	20	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160499	10.1371/journal.pone.0160499	http://dx.doi.org/10.1371/journal.pone.0160499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486751	Green Published, gold			2022-12-27	WOS:000381367800079
J	Peter, AK; Bradford, WH; Dalton, ND; Gu, Y; Chao, CJ; Peterson, KL; Knowlton, KU				Peter, Angela K.; Bradford, William H.; Dalton, Nancy D.; Gu, Yusu; Chao, Chieh-Ju; Peterson, Kirk L.; Knowlton, Kirk U.			Increased Echogenicity and Radiodense Foci on Echocardiogram and MicroCT in Murine Myocarditis	PLOS ONE			English	Article							TISSUE CHARACTERIZATION; MAGNETIC-RESONANCE; HEART-DISEASE; CARDIOMYOPATHY; COXSACKIEVIRUS; DYSTROPHIN; ADENOVIRUS; CALCIFICATION; DIAGNOSIS; CHILDREN	Objectives To address the question as to whether echocardiographic and/or microcomputed tomography (microCT) analysis can be utilized to assess the extent of Coxsackie B virus (CVB) induced myocarditis in the absence of left ventricular dysfunction in the mouse. Background Viral myocarditis is a significant clinical problem with associated inflammation of the myocardium and myocardial injury. Murine models of myocarditis are commonly used to study the pathophysiology of the disease, but methods for imaging the mouse myocardium have been limited to echocardiographic assessment of ventricular dysfunction and, to a lesser extent, MRI imaging. Methods Using a murine model of myocarditis, we used both echocardiography and microCT to assess the extent of myocardial involvement in murine myocarditis using both wild-type mice and CVB cleavage-resistant dystrophin knock-in mice. Results Areas of increased echogenicity were only observed in the myocardium of Coxsackie B virus infected mice. These echocardiographic abnormalities correlated with the extent of von Kossa staining (a marker of membrane permeability), inflammation, and fibrosis. Given that calcium phosphate uptake as imaged by von Kossa staining might also be visualized using microCT, we utilized microCT imaging which allowed for high-resolution, 3-dimensional images of radiodensities that likely represent calcium phosphate uptake. As with echocardiography, only mice infected with Coxsackie B virus displayed abnormal accumulation of calcium within individual myocytes indicating increased membrane permeability only upon exposure to virus. Conclusions These studies demonstrate new, quantitative, and semi-quantitative imaging approaches for the assessment of myocardial involvement in the setting of viral myocarditis in the commonly utilized mouse model of viral myocarditis.	[Peter, Angela K.; Bradford, William H.; Dalton, Nancy D.; Gu, Yusu; Chao, Chieh-Ju; Peterson, Kirk L.; Knowlton, Kirk U.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Peter, Angela K.] Univ Colorado, BioFrontiers, Boulder, CO 80309 USA; [Chao, Chieh-Ju] Mayo Clin, Coll Med, Dept Internal Med, Phoenix, AZ USA; [Chao, Chieh-Ju] John H Stroger Jr Hosp Cook Cty, Dept Med, Chicago, IL USA; [Knowlton, Kirk U.] Intermt Med Ctr, Intermt Heart Inst, Salt Lake City, UT USA	University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; Mayo Clinic; Mayo Clinic Phoenix; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Intermountain Healthcare; Intermountain Medical Center	Knowlton, KU (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA.; Knowlton, KU (corresponding author), Intermt Med Ctr, Intermt Heart Inst, Salt Lake City, UT USA.	Kirk.knowlton@imail.org			National Heart, Blood, and Lung Institute [5P01HL046345]; Training in Cardiovascular Physiology & Pharmacology, National Heart, Blood, and Lung Institute [5T32HL007444]; NHLBI [5P01HL046345]; Training in Cardiovascular Physiology & Pharmacology, NHLBI [5T32HL007444]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046345, T32HL007444] Funding Source: NIH RePORTER	National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Training in Cardiovascular Physiology & Pharmacology, National Heart, Blood, and Lung Institute; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Training in Cardiovascular Physiology & Pharmacology, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from: a. National Heart, Blood, and Lung Institute: www.nhlbi.nih.gov (5P01HL046345, to KUK) b. Training in Cardiovascular Physiology & Pharmacology, National Heart, Blood, and Lung Institute: www.nhlbi.nh.gov (5T32HL007444 to AKP) 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from NHLBI (5P01HL046345, to K.U. Knowlton) and Training in Cardiovascular Physiology & Pharmacology, NHLBI (5T32HL007444 to A.K. Peter).	Baboonian C, 1997, CURR TOP MICROBIOL, V223, P31; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Itoh E, 1997, JPN CIRC J, V61, P798, DOI 10.1253/jcj.61.798; Kallewaard NL, 2009, CELL HOST MICROBE, V6, P91, DOI 10.1016/j.chom.2009.05.018; Knowlton KU, 1996, J VIROL, V70, P7811, DOI 10.1128/JVI.70.11.7811-7818.1996; Lee GH, 2000, CIRC RES, V87, P489; Lieback E, 1996, EUR HEART J, V17, P135; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lim BK, 2013, J CLIN INVEST, V123, P5146, DOI 10.1172/JCI66271; Lurz P, 2012, JACC-CARDIOVASC IMAG, V5, P513, DOI 10.1016/j.jcmg.2011.11.022; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nance JW, 2015, J CARDIOVASC COMPUT, V9, P58, DOI 10.1016/j.jcct.2014.10.004; OLBRICH HG, 1990, J CLIN PATHOL, V43, P650, DOI 10.1136/jcp.43.8.650; Omi W, 2002, CIRC J, V66, P416, DOI 10.1253/circj.66.416; Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI [10.4065/84.11.1001, 10.1016/S0025-6196(11)60670-8]; Skouri HN, 2006, J AM COLL CARDIOL, V48, P2085, DOI 10.1016/j.jacc.2006.08.017; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Ueda T, 2000, JPN CIRC J, V64, P144, DOI 10.1253/jcj.64.144; Ursu ON, 2014, CELL PHYSIOL BIOCHEM, V33, P52, DOI 10.1159/000356649; van Heeswijk RB, 2013, CIRC-CARDIOVASC IMAG, V6, P277, DOI 10.1161/CIRCIMAGING.112.000125; van Kruijsdijk RCM, 2011, CIRC-HEART FAIL, V4, pE16, DOI 10.1161/CIRCHEARTFAILURE.111.962183; Xiong DD, 2002, NAT MED, V8, P872, DOI 10.1038/nm737	25	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159971	10.1371/journal.pone.0159971	http://dx.doi.org/10.1371/journal.pone.0159971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486657	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800048
J	Saito, Y; Noguchi, N				Saito, Yoshiro; Noguchi, Noriko			Oxidized Lipoprotein as a Major Vessel Cell Proliferator in Oxidized Human Serum	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; VASCULAR SMOOTH-MUSCLE; LIPID-PEROXIDATION; OXIDATIVE STRESS; PROTEIN OXIDATION; IN-VIVO; ATHEROSCLEROSIS; DISEASE; ANGIOGENESIS; DYSFUNCTION	Oxidative stress is correlated with the incidence of several diseases such as atherosclerosis and cancer, and oxidized biomolecules have been determined as biomarkers of oxidative stress; however, the detailed molecular relationship between generated oxidation products and the promotion of diseases has not been fully elucidated. In the present study, to clarify the role of serum oxidation products in vessel cell proliferation, which is related to the incidence of atherosclerosis and cancer, the major vessel cell proliferator in oxidized human serum was investigated. Oxidized human serum was prepared by free radical exposure, separated using gel chromatography, and then each fraction was added to several kinds of vessel cells including endothelial cells and smooth muscle cells. It was found that a high molecular weight fraction in oxidized human serum specifically induced vessel cell proliferation. Oxidized lipids were contained in this high molecular weight fraction, while cell proliferation activity was not observed in oxidized lipoprotein-deficient serum. Oxidized low-density lipoproteins induced vessel cell proliferation in a concentration-dependent manner. Taken together, these results indicate that oxidized lipoproteins containing lipid oxidation products function as a major vessel cell proliferator in oxidized human serum. These findings strongly indicate the relevance of determination of oxidized lipoproteins and lipid oxidation products in the diagnosis of vessel cell proliferation-related diseases such as atherosclerosis and cancer.	[Saito, Yoshiro; Noguchi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Kyoto 6100321, Japan	Doshisha University	Saito, Y (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Kyoto 6100321, Japan.	ysaito@mail.doshisha.ac.jp	Saito, Yoshiro/H-4597-2019	Saito, Yoshiro/0000-0002-0559-5889	KAKENHI Grant from the Japan Society for the Promotion of Science (JSPS) [16790079, 25292078]	KAKENHI Grant from the Japan Society for the Promotion of Science (JSPS)	This work was supported in part by KAKENHI Grant Number 16790079 and 25292078 from the Japan Society for the Promotion of Science (JSPS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Davies KJA, 1999, IUBMB LIFE, V48, P41, DOI 10.1080/152165499307404; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; Halliwell B., 2007, FREE RADICALS BIOL M; Hutchins PM, 2011, J LIPID RES, V52, P2070, DOI 10.1194/jlr.M019174; Ivey ME, 2008, ATHEROSCLEROSIS, V199, P237, DOI 10.1016/j.atherosclerosis.2008.03.006; Kinumi T, 2005, FREE RADICAL RES, V39, P1335, DOI 10.1080/10715760500306695; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Niki E, 2005, BIOCHEM BIOPH RES CO, V338, P668, DOI 10.1016/j.bbrc.2005.08.072; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Parthasarathy S, 2010, METHODS MOL BIOL, V610, P403, DOI 10.1007/978-1-60327-029-8_24; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; RAMOS P, 1995, J LIPID RES, V36, P2113; Saito Y, 2015, J LIPID RES, V56, P2172, DOI 10.1194/jlr.M059105; Saito Y, 2014, BIOCHEM BIOPH RES CO, V446, P741, DOI 10.1016/j.bbrc.2013.12.083; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Taguchi S, 2000, J Atheroscler Thromb, V7, P132; Upston JM, 2002, AM J PATHOL, V160, P701, DOI 10.1016/S0002-9440(10)64890-0; Wang Y, 2014, J ATHEROSCLER THROMB, V21, P204, DOI 10.5551/jat.19448; Yoshida Y, 2004, FREE RADICAL RES, V38, P787, DOI 10.1080/10715760410001700460; Yoshida Y, 2004, FREE RADICAL RES, V38, P375, DOI 10.1080/1071576042000191763; Yoshida Y, 2013, J CLIN BIOCHEM NUTR, V52, P9, DOI 10.3164/jcbn.12-112	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160530	10.1371/journal.pone.0160530	http://dx.doi.org/10.1371/journal.pone.0160530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483438	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700056
J	Suzuki, S; Kakuta, M; Ishida, T; Akiyama, Y				Suzuki, Shuji; Kakuta, Masanori; Ishida, Takashi; Akiyama, Yutaka			GPU-Acceleration of Sequence Homology Searches with Database Subsequence Clustering	PLOS ONE			English	Article							GRAPHICS PROCESSORS; PROTEIN FAMILIES; SMITH-WATERMAN; ALIGNMENT; GENERATION; TOOL; BLAST; SETS; KEGG	Sequence homology searches are used in various fields and require large amounts of computation time, especially for metagenomic analysis, owing to the large number of queries and the database size. To accelerate computing analyses, graphics processing units (GPUs) are widely used as a low-cost, high-performance computing platform. Therefore, we mapped the time-consuming steps involved in GHOSTZ, which is a state-of-the-art homology search algorithm for protein sequences, onto a GPU and implemented it as GHOSTZ-GPU. In addition, we optimized memory access for GPU calculations and for communication between the CPU and GPU. As per results of the evaluation test involving metagenomic data, GHOSTZ-GPU with 12 CPU threads and 1 GPU was approximately 3.0- to 4.1-fold faster than GHOSTZ with 12 CPU threads. Moreover, GHOSTZ-GPU with 12 CPU threads and 3 GPUs was approximately 5.8- to 7.7-fold faster than GHOSTZ with 12 CPU threads.	[Suzuki, Shuji; Kakuta, Masanori; Ishida, Takashi; Akiyama, Yutaka] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo, Japan; [Suzuki, Shuji; Ishida, Takashi; Akiyama, Yutaka] Tokyo Inst Technol, Educ Acad Computat Life Sci ACLS, Meguro Ku, Tokyo, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Akiyama, Y (corresponding author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo, Japan.; Akiyama, Y (corresponding author), Tokyo Inst Technol, Educ Acad Computat Life Sci ACLS, Meguro Ku, Tokyo, Japan.	akiyama@cs.titech.ac.jp	Kakuta, Masanori/AAA-5810-2020; Akiyama, Yutaka/D-2048-2015	Akiyama, Yutaka/0000-0003-2863-8703	Strategic Programs for Innovative Research Field 1 Supercomputational Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Cancer Research Development from the National Cancer Center of Japan;  [248766]	Strategic Programs for Innovative Research Field 1 Supercomputational Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Cancer Research Development from the National Cancer Center of Japan; 	This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science Fellows (Grant number 248766) to SS, the Strategic Programs for Innovative Research Field 1 Supercomputational Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan to YA, and Cancer Research Development funding from the National Cancer Center of Japan to YA.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goudey B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S10; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Korpar M, 2016, PLOS ONE, V10, P1; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Liu WG, 2011, IEEE ACM T COMPUT BI, V8, P1678, DOI 10.1109/TCBB.2011.33; Liu YC, 2014, IEEE DES TEST, V31, P31, DOI 10.1109/MDAT.2013.2284198; Liu YC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-117; Liu Y, 2015, INT J GENOMICS, V2015, DOI [10.1155/2015/761063, 10.1155/2015/429469]; Luo RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065632; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Shimoda T., 2013, P INT C BIOINF COMP; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Suzuki S, 2015, BIOINFORMATICS, V31, P1183, DOI 10.1093/bioinformatics/btu780; Suzuki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103833; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zhao KY, 2014, BIOINFORMATICS, V30, P1384, DOI 10.1093/bioinformatics/btu047; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0157338	10.1371/journal.pone.0157338	http://dx.doi.org/10.1371/journal.pone.0157338			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482905	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700003
J	Takagi, R; Sasaki, K; Sasaki, D; Fukuda, I; Tanaka, K; Yoshida, K; Kondo, A; Osawa, R				Takagi, Risa; Sasaki, Kengo; Sasaki, Daisuke; Fukuda, Itsuko; Tanaka, Kosei; Yoshida, Ken-ichi; Kondo, Akihiko; Osawa, Ro			A Single-Batch Fermentation System to Simulate Human Colonic Microbiota for High-Throughput Evaluation of Prebiotics	PLOS ONE			English	Article							CONTINUOUS-CULTURE SYSTEM; HUMAN LARGE-INTESTINE; CHAIN FATTY-ACIDS; GUT MICROBIOTA; ENTEROPATHOGENIC INFECTION; EXPERIMENTAL-MODELS; DIVERSITY; HOST; BIFIDOBACTERIA; BACTERIA	We devised a single-batch fermentation system to simulate human colonic microbiota from fecal samples, enabling the complex mixture of microorganisms to achieve densities of up to 1011 cells/mL in 24 h. 16S rRNA gene sequence analysis of bacteria grown in the system revealed that representatives of the major phyla, including Bacteroidetes, Firmicutes, and Actinobacteria, as well as overall species diversity, were consistent with those of the original feces. On the earlier stages of fermentation (up to 9 h), trace mixtures of acetate, lactate, and succinate were detectable; on the later stages (after 24 h), larger amounts of acetate accumulated along with some of propionate and butyrate. These patterns were similar to those observed in the original feces. Thus, this system could serve as a simple model to simulate the diversity as well as the metabolism of human colonic microbiota. Supplementation of the system with several prebiotic oligosaccharides (including fructo-, galacto-, isomalto-, and xylo-oligosaccharides; lactulose; and lactosucrose) resulted in an increased population in genus Bifidobacterium, concomitant with significant increases in acetate production. The results suggested that this fermentation system may be useful for in vitro, preclinical evaluation of the effects of prebiotics prior to testing in humans.	[Takagi, Risa; Fukuda, Itsuko; Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Sasaki, Kengo; Sasaki, Daisuke; Yoshida, Ken-ichi; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Tanaka, Kosei; Yoshida, Ken-ichi; Kondo, Akihiko; Osawa, Ro] Kobe Univ, Org Adv Sci & Technol, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Kondo, Akihiko] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Itsuko; Osawa, Ro] Kobe Univ, Grad Sch Agr Sci, Res Ctr Food Safety & Secur, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan	Kobe University; Kobe University; Kobe University; RIKEN; Kobe University	Sasaki, K (corresponding author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	sikengo@people.kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015; Sasaki, Kengo/O-6739-2018; SASAKI, Daisuke/F-9597-2015; Yoshida, Ken-ichi/R-8863-2016	Sasaki, Kengo/0000-0002-5764-1429; Yoshida, Ken-ichi/0000-0002-3383-4664	Japan Innovative Bioproduction Kobe	Japan Innovative Bioproduction Kobe	This work was supported by Japan Innovative Bioproduction Kobe (http://www.org.kobe-u.ac.jp/bioproduction/).	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Becker N, 2011, GUT MICROBES, V2, P25, DOI 10.4161/gmic.2.1.14651; Cenit MC, 2014, BBA-MOL BASIS DIS, V1842, P1981, DOI 10.1016/j.bbadis.2014.05.023; Chassard C, 2014, CURR OPIN BIOTECH, V26, P141, DOI 10.1016/j.copbio.2013.12.012; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Dinoto A, 2006, APPL ENVIRON MICROB, V72, P7739, DOI 10.1128/AEM.01777-06; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Feria-Gervasio D, 2014, J MICROBIOL METH, V96, P111, DOI 10.1016/j.mimet.2013.11.015; Finegold SM, 2014, FOOD FUNCT, V5, P436, DOI 10.1039/c3fo60348b; Fossum S, 2007, EMBO J, V26, P4514, DOI 10.1038/sj.emboj.7601871; Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14; Fukuda S, 2012, GUT MICROBES, V3, P449, DOI [10.4161.gmic.21214, 10.4161/gmic.21214]; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GIBSON GR, 1988, APPL ENVIRON MICROB, V54, P2750, DOI 10.1128/AEM.54.11.2750-2755.1988; Gibson GR, 2000, J NUTR, V130, p391S, DOI 10.1093/jn/130.2.391S; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hara H., 1994, BIFIDOBACTERIA MICRO, V13, P51, DOI [10.12938/bifidus1982.13.2_8, DOI 10.12938/BIFIDUS1982.13.2_8, DOI 10.12938/BIFIDUS1982.13.2_]; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; KIKUCHI HE, 1986, APPL ENVIRON MICROB, V52, P971, DOI 10.1128/AEM.52.4.971-973.1986; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Minekus M, 1999, APPL MICROBIOL BIOT, V53, P108, DOI 10.1007/s002530051622; Mitsuoka Tomotari, 2014, Biosci Microbiota Food Health, V33, P117, DOI [10.12938/bmfh.33.117, 10.12938/bmfh.2014-003]; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Possemiers S, 2013, J AGR FOOD CHEM, V61, P9380, DOI 10.1021/jf402137r; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quigley Eamonn M M, 2013, Gastroenterol Hepatol (N Y), V9, P560; Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Rastall RA, 2015, CURR OPIN BIOTECH, V32, P42, DOI 10.1016/j.copbio.2014.11.002; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Rycroft CE, 2001, J APPL MICROBIOL, V91, P878, DOI 10.1046/j.1365-2672.2001.01446.x; Scott Karen P, 2015, Microb Ecol Health Dis, V26, P25877, DOI 10.3402/mehd.v26.25877; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stewart CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17141; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Venema K, 2013, BEST PRACT RES CL GA, V27, P115, DOI 10.1016/j.bpg.2013.03.002; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x	55	58	58	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160533	10.1371/journal.pone.0160533	http://dx.doi.org/10.1371/journal.pone.0160533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483470	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110700057
J	Li, K; Wang, HW; Hu, XJ; Liu, ZF; Wu, YJ; Huang, CL				Li, Kun; Wang, Hongwu; Hu, Xiaojiao; Liu, Zhifang; Wu, Yujin; Huang, Changling			Genome-Wide Association Study Reveals the Genetic Basis of Stalk Cell Wall Components in Maize	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; EUROPEAN CORN-BORER; RECOMBINANT INBRED LINES; RIND PENETROMETER RESISTANCE; DENT FORAGE MAIZE; PER-SE VALUE; TOP-CROSS; LINKAGE DISEQUILIBRIUM; CHILLING TOLERANCE; AFFECTING FIBER	Lignin, cellulose and hemicellulose are the three main components of the plant cell wall and can impact stalk quality by affecting cell wall structure and strength. In this study, we evaluated the lignin (LIG), cellulose (CEL) and hemicellulose (HC) contents in maize using an association mapping panel that included 368 inbred lines in seven environments. A genome-wide association study using approximately 0.56 million SNPs with a minor allele frequency of 0.05 identified 22, 18 and 24 loci significantly associated with LIG, CEL and HC at P < 1.0x10(-4), respectively. The allelic variation of each significant association contributed 4 to 7% of the phenotypic variation. Candidate genes identified by GWAS mainly encode enzymes involved in cell wall metabolism, transcription factors, protein kinase and protein related to other biological processes. Among the association signals, six candidate genes had pleiotropic effects on lignin and cellulose content. These results provide valuable information for better understanding the genetic basis of stalk cell wall components in maize.	[Li, Kun; Wang, Hongwu; Hu, Xiaojiao; Liu, Zhifang; Wu, Yujin; Huang, Changling] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Huang, CL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China.	huangchangling@caas.cn			National Natural Science Foundation of China [31171561]; Agricultural Science and Technology Innovation Program at CAAS; National Basic Research Program of China (973 Program) [2014CB138200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program at CAAS; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (Grant No. 31171561), the Agricultural Science and Technology Innovation Program at CAAS and the National Basic Research Program of China (973 Program) (Grant No. 2014CB138200).; We greatly appreciate Dr. Xiaohong Yang at China Agricultural University for providing the maize association mapping panel and its genotype and giving valuable suggestions to improve this manuscript. This study was supported by the National Natural Science Foundation of China (Grant No. 31171561), the Agricultural Science and Technology Innovation Program at CAAS and the National Basic Research Program of China (973 Program) (Grant No. 2014CB138200).	AMAN P, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P183; Andersen JR, 2007, THEOR APPL GENET, V114, P307, DOI 10.1007/s00122-006-0434-8; Andersen JR, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-2; Bajsa J, 2011, PLANT SIGNAL BEHAV, V6, P1921, DOI 10.4161/psb.6.12.18146; Barriere Y, 2003, ANIM RES, V52, P193, DOI 10.1051/animres:2003018; Barriere Y, 2001, MAYDICA, V46, P253; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; Barriere Y, 2010, CROP SCI, V50, P1761, DOI 10.2135/cropsci2009.11.0671; Barriere Y, 2012, THEOR APPL GENET, V125, P531, DOI 10.1007/s00122-012-1851-5; Barros-Rios J, 2011, PHYTOCHEMISTRY, V72, P365, DOI 10.1016/j.phytochem.2011.01.004; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bohn M, 2000, THEOR APPL GENET, V101, P907, DOI 10.1007/s001220051561; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BUENDGEN MR, 1990, CROP SCI, V30, P505, DOI 10.2135/cropsci1990.0011183X003000030005x; Cardinal AJ, 2005, THEOR APPL GENET, V111, P1, DOI 10.1007/s00122-004-1831-5; Cardinal AJ, 2003, THEOR APPL GENET, V106, P866, DOI 10.1007/s00122-002-1136-5; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Courtial A, 2012, MAYDICA, V57, P56; Lopes AMD, 2013, BIORESOURCE TECHNOL, V142, P198, DOI 10.1016/j.biortech.2013.05.032; Ding JQ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0589-z; Farfan IDB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117737; Flint-Garcia SA, 2003, CROP SCI, V43, P13, DOI 10.2135/cropsci2003.0013; Fontaine AS, 2003, MAYDICA, V48, P75; Fornale S, 2015, PLANT SCI, V236, P272, DOI 10.1016/j.plantsci.2015.04.007; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Gowda M, 2015, THEOR APPL GENET, V128, P1957, DOI 10.1007/s00122-015-2559-0; Guillet-Claude C, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-19; Guillet-Claude C, 2004, THEOR APPL GENET, V110, P126, DOI 10.1007/s00122-004-1808-4; Houston K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130890; Houston K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-907; Hu HX, 2012, THEOR APPL GENET, V124, P1439, DOI 10.1007/s00122-012-1799-5; Huang J, 2013, J INTEGR PLANT BIOL, V55, P735, DOI 10.1111/jipb.12051; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Krakowsky MD, 2006, THEOR APPL GENET, V112, P717, DOI 10.1007/s00122-005-0175-0; Krakowsky MD, 2005, THEOR APPL GENET, V111, P337, DOI 10.1007/s00122-005-2026-4; Krakowsky MD, 2003, MAYDICA, V48, P283; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036807; Lipka AE, 2013, G3-GENES GENOM GENET, V3, P1287, DOI 10.1534/g3.113.006148; Liu L, 2015, THEOR APPL GENET, V128, P2243, DOI 10.1007/s00122-015-2581-2; Lubberstedt T, 1997, CROP SCI, V37, P1913, DOI 10.2135/cropsci1997.0011183X003700060041x; Lubberstedt T, 1997, CROP SCI, V37, P921, DOI 10.2135/cropsci1997.0011183X003700030037x; LUNDVALL JP, 1994, CROP SCI, V34, P1672, DOI 10.2135/cropsci1994.0011183X003400060046x; Martin SA, 2004, CROP SCI, V44, P711, DOI 10.2135/cropsci2004.0711; Mechin V, 2000, J SCI FOOD AGR, V80, P574, DOI 10.1002/(SICI)1097-0010(200004)80:5&lt;574::AID-JSFA575&gt;3.0.CO;2-R; Mechin V, 2001, CROP SCI, V41, P690, DOI 10.2135/cropsci2001.413690x; Ogura T, 2015, CURR OPIN PLANT BIOL, V23, P98, DOI 10.1016/j.pbi.2014.11.008; Pace J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1226-9; Papst C, 2001, MAYDICA, V46, P195; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Ralph J, 2004, CR BIOL, V327, P467, DOI 10.1016/j.crvi.2004.03.004; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Riboulet C, 2008, MAYDICA, V53, P1; Roussel V, 2002, MAYDICA, V47, P9; Samayoa LF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0403-3; Santiago R, 2013, INT J MOL SCI, V14, P6960, DOI 10.3390/ijms14046960; SHENK JS, 1991, CROP SCI, V31, P469, DOI 10.2135/cropsci1991.0011183X003100020049x; Shi LY, 2014, CROP J, V2, P132, DOI 10.1016/j.cj.2014.02.001; Strigens A, 2013, PLANT CELL ENVIRON, V36, P1871, DOI 10.1111/pce.12096; Suwarno WB, 2015, THEOR APPL GENET, V128, P851, DOI 10.1007/s00122-015-2475-3; Tang JD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1874-9; Truntzler M, 2010, THEOR APPL GENET, V121, P1465, DOI 10.1007/s00122-010-1402-x; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Weng JF, 2012, PHYTOPATHOLOGY, V102, P692, DOI 10.1094/PHYTO-12-11-0330; WOLF DP, 1993, CROP SCI, V33, P1353, DOI 10.2135/cropsci1993.0011183X003300060046x; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yang N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004573; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zila CT, 2013, G3-GENES GENOM GENET, V3, P2095, DOI 10.1534/g3.113.007328	74	32	37	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0158906	10.1371/journal.pone.0158906	http://dx.doi.org/10.1371/journal.pone.0158906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479588	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110300009
J	Velez, MA; Trujillo, CA; Moros, L; Forero, C				Alejandra Velez, Maria; Andres Trujillo, Carlos; Moros, Lina; Forero, Clemente			Prosocial Behavior and Subjective Insecurity in Violent Contexts: Field Experiments	PLOS ONE			English	Article							TRUST; COOPERATION; RECIPROCITY; EVOLUTION; SECURITY; PERSPECTIVE; COMPETITION; ECONOMICS; CONFLICT; GAMES	Subjective insecurity is a key determinant of different forms of prosocial behavior. In Study 1, we used field experiments with farmers in Colombian villages exposed to different levels of violence to investigate how individual perceptions of insecurity affect cooperation, trust, reciprocity and altruism. To do so, we developed a cognitive-affective measure of subjective insecurity. We found that subjective insecurity has a negative effect on cooperation but influences trust and altruism positively. In Study 2, carried out three years after Study 1, we repeated the initial design with additional measures of victimization. Our goal was to relate subjective insecurity with actual victimization. The findings of Study 2 support the initial results, and are robust and consistent for cooperative behavior and trust when including victimization as a mediator. Different indicators of victimization are positively correlated with subjective insecurity and an aggregate index of victimization has a negative effect on cooperation but exerts a positive influence on trust.	[Alejandra Velez, Maria; Andres Trujillo, Carlos; Moros, Lina; Forero, Clemente] Univ Los Andes, Sch Management, Bogota, Colombia; [Forero, Clemente] Calle 21 1-20 SD 925, Bogota, Colombia	Universidad de los Andes (Colombia)	Velez, MA (corresponding author), Univ Los Andes, Sch Management, Bogota, Colombia.	mavelez@uniandes.edu.co	Trujillo, Carlos Andres/AAE-8224-2022	Trujillo, Carlos Andres/0000-0003-3484-0756; Velez, Maria Alejandra/0000-0002-8916-8808	National Federation of Coffee Growers (Convenio H+D - FNC Huellas de Paz); Research Committee from Universidad de Los Andes' School of Management	National Federation of Coffee Growers (Convenio H+D - FNC Huellas de Paz); Research Committee from Universidad de Los Andes' School of Management	The authors greatly appreciate funding for this work from both the National Federation of Coffee Growers (Convenio H+D - FNC Huellas de Paz) and the Research Committee from Universidad de Los Andes' School of Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2005, HANDBOOK OF ATTITUDES, P173; Arjona A, 2014, J CONFLICT RESOLUT, V58, P1360, DOI 10.1177/0022002714547904; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bar-Tal D, 1998, APPL PSYCHOL-INT REV, V47, P59, DOI 10.1080/026999498378079; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Bauer M, 2014, PSYCHOL SCI, V25, P47, DOI 10.1177/0956797613493444; Bellows J, 2009, J PUBLIC ECON, V93, P1144, DOI 10.1016/j.jpubeco.2009.07.012; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bowles S, 2003, DAHL WS ENV, P429; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Callen M, 2014, AM ECON REV, V104, P123, DOI 10.1257/aer.104.1.123; Cardenas JC, 2013, SSRN ELECT J, DOI [10.2139/ssrn.2304566, DOI 10.2139/SSRN.2304566]; Cardenas JC, 2008, J DEV STUD, V44, P311, DOI 10.1080/00220380701848327; Cassar A, 2013, J ECON GROWTH, V18, P285, DOI 10.1007/s10887-013-9091-3; Chapman LJ, 1982, JUDGMENT UNCERTAINTY, P239; Cox JC, 2004, GAME ECON BEHAV, V46, P260, DOI 10.1016/S0899-8256(03)00119-2; Czaja R, 1990, J QUANT CRIMINOL, V6, P185, DOI [DOI 10.1007/BF01065850, 10.1007/bf01065850]; Diprose R, 2007, OXF DEV STUD, V35, P431, DOI 10.1080/13600810701701913; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Eslava A, 2014, ORO COMO FORTUNA I C, P287; Estadistica DANE, 2009, ENC VICT; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Fehr E, 2002, ECON J, V112, pC1, DOI 10.1111/1468-0297.00027; Forero-Pineda C, 2014, J DEV STUD, V50, P789, DOI 10.1080/00220388.2013.874554; Fredrickson BL, 2000, COGNITION EMOTION, V14, P577, DOI 10.1080/026999300402808; Gilligan MJ, 2014, AM J POLIT SCI, V58, P604, DOI 10.1111/ajps.12067; Giraldo J, 2013, VALORES REPRESENTACI; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hoffrage U, 2004, COGNITIVE ILLUSIONS: A HANDBOOK ON FALLACIES AND BIASES IN THINKING, JUDGEMENT AND MEMORY, P235; HOGARTH RM, 1992, COGNITIVE PSYCHOL, V24, P1, DOI 10.1016/0010-0285(92)90002-J; Hopfensitz A, 2014, INVESTING SOCIAL CAP; Johnson ND, 2011, J ECON PSYCHOL, V32, P865, DOI 10.1016/j.joep.2011.05.007; KAHNEMAN D, 1986, J BUS, V59, pS285, DOI 10.1086/296367; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Kalyvas Stathis, 2006, LOGIC VIOLENCE CIVIL; Karlan DS, 2005, AM ECON REV, V95, P1688, DOI 10.1257/000282805775014407; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Lopez MC, 2009, SSRN ELECT J, DOI [10.2139/ssrn.1476848, DOI 10.2139/SSRN.1476848]; Lynch J.P., 2000, MEASUREMENT ANAL CRI, P85; Mantzavinos C., 2004, PERSPECT POLIT, V2, P75, DOI [https://doi.org/10.1017/S1537592704000635, DOI 10.1017/S1537592704000635]; Martin M, 2014, ROUTLEDGE HDB HUMAN, P297; Moore DA, 2008, PSYCHOL REV, V115, P502, DOI 10.1037/0033-295X.115.2.502; Moya A, 2013, SOCIAL SCI RES NETWO; Ostrom E, 2003, RUSSELL SAGE TRUST, V6, P3; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E, 2003, TRUST RECIPROCITY IN, P381; Owen T, 2008, SECUR DIALOGUE, V39, P445, DOI 10.1177/0967010608094038; Palacios M., 2012, INT J CRIME JUSTICE, V2, DOI [10.5204/ijcjsd.v2i2.113, DOI 10.5204/IJCJSD.V2I2.113]; Pizarro Leongomez E.., 2004, DEMOCRACIA ASEDIADA; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Rockmore M, 2011, 109 HOUS CONFL NETW, DOI 10.1.1.225.2355; Rockmore M., 2012, 121 HOUS CONFL NETW; Tadjbakhsh S, 2014, HUMAN SECURITY 20 YE; Tadjbakhsh S., 2007, HUMAN SECURITY CONCE; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; UNDP, 1994, NEW DIM HUM SEC, P22; Velez M, 2006, SSRN ELECT J, DOI [10.2139/ssrn.928968, DOI 10.2139/SSRN.928968]; Voors MJ, 2012, AM ECON REV, V102, P941, DOI 10.1257/aer.102.2.941; Wakslak CJ, 2006, J EXP PSYCHOL GEN, V135, P641, DOI 10.1037/0096-3445.135.4.641; Whitt S, 2007, AM J POLIT SCI, V51, P655, DOI 10.1111/j.1540-5907.2007.00273.x; Wills-Herrera E., 2011, Journal of Socio-Economics, V40, P88, DOI 10.1016/j.socec.2010.08.002; Zelmer J., 2003, Experimental Economics, V6, P299, DOI 10.1023/A:1026277420119	66	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0158878	10.1371/journal.pone.0158878	http://dx.doi.org/10.1371/journal.pone.0158878			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27472437	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516300007
J	Feng, F; Li, XL; Yao, YJ; Liang, SL; Chen, JQ; Zhao, X; Jia, K; Pinter, K; McCaughey, JH				Feng, Fei; Li, Xianglan; Yao, Yunjun; Liang, Shunlin; Chen, Jiquan; Zhao, Xiang; Jia, Kun; Pinter, Krisztina; McCaughey, J. Harry			An Empirical Orthogonal Function-Based Algorithm for Estimating Terrestrial Latent Heat Flux from Eddy Covariance, Meteorological and Satellite Observations	PLOS ONE			English	Article							ENERGY-BALANCE CLOSURE; EVAPOTRANSPIRATION MODELS; RADIATIVE FLUXES; SURFACE; MODIS; RECONSTRUCTION; VALIDATION; TOWER	Accurate estimation of latent heat flux (LE) based on remote sensing data is critical in characterizing terrestrial ecosystems and modeling land surface processes. Many LE products were released during the past few decades, but their quality might not meet the requirements in terms of data consistency and estimation accuracy. Merging multiple algorithms could be an effective way to improve the quality of existing LE products. In this paper, we present a data integration method based on modified empirical orthogonal function (EOF) analysis to integrate the Moderate Resolution Imaging Spectroradiometer (MODIS) LE product (MOD16) and the Priestley-Taylor LE algorithm of Jet Propulsion Laboratory (PT-JPL) estimate. Twenty-two eddy covariance (EC) sites with LE observation were chosen to evaluate our algorithm, showing that the proposed EOF fusion method was capable of integrating the two satellite data sets with improved consistency and reduced uncertainties. Further efforts were needed to evaluate and improve the proposed algorithm at larger spatial scales and time periods, and over different land cover types.	[Feng, Fei; Li, Xianglan] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Yao, Yunjun; Liang, Shunlin; Zhao, Xiang; Jia, Kun] Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China; [Liang, Shunlin] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Chen, Jiquan] Michigan State Univ, CGCEO, Landscape Ecol & Ecosyst Sci LEES Lab, E Lansing, MI 48823 USA; [Pinter, Krisztina] Szent Istvan Univ, Inst Bot & Ecophysiol, Pater Ku 1, H-2100 Godollo, Hungary; [McCaughey, J. Harry] Queens Univ, Dept Geog, Mackintosh Corry Hall,Room E112, Kingston, ON, Canada; [Pinter, Krisztina] MTA SZIE Plant Ecol Res Grp, H-2103 Godollo, Hungary	Beijing Normal University; Beijing Normal University; University System of Maryland; University of Maryland College Park; Michigan State University; Hungarian University of Agriculture & Life Sciences; Queens University - Canada; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH)	Li, XL (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.; Yao, YJ (corresponding author), Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing 100875, Peoples R China.	xlli@bnu.edu.cn; boyyunjun@163.com	Chen, Jiquan/D-1955-2009; liang, shunlin/C-2809-2015; Jia, Kun/Q-6539-2016	Jia, Kun/0000-0001-8586-4243; Pinter, Krisztina/0000-0001-8737-706X; Chen, Jiquan/0000-0003-0761-9458	High-Tech Research and Development Program of China [2013AA122801]; Natural Science Fund of China [41205104, 41201331]; National Basic Research Program of China [2012CB955302]; Fundamental Research Funds for the Central Universities [2012LYB38]; High Resolution Earth Observation Systems of National Science and Technology Major Projects [05-Y30B02-9001-13/15-9]	High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); High Resolution Earth Observation Systems of National Science and Technology Major Projects	This work was partially supported by the High-Tech Research and Development Program of China (Grant number 2013AA122801), the Natural Science Fund of China (grant number 41205104 and 41201331), the National Basic Research Program of China (grant number 2012CB955302), the Fundamental Research Funds for the Central Universities (grant number 2012LYB38), and the High Resolution Earth Observation Systems of National Science and Technology Major Projects (grant number 05-Y30B02-9001-13/15-9).	Alvera-Azcarate A, 2005, OCEAN MODEL, V9, P325, DOI 10.1016/j.ocemod.2004.08.001; Badgley G, 2015, J HYDROMETEOROL, V16, P1449, DOI 10.1175/JHM-D-14-0040.1; Beckers JM, 2003, J ATMOS OCEAN TECH, V20, P1839, DOI 10.1175/1520-0426(2003)020<1839:ECADFF>2.0.CO;2; Behrangi A, 2014, INT J REMOTE SENS, V35, P2170, DOI 10.1080/01431161.2014.889866; Cammalleri C, 2014, AGR FOREST METEOROL, V186, P1, DOI 10.1016/j.agrformet.2013.11.001; Caparrini F, 2003, BOUND-LAY METEOROL, V107, P605, DOI 10.1023/A:1022821718791; CHEN JM, 1993, MON WEATHER REV, V121, P2631, DOI 10.1175/1520-0493(1993)121<2631:IOEEOF>2.0.CO;2; Chen Y, 2014, REMOTE SENS ENVIRON, V140, P279, DOI 10.1016/j.rse.2013.08.045; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Council N, 2007, EARTH SCI APPL SPAC; Dirmeyer PA, 2013, J HYDROMETEOROL, V14, P829, DOI 10.1175/JHM-D-12-0107.1; Duan QY, 2007, ADV WATER RESOUR, V30, P1371, DOI 10.1016/j.advwatres.2006.11.014; Ershadi A, 2014, AGR FOREST METEOROL, V187, P46, DOI 10.1016/j.agrformet.2013.11.008; Ershadi A, 2013, REMOTE SENS ENVIRON, V131, P51, DOI 10.1016/j.rse.2012.12.007; Fisher JB, 2005, ENVIRON MODELL SOFTW, V20, P783, DOI 10.1016/j.envsoft.2004.04.009; Fisher JB, 2008, REMOTE SENS ENVIRON, V112, P901, DOI 10.1016/j.rse.2007.06.025; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; Hannachi A, 2007, INT J CLIMATOL, V27, P1119, DOI 10.1002/joc.1499; Jia ZZ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017037; Jimenez C, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014545; Kim HW, 2012, KSCE J CIV ENG, V16, P229, DOI 10.1007/s12205-012-0006-1; Kustas WP, 2004, REMOTE SENS ENVIRON, V92, P535, DOI 10.1016/j.rse.2004.02.020; Liang SL, 2013, INT J DIGIT EARTH, V6, P5, DOI 10.1080/17538947.2013.805262; Liu SM, 2011, HYDROL EARTH SYST SC, V15, P1291, DOI 10.5194/hess-15-1291-2011; Long D, 2014, WATER RESOUR RES, V50, P1131, DOI 10.1002/2013WR014581; Meyer W, 1999, 3498 CSIRO; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Montenegro A, 2009, GLOBAL PLANET CHANGE, V69, P195, DOI 10.1016/j.gloplacha.2009.08.005; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Mueller B, 2013, HYDROL EARTH SYST SC, V17, P3707, DOI 10.5194/hess-17-3707-2013; Mueller B, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046230; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Qin J, 2007, IEEE GEOSCI REMOTE S, V4, P649, DOI 10.1109/LGRS.2007.904004; Ramoelo A, 2014, REMOTE SENS-BASEL, V6, P7406, DOI 10.3390/rs6087406; RICHMAN MB, 1989, NATURE, V339, P673, DOI 10.1038/339673a0; Ruhoff AL, 2012, IAHS-AISH P, V352, P128; Smith TM, 1996, J CLIMATE, V9, P1403, DOI 10.1175/1520-0442(1996)009<1403:ROHSST>2.0.CO;2; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; Vinukollu RK, 2011, REMOTE SENS ENVIRON, V115, P801, DOI 10.1016/j.rse.2010.11.006; Wald L, 1999, IEEE T GEOSCI REMOTE, V37, P1190, DOI 10.1109/36.763269; Wang DD, 2011, IEEE T GEOSCI REMOTE, V49, P1513, DOI 10.1109/TGRS.2010.2086463; Wang KC, 2008, J HYDROMETEOROL, V9, P712, DOI 10.1175/2007JHM911.1; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; Wang KC, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD013847; Wang KC, 2010, J GEOPHYS RES-ATMOS, V115; Wang S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016847; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Xu TR, 2014, J GEOPHYS RES-ATMOS, V119, P10780, DOI 10.1002/2014JD021814; Xu TR, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015150; Xu ZW, 2013, J GEOPHYS RES-ATMOS, V118, P13140, DOI 10.1002/2013JD020260; Yao YJ, 2014, REMOTE SENS-BASEL, V6, P880, DOI 10.3390/rs6010880; Yao YJ, 2014, J GEOPHYS RES-ATMOS, V119, P4521, DOI 10.1002/2013JD020864; Yao YJ, 2013, AGR FOREST METEOROL, V171, P187, DOI 10.1016/j.agrformet.2012.11.016; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Zhang BL, 2007, J APPL METEOROL CLIM, V46, P435, DOI 10.1175/JAM2478.1; Zhang K, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008800; Zhao L, 2013, J GEOPHYS RES-ATMOS, V118, P9552, DOI 10.1002/jgrd.50697; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011; Zib BJ, 2012, J CLIMATE, V25, P2291, DOI 10.1175/JCLI-D-11-00147.1	60	12	14	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160150	10.1371/journal.pone.0160150	http://dx.doi.org/10.1371/journal.pone.0160150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472383	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300030
J	Engel, C; Hamann, H				Engel, Christoph; Hamann, Hanjo			The Hog Cycle of Law Professors: An Econometric Time Series Analysis of the Entry-Level Job Market in Legal Academia	PLOS ONE			English	Article							RATIONAL-EXPECTATIONS; NONLINEAR DYNAMICS; HARMONIC MOTION; PIG-CYCLE	The (German) market for law professors fulfils the conditions for a hog cycle: In the short run, supply cannot be extended or limited; future law professors must be hired soon after they first present themselves, or leave the market; demand is inelastic. Using a comprehensive German dataset, we show that the number of market entries today is negatively correlated with the number of market entries eight years ago. This suggests short-sighted behavior of young scholars at the time when they decide to prepare for the market. Using our statistical model, we make out-of-sample predictions for the German academic market in law until 2020.	[Engel, Christoph; Hamann, Hanjo] Max Planck Inst Res Collect Goods, Bonn, Germany	Max Planck Society	Engel, C (corresponding author), Max Planck Inst Res Collect Goods, Bonn, Germany.	engel@coll.mpg.de		Engel, Christoph/0000-0001-8513-8532				Abualrub RF, 2007, J PROF NURS, V23, P117, DOI 10.1016/j.profnurs.2006.07.008; Baade F, 1930, SCHWEINEFIBEL ODER W; Bosch-Domenech A, 2002, AM ECON REV, V92, P1687, DOI 10.1257/000282802762024737; CHAVAS JP, 1991, AM J AGR ECON, V73, P819, DOI 10.2307/1242834; Coase RH, 1935, ECONOMICA-NEW SER, V2, P423, DOI 10.2307/2548719; Coase RH, 1935, ECONOMICA-NEW SER, V2, P142, DOI 10.2307/2548676; Ezekiel M, 1938, Q J ECON, V52, P255, DOI 10.2307/1881734; George TE, 2014, J EMPIR LEGAL STUD, V11, P1, DOI 10.1111/jels.12033; Haas G. C., 1926, FACTORS AFFECTING PR; Hanau A., 1928, PROGNOSE SCHWEINEPRE; HARLOW AA, 1960, J FARM ECON, V42, P842, DOI 10.2307/1235116; HAYES DJ, 1987, AM J AGR ECON, V69, P762, DOI 10.2307/1242186; Holt MT, 2006, AM J AGR ECON, V88, P215, DOI 10.1111/j.1467-8276.2006.00849.x; Horstkotte H, 2015, JUNIORPROFESSUR JURI; JELAVICH MS, 1973, AM J AGR ECON, V55, P223, DOI 10.2307/1238442; Keynes John Maynard, 1964, GEN THEORY EMPLOYMEN; Kobler Gerhard, 2010, LATEINISCHES ABKUNFT; Krugman PR, 2001, NY TIMES, V18, P14; LARSON AB, 1964, J FARM ECON, V46, P375, DOI 10.2307/1236542; Legal Tribune Online, 2016, UN JUR; MAKI WR, 1962, J FARM ECON, V44, P731, DOI 10.2307/1235949; MUTH JF, 1961, ECONOMETRICA, V29, P315, DOI 10.2307/1909635; Nagel R, 1995, AM ECON REV, V85, P1313; Ruthers B, 1972, JURISTENZEITUNG, V27, P185; SAMUELSON PA, 1976, POP STUD-J DEMOG, V30, P243, DOI 10.1080/00324728.1976.10412732; Schultz H, 1958, THEORY MEASUREMENT D; Shonkwiler JS, 1986, SO J AGR EC, V18; Simmons W.M., 1962, EC STUDY US POTATO I; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; STAHL DO, 1995, GAME ECON BEHAV, V10, P218, DOI 10.1006/game.1995.1031; STEIN JL, 1992, REV ECON STAT, V74, P127, DOI 10.2307/2109550; Wernecke M., 2004, J REAL ESTATE PORTFO, V10, P171; Wheaton WC, 1999, REAL ESTATE ECON, V27, P209, DOI 10.1111/1540-6229.00772; Wood RE, 2008, ORGAN RES METHODS, V11, P270, DOI 10.1177/1094428106297811	34	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159815	10.1371/journal.pone.0159815	http://dx.doi.org/10.1371/journal.pone.0159815			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IL	27467518	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100058
J	Fukunishi, T; Best, CA; Sugiura, T; Shoji, T; Yi, T; Udelsman, B; Ohst, D; Ong, CS; Zhang, HT; Shinoka, T; Breuer, CK; Johnson, J; Hibino, N				Fukunishi, Takuma; Best, Cameron A.; Sugiura, Tadahisa; Shoji, Toshihiro; Yi, Tai; Udelsman, Brooks; Ohst, Devan; Ong, Chin Siang; Zhang, Huaitao; Shinoka, Toshiharu; Breuer, Christopher K.; Johnson, Jed; Hibino, Narutoshi			Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model	PLOS ONE			English	Article							CRITICAL LIMB ISCHEMIA; SMOOTH-MUSCLE-CELLS; IN-VITRO; BLOOD-VESSELS; CHITOSAN SCAFFOLDS; N-ACETYLATION; EPTFE GRAFT; VIVO; ENDOTHELIALIZATION; REPLACEMENT	Tissue engineered vascular grafts (TEVGs) have the potential to overcome the issues faced by existing small diameter prosthetic grafts by providing a biodegradable scaffold where the patient's own cells can engraft and form functional neotissue. However, applying classical approaches to create arterial TEVGs using slow degrading materials with supraphysiological mechanical properties, typically results in limited host cell infiltration, poor remodeling, stenosis, and calcification. The purpose of this study is to evaluate the feasibility of novel small diameter arterial TEVGs created using fast degrading material. A 1.0mm and 5.0mm diameter TEVGs were fabricated with electrospun polycaprolactone (PCL) and chitosan (CS) blend nanofibers. The 1.0mm TEVGs were implanted in mice (n = 3) as an unseeded infrarenal abdominal aorta interposition conduit., The 5.0mm TEVGs were implanted in sheep (n = 6) as an unseeded carotid artery (CA) interposition conduit. Mice were followed with ultrasound and sacrificed at 6 months. All 1.0mm TEVGs remained patent without evidence of thrombosis or aneurysm formation. Based on small animal outcomes, sheep were followed with ultrasound and sacrificed at 6 months for histological and mechanical analysis. There was no aneurysm formation or calcification in the TEVGs. 4 out of 6 grafts (67%) were patent. After 6 months in vivo, 9.1 +/- 5.4% remained of the original scaffold. Histological analysis of patent grafts demonstrated deposition of extracellular matrix constituents including elastin and collagen production, as well as endothelialization and organized contractile smooth muscle cells, similar to that of native CA. The mechanical properties of TEVGs were comparable to native CA. There was a significant positive correlation between TEVG wall thickness and CD68(+) macrophage infiltration into the scaffold (R-2 = 0.95, p = 0.001). The fast degradation of CS in our novel TEVG promoted excellent cellular infiltration and neotissue formation without calcification or aneurysm. Modulating host macrophage infiltration into the scaffold is a key to reducing excessive neotissue formation and stenosis.	[Fukunishi, Takuma; Ong, Chin Siang; Zhang, Huaitao; Hibino, Narutoshi] Johns Hopkins Univ, Dept Cardiac Surg, Baltimore, MD USA; [Best, Cameron A.; Sugiura, Tadahisa; Shoji, Toshihiro; Yi, Tai; Shinoka, Toshiharu; Breuer, Christopher K.] Nationwide Childrens Hosp, Tissue Engn & Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Udelsman, Brooks] Yale Univ, Sch Med, New Haven, CT USA; [Ohst, Devan; Johnson, Jed] Nanofiber Solut Inc, Columbus, OH USA	Johns Hopkins University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Yale University	Hibino, N (corresponding author), Johns Hopkins Univ, Dept Cardiac Surg, Baltimore, MD USA.	nhibino1@jhmi.edu		Ong, Chin Siang/0000-0002-4521-0971; Breuer, Christopher/0000-0003-0987-3898; Udelsman, Brooks/0000-0001-8482-5218; Johnson, Jed/0000-0003-2166-4132	NIH Center for Accelerated Innovations: Technology Development Program [1UH54HL119810-01]; Gunze Ltd (Kyoto, Japan); Nanonfiber solutions; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL119810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	NIH Center for Accelerated Innovations: Technology Development Program; Gunze Ltd (Kyoto, Japan); Nanonfiber solutions; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the NIH Center for Accelerated Innovations: Technology Development Program (1UH54HL119810-01) to NH and JJ. C. Breuer and T. Shinoka received grant support from Gunze Ltd (Kyoto, Japan). Nanonfiber solutions provided support in the form of materials and salaries to DO and JJ. The specific roles of these authors are articulated in the 'author contributions' section.; This study was supported by grants from the NIH Center for Accelerated Innovations: Technology Development Program (1UH54HL119810-01) and by electrospun nanofiber PCL/CS Tissue Engineered Vascular Grafts from Nanofiber Solution Inc. C. Breuer and T. Shinoka received grant support from Gunze Ltd (Kyoto, Japan).	Bergmeister H, 2013, ACTA BIOMATER, V9, P6032, DOI 10.1016/j.actbio.2012.12.009; Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024; Chung SW, 2010, ACTA BIOMATER, V6, P1958, DOI 10.1016/j.actbio.2009.12.007; Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7; CLOWES AW, 1986, AM J PATHOL, V123, P220; de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024; Dorigo W, 2011, J VASC SURG, V54, P1332, DOI 10.1016/j.jvs.2011.05.046; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037; Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053; Garg K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031001; Hibino N, 2015, FASEB J, V29, P2431, DOI 10.1096/fj.14-268334; Hibino N, 2011, FASEB J, V25, P4253, DOI 10.1096/fj.11-186585; Hibino N, 2011, FASEB J, V25, P2731, DOI 10.1096/fj.11-182246; HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5; Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013; Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036; Johnson J., 2015, J TISSUE SCI ENG, V6, P1, DOI DOI 10.4172/2157-7552.1000151; Johnson J, 2009, J BIOMAT SCI-POLYM E, V20, P467, DOI 10.1163/156856209X416485; Koobatian MT, 2016, BIOMATERIALS, V76, P344, DOI 10.1016/j.biomaterials.2015.10.020; Kurobe H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120328; L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364; Lindholt JS, 2011, EUR J VASC ENDOVASC, V41, P668, DOI 10.1016/j.ejvs.2011.01.021; Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025; Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3; Mahara A, 2015, BIOMATERIALS, V58, P54, DOI 10.1016/j.biomaterials.2015.04.031; Mrowczynski W, 2014, J VASC SURG, V59, P210, DOI 10.1016/j.jvs.2013.03.004; OWENS GK, 1995, PHYSIOL REV, V75, P487; PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6; Pashneh-Tala S, 2016, TISSUE ENG PART B-RE, V22, P68, DOI 10.1089/ten.teb.2015.0100; Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393; Pulli R, 2010, J VASC SURG, V51, P1167, DOI 10.1016/j.jvs.2009.12.042; Raghavan ML, 2000, J BIOMECH, V33, P475, DOI 10.1016/S0021-9290(99)00201-8; Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041; Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107; Rothuizen TC, 2016, BIOMATERIALS, V75, P82, DOI 10.1016/j.biomaterials.2015.10.023; Row S, 2015, BIOMATERIALS, V50, P115, DOI 10.1016/j.biomaterials.2015.01.045; Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071; Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Stehouwer CDA, 2009, EUR J INTERN MED, V20, P132, DOI 10.1016/j.ejim.2008.09.013; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Tara S, 2014, ATHEROSCLEROSIS, V237, P684, DOI 10.1016/j.atherosclerosis.2014.09.030; Tara S, 2014, CIRC J, V78, P12, DOI 10.1253/circj.CJ-13-1440; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; Vorp DA, 2003, ANN THORAC SURG, V75, P1210, DOI 10.1016/S0003-4975(02)04711-2; Yang YM, 2007, J MATER SCI-MATER M, V18, P2117, DOI 10.1007/s10856-007-3013-x; Yao Y, 2014, ACTA BIOMATER, V10, P2739, DOI 10.1016/j.actbio.2014.02.042; Zhang H, 2001, BIOMATERIALS, V22, P1653, DOI 10.1016/S0142-9612(00)00326-4; Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047; Zhou M, 2014, TISSUE ENG PT A, V20, P79, DOI [10.1089/ten.TEA.2013.0020, 10.1089/ten.tea.2013.0020]	53	115	118	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0158555	10.1371/journal.pone.0158555	http://dx.doi.org/10.1371/journal.pone.0158555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467821	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100012
J	Houten, SM; Chen, J; Belpoggi, F; Manservisi, F; Sanchez-Guijo, A; Wudy, SA; Teitelbaum, SL				Houten, Sander M.; Chen, Jia; Belpoggi, Fiorella; Manservisi, Fabiana; Sanchez-Guijo, Alberto; Wudy, Stefan A.; Teitelbaum, Susan L.			Changes in the Metabolome in Response to Low-Dose Exposure to Environmental Chemicals Used in Personal Care Products during Different Windows of Susceptibility	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; DIETHYL PHTHALATE; BENZENES TOXICITY; DIETARY EXPOSURE; BISPHENOL-A; TRICLOSAN; ACTIVATION; SULFATE; SERUM; SULFOTRANSFERASES	The consequences of ubiquitous exposure to environmental chemicals remain poorly defined. Non-targeted metabolomic profiling is an emerging method to identify biomarkers of the physiological response to such exposures. We investigated the effect of three commonly used ingredients in personal care products, diethyl phthalate (DEP), methylparaben (MPB) and triclosan (TCS), on the blood metabolome of female Sprague-Dawley rats. Animals were treated with low levels of these chemicals comparable to human exposures during prepubertal and pubertal windows as well as chronically from birth to adulthood. Non-targeted metabolomic profiling revealed that most of the variation in the metabolites was associated with developmental stage. The low-dose exposure to DEP, MPB and TCS had a relatively small, but detectable impact on the metabolome. Multiple metabolites that were affected by chemical exposure belonged to the same biochemical pathways including phenol sulfonation and metabolism of pyruvate, lyso-plasmalogens, unsaturated fatty acids and serotonin. Changes in phenol sulfonation and pyruvate metabolism were most pronounced in rats exposed to DEP during the prepubertal period. Our metabolomics analysis demonstrates that human level exposure to personal care product ingredients has detectable effects on the rat metabolome. We highlight specific pathways such as sulfonation that warrant further study.	[Houten, Sander M.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Houten, Sander M.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Chen, Jia; Teitelbaum, Susan L.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA; [Belpoggi, Fiorella; Manservisi, Fabiana] Ramazzini Inst, Cesare Maltoni Canc Res Ctr, Bologna, Italy; [Sanchez-Guijo, Alberto; Wudy, Stefan A.] Univ Giessen, Steroid Res & Mass Spectrometry Unit, Div Pediat Endocrinol & Diabetol, Ctr Child & Adolescent Med, D-35392 Giessen, Germany	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Justus Liebig University Giessen	Houten, SM (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Houten, SM (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.	sander.houten@mssm.edu	Wudy, Stefan/ABC-7173-2020; Houten, Sander/Y-3599-2019; Guijo, Alberto Sánchez/L-6184-2017	Houten, Sander/0000-0002-6167-9147; Guijo, Alberto Sánchez/0000-0001-7770-1882; manservisi, fabiana/0000-0001-9548-5116	National Institute of Environmental Health Sciences; National Cancer Institute [U01ES019459-01, 3U01ES019459-05S1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023515] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences and National Cancer Institute (U01ES019459-01 and 3U01ES019459-05S1: Breast Cancer Genomics in Windows of Susceptibility to Endocrine Disruptors).	Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Biro FM, 2013, J ADOLESCENT HEALTH, V52, pS15, DOI 10.1016/j.jadohealth.2012.09.019; Bondia-Pons I, 2013, MOL NUTR FOOD RES, V57, P412, DOI 10.1002/mnfr.201200571; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Cabaton NJ, 2013, ENVIRON HEALTH PERSP, V121, P586, DOI 10.1289/ehp.1205588; Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031; Crepet A, 2013, TOXICOLOGY, V313, P83, DOI 10.1016/j.tox.2013.04.005; da Silva TF, 2012, BBA-MOL BASIS DIS, V1822, P1501, DOI 10.1016/j.bbadis.2012.05.014; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; DeKeyser JG, 2011, TOXICOL SCI, V120, P381, DOI 10.1093/toxsci/kfq394; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans M., 2014, METABOLOMICS, V4, P1, DOI DOI 10.4172/2153-0769.1000132; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Golden R, 2005, CRIT REV TOXICOL, V35, P435, DOI 10.1080/10408440490920104; James EL, 2015, CURR OPIN CLIN NUTR, V18, P478, DOI 10.1097/MCO.0000000000000200; Khan HA, 2007, HUM EXP TOXICOL, V26, P677, DOI 10.1177/0960327107083974; LEVY G, 1986, FASEB J, V45, P2235; Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091; Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429; Manservisi F, 2015, REPROD TOXICOL, V54, P110, DOI 10.1016/j.reprotox.2014.12.013; Martinez-Nava GA, 2013, BIOMARKERS, V18, P493, DOI 10.3109/1354750X.2013.816776; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Modeer T, 1996, J CLIN PERIODONTOL, V23, P927, DOI 10.1111/j.1600-051X.1996.tb00513.x; Mouritsen A, 2013, J CLIN ENDOCR METAB, V98, P3755, DOI 10.1210/jc.2013-1284; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; Paul KB, 2013, TOXICOL IN VITRO, V27, P2049, DOI 10.1016/j.tiv.2013.07.008; Pitt JJ, 1998, CLIN CHEM, V44, P1497; Rouzaud-Laborde C, 2015, AM J HEMATOL, V90, P15, DOI 10.1002/ajh.23855; Runge-Morris M, 2005, CURR DRUG METAB, V6, P299, DOI 10.2174/1389200054633871; Runge-Morris M, 2009, PPAR RES, V2009, DOI 10.1155/2009/728941; Sanchez-Guijo A, 2015, J LIPID RES, V56, P1843, DOI 10.1194/jlr.D061499; SANTNER SJ, 1986, BREAST CANCER RES TR, V7, P35, DOI 10.1007/BF01886734; Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P451, DOI 10.2307/3454536; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Snyder R, 2007, HUM EXP TOXICOL, V26, P687, DOI 10.1177/0960327107083975; Stoker TE, 2010, TOXICOL SCI, V117, P45, DOI 10.1093/toxsci/kfq180; Sumner S, 2009, J APPL TOXICOL, V29, P703, DOI 10.1002/jat.1462; Teitelbaum SL, 2016, ENVIRON HEALTH PERSP, V124, P39, DOI 10.1289/ehp.1409586; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; van Ravenzwaay B, 2010, TOXICOL LETT, V198, P159, DOI 10.1016/j.toxlet.2010.06.009; Velez MP, 2015, FERTIL STERIL, V103, P1011, DOI 10.1016/j.fertnstert.2015.01.005; Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yueh MF, 2014, P NATL ACAD SCI USA, V111, P17200, DOI 10.1073/pnas.1419119111; Zeng J, 2013, ENVIRON SCI TECHNOL, V47, P7457, DOI 10.1021/es400490f; Zhang J, 2012, J PHARMACEUT BIOMED, V66, P287, DOI 10.1016/j.jpba.2012.03.045; Zorrilla LM, 2009, TOXICOL SCI, V107, P56, DOI 10.1093/toxsci/kfn225	52	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159919	10.1371/journal.pone.0159919	http://dx.doi.org/10.1371/journal.pone.0159919			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467775	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516100072
J	Yin, XP; Huang, X; Feng, YD; Tan, WC; Liu, HJ; Huo, YL				Yin, Xiaoping; Huang, Xu; Feng, Yundi; Tan, Wenchang; Liu, Huaijun; Huo, Yunlong			Interplay of Proximal Flow Confluence and Distal Flow Divergence in Patient-Specific Vertebrobasilar System	PLOS ONE			English	Article							HEMODYNAMIC SHEAR-STRESS; BLOOD-FLOW; VERTEBRAL ARTERY; SCALING LAWS; PATTERNS; VESSEL; ANGLE; ENDOTHELIUM; PARAMETERS	Approximately one-quarter of ischemic strokes involve the vertebrobasilar arterial system that includes the upstream flow confluence and downstream flow divergence. A patient-specific hemodynamic analysis is needed to understand the posterior circulation. The objective of this study is to determine the distribution of hemodynamic parameters in the vertebrobasilar system, based on computer tomography angiography images. Here, the interplay of upstream flow confluence and downstream flow divergence was hypothesized to be a determinant factor for the hemodynamic distribution in the vertebrobasilar system. A computational fluid dynamics model was used to compute the flow fields in patient-specific vertebrobasilar models (n = 6). The inlet and outlet boundary conditions were the aortic pressure waveform and flow resistances, respectively. A 50% reduction of total outlet area was found to induce a ten-fold increase in surface area ratio of low time-averaged wall shear stress (i.e., TAWSS <= 4 dynes/cm(2)). This study enhances our understanding of the posterior circulation associated with the incidence of atherosclerotic plaques.	[Yin, Xiaoping; Liu, Huaijun] Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Peoples R China; [Huang, Xu; Feng, Yundi; Tan, Wenchang; Huo, Yunlong] Peking Univ, Dept Mech & Engn Sci, Coll Engn, Beijing, Peoples R China; [Huang, Xu; Feng, Yundi; Tan, Wenchang; Huo, Yunlong] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing, Peoples R China; [Tan, Wenchang] Peking Univ, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Huo, Yunlong] Hebei Univ, Coll Med, Baoding, Peoples R China	Hebei Medical University; Peking University; Peking University; Peking University; University Town of Shenzhen; Hebei University	Liu, HJ (corresponding author), Hebei Med Univ, Hosp 2, Dept Med Imaging, Shijiazhuang, Peoples R China.; Huo, YL (corresponding author), Peking Univ, Dept Mech & Engn Sci, Coll Engn, Beijing, Peoples R China.; Huo, YL (corresponding author), Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing, Peoples R China.; Huo, YL (corresponding author), Hebei Univ, Coll Med, Baoding, Peoples R China.	hebeiliu@outlook.com; yhuo@pku.edu.cn	Huo, Yunlong/N-8155-2013	Huo, Yunlong/0000-0003-4121-3224	Natural Science Foundation of China Grant [11372010]; China MOST Grant [2014DFG32740]	Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); China MOST Grant	This research is supported in part by the Natural Science Foundation of China Grant 11372010 (Y. Huo) and the China MOST Grant 2014DFG32740 (Y. Huo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brott TG, 2011, STROKE, V42, pE464, DOI 10.1161/STR.0b013e3182112cc2; Buhre W, 2003, BRIT J ANAESTH, V90, P291, DOI 10.1093/bja/aeg073; Caplan Lr, 2005, J Clin Neurol, V1, P14, DOI 10.3988/jcn.2005.1.1.14; Caplan LR, 2004, ANN NEUROL, V56, P389, DOI 10.1002/ana.20204; Cassot F, 2009, MICROCIRCULATION, V16, P331, DOI 10.1080/10739680802662607; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; CHONG BW, 1994, AM J NEURORADIOL, V15, P733; Choy JS, 2008, J APPL PHYSIOL, V104, P1281, DOI 10.1152/japplphysiol.01261.2007; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; de Monye C, 2008, J NEUROL, V255, P239, DOI 10.1007/s00415-008-0699-8; Fan TT, 2016, J BIOMECH, V49, P645, DOI 10.1016/j.jbiomech.2016.01.031; FEI DY, 1994, J BIOMECH ENG-T ASME, V116, P331, DOI 10.1115/1.2895739; FRIEDMAN MH, 1992, J BIOMECH ENG-T ASME, V114, P317, DOI 10.1115/1.2891389; Hong JM, 2009, J NEUROL NEUROSUR PS, V80, P1087, DOI 10.1136/jnnp.2008.169805; Huang X, 2016, AM J PHYSIOL-HEART C, V310, pH639, DOI 10.1152/ajpheart.00464.2015; Huo Y, 2007, AM J PHYSIOL-HEART C, V293, pH2959, DOI 10.1152/ajpheart.00586.2007; Huo YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073769; Huo Y, 2012, J BIOMECH, V45, P1273, DOI 10.1016/j.jbiomech.2012.01.033; Huo YL, 2012, J R SOC INTERFACE, V9, P190, DOI 10.1098/rsif.2011.0270; Huo YL, 2009, BIOPHYS J, V96, P339, DOI 10.1016/j.bpj.2008.09.038; Huo YL, 2009, BIOPHYS J, V96, P347, DOI 10.1016/j.bpj.2008.09.039; Huo YL, 2009, J BIOMECH, V42, P594, DOI 10.1016/j.jbiomech.2008.12.011; Jeng JS, 2004, ULTRASOUND MED BIOL, V30, P605, DOI 10.1016/j.ultrasmedbio.2004.03.004; Jiang J, 2007, J MAGN RESON IMAGING, V25, P1226, DOI 10.1002/jmri.20918; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Kleinstreuer C, 2001, CRIT REV BIOMED ENG, V29, P1, DOI 10.1615/CritRevBiomedEng.v29.i1.10; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mohamied Y, 2015, ANN BIOMED ENG, V43, P16, DOI 10.1007/s10439-014-1095-4; Nichols W. W., 2011, MCDONALDS BLOOD FLOW, pxiv; Qureshi AI, 2014, LANCET, V383, P984, DOI 10.1016/S0140-6736(13)61088-0; Ravensbergen J, 1996, J BIOMECH, V29, P281, DOI 10.1016/0021-9290(95)00064-X; Ravensbergen J, 1997, J BIOMECH ENG-T ASME, V119, P195, DOI 10.1115/1.2796080; Ravensbergen J, 1998, ARTERIOSCL THROM VAS, V18, P708, DOI 10.1161/01.ATV.18.5.708; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; SMITH AS, 1995, AM J NEURORADIOL, V16, P1587; Valen-Sendstad K, 2013, J BIOMECH, V46, P402, DOI 10.1016/j.jbiomech.2012.10.042; van Raamt AF, 2006, CEREBROVASC DIS, V22, P217, DOI 10.1159/000094007; Wake-Buck AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051346	39	8	8	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159836	10.1371/journal.pone.0159836	http://dx.doi.org/10.1371/journal.pone.0159836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467755	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100061
J	Abdelfattah, A; Wisniewski, M; Nicosia, MGL; Cacciola, SO; Schena, L				Abdelfattah, Ahmed; Wisniewski, Michael; Nicosia, Maria Giulia Li Destri; Cacciola, Santa Olga; Schena, Leonardo			Metagenomic Analysis of Fungal Diversity on Strawberry Plants and the Effect of Management Practices on the Fungal Community Structure of Aerial Organs	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; ERYSIPHE-AQUILEGIAE; GROWN STRAWBERRIES; POSTHARVEST ROTS; SWEET CHERRIES; BOTRYTIS; PHYLLOSPHERE; QUALITY; SEARCH; HOST	An amplicon metagenomic approach based on the ITS2 region of fungal rDNA was used to identify the composition of fungal communities associated with different strawberry organs (leaves, flowers, immature and mature fruits), grown on a farm using management practices that entailed the routine use of various chemical pesticides. ITS2 sequences clustered into 316 OTUs and Ascomycota was the dominant phyla (95.6%) followed by Basidiomycota (3.9%). Strawberry plants supported a high diversity of microbial organisms, but two genera, Botrytis and Cladosporium, were the most abundant, representing 70-99% of the relative abundance (RA) of all detected sequences. According to alpha and beta diversity analyses, strawberry organs displayed significantly different fungal communities with leaves having the most diverse fungal community, followed by flowers, and fruit. The interruption of chemical treatments for one month resulted in a significant modification in the structure of the fungal community of leaves and flowers while immature and mature fruit were not significantly affected. Several plant pathogens of other plant species, that would not be intuitively expected to be present on strawberry plants such as Erysiphe, were detected, while some common strawberry pathogens, such as Rhizoctonia, were less evident or absent.	[Abdelfattah, Ahmed; Nicosia, Maria Giulia Li Destri; Schena, Leonardo] Univ Mediterranea Reggio Calabria, Dipartimento Agr, I-89122 Reggio Di Calabria, Italy; [Wisniewski, Michael] ARS, USDA, AFRS, 2217 Wiltshire Rd, Kearneysville, WV USA; [Cacciola, Santa Olga] Univ Catania, Dipartimento Agr Alimentazione & Ambiente, Via S Sofia 100, I-95123 Catania, Italy	Universita Mediterranea di Reggio Calabria; United States Department of Agriculture (USDA); University of Catania	Schena, L (corresponding author), Univ Mediterranea Reggio Calabria, Dipartimento Agr, I-89122 Reggio Di Calabria, Italy.	lschena@unirc.it	Abdelfattah, Ahmed/P-1943-2015; Schena, Leonardo/A-7492-2018; , Santa Olga Cacciola/H-7416-2019; Li Destri Nicosia, Maria Giulia/AGG-0569-2022	Abdelfattah, Ahmed/0000-0001-6090-7200; Schena, Leonardo/0000-0002-9737-2593; Wisniewski, Michael/0000-0002-7481-5590; Li Destri Nicosia, Maria Giulia/0000-0001-5201-0057	Italian Ministry of Education, University and Research (MIUR) [PON03PE_00090_03]; ARS [ARS-0423158] Funding Source: Federal RePORTER	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by The Italian Ministry of Education, University and Research (MIUR) with grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee"-PON Ricerca e competitivita 2007-2013 (PON03PE_00090_03). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by The Italian Ministry of Education, University and Research (MIUR) with grant "Modelli sostenibili e nuove tecnologie per la valorizzazione delle filiere vegetali mediterranee"-PON Ricerca e competitivita 2007-2013 (PON03PE_00090_03).	Abdelfattah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131069; Agrios GN, 2005, PLANT PATHOLOGY; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amsalem L, 2006, EUR J PLANT PATHOL, V114, P283, DOI 10.1007/s10658-005-5804-6; Baroncelli R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129140; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; BUCKLEY PM, 1966, J BACTERIOL, V91, P2037, DOI 10.1128/JB.91.5.2037-2044.1966; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlucci A, 2012, PERSOONIA, V28, P34, DOI 10.3767/003158512X638251; Chehri K, 2011, SAUDI J BIOL SCI, V18, P341, DOI 10.1016/j.sjbs.2011.01.007; Crous Pedro W., 1995, Mycoscience, V36, P105, DOI 10.1007/BF02268579; Cunnington JH, 2004, FUNGAL DIVERS, V16, P1; Damm U, 2014, STUD MYCOL, P49, DOI 10.1016/j.simyco.2014.09.003; Damm U, 2012, STUD MYCOL, P37, DOI 10.3114/sim0010; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elad Y., 2004, BOTRYTIS BIOL PATHOL, P119, DOI [10.1007/978-1-4020-2626-3, DOI 10.1007/978-1-4020-2626-3]; Ippolito A, 2005, POSTHARVEST BIOL TEC, V36, P245, DOI 10.1016/j.postharvbio.2005.02.007; Jensen B, 2013, INT J FOOD MICROBIOL, V160, P313, DOI 10.1016/j.ijfoodmicro.2012.11.005; Kellenberger E, 2001, EMBO REP, V2, P5, DOI 10.1093/embo-reports/kve014; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Lattin J., 2003, ANAL MULTIVARIATE DA; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Liberato JR, 2006, AUSTRALAS PLANT PATH, V35, P291, DOI 10.1071/AP06002; Lima G, 1997, POSTHARVEST BIOL TEC, V10, P169, DOI 10.1016/S0925-5214(96)01302-6; Liu J, 2013, INT J FOOD MICROBIOL, V167, P153, DOI 10.1016/j.ijfoodmicro.2013.09.004; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maas J.L., 1998, COMPENDIUM STRAWBERR; McGovern R, 2006, PLANT HLTH PROGR; Muller T, 2014, FEMS MICROBIOL ECOL, V87, P2, DOI 10.1111/1574-6941.12198; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; Prigigallo MI, 2015, PLANT PATHOL, V64, P1308, DOI 10.1111/ppa.12362; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RADLER F, 1990, ARCH MICROBIOL, V154, P175, DOI 10.1007/BF00423329; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Sambrook J, 1989, MOL CLONING; Sanzani SM, 2012, POSTHARVEST BIOL TEC, V68, P64, DOI 10.1016/j.postharvbio.2012.02.003; Schena L, 2003, POSTHARVEST BIOL TEC, V30, P209, DOI 10.1016/S0925-5214(03)00111-X; Sharon M, 2007, EUR J PLANT PATHOL, V117, P247, DOI 10.1007/s10658-006-9091-7; Singh S, 2015, ENVIRON SCI POLLUT R, V22, P11290, DOI 10.1007/s11356-015-4341-x; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Sylla J, 2013, AGRONOMY-BASEL, V3, P704, DOI 10.3390/agronomy3040704; Sylla J, 2013, PHYTOPATHOLOGY, V103, P1001, DOI 10.1094/PHYTO-01-13-0014-R; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MW, 2014, ENVIRON MICROBIOL, V16, P2848, DOI 10.1111/1462-2920.12456; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0	49	63	66	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160470	10.1371/journal.pone.0160470	http://dx.doi.org/10.1371/journal.pone.0160470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490110	Green Submitted, gold, Green Published			2022-12-27	WOS:000381368900060
J	Al Hassan, M; Pacurar, A; Lopez-Gresa, MP; Donat-Torres, MP; Llinares, JV; Boscaiu, M; Vicente, O				Al Hassan, Mohamad; Pacurar, Andrea; Lopez-Gresa, Maria P.; Donat-Torres, Maria P.; Llinares, Josep V.; Boscaiu, Monica; Vicente, Oscar			Effects of Salt Stress on Three Ecologically Distinct Plantago Species	PLOS ONE			English	Article							INDUCED POTASSIUM EFFLUX; COMPATIBLE SOLUTES; ABIOTIC STRESS; SALINITY TOLERANCE; EXTREME HALOPHYTE; SODIUM-TRANSPORT; GROWTH; RESPONSES; PROLINE; GLYCINEBETAINE	Comparative studies on the responses to salt stress of taxonomically related taxa should help to elucidate relevant mechanisms of stress tolerance in plants. We have applied this strategy to three Plantago species adapted to different natural habitats, P. crassifolia and P. coronopus-both halophytes-and P. major, considered as salt-sensitive since it is never found in natural saline habitats. Growth inhibition measurements in controlled salt treatments indicated, however, that P. major is quite resistant to salt stress, although less than its halophytic congeners. The contents of monovalent ions and specific osmolytes were determined in plant leaves after four-week salt treatments. Salt-treated plants of the three taxa accumulated Na+ and Cl- in response to increasing external NaCl concentrations, to a lesser extent in P. major than in the halophytes; the latter species also showed higher ion contents in the non-stressed plants. In the halophytes, K+ concentration decreased at moderate salinity levels, to increase again under high salt conditions, whereas in P. major K+ contents were reduced only above 400 mM NaCl. Sorbitol contents augmented in all plants, roughly in parallel with increasing salinity, but the relative increments and the absolute values reached did not differ much in the three taxa. On the contrary, a strong (relative) accumulation of proline in response to high salt concentrations (600-800 mM NaCl) was observed in the halophytes, but not in P. major. These results indicate that the responses to salt stress triggered specifically in the halophytes, and therefore the most relevant for tolerance in the genus Plantago are: a higher efficiency in the transport of toxic ions to the leaves, the capacity to use inorganic ions as osmotica, even under low salinity conditions, and the activation, in response to very high salt concentrations, of proline accumulation and K+ transport to the leaves of the plants.	[Al Hassan, Mohamad; Pacurar, Andrea; Lopez-Gresa, Maria P.; Vicente, Oscar] Univ Politecn Valencia, Inst Plant Mol & Cellular Biol IBMCP, CSIC, Camino Vera S-N, E-46022 Valencia, Spain; [Donat-Torres, Maria P.] Univ Politecn Valencia, Res Inst Integrated Coastal Zone Management IGIC, C Paranimf 1, Gandia, Spain; [Llinares, Josep V.; Boscaiu, Monica] Univ Politecn Valencia, Mediterranean Agroforestal Inst IAM, Camino Vera S-N, E-46022 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universitat Politecnica de Valencia; Universitat Politecnica de Valencia	Boscaiu, M (corresponding author), Univ Politecn Valencia, Mediterranean Agroforestal Inst IAM, Camino Vera S-N, E-46022 Valencia, Spain.	mobosnea@eaf.upv.es	Palacios, Josep Vicent JVLLP Llinares/H-7967-2015; Donat-Torres, Maria P./F-7825-2016; Vicente, Oscar/A-3858-2009; Pacurar, Andrea/R-4603-2017; Al Hassan, Mohamad/E-3097-2017; Boscaiu, Monica/H-7878-2015; Gresa, María Pilar López/N-8830-2013	Palacios, Josep Vicent JVLLP Llinares/0000-0002-9740-3281; Donat-Torres, Maria P./0000-0001-5521-9868; Vicente, Oscar/0000-0001-5076-3784; Pacurar, Andrea/0000-0001-8818-2889; Al Hassan, Mohamad/0000-0002-2297-3394; Boscaiu, Monica/0000-0002-9691-4223; Gresa, María Pilar López/0000-0001-9251-0160	Erasmus Mundus pre-doctoral scholarship - European Commission (Welcome Consortium); Erasmus mobility programme	Erasmus Mundus pre-doctoral scholarship - European Commission (Welcome Consortium); Erasmus mobility programme	MAH was a recipient of an Erasmus Mundus pre-doctoral scholarship financed by the European Commission (Welcome Consortium). AP acknowledges the Erasmus mobility programme for funding her stay in Valencia to carry out her Master Thesis.	Adams E, 2014, J INTEGR PLANT BIOL, V56, P231, DOI 10.1111/jipb.12159; AHMAD I, 1979, NEW PHYTOL, V82, P671, DOI 10.1111/j.1469-8137.1979.tb01661.x; Al Hassan M, 2014, NOT BOT HORTI AGROBO, V42, P180; Apaydin Z, 2009, POL J ECOL, V57, P99; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; ASHWELL G, 1957, METHOD ENZYMOL, V3, P73, DOI 10.1016/S0076-6879(57)03350-9; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Boira H., 2012, VEGETACION HUMEDALES; Bolos O, 1967, MEMORIAS REAL ACAD C, V38; Boscaiu M, 2005, BIOL PLANTARUM, V49, P141, DOI 10.1007/s10535-005-1143-x; Boscaiu M, 2013, J PLANT ECOL, V6, P177, DOI 10.1093/jpe/rts017; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRIENS M, 1982, PLANT CELL ENVIRON, V5, P287, DOI 10.1111/1365-3040.ep11572682; Chater A.O., 1976, FLORA EUROPAEA, P38; Chen THH, 2008, TRENDS PLANT SCI, V13, P499, DOI 10.1016/j.tplants.2008.06.007; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Cuin TA, 2005, PLANT CELL PHYSIOL, V46, P1924, DOI 10.1093/pcp/pci205; Cuin TA, 2007, PLANT CELL ENVIRON, V30, P875, DOI 10.1111/j.1365-3040.2007.01674.x; de Vos A.C., 2011, THESIS; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ERDEI L, 1979, PHYSIOL PLANTARUM, V47, P95, DOI 10.1111/j.1399-3054.1979.tb03197.x; European Commission DG Environment, 2013, INTERPRETATION MANUA; FLANAGAN LB, 1989, PLANTA, V178, P377, DOI 10.1007/BF00391865; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Flowers TJ, 2010, FUNCT PLANT BIOL, V37, P604, DOI 10.1071/FP09269; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; FLOWERS TJ, 1986, Q REV BIOL, V61, P313, DOI 10.1086/415032; Gagneul D, 2007, PLANT PHYSIOL, V144, P1598, DOI 10.1104/pp.107.099820; Gil R, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu049; Gil R, 2013, FUNCT PLANT BIOL, V40, P805, DOI 10.1071/FP12359; Gil R, 2011, NOT BOT HORTI AGROBO, V39, P9; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; GORHAM J, 1981, PHYSIOL PLANTARUM, V53, P27, DOI 10.1111/j.1399-3054.1981.tb05040.x; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Grigore M. N., 2012, Notulae Scientia Biologicae, V4, P23; Grigore MN, 2011, EUR J PLANT SCI BIOT, V5, P12; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; JEFFERIES RL, 1979, PLANT PHYSIOL, V64, P989, DOI 10.1104/pp.64.6.989; Jones R. G. W., 1977, Regulation of cell membrane activities in plants. Proceedings of the International Workshop held in Pallanza, Italy, August 26-29, 1976., P121; Khan MA, 2000, J ARID ENVIRON, V45, P73, DOI 10.1006/jare.1999.0617; KONIGSHOFER H, 1983, PLANT SOIL, V72, P289, DOI 10.1007/BF02181968; Koyro HW, 2006, ENVIRON EXP BOT, V56, P136, DOI 10.1016/j.envexpbot.2005.02.001; Kronzucker HJ, 2011, NEW PHYTOL, V189, P54, DOI 10.1111/j.1469-8137.2010.03540.x; LAMBERS H, 1981, PHYSIOL PLANTARUM, V51, P63, DOI 10.1111/j.1399-3054.1981.tb00880.x; MAATHUIS FJM, 1990, PLANT PHYSIOL, V92, P23, DOI 10.1104/pp.92.1.23; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; MUNNS R, 1986, AUST J PLANT PHYSIOL, V13, P143, DOI 10.1071/PP9860143; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nawaz K, 2010, J AGRON CROP SCI, V196, P28, DOI 10.1111/j.1439-037X.2009.00385.x; Pardo-Domenech LL, 2016, PLANT BIOSYST, V150, P904, DOI 10.1080/11263504.2014.990943; Pedrol J, 2009, FLORA IBERICA, VXIII, P4; RAVEN JA, 1985, NEW PHYTOL, V101, P25, DOI 10.1111/j.1469-8137.1985.tb02816.x; Redondo-Gomez S, 2010, PLANT BIOLOGY, V12, P79, DOI 10.1111/j.1438-8677.2009.00207.x; Redondo-Gomez S, 2006, PHYSIOL PLANTARUM, V128, P116, DOI 10.1111/j.1399-3054.2006.00719.x; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Ronsted N, 2002, BOT J LINN SOC, V139, P323, DOI 10.1046/j.1095-8339.2002.00070.x; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Sanchez DH, 2011, PLANT CELL ENVIRON, V34, P605, DOI 10.1111/j.1365-3040.2010.02266.x; Sekmen AH, 2007, PHYSIOL PLANTARUM, V131, P399, DOI 10.1111/j.1399-3054.2007.00970.x; Shabala L, 2005, PLANTA, V222, P1041, DOI 10.1007/s00425-005-0074-2; Shabala S, 2003, FUNCT PLANT BIOL, V30, P507, DOI 10.1071/FP03016; Sleimi N, 2015, ECOL INDIC, V48, P570, DOI 10.1016/j.ecolind.2014.08.035; STAAL M, 1991, PHYSIOL PLANTARUM, V82, P179, DOI 10.1111/j.1399-3054.1991.tb00078.x; STEWART GR, 1979, ECOLOGICAL PROCESSES, P211; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; TANCZOS OG, 1981, PLANT SOIL, V63, P27, DOI 10.1007/BF02374253; Tipirdamaz R, 2006, ENVIRON EXP BOT, V57, P139, DOI 10.1016/j.envexpbot.2005.05.007; Turkan I, 2009, ENVIRON EXP BOT, V67, P2, DOI 10.1016/j.envexpbot.2009.05.008; Vicente O, 2004, J ARID ENVIRON, V58, P463, DOI 10.1016/j.jaridenv.2003.12.003; Villellas J, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00291.1; WEIMBERG R, 1987, PHYSIOL PLANTARUM, V70, P381, DOI 10.1111/j.1399-3054.1987.tb02832.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	76	43	43	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160236	10.1371/journal.pone.0160236	http://dx.doi.org/10.1371/journal.pone.0160236			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490924	gold, Green Published			2022-12-27	WOS:000381368900040
J	Baron-Cohen, S; Robson, E; Lai, MC; Allison, C				Baron-Cohen, Simon; Robson, Emma; Lai, Meng-Chuan; Allison, Carrie			Mirror-Touch Synaesthesia Is Not Associated with Heightened Empathy, and Can Occur with Autism	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SPECTRUM QUOTIENT AQ; ASPERGER-SYNDROME; SAVANT MEMORY; SYNESTHESIA; EXPERIENCES; PREVALENCE; FEMALES; ADULTS; COMMON	Research has linked Mirror-Touch (MT) synaesthesia with enhanced empathy. We test the largest sample of MT synaesthetes to date to examine two claims that have been previously made: that MT synaesthetes (1) have superior empathy; and (2) only ever experience their MT synaesthesia in response to viewing a person being touched. Given that autism has been suggested to involve deficits in cognitive empathy, we also test two predictions: that MT synaesthetes should (3) be less likely than general population individuals without MT synaesthesia to have an autism spectrum condition (ASC), if MT is characterized by superior empathy; and (4) have fewer autistic traits. We selected three groups: a pure MT synaesthesia group (N = 46), a pure grapheme-colour (GC) synaesthesia group (N = 36), and a typical control group without synaesthesia (N = 46). Participants took three measures of empathy and one measure of autistic traits. MT synaesthetes did not show enhanced empathy. In addition, 30% of all MT synaesthetes recruited into this study (N = 135) reported also having ASC, and MT synaesthetes showed higher autistic trait scores than controls. Finally, some MT experiences were reported in response to viewing objects being touched. Our findings dispute the views that MT synaesthesia is linked with enhanced empathy, is less likely to occur with ASC or elevated autistic traits, and is specific to seeing a person being touched.	[Baron-Cohen, Simon; Robson, Emma; Lai, Meng-Chuan; Allison, Carrie] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge Lifespan Asperger Syndrome Serv CLASS C, Cambridge, England; [Lai, Meng-Chuan] Univ Toronto, Child & Youth Mental Hlth Collaborat, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lai, Meng-Chuan] Univ Toronto, Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada; [Lai, Meng-Chuan] Natl Taiwan Univ Hosp & Coll Med, Dept Psychiat, Taipei, Taiwan	University of Cambridge; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Taiwan University; National Taiwan University Hospital	Baron-Cohen, S (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.; Baron-Cohen, S (corresponding author), Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge Lifespan Asperger Syndrome Serv CLASS C, Cambridge, England.	sb205@cam.ac.uk	Lai, Meng-Chuan/K-7407-2016	Lai, Meng-Chuan/0000-0002-9593-5508; Baron-Cohen, Simon/0000-0001-9217-2544	European Commission; Wellcome Trust; UK Medical Research Council; Autism Research Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; William Binks Autism Neuroscience Fellowship; Wolfson College, Cambridge, UK; O'Brien Scholars Program within the Child and Youth Mental Health Collaborative at the Centre for Addiction and Mental Health; O'Brien Scholars Program within the Child and Youth Mental Health Collaborative at the Hospital for Sick Children, Toronto, Canada; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autism Research Trust; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; William Binks Autism Neuroscience Fellowship; Wolfson College, Cambridge, UK; O'Brien Scholars Program within the Child and Youth Mental Health Collaborative at the Centre for Addiction and Mental Health; O'Brien Scholars Program within the Child and Youth Mental Health Collaborative at the Hospital for Sick Children, Toronto, Canada; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a studentship from the European Commission to ER. SB-C and CA were supported by the Wellcome Trust, the UK Medical Research Council, the Autism Research Trust and the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust. M-CL was supported by the William Binks Autism Neuroscience Fellowship and Wolfson College, Cambridge, UK, and the O'Brien Scholars Program within the Child and Youth Mental Health Collaborative at the Centre for Addiction and Mental Health and The Hospital for Sick Children, Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to the organizations and researchers who helped with recruitment, and to Bhismadev Chakrabarti, Dorothea Floris, Laura Murphy, Daria Martin, and Simon Fisher for discussions. We thank Rebecca Kenny for assistance in the preparation of the manuscript. This work was funded by a studentship from the European Commission to ER. SB-C and CA were supported by the Wellcome Trust, the UK Medical Research Council, the Autism Research Trust and the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. M-CL was supported by the William Binks Autism Neuroscience Fellowship and Wolfson College, Cambridge, UK, and the O'Brien Scholars Program within the Child and Youth Mental Health Collaborative at the Centre for Addiction and Mental Health and The Hospital for Sick Children, Toronto, Canada. The paper was submitted in part-fulfilment of the degree of MPhil, to Cambridge University by ER.	Asher JE, 2006, CORTEX, V42, P137, DOI 10.1016/S0010-9452(08)70337-X; Asher JE, 2009, AM J HUM GENET, V84, P279, DOI 10.1016/j.ajhg.2009.01.012; Banissy MJ, 2007, NAT NEUROSCI, V10, P815, DOI 10.1038/nn1926; Banissy MJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00112; Banissy MJ, 2009, EXP BRAIN RES, V198, P261, DOI 10.1007/s00221-009-1810-9; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S, 1996, PSYCHE, V2; Baron-Cohen S, 2007, J CONSCIOUSNESS STUD, V14, P237; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Baron-Cohen S, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-40; Baron-Cohen S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001081; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; BaronCohen S, 1996, PERCEPTION, V25, P1073, DOI 10.1068/p251073; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Bor D, 2007, NEUROCASE, V13, P311, DOI 10.1080/13554790701844945; Cioffi MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00256; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Fitzgibbon BM, 2012, NEUROSCI BIOBEHAV R, V36, P645, DOI 10.1016/j.neubiorev.2011.09.006; Goller AI, 2013, CORTEX, V49, P243, DOI 10.1016/j.cortex.2011.05.002; Holle H, 2013, NEUROIMAGE, V83, P1041, DOI 10.1016/j.neuroimage.2013.07.073; Holle H, 2011, CONSCIOUS COGN, V20, P720, DOI 10.1016/j.concog.2010.12.002; Jewanski J, 2009, J HIST NEUROSCI, V18, P293, DOI 10.1080/09647040802431946; Lai MC, 2015, J AM ACAD CHILD PSY, V54, P11, DOI 10.1016/j.jaac.2014.10.003; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lundqvist D., 1998, KAROLINSKA DIRECTED; Ramachandran V, 2003, J CONSCIOUSNESS STUD, V10, P49; Ramachandran VS, 2001, P ROY SOC B-BIOL SCI, V268, P979, DOI 10.1098/rspb.2000.1576; Rich AN, 2005, COGNITION, V98, P53, DOI 10.1016/j.cognition.2004.11.003; Rouw R, 2007, NAT NEUROSCI, V10, P792, DOI 10.1038/nn1906; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; Sagiv N, 2006, PROG BRAIN RES, V155, P259, DOI 10.1016/S0079-6123(06)55015-0; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Sowden S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00789; Sucksmith E, 2013, NEUROPSYCHOLOGIA, V51, P98, DOI 10.1016/j.neuropsychologia.2012.11.013; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6	41	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160543	10.1371/journal.pone.0160543	http://dx.doi.org/10.1371/journal.pone.0160543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490947	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900067
J	Bauder, JM; Breininger, DR; Bolt, MR; Legare, ML; Jenkins, CL; Rothermel, BB; McGarigal, K				Bauder, Javan M.; Breininger, David R.; Bolt, M. Rebecca; Legare, Michael L.; Jenkins, Christopher L.; Rothermel, Betsie B.; McGarigal, Kevin			The Influence of Sex and Season on Conspecific Spatial Overlap in a Large, Actively-Foraging Colubrid Snake	PLOS ONE			English	Article							EASTERN INDIGO SNAKE; RATTLESNAKES CROTALUS-VIRIDIS; KERNEL DENSITY-ESTIMATION; HOME-RANGE OVERLAP; DRYMARCHON-COUPERI; BODY-SIZE; SPACE-USE; MASTICOPHIS-FLAGELLUM; POPULATION REGULATION; TERRITORIAL BEHAVIOR	Understanding the factors influencing the degree of spatial overlap among conspecifics is important for understanding multiple ecological processes. Compared to terrestrial carnivores, relatively little is known about the factors influencing conspecific spatial overlap in snakes, although across snake taxa there appears to be substantial variation in conspecific spatial overlap. In this study, we described conspecific spatial overlap of eastern indigo snakes (Drymarchon couperi) in peninsular Florida and examined how conspecific spatial overlap varied by sex and season (breeding season vs. non-breeding season). We calculated multiple indices of spatial overlap using 6-and 3-month utilization distributions (UD) of dyads of simultaneously adjacent telemetered snakes. We also measured conspecific UD density values at each telemetry fix and modeled the distribution of those values as a function of overlap type, sex, and season using generalized Pareto distributions. Home range overlap between males and females was significantly greater than overlap between individuals of the same sex and male home ranges often completely contained female home ranges. Male home ranges overlapped little during both seasons, whereas females had higher levels of overlap during the non-breeding season. The spatial patterns observed in our study are consistent with those seen in many mammalian carnivores, in which low male-male overlap and high inter-sexual overlap provides males with greater access to females. We encourage additional research on the influence of prey availability on conspecific spatial overlap in snakes as well as the behavioral mechanisms responsible for maintaining the low levels of overlap we observed.	[Bauder, Javan M.; McGarigal, Kevin] Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA; [Breininger, David R.; Bolt, M. Rebecca] NASA, Ecol Programs, Integrated Miss Support Serv, Kennedy Space Ctr, Titusville, FL USA; [Legare, Michael L.] Merritt Isl Natl Wildlife Refuge, Titusville, FL USA; [Jenkins, Christopher L.] Orianne Soc, Athens, GA USA; [Rothermel, Betsie B.] Archbold Biol Stn, Venus, FL USA	University of Massachusetts System; University of Massachusetts Amherst; National Aeronautics & Space Administration (NASA)	Bauder, JM (corresponding author), Univ Massachusetts, Dept Environm Conservat, Amherst, MA 01003 USA.	javanvonherp@gmail.com	Rothermel, Betsie B/L-6774-2013; breininger, david r/AAJ-4733-2020	Rothermel, Betsie/0000-0002-3951-2623	United States Fish and Wildlife Service; Orianne Society; NASA; Bailey Wildlife Foundation	United States Fish and Wildlife Service(US Fish & Wildlife Service); Orianne Society; NASA(National Aeronautics & Space Administration (NASA)); Bailey Wildlife Foundation	Funding for this project was provided by the United States Fish and Wildlife Service (www.fws.gov) and The Orianne Society (www.oriannesociety.org) to JMB and CLJ and by the United States Fish and Wildlife Service, NASA, and the Bailey Wildlife Foundation to DRB, MRB, and MLL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ABRAHAMSON W G, 1984, Florida Scientist, V47, P209; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anguiano MP, 2015, J HERPETOL, V49, P420, DOI 10.1670/13-014; Bateson M, 2002, P NUTR SOC, V61, P509, DOI 10.1079/PNS2002181; Bauder JM, 2015, WILDLIFE RES, V42, P437, DOI 10.1071/WR14233; Bauder Javan M., 2014, Herpetological Review, V45, P590; Bauder JM, HERPETOLOGI IN PRESS, V72; Blouin-Demers G, 2002, CAN J ZOOL, V80, P1162, DOI 10.1139/Z02-096; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Breinnger DR, 2011, J HERPETOL, V45, P484; BROWN JL, 1969, WILSON BULL, V81, P293; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carfagno GLF, 2008, J ANIM ECOL, V77, P416, DOI 10.1111/j.1365-2656.2008.01342.x; CARPENTER FL, 1976, SCIENCE, V194, P639, DOI 10.1126/science.194.4265.639; Clark RW, 2004, J CHEM ECOL, V30, P607, DOI 10.1023/B:JOEC.0000018632.27010.1e; Conant R., 1991, FIELD GUIDE REPTILES; Corey B, 2010, J ZOOL, V281, P293, DOI 10.1111/j.1469-7998.2010.00705.x; Cottone AM, 2013, COPEIA, P194, DOI 10.1643/CE-12-067; Diffendorfer JE, 2005, J HERPETOL, V39, P24, DOI 10.1670/212-03A; DONCASTER CP, 1991, J ANIM ECOL, V60, P423, DOI 10.2307/5288; Duong T, 2003, J NONPARAMETR STAT, V15, P17, DOI 10.1080/10485250306039; Duong T, 2014, KS KERNEL SMOOTHING; Duong T, 2007, J STAT SOFTW, V21, P1, DOI 10.18637/jss.v021.i07; DUVALL D, 1990, J CHEM ECOL, V16, P87, DOI 10.1007/BF01021270; Eide NE, 2004, J ANIM ECOL, V73, P1056, DOI 10.1111/j.0021-8790.2004.00885.x; Enge KM, 2013, HERPETOL CONSERV BIO, V8, P288; Ferreras P, 1997, J ZOOL, V243, P163, DOI 10.1111/j.1469-7998.1997.tb05762.x; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fieberg J., 2014, HOME RANGE OVERLAP I; Fitzgerald M, 2002, AUSTRAL ECOL, V27, P537, DOI 10.1046/j.1442-9993.2002.01214.x; Fryxell JM, 1999, ECOLOGY, V80, P1311, DOI 10.2307/177077; Gehrt SD, 1998, ANIM BEHAV, V55, P1211, DOI 10.1006/anbe.1997.0657; Gese EM, 2001, CAN J ZOOL, V79, P980, DOI 10.1139/cjz-79-6-980; GILLINGHAM J C, 1987, P184; Giuggioli L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002008; Graves Brent M., 1995, Herpetological Monographs, V9, P102, DOI 10.2307/1466999; Greene H. W., 1997, SNAKES EVOLUTION MYS; Gregory P. G., 1984, VERTEBRATE ECOLOGY S; GREGORY P T, 1987, P366; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; HOLM S, 1979, SCAND J STAT, V6, P65; Huang WS, 2011, P NATL ACAD SCI USA, V108, P7455, DOI 10.1073/pnas.1101804108; Hyslop N., 2007, THESIS; Hyslop NL, 2014, J WILDLIFE MANAGE, V78, P101, DOI 10.1002/jwmg.645; Hyslop NL, 2009, COPEIA, P458, DOI 10.1643/CH-07-171; Hyslop NL, 2009, HERPETOLOGICA, V65, P199, DOI 10.1655/08-004R1.1; JENKINS C.L., 2007, THESIS; Laver PN, 2008, J WILDLIFE MANAGE, V72, P290, DOI 10.2193/2005-589; Layne J.N., 1996, 4391060134 US FISH W; Lelievre H, 2012, HERPETOLOGICA, V68, P358, DOI 10.1655/HERPETOLOGICA-D-12-00007.1; Lelievre H, 2010, J COMP PHYSIOL B, V180, P415, DOI 10.1007/s00360-009-0423-8; LeMaster MP, 2001, ANIM BEHAV, V61, P827, DOI 10.1006/anbe.2000.1658; Lopez-Bao JV, 2014, J ANIM ECOL, V83, P934, DOI 10.1111/1365-2656.12226; MacDonald DW, 2010, BIOL CONSERVATION WI, P126; MAHER CR, 1995, ANIM BEHAV, V49, P1581, DOI 10.1016/0003-3472(95)90080-2; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCue MD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P25, DOI 10.1086/509057; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Mitrovich MJ, 2009, J HERPETOL, V43, P646, DOI 10.1670/08-147.1; Moser BW, 2007, J WILDLIFE MANAGE, V71, P2421, DOI 10.2193/2007-003; Nagy KA, 2005, J EXP BIOL, V208, P1621, DOI 10.1242/jeb.01553; Nowak EM, 2008, BIOL REV, V83, P601, DOI 10.1111/j.1469-185X.2008.00056.x; Oksanen J., 2019, VEGAN COMMUNITY ECOL; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; OSTFELD RS, 1986, J ANIM ECOL, V55, P691, DOI 10.2307/4748; OWENSMITH N, 1977, Q REV BIOL, V52, P1, DOI 10.1086/409720; Pearson D, 2005, AUSTRAL ECOL, V30, P261, DOI 10.1111/j.1442-9993.2005.01462.x; Plummer MV, 1996, COPEIA, P8, DOI 10.2307/1446937; PLUMMER MV, 1994, COPEIA, P20, DOI 10.2307/1446666; POUGH FH, 1980, AM NAT, V115, P92, DOI 10.1086/283547; Powell RA, 1979, J COMP ETHOL, V50, P15; Powell Roger A., 1994, P101; Powell Roger A., 1993, Proceedings of the International Union of Game Biologists Congress, V21, P268; REINERT HK, 1988, COPEIA, P1057; ROGERS LL, 1987, WILDLIFE MONOGR, P1; RUBEN JA, 1976, J COMP PHYSIOL, V109, P147, DOI 10.1007/BF00689414; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; Sandell M., 1989, P164; SECOR SM, 1994, ECOLOGY, V75, P1600, DOI 10.2307/1939621; SECOR SM, 1994, COPEIA, P631; Shine R, 2003, BEHAV ECOL SOCIOBIOL, V54, P162, DOI 10.1007/s00265-003-0620-5; SLIP DJ, 1988, AUST WILDLIFE RES, V15, P515; SMITH CC, 1968, ECOL MONOGR, V38, P31, DOI 10.2307/1948536; Smith CF., 1987, THESIS; Southworth H., 2013, TEXMEX STAT MODELING; Speake D.W., 1987, P 3 SE NONG END WILD, P84; Stamps JA, 1983, LIZARD ECOLOGY, P169; Steen DA, 2009, SOUTHEAST NAT, V8, P553, DOI 10.1656/058.008.0316; Stevenson DJ, 2009, HERPETOL CONSERV BIO, V4, P30; Stevenson DJ, 2010, SOUTHEAST NAT, V9, P1, DOI 10.1656/058.009.0101; Stevenson DJ, 2003, SOUTHEAST NAT, V2, P393, DOI 10.1656/1528-7092(2003)002[0393:SAMOTE]2.0.CO;2; Theodoratus DH, 2000, BEHAVIOUR, V137, P119; WEATHERHEAD PJ, 1989, CAN J ZOOL, V67, P463, DOI 10.1139/z89-067; Webb JK, 1997, BIOL CONSERV, V82, P203, DOI 10.1016/S0006-3207(97)00032-3; Webb JK, 2015, BEHAV ECOL SOCIOBIOL, V69, P1657, DOI 10.1007/s00265-015-1977-y; Whitaker PB, 2003, HERPETOL MONOGR, V17, P130, DOI 10.1655/0733-1347(2003)017[0130:ARSOMA]2.0.CO;2; WHITE PJ, 1993, J WILDLIFE MANAGE, V57, P861, DOI 10.2307/3809090; Wilson D, 2006, AUSTRAL ECOL, V31, P577, DOI 10.1111/j.1442-9993.2006.01519.x; Wolff JO, 1997, J ANIM ECOL, V66, P1, DOI 10.2307/5959; Wronski T, 2006, J ZOOL, V270, P49, DOI 10.1111/j.1469-7998.2006.00109.x	101	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160033	10.1371/journal.pone.0160033	http://dx.doi.org/10.1371/journal.pone.0160033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490346	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900027
J	Farahani, M; Price, N; El-Halabi, S; Mlaudzi, N; Keapoletswe, K; Lebelonyane, R; Fetogang, EB; Chebani, T; Kebaabetswe, P; Masupe, T; Gabaake, K; Auld, AF; Nkomazana, O; Marlink, R				Farahani, Mansoor; Price, Natalie; El-Halabi, Shenaaz; Mlaudzi, Naledi; Keapoletswe, Koona; Lebelonyane, Refeletswe; Fetogang, Ernest Benny; Chebani, Tony; Kebaabetswe, Poloko; Masupe, Tiny; Gabaake, Keba; Auld, Andrew F.; Nkomazana, Oathokwa; Marlink, Richard			Impact of Health System Inputs on Health Outcome: A Multilevel Longitudinal Analysis of Botswana National Antiretroviral Program (2002-2013)	PLOS ONE			English	Article							SERVICE DELIVERY; SOUTHERN AFRICA; HUMAN-RESOURCES; HIV/AIDS; SURVIVAL; THERAPY; MORTALITY; COUNTRIES; INFANT; MODELS	Objective To measure the association between the number of doctors, nurses and hospital beds per 10,000 people and individual HIV-infected patient outcomes in Botswana. Design Analysis of routinely collected longitudinal data from 97,627 patients who received ART through the Botswana National HIV/AIDS Treatment Program across all 24 health districts from 2002 to 2013. Doctors, nurses, and hospital bed density data at district-level were collected from various sources. Methods A multilevel, longitudinal analysis method was used to analyze the data at both patient-and district-level simultaneously to measure the impact of the health system input at district-level on probability of death or loss-to-follow-up (LTFU) at the individual level. A marginal structural model was used to account for LTFU over time. Results Increasing doctor density from one doctor to two doctors per 10,000 population decreased the predicted probability of death for each patient by 27%. Nurse density changes from 20 nurses to 25 nurses decreased the predicted probability of death by 28%. Nine percent decrease was noted in predicted mortality of an individual in the Masa program for every five hospital bed density increase. Conclusion Considerable variation was observed in doctors, nurses, and hospital bed density across health districts. Predictive margins of mortality and LTFU were inversely correlated with doctor, nurse and hospital bed density. The doctor density had much greater impact than nurse or bed density on mortality or LTFU of individual patients. While long-term investment in training more healthcare professionals should be made, redistribution of available doctors and nurses can be a feasible solution in the short term.	[Farahani, Mansoor; Price, Natalie; Chebani, Tony; Marlink, Richard] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [El-Halabi, Shenaaz; Mlaudzi, Naledi; Keapoletswe, Koona; Lebelonyane, Refeletswe; Fetogang, Ernest Benny] Minist Hlth, Gaborone, Botswana; [Kebaabetswe, Poloko; Masupe, Tiny; Gabaake, Keba; Nkomazana, Oathokwa] Univ Botswana, Gaborone, Botswana; [Auld, Andrew F.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Botswana; Centers for Disease Control & Prevention - USA	Farahani, M (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA USA.	mfarahan@gmail.com	Masupe, Tiny/AAY-4195-2020; Nkomazana, Oathokwa/AAP-7953-2020	Auld, Andrew/0000-0001-5089-9163; Masupe, Tiny/0000-0001-8366-6585; Nkomazana, Oathokwa/0000-0002-2040-4059	US Centers for Disease Control and Prevention [GH005-000512-01]; Botswana Ministry of Health	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Botswana Ministry of Health	This work was supported by the US Centers for Disease Control and Prevention [grant number GH005-000512-01].; We would like to acknowledge Mr. Bud Bowen at the US Centers for Disease Control for his support on this project. We would also like to acknowledge Emmanuel Bulayani's assistance in managing the data for the health facility survey. We would also like to acknowledge the support of the Botswana Ministry of Health, specifically those at the Department of HIV/AIDS Prevention and Care, and the Department of Health Policy, Development, Monitoring and Evaluation, including the Monitoring and Evaluation Division.	Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Cameron AC, 2012, J BUSINESS EC STAT; Chen L, 2005, B WORLD HEALTH ORGAN, V83, P243; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Farahani M, 2016, TROP MED INT HEALTH, V21, P18, DOI 10.1111/tmi.12623; Farahani M, 2016, AIDS, V30, P477, DOI 10.1097/QAD.0000000000000921; Farahani M, 2014, LANCET GLOB HEALTH, V2, pE44, DOI 10.1016/S2214-109X(13)70149-9; Farahani M, 2009, SOC SCI MED, V68, P1918, DOI 10.1016/j.socscimed.2009.03.023; Fernandes QF, 2014, LANCET GLOB HEALTH, V2, pE468, DOI 10.1016/S2214-109X(14)70276-1; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; HIV/AIDS JUNPo, 2014, FAST TRACK END AIDS; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Lazarus JV, 2014, TROP MED INT HEALTH, V19, P1198, DOI 10.1111/tmi.12366; Miles K, 2007, B WORLD HEALTH ORGAN, V85, P555, DOI 10.2471/BLT.06.033076; Nkomazana O, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.716; Reid Michael J A, 2016, J Int Assoc Provid AIDS Care, V15, P7, DOI 10.1177/2325957415569310; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Seitio-Kgokgwe O, 2014, INT J HEALTH POLICY, V3, P179, DOI 10.15171/ijhpm.2014.85; StataCorp, 2015, STAT STAT SOFTW REL; Van Damme W, 2006, AIDS, V20, P653, DOI 10.1097/01.aids.0000216364.44409.b1; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; WHO, 2011, GLOB REP UNAIDS REP; WHO, 2015, GLOB HLTH WORKF STAT; Williams R, 2012, STATA J, V12, P308, DOI 10.1177/1536867X1201200209; World Health Organization, 2006, WORLD HLTH REP 2006; World Health Organization, 2013, GLOB HLTH OBS DAT RE	34	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160206	10.1371/journal.pone.0160206	http://dx.doi.org/10.1371/journal.pone.0160206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490477	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900037
J	Jalili, M; Hekmatdoost, A; Vahedi, H; Poustchi, H; Khademi, B; Saadi, M; Zemestani, M; Janani, L				Jalili, Mahsa; Hekmatdoost, Azita; Vahedi, Homayoon; Poustchi, Hossein; Khademi, Behnam; Saadi, Mohsen; Zemestani, Maryam; Janani, Leila			Co-Administration of Soy Isoflavones and Vitamin D in Management of Irritable Bowel Disease	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; MENSTRUAL-CYCLE; ESTRADIOL; CELLS; WOMEN; TRIAL	Background and Aims The substantial characteristics of Irritable Bowel Syndrome (IBS) are associated with estrogens in women. Both soy isoflavones and vitamin D can modulate estrogen receptors in the colonic smooth muscles. The aim of this study was to investigate the effects of soy isoflavones, vitamin D and their probable interactions in women with IBS. Methods In a factorial blinded randomized clinical trial, 100 women with IBS (age: 18-75yr, were randomly assigned in 4 arms to receive either placebo of vitamin D and placebo of soy isoflavones (P+P), or placebo of vitamin D and soy isoflavones (P+S), or vitamin D and placebo of soy isoflavones (D+P), or vitamin D and soy isoflavones (D+S) for 6 weeks. Dosage of soy isoflavone was 2 capsules of 20 mg soy isoflavones per day, and dosage of vitamin D was one pearl of 50'000 IU biweekly. The clinical outcomes were IBS symptoms severity scores (IBS-SSS), disease-specific quality of life (IBS-QOL) and total score (IBS-TS) that evaluated at weeks 0, 6, and 10, and compared to each other. Results IBS-TS improved significantly in both S+P and D+P groups (p-value = 0.004, 0.015). The interaction effect of soy isoflavones and vitamin D on IBS-TS was significant (p<0.05). The interaction effect of soy isoflavones with vitamin D and the main effect of vitamin D on IBS-SSS were not statistically significant, whereas IBS-SSS decreased significantly in S+P and D+P groups (p-value = 0.001, 0.047 respectively). Conclusion Our results indicate that co-administration of soy isoflavones with vitamin D did not improve the IBS-SSS and IBS-QOL; however, it improved the IBS-TS.	[Jalili, Mahsa] Norwegian Univ Sci & Technol NTNU, Dept Biol, Trondheim, Norway; [Hekmatdoost, Azita] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran; [Vahedi, Homayoon] Digest Dis Res Inst, Digest Dis Res Ctr DDRC, Tehran, Iran; [Poustchi, Hossein] Digest Dis Res Inst, Liver & Pancreat Biliary Res Grp, Tehran, Iran; [Khademi, Behnam; Saadi, Mohsen] Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Students Res Comm, Tehran, Iran; [Zemestani, Maryam] Tabriz Univ Med Sci, Fac Nutr, Students Res Comm, Tabriz, Iran; [Janani, Leila] Iran Univ Med Sci, Sch Publ Hlth, Dept Biostat, Tehran, Iran	Norwegian University of Science & Technology (NTNU); Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Tabriz University of Medical Science; Iran University of Medical Sciences	Janani, L (corresponding author), Shahid Beheshti Univ Med Sci, Fac Nutr & Food Technol, Natl Nutr & Food Technol Res Inst, Tehran, Iran.	a_hekmat2000@yahoo.com; leila_janani@yahoo.com	Jalili, Mahsa/H-6293-2019; Hekmatdoost, Azita/AGM-6497-2022	Jalili, Mahsa/0000-0001-7825-9483; Hekmatdoost, Azita/0000-0002-1944-0052; Janani, Leila/0000-0002-3370-9310; Janani, Leila/0000-0003-3829-6364	National Nutrition and Food Technology Research Institute, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran	National Nutrition and Food Technology Research Institute, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran	This work was supported by Hekmatdoost, Vahedi, Poustchi. Funding was granted from National Nutrition and Food Technology Research Institute, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.	Andrae DA, 2014, CLIN THER, V36, P663, DOI 10.1016/j.clinthera.2014.04.009; Bakhai A., 2006, CLIN TRIALS PRACTICA; Braniste V, 2009, J PHYSIOL-LONDON, V587, P3317, DOI 10.1113/jphysiol.2009.169300; Chapman RW, 2013, AM J GASTROENTEROL, V108, P1508, DOI 10.1038/ajg.2013.197; Chey WD, 2015, JAMA-J AM MED ASSOC, V313, P949, DOI 10.1001/jama.2015.0954; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Francis CY, IRRITABLE BOWEL SEVE; Ghaffarpour M., 1999, TEHRAN NASHRE OLUME, P42; Gholamrezaei Ali, 2011, Acta Med Iran, V49, P390; Haeuser W, 2012, DTSCH ARZTEBL INT, V109, P83, DOI 10.3238/arztebl.2012.0083; Heitkamper MM, 2003, AM J GASTROENTEROL, V98, P420, DOI 10.1016/S0002-9270(02)05901-4; Houghton LA, 2002, GUT, V50, P471, DOI 10.1136/gut.50.4.471; Jalili Mahsa, 2015, Middle East J Dig Dis, V7, P170; Karaahmet F, 2013, ALIMENT PHARM THER, V37, P499, DOI 10.1111/apt.12188; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Ligaarden SC, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-16; Ludidi S, 2012, NEUROGASTROENT MOTIL, V24, P729, DOI 10.1111/j.1365-2982.2012.01926.x; Morito K, 2001, BIOL PHARM BULL, V24, P351, DOI 10.1248/bpb.24.351; Murray K, 2014, AM J GASTROENTEROL, V109, P110, DOI 10.1038/ajg.2013.386; Nicholl BI, 2008, PAIN, V137, P147, DOI 10.1016/j.pain.2007.08.029; Rao SS, 2015, ALIMENT PHARM THER; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Smith YR, 2006, J NEUROSCI, V26, P5777, DOI 10.1523/JNEUROSCI.5223-05.2006; Somjen D, 2004, J STEROID BIOCHEM, V89-90, P397, DOI 10.1016/j.jsbmb.2004.03.006; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Sprake EF, 2012, BMJ CASE REP, V2012; Tanaka Y, 2011, J NEUROGASTROENTEROL, V17, P131, DOI 10.5056/jnm.2011.17.2.131; Zhou QQ, 2009, PAIN, V146, P41, DOI 10.1016/j.pain.2009.06.017	29	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0158545	10.1371/journal.pone.0158545	http://dx.doi.org/10.1371/journal.pone.0158545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490103	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900006
J	Saikia, N; Bora, JK; Jasilionis, D; Shkolnikov, VM				Saikia, Nandita; Bora, Jayanta Kumar; Jasilionis, Domantas; Shkolnikov, Vladimir M.			Disability Divides in India: Evidence from the 2011 Census	PLOS ONE			English	Article							GENDER-DIFFERENCES; LIFE EXPECTANCY; PREVALENCE; MORTALITY; CHILDREN; POVERTY; WOMEN	Background Understanding the socioeconomic and regional divides in disability prevalence in India has considerable relevance for designing public health policies and programs. Objectives The aim of the present study is to quantify the prevalence of disability by gender, region (rural and urban; states and districts), and caste. We also examine the association between disability prevalence and the major socio-demographic and socioeconomic characteristics of the districts in India. Methods Age-standardized disability prevalence (ASDP) was calculated using 2011 census data and applying the WHO World Standard Population. A regression analysis was carried out to examine the association between disability prevalence and demographic and socioeconomic characteristics across districts of India. Results The study found that ASDP varies substantially across districts and is higher among women, rural dwellers, and members of scheduled tribes (STs) and scheduled castes (SCs). The regression model showed that the disability rate in districts rises with increasing proportions of the population who are urban dwellers, aged 65 or older, members of STs, and living in dilapidated housing; and that the disability prevalence decreases with increasing proportions of the female population who are literate, and of the general population who are working and have access to safe drinking water. Conclusion As the burden of disability falls disproportionately across geographic regions and socioeconomic groups, public health policies in India should take this variation into account. The definition of disability used in the census should be modified to generate internationally comparable estimates of disability prevalence.	[Saikia, Nandita] Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi, India; [Bora, Jayanta Kumar] Publ Hlth Fdn India, Gurgaon, India; [Jasilionis, Domantas; Shkolnikov, Vladimir M.] Max Planck Inst Demog Res, Rostock, Germany; [Shkolnikov, Vladimir M.] New Econ Sch, Moscow, Russia	Jawaharlal Nehru University, New Delhi; Public Health Foundation of India; Max Planck Society; New Economic School	Saikia, N (corresponding author), Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi, India.	nanditasts@gmail.com	Bora, Jayanta/AAK-9419-2020; Bora, Jayanta/AEB-9789-2022; Shkolnikov, Vladimir/D-2986-2017	Bora, Jayanta/0000-0002-9735-3042; Bora, Jayanta/0000-0002-9735-3042; Shkolnikov, Vladimir/0000-0003-2259-5423; Jasilionis, Domantas/0000-0001-9959-9292	Deutsche Forschungs Gemeinschaft (DFG) (Germany) [JA 2302/1-1 (DFG) / ANR-12-FRAL-0003-01 DIMOCHA (ANR)]; Agence Nationale de la Recherche (ANR) (France) [JA 2302/1-1 (DFG) / ANR-12-FRAL-0003-01 DIMOCHA (ANR)]; AXA fund (Le projet AXA Mortality Divergence and Causes of Death); Max Planck Society, Germany	Deutsche Forschungs Gemeinschaft (DFG) (Germany)(German Research Foundation (DFG)); Agence Nationale de la Recherche (ANR) (France)(French National Research Agency (ANR)); AXA fund (Le projet AXA Mortality Divergence and Causes of Death); Max Planck Society, Germany(Max Planck Society)	This study was supported by the joint grant (DIMOCHA) from the Deutsche Forschungs Gemeinschaft (DFG) (Germany) and Agence Nationale de la Recherche (ANR) (France) (JA 2302/1-1 (DFG) / ANR-12-FRAL-0003-01 DIMOCHA (ANR)) and the grant from the AXA fund (Le projet AXA Mortality Divergence and Causes of Death). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted when Dr Nandita Saikia was a Max Planck-India Fellow at the Max Planck Institute for Demographic Research (MPIDR), Germany. Dr. Saikia is grateful to the Max Planck Society, Germany for providing "MAX PLANCK-INDIA FELLOWSHIPS (MPIF)" for collaborative research with the scientists at the MPIDR. Authors are grateful to all three anonymous reviewers for the constructive comments in improving the manuscript.	[Anonymous], 2008, EC POLITICAL WEEKLY; [Anonymous], 2001, GPE DISCUSSION PAPER; [Anonymous], 2009, PEOPL DIS IND COMM O; [Anonymous], 2006, EC POL WKLY; Blackburn CM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-21; Bongaarts J, 2015, POPUL DEV REV, V41, P241, DOI 10.1111/j.1728-4457.2015.00046.x; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Census of India, 2011, DAT ON DIS; Das D, 1998, ECON POLIT WEEKLY, V33, P3333; Desai S, 2008, DEMOGRAPHY, V45, P245; Andrade FCD, 2011, WOMEN HEALTH ISS, V21, P64, DOI 10.1016/j.whi.2010.08.007; Elwan A, 1999, 9932 SP; Filmer D, 2008, WORLD BANK ECON REV, V22, P141, DOI 10.1093/wber/lhm021; Harriss WB, 1999, LOSER DISABILITY IND, P135; Hoogeveen JG, 2005, J AFR ECON, V14, P603, DOI 10.1093/jae/eji020; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Irudaya Rajan S, 1997, SEX RATIOS INDIA WHA; Kandamuthan S, 2004, 91 CTR DEV STUD; Lai DC, 2012, RES DEV DISABIL, V33, P2301, DOI 10.1016/j.ridd.2012.07.001; Leveille SG, 2000, AGING-CLIN EXP RES, V12, P106, DOI 10.1007/BF03339897; Luy M, 2014, HEALTH REP, V25, P12; Mitra S., 2006, ECON POLIT WEEKLY, V41, P4022; Mont D., 2007, 706 WORLD BANK; Oksuzyan A, 2009, ANN EPIDEMIOL, V19, P504, DOI 10.1016/j.annepidem.2009.03.014; Oman D, 1999, AM J EPIDEMIOL, V150, P834; Patel S, 2009, INTERNET J EPIDEMIOL, V6; Saikia N, 2011, POP STUD-J DEMOG, V65, P73, DOI 10.1080/00324728.2010.534642; Sen A, 1998, ECON J, V108, P1, DOI 10.1111/1468-0297.00270; Singh Amarjeet, 2008, Indian J Community Med, V33, P113, DOI 10.4103/0970-0218.40880; United Nations Population Division, 2011, WORLD POP PROSP 2010; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2001, WHO INT CLASS FUNCT	32	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159809	10.1371/journal.pone.0159809	http://dx.doi.org/10.1371/journal.pone.0159809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490469	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900019
J	Sato, T				Sato, Tatsuhiko			Analytical Model for Estimating the Zenith Angle Dependence of Terrestrial Cosmic Ray Fluxes	PLOS ONE			English	Article							EXTENSIVE AIR-SHOWERS; SEA-LEVEL; MOUNTAIN ALTITUDE; GEANT4 SIMULATIONS; RADIATION-EXPOSURE; FLIGHT ALTITUDES; SOLAR MODULATION; MUON RADIOGRAPHY; NEUTRON-SPECTRA; GROUND-LEVEL	A new model called "PHITS-based Analytical Radiation Model in the Atmosphere (PARMA) version 4.0" was developed to facilitate instantaneous estimation of not only omnidirectional but also angular differential energy spectra of cosmic ray fluxes anywhere in Earth's atmosphere at nearly any given time. It consists of its previous version, PARMA3.0, for calculating the omnidirectional fluxes and several mathematical functions proposed in this study for expressing their zenith-angle dependences. The numerical values of the parameters used in these functions were fitted to reproduce the results of the extensive air shower simulation performed by Particle and Heavy Ion Transport code System (PHITS). The angular distributions of ground-level muons at large zenith angles were specially determined by introducing an optional function developed on the basis of experimental data. The accuracy of PARMA4.0 was closely verified using multiple sets of experimental data obtained under various global conditions. This extension enlarges the model's applicability to more areas of research, including design of cosmic-ray detectors, muon radiography, soil moisture monitoring, and cosmic-ray shielding calculation. PARMA4.0 is available freely and is easy to use, as implemented in the open-access EXcel-based Program for Calculating Atmospheric Cosmic-ray Spectrum (EXPACS).	[Sato, Tatsuhiko] Japan Atom Energy Agcy JAEA, Res Grp Radiat Transport Anal, Shirakata 2-4, Tokai, Ibaraki 3191195, Japan	Japan Atomic Energy Agency	Sato, T (corresponding author), Japan Atom Energy Agcy JAEA, Res Grp Radiat Transport Anal, Shirakata 2-4, Tokai, Ibaraki 3191195, Japan.	sato.tatsuhiko@jaea.go.jp						Abe SI, 2017, J NUCL SCI TECHNOL, V54, P101, DOI 10.1080/00223131.2016.1210043; Abe S, 2011, J PHYS CONF SER, V312, DOI 10.1088/1742-6596/312/6/062004; Aglietta M, 1998, PHYS REV D, V58; ALLKOFER OC, 1985, NUCL PHYS B, V259, P1, DOI 10.1016/0550-3213(85)90294-9; ALVAREZ LW, 1970, SCIENCE, V167, P832, DOI 10.1126/science.167.3919.832; Arakelyan K, 2014, NUCL INSTRUM METH A, V763, P308, DOI 10.1016/j.nima.2014.06.038; Argento DC, 2013, NUCL INSTRUM METH B, V294, P464, DOI 10.1016/j.nimb.2012.05.022; BARBER HB, 1980, PHYS REV D, V22, P2667, DOI 10.1103/PhysRevD.22.2667; Borozdin K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.152501; Boudard A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.014606; Burda O, 2013, J RADIOL PROT, V33, P339, DOI 10.1088/0952-4746/33/2/339; Cheminet A, 2013, J GEOPHYS RES-SPACE, V118, P7488, DOI 10.1002/2013JA019166; Chen J, 2009, RADIAT ENVIRON BIOPH, V48, P317, DOI 10.1007/s00411-009-0226-z; Clem JM, 2004, RADIAT PROT DOSIM, V110, P423, DOI 10.1093/rpd/nch175; DIGGORY IS, 1974, J PHYS A-MATH GEN, V7, P741, DOI 10.1088/0305-4470/7/6/010; Ebisuzaki T, 2011, GONDWANA RES, V19, P1054, DOI 10.1016/j.gr.2010.11.004; GOLDEN RL, 1995, J GEOPHYS RES-SPACE, V100, P23515, DOI 10.1029/95JA02449; Hagmann C., 2012, UCRLTM229453 LAWR LI; Haino S, 2004, PHYS LETT B, V594, P35, DOI 10.1016/j.physletb.2004.05.019; Hubert G, 2015, RADIAT RES, V184, P83, DOI 10.1667/RR14028.1; JOKISCH H, 1979, PHYS REV D, V19, P1368, DOI 10.1103/PhysRevD.19.1368; Karapetyan GG, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.093005; Kataoka R, 2014, GONDWANA RES, V25, P1153, DOI 10.1016/j.gr.2013.05.003; Kato T, 2014, IEEE T NUCL SCI, V61, P3408, DOI 10.1109/TNS.2014.2369014; Kikuchi S, 2009, J ENVIRON RADIOACTIV, V100, P515, DOI 10.1016/j.jenvrad.2009.03.017; Knapp J, 1998, UPGRADE MONTE CARLO; KOCHARIAN NM, 1959, SOV PHYS JETP-USSR, V8, P933; Kohli M, 2015, WATER RESOUR RES, V51, P5772, DOI 10.1002/2015WR017169; Kole M, 2015, ASTROPART PHYS, V62, P230, DOI 10.1016/j.astropartphys.2014.10.002; KORNMAYER H, 1995, J PHYS G NUCL PARTIC, V21, P439, DOI 10.1088/0954-3899/21/3/018; Kremer J, 1999, PHYS REV LETT, V83, P4241, DOI 10.1103/PhysRevLett.83.4241; Lifton N, 2014, EARTH PLANET SC LETT, V386, P149, DOI 10.1016/j.epsl.2013.10.052; MAEDA K, 1973, FORTSCHR PHYS, V21, P113, DOI 10.1002/prop.19730210302; Masarik J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010557; Matthia D, 2014, SPACE WEATHER, V12, P161, DOI 10.1002/2013SW001022; Matthia D, 2013, ADV SPACE RES, V51, P329, DOI 10.1016/j.asr.2012.09.022; Mishev A, 2015, J SPACE WEATHER SPAC, V5, DOI 10.1051/swsc/2015011; Mochiutti E., 2003, THESIS; Nesterenok A, 2013, NUCL INSTRUM METH B, V295, P99, DOI 10.1016/j.nimb.2012.11.005; Nishiyama R, 2014, J GEOPHYS RES-SOL EA, V119, P699, DOI 10.1002/2013JB010234; O'Brien K, 1998, ADV SPACE RES, V21, P1739, DOI 10.1016/S0273-1177(98)00060-X; PRESZLER AM, 1976, J GEOPHYS RES-SPACE, V81, P4715, DOI 10.1029/JA081i025p04715; RASTIN BC, 1984, J PHYS G NUCL PARTIC, V10, P1609, DOI 10.1088/0305-4616/10/11/017; Roesler S, 1998, RADIAT RES, V149, P87, DOI 10.2307/3579685; RYAN JM, 1979, J GEOPHYS RES-SPACE, V84, P5279, DOI 10.1029/JA084iA09p05279; Sanuki T, 2003, PHYS LETT B, V577, P10, DOI 10.1016/j.physletb.2003.10.021; Sanuki T, 2002, PHYS LETT B, V541, P234, DOI 10.1016/S0370-2693(02)02265-7; Sato T, 2014, RADIAT PROT DOSIM, V161, P274, DOI 10.1093/rpd/nct332; Sato T, 2008, RADIAT RES, V170, P244, DOI 10.1667/RR1094.1; Sato T, 2006, RADIAT RES, V166, P544, DOI 10.1667/RR0610.1; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144679; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Sierawski BD, 2010, IEEE T NUCL SCI, V57, P3273, DOI 10.1109/TNS.2010.2080689; Takamatsu K, 2015, ANN NUCL ENERGY, V78, P166, DOI 10.1016/j.anucene.2014.12.017; Tanaka HKM, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008256; Yasuda H, 2011, RADIAT PROT DOSIM, V146, P123, DOI [10.1093/rpd/ncr133, 10.1093/rpd/ncr.133]; Ziegler JF, 1998, IBM J RES DEV, V42, P117, DOI 10.1147/rd.421.0117	57	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160390	10.1371/journal.pone.0160390	http://dx.doi.org/10.1371/journal.pone.0160390			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490175	gold, Green Submitted, Green Published			2022-12-27	WOS:000381368900052
J	Son, S; Park, KJ; Park, EC				Son, Sunghwa; Park, Kyung-Joon; Park, Eun-Chan			Medical-Grade Channel Access and Admission Control in 802.11e EDCA for Healthcare Applications	PLOS ONE			English	Article								In this paper, we deal with the problem of assuring medical-grade quality of service (QoS) for real-time medical applications in wireless healthcare systems based on IEEE 802.11e. Firstly, we show that the differentiated channel access of IEEE 802.11e cannot effectively assure medical-grade QoS because of priority inversion. To resolve this problem, we propose an efficient channel access algorithm. The proposed algorithm adjusts arbitrary interframe space (AIFS) in the IEEE 802.11e protocol depending on the QoS measurement of medical traffic, to provide differentiated near-absolute priority for medical traffic. In addition, based on rigorous capacity analysis, we propose an admission control scheme that can avoid performance degradation due to network overload. Via extensive simulations, we show that the proposed mechanism strictly assures the medical-grade QoS and improves the throughput of low-priority traffic by more than several times compared to the conventional IEEE 802.11e.	[Son, Sunghwa; Park, Kyung-Joon] DGIST, Dept Informat & Commun Engn, Daegu, South Korea; [Park, Eun-Chan] Dongguk Univ, Dept Informat & Commun Engn, Seoul, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Dongguk University	Park, EC (corresponding author), Dongguk Univ, Dept Informat & Commun Engn, Seoul, South Korea.	ecpark@dongguk.edu	Park, Kyung-Joon/A-7354-2009	Park, Kyung-Joon/0000-0003-4807-6461	Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP) (Resilient Cyber-Physical Systems Research) [B0101-15-0557]	Institute for Information & communications Technology Promotion (IITP) grant - Korea government (MSIP) (Resilient Cyber-Physical Systems Research)	This work was supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIP) (No. B0101-15-0557, Resilient Cyber-Physical Systems Research).	Andreadis A, 2012, INT J WIREL INF NETW, V19, P49, DOI 10.1007/s10776-011-0162-0; Arora A, 2010, IEEE T VEH TECHNOL, V59, P1087, DOI 10.1109/TVT.2009.2031677; Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Baker SD, 2008, IEEE ENG MED BIOL, V27, P86, DOI 10.1109/EMB.2008.915498; Deb B, 2012, IEEE INT S WORLD WIR, P1; Du QH, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0506-5; Freitag J, 2006, IEEE COMMUN LETT, V10, P611, DOI 10.1109/LCOMM.2006.060334; Ghazvini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062925; Jiang Yu, 2016, IEEE T IND INFORM, DOI [10.1109/Tll.2016.2573762, DOI 10.1109/TLL.2016.2573762]; Laufer R, 2013, IEEE INFOCOM SER, P1312; Lee H, 2011, J COMMUN NETW-S KOR, V13, P149, DOI 10.1109/JCN.2011.6157414; Luo HL, 2011, HUM-CENT COMPUT INFO, V1, DOI 10.1186/2192-1962-1-5; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Pudasaini S., 2012, 2012 Fourth International Conference on Ubiquitous and Future Networks (ICUFN 2012), P340, DOI 10.1109/ICUFN.2012.6261725; Romdhani L, 2003, IEEE WCNC, P1373; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Welch Allyn, MICROPAQ WEARABLE MO; Zhang Y, 2014, IEEE INTERNET THINGS, V1, P311, DOI 10.1109/JIOT.2014.2329462; Zhang YY, 2015, 2015 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION, AND KNOWLEDGE IN THE INTERNET OF THINGS (IIKI), P197, DOI 10.1109/IIKI.2015.49; Zigel Y, 2000, IEEE T BIO-MED ENG, V47, P1422, DOI 10.1109/TBME.2000.880093	20	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160052	10.1371/journal.pone.0160052	http://dx.doi.org/10.1371/journal.pone.0160052			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490666	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900029
J	Jacobs, R; Maasdorp, E; Malherbe, S; Loxton, AG; Stanley, K; van der Spuy, G; Walzl, G; Chegou, NN				Jacobs, Ruschca; Maasdorp, Elizna; Malherbe, Stephanus; Loxton, Andre G.; Stanley, Kim; van der Spuy, Gian; Walzl, Gerhard; Chegou, Novel N.			Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEIN-1; MYCOBACTERIUM-TUBERCULOSIS; PROGRESSION; BLOOD; CELLS; ASSAY	Background There is an urgent need for new tools for the early diagnosis of TB disease and monitoring of the response to treatment, especially in resource-constrained settings. We investigated the usefulness of host markers detected in saliva as candidate biomarkers for the immunological diagnosis of TB disease and monitoring of treatment response. Methods We prospectively collected saliva samples from 51 individuals that presented with signs and symptoms suggestive of TB disease at a health centre in Cape Town, South Africa, prior to the establishment of a clinical diagnosis. Patients were later classified as having TB disease or other respiratory disease (ORD), using a combination of clinical, radiological and laboratory findings. We evaluated the concentrations of 69 host markers in saliva samples using a multiplex cytokine platform, and assessed the diagnostic potentials of these markers by receiver operator characteristics (ROC) curve analysis, and general discriminant analysis. Results Out of the 51 study participants, 18 (35.4%) were diagnosed with TB disease and 12 (23.5%) were HIV infected. Only two of the 69 host markers that were evaluated (IL-16 and IL-23) diagnosed TB disease individually with area under the ROC curve >= 0.70. A fivemarker biosignature comprising of IL-1 beta, IL-23, ECM-1, HCC1 and fibrinogen diagnosed TB disease with a sensitivity of 88.9%(95% CI, 76.7-99.9%) and specificity of 89.7% (95% CI, 60.4-96.6%) after leave-one-out cross validation, regardless of HIV infection status. Eightmarker biosignatures performed with a sensitivity of 100% (95% CI, 83.2-100%) and specificity of 95% (95% CI, 68.1-99.9%) in the absence of HIV infection. Furthermore, the concentrations of 11 of the markers changed during treatment, indicating that they may be useful in monitoring of TB treatment response. Conclusion We have identified novel salivary biosignatures which may be useful in the diagnosis of TB disease and monitoring of the response to TB treatment. Our findings require further validation in larger studies before these biosignatures could be considered for point-of-care screening test development.	[Chegou, Novel N.] Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa; Univ Stellenbosch, Fac Med & Hlth Sci, SAMRC Ctr TB Res, Dept Biomed Sci,Div Mol Biol & Human Genet, Cape Town, South Africa	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University	Chegou, NN (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa.	novel@sun.ac.za	van der Spuy, Gian/AAY-7701-2020; Walzl, Gerhard/N-6371-2016	van der Spuy, Gian/0000-0002-9067-5903; Maasdorp, Elizna/0000-0002-3402-169X; Chegou, Novel N/0000-0002-8690-1699; Walzl, Gerhard/0000-0003-2487-125X; Loxton, Andre/0000-0003-0659-9803	European and Developing Countries Clinical Trials Partnership (EDCTP); African European Tuberculosis Consortium (AE-TBC) [IP_2009_32040]; National Research Foundation (NRF); South African Medical Research Council (SAMRC)	European and Developing Countries Clinical Trials Partnership (EDCTP); African European Tuberculosis Consortium (AE-TBC); National Research Foundation (NRF); South African Medical Research Council (SAMRC)	This work was supported by the European and Developing Countries Clinical Trials Partnership (EDCTP); grant number IP_2009_32040, through the African European Tuberculosis Consortium (AE-TBC, www.ae-tbc.eu), with Prof. Gerhard Walzl as Principal Investigator. The financial assistance of the National Research Foundation (NRF) and the South African Medical Research Council (SAMRC) is hereby also acknowledged. Opinions expressed and conclusions arrived at, are those of the authors and are not necessarily to be attributed to any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel C, 1999, J INFECT DIS, V179, P83, DOI 10.1086/314550; [Anonymous], 2010, INT UNION TUBERC LUN; [Anonymous], 2015, GLOBAL TUBERCULOSIS; Center DM, 2000, IMMUNOL TODAY, V21, P273, DOI 10.1016/S0167-5699(00)01629-7; Chegou NN, 2016, THORAX; Chegou NN, 2008, RESPIRATION, V76, P131, DOI 10.1159/000128575; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Chegou NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038501; Chen T, 2016, TUBERCULOSIS, V97, P108, DOI 10.1016/j.tube.2015.12.007; Corstjens PLAM, 2016, CLIN BIOCHEM, V49, P22, DOI 10.1016/j.clinbiochem.2015.08.013; Denkinger CM, 2013, J CLIN MICROBIOL, V51, P607, DOI 10.1128/JCM.02278-12; Desikan P, 2013, INDIAN J MED RES, V137, P442; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Higuchi K, 2008, RESPIROLOGY, V13, P468, DOI 10.1111/j.1440-1843.2008.01244.x; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Jacobs R, 2016, RSA Patent Application, Patent No. [2016/02557, 201602557]; Jacobs R, 2016, CYTOKINE, V81, P50, DOI 10.1016/j.cyto.2016.02.004; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Krishnan N, 2013, TUBERCULOSIS, V93, P538, DOI 10.1016/j.tube.2013.05.002; Martin Boegemann FJW, 2014, J MOL BIOMARK DIAGN, V5; Martins C, 2014, J BRAS PATOL E MED L, V50; Phalane KG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/981984; Piatek AS, 2013, GLOB HEALTH-SCI PRAC, V1, P18, DOI 10.9745/GHSP-D-12-00004; Riou C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036886; Schipper RG, 2007, ARCH ORAL BIOL, V52, P1114, DOI 10.1016/j.archoralbio.2007.06.009; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Sindhu S., 2014, J ORAL DIS, V2014; Singh PP, 2006, MICROBES INFECT, V8, P541, DOI 10.1016/j.micinf.2005.08.007	29	31	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160546	10.1371/journal.pone.0160546	http://dx.doi.org/10.1371/journal.pone.0160546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487181	gold, Green Published			2022-12-27	WOS:000381367800085
J	Kastberger, G; Waddoup, D; Weihmann, F; Hoetzl, T				Kastberger, Gerald; Waddoup, Dominique; Weihmann, Frank; Hoetzl, Thomas			Evidence for Ventilation through Collective Respiratory Movements in Giant Honeybee (Apis dorsata) Nests	PLOS ONE			English	Article							BODY-TEMPERATURE REGULATION; COLONY DEFENSE; SOCIAL WAVES; MELLIFERA; BEES; BEHAVIOR; THERMOREGULATION; MECHANISMS; BROOD; HEAD	The Asian giant honeybees (Apis dorsata) build single-comb nests in the open, which makes this species particularly susceptible to environmental strains. Long-term infrared (IR) records documented cool nest regions (CNR) at the bee curtain (n(CNR) = 207, n(nests) > 20) distinguished by marked negative gradients (Delta T-CNR/d < -3 degrees C / 5 cm) at their margins. CNRs develop and recede within minutes, predominantly at higher ambient temperatures in the early afternoon. The differential size (Delta A(CNR)) and temperature (Delta T-CNR) values per time unit correlated mostly positively (R-AT > 0) displaying the Venturi effect, which evidences funnel properties of CNRs. The air flows inwards through CNRs, which is verified by the negative spatial gradient Delta T-CNR/d, by the positive grading of T-CNR with T-amb and lastly by fanners which have directed their abdomens towards CNRs. Rare cases of R-AT < 0 (< 3%) document closing processes (for Delta A(CNR)/Delta t < -0.4 cm(2)/s) but also suggest ventilation of the bee curtain (for Delta A(CNR)/Delta t > +0.4 cm(2)/s) displaying "inhalation" and "exhalation" cycling. "Inhalation" could be boosted by bees at the inner curtain layers, which stretch their extremities against the comb enlarging the inner nest lumen and thus causing a pressure fall which drives ambient air inwards through CNR funnels. The relaxing of the formerly "activated" bees could then trigger the "exhalation" process, which brings the bee curtain, passively by gravity, close to the comb again. That way, warm, CO2-enriched nest-borne air is pressed outwards through the leaking mesh of the bee curtain. This ventilation hypothesis is supported by IR imaging and laser vibrometry depicting CNRs in at least four aspects as low-resistance convection funnels for maintaining thermoregulation and restoring fresh air in the nest.	[Kastberger, Gerald; Waddoup, Dominique; Weihmann, Frank; Hoetzl, Thomas] Graz Univ, Inst Zool, Graz, Austria; [Waddoup, Dominique] Austrian Biologist Assoc, Graz, Austria; [Weihmann, Frank] Austrian League Nat Conservat Styria, Graz, Austria	University of Graz	Kastberger, G (corresponding author), Graz Univ, Inst Zool, Graz, Austria.	gerald.kastberger@uni-graz.at			Austrian Science Foundation (FWF Project) [P 20515-B16]	Austrian Science Foundation (FWF Project)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation (FWF Project P 20515-B16) URL: https://www.fwf.ac.at/en/. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baehr HD, 2004, WARME STOFFUBERTRAGU; Batchelor G. K., 2000, CHROMOPHOBIA; Bruman P, 1928, J COMP PHYSIOL A, V8, P366; Buchwald R, 2008, J EXP BIOL, V211, P121, DOI 10.1242/jeb.007583; BUTLER CG, 1954, WORLD HONEYBEE; Chadwick P, 1922, AM BEE J, V62, P158; Coggshall W. L., 1984, BEESWAX PRODUCTION H; COOPER PD, 1985, J EXP BIOL, V114, P1; Deodikar G. B. (and 6 others), 1977, Indian Bee Journal, V39, P1; DYER FC, 1991, ECOLOGY, V72, P156, DOI 10.2307/1938911; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; ESCH H, 1960, Z VERGL PHYSIOL, V43, P305, DOI 10.1007/BF00298066; Etling D., 2008, THEORETISCHE METEORO; Glenn E, 2015, EHYS HYPERTEXTBOOK; HAZELHOFF E. H., 1954, PHYSIOL COMPARATA ET OECOL, V3, P343; HEINRICH B, 1980, J EXP BIOL, V85, P73; HEINRICH B, 1980, J EXP BIOL, V85, P61; HEINRICH B, 1979, SCIENCE, V205, P1269, DOI 10.1126/science.205.4412.1269; Heinrich B., 1993, HOT BLOODED INSECTS; JACOBS W, 1925, Z MORPHOL OKOL TIERE, V3, P1; Jay S. C., 1963, Journal of Apicultural Research London, V2, P117; Jones JC, 2007, ADV INSECT PHYSIOL, V33, P153, DOI 10.1016/S0065-2806(06)33003-2; Kafer HK, 2002, MOBILISING MASS RELE; Kastberger G, 2003, BEHAV RES METH INS C, V35, P429, DOI 10.3758/BF03195520; Kastberger G, 1996, APIDOLOGIE, V27, P381, DOI 10.1051/apido:19960506; Kastberger G, 1998, ETHOLOGY, V104, P27, DOI 10.1111/j.1439-0310.1998.tb00027.x; Kastberger G, 2000, APIDOLOGIE, V31, P727, DOI 10.1051/apido:2000157; KASTBERGER G, 1999, MAGIC TREES ASSAM DO; Kastberger G, 2014, NATURWISSENSCHAFTEN, V101, P861, DOI 10.1007/s00114-014-1220-0; Kastberger G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086315; Kastberger G, 2013, NATURWISSENSCHAFTEN, V100, P595, DOI 10.1007/s00114-013-1056-z; Kastberger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036736; Kastberger G, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-3; Kastberger G, 2011, HONEYBEES OF ASIA, P397, DOI 10.1007/978-3-642-16422-4_18; Kastberger G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003141; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Kleinhenz M, 1995, J THEOR BIOL, V176, P280; Koetz Anna H., 2013, Insects, V4, P558, DOI 10.3390/insects4040558; Kovac H, 2014, APIDOLOGIE, V45, P664, DOI 10.1007/s13592-014-0284-3; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; LACHER V, 1964, J COMP PHYSIOL A, V48, P587, DOI DOI 10.1007/BF00333743; LINDAUER M, 1954, Z VERGL PHYSIOL, V36, P391, DOI 10.1007/BF00345028; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; LINDAUER M, 1971, COMMUNICATION SOCIAL; MARDAN M, 1989, NATURE, V341, P191, DOI 10.1038/341191a0; Mardan M, 2002, APIDOLOGIE, V33, P295, DOI 10.1051/apido:2002017; Mardan M, 2008, CONNECTING BEE DOTS; Mardan M, 1989, THESIS; Moritz R.F.A., 1992, BEES SUPERORGANISMS; Morse R.A, 1969, PHILIPPINE ASS ENTOM, V1, P1; Oldroyd BP, 2006, ASIAN HONEY BEES BIO; PHIANCHAROEN M, 2011, HONEYBEES OF ASIA; Punchihewa R.W.K., 1994, BEEKEEPING HONEY PRO; Ratnovsky A, 2008, RESP PHYSIOL NEUROBI, V163, P82, DOI 10.1016/j.resp.2008.04.019; ROEPKE W., 1930, Mededelingen van de Landbouwhogeschool, V34, P1; Rogstam J., 2011, ENERGI KYLANALY 0401; RUTTNER F, 1992, NATURGESCHICHTE HONI; Schmaranzer S, 1988, WISSENSCHAFTLICHER F; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1974, J INSECT PHYSIOL, V20, P2301, DOI 10.1016/0022-1910(74)90052-3; SEELEY TD, 1982, ECOL MONOGR, V52, P43, DOI 10.2307/2937344; SIMPSON J, 1961, SCIENCE, V133, P1327, DOI 10.1126/science.133.3461.1327; SOUTHWICK EE, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P28; Stabentheiner A, 2003, J EXP BIOL, V206, P353, DOI 10.1242/jeb.00082; Sudarsan R, 2012, J THEOR BIOL, V295, P168, DOI 10.1016/j.jtbi.2011.11.007; Tautz J, 2015, ERFORSCHUNG BIENENWE; Tautz J., 2008, THE BUZZ ABOUT BEES; Weihmann Frank, 2014, Insects, V5, P689, DOI 10.3390/insects5030689; Whiteman C.D., 2000, MOUNTAIN METEOROLOGY; Winston ML, 1991, BIOL HONEYBEE; Woyke J, 2004, J APICULT RES, V43, P181, DOI 10.1080/00218839.2004.11101134	71	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0157882	10.1371/journal.pone.0157882	http://dx.doi.org/10.1371/journal.pone.0157882			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487188	Green Submitted, gold, Green Published			2022-12-27	WOS:000381367800006
J	Laessoe, U; Grarup, B; Bangshaab, J				Laessoe, Uffe; Grarup, Bo; Bangshaab, Jette			The Use of Cognitive Cues for Anticipatory Strategies in a Dynamic Postural Control Task - Validation of a Novel Approach to Dual-Task Testing	PLOS ONE			English	Article							PARKINSONS-DISEASE; GAIT; WALKING; BALANCE; PEOPLE; FALLS	Introduction Dual-task testing is relevant in the assessment of postural control. A combination of a primary (motor) and a secondary (distracting cognitive) tasks is most often used. It remains a challenge however, to standardize and monitor the cognitive task. In this study a new dual-task testing approach with a facilitating, rather than distracting, cognitive component was evaluated. Methods Thirty-one community-dwelling elderly and fifteen young people were tested with respect to their ability to use anticipatory postural control strategies. The motor task consisted of twenty-five repetitive tasks in which the participants needed to exceed their limit of stability in order to touch one out of eight lights. The participants performed three tests. In two of the tests the color cues of the lights allowed the participants to utilize cognitive strategies to plan their next movement and improve their performance time. Results The young performed the baseline motor task test in an average of 29 seconds, while the average time for the elderly was 44 seconds. When comparing the performance time with a leading cue to the time with no cue, the young group improved their performance time significantly better than the elderly did: young: 17% (5), elderly: 5% (8); p<0.001. Similar differences were seen with a more complicated leading cue: young: 12% (5), elderly: 4% (9); p<0.01. The reliability of the test showed moderate to substantial agreement (ICC = 0.74), with a small learning effect between two sessions. Conclusion The dual-task test was sensitive enough to discriminate between elderly and young people. It revealed that the elderly did not utilize cognitive cues for their anticipatory postural control strategies as well as the young were able to. The test procedure was feasible and comprehensible for the participants, and it may be relevant to standardize a similar test for an alternative dual-task approach in the clinical setting.	[Laessoe, Uffe; Grarup, Bo] Univ Coll North Denmark, Physiotherapy Dept, Region Nordjylland, Denmark; [Laessoe, Uffe; Bangshaab, Jette] Univ Coll North Denmark, Dept Res & Dev, Region Nordjylland, Denmark		Laessoe, U (corresponding author), Univ Coll North Denmark, Physiotherapy Dept, Region Nordjylland, Denmark.; Laessoe, U (corresponding author), Univ Coll North Denmark, Dept Res & Dev, Region Nordjylland, Denmark.	ufl@ucn.dk	Laessoe, Uffe/AAE-5563-2020	Bangshaab, Jette/0000-0002-0362-2222; Grarup, Bo/0000-0001-5437-1665; Laessoe, Uffe/0000-0001-5388-1671				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; DUNCAN PW, 1992, J GERONTOL, V47, pM93, DOI 10.1093/geronj/47.3.M93; Fernandes A, 2015, MED ENG PHYS, V37, P1070, DOI 10.1016/j.medengphy.2015.08.011; Fernandes A, 2015, SOMATOSENS MOT RES, V32, P122, DOI 10.3109/08990220.2014.1002605; Foreman MD, 1996, GERIATR NURS, V17, P228, DOI 10.1016/S0197-4572(96)80210-2; Fraizer EV, 2008, GAIT POSTURE, V27, P271, DOI 10.1016/j.gaitpost.2007.04.002; Hauer K, 2010, GERONTOLOGY, V56, P190, DOI 10.1159/000236027; Huang H J, 2001, Pediatr Phys Ther, V13, P133, DOI 10.1097/00001577-200110000-00005; Kandel E., 2000, PRINCIPLES NEURAL SC; Laessoe U, 2008, HUM MOVEMENT SCI, V27, P496, DOI 10.1016/j.humov.2007.12.001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; McIsaac TL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/591475; Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Mulder T, 2002, GAIT POSTURE, V16, P198, DOI 10.1016/S0966-6362(01)00157-6; Panel on Prevention of Falls in Older Persons American Geriatrics Society and British Geriatrics Society, 2010, JAMGERIATRSOC, V59, P148; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Prince F, 1997, GAIT POSTURE, V5, P128, DOI 10.1016/S0966-6362(97)01118-1; Schmidt RA, 2005, MOTOR CONTROL LEARNI; Shumway-Cook A., 2001, MOTOR CONTROL THEORY, V2nd; Sousa ASP, 2012, SOMATOSENS MOT RES, V29, P131, DOI 10.3109/08990220.2012.725680; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4	26	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0157421	10.1371/journal.pone.0157421	http://dx.doi.org/10.1371/journal.pone.0157421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487000	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800003
J	McAuley, A; Denny, C; Taulbut, M; Mitchell, R; Fischbacher, C; Graham, B; Grant, I; O'Hagan, P; McAllister, D; McCartney, G				McAuley, Andrew; Denny, Cheryl; Taulbut, Martin; Mitchell, Rory; Fischbacher, Colin; Graham, Barbara; Grant, Ian; O'Hagan, Paul; McAllister, David; McCartney, Gerry			Informing Investment to Reduce Inequalities: A Modelling Approach	PLOS ONE			English	Article							HEALTH INEQUALITIES; SOCIAL INEQUALITIES; FUNDAMENTAL CAUSES; MORTALITY; SMOKING; SCOTLAND; DISEASE; IMPACT	Background Reducing health inequalities is an important policy objective but there is limited quantitative information about the impact of specific interventions. Objectives To provide estimates of the impact of a range of interventions on health and health inequalities. Materials and Methods Literature reviews were conducted to identify the best evidence linking interventions to mortality and hospital admissions. We examined interventions across the determinants of health: a 'living wage'; changes to benefits, taxation and employment; active travel; tobacco taxation; smoking cessation, alcohol brief interventions, and weight management services. A model was developed to estimate mortality and years of life lost (YLL) in intervention and comparison populations over a 20-year time period following interventions delivered only in the first year. We estimated changes in inequalities using the relative index of inequality (RII). Results Introduction of a 'living wage' generated the largest beneficial health impact, with modest reductions in health inequalities. Benefits increases had modest positive impacts on health and health inequalities. Income tax increases had negative impacts on population health but reduced inequalities, while council tax increases worsened both health and health inequalities. Active travel increases had minimally positive effects on population health but widened health inequalities. Increases in employment reduced inequalities only when targeted to the most deprived groups. Tobacco taxation had modestly positive impacts on health but little impact on health inequalities. Alcohol brief interventions had modestly positive impacts on health and health inequalities only when strongly socially targeted, while smoking cessation and weight-reduction programmes had minimal impacts on health and health inequalities even when socially targeted. Conclusions Interventions have markedly different effects on mortality, hospitalisations and inequalities. The most effective (and likely cost-effective) interventions for reducing inequalities were regulatory and tax options. Interventions focused on individual agency were much less likely to impact on inequalities, even when targeted at the most deprived communities.	[McAuley, Andrew; Taulbut, Martin; Mitchell, Rory; McCartney, Gerry] NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland; [Denny, Cheryl; Fischbacher, Colin; Graham, Barbara; Grant, Ian; O'Hagan, Paul] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [McAllister, David] NHS Fife, Publ Hlth, Kirkcaldy, Scotland; [McAllister, David] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	NHS National Services Scotland; University of Dundee; University of Edinburgh	McAuley, A (corresponding author), NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland.	andrew.mcauley@nhs.net	McAuley, Andrew/AGX-9647-2022	McCartney, Gerry/0000-0001-6341-3521; McAuley, Andrew/0000-0002-6047-2400; Fischbacher, Colin/0000-0003-3090-1857	Scottish Government Chief Scientist Office [CZG/2/580]; Chief Scientist Office [CZG/2/580] Funding Source: researchfish	Scottish Government Chief Scientist Office; Chief Scientist Office	This research was funded by the Scottish Government Chief Scientist Office (Grant award number: CZG/2/580). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinwale B, 2011, J EPIDEMIOL COMMUN H, V65, P786, DOI 10.1136/jech.2009.099325; [Anonymous], 2014, INF INV RED HLTH IN; APPLEBY J, 2014, BMJ-BRIT MED J, V349, P42125, DOI DOI 10.1136/BMJ.G5184; Association of Public Health Observatories, 2008, HLTH IN INT TOOL ALL; Beatty C., 2011, TACKLING WORKLESSNES; Beeston C., 2013, HLTH INEQUALITIES PO; Beeston C., 2013, MONITORING EVALUATIN; Benach J, 2013, J EPIDEMIOL COMMUN H, V67, P286, DOI 10.1136/jech-2011-200363; Clemens Tom, 2009, Health Stat Q, P7; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Davila EP, 2010, J OCCUP ENVIRON MED, V52, P501, DOI 10.1097/JOM.0b013e3181d5e371; Department of Health Physical Activity Health Improvement and Protection, 2011, START ACT STAY ACT R; Doesken N., TEMPERATURE INVERSIO; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eikemo TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110952; Eiser D, 2014, CONSTITUTIONAL CHANG; Galea S, 2010, AM J PUBLIC HEALTH, V101, P1456, DOI [10.2015/AJPH2010.300086, DOI 10.2015/AJPH2010.300086]; Geue C, 2012, HEALTH ECON, V21, P1201, DOI 10.1002/hec.1785; Graham H, 2009, UNDERSTANDING HLTH I; Gray L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002647; Hart CL, 2008, ADDICTION, V103, P1979, DOI 10.1111/j.1360-0443.2008.02373.x; Iversen L, 2013, BRIT J GEN PRACT, V63, pE523, DOI 10.3399/bjgp13X670651; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Krieger N, 2008, AM J PUBLIC HEALTH, V98, P221, DOI 10.2105/AJPH.2007.111278; Lawder R, 2007, USING THE LINKED SCO; Leyland AH, 2007, 16 MRC SOC PUBL HLTH; MacIntyre S, 1997, SOC SCI MED, V44, P723, DOI 10.1016/S0277-9536(96)00183-9; Mackenbach JP, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3460; McCartney G, 2012, WHAT WOULD BE SUFFIC; MCKEE M, 2011, BMJ-BRIT MED J, V343, pD7973, DOI DOI 10.1136/BMJ.D7973; McLoone P, 2001, BRIT MED J, V323, P374, DOI 10.1136/bmj.323.7309.374; Mitchell R, 2012, HLTH INEQUALITIES TO; National Institute of Clinical Excellence (NICE), 2010, PUBL HLTH GUID 24; NHS Health Scotland, 2010, GUIDE SMOKING CESSAT; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; Ormston R, 2012, EVALUATION QUIT4U MA; Phelan JC, 2005, J GERONTOL B-PSYCHOL, V60, P27; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Robinson M, 2013, ALCOHOL ALCOHOLISM, V48, P231, DOI 10.1093/alcalc/ags098; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Ross HM, 2008, BRIT J GEN PRACT, V58, P548, DOI 10.3399/bjgp08X319710; Scott S., 2013, WHAT WOULD IT TAKE E; Scottish Government, SCOTT IND MULT DEPR; Scottish Government, 2008, EQ WELL REP MIN TASK; Scottish Government, SCOTL PERF; Scottish Government, 2013, PROJ SMOK POP SCOTL; Scottish Government, 2008, FAIR LOC TAX SCOTL; Scottish Intercollegiate Guidelines Network (SIGN), 2004, MAN HARMF DRINK ALC; Sergeant JC, 2006, BIOSTATISTICS, V7, P213, DOI 10.1093/biostatistics/kxj002; Smith BT, 2014, J EPIDEMIOL COMMUN H, V68, P384, DOI 10.1136/jech-2013-202756; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; The Scottish Government, 2010, PREV OV OB SCOTL ROU; Thomson H., 2009, AM J PUBLIC HLTH S3, V99, pS681, DOI [DOI 10.2105/AJPH.2008.143909, 10.2105/AJPH.2008.143909]; Whitehead M, 1991, GEOL FORENINGAN STOC; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Whittam G, 2003, CAPITAL CLASS, V81, P61; Wightman A, LAND VALUE TAX SCOTL	59	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159256	10.1371/journal.pone.0159256	http://dx.doi.org/10.1371/journal.pone.0159256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486857	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800021
J	Petrie, MA; Kimball, AL; McHenry, CL; Suneja, M; Yen, CL; Sharma, A; Shields, RK				Petrie, Michael A.; Kimball, Amy L.; McHenry, Colleen L.; Suneja, Manish; Yen, Chu-Ling; Sharma, Arpit; Shields, Richard K.			Distinct Skeletal Muscle Gene Regulation from Active Contraction, Passive Vibration, and Whole Body Heat Stress in Humans	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SPINAL-CORD-INJURY; EXERCISE INTENSITY; INSULIN-RESISTANCE; LIPID-METABOLISM; INDIVIDUALS; PGC-1-ALPHA; INCREASES; BONE; HEAT-SHOCK-PROTEIN-72	Skeletal muscle exercise regulates several important metabolic genes in humans. We know little about the effects of environmental stress (heat) and mechanical stress (vibration) on skeletal muscle. Passive mechanical stress or systemic heat stress are often used in combination with many active exercise programs. We designed a method to deliver a vibration stress and systemic heat stress to compare the effects with active skeletal muscle contraction. Purpose: The purpose of this study is to examine whether active mechanical stress (muscle contraction), passive mechanical stress (vibration), or systemic whole body heat stress regulates key gene signatures associated with muscle metabolism, hypertrophy/atrophy, and inflammation/repair. Methods: Eleven subjects, six able-bodied and five with chronic spinal cord injury (SCI) participated in the study. The six able-bodied subjects sat in a heat stress chamber for 30 minutes. Five subjects with SCI received a single dose of limbsegment vibration or a dose of repetitive electrically induced muscle contractions. Three hours after the completion of each stress, we performed a muscle biopsy (vastus lateralis or soleus) to analyze mRNA gene expression. Results: We discovered repetitive active muscle contractions up regulated metabolic transcription factors NR4A3 (12.45 fold), PGC-1 alpha (5.46 fold), and ABRA (5.98 fold); and repressed MSTN (0.56 fold). Heat stress repressed PGC-1 alpha (0.74 fold change; p < 0.05); while vibration induced FOXK2 (2.36 fold change; p < 0.05). Vibration similarly caused a down regulation of MSTN (0.74 fold change; p < 0.05), but to a lesser extent than active muscle contraction. Vibration induced FOXK2 (p < 0.05) while heat stress repressed PGC-1 alpha (0.74 fold) and ANKRD1 genes (0.51 fold; p < 0.05). Conclusion: These findings support a distinct gene regulation in response to heat stress, vibration, and muscle contractions. Understanding these responses may assist in developing regenerative rehabilitation interventions to improve muscle cell development, growth, and repair.	[Petrie, Michael A.; Kimball, Amy L.; McHenry, Colleen L.; Yen, Chu-Ling; Shields, Richard K.] Univ Iowa, Dept Phys Therapy & Rehabil Sci, Carver Coll Med, Iowa City, IA 52242 USA; [Suneja, Manish] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Sharma, Arpit] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Suneja, Manish; Shields, Richard K.] VA Med Ctr, Dept Vet Affairs, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Shields, RK (corresponding author), Univ Iowa, Dept Phys Therapy & Rehabil Sci, Carver Coll Med, Iowa City, IA 52242 USA.; Shields, RK (corresponding author), VA Med Ctr, Dept Vet Affairs, Iowa City, IA 52246 USA.	richard-shields@uiowa.edu	Sharma, Arpit/AAE-2638-2022	Suneja, Manish/0000-0002-1613-8456; Petrie, Michael/0000-0002-5212-0907; SHARMA, ARPIT/0000-0002-6132-1129; Shields, Richard/0000-0002-5838-9317; Kimball, Amy/0000-0002-1389-0124	National Institute of Child Health and Human Development [R01HD062507, R01HD084645, R01HD082109]; Craig H. Neilsen Foundation; University of Iowa Carver College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084645, R01HD082109, R01HD062507] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Craig H. Neilsen Foundation; University of Iowa Carver College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Awarded to RKS - National Institute of Child Health and Human Development https://www.nichd.nih.gov, and Grant R01HD062507, R01HD084645, and R01HD082109 and the Craig H. Neilsen Foundation http://chnfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Tom Bair of the University of Iowa DNA Facility for his expertise with the microarray analysis. Data presented herein were obtained at the Genomics Division of the Iowa Institute of Human Genetics which is supported, in part, by the University of Iowa Carver College of Medicine.	Adams CM, 2011, MUSCLE NERVE, V43, P65, DOI 10.1002/mus.21831; BAUMAN WA, 1994, METABOLISM, V43, P749, DOI 10.1016/0026-0495(94)90126-0; Bauman WA, 1999, ASSIST TECHNOL, V11, P88, DOI 10.1080/10400435.1999.10131993; Bjornholm M, 2005, BIOCHEM SOC T, V33, P354; Buchholz AC, 2003, OBES RES, V11, P563, DOI 10.1038/oby.2003.79; Burstein R, 1996, INT J SPORTS MED, V17, P272, DOI 10.1055/s-2007-972846; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Ceccarelli G, 2014, J TISSUE ENG REGEN M, V8, P396, DOI 10.1002/term.1533; Chan MC, 2014, METABOLISM, V63, P441, DOI 10.1016/j.metabol.2014.01.006; Chang SH, 2012, CLIN NEUROPHYSIOL, V123, P558, DOI 10.1016/j.clinph.2011.08.001; Chang SH, 2011, J ELECTROMYOGR KINES, V21, P847, DOI 10.1016/j.jelekin.2011.06.001; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; DUCKWORTH WC, 1980, DIABETES, V29, P906, DOI 10.2337/diabetes.29.11.906; Dudley-Javoroski S, 2008, J REHABIL RES DEV, V45, P283, DOI 10.1682/JRRD.2007.02.0031; Dumke CL, 2015, WILD ENVIRON MED, V26, P335, DOI 10.1016/j.wem.2015.03.002; EDHOLM OG, 1956, J PHYSIOL-LONDON, V134, P612, DOI 10.1113/jphysiol.1956.sp005669; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; ERICSON MO, 1986, SCAND J REHABIL MED, V18, P159; Febbraio MA, 2002, J PHYSIOL-LONDON, V544, P957, DOI 10.1113/jphysiol.2002.025148; Fehrenbach E, 2005, INT J SPORTS MED, V26, P552, DOI 10.1055/s-2004-830334; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gorgey AS, 2012, MED SCI SPORT EXER, V44, P165, DOI 10.1249/MSS.0b013e31822672aa; Gorgey AS, 2011, METABOLISM, V60, P843, DOI 10.1016/j.metabol.2010.08.002; Hamrick MW, 2011, EXERC SPORT SCI REV, V39, P43, DOI 10.1097/JES.0b013e318201f601; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Iguchi M, 2012, J ATHL TRAINING, V47, P184; Irrcher I, 2004, J APPL PHYSIOL, V97, P2207, DOI 10.1152/japplphysiol.00388.2004; Item F, 2013, EUR J APPL PHYSIOL, V113, P1081, DOI 10.1007/s00421-012-2524-4; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Kojic S, 2011, CRIT REV CL LAB SCI, V48, P269, DOI 10.3109/10408363.2011.643857; Laukkanen T, 2015, JAMA INTERN MED, V175, P542, DOI 10.1001/jamainternmed.2014.8187; LaVela SL, 2006, J SPINAL CORD MED, V29, P387, DOI 10.1080/10790268.2006.11753887; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Liu XM, 2015, EURASIP J ADV SIG PR, P1, DOI 10.1186/s13634-015-0249-3; Luden N, 2008, AM J PHYSIOL-REG I, V295, pR1593, DOI 10.1152/ajpregu.90564.2008; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luzi L., 2012, CELLULAR PHYSL METAB, P1, DOI 10.1007/978-88-470-2418-2_1; McCully KK, 2011, J APPL PHYSIOL, V111, P143, DOI 10.1152/japplphysiol.00094.2011; McHenry Colleen L, 2014, BMC Res Notes, V7, P334, DOI 10.1186/1756-0500-7-334; Mohamed JS, 2012, FASEB J, V26, P757, DOI 10.1096/fj.10-160291; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Petrie M, 2014, JOURNAL OF APPLIED P, V2015, DOI [10.1152/japplphysiol, DOI 10.1152/JAPPLPHYSIOL.]; Petrie MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115791; Petrie MA, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.248; Pietrangelo T, 2009, INT J MOL MED, V24, P503, DOI 10.3892/ijmm_00000259; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Seebacher F, 2009, J EXP BIOL, V212, P2885, DOI 10.1242/jeb.024430; SHIELDS RK, 1995, J NEUROPHYSIOL, V73, P2195, DOI 10.1152/jn.1995.73.6.2195; SMOLANDER J, 1985, EUR J APPL PHYSIOL O, V54, P371, DOI 10.1007/BF02337180; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Sun ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P4765, DOI 10.2741/3038; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Wallace MA, 2011, J PHYSIOL-LONDON, V589, P2027, DOI 10.1113/jphysiol.2011.205468; Walsh RC, 2001, CELL STRESS CHAPERON, V6, P386, DOI 10.1379/1466-1268(2001)006<0386:EISHIH>2.0.CO;2; Wang WQ, 2015, DEV CELL, V32, P707, DOI 10.1016/j.devcel.2015.01.031; WILMET E, 1995, PARAPLEGIA, V33, P674, DOI 10.1038/sc.1995.141; Xie LQ, 2008, J APPL PHYSIOL, V104, P1056, DOI 10.1152/japplphysiol.00764.2007; Yamada P, 2008, SPORTS MED, V38, P715, DOI 10.2165/00007256-200838090-00002; Zhorne R, 2016, NEURAL REGEN RES, V11, P69, DOI 10.4103/1673-5374.169623	60	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160594	10.1371/journal.pone.0160594	http://dx.doi.org/10.1371/journal.pone.0160594			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486743	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800089
J	Tong, YB; Udupa, JK; Sin, SH; Liu, ZB; Wileyto, EP; Torigian, DA; Arens, R				Tong, Yubing; Udupa, Jayaram K.; Sin, Sanghun; Liu, Zhengbing; Wileyto, E. Paul; Torigian, Drew A.; Arens, Raanan			MR Image Analytics to Characterize the Upper Airway Structure in Obese Children with Obstructive Sleep Apnea Syndrome	PLOS ONE			English	Article							VOLUME; ADENOTONSILLECTOMY; PREDICTORS; ENDOSCOPY; CHILDHOOD; SEVERITY; ADULTS	Purpose Quantitative image analysis in previous research in obstructive sleep apnea syndrome (OSAS) has focused on the upper airway or several objects in its immediate vicinity and measures of object size. In this paper, we take a more general approach of considering all major objects in the upper airway region and measures pertaining to their individual morphological properties, their tissue characteristics revealed by image intensities, and the 3D architecture of the object assembly. We propose a novel methodology to select a small set of salient features from this large collection of measures and demonstrate the ability of these features to discriminate with very high prediction accuracy between obese OSAS and obese non-OSAS groups. Materials and Methods Thirty children were involved in this study with 15 in the obese OSAS group with an apneahypopnea index (AHI) = 14.4 +/- 10.7) and 15 in the obese non-OSAS group with an AHI = 1.0 +/- 1.0 (p<0.001). Subjects were between 8-17 years and underwent T1- and T2-weighted magnetic resonance imaging (MRI) of the upper airway during wakefulness. Fourteen objects in the vicinity of the upper airways were segmented in these images and a total of 159 measurements were derived from each subject image which included object size, surface area, volume, sphericity, standardized T2-weighted image intensity value, and inter-object distances. A small set of discriminating features was identified from this set in several steps. First, a subset of measures that have a low level of correlation among the measures was determined. A heat map visualization technique that allows grouping of parameters based on correlations among them was used for this purpose. Then, through T-tests, another subset of measures which are capable of separating the two groups was identified. The intersection of these subsets yielded the final feature set. The accuracy of these features to perform classification of unseen images into the two patient groups was tested by using logistic regression and multi-fold cross validation. Results A set of 16 features identified with low inter-feature correlation (< 0.36) yielded a high classification accuracy of 96% with sensitivity and specificity of 97.8% and 94.4%, respectively. In addition to the previously observed increase in linear size, surface area, and volume of adenoid, tonsils, and fat pad in OSAS, the following new markers have been found. Standardized T2-weighted image intensities differed between the two groups for the entire neck body region, pharynx, and nasopharynx, possibly indicating changes in object tissue characteristics. Fat pad and oropharynx become less round or more complex in shape in OSAS. Fat pad and tongue move closer in OSAS, and so also oropharynx and tonsils and fat pad and tonsils. In contrast, fat pad and oropharynx move farther apart from the skin object. Conclusions The study has found several new anatomic bio-markers of OSAS. Changes in standardized T2-weighted image intensities in objects may imply that intrinsic tissue composition undergoes changes in OSAS. The results on inter-object distances imply that treatment methods should respect the relationships that exist among objects and not just their size. The proposed method of analysis may lead to an improved understanding of the mechanisms underlying OSAS.	[Tong, Yubing; Udupa, Jayaram K.; Liu, Zhengbing; Torigian, Drew A.] Univ Penn, Dept Radiol, Med Image Proc Grp, Philadelphia, PA 19104 USA; [Sin, Sanghun; Arens, Raanan] Childrens Hosp Montefiore, Div Resp & Sleep Med, Bronx, NY USA; [Wileyto, E. Paul] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; University of Pennsylvania	Udupa, JK (corresponding author), Univ Penn, Dept Radiol, Med Image Proc Grp, Philadelphia, PA 19104 USA.	jay@mail.med.upenn.edu			DHHS [HL105212]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105212] Funding Source: NIH RePORTER	DHHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research reported here is supported by a DHHS grant (HL105212).; The research reported here is partly supported by a DHHS grant HL105212.	Abramson Z, 2011, J ORAL MAXIL SURG, V69, P677, DOI 10.1016/j.joms.2010.11.037; Abramson Z, 2010, J ORAL MAXIL SURG, V68, P354, DOI 10.1016/j.joms.2009.09.087; Arens R, 2003, AM J RESP CRIT CARE, V167, P65, DOI 10.1164/rccm.200206-613OC; Arens R, 2002, AM J RESP CRIT CARE, V165, P117, DOI 10.1164/ajrccm.165.1.2107140; Arens R, 2001, AM J RESP CRIT CARE, V164, P698, DOI 10.1164/ajrccm.164.4.2101127; Arens R, 2011, AM J RESP CRIT CARE, V183, P782, DOI 10.1164/rccm.201008-1249OC; Armstrong JJ, 2006, AM J RESP CRIT CARE, V173, P226, DOI 10.1164/rccm.200507-1148OC; Borek RC, 2012, LARYNGOSCOPE, V122, P2592, DOI 10.1002/lary.23553; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Falcao AX, 2000, IEEE T MED IMAGING, V19, P55, DOI 10.1109/42.832960; Furuhashi A, 2013, J ORAL REHABIL, V40, P582, DOI 10.1111/joor.12059; Ge YL, 2000, J MAGN RESON IMAGING, V12, P715, DOI 10.1002/1522-2586(200011)12:5<715::AID-JMRI8>3.3.CO;2-4; Grevera G, 2007, J DIGIT IMAGING, V20, P101, DOI 10.1007/s10278-007-9060-5; Hong JS, 2011, AM J ORTHOD DENTOFAC, V140, pE161, DOI 10.1016/j.ajodo.2011.04.020; Hsu PP, 2012, CLIN OTOLARYNGOL, V37, P188, DOI 10.1111/j.1749-4486.2012.02491.x; Hsu PP, 2004, LARYNGOSCOPE, V114, P791, DOI 10.1097/00005537-200405000-00001; Hsu PP, 2002, ANN ACAD MED SINGAP, V31, P393; Iida-Kondo Chisato, 2006, Journal of Medical and Dental Sciences, V53, P119; Kolhi P, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130403; Li YR, 2012, RESP CARE, V57, P1098, DOI 10.4187/respcare.00929; Mitchell RB, 2015, JAMA OTOLARYNGOL, V141, P130, DOI 10.1001/jamaoto.2014.3049; Modrykamien AM, 2009, RESP CARE, V54, P474; Muzumdar H, 2013, RESP PHYSIOL NEUROBI, V188, P370, DOI 10.1016/j.resp.2013.05.006; Nandalike K, 2013, SLEEP, V36, P841, DOI 10.5665/sleep.2708; National Center for Health Statistics, 2012, HLTH US 2011 SPEC FE; Nouraei SAR, 2006, LARYNGOSCOPE, V116, P12, DOI 10.1097/01.mlg.0000186657.62474.88; Nystrom I, 2011, COMPUT MED IMAG GRAP, V35, P460, DOI 10.1016/j.compmedimag.2010.11.001; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pereira Suelen Cristina da Costa, 2014, Dental Press J. Orthod., V19, P89, DOI 10.1590/2176-9451.19.4.089-093.oar; Sonka M, 2015, IMAGE PROCESSING ANA, P74; Strauss T, 2012, CHEST, V142, P94, DOI 10.1378/chest.11-2013; Supriyatno Bambang, 2010, Acta Med Indones, V42, P152; Tong YB, 2015, C P SPIE, V9417, DOI 10.1007/s10278-007-9060-5; Ward SLD, 2014, IEEE PULSE, V5, P33, DOI 10.1109/MPUL.2014.2339293; Weinstock TG, 2014, SLEEP, V37, P261, DOI 10.5665/sleep.3394; Wijesundara K, 2014, BIOMED OPT EXPRESS, V5, P788, DOI 10.1364/BOE.5.000788; Xu C, 2006, J BIOMECH, V39, P2043, DOI 10.1016/j.jbiomech.2005.06.021	38	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159327	10.1371/journal.pone.0159327	http://dx.doi.org/10.1371/journal.pone.0159327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487240	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800027
J	Wittevrongel, B; Van Hulle, MM				Wittevrongel, Benjamin; Van Hulle, Marc M.			Frequency- and Phase Encoded SSVEP Using Spatiotemporal Beamforming	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; BRAIN-COMPUTER INTERFACES; COMMUNICATION	In brain-computer interfaces (BCIs) based on steady-state visual evoked potentials (SSVEPs) the number of selectable targets is rather limited when each target has its own stimulation frequency. One way to remedy this is by combining frequency- with phase encoding. We introduce a new multivariate spatiotemporal filter, based on Linearly Constrained Minimum Variance (LCMV) beamforming, for discriminating between frequency-phase encoded targets more accurately, even when using short signal lengths than with (extended) Canonical Correlation Analysis (CCA), which is traditionally posited for this stimulation paradigm.	[Wittevrongel, Benjamin; Van Hulle, Marc M.] Katholieke Univ Leuven, Lab Neuro & Psychophysiol, Leuven, Belgium	KU Leuven	Wittevrongel, B (corresponding author), Katholieke Univ Leuven, Lab Neuro & Psychophysiol, Leuven, Belgium.	benjamin.wittevrongel@kuleuven.be	Wittevrongel, Benjamin/AAE-2517-2021	Wittevrongel, Benjamin/0000-0002-4662-5749; Van Hulle, Marc/0000-0003-1060-7044	Agency for Innovation by Science and Technology in Flanders (IWT); program Financing program of the KU Leuven [PFV/10/008]; Belgian Fund for Scientific Research - Flanders [G088314N, G0A0914N]; Inter-university Attraction Poles Programme - Belgian Science Policy [IUAP P7/11]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Hercules Foundation [AKUL 043]	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); program Financing program of the KU Leuven; Belgian Fund for Scientific Research - Flanders(FWO); Inter-university Attraction Poles Programme - Belgian Science Policy(Belgian Federal Science Policy Office); Flemish Regional Ministry of Education (Belgium)(FWO); Hercules Foundation	BW is supported by the Agency for Innovation by Science and Technology in Flanders (IWT). MMVH is supported by research grants received from the program Financing program (PFV/10/008) of the KU Leuven, the Belgian Fund for Scientific Research - Flanders (G088314N, G0A0914N), the Inter-university Attraction Poles Programme - Belgian Science Policy (IUAP P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), and the Hercules Foundation (AKUL 043).	Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Bridge H, 2011, EYE, V25, P291, DOI 10.1038/eye.2010.166; Brunner C, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025010; Chen XG, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046008; Chen XG, 2014, IEEE ENG MED BIO, P3993, DOI 10.1109/EMBC.2014.6944499; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; Combaz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073691; COWEY A, 1974, EXP BRAIN RES, V21, P447; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Di Russo F, 1999, VISION RES, V39, P2975, DOI 10.1016/S0042-6989(99)00031-0; Di Russo F., 2002, COGNITIVE ELECTROPHY, P259; Di Russo F, 2007, HUM BRAIN MAPP, V28, P323, DOI 10.1002/hbm.20276; Falzon O, 2012, IEEE T BIO-MED ENG, V59, P2486, DOI 10.1109/TBME.2012.2205246; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Fuchs S, 2008, NEUROIMAGE, V41, P1086, DOI 10.1016/j.neuroimage.2008.02.040; Grosse-Wentrup M, 2009, IEEE T BIO-MED ENG, V56, P1209, DOI 10.1109/TBME.2008.2009768; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Levin N, 2015, NEUROVISION NEURAL B, P90; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Liu Q., 2013, J MED BIOL ENG; Lopez-Gordo MA, 2010, NEURAL PROCESS LETT, V32, P1, DOI 10.1007/s11063-010-9139-8; Luo A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026010; Manyakov NV, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036011; Manyakov NV, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S0129065712500220; Manyakov NV, 2011, LECT NOTES COMPUT SC, V6936, P135, DOI 10.1007/978-3-642-23878-9_17; Manyakov NV, 2010, ICFC 2010/ ICNC 2010: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON FUZZY COMPUTATION AND INTERNATIONAL CONFERENCE ON NEURAL COMPUTATION, P376; Nakanishi M, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500191; Pintelon R, 2014, IDENTIFICATION OF LI; Pruzek Robert M, 1994, P 1 US JAP C FRONT S, P233; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Regan D., 1989, HUMAN BRAIN ELECTROP; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Tobimatsu S, 1996, EVOKED POTENTIAL, V100, P171, DOI 10.1016/0168-5597(95)00279-0; Van Veen B. D., 1988, IEEE ASSP Magazine, V5, P4, DOI 10.1109/53.665; van Vliet M, 2015, BIOMED ENG, P1; Vanegas MI, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036003; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wittevrongel B, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065716500143; Wu CH, 2011, J NEUROSCI METH, V196, P170, DOI 10.1016/j.jneumeth.2010.12.014; Wu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093884; Xie J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039707; Yin EW, 2015, IEEE T BIO-MED ENG, V62, P1447, DOI 10.1109/TBME.2014.2320948; Zhang Y, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500130; Zhao JB, 2012, CHINESE SCI BULL, V57, P1680, DOI 10.1007/s11434-012-5078-2; Zhu DH, 2011, LECT NOTES COMPUT SC, V6766, P645, DOI 10.1007/978-3-642-21663-3_70	50	37	37	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159988	10.1371/journal.pone.0159988	http://dx.doi.org/10.1371/journal.pone.0159988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486801	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800050
J	Huang, SF; Chen, K; Wu, JJ; Liu, FT; Zhao, J; Lin, W; Guo, SS; Wang, YX; Wang, Y; Luo, SS; Sun, YM; Ding, ZT; Yu, H; Wang, J				Huang, Si-Fei; Chen, Kui; Wu, Jian-Jun; Liu, Feng-Tao; Zhao, Jue; Lin, Wei; Guo, Si-Si; Wang, Yi-Xuan; Wang, Ying; Luo, Su-Shan; Sun, Yi-Min; Ding, Zheng-Tong; Yu, Huan; Wang, Jian			Odor Identification Test in Idiopathic REM-Behavior Disorder and Parkinson's Disease in China	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; OLFACTORY DYSFUNCTION; SMELL IDENTIFICATION; ALZHEIMERS-DISEASE; LEWY BODIES; SLEEP; DEMENTIA; DIAGNOSIS; JAPANESE; NEURODEGENERATION	Background Olfactory dysfunction is common in Parkinson's disease (PD) and idiopathic rapid eye movement sleep behavior disorder (iRBD), which is a risk factor in the development of PD. However, a few studies have conflicting results when comparing dysosmia in the patients with iRBD and PD. There is no study investigating the olfactory function in Chinese patients with iRBD. Additionally, the Sniffin' Sticks screening 12 test (SS-12) contains several odors that are not familiar to people in different cultures. Methods Odor identification was evaluated in iRBD patients (n = 54), PD patients (n = 54) and healthy controls (n = 54). With the identification data, a brief odor identification test was established and then validated in other subjects. Results Odor identification scores in iRBD patients were significantly higher than those in PD patients (P< 0.001) but lower than those in controls (P< 0.001). At the cut-off value of 7.5, the Sniffin' Sticks clearly differentiated iRBD and PD patients from the controls, and the brief test could increase the specificity in diagnosing PD. Neither the Sniffin' Sticks nor the brief test could clearly differentiate PD and iRBD patients from each other. Conclusions Olfaction is more impaired in PD patients than in iRBD patients, possibly due to the heterogeneity of iRBD patients. The Sniffin' Sticks could be a useful tool for differentiating iRBD patients from the healthy population, and it could be useful for screening people at high-risk of PD in China, especially when combined with polysomnography. To reduce the expense and time required for the Sniffin' Sticks test, this study shows that a brief test is feasible.	[Huang, Si-Fei; Chen, Kui; Wu, Jian-Jun; Liu, Feng-Tao; Zhao, Jue; Lin, Wei; Guo, Si-Si; Wang, Yi-Xuan; Wang, Ying; Luo, Su-Shan; Sun, Yi-Min; Ding, Zheng-Tong; Yu, Huan; Wang, Jian] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China; [Huang, Si-Fei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Neurosci Inst, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Yu, Huan] Fudan Univ, Sleep & Wake Disorders Ctr, Shanghai, Peoples R China	Fudan University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Fudan University	Yu, H; Wang, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai, Peoples R China.; Yu, H (corresponding author), Fudan Univ, Sleep & Wake Disorders Ctr, Shanghai, Peoples R China.	dr.yuhuan@163.com; wangjian336@hotmail.com	yu, huan/T-5615-2017; wang, yixuan/GXW-2866-2022; Luo, Sushan/GNM-9927-2022; Wu, Jian/AAU-5221-2020; Luo, Sushan/AAF-7736-2019; Wang, Yixuan/GZK-6559-2022; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Luo, Sushan/0000-0002-9033-7568; Wu, Jian/0000-0002-3394-1507	National Foundation of Natural Science of China [81371413, 81301136, 81571232, 81401048]; Science and Technology Commission of Shanghai Municipality [13JC1401103, 15ZR1435800, JA2015Z002]; Shanghai Municipal Commission of Health [XBR2013088, 20134042]	National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Commission of Health	This work was supported by grants from the National Foundation of Natural Science of China [No. 81371413 (JW), No. 81301136 (HY), No. 81571232 (JW) and No. 81401048 (YMS)](http://www.nsfc.gov.cn/), projects from the Science and Technology Commission of Shanghai Municipality [13JC1401103 (JW), 15ZR1435800 (JJW), JA2015Z002 (JJW)](http://www.stcsm.gov.cn/), and projects of the Shanghai Municipal Commission of Health [XBR2013088 (JW), 20134042 (HY)](http://www.wsjsw.gov.cn/wsj/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsov E, 2014, PARKINSONISM RELAT D, V20, P830, DOI 10.1016/j.parkreldis.2014.04.012; Berg D, 2015, MOVEMENT DISORD, V30, P1600, DOI 10.1002/mds.26431; Chaudhuri KR, 2008, J NEUROL, V255, P33, DOI 10.1007/s00415-008-5006-1; Chen W, 2012, J NEUROL SCI, V316, P47, DOI 10.1016/j.jns.2012.01.033; Comella CL, 1998, NEUROLOGY, V51, P526, DOI 10.1212/WNL.51.2.526; De Cock VC, 2007, BRAIN, V130, P450, DOI 10.1093/brain/awl363; Diederich NJ, 2005, SLEEP MED, V6, P313, DOI 10.1016/j.sleep.2005.03.011; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Fantini ML, 2006, BRAIN RES BULL, V70, P386, DOI 10.1016/j.brainresbull.2006.07.008; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; Glass Philip G, 2012, Mov Disord, V27, P327, DOI 10.1002/mds.23972; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goldstein DS, 2008, PARKINSONISM RELAT D, V14, P600, DOI 10.1016/j.parkreldis.2008.01.010; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Hubbard PS, 2007, J ANAT, V211, P117, DOI 10.1111/j.1469-7580.2007.00748.x; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Hummel T, 2010, J NEUROL, V257, P1316, DOI 10.1007/s00415-010-5516-5; Iijima M, 2008, INTERNAL MED, V47, P1887, DOI 10.2169/internalmedicine.47.1345; Iranzo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089741; Iranzo A, 2009, SLEEP MED REV, V13, P385, DOI 10.1016/j.smrv.2008.11.003; Iwanami M, 2010, SLEEP MED, V11, P361, DOI 10.1016/j.sleep.2009.12.006; Jellinger KA, 2015, J NEURAL TRANSM, V122, P1429, DOI 10.1007/s00702-015-1405-5; Jennings DL, 2004, ARCH NEUROL-CHICAGO, V61, P1224, DOI 10.1001/archneur.61.8.1224; Joo YH, 2015, AM J RHINOL ALLERGY, V29, P268, DOI 10.2500/ajra.2015.29.4194; Kikuchi A, 2011, PARKINSONISM RELAT D, V17, P698, DOI 10.1016/j.parkreldis.2011.07.011; Medicine AAoS, 2005, INT CLASSIFICATION S; Miyamoto T, 2010, MOVEMENT DISORD, V25, P1524, DOI 10.1002/mds.23170; Miyamoto T, 2010, SLEEP MED, V11, P458, DOI 10.1016/j.sleep.2009.09.013; Miyamoto T, 2009, MOVEMENT DISORD, V24, P268, DOI 10.1002/mds.22361; Mueller C, 2006, AM J RHINOL, V20, P113, DOI 10.1177/194589240602000121; Postuma RB, 2009, BRAIN, V132, P3298, DOI 10.1093/brain/awp244; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Postuma RB, 2006, NEUROLOGY, V66, P845, DOI 10.1212/01.wnl.0000203648.80727.5b; Postuma Ronald B, 2012, Mov Disord, V27, P913, DOI 10.1002/mds.25037; Postuma RB, 2011, ANN NEUROL, V69, P811, DOI 10.1002/ana.22282; Sato T, 2011, J AM GERIATR SOC, V59, P947, DOI 10.1111/j.1532-5415.2011.03380.x; Schenck CH, 2013, SLEEP MED, V14, P744, DOI 10.1016/j.sleep.2012.10.009; SCHENCK CH, 1987, JAMA-J AM MED ASSOC, V257, P1786, DOI 10.1001/jama.257.13.1786; Shin HY, 2013, NEUROL SCI, V34, P935, DOI 10.1007/s10072-012-1164-0; Stiasny-Kolster K, 2005, BRAIN, V128, P126, DOI 10.1093/brain/awh322; Suzuki M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-157; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tolosa E, 2009, NEUROLOGY, V72, pS12, DOI 10.1212/WNL.0b013e318198db11; Williams SS, 2009, J NEUROL NEUROSUR PS, V80, P667, DOI 10.1136/jnnp.2008.155895; Wood Heather, 2014, Nat Rev Neurol, V10, P305, DOI 10.1038/nrneurol.2014.81; ZHANG MY, 1990, ANN NEUROL, V27, P428, DOI 10.1002/ana.410270412; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1	49	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160199	10.1371/journal.pone.0160199	http://dx.doi.org/10.1371/journal.pone.0160199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483429	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700028
J	Sun, Y; Jiang, YR; Wang, Y; Li, XS; Yang, RS; Yu, ZG; Qin, L				Sun, Ying; Jiang, Yiren; Wang, Yong; Li, Xisheng; Yang, Ruisheng; Yu, Zhiguo; Qin, Li			The Toll Signaling Pathway in the Chinese Oak Silkworm, Antheraea pernyi: Innate Immune Responses to Different Microorganisms	PLOS ONE			English	Article							PROTEOLYTIC ACTIVATION; RECOGNITION PROTEINS; PATHOGEN RECOGNITION; DROSOPHILA SPATZLE; EXPRESSION; GENE; PATTERN; CLONING; IDENTIFICATION; SILKMOTH	The Toll pathway is one of the most important signaling pathways regulating insect innate immunity. Spatzle is a key protein that functions as a Toll receptor ligand to trigger Toll-dependent expression of immunity-related genes. In this study, a novel spatzle gene (ApSPZ) from the Chinese oak silkworm Antheraea pernyi was identified. The ApSPZ cDNA is 1065 nucleotides with an open reading frame (ORF) of 777 bp encoding a protein of 258 amino acids. The protein has an estimated molecular weight of 29.71 kDa and an isoelectric point (PI) of 8.53. ApSPZ is a nuclear and secretory protein with no conserved domains or membrane helices and shares 40% amino acid identity with SPZ from Manduca sexta. Phylogenetic analysis indicated that ApSPZ might be a new member of the Spatzle type 1 family, which belongs to the Spatzle superfamily. The expression patterns of several genes involved in the Toll pathway were examined at different developmental stages and various tissues in 5th instar larvae. The examined targets included A. pernyi spatzle, GNBP, MyD88, Tolloid, cactus and dorsalA. The RT-PCR results showed that these genes were predominantly expressed in immune-responsive fat body tissue, indicating that the genes play a crucial role in A. pernyi innate immunity. Moreover, A. pernyi infection with the fungus Nosema pernyi and the gram-positive bacterium Enterococcus pernyi, but not the gram-negative bacterium Escherichia coli, activated the Toll signaling pathway. These results represent the first study of the Toll pathway in A. pernyi, which provides insight into the A. pernyi innate immune system.	[Sun, Ying; Li, Xisheng; Yu, Zhiguo; Qin, Li] Shenyang Agr Univ, Coll Plant Protect, Shenyang 110866, Peoples R China; [Sun, Ying; Jiang, Yiren; Wang, Yong; Yang, Ruisheng; Qin, Li] Shenyang Agr Univ, Coll Biosci & Biotechnol, Liaoning Engn & Technol Res Ctr Insect Resources, Shenyang 110866, Peoples R China; [Li, Xisheng] Sericultural Res Inst Liaoning Prov, Fengcheng 118100, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University	Yu, ZG; Qin, L (corresponding author), Shenyang Agr Univ, Coll Plant Protect, Shenyang 110866, Peoples R China.; Qin, L (corresponding author), Shenyang Agr Univ, Coll Biosci & Biotechnol, Liaoning Engn & Technol Res Ctr Insect Resources, Shenyang 110866, Peoples R China.	yu_zhiguo2012@163.com; qinli1963@163.com	Wang, Yong/Q-9584-2016	Wang, Yong/0000-0003-1010-6450	National Modern Agriculture Industry Technology System Construction Project (Silkworm); Magnitude Science and Technology Projects of Liaoning Province; Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province [2014040]; Scientific Research Project for the Education Department of Liaoning Province [L2014255]; Scientific Research Project for Education Department of Liaoning Province [L2015488]; National Modern Agriculture Industry Technology System Construction Project (Mulberry)	National Modern Agriculture Industry Technology System Construction Project (Silkworm); Magnitude Science and Technology Projects of Liaoning Province; Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province; Scientific Research Project for the Education Department of Liaoning Province; Scientific Research Project for Education Department of Liaoning Province; National Modern Agriculture Industry Technology System Construction Project (Mulberry)	This work was partially supported by the National Modern Agriculture Industry Technology System Construction Project (Silkworm and Mulberry) and the Magnitude Science and Technology Projects of Liaoning Province to LQ; the Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province (2014040) and the Scientific Research Project for the Education Department of Liaoning Province (L2014255) to YJ; and the Scientific Research Project for Education Department of Liaoning Province (L2015488) to YW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; Anderson KV, 2000, CURR OPIN IMMUNOL, V12, P13, DOI 10.1016/S0952-7915(99)00045-X; DeLotto Y, 2001, MOL GEN GENET, V264, P643, DOI 10.1007/s004380000350; Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Hirai M, 2004, INSECT MOL BIOL, V13, P399, DOI 10.1111/j.0962-1075.2004.00497.x; Hoffmann A, 2008, J BIOL CHEM, V283, P32598, DOI 10.1074/jbc.M801815200; Hu XD, 2004, P NATL ACAD SCI USA, V101, P9369, DOI 10.1073/pnas.0307062101; Hua SJ, 2001, BIOINFORMATICS, V17, P721, DOI 10.1093/bioinformatics/17.8.721; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kurata S, 2014, DEV COMP IMMUNOL, V42, P36, DOI 10.1016/j.dci.2013.06.006; Li Fengjuan, 2012, Insects, V3, P1093, DOI 10.3390/insects3041093; Li WL, 2005, DEV COMP IMMUNOL, V29, P853, DOI 10.1016/j.dci.2005.02.003; Li WL, 2014, SCI SERICULTURE, V40, P32; Li YP, 2009, INT J BIOL SCI, V5, P451; Liu QN, 2015, ARCH INSECT BIOCHEM, V88, P155, DOI 10.1002/arch.21210; Liu QN, 2013, J INVERTEBR PATHOL, V114, P313, DOI 10.1016/j.jip.2013.09.004; Liu QN, 2013, J INSECT PHYSIOL, V59, P848, DOI 10.1016/j.jinsphys.2013.06.001; Liu W, 2015, MOL IMMUNOL, V65, P391, DOI 10.1016/j.molimm.2015.02.018; Liu YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131751; Liu YQ, 2010, J INSECT SCI, V10, P1, DOI 10.1673/031.010.14140; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WX, 2015, ARCH INSECT BIOCHEM, V88, P45, DOI 10.1002/arch.21219; Ma YL, 2013, BMB REP, V46, P264, DOI 10.5483/BMBRep.2013.46.5.222; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pagni M, 2007, NUCLEIC ACIDS RES, V35, pW433, DOI 10.1093/nar/gkm352; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; [秦利 QIN Li], 2006, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V37, P677; QU XM, 1987, J BIOCHEM-TOKYO, V101, P545, DOI 10.1093/jb/101.3.545; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stelter M, 2013, BIOL CHEM, V394, P1091, DOI 10.1515/hsz-2013-0136; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang J, 2015, INT J BIOL MACROMOL, V79, P316, DOI 10.1016/j.ijbiomac.2015.04.052; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wang XL, 2013, BMB REP, V46, P358, DOI 10.5483/BMBRep.2013.46.7.009; Wang Y, 2007, DEV COMP IMMUNOL, V31, P1002, DOI 10.1016/j.dci.2007.01.001; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Wu S, 2010, AFR J AGR RES, V5, P1095; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhang CF, 2015, GENE, V562, P32, DOI 10.1016/j.gene.2014.12.035; Zhang CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121296; Zhu JL, 2016, J FOOD SCI, V81, pE396, DOI 10.1111/1750-3841.13184	46	18	21	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160200	10.1371/journal.pone.0160200	http://dx.doi.org/10.1371/journal.pone.0160200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483463	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700029
J	Torre, S; Tattini, M; Brunetti, C; Guidi, L; Gori, A; Marzano, C; Landi, M; Sebastiani, F				Torre, Sara; Tattini, Massimiliano; Brunetti, Cecilia; Guidi, Lucia; Gori, Antonella; Marzano, Cristina; Landi, Marco; Sebastiani, Federico			De Novo Assembly and Comparative Transcriptome Analyses of Red and Green Morphs of Sweet Basil Grown in Full Sunlight	PLOS ONE			English	Article							RNA-SEQ DATA; FLAVONOID BIOSYNTHESIS; WAX BIOSYNTHESIS; PLANT; ANTHOCYANINS; GENE; ANNOTATION; LEAVES; STRESS; TOOL	Sweet basil (Ocimum basilicum), one of the most popular cultivated herbs worldwide, displays a number of varieties differing in several characteristics, such as the color of the leaves. The development of a reference transcriptome for sweet basil, and the analysis of differentially expressed genes in acyanic and cyanic cultivars exposed to natural sunlight irradiance, has interest from horticultural and biological point of views. There is still great uncertainty about the significance of anthocyanins in photoprotection, and how green and red morphs may perform when exposed to photo-inhibitory light, a condition plants face on daily and seasonal basis. We sequenced the leaf transcriptome of the green-leaved Tigullio (TIG) and the purple-leaved Red Rubin (RR) exposed to full sunlight over a four-week experimental period. We assembled and annotated 111,007 transcripts. A total of 5,468 and 5,969 potential SSRs were identified in TIG and RR, respectively, out of which 66 were polymorphic in silico. Comparative analysis of the two transcriptomes showed 2,372 differentially expressed genes (DEGs) clustered in 222 enriched Gene ontology terms. Green and red basil mostly differed for transcripts abundance of genes involved in secondary metabolism. While the biosynthesis of waxes was up-regulated in red basil, the biosynthesis of flavonols and carotenoids was up-regulated in green basil. Data from our study provides a comprehensive transcriptome survey, gene sequence resources and microsatellites that can be used for further investigations in sweet basil. The analysis of DEGs and their functional classification also offers new insights on the functional role of anthocyanins in photoprotection.	[Torre, Sara; Tattini, Massimiliano; Sebastiani, Federico] Natl Res Council Italy, Dept Biol Agr & Food Sci, Inst Sustainable Plant Protect, Sesto Fiorentino, Italy; [Brunetti, Cecilia] Natl Res Council Italy, Dept Biol Agr & Food Sci, Trees & Timber Inst, Sesto Fiorentino, Italy; [Brunetti, Cecilia; Gori, Antonella; Marzano, Cristina] Univ Florence, Dept Agrifood Prod & Environm Sci, Sesto Fiorentino, Italy; [Guidi, Lucia; Landi, Marco] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per la Valorizzazione del Legno e delle Specie Arboree (IVALSA-CNR); University of Florence; University of Pisa	Sebastiani, F (corresponding author), Natl Res Council Italy, Dept Biol Agr & Food Sci, Inst Sustainable Plant Protect, Sesto Fiorentino, Italy.	federico.sebastiani@ipsp.cnr.it	Cecilia, Brunetti/Q-4724-2018; Tattini, Massimiliano/K-1238-2019; GORI, ANTONELLA/Q-5222-2018; Brunetti, Cecilia/D-3439-2016	Tattini, Massimiliano/0000-0001-5434-8860; Landi, Marco/0000-0003-0121-0715; TORRE, SARA/0000-0002-3496-4057; GUIDI, LUCIA/0000-0002-2472-720X; GORI, ANTONELLA/0000-0002-7304-7526; SEBASTIANI, FEDERICO/0000-0003-4676-7381; Brunetti, Cecilia/0000-0002-8531-6076				Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Agati G, 2009, ANN BOT-LONDON, V104, P853, DOI 10.1093/aob/mcp177; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S, 2011, FASTQC QUALITY CONTR; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Archetti M, 2009, TRENDS ECOL EVOL, V24, P166, DOI 10.1016/j.tree.2008.10.006; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chang WC, 2013, CURR OPIN CHEM BIOL, V17, P571, DOI 10.1016/j.cbpa.2013.06.020; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Clifford M, 2006, DIETARY FLAVONOIDS H, P319; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Bruijn N.G., 1946, KONINKLIJKE NEDERLAN, V49, P758; Esteban R, 2015, ENVIRON EXP BOT, V119, P63, DOI 10.1016/j.envexpbot.2015.04.009; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gang DR, 2001, PLANT PHYSIOL, V125, P539, DOI 10.1104/pp.125.2.539; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Gould KS, 2002, PLANT CELL ENVIRON, V25, P1261, DOI 10.1046/j.1365-3040.2002.00905.x; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guzman F, 2014, PLANT SCI, V229, P238, DOI 10.1016/j.plantsci.2014.10.003; HARBORNE JB, 1965, CHEM BIOCH PLANT PIG, P247; Hatier JHB, 2008, J THEOR BIOL, V253, P625, DOI 10.1016/j.jtbi.2008.04.018; Havaux M, 2014, ADV PHOTOSYNTH RESP, V40, P583, DOI 10.1007/978-94-017-9032-1_26; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holmes MG, 2002, PLANT CELL ENVIRON, V25, P85, DOI 10.1046/j.1365-3040.2002.00779.x; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Hughes NM, 2007, AM J BOT, V94, P784, DOI 10.3732/ajb.94.5.784; Hughes NM, 2013, J PLANT PHYSIOL, V170, P230, DOI 10.1016/j.jplph.2012.09.006; Hughes NM, 2011, NEW PHYTOL, V190, P573, DOI 10.1111/j.1469-8137.2011.03662.x; JENKS MA, 1995, PLANT PHYSIOL, V108, P369, DOI 10.1104/pp.108.1.369; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kumar V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1724-9; Landi M, 2015, ENVIRON EXP BOT, V119, P4, DOI 10.1016/j.envexpbot.2015.05.012; Landi M, 2013, ENVIRON EXP BOT, V85, P64, DOI 10.1016/j.envexpbot.2012.08.008; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan BA, 2015, PHOTOSYNTH RES, V124, P267, DOI 10.1007/s11120-015-0130-0; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; Makri O., 2007, Journal of Herbs, Spices & Medicinal Plants, V13, P123, DOI 10.1300/J044v13n03_10; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Menzies IJ, 2016, J ECOL, V104, P104, DOI 10.1111/1365-2745.12494; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Onda Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08753; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Rastogi S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-588; Riederer M., 2008, ANN PLANT REV, V23; Sablok G, 2014, PLANT BIOTECHNOL J, V12, P554, DOI 10.1111/pbi.12159; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Siipola SM, 2015, PLANT CELL ENVIRON, V38, P941, DOI 10.1111/pce.12403; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tattini M, 2014, PLANT CELL ENVIRON, V37, P1950, DOI 10.1111/pce.12350; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tian J, 2015, PLANT BIOTECHNOL J, V13, P948, DOI 10.1111/pbi.12331; Tignor ME, 1997, HORTSCIENCE, V32, P854, DOI 10.21273/HORTSCI.32.5.854; Torre S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112487; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Villarino GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094651; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Wu ZG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1547-8; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; YATSUHASHI H, 1982, PLANT PHYSIOL, V70, P735, DOI 10.1104/pp.70.3.735; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	73	21	21	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160370	10.1371/journal.pone.0160370	http://dx.doi.org/10.1371/journal.pone.0160370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483170	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700040
J	Halim, A; Dewez, JE; Biswas, A; Rahman, F; White, S; van den Broek, N				Halim, Abdul; Dewez, Juan Emmanuel; Biswas, Animesh; Rahman, Fazlur; White, Sarah; van den Broek, Nynke			When, Where, and Why Are Babies Dying? Neonatal Death Surveillance and Review in Bangladesh	PLOS ONE			English	Article							VERBAL AUTOPSY DATA; CARE-SEEKING; TRIAL; SURVIVAL; COVERAGE	Background Better data on cause of, and factors contributing to, neonatal deaths are needed to improve interventions aimed at reducing neonatal mortality in low-and middle-income countries. Methods Community surveillance to identify all neonatal deaths across four districts in Bangladesh. Verbal autopsy for every fifth case and InterVA-4 used to assign likely cause of death. Findings 6748 neonatal deaths identified, giving a neonatal mortality rate of 24.4 per 1000 live births. Of these, 51.3% occurred in the community and 48.7% at or on the way to a health facility. Almost half (46.1%) occurred within 24 hours of birth with 83.6% of all deaths occurring in the first seven days of life. Birth asphyxia was the leading cause of death (43%), followed by infections (29.3%), and prematurity (22.2%). In 68.3% of cases, care had been provided at a health facility before death occurred. Care-seeking was significantly higher among mothers who were educated (RR 1.18, 95% CI: 1.04-1.35) or who delivered at a health facility (RR 1.48, 95% CI 1.37-1.60) and lower among mothers who had 2-4 previous births (RR 0.89, 95% CI 0.82-0.96), for baby girls (RR 0.87, 95% CI 0.80-0.93), and for low birth weight babies (RR 0.89, 95% CI 0.82-0.96). Interpretation Most parents of neonates who died had accessed and received care from a qualified health-care provider. To further reduce neonatal mortality, it is important that the quality of care provided, particularly skilled birth attendance, emergency obstetric care, and neonatal care during the first month of life is improved, such that it is timely, safe, and effective.	[Halim, Abdul; Biswas, Animesh; Rahman, Fazlur] CIPRB, Dhaka, Bangladesh; [Dewez, Juan Emmanuel; White, Sarah; van den Broek, Nynke] Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England; [Biswas, Animesh] Univ Orebro, Orebro, Sweden	Liverpool School of Tropical Medicine; Orebro University	Dewez, JE (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England.	Juan.Dewez@lstmed.ac.uk	Biswas, Animesh/D-7011-2015	White, Sarah/0000-0001-5535-8075	DFID [202945-101];  [PCA-UNICEF/PCA/2011/015];  [PCA-UNICEF/PCA/2012/009]	DFID; ; 	The Making it Happen Programme funded by DFID (Contract: 202945-101) supported the salaries of JE Dewez, N van den Broek, and S White. UNICEF funded the study. Moreover, UNICEF had an advisory role on the study tools and the implementation plans (i.e., they reviewed the study questionnaire and give advice on operational aspect of the study, at the design phase), contract numbers PCA-UNICEF/PCA/2011/015 and PCA-UNICEF/PCA/2012/009. UNICEF had no other role.	Ahmed S, 2001, J TROP PEDIATRICS, V47, P98, DOI 10.1093/tropej/47.2.98; Alam N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25511; Ameh C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049938; [Anonymous], COUNTR STAT; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Byass P, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19281; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; Chowdhury HR, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-88; Chowdhury HR, 2010, J HEALTH POPUL NUTR, V28, P375; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Fottrell E, 2013, JAMA PEDIATR, V167, P816, DOI 10.1001/jamapediatrics.2013.2534; Gladstone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120566; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Khatun F, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-84; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liu L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-43; [Ministry of Health and Family Welfare Bangladesh Ministry of Health and Family Welfare (MoHFW)], 2008, BAS SURV REP 2008 DH; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ICF International and ICBBRB, 2012, BANGL MAT MORT HLTH; Rubayet S, 2012, HEALTH POLICY PLANN, V27, P40, DOI 10.1093/heapol/czs044; Shah R, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-417; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; World Health Organization, 2012, VERB AUT STAND 2012; World Health Organization, 2014, EV NEWB ACT PLAN ACT	25	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159388	10.1371/journal.pone.0159388	http://dx.doi.org/10.1371/journal.pone.0159388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27478900	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000381110300011
J	Reinartz, S; Distl, O				Reinartz, Sina; Distl, Ottmar			Validation of Deleterious Mutations in Vorderwald Cattle	PLOS ONE			English	Article							VITAMIN-D; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; GERMAN VORDERWALD; HINTERWALD CATTLE; TRAITS; MOUSE; GENE	In Montbeliarde cattle two candidate mutations on bovine chromosomes 19 and 29 responsible for embryonic lethality have been detected. Montbeliarde bulls have been introduced into Vorderwald cattle to improve milk and fattening performance. Due to the small population size of Vorderwald cattle and the wide use of a few Montbeliarde bulls through artificial insemination, inbreeding on Montbeliarde bulls in later generations was increasing. Therefore, we genotyped an aborted fetus which was inbred on Montbeliarde as well as Vorderwald x Montbeliarde crossbred bulls for both deleterious mutations. The abortion was observed in an experimental herd of Vorderwald cattle. The objectives of the present study were to prove if one or both lethal mutations may be assumed to have caused this abortion and to show whether these deleterious mutations have been introduced into the Vorderwald cattle population through Montbeliarde bulls. The aborted fetus was homozygous for the SLC37A2: g. 28879810C>T mutation (ss2019324563) on BTA29 and both parents as well as the paternal and maternal grandsire were heterozygous for this mutation. In addition, the parents and the paternal grandsire were carriers of the MH2-haplotype linked with the T-allele of the SLC37A2: g. 28879810C>T mutation. For the SHBG: g. 27956790C>T mutation (rs38377500) on BTA19 (MH1), the aborted fetus and its sire were heterozygous. Among all further 341 Vorderwald cattle genotyped we found 27 SLC37A2: g. 28879810C>T heterozygous animals resulting in an allele frequency of 0.0396. Among the 120 male Vorderwald cattle, there were 12 heterozygous with an allele frequency of 0.05. The SLC37A2: g. 28879810C>T mutation could not be found in further nine cattle breeds nor in Vorderwald cattle with contributions from Ayrshire bulls. In 69 Vorderwald cattle without genes from Montbeliarde bulls the mutated allele of SLC37A2: g. 28879810C>T could not be detected. The SHBG: g. 27956790C>T mutation appeared unlikely to be responsible for the present case of abortion and, in addition, we observed this mutation in a homozygous state in a living animal. In conclusion, we could demonstrate the first case of an aborted fetus carrying the deleterious SLC37A2: g. 28879810C>T mutation homozygous and show that this deleterious mutation had been introduced through Montbeliarde bulls into Vorderwald cattle.	[Reinartz, Sina; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			University of Veterinary Medicine Hannover [DI-TIHO-VW1-1]	University of Veterinary Medicine Hannover	This work was supported by University of Veterinary Medicine Hannover, DI-TIHO-VW1-1, SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Biedermann G, 2004, ARCH TIERZUCHT, V47, P141, DOI 10.5194/aab-47-141-2004; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chou JY, 2014, CURR TOP MEMBR, V73, P357, DOI 10.1016/B978-0-12-800223-0.00010-4; Fritz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065550; Hartwig S, 2015, J DAIRY SCI, V98, P2033, DOI 10.3168/jds.2014-8571; Hartwig S, 2014, J ANIM BREED GENET, V131, P496, DOI 10.1111/jbg.12099; Hartwig S, 2013, ZUCHTUNGSKUNDE, V85, P270; Ingraham BA, 2008, CURR MED RES OPIN, V24, P139, DOI 10.1185/030079907X253519; Khatib H, 2009, J DAIRY SCI, V92, P2238, DOI 10.3168/jds.2008-1767; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; PEARCE SR, 1995, MAMM GENOME, V6, P858, DOI 10.1007/BF00292435; Saksa N, 2015, J STEROID BIOCHEM, V148, P275, DOI 10.1016/j.jsbmb.2014.11.012; Sambraus HH, 1994, GEFAHRDETE NUTZIERRA, P184; Schmidt T, OPTI MATE VERSION 3; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Wilfinger J, 2014, J NUTR BIOCHEM, V25, P875, DOI 10.1016/j.jnutbio.2014.04.002; Yang HC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.132	19	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160013	10.1371/journal.pone.0160013	http://dx.doi.org/10.1371/journal.pone.0160013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472836	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300025
J	Al-Horani, RA; Karuturi, R; Lee, M; Afosah, DK; Desai, UR				Al-Horani, Rami A.; Karuturi, Rajesh; Lee, Michael; Afosah, Daniel K.; Desai, Umesh R.			Allosteric Inhibition of Factor XIIIa. Non-Saccharide Glycosaminoglycan Mimetics, but Not Glycosaminoglycans, Exhibit Promising Inhibition Profile	PLOS ONE			English	Article							TRYPSIN-LIKE PROTEASES; HEPARIN-BINDING-SITE; HAEMENTERIA-GHILIANII; SMALL MOLECULES; TISSUE TRANSGLUTAMINASE; ORAL ANTICOAGULANTS; PEPTIDIC INHIBITOR; THROMBIN ALLOSTERY; COAGULATION-FACTOR; DRUG DISCOVERY	Factor XIIIa (FXIIIa) is a transglutaminase that catalyzes the last step in the coagulation process. Orthostery is the only approach that has been exploited to design FXIIIa inhibitors. Yet, allosteric inhibition of FXIIIa is a paradigm that may offer a key advantage of controlled inhibition over orthosteric inhibition. Such an approach is likely to lead to novel FXIIIa inhibitors that do not carry bleeding risks. We reasoned that targeting a collection of basic amino acid residues distant from FXIIIa's active site by using sulfated glycosaminoglycans (GAGs) or non-saccharide GAG mimetics (NSGMs) would lead to the discovery of the first allosteric FXIIIa inhibitors. We tested a library of 22 variably sulfated GAGs and NSGMs against human FXIIIa to discover promising hits. Interestingly, although some GAGs bound to FXIIIa better than NSGMs, no GAG displayed any inhibition. An undecasulfated quercetin analog was found to inhibit FXIIIa with reasonable potency (efficacy of 98%). MichaelisMenten kinetic studies revealed an allosteric mechanism of inhibition. Fluorescence studies confirmed close correspondence between binding affinity and inhibition potency, as expected for an allosteric process. The inhibitor was reversible and at least 9-fold-and 26-fold selective over two GAG-binding proteins factor Xa (efficacy of 71%) and thrombin, respectively, and at least 27-fold selective over a cysteine protease papain. The inhibitor also inhibited the FXIIIa-mediated polymerization of fibrin in vitro. Overall, our work presents the proof-of-principle that FXIIIa can be allosterically modulated by sulfated non-saccharide agents much smaller than GAGs, which should enable the design of selective and safe anticoagulants.	[Desai, Umesh R.] Virginia Commonwealth Univ, Dept Med Chem, Drug Discovery & Dev, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Inst Biol Struct, Drug Discovery & Dev, Richmond, VA USA; [Karuturi, Rajesh] Biogene Organ, Raleigh, NC USA	Virginia Commonwealth University; Virginia Commonwealth University	Desai, UR (corresponding author), Virginia Commonwealth Univ, Dept Med Chem, Drug Discovery & Dev, Richmond, VA 23298 USA.	urdesai@vcu.edu	Afosah, Daniel/GSD-8459-2022; Desai, Umesh/D-3741-2013; Al-Horani, Rami A/H-5830-2019	Desai, Umesh/0000-0002-1976-6597; Al-Horani, Rami A/0000-0001-9146-2662	National Institutes of Health [HL107152, HL090586]; Nancy and Donald Abraham Postdoctoral Award	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy and Donald Abraham Postdoctoral Award	This work was funded by grants HL107152 and HL090586 from the National Institutes of Health to URD and the 2016 Nancy and Donald Abraham Postdoctoral Award to RAAH.	Al-Horani RA, 2016, EXPERT OPIN THER PAT, V26, P323, DOI 10.1517/13543776.2016.1154045; Al-Horani RA, 2015, THROMB RES, V136, P379, DOI 10.1016/j.thromres.2015.04.017; Al-Horani Rami A., 2015, Cardiovascular & Hematological Agents in Medicinal Chemistry, V12, P91; Al-Horani RA, 2015, MOLECULES, V20, P608, DOI 10.3390/molecules20010608; Al-Horani RA, 2015, METHODS MOL BIOL, V1229, P49, DOI 10.1007/978-1-4939-1714-3_7; Al-Horani RA, 2014, J MED CHEM, V57, P4805, DOI 10.1021/jm500311e; Al-Horani RA, 2011, J MED CHEM, V54, P6125, DOI 10.1021/jm2008387; Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386; Andresen MS, 2011, THROMB RES, V127, P540, DOI 10.1016/j.thromres.2011.02.017; Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743; Ashrani AA, 2009, J THROMB THROMBOLYS, V28, P465, DOI 10.1007/s11239-009-0309-3; Aziz MHA, 2012, J MED CHEM, V55, P6888, DOI 10.1021/jm300670q; Badarau E, 2013, EUR J MED CHEM, V66, P526, DOI 10.1016/j.ejmech.2013.05.018; Bagoly Z, 2012, THROMB RES, V129, P382, DOI 10.1016/j.thromres.2011.11.040; Biela A, 2012, J MED CHEM, V55, P6094, DOI 10.1021/jm300337q; Bohm M, 2014, J MED CHEM, V57, P10355, DOI [10.1021/jm5010589, 10.1021/jm501058g]; Bohm M, 2012, CHEMMEDCHEM, V7, P326, DOI 10.1002/cmdc.201100405; Byrnes JR, 2015, BLOOD, V126, P1940, DOI 10.1182/blood-2015-06-652263; Desai UR, 2013, FUTURE MED CHEM, V5, P1363, DOI 10.4155/fmc.13.117; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a; Dokholyan NV, 2016, CHEM REV, V116, P6463, DOI 10.1021/acs.chemrev.5b00544; Finney S, 1997, BIOCHEM J, V324, P797, DOI 10.1042/bj3240797; Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; Henry B.L., 2010, BURGERS MED CHEM DRU, P365; Iwata Y, 2000, J MOL GRAPH MODEL, V18, P591, DOI 10.1016/S1093-3263(00)00054-1; Janning M, 2013, HAMOSTASEOLOGIE, V33, pS50, DOI 10.1055/s-0037-1619795; Kar G, 2010, CURR OPIN PHARMACOL, V10, P715, DOI 10.1016/j.coph.2010.09.002; Klock C, 2012, PROTEIN SCI, V21, P1781, DOI 10.1002/pro.2162; Komaromi I, 2011, J THROMB HAEMOST, V9, P9, DOI 10.1111/j.1538-7836.2010.04070.x; Lauer P, 2002, THROMB HAEMOSTASIS, V88, P967, DOI 10.1055/s-0037-1613342; Lechtenberg BC, 2012, BIOL CHEM, V393, P889, DOI 10.1515/hsz-2012-0178; Leung-Toung R, 2005, J MED CHEM, V48, P2266, DOI 10.1021/jm049221w; Lortat-Jacob H, 2012, J BIOL CHEM, V287, P18005, DOI 10.1074/jbc.M111.337089; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Merdanovic M, 2013, ACS CHEM BIOL, V8, P19, DOI 10.1021/cb3005935; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Patel NJ, 2014, ACS CHEM BIOL, V9, P1826, DOI 10.1021/cb500402f; Penzes K, 2009, J THROMB HAEMOST, V7, P627, DOI 10.1111/j.1538-7836.2009.03291.x; Pietsch M, 2013, BIOORG MED CHEM LETT, V23, P6528, DOI 10.1016/j.bmcl.2013.09.060; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Raskob GE, 2014, J THROMB HAEMOST, V12, P1580, DOI 10.1111/jth.12698; Richardson VR, 2013, CLIN SCI, V124, P123, DOI 10.1042/CS20120233; Riva N, 2016, SEMIN THROMB HEMOST, V42, P42, DOI 10.1055/s-0035-1568875; Schroeder V, 2013, J THROMB HAEMOST, V11, P234, DOI 10.1111/jth.12074; Seale L, 1997, THROMB HAEMOSTASIS, V77, P959; Sidhu PS, 2013, J MED CHEM, V56, P5059, DOI 10.1021/jm400369q; Verespy S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24043; Verso M, 2015, INTERN EMERG MED, V10, P651, DOI 10.1007/s11739-015-1233-5; Wallis RB, 1997, BLOOD COAGUL FIBRIN, V8, P291, DOI 10.1097/00001721-199707000-00005; Wang Z, 2012, J BIOL CHEM, V287, P13063, DOI 10.1074/jbc.M111.294819; Wu YW, 2006, J BIOMOL SCREEN, V11, P836, DOI 10.1177/1087057106291585	56	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160189	10.1371/journal.pone.0160189	http://dx.doi.org/10.1371/journal.pone.0160189			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467511	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100128
J	Beckett, LH; Baldwin, AH; Kearney, MS				Beckett, Leah H.; Baldwin, Andrew H.; Kearney, Michael S.			Tidal Marshes across a Chesapeake Bay Subestuary Are Not Keeping up with Sea-Level Rise	PLOS ONE			English	Article							SURFACE ELEVATION; FRESH-WATER; VERTICAL ACCRETION; SEDIMENT ELEVATION; ATLANTIC COAST; LAND-USE; WETLAND; RESPONSES; DYNAMICS; SURVIVAL	Sea-level rise is a major factor in wetland loss worldwide, and in much of Chesapeake Bay (USA) the rate of sea-level rise is higher than the current global rate of 3.2 mm yr(-1) due to regional subsidence. Marshes along estuarine salinity gradients differ in vegetation composition, productivity, decomposition pathways, and sediment dynamics, and may exhibit different responses to sea-level rise. Coastal marshes persist by building vertically at rates at or exceeding regional sea-level rise. In one of the first studies to examine elevation dynamics across an estuarine salinity gradient, we installed 15 surface elevation tables (SET) and accretion marker-horizon plots (MH) in tidal freshwater, oligohaline, and brackish marshes across a Chesapeake Bay subestuary. Over the course of four years, wetlands across the subestuary decreased 1.8 +/- 2.7 mm yr(-1) in elevation on average, at least 5 mm yr(-1) below that needed to keep pace with global sea-level rise. Elevation change rates did not significantly differ among the marshes studied, and ranged from -9.8 +/- 6.9 to 4.5 +/- 4.3 mm yr(-1). Surface accretion of deposited mineral and organic matter was uniformly high across the estuary (similar to 9-15 mm yr(-1)), indicating that elevation loss was not due to lack of accretionary input. Position in the estuary and associated salinity regime were not related to elevation change or surface matter accretion. Previous studies have focused on surface elevation change in marshes of uniform salinity (e.g., salt marshes); however, our findings highlight the need for elevation studies in marshes of all salinity regimes and different geomorphic positions, and warn that brackish, oligohaline, and freshwater tidal wetlands may be at similarly high risk of submergence in some estuaries.	[Beckett, Leah H.] Univ Maryland, Marine Estuarine Environm Sci, College Pk, MD 20742 USA; [Baldwin, Andrew H.; Kearney, Michael S.] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA; [Beckett, Leah H.] Northwest Indian Fisheries Commiss, Olympia, WA 98516 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Beckett, LH (corresponding author), Univ Maryland, Marine Estuarine Environm Sci, College Pk, MD 20742 USA.; Beckett, LH (corresponding author), Northwest Indian Fisheries Commiss, Olympia, WA 98516 USA.	leahbeckett5@gmail.com			U.S. Department of Energy's National Institute for Climatic Change Research [TUL-543-06/07]	U.S. Department of Energy's National Institute for Climatic Change Research(United States Department of Energy (DOE))	This work was funded by a grant from the U.S. Department of Energy's National Institute for Climatic Change Research awarded to Andrew Baldwin (P.I.) and Michael Kearney, award number: TUL-543-06/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Karen Prestegaard and Don Cahoon for comments on figures, organization and text. We are also grateful to the private land owners who allowed us to install SETs on their land and to the numerous people that helped make this research possible by providing help in the field: Todd Beckett, Scott Allen, Jennifer Brundage, Jenny Allen, Ryan Adams, Metthea Yepsen, Diane Peng, John Powell, and Misha Beckett. Funding was provided by a grant from the U.S. Department of Energy National Institute for Climatic Change Research.	Boon JD, 2015, J COASTAL RES, V31, P1295, DOI 10.2112/JCOASTRES-D-15-00041; Butzeck C, 2015, ESTUAR COAST, V38, P434, DOI 10.1007/s12237-014-9848-8; Cahoon DR, 2006, ESTUAR COAST, V29, P889, DOI 10.1007/BF02798648; Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Cahoon DR, 1996, J SEDIMENT RES, V66, P1025, DOI 10.2110/jsr.66.1025; Cahoon DR, 2000, J SEDIMENT RES, V70, P1250, DOI 10.1306/020800701250; Cahoon DR, 2002, J SEDIMENT RES, V72, P734, DOI 10.1306/020702720734; CAHOON DR, 1995, MAR GEOL, V128, P1, DOI 10.1016/0025-3227(95)00087-F; Cardoni DA, 2011, MAR ENVIRON RES, V71, P122, DOI 10.1016/j.marenvres.2010.12.003; CHILDERS DL, 1993, J COASTAL RES, V9, P986; Cole ML, 2006, BIOGEOCHEMISTRY, V77, P199, DOI 10.1007/s10533-005-1036-2; Cole ML, 2005, WATER RESOUR RES, P41; Cowardin L.M., 1979, CLASSIFICATION WETLA; Dauer DM, 2000, ESTUARIES, V23, P80, DOI 10.2307/1353227; Day JW, 1999, ESTUAR COAST SHELF S, V49, P607, DOI 10.1006/ecss.1999.0522; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DeLaune RD, 2012, CLIMATIC CHANGE, V110, P297, DOI 10.1007/s10584-011-0089-6; DELAUNE RD, 1994, J COASTAL RES, V10, P1021; Delgado P, 2013, ESTUAR COAST, V36, P585, DOI 10.1007/s12237-013-9587-2; Denver JM, 2004, US GEOLOGICAL SURVEY, P1228; Erwin RM, 2006, ESTUAR COAST, V29, P96, DOI 10.1007/BF02784702; Fisher CW, 1986, TIDAL CIRCULATION CH; Goddard PB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7346; Holgate SJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028492; Howard RJ, 2000, AQUAT BOT, V68, P143, DOI 10.1016/S0304-3770(00)00108-X; Jacobs AD, 2008, CONDITION NONTIDAL W, P1; KEARNEY MS, 1991, J COASTAL RES, V7, P403; KEARNEY MS, 1988, GEOGR REV, V78, P205, DOI 10.2307/214178; Kearney MS, J COASTAL RES; Kearney MS., 2013, COASTAL HAZARDS, P101; Kennish MJ, 2001, J COASTAL RES, V17, P731; KNOTT JF, 1987, HYDROL PROCESS, V1, P211, DOI 10.1002/hyp.3360010208; Lovelock CE, 2011, ECOSYSTEMS, V14, P745, DOI 10.1007/s10021-011-9443-9; Martinetto P, 2010, ESTUAR COAST SHELF S, V88, P357, DOI 10.1016/j.ecss.2010.04.012; Mckee KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P545, DOI 10.1111/j.1466-8238.2007.00317.x; Mendelssohn IA, 1999, AQUAT BOT, V64, P381, DOI 10.1016/S0304-3770(99)00065-0; Middelburg JJ, 1996, MAR ECOL PROG SER, V132, P157, DOI 10.3354/meps132157; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Neubauer SC, 2002, ESTUAR COAST SHELF S, V54, P713, DOI 10.1006/ecss.2001.0854; NYMAN JA, 1993, MAR ECOL PROG SER, V96, P269, DOI 10.3354/meps096269; ODUM WE, 1988, ANNU REV ECOL SYST, V19, P147, DOI 10.1146/annurev.es.19.110188.001051; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; REDFIELD AC, 1972, ECOL MONOGR, V42, P201, DOI 10.2307/1942263; REDFIELD AC, 1962, P NATL ACAD SCI USA, V48, P1728, DOI 10.1073/pnas.48.10.1728; REED DJ, 1995, EARTH SURF PROC LAND, V20, P39, DOI 10.1002/esp.3290200105; Sallenger AH, 2012, NAT CLIM CHANGE, V2, P884, DOI [10.1038/nclimate1597, 10.1038/NCLIMATE1597]; Snedden GA, 2015, ECOL ENG, V81, P133, DOI 10.1016/j.ecoleng.2015.04.035; Stevenson J.C., 1986, ESTUARINE VARIABILIT, P241, DOI [10.1016/B978-0-12-761890-6.50020-4, DOI 10.1016/B978-0-12-761890-6.50020-4]; STEVENSON JC, 1985, MAR GEOL, V67, P213, DOI 10.1016/0025-3227(85)90093-3; Stevenson JC, 1985, ESTUARINE VARIABILIT, V8, P241; Stribling JM, 2006, MAR ECOL PROG SER, V320, P121, DOI 10.3354/meps320121; Valiela I, 1997, ECOL APPL, V7, P358, DOI 10.1890/1051-0761(1997)007[0358:NLFCWT]2.0.CO;2; van Asselen S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049835; Watson EB, 2009, PLANT ECOL, V205, P113, DOI 10.1007/s11258-009-9602-7; Webb EL, 2013, NAT CLIM CHANGE, V3, P458, DOI [10.1038/NCLIMATE1756, 10.1038/nclimate1756]; Whelan KRT, 2005, ESTUARIES, V28, P833, DOI 10.1007/BF02696013	57	29	29	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159753	10.1371/journal.pone.0159753	http://dx.doi.org/10.1371/journal.pone.0159753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467784	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100052
J	Chen, J; Li, XZ; Bai, ZJ; Fang, F; Hua, J; Li, Y; Pan, J; Wang, J; Feng, X; Li, YH				Chen, Jiao; Li, Xiaozhong; Bai, Zhenjiang; Fang, Fang; Hua, Jun; Li, Ying; Pan, Jian; Wang, Jian; Feng, Xing; Li, Yanhong			Association of Fluid Accumulation with Clinical Outcomes in Critically Ill Children with Severe Sepsis	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; PEDIATRIC SEVERE SEPSIS; GOAL-DIRECTED THERAPY; VASOACTIVE-INOTROPIC SCORE; SEPTIC SHOCK; INTENSIVE-CARE; CARDIAC-SURGERY; MORTALITY; OVERLOAD; RESUSCITATION	Objective To evaluate whether early and acquired daily fluid overload (FO), as well as fluctuations in fluid accumulation, were associated with adverse outcomes in critically ill children with severe sepsis. Methods This study enrolled 202 children in a pediatric intensive care unit (PICU) with severe sepsis. Early fluid overload was defined as >= 5% fluid accumulation occurring in the first 24 hours of PICU admission. The maximum daily fluid accumulation >= 5% occurring during the next 6 days in patients with at least 48 hours of PICU stay was defined as PICU-acquired daily fluid overload. The fluctuation in fluid accumulation was calculated as the difference between the maximum and the minimum daily fluid accumulation obtained during the first 7 days after admission. Results Of the 202 patients, 61 (30.2%) died during PICU stay. Among all patients, 41 (20.3%) experienced early fluid overload, including 9 with a FO >= 10%. Among patients with at least 48 hours of PICU stay (n = 154), 36 (23.4%) developed PICU-acquired daily fluid overload, including 2 with a FO >= 10%. Both early fluid overload (AOR = 1.20; 95% CI 1.08-1.33; P = 0.001; n = 202) and PICU-acquired daily fluid overload (AOR = 5.47 per log increase; 95% CI 1.15-25.96; P = 0.032; n = 154) were independent risk factors associated with mortality after adjusting for age, illness severity, etc. However, fluctuations in fluid accumulation were not associated with mortality after adjustment. Length of PICU stay increased with greater fluctuations in fluid accumulation in all patients with at least 48 hours of PICU stay (FO <5%, 5%-10% vs. >= 10%: 4 [3-8], 7 [4-11] vs. 10 [6-16] days; P <0.001; n = 154) and in survivors (4 [3-8], 7 [5-11] vs. 10 [5-15] days; P <0.001; n = 121). Early fluid overload achieved an area under-the-receiver-operating-characteristic curve of 0.74 (95% CI 0.65-0.82; P <0.001; n = 202) for predicting mortality in patients with severe sepsis, with a sensitivity of 67.2% and a specificity of 80.1% at the optimal cut-off value of 2.65%. Conclusions Both early and acquired daily fluid overload were independently associated with PICU mortality in children with severe sepsis.	[Chen, Jiao; Bai, Zhenjiang; Hua, Jun; Li, Ying] Soochow Univ, Childrens Hosp, Pediat Intens Care Unit, Suzhou, Jiangsu, Peoples R China; [Chen, Jiao; Li, Xiaozhong; Li, Yanhong] Soochow Univ, Childrens Hosp, Dept Nephrol, Suzhou, Jiangsu, Peoples R China; [Fang, Fang; Pan, Jian; Wang, Jian; Li, Yanhong] Soochow Univ, Childrens Hosp, Pediat Res Inst, Suzhou, Jiangsu, Peoples R China; [Feng, Xing] Soochow Univ, Childrens Hosp, Dept Neonatol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Li, YH (corresponding author), Soochow Univ, Childrens Hosp, Dept Nephrol, Suzhou, Jiangsu, Peoples R China.; Li, YH (corresponding author), Soochow Univ, Childrens Hosp, Pediat Res Inst, Suzhou, Jiangsu, Peoples R China.	lyh072006@hotmail.com			National Natural Science Foundation of China [81370773]; Natural Science Foundation of Jiangsu Province [BK2012604]; Innovation Projects of Graduate Students in Colleges and Universities of Jiangsu Province; Key Research and Development Program of JiangSu province (Social Development) [BE2016675]; National Natural Science Foundation of China [81370773]; Natural Science Foundation of Jiangsu Province [BK2012604]; Innovation Projects of Graduate Students in Colleges and Universities of Jiangsu Province; Key Research and Development Program of JiangSu province (Social Development) [BE2016675]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Innovation Projects of Graduate Students in Colleges and Universities of Jiangsu Province; Key Research and Development Program of JiangSu province (Social Development); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Innovation Projects of Graduate Students in Colleges and Universities of Jiangsu Province; Key Research and Development Program of JiangSu province (Social Development)	This work was supported by grants from the National Natural Science Foundation of China (81370773), the Natural Science Foundation of Jiangsu Province (BK2012604), the Innovation Projects of Graduate Students in Colleges and Universities of Jiangsu Province, and the Key Research and Development Program of JiangSu province (Social Development, BE2016675). The funders had no role in study design, data collection and, decision to publish, or preparation of the manuscript.	Acheampong A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0970-1; Arikan AA, 2012, PEDIATR CRIT CARE ME, V13, P253, DOI 10.1097/PCC.0b013e31822882a3; Balamuth F, 2014, PEDIATR CRIT CARE ME, V15, P798, DOI 10.1097/PCC.0000000000000225; Basu RK, 2012, PEDIATR NEPHROL, V27, P1067, DOI 10.1007/s00467-011-2024-5; Bellomo R, 2012, CRIT CARE MED, V40, P1753, DOI 10.1097/CCM.0b013e318246b9c6; Bhaskar P, 2015, INTENS CARE MED, V41, P1445, DOI 10.1007/s00134-015-3851-9; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; Carcillo JA, 2003, CRIT CARE CLIN, V19, P413, DOI 10.1016/S0749-0704(03)00013-7; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Cvetkovic M, 2015, PEDIATR CRIT CARE ME, V16, P410, DOI 10.1097/PCC.0000000000000385; de Galasso L, 2015, PEDIAT NEPHROL; de Oliveira CF, 2010, SHOCK, V34, P44, DOI 10.1097/SHK.0b013e3181e7e6d5; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Foland JA, 2004, CRIT CARE MED, V32, P1771, DOI 10.1097/01.CCM.0000132897.52737.49; Gaies MG, 2014, PEDIATR CRIT CARE ME, V15, P529, DOI 10.1097/PCC.0000000000000153; Gaies MG, 2010, PEDIATR CRIT CARE ME, V11, P234, DOI 10.1097/PCC.0b013e3181b806fc; Gelbart B, 2015, PEDIATR CRIT CARE ME, V16, pE297, DOI 10.1097/PCC.0000000000000507; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Goldstein SL, 2001, PEDIATRICS, V107, P1309, DOI 10.1542/peds.107.6.1309; Gupta RG, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1011-9; Hassinger AB, 2014, PEDIATR CRIT CARE ME, V15, P131, DOI 10.1097/PCC.0000000000000043; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Kelm DJ, 2015, SHOCK, V43, P68, DOI 10.1097/SHK.0000000000000268; Li Y, 2015, EUR J PEDIAT; Lombel RM, 2012, INTENS CARE MED, V38, P663, DOI 10.1007/s00134-012-2503-6; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Malbrain MLNG, 2014, ANAESTH INTENSIVE TH, V46, P361, DOI 10.5603/AIT.2014.0060; Marik PE, 2014, CHEST, V145, P1407, DOI 10.1378/chest.13-2104; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Murphy CV, 2009, CHEST, V136, P102, DOI 10.1378/chest.08-2706; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Pickering JW, 2010, CLIN J AM SOC NEPHRO, V5, P1165, DOI 10.2215/CJN.08531109; Randolph AG, 2014, VIRULENCE, V5, P179, DOI 10.4161/viru.27045; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ruth A, 2014, PEDIATR CRIT CARE ME, V15, P828, DOI 10.1097/PCC.0000000000000254; Seguin J, 2014, CRIT CARE MED, V42, P2591, DOI 10.1097/CCM.0000000000000517; Selewski DT, 2011, INTENS CARE MED, V37, P1166, DOI 10.1007/s00134-011-2231-3; Sinitsky L, 2015, PEDIATR CRIT CARE ME, V16, P205, DOI 10.1097/PCC.0000000000000318; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Soler YA, 2013, PEDIATR CRIT CARE ME, V14, pE189, DOI 10.1097/PCC.0b013e3182745675; van Paridon BM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1010-x; Waechter J, 2014, CRIT CARE MED, V42, P2158, DOI 10.1097/CCM.0000000000000520; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Weiss SL, 2015, CRIT CARE, V19, DOI [10.1186/s13054-015-1055-x, 10.1186/s13054-014-0623-9]; WERNOVSKY G, 1995, CIRCULATION, V92, P2226, DOI 10.1161/01.CIR.92.8.2226	46	36	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160093	10.1371/journal.pone.0160093	http://dx.doi.org/10.1371/journal.pone.0160093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467522	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100108
J	Eidel, O; Neumann, JO; Burth, S; Kieslich, PJ; Jungk, C; Sahm, F; Kickingereder, P; Kiening, K; Unterberg, A; Wick, W; Schlemmer, HP; Bendszus, M; Radbruch, A				Eidel, Oliver; Neumann, Jan-Oliver; Burth, Sina; Kieslich, Pascal J.; Jungk, Christine; Sahm, Felix; Kickingereder, Philipp; Kiening, Karl; Unterberg, Andreas; Wick, Wolfgang; Schlemmer, Heinz-Peter; Bendszus, Martin; Radbruch, Alexander			Automatic Analysis of Cellularity in Glioblastoma and Correlation with ADC Using Trajectory Analysis and Automatic Nuclei Counting	PLOS ONE			English	Article							APPARENT DIFFUSION-COEFFICIENT; NERVOUS-SYSTEM LYMPHOMA; TUMOR CELLULARITY; HUMAN GLIOMA; ASTROCYTOMAS; SURVIVAL; GRADE; DIFFERENTIATION; MULTIFORME; VALUES	Objective Several studies have analyzed a correlation between the apparent diffusion coefficient (ADC) derived from diffusion-weighted MRI and the tumor cellularity of corresponding histopathological specimens in brain tumors with inconclusive findings. Here, we compared a large dataset of ADC and cellularity values of stereotactic biopsies of glioblastoma patients using a new postprocessing approach including trajectory analysis and automatic nuclei counting. Materials and Methods Thirty-seven patients with newly diagnosed glioblastomas were enrolled in this study. ADC maps were acquired preoperatively at 3T and coregistered to the intraoperative MRI that contained the coordinates of the biopsy trajectory. 561 biopsy specimens were obtained; corresponding cellularity was calculated by semi-automatic nuclei counting and correlated to the respective preoperative ADC values along the stereotactic biopsy trajectory which included areas of T1-contrast-enhancement and necrosis. Results There was a weak to moderate inverse correlation between ADC and cellularity in glioblastomas that varied depending on the approach towards statistical analysis: for mean values per patient, Spearman's rho = -0.48 (p = 0.002), for all trajectory values in one joint analysis Spearman's rho = -0.32 (p < 0.001). The inverse correlation was additionally verified by a linear mixed model. Conclusions Our data confirms a previously reported inverse correlation between ADC and tumor cellularity. However, the correlation in the current article is weaker than the pooled correlation of comparable previous studies. Hence, besides cell density, other factors, such as necrosis and edema might influence ADC values in glioblastomas.	[Eidel, Oliver; Burth, Sina; Kickingereder, Philipp; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany; [Neumann, Jan-Oliver; Jungk, Christine; Kiening, Karl; Unterberg, Andreas] Heidelberg Univ, Med Ctr, Dept Neurosurg, Div Stereotact Neurosurg, Heidelberg, Germany; [Kieslich, Pascal J.] Univ Mannheim, Sch Social Sci, Dept Psychol, Mannheim, Germany; [Sahm, Felix] Heidelberg Univ, Med Ctr, Dept Neuropathol, Heidelberg, Germany; [Wick, Wolfgang] Heidelberg Univ, Med Ctr, Neurol Clin, Heidelberg, Germany; [Schlemmer, Heinz-Peter; Radbruch, Alexander] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Radbruch, Alexander] German Canc Consortium DKTK, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Mannheim; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany.; Radbruch, A (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.; Radbruch, A (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.	Alexander.Radbruch@med.uni-heidelberg.de	Radbruch, Alexander/ABA-6277-2021; Vollmuth, Philipp/AAK-3267-2021; Sahm, Felix/GQY-8202-2022; Wick, Wolfgang/AAA-2545-2020	Sahm, Felix/0000-0001-5441-1962; Wick, Wolfgang/0000-0002-6171-634X; Radbruch, Alexander/0000-0001-6238-6525; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Kieslich, Pascal J./0000-0002-0853-9364				Barajas RF, 2010, AM J NEURORADIOL, V31, P60, DOI 10.3174/ajnr.A1750; Barajas RF, 2012, NEURO-ONCOLOGY, V14, P942, DOI 10.1093/neuonc/nos128; Chen Jun, 2005, Zhonghua Zhongliu Zazhi, V27, P309; Chen LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079008; Crawford FW, 2009, J NEURO-ONCOL, V91, P337, DOI 10.1007/s11060-008-9719-x; Deroulers C, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-92; Doskaliyev A, 2012, EUR J RADIOL, V81, P339, DOI 10.1016/j.ejrad.2010.11.005; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Gauvain KM, 2001, AM J ROENTGENOL, V177, P449, DOI 10.2214/ajr.177.2.1770449; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Gupta RK, 2000, J NEURO-ONCOL, V50, P215, DOI 10.1023/A:1006431120031; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; Hilario A, 2014, AM J NEURORADIOL, V35, P1096, DOI 10.3174/ajnr.A3837; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jenkinson MD, 2010, J NEURO-ONCOL, V96, P385, DOI 10.1007/s11060-009-9970-9; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Kikuchi T, 2009, NEUROL RES, V31, P1102, DOI 10.1179/174313209X382539; Kono K, 2001, AM J NEURORADIOL, V22, P1081; LaViolette PS, 2014, NEURO-ONCOLOGY, V16, P1599, DOI 10.1093/neuonc/nou142; Murakami R, 2008, ACTA RADIOL, V49, P462, DOI 10.1080/02841850801918555; Murakami R, 2007, RADIOLOGY, V243, P493, DOI 10.1148/radiol.2432060450; Oh J, 2004, J MAGN RESON IMAGING, V19, P546, DOI 10.1002/jmri.20039; Sadeghi N, 2008, AM J NEURORADIOL, V29, P476, DOI 10.3174/ajnr.A0851; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stadlbauer A, 2006, RADIOLOGY, V240, P803, DOI 10.1148/radiol.2403050937; Stummer W, 2009, CURR OPIN NEUROL, V22, P645, DOI 10.1097/WCO.0b013e3283320165; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Toh CH, 2008, AM J NEURORADIOL, V29, P471, DOI 10.3174/ajnr.A0872; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yamashita Y, 2009, NEUROL RES, V31, P940, DOI 10.1179/174313209X382520; Yoshikawa MI, 2008, RADIAT MED, V26, P222, DOI 10.1007/s11604-007-0218-3; Zulfiqar M, 2013, AM J ROENTGENOL, V200, P624, DOI 10.2214/AJR.12.8679	33	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160250	10.1371/journal.pone.0160250	http://dx.doi.org/10.1371/journal.pone.0160250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467557	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100139
J	Oberoi, R; Schuett, J; Schuett, H; Koch, AK; Luchtefeld, M; Grote, K; Schieffer, B				Oberoi, Raghav; Schuett, Jutta; Schuett, Harald; Koch, Ann-Kathrin; Luchtefeld, Maren; Grote, Karsten; Schieffer, Bernhard			Targeting Tumor Necrosis Factor-alpha with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; TNF-ALPHA; ATHEROSCLEROSIS; INFLAMMATION; DYSFUNCTION; INHIBITION; MOLECULE-1; DISEASES; AGENTS; FOCUS	Objective It is well known that atherosclerotic inflammatory vascular disease is critically driven by oxidized lipids and cytokines. In this regard, tumor necrosis factor (TNF)-alpha is known as a crucial mediator of early pro-atherosclerotic events. Epidemiologic data suggest that blockade of TNF-alpha has beneficial effects on vascular outcomes in patients with rheumatoid arthritis, however, detailed mechanistic studies are still lacking. This study aims to elucidate effects of TNF-alpha blockade by adalimumab-which is approved for several inflammatory disorderson endothelial activation and monocyte adhesion under pro-atherosclerotic conditions. Methods and Results Phorbol myristate acetate (PMA) differentiated THP-1 macrophages were stimulated with oxidized low density lipoprotein and subsequent analysis of this conditioned media (oxLDL CM) revealed a strong release of TNF-alpha. The TNF-alpha rich supernatant led to activation of human umbilical vein endothelial cells (HUVEC) as shown by enhanced expression of major adhesion molecules, such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and E-selectin which was suppressed by the TNF-alpha inhibitor adalimumab. Accordingly, adalimumab effectively prevented THP-1 monocyte adhesion to endothelial cells under static as well as under flow conditions. Furthermore, adalimumab suppressed endothelial leakage as shown by Evan's blue diffusion across a confluent endothelial monolayer. Of note, after intraperitoneal injection we detected abundant deposition of fluorophore-labelled adalimumab in atherosclerotic plaques of hypercholesterolemic mice. Conclusion Our results show that adalimumab prevents major inflammatory effects of TNF-alpha on endothelial activation, endothelial monocyte adhesion, endothelial leakage and therefore extends the therapeutic options of adalimumab to limit vascular inflammation.	[Oberoi, Raghav; Schuett, Jutta; Schuett, Harald; Koch, Ann-Kathrin; Luchtefeld, Maren; Grote, Karsten; Schieffer, Bernhard] Univ Marburg, Dept Cardiol & Angiol, Marburg, Germany	Philipps University Marburg	Oberoi, R (corresponding author), Univ Marburg, Dept Cardiol & Angiol, Marburg, Germany.	raghav.oberoi@staff.uni-marburg.de		Grote, Karsten/0000-0001-7914-3159; Vlacil, Ann-Kathrin/0000-0001-9743-0290	AbbVie Germany	AbbVie Germany(AbbVie)	This study was funded by AbbVie Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Numani D, 2003, CLIN EXP IMMUNOL, V133, P67, DOI 10.1046/j.1365-2249.2003.02189.x; Armuzzi A, 2014, INT J IMMUNOPATH PH, V27, P11, DOI 10.1177/03946320140270S102; Bain B, 2003, NAT REV DRUG DISCOV, V2, P693, DOI 10.1038/nrd1182; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; Boesten LSM, 2005, CARDIOVASC RES, V66, P179, DOI 10.1016/j.cardiores.2005.01.001; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; CARLOS TM, 1990, BLOOD, V76, P965; Chung K.F., 2001, EUR RESPIR J, V34, P50, DOI DOI 10.1183/09031936.01.00229701; Gonzalez-Juanatey C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/674265; Holgate Stephen T., 2004, Allergology International, V53, P47, DOI 10.1111/j.1440-1592.2004.00329.x; Hurlimann D, 2002, CIRCULATION, V106, P2184, DOI 10.1161/01.CIR.0000037521.71373.44; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kerekes G, 2011, ISR MED ASSOC J, V13, P147; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Licastro F, 2009, INT J IMMUNOPATH PH, V22, P567, DOI 10.1177/039463200902200302; Maiolino G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/714653; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Pasceri V, 1999, CIRCULATION, V100, P2124, DOI 10.1161/01.CIR.100.21.2124; POBER JS, 1987, J IMMUNOL, V138, P3319; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Shetty S, 2014, JOVE-J VIS EXP, DOI 10.3791/51330; Sidiropoulos PI, 2009, SCAND J RHEUMATOL, V38, P6, DOI 10.1080/03009740802363768; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Toussirot E, 2007, EXPERT OPIN PHARMACO, V8, P2089, DOI 10.1517/14656566.8.13.2089; Tuleta I, 2014, ATHEROSCLEROSIS, V236, P400, DOI 10.1016/j.atherosclerosis.2014.08.021; Van Assche G, 2006, GASTROENTEROL CLIN N, V35, P743, DOI 10.1016/j.gtc.2006.09.009; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697; Williams RO, 2007, CURR OPIN PHARMACOL, V7, P412, DOI 10.1016/j.coph.2007.06.001	34	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160145	10.1371/journal.pone.0160145	http://dx.doi.org/10.1371/journal.pone.0160145			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467817	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516100122
J	Fudge, N; Sadler, E; Fisher, HR; Maher, J; Wolfe, CDA; McKevitt, C				Fudge, Nina; Sadler, Euan; Fisher, Helen R.; Maher, John; Wolfe, Charles D. A.; McKevitt, Christopher			Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research	PLOS ONE			English	Review							SCIENCE; HEALTH; BENCH; GOVERNANCE; EFFICIENCY; MEDICINE; BARRIERS; BEDSIDE	Introduction Translational research is central to international health policy, research and funding initiatives. Despite increasing use of the term, the translation of basic science discoveries into clinical practice is not straightforward. This systematic search and narrative synthesis aimed to examine factors enabling or hindering translational research from the perspective of basic and clinician scientists, a key stakeholder group in translational research, and to draw policy-relevant implications for organisations seeking to optimise translational research opportunities. Methods and Results We searched SCOPUS and Web of Science from inception until April 2015 for papers reporting scientists' views of the factors they perceive as enabling or hindering the conduct of translational research. We screened 8,295 papers from electronic database searches and 20 papers from hand searches and citation tracking, identifying 26 studies of qualitative, quantitative or mixed method designs. We used a narrative synthesis approach and identified the following themes: 1) differing concepts of translational research 2) research processes as a barrier to translational research; 3) perceived cultural divide between research and clinical care; 4) interdisciplinary collaboration as enabling translation research, but dependent on the quality of prior and current social relationships; 5) translational research as entrepreneurial science. Across all five themes, factors enabling or hindering translational research were largely shaped by wider social, organisational, and structural factors. Conclusion To optimise translational research, policy could consider refining translational research models to better reflect scientists' experiences, fostering greater collaboration and buy in from all types of scientists. Organisations could foster cultural change, ensuring that organisational practices and systems keep pace with the change in knowledge production brought about by the translational research agenda.	[Fudge, Nina; Fisher, Helen R.; Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll London, Div Hlth & Social Care Res, Fac Life Sci & Med, London, England; [Fudge, Nina; Fisher, Helen R.; Wolfe, Charles D. A.; McKevitt, Christopher] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res NIHR, Comprehens Biomed Res Ctr, London, England; [Fudge, Nina; Fisher, Helen R.; Wolfe, Charles D. A.; McKevitt, Christopher] Kings Coll London, London, England; [Sadler, Euan] Kings Coll London, Ctr Implementat Sci, Dept Hlth Serv & Populat Res, Inst Psychiat Psychol & Neurosci, London, England; [Maher, John] Kings Coll London, Dept Res Oncol, London, England; [Maher, John] Guys Hosp, London, England; [Maher, John] Kings Coll Hosp London, Dept Clin Immunol & Allergy, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital	Fudge, N (corresponding author), Kings Coll London, Div Hlth & Social Care Res, Fac Life Sci & Med, London, England.; Fudge, N (corresponding author), Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res NIHR, Comprehens Biomed Res Ctr, London, England.; Fudge, N (corresponding author), Kings Coll London, London, England.	nina.fudge@kcl.ac.uk	mckevitt, christopher/AAN-7271-2021	Lister, Dr Helen/0000-0002-5958-4587; Fudge, Nina/0000-0002-7161-4355; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613; Sadler, Euan/0000-0003-3827-224X; Maher, John/0000-0001-8275-8488	National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London [652300]; NIHR Collaboration for Leadership in Applied Health Research and Care South London at King's College London NHS Foundation Trust [NIHR CLAHRC-2013-10022]; National Institute for Health Research [RP-PG-0407-10184, NF-SI-0510-10060] Funding Source: researchfish	National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; NIHR Collaboration for Leadership in Applied Health Research and Care South London at King's College London NHS Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) Comprehensive Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London (award number 652300), www.nihr.ac.uk/about/biomedical-research-centres.htm; and the NIHR Collaboration for Leadership in Applied Health Research and Care South London at King's College London NHS Foundation Trust (award number NIHR CLAHRC-2013-10022), Prof Charles DA Wolfe, http://www.nihr.ac.uk/about/collaborations-for-leadership-in-applied-health-research-and-care.htm. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boaz Annette, 2011, BMC Res Notes, V4, P212, DOI 10.1186/1756-0500-4-212; Boland J, 2015, J PAIN SYMPTOM MANAG, V49, P762, DOI 10.1016/j.jpainsymman.2014.09.018; Bower P, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-399; Cambrosio A., 2011, CAMBROSIO CANC TRIAL; Campbell EG, 2001, JAMA-J AM MED ASSOC, V286, P800, DOI 10.1001/jama.286.7.800; Chen HD, 2009, NEW GENET SOC, V28, P267, DOI 10.1080/14636770903151984; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Dixon-Woods M, 2004, QUAL SAF HEALTH CARE, V13, P223, DOI 10.1136/qshc.2003.008714; Dixon-Woods Mary, 2006, BMC Med Res Methodol, V6, P35, DOI 10.1186/1471-2288-6-35; Drolet BC, 2011, TRANSL RES, V157, P1, DOI 10.1016/j.trsl.2010.10.002; Etzkowitz H, 1998, RES POLICY, V27, P823, DOI 10.1016/S0048-7333(98)00093-6; Francke Anneke L, 2008, BMC Med Inform Decis Mak, V8, P38, DOI 10.1186/1472-6947-8-38; French M, 2012, SOC SCI MED, V75, P717, DOI 10.1016/j.socscimed.2012.04.010; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Hallowell N, 2009, J MED ETHICS, V35, P113, DOI 10.1136/jme.2008.024224; Harris JK, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-69; Heller C, 2009, ACAD MED, V84, P424, DOI 10.1097/ACM.0b013e31819a7d81; Horig H, 2005, NAT MED, V11, P705, DOI 10.1038/nm0705-705; Kahn K, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-34; Kotarba Joseph A, 2013, Int Rev Qual Res, V6, P127; Lander B, 2011, SOC SCI MED, V72, P537, DOI 10.1016/j.socscimed.2010.11.019; Lander B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013168; Ledford H, 2008, NATURE, V453, P843, DOI 10.1038/453843a; Long JC, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-225; Martin P., 2008, SCI CULTURE, V17, P29, DOI DOI 10.1080/09505430701872921; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Morgan M, 2011, SOC SCI MED, V73, P945, DOI 10.1016/j.socscimed.2011.06.060; Ostergren JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093482; Payne PRO, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-20; Payne PRO, 2005, J INVEST MED, V53, P192, DOI 10.2310/6650.2005.00402; Rajan KS, 2013, PUBLIC CULTURE, V25, P463, DOI 10.1215/08992363-2144607; Restifo LL, 2011, DIS MODEL MECH, V4, P423, DOI 10.1242/dmm.008177; Rodgers M., 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643; Salazar M, 2011, CTS-CLIN TRANSL SCI, V4, P274, DOI 10.1111/j.1752-8062.2011.00321.x; Snape K, 2008, QJM-INT J MED, V101, P901, DOI 10.1093/qjmed/hcn100; Stephens N, 2013, SOCIOL HEALTH ILL, V35, P345, DOI 10.1111/j.1467-9566.2012.01482.x; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181; van der Laan AL, 2015, HEALTH CARE ANAL, V23, P32, DOI 10.1007/s10728-012-0236-x; Vignola- Gagne E., 2013, ENCY CREATIVITY INVE, P1834, DOI DOI 10.1007/978-1-4614-3858-8_338; Vignola-Gagne E, 2014, SCI PUBL POLICY, V41, P94, DOI 10.1093/scipol/sct039; Vignola-Gagne E, 2013, J COMMUN GENET, V4, P189, DOI 10.1007/s12687-012-0130-0; Wainwright SP, 2008, SOCIOL HEALTH ILL, V30, P959, DOI 10.1111/j.1467-9566.2008.01118.x; Wainwright SP, 2006, SOC SCI MED, V63, P2052, DOI 10.1016/j.socscimed.2006.05.003; Weston CM, 2010, J INVEST MED, V58, P770, DOI 10.231/JIM.0b013e3181e70a78; Wilson-Kovacs DM, 2012, SOCIOL HEALTH ILL, V34, P497, DOI 10.1111/j.1467-9566.2011.01389.x; Wooding S, 2015, INSIGHTS ON EARLIER; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867; Zerhouni EA, 2005, NEW ENGL J MED, V353, P1621, DOI 10.1056/NEJMsb053723; Zhang JY, 2011, NEW GENET SOC, V30, P193, DOI 10.1080/14636778.2011.574372; Zhou LX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-256; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x; Zwolsman S, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652382	56	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160475	10.1371/journal.pone.0160475	http://dx.doi.org/10.1371/journal.pone.0160475			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490373	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000381368900063
J	Rodriguez, LAG; Martin-Perez, M; Hennekens, CH; Rothwell, PM; Lanas, A				Garcia Rodriguez, Luis A.; Martin-Perez, Mar; Hennekens, Charles H.; Rothwell, Peter M.; Lanas, Angel			Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies	PLOS ONE			English	Review							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HELICOBACTER-PYLORI INFECTION; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; INTRACEREBRAL HEMORRHAGE; ACETYLSALICYLIC-ACID; STROKE; USERS; ASSOCIATION; INHIBITORS	Background Low-dose aspirin has proven effectiveness in secondary and primary prevention of cardiovascular events, but is also associated with an increased risk of major bleeding events. For primary prevention, this absolute risk must be carefully weighed against the benefits of aspirin; such assessments are currently limited by a lack of data from general populations. Methods Systematic searches of Medline and Embase were conducted to identify observational studies published between 1946 and 4 March 2015 that reported the risks of gastrointestinal (GI) bleeding or intracranial hemorrhage (ICH) with long-term, low-dose aspirin (75-325 mg/day). Pooled estimates of the relative risk (RR) for bleeding events with aspirin versus non-use were calculated using random-effects models, based on reported estimates of RR (including odds ratios, hazard ratios, incidence rate ratios and standardized incidence ratios) in 39 articles. Findings The incidence of GI bleeding with low-dose aspirin was 0.48-3.64 cases per 1000 personyears, and the overall pooled estimate of the RR with low-dose aspirin was 1.4 (95% confidence interval [CI]: 1.2-1.7). For upper and lower GI bleeding, the RRs with low-dose aspirin were 2.3 (2.0-2.6) and 1.8 (1.1-3.0), respectively. Neither aspirin dose nor duration of use had consistent effects on RRs for upper GI bleeding. The estimated RR for ICH with low-dose aspirin was 1.4 (1.2-1.7) overall. Aspirin was associated with increased bleeding risks when combined with non-steroidal anti-inflammatory drugs, clopidogrel and selective serotonin reuptake inhibitors compared with monotherapy. By contrast, concomitant use of proton pump inhibitors decreased upper GI bleeding risks relative to aspirin monotherapy. Conclusions The risks of major bleeding with low-dose aspirin in real-world settings are of a similar magnitude to those reported in randomized trials. These data will help inform clinical judgements regarding the use of low-dose aspirin in prevention of cardiovascular events.	[Garcia Rodriguez, Luis A.; Martin-Perez, Mar] Spanish Ctr Pharmacoepidemiol Res CEIFE, Madrid, Spain; [Hennekens, Charles H.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Rothwell, Peter M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Stroke Prevent Res Unit, Oxford, England; [Lanas, Angel] Univ Zaragoza, Univ Clin Hosp, IIS Aragon, CIBERehd, Zaragoza, Spain	State University System of Florida; Florida Atlantic University; University of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Zaragoza	Lanas, A (corresponding author), Univ Zaragoza, Univ Clin Hosp, IIS Aragon, CIBERehd, Zaragoza, Spain.	angel.lanas@gmail.com	Martín-Pérez, Mar/D-3193-2019; rodriguez, luis a garcia/B-1980-2010; Rothwell, Peter/ABE-5913-2020; Martín-Pérez, Mar/A-7936-2019	Rothwell, Peter/0000-0001-9739-9211; 	Bayer Pharma AG; National Institute for Health Research [NF-SI-0514-10168] Funding Source: researchfish	Bayer Pharma AG; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors received no specific funding for this work. Medical writing support was provided by Oxford Pharmagenesis, Oxford, UK, with funding from Bayer Pharma AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Medical writing support was provided by Emma Moorhouse and Lucy Ambrose of Oxford Pharmagenesis, Oxford, UK, with funding from Bayer Pharma AG.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Baigent C, 1998, BMJ-BRIT MED J, V316, P1337, DOI 10.1136/bmj.316.7141.1337; Battistoni A, 2015, CLIN CARDIOL; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Blot W J, 2000, J Epidemiol Biostat, V5, P137; Calonge N, 2009, ANN INTERN MED, V150, P396; Soriano LC, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00126; COLLIER HOJ, 1969, ADV PHARMACOL CHEMOT, V7, P333; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2013, ANN INTERN MED, V159, P77, DOI 10.7326/0003-4819-159-2-201307160-00002; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; de Abajo FJ, 2013, EUR J CLIN PHARMACOL, V69, P691, DOI 10.1007/s00228-012-1386-3; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Endo H, 2009, J GASTROENTEROL, V44, P544, DOI 10.1007/s00535-009-0040-z; Gaist D, 2013, PHARMACOEPIDEM DR S, V22, P176, DOI 10.1002/pds.3391; Rodriguez LAG, 2011, CIRCULATION, V123, P1108, DOI 10.1161/CIRCULATIONAHA.110.973008; Garcia-Rodriguez LA, 2013, NEUROLOGY, V81, P566, DOI 10.1212/WNL.0b013e31829e6ffa; Gorelick PB, 2003, JAMA-J AM MED ASSOC, V289, P2947, DOI 10.1001/jama.289.22.2947; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Halvorsen S, 2014, J AM COLL CARDIOL, V64, P319, DOI 10.1016/j.jacc.2014.03.049; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hennekens CH, 2014, NAT REV CARDIOL, V11, P438, DOI 10.1038/nrcardio.2014.88; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Hirata Y, 2011, SCAND J GASTROENTERO, V46, P803, DOI 10.3109/00365521.2011.568522; Ho CW, 2015, STROKE, V46, P23, DOI 10.1161/STROKEAHA.114.006476; Huang ES, 2011, AM J MED, V124, P426, DOI 10.1016/j.amjmed.2010.12.022; Huang ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015721; Ibanez L, 2006, ALIMENT PHARM THER, V23, P235, DOI 10.1111/j.1365-2036.2006.02759.x; Ikeda Y, 2014, JAMA-J AM MED ASSOC, V312, P2510, DOI 10.1001/jama.2014.15690; Iwamoto J, 2013, WORLD J GASTROENTERO, V19, P1673, DOI 10.3748/wjg.v19.i11.1673; Kaufman DW, 1999, AM J GASTROENTEROL, V94, P3189, DOI 10.1111/j.1572-0241.1999.01517.x; KAUFMAN DW, 1993, CLIN PHARMACOL THER, V53, P485, DOI 10.1038/clpt.1993.55; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lanas A, 2015, CLIN GASTROENTEROL H, V13, P906, DOI 10.1016/j.cgh.2014.11.007; Lanas A, 2011, CLIN GASTROENTEROL H, V9, P762, DOI 10.1016/j.cgh.2011.05.020; Leung WY, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-57; Lin KJ, 2014, CIRC-CARDIOVASC QUAL, V7, P70, DOI 10.1161/CIRCOUTCOMES.113.000494; Lovelock CE, 2007, LANCET NEUROL, V6, P487, DOI 10.1016/S1474-4422(07)70107-2; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mo C, 2015, WORLD J GASTROENTERO, V21, P5382, DOI 10.3748/wjg.v21.i17.5382; Mohr JP, 2001, NEW ENGL J MED, V345, P1444, DOI 10.1056/NEJMoa011258; Nakayama M, 2009, J GASTROENTEROL, V44, P912, DOI 10.1007/s00535-009-0074-2; PATRONO C, 1980, THROMB RES, V17, P317, DOI 10.1016/0049-3848(80)90066-3; Pilotto A, 2003, AGING CLIN EXP RES, V15, P494, DOI 10.1007/BF03327372; Pottegard A, 2015, THROMB HAEMOST, V114; Sakamoto C, 2006, EUR J CLIN PHARMACOL, V62, P765, DOI 10.1007/s00228-006-0171-6; Santolaria S, 1999, ALIMENT PHARM THERAP, V13, P1511; Shiotani A, 2010, SCAND J GASTROENTERO, V45, P292, DOI 10.3109/00365520903453182; Sorensen HT, 2000, AM J GASTROENTEROL, V95, P2218; Sostres C, 2015, AM J GASTROENTEROL, V110, P684, DOI 10.1038/ajg.2015.98; Stack WA, 2002, ALIMENT PHARM THER, V16, P497, DOI 10.1046/j.1365-2036.2002.01197.x; Strate LL, 2011, GASTROENTEROLOGY, V140, P1427, DOI 10.1053/j.gastro.2011.02.004; Taha AS, 2006, ALIMENT PHARM THER, V23, P489, DOI 10.1111/j.1365-2036.2006.02784.x; Thorat MA, 2015, EUR J EPIDEMIOL, V30, P5, DOI 10.1007/s10654-014-9971-7; Thrift AG, 1999, BMJ-BRIT MED J, V318, P759, DOI 10.1136/bmj.318.7186.759; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Vandvik O, 2012, CHEST, V141, pE637S, DOI 10.1378/chest.11-2306; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Warner TD, 2011, BRIT J CLIN PHARMACO, V72, P619, DOI 10.1111/j.1365-2125.2011.03943.x; Whitlock E, 2015, DRAFT EVIDENCE SUMMA; Wu IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098326; Yamada A, 2008, DIS COLON RECTUM, V51, P116, DOI 10.1007/s10350-007-9137-8	68	83	85	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160046	10.1371/journal.pone.0160046	http://dx.doi.org/10.1371/journal.pone.0160046			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490468	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900028
J	Guo, L; An, JN; Ma, YN; Ye, LY; Luo, YP; Tao, CM; Yang, JY				Guo, Ling; An, Jingna; Ma, Yanning; Ye, Liyan; Luo, Yanping; Tao, Chuanmin; Yang, Jiyong			Nosocomial Outbreak of OXA-48-Producing Klebsiella pneumoniae in a Chinese Hospital: Clonal Transmission of ST147 and ST383	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXA-48-LIKE CARBAPENEMASES; MOLECULAR EPIDEMIOLOGY; BETA-LACTAMASE; 1ST REPORT; PLASMID; EMERGENCE; RESISTANCE; SEQUENCE; FEATURES	Background In China, the spread and outbreak of OXA-48-producing Enterobacteriaceae remains largely unknown. Methods OXA-48-producing isolates were analyzed for genetic relatedness by pulsed-field gel electrophoresis (PFGE), antimicrobial susceptibility by E-test, and sequence type (ST) by multilocus sequence typing. S1-PFGE and southern blotting were used for plasmid profiling, and PCR and subsequent sequencing were performed to determine the genetic environment of bla(OXA-48) gene. Results In total, 37 non-duplicated OXA-48-producing K. pneumoniae (OXAKp) isolates were recovered. From December 2013 to August 2014, an outbreak was observed at a respiratory ICU. The 37 isolates of K. pneumoniae were categorized into four PFGE types (A, B, C, and D). The predominant strains associated with the outbreak were strains with PFGE type A and B, which belonged to ST383 and ST147, respectively. Plasmid sequencing revealed that the bla(OXA-48)-carrying plasmid is 69,069 bp in length and belongs to the IncL/M incompatibility group. Sequence analysis revealed that the IS1999 element was located upstream of the bla(OXA-48) gene and was truncated by IS1R. Conclusions In this study, the dissemination and outbreak of OXAKp isolates were clonal, and ST147 and ST383 K. pneumoniae were the predominant clones that were associated with the outbreak. Meanwhile, the horizontal transfer of plasmids potentially mediate the spread of bla(OXA-48) gene between different K. pneumoniae strains.	[Guo, Ling; An, Jingna; Ma, Yanning; Ye, Liyan; Luo, Yanping; Yang, Jiyong] Chinese Peoples Liberat Army Gen Hosp, Dept Microbiol, Beijing, Peoples R China; [An, Jingna; Tao, Chuanmin] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu, Peoples R China	Chinese People's Liberation Army General Hospital; Sichuan University	Yang, JY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Microbiol, Beijing, Peoples R China.	yangjy301@hotmail.com			China Mega-Project on Infectious Disease Prevention [2016ZX10004202-002-002]	China Mega-Project on Infectious Disease Prevention	This study was supported by the China Mega-Project on Infectious Disease Prevention (Grant No. 2016ZX10004202-002-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; Chen L, 2015, ANTIMICROB AGENTS CH, V59, P4305, DOI 10.1128/AAC.00565-15; Chen L, 2014, ANTIMICROB AGENTS CH, V58, P2422, DOI 10.1128/AAC.02587-13; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI, V34; Daikos GL, 2014, ANTIMICROB AGENTS CH, V58, P2322, DOI 10.1128/AAC.02166-13; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dautzenberg M J, 2014, Euro Surveill, V19; Dimou V, 2012, J ANTIMICROB CHEMOTH, V67, P1660, DOI 10.1093/jac/dks124; Dortet L, 2015, ANTIMICROB AGENTS CH, V59, P3823, DOI 10.1128/AAC.05058-14; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Giani T, 2012, ANTIMICROB AGENTS CH, V56, P2211, DOI 10.1128/AAC.00035-12; Gottig S, 2015, CLIN INFECT DIS, V60, P1808, DOI 10.1093/cid/civ191; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Lascols C, 2013, ANTIMICROB AGENTS CH, V57, P130, DOI 10.1128/AAC.01686-12; Lee CH, 2007, J ANTIMICROB CHEMOTH, V60, P410, DOI 10.1093/jac/dkm215; Liapis E, 2014, CLIN MICROBIOL INFEC, V20, pO1121, DOI 10.1111/1469-0691.12727; Ma L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139152; Oteo J, 2013, J ANTIMICROB CHEMOTH, V68, P317, DOI 10.1093/jac/dks383; Oueslati S, 2015, J ANTIMICROB CHEMOTH, V70, P1059, DOI 10.1093/jac/dku524; Papagiannitsis CC, 2015, J ANTIMICROB CHEMOTH, V70, P1981, DOI 10.1093/jac/dkv055; Papagiannitsis CC, 2010, INT J ANTIMICROB AG, V36, P573, DOI 10.1016/j.ijantimicag.2010.07.018; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Potron A, 2011, CLIN MICROBIOL INFEC, V17, pE24, DOI 10.1111/j.1469-0691.2011.03669.x; Potron A, 2013, J ANTIMICROB CHEMOTH, V68, P476, DOI 10.1093/jac/dks397; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Samuelsen O, 2011, CLIN MICROBIOL INFEC, V17, P1811, DOI 10.1111/j.1469-0691.2011.03532.x; Vaux S, 2011, EUROSURVEILLANCE, V16, P11; Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356; Yang J, 2013, CLIN MICROBIOL INFEC, V19, pE509, DOI 10.1111/1469-0691.12275	33	47	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160754	10.1371/journal.pone.0160754	http://dx.doi.org/10.1371/journal.pone.0160754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490695	gold, Green Submitted, Green Published			2022-12-27	WOS:000381368900083
J	Muturi-Kioi, V; Lewis, D; Launay, O; Leroux-Roels, G; Anemona, A; Loulergue, P; Bodinham, CL; Aerssens, A; Groth, N; Saul, A; Podda, A				Muturi-Kioi, Vincent; Lewis, David; Launay, Odile; Leroux-Roels, Geert; Anemona, Alessandra; Loulergue, Pierre; Bodinham, Caroline L.; Aerssens, Annelies; Groth, Nicola; Saul, Allan; Podda, Audino			Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review	PLOS ONE			English	Review							TETRAVALENT DENGUE VACCINE; FLAVIVIRUS-NAIVE ADULTS; VIRUS-INFECTED CHILDREN; PHASE-I TRIAL; CONJUGATE VACCINE; SAFETY; IMMUNOGENICITY; VOLUNTEERS; ADOLESCENTS; HIV-1	Background In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often reported. It is therefore important to evaluate how these trials should be planned not to miss potentially important safety signals, but also to understand the implications and the clinical relevance. Methodology We report and discuss the results from five clinical trials (two with a new Shigella vaccine in the early stage of clinical development and three with licensed vaccines) where the absolute neutrophil counts (ANC) were evaluated before and after vaccination. Additionally, we have performed a systematic review of the literature on cases of neutropenia reported during vaccine trials to discuss our results in a more general context. Principal Findings Both in our clinical trials and in the literature review, several cases of neutropenia have been reported, in the first two weeks after vaccination. However, neutropenia was generally transient and had a benign clinical outcome, after vaccination with either multiple novel candidates or well-known licensed vaccines. Additionally, the vaccine recipients with neutropenia frequently had lower baseline ANC than non-neutropenic vaccinees. In many instances neutropenia occurred in subjects of African descent, known to have lower ANC compared to western populations. Conclusions It is important to include ANC and other haematological tests in early vaccine trials to identify potential safety signals. Post-vaccination neutropenia is not uncommon, generally transient and clinically benign, but many vaccine trials do not have a sampling schedule that allows its detection. Given ethnic variability in the level of circulating neutrophils, normal ranges taking into account ethnicity should be used for determination of trial inclusion/exclusion criteria and classification of neutropenia related adverse events.	[Muturi-Kioi, Vincent; Anemona, Alessandra; Saul, Allan; Podda, Audino] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Lewis, David; Bodinham, Caroline L.] Univ Surrey, Surrey Clin Res Ctr, Guildford, Surrey, England; [Launay, Odile; Loulergue, Pierre] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Launay, Odile; Loulergue, Pierre] CIC Cochin Pasteur, AP HP, F CRIN I Reivac, INSERM,CIC 1417, Paris, France; [Leroux-Roels, Geert; Aerssens, Annelies] Univ Ghent, Ghent, Belgium; [Leroux-Roels, Geert; Aerssens, Annelies] Univ Hosp, Ghent, Belgium; [Groth, Nicola] Novartis Vaccines & Diagnost, Siena, Italy; [Muturi-Kioi, Vincent] GSK, Nairobi, Kenya; [Lewis, David] Imperial Coll, London, England; [Anemona, Alessandra; Saul, Allan; Podda, Audino] GSK Vaccines Inst Global Hlth, Siena, Italy; [Groth, Nicola] GSK Vaccines, Siena, Italy	Novartis; University of Surrey; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ghent University; Ghent University; Ghent University Hospital; Novartis; GlaxoSmithKline; Imperial College London; GlaxoSmithKline; GlaxoSmithKline	Podda, A (corresponding author), Novartis Vaccines Inst Global Hlth, Siena, Italy.; Podda, A (corresponding author), GSK Vaccines Inst Global Hlth, Siena, Italy.	audino.p.podda@gsk.com	Saul, Allan/ABH-2091-2020; Saul, Allan J/I-6968-2013; loulergue, pierre/AAI-6725-2021	Saul, Allan/0000-0003-0665-4091; Saul, Allan J/0000-0003-0665-4091; Muturi-Kioi, Vincent/0000-0003-1620-3999	EUROPEAN COMMISSION [261472, 280873]; Innovative Medicines Initiative Joint Undertaking [115308]; Novartis	EUROPEAN COMMISSION(European CommissionEuropean Commission Joint Research Centre); Innovative Medicines Initiative Joint Undertaking; Novartis(Novartis)	This work was supported by EUROPEAN COMMISSION - Grant 261472 (STOPENTERICS) (http://stopenterics.bio-med.ch/cms/default.aspx) to OL, PL, A. Anemona, AS, and AP; EUROPEAN COMMISSION - Grant 280873 (ADITEC) (http://www.aditecproject.eu/) to DL, A. Anemona, AS, and AP; Innovative Medicines Initiative Joint Undertaking. Grant 115308 (http://www.biovacsafe.eu/) to DL, GLR, and A. Aerssens. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, A. Anemona, NG, AS and AP were employed by Novartis at the time these studies were conducted and are currently employed by GSK. VMK was a medical intern in Novartis at the time these studies were conducted and is currently employed by GSK. The company provided support in the form of salaries for these authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Administration FUSFaD, TOX GRAD SCAL HLTH A; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057; Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Cunningham CK, 2001, CLIN INFECT DIS, V32, P801, DOI 10.1086/319215; Dieye TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067177; Duncan CJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022271; Durbin AP, 2006, HUM VACCINES, V2, P167, DOI 10.4161/hv.2.4.2944; Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494; Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064; Durbin AP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001267; Edelman R, 2003, AM J TROP MED HYG  S, V69, P48, DOI DOI 10.4269/AJTMH.2003.69.48; Ellis RD, 2009, VACCINE, V27, P4104, DOI 10.1016/j.vaccine.2009.04.077; Gerke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134478; Gershon AA, 2009, PEDIATR INFECT DIS J, V28, P653, DOI 10.1097/INF.0b013e3181998f06; Haddy TB, 1999, J LAB CLIN MED, V133, P15, DOI 10.1053/lc.1999.v133.a94931; Jaoko W, 2008, VACCINE, V26, P2788, DOI 10.1016/j.vaccine.2008.02.071; Kanesa-thasan N, 2000, VACCINE, V19, P483, DOI 10.1016/S0264-410X(00)00191-2; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Karron RA, 2009, VACCINE, V27, P4953, DOI 10.1016/j.vaccine.2009.05.099; Kitchener S, 2006, VACCINE, V24, P1238, DOI 10.1016/j.vaccine.2005.09.029; Kotloff KL, 2004, JAMA-J AM MED ASSOC, V292, P709, DOI 10.1001/jama.292.6.709; Lindow JC, 2013, VACCINE, V31, P3347, DOI 10.1016/j.vaccine.2013.05.075; McArthur JH, 2008, AM J TROP MED HYG, V79, P678, DOI 10.4269/ajtmh.2008.79.678; McFarland EJ, 2006, AIDS, V20, P1481, DOI 10.1097/01.aids.0000237363.33994.45; Morrison D, 2010, J INFECT DIS, V201, P370, DOI 10.1086/649916; Njuguna IN, 2014, VACCINE, V32, P5801, DOI 10.1016/j.vaccine.2014.08.034; O'Leary ST, 2012, PEDIATRICS, V129, P248, DOI 10.1542/peds.2011-1111; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078679; Reading R., 2008, CHILD CARE HLTH DEV, V34, P548, DOI [10.1111/j.1365-2214.2008.00864_6.x, DOI 10.1111/J.1365-2214.2008.00864_X]; REED WW, 1991, ARCH INTERN MED, V151, P501, DOI 10.1001/archinte.151.3.501; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Sanchez V, 2006, VACCINE, V24, P4914, DOI 10.1016/j.vaccine.2006.03.066; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sheldon EA, 2012, HUM VACC IMMUNOTHER, V8, P888, DOI 10.4161/hv.19983; SHOENFELD Y, 1985, BIOMED PHARMACOTHER, V39, P23; Siberry GK, 2012, PEDIATR INFECT DIS J, V31, P47, DOI 10.1097/INF.0b013e318236c67b; Siberry GK, 2010, PEDIATR INFECT DIS J, V29, P391, DOI 10.1097/INF.0b013e3181c38f3b; Sun W, 2003, AM J TROP MED HYG, V69, P24; Sun W, 2009, HUM VACCINES, V5, P33, DOI 10.4161/hv.5.1.6348; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Vardas E, 2010, AIDS RES HUM RETROV, V26, P933, DOI 10.1089/aid.2009.0242; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; Watanaveeradej V, 2011, AM J TROP MED HYG, V85, P341, DOI 10.4269/ajtmh.2011.10-0501; Wright PF, 2008, VACCINE, V26, P882, DOI 10.1016/j.vaccine.2007.12.015	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0157385	10.1371/journal.pone.0157385	http://dx.doi.org/10.1371/journal.pone.0157385			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490698	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900002
J	Tang-Siegel, G; Bumgarner, R; Ruiz, T; Kittichotirat, W; Chen, WZ; Chen, C				Tang-Siegel, Gaoyan; Bumgarner, Roger; Ruiz, Teresa; Kittichotirat, Weerayuth; Chen, Weizhen; Chen, Casey			Human Serum-Specific Activation of Alternative Sigma Factors, the Stress Responders in Aggregatibacter actinomycetemcomitans	PLOS ONE			English	Article							PHAGE-SHOCK-PROTEIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ESCHERICHIA-COLI; BACTERIAL PATHOGENS; O-POLYSACCHARIDE; GENOME SEQUENCE; SEROTYPE; EMAA; LIPOPOLYSACCHARIDE; INFECTION	Aggregatibacter actinomycetemcomitans, a known pathogen causing periodontal disease and infective endocarditis, is a survivor in the periodontal pocket and blood stream; both environments contain serum as a nutrient source. To screen for unknown virulence factors associated with this microorganism, A. actinomycetemcomitans was grown in serumbased media to simulate its in vivo environment. Different strains of A. actinomycetemcomitans showed distinct growth phenotypes only in the presence of human serum, and they were grouped into high-and low-responder groups. High-responders comprised mainly serotype c strains, and showed an unusual growth phenomenon, featuring a second, rapid increase in turbidity after 9-h incubation that reached a final optical density 2-to 7-fold higher than low-responders. Upon further investigation, the second increase in turbidity was not caused by cell multiplication, but by cell death. Whole transcriptomic analysis via RNA-seq identified 35 genes that were up-regulated by human serum, but not horse serum, in high-responders but not in low-responders, including prominently an alternative sigma factor rpoE (sigma(E)). A lacZ reporter construct driven by the 132-bp rpoE promoter sequence of A. actinomycetemcomitans responded dramatically to human serum within 90 min of incubation only when the construct was carried by a high responder strain. The rpoE promoter is 100% identical among high-and low-responder strains. Proteomic investigation showed potential interactions between human serum protein, e.g. apolipoprotein A1 (ApoA1) and A. actinomycetemcomitans. The data clearly indicated a different activation process for rpoE in high-versus low-responder strains. This differential human serum-specific activation of rpoE, a putative extra-cytoplasmic stress responder and global regulator, suggests distinct in vivo adaptations among different strains of A. actinomycetemcomitans.	[Tang-Siegel, Gaoyan; Ruiz, Teresa] Univ Vermont, Coll Med, Dept Mol Physiol & Biophys, Burlington, VT USA; [Bumgarner, Roger] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Kittichotirat, Weerayuth] King Mongkuts Univ Technol Thonburi, Pilot Plant Dev & Training Inst, Syst Biol & Bioinformat Res Grp, Bangkok, Thailand; [Chen, Weizhen; Chen, Casey] Univ Southern Calif, Ostrow Sch Dent, Los Angeles, CA USA	University of Vermont; University of Washington; University of Washington Seattle; King Mongkuts University of Technology Thonburi; University of Southern California	Chen, C (corresponding author), Univ Southern Calif, Ostrow Sch Dent, Los Angeles, CA USA.	ccchen@usc.edu	Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger/K-3531-2015	Tang-Siegel, Gaoyan Grace/0000-0002-2245-0227; Kittichotirat, Weerayuth/0000-0001-8397-633X; Bumgarner, Roger/0000-0002-8168-6985	NIH-NIDCR [R90-DE022528, R01-DE012212];  [R01-DE024554]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE012212] Funding Source: NIH RePORTER	NIH-NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by NIH-NIDCR (http://www.nidcr.nih.gov/grantsandfunding/) R90-DE022528 (G.T.S.), R01-DE012212 (C.C.), and has also benefited from developments supported by R01-DE024554 (T.R.).	Ades S, 2014, PLOS ONE, V3, pe1573; Beck WHJ, 2013, BBA-BIOMEMBRANES, V1828, P1503, DOI 10.1016/j.bbamem.2013.02.009; Becker LA, 2005, MOL MICROBIOL, V56, P1004, DOI 10.1111/j.1365-2958.2005.04604.x; Bianchi AA, 1999, MOL MICROBIOL, V34, P1029, DOI 10.1046/j.1365-2958.1999.01664.x; BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Chen C, 2010, J BACTERIOL, V192, P2643, DOI 10.1128/JB.00157-10; Chen C, 2009, J BACTERIOL, V191, P7378, DOI 10.1128/JB.01203-09; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; Fallico V, 2011, J VIROL, V85, P12032, DOI 10.1128/JVI.00275-11; Gallant CV, 2008, J BACTERIOL, V190, P5972, DOI 10.1128/JB.00548-08; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Juarez-Rodriguez MD, 2013, PLASMID, V69, P211, DOI 10.1016/j.plasmid.2013.01.002; Kaplan JB, 2001, INFECT IMMUN, V69, P5375, DOI 10.1128/IAI.69.9.5375-5384.2001; Karched M, 2012, J BACTERIOL, V194, P1275, DOI 10.1128/JB.06710-11; Kittichotirat W, 2016, J DENT RES, V95, P94, DOI 10.1177/0022034515608163; Kittichotirat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022420; Kovacikova G, 2002, INFECT IMMUN, V70, P5355, DOI 10.1128/IAI.70.10.5355-5362.2002; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matzumura-Kuan M, 2014, SCAND J INFECT DIS, V46, P669, DOI 10.3109/00365548.2014.920104; Mellata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029481; Miller J.H., 1972, EXPT MOL GENETICS; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Mortensen NP, 2009, LANGMUIR, V25, P3728, DOI 10.1021/la803898g; Nakano Y, 2000, BBA-GENE STRUCT EXPR, V1493, P259, DOI 10.1016/S0167-4781(00)00179-2; Norskov-Lauritsen N, 2014, CLIN MICROBIOL REV, V27, P214, DOI 10.1128/CMR.00103-13; Permpanich P, 2006, CELL MICROBIOL, V8, P72, DOI 10.1111/j.1462-5822.2005.00601.x; Perry MB, 1996, INFECT IMMUN, V64, P1215, DOI 10.1128/IAI.64.4.1215-1219.1996; Perry MB, 1996, EUR J BIOCHEM, V242, P682, DOI 10.1111/j.1432-1033.1996.0682r.x; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Sawa J, 2011, J BIOL CHEM, V286, P30680, DOI 10.1074/jbc.M111.243832; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; SREENIVASAN PK, 1991, INFECT IMMUN, V59, P4621, DOI 10.1128/IAI.59.12.4621-4627.1991; Takada K, 2010, MOL ORAL MICROBIOL, V25, P200, DOI 10.1111/j.2041-1014.2010.00572.x; Tang GY, 2008, INFECT IMMUN, V76, P2316, DOI 10.1128/IAI.00021-08; Tang GY, 2007, MICROBIOL-SGM, V153, P2447, DOI 10.1099/mic.0.2007/005892-0; Tang GY, 2010, J BACTERIOL, V192, P1395, DOI 10.1128/JB.01453-09; Uitto VJ, 2003, PERIODONTOL 2000, V31, P9, DOI 10.1034/j.1600-0757.2003.03101.x; Wagner MA, 2009, J BACTERIOL, V191, P1695, DOI 10.1128/JB.01536-08; WISSENBACH U, 1995, MOL MICROBIOL, V17, P675, DOI 10.1111/j.1365-2958.1995.mmi_17040675.x; Yenugu Suresh, 2004, Reprod Biol Endocrinol, V2, P61, DOI 10.1186/1477-7827-2-61; Zhou Y, 2011, J PROTEOMICS, V74, P1030, DOI 10.1016/j.jprot.2011.02.007	43	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160018	10.1371/journal.pone.0160018	http://dx.doi.org/10.1371/journal.pone.0160018			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490177	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900025
J	Slade, JA; Hall, JV; Kintner, J; Phillips-Campbell, R; Schoborg, RV				Slade, Jessica A.; Hall, Jennifer V.; Kintner, Jennifer; Phillips-Campbell, Regenia; Schoborg, Robert V.			Host Nectin-1 Promotes Chlamydial Infection in the Female Mouse Genital Tract, but Is Not Required for Infection in a Novel Male Murine Rectal Infection Model	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CELL-CELL ADHESION; EPITHELIAL-CELLS; TRACHOMATIS; MOLECULES; ROLES; ENTRY; MICE; SEX; MEN	Chlamydia trachomatis is the most common bacterial sexually transmitted pathogen, but more than 70% of patients fail to seek treatment due to the asymptomatic nature of these infections. Women suffer from numerous complications from chronic chlamydial infections, which include pelvic inflammatory disease and infertility. We previously demonstrated in culture that host cell nectin-1 knockdown significantly reduced chlamydial titers and inclusion size. Here, we sought to determine whether nectin-1 was required for chlamydial development in vivo by intravaginally infecting nectin-1(-/-) mice with Chlamydia muridarum and monitoring chlamydial shedding by chlamydial titer assay. We observed a significant reduction in chlamydial shedding in female nectin-1(-/-) mice compared to nectin-1(+/+) control mice, an observation that was confirmed by PCR. Immunohistochemical staining in mouse cervical tissue confirmed that there are fewer chlamydial inclusions in Chlamydia-infected nectin-1(-/-) mice. Notably, anorectal chlamydial infections are becoming a substantial health burden, though little is known regarding the pathogenesis of these infections. We therefore established a novel male murine model of rectal chlamydial infection, which we used to determine whether nectin-1 is required for anorectal chlamydial infection in male mice. In contrast to the data from vaginal infection, no difference in rectal chlamydial shedding was observed when male nectin-1(+/+) and nectin-1(-/-) mice were compared. Through the use of these two models, we have demonstrated that nectin-1 promotes chlamydial infection in the female genital tract but does not appear to contribute to rectal infection in male mice. These models could be used to further characterize tissue and sex related differences in chlamydial infection.	[Slade, Jessica A.; Hall, Jennifer V.; Kintner, Jennifer; Phillips-Campbell, Regenia; Schoborg, Robert V.] East Tennessee State Univ, James H Quillen Coll Med, Ctr Inflammat Infect Dis & Immun, Dept Biomed Sci, Johnson City, TN 37604 USA	East Tennessee State University	Schoborg, RV (corresponding author), East Tennessee State Univ, James H Quillen Coll Med, Ctr Inflammat Infect Dis & Immun, Dept Biomed Sci, Johnson City, TN 37604 USA.	schoborg@etsu.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases [5R01AI095637-04]; ETSU Biomedical Sciences Graduate Program; National Institutes of Health, National Center for Research Resources [1C06RR030651-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095637] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ETSU Biomedical Sciences Graduate Program; National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases grant number 5R01AI095637-04 awarded to RVS. The authors would also like to thank the ETSU Biomedical Sciences Graduate Program for providing financial support to JAS, in addition to the ETSU Graduate School for providing JAS with a Student Research Grant to complete these experiments. This work was also supported by the National Institutes of Health, National Center for Research Resources grant number 1C06RR030651-01 awarded to Dr. Gregory Ordway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annan NT, 2009, SEX TRANSM INFECT, V85, P176, DOI 10.1136/sti.2008.031773; Barron MJ, 2008, HUM MOL GENET, V17, P3509, DOI 10.1093/hmg/ddn243; Campbell RP, 2012, MICROBES INFECT, V14, P1177, DOI 10.1016/j.micinf.2012.07.017; Chin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046949; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Deka S, 2006, CELL MICROBIOL, V8, P149, DOI 10.1111/j.1462-5822.2005.00608.x; Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277; Galen B, 2006, J VIROL, V80, P12209, DOI 10.1128/JVI.01503-06; Hall JV, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00158; Hall JV, 2011, CELL MICROBIOL, V13, P1183, DOI 10.1111/j.1462-5822.2011.01608.x; Hogan RJ, 2004, INFECT IMMUN, V72, P1843, DOI 10.1128/IAI.72.4.1843-1855.2004; Huffam S, 2015, SEX TRANSM INFECT, V91, P434, DOI 10.1136/sextrans-2015-052068; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Inagaki M, 2005, DEVELOPMENT, V132, P1525, DOI 10.1242/dev.01697; Irie K, 2004, SEMIN CELL DEV BIOL, V15, P643, DOI 10.1016/j.semcdb.2004.09.002; Kintner J, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv015; Kong FYS, 2015, J ANTIMICROB CHEMOTH, V70, P1290, DOI 10.1093/jac/dku574; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; Li CP, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01875.x; Linehan MM, 2004, J VIROL, V78, P2530, DOI 10.1128/JVI.78.5.2530-2536.2004; Manavi K, 2006, BEST PRACT RES CL OB, V20, P941, DOI 10.1016/j.bpobgyn.2006.06.003; Marrazzo Jeanne, 2014, F1000Prime Rep, V6, P120, DOI 10.12703/P6-120; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ogita H, 2010, P JPN ACAD B-PHYS, V86, P621, DOI 10.2183/pjab.86.621; Paavonen J, 2004, INT CONGR SER, V1266, P277, DOI 10.1016/j.ics.2004.01.114; Patton ME, 2014, CLIN INFECT DIS, V58, P1564, DOI 10.1093/cid/ciu184; Perry LL, 1999, INFECT IMMUN, V67, P3686, DOI 10.1128/IAI.67.7.3686-3689.1999; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; Schoborg RV, 2011, MICROBES INFECT, V13, P649, DOI 10.1016/j.micinf.2011.03.004; Stiles KM, 2010, VIROLOGY, V399, P109, DOI 10.1016/j.virol.2009.12.034; Tanaka-Okamoto M, 2011, J CELL SCI, V124, P2231, DOI 10.1242/jcs.081000; Taylor JM, 2007, CELL HOST MICROBE, V2, P19, DOI 10.1016/j.chom.2007.06.005; van Liere GAFS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140297; van Liere GAFS, 2013, SEX TRANSM DIS, V40, P285, DOI 10.1097/OLQ.0b013e31828098f8; World Health Organization, 2011, GLOB INC PREV SEL CU; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; WYRICK PB, 1994, MICROB PATHOGENESIS, V17, P159, DOI 10.1006/mpat.1994.1062; Yang CF, 2015, MBIO, V6, DOI 10.1128/mBio.01648-15; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; Yoshida T, 2010, DEV DYNAM, V239, P2558, DOI 10.1002/dvdy.22395	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160511	10.1371/journal.pone.0160511	http://dx.doi.org/10.1371/journal.pone.0160511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486990	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800082
J	Angira, F; Akoth, B; Omolo, P; Opollo, V; Bornheimer, S; Judge, K; Tilahun, H; Lu, B; Omana-Zapata, I; Zeh, C				Angira, Francis; Akoth, Benta; Omolo, Paul; Opollo, Valarie; Bornheimer, Scott; Judge, Kevin; Tilahun, Henok; Lu, Beverly; Omana-Zapata, Imelda; Zeh, Clement			Clinical Evaluation of the BD FACSPresto (TM) Near-Patient CD4 Counter in Kenya	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; TOTAL LYMPHOCYTE COUNT; T-CELL ENUMERATION; CAPILLARY BLOOD; SOUTH-AFRICA; PERFORMANCE EVALUATION; REGRESSION-ANALYSIS; PIMA CD4; CARE	Background The BD FACSPresto (TM) Near-Patient CD4 Counter was developed to expand HIV/AIDS management in resource-limited settings. It measures absolute CD4 counts (AbsCD4), percent CD4 (%CD4), and hemoglobin (Hb) from a single drop of capillary or venous blood in approximately 23 minutes, with throughput of 10 samples per hour. We assessed the performance of the BD FACSPresto system, evaluating accuracy, stability, linearity, precision, and reference intervals using capillary and venous blood at KEMRI/CDC HIV-research laboratory, Kisumu, Kenya, and precision and linearity at BD Biosciences, California, USA. Methods For accuracy, venous samples were tested using the BD FACSCalibur (TM) instrument with BD Tritest (TM) CD3/CD4/CD45 reagent, BD Trucount T tubes, and BD Multiset (TM) software for AbsCD4 and %CD4, and the Sysmex (TM) KX-21N for Hb. Stability studies evaluated duration of staining (18-120-minute incubation), and effects of venous blood storage <6-24 hours post-draw. A normal cohort was tested for reference intervals. Precision covered multiple days, operators, and instruments. Linearity required mixing two pools of samples, to obtain evenly spaced concentrations for AbsCD4, total lymphocytes, and Hb. Results AbsCD4 and %CD4 venous/capillary (N = 189/N = 162) accuracy results gave Deming regression slopes within 0.97-1.03 and R-2 >= 0.96. For Hb, Deming regression results were R-2 >= 0.94 and slope >= 0.94 for both venous and capillary samples. Stability varied within 10% 2 hours after staining and for venous blood stored less than 24 hours. Reference intervals results showed that gender-but not age-differences were statistically significant (p<0.05). Precision results had <3.5% coefficient of variation for AbsCD4, %CD4, and Hb, except for low AbsCD4 samples (<6.8%). Linearity was 42-4,897 cells/mu L for AbsCD4, 182-11,704 cells/mu L for total lymphocytes, and 2-24 g/dL for Hb. Conclusions The BD FACSPresto system provides accurate, precise clinical results for capillary or venous blood samples and is suitable for near-patient CD4 testing.	[Angira, Francis; Akoth, Benta; Omolo, Paul; Opollo, Valarie] US CDC Res & Publ Hlth Collaborat, Kenya Med Res Inst, Kisumu, Kenya; [Bornheimer, Scott; Judge, Kevin; Tilahun, Henok; Lu, Beverly; Omana-Zapata, Imelda] BD Biosci, 2350 Qume Dr, San Jose, CA USA; [Zeh, Clement] US Ctr Dis Control & Prevent CDC Kenya, Kisumu, Kenya	Kenya Medical Research Institute	Angira, F (corresponding author), US CDC Res & Publ Hlth Collaborat, Kenya Med Res Inst, Kisumu, Kenya.; Omana-Zapata, I (corresponding author), BD Biosci, 2350 Qume Dr, San Jose, CA USA.	fangira@kemricdc.org; imelda_omana-zapata@bd.com						Anastos K, 2004, JAIDS-J ACQ IMM DEF, V35, P383, DOI 10.1097/00126334-200404010-00008; [Anonymous], 1997, FED REG; [Anonymous], 2008, H04A6 CLSI; Bekolo Cavin Epie, 2013, BMC Res Notes, V6, P512, DOI 10.1186/1756-0500-6-512; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Briggs C, 2009, INT J LAB HEMATOL, V31, P169, DOI 10.1111/j.1751-553X.2007.01017.x; CDC, 2019, HIV SURVEILLANCE REP; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P2; Centers for Disease Control and Prevention CDC, 1998, MMWR-MORBID MORTAL W, V47, P3; Clinical and Laboratory Standards Institute, 2004, EP5A2 CLSI; CLSI, 2011, EP24A2 CLSI; CLSI, 2010, EP09A2IR CLSI, VSecond; CLSI guideline EP06-A, 2018, CLSI EV LIN QUANT ME, V2nd Ed; Costello C, 2005, INT J EPIDEMIOL, V34, P577, DOI 10.1093/ije/dyi023; DAAE LNW, 1988, SCAND J CLIN LAB INV, V48, P723, DOI 10.3109/00365518809085796; Deming W.E., 1985, STAT ADJUSTMENT DATA; DENNY T, 1992, JAMA-J AM MED ASSOC, V267, P1484, DOI 10.1001/jama.267.11.1484; Diaw PA, 2011, JAIDS-J ACQ IMM DEF, V58, pE103, DOI 10.1097/QAI.0b013e318235b378; Eholie SP, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17334; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; FDA, 1996, FED REG; Gale HB, 2013, CLIN INFECT DIS, V56, P1340, DOI 10.1093/cid/cit004; Gange SJ, 2003, AIDS, V17, P119, DOI 10.1097/00002030-200301030-00016; Girard PM, 2013, AIDS, V27, P2759, DOI 10.1097/01.aids.0000432458.98851.c1; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; HENRY DH, 1992, ANN INTERN MED, V117, P739, DOI 10.7326/0003-4819-117-9-739; Horowitz GL., 2010, DEFINING ESTABLISHIN; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; LINNET K, 1993, CLIN CHEM, V39, P424; LINNET K, 1990, STAT MED, V9, P1463, DOI 10.1002/sim.4780091210; Linnet K, 1998, CLIN CHEM, V44, P1024; Linnet K, 1999, CLIN CHEM, V45, P882; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 2002, J ACQ IMMUN DEF SYND, V29, P54, DOI 10.1097/00042560-200201010-00007; Mtapuri-Zinyowera S, 2010, JAIDS-J ACQ IMM DEF, V55, P1, DOI 10.1097/QAI.0b013e3181e93071; NASCOP, 2008, GUID HIV TEST COUNS; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Reynolds S, 2014, 2014 C RETR OPP INF; Schalk E, 2007, VOX SANG, V93, P348, DOI 10.1111/j.1423-0410.2007.00978.x; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Sitoe N, 2011, J IMMUNOL METHODS, V372, P1, DOI 10.1016/j.jim.2011.07.008; Sukapirom K, 2011, JAIDS-J ACQ IMM DEF, V58, P141, DOI 10.1097/QAI.0b013e31822866a2; Thakar M, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-26; UNAIDS, 90 90 90 TRANSF AG L; WHO, 2010, ANT THER HIV INF AD; WHO, 2000, MILL DEV GOALS MDGS; WHO, 2002, SCAL ANT THER RES LI; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; World Health Organization, 2010, GUID ART IN INF CHIL; World Health Organization, 2014, MARCH 2014 SUPPL 201, P56; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	58	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0157939	10.1371/journal.pone.0157939	http://dx.doi.org/10.1371/journal.pone.0157939			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483008	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700004
J	Gashu, Z; Jerene, D; Ensermu, M; Habte, D; Melese, M; Hiruy, N; Shibeshi, E; Hamusse, SD; Nigussie, G; Girma, B; Kassie, Y; Haile, YK; Suarez, P				Gashu, Zewdu; Jerene, Degu; Ensermu, Mitiku; Habte, Dereje; Melese, Muluken; Hiruy, Nebiyu; Shibeshi, Endale; Hamusse, Shallo D.; Nigussie, G.; Girma, B.; Kassie, Yewulsew; Haile, Yared Kebede; Suarez, Pedro			The Yield of Community-Based "Retrospective" Tuberculosis Contact Investigation in a High Burden Setting in Ethiopia	PLOS ONE			English	Article							HEALTH-SERVICE DELAY; PULMONARY TUBERCULOSIS; RISK-FACTORS; HOUSEHOLD CONTACTS; TRANSMISSION; PREVALENCE; COHORT; INFECTION; DIAGNOSIS; CHILDREN	Objective To determine the yield and determinants of retrospective TB contact investigation in selected zones in Ethiopia. Materials and Methods This was a community-based cross-sectional study conducted during June-October 2014. Trained lay providers performed symptom screening for close contacts of index cases with all types of TB registered for anti-TB treatment within the last three years. We used logistic regression to determine factors associated with TB diagnosis among the contacts. Results Of 272,441 close contacts of 47, 021 index cases screened, 13,886 and 2, 091 had presumptive and active TB respectively. The yield of active TB was thus 768/100, 000, contributing 25.4% of the 7,954 TB cases reported from the study zones over the study period. The yield was highest among workplace contacts (12,650/100, 000). Active TB was twice more likely among contacts whose index cases had been registered for TB treatment within the last 12 months compared with those who had been registered 24 or more months earlier (adjusted odds ratio, AOR: 1.77 95% CI 1.42-2.21). Sex or clinical type of TB in index cases was not associated with the yield. Smear negative (SS-) index cases (AOR: 1.74 955 CI 1.13-2.68), having index cases who registered for treatment within < 12 months (AOR: 2.41 95% CI 1.51-3.84) and being household contact (AOR: 0.072 95% CI 0.01-0.52) were associated with the occurrence of active TB in children. Conclusions The yield of retrospective contact investigation was about six times the case notification in the study zones, contributing a fourth of all TB cases notified over the same period. The yield was highest among workplace contacts and in those with recent past history of contact. Retrospective contact screening can serve as additional strategy to identify high risk groups not addressed through currently recommended screening approaches.	[Gashu, Zewdu; Jerene, Degu; Ensermu, Mitiku; Habte, Dereje; Melese, Muluken; Hiruy, Nebiyu; Shibeshi, Endale; Girma, B.] Help Ethiopia Address Low Performance TB HEAL TB, Management Sci Hlth, Addis Ababa, Ethiopia; [Hamusse, Shallo D.] Oromia Reg Hlth Bur, Addis Ababa, Ethiopia; [Nigussie, G.] Amhara Reg Hlth Bur, Bahirdar, Ethiopia; [Kassie, Yewulsew; Haile, Yared Kebede] US Agcy Int Dev, Addis Ababa, Ethiopia; [Suarez, Pedro] Ctr Hlth Serv, Management Sci Hlth, Arlington, VA USA	United States Agency for International Development (USAID)	Gashu, Z (corresponding author), Help Ethiopia Address Low Performance TB HEAL TB, Management Sci Hlth, Addis Ababa, Ethiopia.	zgashu@msh.org	Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761; Habte, Dereje/0000-0002-4720-4188	United States Agency for International Development (USAID) [AID-663-A-11-00011]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The United States Agency for International Development (USAID) supported this work through HEAL TB, under cooperative agreement number AID-663-A-11-00011. The contents of the article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the United States government.	Assefa D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129135; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Beyers N, 1997, INT J TUBERC LUNG D, V1, P38; Chheng P, 2015, CLIN EPIDEMIOL, V7, P411, DOI 10.2147/CLEP.S82389; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Duarte R, 2012, INT J TUBERC LUNG D, V16, P55, DOI 10.5588/ijtld.10.0511; Federal Democratic republic of Ethiopia, 2013, FED DEM REP ETH ANN, V5; FMoH E, 2008, TUB LEPR TB HIV PREV, P207; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; GOTHI GD, 1976, INDIAN J MED RES, V64, P1150; James J S, 1999, AIDS Treat News, P5; Jerene D, 2015, INT J TUBERC LUNG D, V19, P898, DOI 10.5588/ijtld.14.0978; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Kilicaslan Z, 2009, INT J TUBERC LUNG D, V13, P93; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Melese M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151366; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150405; MUNSIFF S, 2008, CLIN POLICIES PROTOC; OSBORNE CM, 1995, ARCH DIS CHILD, V72, P369, DOI 10.1136/adc.72.4.369; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Salinas C, 2007, ARCH BRONCONEUMOL, V43, P317, DOI 10.1157/13106562; Saunders MJ, 2014, INT J TUBERC LUNG D, V18, P640, DOI 10.5588/ijtld.13.0486; Schlomer GL, 2010, J COUNS PSYCHOL, V57, P1, DOI 10.1037/a0018082; Sebhatu M, 2007, B WORLD HEALTH ORGAN, V85, P593, DOI 10.2471/BLT.06.038604; Shapiro AE, 2012, AM J RESP CRIT CARE, V185, P1110, DOI 10.1164/rccm.201111-1941OC; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Tadesse T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028258; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Verdier JE, 2012, INFECT DIS REP, V4, P101, DOI 10.4081/idr.2012.e26; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2012, REC INV CONT PERS IN; World Health Organization, 2013, WHO GLOB TUB REP 201; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2014, WHOHTMTB201408; Xu Chen, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P693; Yimer S, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-112	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160514	10.1371/journal.pone.0160514	http://dx.doi.org/10.1371/journal.pone.0160514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483160	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700054
J	Pedersen, NM; Thorvaldsen, TE; Schultz, SW; Wenzel, EM; Stenmark, H				Pedersen, Nina Marie; Thorvaldsen, Tor Espen; Schultz, Sebastian Wolfgang; Wenzel, Eva Maria; Stenmark, Harald			Formation of Tankyrase Inhibitor-Induced Degradasomes Requires Proteasome Activity	PLOS ONE			English	Article							BETA-CATENIN; PROTEIN ASSEMBLIES; CANCER-CELLS; WNT PATHWAY; FOXM1; AXIN; GROWTH; ACCUMULATION; TARGET; APC	In canonical Wnt signaling, the protein levels of the key signaling mediator beta-catenin are under tight regulation by the multimeric destruction complex that mediates proteasomal degradation of beta-catenin. In colorectal cancer, destruction complex activity is often compromised due to mutations in the multifunctional scaffolding protein Adenomatous Polyposis Coli (APC), leading to a stabilization of beta-catenin. Recently, tankyrase inhibitors (TNKSi), a novel class of small molecule inhibitors, were shown to re-establish a functional destruction complex in APC-mutant cancer cell lines by stabilizing AXIN1/2, whose protein levels are usually kept low via poly(ADP-ribosyl) ation by the tankyrase enzymes (TNKS1/2). Surprisingly, we found that for the formation of the morphological correlates of destruction complexes, called degradasomes, functional proteasomes are required. In addition we found that AXIN2 is strongly upregulated after 6 h of TNKS inhibition. The proteasome inhibitor MG132 counteracted TNKSi-induced degradasome formation and AXIN2 stabilization, and this was accompanied by reduced transcription of AXIN2. Mechanistically we could implicate the transcription factor FoxM1 in this process, which was recently shown to be a transcriptional activator of AXIN2. We observed a substantial reduction in TNKSi-induced stabilization of AXIN2 after siRNA-mediated depletion of FoxM1 and found that proteasome inhibition reduced the active (phosphorylated) fraction of FoxM1. This can explain the decreased protein levels of AXIN2 after MG132 treatment. Our findings have implications for the design of in vitro studies on the destruction complex and for clinical applications of TNKSi.	[Pedersen, Nina Marie; Thorvaldsen, Tor Espen; Schultz, Sebastian Wolfgang; Wenzel, Eva Maria; Stenmark, Harald] Oslo Univ Hosp, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Pedersen, Nina Marie; Thorvaldsen, Tor Espen; Schultz, Sebastian Wolfgang; Wenzel, Eva Maria; Stenmark, Harald] Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway	University of Oslo; University of Oslo	Wenzel, EM; Stenmark, H (corresponding author), Oslo Univ Hosp, Fac Med, Ctr Canc Biomed, Oslo, Norway.; Wenzel, EM; Stenmark, H (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Mol Cell Biol, Oslo, Norway.	eva.wenzel@rr-research.no; stenmark@ulrik.uio.no	Stenmark, Harald/B-8868-2008	Wenzel, Eva Maria/0000-0002-5561-3344	Norwegian Cancer Society [4541899145315, 6789795-2015]; South-Eastern Norway Regional Health Authority [2015014]; Research Council of Norway [179571]	Norwegian Cancer Society(Norwegian Cancer Society); South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway)	NMP is a postdoctoral fellow of the Norwegian Cancer Society (Grant number 4541899145315, https://kreftforeningen.no/en/). TET is a PhD student of the South-Eastern Norway Regional Health Authority (http://www.helse-sorost.no/). SWS is a research fellow of the Norwegian Cancer Society (Grant number 6789795-2015). EMW is a senior research fellow of the South-Eastern Norway Regional Health Authority (Grant number 2015014). HS has been supported by the Norwegian Cancer Society. This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179571 (http://www.forskningsradet.no/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006593; Chen YH, 2016, EMBO J, V35, P668, DOI 10.15252/embj.201592810; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DaRosa PA, 2016, PROTEIN SCI, V25, P1744, DOI 10.1002/pro.2968; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; De Rycker M, 2004, MOL CELL BIOL, V24, P9802, DOI 10.1128/MCB.24.22.9802-9812.2004; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Grigoreva TA, 2015, ONCOTARGET, V6, P24733, DOI 10.18632/oncotarget.4619; Haikarainen T, 2014, CURR PHARM DESIGN, V20, P6472, DOI 10.2174/1381612820666140630101525; Halasi M, 2016, J BIOL CHEM, V291, P142, DOI 10.1074/jbc.M115.678227; Haslekas C, 2005, MOL BIOL CELL, V16, P5832, DOI 10.1091/mbc.E05-05-0456; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Liu CM, 2010, J MOL CELL BIOL, V2, P70, DOI 10.1093/jmcb/mjp040; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Martino-Echarri E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150484; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Pedersen NM, 2012, TRAFFIC, V13, P1547, DOI 10.1111/j.1600-0854.2012.01400.x; Rastogi N, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-26; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Thorvaldsen TE, 2015, MOL CANCER RES, V13, P1487, DOI 10.1158/1541-7786.MCR-15-0125; Voronkov A, 2013, J MED CHEM, V56, P3012, DOI 10.1021/jm4000566; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Wang ZH, 2016, GENETICS, V203, P269, DOI 10.1534/genetics.115.183244; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhu HB, 2005, CANCER BIOL THER, V4, P781, DOI 10.4161/cbt.4.7.1897; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160507	10.1371/journal.pone.0160507	http://dx.doi.org/10.1371/journal.pone.0160507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482906	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700052
J	Yao, J; Wang, BJ				Yao, Jun; Wang, Bao-jie			Genetic Variation of 25 Y-Chromosomal and 15 Autosomal STR Loci in the Han Chinese Population of Liaoning Province, Northeast China	PLOS ONE			English	Article							ETHNIC-MINORITY; GUIZHOU PROVINCE; SOUTHWEST CHINA; EAST CHINA; PATERNAL LINEAGES; HAPLOTYPES; DIVERSITY; STRATIFICATION; POLYMORPHISMS; ESTABLISHMENT	In the present study, we investigated the genetic characteristics of 25 Y-chromosomal and 15 autosomal short tandem repeat (STR) loci in 305 unrelated Han Chinese male individuals from Liaoning Province using AmpFISTR1 Yfiler1 Plus and Identifiler (TM) PCR amplification kits. Population comparison was performed between Liaoning Han population and different ethnic groups to better understand the genetic background of the Liaoning Han population. For Y-STR loci, the overall haplotype diversity was 0.9997 and the discrimination capacity was 0.9607. Gene diversity values ranged from 0.4525 (DYS391) to 0.9617 (DYS385). Rst and two multi-dimensional scaling plots showed that minor differences were observed when the Liaoning Han population was compared to the Jilin Han Chinese, Beijing Han Chinese, Liaoning Manchu, Liaoning Mongolian, Liaoning Xibe, Shandong Han Chinese, Jiangsu Han Chinese, Anhui Han Chinese, Guizhou Han Chinese and Liaoning Hui populations; by contrast, major differences were observed when the Shanxi Han Chinese, Yunnan Bai, Jiangxi Han Chinese, Guangdong Han Chinese, Liaoning Korean, Hunan Tujia, Guangxi Zhuang, Gansu Tibetan, Xishuangbanna Dai, South Korean, Japanese and Hunan Miao populations. For autosomal STR loci, DP ranged from 0.9621 (D2S1338) to 0.8177 (TPOX), with PE distributing from 0.7521 (D18S51) to 0.2988 (TH01). A population comparison was performed and no statistically significant differences were detected at any STR loci between Liaoning Han, China Dong, and Shaanxi Han populations. The results showed that the 25 Y-STR and 15 autosomal STR loci in the Liaoning Han population were valuable for forensic applications and human genetics, and Liaoning Han was an independent endogenous ethnicity with a unique subpopulation structure.	[Yao, Jun; Wang, Bao-jie] China Med Univ, Sch Forens Med, Shenyang 110122, Peoples R China	China Medical University	Wang, BJ (corresponding author), China Med Univ, Sch Forens Med, Shenyang 110122, Peoples R China.	wangbj77@163.com	WANG, JINGYI/GSJ-1241-2022; wang, jie/GRS-0942-2022					Bai RF, 2013, FORENSIC SCI INT-GEN, V7, P214, DOI 10.1016/j.fsigen.2012.10.004; Black ML, 2006, HUM BIOL, V78, P277, DOI 10.1353/hub.2006.0041; Budowle B, 2009, J FORENSIC SCI, V54, P1016, DOI 10.1111/j.1556-4029.2009.01105.x; Chen JG, 2012, FORENSIC SCI INT-GEN, V6, pE178, DOI 10.1016/j.fsigen.2012.06.009; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Chu D S, 1984, Chin Sociol Anthropol, V16, P1; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Guo F, 2016, FORENSIC SCI INT-GEN, V22, pE9, DOI 10.1016/j.fsigen.2016.01.007; Guo F, 2015, FORENSIC SCI INT-GEN, V17, P153, DOI 10.1016/j.fsigen.2015.05.008; Guo F, 2015, FORENSIC SCI INT-GEN, V16, P86, DOI 10.1016/j.fsigen.2014.12.007; Guo JJ, 2015, FORENSIC SCI INT-GEN, V17, P81, DOI 10.1016/j.fsigen.2015.03.016; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Han YN, 2016, FORENSIC SCI INT-GEN, V22, P8, DOI 10.1016/j.fsigen.2016.01.003; He J, 2013, FORENSIC SCI INT-GEN, V7, pE84, DOI 10.1016/j.fsigen.2012.12.006; Huang Q, 2013, FORENSIC SCI INT-GEN, V7, pE31, DOI 10.1016/j.fsigen.2012.10.006; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Kim YJ, 2001, FORENSIC SCI INT, V115, P231, DOI 10.1016/S0379-0738(00)00332-7; Larmuseau MHD, 2015, HEREDITY, V115, P3, DOI 10.1038/hdy.2015.5; Li LM, 2016, FORENSIC SCI INT-GEN, V20, P101, DOI 10.1016/j.fsigen.2015.10.007; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mizuno N, 2008, FORENSIC SCI INT, V174, P70, DOI 10.1016/j.forsciint.2007.01.032; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park MJ, 2005, FORENSIC SCI INT, V152, P133, DOI 10.1016/j.forsciint.2004.07.016; Pickrahn I, 2016, FORENSIC SCI INT-GEN, V21, P90, DOI 10.1016/j.fsigen.2015.12.014; Ploski R, 2002, HUM GENET, V110, P592, DOI 10.1007/s00439-002-0728-0; Qin PF, 2014, EUR J HUM GENET, V22, P248, DOI 10.1038/ejhg.2013.111; Roewer L, 2001, FORENSIC SCI INT, V118, P106, DOI 10.1016/S0379-0738(00)00478-3; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; Silva RC, 2016, FORENSIC SCI INT-GEN, V21, pE10, DOI 10.1016/j.fsigen.2015.11.007; Tang Jianpin, 2009, Legal Medicine, V11, P144, DOI 10.1016/j.legalmed.2008.10.003; Tereba A., 1999, PROFILES DNA, V2, P14, DOI [10.1016/S0958-2118(99)90163-5, DOI 10.1016/S0958-2118(99)90163-5]; Tie J, 2006, J FORENSIC SCI, V51, P188, DOI 10.1111/j.1556-4029.2005.00037.x; Trejaut JA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-77; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang Y, 2016, FORENSIC SCI INT-GEN, V21, P5, DOI 10.1016/j.fsigen.2015.09.013; Wu Yuan-Ming, 2008, Forensic Sci Int Genet, V2, pe15, DOI 10.1016/j.fsigen.2007.11.003; Xu J, 2016, FORENSIC SCI INT-GEN, V22, pE15, DOI 10.1016/j.fsigen.2016.01.016; Xu SH, 2009, AM J HUM GENET, V85, P762, DOI 10.1016/j.ajhg.2009.10.015; Yang Y, 1994, Chin J Popul Sci, V6, P129; Yao J, 2016, FORENSIC SCI INT-GEN, V23, pE20, DOI 10.1016/j.fsigen.2016.04.012; Yoo SY, 2011, MOL CELLS, V32, P15, DOI 10.1007/s10059-011-2288-4; Zhang L, 2015, FORENSIC SCI INT-GEN, V17, P108, DOI 10.1016/j.fsigen.2015.04.006; Zhang L, 2015, FORENSIC SCI INT-GEN, V16, P237, DOI 10.1016/j.fsigen.2015.02.005; Zhang L, 2015, FORENSIC SCI INT-GEN, V16, pE3, DOI 10.1016/j.fsigen.2014.11.002; Zhang YD, 2015, SCI REP-UK, V5, DOI 10.1038/srep08872; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247; Zhu G, 1987, Renkou Yanjiu, P24	49	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160415	10.1371/journal.pone.0160415	http://dx.doi.org/10.1371/journal.pone.0160415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483472	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700043
J	de Fante, T; Simino, LA; Reginato, A; Payolla, TB; Vitoreli, DCG; de Souza, M; Torsoni, MA; Milanski, M; Torsoni, AS				de Fante, Thais; Simino, Lais Angelica; Reginato, Andressa; Payolla, Tanyara Baliani; Gustavo Vitoreli, Debora Cristina; de Souza, Monique; Torsoni, Marcio Alberto; Milanski, Marciane; Torsoni, Adriana Souza			Diet-Induced Maternal Obesity Alters Insulin Signalling in Male Mice Offspring Rechallenged with a High-Fat Diet in Adulthood	PLOS ONE			English	Article							IN-UTERO EXPOSURE; GLUCOSE-METABOLISM; AUTONOMIC CONTROL; LIPID-METABOLISM; GENE-EXPRESSION; RESISTANCE; INFLAMMATION; PREGNANCY; SENSITIVITY; METHYLATION	Modern lifestyle has resulted in an increase in the prevalence of obesity and its comorbidities in pregnant women and the young population. It has been well established that the consumption of a high-fat diet (HFD) has many direct effects on glucose metabolism. However, it is important to assess whether maternal consumption of a HFD during critical periods of development can lead to metabolic changes in the offspring metabolism. This study evaluated the potential effects of metabolic programming on the impairment of insulin signalling in recently weaned offspring from obese dams. Additionally, we investigated if early exposure to an obesogenic environment could exacerbate the impairment of glucose metabolism in adult life in response to a HFD. Swiss female mice were fed with Standard Chow (SC) or a HFD during gestation and lactation and tissues from male offspring were analysed at d28 and d82. Offspring from obese dams had greater weight gain and higher adiposity and food intake than offspring from control dams. Furthermore, they showed impairment in insulin signalling in central and peripheral tissues, which was associated with the activation of inflammatory pathways. Adipose tissue was ultimately the most affected in adult offspring after HFD rechallenge; this may have contributed to the metabolic deregulation observed. Overall, our results suggest that diet-induced maternal obesity leads to increased susceptibility to obesity and impairment of insulin signalling in offspring in early and late life that cannot be reversed by SC consumption, but can be aggravated by HFD re-exposure.	[de Fante, Thais; Simino, Lais Angelica; Reginato, Andressa; Payolla, Tanyara Baliani; Gustavo Vitoreli, Debora Cristina; de Souza, Monique; Torsoni, Marcio Alberto; Milanski, Marciane; Torsoni, Adriana Souza] Univ Estadual Campinas, Sch Appl Sci, Lab Metab Disorders, Limeira, SP, Brazil	Universidade Estadual de Campinas	Torsoni, AS (corresponding author), Univ Estadual Campinas, Sch Appl Sci, Lab Metab Disorders, Limeira, SP, Brazil.	adriana.torsoni@fca.unicamp.br	Torsoni, Marcio/AAH-3450-2020; Milanski, Marciane/F-5410-2012; Torsoni, Adriana/HGC-4584-2022	Milanski, Marciane/0000-0002-6322-5368; Torsoni, Marcio/0000-0002-9663-5291; Baliani Payolla, Tanyara/0000-0003-0273-8589; Torsoni, Adriana/0000-0003-2287-7180	Sao Paulo Research Foundation (FAPESP) [2011/22156-7, 2013/12003-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project has been funded by grants 2011/22156-7 (AST) and 2013/12003-4 (TF), Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2011, BIOCHEM J, V438, P369, DOI 10.1042/BJ20110373; Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Benatti RO, 2014, BRIT J NUTR, V111, P2112, DOI 10.1017/S0007114514000579; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Bouret SG, 2010, FORUM NUTR, V63, P84, DOI 10.1159/000264396; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Challier JC, 2008, PLACENTA, V29, P274, DOI 10.1016/j.placenta.2007.12.010; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chen H, 2014, J NEUROCHEM, V129, P297, DOI 10.1111/jnc.12623; Chen L, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/508409; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Dearden L, 2015, FRONT NEUROENDOCRIN, V39, P3, DOI 10.1016/j.yfrne.2015.08.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Geerling JJ, 2014, J LIPID RES, V55, P180, DOI 10.1194/jlr.R045013; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gregorio BM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.042; Gupta A, 2009, J ENDOCRINOL, V200, P293, DOI 10.1677/JOE-08-0429; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Isganaitis E, 2014, DIABETES, V63, P688, DOI 10.2337/db13-0558; Kang SS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0156-9; Kruse M, 2013, ENDOCRINOLOGY, V154, P3565, DOI 10.1210/en.2012-1877; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Lottenberg AM, 2012, J NUTR BIOCHEM, V23, P1027, DOI 10.1016/j.jnutbio.2012.03.004; Marco A, 2014, FASEB J, V28, P4148, DOI 10.1096/fj.14-255620; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; Matsusue K, 2010, BIOL PHARM BULL, V33, P346, DOI 10.1248/bpb.33.346; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Melo AM, 2014, METABOLISM, V63, P682, DOI 10.1016/j.metabol.2014.02.002; Munzberg H, 2005, CELL MOL LIFE SCI, V62, P642, DOI 10.1007/s00018-004-4432-1; National Research Council, GUIDE FOR THE CARE A; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Rother E, 2012, ENDOCRINOLOGY, V153, P770, DOI 10.1210/en.2011-1589; Ruchat SM, 2013, NUTR REV, V71, pS88, DOI 10.1111/nure.12057; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Seoane-Collazo P, 2015, ENDOCRINE, V50, P276, DOI 10.1007/s12020-015-0658-y; Shamsi BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106992; Shankar K, 2011, ENDOCRINOLOGY, V152, P4158, DOI 10.1210/en.2010-1078; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Thakali KM, 2014, PEDIATR RES, V76, P202, DOI 10.1038/pr.2014.72; Tiganis T, 2013, FEBS J, V280, P445, DOI 10.1111/j.1742-4658.2012.08563.x; Valdearcos M, 2015, ANNU REV PHYSIOL, V77, P131, DOI 10.1146/annurev-physiol-021014-071656; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wieser V, 2013, ARCH IMMUNOL THER EX, V61, P119, DOI 10.1007/s00005-012-0210-1; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Yokomizo H, 2014, AM J PHYSIOL-ENDOC M, V306, pE1163, DOI 10.1152/ajpendo.00688.2013; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zheng J, 2014, BRIT J NUTR, V112, P1850, DOI 10.1017/S0007114514002827; Zhu MJ, 2010, PLACENTA, V31, P387, DOI 10.1016/j.placenta.2010.02.002	54	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160184	10.1371/journal.pone.0160184	http://dx.doi.org/10.1371/journal.pone.0160184			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479001	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110300030
J	Ferroni, FM; Tolmie, C; Smit, MS; Opperman, DJ				Ferroni, Felix Martin; Tolmie, Carmien; Smit, Martha Sophia; Opperman, Diederik Johannes			Structural and Catalytic Characterization of a Fungal Baeyer-Villiger Monooxygenase	PLOS ONE			English	Article							4-HYDROXYACETOPHENONE MONOOXYGENASE; CRYSTAL-STRUCTURE; CLONING; EXPRESSION; OXIDATION; DISCOVERY; INSIGHT; DESIGN	Baeyer-Villiger monooxygenases (BVMOs) are biocatalysts that convert ketones to esters. Due to their high regio-, stereo- and enantioselectivity and ability to catalyse these reactions under mild conditions, they have gained interest as alternatives to chemical BaeyerVilliger catalysts. Despite their widespread occurrence within the fungal kingdom, most of the currently characterized BVMOs are from bacterial origin. Here we report the catalytic and structural characterization of BVMOAFL838 from Aspergillus flavus. BVMOAFL838 converts linear and aryl ketones with high regioselectivity. Steadystate kinetics revealed BVMOAFL838 to show significant substrate inhibition with phenylacetone, which was more pronounced at low pH, enzyme and buffer concentrations. Para substitutions on the phenyl group significantly improved substrate affinity and increased turnover frequencies. Steadystate kinetics revealed BVMOAFL838 to preferentially oxidize aliphatic ketones and aryl ketones when the phenyl group are separated by at least two carbons from the carbonyl group. The Xray crystal structure, the first of a fungal BVMO, was determined at 1.9 angstrom and revealed the typical overall fold seen in type I bacterial BVMOs. The active site Arg and Asp are conserved, with the Arg found in the "in" position. Similar to phenylacetone monooxygenase (PAMO), a two residue insert relative to cyclohexanone monooxygenase (CHMO) forms a bulge within the active site. Approximately half of the "variable" loop is folded into a short ahelix and covers part of the active site entry channel in the non-NADPH bound structure. This study adds to the current efforts to rationalize the substrate scope of BVMOs through comparative catalytic and structural investigation of different BVMOs.	[Ferroni, Felix Martin; Tolmie, Carmien; Smit, Martha Sophia; Opperman, Diederik Johannes] Univ Free State, Dept Biotechnol, Bloemfontein, South Africa	University of the Free State	Opperman, DJ (corresponding author), Univ Free State, Dept Biotechnol, Bloemfontein, South Africa.	opperdj@ufs.ac.za	Smit, Martha S/B-5410-2013; Opperman, Diederik J/F-5400-2012; Ferroni, Felix M/G-7664-2014	Smit, Martha S/0000-0002-1295-6507; Opperman, Diederik J/0000-0002-2737-8797; Ferroni, Felix M/0000-0001-6257-6898; Tolmie, Carmien/0000-0001-9095-3048	National Research Foundation, South Africa (NRF) [87889]	National Research Foundation, South Africa (NRF)(National Research Foundation - South Africa)	Support was provided by DJO-National Research Foundation, South Africa (NRF Grant No 87889). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke K, 2012, ORG BIOMOL CHEM, V10, P6249, DOI 10.1039/c2ob25704a; Bisagni S, 2014, J MOL CATAL B-ENZYM, V109, P161, DOI 10.1016/j.molcatb.2014.08.020; Bocola M, 2005, ADV SYNTH CATAL, V347, P979, DOI 10.1002/adsc.200505069; Clouthier CM, 2006, J ORG CHEM, V71, P8431, DOI 10.1021/jo0613636; Dudek HM, 2014, APPL MICROBIOL BIOT, V98, P4009, DOI 10.1007/s00253-013-5364-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferroni FM, 2014, J MOL CATAL B-ENZYM, V107, P47, DOI 10.1016/j.molcatb.2014.05.015; Fraaije MW, 2005, APPL MICROBIOL BIOT, V66, P393, DOI 10.1007/s00253-004-1749-5; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Franceschini S, 2012, J BIOL CHEM, V287, P22626, DOI 10.1074/jbc.M112.372177; Kamerbeek NM, 2003, ADV SYNTH CATAL, V345, P667, DOI 10.1002/adsc.200303014; Kamerbeek NM, 2003, APPL ENVIRON MICROB, V69, P419, DOI 10.1128/AEM.69.1.419-426.2003; Kamerbeek NM, 2001, EUR J BIOCHEM, V268, P2547, DOI 10.1046/j.1432-1327.2001.02137.x; Mascotti ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132689; Leisch H, 2012, APPL ENVIRON MICROB, V78, P2200, DOI 10.1128/AEM.07694-11; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Leslie A. G. W., 2007, NATO SCI SERIES, V245, P45, DOI DOI 10.1007/978-1-4020-6316-9_; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Mascotti ML, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-33; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; MIYAMOTO M, 1995, BBA-PROTEIN STRUCT M, V1251, P115, DOI 10.1016/0167-4838(95)00090-H; Moonen MJH, 2005, ADV SYNTH CATAL, V347, P1027, DOI 10.1002/adsc.200404307; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Opperman DJ, 2010, CHEMBIOCHEM, V11, P2589, DOI 10.1002/cbic.201000464; Orru R, 2011, J BIOL CHEM, V286, P29284, DOI 10.1074/jbc.M111.255075; Pazmino DET, 2010, CURR OPIN CHEM BIOL, V14, P138, DOI 10.1016/j.cbpa.2009.11.017; Pham SQ, 2013, BIOTECHNOL BIOENG, V110, P363, DOI 10.1002/bit.24632; Rehdorf J, 2007, BIOTECHNOL LETT, V29, P1393, DOI 10.1007/s10529-007-9401-y; Rehdorf J, 2009, APPL ENVIRON MICROB, V75, P3106, DOI 10.1128/AEM.02707-08; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Volker A, 2008, APPL MICROBIOL BIOT, V77, P1251, DOI 10.1007/s00253-007-1264-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yachnin BJ, 2014, ACS CHEM BIOL, V9, P2843, DOI 10.1021/cb500442e; Yachnin BJ, 2012, J AM CHEM SOC, V134, P7788, DOI 10.1021/ja211876p; Zhang ZG, 2012, CHEM-EUR J, V18, P10160, DOI 10.1002/chem.201202163	37	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160186	10.1371/journal.pone.0160186	http://dx.doi.org/10.1371/journal.pone.0160186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472055	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300035
J	Troger, B; Hartel, C; Buer, J; Dordelmann, M; Felderhoff-Muser, U; Hohn, T; Hepping, N; Hillebrand, G; Kribs, A; Marissen, J; Olbertz, D; Rath, PM; Schmidtke, S; Siegel, J; Herting, E; Gopel, W; Steinmann, J; Stein, A				Troeger, Birte; Haertel, Christoph; Buer, Jan; Doerdelmann, Michael; Felderhoff-Mueser, Ursula; Hoehn, Thomas; Hepping, Nico; Hillebrand, Georg; Kribs, Angela; Marissen, Janina; Olbertz, Dirk; Rath, Peter-Michael; Schmidtke, Susanne; Siegel, Jens; Herting, Egbert; Goepel, Wolfgang; Steinmann, Joerg; Stein, Anja			Clinical Relevance of Pathogens Detected by Multiplex PCR in Blood of Very-Low-Birth Weight Infants with Suspected Sepsis - Multicentre Study of the German Neonatal Network	PLOS ONE			English	Article							REAL-TIME PCR; LATE-ONSET SEPSIS; STREAM INFECTIONS; MOLECULAR-DETECTION; DIAGNOSIS; DIFFERENTIATION; CULTURE	Introduction In the German Neonatal Network (GNN) 10% of very-low-birth weight infants (VLBWI) suffer from blood-culture confirmed sepsis, while 30% of VLBWI develop clinical sepsis. Diagnosis of sepsis is a difficult task leading to potential over-treatment with antibiotics. This study aims to investigate whether the results of blood multiplex-PCR (SeptiFast (R)) for common sepsis pathogens are relevant for clinical decision making when sepsis is suspected in VLBWI. Methods We performed a prospective, multi-centre study within the GNN including 133 VLBWI with 214 episodes of suspected late onset sepsis (LOS). In patients with suspected sepsis a multiplex-PCR (LightCycler SeptiFast MGRADE-test (R)) was performed from 100 mu l EDTA blood in addition to center-specific laboratory biomarkers. The attending neonatologist documented whether the PCR-result, which was available after 24 to 48 hrs, had an impact on the choice of antibiotic drugs and duration of therapy. Results PCR was positive in 110/214 episodes (51%) and blood culture (BC) was positive in 55 episodes (26%). Both methods yielded predominantly coagulase-negative staphylococci (CoNS) followed by Escherichia coli and Staphylococcus aureus. In 214 BC-PCR paired samples concordant results were documented in 126 episodes (59%; n = 32 were concordant pathogen positive results, n = 94 were negative in both methods). In 65 episodes (30%) we found positive PCR results but negative BCs, with CoNS being identified in 43 (66%) of these samples. Multiplex-PCR results influenced clinical decision making in 30% of episodes, specifically in 18% for the choice of antimicrobial therapy and in 22% for the duration of antimicrobial therapy. Conclusions Multiplex-PCR results had a moderate impact on clinical management in about one third of LOS-episodes. The main advantage of multiplex-PCR was the rapid detection of pathogens from micro-volume blood samples. In VLBWI limitations include risk of contamination, lack of resistance testing and high costs. The high rate of positive PCR results in episodes of negative BC might lead to overtreatment of infants which is associated with risk of mortality, antibiotic resistance, fungal sepsis and NEC.	[Troeger, Birte; Haertel, Christoph; Marissen, Janina; Herting, Egbert; Goepel, Wolfgang] Univ Lubeck, Dept Pediat, Lubeck, Germany; [Buer, Jan; Rath, Peter-Michael; Steinmann, Joerg] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Doerdelmann, Michael] Diakonissen Hosp Flensburg, Dept Pediat, Flensburg, Germany; [Felderhoff-Mueser, Ursula; Stein, Anja] Univ Duisburg Essen, Univ Hosp Essen, Dept Pediat, Essen, Germany; [Hoehn, Thomas] Univ Dusseldorf, Dept Pediat, Dusseldorf, Germany; [Hepping, Nico] St Marien Hosp Bonn, Dept Pediat, Bonn, Germany; [Hillebrand, Georg] Hosp Itzehoe, Dept Pediat, Itzehoe, Germany; [Kribs, Angela] Univ Cologne, Dept Pediat, Cologne, Germany; [Olbertz, Dirk] Sudstadt Hosp Rostock, Neonatol Unit, Rostock, Germany; [Schmidtke, Susanne] Asclepios Hosp Hamburg Barmbek, Neonatol Unit, Hamburg, Germany; [Siegel, Jens] Childrens Hosp Hannover Auf der Bult, Neonatol Unit, Hannover, Germany	University of Lubeck; University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf; St. Marien Hospital; University of Cologne	Troger, B (corresponding author), Univ Lubeck, Dept Pediat, Lubeck, Germany.	birte.troeger@uksh.de	Härtel, Christoph/ABD-8841-2020; Felderhoff-Müser, Ursula/AAU-9682-2020	Buer, Jan/0000-0002-7602-1698; Stein, Anja/0000-0002-0497-4609	German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research) [Go955/1-3]	German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research)	This study is supported by a grant of German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research), award number: Go955/1-3, recipient Wolfgang Gopel. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Cantey JB, 2014, INFECT DIS CLIN N AM, V28, P247, DOI 10.1016/j.idc.2014.01.005; Chang SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062323; Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1542/peds.2005-2677; Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126; Faust K, 2011, CHEMOTHERAPIE J, V20, P1; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Hartel C, 2016, INFECT CONT HOSP EP, V4, P1; Idelevich E, 2015, MED MICROBIOL IMMUN, V204, P585, DOI 10.1007/s00430-014-0385-7; Kasper DC, 2013, NEONATOLOGY, V103, P268, DOI 10.1159/000346365; Klaschik S, 2004, J CLIN MICROBIOL, V42, P512, DOI 10.1128/JCM.42.2.512-517.2004; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lucignano B, 2011, J CLIN MICROBIOL, V49, P2252, DOI 10.1128/JCM.02460-10; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Mussap M, 2007, J Chemother, V19 Suppl 2, P31; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Schwab F, 2007, J HOSP INFECT, V65, P319, DOI 10.1016/j.jhin.2006.12.020; SONG JH, 1993, J CLIN MICROBIOL, V31, P1439, DOI 10.1128/JCM.31.6.1439-1443.1993; Stoll BJ, 2005, PEDIATR INFECT DIS J, V24, P635, DOI 10.1097/01.inf.0000168749.82105.64; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Troger B, 2014, PEDIATR INFECT DIS J, V33, P238, DOI 10.1097/INF.0000000000000031; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Tschiedel E, 2012, KLIN PADIATR, V224, P12, DOI 10.1055/s-0031-1285878; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x	25	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159821	10.1371/journal.pone.0159821	http://dx.doi.org/10.1371/journal.pone.0159821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472282	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300021
J	Huang, LT; Yang, XJ; Huang, Y; Sun, EY; Sun, M				Huang, Lanting; Yang, Xiu-Juan; Huang, Ying; Sun, Eve Y.; Sun, Mu			Ketamine Protects Gamma Oscillations by Inhibiting Hippocampal LTD	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RECEPTOR ANTAGONIST MEMANTINE; IN-VITRO; FREQUENCY OSCILLATIONS; SYNAPTIC PLASTICITY; RAT HIPPOCAMPUS; NETWORK OSCILLATIONS; CA1; SLICES; MECHANISMS	NMDA receptors have been widely reported to be involved in the regulation of synaptic plasticity through effects on long-term potentiation (LTP) and long-term depression (LTD). LTP and LTD have been implicated in learning and memory processes. Besides synaptic plasticity, it is known that the phenomenon of gamma oscillations is critical in cognitive functions. Synaptic plasticity has been widely studied, however it is still not clear, to what degree synaptic plasticity regulates the oscillations of neuronal networks. Two NMDA receptor antagonists, ketamine and memantine, have been shown to regulate LTP and LTD, to promote cognitive functions, and have even been reported to bring therapeutic effects in major depression and Alzheimer's disease respectively. These compounds allow us to investigate the putative interrelationship between network oscillations and synaptic plasticity and to learn more about the mechanisms of their therapeutic effects. In the present study, we have identified that ketamine and memantine could inhibit LTD, without impairing LTP in the CA1 region of mouse hippocampus, which may underlie the mechanism of these drugs' therapeutic effects. Our results suggest that NMDA-induced LTD caused a marked loss in the gamma power, and pretreatment with 10 mu M ketamine prevented the oscillatory loss via its inhibitory effect on LTD. Our study provides a new understanding of the role of NMDA receptors on hippocampal plasticity and oscillations.	[Huang, Lanting; Yang, Xiu-Juan; Sun, Mu] GSK, Neurodegenerat Discovery Performance Unit, R&D Shanghai, Bldg 1,917 Halei Rd,Zhangjiang Hitech Pk, Shanghai, Peoples R China; [Huang, Ying] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai, Peoples R China; [Huang, Lanting; Sun, Eve Y.] Tongji Univ, Collaborat Innovat Ctr Brain Sci, Stem Cell Translat Res Ctr, Tongji Hosp,Sch Med, Shanghai, Peoples R China	GlaxoSmithKline; Fudan University; Tongji University	Sun, M (corresponding author), GSK, Neurodegenerat Discovery Performance Unit, R&D Shanghai, Bldg 1,917 Halei Rd,Zhangjiang Hitech Pk, Shanghai, Peoples R China.	sunmu@hotmail.com	Sun, Mu/A-6772-2008	Sun, Mu/0000-0001-8261-3705	GSK	GSK(GlaxoSmithKline)	GSK provided support in the form of salaries for authors LH, XY, and MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Babiloni C, 2013, CLIN NEUROPHYSIOL, V124, P837, DOI 10.1016/j.clinph.2012.09.017; Bartlett TE, 2013, NEUROPHARMACOLOGY, V74, P59, DOI 10.1016/j.neuropharm.2013.01.012; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bikbaev A, 2008, FRONT NEUROSCI-SWITZ, V2, P56, DOI 10.3389/neuro.01.010.2008; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2015, NAT NEUROSCI, V18, P484, DOI 10.1038/nn.3952; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Carlson PJ, 2013, BIOL PSYCHIAT, V73, P1213, DOI 10.1016/j.biopsych.2013.02.008; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Dickinson R, 2003, NEUROPHARMACOLOGY, V44, P864, DOI 10.1016/S0028-3908(03)00083-2; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Driver JE, 2007, EUR J NEUROSCI, V26, P1280, DOI 10.1111/j.1460-9568.2007.05705.x; Faulkner HJ, 1999, BRIT J PHARMACOL, V128, P1813, DOI 10.1038/sj.bjp.0702948; Fisahn A, 2005, J PHYSIOL-LONDON, V562, P65, DOI 10.1113/jphysiol.2004.077388; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Frankiewicz T, 1996, BRIT J PHARMACOL, V117, P689, DOI 10.1111/j.1476-5381.1996.tb15245.x; Frankiewicz T, 1999, NEUROPHARMACOLOGY, V38, P1253, DOI 10.1016/S0028-3908(99)00060-X; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Graef JD, 2015, BRAIN RES, V1609, P31, DOI 10.1016/j.brainres.2015.03.019; Guadagna S, 2012, NEUROPHARMACOLOGY, V62, P2208, DOI 10.1016/j.neuropharm.2012.01.014; Gunduz-Bruce H, 2009, BRAIN RES REV, V60, P279, DOI 10.1016/j.brainresrev.2008.07.006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hesselink MB, 1999, PHARMACEUT RES, V16, P637, DOI 10.1023/A:1018856020583; Hosenbocus S, 2013, J CAN ACAD CHILD ADO, V22, P166; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Hyman JM, 2003, J NEUROSCI, V23, P11725; Izumi Y, 2014, NEUROPHARMACOLOGY, V86, P273, DOI 10.1016/j.neuropharm.2014.08.002; Kamal A, 1999, EUR J NEUROSCI, V11, P3512, DOI 10.1046/j.1460-9568.1999.00769.x; KORNHUBER J, 1995, NEUROSCI LETT, V195, P137, DOI 10.1016/0304-3940(95)11785-U; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Leiser SC, 2011, BIOCHEM PHARMACOL, V81, P1408, DOI 10.1016/j.bcp.2010.10.002; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Maxwell CR, 2006, J PHARMACOL EXP THER, V316, P315, DOI 10.1124/jpet.105.091199; McNally JM, 2011, NEUROSCIENCE, V199, P51, DOI 10.1016/j.neuroscience.2011.10.015; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Okamoto SI, 2009, NAT MED, V15, P1407, DOI 10.1038/nm.2056; Pozueta J, 2013, NEUROSCIENCE, V251, P51, DOI 10.1016/j.neuroscience.2012.05.050; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Ribeiro PO, 2014, BRAIN RES, V1560, P10, DOI 10.1016/j.brainres.2014.03.004; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Rosenzweig ES, 2003, PROG NEUROBIOL, V69, P143, DOI 10.1016/S0301-0082(02)00126-0; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stopps M, 2004, J NEUROSCI METH, V132, P137, DOI 10.1016/j.jneumeth.2003.08.015; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Tikhonravov D, 2010, NEUROSCIENCE, V167, P1175, DOI 10.1016/j.neuroscience.2010.03.014; Traub RD, 1998, PROG NEUROBIOL, V55, P563, DOI 10.1016/S0301-0082(98)00020-3; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van Dam EJM, 2002, NEUROSCI LETT, V320, P129, DOI 10.1016/S0304-3940(02)00037-X; Voytek B, 2015, BIOL PSYCHIAT, V77, P1089, DOI 10.1016/j.biopsych.2015.04.016; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Whittington MA, 1997, J PHYSIOL-LONDON, V502, P591, DOI 10.1111/j.1469-7793.1997.591bj.x; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yamada K, 2005, BEHAV BRAIN RES, V162, P191, DOI 10.1016/j.bbr.2005.02.036	68	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159192	10.1371/journal.pone.0159192	http://dx.doi.org/10.1371/journal.pone.0159192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467732	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100021
J	Yirgu, R; Molla, M; Sibley, L; Gebremariam, A				Yirgu, Robel; Molla, Mitike; Sibley, Lynn; Gebremariam, Abebe			Perinatal Mortality Magnitude, Determinants and Causes in West Gojam: Population-Based Nested Case-Control Study	PLOS ONE			English	Article							DEATHS	Introduction In Ethiopia, even if a significant reduction in child mortality is recorded recently, perinatal mortality rate is still very high. This study assessed the magnitude, determinants and causes of perinatal death in West Gojam zone, Ethiopia. Methods and materials A nested case control study was conducted on 102 cases (mothers who lost their newborns for perinatal death) and 204 controls (mothers who had live infants in the same year) among a cohort of 4097 pregnant mothers in three districts of the West Gojam zone, from Feb 2011 to Mar 2012. Logistic regression models were used to identify the independent determinant factors for perinatal mortality. The World Health Organization verbal autopsy instrument for neonatal death was used to collect mortality data and cause of death was assigned by a pediatrician and a neonatologist. Result Perinatal mortality rate was 25.1(95% CI 20.3, 29.9) per 1000 live and stillbirths. Primiparous mothers had a higher risk of losing their newborn babies for perinatal death than mothers who gave birth to five or more children (AOR = 3.15, 95% CI 1.03-9.60). Babies who were born to women who had a previous history of losing their baby to perinatal death during their last pregnancy showed higher odds of perinatal death than their counterparts (AOR = 9.55, 95% CI 4.67-19.54). Preterm newborns were more at risk for perinatal death (AOR = 9.44, 95% CI 1.81-49.22) than term babies. Newborns who were born among a household of more than two had a lesser risk of dying during the perinatal period as compared to those who were born among a member of only two. Paradoxically, home delivery was found to protect against perinatal death (AOR = 0.07 95% CI, 0.02-0.24) in comparison to institutional delivery. Bacterial sepsis, birth asphyxia and obstructed labour were among the leading causes of perinatal death. Conclusion Perinatal mortality rate remains considerably high, but proper maternal and child health care services can significantly decrease the burden.	[Yirgu, Robel; Molla, Mitike] Univ Addis Ababa, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Coll Hlth Sci, Addis Ababa, Ethiopia; [Sibley, Lynn] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Sibley, Lynn] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Gebremariam, Abebe] Emory Univ, Maternal & Newborn Hlth Ethiopia Partnership Proj, Addis Ababa, Ethiopia	Addis Ababa University; Emory University; Emory University; Rollins School Public Health	Yirgu, R (corresponding author), Univ Addis Ababa, Sch Publ Hlth, Dept Reprod Hlth & Hlth Serv Management, Coll Hlth Sci, Addis Ababa, Ethiopia.	yirgurob@gmail.com	Gobezayehu, Abebe Gebremariam Gebremariam/GXV-9214-2022	Gobezayehu, Abebe Gebremariam Gebremariam/0000-0001-9628-2572	Addis Ababa University; Maternal and Newborn Health in Ethiopia Partnership (MaNHEP) project	Addis Ababa University; Maternal and Newborn Health in Ethiopia Partnership (MaNHEP) project	This work was supported by Addis Ababa University (www.aau.edu.et) to RYB, and Maternal and Newborn Health in Ethiopia Partnership (MaNHEP) project (nursing.emory.edu/manhep/) to MMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainbinder WS, 2007, CURRENT DIAGNOSIS TR; [Anonymous], 2003, REV INCOME WEALTH; Berrington JE, 2012, J PEDIATR-US, V160, P49, DOI 10.1016/j.jpeds.2011.06.046; Centre for Maternal and Child Enquiries (CMACE), 2009, PER MORT; Chalumeau M, 2000, ACTA PAEDIATR, V89, P1115, DOI 10.1080/713794568; CHITTY LS, 1989, ARCH DIS CHILD, V64, P1036, DOI 10.1136/adc.64.7.1036; Diallo AH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-45; Emmanuel T, 2011, PAN AFR MED J, V8; Emory University, 2010, REP BILL MEL GAT FDN; Essen B, 2002, BJOG-INT J OBSTET GY, V109, P677, DOI 10.1016/S1470-0328(02)01077-7; Essen B, 2000, ACTA OBSTET GYN SCAN, V79, P737, DOI 10.1034/j.1600-0412.2000.079009737.x; Federal Democratic Republic of Ethiopia Population Census Commission, 2008, SUMM STAT REP POP HO; Gaym A., 2000, Ethiopian Journal of Health Development, V14, P335; Henriet L, 2011, BRIT J OBSTET GYNAEC, V108, P1036; Hinderaker SG, 2003, J HEALTH POPUL NUTR, V21, P8; Khasakhala AA, 2003, KENYA DEMOGRAPHIC HL; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Molla M., 2012, T GENERATIONAL UNPUB; Nankabirwa V, 2011, PLOS ONE, V6, P1; ORC/Macro/CSA, 2012, ETH DEM HLTH SURV 20; Rhman A, 2011, BIOMED CENTRAL PUBLI, V11, P1; SEIDMAN DS, 1988, J EPIDEMIOL COMMUN H, V42, P294, DOI 10.1136/jech.42.3.294; Tedla TY, 2003, THESIS; Tegegne AB, 2010, ETHIOPIAN J REPROD H, V4, P37; West Gojam zonal health office, 2011, ANN ZON PERF REP 201; World Health Organization, 2006, NEON PER MORT COUNTR; Zhou WJ, 2000, INT J EPIDEMIOL, V29, P100, DOI 10.1093/ije/29.1.100; Zupan J, 2005, NEW ENGL J MED, V352, P2047, DOI 10.1056/NEJMp058032	28	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159390	10.1371/journal.pone.0159390	http://dx.doi.org/10.1371/journal.pone.0159390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467696	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100030
J	Allen, MS; Vella, SA				Allen, Mark S.; Vella, Stewart A.			Personality and Body-Mass-Index in School-Age Children: An Exploration of Mediating and Moderating Variables	PLOS ONE			English	Article							BMI Z-SCORE; CHILDHOOD OBESITY; ADIPOSITY CHANGE; SELF-REGULATION; TRAITS; TEMPERAMENT; ADOLESCENTS; RISK; INTERVENTIONS; ASSOCIATION	This study explored longitudinal associations between personality and body-mass-index (BMI) in school-age children, including the potential mediating role of screen time and physical activity, and the potential moderating roles of child demographics and neighbourhood socioeconomic position. Participants were the parents (and teachers) of 3857 ten-year-old children, who completed questionnaires at baseline with a two-year follow-up. After controlling for child demographics (e.g., sex, pubertal status), we found that personality was unimportant for concurrent BMI, but was important for subsequent BMI and change in BMI over two years. Low levels of introversion and persistence at baseline, and decreases in persistence over time, were associated with a higher BMI at follow-up and a greater increase in BMI over time. Moderator analyses showed that introversion was more strongly related to subsequent BMI for children listed as aboriginal or Torres Strait Islander. The relationship between personality and change in BMI was mediated by screen time, but not by physical activity. To conclude, findings demonstrate that personality is important for change in body mass in Australian children (particularly indigenous children), and that screen-based sedentary behaviour features an important role in this association.	[Allen, Mark S.] Univ Wollongong, Fac Social Sci, Sch Psychol, Northfields Ave, Wollongong, NSW 2522, Australia; [Vella, Stewart A.] Univ Wollongong, Fac Social Sci, Early Start Res Inst, Northfields Ave, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong	Allen, MS (corresponding author), Univ Wollongong, Fac Social Sci, Sch Psychol, Northfields Ave, Wollongong, NSW 2522, Australia.	mark_allen@uow.edu.au		Vella, Stewart/0000-0003-0537-9366; Allen, Mark/0000-0001-5511-9680; Russell-Mayhew, Shelly/0000-0001-5103-8031				Aiken L. S., 1991, MULTIPLE REGRESSION; Allen MS, 2015, BRIT J DEV PSYCHOL, V33, P375, DOI 10.1111/bjdp.12102; Armon G, 2013, EUR J PERSONALITY, V27, P398, DOI 10.1002/per.1902; Bergmeier H, 2014, APPETITE, V74, P125, DOI 10.1016/j.appet.2013.12.006; Berkey CS, 2007, ANN EPIDEMIOL, V17, P44, DOI 10.1016/j.annepidem.2006.07.014; Brummett BH, 2006, J RES PERS, V40, P222, DOI 10.1016/j.jrp.2004.12.002; Casey R, 2014, FOOD QUAL PREFER, V31, P164, DOI 10.1016/j.foodqual.2011.06.003; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; Chapman BP, 2009, HEALTH PSYCHOL, V28, P419, DOI 10.1037/a0015212; Cole TJ, 2005, EUR J CLIN NUTR, V59, P419, DOI 10.1038/sj.ejcn.1602090; de Bruijn GJ, 2005, HEALTH EDUC RES, V20, P635, DOI 10.1093/her/cyh025; Faith MS, 2010, INT J OBESITY, V34, P1515, DOI 10.1038/ijo.2010.156; Francis LA, 2009, ARCH PEDIAT ADOL MED, V163, P297, DOI 10.1001/archpediatrics.2008.579; Graziano PA, 2010, INT J OBESITY, V34, P633, DOI 10.1038/ijo.2009.288; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hampson SE, 2006, HEALTH PSYCHOL, V25, P57, DOI 10.1037/0278-6133.25.1.57; Haycraft E, 2011, APPETITE, V56, P689, DOI 10.1016/j.appet.2011.02.005; Hintsanen M, 2012, J PSYCHOSOM RES, V73, P391, DOI 10.1016/j.jpsychores.2012.08.012; Ho M, 2012, PEDIATRICS, V130, pE1647, DOI 10.1542/peds.2012-1176; Inokuchi M, 2011, ANN HUM BIOL, V38, P747, DOI 10.3109/03014460.2011.620625; Jokela M, 2013, OBES REV, V14, P315, DOI 10.1111/obr.12007; Leung CYY, 2016, PEDIATR OBES, V11, P181, DOI 10.1111/ijpo.12042; Magee CA, 2011, J RES PERS, V45, P332, DOI 10.1016/j.jrp.2011.02.009; MCCLOWRY SG, 1995, MERRILL PALMER QUART, V41, P271; Mottus R, 2013, HEALTH PSYCHOL, V32, P353, DOI 10.1037/a0025537; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Park MH, 2012, OBES REV, V13, P985, DOI 10.1111/j.1467-789X.2012.01015.x; Persegani C, 2002, PERS INDIV DIFFER, V32, P977, DOI 10.1016/S0191-8869(01)00102-7; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Pietrobelli A, 1998, J PEDIATR-US, V132, P204, DOI 10.1016/S0022-3476(98)70433-0; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Pulkki-Raback L, 2005, HEALTH PSYCHOL, V24, P307, DOI 10.1037/0278-6133.24.3.307; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Sullivan S, 2007, INT J OBESITY, V31, P669, DOI 10.1038/sj.ijo.0803464; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Sutin AR, 2016, PSYCHOL HEALTH, V31, P259, DOI 10.1080/08870446.2015.1082561; Sutin AR, 2016, J PERS, V84, P102, DOI 10.1111/jopy.12143; Sutin AR, 2015, J RES PERS, V58, P137, DOI 10.1016/j.jrp.2015.07.006; Sutin AR, 2015, APPETITE, V90, P74, DOI 10.1016/j.appet.2015.02.036; Sutin AR, 2011, J PERS SOC PSYCHOL, V101, P579, DOI 10.1037/a0024286; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Vollrath ME, 2012, APPETITE, V58, P1113, DOI 10.1016/j.appet.2012.02.056; Wang Y, 2013, COMP EFFECTIVENESS R, V115; Whitlock EP, 2010, PEDIATRICS, V125, pE396, DOI 10.1542/peds.2009-1955; Woo JG, 2009, INT J PEDIATR OBES, V4, P405, DOI 10.3109/17477160902957133	47	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0158353	10.1371/journal.pone.0158353	http://dx.doi.org/10.1371/journal.pone.0158353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486752	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800009
J	Li, BBV; Hughes, AC; Jenkins, CN; Ocampo-Penuela, N; Pimm, SL				Li, Binbin V.; Hughes, Alice C.; Jenkins, Clinton N.; Ocampo-Penuela, Natalia; Pimm, Stuart L.			Remotely Sensed Data Informs Red List Evaluations and Conservation Priorities in Southeast Asia	PLOS ONE			English	Article							BIODIVERSITY; EXTINCTION; AGRICULTURE; EXPANSION; FOREST; BIRDS; RISK	The IUCN Red List has assessed the global distributions of the majority of the world's amphibians, birds and mammals. Yet these assessments lack explicit reference to widely available, remotely-sensed data that can sensibly inform a species' risk of extinction. Our first goal is to add additional quantitative data to the existing standardised process that IUCN employs. Secondly, we ask: do our results suggest species of concern-those at considerably greater risk than hitherto appreciated? Thirdly, these assessments are not only important on a species-by-species basis. By combining distributions of species of concern, we map conservation priorities. We ask to what degree these areas are currently protected and how might knowledge from remote sensing modify the priorities? Finally, we develop a quick and simple method to identify and modify the priority setting in a landscape where natural habitats are disappearing rapidly and so where conventional species' assessments might be too slow to respond. Tropical, mainland Southeast Asia is under exceptional threat, yet relatively poorly known. Here, additional quantitative measures may be particularly helpful. This region contains over 122, 183, and 214 endemic mammals, birds, and amphibians, respectively, of which the IUCN considers 37, 21, and 37 threatened. When corrected for the amount of remaining natural habitats within the known elevation preferences of species, the average sizes of species ranges shrink to < 40% of their published ranges. Some 79 mammal, 49 bird, and 184 amphibian ranges are < 20,000km(2)-an area at which IUCN considers most other species to be threatened. Moreover, these species are not better protected by the existing network of protected areas than are species that IUCN accepts as threatened. Simply, there appear to be considerably more species at risk than hitherto appreciated. Furthermore, incorporating remote sensing data showing where habitat loss is prevalent changes the locations of conservation priorities.	[Li, Binbin V.; Ocampo-Penuela, Natalia; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Hughes, Alice C.] Chinese Acad Sci, Xishuangbanna Trop Bot Gardens, Ctr Integrat Conservat, Menglun, Yunnan, Peoples R China; [Jenkins, Clinton N.] Inst Pesquisas Ecol, Sao Paulo, Brazil	Duke University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Instituto de Pesquisas Ecologicas	Pimm, SL (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	stuartpimm@me.com	Jenkins, Clinton/D-6134-2011; Ocampo-Peñuela, Natalia/X-2458-2019; pimm, stuart/ABF-1082-2020; hughes, Alice/HCH-3838-2022	Jenkins, Clinton/0000-0003-2198-0637; Ocampo-Peñuela, Natalia/0000-0002-5120-7226; hughes, Alice/0000-0002-4899-3158	China Scholarship Council; Xishuangbanna Tropical Botanical Garden	China Scholarship Council(China Scholarship Council); Xishuangbanna Tropical Botanical Garden(Chinese Academy of Sciences)	The first author is supported by China Scholarship Council.; We would like to thank the support from Xishuangbanna Tropical Botanical Garden. We gratefully acknowledge the input and comments from Dr. Richard Corlett, Dr. Jennifer Swenson, Dr. Jeffrey Vincent, Dr. Alexander Pfaff and Varsha Vijay.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; Ahrends A, 2015, GLOBAL ENVIRON CHANG, V34, P48, DOI 10.1016/j.gloenvcha.2015.06.002; [Anonymous], 2015, HDB BIRDS WORLD ALIV; Bickford D, 2010, BIODIVERS CONSERV, V19, P1043, DOI 10.1007/s10531-010-9782-4; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Cuthbert RJ, 2016, ORYX, V50, P104, DOI 10.1017/S003060531500037X; Dong J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0082342, 10.1371/journal.pone.0085801]; FAO F, 2013, STAT YB 2013 WORLD F; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Fox J, 2012, ENVIRON MANAGE, V49, P968, DOI 10.1007/s00267-012-9828-3; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; International Bird Life, 2015, IUCN RED LIST BIRDS; IUCN, IUCN RED LIST THREAT; Jenkins CN, 2015, P NATL ACAD SCI USA, V112, P5081, DOI 10.1073/pnas.1418034112; Jenkins CN, 2011, NAT CONSERVACAO, V9, P152, DOI 10.4322/natcon.2011.021; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2011, P NATL ACAD SCI USA, V108, P5127, DOI 10.1073/pnas.1018776108; Koh LP, 2013, BIODIVERSITY STATE T, P509; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lemmens Roeland Hendrikus Maria Julien, 1995, TIMBER TREES MINOR C; Li BBV, 2016, CONSERV BIOL, V30, P329, DOI 10.1111/cobi.12618; Li Z, 2012, APPL GEOGR, V32, P420, DOI 10.1016/j.apgeog.2011.06.018; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; Miettinen J, 2012, REMOTE SENS LETT, V3, P11, DOI 10.1080/01431161.2010.526971; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ocampo-Penuela N, 2014, CONSERV BIOL, V28, P1260, DOI 10.1111/cobi.12312; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Pimm SL, 2015, TRENDS ECOL EVOL, V30, P685, DOI 10.1016/j.tree.2015.08.008; Pimm SL, 2010, CONSERVATION BIOLOGY FOR ALL, P181; Rao P. S., 1992, DEV CROP SCI, V23, P200; Sexton JO, 2016, NAT CLIM CHANGE, V6, P192, DOI [10.1038/NCLIMATE2816, 10.1038/nclimate2816]; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Sodhi N. S., 2006, SE ASIAN BIODIVERSIT; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; van Noordwijk M., 2012, AGROFORESTRY FUTURE, P69, DOI DOI 10.1007/978-94-007-4676-3_8; Vijay V, PLOS ONE IN PRESS; Warren-Thomas E, 2015, CONSERV LETT, V8, P230, DOI 10.1111/conl.12170; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; Wohlfart C, 2014, TROP CONSERV SCI, V7, P597, DOI 10.1177/194008291400700402	48	56	57	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160566	10.1371/journal.pone.0160566	http://dx.doi.org/10.1371/journal.pone.0160566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487238	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800086
J	Zhang, HH; Jin, WB; Zhu, XL; Liu, L; He, ZG; Yang, SS; Liang, ZS; Yan, XJ; He, YF; Liu, Y				Zhang, Haihua; Jin, Weibo; Zhu, Xiaole; Liu, Lin; He, Zhigui; Yang, Shushen; Liang, Zongsuo; Yan, Xijun; He, Yanfeng; Liu, Yan			Identification and Characterization of Salvia miltiorrhizain miRNAs in Response to Replanting Disease	PLOS ONE			English	Article							LATERAL ROOT DEVELOPMENT; TANSHINONE BIOSYNTHESIS; ARABIDOPSIS; MICRORNAS; EXPRESSION; SEQUENCES; GENOME; PLANTS; INFECTION; CLEAVAGE	Replanting disease is a major factor limiting the artificial cultivation of the traditional Chinese medicinal herb Salvia miltiorrhiza. At present, little information is available regarding the role of miRNAs in response to replanting disease. In this study, two small RNA libraries obtained from first-year (FPR) and second-year plant (SPR) roots were subjected to a high-throughput sequencing method. Bioinformatics analysis revealed that 110 known and 7 novel miRNAs were annotated in the roots of S. miltiorrhiza. Moreover, 39 known and 2 novel miRNAs were identified and validated for differential expression in FPR compared with SPR. Thirtyone of these miRNAs were further analyzed by qRT-PCR, which revealed that 5 miRNAs negatively regulated the expression levels of 7 target genes involved in root development or stress responses. This study not only provides novel insights into the miRNA content of S. miltiorrhiza in response to replanting disease but also demonstrates that 5 miRNAs may be involved in these responses. Interactions among the differentially expressed miRNAs with their targets may form an important component of the molecular basis of replanting disease in S. miltiorrhiza.	[Zhang, Haihua; Zhu, Xiaole; Liu, Lin; He, Zhigui; Yang, Shushen; Liang, Zongsuo] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Peoples R China; [Zhang, Haihua; Jin, Weibo; Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China; [Yan, Xijun; He, Yanfeng] Tasly Holding Grp Co Ltd, Tasly R&D Inst, Tianjin 300410, Peoples R China; [Liu, Yan] Tianjin Tasly Modern TCM Resources Co Ltd, Tianjin 300402, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Yang, SS; Liang, ZS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Peoples R China.; Jin, WB; Liang, ZS (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China.	jwb@zstu.edu.cn; yangshushen2002@163.com; liangzs@ms.iswc.ac.cn			National Natural Science Foundation of China [81373908, 81403033]; Natural Science Foundation of Zhejiang Province [LQ15H280009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by the National Natural Science Foundation of China (no. 81373908 and no. 81403033), ZL; and the Natural Science Foundation of Zhejiang Province (no. LQ15H280009), HZ.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Bao ML, 2014, PLANT CELL PHYSIOL, V55, P1343, DOI 10.1093/pcp/pcu058; Chen L, 2012, GENE, V504, P160, DOI 10.1016/j.gene.2012.05.034; Dong M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075978; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-73; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Guo J, 2013, P NATL ACAD SCI USA, V110, P12108, DOI 10.1073/pnas.1218061110; Hewezi T, 2012, PLANT PHYSIOL, V159, P321, DOI 10.1104/pp.112.193649; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jin WB, 2015, GENE, V569, P225, DOI 10.1016/j.gene.2015.05.064; Jin WB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0410-4; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kai G., 2014, BIOTECHNOL ADV; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Li J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-220; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Liu Wei, 2015, Zhong Yao Cai, V38, P5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HM, 2014, PHYSIOL PLANTARUM, V152, P241, DOI 10.1111/ppl.12193; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Ogweno JO, 2006, ALLELOPATHY J, V18, P93; Shao YX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149747; Singh A, 2014, PLANT CELL REP, V33, P945, DOI 10.1007/s00299-014-1573-z; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Thakur V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-108; Turner M, 2013, PLANT PHYSIOL, V162, P2042, DOI 10.1104/pp.113.220699; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044385; Wu L., 2008, SPECIAL WILD EC ANIM, V2, P68, DOI DOI 10.16720/J.CNKI.TCYJ.2008.02.005; Xiao Chun-ping, 2014, Zhongguo Zhong Yao Za Zhi, V39, P4740; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xing BC, 2015, MOLECULES, V20, P309, DOI 10.3390/molecules20010309; Xu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111679; Xu ZC, 2015, PLANT J, V82, P951, DOI 10.1111/tpj.12865; Yan Z., 2012, PHARM CLIN CHIN MAT, V3, P5; Yang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118555; Yang YH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-53; Yu N, 2015, PLANT J, V83, P673, DOI 10.1111/tpj.12919; Zhang ChenLu, 2005, Acta Botanica Boreali-Occidentalia Sinica, V25, P1029; Zhao S, 2015, J EXP BOT, DOI [10.3390/molecules20010309, DOI 10.3390/MOLECULES20010309]	47	13	13	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159905	10.1371/journal.pone.0159905	http://dx.doi.org/10.1371/journal.pone.0159905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483013	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110700018
J	Rudy, MD; Kainz, MJ; Graeve, M; Colombo, SM; Arts, MT				Rudy, Martina D.; Kainz, Martin J.; Graeve, Martin; Colombo, Stefanie M.; Arts, Michael T.			Handling and Storage Procedures Have Variable Effects on Fatty Acid Content in Fishes with Different Lipid Quantities	PLOS ONE			English	Article							SALMON SALMO-SALAR; FRESH-WATER FISH; -20 DEGREES-C; GRAVIMETRIC-DETERMINATION; MERLUCCIUS-HUBBSI; FROZEN STORAGE; DARK MUSCLE; FILLETS; MARINE; STABILITY	It is commonly assumed that the most accurate data on fatty acid (FA) contents are obtained when samples are analyzed immediately after collection. For logistical reasons, however, this is not always feasible and samples are often kept on ice or frozen at various temperatures and for diverse time periods. We quantified temporal changes of selected FA (mu g FAME per mg tissue dry weight) from 6 fish species subjected to 2 handling and 3 storage methods and compared them to FA contents from muscle tissue samples that were processed immediately. The following species were investigated: Common Carp (Cyprinus carpio), Freshwater Drum (Aplodinotus grunniens), Channel Catfish (Ictalurus punctatus), Antarctic Eelpout (Pachycara brachycephalum), Rainbow Trout (Oncorhynchus mykiss) and Arctic Charr (Salvelinus alpinus). The impact of storage method and duration of storage on FA contents were species-specific, but not FA-specific. There was no advantage in using nitrogen gas for tissue samples held on ice for 1 week; however, holding tissue samples on ice for 1 week resulted in a loss of FA in Charr. In addition, most FA in Trout and Charr decreased in quantity after being stored between 3 and 6 hours on ice. Freezer storage temperature (-80 or -20 degrees C) also had a significant effect on FA contents in some species. Generally, we recommend that species with high total lipid content (e.g. Charr and Trout) should be treated with extra caution to avoid changes in FA contents, with time on ice and time spent in a freezer emerging as significant factors that changed FA contents.	[Rudy, Martina D.; Arts, Michael T.] Environm & Climate Change Canada, Natl Water Res Inst, 867 Lakeshore Rd, Burlington, ON, Canada; [Kainz, Martin J.] WasserCluster Biol Stn Lunz, Dr Carl Kupelwieser Promenade 5, Lunz Am See, Austria; [Graeve, Martin] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Handelshafen 12, Bremerhaven, Germany; [Colombo, Stefanie M.; Arts, Michael T.] Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON, Canada	Environment & Climate Change Canada; National Water Research Institute; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Toronto Metropolitan University	Arts, MT (corresponding author), Environm & Climate Change Canada, Natl Water Res Inst, 867 Lakeshore Rd, Burlington, ON, Canada.; Arts, MT (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON, Canada.	michael.arts@ryerson.ca	Kainz, Martin/AAG-6268-2021; Colombo, Stefanie/ABD-4750-2020; Arts, Michael/H-4973-2012; Graeve, Martin/B-5751-2017	Colombo, Stefanie/0000-0003-1828-7145; Arts, Michael/0000-0002-2335-4317; Graeve, Martin/0000-0002-2294-1915	Natural Sciences and Engineering Research Council of Canada [04537-2014]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided to MTA by the Natural Sciences and Engineering Research Council of Canada (Grant #04537-2014).	Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P237, DOI 10.1007/978-0-387-89366-2_10; AURSAND M, 1994, J SCI FOOD AGR, V64, P239, DOI 10.1002/jsfa.2740640214; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Christie W., 1989, GAS CHROMATOGRAPHY L; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Din JN, 2008, ATHEROSCLEROSIS, V197, P290, DOI 10.1016/j.atherosclerosis.2007.04.047; FAO, 2002, FISH AQ STAT AQ PROD, P229; FAO, 1995, QUAL QUAL CHANG FRES, V6, P2; Firestone F, 1997, NEW TECHNIQUES APPL, P12; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRASER AJ, 1989, CAN J FISH AQUAT SCI, V46, P1868, DOI 10.1139/f89-235; Harris WS, 2007, CURR CARDIOVASC RISK, V1, P39, DOI 10.1007/s12170-007-0007-7; Hartwich M, 2013, J PLANKTON RES, V35, P121, DOI 10.1093/plankt/fbs078; Hellberg RS, 2012, COMPR REV FOOD SCI F, V11, P490, DOI 10.1111/j.1541-4337.2012.00200.x; Hixson SM, 2013, FISH PHYSIOL BIOCHEM, V39, P1441, DOI 10.1007/s10695-013-9798-2; INGEMANSSON T, 1995, J AGR FOOD CHEM, V43, P2046, DOI 10.1021/jf00056a017; Kainz MJ, 2009, J PLANKTON RES, V31, P635, DOI 10.1093/plankt/fbp015; Kaneniwa M, 2000, J AM OIL CHEM SOC, V77, P825, DOI 10.1007/s11746-000-0132-3; Katikou P, 2001, AQUACULTURE, V202, P89, DOI 10.1016/S0044-8486(01)00562-2; Kattner G, 2012, MAR CHEM, V138, P7, DOI 10.1016/j.marchem.2012.05.002; KE PJ, 1975, J AM OIL CHEM SOC, V52, P349, DOI 10.1007/BF02639193; Lochmann SE, 1996, MAR ECOL PROG SER, V134, P27, DOI 10.3354/meps134027; Losada V, 2005, FOOD CHEM, V93, P619, DOI 10.1016/j.foodchem.2004.09.041; MAI J, 1978, J FOOD SCI, V43, P1669, DOI 10.1111/j.1365-2621.1978.tb07384.x; McMeans BC, 2013, MAR ECOL PROG SER, V482, P17, DOI 10.3354/meps10278; McMeans BC, 2012, MAR BIOL, V159, P1095, DOI 10.1007/s00227-012-1889-6; Metherel AH, 2013, LIPIDS, V48, P1079, DOI 10.1007/s11745-013-3827-x; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Nazemroaya S, 2011, J AGR SCI TECH-IRAN, V13, P553; Nishimoto J., 1977, Memoirs of Faculty of Fisheries Kagoshima University, V26, P111; Ohman MD, 1996, MAR ECOL PROG SER, V130, P295, DOI 10.3354/meps130295; Palmeri G, 2007, FOOD CHEM, V102, P796, DOI 10.1016/j.foodchem.2006.06.018; Perhar G, 2013, ECOL INFORM, V13, P77, DOI 10.1016/j.ecoinf.2012.10.005; Pernet F, 2003, LIPIDS, V38, P1191, DOI 10.1007/s11745-003-1178-6; Petillo D, 1998, J AGR FOOD CHEM, V46, P4128, DOI 10.1021/jf980364z; Phillips KM, 2008, J FOOD LIPIDS, V15, P309, DOI 10.1111/j.1745-4522.2008.00121.x; Phillips KM, 1997, J AM OIL CHEM SOC, V74, P137, DOI 10.1007/s11746-997-0158-1; Pottala JV, 2012, LIPIDS, V47, P835, DOI 10.1007/s11745-012-3693-y; Roldan HA, 2005, J FOOD BIOCHEM, V29, P187, DOI 10.1111/j.1745-4514.2005.00006.x; Ryckebosch E, 2011, J AGR FOOD CHEM, V59, P11063, DOI 10.1021/jf2025456; Saldanha T, 2007, LIPIDS, V42, P671, DOI 10.1007/s11745-007-3062-4; SASAKI GC, 1984, COMP BIOCHEM PHYS B, V78, P525, DOI 10.1016/0305-0491(84)90091-9; Shahidi, 2005, BAILEYS IND OIL FAT, DOI DOI 10.1002/047167849X.BIO050; Stolzing A, 2012, TRANSFUS APHER SCI, V46, P137, DOI 10.1016/j.transci.2012.01.007; Taipale SJ, 2012, FEMS MICROBIOL ECOL, V82, P50, DOI 10.1111/j.1574-6941.2012.01406.x; TINOCO J, 1963, J LIPID RES, V4, P359; Tocher DR, 2010, AQUAC RES, V41, P717, DOI 10.1111/j.1365-2109.2008.02150.x	47	23	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160497	10.1371/journal.pone.0160497	http://dx.doi.org/10.1371/journal.pone.0160497			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479304	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110300053
J	Buras, A; van der Maaten-Theunissen, M; van der Maaten, E; Ahlgrimm, S; Hermann, P; Simard, S; Heinrich, I; Helle, G; Unterseher, M; Schnittler, M; Eusemann, P; Wilmking, M				Buras, Allan; van der Maaten-Theunissen, Marieke; van der Maaten, Ernst; Ahlgrimm, Svenja; Hermann, Philipp; Simard, Sonia; Heinrich, Ingo; Helle, Gerd; Unterseher, Martin; Schnittler, Martin; Eusemann, Pascal; Wilmking, Martin			Tuning the Voices of a Choir: Detecting Ecological Gradients in Time-Series Populations	PLOS ONE			English	Article							GROWTH-RESPONSES; WHITE SPRUCE; TREE GROWTH; CLIMATE; ALASKA; DIVERGENCE; FORESTS; SCENARIOS; CHINA	This paper introduces a new approach-the Principal Component Gradient Analysis (PCGA)-to detect ecological gradients in time-series populations, i.e. several time-series originating from different individuals of a population. Detection of ecological gradients is of particular importance when dealing with time-series from heterogeneous populations which express differing trends. PCGA makes use of polar coordinates of loadings from the first two axes obtained by principal component analysis (PCA) to define groups of similar trends. Based on the mean inter-series correlation (rbar) the gain of increasing a common underlying signal by PCGA groups is quantified using Monte Carlo Simulations. In terms of validation PCGA is compared to three other existing approaches. Focusing on dendrochronological examples, PCGA is shown to correctly determine population gradients and in particular cases to be advantageous over other considered methods. Furthermore, PCGA groups in each example allowed for enhancing the strength of a common underlying signal and comparably well as hierarchical cluster analysis. Our results indicate that PCGA potentially allows for a better understanding of mechanisms causing time-series population gradients as well as objectively enhancing the performance of climate transfer functions in dendroclimatology. While our examples highlight the relevance of PCGA to the field of dendrochronology, we believe that also other disciplines working with data of comparable structure may benefit from PCGA.	[Buras, Allan; van der Maaten-Theunissen, Marieke; van der Maaten, Ernst; Ahlgrimm, Svenja; Hermann, Philipp; Unterseher, Martin; Schnittler, Martin; Eusemann, Pascal; Wilmking, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Soldmannstr 15, D-17487 Greifswald, Germany; [Simard, Sonia; Heinrich, Ingo; Helle, Gerd] GFZ German Res Ctr Geosci, Sect 5-2, D-14473 Potsdam, Germany; [Buras, Allan] Tech Univ Munich, Dept Ecol & Ecosyst Management, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany	Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Technical University of Munich	Buras, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Soldmannstr 15, D-17487 Greifswald, Germany.; Buras, A (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	allan@buras.eu	Buras, Allan/B-1412-2012; Wilmking, Martin/AAV-9310-2020	Wilmking, Martin/0000-0003-4964-2402; Buras, Allan/0000-0003-2179-0681; van der Maaten, Ernst/0000-0002-5218-6682; Eusemann, Pascal/0000-0003-3842-4653; Helle, Gerhard/0000-0001-9988-6638; van der Maaten-Theunissen, Marieke/0000-0002-2942-9180	DFG [EU 132/1-1]; Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA - of the Helmholtz Association [VH-VI-415]	DFG(German Research Foundation (DFG)); Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA - of the Helmholtz Association	This study is a contribution to the Virtual Institute of Integrated Climate and Landscape Evolution Analysis - ICLEA - of the Helmholtz Association, grant number VH-VI-415. Funding for PE was provided by the DFG grant EU 132/1-1; in the frame of this project the Alaskan data were sampled.	Barber VA, 2004, CLIMATIC CHANGE, V63, P91, DOI 10.1023/B:CLIM.0000018501.98266.55; Briffa KR, 1998, PHILOS T ROY SOC B, V353, P65, DOI 10.1098/rstb.1998.0191; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Buras A, 2015, DENDROCHRONOLOGIA, V34, P29, DOI 10.1016/j.dendro.2015.03.003; Carrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022813; Crawley M.J., 2007, R BOOK; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; Driscoll WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024258; Fang KY, 2012, DENDROCHRONOLOGIA, V30, P113, DOI 10.1016/j.dendro.2011.04.003; Fritts H. C., 1976, TREE RINGS CLIMATE; Hartmann B, 2005, J CLIMATE, V18, P4824, DOI 10.1175/JCLI3532.1; Hay LE, 2000, J AM WATER RESOUR AS, V36, P387, DOI 10.1111/j.1752-1688.2000.tb04276.x; Hayhoe K. A., 2010, THESIS; JACOBY GC, 1995, GLOBAL BIOGEOCHEM CY, V9, P227, DOI 10.1029/95GB00321; Leyer I., 2007, MULTIVARIATE STAT OK; Martin-Benito D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009121; Ohse B, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015505; Piovesan G, 2008, GLOBAL CHANGE BIOL, V14, P1265, DOI 10.1111/j.1365-2486.2008.01570.x; Pisaric MFJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029139; Porter TJ, 2011, GLOBAL CHANGE BIOL, V17, P3418, DOI 10.1111/j.1365-2486.2011.02507.x; Schweingruber F.H., 1983, JAHRRING STANDORT ME; Singh J., 2008, CLIMATE DISCUSSIONS, V4, P741, DOI DOI 10.5194/CPD-4-741-2008; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Walker X, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064016; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmking M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023331; Wilmking M, 2005, GLOBAL PLANET CHANGE, V47, P282, DOI 10.1016/j.gloplacha.2004.10.017; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wilmking M, 2006, ERDKUNDE, V60, P113; Zhang YX, 2011, DENDROCHRONOLOGIA, V29, P185, DOI 10.1016/j.dendro.2010.11.001; Zhang YX, 2010, FOREST ECOL MANAG, V260, P1076, DOI 10.1016/j.foreco.2010.06.034; Zhang YX, 2009, PLANT ECOL, V201, P39, DOI [10.1007/s11258-008-9478-y, 10.1007/978-90-481-2795-5_4]	32	37	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0158346	10.1371/journal.pone.0158346	http://dx.doi.org/10.1371/journal.pone.0158346			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467508	Green Published, gold			2022-12-27	WOS:000381516100008
J	Lin, WW; Chen, IJ; Cheng, TC; Tung, YC; Chu, PY; Chuang, CH; Hsieh, YC; Huang, CC; Wang, YT; Kao, CH; Roffler, SR; Cheng, TL				Lin, Wen-Wei; Chen, I-Ju; Cheng, Ta-Chun; Tung, Yi-Ching; Chu, Pei-Yu; Chuang, Chih-Hung; Hsieh, Yuan-Chin; Huang, Chien-Chiao; Wang, Yeng-Tseng; Kao, Chien-Han; Roffler, Steve R.; Cheng, Tian-Lu			A Secondary Antibody-Detecting Molecular Weight Marker with Mouse and Rabbit IgG Fc Linear Epitopes for Western Blot Analysis	PLOS ONE			English	Article							TAGGED FUSION PROTEINS; GEL-ELECTROPHORESIS; LADDER; CALIBRATION; AFFINITY	Molecular weight markers that can tolerate denaturing conditions and be auto-detected by secondary antibodies offer great efficacy and convenience for Western Blotting. Here, we describe M&R LE protein markers which contain linear epitopes derived from the heavy chain constant regions of mouse and rabbit immunoglobulin G (IgG Fc LE). These markers can be directly recognized and stained by a wide range of anti-mouse and anti-rabbit secondary antibodies. We selected three mouse (M1, M2 and M3) linear IgG1 and three rabbit (R1, R2 and R3) linear IgG heavy chain epitope candidates based on their respective crystal structures. Western blot analysis indicated that M2 and R2 linear epitopes are effectively recognized by anti-mouse and anti-rabbit secondary antibodies, respectively. We fused the M2 and R2 epitopes (M&R LE) and incorporated the polypeptide in a range of 15-120 kDa auto-detecting markers (M&R LE protein marker). The M&R LE protein marker can be auto-detected by anti-mouse and anti-rabbit IgG secondary antibodies in standard immunoblots. Linear regression analysis of the M&R LE protein marker plotted as gel mobility versus the log of the marker molecular weights revealed good linearity with a correlation coefficient R2 value of 0.9965, indicating that the M&R LE protein marker displays high accuracy for determining protein molecular weights. This accurate, regular and auto-detected M&R LE protein marker may provide a simple, efficient and economical tool for protein analysis.	[Lin, Wen-Wei; Cheng, Tian-Lu] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Chen, I-Ju; Hsieh, Yuan-Chin; Kao, Chien-Han; Cheng, Tian-Lu] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Cheng, Ta-Chun; Chuang, Chih-Hung; Cheng, Tian-Lu] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan; [Tung, Yi-Ching] Kaohsiung Med Univ, Dept Publ Hlth & Environm Med, Coll Med, Kaohsiung, Taiwan; [Chu, Pei-Yu] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung, Taiwan; [Huang, Chien-Chiao] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Huang, Chien-Chiao; Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Wang, Yeng-Tseng] Kaohsiung Med Univ, Dept Biochem, Kaohsiung, Taiwan; [Roffler, Steve R.] Acad Sinica, Inst Biomed Sci, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed & Environm Biol, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan	National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Academia Sinica - Taiwan; Kaohsiung Medical University	Cheng, TL (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.; Cheng, TL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.; Cheng, TL (corresponding author), Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan.; Cheng, TL (corresponding author), Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan.; Roffler, SR (corresponding author), Acad Sinica, Inst Biomed Sci, 128,Sect 2,Acad Rd, Taipei 11529, Taiwan.; Cheng, TL (corresponding author), Kaohsiung Med Univ, Dept Biomed & Environm Biol, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.	sroff@ibms.sinica.edu.tw; tlcheng@kmu.edu.tw	Wang, Yeng-Tseng/AAZ-7564-2020; Wang, Yeng-Tseng/AAZ-4252-2020; Roffler, Steve R/N-7791-2018	Wang, Yeng-Tseng/0000-0002-7575-4953; Roffler, Steve R/0000-0003-2543-7295; Cheng, Tian-Lu/0000-0002-7263-2766; Hsieh, Yuan Chin/0000-0003-4005-5340	National Research Program for Biopharmaceuticals, Ministry of Science and Technology, Taipei, Taiwan [MOST 104-2325-B-037-003, MOST 104-2325-B-037-001, MOST 104-2325-B-041-001, MOST 104-2314-B-037-010-MY3]; Grant of Academia Sinica, Taiwan [BM104010112]; Kaohsiung Medical University [D08-00005]; KMU Aim for the Top 500 Universities grant [KMU-DT105003, KMU-TP104D06, KMU-TP104C00]	National Research Program for Biopharmaceuticals, Ministry of Science and Technology, Taipei, Taiwan; Grant of Academia Sinica, Taiwan; Kaohsiung Medical University; KMU Aim for the Top 500 Universities grant	This work was supported by grants from the National Research Program for Biopharmaceuticals, Ministry of Science and Technology, Taipei, Taiwan (MOST 104-2325-B-037-003, MOST 104-2325-B-037-001, MOST 104-2325-B-041-001, MOST 104-2314-B-037-010-MY3) and the Grant of Academia Sinica, Taiwan (BM104010112). This study is also supported partially by Kaohsiung Medical University (D08-00005) and "KMU Aim for the Top 500 Universities grant (KMU-DT105003, KMU-TP104D06 and KMU-TP104C00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof DF, 2011, ANAL BIOCHEM, V409, P213, DOI 10.1016/j.ab.2010.10.022; Burgess RR, 2000, METHOD ENZYMOL, V328, P141, DOI 10.1016/S0076-6879(00)28396-1; Camacho CJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000231; Chang M, 2005, ELECTROPHORESIS, V26, P3062, DOI 10.1002/elps.200500041; Compton MM, 2002, ELECTROPHORESIS, V23, P3262, DOI 10.1002/1522-2683(200210)23:19<3262::AID-ELPS3262>3.0.CO;2-8; Daskalow K, 2008, BIOSCI BIOTECH BIOCH, V72, P346, DOI 10.1271/bbb.70406; Einhauer A, 2001, J CHROMATOGR A, V921, P25, DOI 10.1016/S0021-9673(01)00831-7; Feodorova VA, 2003, J MED MICROBIOL, V52, P389, DOI 10.1099/jmm.0.05036-0; Fowler CB, 2011, J HISTOCHEM CYTOCHEM, V59, P366, DOI 10.1369/0022155411400866; Giersberg M, 2010, BIOTECHNOL BIOENG, V106, P161, DOI 10.1002/bit.22653; Hodge AJ, 2016, BIOTECHNOL BIOENG, V113, P882, DOI 10.1002/bit.25849; Johnson M., 2012, MAT METHODS, V2, DOI 10.13070; JONES C, 1995, J CHROMATOGR A, V707, P3, DOI 10.1016/0021-9673(95)00466-Z; Kao CH, 2012, ANAL BIOCHEM, V431, P1, DOI 10.1016/j.ab.2012.08.001; Lee JS, 2013, BIOTECHNOL BIOENG, V110, P2195, DOI 10.1002/bit.24879; LINDBLADH C, 1991, ANAL BIOCHEM, V197, P187, DOI 10.1016/0003-2697(91)90377-6; MAKELA O, 1970, IMMUNOCHEMISTRY, V7, P917, DOI 10.1016/0019-2791(70)90053-4; Moyo SR, 2003, J MED MICROBIOL, V52, P379, DOI 10.1099/jmm.0.05087-0; Nuccitelli A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003115; PARKINSON D, 1984, ANAL BIOCHEM, V141, P121, DOI 10.1016/0003-2697(84)90434-2; Pease LF, 2008, BIOTECHNOL BIOENG, V101, P1214, DOI 10.1002/bit.22017; Pfeifer S, 2015, MOL NUTR FOOD RES, V59, P2077, DOI 10.1002/mnfr.201500071; Qi GF, 2004, VACCINE, V22, P3187, DOI 10.1016/j.vaccine.2004.01.060; Reeve R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001027; Thermo S., 2007, CHOOSING SECONDARY A; TSANG VCW, 1984, ANAL BIOCHEM, V143, P304, DOI 10.1016/0003-2697(84)90667-5; Zhang YM, 2009, ANAL BIOCHEM, V390, P206, DOI 10.1016/j.ab.2009.04.023; Zhu-Shimoni J, 2014, BIOTECHNOL BIOENG, V111, P2367, DOI 10.1002/bit.25327	28	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160418	10.1371/journal.pone.0160418	http://dx.doi.org/10.1371/journal.pone.0160418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494183	gold, Green Published, Green Submitted			2022-12-27	WOS:000381369500042
J	Wang, C; Qiu, TT; Song, RR; Jiaerken, Y; Yang, LL; Wang, SZ; Zhang, MM; Yu, XF				Wang, Chao; Qiu, Tiantian; Song, Ruirui; Jiaerken, Yerfan; Yang, Linglin; Wang, Shaoze; Zhang, Minming; Yu, Xinfeng			A Comparison Study of Single-Echo Susceptibility Weighted Imaging and Combined Multi-Echo Susceptibility Weighted Imaging in Visualizing Asymmetric Medullary Veins in Stroke Patients	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; MOYAMOYA-DISEASE; MR-ANGIOGRAPHY; HUMAN BRAIN; BRUSH SIGN; 3 TESLA; VENOGRAPHY; IMAGES; MICROBLEEDS; ACQUISITION	Background Asymmetric medullary veins (AMV) are frequently observed in stroke patients and single-echo susceptibility weighted imaging (SWIs) is the main technique in detecting AMV. Our study aimed to investigate which echo time (TE) on single-echo susceptibility is the optimal echo for visualizing AMV and to compare the ability in detecting AMV in stroke patients between SWIs and multi-echo susceptibility weighted imaging (SWIc). Materials and Methods Twenty patients with middle cerebral artery stroke were included. SWI was acquired by using a multi-echo gradient-echo sequence with six echoes ranging from 5 ms to 35.240 ms. Three different echoes of SWIs including SWIs1 (TE = 23.144 ms), SWIs2 (TE = 29.192 ms) and SWIs3 (TE = 35.240 ms) were reconstructed. SWIc was averaged using the three echoes of SWIs. Image quality and venous contrast of medullary veins were compared between SWIs and SWIc using peak signal-to-noise ratio (PSNR), mean opinion score (MOS), contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR). The presence of AMV was evaluated in each SWIs ((1-3)) and SWIc. Results SWIs2 had the highest PSNR, MOS and CNR and SWIs1 had the highest SNR among three different echoes of SWIs. No significant difference was found in SNR between SWIs1 and SWIs2. PSNR, MOS and CNR in SWIc were significantly increased by 27.9%, 28.2% and 17.2% compared with SWIs2 and SNR in SWIc was significantly increased by 32.4% compared with SWIs1. 55% of patients with AMV were detected in SWIs2, SWIs3 and SWIc, while 50% AMV were found in SWIs1. Conclusions SWIs using TE around 29ms was optimal in visualizing AMV. SWIc could improve image quality and venous contrast, but was equal to SWIs using a relative long TE in evaluating AMV. These results provide the technique basis for further research of AMV in stroke.	[Wang, Chao; Qiu, Tiantian; Song, Ruirui; Jiaerken, Yerfan; Zhang, Minming; Yu, Xinfeng] Zhejiang Univ, Sch Med, Dept Radiol, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Yang, Linglin] Zhejiang Univ, Sch Med, Dept Neurol, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Wang, Shaoze] Zhejiang Univ, Dept Elect Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yu, XF (corresponding author), Zhejiang Univ, Sch Med, Dept Radiol, Affiliated Hosp 2, Hangzhou, Zhejiang, Peoples R China.	angek-4125@163.com	Yu, Xinfeng/K-6886-2019	Yu, Xinfeng/0000-0001-6024-8591; Yang, Linglin/0000-0002-6794-5987; Jiaerken, Yeerfan/0000-0002-0734-4012	National Natural Science Foundation of China [81271530]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (no. 81271530) http://www.nsfc.gov.cn/publish/portal1/. Minming Zhang received the funding and contributed to designing the experiments, purchasing materials.	Boeckh-Behrens T, 2012, EUR J RADIOL, V81, P1238, DOI 10.1016/j.ejrad.2011.02.057; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; COSMAN PC, 1994, P IEEE, V82, P919, DOI 10.1109/5.286196; De Guio F, 2014, STROKE, V45, P2124, DOI 10.1161/STROKEAHA.114.005726; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Denk C, 2010, J MAGN RESON IMAGING, V31, P185, DOI 10.1002/jmri.21995; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Du YP, 2008, MAGN RESON MED, V59, P954, DOI 10.1002/mrm.21581; Du YPP, 2009, J MAGN RESON IMAGING, V30, P449, DOI 10.1002/jmri.21833; Ghrare S. E., 2008, 2008 Second Asia International Conference on Modeling & Simulation, P923, DOI 10.1109/AMS.2008.10; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HOOSHMAND I, 1974, NEURORADIOLOGY, V7, P75, DOI 10.1007/BF00341874; Horie N, 2011, AM J NEURORADIOL, V32, P1697, DOI 10.3174/ajnr.A2568; Jang U, 2013, NEUROIMAGE, V70, P308, DOI 10.1016/j.neuroimage.2012.12.067; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jensen-Kondering U, 2013, WORLD J RADIOL, V5, P156, DOI 10.4329/wjr.v5.i4.156; Kesavadas C, 2010, NEURORADIOLOGY, V52, P1047, DOI 10.1007/s00234-010-0733-2; Koopmans PJ, 2008, MAGN RESON MATER PHY, V21, P149, DOI 10.1007/s10334-007-0101-3; Lobsien D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062644; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Mori N, 2008, INVEST RADIOL, V43, P574, DOI 10.1097/RLI.0b013e31817fb432; Morita N, 2008, CEREBROVASC DIS, V26, P367, DOI 10.1159/000151640; Mucke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120801; Quinn MP, 2014, AM J NEURORADIOL, V35, P38, DOI 10.3174/ajnr.A3584; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 2000, J COMPUT ASSIST TOMO, V24, P949, DOI 10.1097/00004728-200011000-00023; Rosso C, 2012, EUR J RADIOL, V81, P1282, DOI 10.1016/j.ejrad.2011.03.025; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Sedlacik J, 2007, MAGN RESON MED, V58, P1035, DOI 10.1002/mrm.21283; Tamura H, 2002, STROKE, V33, P967, DOI 10.1161/01.STR.0000013672.70986.E2; Tanchenko A, 2014, J VIS COMMUN IMAGE R, V25, P874, DOI 10.1016/j.jvcir.2014.01.008; Terasawa Y, 2014, STROKE, V45, P274, DOI 10.1161/STROKEAHA.113.002640; Xu X, 2008, NEUROIMAGE, V40, P35, DOI 10.1016/j.neuroimage.2007.11.017; Xu YB, 2006, MAGN RESON IMAGING, V24, P155, DOI 10.1016/j.mri.2005.10.030; Yan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031748; Yu X, 2016, AM J NEURORADIOL, V37, P423, DOI 10.3174/ajnr.A4541	38	0	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0159251	10.1371/journal.pone.0159251	http://dx.doi.org/10.1371/journal.pone.0159251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494171	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500006
J	Avizienyte, E; Cole, CL; Rushton, G; Miller, GJ; Bugatti, A; Presta, M; Gardiner, JM; Jayson, GC				Avizienyte, Egle; Cole, Claire L.; Rushton, Graham; Miller, Gavin J.; Bugatti, Antonella; Presta, Marco; Gardiner, John M.; Jayson, Gordon C.			Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; MITOGENIC ACTIVITY; OVARIAN-CANCER; BEVACIZUMAB; OLIGOSACCHARIDES; MODULATION; 6-O-SULFATION; REQUIREMENTS; CHEMOTHERAPY; RESISTANCE	Heparan sulphate (HS), a ubiquitously expressed glycosaminoglycan (GAG), regulates multiple cellular functions by mediating interactions between numerous growth factors and their cell surface cognate receptors. However, the structural specificity of HS in these interactions remains largely undefined. Here, we used completely synthetic, structurally defined, alternating N-sulfated glucosamine (NS) and 2-O-sulfated iduronate (IS) residues to generate dodecasaccharides ([NSIS](6)) that contained no, one or six glucosamine 6-Osulfates (6S). The aim was to address how 6S contributes to the potential of defined HS dodecasaccharides to inhibit the angiogenic growth factors FGF2 and VEGF(165), in vitro and in vivo. We show that the addition of a single 6S at the non-reducing end of [NSIS](6), i.e. [NSIS6S]-[NSIS](5), significantly augments the inhibition of FGF2-dependent endothelial cell proliferation, migration and sprouting in vitro when compared to the non-6S variant. In contrast, the fully 6-O-sulfated dodecasaccharide, [NSIS6S](6), is not a potent inhibitor of FGF2. Addition of a single 6S did not significantly improve inhibitory properties of [NSIS](6) when tested against VEGF(165)-dependent endothelial cell functions. In vivo, [NSIS6S]-[NSIS](5) blocked FGF2-dependent blood vessel formation without affecting tumor growth. Reduction of non-FGF2-dependent ovarian tumor growth occurred when [NSIS6S]-[NSIS](5) was combined with cisplatin. The degree of inhibition by [NSIS6S]-[NSIS](5) in combination with cisplatin in vivo equated with that induced by bevacizumab and sunitinib when administered with cisplatin. Evaluation of post-treatment vasculature revealed that [NSIS6S][NSIS](5) treatment had the greatest impact on tumor blood vessel size and lumen formation. Our data for the first time demonstrate that synthetic, structurally defined oligosaccharides have potential to be developed as active anti-angiogenic agents that sensitize tumors to chemotherapeutic agents.	[Avizienyte, Egle; Cole, Claire L.; Rushton, Graham; Jayson, Gordon C.] Univ Manchester, Inst Canc Sci, Fac Med & Human Sci, Manchester M20 4BX, Lancs, England; [Miller, Gavin J.; Gardiner, John M.] Univ Manchester, Sch Chem, Manchester M1 7ND, Lancs, England; [Miller, Gavin J.; Gardiner, John M.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7ND, Lancs, England; [Bugatti, Antonella; Presta, Marco] Univ Brescia, Unit Gen Pathol & Immunol, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; [Miller, Gavin J.] Keele Univ, Synth & Med Chem Cluster, Keele ST5 5BG, Staffs, England	University of Manchester; University of Manchester; University of Manchester; University of Brescia; Keele University	Avizienyte, E (corresponding author), Univ Manchester, Inst Canc Sci, Fac Med & Human Sci, Manchester M20 4BX, Lancs, England.	egle.avizienyte@ics.manchester.ac.uk; gordon.jayson@ics.manchester.ac.uk	Gardiner, John M/Q-7268-2017; Miller, Gavin J/AAL-5783-2021; Jayson, Gordon/O-8224-2015	Gardiner, John M/0000-0003-1827-6817; Miller, Gavin J/0000-0001-6533-3306; Jayson, Gordon/0000-0002-8515-8944; PRESTA, Marco/0000-0002-4398-8376	Medical Research Council [G0601746, G902173]; Ministero dell'Istruzione, Universita e Ricerca (FIRB project) [RBAP11H2R9 2011]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [14395]; Medical Research Council [G0902173] Funding Source: researchfish; MRC [G0601746, G0902173] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministero dell'Istruzione, Universita e Ricerca (FIRB project); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council grants (G0601746 and G902173) to GCJ and JMG. This work was also supported by the Ministero dell'Istruzione, Universita e Ricerca (FIRB project RBAP11H2R9 2011) grant to MP and the Associazione Italiana per la Ricerca sul Cancro (AIRC grant no 14395) grant to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Medical Research Council grants (G0601746 and G902173) and Ministero dell'Istruzione, Universita e Ricerca (FIRB project RBAP11H2R9 2011) and Associazione Italiana per la Ricerca sul Cancro (AIRC grant no 14395) to M.P.	Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cole CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011644; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Gallagher J, 2015, INT J EXP PATHOL, V96, P203, DOI 10.1111/iep.12135; Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8; Giavazzi R, 2001, CANCER RES, V61, P309; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hansen SU, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3016; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Jayson GC, 2015, CHEM COMMUN, V51, P13846, DOI 10.1039/c5cc05222j; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Liekens S, 1999, MOL PHARMACOL, V56, P204, DOI 10.1124/mol.56.1.204; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Miller GJ, 2013, CHEM SCI, V4, P3218, DOI 10.1039/c3sc51217g; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pfankuchen DB, 2015, BIOCHEM PHARMACOL, V97, P147, DOI 10.1016/j.bcp.2015.07.013; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Reddy K, 2008, INT J CANCER, V123, P831, DOI 10.1002/ijc.23582	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159739	10.1371/journal.pone.0159739	http://dx.doi.org/10.1371/journal.pone.0159739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490176	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000381368900016
J	Kattula, D; Venugopal, S; Velusamy, V; Sarkar, R; Jiang, V; Gowri, SM; Henry, A; Deosaran, JD; Muliyil, J; Kang, G				Kattula, Deepthi; Venugopal, Srinivasan; Velusamy, Vasanthakumar; Sarkar, Rajiv; Jiang, Victoria; Gowri, Mahasampath S.; Henry, Ankita; Deosaran, Jordanna Devi; Muliyil, Jayaprakash; Kang, Gagandeep			Measuring Poverty in Southern India: A Comparison of Socio-Economic Scales Evaluated against Childhood Stunting	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; HEALTH; MALNUTRITION; UNDERNUTRITION; INEQUALITY; MORTALITY; COHORT; SLUM	Introduction Socioeconomic status (SES) scales measure poverty, wealth and economic inequality in a population to guide appropriate economic and public health policies. Measurement of poverty and comparison of material deprivation across nations is a challenge. This study compared four SES scales which have been used locally and internationally and evaluated them against childhood stunting, used as an indicator of chronic deprivation, in urban southern India. Methods A door-to-door survey collected information on socio-demographic indicators such as education, occupation, assets, income and living conditions in a semi-urban slum area in Vellore, Tamil Nadu in southern India. A total of 7925 households were categorized by four SES scales-Kuppuswamy scale, Below Poverty Line scale (BPL), the modified Kuppuswamy scale, and the multidimensional poverty index (MDPI) and the level of agreement compared between scales. Logistic regression was used to test the association of SES scales with stunting. Findings The Kuppuswamy, BPL, MDPI and modified Kuppuswamy scales classified 7.1%, 1%, 5.5%, and 55.3% of families as low SES respectively, indicating conservative estimation of low SES by the BPL and MDPI scales in comparison with the modified Kuppuswamy scale, which had the highest sensitivity (89%). Children from low SES classified by all scales had higher odds of stunting, but the level of agreement between scales was very poor ranging from 1%-15%. Conclusion There is great non-uniformity between existing SES scales and cautious interpretation of SES scales is needed in the context of social, cultural, and economic realities.	[Kattula, Deepthi; Venugopal, Srinivasan; Velusamy, Vasanthakumar; Sarkar, Rajiv; Muliyil, Jayaprakash; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Jiang, Victoria] Georgia Inst Technol, Dept Biol, Atlanta, GA 30332 USA; [Gowri, Mahasampath S.] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Henry, Ankita] Denison Univ, Dept Biol, Granville, OH 43023 USA; [Deosaran, Jordanna Devi] Univ Aberdeen, Div Med & Dent Educ, Aberdeen, Scotland	Christian Medical College & Hospital (CMCH) Vellore; University System of Georgia; Georgia Institute of Technology; Christian Medical College & Hospital (CMCH) Vellore; Denison University; University of Aberdeen	Kang, G (corresponding author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India.	gkang@cmcvellore.ac.in	Sarkar, Rajiv/AAU-7203-2021	Sarkar, Rajiv/0000-0003-0616-3129; Kang, Gagandeep/0000-0002-3656-564X	Fogarty International Center [D43 TW007392]; FOGARTY INTERNATIONAL CENTER [D43TW009377] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	DK and RS were supported by Fogarty International Center training grant D43 TW007392, which was awarded to GK.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bredenkamp C, 2014, INT J EPIDEMIOL, V43, P1328, DOI 10.1093/ije/dyu075; Dandekar VM, 1971, POVERTY IN INDIA, Vvii; Fotso JC, 2012, HEALTH PLACE, V18, P375, DOI 10.1016/j.healthplace.2011.12.003; Gladstone BP, 2008, ARCH DIS CHILD, V93, P479, DOI 10.1136/adc.2006.114546; Government oI, 2010, REP PRON SEN COMM SL; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Kumar Neeta, 2012, Indian J Public Health, V56, P103, DOI 10.4103/0019-557X.96988; Kuppuswamy B, 1981, MANUAL SOCIOECONOMIC, DOI [10.1136/adc.2006.114546, DOI 10.1136/ADC.2006.114546]; Mohan VR, 2009, T ROY SOC TROP MED H, V103, P801, DOI 10.1016/j.trstmh.2009.04.014; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Pradhan M, 2003, J HEALTH ECON, V22, P271, DOI 10.1016/S0167-6296(02)00123-6; Prasad BG, 1961, J INDIAN MED ASSOC, P250; Praveen Kulkarni, 2013, J FAMILY MED PRIMARY, V2, P69; Regionalkomitee fur Europa, 2011, STRAT AKT BEK ANT EU, P1, DOI DOI 10.4103/0019-557X96988; Sabina Alkire MES, 2010, ACUTE MULTIDIMENSION, DOI [10.1093/ije/dyu075, DOI 10.1093/IJE/DYU075]; Sarkar R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-87; United Nations, MILL DEV GOALS REP; Van De Poel E, 2008, B WORLD HEALTH ORGAN, V86, P282, DOI 10.2471/BLT.07.044800; Viera AJ, 2005, FAM MED, V37, P360; WHO, 2006, WHO CHILD GROWTH STA; Williams RB, 1998, JAMA-J AM MED ASSOC, V279, P1745, DOI 10.1001/jama.279.21.1745	24	16	16	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160706	10.1371/journal.pone.0160706	http://dx.doi.org/10.1371/journal.pone.0160706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490200	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900079
J	Atwood, EC; Englhart, S; Lorenz, E; Halle, W; Wiedemann, W; Siegert, F				Atwood, Elizabeth C.; Englhart, Sandra; Lorenz, Eckehard; Halle, Winfried; Wiedemann, Werner; Siegert, Florian			Detection and Characterization of Low Temperature Peat Fires during the 2015 Fire Catastrophe in Indonesia Using a New High-Sensitivity Fire Monitoring Satellite Sensor (FireBird)	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; FOREST-FIRES; MODIS; VEGETATION; ALGORITHM; BIOMASS; KALIMANTAN; EMISSIONS; QUALITY; MISSION	Vast and disastrous fires occurred on Borneo during the 2015 dry season, pushing Indonesia into the top five carbon emitting countries. The region was affected by a very strong El Nino-Southern Oscillation (ENSO) climate phenomenon, on par with the last severe event in 1997/98. Fire dynamics in Central Kalimantan were investigated using an innovative sensor offering higher sensitivity to a wider range of fire intensities at a finer spatial resolution (160 m) than heretofore available. The sensor is onboard the TET-1 satellite, part of the German Aerospace Center (DLR) FireBird mission. TET-1 images (acquired every 2-3 days) from the middle infrared were used to detect fires continuously burning for almost three weeks in the protected peatlands of Sebangau National Park as well as surrounding areas with active logging and oil palm concessions. TET-1 detection capabilities were compared with MODIS active fire detection and Landsat burned area algorithms. Fire dynamics, including fire front propagation speed and area burned, were investigated. We show that TET-1 has improved detection capabilities over MODIS in monitoring low-intensity peatland fire fronts through thick smoke and haze. Analysis of fire dynamics revealed that the largest burned areas resulted from fire front lines started from multiple locations, and the highest propagation speeds were in excess of 500 m/day (all over peat > 2m deep). Fires were found to occur most often in concessions that contained drainage infrastructure but were not cleared prior to the fire season. Benefits of implementing this sensor system to improve current fire management techniques are discussed. Near real-time fire detection together with enhanced fire behavior monitoring capabilities would not only improve firefighting efforts, but also benefit analysis of fire impact on tropical peatlands, greenhouse gas emission estimations as well as mitigation measures to reduce severe fire events in the future.	[Atwood, Elizabeth C.; Siegert, Florian] Ludwig Maximilians Univ Munchen, Dept Biol 2, GeoBio Ctr, Planegg Martinsried, Germany; [Atwood, Elizabeth C.; Englhart, Sandra; Wiedemann, Werner; Siegert, Florian] RSS Remote Sensing Solut GmbH, Baierbrunn, Germany; [Lorenz, Eckehard; Halle, Winfried] German Aerosp Ctr DLR eV, Inst Opt Sensor Syst, Berlin, Germany	University of Munich; Helmholtz Association; German Aerospace Centre (DLR)	Atwood, EC (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, GeoBio Ctr, Planegg Martinsried, Germany.; Atwood, EC (corresponding author), RSS Remote Sensing Solut GmbH, Baierbrunn, Germany.	atwood@rssgmbh.de	Lohberger, Sandra/J-7349-2016	Lohberger, Sandra/0000-0002-6180-7372	German Aerospace Center (DLR e.V.); RSS Remote Sensing Solutions GmbH; RSS GmbH	German Aerospace Center (DLR e.V.)(Helmholtz AssociationGerman Aerospace Centre (DLR)); RSS Remote Sensing Solutions GmbH; RSS GmbH	Publication funding was provided by the German Aerospace Center (DLR e.V.) and RSS Remote Sensing Solutions GmbH. The authors received no specific funding for this work. The commercial funder, RSS GmbH, provided support in the form of salaries for the authors ECA, SE, WW and FS, who were involved with the study design, collaborative data collection and analysis, decision to publish, and preparation of the manuscript. This funding was provided as purely research oriented support in order to enable development of novel methods for examining this system. The specific roles of each author is articulated in the 'author contributions' section.	Anno O, ATSR WORLD FIRE ATLA; [Anonymous], 1999, HLTH GUIDELINES VEGE; [Anonymous], 2005, FOREST RESTORATION L; Atwood SA, 2013, ATMOS ENVIRON, V78, P219, DOI 10.1016/j.atmosenv.2013.04.047; Austin K, 2012, INDONESIAS MORATORIU; Ballhorn U, 2009, P NATL ACAD SCI USA, V106, P21213, DOI 10.1073/pnas.0906457106; Barber C, 2000, TRIAL FIRE FOREST FI; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Blaschke T., 2001, GEOINFORMATIONSSYST, P12, DOI DOI 10.1364/AO.52.007629; Box JE, 2006, J CLIMATE, V19, P2783, DOI 10.1175/JCLI3738.1; CARD DH, 1982, PHOTOGRAMM ENG REM S, V48, P431; Carvalho JA, 2010, INT J WILDLAND FIRE, V19, P795, DOI 10.1071/WF08047; Chistjakov V.I., 1983, ROLE FIRE CIRCUMPOLA, P259; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; d'Oliveira MVN, 2011, FOREST ECOL MANAG, V261, P1490, DOI 10.1016/j.foreco.2011.01.014; Drusch M, 2012, REMOTE SENS ENVIRON, V120, P25, DOI 10.1016/j.rse.2011.11.026; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Fuller DO, 2000, PROG PHYS GEOG, V24, P543, DOI 10.1177/030913330002400404; Giglio L, 1999, INT J REMOTE SENS, V20, P1947, DOI 10.1080/014311699212290; Giglio L, 2003, REMOTE SENS ENVIRON, V87, P273, DOI 10.1016/S0034-4257(03)00184-6; Giglio L, 2003, INT J REMOTE SENS, V24, P3515, DOI 10.1080/0143116031000117056; Gitelson AA, 2008, REMOTE SENS ENVIRON, V112, P3582, DOI 10.1016/j.rse.2008.04.015; Goldammer J. G., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P13, DOI 10.1007/s11027-006-9044-7; Haines SL, 2007, IEEE T GEOSCI REMOTE, V45, P2919, DOI 10.1109/TGRS.2007.898274; Hall DK, 2002, REMOTE SENS ENVIRON, V83, P181, DOI 10.1016/S0034-4257(02)00095-0; Hoscilo A, 2013, INT J REMOTE SENS, V34, P412, DOI 10.1080/01431161.2012.709328; Hoscilo A, 2011, INT J WILDLAND FIRE, V20, P578, DOI 10.1071/WF10029; Hu CM, 2004, REMOTE SENS ENVIRON, V93, P423, DOI 10.1016/j.rse.2004.08.007; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Hyer EJ, 2010, ATMOS ENVIRON, V44, P1422, DOI 10.1016/j.atmosenv.2010.01.043; Immirzi C. P., 1992, 11 U EX WETL EC RES; Kilpatrick KA, 2001, J GEOPHYS RES-OCEANS, V106, P9179, DOI 10.1029/1999JC000065; Konecny K, 2016, GLOBAL CHANGE BIOL, V22, P1469, DOI 10.1111/gcb.13186; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li Z, 2000, INT J REMOTE SENS, V21, P3057, DOI 10.1080/01431160050144956; Li Zhanqing, 2001, P199; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Marlier ME, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085005; Mas J. F., 2014, GEOGR J, DOI [10.1155/2014/372349, DOI 10.1155/2014/372349]; Miettinen J, 2012, GCB BIOENERGY, V4, P908, DOI 10.1111/j.1757-1707.2012.01172.x; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Miller RL, 2004, REMOTE SENS ENVIRON, V93, P259, DOI 10.1016/j.rse.2004.07.012; Mota BW, 2006, ATMOS CHEM PHYS, V6, P1409, DOI 10.5194/acp-6-1409-2006; MUHAMAD NZ, 2002, PEATLANDS PEOPLE NAT, P155; Muraleedharan TR, 2000, ATMOS ENVIRON, V34, P3033, DOI 10.1016/S1352-2310(99)00512-9; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Page SE, 1999, PHILOS T R SOC B, V354, P1885, DOI 10.1098/rstb.1999.0529; Page Susan, 2009, P263, DOI 10.1007/978-3-540-77381-8_9; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Posa MRC, 2011, BIOSCIENCE, V61, P49, DOI 10.1525/bio.2011.61.1.10; PRINS EM, 1994, J GEOPHYS RES-ATMOS, V99, P16719, DOI 10.1029/94JD01208; Reddington CL, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/094006; Remer LA, 2005, J ATMOS SCI, V62, P947, DOI 10.1175/JAS3385.1; Rieley Jack O., 1992, Suo (Helsinki), V43, P241; ROBINSON JM, 1991, INT J REMOTE SENS, V12, P3, DOI 10.1080/01431169108929628; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Roy DP, 2005, REMOTE SENS ENVIRON, V97, P137, DOI 10.1016/j.rse.2005.04.007; Scambos TA, 2007, REMOTE SENS ENVIRON, V111, P242, DOI 10.1016/j.rse.2006.12.020; Schiewe J., 2001, GIS Z GEOINFORMATION, V6, P34; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Siegert F, 2000, REMOTE SENS ENVIRON, V72, P64, DOI 10.1016/S0034-4257(99)00092-9; Simorangkir D., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P147, DOI 10.1007/s11027-006-9049-2; Spessa AC, 2015, NAT HAZARD EARTH SYS, V15, P429, DOI 10.5194/nhess-15-429-2015; Stolle F, 2004, INT J REMOTE SENS, V25, P471, DOI 10.1080/01431160310001618022; Takahashi H., 2002, PEATLANDS PEOPLE NAT, P63; Taylor D, 2010, BIODIVERS CONSERV, V19, P1025, DOI 10.1007/s10531-009-9756-6; Usup A., 2004, TROPICS, V14, P1, DOI [10.3759/tropics.14.1, DOI 10.3759/TROPICS.14.1]; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; VanderWerf G. R., 2015, INDONESIAN FIRE SEAS; Wein R. W., 1983, The role of fire in northern circumpolar ecosystems, P81; Wijaya A, 2015, ASSESSMENT LARGE SCA; World Bank, 2015, IND EC Q REF AM UNC; WWF, 2012, REWETTING TROPICAL P, P1; Zhukov B, 2006, REMOTE SENS ENVIRON, V100, P29, DOI 10.1016/j.rse.2005.09.019; Zhukov B, 2005, ACTA ASTRONAUT, V56, P65, DOI 10.1016/j.actaastro.2004.09.014	76	39	40	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159410	10.1371/journal.pone.0159410	http://dx.doi.org/10.1371/journal.pone.0159410			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486664	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800028
J	Buehler, EA; Mesbah, A				Buehler, Edward A.; Mesbah, Ali			Kinetic Study of Acetone-Butanol-Ethanol Fermentation in Continuous Culture	PLOS ONE			English	Article							CLOSTRIDIUM-ACETOBUTYLICUM FERMENTATIONS; 2-STAGE CONTINUOUS FERMENTATION; SOLVENT PRODUCTION; BUTYRIC-ACID; BIOBUTANOL PRODUCTION; PH; BEIJERINCKII; BATCH; GROWTH; SACCHAROPERBUTYLACETONICUM	Acetone-butanol-ethanol (ABE) fermentation by clostridia has shown promise for industrial-scale production of biobutanol. However, the continuous ABE fermentation suffers from low product yield, titer, and productivity. Systems analysis of the continuous ABE fermentation will offer insights into its metabolic pathway as well as into optimal fermentation design and operation. For the ABE fermentation in continuous Clostridium acetobutylicum culture, this paper presents a kinetic model that includes the effects of key metabolic intermediates and enzymes as well as culture pH, product inhibition, and glucose inhibition. The kinetic model is used for elucidating the behavior of the ABE fermentation under the conditions that are most relevant to continuous cultures. To this end, dynamic sensitivity analysis is performed to systematically investigate the effects of culture conditions, reaction kinetics, and enzymes on the dynamics of the ABE production pathway. The analysis provides guidance for future metabolic engineering and fermentation optimization studies.	[Buehler, Edward A.; Mesbah, Ali] Univ Calif Berkeley, Dept Biomol & Chem Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Mesbah, A (corresponding author), Univ Calif Berkeley, Dept Biomol & Chem Engn, Berkeley, CA 94720 USA.	mesbah@berkeley.edu			Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	Berkeley Research Impact Initiative (BRII) - UC Berkeley Library	Publication made possible in part by support from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library.	BALLONGUE J, 1987, APPL MICROBIOL BIOT, V26, P568, DOI 10.1007/BF00253034; Bard Y., 1974, NONLINEAR PARAMETER; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Dash S, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0144-4; Desai RP, 1999, J BIOTECHNOL, V71, P191, DOI 10.1016/S0168-1656(99)00022-X; Duerre Peter, 2007, Biotechnology Journal, V2, P1525, DOI 10.1002/biot.200700168; DURRE P, 1996, BIOTECHNOLOGY, V6, P229; Ezeji TC, 2007, CURR OPIN BIOTECH, V18, P220, DOI 10.1016/j.copbio.2007.04.002; Fedorov V. V., 1972, THEORY OF OPTIMAL EX; Gabriel CL, 1928, IND ENG CHEM, V20, P1063, DOI 10.1021/ie50226a020; Gapes JR, 1996, APPL ENVIRON MICROB, V62, P3210, DOI 10.1128/AEM.62.9.3210-3219.1996; Garcia V, 2011, RENEW SUST ENERG REV, V15, P964, DOI 10.1016/j.rser.2010.11.008; GEORGE HA, 1983, APPL ENVIRON MICROB, V46, P321, DOI 10.1128/AEM.46.2.321-327.1983; GODIN C, 1990, APPL MICROBIOL BIOT, V33, P269, DOI 10.1007/BF00164520; GOTTSCHAL JC, 1981, BIOTECHNOL LETT, V3, P525, DOI 10.1007/BF00147566; Green EM, 2011, CURR OPIN BIOTECH, V22, P337, DOI 10.1016/j.copbio.2011.02.004; Grimmler C, 2011, J MOL MICROB BIOTECH, V20, P1, DOI 10.1159/000320973; Haus S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-10; HOLT RA, 1984, APPL ENVIRON MICROB, V48, P1166, DOI 10.1128/AEM.48.6.1166-1170.1984; HUANG L, 1986, APPL ENVIRON MICROB, V51, P1230, DOI 10.1128/AEM.51.6.1230-1234.1986; HUSEMANN MHW, 1988, BIOTECHNOL BIOENG, V32, P843, DOI 10.1002/bit.260320702; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; JONES DT, 1995, FEMS MICROBIOL REV, V17, P223, DOI 10.1111/j.1574-6976.1995.tb00206.x; KIM J, 1988, APPL BIOCHEM BIOTECH, V18, P175, DOI 10.1007/BF02930824; KROUWEL PG, 1983, BIOTECHNOL BIOENG, V25, P281, DOI 10.1002/bit.260250121; Kumar M, 2011, APPL ENERG, V88, P1999, DOI 10.1016/j.apenergy.2010.12.055; LAI MC, 1994, ENZYME MICROB TECH, V16, P1021, DOI 10.1016/0141-0229(94)90136-8; Leung JCY., 1981, P 2 ND WORLD C CHEM, V1, P348; Li RD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S12; Liao C, 2015, P NATL ACAD SCI USA, V112, P8505, DOI 10.1073/pnas.1423143112; MADDOX IS, 1989, BIOTECHNOL GENET ENG, V7, P189, DOI 10.1080/02648725.1989.10647859; Mayank R, 2013, CRIT REV BIOTECHNOL, V33, P419, DOI 10.3109/07388551.2012.726208; MCNEIL B, 1987, BIOTECHNOL BIOENG, V29, P383, DOI 10.1002/bit.260290315; Michael K, 2011, BIOFUEL PRODUCTION - RECENT DEVELOPMENTS AND PROSPECTS, P451; Michaelis L, 1913, BIOCHEM Z, V49, P333; Millat T, 2014, APPL MICROBIOL BIOT, V98, P9059, DOI 10.1007/s00253-014-5987-x; Millat T, 2013, MICROB BIOTECHNOL, V6, P526, DOI 10.1111/1751-7915.12033; Millat T, 2013, APPL MICROBIOL BIOT, V97, P6451, DOI 10.1007/s00253-013-4860-7; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; MONOT F, 1983, BIOTECHNOL LETT, V5, P213, DOI 10.1007/BF00161117; MONOT F, 1983, EUR J APPL MICROBIOL, V18, P246, DOI 10.1007/BF00501517; MONOT F, 1984, APPL MICROBIOL BIOT, V19, P422, DOI 10.1007/BF00454381; Moon HG, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw001; Morone A, 2014, RENEW SUST ENERG REV, V37, P21, DOI 10.1016/j.rser.2014.05.009; MULCHANDANI A, 1986, CAN J CHEM ENG, V64, P625, DOI 10.1002/cjce.5450640413; Mutschlechner O, 2000, J MOL MICROB BIOTECH, V2, P101; National Research Council, 2006, TRENDS IN OIL SUPPLY; OKAMOTO M, 1988, BIOL CYBERN, V58, P295, DOI 10.1007/BF00363938; PAPOUTSAKIS ET, 1984, BIOTECHNOL BIOENG, V26, P174, DOI 10.1002/bit.260260210; Peabody GL, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw017; QURESHI N, 1988, BIOPROCESS ENG, V3, P69, DOI 10.1007/BF00369330; Qureshi N, 2000, WORLD J MICROB BIOT, V16, P377, DOI 10.1023/A:1008984509404; Ranjan A, 2012, INT J ENERG RES, V36, P277, DOI 10.1002/er.1948; Richter H, 2012, BIOTECHNOL BIOENG, V109, P913, DOI 10.1002/bit.24380; ROOS JW, 1985, BIOTECHNOL BIOENG, V27, P681, DOI 10.1002/bit.260270518; Shinto H, 2007, J BIOTECHNOL, V131, P45, DOI 10.1016/j.jbiotec.2007.05.005; SONI BK, 1987, CURR MICROBIOL, V16, P61, DOI 10.1007/BF01588173; SONI BK, 1987, APPL MICROBIOL BIOT, V27, P1; SONI BK, 1987, APPL MICROBIOL BIOT, V25, P317; STEPHENS GM, 1985, J APPL BACTERIOL, V58, P597, DOI 10.1111/j.1365-2672.1985.tb01716.x; Tashiro Y, 2004, J BIOSCI BIOENG, V98, P263; Visioli LZ., 2014, IND BIOTECHNOL, V2, P316, DOI [10.1089/ind.2015.0023, DOI 10.1089/IND.2015.0023]; VOTRUBA J, 1986, BIOTECHNOL BIOENG, V28, P247, DOI 10.1002/bit.260280215; Wang S, 2011, BIOTECHNOLOGICAL PRO, V93, P1021; Wild CJ, 1989, WILEY SERIES IN PROB; YANG XP, 1994, BIOTECHNOL PROGR, V10, P532, DOI 10.1021/bp00029a012	67	34	34	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0158243	10.1371/journal.pone.0158243	http://dx.doi.org/10.1371/journal.pone.0158243			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486663	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800008
J	Csoma, RZ; Toth-Molnar, E; Varga, A; Szabo, H; Orvos, H; Kemeny, L; Olah, J				Csoma, Renata Zsanett; Toth-Molnar, Edit; Varga, Anita; Szabo, Hajnalka; Orvos, Hajnalka; Kemeny, Lajos; Olah, Judit			Risk Factors and Relationship of Cutaneous and Uveal Melanocytic Lesions in Monozygotic and Dizygotic Twin Pairs	PLOS ONE			English	Article							BLUE-LIGHT PHOTOTHERAPY; CHOROIDAL NEVI; ULTRAVIOLET-RADIATION; WHITE-POPULATION; ADOLESCENT TWINS; OCULAR MELANOMA; SUN EXPOSURE; METAANALYSIS; ASSOCIATION; AUSTRALIA	Background The similar genetic background of a pair of twins, and the similar environmental impacts to which they are exposed allow an exact and objective investigation of various constitutional and environmental factors in naevus development. As far as we are aware, this is the first published survey that simultaneously examines cutaneous and ocular pigmented lesions in an appreciable sample of identical and non-identical twins. Methods 172 pairs of twins of Caucasian origin were included in this study. A whole-body skin examination and a detailed ophthalmological examination were performed to determine the density of melanocytic lesions. A standardized questionnaire was used to assess the data relating to constitutional, sun exposure and other variables. Results A notably high proportion of the subjects (36.78%) manifested one or more clinically atypical melanocytic naevi (CAMNs), and approximately one-third (31.4%) of them at least one benign uveal pigmented lesion (BUPL). The incidence of iris freckles (IFs), iris naevi (INs) and choroidal naevi (CHNs) proved to be 25.35%, 5.98% and 3.52%, respectively. The interclass correlation coefficients for commonmelanocytic naevi (CMNs), CAMNs, and INs were 0.77, 0.76 and 0.86 in monozygotic twins, as compared with 0.5, 0.27 and 0.25 in dizygotic twin pairs, respectively. A statistically significant correlation was found between the prevalence of CAMNs and that of INs. Conclusions This significant correlation suggests the existence of a subgroup of Caucasian people with an increased susceptibility to both cutaneous and ocular naevus formation. There is accumulating evidence that, besides the presence of cutaneous atypical naevi, INs can serve as a marker of a predisposed phenotype at risk of uveal melanoma. The correlation between cutaneous and ocular pigmented lesions underlines the need for the adequate ophthalmological screening of subjects with CAMNs and INs.	[Csoma, Renata Zsanett; Varga, Anita; Kemeny, Lajos; Olah, Judit] Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary; [Toth-Molnar, Edit] Univ Szeged, Dept Ophthalmol, Szeged, Hungary; [Szabo, Hajnalka] Univ Szeged, Dept Paediat, Szeged, Hungary; [Orvos, Hajnalka] Univ Szeged, Dept Obstet & Gynaecol, Szeged, Hungary; [Kemeny, Lajos] Univ Szeged, Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary	Szeged University; Szeged University; Szeged University; Szeged University; Hungarian Academy of Sciences; Szeged University	Csoma, RZ (corresponding author), Univ Szeged, Dept Dermatol & Allergol, Szeged, Hungary.	csoma.zsanett@med.u-szeged.hu	Kemeny, Lajos/ABF-1339-2021	Kemeny, Lajos/0000-0002-2119-9501	European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]	European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program' (RZC).; This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program'.	Bataille V, 2000, JNCI-J NATL CANCER I, V92, P457, DOI 10.1093/jnci/92.6.457; Belmar-Lopez C, 2008, CLIN TRANSL ONCOL, V10, P137, DOI 10.1007/s12094-008-0170-4; Csoma Z, 2008, NEW ENGL J MED, V358, P2523; Csoma Z, 2007, PEDIATRICS, V119, P1036, DOI 10.1542/peds.2007-0180; Csoma Z, 2011, PEDIATRICS, V128, pE856, DOI 10.1542/peds.2011-0292; Damato B, 2010, BRIT J CANCER, V103, P285, DOI 10.1038/sj.bjc.6605765; Eskelin S, 2000, OPHTHALMOLOGY, V107, P1443, DOI 10.1016/S0161-6420(00)00182-2; GASS JDM, 1977, AM J OPHTHALMOL, V83, P299; Greenstein MB, 2011, OPHTHALMOLOGY, V118, P2468, DOI 10.1016/j.ophtha.2011.05.007; HAMMER H, 1995, LANCET, V346, P255, DOI 10.1016/S0140-6736(95)91305-X; Harbour JW, 2004, BRIT J OPHTHALMOL, V88, P39, DOI 10.1136/bjo.88.1.39; Kujala E, 2003, INVEST OPHTH VIS SCI, V44, P4651, DOI 10.1167/iovs.03-0538; Mallet JD, 2013, PHOTOCHEM PHOTOBIOL; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Nikolaou V, 2014, BRIT J DERMATOL, V170, P11, DOI 10.1111/bjd.12492; Schmidt-Pokrzywniak A, 2009, OPHTHALMOLOGY, V116, P340, DOI 10.1016/j.ophtha.2008.09.040; Shah CP, 2005, OPHTHALMOLOGY, V112, P1599, DOI 10.1016/j.ophtha.2005.04.020; Shields CL, 2009, ARCH OPHTHALMOL-CHIC, V127, P981, DOI 10.1001/archophthalmol.2009.151; Shields JA., 1983, DIAGNOSIS MANAGEMENT; Singh AD, 2004, SURV OPHTHALMOL, V49, P419, DOI 10.1016/j.survophthal.2004.04.009; Sumich P, 1998, ARCH OPHTHALMOL-CHIC, V116, P645, DOI 10.1001/archopht.116.5.645; Toth-Molnar E, 2004, MELANOMA RES, V14, P43, DOI 10.1097/01.cmr.0000114315.54394.e7; Vajdic CM, 2004, INT J CANCER, V112, P896, DOI 10.1002/ijc.20476; Vajdic CM, 2002, INT J CANCER, V101, P175, DOI 10.1002/ijc.10579; Wachsmuth RC, 2005, J INVEST DERMATOL, V124, P56, DOI 10.1111/j.0022-202X.2004.23548.x; Wachsmuth RC, 2001, J INVEST DERMATOL, V117, P348, DOI 10.1046/j.0022-202x.2001.01415.x; Weis E, 2006, ARCH OPHTHALMOL-CHIC, V124, P54, DOI 10.1001/archopht.124.1.54; Weis E, 2009, OPHTHALMOLOGY, V116, P536, DOI 10.1016/j.ophtha.2008.10.008; Zimmermann LE, 1965, INVEST OPHTHALMOL, V4, P14	29	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160146	10.1371/journal.pone.0160146	http://dx.doi.org/10.1371/journal.pone.0160146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486750	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000381367800059
J	De Pascalis, V; Scacchia, P				De Pascalis, Vilfredo; Scacchia, Paolo			Hypnotizability and Placebo Analgesia in Waking and Hypnosis as Modulators of Auditory Startle Responses in Healthy Women: An ERP Study	PLOS ONE			English	Article							FEAR-POTENTIATED STARTLE; EVENT-RELATED POTENTIALS; TASK-RELATED RESPONSES; MEDULLARY DORSAL-HORN; PREPULSE-INHIBITION; HYPNOTIC ANALGESIA; PAIN PERCEPTION; FOCUSED ANALGESIA; REFLEX MODIFICATION; HUMAN BRAIN	We evaluated the influence of hypnotizability, pain expectation, placebo analgesia in waking and hypnosis on tonic pain relief. We also investigated how placebo analgesia affects somatic responses (eye blink) and N100 and P200 waves of event-related potentials (ERPs) elicited by auditory startle probes. Although expectation plays an important role in placebo and hypnotic analgesia, the neural mechanisms underlying these treatments are still poorly understood. We used the cold cup test (CCT) to induce tonic pain in 53 healthy women. Placebo analgesia was initially produced by manipulation, in which the intensity of pain induced by the CCT was surreptitiously reduced after the administration of a sham analgesic cream. Participants were then tested in waking and hypnosis under three treatments: (1) resting (Baseline); (2) CCT-alone (Pain); and (3) CCT plus placebo cream for pain relief (Placebo). For each painful treatment, we assessed pain and distress ratings, eye blink responses, N100 and P200 amplitudes. We used LORETA analysis of N100 and P200 waves, as elicited by auditory startle, to identify cortical regions sensitive to pain reduction through placebo and hypnotic analgesia. Higher pain expectation was associated with higher pain reductions. In highly hypnotizable participants placebo treatment produced significant reductions of pain and distress perception in both waking and hypnosis condition. P200 wave, during placebo analgesia, was larger in the frontal left hemisphere while placebo analgesia, during hypnosis, involved the activity of the left hemisphere including the occipital region. These findings demonstrate that hypnosis and placebo analgesia are different processes of top-down regulation. Pain reduction was associated with larger EMG startle amplitudes, N100 and P200 responses, and enhanced activity within the frontal, parietal, and anterior and posterior cingulate gyres. LORETA results showed that placebo analgesia modulated pain-responsive areas known to reflect the ongoing pain experience.	[De Pascalis, Vilfredo; Scacchia, Paolo] Univ Roma La Sapienza, Rome, Italy	Sapienza University Rome	De Pascalis, V (corresponding author), Univ Roma La Sapienza, Rome, Italy.	vilfredo.depascalis@uniroma1.it	De Pascalis, Vilfredo/ABC-5534-2021	Scacchia, Paolo/0000-0002-4522-453X; DE PASCALIS, Vilfredo/0000-0003-4594-8877	"La Sapienza" University of Rome (Ricerche Universitarie) [C26A15RC5R]	"La Sapienza" University of Rome (Ricerche Universitarie)	This study was supported by an annual grant (Ricerche Universitarie, 2015-prot. C26A15RC5R) from the "La Sapienza" University of Rome.	Andreatta M, 2010, P ROY SOC B-BIOL SCI, V277, P2411, DOI 10.1098/rspb.2010.0103; Annic A, 2014, CLIN NEUROPHYSIOL, V125, P1576, DOI 10.1016/j.clinph.2013.12.002; ANTHONY BJ, 1985, BIOL PSYCHOL, V21, P43, DOI 10.1016/0301-0511(85)90052-3; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Barber J.E., 1996, HYPNOSIS SUGGESTION; Benedetti F., 2008, PLACEBO EFFECTS UNDE; Benedetti F, 2010, PAIN, V148, P357, DOI 10.1016/j.pain.2009.10.009; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Benke C, 2015, PSYCHOPHARMACOLOGY, V232, P3403, DOI 10.1007/s00213-015-3996-9; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Blumenthal TD, 2006, BIOL PSYCHOL, V72, P173, DOI 10.1016/j.biopsycho.2005.10.001; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BLUMENTHAL TD, 1994, PSYCHOPHYSIOLOGY, V31, P201, DOI 10.1111/j.1469-8986.1994.tb01041.x; Boutros NN, 1999, PSYCHIAT RES, V88, P119, DOI 10.1016/S0165-1781(99)00074-8; Bradley M. M., 1999, STARTLE MODIFICATION, P157, DOI [10.1017/CBO9780511665523.010, DOI 10.1017/CBO9780511665523.010]; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; BRADLEY MM, 2000, COGNITIVE NEUROSCIEN, V25, P49, DOI DOI 10.1016/0005-7916(94)90063-9; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Braff DL, 2001, SCHIZOPHR RES, V49, P171, DOI 10.1016/S0920-9964(00)00139-0; Campbell LE, 2007, EUR J NEUROSCI, V26, P2327, DOI 10.1111/j.1460-9568.2007.05858.x; Chen ACN, 2000, NEUROIMAGE, V11, P734, DOI DOI 10.1016/S1053-8119(00)91664-1; Codispoti M, 2001, PSYCHOPHYSIOLOGY, V38, P474, DOI 10.1111/1469-8986.3830474; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; Colloca L, 2008, PAIN, V139, P306, DOI 10.1016/j.pain.2008.04.021; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; COOK EW, 1991, J ABNORM PSYCHOL, V100, P5, DOI 10.1037/0021-843X.100.1.5; Craggs JG, 2008, PAIN, V139, P660, DOI 10.1016/j.pain.2008.07.025; CRAWFORD HJ, 1994, INT J CLIN EXP HYP, V42, P204, DOI 10.1080/00207149408409352; Crawford HJ., 1992, CONT HYPNOSIS RES, P227; Danziger N, 1998, PAIN, V75, P85, DOI 10.1016/S0304-3959(97)00208-X; DAVIS H, 1966, J ACOUST SOC AM, V39, P109, DOI 10.1121/1.1909858; De Pascalis V, 1999, PAIN, V83, P499, DOI 10.1016/S0304-3959(99)00157-8; De Pascalis V, 2002, PAIN, V96, P393, DOI 10.1016/S0304-3959(01)00485-7; De Pascalis V, 2008, PAIN, V134, P197, DOI 10.1016/j.pain.2007.09.005; De Pascalis V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128474; De Pascalis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079605; De Pascalis V, 2013, CLIN NEUROPHYSIOL, V124, P292, DOI 10.1016/j.clinph.2012.07.018; de Peuter S, 2009, 49 ANN M SOC PSYCH R; Decety J, 2010, NEUROIMAGE, V50, P1676, DOI 10.1016/j.neuroimage.2010.01.025; Deuter CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049866; DUBNER R, 1981, J NEUROPHYSIOL, V46, P444, DOI 10.1152/jn.1981.46.3.444; DUNCAN GH, 1987, J NEUROPHYSIOL, V57, P289, DOI 10.1152/jn.1987.57.1.289; Efron B., 1987, JACKKNIFE BOOTSTRAP; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Faymonville ME, 2006, J PHYSIOL-PARIS, V99, P463, DOI 10.1016/j.jphysparis.2006.03.018; Faymonville ME, 2000, ANESTHESIOLOGY, V92, P1257, DOI 10.1097/00000542-200005000-00013; Faymonville ME, 2003, COGNITIVE BRAIN RES, V17, P255, DOI 10.1016/S0926-6410(03)00113-7; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; FILION DL, 1993, BIOL PSYCHOL, V35, P185, DOI 10.1016/0301-0511(93)90001-O; Franklin JC, 2009, PERS INDIV DIFFER, V46, P369, DOI 10.1016/j.paid.2008.11.004; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; GARCIALARREA L, 1995, PSYCHOPHYSIOLOGY, V32, P526, DOI 10.1111/j.1469-8986.1995.tb01229.x; GARCIALARREA L, 1992, NEUROPSYCHOLOGIA, V30, P723, DOI 10.1016/0028-3932(92)90042-K; GIARD MH, 1994, ELECTROEN CLIN NEURO, V92, P238, DOI 10.1016/0168-5597(94)90067-1; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greenblatt RE, 2005, IEEE T SIGNAL PROCES, V53, P3403, DOI 10.1109/TSP.2005.853201; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; Grillon C, 1997, PSYCHOPHYSIOLOGY, V34, P451, DOI 10.1111/j.1469-8986.1997.tb02389.x; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; HAERICH P, 1994, PSYCHOL SCI, V5, P407, DOI 10.1111/j.1467-9280.1994.tb00294.x; Hilgard E.R., 1994, HYPNOSIS RELIEF PAIN; Hillyard S.A., 1979, PROGR CLIN NEUROPHYS, V6, P1; Hines EA, 1940, AM HEART J, V19, P408, DOI 10.1016/S0002-8703(40)90053-9; Hirano C, 1996, INT J PSYCHOPHYSIOL, V22, P97, DOI 10.1016/0167-8760(96)00018-9; Hofbauer RK, 2001, J NEUROPHYSIOL, V86, P402, DOI 10.1152/jn.2001.86.1.402; Horn C, 2012, INT J PSYCHOPHYSIOL, V84, P254, DOI 10.1016/j.ijpsycho.2012.03.002; Horn C, 2012, PAIN RES MANAG, V17, P15, DOI 10.1155/2012/478019; Horton JE, 2004, BRAIN, V127, P1741, DOI 10.1093/brain/awh196; Hu L, 2005, NEUR ENG 2005 C P 2; Jarcho JM, 2016, NEUROIMAGE-CLIN, V10, P107, DOI 10.1016/j.nicl.2015.11.009; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kauramaki J, 2007, SELECTIVE ATTENTION; Kihlstrom JF, 2013, CORTEX, V49, P365, DOI 10.1016/j.cortex.2012.05.016; Kirjanen S, 2012, J EUROPEAN PSYCHOL S, V3; KIRSCH I, 1988, BEHAV NEUROSCI, V102, P319, DOI 10.1037/0735-7044.102.2.319; Kirsch I, 2004, CONDITIONING EXPECTN; Kong J, 2006, J NEUROSCI, V26, P381, DOI 10.1523/JNEUROSCI.3556-05.2006; Kumari V, 2005, NEUROIMAGE, V26, P1052, DOI 10.1016/j.neuroimage.2005.03.002; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Legrain V, 2012, NEUROPHYSIOL CLIN, V42, P325, DOI 10.1016/j.neucli.2012.06.003; Leknes S, 2008, EUR J NEUROSCI, V28, P794, DOI 10.1111/j.1460-9568.2008.06380.x; Lichtenberg P, 2004, INT J CLIN EXP HYP, V52, P47, DOI 10.1076/iceh.52.1.47.23922; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; Ludewig S, 2005, J PSYCHIATR NEUROSCI, V30, P37; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCGLASHA.TH, 1969, PSYCHOSOM MED, V31, P227, DOI 10.1097/00006842-196905000-00003; Montgomery GH, 1997, PAIN, V72, P107, DOI 10.1016/S0304-3959(97)00016-X; MORGAN AH, 1979, AM J CLIN HYPN, V21, P134; Neuner I, 2010, HUM BRAIN MAPP, V31, P1675, DOI 10.1002/hbm.20965; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nir RR, 2008, J PAIN, V9, P1058, DOI 10.1016/j.jpain.2008.06.008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Panayiotou G, 1998, PSYCHOPHYSIOLOGY, V35, P328, DOI 10.1017/S0048577298960875; PARASURAMAN R, 1980, BIOL PSYCHOL, V11, P217, DOI 10.1016/0301-0511(80)90057-5; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Perlstein WM, 2001, BIOL PSYCHOL, V56, P83, DOI 10.1016/S0301-0511(01)00075-8; Peterson CK, 2008, SOC NEUROSCI, V3, P113, DOI 10.1080/17470910701612736; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Pollo A, 2001, PAIN, V93, P77, DOI 10.1016/S0304-3959(01)00296-2; Price D.D., 1999, PROGR PAIN RES MANAG; PRICE DD, 1987, PAIN, V28, P297, DOI 10.1016/0304-3959(87)90065-0; Price DD, 2000, PROG BRAIN RES, V122, P255; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Ray WJ, 2002, BIOL PSYCHOL, V60, P17, DOI 10.1016/S0301-0511(02)00029-7; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Sambo CF, 2012, J NEUROPHYSIOL, V107, P880, DOI 10.1152/jn.00731.2011; Schall U, 1996, INT J NEUROSCI, V84, P15, DOI 10.3109/00207459608987247; Schneider S, 2009, NEUROSCI LETT, V467, P131, DOI 10.1016/j.neulet.2009.10.022; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Sharav Y, 2004, INT J PSYCHOPHYSIOL, V52, P187, DOI 10.1016/j.ijpsycho.2003.10.001; Sharav Y, 2006, PAIN, V124, P280, DOI 10.1016/j.pain.2006.04.016; Simons RF, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P229; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Sommer K, 2016, PHYSIOL BEHAV, V154, P100, DOI 10.1016/j.physbeh.2015.11.021; SPIEGEL D, 1988, AM J CLIN HYPN, V31, P11, DOI 10.1080/00029157.1988.10402762; SPIEGEL D, 1992, BIOL PSYCHIAT, V31, P95, DOI 10.1016/0006-3223(92)90009-O; Spielberger C., 1988, MANUAL STATE TRAIT A; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Streff A, 2010, EUR J PAIN, V14, P266, DOI 10.1016/j.ejpain.2009.05.011; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Talairach J., 1988, COPLANAR STEREOTAXIC; Tavernor SJ, 2000, J PSYCHOPHARMACOL, V14, P387, DOI 10.1177/026988110001400407; Tomberg C, 1989, ELECTROENCEPHALOGRAP, V74; TOWLE VL, 1993, ELECTROEN CLIN NEURO, V86, P1, DOI 10.1016/0013-4694(93)90061-Y; Valentini E, 2013, CORTEX, V49, P446, DOI 10.1016/j.cortex.2012.02.005; Valet M, 2009, PSYCHOSOM MED, V71, P49, DOI 10.1097/PSY.0b013e31818d1e02; Van Boxtel A, 1998, PSYCHOPHYSIOLOGY, V35, P690, DOI 10.1017/S0048577298970317; VANBOXTEL A, 1993, PSYCHOPHYSIOLOGY, V30, P589, DOI 10.1111/j.1469-8986.1993.tb02085.x; Vanhaudenhuyse A, 2009, NEUROIMAGE, V47, P1047, DOI 10.1016/j.neuroimage.2009.05.031; Villemure C, 2009, J NEUROSCI, V29, P705, DOI 10.1523/JNEUROSCI.3822-08.2009; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1985, J PERS SOC PSYCHOL, V48, P47, DOI 10.1037/0022-3514.48.1.47; VOUDOURIS NJ, 1989, PAIN, V38, P109, DOI 10.1016/0304-3959(89)90080-8; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2015, NAT REV NEUROSCI, V16, P403, DOI 10.1038/nrn3976; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Watkins JG, 2005, HYPNOTHERAPEUTIC T E; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; WICKRAMASEKERA I, 1980, BIOFEEDBACK SELF-REG, V5, P5, DOI 10.1007/BF00999060; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Witvliet CV, 2000, BIOL PSYCHOL, V52, P187, DOI 10.1016/S0301-0511(00)00027-2; WITVLIET CV, 1995, PSYCHOPHYSIOLOGY, V32, P436; WOODS DL, 1990, EVENT RELATED BRAIN, P178; Wynn JK, 2004, BIOL PSYCHIAT, V55, P518, DOI 10.1016/j.biopsych.2003.10.018; Zachariae R, 1998, EUR J PAIN, V2, P25, DOI 10.1016/S1090-3801(98)90043-X; ZACHARIAE R, 1994, INT J CLIN EXP HYP, V42, P56, DOI 10.1080/00207149408409341; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x	157	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159135	10.1371/journal.pone.0159135	http://dx.doi.org/10.1371/journal.pone.0159135			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486748	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800019
J	Parle, E; Larmon, H; Taylor, D				Parle, Eoin; Larmon, Hannah; Taylor, David			Biomechanical Factors in the Adaptations of Insect Tibia Cuticle	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; LEG DESIGN; WALKING	Insects are among the most diverse groups of animals on Earth. Their cuticle exoskeletons vary greatly in terms of size and shape, and are subjected to different applied forces during daily activities. We investigated the biomechanics of the tibiae of three different insect species: the desert locust (Schistocerca gregaria), American cockroach (Periplaneta americana) and Death's Head cockroach (Blaberus discoidalis). In a previous work, we showed that these tibiae vary not only in geometry (length, radius and thickness) but also in material quality (Young's modulus) and in the applied stress required to cause failure when loaded in bending. In the present work we used kinematic data from the literature to estimate the forces and stresses arising in vivo for various different activities, and thus calculated factors of safety defined as the ratio between the failure stress and the in vivo stress, adjusting the failure stress to a lower value to allow for fatigue failure in the case of frequently repeated activities. Factors of safety were found to vary considerably, being as little as 1.7 for the most strenuous activities, such as jumping or escaping from tight spaces. Our results show that these limbs have evolved to the point where they are close to optimal, and that instantaneous failure during high-stress activities is more critical than long-term fatigue failure. This work contributes to the discussion on how form and material properties have evolved in response to the mechanical functions of the same body part in different insects.	[Parle, Eoin; Larmon, Hannah; Taylor, David] Trinity Coll Dublin, Trinity Ctr Bioengn, Dept Mech & Mfg Engn, Dublin 2, Ireland	Trinity College Dublin	Parle, E (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dept Mech & Mfg Engn, Dublin 2, Ireland.	parlee@tcd.ie						ALEXANDER DE, 1995, INVERTEBR BIOL, V114, P169, DOI 10.2307/3226889; ALEXANDER RM, 1995, PHILOS T R SOC B, V347, P235, DOI 10.1098/rstb.1995.0024; Bayley TG, 2012, J EXP BIOL, V215, P1151, DOI 10.1242/jeb.068080; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; BURNS MD, 1973, J EXP BIOL, V58, P45; Burr A., 1995, MECH DESIGN ANAL, V2nd; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; Chapman RF, 2013, J CHEM INF MODEL, V5th; Currey J.D., 2002, BONES STRUCTURE MECH; Dirks JH, 2013, J EXP BIOL, V216, P1924, DOI 10.1242/jeb.083824; Dirks JH, 2012, J EXP BIOL, V215, P1502, DOI 10.1242/jeb.068221; Dudek DM, 2006, J EXP BIOL, V209, P1502, DOI 10.1242/jeb.02146; FULL RJ, 1995, J EXP BIOL, V198, P2441; FULL RJ, 1990, J EXP BIOL, V148, P129; FULL RJ, 1991, J EXP BIOL, V156, P215; FULL RJ, 1991, J EXP BIOL, V158, P369; FULL RJ, 1995, J EXP BIOL, V198, P1285; Jayaram K, 2013, SOC EXP BIOL ANN M V; Jayaram K, 2016, P NATL ACAD SCI USA, V113, pE950, DOI 10.1073/pnas.1514591113; KATZ SL, 1992, J EXP BIOL, V168, P125; Klocke D, 2011, ACTA BIOMATER, V7, P2935, DOI 10.1016/j.actbio.2011.04.004; McCullough EL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0696; MOORHOUSE JE, 1978, J EXP BIOL, V72, P1; Palmer AR, 1999, BIOL BULL-US, V196, P281, DOI 10.2307/1542953; Parle E, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/1/016003; Reinhardt L, 2009, J EXP BIOL, V212, P2426, DOI 10.1242/jeb.026880; Sabick MB, 2004, AM J SPORT MED, V32, P892, DOI 10.1177/0363546503259354; Taylor D, 2013, J POSTGRADUATE RES T, VXII, P90; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Taylor D, 2012, J R SOC INTERFACE, V9, P3480, DOI 10.1098/rsif.2012.0567; Taylor D, 2011, MAT SCI ENG C-MATER, V31, P1160, DOI 10.1016/j.msec.2010.12.006; Taylor GM, 2000, BIOL J LINN SOC, V70, P37; TELEWSKI FW, 1986, PHYSIOL PLANTARUM, V66, P211, DOI 10.1111/j.1399-3054.1986.tb02411.x; WHALEN RT, 1988, J BIOMECH, V21, P825, DOI 10.1016/0021-9290(88)90015-2; Young W C, 1989, ROARKS FORMULAS STRE	36	9	10	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159262	10.1371/journal.pone.0159262	http://dx.doi.org/10.1371/journal.pone.0159262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486904	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800022
J	Rinta, P; van Hardenbroek, M; Jones, RI; Kankaala, P; Rey, F; Szidat, S; Wooller, MJ; Heiri, O				Rinta, Paivi; van Hardenbroek, Maarten; Jones, Roger I.; Kankaala, Paula; Rey, Fabian; Szidat, Sonke; Wooller, Matthew J.; Heiri, Oliver			Land Use Affects Carbon Sources to the Pelagic Food Web in a Small Boreal Lake	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; ORGANIC-CARBON; DAPHNIA-LONGISPINA; BIOGENIC METHANE; HUMIC LAKE; DELTA-C-13; RADIOCARBON; SEDIMENTS; SIGNATURES; FRACTIONATION	Small humic forest lakes often have high contributions of methane-derived carbon in their food webs but little is known about the temporal stability of this carbon pathway and how it responds to environmental changes on longer time scales. We reconstructed past variations in the contribution of methanogenic carbon in the pelagic food web of a small boreal lake in Finland by analyzing the stable carbon isotopic composition (delta C-13 values) of chitinous fossils of planktivorous invertebrates in sediments from the lake. The d13C values of zooplankton remains show several marked shifts (approx. 10 parts per thousand), consistent with changes in the proportional contribution of carbon from methane-oxidizing bacteria in zooplankton diets. The results indicate that the lake only recently (1950s) obtained its present state with a high contribution of methanogenic carbon to the pelagic food web. A comparison with historical and palaeobotanical evidence indicates that this most recent shift coincided with agricultural land-use changes and forestation of the lake catchment and implies that earlier shifts may also have been related to changes in forest and land use. Our study demonstrates the sensitivity of the carbon cycle in small forest lakes to external forcing and that the effects of past changes in local land use on lacustrine carbon cycling have to be taken into account when defining environmental and ecological reference conditions in boreal headwater lakes.	[Rinta, Paivi; van Hardenbroek, Maarten; Rey, Fabian; Heiri, Oliver] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Rinta, Paivi; van Hardenbroek, Maarten; Rey, Fabian; Szidat, Sonke; Heiri, Oliver] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Jones, Roger I.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kankaala, Paula] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Szidat, Sonke] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Wooller, Matthew J.] Univ Alaska, Sch Fisheries & Ocean Sci, Fairbanks, AK 99701 USA; [Wooller, Matthew J.] Univ Alaska, Water & Environm Res Ctr, Fairbanks, AK 99701 USA; [van Hardenbroek, Maarten] Univ Southampton, Geog & Environm, Southampton, Hants, England	University of Bern; University of Bern; University of Jyvaskyla; University of Eastern Finland; University of Bern; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Southampton	Rinta, P (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.; Rinta, P (corresponding author), Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland.	paivi.rinta@gmail.com	Szidat, Sönke/D-6706-2011; van Hardenbroek, Maarten/R-1590-2017; Heiri, Oliver/A-2403-2008; Jones, Roger/C-7703-2011	Szidat, Sönke/0000-0002-1824-6207; van Hardenbroek, Maarten/0000-0001-6330-6363; Heiri, Oliver/0000-0002-3957-5835; Rey, Fabian/0000-0002-0737-3921; Jones, Roger/0000-0002-0835-8264	European Research Council under the European Union [239858]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council (http://erc.europa.eu/) under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. 239858 (RECONMET) to OH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas MUM, 2015, ENVIRON REV, V23, P275, DOI 10.1139/er-2014-0074; Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; ARVOLA L, 1992, HYDROBIOLOGIA, V229, P253, DOI 10.1007/BF00007004; Bade DL, 2006, AQUAT SCI, V68, P142, DOI 10.1007/s00027-006-0818-5; Belle S, 2014, J PALEOLIMNOL, V52, P215, DOI 10.1007/s10933-014-9789-z; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; Beug H.J, 2004, LEITFADEN POLLENBEST; Bredesen EL, 2002, J PALEOLIMNOL, V28, P389, DOI 10.1023/A:1021887915458; Brenner M, 1999, J PALEOLIMNOL, V22, P205, DOI 10.1023/A:1008078222806; Brooks S.J, 2007, IDENTIFICATION USE P; Caceres CE, 2004, LIMNOL OCEANOGR, V49, P1333, DOI 10.4319/lo.2004.49.4_part_2.1333; DAVIS RB, 1984, CHEM GEOL, V44, P151, DOI 10.1016/0009-2541(84)90071-8; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Finsinger W, 2005, HOLOCENE, V15, P293, DOI 10.1191/0959683605hl808rr; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Frossard V, 2014, FRESHWATER BIOL, V59, P789, DOI 10.1111/fwb.12304; Goslar T, 2005, RADIOCARBON, V47, P115, DOI 10.1017/S0033822200052243; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Houser JN, 2003, BIOGEOCHEMISTRY, V64, P247, DOI 10.1023/A:1024933931691; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; Huttunen P, 1980, ACTA BOT FENN, V133, P1; Ilus E, 2005, J ENVIRON RADIOACTIV, V82, P199, DOI 10.1016/j.jenvrad.2005.01.008; Jones RI, 1999, OIKOS, V86, P97, DOI 10.2307/3546573; Jones RI, 2004, BOREAL ENVIRON RES, V9, P17; Jones RI, 2008, ECOLOGY, V89, P857, DOI 10.1890/06-2010.1; Jones RI, 2011, FRESHWATER BIOL, V56, P213, DOI 10.1111/j.1365-2427.2010.02494.x; Juutinen S, 2009, BIOGEOSCIENCES, V6, P209, DOI 10.5194/bg-6-209-2009; KAMINSKI M, 1984, Polskie Archiwum Hydrobiologii, V31, P45; Kankaala P, 2010, AQUAT ECOL, V44, P781, DOI 10.1007/s10452-010-9316-x; Koskue K, 2012, EVON KRUUNUNMETSATOR; Kreutzweiser DP, 2008, ENVIRON REV, V16, P157, DOI 10.1139/A08-006; Lampert W, 2011, DAPHNIA DEV MODEL OR; Luoto TP, 2009, ANN ZOOL FENN, V46, P259, DOI 10.5735/086.046.0403; Luoto TP, 2009, HYDROBIOLOGIA, V631, P185, DOI 10.1007/s10750-009-9810-0; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Meyers PA, 2002, DEV PALEOENVIRON RES, V2, P239; Moore P.D., 1991, BLACKWELL SCI PUBLI; Ojala A, 2001, J PLANKTON RES, V23, P1207, DOI 10.1093/plankt/23.11.1207; OKAMURA B, 1995, EXPERIENTIA, V51, P510, DOI 10.1007/BF02143202; Okamura B, 2005, FRESHWATER BIOL ASS, V63; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Peura S, 2014, BIOGEOCHEMISTRY, V118, P177, DOI 10.1007/s10533-013-9917-2; Planas D, 2000, CAN J FISH AQUAT SCI, V57, P136, DOI 10.1139/cjfas-57-S2-136; Rask Martti, 1998, Boreal Environment Research, V3, P75; Raunio A, 2008, ASSESSMENT THREATENE; Reille M., 1992, POLLEN SPORES EUROPE; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rinta P, 2014, THESIS; SALONEN K, 1992, HYDROBIOLOGIA, V229, P271, DOI 10.1007/BF00007005; Schilder J, 2015, BIOGEOSCIENCES, V12, P3819, DOI 10.5194/bg-12-3819-2015; Schilder J, 2015, LIMNOL OCEANOGR, V60, P1064, DOI 10.1002/lno.10079; Smyntek PM, 2012, LIMNOL OCEANOGR, V57, P1292, DOI 10.4319/lo.2012.57.5.1292; STOCKMARR J, 1971, Pollen et Spores, V13, P615; Sugita S, 1997, SEDIMENT RECORDS BIO, P387; Sweetman JN, 2006, QUATERNARY SCI REV, V25, P2013, DOI 10.1016/j.quascirev.2006.01.007; Szidat S, 2014, RADIOCARBON, V56, P561, DOI 10.2458/56.17457; Taipale S, 2008, ECOLOGY, V89, P463, DOI 10.1890/07-0702.1; Taipale S, 2007, ECOSYSTEMS, V10, P757, DOI 10.1007/s10021-007-9056-5; Templeton AS, 2006, GEOCHIM COSMOCHIM AC, V70, P1739, DOI 10.1016/j.gca.2005.12.002; Teranes JL, 2005, LIMNOL OCEANOGR, V50, P914, DOI 10.4319/lo.2005.50.3.0914; The National Archives of Finland, 1870, METS HIST KART KART; The Provincial Archive of Hameenlinna, 1838, EV METS ARK TORPP JA; Tinner W, 2003, HOLOCENE, V13, P499, DOI 10.1191/0959683603hl615rp; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Turunen J, 2008, BOREAL ENVIRON RES, V13, P319; van Hardenbroek M, 2016, HYDROBIOLOGIA, V765, P209, DOI 10.1007/s10750-015-2414-y; van Hardenbroek M, 2014, J PALEOLIMNOL, V52, P95, DOI 10.1007/s10933-014-9780-8; van Hardenbroek M, 2013, QUATERNARY SCI REV, V66, P74, DOI 10.1016/j.quascirev.2012.04.009; Vandekerkhove Jochen, 2004, Journal of Limnology, V63, P75; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Verbruggen F, 2010, QUATERNARY SCI REV, V29, P2271, DOI 10.1016/j.quascirev.2010.05.030; Verbruggen F, 2010, J PALEOLIMNOL, V43, P857, DOI 10.1007/s10933-009-9374-z; von Gunten L, 2009, J PALEOLIMNOL, V42, P401, DOI 10.1007/s10933-008-9284-5; Vuorio K, 2006, FRESHWATER BIOL, V51, P807, DOI 10.1111/j.1365-2427.2006.01529.x; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Wooller MJ, 2012, J PALEOLIMNOL, V48, P27, DOI 10.1007/s10933-012-9591-8	76	14	14	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159900	10.1371/journal.pone.0159900	http://dx.doi.org/10.1371/journal.pone.0159900			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487044	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800044
J	Toews, I; Glenton, C; Lewin, S; Berg, RC; Noyes, J; Booth, A; Marusic, A; Malicki, M; Munthe-Kaas, HM; Meerpohl, JJ				Toews, Ingrid; Glenton, Claire; Lewin, Simon; Berg, Rigmor C.; Noyes, Jane; Booth, Andrew; Marusic, Ana; Malicki, Mario; Munthe-Kaas, Heather M.; Meerpohl, Joerg J.			Extent, Awareness and Perception of Dissemination Bias in Qualitative Research: An Explorative Survey	PLOS ONE			English	Article							PUBLICATION BIAS; SELF	Background Qualitative research findings are increasingly used to inform decision-making. Research has indicated that not all quantitative research on the effects of interventions is disseminated or published. The extent to which qualitative researchers also systematically underreport or fail to publish certain types of research findings, and the impact this may have, has received little attention. Methods A survey was delivered online to gather data regarding non-dissemination and dissemination bias in qualitative research. We invited relevant stakeholders through our professional networks, authors of qualitative research identified through a systematic literature search, and further via snowball sampling. Results 1032 people took part in the survey of whom 859 participants identified as researchers, 133 as editors and 682 as peer reviewers. 68.1% of the researchers said that they had conducted at least one qualitative study that they had not published in a peer-reviewed journal. The main reasons for non-dissemination were that a publication was still intended (35.7%), resource constraints (35.4%), and that the authors gave up after the paper was rejected by one or more journals (32.5%). A majority of the editors and peer reviewers "(strongly) agreed" that the main reasons for rejecting a manuscript of a qualitative study were inadequate study quality (59.5%; 68.5%) and inadequate reporting quality (59.1%; 57.5%). Of 800 respondents, 83.1% "(strongly) agreed" that non-dissemination and possible resulting dissemination bias might undermine the willingness of funders to support qualitative research. 72.6% and 71.2%, respectively, "(strongly) agreed" that non-dissemination might lead to inappropriate health policy and health care. Conclusions The proportion of non-dissemination in qualitative research is substantial. Researchers, editors and peer reviewers play an important role in this. Non-dissemination and resulting dissemination bias may impact on health care research, practice and policy. More detailed investigations on patterns and causes of the non-dissemination of qualitative research are needed.	[Toews, Ingrid] Univ Freiburg, Med Ctr, Cochrane Germany, Fac Med, Freiburg, Germany; [Glenton, Claire; Lewin, Simon] Norwegian Inst Publ Hlth, Knowledge Ctr Hlth Serv, Global Hlth Unit, Oslo, Norway; [Lewin, Simon] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Berg, Rigmor C.; Munthe-Kaas, Heather M.] Norwegian Inst Publ Hlth, Knowledge Ctr Hlth Serv, Unit Social Welf Res, Oslo, Norway; [Berg, Rigmor C.] Univ Tromso, Dept Community Med, Tromso, Norway; [Noyes, Jane] Bangor Univ, Sch Social Sci, Bangor, Gwynedd, Wales; [Booth, Andrew] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Marusic, Ana; Malicki, Mario] Univ Split, Sch Med, Cochrane Croatia & Dept Res Biomed & Hlth, Split, Croatia; [Meerpohl, Joerg J.] Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Epidemiol & Stat, Inserm,Cochrane France,Hop Hotel Dieu,U1153, Paris, France	University of Freiburg; Norwegian Institute of Public Health (NIPH); Norwegian Knowledge Centre for Health Services; South African Medical Research Council; Norwegian Institute of Public Health (NIPH); Norwegian Knowledge Centre for Health Services; UiT The Arctic University of Tromso; Bangor University; University of Sheffield; University of Split; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Meerpohl, JJ (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Epidemiol & Stat, Inserm,Cochrane France,Hop Hotel Dieu,U1153, Paris, France.	meerpohl.jj@gmail.com	Lewin, Simon/HCH-1959-2022; Glenton, Claire/GSE-3606-2022; Booth, Andrew/A-7872-2008; Meerpohl, Joerg J/J-4224-2013; Marusic, Ana/E-7683-2013; Malički, Mario/E-8621-2016	Glenton, Claire/0000-0002-7558-7737; Booth, Andrew/0000-0003-4808-3880; Meerpohl, Joerg J/0000-0002-1333-5403; Marusic, Ana/0000-0001-6272-0917; Malički, Mario/0000-0003-0698-1930	Norad (Norwegian Agency for Development Cooperation); Alliance for Health Policy and Systems Research; "Methodological Investigation of Cochrane reviews of Complex Interventions" (MICCI) project; South African Medical Research Council; Croatian National Science foundation; German Research Foundation (DFG); University of Freiburg	Norad (Norwegian Agency for Development Cooperation); Alliance for Health Policy and Systems Research; "Methodological Investigation of Cochrane reviews of Complex Interventions" (MICCI) project; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Croatian National Science foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	This work was supported in part by funding from: (1) Norad (Norwegian Agency for Development Cooperation: www.norad.no) to the Norwegian Knowledge Centre for the Health Services; (2) the Alliance for Health Policy and Systems Research (www.who.int/alliance-hpsr/en/); and, (3) the Cochrane supported "Methodological Investigation of Cochrane reviews of Complex Interventions" (MICCI) project (www.cochrane.org). SL receives additional funding from the South African Medical Research Council (www.mrc.ac.za) and AM receives additional funding from the Croatian National Science foundation (http://www.hrzz.hr/). The funders had no role in study design, data collection and analysis, preparation of the manuscript or the decision to publish. The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Blumle A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087184; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chang L, 2010, PUBLIC OPIN QUART, V74, P154, DOI 10.1093/poq/nfp090; Creswell JW, 2013, RES DESIGN QUALITATI; Dwan K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001666; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Epley N, 2000, J PERS SOC PSYCHOL, V79, P861, DOI 10.1037//0022-3514.79.6.861; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Fu Y.., 2015, HLTH SOCIAL CARE COM; Hannes K, 2012, QUAL RES, V12, P402, DOI 10.1177/1468794111432992; Lewin S, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001895; Lewin S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001187; Longworth L, 2011, INT J TECHNOL ASSESS, V27, P180, DOI 10.1017/S0266462311000043; Malicki M, 2014, J CLIN EPIDEMIOL, V67, P1103, DOI 10.1016/j.jclinepi.2014.06.002; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Meerpohl JJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006666; Noyes J, 2011, COCHRANE HDB SYSTEMA; Petticrew M, 2008, J EPIDEMIOL COMMUN H, V62, P552, DOI 10.1136/jech.2006.059394; Pope C, 2006, QUALITATIVE RES HLTH; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riese H, 2014, ANTHROPOL ACTION, V21, P23, DOI 10.3167/aia.2014.210204; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Scherer RW, 2015, J CLIN EPIDEMIOL, V68, P803, DOI 10.1016/j.jclinepi.2015.01.027; Schmucker C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114023; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Wong SSL, 2004, STUD HEALTH TECHNOL, V107, P311	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159290	10.1371/journal.pone.0159290	http://dx.doi.org/10.1371/journal.pone.0159290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487090	Green Published, Green Accepted, gold			2022-12-27	WOS:000381367800025
J	Bennani-Baiti, B; Bennani-Baiti, N; Baltzer, PA				Bennani-Baiti, Barbara; Bennani-Baiti, Nabila; Baltzer, Pascal A.			Diagnostic Performance of Breast Magnetic Resonance Imaging in Non-Calcified Equivocal Breast Findings: Results from a Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HIGH-RISK; MICROCALCIFICATION LESIONS; MRI; CANCER; MAMMOGRAPHY; US; UTILITY; RECOMMENDATIONS; BENIGN; IMPACT	Objectives To evaluate the performance of MRI for diagnosis of breast cancer in non-calcified equivocal breast findings. Materials and Methods We performed a systematic review and meta-analysis of peer-reviewed studies in PubMed from 01/01/1986 until 06/15/2015. Eligible were studies applying dynamic contrast-enhanced breast MRI as an adjunct to conventional imaging (mammography, ultrasound) to clarify equivocal findings without microcalcifications. Reference standard for MRI findings had to be established by histopathological sampling or imaging follow-up of at least 12 months. Number of true or false positives and negatives and other characteristics were extracted, and possible bias was determined using the QUADAS-2 applet. Statistical analyses included data pooling and heterogeneity testing. Results Fourteen out of 514 studies comprising 2,316 lesions met our inclusion criteria. Pooled diagnostic parameters were: sensitivity (99%, 95%-CI: 93-100%), specificity (89%, 95%-CI: 85-92%), PPV (56%, 95%-CI: 42-70%) and NPV (100%, 95%-CI: 99-100%). These estimates displayed significant heterogeneity (P<0.001). Conclusions Breast MRI demonstrates an excellent diagnostic performance in case of non-calcified equivocal breast findings detected in conventional imaging. However, considering the substantial heterogeneity with regard to prevalence of malignancy, problem solving criteria need to be better defined.	[Bennani-Baiti, Barbara] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Bennani-Baiti, Barbara; Baltzer, Pascal A.] Med Univ Vienna, Vienna Gen Hosp AKH, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Bennani-Baiti, Nabila] Mayo Clin, Div Hematol, Rochester, MN USA	University of Vienna; Medical University of Vienna; Mayo Clinic	Bennani-Baiti, B (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria.; Bennani-Baiti, B; Baltzer, PA (corresponding author), Med Univ Vienna, Vienna Gen Hosp AKH, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	barbara.bennani-baiti@meduniwien.ac.at; pascal.baltzer@meduniwien.ac.at		Baltzer, Pascal/0000-0002-3755-5398	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna.	Ballesio L, 2008, RADIOL MED, V113, P249, DOI 10.1007/s11547-008-0245-x; Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Benndorf M, 2010, ACTA RADIOL, V51, P715, DOI 10.3109/02841851.2010.497164; Bick U, 2013, ROFO-FORTSCHR RONTG, V185, P849, DOI 10.1055/s-0033-1335518; Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; Cilotti A, 2007, RADIOL MED, V112, P272, DOI 10.1007/s11547-007-0141-9; D'Orsi CJ., 2013, ACR BIRADS ATLAS BRE; Dorrius MD, 2012, EUR RADIOL, V22, P915, DOI 10.1007/s00330-011-2322-0; Dorrius MD, 2012, EUR J RADIOL, V81, P209, DOI 10.1016/j.ejrad.2010.12.046; Dorrius M D, 2010, Cancer Imaging, V10 Spec no A, pS54, DOI 10.1102/1470-7330.2010.9020; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Barhoun EN, 2011, J MED IMAG RADIAT ON, V55, P461, DOI 10.1111/j.1754-9485.2011.02302.x; Fiaschetti Valeria, 2011, ISRN Oncol, V2011, P643890, DOI 10.5402/2011/643890; Friedlander LC, 2011, RADIOLOGY, V261, P421, DOI 10.1148/radiol.11103516; Gokalp G, 2006, EUR J RADIOL, V57, P436, DOI 10.1016/j.ejrad.2005.10.004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Hyun SJ, 2016, EUR RADIOL, V26, P3865, DOI 10.1007/s00330-016-4235-4; Jalali S, 2012, INT SYMP EMP SOFTWAR, P29, DOI 10.1145/2372251.2372257; Jiang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099669; Keller DL, 2014, JAMA INTERN MED, V174, P1417, DOI 10.1001/jamainternmed.2014.810; Kikuchi M, 2014, ANTICANCER RES, V34, P6749; Kneeshaw PJ, 2006, BREAST, V15, P29, DOI 10.1016/j.breast.2005.05.002; Kreienberg R, 2012, INTERDISCIPLINARY GE; Kuhl CK, 2014, J CLIN ONCOL, V32, P2304, DOI 10.1200/JCO.2013.52.5386; Lazarus E, 2006, RADIOLOGY, V239, P385, DOI 10.1148/radiol.2392042127; Lee CH, 1999, AM J ROENTGENOL, V173, P1323, DOI 10.2214/ajr.173.5.10541112; Lee CI, 2014, ACAD RADIOL, V21, P1370, DOI 10.1016/j.acra.2014.06.003; Li E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111217; Linda A, 2012, EUR J RADIOL, V81, P3201, DOI 10.1016/j.ejrad.2012.01.038; Linda A, 2012, AM J ROENTGENOL, V198, P272, DOI 10.2214/AJR.11.7040; Lobrano Mary Beth, 2012, J La State Med Soc, V164, P38; Manganaro L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806368; Mann RM, 2015, EUR RADIOL, V25, P3669, DOI 10.1007/s00330-015-3807-z; Marinovich ML, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1664-4; Marinovich ML, 2013, JNCI-J NATL CANCER I, V105, P321, DOI 10.1093/jnci/djs528; Merckel LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094233; Moy L, 2009, AM J ROENTGENOL, V193, P986, DOI 10.2214/AJR.08.1229; Nakahara H, 2001, Breast Cancer, V8, P116, DOI 10.1007/BF02967490; NICE, EARL LOC ADV BREAST; Olsen ML, 2012, J WOMENS HEALTH, V21, P1149, DOI 10.1089/jwh.2012.3735; Ozcan Umit Aksoy, 2012, Eur J Radiol, V81 Suppl 1, pS112, DOI 10.1016/S0720-048X(12)70046-3; Oztekin PS, 2014, BREAST J, V20, P622, DOI 10.1111/tbj.12334; Pediconi F, 2009, INVEST RADIOL, V44, P412, DOI 10.1097/RLI.0b013e3181a53654; Perry N, 2008, ANN ONCOL, V19, P614, DOI 10.1093/annonc/mdm481; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; Price J, 2015, J MED IMAG RADIAT ON, V59, P312, DOI 10.1111/1754-9485.12281; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Si LF, 2016, DIAGN INTERV RADIOL, V22, P141, DOI 10.5152/dir.2016.15017; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spick C, 2015, EUR J RADIOL, V84, P61, DOI 10.1016/j.ejrad.2014.10.005; Spick C, 2014, RADIOLOGY, V273, P401, DOI 10.1148/radiol.14140474; Strobel K, 2015, RADIOLOGY, V274, P343, DOI 10.1148/radiol.14140645; Uematsu T, 2007, BREAST CANCER RES TR, V103, P269, DOI 10.1007/s10549-006-9373-y; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yau EJ, 2011, BREAST J, V17, P273, DOI 10.1111/j.1524-4741.2011.01075.x	57	69	71	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160346	10.1371/journal.pone.0160346	http://dx.doi.org/10.1371/journal.pone.0160346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482715	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110700037
J	Lee, SA; Bacchetti, P; Chomont, N; Fromentin, R; Lewin, SR; O'Doherty, U; Palmer, S; Richman, DD; Siliciano, JD; Yukl, SA; Deeks, SG; Burbelo, PD				Lee, Sulggi A.; Bacchetti, Peter; Chomont, Nicolas; Fromentin, Remi; Lewin, Sharon R.; O'Doherty, Una; Palmer, Sarah; Richman, Douglas D.; Siliciano, Janet D.; Yukl, Steven A.; Deeks, Steven G.; Burbelo, Peter D.			Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy	PLOS ONE			English	Article							INFECTED-CELLS; INTEGRATION; REPLICATION; PCR; PERSISTENCE; PLASMA; ASSAY	Background A major challenge to HIV eradication strategies is the lack of an accurate measurement of the total burden of replication-competent HIV (the "reservoir"). We assessed the association of anti-HIV antibody responses and the estimated size of the reservoir during antiretroviral therapy (ART). Methods We evaluated anti-HIV antibody profiles using luciferase immunoprecipitation systems (LIPS) assay in relation to several blood-based HIV reservoir measures: total and 2-LTR DNA (rtPCR or droplet digital PCR); integrated DNA (Alu PCR); unspliced RNA (rtPCR), multiply-spliced RNA (TILDA), residual plasma HIV RNA (single copy PCR), and replication- competent virus (outgrowth assay). We also assessed total HIV DNA and RNA in gut-associated lymphoid tissue (rtPCR). Spearman correlations and linear regressions were performed using log-transformed blood-or tissue-based reservoir measurements as predictors and log-transformed antibody levels as outcome variables. Results Among 51 chronically HIV-infected ART-suppressed participants (median age = 57, nadir CD4+ count = 196 cells/mm3, ART duration = 9 years), the most statistically significant associations were between antibody responses to integrase and HIV RNA in gut-associated lymphoid tissue (1.17 fold-increase per two-fold RNA increase, P = 0.004) and between antibody responses to matrix and integrated HIV DNA in resting CD4+ T cells (0.35 fold-decrease per two-fold DNA increase, P = 0.003). However, these associations were not statistically significant after a stringent Bonferroni-adjustment of P<0.00045. Multivariate models including age and duration of ART did not markedly alter results. Conclusions Our findings suggest that anti-HIV antibody responses may reflect the size of the HIV reservoir during chronic treated HIV disease, possibly via antigen recognition in reservoir sites. Larger, prospective studies are needed to validate the utility of antibody levels as a measure of the total body burden of HIV during treatment.	[Lee, Sulggi A.; Bacchetti, Peter; Yukl, Steven A.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chomont, Nicolas; Fromentin, Remi] Univ Montreal, CR CHUM, Montreal, PQ, Canada; [Chomont, Nicolas; Fromentin, Remi] Univ Montreal, Dept Microbiol Infect Dis & Immunol, Montreal, PQ, Canada; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hosp, Melbourne, Vic, Australia; [O'Doherty, Una] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Palmer, Sarah] Univ Sydney, Westmead Inst Med Res, Ctr Virus Res, Sydney, NSW, Australia; [Richman, Douglas D.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Siliciano, Janet D.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Yukl, Steven A.] Vet Affairs San Francisco Healthcare Syst, San Francisco, CA USA; [Burbelo, Peter D.] Natl Inst Dent & Craniofacial Res, Dent Clin Res Core, Bethesda, MD USA; [Lee, Sulggi A.] Univ Calif San Francisco, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Universite de Montreal; Universite de Montreal; University of Melbourne; Royal Melbourne Hospital; Monash University; Florey Institute of Neuroscience & Mental Health; University of Pennsylvania; University of Sydney; Westmead Institute for Medical Research; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of California System; University of California San Francisco	Lee, SA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Lee, SA (corresponding author), Univ Calif San Francisco, Dept Med, Div HIV AIDS, San Francisco, CA 94143 USA.	sulggi.lee@ucsf.edu	Lewin, Sharon/Z-3297-2019; Chomont, Nicolas/ABG-2545-2020	Chomont, Nicolas/0000-0001-9747-5018; Deeks, Steven/0000-0001-6371-747X; Lewin, Sharon Ruth/0000-0002-0330-8241	National Institutes of Health [1K23GM112526, 1R01DK108349]; DARE Collaboratory [U19 AI096109]; CARE Collaboratory [U19 AI096113]; Division of Intramural Research of the National Institutes, the National Institute of Dental and Craniofacial Research; National Health and Medical Research Council of Australia; amfAR Research Consortium on HIV Eradication a.k.a. ARCHE [108072-50-RGRL]; Department of Veterans Affairs [IK2 CX000520]; UCSD Center for AIDS Research [P30 AI36214]; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM112526] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DARE Collaboratory; CARE Collaboratory; Division of Intramural Research of the National Institutes, the National Institute of Dental and Craniofacial Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); amfAR Research Consortium on HIV Eradication a.k.a. ARCHE; Department of Veterans Affairs(US Department of Veterans Affairs); UCSD Center for AIDS Research; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the National Institutes of Health (1K23GM112526, 1R01DK108349, the DARE Collaboratory [U19 AI096109], the CARE Collaboratory [U19 AI096113]), the Division of Intramural Research of the National Institutes, the National Institute of Dental and Craniofacial Research, and the National Health and Medical Research Council of Australia. This work was also supported by the amfAR Research Consortium on HIV Eradication a.k.a. ARCHE (108072-50-RGRL), the Department of Veterans Affairs (IK2 CX000520), the UCSD Center for AIDS Research (P30 AI36214), and the James B. Pendleton Charitable Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalid-Peralta L, 2006, HIV MED, V7, P514, DOI 10.1111/j.1468-1293.2006.00406.x; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Burbelo PD, 2014, J INFECT DIS, V209, P1613, DOI 10.1093/infdis/jit667; Ciuffi A, 2016, CLIN MICROBIOL INFEC, V22, P324, DOI 10.1016/j.cmi.2016.02.013; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Graf EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071879; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Ho YC, 2015, 22 C RETR OPP INF 20; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Selleri M, 2007, JAIDS-J ACQ IMM DEF, V46, P145, DOI 10.1097/QAI.0b013e318120039b; Stephenson KE, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw100; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14	21	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160192	10.1371/journal.pone.0160192	http://dx.doi.org/10.1371/journal.pone.0160192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483366	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700027
J	Pietribiasi, M; Waniewski, J; Zaluska, A; Zaluska, W; Lindholm, B				Pietribiasi, Mauro; Waniewski, Jacek; Zaluska, Alicja; Zaluska, Wojciech; Lindholm, Bengt			Modelling Transcapillary Transport of Fluid and Proteins in Hemodialysis Patients	PLOS ONE			English	Article							ISOGRAVIMETRIC CAPILLARY-PRESSURE; HUMAN MICROVASCULAR EXCHANGE; ATRIAL-NATRIURETIC-PEPTIDE; FILTRATION COEFFICIENTS; SENSITIVITY-ANALYSIS; SKELETAL-MUSCLE; BLOOD-PRESSURE; PLASMA-VOLUME; ULTRAFILTRATION; HYPOTENSION	Background The kinetics of protein transport to and from the vascular compartment play a major role in the determination of fluid balance and plasma refilling during hemodialysis (HD) sessions. In this study we propose a whole-body mathematical model describing water and protein shifts across the capillary membrane during HD and compare its output to clinical data while evaluating the impact of choosing specific values for selected parameters. Methods The model follows a two-compartment structure (vascular and interstitial space) and is based on balance equations of protein mass and water volume in each compartment. The capillary membrane was described according to the three-pore theory. Two transport parameters, the fractional contribution of large pores (alpha(LP)) and the total hydraulic conductivity (LpS) of the capillary membrane, were estimated from patient data. Changes in the intensity and direction of individual fluid and solute flows through each part of the transport system were analyzed in relation to the choice of different values of small pores radius and fractional conductivity, lymphatic sensitivity to hydraulic pressure, and steady-state interstitial-to-plasma protein concentration ratio. Results The estimated values of LpS and alpha(LP) were respectively 10.0 +/- 8.4 mL/min/mmHg (mean +/- standard deviation) and 0.062 +/- 0.041. The model was able to predict with good accuracy the profiles of plasma volume and serum total protein concentration in most of the patients (average root-mean-square deviation < 2% of the measured value). Conclusions The applied model provides a mechanistic interpretation of fluid transport processes induced by ultrafiltration during HD, using a minimum of tuned parameters and assumptions. The simulated values of individual flows through each kind of pore and lymphatic absorption rate yielded by the model may suggest answers to unsolved questions on the relative impact of these not-measurable quantities on total vascular refilling and fluid balance.	[Pietribiasi, Mauro; Waniewski, Jacek] Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Zaluska, Alicja] Med Univ Lublin, Dept Rehabil & Physiotherapy, Lublin, Poland; [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland; [Lindholm, Bengt] Karolinska Inst, Baxter Novum & Renal Med, Stockholm, Sweden	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin; Karolinska Institutet	Pietribiasi, M (corresponding author), Inst Biocybernet & Biomed Engn, Warsaw, Poland.	mpietribiasi@ibib.waw.pl	; Lindholm, Bengt/P-1334-2017	Pietribiasi, Mauro/0000-0001-8224-783X; Lindholm, Bengt/0000-0003-4269-4293	National Science Centre [N N518 289840];  [UMO-2014/15/N/ST7/05316]	National Science Centre(National Science Centre, Poland); 	This work was supported by grant no. UMO-2014/15/N/ST7/05316 issued by the National Science Center (Poland, http://www.ncn.gov.pl/). M.P. is the beneficiary of the grant. The data were originally collected for the study "Evaluation of disturbances of calcium-phosphate management in patients on dialysis" supported by the National Science Centre, grant no N N518 289840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcahuseyin E, 2000, ASAIO J, V46, P81, DOI 10.1097/00002480-200001000-00021; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Boon D, 2004, NEPHRON CLIN PRACT, V96, P82, DOI 10.1159/000076745; Bos WJW, 2000, AM J KIDNEY DIS, V35, P819, DOI 10.1016/S0272-6386(00)70250-2; BRACE RA, 1977, AM J PHYSIOL, V233, pH136, DOI 10.1152/ajpheart.1977.233.1.H136; BRACE RA, 1976, CIRC RES, V38, P192, DOI 10.1161/01.RES.38.3.192; BRACE RA, 1977, AM J PHYSIOL, V233, pH130, DOI 10.1152/ajpheart.1977.233.1.H130; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; CHAPPLE C, 1993, COMPUT METH PROG BIO, V41, P33, DOI 10.1016/0169-2607(93)90064-R; Cooper LJ, 2016, B MATH BIOL, V78, P52, DOI 10.1007/s11538-015-0128-y; de los Reyes AA, 2016, J THEOR BIOL, V390, P146, DOI 10.1016/j.jtbi.2015.11.012; Ebah LM, 2013, KIDNEY INT, V84, P980, DOI 10.1038/ki.2013.208; Ellmerer M, 2000, AM J PHYSIOL-ENDOC M, V278, pE352, DOI 10.1152/ajpendo.2000.278.2.E352; GORE RW, 1974, CIRC RES, V34, P581, DOI 10.1161/01.RES.34.4.581; Granger HJ, 1984, DYNAMICS CONTROL TRA, pp189; Guyton A., 2000, KIDNEYS BODY FLUIDS, P264; GUYTON ARTHUR C., 1965, INVEST OPHTHALMOL, V4, P1075; Iimura O, 1996, NEPHRON, V74, P19, DOI 10.1159/000189276; KEDEM O, 1989, BIOCHIM BIOPHYS ACTA, V1000, P411, DOI 10.1016/S0006-3002(89)80036-8; Kellen MR, 2003, AM J PHYSIOL-HEART C, V285, pH1303, DOI 10.1152/ajpheart.00933.2001; Kennedy J., 1995, P ICNN 95 INT C NEUR, V194, P2; Landis E.M., 1963, HDB PHYSL SECTION 2, P961; Lentner C., 1984, GEIGY SCI TABLES PHY; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Machek P, 2010, NEPHROL DIAL TRANSPL, V25, P538, DOI 10.1093/ndt/gfp487; MASON EA, 1980, J MEMBRANE SCI, V6, P283, DOI 10.1016/S0376-7388(00)82170-5; Michel CC, 1984, HDB PHYSL, VIV, P375; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Palmer BF, 2008, J AM SOC NEPHROL, V19, P8, DOI 10.1681/ASN.2007091006; Pianosi F, 2015, ENVIRON MODELL SOFTW, V70, P80, DOI 10.1016/j.envsoft.2015.04.009; Pietribiasi M, 2015, ASAIO J, V61, P350, DOI 10.1097/MAT.0000000000000206; REDDY NP, 1986, CRIT REV BIOMED ENG, V14, P45; Reed RK, 2010, CARDIOVASC RES, V87, P211, DOI 10.1093/cvr/cvq143; RENKIN EM, 1977, MICROVASC RES, V14, P191, DOI 10.1016/0026-2862(77)90018-8; Ribitsch W, 2012, CLIN NEPHROL, V77, P376, DOI 10.5414/CN107078; Rippe B, 1993, Perit Dial Int, V13 Suppl 2, pS35; RIPPE B, 1994, PHYSIOL REV, V74, P163, DOI 10.1152/physrev.1994.74.1.163; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Stachowska-Pietka Joanna, 2007, Adv Perit Dial, V23, P23; Stachowska-Pietka J, 2012, AM J PHYSIOL-RENAL, V302, pF1331, DOI 10.1152/ajprenal.00301.2011; System USRD, USRDS ANN DAT REP 20; Tabei K, 1996, NEPHRON, V74, P266, DOI 10.1159/000189320; THEWS O, 1991, NEPHROL DIAL TRANSPL, V6, P180, DOI 10.1093/ndt/6.3.180; Ursino M, 1997, ARTIF ORGANS, V21, P891; Ursino M, 1997, ARTIF ORGANS, V21, P873; WANIEWSKI J, 1994, J MEMBRANE SCI, V95, P179, DOI 10.1016/0376-7388(94)00110-3; Waniewski J, 2014, ASAIO J, V60, P576, DOI 10.1097/MAT.0000000000000105; WOLF MB, 1989, AM J PHYSIOL, V256, pH282, DOI 10.1152/ajpheart.1989.256.1.H282; WOLF MB, 1994, AM J PHYSIOL, V267, pH383, DOI 10.1152/ajpheart.1994.267.1.H383; WRAIGHT EP, 1974, J PHYSIOL-LONDON, V237, P39, DOI 10.1113/jphysiol.1974.sp010468; XIE SL, 1995, MICROVASC RES, V49, P141, DOI 10.1006/mvre.1995.1012; Yashiro M, 2005, BLOOD PURIFICAT, V23, P431, DOI 10.1159/000088214; Yashiro M, 2002, BLOOD PURIFICAT, V20, P569, DOI 10.1159/000066957; Yashiro M, 2007, THER APHER DIAL, V11, P131, DOI 10.1111/j.1744-9987.2007.00471.x	54	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159748	10.1371/journal.pone.0159748	http://dx.doi.org/10.1371/journal.pone.0159748			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483369	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700013
J	Valencia, CA; Wang, XJ; Wang, J; Peters, A; Simmons, JR; Moran, MC; Mathur, A; Husami, A; Qian, YP; Sheridan, R; Bove, KE; Witte, D; Huang, TS; Miethke, AG				Valencia, C. Alexander; Wang, Xinjian; Wang, Jin; Peters, Anna; Simmons, Julia R.; Moran, Molly C.; Mathur, Abhinav; Husami, Ammar; Qian, Yaping; Sheridan, Rachel; Bove, Kevin E.; Witte, David; Huang, Taosheng; Miethke, Alexander G.			Deep Sequencing Reveals Novel Genetic Variants in Children with Acute Liver Failure and Tissue Evidence of Impaired Energy Metabolism	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DEPLETION; COMPLEX I DEFICIENCY; RIBONUCLEOTIDE REDUCTASE SUBUNIT; MOLECULAR CHARACTERISTICS; DISEASE; MUTATIONS; ACAD9; P53R2; CHOLESTASIS; DIAGNOSIS	Background & Aims The etiology of acute liver failure (ALF) remains elusive in almost half of affected children. We hypothesized that inherited mitochondrial and fatty acid oxidation disorders were occult etiological factors in patients with idiopathic ALF and impaired energy metabolism. Methods Twelve patients with elevated blood molar lactate/pyruvate ratio and indeterminate etiology were selected from a retrospective cohort of 74 subjects with ALF because their fixed and frozen liver samples were available for histological, ultrastructural, molecular and biochemical analysis. Results A customized next-generation sequencing panel for 26 genes associated with mitochondrial and fatty acid oxidation defects revealed mutations and sequence variants in five subjects. Variants involved the genes ACAD9, POLG, POLG2, DGUOK, and RRM2B; the latter not previously reported in subjects with ALF. The explanted livers of the patients with heterozygous, truncating insertion mutations in RRM2B showed patchy micro- and macrovesicular steatosis, decreased mitochondrial DNA (mtDNA) content <30% of controls, and reduced respiratory chain complex activity; both patients had good post-transplant outcome. One infant with severe lactic acidosis was found to carry two heterozygous variants in ACAD9, which was associated with isolated complex I deficiency and diffuse hypergranular hepatocytes. The two subjects with heterozygous variants of unknown clinical significance in POLG and DGUOK developed ALF following drug exposure. Their hepatocytes displayed abnormal mitochondria by electron microscopy. Conclusion Targeted next generation sequencing and correlation with histological, ultrastructural and functional studies on liver tissue in children with elevated lactate/pyruvate ratio expand the spectrum of genes associated with pediatric ALF.	[Valencia, C. Alexander; Wang, Xinjian; Wang, Jin; Mathur, Abhinav; Husami, Ammar; Qian, Yaping; Huang, Taosheng] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Peters, Anna; Simmons, Julia R.; Moran, Molly C.; Miethke, Alexander G.] Cincinnati Childrens Hosp Med Ctr, Pediat Gastroenterol Hepatol & Nutr, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Sheridan, Rachel; Bove, Kevin E.; Witte, David] Cincinnati Childrens Hosp Med Ctr, Pediat Pathol, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Valencia, C. Alexander; Huang, Taosheng; Miethke, Alexander G.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Valencia, CA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, 3333 Burnet Ave, Cincinnati, OH 45229 USA.; Valencia, CA (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.	alexander.valencia@cchmc.org	Husami, Ammar/K-7777-2012	Husami, Ammar/0000-0002-4287-2857; Mathur, Abhinav/0000-0001-5669-9488; Sheridan, Rachel/0000-0002-8318-8920; Huang, Taosheng/0000-0001-6601-6687	National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) [DK62497, DK062453, DK072146]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000077]; Digestive Disease Research Core Center in Cincinnati [P30 DK078392]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007727, P30DK078392] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Digestive Disease Research Core Center in Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The following National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) grants supported this study: DK62497, including a pilot and feasibility grant (DK062453), and DK072146 to A.G. M. The project was supported by the National Center for Advancing Translational Sciences (NCATS) UL1 TR000077 (M.C.M.) and in part by PHS Grant P30 DK078392 (Pathology Core) of the Digestive Disease Research Core Center in Cincinnati.	Al-Hussaini A, 2014, J PEDIATR-US, V164, P553, DOI 10.1016/j.jpeds.2013.10.082; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Brett A, 2013, ANN HEPATOL, V12, P791, DOI 10.1016/S1665-2681(19)31321-3; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; CHAN CH, 1990, NEUROLOGY, V40, P1427, DOI 10.1212/WNL.40.9.1427; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Ducluzeau PH, 1999, J HEPATOL, V30, P149, DOI 10.1016/S0168-8278(99)80019-1; Fellman V, 2011, SEMIN FETAL NEONAT M, V16, P222, DOI 10.1016/j.siny.2011.05.002; Freisinger P, 2006, ARCH NEUROL-CHICAGO, V63, P1129, DOI 10.1001/archneur.63.8.1129; Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273; Guittet O, 2008, NITRIC OXIDE-BIOL CH, V19, P84, DOI 10.1016/j.niox.2008.04.011; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; Helbling D, 2013, J PEDIATR GASTR NUTR, V57, P438, DOI 10.1097/MPG.0b013e31829ef4b4; Honzik T, 2012, J INHERIT METAB DIS, V35, P749, DOI 10.1007/s10545-011-9440-3; Liu ZJ, 2014, NEUROBIOL AGING, V35, DOI DOI 10.1016/J.NEUROBIOLAGING.2014.07.003; Lucas TG, 2011, BBA-MOL BASIS DIS, V1812, P1658, DOI 10.1016/j.bbadis.2011.09.009; Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777; Molleston JP, 2013, J PEDIATR GASTR NUTR, V57, P269, DOI 10.1097/MPG.0b013e31829ef67a; Nguyen KV, 2006, J HEPATOL, V45, P108, DOI 10.1016/j.jhep.2005.12.026; Nouws J, 2014, JIMD REP, V12, P37, DOI 10.1007/8904_2013_242; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; PARTIN JS, 1984, HEPATOLOGY, V4, P687, DOI 10.1002/hep.1840040421; Pitceathly RDS, 2012, BRAIN, V135, P3392, DOI 10.1093/brain/aws231; Rudolph JA, 2007, CELL SIGNAL, V19, P1221, DOI 10.1016/j.cellsig.2007.01.002; Sarzi E, 2007, J PEDIATR-US, V150, P531, DOI 10.1016/j.jpeds.2007.01.044; Sokal EM, 1999, EUR J PEDIATR, V158, pS81, DOI 10.1007/PL00014328; Sundaram SS, 2011, J PEDIATR-US, V159, P813, DOI 10.1016/j.jpeds.2011.04.016; Tang S, 2011, J MED GENET, V48, P669, DOI 10.1136/jmedgenet-2011-100222; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Vilarinho S, 2014, J HEPATOL, V61, P1056, DOI 10.1016/j.jhep.2014.06.038; Wang XC, 2011, BIOCHEM BIOPH RES CO, V410, P102, DOI 10.1016/j.bbrc.2011.05.114; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wong Alice, 2002, Methods Mol Biol, V197, P129, DOI 10.1385/1-59259-284-8:129; Wong LJC, 2007, HEPATOLOGY, V46, P1218, DOI 10.1002/hep.21799; Young MJ, 2011, HUM MOL GENET, V20, P3052, DOI 10.1093/hmg/ddr209; Zhang J, 2002, BIOCHEM BIOPH RES CO, V297, P1033, DOI 10.1016/S0006-291X(02)02336-7	39	23	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0156738	10.1371/journal.pone.0156738	http://dx.doi.org/10.1371/journal.pone.0156738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483465	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110700001
J	Garcia, GD; dos Santos, LMB; Villela, DAM; Maciel-de-Freitas, R				Garcia, Gabriela de Azambuja; Barbosa dos Santos, Lilha Maria; Maciel Villela, Daniel Antunes; Maciel-de-Freitas, Rafael			Using Wolbachia Releases to Estimate Aedes aegypti (Diptera: Culicidae) Population Size and Survival	PLOS ONE			English	Article							RIO-DE-JANEIRO; ZIKA VIRUS; CONTAINER PRODUCTIVITY; FIELD-EVALUATION; BG-SENTINEL; DENGUE; RATES; DISPERSAL; RECAPTURE; MOSQUITOS	Mosquitoes carrying the endosymbiont bacterium Wolbachia have been deployed in field trials as a biological control intervention due to Wolbachia effects on reducing transmission of arboviruses. We performed mark, release and recapture (MRR) experiments using Wolbachia as an internal marker with daily collections with BG-Traps during the first two weeks of releases in Rio de Janeiro, Brazil. The MRR design allowed us to investigate two critical parameters that determine whether Wolbachia would successful invade a field population: the probability of daily survival (PDS) of Wolbachia-infected Aedes aegypti females, and the wild population density during releases. Released females had a PDS of 0.82 and 0.89 in the first and second weeks, respectively, immediately after releases, which is well within the range of previous estimates of survivorship of wild mosquitoes in Rio de Janeiro. Abundance estimation of wild population varied up to 10-fold higher depending on the estimation method used (634-3565 females on the average-difference model to 6365-16188 females according to Lincoln-Petersen). Wolbachia-released mosquitoes were lower than the density estimation of their wild counterparts, irrespectively of the model used. Individually screening mosquitoes for the presence of Wolbachia reduced uncertainty on abundance estimations due to fluctuation in capturing per week. A successful invasion into local population requires Ae. aegypti fitness is unaffected by Wolbachia presence, but also reliable estimates on the population size of wild mosquitoes.	[Garcia, Gabriela de Azambuja; Barbosa dos Santos, Lilha Maria; Maciel-de-Freitas, Rafael] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz IOC FIOCRUZ, Lab Transmissao Hematozoarios, Rio De Janeiro, Brazil; [Maciel Villela, Daniel Antunes] Fundacao Oswaldo Cruz PROCC, Programa Computacao Cient, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Maciel-de-Freitas, R (corresponding author), Inst Oswaldo Cruz, Fundacao Oswaldo Cruz IOC FIOCRUZ, Lab Transmissao Hematozoarios, Rio De Janeiro, Brazil.	freitas@ioc.fiocruz.br	Maciel-de-Freitas, Rafael/J-1997-2012; Villela, Daniel/AAG-6445-2019	Villela, Daniel/0000-0001-8371-2959; Maciel-de-Freitas, Rafael/0000-0002-2198-6492	FAPERJ [E-26/110.168/2014]; CNPq; Brazilian Ministry of Health (DECIT/SVS); Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health Initiatives of the Bill and Melinda Gates Foundation	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health (DECIT/SVS); Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health Initiatives of the Bill and Melinda Gates Foundation	This work was partially supported by FAPERJ (E-26/110.168/2014), CNPq, the Brazilian Ministry of Health (DECIT/SVS) as well as a grant to Monash University from the Foundation for the National Institutes of Health through the Vector-Based Transmission of Control: Discovery Research (VCTR) program of the Grand Challenges in Global Health Initiatives of the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689; Castro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081875; Cattand P, 2006, DIS CONTROL PRIORITI; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401; Codeco CT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003475; Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219; David MR, 2009, MEM I OSWALDO CRUZ, V104, P927, DOI 10.1590/S0074-02762009000600019; de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085; EDMAN JD, 1992, J MED ENTOMOL, V29, P1033; Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688; GILLIES M. T., 1961, BULL ENT RES, V52, P99, DOI 10.1017/S0007485300055309; Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2; Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115; Johnson PH, 2012, J MED ENTOMOL, V49, P29, DOI 10.1603/ME11116; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003; Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Maciel-de-Freitas R, 2014, B WORLD HEALTH ORGAN, V92, P685, DOI 10.2471/BLT.13.119081; Maciel-de-Freitas R, 2011, TROP MED INT HEALTH, V16, P965, DOI 10.1111/j.1365-3156.2011.02797.x; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; PAHO/WHO, 2016, NUMB REP CAS DENG SE; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201; Schatzmayr HG, 2000, MEM I OSWALDO CRUZ, V95, P179, DOI 10.1590/S0074-02762000000700030; SHEPPARD PM, 1969, B WORLD HEALTH ORGAN, V40, P467; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x; TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	54	11	12	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160196	10.1371/journal.pone.0160196	http://dx.doi.org/10.1371/journal.pone.0160196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479050	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300031
J	Li, J; Chai, HY; Li, Y; Chai, XY; Zhao, Y; Zhao, YF; Tao, T; Xiang, XQ				Li, Jin; Chai, Hongyu; Li, Yang; Chai, Xuyu; Zhao, Yan; Zhao, Yunfan; Tao, Tao; Xiang, Xiaoqiang			A Three-Pulse Release Tablet for Amoxicillin: Preparation, Pharmacokinetic Study and Physiologically Based Pharmacokinetic Modeling	PLOS ONE			English	Article							ACETATE SUCCINATE HPMCAS; DRUG-DELIVERY; IN-VITRO; PELLETS; EXTRUSION/SPHERONIZATION; SIMULATION; GRANULES; SPHERONIZATION; PERMEABILITY; PARAMETERS	Background Amoxicillin is a commonly used antibiotic which has a short half-life in human. The frequent administration of amoxicillin is often required to keep the plasma drug level in an effective range. The short dosing interval of amoxicillin could also cause some side effects and drug resistance, and impair its therapeutic efficacy and patients' compliance. Therefore, a three-pulse release tablet of amoxicillin is desired to generate sustained release in vivo, and thus to avoid the above mentioned disadvantages. Methods The pulsatile release tablet consists of three pulsatile components: one immediate-release granule and two delayed release pellets, all containing amoxicillin. The preparation of a pulsatile release tablet of amoxicillin mainly includes wet granulation craft, extrusion/spheronization craft, pellet coating craft, mixing craft, tablet compression craft and film coating craft. Box-Behnken design, Scanning Electron Microscope and in vitro drug release test were used to help the optimization of formulations. A crossover pharmacokinetic study was performed to compare the pharmacokinetic profile of our in-house pulsatile tablet with that of commercial immediate release tablet. The pharmacokinetic profile of this pulse formulation was simulated by physiologically based pharmacokinetic (PBPK) model with the help of Simcyp (R). Results and Discussion Single factor experiments identify four important factors of the formulation, namely, coating weight of Eudragit L30 D-55 (X-1), coating weight of AQOAT AS-HF (X-2), the extrusion screen aperture (X-3) and compression forces (X-4). The interrelations of the four factors were uncovered by a Box-Behnken design to help to determine the optimal formulation. The immediate-release granule, two delayed release pellets, together with other excipients, namely, Avicel PH 102, colloidal silicon dioxide, polyplasdone and magnesium stearate were mixed, and compressed into tablets, which was subsequently coated with Opadry (R) film to produce pulsatile tablet of amoxicillin. In vitro release study firstly indicated a three-pulse release profile of the tablet. Later the pulse tablet was found to generate the sustained release of amoxicillin in beagle dogs. Furthermore, the Simcyp (R) software was used to simulate the in vivo concentration time curve model of the three-pulse release tablet for amoxicillin in both human and beagle dog. The prediction by PBPK model nicely fitted the observation in human and beagle dog. Conclusions This study has demonstrated the interrelation of factors affecting the pulsatile formulation of amoxicillin using a Box-Behnken design. The three-pulse release tablets of amoxicillin were proven to generate pulsatile release in vitro and sustained release in vivo. This formulation was also found to extend the effective plasma concentration in human compared to the tablet of immediate release based on the simulation data by PBPK modeling. This study provides an example of using PBPK to guide the development of pulsatile dosage forms.	[Li, Jin; Chai, Hongyu; Li, Yang; Chai, Xuyu; Zhao, Yan; Tao, Tao] China State Inst Pharmaceut Ind, Natl Pharmaceut Engn Res Ctr, Shanghai, Peoples R China; [Zhao, Yunfan] Camelot Acad, Durham, NC USA; [Xiang, Xiaoqiang] Fudan Univ, Sch Pharm, Dept Clin Pharm, Shanghai, Peoples R China	Fudan University	Xiang, XQ (corresponding author), Fudan Univ, Sch Pharm, Dept Clin Pharm, Shanghai, Peoples R China.	xiangxq@fudan.edu.cn	Xiang, Xiaoqiang/AAH-2600-2020	Xiang, Xiaoqiang/0000-0002-8683-2603				Abbaspour MR, 2008, EUR J PHARM BIOPHARM, V68, P747, DOI 10.1016/j.ejpb.2007.09.010; Akhter H, 2011, ACTA PHARMACEUT, V61, P313, DOI 10.2478/v10007-011-0026-2; Beloica S, 2015, EUR J PHARM SCI, V75, P151, DOI 10.1016/j.ejps.2015.03.027; Boutell S, 2002, INT J PHARM, V238, P61, DOI 10.1016/S0378-5173(02)00064-9; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Bruce LD, 2003, INT J PHARM, V264, P85, DOI 10.1016/S0378-5173(03)00392-2; Eichie FE, 2009, AFR J BIOTECHNOL, V8, P5913; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Gaikwad A., 2013, J PHARM RES, V6, DOI 10.1016/j.jopr.2013.07.019; Gu Q, 2004, J CHROMATOGR B, V813, P337, DOI 10.1016/j.jchromb.2004.09.031; Hoffman A, 1998, J CONTROL RELEASE, V54, P29, DOI 10.1016/S0168-3659(97)00165-X; Jamei M, 2009, EXPERT OPIN DRUG MET, V5, P211, DOI [10.1517/17425250802691074, 10.1517/17425250802691074 ]; Kambayashi A, 2014, EUR J PHARM BIOPHARM, V87, P236, DOI 10.1016/j.ejpb.2014.01.007; Kanneti R, 2009, CHROMATOGRAPHIA, V70, P407, DOI 10.1365/s10337-009-1171-3; Kesisoglou F, 2015, AAPS J, V17, P1492, DOI 10.1208/s12248-015-9816-7; Lee KN, 2011, J MICROENCAPSUL, V28, P363, DOI 10.3109/02652048.2011.569766; Lennernas H, 2002, EUR J PHARM SCI, V15, P271, DOI 10.1016/S0928-0987(02)00005-2; Mise R, 2015, CHEM PHARM BULL, V63, P1070, DOI 10.1248/cpb.c15-00491; Mu L, 2012, THESIS; Pan Rui-xue, 2014, Yaoxue Xuebao, V49, P1155; Podczeck F, 2008, INT J PHARMACEUT, V361, P33, DOI 10.1016/j.ijpharm.2008.05.008; Qi XL, 2015, J PHARM PHARMACOL, V67, P493, DOI 10.1111/jphp.12339; Ravishankar H, 2006, DRUG DEV IND PHARM, V32, P709, DOI 10.1080/03639040600637556; ROBERTSON S, 2007, AMOXICILLIN CLINPHAR; Ross AC, 2000, J PHARM PHARMACOL, V52, P903, DOI 10.1211/0022357001774787; Rostami-Hodjegan A, 2007, NAT REV DRUG DISCOV, V6, P140, DOI 10.1038/nrd2173; Saigal Nitin, 2009, Recent Pat Drug Deliv Formul, V3, P64; SARISUTA N, 1994, J CONTROL RELEASE, V31, P215, DOI 10.1016/0168-3659(94)90002-7; Sawicki W, 2005, EUR J PHARM BIOPHARM, V60, P153, DOI 10.1016/j.ejpb.2004.11.003; Schellekens RCA, 2008, J CONTROL RELEASE, V132, P91, DOI 10.1016/j.jconrel.2008.08.008; Sousa JJ, 2002, INT J PHARM, V232, P91, DOI 10.1016/S0378-5173(01)00908-5; Tanno F, 2004, DRUG DEV IND PHARM, V30, P9, DOI 10.1081/DDC-120027506; Tanno FK, 2008, J PHARM SCI-US, V97, P2665, DOI 10.1002/jps.21172; Tomer G, 2002, INT J PHARM, V231, P107, DOI 10.1016/S0378-5173(01)00876-6; Tomer G, 2001, INT J PHARM, V217, P237, DOI 10.1016/S0378-5173(01)00611-1; Weitschies W, 2008, EUR J PHARM BIOPHARM, V70, P641, DOI 10.1016/j.ejpb.2008.05.011; Young CR, 2005, INT J PHARMACEUT, V301, P112, DOI 10.1016/j.ijpharm.2005.05.025; Zhang CG, 2012, INT J PHARMACEUT, V430, P141, DOI 10.1016/j.ijpharm.2012.04.013	38	3	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160260	10.1371/journal.pone.0160260	http://dx.doi.org/10.1371/journal.pone.0160260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479702	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300037
J	Abdel-Wahab, N; Shah, M; Suarez-Almazor, ME				Abdel-Wahab, Noha; Shah, Mohsin; Suarez-Almazor, Maria E.			Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports	PLOS ONE			English	Review							ANTI-CTLA4 ANTIBODY; IPILIMUMAB; MELANOMA; SAFETY; PEMBROLIZUMAB; ANTI-PD-1; SURVIVAL	Background Three checkpoint inhibitor drugs have been approved by the US Food and Drug Administration for use in specific types of cancers. While the results are promising, severe immunotherapy-related adverse events (irAEs) have been reported. Objectives To conduct a systematic review of case reports describing the occurrence of irAEs in patients with cancer following checkpoint blockade therapy, primarily to identify potentially unrecognized or unusual clinical findings and toxicity. Data Sources We searched Medline, EMBASE, Web of Science, PubMed ePubs, and Cochrane CENTRAL with no restriction through August 2015. Study Selection Studies reporting cases of cancer develop irAEs following treatment with anti CTLA-4 (ipilimumab) or anti PD-1 (nivolumab or pembrolizumab) antibodies were included. Data Extraction We extracted data on patient characteristics, irAEs characteristics, how irAEs were managed, and their outcomes. Data Synthesis 191 publications met inclusion criteria, reporting on 251 cases. Most patients had metastatic melanoma (95.6%), and the majority were treated with ipilimumab (93.2%). Autoimmune colitis, hepatitis, endocrinopathies, and cutaneous irAEs were the most frequently reported irAEs in ipilimumab treated patients. A broad spectrum of toxicities were reported for almost every body system. Moreover, well-defined diseases such as sarcoidosis, polyarthritis, polymyalgia rheumatica/arteritis, lupus, celiac disease, dermatomyositis, and Vogt-Koyanagi-like syndrome were reported. The most frequent irAEs reported with anti-PD1 agents were dermatitis for pembrolizumab, and thyroid disease and pneumonitis for nivolumab. Complete resolution of adverse events occurred in most cases. However, persistent irAEs and death were reported, mainly in patients treated with ipilimumab. Limitations Our study is limited by information available in the original reports. Conclusions Evidence from case reports shows that cancer patients develop irAEs following checkpoint blockade therapy, and can occasionally develop clearly defined autoimmune systemic diseases. While discontinuation of therapy and/or treatment can result in resolution of irAEs, long-term sequelae and death have been reported.	[Abdel-Wahab, Noha; Shah, Mohsin; Suarez-Almazor, Maria E.] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX 77030 USA; [Abdel-Wahab, Noha] Assiut Univ Hosp, Rheumatol & Rehabil Dept, Assiut, Egypt	University of Texas System; UTMD Anderson Cancer Center; Egyptian Knowledge Bank (EKB); Assiut University	Suarez-Almazor, ME (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX 77030 USA.	msalmazor@mdanderson.org	Shah, Mohsin/H-3025-2019	Shah, Mohsin/0000-0002-3450-4843	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR053593]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by a K24 career award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS: grant # AR053593). The funding agency had no role in the study's design, conduct, and reporting.	Ai MD, 2015, CANCER IMMUNOL IMMUN, V64, P885, DOI 10.1007/s00262-014-1650-8; Ali SS, 2015, JAMA DERMATOL, V151, P195, DOI 10.1001/jamadermatol.2014.2233; Bertrand A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0455-8; Chan MMK, 2015, J IMMUNOTHER, V38, P37, DOI 10.1097/CJI.0000000000000060; Chen TW, 2015, ANN ONCOL, V26, P1824, DOI 10.1093/annonc/mdv182; Dadu R, 2016, CANCER J, V22, P121, DOI 10.1097/PPO.0000000000000186; Fadel F, 2009, NEW ENGL J MED, V361, P211, DOI 10.1056/NEJMc0904283; Faghfuri E, 2015, EXPERT REV ANTICANC, V15, P981, DOI 10.1586/14737140.2015.1074862; Gao J, 2015, ONCOGENE, V34, P5411, DOI 10.1038/onc.2015.5; Gardner D, 2014, AM J TRANSPLANT, V14, P1985, DOI 10.1111/ajt.12834; Goldstein BL, 2014, ARTHRITIS RHEUMATOL, V66, P768, DOI 10.1002/art.38282; Hamid O, 2013, ASCO M S, V31, P9010, DOI DOI 10.1200/jco.2013.31.15_suppl.9010; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanrahan P, 2013, J DTSCH DERMATOL GES, V11, P16; Harris TJ, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-12; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horvat TZ, 2015, J CLIN ONCOL, V33, P3193, DOI 10.1200/JCO.2015.60.8448; Horvat TZ, 2014, PIGM CELL MELANOMA R, V27; Hunter G, 2009, CAN J NEUROL SCI, V36, P518, DOI 10.1017/S0317167100007939; IBM Corp, 2012, REL IBM SPSS STAT WI; Ibrahim RA, 2011, JOURNAL OF CLINICAL, V29; Johnson DB, 2015, CANC IMMUNOL RES; Kelly WN, 2007, DRUG SAFETY, V30, P367, DOI 10.2165/00002018-200730050-00001; Ledezma B, 2011, CLIN J ONCOL NURS, V15, P393, DOI 10.1188/11.CJON.393-403; Michot JM, 2016, EUR J CANCER, V54, P139, DOI 10.1016/j.ejca.2015.11.016; Nishino M, 2015, NEW ENGL J MED, V373, P288, DOI 10.1056/NEJMc1505197; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Tarhini A, 2010, CANCER BIOTHER RADIO, V25, P601, DOI 10.1089/cbr.2010.0865; Tomasello G, 2015, J BIOL REG HOMEOS AG, V29, P265; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Turnis ME, 2015, EUR J IMMUNOL, V45, P1892, DOI 10.1002/eji.201344413; Voskens CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053745; Weber JS, 2015, J CLIN ONCOL, V33, P2092, DOI 10.1200/JCO.2014.60.0379; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750	38	286	290	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160221	10.1371/journal.pone.0160221	http://dx.doi.org/10.1371/journal.pone.0160221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472273	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516300037
J	Niwayama, R; Nagao, H; Kitajima, TS; Hufnagel, L; Shinohara, K; Higuchi, T; Ishikawa, T; Kimura, A				Niwayama, Ritsuya; Nagao, Hiromichi; Kitajima, Tomoya S.; Hufnagel, Lars; Shinohara, Kyosuke; Higuchi, Tomoyuki; Ishikawa, Takuji; Kimura, Akatsuki			Bayesian Inference of Forces Causing Cytoplasmic Streaming in Caenorhabditis elegans Embryos and Mouse Oocytes	PLOS ONE			English	Article							ANTERIOR-POSTERIOR POLARITY; PAR PROTEINS; FLOW; POSITION	Cellular structures are hydrodynamically interconnected, such that force generation in one location can move distal structures. One example of this phenomenon is cytoplasmic streaming, whereby active forces at the cell cortex induce streaming of the entire cytoplasm. However, it is not known how the spatial distribution and magnitude of these forces move distant objects within the cell. To address this issue, we developed a computational method that used cytoplasm hydrodynamics to infer the spatial distribution of shear stress at the cell cortex induced by active force generators from experimentally obtained flow field of cytoplasmic streaming. By applying this method, we determined the shear-stress distribution that quantitatively reproduces in vivo flow fields in Caenorhabditis elegans embryos and mouse oocytes during meiosis II. Shear stress in mouse oocytes were predicted to localize to a narrower cortical region than that with a high cortical flow velocity and corresponded with the localization of the cortical actin cap. The predicted patterns of pressure gradient in both species were consistent with species-specific cytoplasmic streaming functions. The shear-stress distribution inferred by our method can contribute to the characterization of active force generation driving biological streaming.	[Niwayama, Ritsuya; Kimura, Akatsuki] Grad Univ Adv Studies, SOKENDAI, Sch Life Sci, Dept Genet, Mishima, Shizuoka, Japan; [Niwayama, Ritsuya; Kimura, Akatsuki] Natl Inst Genet, Struct Biol Ctr, Cell Architecture Lab, Mishima, Shizuoka, Japan; [Niwayama, Ritsuya; Nagao, Hiromichi; Higuchi, Tomoyuki; Kimura, Akatsuki] Res Org Informat & Syst, Transdisciplinary Res Integrat Ctr, Tokyo, Japan; [Nagao, Hiromichi; Higuchi, Tomoyuki] Inst Stat Math, Res & Dev Ctr Data Assimilat, Tachikawa, Tokyo, Japan; [Kitajima, Tomoya S.] RIKEN, CDB, Lab Chromosome Segregat, Kobe, Hyogo, Japan; [Hufnagel, Lars] EMBL Heidelberg, Cell Biol & Biophys Unit, Heidelberg, Germany; [Shinohara, Kyosuke] Osaka Univ, Grad Sch Frontier Biosci, Dev Genet Grp, Suita, Osaka, Japan; [Ishikawa, Takuji] Tohoku Univ, Dept Bioengn & Robot, Biol Flow Studies Lab, Sendai, Miyagi, Japan; [Niwayama, Ritsuya] EMBL Heidelberg, Dev Biol Unit, Heidelberg, Germany; [Nagao, Hiromichi] Univ Tokyo, Earthquake Res Inst, Tokyo, Japan; [Shinohara, Kyosuke] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; RIKEN; European Molecular Biology Laboratory (EMBL); Osaka University; Tohoku University; European Molecular Biology Laboratory (EMBL); University of Tokyo; Tokyo University of Agriculture & Technology	Kimura, A (corresponding author), Grad Univ Adv Studies, SOKENDAI, Sch Life Sci, Dept Genet, Mishima, Shizuoka, Japan.; Kimura, A (corresponding author), Natl Inst Genet, Struct Biol Ctr, Cell Architecture Lab, Mishima, Shizuoka, Japan.; Kimura, A (corresponding author), Res Org Informat & Syst, Transdisciplinary Res Integrat Ctr, Tokyo, Japan.	akkimura@nig.ac.jp	Shinohara, Kyosuke/I-1470-2016; Kitajima, Tomoya/A-7049-2016; Shinohara, Kyosuke/AAU-2471-2020	Kitajima, Tomoya/0000-0002-6486-7143; Shinohara, Kyosuke/0000-0002-6350-1684; Ishikawa, Takuji/0000-0002-3573-8414	JSPS [22-3126]; European Molecular Biology Laboratory; Center of Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg; Institute of Statistical Mathematics General Cooperative Research 1 [25-GCR1-1001]; Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan; JSPS/MEXT KAKENHI Grant [15KT0083, 15H04372, 16H00816]; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16H00816, 15KT0083, 26280010] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Molecular Biology Laboratory; Center of Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg; Institute of Statistical Mathematics General Cooperative Research 1; Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan; JSPS/MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	RN was a Research Fellow of the Japan Society for the Promotion of Science, and was supported by JSPS KAKENHI Grant Number 22-3126. LH acknowledges support from European Molecular Biology Laboratory and the Center of Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg. AK was supported by the Institute of Statistical Mathematics General Cooperative Research 1 (25-GCR1-1001), by the Transdisciplinary Research Integration Center of the Research Organization of Information and Systems, Japan, and by JSPS/MEXT KAKENHI Grant Numbers 15KT0083, 15H04372, and 16H00816. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Takashi Hiiragi (EMBL, Germany) and Hiroshi Hamada (Osaka University, Japan) for supporting this study; and Dr. Jean-Leon Maitre (EMBL, Germany) and members of the Cell Architecture Laboratory and Office for Research Development at the National Institute of Genetics for helpful discussions. Strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). R.N. was a Research Fellow of the Japan Society for the Promotion of Science. L.H. acknowledges support from European Molecular Biology Laboratory and the Center of Modeling and Simulation in the Biosciences (BIOMS) of the University of Heidelberg. This study was carried out under the Institute of Statistical Mathematics General Cooperative Research 1 (25-GCR1-1001). This study was supported by Transdisciplinary Research Integration Center, Research Organization of Information and Systems, and MEXT/JSPS KAKENHI Grant Numbers 22-3126, 15H04372, 15KT0083, and 16H00816.	Bienkowska D, 2012, CURR BIOL, V22, P583, DOI 10.1016/j.cub.2012.01.064; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Evensen G., 2009, DATA ASSIMILATION, DOI [10.1007/978-3-642-03711-5, DOI 10.1007/978-3-642-03711-5]; Ferziger J.H., 2002, COMPUTATIONAL METHOD; Ganguly S, 2012, P NATL ACAD SCI USA, V109, P15109, DOI 10.1073/pnas.1203575109; Goehring NW, 2011, SCIENCE, V334, P1137, DOI 10.1126/science.1208619; Goldstein RE, 2008, P NATL ACAD SCI USA, V105, P3663, DOI 10.1073/pnas.0707223105; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; Happel, 2012, LOW REYNOLDS NUMBER; He B, 2014, NATURE, V508, P392, DOI 10.1038/nature13070; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hosu BG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002787; Ishikawa T, 2000, FLUID DYN RES, V26, P35, DOI 10.1016/S0169-5983(98)00047-1; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Kimura A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00060; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nagao H, 2013, COMPUT J, V56, P355, DOI 10.1093/comjnl/bxs139; Niwayama Ritsuya, 2012, Worm, V1, P72, DOI 10.4161/worm.19039; Niwayama R, 2011, P NATL ACAD SCI USA, V108, P11900, DOI 10.1073/pnas.1101853108; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; Sugii Y, 2000, MEAS SCI TECHNOL, V11, P1666, DOI 10.1088/0957-0233/11/12/303; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159917	10.1371/journal.pone.0159917	http://dx.doi.org/10.1371/journal.pone.0159917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472658	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516300024
J	Bailly, C; Bodet-Milin, C; Couespel, S; Necib, H; Kraeber-Bodere, F; Ansquer, C; Carlier, T				Bailly, Clement; Bodet-Milin, Caroline; Couespel, Solene; Necib, Hatem; Kraeber-Bodere, Franoise; Ansquer, Catherine; Carlier, Thomas			Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials	PLOS ONE			English	Article							F-18-FDG PET; FDG PET/CT; INTRATUMOR HETEROGENEITY; LYMPHOMA PATIENTS; TUMOR HETEROGENEITY; THERAPY RESPONSE; CANCER; RADIOMICS; IMAGES; INDEXES	Purpose This study aimed to investigate the variability of textural features (TF) as a function of acquisition and reconstruction parameters within the context of multi-centric trials. Methods The robustness of 15 selected TFs were studied as a function of the number of iterations, the post-filtering level, input data noise, the reconstruction algorithm and the matrix size. A combination of several reconstruction and acquisition settings was devised to mimic multicentric conditions. We retrospectively studied data from 26 patients enrolled in a diagnostic study that aimed to evaluate the performance of PET/CT 68Ga-DOTANOC in gastro-entero-pancreatic neuroendocrine tumors. Forty-one tumors were extracted and served as the database. The coefficient of variation (COV) or the absolute deviation (for the noise study) was derived and compared statistically with SUVmax and SUVmean results. Results The majority of investigated TFs can be used in a multi-centric context when each parameter is considered individually. The impact of voxel size and noise in the input data were predominant as only 4 TFs presented a high/intermediate robustness against SUV-based metrics (Entropy, Homogeneity, RP and ZP). When combining several reconstruction settings to mimic multi-centric conditions, most of the investigated TFs were robust enough against SUVmax except Correlation, Contrast, LGRE, LGZE and LZLGE. Conclusion Considering previously published results on either reproducibility or sensitivity against delineation approach and our findings, it is feasible to consider Homogeneity, Entropy, Dissimilarity, HGRE, HGZE and ZP as relevant for being used in multi-centric trials.	[Bailly, Clement; Bodet-Milin, Caroline; Couespel, Solene; Kraeber-Bodere, Franoise; Ansquer, Catherine; Carlier, Thomas] Univ Hosp Nantes, Nucl Med Dept, Nantes, France; [Bodet-Milin, Caroline; Necib, Hatem; Kraeber-Bodere, Franoise; Ansquer, Catherine; Carlier, Thomas] Univ Nantes, CRCNA, INSERM, UMR 892, Nantes, France; [Necib, Hatem] Univ Hosp Nantes, Dept Radiol, Nantes, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes	Carlier, T (corresponding author), Univ Hosp Nantes, Nucl Med Dept, Nantes, France.; Carlier, T (corresponding author), Univ Nantes, CRCNA, INSERM, UMR 892, Nantes, France.	thomas.carlier@chu-nantes.fr	Kraeber-Bodéré, Françoise/F-7143-2013; Bailly, Clément/AAX-9022-2020; Bodet-Milin, Caroline/F-7721-2013; Carlier, Thomas/L-2924-2015; Aguiar, Isabel/AAC-1095-2020	Kraeber-Bodéré, Françoise/0000-0002-3417-0759; Bailly, Clément/0000-0001-8313-3287; Bodet-Milin, Caroline/0000-0002-8219-3592; 	French National Agency for Research "Investissements d'Avenir" [ANR-11-LABX-0018-01]	French National Agency for Research "Investissements d'Avenir"(French National Research Agency (ANR))	This work was supported by a grant from the French National Agency for Research called "Investissements d'Avenir" no ANR-11-LABX-0018-01.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Bodet-Milin C, 2015, J NUCL MED, V56; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; Carlier T, 2015, J NUCL MED, V56; Carlier T, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00018; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Cheng NM, 2015, EUR J NUCL MED MOL I, V42, P419, DOI 10.1007/s00259-014-2933-1; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Cook GJR, 2014, CLIN TRANSL IMAGING, V2, P269, DOI 10.1007/s40336-014-0064-0; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Lartizien C, 2014, IEEE J BIOMED HEALTH, V18, P946, DOI 10.1109/JBHI.2013.2283658; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Mu W, 2015, PHYS MED BIOL, V60, P5123, DOI 10.1088/0031-9155/60/13/5123; O'Connor JPB, 2015, CLIN CANCER RES, V21, P249, DOI 10.1158/1078-0432.CCR-14-0990; Oh JS, 2015, ANN SURG ONCOL, V22, P2746, DOI 10.1245/s10434-014-4284-3; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Pugachev A, 2005, INT J RADIAT ONCOL, V62, P545, DOI 10.1016/j.ijrobp.2005.02.009; Pyka T, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0407-7; Scheuermann JS, 2009, J NUCL MED, V50, P1187, DOI 10.2967/jnumed.108.057455; Soussan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094017; Tixier F, 2014, J NUCL MED, V55, P1235, DOI 10.2967/jnumed.113.133389; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vauclin S, 2009, PHYS MED BIOL, V54, P6901, DOI 10.1088/0031-9155/54/22/010; Visvikis D, 2012, EUR J NUCL MED MOL I, V39, P1670, DOI 10.1007/s00259-012-2239-0; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927	35	53	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159984	10.1371/journal.pone.0159984	http://dx.doi.org/10.1371/journal.pone.0159984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467882	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100082
J	Schlosser, TPC; van Stralen, M; Chu, WCW; Lam, TP; Ng, BKW; Vincken, KL; Cheng, JCY; Castelein, RM				Schlosser, Tom P. C.; van Stralen, Marijn; Chu, Winnie C. W.; Lam, Tsz-Ping; Ng, Bobby K. W.; Vincken, Koen L.; Cheng, Jack C. Y.; Castelein, Rene M.			Anterior Overgrowth in Primary Curves, Compensatory Curves and Junctional Segments in Adolescent Idiopathic Scoliosis	PLOS ONE			English	Article							VERTEBRAL BODIES; SAGITTAL PLANE; SPINAL-CORD; LORDOSIS; PATHOGENESIS; ASYMMETRY	Introduction Although much attention has been given to the global three-dimensional aspect of adolescent idiopathic scoliosis (AIS), the accurate three-dimensional morphology of the primary and compensatory curves, as well as the intervening junctional segments, in the scoliotic spine has not been described before. Methods A unique series of 77 AIS patients with high-resolution CT scans of the spine, acquired for surgical planning purposes, were included and compared to 22 healthy controls. Non-idiopathic curves were excluded. Endplate segmentation and local longitudinal axis in endplate plane enabled semi-automatic geometric analysis of the complete three-dimensional morphology of the spine, taking inter-vertebral rotation, intra-vertebral torsion and coronal and sagittal tilt into account. Intraclass correlation coefficients for interobserver reliability were 0.98-1.00. Coronal deviation, axial rotation and the exact length discrepancies in the reconstructed sagittal plane, as defined per vertebra and disc, were analyzed for each primary and compensatory curve as well as for the junctional segments in-between. Results The anterior-posterior difference of spinal length, based on "true" anterior and posterior points on endplates, was +3.8% for thoracic and +9.4% for (thoraco) lumbar curves, while the junctional segments were almost straight. This differed significantly from control group thoracic kyphosis (-4.1%; P<0.001) and lumbar lordosis (+7.8%; P<0.001). For all primary as well as compensatory curves, we observed linear correlations between the coronal Cobb angle, axial rotation and the anterior-posterior length difference (r >= 0.729 for thoracic curves; r >= 0.485 for (thoraco) lumbar curves). Conclusions Excess anterior length of the spine in AIS has been described as a generalized growth disturbance, causing relative anterior spinal overgrowth. This study is the first to demonstrate that this anterior overgrowth is not a generalized phenomenon. It is confined to the primary as well as the compensatory curves, the junctional zones do not exhibit this growth discrepancy, however, they are straight.	[Schlosser, Tom P. C.; Castelein, Rene M.] Univ Med Ctr Utrecht, Dept Orthopaed Surg, Utrecht, Netherlands; [van Stralen, Marijn; Vincken, Koen L.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Chu, Winnie C. W.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Diagnost Radiol & Organ Imaging, Shatin, Hong Kong, Peoples R China; [Lam, Tsz-Ping; Ng, Bobby K. W.; Cheng, Jack C. Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Castelein, RM (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed Surg, Utrecht, Netherlands.	r.m.castelein@umcutrecht.nl	Vincken, Koen/AAP-3558-2021; Cheng, Jack/J-3878-2018; Schloesser, Tom/H-9625-2019; Lam, Tsz Ping/P-9963-2016; Chu, Winnie CW/F-8449-2014	Cheng, Jack/0000-0001-8153-364X; Schloesser, Tom/0000-0003-1517-5914; Lam, Tsz Ping/0000-0002-2427-2719; Chu, Winnie CW/0000-0003-4962-4132	Alexandre Suerman MD/PhD Programme; AOSpine 7th European Young Researcher Award; Medtronic Inc. research grant; K2M research grant	Alexandre Suerman MD/PhD Programme; AOSpine 7th European Young Researcher Award; Medtronic Inc. research grant; K2M research grant	The work was supported by Alexandre Suerman MD/PhD Programme, AOSpine 7th European Young Researcher Award, Medtronic Inc. research grant, K2M research grant.	Cheng JC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.30; Chu WCW, 2006, SPINE, V31, pE19, DOI 10.1097/01.brs.0000193892.20764.51; Clement JL, 2013, EUR SPINE J, V22, P2414, DOI 10.1007/s00586-013-2852-z; Cobb J. R., 1948, OUTLINE STUDY SCOLIO, P261; DICKSON RA, 1984, J BONE JOINT SURG BR, V66, P8, DOI 10.1302/0301-620X.66B1.6693483; Glaser DA, 2012, SPINE, V37, P1391, DOI 10.1097/BRS.0b013e3182518a15; Guo X, 2003, J BONE JOINT SURG BR, V85B, P1026, DOI 10.1302/0301-620X.85B7.14046; Hayashi K, 2009, SPINE, V34, P792, DOI 10.1097/BRS.0b013e31818e2c36; Illes T, 2011, EUR SPINE J, V20, P135, DOI 10.1007/s00586-010-1566-8; Kouwenhoven JWM, 2006, SPINE, V31, P1467, DOI 10.1097/01.brs.0000219938.14686.b3; Kouwenhoven JWM, 2008, SPINE, V33, P2898, DOI 10.1097/BRS.0b013e3181891751; Lenke LG, 2001, J BONE JOINT SURG AM, V83A, P1169, DOI 10.2106/00004623-200108000-00006; Newton PO, 2015, J BONE JOINT SURG AM, V97A, P1694, DOI 10.2106/JBJS.O.00148; Porter RW, 2001, EUR SPINE J, V10, P2, DOI 10.1007/s005860000188; Porter RW, 2000, SPINE, V25, P1360, DOI 10.1097/00007632-200006010-00007; Qiu Y, 2012, SPINE, V37, pE714, DOI 10.1097/BRS.0b013e3182444402; RASO VJ, 1991, J PEDIATR ORTHOPED, V11, P599; ROAF ROBERT, 1966, J BONE JOINT SURG B BRIT, V48, P786; Roussouly P, 2013, EUR SPINE J, V22, pS203, DOI 10.1007/s00586-012-2571-x; Schlosser TPC, 2014, SPINE, V39, pE1159, DOI 10.1097/BRS.0000000000000467; SOMERVILLE EW, 1952, J BONE JOINT SURG BR, V34, P421, DOI 10.1302/0301-620X.34B3.421; STAGNARA P, 1982, SPINE, V7, P335, DOI 10.1097/00007632-198207000-00003; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3	23	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160267	10.1371/journal.pone.0160267	http://dx.doi.org/10.1371/journal.pone.0160267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467745	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100141
J	Sessa, M; Mascolo, A; Andersen, MP; Rosano, G; Rossi, F; Capuano, A; Torp-Pedersen, C				Sessa, Maurizio; Mascolo, Annamaria; Andersen, Mikkel Porsborg; Rosano, Giuseppe; Rossi, Francesco; Capuano, Annalisa; Torp-Pedersen, Christian			Effect of Chronic Kidney Diseases on Mortality among Digoxin Users Treated for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study	PLOS ONE			English	Article							HEART-FAILURE PATIENTS; SERUM DIGOXIN; CLINICAL-OUTCOMES; RISK; DIGITALIS; EPIDEMIOLOGY; MANAGEMENT; METAANALYSIS; ASSOCIATION; SOCIETY	Purpose This study investigated the impact of chronic kidney disease on all-causes and cardiovascular mortality in patients with atrial fibrillation treated with digoxin. Methods All patients with non-valvular atrial fibrillation and/or atrial flutter as hospitalization diagnosis from January 1, 1997 to December 31, 2012 were identified in Danish nationwide administrative registries. Cox proportional hazard model was used to compare the adjusted risk of all-causes and cardiovascular mortality among patients with and without chronic kidney disease and among patients with different chronic kidney disease stages within 180 days and 2 years from the first digoxin prescription. Results We identified 37,981 patients receiving digoxin; 1884 patients had the diagnosis of chronic kidney disease. Cox regression analysis showed no statistically significant differences in all-causes (Hazard Ratio, HR 0.89; 95% confident interval, CI 0.78-1.03) and cardiovascular mortality (HR 0.88; 95% CI 0.74-1.05) among patients with and without chronic kidney disease within 180 days of follow-up period. No statistically significant differences was found using a 2 years follow-up period neither for all causes mortality (HR 0.90; 95% CI 0.79-1.03), nor for cardiovascular mortality (HR 0.87; 95% CI 0.74-1.02). No statistically significant differences was found comparing patients with and without estimated Glomerular Filtration Rate < 30ml/min/1.73m(2) and patients with different stages of chronic kidney disease, for all-causes and cardiovascular mortality within 180 days and 2 years from the first digoxin prescription. Conclusions This study suggest no direct effect of chronic kidney disease and chronic kidney disease stages on all-causes and cardiovascular mortality within both 180 days and 2 years from the first digoxin prescription in patients treatment-naive with digoxin for non-valvular atrial fibrillation.	[Sessa, Maurizio; Mascolo, Annamaria; Rossi, Francesco; Capuano, Annalisa] Univ Naples 2, Sect Pharmacol L Donatelli, Dept Expt Med, Naples, Italy; [Andersen, Mikkel Porsborg; Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Rosano, Giuseppe] IRCCS San Raffaele Pisana, Rome, Italy; [Rosano, Giuseppe] St Georges Univ London, Cardiovasc & Cell Sci Res Inst, London, England	Universita della Campania Vanvitelli; Aalborg University; IRCCS San Raffaele Pisana; St Georges University London	Sessa, M (corresponding author), Univ Naples 2, Sect Pharmacol L Donatelli, Dept Expt Med, Naples, Italy.	maurizio.sessa@unina2.it	Rosano, Giuseppe M. C./K-8718-2018	Rosano, Giuseppe M. C./0000-0003-4023-2263; Andersen, Mikkel Porsborg/0000-0001-6162-5205; Sessa, Maurizio/0000-0003-0874-4744				Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Andersson C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000433; Andersson C, 2010, EUR J HEART FAIL, V12, P1333, DOI 10.1093/eurjhf/hfq160; Bansal N, 2014, CURR OPIN NEPHROL HY, V23, P275, DOI 10.1097/01.mnh.0000444820.80249.56; BAYLIS EM, 1972, BMJ-BRIT MED J, V1, P338, DOI 10.1136/bmj.1.5796.338; BELZ GG, 1978, EUR J CLIN PHARMACOL, V13, P103, DOI 10.1007/BF00609753; Boriani G, 2015, EUROPACE, V17, P1169, DOI 10.1093/europace/euv202; BUCH I, 1980, DAN MED BULL, V27, P287; Butler Javed, 2010, Congest Heart Fail, V16, P191, DOI 10.1111/j.1751-7133.2010.00161.x; Camm AJ, 2007, HEART, V93, P35, DOI 10.1136/hrt.2006.099903; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chao TF, 2014, CAN J CARDIOL, V30, P1190, DOI 10.1016/j.cjca.2014.05.009; Dhaliwal AS, 2008, AM J CARDIOL, V102, P1356, DOI 10.1016/j.amjcard.2008.07.014; Domanski M, 2005, J CARD FAIL, V11, P83, DOI 10.1016/j.cardfail.2004.07.002; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eknoyan G, 2003, AM J KIDNEY DIS, V42, pS1, DOI DOI 10.1016/S0272-6386(03)00905-3; ENAS EA, 1992, AM J CARDIOL, V70, P945, DOI 10.1016/0002-9149(92)90744-J; Fauchier L, 2009, AM J CARDIOL, V103, P248, DOI 10.1016/j.amjcard.2008.09.064; Freeman JV, 2015, CIRC-ARRHYTHMIA ELEC, V8, P49, DOI 10.1161/CIRCEP.114.002292; Freeman JV, 2013, CIRC-CARDIOVASC QUAL, V6, P525, DOI 10.1161/CIRCOUTCOMES.111.000079; Friberg L, 2010, HEART, V96, P275, DOI 10.1136/hrt.2009.175786; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gaist D, 1997, DAN MED B; Gamst J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006486; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Gjesdal K, 2008, HEART, V94, P191, DOI 10.1136/hrt.2006.108399; Grann Anne Fia, 2011, Clin Epidemiol, V3, P133, DOI 10.2147/CLEP.S17901; Hallberg P, 2007, EUR J CLIN PHARMACOL, V63, P959, DOI 10.1007/s00228-007-0346-9; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; HOESCHEN RJ, 1975, AM J CARDIOL, V35, P469, DOI 10.1016/0002-9149(75)90828-0; ISERI LT, 1975, AM J MED, V58, P837, DOI 10.1016/0002-9343(75)90640-3; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Jones C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3655; KNOCHEL JP, 1984, AM J MED, V77, P18, DOI 10.1016/S0002-9343(84)80004-2; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Lip GYH, 2014, EUROPACE, V16, P308, DOI 10.1093/europace/eut373; LISALO E, 1977, CLIN PHARMACOKINET, V2, P1; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mulder BA, 2014, HEART RHYTHM, V11, P1543, DOI 10.1016/j.hrthm.2014.06.007; Olesen JB, 2015, EUROPACE, V17, P187, DOI DOI 10.1093/EUR0PACE/; Ouyang AJ, 2015, AM J CARDIOL, V115, P901, DOI 10.1016/j.amjcard.2015.01.013; Pastori D, 2015, INT J CARDIOL, V180, P1, DOI 10.1016/j.ijcard.2014.11.112; Patel NJ, 2015, WORLD J CARDIOL, V7, P397, DOI 10.4330/wjc.v7.i7.397; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perry G, 1997, NEW ENGL J MED, V336, P525; Rathore SS, 2003, JAMA-J AM MED ASSOC, V289, P871, DOI 10.1001/jama.289.7.871; RODIN SM, 1988, CLIN PHARMACOKINET, V15, P227, DOI 10.2165/00003088-198815040-00003; Rodriguez-Manero M, 2014, REV ESP CARDIOL, V67, P890, DOI 10.1016/j.rec.2014.01.014; Saliba W, 2014, AM J MED, V127, P45, DOI 10.1016/j.amjmed.2013.10.004; SANDOR FF, 1982, BRIT MED J, V284, P711, DOI 10.1136/bmj.284.6317.711; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shah M, 2014, AM J CARDIOL, V114, P401, DOI 10.1016/j.amjcard.2014.05.013; SHAPIRO S, 1969, J CHRON DIS, V22, P361, DOI 10.1016/0021-9681(69)90077-0; Simons LA, 2005, MED J AUSTRALIA, V182, P286, DOI 10.5694/j.1326-5377.2005.tb06703.x; STEINESS E, 1976, BRIT HEART J, V38, P167; TANNEN RL, 1985, KIDNEY INT, V28, P988, DOI 10.1038/ki.1985.229; Turakhia MP, 2014, J AM COLL CARDIOL, V64, P660, DOI 10.1016/j.jacc.2014.03.060; Vamos M, 2015, EUR HEART J, V36, P1831, DOI 10.1093/eurheartj/ehv143; Wang MT, 2010, BRIT J CLIN PHARMACO, V70, P258, DOI 10.1111/j.1365-2125.2010.03687.x; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; WHANG R, 1985, ARCH INTERN MED, V145, P655, DOI 10.1001/archinte.145.4.655; Whitbeck MG, 2013, EUR HEART J, V34, P1481, DOI 10.1093/eurheartj/ehs348; WILKERSON RD, 1981, AM HEART J, V102, P63, DOI 10.1016/0002-8703(81)90414-2	65	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160337	10.1371/journal.pone.0160337	http://dx.doi.org/10.1371/journal.pone.0160337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467520	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000381516100148
J	Winter, U; Mena, HA; Negrotto, S; Arana, E; Pascual-Pasto, G; Laurent, V; Sunol, M; Chantada, GL; Carcaboso, AM; Schaiquevich, P				Winter, Ursula; Mena, Hebe A.; Negrotto, Soledad; Arana, Eloisa; Pascual-Pasto, Guillem; Laurent, Viviana; Sunol, Mariona; Chantada, Guillermo L.; Carcaboso, Angel M.; Schaiquevich, Paula			Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells	PLOS ONE			English	Article							METRONOMIC CHEMOTHERAPY; INTRAVITREAL CHEMOTHERAPY; TOPOTECAN COMBINATION; RESISTANCE; MELPHALAN; THERAPY; NEUROBLASTOMA; CHILDREN; CANCER; MODELS	Current treatment of retinoblastoma involves using the maximum dose of chemotherapy that induces tumor control and is tolerated by patients. The impact of dose and schedule on the cytotoxicity of chemotherapy has not been studied. Our aim was to gain insight into the cytotoxic and antiangiogenic effect of the treatment scheme of chemotherapy used in retinoblastoma by means of different in vitro models and to evaluate potential effects on multidrug resistance proteins. Two commercial and two patient-derived retinoblastoma cell types and two human vascular endothelial cell types were exposed to increasing concentrations of melphalan or topotecan in a conventional (single exposure) or metronomic (7-day continuous exposure) treatment scheme. The concentration of chemotherapy causing a 50% decrease in cell proliferation (IC50) was determined by MTT and induction of apoptosis was evaluated by flow cytometry. Expression of ABCB1, ABCG2 and ABCC1 after conventional or metronomic treatments was assessed by RT-qPCR. We also evaluated the in vivo response to conventional (0.6 mg/kg once a week for 2 weeks) and metronomic (5 days a week for 2 weeks) topotecan in a retinoblastoma xenograft model. Melphalan and topotecan were cytotoxic to both retinoblastoma and endothelial cells after conventional and metronomic treatments. A significant decrease in the IC50 (median, 13-fold; range: 3-23) was observed following metronomic chemotherapy treatment in retinoblastoma and endothelial cell types compared to conventional treatment (p<0.05). Metronomic topotecan or melphalan significantly inhibited in vitro tube formation in HUVEC and EPC compared to vehicle-treated cells (p<0.05). Both treatment schemes induced apoptosis and/or necrosis in all cell models. No significant difference was observed in the expression of ABCB1, ABCC1 or ABCG2 when comparing cells treated with melphalan or topotecan between treatment schedules at the IC50 or with control cells (p>0.05). In mice, continuous topotecan lead to significantly lower tumor volumes compared to conventional treatment after 14 days of treatment (p<0.05). Continuous exposure to melphalan or topotecan increased the chemosensitivity of retinoblastoma and endothelial cells to both chemotherapy agents with lower IC50 values compared to short-term treatment. These findings were validated in an in vivo model. None of the dosing modalities induced multidrug resistance mechanisms while apoptosis was the mechanism of cell death after both treatment schedules. Metronomic chemotherapy may be a valid option for retinoblastoma treatment allowing reductions of the daily dose.	[Winter, Ursula; Laurent, Viviana; Schaiquevich, Paula] Hosp Pediat JP Garrahan, Clin Pharmacokinet Unit, Buenos Aires, DF, Argentina; [Winter, Ursula; Negrotto, Soledad; Arana, Eloisa; Chantada, Guillermo L.; Schaiquevich, Paula] Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina; [Mena, Hebe A.; Negrotto, Soledad] Natl Acad Med, IMEX, Expt Thrombosis Lab, Buenos Aires, DF, Argentina; [Arana, Eloisa] Univ Buenos Aires, Inmunogenet Lab, INIGEM, Buenos Aires, DF, Argentina; [Pascual-Pasto, Guillem; Carcaboso, Angel M.] Hosp St Joan de Deu, Dev Tumor Biol Lab, Barcelona, Spain; [Pascual-Pasto, Guillem; Carcaboso, Angel M.] Hosp St Joan de Deu, Dept Pediat Hematol & Oncol, Barcelona, Spain; [Sunol, Mariona] Hosp St Joan de Deu, Pathol, Barcelona, Spain; [Chantada, Guillermo L.] Hosp Pediat JP Garrahan, Buenos Aires, DF, Argentina	Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; University of Buenos Aires; University of Barcelona; University of Barcelona; University of Barcelona; Hospital de Pediatria Doctor Juan Garrahan; University of Buenos Aires	Schaiquevich, P (corresponding author), Hosp Pediat JP Garrahan, Clin Pharmacokinet Unit, Buenos Aires, DF, Argentina.; Schaiquevich, P (corresponding author), Consejo Nacl Invest Cient & Tecn, Natl Sci & Tech Res Council, Buenos Aires, DF, Argentina.	paulas@conicet.gov.ar	Schaiquevich, Paula/AAF-8915-2019; Chantada, Guillermo Luis/S-9310-2019	Pascual-Pasto, Guillem/0000-0001-8537-261X; Mena, Hebe Agustina/0000-0003-1724-8582; Carcaboso, Angel/0000-0002-8485-426X	National Institute of Cancer, Ministry of Health, Argentina; National Council of Scientific and Technical Research (CONICET) [11220120100383CO01]; National Agency for Science and Technology Promotion [PICT 0612/13]; Fund for Ophthalmic Knowledge, New York, NY, USA; Fundacion Natalie D Flexer de Ayuda al Nino con Cancer; ISCIII-FEDER [CP13/00189]; Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya	National Institute of Cancer, Ministry of Health, Argentina; National Council of Scientific and Technical Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Science and Technology Promotion; Fund for Ophthalmic Knowledge, New York, NY, USA; Fundacion Natalie D Flexer de Ayuda al Nino con Cancer; ISCIII-FEDER; Xarxa de Bancs de Tumors de Catalunya (XBTC) - Pla Director d'Oncologia de Catalunya	This work was funded by the National Institute of Cancer, Ministry of Health, Argentina; National Council of Scientific and Technical Research (CONICET, PIP #11220120100383CO01); National Agency for Science and Technology Promotion (PICT 0612/13); Fund for Ophthalmic Knowledge (GLC, ACF), New York, NY, USA; Fundacion Natalie D Flexer de Ayuda al Nino con Cancer (GLC and ACF) and ISCIII-FEDER (CP13/00189) to AMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present work was further supported by the Xarxa de Bancs de Tumors de Catalunya (XBTC) sponsored by Pla Director d'Oncologia de Catalunya.	Abramson DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146582; Abramson DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145436; Abramson DH, 2015, JAMA OPHTHALMOL, V133, P1341, DOI 10.1001/jamaophthalmol.2015.3108; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Andre N, 2013, LANCET ONCOLOGY; Andre N, 2015, ONCOTARGET, V6, P23008, DOI 10.18632/oncotarget.3984; Andre N, 2014, NAT REV CLIN ONCOL, V11, P413, DOI 10.1038/nrclinonc.2014.89; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bertolini F, 2015, NAT REV CLIN ONCOL, V12, P732, DOI 10.1038/nrclinonc.2015.169; Bond WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063519; Bouche G, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.463; Carcaboso AM, 2010, INVEST OPHTH VIS SCI, V51, P2126, DOI 10.1167/iovs.09-4050; Carol H, 2010, PEDIATR BLOOD CANCER, V54, P707, DOI 10.1002/pbc.22352; Clements MK, 1999, CANCER CHEMOTH PHARM, V44, P411, DOI 10.1007/s002800050997; De Souza R, 2011, MOL CANCER THER, V10, P1289, DOI 10.1158/1535-7163.MCT-11-0058; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Dunkel IJ, 2010, PEDIATR BLOOD CANCER, V55, P149, DOI 10.1002/pbc.22491; Fousseyni T, 2011, J PEDIAT HEMATOL ONC, V33, P31, DOI 10.1097/MPH.0b013e3182018ab8; Francis JH, 2015, OPHTHALMOLOGY, V122, P1173, DOI 10.1016/j.ophtha.2015.01.017; Francis JH, 2014, OPHTHALMOLOGY, V121, P1810, DOI 10.1016/j.ophtha.2014.03.028; Francis JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084247; Francis JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072441; Ghassemi F, 2014, JAMA OPHTHALMOL, V132, P936, DOI 10.1001/jamaophthalmol.2014.414; Gnoni A, 2015, CRIT REV ONCOL HEMAT, V95, P46, DOI 10.1016/j.critrevonc.2015.01.008; GRIEGEL S, 1990, INT J CANCER, V46, P125, DOI 10.1002/ijc.2910460123; Jensen NF, 2015, MOL ONCOL, V9, P1169, DOI 10.1016/j.molonc.2015.02.008; Kang KB, 2014, J OCUL PHARMACOL TH, V30, P688, DOI 10.1089/jop.2014.0051; Kareva I, 2015, CANCER LETT, V358, P100, DOI 10.1016/j.canlet.2014.12.039; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Krysko DV, 2008, METHOD ENZYMOL, V442, P307, DOI [10.1016/S0070-6879(08)01416-X, 10.1016/S0076-6879(08)01416-X]; Kuhne A, 2009, BIOCHEM PHARMACOL, V78, P45, DOI 10.1016/j.bcp.2009.03.026; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Lavi O, 2012, DRUG RESIST UPDATE, V15, P90, DOI 10.1016/j.drup.2012.01.003; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Lin F, 2013, CLIN CANCER RES, V19, P2084, DOI 10.1158/1078-0432.CCR-12-3105; Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715; Maiti R, 2014, J PHARMACOL PHARMACO, V5, P186, DOI 10.4103/0976-500X.136098; Mallipatna AC, 2011, ARCH OPHTHALMOL-CHIC, V129, P738, DOI 10.1001/archophthalmol.2011.130; Manjandavida FP, 2015, INDIAN J OPHTHALMOL, V63, P141, DOI 10.4103/0301-4738.154390; McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005; Mena HA, 2014, ANGIOGENESIS, V17, P867, DOI 10.1007/s10456-014-9434-5; Merritt WM, 2009, CANCER BIOL THER, V8, P1596, DOI 10.4161/cbt.8.16.9004; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Morrison PWJ, 2014, THER DELIV, V5, P1297, DOI [10.4155/TDE.14.75, 10.4155/tde.14.75]; Munier FL, 2013, SAUDI J OPHTHALMOL, V27, P147, DOI 10.1016/j.sjopt.2013.06.003; Munier FL, 2012, BRIT J OPHTHALMOL, V96, P1078, DOI 10.1136/bjophthalmol-2011-301450; Nemeth KM, 2011, CANCER-AM CANCER SOC, V117, P421, DOI 10.1002/cncr.25574; Ortiz MV, 2016, J CHILD NEUROL, V31, P227, DOI 10.1177/0883073815587943; Panetta JC, 2008, CLIN CANCER RES, V14, P318, DOI 10.1158/1078-0432.CCR-07-1243; Pascual-Pasto G, 2016, CANCER LETT, V380, P10, DOI 10.1016/j.canlet.2016.06.012; Pasquier E, 2013, ANGIOGENESIS, V16, P373, DOI 10.1007/s10456-012-9321-x; Pasquier E, 2011, TRANSL ONCOL, V4, P189, DOI 10.1593/tlo.11124; Penel N, 2012, CRIT REV ONCOL HEMAT, V82, P40, DOI 10.1016/j.critrevonc.2011.04.009; Roberts JK, 2016, DRUG METAB DISPOS; Saletta F, 2014, TRANSL PEDIATR, V3, P156, DOI 10.3978/j.issn.2224-4336.2014.02.01; Samuels AL, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.52; Santana VM, 2005, J CLIN ONCOL, V23, P4039, DOI 10.1200/JCO.2005.02.097; Schaiquevich P, 2014, RETINA-J RET VIT DIS, V34, P1719, DOI 10.1097/IAE.0000000000000253; SKIPPER HE, 1970, CANCER CHEMOTH REP 1, V54, P431; Suzuki S, 2015, JPN J OPHTHALMOL, V59, P164, DOI 10.1007/s10384-015-0378-0; Taich P, 2014, OPHTHALMOLOGY, V121, P889, DOI 10.1016/j.ophtha.2013.10.045; Tan DSW, 2010, EUR J CANCER, V46, P2166, DOI 10.1016/j.ejca.2010.03.019; Taschner-Mandl S, 2016, ONCOTARGET, V7, P3571, DOI 10.18632/oncotarget.6527; Thomas E, 2014, RESISTANCE TARGETED; Tiwari AK, 2013, MOL CANCER THER, V12, P1343, DOI 10.1158/1535-7163.MCT-13-0100; Traore F, 2013, INDIAN J CANCER, V50, P250, DOI 10.4103/0019-509X.118741; WEITMAN SD, 1993, J CLIN ONCOL, V11, P820, DOI 10.1200/JCO.1993.11.5.820; Wilson MW, 2006, INVEST OPHTH VIS SCI, V47, P1269, DOI 10.1167/iovs.05-1321; Yang Y., 2015, TUMOUR BIOL; Zamboni WC, 1998, J NATL CANCER I, V90, P505, DOI 10.1093/jnci/90.7.505; Zapletalova D, 2012, ONCOLOGY-BASEL, V82, P249, DOI 10.1159/000336483	71	14	14	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160094	10.1371/journal.pone.0160094	http://dx.doi.org/10.1371/journal.pone.0160094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467588	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100109
J	Lang, E; Zoz, F; Iaconelli, C; Guyot, S; Alvarez-Martin, P; Beney, L; Perrier-Cornet, JM; Gervais, P				Lang, Emilie; Zoz, Fiona; Iaconelli, Cyril; Guyot, Stephane; Alvarez-Martin, Pablo; Beney, Laurent; Perrier-Cornet, Jean-Marie; Gervais, Patrick			Recovery Estimation of Dried Foodborne Pathogens Is Directly Related to Rehydration Kinetics	PLOS ONE			English	Article							DESICCATION TOLERANCE; ESCHERICHIA-COLI; WATER ACTIVITY; DEHYDRATION; MEMBRANE; DEATH; ANHYDROBIOSIS; PROKARYOTES; RESISTANCE; SURVIVAL	Drying is a common process which is used to preserve food products and technological microorganisms, but which is deleterious for the cells. The aim of this study is to differentiate the effects of drying alone from the effects of the successive and necessary rehydration. Rehydration of dried bacteria is a critical step already studied in starter culture but not for different kinetics and not for pathogens. In the present study, the influence of rehydration kinetics was investigated for three foodborne pathogens involved in neonatal diseases caused by the consumption of rehydrated milk powder: Salmonella enterica subsp. enterica serovar Typhimurium, Salmonella enterica subsp. enterica serovar Senftenberg and Cronobacter sakazakii. Bacteria were dried in controlled relative humidity atmospheres and then rehydrated using different methods. Our results showed that the survival of the three pathogens was strongly related to rehydration kinetics. Consequently, rehydration is an important step to consider during food safety assessment or during studies of dried foodborne pathogens. Also, it has to be considered with more attention in consumers' homes during the preparation of food, like powdered infant formula, to avoid pathogens recovery.	[Lang, Emilie; Zoz, Fiona; Iaconelli, Cyril; Guyot, Stephane; Beney, Laurent; Perrier-Cornet, Jean-Marie; Gervais, Patrick] Univ Bourgogne Franche Comte, AgroSup Dijon, UMR PAM, F-21000 Dijon, France; [Lang, Emilie; Alvarez-Martin, Pablo] Novolyze, F-21121 Daix, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne	Gervais, P (corresponding author), Univ Bourgogne Franche Comte, AgroSup Dijon, UMR PAM, 1 Esplanade Erasme, F-21000 Dijon, France.	patrick.gervais@u-bourgogne.fr	PERRIER-CORNET, Jean-Marie/D-2456-2014; Lang, Emilie/U-8120-2019; Guyot, Stéphane/A-3482-2012	Guyot, Stéphane/0000-0002-2316-234X; Laurent, Beney/0000-0002-2757-2506; Perrier-Cornet, Jean-Marie/0000-0002-6547-5731	Agence Nationale de la Recherche et de la Technologie; Novolyze	Agence Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Novolyze	Agence Nationale de la Recherche et de la Technologie: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novolyze provided support in the form of salaries for authors [EL and PAM] and had a role in decision to publish, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alvarez-Ordonez A, 2015, INT J FOOD MICROBIOL, V213, P99, DOI 10.1016/j.ijfoodmicro.2015.06.004; Ananta E, 2005, INT DAIRY J, V15, P399, DOI 10.1016/j.idairyj.2004.08.004; Beney L, 2004, APPL MICROBIOL BIOT, V65, P457, DOI 10.1007/s00253-004-1574-x; Beney L, 2007, ARCH MICROBIOL, V187, P387, DOI 10.1007/s00203-006-0203-8; Beuchat LR, 2013, J FOOD PROTECT, V76, P150, DOI 10.4315/0362-028X.JFP-12-211; Billi D, 2002, RES MICROBIOL, V153, P7, DOI 10.1016/S0923-2508(01)01279-7; Dupont S, 2014, APPL MICROBIOL BIOT, V98, P8821, DOI 10.1007/s00253-014-6028-5; Fine F, 2005, ENVIRON MICROBIOL, V7, P40, DOI 10.1111/j.1462-2920.2004.00689.x; Forsythe S, 2014, THE MICROBIOLOGICAL, P177, DOI [10.1007/978-1-4939-2062-4, DOI 10.1007/978-1-4939-2062-4]; Garbowska M, 2015, FOOD MICROBIOL, V49, P1, DOI 10.1016/j.fm.2015.01.004; Gervais P, 2001, CELL MOL BIOL, V47, P831; Gruzdev N, 2012, FOOD MICROBIOL, V32, P415, DOI 10.1016/j.fm.2012.08.003; Lemetais G, 2012, APPL MICROBIOL BIOT, V96, P471, DOI 10.1007/s00253-012-4014-3; Meng XC, 2008, FOOD CHEM, V106, P1406, DOI 10.1016/j.foodchem.2007.04.076; Mille Y, 2003, BIOTECHNOL BIOENG, V83, P578, DOI 10.1002/bit.10706; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Osaili T, 2009, INT J FOOD MICROBIOL, V136, P214, DOI 10.1016/j.ijfoodmicro.2009.08.006; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Potts M, 2001, TRENDS MICROBIOL, V9, P553, DOI 10.1016/S0966-842X(01)02231-4; Simonin H, 2007, BBA-BIOMEMBRANES, V1768, P1600, DOI 10.1016/j.bbamem.2007.03.017; SINHA RN, 1982, J FOOD SCI, V47, P668, DOI 10.1111/j.1365-2621.1982.tb10148.x; Trofimova Y, 2010, FEMS MICROBIOL LETT, V308, P55, DOI 10.1111/j.1574-6968.2010.01989.x; Van Doren JM, 2013, FOOD MICROBIOL, V36, P456, DOI 10.1016/j.fm.2013.04.014; Zoz F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148418	24	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160844	10.1371/journal.pone.0160844	http://dx.doi.org/10.1371/journal.pone.0160844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494169	Green Submitted, Green Published, gold			2022-12-27	WOS:000381369500087
J	Anthony, G; Lee, JA				Anthony, Giovanni; Lee, Ju-Ahng			An Optimized Small Tissue Handling System for Immunohistochemistry and In Situ Hybridization	PLOS ONE			English	Article							ZEBRAFISH EMBRYOS; 3D	Recent development in 3D printing technology has opened an exciting possibility for manufacturing 3D devices on one's desktop. We used 3D modeling programs to design 3D models of a tissue-handling system and these models were "printed" in a stereolithography (SLA) 3D printer to create precision histology devices that are particularly useful to handle multiple samples with small dimensions in parallel. Our system has been successfully tested for in situ hybridization of zebrafish embryos. Some of the notable features include: (1) A conveniently transferrable chamber with 6 mesh-bottomed wells, each of which can hold dozens of zebrafish embryos. This design allows up to 6 different samples to be treated per chamber. (2) Each chamber sits in a well of a standard 6-well tissue culture plate. Thus, up to 36 different samples can be processed in tandem using a single 6 well plate. (3) Precisely fitting lids prevent solution evaporation and condensation, even at high temperatures for an extended period of time: i.e., overnight riboprobe hybridization. (4) Flat bottom mesh maximizes the consistent treatment of individual tissue samples. (5) A magnet-based lifter was created to handle up to 6 chambers (= 36 samples) in unison. (6) The largely transparent resin aids in convenient visual inspection both with eyes and using a stereomicroscope. (7) Surface engraved labeling enables an accurate tracking of different samples. (8) The dimension of wells and chambers minimizes the required amount of precious reagents. (9) Flexible parametric modeling enables an easy redesign of the 3D models to handle larger or more numerous samples. Precise dimensions of 3D models and demonstration of how we use our devices in whole mount in situ hybridization are presented. We also provide detailed information on the modeling software, 3D printing tips, as well as 3D files that can be used with any 3D printer.	[Anthony, Giovanni; Lee, Ju-Ahng] North Carolina Cent Univ, Dept Biol & Biomed Sci, Durham, NC 27707 USA	University of North Carolina; North Carolina Central University	Lee, JA (corresponding author), North Carolina Cent Univ, Dept Biol & Biomed Sci, BBRI 215,700 George St, Durham, NC 27707 USA.	jlee@nccu.edu			NIAAA [U54 AA019765-06]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U54AA019765] Funding Source: NIH RePORTER	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIAAA U54 AA019765-06 to JAL.; The authors thank Dr. Gregory Cole for comments on the manuscript and NCCU animal facility for zebrafish care. This work was supported by NIAAA U54 AA019765-06 to J.-A.L.	Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Chitramuthu BP, 2013, JOVE-J VIS EXP, DOI 10.3791/50644; Dahm R., 2002, ZEBRAFISH PRACTICAL, pxviii; Ho CMB, 2015, LAB CHIP, V15, P3627, DOI 10.1039/c5lc00685f; Huang TY, 2015, ADV MATER, V27, P6644, DOI 10.1002/adma.201503095; Jones N, 2012, NATURE, V487, P22, DOI 10.1038/487022a; Lee JA, 2008, MECH DEVELOP, V125, P167, DOI 10.1016/j.mod.2007.09.009; Lee M, 2014, LANGMUIR, V30, P1210, DOI 10.1021/la404704z; Masselink W, 2014, ZEBRAFISH, V11, P26, DOI 10.1089/zeb.2013.0897; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Oskui SM, 2016, ENVIRON SCI TECH LET, V3, P1, DOI 10.1021/acs.estlett.5b00249; Rifkin J., 2011, 3 IND REVOLUTION LAT; Rudin-Bitterli TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113235; Savage N, 2014, NATURE, V509, pS66, DOI 10.1038/509S66a; Schubert C, 2014, BRIT J OPHTHALMOL, V98, P159, DOI 10.1136/bjophthalmol-2013-304446; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; Wittbrodt JN, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-36	18	1	1	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159991	10.1371/journal.pone.0159991	http://dx.doi.org/10.1371/journal.pone.0159991			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27489962	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900023
J	Bone, JE; McAuliffe, K; Raihani, NJ				Bone, Jonathan E.; McAuliffe, Katherine; Raihani, Nichola J.			Exploring the Motivations for Punishment: Framing and Country-Level Effects	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; ANTISOCIAL PUNISHMENT; HUMAN COOPERATION; SOCIETIES; HUMANS; COMPETITION; SANCTIONS; EVOLUTION	Identifying the motives underpinning punishment is crucial for understanding its evolved function. In principle, punishment of distributional inequality could be motivated by the desire to reciprocate losses ('revenge') or by the desire to reduce payoff asymmetries between the punisher and the target ('inequality aversion'). By separating these two possible motivations, recent work suggests that punishment is more likely to be motivated by disadvantageous inequality aversion than by a desire for revenge. Nevertheless, these findings have not consistently replicated across different studies. Here, we suggest that considering country of origin-previously overlooked as a possible source of variation in responses-is important for understanding when and why individuals punish one another. We conducted a two-player stealing game with punishment, using data from 2,400 subjects recruited from the USA and India. US-based subjects punished in response to losses and disadvantageous inequality, but seldom invested in antisocial punishment (defined here as punishment of non-stealing partners). India-based subjects, on the other hand, punished at higher levels than US-based subjects and, so long as they did not experience disadvantageous inequality, punished stealing and non-stealing partners indiscriminately. Nevertheless, as in the USA, when stealing resulted in disadvantageous inequality, India-based subjects punished stealing partners more than non-stealing partners. These results are consistent with the hypothesis that variation in punitive behavior varies across societies, and support the idea that punishment might sometimes function to improve relative status, rather than to enforce cooperation.	[Bone, Jonathan E.] UCL, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England; [Bone, Jonathan E.] UCL, CoMPLEX, Gower St, London WC1E 6BT, England; [McAuliffe, Katherine] Boston Coll, Dept Psychol, Boston, MA 02467 USA; [Raihani, Nichola J.] UCL, Dept Expt Psychol, 26 Bedford Way, London WC1H 0AP, England	University of London; University College London; University of London; University College London; Boston College; University of London; University College London	Raihani, NJ (corresponding author), UCL, Dept Expt Psychol, 26 Bedford Way, London WC1H 0AP, England.	nicholaraihani@gmail.com	Raihani, Nichola J/C-2083-2015	Raihani, Nichola J/0000-0003-2339-9889	Royal Society University Research Fellowship	Royal Society University Research Fellowship(Royal Society of London)	NR was awarded a Royal Society University Research Fellowship, http://www.royalsociety.org/.; This study was funded by a Royal Society University Research Fellowship to N.R.	Abbink K, 2009, ECON LETT, V105, P306, DOI 10.1016/j.econlet.2009.08.024; Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Anderson CM, 2006, GAME ECON BEHAV, V54, P1, DOI 10.1016/j.geb.2004.08.007; Barclay P, 2016, EVOL HUM BEHAV, V37, P263, DOI 10.1016/j.evolhumbehav.2015.12.004; Barton K., 2013, MUMIN MULTI MODEL IN; Bone JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155773; Bone JE, 2015, EVOL HUM BEHAV, V36, P323, DOI 10.1016/j.evolhumbehav.2015.02.002; Bone JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117183; Bryson JJ, 2014, UNDERSTANDING ADDRES, P201; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burnham K. P., 2002, MODEL SELECTION AND, V60, P488; Burton-Chellew MN, 2013, P NATL ACAD SCI USA, V110, P216, DOI 10.1073/pnas.1210960110; Camerer CF, 2003, ROUNDTABLE SERIES BE, P544; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Falk A, 2005, ECONOMETRICA, V73, P2017, DOI 10.1111/j.1468-0262.2005.00644.x; Fehl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045093; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Grimm V, 2011, ECON LETT, V111, P113, DOI 10.1016/j.econlet.2011.01.025; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI DOI 10.1111/J.1467-9892.1993.TB00144.X; Janssen MA, 2008, J THEOR BIOL, V254, P541, DOI 10.1016/j.jtbi.2008.06.017; Johnson T, 2009, ECON LETT, V102, P192, DOI 10.1016/j.econlet.2009.01.003; Lehmann L, 2009, EVOLUTION, V63, P2896, DOI 10.1111/j.1558-5646.2009.00778.x; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McAuliffe K, 2012, BIOL LETT, P18; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; Moussalli A, 2011, BEHAV ECOLOGY SOCIOB; Nikiforakis N, 2008, EXP ECON, V11, P358, DOI 10.1007/s10683-007-9171-3; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Paal T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120394; Peysakhovich A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5939; Prediger S, 2014, J PUBLIC ECON, V119, P1, DOI 10.1016/j.jpubeco.2014.07.007; Price ME, 2002, EVOL HUM BEHAV, V23, P203, DOI 10.1016/S1090-5138(01)00093-9; Raihani NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073131; Raihani NJ, 2012, SOC JUSTICE RES, V25, P213, DOI 10.1007/s11211-012-0157-8; Raihani NJ, 2012, P ROY SOC B-BIOL SCI, V279, P365, DOI 10.1098/rspb.2011.0690; Raihani NJ, 2010, SCIENCE, V327, P171, DOI 10.1126/science.1183068; Ross J., 2010, HUMAN FACTORS COMPUT, DOI [10.1145/1753846.1753873, DOI 10.1145/1753846.1753873]; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sylwester K, 2013, J NEUROSCI PSYCHOL E, V6, P167, DOI 10.1037/npe0000009; Thomas M, 2005, J CONSUM RES, V32, P54, DOI 10.1086/429600; Wang CS, 2011, ORGAN BEHAV HUM DEC, V116, P46, DOI 10.1016/j.obhdp.2011.05.007; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102	53	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159769	10.1371/journal.pone.0159769	http://dx.doi.org/10.1371/journal.pone.0159769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487269	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800037
J	Ito, H; Katsumata, Y; Hasegawa, E; Yoshimura, J				Ito, Hiromu; Katsumata, Yuki; Hasegawa, Eisuke; Yoshimura, Jin			What Is True Halving in the Payoff Matrix of Game Theory?	PLOS ONE			English	Article							DYNAMIC DECISION-MAKING; PUBLIC-GOODS GAME; COOPERATION; EVOLUTION	In game theory, there are two social interpretations of rewards (payoffs) for decision- making strategies: (1) the interpretation based on the utility criterion derived from expected utility theory and (2) the interpretation based on the quantitative criterion (amount of gain) derived from validity in the empirical context. A dynamic decision theory has recently been developed in which dynamic utility is a conditional (state) variable that is a function of the current wealth of a decision maker. We applied dynamic utility to the equal division in dove-dove contests in the hawk-dove game. Our results indicate that under the utility criterion, the half-share of utility becomes proportional to a player's current wealth. Our results are consistent with studies of the sense of fairness in animals, which indicate that the quantitative criterion has greater validity than the utility criterion. We also find that traditional analyses of repeated games must be reevaluated.	[Ito, Hiromu] Nagasaki Univ, Inst Trop Med, Dept Int Hlth, Nagasaki, Japan; [Ito, Hiromu; Yoshimura, Jin] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka, Japan; [Katsumata, Yuki; Yoshimura, Jin] Shizuoka Univ, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan; [Hasegawa, Eisuke] Hokkaido Univ, Anim Ecol Lab, Dept Systemat & Ecol, Grad Sch Agr, Sapporo, Hokkaido, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan	Nagasaki University; Shizuoka University; Shizuoka University; Hokkaido University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Chiba University	Yoshimura, J (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka, Japan.; Yoshimura, J (corresponding author), Shizuoka Univ, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan.; Yoshimura, J (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA.; Yoshimura, J (corresponding author), Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan.	yoshimura.jin@shizuoka.ac.jp		Ito, Hiromu/0000-0001-9350-0546	Japan Prize Foundation; Japan Society for Promotion of Science (JSPS) [14J02983]; JSPS [22255004, 22370010, 26257405, 15H04420]; Grants-in-Aid for Scientific Research [16H04839] Funding Source: KAKEN	Japan Prize Foundation(Japan Prize Foundation); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Japan Prize Foundation award to HI, grants-in-aid from the Japan Society for Promotion of Science (JSPS) for JSPS fellows to HI (no. 14J02983), and grants-in-aid from the JSPS to JY (nos. 22255004, 22370010, 26257405 and 15H04420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu K, 2007, SCI AM, V296, P90, DOI 10.1038/scientificamerican0607-90; Bellman R., 1957, DYNAMIC PROGRAMMING; Borch KH, 1972, EC UNCERTAINTY; Chen MH, 2016, PHYS LETT A, V380, P40, DOI 10.1016/j.physleta.2015.09.047; Clark CW., 2010, MATH BIOECONOMICMA; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Hirshleifer J., 2005, PRICE THEORY APPL DE; HOUSTON A, 1988, NATURE, V332, P29, DOI 10.1038/332029a0; Huang KK, 2015, APPL MATH COMPUT, V266, P501, DOI 10.1016/j.amc.2015.05.065; Huang KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120317; Ito H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12797; Jeffry RC, 1983, LOGIC DECISION; Littlejohn S.W., 1978, THEORIES HUMAN COMMU; Luce R. D., 1989, GAMES DECISIONS INTR; Mankiw NG, 2004, PRINCIPLE EC; Margolis H., 1984, SELFISHNESS ALTRUISM; Maynard Smith J., 1982, pi; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Proctor D, 2013, P NATL ACAD SCI USA, V110, P2070, DOI 10.1073/pnas.1220806110; Rasmusen E, 2006, GAMES INFORM INTRO G; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Savage L. J., 1972, FDN STAT; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; Walras Leon, 1909, B SOC VAUDOISE SCI N, V45, P313; Walsh C., 2002, ECONOMICS; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep03055; Weber EH., 1846, ZUSATZE LEHRE BAUE V; Xia CY, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500567; Xia CY, 2014, APPL MATH COMPUT, V246, P389, DOI 10.1016/j.amc.2014.08.006; YOSHIMURA J, 1991, EVOL ECOL, V5, P173, DOI 10.1007/BF02270833; Yoshimura J, 2013, J ETHOL, V31, P107, DOI 10.1007/s10164-013-0359-z; Yoshimura J, 2013, J ETHOL, V31, P101, DOI 10.1007/s10164-013-0362-4; Zhu CJ, 2014, PHYSICA A, V406, P145, DOI 10.1016/j.physa.2014.03.035	41	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159670	10.1371/journal.pone.0159670	http://dx.doi.org/10.1371/journal.pone.0159670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487194	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800036
J	Lu, XY; Ni, XJ; Li, LZ; Li, Q				Lu, Xiaoyu; Ni, Xijun; Li, Luzhou; Li, Qiang			Two New Mylagaulid Rodents from the Early Miocene of China	PLOS ONE			English	Article							MAMMALIA; EVOLUTION	Mylagaulid fossorial rodents are a common component of North American Miocene fossil faunas. However outside of North America, only three species are known from Asia. Here we report two new mylagaulids, Irtyshogaulus minor gen. et sp. nov. and Irtyshogaulus major gen. et sp. nov., recovered from early Miocene sediments in the Junggar Basin in northwestern China. The two new taxa are small-sized, high-crowned promylagauline rodents. Their lower molars possess high metastylid crests, small mesostylids, broad and posterolingually expanded labial inflections, and transversely extending metalophid IIs. The mesoconid is absent in both species. The anterior and posterior fossettids are large and equally developed. Their upper M1-2s possess a square occlusal surface with five deep fossettes. The two new taxa are distinguished from each other mainly by their size, the morphology of fossettes and fossettids, development of mesial and distal lophs, posterior reduction of M3, and the orientation of m2 hypolophid. Our phylogenetic analysis indicates that Irtyshogaulus and Lamugaulus (another early Miocene Asian mylagaulid) are sister taxa. The two genera are nested among the North American promylagaulines, and share a common ancestor from North America, indicating early Miocene intercontinental dispersal within this clade of rodents.	[Lu, Xiaoyu; Ni, Xijun; Li, Luzhou; Li, Qiang] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, 142 Xi Zhi Men Wai, Beijing 100044, Peoples R China; [Ni, Xijun; Li, Qiang] CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Ni, XJ (corresponding author), Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Inst Vertebrate Paleontol & Paleoanthropol, 142 Xi Zhi Men Wai, Beijing 100044, Peoples R China.; Ni, XJ (corresponding author), CAS Ctr Excellence Tibetan Plateau Earth Sci, Beijing 100101, Peoples R China.	nixijun@ivpp.ac.cn	lu, xiaoyu/GWU-6357-2022	Li, luzhou/0000-0002-9453-6900	Strategic Priority Research Program of Chinese Academy of Sciences (CAS) [XDB03020000]; National Basic Research Program of China [2012CB821904]; CAS 100-talent Program; National Natural Science Foundation of China [41472025]	Strategic Priority Research Program of Chinese Academy of Sciences (CAS); National Basic Research Program of China(National Basic Research Program of China); CAS 100-talent Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project has been supported by the Strategic Priority Research Program of Chinese Academy of Sciences (CAS, XDB03020000), the National Basic Research Program of China (2012CB821904), the CAS 100-talent Program, and the National Natural Science Foundation of China (41472025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has been supported by the Strategic Priority Research Program of Chinese Academy of Sciences (CAS, XDB03020000), the National Basic Research Program of China (2012CB821904), the CAS 100-talent Program, and the National Natural Science Foundation of China (41472025). We thank Drs. J. Meng, J. Ye and S. Bi for their assistance in the field. We thank Drs. Z. Qiu and W. Wu for helpful comments and discussion. We thank Drs. L. J. Flynn and T. Stidham for instructive comments and English editing. Dr. S. Hopkins provided the updated version of the data matrix for phylogenetic analysis. Mr. Y. Hou performed the CT scanning.	FAGAN SYLVIA ROBONSPN, 1960, UNIV KANSAS PALEONTOL CONTR, V26, P1; Flynn LJ, 2008, EVOLUTION OF TERTIARY MAMMALS OF NORTH AMERICA, VOL 2, P377; Gidley James Williams, 1907, Proceedings of the United States National Museum Smithsonian Institution Washington, V32; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hopkins SSB, 2008, ZOOL J LINN SOC-LOND, V153, P769, DOI 10.1111/j.1096-3642.2008.00399.x; Hopkins SSB, 2005, P ROY SOC B-BIOL SCI, V272, P1705, DOI 10.1098/rspb.2005.3171; Korth W.W., 1994, TERTIARY RECORD RODE; Korth WW, 2011, ANN CARNEGIE MUS, V80, P67, DOI 10.2992/007.080.0107; Korth WW, 2000, ANN CARNEGIE MUS, V69, P227; Maddison WP., 2021, MESQUITE MODULAR SYS; Maridet O, 2014, ACTA PALAEONTOL POL, V59, P1, DOI 10.4202/app.2012.0007; Maridet Olivier, 2011, Swiss Journal of Palaeontology, V130, P315, DOI 10.1007/s13358-011-0022-7; Matthew WD, 1902, B AM MUS NAT HIST, V16, P291; Ni XJ, 2013, NATURE, V498, P60, DOI 10.1038/nature12200; RENSBERGER JM, 1980, J PALEONTOL, V54, P1267; Rensberger JM, 1979, CONTRIBUTIONS SCI NA, V312, P1; Shevyreva N.S., 1971, Soobshcheniya Akad Nauk gruz SSR, V62, P481; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tesakov A S, 2015, Dokl Biol Sci, V460, P23, DOI 10.1134/S0012496615010032; Wu Wen-Yu, 2013, Vertebrata Palasiatica, V51, P55	20	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159445	10.1371/journal.pone.0159445	http://dx.doi.org/10.1371/journal.pone.0159445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486803	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800030
J	Verstappen, KM; Tulinski, P; Duim, B; Fluit, AC; Carney, J; van Nes, A; Wagenaar, JA				Verstappen, Koen M.; Tulinski, Pawel; Duim, Birgitta; Fluit, Ad C.; Carney, Jennifer; van Nes, Arie; Wagenaar, Jaap A.			The Effectiveness of Bacteriophages against Methicillin-Resistant Staphylococcus aureus ST398 Nasal Colonization in Pigs	PLOS ONE			English	Article							INFECTIONS; SEQUENCE; THERAPY; PIGLETS; HUMANS; PHAGES	Methicillin-resistant Staphylococcus aureus (MRSA) is an important colonizer in animals and an opportunistic pathogen in humans. In humans, MRSA can cause infections that might be difficult to treat because of antimicrobial resistance. The use of bacteriophages has been suggested as a potential approach for the control of MRSA colonization to minimize the-often occupational-exposure of humans. The aim of this study was to assess the efficacy of bacteriophage treatment on porcine nasal colonization with MRSA in vitro, in vivo, and ex vivo. The effectiveness of a bacteriophage combination of phage K*710 and P68 was assessed in vitro by incubating them with MRSA V0608892/1 (ST398) measuring the OD600 hourly. To study the in vivo effect, bacteriophages were administered in a gel developed for human application, which contain 10(9) plaque-forming units (pfu)/mL (K and P68 in a 19.25:1 ratio) for 5 days to piglets (N = 8) that were experimentally colonized with the MRSA strain. Eight piglets experimentally colonized were used as a negative control. The MRSA strain was also used to colonize porcine nasal mucosa explants and bacteriophages were applied to assess the ex vivo efficacy of treatment. Bacteriophages were effective in vitro. In vivo, sixteen piglets were colonized with MRSA but the number of CFU recovered after the application of the bacteriophages in 8 piglets was not reduced compared to the control animals (approx. 10(5) CFU/swab). In the ex vivo model, 10(8) CFU were used to establish colonization with MRSA; a reduction of colonization was not observed after application of bacteriophages. However, application of mupirocin both in vivo and ex vivo resulted in a near eradication of MRSA. In conclusion: i) The MRSA strain was killed in the presence of the bacteriophages phage K*710 and P68 in vitro. ii) Bacteriophages did not reduce porcine nasal colonization in vivo or ex vivo. Physiological in vivo and ex vivo conditions may explain these observations. Efficacy in the ex vivo model matched that of the in vivo system.	[Verstappen, Koen M.; Tulinski, Pawel; Duim, Birgitta; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Carney, Jennifer] Novolytics Ltd, Warrington, Cheshire, England; [van Nes, Arie] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Tulinski, Pawel] Delft Univ Technol, Dept Bionanosci, Delft, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Wageningen University & Research; Delft University of Technology	Duim, B (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	b.duim@uu.nl	Tulinski, Pawel/P-8365-2014	Tulinski, Pawel/0000-0002-5033-5859	European Union Framework 7 Programme HEALTH project CONCORD (CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions) [222718]	European Union Framework 7 Programme HEALTH project CONCORD (CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions)	This work was funded by European Union Framework 7 Programme HEALTH project CONCORD (CONtrol of COmmunity-acquired MRSA: Rationale and Development of counteractions), grant number 222718.	Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Dekker N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061339; Gill JJ, 2006, J APPL MICROBIOL, V101, P377, DOI 10.1111/j.1365-2672.2006.02918.x; Golding GR, 2010, EMERG INFECT DIS, V16, P587, DOI 10.3201/eid1604.091435; Gorski A, 2009, CURR OPIN INVEST DR, V10, P766; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Massey RC, 2002, INFECT IMMUN, V70, P5339, DOI 10.1128/IAI.70.10.5339-5345.2002; O'Flaherty S, 2004, J BACTERIOL, V186, P2862, DOI 10.1128/JB.186.9.2862-2871.2004; Oogai Y, 2011, APPL ENVIRON MICROB, V77, P8097, DOI 10.1128/AEM.05316-11; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Tulinski P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053783; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; Verstappen KM, 2014, VET MICROBIOL, V174, P483, DOI 10.1016/j.vetmic.2014.09.019; Vybiral D, 2003, FEMS MICROBIOL LETT, V219, P275, DOI 10.1016/S0378-1097(03)00028-4; Wagenaar JA, 2005, VET MICROBIOL, V109, P275, DOI 10.1016/j.vetmic.2005.06.002; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9	24	22	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160242	10.1371/journal.pone.0160242	http://dx.doi.org/10.1371/journal.pone.0160242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487020	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800063
J	Lee, JS; Hong, SS; Kim, HG; Lee, HW; Kim, WY; Lee, SK; Son, CG				Lee, Jin-Seok; Hong, Sung-Shin; Kim, Hyeong-Geug; Lee, Hye-Won; Kim, Won-Yong; Lee, Sam-Keun; Son, Chang-Gue			Gongjin-Dan Enhances Hippocampal Memory in a Mouse Model of Scopolamine-Induced Amnesia	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEUROTROPHIC FACTOR; NEUROGENESIS; METAANALYSIS; MODULATION; INHIBITORS; DONEPEZIL; RAT	We evaluated the neuropharmacological effects of Gongjin-Dan (GJD) on the memory impairment caused by scopolamine injection. BALB/c mice were orally treated with GJD (100, 200, or 400 mg/kg, daily) or tacrine (THA, 10 mg/kg) for 10 days, and scopolamine (2 mg/kg) was injected intraperitoneally. The radial arm maze and passive avoidance tests were performed to evaluate the animal's learning and memory. Scopolamine increased the task completing time, the number of total errors (reference and working memory error) in the radial arm maze task, and the latency time in the passive avoidance test, which were significantly ameliorated by treatment with GJD. The GJD treatment also attenuated the scopolamine-induced hyperactivation of acetylcholinesterase activity, and suppression of the expression of brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF) and their receptors in the hippocampus. These effects of GJD were supported by both the doublecortin (DCX)-positive staining and Nissl staining, which were used to measure hippocampal neurogenesis and atrophy, respectively. These findings strongly suggest that GJD exerts a potent anti-amnesic effect, and its underlying mechanism might involve the modulation of cholinergic activity.	[Lee, Jin-Seok; Kim, Hyeong-Geug; Kim, Won-Yong; Son, Chang-Gue] Daejeon Univ, Oriental Med Coll, Liver & Immunol Res Ctr, 22-5 Daehung Dong, Daejeon 301724, South Korea; [Hong, Sung-Shin] Daejeon Univ, Korean Med Coll, 22-5 Yongwoon Dong, Daejeon 301724, South Korea; [Lee, Hye-Won] Korea Inst Oriental Med, TKM Based Herbal Drug Res Grp, Daejeon 305811, South Korea; [Lee, Sam-Keun] Daejeon Univ, Dept Appl Chem, 62 Daehak Ro, Daejeon 34520, South Korea	Daejeon University; Daejeon University; Korea Institute of Oriental Medicine (KIOM); Daejeon University	Son, CG (corresponding author), Daejeon Univ, Oriental Med Coll, Liver & Immunol Res Ctr, 22-5 Daehung Dong, Daejeon 301724, South Korea.	ckson@dju.ac.kr	son, chang gue/ABC-2215-2021		National Research Foundation of Korea (NRF); Ministry of Science, ICT and Future Planning [2015003195]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the National Research Foundation of Korea (NRF) and funded by the Ministry of Science, ICT and Future Planning (grant number: 2015003195, URL: www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052755; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Birch AM, 2013, NEUROPHARMACOLOGY, V75, P255, DOI 10.1016/j.neuropharm.2013.07.023; Blake MG, 2014, J PHYSIOL-PARIS, V108, P286, DOI 10.1016/j.jphysparis.2014.04.005; Brinton Roberta Diaz, 2006, Current Alzheimer Research, V3, P185; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Craig LA, 2011, NEUROSCI BIOBEHAV R, V35, P1397, DOI 10.1016/j.neubiorev.2011.03.001; Cutuli D, 2009, J ALZHEIMERS DIS, V17, P161, DOI 10.3233/JAD-2009-1040; Deogracias R, 2004, MOL CELL NEUROSCI, V26, P470, DOI 10.1016/j.mcn.2004.03.007; Doralp S, 2008, NEUROBIOL LEARN MEM, V90, P382, DOI 10.1016/j.nlm.2008.05.013; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Falsafi SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032082; Garibotto V, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.05.020; Goodrich-Hunsaker NJ, 2010, BEHAV NEUROSCI, V124, P405, DOI 10.1037/a0019193; Hagg T, 2009, NEUROSCIENTIST, V15, P20, DOI 10.1177/1073858408324789; Hansen RA, 2008, CLIN INTERV AGING, V3, P211; Hong SS, 2015, J ETHNOPHARMACOL, V168, P268, DOI 10.1016/j.jep.2015.04.001; Imam A., 2016, Bulletin of the Faculty of Pharmacy, Cairo University, V54, P49, DOI 10.1016/j.bfopcu.2015.12.005; Kenney JW, 2008, MOL NEUROBIOL, V38, P101, DOI 10.1007/s12035-008-8037-9; Kida Satoshi, 2012, Exp Neurobiol, V21, P136, DOI 10.5607/en.2012.21.4.136; Mimica N, 2009, PSYCHIAT DANUB, V21, P108; Moon E, 2009, NEUROSCI LETT, V466, P114, DOI 10.1016/j.neulet.2009.09.033; O'Bryant SE, 2009, J ALZHEIMERS DIS, V17, P337, DOI 10.3233/JAD-2009-1051; Prince M, 2015, GLOBAL IMPACT DEMENT; Puzzo D, 2014, BIOCHEM PHARMACOL, V88, P450, DOI 10.1016/j.bcp.2014.01.011; Qizilbash N, 1998, JAMA-J AM MED ASSOC, V280, P1777, DOI 10.1001/jama.280.20.1777; Rafii MS, 2011, NEUROLOGY, V76, P1389, DOI 10.1212/WNL.0b013e318216eb7b; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Sunwoo YY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/682720; Tarawneh R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006148; Tota S, 2012, PSYCHOPHARMACOLOGY, V222, P185, DOI 10.1007/s00213-012-2639-7; Tyler WJ, 2002, NEUROSCIENTIST, V8, P524, DOI 10.1177/1073858402238511; UNESCO, 2009, MEM OF THE WORLD; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; WILSON WJ, 1994, ACTA NEUROBIOL EXP, V54, P377	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159823	10.1371/journal.pone.0159823	http://dx.doi.org/10.1371/journal.pone.0159823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483466	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110700015
J	Liu, YY; Chen, HW; Chou, JY				Liu, Yen-Yu; Chen, Hung-Wei; Chou, Jui-Yu			Variation in Indole-3-Acetic Acid Production by Wild Saccharomyces cerevisiae and S-paradoxus Strains from Diverse Ecological Sources and Its Effect on Growth	PLOS ONE			English	Article							YEAST RHODOSPORIDIUM-PALUDIGENUM; FUNGUS USTILAGO-MAYDIS; AZOSPIRILLUM-BRASILENSE; INDOLEACETIC-ACID; IAA BIOSYNTHESIS; PLANT-GROWTH; TRYPTOPHAN; POPULATIONS; PATHWAYS; REVEALS	Phytohormone indole-3-acetic acid (IAA) is the most common naturally occurring and most thoroughly studied plant growth regulator. Microbial synthesis of IAA has long been known. Microbial IAA biosynthesis has been proposed as possibly occurring through multiple pathways, as has been proven in plants. However, the biosynthetic pathways of IAA and the ecological roles of IAA in yeast have not been widely studied. In this study, we investigated the variation in IAA production and its effect on the growth of Saccharomyces cerevisiae and its closest relative Saccharomyces paradoxus yeasts from diverse ecological sources. We found that almost all Saccharomyces yeasts produced IAA when cultured in medium supplemented with the primary precursor of IAA, L-tryptophan (L-Trp). However, when cultured in medium without L-Trp, IAA production was only detected in three strains. Furthermore, exogenous added IAA exerted stimulatory and inhibitory effects on yeast growth. Interestingly, a negative correlation was observed between the amount of IAA production in the yeast cultures and the IAA inhibition ratio of their growth.	[Liu, Yen-Yu; Chen, Hung-Wei; Chou, Jui-Yu] Natl Changhua Univ Educ, Dept Biol, Changhua 500, Taiwan	National Changhua University of Education	Chou, JY (corresponding author), Natl Changhua Univ Educ, Dept Biol, Changhua 500, Taiwan.	jackyjau@cc.ncue.edu.tw			Ministry of Science and Technology [MOST 104-2311-B-018-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the Ministry of Science and Technology (MOST 104-2311-B-018-001 to J.-Y. Chou).; We thank members of the Chou labs for their contribution to the manuscript. This work was supported by grants from the Ministry of Science and Technology (MOST 104-2311-B-018-001 to J.-Y. Chou).	Barton MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011935; Basse CW, 1996, EUR J BIOCHEM, V242, P648, DOI 10.1111/j.1432-1033.1996.0648r.x; Bergstrom A, 2014, MOL BIOL EVOL, V31, P872, DOI 10.1093/molbev/msu037; Bianco C, 2009, J EXP BOT, V60, P3097, DOI 10.1093/jxb/erp140; Carreno-Lopez R, 2000, MOL GEN GENET, V264, P521, DOI 10.1007/s004380000340; Chung KR, 2003, FEMS MICROBIOL LETT, V226, P23, DOI 10.1016/S0378-1097(03)00605-0; Duca D, 2014, ANTON LEEUW INT J G, V106, P85, DOI 10.1007/s10482-013-0095-y; Fu SF, 2016, FUNGAL BIOL-UK, V120, P433, DOI 10.1016/j.funbio.2015.12.006; GAY G, 1989, CAN J BOT, V67, P2235, DOI 10.1139/b89-285; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Kulkarni GB, 2013, APPL BIOCHEM BIOTECH, V169, P1292, DOI 10.1007/s12010-012-0037-6; Lewis JA, 2014, GENETICS, V198, P369, DOI 10.1534/genetics.114.167429; Limtong S, 2012, WORLD J MICROB BIOT, V28, P3323, DOI 10.1007/s11274-012-1144-9; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Liu J, 2013, INT J FOOD MICROBIOL, V167, P153, DOI 10.1016/j.ijfoodmicro.2013.09.004; Maclean CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-1; Matsukawa E., 2007, ACTINOMYCETOLOGICA, V21, P32; MCCORMACK PJ, 1994, APPL ENVIRON MICROB, V60, P927, DOI 10.1128/AEM.60.3.927-931.1994; Naumov GI, 1998, CAN J MICROBIOL, V44, P1045, DOI 10.1139/cjm-44-11-1045; Nutaratat P, 2016, ARCH MICROBIOL, V198, P429, DOI 10.1007/s00203-016-1202-z; Nutaratat P, 2015, J GEN APPL MICROBIOL, V61, P1, DOI 10.2323/jgam.61.1; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; RADWANSKI ER, 1995, PLANT CELL, V7, P921, DOI 10.1105/tpc.7.7.921; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; Robinson M, 1998, APPL ENVIRON MICROB, V64, P5030; Salinas F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049640; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; SHIN M, 1991, CHEM PHARM BULL, V39, P1792; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Singh JS, 2011, AGR ECOSYST ENVIRON, V140, P339, DOI 10.1016/j.agee.2011.01.017; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; STARK MJR, 1990, YEAST, V6, P1, DOI 10.1002/yea.320060102; Sun PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114196; Sweeney JY, 2004, FEMS YEAST RES, V4, P521, DOI 10.1016/S1567-1356(03)00171-5; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Xin G, 2009, MYCOL RES, V113, P973, DOI 10.1016/j.mycres.2009.06.001; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07; Zakharova EA, 1999, EUR J BIOCHEM, V259, P572, DOI 10.1046/j.1432-1327.1999.00033.x	42	20	20	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160524	10.1371/journal.pone.0160524	http://dx.doi.org/10.1371/journal.pone.0160524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483373	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700055
J	Shan, L; Colazet, M; Rosenthal, KL; Yu, XQ; Bee, JS; Ferguson, A; Damschroder, MM; Wu, HR; Dall'Acqua, WF; Tsui, P; Oganesyan, V				Shan, Lu; Colazet, Magali; Rosenthal, Kim L.; Yu, Xiang-Qing; Bee, Jared S.; Ferguson, Andrew; Damschroder, Melissa M.; Wu, Herren; Dall'Acqua, William F.; Tsui, Ping; Oganesyan, Vaheh			Generation and Characterization of an IgG4 Monomeric Fc Platform	PLOS ONE			English	Article							FUSION PROTEINS; HALF-LIFE; GAMMA-RI; RECEPTOR; ANTIBODIES; DOMAINS; BINDING; MACROMOLECULES; GLYCOSYLATION; TRANSCYTOSIS	The immunoglobulin Fc region is a homodimer consisted of two sets of CH2 and CH3 domains and has been exploited to generate two-arm protein fusions with high expression yields, simplified purification processes and extended serum half-life. However, attempts to generate one-arm fusion proteins with monomeric Fc, with one set of CH2 and CH3 domains, are often plagued with challenges such as weakened binding to FcRn or partial monomer formation. Here, we demonstrate the generation of a stable IgG4 Fc monomer with a unique combination of mutations at the CH3-CH3 interface using rational design combined with in vitro evolution methodologies. In addition to size-exclusion chromatography and analytical ultracentrifugation, we used multi-angle light scattering (MALS) to show that the engineered Fc monomer exhibits excellent monodispersity. Furthermore, crystal structure analysis (PDB ID: 5HVW) reveals monomeric properties supported by disrupted interactions at the CH3-CH3 interface. Monomeric Fc fusions with Fab or scFv achieved FcRn binding and serum half-life comparable to wildtype IgG. These results demonstrate that this monomeric IgG4 Fc is a promising therapeutic platform to extend the serum half-life of proteins in a monovalent format.	[Shan, Lu; Colazet, Magali; Rosenthal, Kim L.; Damschroder, Melissa M.; Wu, Herren; Dall'Acqua, William F.; Tsui, Ping; Oganesyan, Vaheh] MedImmune, Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Yu, Xiang-Qing] MedImmune, Clin Pharmacol & Drug Metab & Pharmacokinet, Gaithersburg, MD USA; [Bee, Jared S.] MedImmune, Analyt Biotechnol, Gaithersburg, MD USA; [Ferguson, Andrew] AstraZeneca, Discovery Sci Struct & Biophys, Waltham, MA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca	Tsui, P; Oganesyan, V (corresponding author), MedImmune, Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	TsuiP@medimmune.com; OganesyanV@MedImmune.com		Shan, Lu/0000-0003-2334-9216; Bee, Jared/0000-0002-4391-0560	MedImmune; AstraZeneca	MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca)	This study was funded solely by MedImmune which is a subsidiary of AstraZeneca Plc. AstraZeneca has provided support in the form of salaries for all of the authors [LS, MC, KLR, XQY, JSB, AF, MMD, HW, WFD, PT, VO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "Author Contributions" section.	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Beck A, 2011, MABS-AUSTIN, V3, P415, DOI 10.4161/mabs.3.5.17334; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; CHANG RLS, 1975, BIOPHYS J, V15, P861, DOI 10.1016/S0006-3495(75)85862-0; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Davies AM, 2013, MOL IMMUNOL, V54, P1, DOI 10.1016/j.molimm.2012.10.029; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; Dumont JA, 2006, BIODRUGS, V20, P151, DOI 10.2165/00063030-200620030-00002; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; Ishino T, 2013, J BIOL CHEM, V288, P16529, DOI 10.1074/jbc.M113.457689; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Kabat EA., 1991, SEQUENCES PROTEINS I, V5, P91; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; MILLER S, 1990, J MOL BIOL, V216, P965, DOI 10.1016/S0022-2836(99)80014-X; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oganesyan V, 2015, ACTA CRYSTALLOGR D, V71, P2354, DOI 10.1107/S1399004715018015; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Prat M, 1998, J CELL SCI, V111, P237; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Rose RJ, 2013, MABS-AUSTIN, V5, P219, DOI 10.4161/mabs.23532; Salas J, 2015, THROMB RES, V135, P970, DOI 10.1016/j.thromres.2014.12.018; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tesar DB, 2006, TRAFFIC, V7, P1127, DOI 10.1111/j.1600-0854.2006.00457.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wenig K, 2004, P NATL ACAD SCI USA, V101, P17371, DOI 10.1073/pnas.0407965101; Wilkinson IC, 2013, MABS-AUSTIN, V5, P406, DOI 10.4161/mabs.23941; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ying TL, 2015, MABS-AUSTIN, V7, P922, DOI 10.1080/19420862.2015.1067353; Ying TL, 2014, MABS-AUSTIN, V6, P1201, DOI 10.4161/mabs.29835; Ying TL, 2012, J BIOL CHEM, V287, P19399, DOI 10.1074/jbc.M112.368647	42	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160345	10.1371/journal.pone.0160345	http://dx.doi.org/10.1371/journal.pone.0160345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479095	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300042
J	Yamakoshi, Y; Motegi, S; Ishikawa, O				Yamakoshi, Yoshiki; Motegi, Sei-ichiro; Ishikawa, Osamu			Evaluation of Peripheral Blood Circulation Disorder in Scleroderma Patients Using an Optical Sensor with a Pressurization Mechanism	PLOS ONE			English	Article							JAPANESE PATIENTS; PULSE OXIMETRY; LASER-DOPPLER; FLOW; SCLEROSIS; DIAGNOSIS	Blood circulation function of peripheral blood vessels in skin dermis was evaluated employing an optical sensor with a pressurization mechanism using the blood outflow and reflow characteristics. The device contains a light source and an optical sensor. When applied to the skin surface, it first exerts the primary pressure (higher than the systolic blood pressure), causing an outflow of blood from the dermal peripheral blood vessels. After two heartbeats, the pressure is lowered (secondary pressure) and blood reflows into the peripheral blood vessels. Hemoglobin concentration, which changes during blood outflow and reflow, is derived from the received light intensity using the Beer-Lambert law. This method was evaluated in 26 healthy female volunteers and 26 female scleroderma patients. In order to evaluate the blood circulation function of the peripheral blood vessels of scleroderma patients, pressurization sequence which consists of primary pressure followed by secondary pressure was adopted. Blood reflow during the first heartbeat period after applying the secondary pressure of 40mmHg was (mean +/- SD) 0.059 +/- 0.05% mm for scleroderma patients and 0.173 +/- 0.104% mm for healthy volunteers. Blood reflow was significantly lower in scleroderma patients than in healthy volunteers (p<0.05). This result indicates that the information necessary for assessing blood circulation disorder of peripheral blood vessels in scleroderma patients is objectively obtained by the proposed method.	[Yamakoshi, Yoshiki] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gunma, Japan; [Motegi, Sei-ichiro; Ishikawa, Osamu] Gunma Univ, Grad Sch Med, Maebashi, Gunma, Japan	Gunma University; Gunma University	Yamakoshi, Y (corresponding author), Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gunma, Japan.	yamakoshi@gunma-u.ac.jp		Ishikawa, Osamu/0000-0002-7655-0610				Akdogan A, 2015, MICROVASC RES, V98, P183, DOI 10.1016/j.mvr.2014.02.002; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Asano Y, 2010, J DERMATOL, V37, P54, DOI 10.1111/j.1346-8138.2009.00758.x; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Chen ZP, 1997, OPT LETT, V22, P1119, DOI 10.1364/OL.22.001119; Christopher DA, 1997, ULTRASOUND MED BIOL, V23, P997, DOI 10.1016/S0301-5629(97)00076-8; Cutolo M, 2006, RHEUMATOLOGY, V45, P43, DOI 10.1093/rheumatology/kel310; Cutolo M, 2003, ARTHRITIS RHEUM-US, V48, P3023, DOI 10.1002/art.11310; Cutolo M, 2010, NAT REV RHEUMATOL, V6, P578, DOI 10.1038/nrrheum.2010.104; Goertz DE, 2003, ULTRASOUND MED BIOL, V29, P39, DOI 10.1016/S0301-5629(02)00682-8; Horn A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3026; Jesic MM, 2010, SRP ARK CELOK LEK, V138, P297, DOI 10.2298/SARH1006297J; Jinnin M, 2010, J DERMATOL, V37, P11, DOI 10.1111/j.1346-8138.2009.00738.x; LAWSON D, 1987, ANESTHESIOLOGY, V67, P599, DOI 10.1097/00000542-198710000-00032; Motegi S, 2014, J DERMATOL, V41, P986, DOI 10.1111/1346-8138.12642; Motegi S, 2014, J DERMATOL, V41, P604, DOI 10.1111/1346-8138.12532; Ring HC, 2015, J EUR ACAD DERMATOL, V29, P890, DOI 10.1111/jdv.12708; Rosato E, 2009, J RHEUMATOL, V36, P2257, DOI 10.3899/jrheum.090187; Schlager O, 2010, MICROVASC RES, V80, P54, DOI 10.1016/j.mvr.2010.01.010; Sinex JE, 1999, AM J EMERG MED, V17, P59, DOI 10.1016/S0735-6757(99)90019-0; Toki S, 2014, J DERMATOL, V41, P1053, DOI 10.1111/1346-8138.12698; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Wang RK, 2010, OPT LETT, V35, P1467, DOI 10.1364/OL.35.001467; WARDELL K, 1993, IEEE T BIO-MED ENG, V40, P309, DOI 10.1109/10.222322; Yamakoshi Y, 2013, MED BIOL ENG COMPUT, V51, P497, DOI 10.1007/s11517-012-1017-2; Zhang HD, 2010, COMPUT BIOL MED, V40, P650, DOI 10.1016/j.compbiomed.2010.05.003; ZIJLSTRA WG, 1991, CLIN CHEM, V37, P1633	27	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159611	10.1371/journal.pone.0159611	http://dx.doi.org/10.1371/journal.pone.0159611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479094	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300015
J	Bayliss, JA; Lemus, MB; Santos, VV; Deo, M; Davies, JS; Kemp, BE; Elsworth, JD; Andrews, ZB				Bayliss, Jacqueline A.; Lemus, Moyra B.; Santos, Vanessa V.; Deo, Minh; Davies, Jeffrey S.; Kemp, Bruce E.; Elsworth, John D.; Andrews, Zane B.			Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons	PLOS ONE			English	Article							PARKINSONS-DISEASE; PROTEIN-KINASE; DIETARY RESTRICTION; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; SKELETAL-MUSCLE; LIFE-SPAN; RISK; SIRT1; INCREASES	Metformin is a widely prescribed drug used to treat type-2 diabetes, although recent studies show it has wide ranging effects to treat other diseases. Animal and retrospective human studies indicate that Metformin treatment is neuroprotective in Parkinson's Disease (PD), although the neuroprotective mechanism is unknown, numerous studies suggest the beneficial effects on glucose homeostasis may be through AMPK activation. In this study we tested whether or not AMPK activation in dopamine neurons was required for the neuroprotective effects of Metformin in PD. We generated transgenic mice in which AMPK activity in dopamine neurons was ablated by removing AMPK beta 1 and beta 2 subunits from dopamine transporter expressing neurons. These AMPK WT and KO mice were then chronically exposed to Metformin in the drinking water then exposed to MPTP, the mouse model of PD. Chronic Metformin treatment significantly attenuated the MPTP-induced loss of Tyrosine Hydroxylase (TH) neuronal number and volume and TH protein concentration in the nigrostriatal pathway. Additionally, Metformin treatment prevented the MPTP-induced elevation of the DOPAC: DA ratio regardless of genotype. Metformin also prevented MPTP induced gliosis in the Substantia Nigra. These neuroprotective actions were independent of genotype and occurred in both AMPK WT and AMPK KO mice. Overall, our studies suggest that Metformin's neuroprotective effects are not due to AMPK activation in dopaminergic neurons and that more research is required to determine how metformin acts to restrict the development of PD.	[Bayliss, Jacqueline A.; Lemus, Moyra B.; Santos, Vanessa V.; Deo, Minh; Andrews, Zane B.] Monash Univ, Sch Biomed & Psychol Sci, Dept Physiol, Melbourne, Vic 3800, Australia; [Davies, Jeffrey S.] Swansea Univ, Inst Life Sci, Mol Neurobiol, Swansea SA2 8PP, W Glam, Wales; [Kemp, Bruce E.] Univ Melbourne, St Vincents Inst, 41 Victoria Parade, Fitzroy, Vic 3065, Australia; [Kemp, Bruce E.] Univ Melbourne, Dept Med, 41 Victoria Parade, Fitzroy, Vic 3065, Australia; [Elsworth, John D.] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT 06520 USA	Monash University; Swansea University; St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; Yale University	Andrews, ZB (corresponding author), Monash Univ, Sch Biomed & Psychol Sci, Dept Physiol, Melbourne, Vic 3800, Australia.	Zane.Andrews@monash.edu	Santos, Vanessa/AAP-4130-2020; Davies, Jeffrey S/K-1400-2019; Kemp, Bruce/G-9602-2019	Davies, Jeffrey S/0000-0002-4234-0033; Kemp, Bruce/0000-0001-6735-5082; Andrews, Zane B./0000-0002-9097-7944	National Health Medicine Research Council of Australia, Australian Research Council; NATIONAL INSTITUTE ON AGING [R01AG048918] Funding Source: NIH RePORTER; Parkinson&quot;s UK [K-1008] Funding Source: researchfish	National Health Medicine Research Council of Australia, Australian Research Council; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by the National Health Medicine Research Council of Australia, Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aatsinki SM, 2014, BRIT J PHARMACOL, V171, P2351, DOI 10.1111/bph.12585; Adedeji HA, 2014, PROG NEURO-PSYCHOPH, V48, P245, DOI 10.1016/j.pnpbp.2013.10.014; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bannister CA, 2014, DIABETES OBES METAB, V16, P1165, DOI 10.1111/dom.12354; Bayliss JA, 2016, J NEUROCHEM, V137, P460, DOI 10.1111/jnc.13576; Bayliss JA, 2016, J NEUROSCI, V36, P3049, DOI 10.1523/JNEUROSCI.4373-15.2016; Bayliss JA, 2013, THER ADV ENDOCRINOL, V4, P25, DOI 10.1177/2042018813479645; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Chakraborty A, 2011, DIABETES RES CLIN PR, V93, P56, DOI 10.1016/j.diabres.2010.11.030; Cheng YY, 2014, J STROKE CEREBROVASC, V23, pE99, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.001; Choi JS, 2010, BIOCHEM BIOPH RES CO, V391, P147, DOI 10.1016/j.bbrc.2009.11.022; Clark J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-69; D'Amelio M, 2009, PARKINSONISM RELAT D, V15, P660, DOI 10.1016/j.parkreldis.2009.02.013; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Driver JA, 2008, DIABETES CARE, V31, P2003, DOI 10.2337/dc08-0688; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Dulovic M, 2014, NEUROBIOL DIS, V63, P1, DOI 10.1016/j.nbd.2013.11.002; El Messaoudi S, 2011, CURR OPIN LIPIDOL, V22, P445, DOI 10.1097/MOL.0b013e32834ae1a7; El-Mir MY, 2008, J MOL NEUROSCI, V34, P77, DOI 10.1007/s12031-007-9002-1; Espeland M, 2007, DIABETES CARE, V30, P1374; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Horvath TL, 2011, NEUROBIOL DIS, V43, P152, DOI 10.1016/j.nbd.2011.03.005; Hu G, 2007, DIABETES CARE, V30, P842, DOI 10.2337/dc06-2011; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Jiang T, 2014, BRIT J PHARMACOL, V171, P3146, DOI 10.1111/bph.12655; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Labuzek K, 2010, PHARMACOL REP, V62, P956; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Lu DY, 2010, J CELL BIOCHEM, V110, P697, DOI 10.1002/jcb.22580; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f; Mazza A, 2012, EXP DIABETES RES, DOI 10.1155/2012/716404; MCINTYRE HD, 1991, AUST NZ J MED, V21, P714; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mulherin AJ, 2011, ENDOCRINOLOGY, V152, P4610, DOI 10.1210/en.2011-1485; Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074; Ng CH, 2012, J NEUROSCI, V32, P14311, DOI 10.1523/JNEUROSCI.0499-12.2012; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pasquier F, 2006, DIABETES METAB, V32, P403, DOI 10.1016/S1262-3636(07)70298-7; Patil SP, 2014, NEUROSCIENCE, V277, P747, DOI 10.1016/j.neuroscience.2014.07.046; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Pilmore HL, 2010, NEPHROLOGY, V15, P412, DOI 10.1111/j.1440-1797.2010.01328.x; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Sandyk R, 1993, Int J Neurosci, V69, P125; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Wahlqvist ML, 2012, PARKINSONISM RELAT D, V18, P753, DOI 10.1016/j.parkreldis.2012.03.010; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	66	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159381	10.1371/journal.pone.0159381	http://dx.doi.org/10.1371/journal.pone.0159381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467571	Green Published, gold			2022-12-27	WOS:000381516100029
J	Stahmeyer, JT; Rossol, S; Bert, F; Boker, KHW; Bruch, HR; Eisenbach, C; Link, R; John, C; Mauss, S; Heyne, R; Schott, E; Pfeiffer-Vornkahl, H; Huppe, D; Krauth, C				Stahmeyer, Jona T.; Rossol, Siegbert; Bert, Florian; Boeker, Klaus H. W.; Bruch, Harald-Robert; Eisenbach, Christoph; Link, Ralph; John, Christine; Mauss, Stefan; Heyne, Renate; Schott, Eckart; Pfeiffer-Vornkahl, Heike; Hueppe, Dietrich; Krauth, Christian			Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; PEGYLATED INTERFERON-ALPHA; REAL-LIFE COHORT; CHRONIC HCV; TELAPREVIR; VIRUS; BOCEPREVIR; RIBAVIRIN; THERAPY; SOFOSBUVIR	1. Objective Chronic hepatitis C virus infections (HCV) cause a significant public health burden. Introduction of telaprevir (TVR) and boceprevir (BOC) has increased sustained virologic response rates (SVR) in genotype 1 patients but were accompanied by higher treatment costs and more side effects. Aim of the study was to assess outcomes and costs of treating HCV with TVR or BOC in routine care. 2. Material and Methods Data was obtained from a non-interventional study. This analysis relates on a subset of 1,786 patients for whom resource utilisation was documented. Sociodemografic and clinical parameters as well as resource utilisation were collected using a web-based data recording system. Costs were calculated using official remuneration schemes. 3. Results Mean age of patients was 49.2 years, 58.6% were male. In treatment-naive patients SVRrates of 62.2% and 55.7% for TVR and BOC were observed (prior relapser: 68.5% for TVR and 63.5% for BOC; prior non-responder: 45.6% for TVR and 39.1% for BOC). Treatment costs are dominated by costs for pharmaceuticals and range between (sic)39,081 and (sic)53,491. We calculated average costs per SVR of (sic)81,347 (TVR) and (sic)70,163 (BOC) in treatment-naive patients (prior relapser: 78,089 (sic)/SVR for TVR and 82,077 (sic)/SVR for BOC; prior non-responder: 116,509 (sic)/SVR for TVR and 110,156 (sic)/SVR for BOC). Quality of life data showed a considerable decrease during treatment. 4. Conclusion Our study is one of few investigating both, outcomes and costs, of treating HCV in a real-life setting. Data can serve as a reference in the discussion of increasing costs in recently introduced agents.	[Stahmeyer, Jona T.; Krauth, Christian] Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany; [Rossol, Siegbert; Bert, Florian] Krankenhaus NW Frankfurt, Dept Internal Med, Frankfurt, Germany; [Boeker, Klaus H. W.] Leberpraxis, Hannover, Germany; [Bruch, Harald-Robert] Schwerpunktpraxis Bonn, Bonn, Germany; [Eisenbach, Christoph] Univ Heidelberg Hosp, Dept Gastroenterol, Heidelberg, Germany; [Link, Ralph] St Josefs Hosp, Offenburg, Germany; [John, Christine] Med Practice, Berlin, Germany; [Mauss, Stefan] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany; [Heyne, Renate] Leberzentrum Checkpoint, Berlin, Germany; [Schott, Eckart] Charite, Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, Berlin, Germany; [Pfeiffer-Vornkahl, Heike] E Factum GmbH, Butzbach, Germany; [Hueppe, Dietrich] Ctr Gastroenterol, Herne, Germany	Hannover Medical School; Krankenhaus Nordwest; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Stahmeyer, JT (corresponding author), Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany.	Stahmeyer.Jona@mh-hannover.de			German Center for Infection Research (DZIF); AbbVie Deutschland GmbH Co. KG; Bristol-Myers Squibb GmbH Co. KGaA; Gilead Sciences GmbH; Janssen-Cilag GmbH; MSD Sharp Dohme GmbH; Roche Pharma AG	German Center for Infection Research (DZIF); AbbVie Deutschland GmbH Co. KG; Bristol-Myers Squibb GmbH Co. KGaA(Bristol-Myers Squibb); Gilead Sciences GmbH(Gilead Sciences); Janssen-Cilag GmbH; MSD Sharp Dohme GmbH; Roche Pharma AG(Roche Holding)	Data were derived from: German Hepatitis C-Registry (DHC-R, Deutsches Hepatitis C Register) of the Deutsche Leberstiftung (German Liver Foundation), managed by Leberstiftungs-GmbH Deutschland in cooperation with the Association of German gastroenterologists in private practice (bng) with financial support from the German Center for Infection Research (DZIF) as well as from the companies AbbVie Deutschland GmbH & Co. KG, Bristol-Myers Squibb GmbH & Co. KGaA, Gilead Sciences GmbH, Janssen-Cilag GmbH, MSD Sharp & Dohme GmbH and Roche Pharma AG. The German Liver Foundation provided support in the form of service fees for authors [HPV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; [Anonymous], 2014, PAIS; Backus LI, 2014, ALIMENT PHARM THER, V39, P93, DOI 10.1111/apt.12546; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bichoupan K, 2014, HEPATOLOGY, V60, P1187, DOI 10.1002/hep.27340; Boseley S, 2015, GUARDIAN; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Bundesausschuss Gemeinsamen, 2012, BUNDESANZEIGER, V52, P1269; Bundesvereinigung Kassenarztliche, 2012, EINHEITLICHER BEWERT; Camma C, 2013, J HEPATOL, V59, P658, DOI 10.1016/j.jhep.2013.05.019; Camma C, 2012, HEPATOLOGY, V56, P850, DOI 10.1002/hep.25734; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chhatwal J, 2013, VALUE HEALTH, V16, P973, DOI 10.1016/j.jval.2013.07.006; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Cohen J, 2013, SCIENCE, V342, P1302, DOI 10.1126/science.342.6164.1302; Cure Sandrine, 2014, J Med Econ, V17, P65, DOI 10.3111/13696998.2013.860033; Cure Sandrine, 2014, J Med Econ, V17, P77, DOI 10.3111/13696998.2013.844159; Drummond M, 2009, VALUE HEALTH, V12, P409, DOI 10.1111/j.1524-4733.2008.00489.x; Dutkowski P, 2015, GASTROENTEROLOGY, V148, P307, DOI 10.1053/j.gastro.2014.08.045; Feeney ER, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3308; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Hofmann WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134839; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Huppe D, 2008, Z GASTROENTEROL, V46, P34, DOI 10.1055/s-2007-963691; InEK-Institut fur Entgeldsystem im Krankenhaus, 2012, G DRG FALLPAUSCHALEN; Innes HA, 2015, HEPATOLOGY, V62, P355, DOI 10.1002/hep.27766; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Mauss S, 2015, Z GASTROENTEROL, V53, P644, DOI 10.1055/s-0034-1399383; Najafzadeh M, 2015, ANN INTERN MED, V162, P407, DOI 10.7326/M14-1152; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P707, DOI 10.1007/s00103-013-1673-x; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Santi Pascal, 2014, MONDE; Sarkar S, 2012, J HEPATOL, V57, P946, DOI 10.1016/j.jhep.2012.06.030; Stahmeyer JT, 2016, J VIRAL HEPATITIS, V23, P105, DOI 10.1111/jvh.12471; Stahmeyer JT, 2015, J COMP EFFECT RES, P1; Stahmeyer JT, 2013, J HLTH EC OUTCOMES H, V1, P239; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vermehren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041206; Vo KP, 2015, DIGEST DIS SCI, V60, P1045, DOI 10.1007/s10620-015-3621-0; Wehmeyer MH, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-87; [WHO W. H. Organization], 2014, GUID SCREEN CAR TREA; Younossi ZM, 2015, ALIMENT PHARM THER, V41, P544, DOI 10.1111/apt.13081; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang S, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0320-4	52	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159976	10.1371/journal.pone.0159976	http://dx.doi.org/10.1371/journal.pone.0159976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467772	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100081
J	Gondor, OK; Pal, M; Darko, E; Janda, T; Szalai, G				Gondor, Orsolya Kinga; Pal, Magda; Darko, Eva; Janda, Tibor; Szalai, Gabriella			Salicylic Acid and Sodium Salicylate Alleviate Cadmium Toxicity to Different Extents in Maize (Zea mays L.)	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; PLANTS; GLUTATHIONE; TOLERANCE; ARABIDOPSIS; SEEDLINGS; WHEAT; DAMAGE; OVEREXPRESSION; PHYTOCHELATINS	The role of salicylic acid in Cd tolerance has attracted more attention recently but no information is available on the efficiency of different forms of salicylic acid. The aim was thus to investigate whether both the acid and salt forms of salicylic acid provide protection against Cd stress and to compare their mode of action. Young maize plants were grown under controlled environmental conditions. One group of 10-day-old seedlings were treated with 0.5 mM SA or NaSA for 1 day then half of the pants were treated with 0.5 mM Cd for 1 day. Another group of seedlings was treated with 0.5 mM CdSO4 for 1 day without pre-treatment with SA or NaSA, while a third group was treated simultaneously with Cd and either SA or NaSA. Both salicylic acid forms reduced the Cd accumulation in the roots. Treatment with the acidic form meliorated the Cd accumulation in the leaves, while Na-salicylate increased the phytochelatin level in the roots and the amount of salicylic acid in the leaves. Furthermore, increased antioxidant enzyme activity was mainly induced by the acid form, while glutathione-related redox changes were influenced mostly by the salt form. The acidic and salt forms of salicylic acid affected the two antioxidant systems in different ways, and the influence of these two forms on the distribution and detoxification of Cd also differed. The present results also draw attention to the fact that generalisations about the stress protective mechanisms induced by salicylic acid are misleading since different forms of SA may exert different effects on the plants via separate mechanisms.	[Gondor, Orsolya Kinga; Pal, Magda; Darko, Eva; Janda, Tibor; Szalai, Gabriella] Hungarian Acad Sci, Agr Res Ctr, Inst Agr, Dept Plant Physiol, Martonvasar, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Szalai, G (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Agr, Dept Plant Physiol, Martonvasar, Hungary.	szalai.gabriella@agrar.mta.hu	Darkó, Éva/AAR-8167-2021; Pál, Magda/I-5039-2019	Pál, Magda/0000-0003-3468-962X	National Research Development and Innovation Office, Hungary [K101367, OTKA K101367]	National Research Development and Innovation Office, Hungary	This work was supported by grant No. K101367 from National Research Development and Innovation Office, Hungary.; Thanks are due to Timea Olah and Edit Kovesdi for their technical assistance. The authors wish to thank Dr Gabor Kocsy for his advice on the glutathione half-cell reduction potential. Thanks are also due to Barbara Hooper for revising the manuscript linguistically. This work was supported by grant No. OTKA K101367 from the National Research Development and Innovation Office, Hungary.	ADAM AL, 1995, PLANTA, V197, P240, DOI 10.1007/BF00202643; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNNER M, 1995, J PLANT PHYSIOL, V146, P743, DOI 10.1016/S0176-1617(11)81942-5; Delalande O, 2010, FEBS J, V277, P5086, DOI 10.1111/j.1742-4658.2010.07913.x; Drazic G, 2005, PLANT SCI, V168, P511, DOI 10.1016/j.plantsci.2004.09.019; Galant A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00045; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Guan CF, 2015, PLANT CELL REP, V34, P871, DOI 10.1007/s00299-015-1750-8; Gulyas Z, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-91; HATCH DJ, 1988, PLANT SOIL, V105, P121, DOI 10.1007/BF02371149; Hayat Q, 2010, ENVIRON EXP BOT, V68, P14, DOI 10.1016/j.envexpbot.2009.08.005; Hegedus A, 2001, PLANT SCI, V160, P1085, DOI 10.1016/S0168-9452(01)00330-2; Horvath E, 2007, J PLANT GROWTH REGUL, V26, P290, DOI 10.1007/s00344-007-9017-4; Janda T., 2007, Salicylic acid: a plant hormone, P91, DOI 10.1007/1-4020-5184-0_5; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kovacs V, 2014, ENVIRON EXP BOT, V100, P122, DOI 10.1016/j.envexpbot.2013.12.019; Kovacs V, 2014, J HAZARD MATER, V280, P12, DOI 10.1016/j.jhazmat.2014.07.048; Krantev A, 2008, J PLANT PHYSIOL, V165, P920, DOI 10.1016/j.jplph.2006.11.014; Mannervik B, 1981, Methods Enzymol, V77, P231; Mishra A, 1997, SEED SCI TECHNOL, V25, P263; Pal M, 2006, J PLANT NUTR SOIL SC, V169, P239, DOI 10.1002/jpln.200520573; Pal M, 2005, PHYSIOL PLANTARUM, V125, P356, DOI 10.1111/j.1399-3054.2005.00545.x; Panda SK, 2007, ACTA PHYSIOL PLANT, V29, P567, DOI 10.1007/s11738-007-0069-7; Popova LP, 2009, PLANT PHYSIOL BIOCH, V47, P224, DOI 10.1016/j.plaphy.2008.11.007; RASKIN I, 1992, ANNU REV PLANT PHYS, V43, P439, DOI 10.1146/annurev.pp.43.060192.002255; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Singh I, 2015, PLANT GROWTH REGUL, V76, P99, DOI 10.1007/s10725-015-0023-4; SMITH IK, 1988, ANAL BIOCHEM, V175, P408, DOI 10.1016/0003-2697(88)90564-7; STROBEL NE, 1995, PHYTOPATHOLOGY, V85, P1306, DOI 10.1094/Phyto-85-1306; Szalai G, 2014, ACTA BIOL HUNG, V65, P205, DOI 10.1556/ABiol.65.2014.2.8; Szalai G, 2013, TURK J BOT, V37, P708, DOI 10.3906/bot-1210-6; Tao SY, 2013, PLANT SOIL, V372, P309, DOI 10.1007/s11104-013-1749-2; Torok A, 2015, J HAZARD MATER, V299, P371, DOI 10.1016/j.jhazmat.2015.06.042; VERLOO M, 1986, STUD ENVIRON SCI, V29, P207; Zawoznik MS, 2007, PLANT SCI, V173, P190, DOI 10.1016/j.plantsci.2007.05.004; Zhu YL, 1999, PLANT PHYSIOL, V119, P73, DOI 10.1104/pp.119.1.73	40	51	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160157	10.1371/journal.pone.0160157	http://dx.doi.org/10.1371/journal.pone.0160157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490102	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900033
J	La, T; Rohde, J; Phillips, ND; Hampson, DJ				La, Tom; Rohde, Judith; Phillips, Nyree Dale; Hampson, David J.			Comparison of Brachyspira hyodysenteriae Isolates Recovered from Pigs in Apparently Healthy Multiplier Herds with Isolates from Herds with Swine Dysentery	PLOS ONE			English	Article							SERPULINA-HYODYSENTERIAE; LIFE-STYLE; DIFFERENTIATION; PILOSICOLI; SEQUENCE; PATHOGENICITY; VIRULENT; INULIN; GENES; CELLS	Swine dysentery (SD) is a mucohaemorrhagic colitis of grower/finisher pigs classically resulting from infection by the anaerobic intestinal spirochaete Brachyspira hyodysenteriae. This study aimed to determine whether B. hyodysenteriae isolates from pigs in three healthy German multiplier herds supplying gilts to other farms differed from isolates from nine German production herds with SD. Isolates were subjected to whole genomic sequencing, and in silico multilocus sequence typing showed that those from the three multiplier herds were of previously undescribed sequence types (ST132, ST133 and ST134), with all isolates from the same herd having the same ST. All isolates were examined for the presence of 332 genes encoding predicted virulence or virulence lifestyle associated factors, and these were well conserved. Isolates from one multiplier herd were atypical in being weakly haemolytic: they had 10 amino acid substitutions in the haemolysin III protein and five in the haemolysin activation protein compared to reference strain WA1, and had a disruption in the promoter site of the hlyA gene. These changes likely contribute to the weakly haemolytic phenotype and putative lack of virulence. These same isolates also had nine base pair insertions in the iron metabolism genes bitB and bitC and lacked five of six plasmid genes that previously have been associated with colonisation. Other overall differences between isolates from the different herds were in genes from three of five outer membrane proteins, which were not found in all the isolates, and in members of a block of six plasmid genes. Isolates from three herds with SD had all six plasmid genes, while isolates lacking some of these genes were found in the three healthy herds-but also in isolates from six herds with SD. Other differences in genes of unknown function or in gene expression may contribute to variation in virulence; alternatively, superior husbandry and better general health may have made pigs in the two multiplier herds colonised by "typical" strongly haemolytic isolates less susceptible to disease expression.	[La, Tom; Phillips, Nyree Dale; Hampson, David J.] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Rohde, Judith] Univ Vet Med, Inst Microbiol, Hannover, Germany	Murdoch University; University of Veterinary Medicine Hannover, Foundation	Hampson, DJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	d.hampson@murdoch.edu.au	Hampson, David J/A-9464-2008; Hampson, David/AAE-3666-2019	Hampson, David J/0000-0002-7729-0427; Rohde, Judith/0000-0002-4671-2164				Achacha M, 1996, CAN J VET RES, V60, P45; Atyeo RF, 1999, VET MICROBIOL, V67, P47, DOI 10.1016/S0378-1135(99)00030-9; Backhans A, 2011, VET MICROBIOL, V153, P156, DOI 10.1016/j.vetmic.2011.03.023; Barth S, 2012, VET MICROBIOL, V155, P438, DOI 10.1016/j.vetmic.2011.09.032; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Black M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131050; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; CLSI, 2008, MM18A CLSI; Dugourd D, 1999, J BACTERIOL, V181, P6948, DOI 10.1128/JB.181.22.6948-6957.1999; Dunser M, 1997, WIEN TIERARZTL MONAT, V84, P151; Durmic Z, 1998, J APPL MICROBIOL, V85, P574, DOI 10.1046/j.1365-2672.1998.853539.x; Francisco AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-87; Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11; Gommel M, 2013, CURR MICROBIOL, V66, P286, DOI 10.1007/s00284-012-0267-4; Hampson DJ, 2016, VET MICROBIOL, V191, P15, DOI 10.1016/j.vetmic.2016.05.016; Hampson DJ, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0002-1; HAMPSON DJ, 1992, VET REC, V131, P318, DOI 10.1136/vr.131.14.318; Hampson DJ, 2012, DIS SWINE, P680; Hansen CF, 2010, J ANIM SCI, V88, P3327, DOI 10.2527/jas.2009-2719; Hansen CF, 2011, BRIT J NUTR, V106, P1506, DOI 10.1017/S000711451100208X; Hsu T, 2001, INFECT IMMUN, V69, P706, DOI 10.1128/IAI.69.2.706-711.2001; JENSEN NS, 1993, VET MICROBIOL, V36, P221, DOI 10.1016/0378-1135(93)90090-T; Kennedy MJ, 1996, VET MICROBIOL, V49, P21, DOI 10.1016/0378-1135(95)00174-3; La T, 2003, J CLIN MICROBIOL, V41, P3372, DOI 10.1128/JCM.41.7.3372-3375.2003; La T, 2014, VET RES, V45, DOI 10.1186/s13567-014-0131-6; La T, 2011, VET MICROBIOL, V153, P150, DOI 10.1016/j.vetmic.2011.02.053; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; La T, 2009, VET MICROBIOL, V133, P98, DOI 10.1016/j.vetmic.2008.06.003; LEMCKE RM, 1982, J MED MICROBIOL, V15, P205, DOI 10.1099/00222615-15-2-205; Lobert S, 2016, TIERAERZTL PRAX G N, V44, P13, DOI 10.15653/TPG-150674; Lysons RJ, 1982, P 7 INT PIG VET SOC, P40; Mahu M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0353-x; Mirajkar NS, 2015, J CLIN MICROBIOL, V53, P2908, DOI 10.1128/JCM.01236-15; Mushtaq M, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0537-y; Naresh R, 2011, MICROBIOL-SGM, V157, P543, DOI 10.1099/mic.0.044594-0; Naresh R, 2010, MICROBIOL-SGM, V156, P191, DOI 10.1099/mic.0.030262-0; Naresh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008352; Nibbelink SK, 1997, MICROB PATHOGENESIS, V23, P181, DOI 10.1006/mpat.1997.0148; NUESSEN ME, 1983, J IMMUNOL, V131, P997; Pluske JR, 1996, J NUTR, V126, P2920; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Rohde J, 2012, VET MICROBIOL, V158, P211, DOI 10.1016/j.vetmic.2012.02.008; Siba PM, 1996, EPIDEMIOL INFECT, V116, P207, DOI 10.1017/S0950268800052456; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TERHUURNE AAHM, 1994, MICROB PATHOGENESIS, V16, P269, DOI 10.1006/mpat.1994.1028; Thomsen LE, 2007, VET MICROBIOL, V119, P152, DOI 10.1016/j.vetmic.2006.09.004; Thomson JR, 2003, P 2 INT C COL SPIR I	47	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160362	10.1371/journal.pone.0160362	http://dx.doi.org/10.1371/journal.pone.0160362			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27489956	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900050
J	Akleyev, A; Deltour, I; Krestinina, L; Sokolnikov, M; Tsareva, Y; Tolstykh, E; Schuz, J				Akleyev, Alexander; Deltour, Isabelle; Krestinina, Lyudmila; Sokolnikov, Mikhail; Tsareva, Yulia; Tolstykh, Evgenia; Schuz, Joachim			Incidence and Mortality of Solid Cancers in People Exposed In Utero to Ionizing Radiation: Pooled Analyses of Two Cohorts from the Southern Urals, Russia	PLOS ONE			English	Article							STRONTIUM BIOKINETIC MODEL; OZYORSK OFFSPRING COHORTS; FETAL ORGAN DOSIMETRY; TECHA RIVER; RECONSTRUCTION; FEDERATION; DEATH; REGISTER; WORKERS; SR-90	Background Previous studies have shown that acute external in utero exposure to ionizing radiation can increase cancer risk. It is not known whether chronic exposure at low dose rates, including due to radionuclide intake, influences the lifetime risk of solid cancers in the offspring. The objective of this study was to investigate solid cancer risk after in utero irradiation. Methods Cancer incidence and mortality over a 60-year period (from January 1950 to December 2009) were analyzed in the Urals Prenatally Exposed Cohort (UPEC). The cohort comprised in utero exposed offspring of Mayak Production Association female workers and of female residents of Techa River villages. Some of the offspring also received postnatal exposure, either due to becoming radiation workers themselves or due to continuing to live in the contaminated areas of the Techa River. The mortality analyses comprised 16,821 subjects (601,372 person-years), and the incidence analyses comprised 15,813 subjects (554,411 person-years). Poisson regression was used to quantify the relative risk as a function of the in utero soft tissue dose (with cumulative doses up to 944.9 mGy, mean dose of 14.1 mGy in the pooled cohort) and the postnatal stomach dose for solid cancer incidence and mortality. Results When a log-linear model was used, relative risk of cancer per 10 mGy of in utero dose was 0.99 (95% confidence interval (CI) = 0.96 to 1.01) based on incidence data and 0.98 (CI = 0.94 to 1.01) based on mortality data. Postnatal exposure to ionizing radiation was positively associated with the solid cancer risk in members of the UPEC, with a relative risk of 1.02 per 10mGy CI = 1.00 to 1.04). Conclusions No strong evidence was found that chronic low-dose-rate exposure of the embryo and fetus increased the risk of solid cancers in childhood or in adulthood. For both incidence and mortality, a tendency towards a decreased relative risk was noted with increasing doses to soft tissues of the fetus. Further follow-up will provide more precise radiation risk estimates of solid cancer as cohort members are approaching their 60s and cancer becomes more common.	[Akleyev, Alexander; Krestinina, Lyudmila; Tolstykh, Evgenia] Urals Res Ctr Radiat Med, Chelyabinsk, Russia; [Akleyev, Alexander] Chelyabinsk State Univ, Chelyabinsk, Russia; [Deltour, Isabelle; Schuz, Joachim] IARC, Sect Environm & Radiat, Lyon, France; [Sokolnikov, Mikhail; Tsareva, Yulia] Southern Urals Biophys Inst, Ozyorsk, France	Chelyabinsk State University; World Health Organization; International Agency for Research on Cancer (IARC)	Akleyev, A (corresponding author), Urals Res Ctr Radiat Med, Chelyabinsk, Russia.; Akleyev, A (corresponding author), Chelyabinsk State Univ, Chelyabinsk, Russia.	akleyev@urcrm.ru	Akleyev, Alexander V./Q-1891-2015; Толстых, Евгения/A-7747-2016; Krestinina, Lyudmila Yu/B-4562-2019	Akleyev, Alexander V./0000-0003-2583-5808; Krestinina, Lyudmila Yu/0000-0003-0497-5879; Tsareva, Yulia/0000-0001-5559-4457; Sokolnikov, Mikhail/0000-0001-9492-4316	project Epidemiological Studies of Exposed Southern Urals Populations (SOLO) under the aegis of the Seventh Framework Programme of the European Commission [249675]	project Epidemiological Studies of Exposed Southern Urals Populations (SOLO) under the aegis of the Seventh Framework Programme of the European Commission	This work was supported by the project Epidemiological Studies of Exposed Southern Urals Populations (SOLO) under the aegis of the Seventh Framework Programme of the European Commission (Grant Agreement Number 249675).	AKLEYEV AV, 1994, SCI TOTAL ENVIRON, V142, P1, DOI 10.1016/0048-9697(94)90066-3; Akleyev AV., 2002, MED BIOL ECOLOGICAL; Akleyev AV, 2006, CHELYABINSK OBLAST C; [Anonymous], 2012, FP6R516478 SOUL EUR; Azizova TV, 2012, METHOD INFORM MED, V51, P144, DOI 10.3414/ME11-01-0049; Boice JD, 1999, TERATOLOGY, V59, P227, DOI 10.1002/(SICI)1096-9926(199904)59:4<227::AID-TERA7>3.0.CO;2-E; Curado MP, 2007, IARC SCI PUBLICATION, VIX; Degteva MO, 2009, INDIVIDUAL DOSE CALC; Degteval MO, 2007, RADIAT PROT DOSIM, V127, P480, DOI 10.1093/rpd/ncm410; Forman D, 2013, CANC INCIDENCE 5 CON, VX; GILMAN E A, 1988, Journal of Radiological Protection, V8, P3, DOI 10.1088/0952-4746/8/1/301; *INT COMM RAD PROT, 2001, ANN ICRP, V31; International Commission on Radiological Protection, 2003, ANN ICRP, V90; [Харюзов Ю.Е. Kharyuzov Yu.E.], 2015, [Радиация и риск (Бюллетень Национального радиационно-эпидемиологического регистра), Radiation and Risk, Radiatsiya i risk (Byulleten' Natsional'nogo radiatsionno-epidemiologicheskogo registra)], V24, P92; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; KONERMANN G, 1987, ADV RADIAT BIOL, V13, P91; Kossenko MM, 2005, RADIAT RES, V164, P591, DOI 10.1667/RR3451.1; Maynard MR, 2015, RADIAT ENVIRON BIOPH, V54, P47, DOI 10.1007/s00411-014-0570-5; Maynard MR, 2015, RADIAT ENVIRON BIOPH, V54, P37, DOI 10.1007/s00411-014-0571-4; Monson R.R., 1984, RAD CARCINOGENESIS E, P97; [Напье Б.А. Napier B.A.], 2013, [Медицинская радиология и радиационная безопасность, Meditsinskaya radiologiya i radiatsionnaya bezopasnost'], V58, P5; Ostroumova Evghenia, 2005, Acta Medica Nagasakiensia, V50, P23; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; PRESTON DL, 1993, EPICURE; Schonfeld SJ, 2012, RADIAT RES, V178, P160, DOI 10.1667/RR2848.1; Shagina NB, 2015, J RADIOL PROT, V35, P659, DOI 10.1088/0952-4746/35/3/659; Shagina NB, 2015, J RADIOL PROT, V35, P677, DOI 10.1088/0952-4746/35/3/677; Sokolnikov M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117784; Startsev N, 2015, METHOD INFORM MED, V54, P359, DOI 10.3414/ME14-01-0101; StataCorp, 2011, STAT STAT SOFTW REL, P173; Tolstykh EI, 2013, HEALTH PHYS, V104, P481, DOI 10.1097/HP.0b013e318285bb7a; Tolstykh EI, 2011, HEALTH PHYS, V101, P28, DOI 10.1097/HP.0b013e318206d0ff; Tolstykh EI, 2008, RADIAT ENVIRON BIOPH, V47, P349, DOI 10.1007/s00411-008-0168-x; Tsareva Y, 2016, RADIAT ENVIRON BIOPH, V55, P291, DOI 10.1007/s00411-016-0650-9; Winkelmann RA, 2002, RADIAT ENVIRON BIOPH, V41, P5, DOI 10.1007/s00411-001-0128-1	35	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160372	10.1371/journal.pone.0160372	http://dx.doi.org/10.1371/journal.pone.0160372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487016	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800073
J	Bujak, R; Mateo, J; Blanco, I; Izquierdo-Garcia, JL; Dudzik, D; Markuszewski, MJ; Peinado, VI; Laclaustra, M; Barbera, JA; Barbas, C; Ruiz-Cabello, J				Bujak, Renata; Mateo, Jesus; Blanco, Isabel; Luis Izquierdo-Garcia, Jose; Dudzik, Danuta; Markuszewski, Michal J.; Ivo Peinado, Victor; Laclaustra, Martin; Albert Barbera, Joan; Barbas, Coral; Ruiz-Cabello, Jesus			New Biochemical Insights into the Mechanisms of Pulmonary Arterial Hypertension in Humans	PLOS ONE			English	Article							RIGHT VENTRICLE; PATHWAY; GLUTAMINOLYSIS; BIOENERGETICS; METABOLISM; RELEVANCE; PLASMA; ACID	Diagnosis of pulmonary arterial hypertension (PAH) is difficult due to the lack of specific clinical symptoms and biomarkers, especially at early stages. We compared plasma metabolic fingerprints of PAH patients (n = 20) with matched healthy volunteers (n = 20) using, for the first time, untargeted multiplatform metabolomics approach consisting of high-performance liquid and gas chromatography coupled with mass spectrometry. Multivariate statistical analyses were performed to select metabolites that contribute most to groups' classification (21 from liquid in both ionization modes and 9 from gas chromatography-mass spectrometry). We found metabolites related to energy imbalance, such as glycolysis-derived metabolites, as well as metabolites involved in fatty acid, lipid and amino acid metabolism. We observed statistically significant changes in threitol and aminomalonic acid in PAH patients, which could provide new biochemical insights into the pathogenesis of the disease. The results were externally validated on independent case and control cohorts, confirming up to 16 metabolites as statistically significant in the validation study. Multiplatform metabolomics, followed by multivariate chemometric data analysis has a huge potential for explaining pathogenesis of PAH and for searching potential and new more specific and less invasive markers of the disease.	[Bujak, Renata; Dudzik, Danuta; Barbas, Coral] Univ CEU San Pablo, Fac Farm, Ctr Metabol & Bioanal CEMBIO, Campus Monteprincipe, Madrid, Spain; [Bujak, Renata; Markuszewski, Michal J.] Med Univ Gdansk, Dept Biopharmaceut & Pharmacodynam, Al Gen J Hallera 107, PL-80416 Gdansk, Poland; [Mateo, Jesus; Luis Izquierdo-Garcia, Jose; Laclaustra, Martin; Ruiz-Cabello, Jesus] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Blanco, Isabel; Ivo Peinado, Victor; Albert Barbera, Joan] Hosp Clin Barcelona IDIBAPS, Barcelona, Spain; [Laclaustra, Martin] Univ Autonoma Madrid, CIBERESP, Prevent Med & Publ Hlth Dept, Fac Med, Madrid, Spain; [Mateo, Jesus; Blanco, Isabel; Luis Izquierdo-Garcia, Jose; Ivo Peinado, Victor; Albert Barbera, Joan; Ruiz-Cabello, Jesus] Ciber Enfermedades Resp CIBERES, Madrid, Spain; [Ruiz-Cabello, Jesus] Univ Complutense Madrid, Madrid, Spain	San Pablo CEU University; Fahrenheit Universities; Medical University Gdansk; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid	Ruiz-Cabello, J (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.; Ruiz-Cabello, J (corresponding author), Ciber Enfermedades Resp CIBERES, Madrid, Spain.; Ruiz-Cabello, J (corresponding author), Univ Complutense Madrid, Madrid, Spain.	ruizcabe@cnic.es	Ruiz-Cabello, Jesus/A-9570-2012; Markuszewski, Michal/X-7198-2019; Laclaustra, Martín/C-6709-2015; Barbas, Coral/K-3871-2014; Dudzik, Danuta/K-5494-2014; Izquierdo-Garcia, Jose/L-3293-2013; de Castro, Jesus Mateo/N-4434-2014	Ruiz-Cabello, Jesus/0000-0001-8681-5056; Markuszewski, Michal/0000-0003-1166-4817; Laclaustra, Martín/0000-0003-3963-0846; Barbas, Coral/0000-0003-4722-491X; Dudzik, Danuta/0000-0002-9833-7618; Izquierdo-Garcia, Jose/0000-0002-7907-3776; de Castro, Jesus Mateo/0000-0003-4459-7083; Wawrzyniak, Renata/0000-0002-0763-4589; Peinado, Victor Ivo/0000-0001-9793-9433	Polish National Science Center [2014/13/N/NZ7/04231]; Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2014-58920R]; Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) [PI14-01427]; Ministry of Science and Higher Education of Poland, Leading National Research Centre; Spanish Ministry of Economy and Competitiveness; Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award) [SEV-2015-0505]	Polish National Science Center; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Ministry of Science and Higher Education of Poland, Leading National Research Centre(Ministry of Science and Higher Education, Poland); Spanish Ministry of Economy and Competitiveness(Spanish Government); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO award)(Spanish Government)	This research was supported by the Polish National Science Center (2014/13/N/NZ7/04231), the Spanish Ministry of Economy and Competitiveness (MINECO) (SAF2014-58920R), by the Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III and co-funding by Fondo Europeo de Desarrollo Regional (FEDER) (PI14-01427), and by the quality-promoting subsidy from the Ministry of Science and Higher Education of Poland, Leading National Research Centre (KNOW programme 2012-2017). The CNIC is supported by the Spanish Ministry of Economy and Competitiveness and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; ALOIA JF, 1973, J LAB CLIN MED, V82, P809; Archer SL, 2013, PULM CIRC, V3, P144, DOI 10.4103/2045-8932.109960; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Bowers R, 2004, AM J RESP CRIT CARE, V169, P764, DOI 10.1164/rccm.200301-147OC; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CHAKRABARTI M, 1995, NUCL MED BIOL, V22, P693, DOI 10.1016/0969-8051(95)00008-L; Chen JW, 2014, AM J RESP CRIT CARE, V190, P1032, DOI 10.1164/rccm.201401-0121OC; Cottrill KA, 2013, EUR J CLIN INVEST, V43, P855, DOI 10.1111/eci.12104; Dang CV, 2010, CELL CYCLE, V9, P3884, DOI 10.4161/cc.9.19.13302; Dean RT, 1997, BIOCHEM J, V324, P1; Dweik RA, 2014, AM J RESP CRIT CARE, V189, P345, DOI 10.1164/rccm.201311-1954ST; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; MacLean MR, 2000, BRIT J PHARMACOL, V131, P161, DOI 10.1038/sj.bjp.0703570; Morecroft I, 2007, HYPERTENSION, V49, P232, DOI 10.1161/01.HYP.0000252210.58849.78; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Pak O, 2010, DRUG DISCOV TODAY DI, V7, P89, DOI DOI 10.1016/J.DDM0D.2011.02.002; Piao L, 2013, J MOL MED, V91, P333, DOI 10.1007/s00109-012-0982-0; Pillarisetti S, 2009, DRUG DISCOV TODAY, V14, P1098, DOI 10.1016/j.drudis.2009.08.002; PITKANEN E, 1977, CLIN CHIM ACTA, V80, P49, DOI 10.1016/0009-8981(77)90262-5; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Pugh ME, 2011, J HEART LUNG TRANSPL, V30, P904, DOI 10.1016/j.healun.2011.02.016; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Ruperez FJ, 2012, ANAL BIOANAL CHEM, V403, P1651, DOI 10.1007/s00216-012-5982-y; Sudhahar V, 2009, EUR J PHARMACOL, V607, P143, DOI 10.1016/j.ejphar.2009.02.002; Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d; Van Veldhoven PP, 2000, CELL SIGNAL, V12, P475, DOI 10.1016/S0898-6568(00)00092-9; VANBUSKIRK JJ, 1984, P NATL ACAD SCI-BIOL, V81, P722; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Zhao YD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088727; Zhao YDD, 2014, METABOLOMICS, V10, P1169, DOI 10.1007/s11306-014-0653-y	40	31	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160505	10.1371/journal.pone.0160505	http://dx.doi.org/10.1371/journal.pone.0160505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486806	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800080
J	Cheng, Y; Lin, CH; Chen, JY; Li, CH; Liu, YT; Chen, BC				Cheng, Yi; Lin, Chien-huang; Chen, Jing-Yun; Li, Chien-Hua; Liu, Yu-Tin; Chen, Bing-Chang			Induction of Connective Tissue Growth Factor Expression by Hypoxia in Human Lung Fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 Pathways	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GENE-REGULATION; ADULT LUNG; ACTIVATION; HEDGEHOG; PROLIFERATION; KINASE; PROTEINS; REQUIRES; CELLS	Several reports have indicated that hypoxia, GLI, and connective tissue growth factor (CTGF) contribute to pulmonary fibrosis in idiopathic pulmonary fibrosis. We investigated the participation of mitogen-activated protein kinase kinase (MEK) kinase 1 (MEKK1)/MEK1/ERK1/GLI-1/2 and activator protein-1 (AP-1) signaling in hypoxia-induced CTGF expression in human lung fibroblasts. Hypoxia time-dependently increased CTGF expression, which was attenuated by the small interfering RNA (siRNA) of GLI-1 (GLI-1 siRNA) and GLI-2 (GLI-2 siRNA) in both human lung fibroblast cell line (WI-38) and primary human lung fibroblasts (NHLFs). Moreover, GLI-1 siRNA and GLI-2 siRNA attenuated hypoxia-induced CTGF-luciferase activity, and the treatment of cells with hypoxia induced GLI-1 and GLI-2 translocation. Furthermore, hypoxia-induced CTGF expression was reduced by an MEK inhibitor (PD98059), MEK1 siRNA, ERK inhibitor (U0126), ERK1 siRNA, and MEKK1 siRNA. Both PD98059 and U0126 significantly attenuated hypoxia-induced CTGF-luciferase activity. Hypoxia time-dependently increased MEKK1, ERK, and p38 MAPK phosphorylation. Moreover, SB203580 (a p38 MAPK inhibitor) also apparently inhibited hypoxia-induced CTGF expression. The treatment of cells with hypoxia induced ERK, GLI-1, or GLI2 complex formation. Hypoxia-induced GLI-1 and GLI-2 translocation into the nucleus was significantly attenuated by U0126. In addition, hypoxia-induced ERK Tyr204 phosphorylation was impeded by MEKK1 siRNA. Moreover, hypoxia-induced CTGF-luciferase activity was attenuated by cells transfected with AP-1 site mutation in a CTGF construct. Exposure to hypoxia caused a time-dependent phosphorylation of c-Jun, but not of c-Fos. Chromatin immunoprecipitation (ChIP) revealed that hypoxia induced the recruitment of c-Jun, GLI-1, and GLI-2 to the AP-1 promoter region of CTGF. Hypoxia-treated cells exhibited an increase in alpha-smooth muscle actin (alpha-SMA) and collagen production, which was blocked by GLI-1 siRNA and GLI-2 siRNA. Overall, these data implied that the MEKK1/MEK1/ERK1/GLI-1/GLI-2, and AP-1 pathways mediated hypoxia-induced CTGF expression in human lung fibroblasts. Furthermore, GLI-1 and GLI-2 found to be involved in hypoxia-induced aSMA and collagen expression.	[Cheng, Yi; Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Lin, Chien-huang; Chen, Jing-Yun; Li, Chien-Hua] Taipei Med Univ, Coll Med, Gradual Inst Med Sci, Taipei, Taiwan; [Liu, Yu-Tin] Taipei Med Univ, Coll Pharm, Sch Pharm, Taipei, Taiwan; [Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Chen, BC (corresponding author), Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.; Chen, BC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	bcchen@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737; Cheng, Henry Yi/0000-0003-4412-4235	Ministry of Science and Technology of Taiwan, R.O.C. [MOST 104-2815-C-038-008-B, 102-2320-B-038-049, 103-2320-B-038-001, 104-2320-B-038-001]	Ministry of Science and Technology of Taiwan, R.O.C.	This study was supported by grants (MOST 104-2815-C-038-008-B, 102-2320-B-038-049, 103-2320-B-038-001, and 104-2320-B-038-001) from the Ministry of Science and Technology of Taiwan, R.O.C.	Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; Andreadi CK, 2006, MOL PHARMACOL, V69, P1033, DOI 10.1124/mol.105.018374; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Bijlsma MF, 2009, J CELL MOL MED, V13, P2053, DOI 10.1111/j.1582-4934.2008.00491.x; Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192, DOI 10.1136/mp.54.3.192; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Bodempudi V, 2014, AM J PHYSIOL-LUNG C, V307, pL283, DOI 10.1152/ajplung.00069.2014; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Distler JHW, 2007, ARTHRITIS RHEUM-US, V56, P4203, DOI 10.1002/art.23074; Engers R, 2006, FEBS J, V273, P4754, DOI 10.1111/j.1742-4658.2006.05476.x; Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065; FALANGA V, 1993, J CELL PHYSIOL, V157, P408, DOI 10.1002/jcp.1041570225; FALANGA V, 1993, J CELL PHYSIOL, V154, P506, DOI 10.1002/jcp.1041540308; Furuya T, 2013, J PLANT RES, V126, P833, DOI 10.1007/s10265-013-0576-0; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Harari S, 2015, EUR RESPIR REV, V24, P420, DOI 10.1183/16000617.0042-2015; Harris LG, 2011, MOL CANCER RES, V9, P1165, DOI 10.1158/1541-7786.MCR-11-0175; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hu LP, 2015, MOL PHARMACOL, V87, P174, DOI 10.1124/mol.114.095141; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Lee YK, 2009, J KOREAN MED SCI, V24, pS176, DOI 10.3346/jkms.2009.24.S1.S176; Lin CH, 2014, J IMMUNOL, V192, P338, DOI 10.4049/jimmunol.1203323; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Lin CC, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/712474; Lin Q, 2010, EXP LUNG RES, V36, P120, DOI 10.3109/01902140903214659; Lin ZW, 2000, AM J PHYSIOL-ENDOC M, V278, pE958, DOI 10.1152/ajpendo.2000.278.5.E958; Liu L, 2013, AM J RESP CELL MOL, V48, P703, DOI 10.1165/rcmb.2012-0347OC; Liu LL, 2010, INT J CANCER, V127, P820, DOI 10.1002/ijc.25098; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Mortimer HJ, 2007, PULM PHARMACOL THER, V20, P718, DOI 10.1016/j.pupt.2006.08.007; Moshai EF, 2014, AM J RESP CELL MOL, V51, P11, DOI 10.1165/rcmb.2013-0154OC; Murthy S, 2012, BIOCHEM J, V445, P229, DOI 10.1042/BJ20120053; Oubrahim H, 2013, CELL SIGNAL, V25, P1136, DOI 10.1016/j.cellsig.2013.01.026; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Ren J, 2015, ONCOL REP, V33, P1929, DOI 10.3892/or.2015.3779; Renzoni Elisabetta, 2014, F1000Prime Rep, V6, P69, DOI 10.12703/P6-69; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Rong Lin-lin, 2005, Beijing Da Xue Xue Bao Yi Xue Ban, V37, P378; Rovida E, 2015, SEMIN CANCER BIOL, V35, P154, DOI 10.1016/j.semcancer.2015.08.003; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Spagnolo P, 2015, PHARMACOL THERAPEUT, V152, P18, DOI 10.1016/j.pharmthera.2015.04.005; Spagnolo P, 2015, ANN MED, V47, P15, DOI 10.3109/07853890.2014.982165; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Wang You-juan, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P378; Weng CM, 2013, AM J RESP CRIT CARE, V188, P298, DOI 10.1164/rccm.201301-0132OC; Whisenant TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000908; Whitson BA, 2014, J THORAC DIS, V6, P1018, DOI 10.3978/j.issn.2072-1439.2014.07.04; Xia W, 2007, ANN SURG, V246, P886, DOI 10.1097/SLA.0b013e318070d54f; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582	55	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160593	10.1371/journal.pone.0160593	http://dx.doi.org/10.1371/journal.pone.0160593			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486656	Green Submitted, gold, Green Published			2022-12-27	WOS:000381367800088
J	Fell, DB; Wilson, K; Ducharme, R; Hawken, S; Sprague, AE; Kwong, JC; Smith, G; Wen, SW; Walker, MC				Fell, Deshayne B.; Wilson, Kumanan; Ducharme, Robin; Hawken, Steven; Sprague, Ann E.; Kwong, Jeffrey C.; Smith, Graeme; Wen, Shi Wu; Walker, Mark C.			Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination	PLOS ONE			English	Article							PREGNANT-WOMEN; IMMUNIZATION; HOSPITALIZATION; MORTALITY; IMMUNOGENICITY; VACCINES; PROGRAM; ILLNESS; VISITS; IMPACT	Background Infants are at high risk for influenza illness, but are ineligible for vaccination before 6 months. Transfer of maternal antibodies to the fetus has been demonstrated for 2009 A/H1N1 pandemic vaccines; however, clinical effectiveness is unknown. Our objective was to evaluate the association between 2009 A/H1N1 pandemic vaccination during pregnancy and rates of infant influenza and pneumonia. Methods We linked a population-based birth cohort to administrative databases to measure rates of influenza and pneumonia diagnosed during ambulatory physician visits, hospitalizations and emergency department visits during one year of follow-up. We estimated incidence rate ratios and 95% confidence intervals (95% CI) using Poisson regression, comparing infants born to A/H1N1-vaccinated women (vaccine-exposed infants) with unexposed infants, adjusted for confounding using high-dimensional propensity scores. Results Among 117,335 infants in the study, 36,033 (31%) were born to A/H1N1-vaccinated women. Crude rates of influenza during the pandemic (per 100,000 infant-days) for vaccine-exposed and unexposed infants were similar (2.19, 95% CI: 1.27-3.76 and 3.60, 95% CI: 2.51-5.14, respectively), as were crude rates of influenza and pneumonia combined. We did not observe any significant differences in rates of study outcomes between study groups during the second wave of the 2009 A/H1N1 pandemic, nor during any post-pandemic time period. Conclusion We observed no difference in rates of study outcomes among infants born to A/H1N1-vaccinated mothers relative to unexposed infants born during the second A/H1N1 pandemic wave; however, due to late availability of the pandemic vaccine, the available follow-up time during the pandemic time period was very limited.	[Fell, Deshayne B.; Sprague, Ann E.; Walker, Mark C.] Better Outcomes Registry & Network BORN Ontario, Ottawa, ON, Canada; [Wilson, Kumanan] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wilson, Kumanan; Ducharme, Robin; Hawken, Steven; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Ottawa, ON, Canada; [Wilson, Kumanan; Ducharme, Robin; Hawken, Steven; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Wilson, Kumanan; Ducharme, Robin; Hawken, Steven; Wen, Shi Wu; Walker, Mark C.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Hawken, Steven] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Smith, Graeme] Queens Univ, Dept Obstet & Gynaecol, Kingston, ON, Canada; [Wen, Shi Wu; Walker, Mark C.] Univ Ottawa, Dept Obstet & Gynecol, OMNI Res Grp, Ottawa, ON, Canada; [Walker, Mark C.] Ottawa Hosp, Dept Obstet Gynecol & Newborn Care, Ottawa, ON, Canada	University of Ottawa; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; University of Toronto; Queens University - Canada; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Wilson, K (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.; Wilson, K (corresponding author), Inst Clin Evaluat Sci, Ottawa, ON, Canada.; Wilson, K (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Wilson, K (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	kwilson@ohri.ca	Smith, Graeme Neil/ABB-6863-2021; Fell, Deshayne/N-7106-2017	Smith, Graeme Neil/0000-0002-3128-4523; Fell, Deshayne/0000-0002-5548-3228; Ducharme, Robin/0000-0002-5665-7429	Canadian Institutes of Health Research (CIHR) [MOP-119601]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research (CIHR) Grant # MOP-119601. CIHR had no role in conducting the study or in the decision to submit the article for publication.	Adegbola R, 2012, AM J OBSTET GYNECOL, V207, pS28, DOI 10.1016/j.ajog.2012.07.001; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2004, OBSTET GYNECOL, DOI DOI 10.1097/00006250-200411000-00058; [Anonymous], EUROSURVEILLANCE; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bateman AC, 2013, J INFECT DIS, V207, P1262, DOI 10.1093/infdis/jit020; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Biggerstaff M, 2015, CLIN INFECT DIS, V60, pS20, DOI 10.1093/cid/ciu1175; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Campitelli MA, 2010, VACCINE, V29, P240, DOI 10.1016/j.vaccine.2010.10.049; Canada National Advisory Committee on Immunization (NACI), 2011, Canada Communicable Disease Report, V37, P1; Chaves SS, 2014, PEDIATR INFECT DIS J, V33, P912, DOI 10.1097/INF.0000000000000321; Dijs-Elsinga J, 2015, BJOG, V59, P709; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; Fell DB, 2015, BJOG-INT J OBSTET GY, V122, P17, DOI 10.1111/1471-0528.12977; Flechelles O, 2013, EXPERT REV ANTI-INFE, V11, P555, DOI [10.1586/ERI.13.40, 10.1586/eri.13.40]; France EK, 2006, ARCH PEDIAT ADOL MED, V160, P1277, DOI 10.1001/archpedi.160.12.1277; Halasa NB, 2008, J INFECT DIS, V197, P1448, DOI 10.1086/587643; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Henninger M, 2013, PERM J, V17, P31; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Kennedy ED, 2012, AM J OBSTET GYNECOL, V207, pS9, DOI 10.1016/j.ajog.2012.06.069; King A., 2010, H1N1 PANDEMIC ONTARI; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; Moore DL, 2006, PEDIATRICS, V118, pE610, DOI 10.1542/peds.2005-2744; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Myers ER, 2011, AM J OBSTET GYNECOL, V204, pS128, DOI 10.1016/j.ajog.2011.04.009; Nelson JC, 2009, J CLIN EPIDEMIOL, V62, P687, DOI 10.1016/j.jclinepi.2008.06.014; Neuzil KM, 2014, CLIN INFECT DIS, V58, P328, DOI 10.1093/cid/cit739; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Ortiz JR, 2011, VACCINE, V29, P4439, DOI 10.1016/j.vaccine.2011.04.048; Poehling KA, 2011, AM J OBSTET GYNECOL, V204, pS141, DOI 10.1016/j.ajog.2011.02.042; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Shakib JH, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2360; Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008; Skowronski DM, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.4.21022; Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, VACCINE, V27, P4754, DOI 10.1016/j.vaccine.2009.03.079; Steinhoff M. C., 2007, Infectious disease epidemiology: theory and practice, P577; Syrjanen RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108538; Szklo M, 2007, EPIDEMIOLOGY BASICS, P109; Tapia MD, 2016, LANCET INFECT DIS, V16, P1026, DOI 10.1016/S1473-3099(16)30054-8; Tsatsaris V, 2011, ANN INTERN MED, V155, P733, DOI 10.7326/0003-4819-155-11-201112060-00005; van Walraven C, 2011, J CLIN EPIDEMIOL, V64, P1054, DOI 10.1016/j.jclinepi.2011.01.001; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zuccotti G, 2010, JAMA-J AM MED ASSOC, V304, P2360, DOI 10.1001/jama.2010.1729	52	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160342	10.1371/journal.pone.0160342	http://dx.doi.org/10.1371/journal.pone.0160342			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486858	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800071
J	Rodriguez-Carrio, J; Alperi-Lopez, M; Lopez, P; Ballina-Garcia, FJ; Suarez, A				Rodriguez-Carrio, Javier; Alperi-Lopez, Mercedes; Lopez, Patricia; Javier Ballina-Garcia, Francisco; Suarez, Ana			Non-Esterified Fatty Acids Profiling in Rheumatoid Arthritis: Associations with Clinical Features and Th1 Response	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; DIETARY FISH-OIL; DOUBLE-BLIND; KAPPA-B; PPAR-ALPHA; INFLAMMATION; SUPPLEMENTATION; OBESITY; METABOLOMICS; EXTRACTION	Objectives Since lipid compounds are known to modulate the function of CD4(+) T-cells and macrophages, we hypothesize that altered levels of serum non-esterified fatty acids (NEFA) may underlie rheumatoid arthritis (RA) pathogenesis. Methods Serum levels of NEFA (palmitic, stearic, palmitoleic, oleic, linoleic, gamma-linoleic, arachidonic-AA-, linolenic, eicosapentaenoic-EPA- and docosahexaenoic-DHA-) were quantified by LC-MS/MS after methyl-tert-butylether (MTBE)-extraction in 124 RA patients and 56 healthy controls (HC). CD4(+) phenotype was studied by flow cytometry. TNF alpha, IL-8, VEGF, GM-CSF, IFN gamma, IL-17, CCL2, CXCL10, leptin and resistin serum levels were quantified by immunoassays. The effect of FA on IFN gamma production by PBMC was evaluated in vitro. Results Lower levels of palmitic (p<0.0001), palmitoleic (p = 0.002), oleic (p = 0.010), arachidonic (p = 0.027), EPA (p<0.0001) and DHA (p<0.0001) were found in RA patients, some NEFA being altered at onset. Cluster analysis identified a NEFA profile (hallmarked by increased stearic and decreased EPA and DHA) overrepresented in RA patients compared to HC (p = 0.002), being associated with clinical features (RF, shared epitope and erosions), increased IFN. expression in CD4(+) T-cells (p = 0.002) and a Th1-enriched serum milieu (IFN gamma, CCL2 and CXCL10, all p<0.005). In vitro assays demonstrated that imbalanced FA could underlie IFN. production by CD4(+) T-cells. Finally, changes on NEFA levels were associated with clinical response upon TNF alpha-blockade. Conclusion An altered NEFA profile can be found in RA patients associated with clinical characteristics of aggressive disease and enhanced Th1 response. These results support the relevance of lipidomic studies in RA and provide a rationale for new therapeutic targets.	[Rodriguez-Carrio, Javier; Lopez, Patricia; Suarez, Ana] Univ Oviedo, Dept Funct Biol, Area Immunol, Oviedo, Asturias, Spain; [Alperi-Lopez, Mercedes; Javier Ballina-Garcia, Francisco] Hosp Univ Cent Asturias, Dept Rheumatol, Oviedo, Asturias, Spain	University of Oviedo; Central University Hospital Asturias	Suarez, A (corresponding author), Univ Oviedo, Dept Funct Biol, Area Immunol, Oviedo, Asturias, Spain.	anasua@uniovi.es	Suarez, Ana/F-4492-2015; López, Patricia/B-8603-2018	Suarez, Ana/0000-0002-4452-7539; López, Patricia/0000-0002-1843-0653; Alperi-Lopez, Mercedes/0000-0002-8727-0876; Rodriguez-Carrio, Javier/0000-0002-0011-5102	European Union FEDER funds; Fondo de Investigaciones Sanitarias Sociedad Espanola de Reumatologia [PI12/00523 MECD AP2010-1614]; FPU grant from the Ministerio de Educacion [AP2010-1614]	European Union FEDER funds(European Commission); Fondo de Investigaciones Sanitarias Sociedad Espanola de Reumatologia; FPU grant from the Ministerio de Educacion(German Research Foundation (DFG))	This work was supported by European Union FEDER funds and Fondo de Investigaciones Sanitarias PI12/00523 MECD AP2010-1614 Sociedad Espanola de Reumatologia (ES). J.R.-C. is a recipient of a FPU grant from the Ministerio de Educacion (AP2010-1614). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Frommer KW, 2015, ANN RHEUM DIS, V74, P303, DOI 10.1136/annrheumdis-2013-203755; Gan RW, 2016, RHEUMATOLOGY, V55, P367, DOI 10.1093/rheumatology/kev266; Genolet Raphael, 2004, Current Drug Targets - Inflammation and Allergy, V3, P361, DOI 10.2174/1568010042634578; Giera M, 2012, BBA-MOL CELL BIOL L, V1821, P1415, DOI 10.1016/j.bbalip.2012.07.011; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Ierna M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-136; Ioan-Facsinay A, 2013, EUR J IMMUNOL, V43, P1578, DOI 10.1002/eji.201243096; Kang KY, 2015, J RHEUMATOL, V42, P2003, DOI 10.3899/jrheum.141505; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Klein-Wieringa IR, 2011, ANN RHEUM DIS, V70, P851, DOI 10.1136/ard.2010.140046; Klein-Wieringa IR, 2013, J IMMUNOL, V191, P1356, DOI 10.4049/jimmunol.1203074; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Kopp A, 2009, EUR J CLIN INVEST, V39, P924, DOI 10.1111/j.1365-2362.2009.02185.x; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; KREMER JM, 1990, ARTHRITIS RHEUM, V33, P810, DOI 10.1002/art.1780330607; LAU CS, 1993, BRIT J RHEUMATOL, V32, P982; Lee YH, 2012, ARCH MED RES, V43, P356, DOI 10.1016/j.arcmed.2012.06.011; Li XZ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001856; Livingstone KM, 2014, ATHEROSCLEROSIS, V234, P65, DOI 10.1016/j.atherosclerosis.2014.02.015; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Miles EA, 2001, CLIN SCI, V100, P91, DOI 10.1042/CS20000198; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; NORDSTROM DCE, 1995, RHEUMATOL INT, V14, P231, DOI 10.1007/BF00262088; Perreault M, 2014, LIPIDS, V49, P255, DOI 10.1007/s11745-013-3874-3; Pizarro C, 2013, ANAL CHEM, V85, P12085, DOI 10.1021/ac403181c; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; Proudman SM, 2015, ANN RHEUM DIS, V74, P89, DOI 10.1136/annrheumdis-2013-204145; Puertollano MA, 2001, FEMS IMMUNOL MED MIC, V32, P47, DOI 10.1111/j.1574-695X.2001.tb00533.x; Qiu JF, 2015, LIPIDS, V50, P977, DOI 10.1007/s11745-015-4060-6; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rodriguez-Carrio J, 2015, EXP GERONTOL, V61, P123, DOI 10.1016/j.exger.2014.12.009; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Sell H, 2012, NAT REV ENDOCRINOL, V8, P709, DOI 10.1038/nrendo.2012.114; Semerano L, 2015, ANN RHEUM DIS, V74, P1325, DOI 10.1136/annrheumdis-2014-206618; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Sijben JWC, 2007, P NUTR SOC, V66, P237, DOI 10.1017/S0029665107005472; Strissel KJ, 2010, OBESITY, V18, P1918, DOI 10.1038/oby.2010.1; Trebble TM, 2004, AM J CLIN NUTR, V80, P1137, DOI 10.1093/ajcn/80.5.1137; van Baarsen LGM, 2015, ANN RHEUM DIS, V74, pA77, DOI 10.1136/annrheumdis-2015-207259.177; van Wietmarschen HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044331; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Xu X, 2001, ENDOCRINOLOGY, V142, P3332, DOI 10.1210/en.142.8.3332	47	25	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159573	10.1371/journal.pone.0159573	http://dx.doi.org/10.1371/journal.pone.0159573			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487156	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800035
J	Karki, S; Newall, AT; MacIntyre, CR; Heywood, AE; McIntyre, P; Banks, E; Liu, B				Karki, Surendra; Newall, Anthony T.; MacIntyre, C. Raina; Heywood, Anita E.; McIntyre, Peter; Banks, Emily; Liu, Bette			Healthcare Resource Utilisation Associated with Herpes Zoster in a Prospective Cohort of Older Australian Adults	PLOS ONE			English	Article							POSTHERPETIC NEURALGIA; NATURAL-HISTORY; COST BURDEN; VACCINE; PAIN	Background Herpes zoster (HZ) is a common condition that increases in incidence with older age but vaccines are available to prevent the disease. However, there are limited data estimating the health system burden attributable to herpes zoster by age. Methods In this study, we quantified excess healthcare resource usage associated with HZ during the acute/sub-acute period of disease (21days before to 90 days after onset) in 5952 cases and an equal number of controls matched on age, sex, and prior healthcare resource usage. Estimates were adjusted for potential confounders in multivariable regression models. Using population-based estimates of HZ incidence, we calculated the age-specific excess number of health service usage events attributable to HZ in the population. Results Per HZ case, there was an average of 0.06 (95% CI 0.04-0.08) excess hospitalisations, 1.61 (95% CI 1.51-1.69) excess general practitioner visits, 1.96 (95% CI 1.86-2.15) excess prescriptions filled and 0.11 (95% CI 0.09-0.13) excess emergency department visits. The average number of healthcare resource use events, and the estimated excess per 100,000 population increased with increasing age but were similar for men and women, except for higher rates of hospitalisation in men. The excess annual HZ associated burden of hospitalisations was highest in adults >= 80 years (N = 2244, 95% CI 1719-2767); GP visits was highest in those 60-69 years (N = 50567, 95% CI 39958-61105), prescriptions and ED visits were highest in 70-79 years (N = 50524, 95% CI 40634-60471 and N = 2891, 95% CI 2319-3449 respectively). Conclusions This study provides important data to establish the healthcare utilisation associated with HZ against which detailed cost-effectiveness analyses of HZ immunisation in older adults can be conducted.	[Karki, Surendra; Newall, Anthony T.; MacIntyre, C. Raina; Heywood, Anita E.; Liu, Bette] UNSW, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [MacIntyre, C. Raina; McIntyre, Peter] Childrens Hosp Network, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia; [Banks, Emily] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Banks, Emily] Sax Inst, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; Australian National University; University of Sydney	Karki, S (corresponding author), UNSW, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	s.karki@unsw.edu.au	McIntyre, Peter/GNM-5277-2022	McIntyre, Peter/0000-0001-5808-7450; Banks, Emily/0000-0002-4617-1302; Newall, Anthony/0000-0003-0836-1065; MacIntyre, C Raina/0000-0002-3060-0555; Karki, Surendra/0000-0003-1561-4171	National Health and Medical Research Council (NHMRC) [1048180]; NHMRC Fellowships	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowships(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) grant (Grant number: 1048180). EB and BL are supported by NHMRC Fellowships.	Australian Bureau of Statistics, 2014, AUSTR DEM STAT; Australian Governement Department of Health, 2016, MED BEN SCHED BOOK; Australian Government Department of Health, 2015, PBS COP SAF NET AM; Australian Government Department of Health, 2016, SHINGL VACC ZOST PRO; Australian Government Department of Health, 2016, SCHED PHARM BEN; Australian Technical Advisory Group on Immunisation (ATAGI), 2008, SYST REV SAF IMM GEN; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; BENNETT GJ, 1994, ANN NEUROL, V35, pS38, DOI 10.1002/ana.410350712; Center for Health Record Linkage, 2016, DAT DICT NSW ADM PAT; Centre for Health Record Linkage, DAT DICT NSW BIRTH R; Centre for Health Record Linkage, DAT DICT NSW EM DEP; CHeReL, QUALITY ASSURANCE; CLEMMENSEN OJ, 1984, CLIN EXP DERMATOL, V9, P557, DOI 10.1111/j.1365-2230.1984.tb00859.x; Dworkin RH, 2007, J AM GERIATR SOC, V55, P1168, DOI 10.1111/j.1532-5415.2007.01231.x; EAGLSTEIN WH, 1970, J AMER MED ASSOC, V211, P1681, DOI 10.1001/jama.211.10.1681; Hadley GR, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0548-x; Hales CM, 2014, MMWR-MORBID MORTAL W, V63; Independent Hospital Pricing Authority, 2014, NAT HOSP COST DAT CO; Insinga RP, 2007, PHARMACOECONOMICS, V25, P155, DOI 10.2165/00019053-200725020-00007; Johnson RW, 2001, J ANTIMICROB CHEMOTH, V47, P1, DOI 10.1093/jac/47.suppl_1.1; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Liu B, 2015, EPIDEMIOL INFECT, V143, P2871, DOI 10.1017/S0950268814003653; MacIntyre R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125025; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Palmer L, 2014, TRANSPLANTATION, V97, P1178, DOI 10.1097/01.tp.0000441826.70687.f6; RAGOZZINO MW, 1982, MEDICINE, V61, P310, DOI 10.1097/00005792-198209000-00003; Sax Institute, DAT BOOKS PHARM BEN; Sax Institute, DAT BOOKS MED BEN SC; Stein AN, 2009, VACCINE, V27, P520, DOI 10.1016/j.vaccine.2008.11.012; STRAUS SE, 1988, ANN INTERN MED, V108, P221, DOI 10.7326/0003-4819-108-2-221; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; WATSON CPN, 1992, PAIN, V48, P29, DOI 10.1016/0304-3959(92)90128-X; WATSON PN, 1986, ARCH NEUROL-CHICAGO, V43, P836, DOI 10.1001/archneur.1986.00520080074027; Weaver BA, 2009, J AM OSTEOPATH ASSOC, V109, pS2; Yawn BP, 2009, MAYO CLIN PROC, V84, P787, DOI [10.4065/84.9.787, 10.1016/S0025-6196(11)60488-6]	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160446	10.1371/journal.pone.0160446	http://dx.doi.org/10.1371/journal.pone.0160446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483007	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700046
J	Mostowy, J; Monten, C; Gudjonsdottir, AH; Arnell, H; Browaldh, L; Nilsson, S; Agardh, D; Naluai, AT				Mostowy, Joanna; Monten, Caroline; Gudjonsdottir, Audur H.; Arnell, Henrik; Browaldh, Lars; Nilsson, Staffan; Agardh, Daniel; Naluai, Asa Torinsson			Shared Genetic Factors Involved in Celiac Disease, Type 2 Diabetes and Anorexia Nervosa Suggest Common Molecular Pathways for Chronic Diseases	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GENOME-WIDE ASSOCIATION; TISSUE TRANSGLUTAMINASE; INSULIN-RESISTANCE; MULTIPLE COMMON; EXPRESSION; MELLITUS; CD36; RISK; VARIANTS	Background and Objectives Genome-wide association studies (GWAS) have identified several genetic regions involved in immune-regulatory mechanisms to be associated with celiac disease. Previous GWAS also revealed an over-representation of genes involved in type 2 diabetes and anorexia nervosa associated with celiac disease, suggesting involvement of common metabolic pathways for development of these chronic diseases. The aim of this study was to extend these previous analyses to study the gene expression in the gut from children with active celiac disease. Material and Methods Thirty six target genes involved in type 2 diabetes and four genes associated with anorexia nervosa were investigated for gene expression in small intestinal biopsies from 144 children with celiac disease at median (range) age of 7.4 years (1.6-17.8) and from 154 disease controls at a median (range) age 11.4. years (1.4-18.3). Results A total of eleven of genes were differently expressed in celiac patients compared with disease controls of which CD36, CD38, FOXP1, SELL, PPARA, PPARG, AGT previously associated with type 2 diabetes and AKAP6, NTNG1 with anorexia nervosa remained significant after correction for multiple testing. Conclusion Shared genetic factors involved in celiac disease, type 2 diabetes and anorexia nervosa suggest common underlying molecular pathways for these diseases.	[Mostowy, Joanna; Naluai, Asa Torinsson] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Gothenburg, Sweden; [Monten, Caroline; Agardh, Daniel] Lund Univ, Dept Clin Sci, Diabet & Celiac Dis Unit, Malmo, Sweden; [Gudjonsdottir, Audur H.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Arnell, Henrik] Karolinska Univ Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Stockholm, Sweden; [Arnell, Henrik] Karolinska Inst, CLINTEC, Div Pediat, Stockholm, Sweden; [Browaldh, Lars] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Nilsson, Staffan] Chalmers, Dept Math Sci, Gothenburg, Sweden	University of Gothenburg; Lund University; University of Gothenburg; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Chalmers University of Technology	Naluai, AT (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Gothenburg, Sweden.	asa.torinsson.naluai@gu.se	Naluai, Åsa Torinsson/AAB-2166-2021; Naluai, Åsa Torinsson/P-3269-2015	Naluai, Åsa Torinsson/0000-0002-0504-6492; Naluai, Åsa Torinsson/0000-0002-0504-6492; Nilsson, Staffan/0000-0003-4748-0446	Bengt Ihre foundation; Swedish Society of Medicine; Professor Nanna Svartz foundation; Ruth and Richard Julin foundation; Clas Groschinskys foundation; Tore Nilson's foundation; Nilsson-Ehle's foundation; Ake Wiberg's foundation	Bengt Ihre foundation; Swedish Society of Medicine; Professor Nanna Svartz foundation; Ruth and Richard Julin foundation; Clas Groschinskys foundation; Tore Nilson's foundation; Nilsson-Ehle's foundation; Ake Wiberg's foundation	Bengt Ihre foundation ATN http://www.sls.se/Forskning-utbildning/Forskningsdelegationen-Prioriteringskommitten-/Bengt-Ihres-fond-/, Swedish Society of Medicine ATN http://www.sls.se/, Professor Nanna Svartz foundation ATN http://www.stiftelseansokan.se/Pages/Svartz.aspx, Ruth and Richard Julin foundation ATN https://internwebben.ki.se/en/ruth-and-richard-julin-foundation, Clas Groschinskys foundation ATN http://www.groschinsky.org/, Tore Nilson's foundation ATN http://www.torenilsonsstiftelse.nu/, Nilsson-Ehle's foundation ATN http://www.fysiografen.se/sv/stipendier/, and Ake Wiberg's foundation ATN http://ake-wiberg.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Alkhatatbeh MJ, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.1; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Byrne G, 2013, CLIN IMMUNOL, V147, P1, DOI 10.1016/j.clim.2013.01.007; Chen LH, 2014, PPAR RES, V2014, DOI 10.1155/2014/653017; Cupi ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100980; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Garner C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101428; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Handberg A, 2010, J CLIN ENDOCR METAB, V95, P1939, DOI 10.1210/jc.2009-2002; Hodgson HJF, 2000, COLOUR HDB GASTROENT, DOI [10.1038/ng.543, DOI 10.1038/NG.543]; Hrdlickova B, 2011, CLIN GENET, V80, P203, DOI 10.1111/j.1399-0004.2011.01707.x; Ikehata F, 1998, J CLIN INVEST, V102, P395, DOI 10.1172/JCI1656; Ilic V, 2014, VOJNOSANIT PREGL, V71, P627, DOI 10.2298/VSP1407627I; Jia ZJ, 2014, PPAR RES, V2014, DOI 10.1155/2014/818530; Kabbani TA, 2013, GASTROENTEROLOGY, V144, P912, DOI 10.1053/j.gastro.2013.01.033; Kamiuchi K, 2002, J DIABETES COMPLICAT, V16, P333, DOI 10.1016/S1056-8727(01)00226-4; Kanungo A, 2002, ANN NY ACAD SCI, V958, P232; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Konopka A, 2011, MOL DIAGN THER, V15, P167, DOI 10.2165/11590650-000000000-00000; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Lin L, 2009, TRENDS NEUROSCI, V32, P142, DOI 10.1016/j.tins.2008.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Mallone R, 2001, DIABETES, V50, P752, DOI 10.2337/diabetes.50.4.752; Monten C, 2016, SCAND J GASTROENTERO, V51, P427, DOI 10.3109/00365521.2015.1101486; Monten C, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0190-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Ohtsuki T, 2008, NEUROSCI LETT, V435, P194, DOI 10.1016/j.neulet.2008.02.053; Ostensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070174; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rubio-Tapia A, 2012, MAYO CLIN PROC, V87, P732, DOI 10.1016/j.mayocp.2012.06.003; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sharma A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152476; Simula MP, 2010, MOL MED, V16, P199, DOI 10.2119/molmed.2009.00173; Strachan T, 1999, HUMAN MOL GENETICS; Takeuchi F, 2012, HYPERTENS RES, V35, P825, DOI 10.1038/hr.2012.43; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walker MM, 2010, GASTROENTEROLOGY, V139, P112, DOI 10.1053/j.gastro.2010.04.007; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; Yang JC, 2008, PPAR RES, V2008, DOI 10.1155/2008/723243	48	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159593	10.1371/journal.pone.0159593	http://dx.doi.org/10.1371/journal.pone.0159593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483138	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700012
J	Kinoshita, K; Shimogiri, T; Ibrahim, HR; Tsudzuki, M; Maeda, Y; Matsuda, Y				Kinoshita, Keiji; Shimogiri, Takeshi; Ibrahim, Hisham R.; Tsudzuki, Masaoki; Maeda, Yoshizane; Matsuda, Yoichi			Identification of TENP as the Gene Encoding Chicken Egg White Ovoglobulin G2 and Demonstration of Its High Genetic Variability in Chickens	PLOS ONE			English	Article							PEPTIDE LIGAND LIBRARIES; PROTEIN POLYMORPHISMS; NATIVE CHICKEN; DOMESTIC-FOWL; FAMILY; BPI; NOMENCLATURE; CONSTITUENT; GLOBULIN; LYSOZYME	Ovoglobulin G2 (G2) has long been known as a major protein constituent of chicken egg white. However, little is known about the biochemical properties and biological functions of G2 because the gene encoding G2 has not been identified. Therefore, the identification of the gene encoding G2 and an analysis of its genetic variability is an important step toward the goal of understanding the biological functions of the G2 protein and its utility in poultry production. To identify and characterize the gene encoding G2, we separated G2 from egg white using electrophoresis on a non-denaturing polyacrylamide gel. Two polymorphic forms of G2 protein (G2(A) and G2(B)), with different mobilities (fast and slow respectively), were detected by staining. The protein band corresponding to G2B was electro-eluted from the native gel, re-electrophoresed under denaturing conditions and its N-terminal sequence was determined by Edman degradation following transfer onto a membrane. Sequencing of the 47 kDa G2(B) band revealed it to be identical to TENP (transiently expressed in neural precursors), also known as BPI fold-containing family B, member 2 (BPIFB2), a protein with strong homology to a bacterial permeability-increasing protein family (BPI) in mammals. Full-length chicken TENP cDNA sequences were determined for 78 individuals across 29 chicken breeds, lines, and populations, and consequently eleven non-synonymous substitutions were detected in the coding region. Of the eleven non-synonymous substitutions, A329G leading to Arg110Gln was completely associated with the noted differential electrophoretic mobility of G2. Specifically G2(B), with a slower mobility is encoded by A329 (Arg110), whereas G2(A), with a faster mobility, is encoded by G329 (Gln110). The sequence data, derived from the coding region, also revealed that the gene encoding G2 demonstrates significant genetic variability across different chicken breeds/lines/populations. These variants, and how they correlate with egg white properties, may allow us to understand further G2's functions.	[Kinoshita, Keiji; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan; [Shimogiri, Takeshi; Ibrahim, Hisham R.; Maeda, Yoshizane] Kagoshima Univ, Fac Agr, Kagoshima, Japan; [Tsudzuki, Masaoki] Hiroshima Univ, Grad Sch Biosphere Sci, Lab Anim Breeding & Genet, Higashihiroshima, Japan; [Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet, Nagoya, Aichi, Japan	Nagoya University; Kagoshima University; Hiroshima University; Nagoya University	Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi, Japan.; Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet, Nagoya, Aichi, Japan.	yoimasu@agr.nagoya-u.ac.jp	Kinoshita, Keiji/GVS-4163-2022; Ibrahim, Hisham/AAB-3945-2021	Ibrahim, Hisham/0000-0002-7809-900X	Japan Society for the Promotion of Science [12575026]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Kieikai Research Foundation; National BioResource Project, Chicken/Quail from the MEXT	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kieikai Research Foundation(Kieikai Research Foundation); National BioResource Project, Chicken/Quail from the MEXT	This research was supported by a Grant-in-Aid (No. 12575026 to Y. Matsuda) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/j-grantsinaid/index.html), from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, Kieikai Research Foundation (Grant number: not applicable, http://www.nakashimafoundation.org/kieikai/, to KK.), and the National BioResource Project (Grant number: not applicable, NBRP, http://www.nbrp.jp/) Chicken/Quail from the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne EDNS, 2013, POULTRY SCI, V92, P3292, DOI 10.3382/ps.2013-03391; ALDERTON G, 1945, J BIOL CHEM, V157, P43; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrault JB, 2003, GENOMICS, V82, P172, DOI 10.1016/S0888-7543(03)00102-2; Baker CM, 1971, COMP BIOCH PHYSL B, V15, P147, DOI [10.1016/0305-0491(71)90071-X, DOI 10.1016/0305-0491(71)90071-X]; BAKER CMA, 1968, GENETICS, V58, P211; BAKER CMA, 1970, ADV GENET, V15, P147, DOI 10.1016/S0065-2660(08)60073-5; BAKER CMA, 1968, EGG QUALITY STUDY HE, P67; Bingle CD, 2004, TRENDS IMMUNOL, V25, P53, DOI 10.1016/j.it.2003.11.007; Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977; BUVANENDRAN V., 1967, BR POULTRY SCI, V8, P119, DOI 10.1080/00071666708415657; Alleoni ACC, 2006, SCI AGR, V63, P291, DOI 10.1590/S0103-90162006000300013; Chiang SC, 2011, DEV COMP IMMUNOL, V35, P285, DOI 10.1016/j.dci.2010.09.013; D'Ambrosio C, 2008, J PROTEOME RES, V7, P3461, DOI 10.1021/pr800193y; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Farinazzo A, 2009, J CHROMATOGR A, V1216, P1241, DOI 10.1016/j.chroma.2008.11.051; FEENEY RE, 1963, J BIOL CHEM, V238, P1732; Gautron J, 2007, J BIOL CHEM, V282, P5273, DOI 10.1074/jbc.M610294200; GILMOUR DG, 1971, THEOR APPL GENET, V41, P57, DOI 10.1007/BF00277046; Gomi M., 2004, CHEM BIO INFORMATICS, V4, P142, DOI DOI 10.1273/CBIJ.4.142; Guerin-Dubiard C, 2006, J AGR FOOD CHEM, V54, P3901, DOI 10.1021/jf0529969; Gupta R., PREDICTION N GLYCOSY; Hollebeke J, 2012, BIOL CHEM, V393, P291, DOI 10.1515/hsz-2011-0228; Kinoshita K, 2002, ASIAN AUSTRAL J ANIM, V15, P157, DOI 10.5713/ajas.2002.157; Kushner HF, 1974, P 15 WORLDS POULT C, P497; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI-CHAN E, 1989, Critical Reviews in Poultry Biology, V2, P21; Longsworth LG, 1940, J AM CHEM SOC, V62, P2580, DOI 10.1021/ja01867a002; LUSH IE, 1961, NATURE, V189, P981, DOI 10.1038/189981a0; Maeda Y, 1992, ANIM SCI TECHNOL, V64, P327, DOI [10.2508/chikusan.64.327dx.doi.org/10.5713/ajas.2002.157, DOI 10.2508/CHIKUSAN.64.327]; Maehashi K, 2014, J AGR FOOD CHEM, V62, P5156, DOI 10.1021/jf5008117; Mann K, 2007, PROTEOMICS, V7, P3558, DOI 10.1002/pmic.200700397; Mann K, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-7; Merat P., 1990, POULTRY BREEDING GEN, P429; Myint SL, 2012, J ANIM SCI, V90, P1747, DOI 10.2527/jas.2011-4501; Myint SL, 2010, ASIAN AUSTRAL J ANIM, V23, P1137, DOI 10.5713/ajas.2010.90589; NAKAMURA R, 1980, AGR BIOL CHEM TOKYO, V44, P2357, DOI 10.1080/00021369.1980.10864333; OBEIDAH A, 1977, ANN GENET SEL ANIM, V9, P301, DOI 10.1186/1297-9686-9-3-301; OSUGA DT, 1977, FOOD PROTEINS, P209; PAVEL U, 1969, ACTA VET ACAD SCI H, V19, P211; SINGH H, 1981, BIOCHEM GENET, V19, P1031, DOI 10.1007/BF00504266; Spada FP, 2012, CIENCIA TECNOL ALIME, V32, P47, DOI 10.1590/S0101-20612012005000017; STEVENS L, 1988, BRIT POULTRY SCI, V29, P665, DOI 10.1080/00071668808417092; STEVENS L, 1991, COMP BIOCHEM PHYS B, V100, P1, DOI 10.1016/0305-0491(91)90076-P; TANABE H, 1980, Japanese Poultry Science, V17, P242; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vadehra D. V., 1973, CRC Critical Reviews in Food Technology, V4, P193; Whenham N, 2014, GENE, V538, P99, DOI 10.1016/j.gene.2013.12.065; Yan RT, 1998, J NEUROBIOL, V34, P319, DOI 10.1002/(SICI)1097-4695(199803)34:4<319::AID-NEU3>3.0.CO;2-9; Yang S. C., 1995, EGG SCI TECHNOLOGY, P405	51	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159571	10.1371/journal.pone.0159571	http://dx.doi.org/10.1371/journal.pone.0159571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472057	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300011
J	Terova, G; Diaz, N; Rimoldi, S; Ceccotti, C; Gliozheni, E; Piferrer, F				Terova, Genciana; Diaz, Noelia; Rimoldi, Simona; Ceccotti, Chiara; Gliozheni, Emi; Piferrer, Francesc			Effects of Sodium Butyrate Treatment on Histone Modifications and the Expression of Genes Related to Epigenetic Regulatory Mechanisms and Immune Response in European Sea Bass (Dicentrarchus Labrax) Fed a Plant-Based Diet	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; TROUT ONCORHYNCHUS-MYKISS; BREAM SPARUS-AURATA; GROWTH-PERFORMANCE; POSTTRANSLATIONAL MODIFICATIONS; DEACETYLASE INHIBITOR; MASS-SPECTROMETRY; COLONIC FUNCTION; PERFUSED LIVER; ORGANIC-ACIDS	Bacteria that inhabit the epithelium of the animals' digestive tract provide the essential biochemical pathways for fermenting otherwise indigestible dietary fibers, leading to the production of short-chain fatty acids (SCFAs). Of the major SCFAs, butyrate has received particular attention due to its numerous positive effects on the health of the intestinal tract and peripheral tissues. The mechanisms of action of this four-carbon chain organic acid are different; many of these are related to its potent regulatory effect on gene expression since butyrate is a histone deacetylase inhibitor that play a predominant role in the epigenetic regulation of gene expression and cell function. In the present work, we investigated in the European sea bass (Dicentrarchus labrax) the effects of butyrate used as a feed additive on fish epigenetics as well as its regulatory role in mucosal protection and immune homeostasis through impact on gene expression. Seven target genes related to inflammatory response and reinforcement of the epithelial defense barrier [tnf alpha (tumor necrosis factor alpha) il1 beta, (interleukin 1beta), il-6, il-8, il-10, and muc2 (mucin 2)] and five target genes related to epigenetic modifications [dicer1(double-stranded RNA-specific endoribonuclease), ehmt2 (euchromatic histone-lysine-N-methyltransferase 2), pcgf2 (polycomb group ring finger 2), hdac11 (histone deacetylase-11), and jarid2a (jumonji)] were analyzed in fish intestine and liver. We also investigated the effect of dietary butyrate supplementation on histone acetylation, by performing an immunoblotting analysis on liver core histone extracts. Results of the eight-week-long feeding trial showed no significant differences in weight gain or SGR (specific growth rate) of sea bass that received 0.2% sodium butyrate supplementation in the diet in comparison to control fish that received a diet without Na-butyrate. Dietary butyrate led to a twofold increase in the acetylation level of histone H4 at lysine 8, but showed no effect on the histone H3 at Lys9. Moreover, two different isoforms of histone H3 that might correspond to the H3.1 and H3.2 isoforms previously found in terrestrial animals were separated on the immunoblots. The expression of four (il1 beta, il8, irf1, and tnf alpha) out of seven analyzed genes related to mucosal protection and inflammatory response was significantly different between the two analyzed tissues but only il10 showed differences in expression due to the interaction between tissue and butyrate treatment. In addition, butyrate caused significant changes in vivo in the expression of genes related to epigenetic regulatory mechanisms such as hdac11, ehmt2, and dicer1. Statistical analysis by two-way ANOVA for these genes showed not only significant differences due to the butyrate treatment, but also due to the interaction between tissue and treatment.	[Terova, Genciana; Rimoldi, Simona; Ceccotti, Chiara; Gliozheni, Emi] Univ Insubria, Dept Biotechnol & Life Sci, Via JH Dunant 3, I-21100 Varese, Italy; [Diaz, Noelia; Piferrer, Francesc] CSIC, Inst Ciencies Mar, Passeig Maritim 37-49, E-08003 Barcelona, Spain; [Terova, Genciana] Polytech Univ Milan, Prot Factory, Interuniv Ctr Res Prot Biotechnol, Varese, Italy; [Terova, Genciana] Univ Insubria, Varese, Italy; [Diaz, Noelia] Max Planck Inst Mol Biomed, Rontgenstr 20, D-48149 Munster, Germany	University of Insubria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Polytechnic University of Milan; University of Insubria; Max Planck Society	Terova, G (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Via JH Dunant 3, I-21100 Varese, Italy.; Terova, G (corresponding author), Polytech Univ Milan, Prot Factory, Interuniv Ctr Res Prot Biotechnol, Varese, Italy.; Terova, G (corresponding author), Univ Insubria, Varese, Italy.	genciana.terova@uninsubria.it	Terova, Genciana/AAL-6412-2021; Díaz, Noelia/AAZ-6001-2020; Ceccotti, Chiara/ABF-6041-2021; Piferrer, Francesc/A-5634-2012; Terova, Genciana/G-1779-2010	Terova, Genciana/0000-0002-7532-7951; Díaz, Noelia/0000-0002-0319-3448; Piferrer, Francesc/0000-0003-0903-4736; Terova, Genciana/0000-0002-7532-7951; Rimoldi, Simona/0000-0002-1995-263X	ARRAINA [288925]	ARRAINA	This work has been funded under the seventh EU Framework Programme by the ARRAINA project No 288925: Advanced Research Initiatives for Nutrition & Aquaculture. Collaboration between the GT and FP labs was fostered by COST Action FA1201: Epigenetics and Periconception Environment ("Epiconcept"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this work are the sole responsibility of the authors and do not necessary reflect the views of the European Commission.	Agricola E, 2006, MOL MICROBIOL, V62, P1433, DOI 10.1111/j.1365-2958.2006.05451.x; Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Allen A, 1998, INT J BIOCHEM CELL B, V30, P797, DOI 10.1016/S1357-2725(98)00028-4; Beauvieux MC, 2001, J NUTR, V131, P1986, DOI 10.1093/jn/131.7.1986; Benedito-Palos L, 2016, AQUACULTURE, V454, P8, DOI 10.1016/j.aquaculture.2015.12.008; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Biancotto C, 2010, ADV GENET, V70, P341, DOI [10.1016/B978-0-12-380866-0.60013-7, 10.1016/S0065-2660(10)70013-4]; Bjerkeng B, 1999, AQUACULT NUTR, V5, P181; Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958; Bloemen JG, 2009, CLIN NUTR, V28, P657, DOI 10.1016/j.clnu.2009.05.011; Bonenfant D, 2006, MOL CELL PROTEOMICS, V5, P541, DOI 10.1074/mcp.M500288-MCP200; Brien JD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002230; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Canani RB, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-4; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; Chiappinelli KB, 2012, MOL CANCER RES, V10, P316, DOI 10.1158/1541-7786.MCR-11-0520; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; De Wet L., 2005, AQUA FEEDS FORMUL, V2, P12; DEMIGNE C, 1986, J NUTR, V116, P77, DOI 10.1093/jn/116.1.77; Diaz N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1862-0; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; EVANS J. A., 1998, THESIS; Facer K., 2006, FUTURELAB HAL, V1, P1; GALFI P, 1990, ACTA VET HUNG, V38, P3; Galfi P, 2001, FOOD RES INT, V34, P581, DOI 10.1016/S0963-9969(01)00075-8; Gallis JL, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-38; Gallis Jean-Louis, 2007, BMC Physiology, V7, P8, DOI 10.1186/1472-6793-7-8; Gansen A, 2015, NUCLEIC ACIDS RES, V43, P1433, DOI 10.1093/nar/gku1354; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gao YL, 2011, AQUACULTURE, V311, P233, DOI 10.1016/j.aquaculture.2010.11.048; Gislason G., 1994, Aquaculture and Fisheries Management, V25, P861, DOI 10.1111/j.1365-2109.1994.tb00750.x; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Hu ZH, 2007, ANIM FEED SCI TECH, V132, P240, DOI 10.1016/j.anifeedsci.2006.03.017; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kien CL, 2008, JPEN PARENTER ENTER, V32, P366; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Koprinarova M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-49; Kotunia A, 2004, J Physiol Pharmacol, V55 Suppl 2, P59; Kumar BM, 2007, J REPROD DEVELOP, V53, P903, DOI 10.1262/jrd.18180; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Liu WS, 2014, BRIT J NUTR, V112, P15, DOI 10.1017/S0007114514000610; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Luckstadt C., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, DOI 10.1079/PAVSNNR20083044; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Matis G, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-12; Miller SJ, 2004, MINI-REV MED CHEM, V4, P839, DOI 10.2174/1389557043403288; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Overland M, 2008, LIVEST SCI, V115, P169, DOI 10.1016/j.livsci.2007.07.007; Overland M, 2000, J ANIM SCI, V78, P1875; Pandey A, 2008, FISHERIES SCI, V74, P867, DOI 10.1111/j.1444-2906.2008.01601.x; Paskova L, 2013, TOXICOL IN VITRO, V27, P1489, DOI 10.1016/j.tiv.2013.03.002; Piferrer F, 2013, DEV DYNAM, V242, P360, DOI 10.1002/dvdy.23924; Robles R, 2013, FISH PHYSIOL BIOCHEM, V39, P1567, DOI 10.1007/s10695-013-9809-3; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scollo G, 2012, DOES BUTYRATE HAVE R; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Takahashi H, 2012, NAT NEUROSCI, V15, P389, DOI 10.1038/nn.3040; Tine M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6770; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; Toden S, 2007, CANCER BIOL THER, V6, pe1; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vielma J, 1999, AQUACULT NUTR, V5, P65, DOI 10.1046/j.1365-2095.1999.00092.x; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Vinolo MAR, 2009, CELL BIOCHEM FUNCT, V27, P48, DOI 10.1002/cbf.1533; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zhang KL, 2002, ANAL BIOCHEM, V306, P259, DOI 10.1006/abio.2002.5719; Zheng R.G., 2009, THESIS; Zhou ZG, 2009, AQUACULTURE, V291, P89, DOI 10.1016/j.aquaculture.2009.02.043	80	54	56	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160332	10.1371/journal.pone.0160332	http://dx.doi.org/10.1371/journal.pone.0160332			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27471849	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300042
J	Barma, M; Goodbrand, JA; Donnan, PT; McGilchrist, MM; Frost, H; McMurdo, MET; Witham, MD				Barma, Maryam; Goodbrand, James A.; Donnan, Peter T.; McGilchrist, Mark M.; Frost, Helen; McMurdo, Marion E. T.; Witham, Miles D.			Slower Decline in C-Reactive Protein after an Inflammatory Insult Is Associated with Longer Survival in Older Hospitalised Patients	PLOS ONE			English	Article							MORTALITY; REHABILITATION; PREDICTION; DISEASE; RISK	Background Enhancing biological resilience may offer a novel way to prevent and ameliorate disease in older patients. We investigated whether changes in C-reactive protein (CRP), as a dynamic marker of the acute inflammatory response to diverse stressors, may provide a way to operationalize the concept of resilience in older adults. We tested this hypothesis by examining whether such changes could predict prognosis by identifying which individuals are at greater risk of 6-month mortality. Methods Analysis of prospective, routinely collected datasets containing data on hospitalization, clinical chemistry and rehabilitation outcomes for rehabilitation inpatients between 1999 and 2011. Maximum CRP response during acute illness and CRP recovery indices (time and slope of CRP decay to half maximum, and to <50mg/L if peak values were greater than 50mg/L) was derived from biochemistry data. 6-month survival plots were conducted on quartiles of CRP recovery indices. Cox proportional hazards models were used to test univariate and multivariate predictors of 6-month mortality. Covariates included age, sex, number of medications, serum calcium, haemoglobin level, renal function, and the presence of previous myocardial infarction, stroke, chronic heart failure, COPD and diabetes. Results 3723 patients, mean age 84 years, were included. 1535 (41%) were male and 733 (20%) died during six-month follow-up. The lower an individual's peak CRP reading, and the longer the time taken for their CRP to fall, the better their 6-month survival. The time for CRP to reach half of its maximum value was the best dynamic CRP index of survival (HR 0.93 per week, 95% CI 0.89 to 0.98; p = 0.004); this remained significant even after adjustment for maximum CRP level and covariates listed above. Conclusion CRP recovery indices are associated with survival in older people; further work is required to explain differences in physiology between patients with a fast and slow CRP recovery.	[Barma, Maryam; Goodbrand, James A.; McMurdo, Marion E. T.; Witham, Miles D.] Univ Dundee, Ninewells Hosp, Ageing & Hlth, Dundee, Scotland; [Donnan, Peter T.] Univ Dundee, Med Res Inst, Dundee Epidemiol & Biostat Unit, Dundee, Scotland; [McGilchrist, Mark M.] Univ Dundee, Hlth Informat Ctr, Tayside Med Sci Ctr, Dundee, Scotland; [Frost, Helen] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Stirling	Witham, MD (corresponding author), Univ Dundee, Ninewells Hosp, Ageing & Hlth, Dundee, Scotland.	m.witham@dundee.ac.uk		Frost, Helen/0000-0001-9241-8970; Witham, Miles/0000-0002-1967-0990; Donnan, Peter/0000-0001-7828-0610	Chief Scientist Office, Scottish Government [SCPH/10]; Dundee Clinical Academic Track; British Geriatrics Society; Chief Scientist Office [SCPH/10] Funding Source: researchfish	Chief Scientist Office, Scottish Government; Dundee Clinical Academic Track; British Geriatrics Society; Chief Scientist Office	This work was supported by Chief Scientist Office, Scottish Government, Grant number: SCPH/10 (http://www.cso.scot.nhs.uk/funding-2/) to MDW, METM, HF, and MMM; Dundee Clinical Academic Track (http://dcat.cmdn.dundee.ac.uk) to MB; and British Geriatrics Society (http://www.bgs.org.uk) to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaz Teslime, 2014, J Aging Res, V2014, P584315, DOI 10.1155/2014/584315; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Budui SL, 2015, CLIN CASES MINER BON, V12, P22, DOI 10.11138/ccmbm/2015.12.1.022; Cao ZX, 2006, EXP BIOL MED, V231, P1353, DOI 10.1177/153537020623100809; Cervoni JP, 2012, J HEPATOL, V56, P1299, DOI 10.1016/j.jhep.2011.12.030; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Doyle EM, 2015, AM J KIDNEY DIS, V66, P768, DOI 10.1053/j.ajkd.2015.04.041; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu A, 2010, AGE AGEING, V39, P559, DOI 10.1093/ageing/afq067; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Scirica BM, 2006, CIRCULATION, V113, P2128, DOI 10.1161/CIRCULATIONAHA.105.611350; Semple SJ, 2006, S AFR J SPORTS MED, V18, P24, DOI [10.17159/2078-516X/2006/v18i1a249, DOI 10.17159/2078-516X/2006/V18I1A249]; Sung KC, 2014, EUR HEART J, V35, P1809, DOI 10.1093/eurheartj/ehu059; Tett P, 2013, MAR ECOL PROG SER, V494, P1, DOI 10.3354/meps10539; Wade D T, 1988, Int Disabil Stud, V10, P64; Walker B, 2004, ECOL SOC, V9; Witham MD, 2015, EUR GERIATR MED, V6, P101, DOI 10.1016/j.eurger.2014.12.008; Witham MD, 2011, ARCH PHYS MED REHAB, V92, P1288, DOI 10.1016/j.apmr.2011.02.019; Zhang ZH, 2014, J CRIT CARE, V29, P88, DOI 10.1016/j.jcrc.2013.09.002	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159412	10.1371/journal.pone.0159412	http://dx.doi.org/10.1371/journal.pone.0159412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467771	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100031
J	Lefebvre, M; Renard, J				Lefebvre, Muriel; Renard, Julie			The Circulation of Scientific Articles in the Sphere of Web-Based Media: Citation Practices, Communities of Interests and Local Ties	PLOS ONE			English	Article							SCIENCE; IMPACT	On 5th December 2012, a scientific article reviewing a change in the feeding behaviour of the European catfish, one of the largest freshwater fish, was published in the American scientific journal, PLOS ONE, an open access journal, which also allows the mass publication of pictures and videos. Within a few days following the publication of this article, it was relayed by numerous web sites and generated a media craze. In this paper, we analyse the circulation of this scientific information in the sphere of Web-based media during the two months following its publication, by revealing the citation mechanisms of the original article and the logic of the Internet users participating in its diffusion. In addition, since the circulation of its informational content travelled beyond linguistic and geographical boundaries, we chose to compare the citation modalities and intertextual relationships of documents in the three countries where the article spread the most widely, namely: France, the United States and Great Britain. Even though our study shows that the media circulation of scientific papers operates in a traditional way, the intertextual analysis underlines the grand variety of participants (such as journalists, non-scientists, fishermen, technology enthusiasts and Internet users) involved in the diffusion of this information, each of them mobilizing different intertextual strategies, according to their various targets. They all transformed, reformulated and appropriated the scientific information according to their own, unique interests. This study also emphasizes the importance of journalistic websites as opinion relays. They were the first diffusers involved in spreading the information but this role was rarely acknowledged by the Internet users - through citations, for example. In contrast, we observed that amateurs' communities (communities of practices and communities of interest of fishermen or of buzz fans), which only became involved in a second temporal phase of the spreading, preferred to build up their credibility through citations of the original article. Finally, this research helps to rethink the mechanisms of the circulation of scientific information in the Web-based media, highlighting both the variety and the inventiveness of the interactions between the academic and public spheres.	[Lefebvre, Muriel; Renard, Julie] Univ Toulouse, LERASS, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lefebvre, M (corresponding author), Univ Toulouse, LERASS, Toulouse, France.	muriel.lefebvre@ut-capitole.fr			French research founding agency (ANR) through the program RESOCIT "Citations scientifiques et reseaux sociaux" [ANR-11-BSH1-0013]; ECOLAB (Laboratoire d'Ecologie Fonctionnelle et Environnement), Toulouse, France	French research founding agency (ANR) through the program RESOCIT "Citations scientifiques et reseaux sociaux"(French National Research Agency (ANR)); ECOLAB (Laboratoire d'Ecologie Fonctionnelle et Environnement), Toulouse, France	This research was supported by: The French research founding agency (ANR) through the program RESOCIT "Citations scientifiques et reseaux sociaux" (ANR-11-BSH1-0013), and ECOLAB (Laboratoire d'Ecologie Fonctionnelle et Environnement), Toulouse, France.	Amossy R., 2010, ARGUMENTATION DISCOU, V3rd; Bensaude-Vincent B, 2013, SCI COMMUNICATION TO, P105; Bornmann L, 2013, J AM SOC INF SCI TEC, V64, P217, DOI 10.1002/asi.22803; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Boure R, 2013, QUESTIONS COMMUNICAT, V24, P169; Boure R, 2015, ENJEUX INFORM COMMUN, V16, p[143, 152]; Bowman S., 2003, WE MEDIA AUDIENCES A; Callon M, 2001, AGIR MONDE INCERTAIN; Cheung C, 2013, JASIST; Cronin B, 2014, BEYOND BIBLIOMETRICS: HARNESSING MULTIDIMENSIONAL INDICATORS OF SCHOLARLY IMPACT, P3; Cucherousset J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050840; De Certeau M, 1990, INVENTION QUOTIDIEN; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; Groth P, 2010, WEB SCI C 2010 APR 2; Jenkins Henry, 2008, CONVERGENCE CULTURE; Katz E., 1955, PERSONAL INFLUENCE P; Lariviere V, 2006, SCIENTOMETRICS, V68, P519, DOI 10.1007/s11192-006-0127-8; Luzon M-J, 2008, JASIST; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Metcalf J, 2013, SCI COMMUNICATION TO, P209; Nowotny H., 2001, RETHINKING SCI KNOWL; Rangel M, 2013, PHYTOCHEM REV, V12, P543, DOI 10.1007/s11101-012-9240-x; Schafer M, 2010, PUBLIC UNDERSTA 1201; Schiele B., 2013, SCI COMMUNICATION TO, P305; Shema H, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035869, 10.4161/psb.19467]; Thelwall M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064841; Wallace ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033339; Watts D. J., 2007, J CONSUMER RES; Wenger E., 1999, COMMUNITIES PRACTICE; Yan KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019917	31	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0158393	10.1371/journal.pone.0158393	http://dx.doi.org/10.1371/journal.pone.0158393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467573	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100009
J	Wang, LZ; Zhou, ML; Wang, JW; Wu, D; Yan, T				Wang, L. Z.; Zhou, M. L.; Wang, J. W.; Wu, D.; Yan, T.			The Effect of Dietary Replacement of Ordinary Rice with Red Yeast Rice on Nutrient Utilization, Enteric Methane Emission and Rumen Archaeal Diversity in Goats	PLOS ONE			English	Article							PURPUREUS-FERMENTED RICE; MONASCUS-PURPUREUS; PHYLOGENETIC ANALYSIS; METHANOGENIC ARCHAEA; MOLECULAR DIVERSITY; DAIRY-COWS; SHEEP; BIOSYNTHESIS; REDUCTASE; INHIBITION	Twenty castrated Boer crossbred goats were used in the present study with two treatments to examine the effect of dietary replacement of ordinary rice with red yeast rice on nutrient utilization, enteric methane emission and ruminal archaea structure and composition. Two treatment diets contained (DM basis) 70.0% of forage, 21.8% of concentrates and 8.2% of either ordinary rice (control) or red yeast rice (RYR). Nutrient utilization was measured and enteric methane emissions were determined in respiration chambers. Results showed that RYR had significantly lower digestibility of N and organic matter compared to control group. However, feeding red yeast rice did not affect N retention as g/d or a proportion of N intake, and reduced heat production as MJ/d or as a proportion of metabolizable energy intake, thus leading to a higher proportion of metabolizable energy intake to be retained in body tissue. RYR also had significantly lower methane emissions either as g/d, or as a proportion of feed intake. Although feeding red yeast rice had no negative effect on any rumen fermentation variables, it decreased serum contents of total cholesterol, triglycerides, HDL-cholesterol and LDL-cholesterol. In the present study, 75616 archaeal sequences were generated and clustered into 2364 Operational Taxonomic Units. At the genus level, the predominant archaea in the rumen of goats was Methanobrevibacter, which was significantly inhibited with the supplementation of red yeast rice. In conclusion, red yeast rice is a potential feed ingredient for mitigation of enteric methane emissions of goats. However, caution should be taken when it is used because it may inhibit the digestibility of some nutrients. Further studies are required to evaluate its potential with different diets and animal species, as well as its effects on animal health and food safety.	[Wang, L. Z.; Zhou, M. L.; Wang, J. W.; Wu, D.; Yan, T.] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Peoples R China; [Wang, L. Z.; Yan, T.] Agri Food & Biosci Inst, Hillsborough, Co Down, North Ireland	Sichuan Agricultural University; Agri-Food & Biosciences Institute	Yan, T (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Peoples R China.; Yan, T (corresponding author), Agri Food & Biosci Inst, Hillsborough, Co Down, North Ireland.	Tianhai.Yan@afbini.gov.uk		Wang, Jiwen/0000-0001-8568-7654	Chinese Ministry of Sciences and Technology [2014DFA32860]	Chinese Ministry of Sciences and Technology	This work was funded by Chinese Ministry of Sciences and Technology (http://www.most.gov.cn/eng/), the grant number: 2014DFA32860). LZ Wang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TC, 2001, AM J MED, V111, P185, DOI 10.1016/S0002-9343(01)00799-9; Bhandari SK, 2007, J DAIRY SCI, V90, P2355, DOI 10.3168/jds.2006-609; Bochar DA, 1997, J BACTERIOL, V179, P3632, DOI 10.1128/jb.179.11.3632-3638.1997; BROUWER E, 1965, P 3 S EN MET, P441; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cheng YF, 2009, LETT APPL MICROBIOL, V48, P585, DOI 10.1111/j.1472-765X.2009.02583.x; COTTYN BG, 1968, J AGR FOOD CHEM, V16, P105, DOI 10.1021/jf60155a002; Cunha IS, 2011, ANAEROBE, V17, P118, DOI 10.1016/j.anaerobe.2011.04.018; DEROSA M, 1986, MICROBIOL REV, V50, P70, DOI 10.1128/MMBR.50.1.70-80.1986; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Grieco A, 2009, J HEPATOL, V50, P1273, DOI 10.1016/j.jhep.2009.02.021; Grochowski LL, 2006, J BACTERIOL, V188, P3192, DOI 10.1128/JB.188.9.3192-3198.2006; Guo W, 2015, ANAEROBE, V34, P74, DOI 10.1016/j.anaerobe.2015.04.010; HOLTER JB, 1992, J DAIRY SCI, V75, P2165, DOI 10.3168/jds.S0022-0302(92)77976-4; Hristov AN, 2012, J ANIM SCI, V90, P4449, DOI 10.2527/jas.2011-4624; Huang XD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-237; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jahromi MF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/397934; Jahromi MF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/604721; Johnson DE, 1993, ATMOSPHERIC METHANE; Klevenhusen F, 2011, ARCH ANIM NUTR, V65, P255, DOI 10.1080/1745039X.2011.588845; LAM WL, 1992, J BIOL CHEM, V267, P5829; Li Y, 2013, IEEE PHOTONICS J, V5, DOI 10.1109/JPHOT.2013.2271718; Miller TL, 2001, J DAIRY SCI, V84, P1445, DOI 10.3168/jds.S0022-0302(01)70177-4; Miller TL, 1999, United States patent US, Patent No. [5,985,907, 5985907]; MOORE RN, 1985, J AM CHEM SOC, V107, P3694, DOI 10.1021/ja00298a046; Morgavi DP, 2013, J ANIM SCI, V91, P848, DOI 10.2527/jas.2012-5665; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; Pascual-Ahuir A, 2014, NUTRIENTS, V6, P2077, DOI 10.3390/nu6052077; Prasad GVR, 2002, TRANSPLANTATION, V74, P1200, DOI 10.1097/01.TP.0000031950.34040.79; Ramirez-Restrepo CA, 2014, ANIM PROD SCI, V54, P1294, DOI 10.1071/AN14246; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Soliva CR, 2011, BRIT J NUTR, V106, P114, DOI 10.1017/S0007114510005684; Tajima K, 2001, FEMS MICROBIOL LETT, V200, P67, DOI 10.1111/j.1574-6968.2001.tb10694.x; Wang JX, 1997, CURR THER RES CLIN E, V58, P964, DOI 10.1016/S0011-393X(97)80063-X; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei W, 2003, J NUTR BIOCHEM, V14, P314, DOI 10.1016/S0955-2863(03)00051-2; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Wigger-Alberti W, 1999, ALLERGY, V54, P1330, DOI 10.1034/j.1398-9995.1999.00374.x; Wright ADG, 2006, ANAEROBE, V12, P134, DOI 10.1016/j.anaerobe.2006.02.002; Wright ADG, 2004, APPL ENVIRON MICROB, V70, P1263, DOI 10.1128/AEM.70.3.1263-1270.2004; Yanagita K, 2000, BIOSCI BIOTECH BIOCH, V64, P1737, DOI 10.1271/bbb.64.1737	43	12	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160198	10.1371/journal.pone.0160198	http://dx.doi.org/10.1371/journal.pone.0160198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467559	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100129
J	Baranyi, A; Amouzadeh-Ghadikolai, O; von Lewinski, D; Rothenhausler, HB; Theokas, S; Robier, C; Mangge, H; Reicht, G; Hlade, P; Meinitzer, A				Baranyi, Andreas; Amouzadeh-Ghadikolai, Omid; von Lewinski, Dirk; Rothenhaeusler, Hans-Bernd; Theokas, Simon; Robier, Christoph; Mangge, Harald; Reicht, Gerhard; Hlade, Peter; Meinitzer, Andreas			Branched-Chain Amino Acids as New Biomarkers of Major Depression - A Novel Neurobiology of Mood Disorder	PLOS ONE			English	Article							ALPHA-INDUCED DEPRESSION; MTOR SIGNALING PATHWAY; TRYPTOPHAN; SYMPTOMS	Background The proteinogenic branched-chain amino acids (BCAAs) valine, leucine and isoleucine might play an unrecognised crucial role in the development of depression through their activation of the mammalian target of rapamycin (mTor) pathway. The aim of this research project is to evaluate whether BCAAs are altered in patients with major depression and might thus be appropriate biomarkers for major depression. Methods The concentrations of valine, leucine and isoleucine were determined in 71 in-patients with major depression and 48 healthy controls by high-pressure liquid chromatography. Psychiatric and laboratory assessments were obtained at the time of in-patient admittance. Results The BCAAs are significantly decreased in patients with major depression in comparison with healthy subjects (valine: Mann-Whitney-U: 968.0; p < 0.0001, leucine: Mann-Whitney-U: 1246.5; p = 0.013, isoleucine: Mann-Whitney-U: 1252.5; p = 0.014). Furthermore, as shown by Spearman's rank correlation coefficients, there is a significant negative correlation between valine, leucine and isoleucine concentrations and the Hamilton Depression Rating Scale (HAMD-17) as well as Beck Depression Inventory (BDI-II) scores. Conclusions Our study results are strong evidence that in patients with major depression, BCAAs might be appropriate biomarkers for depression. Reduced activation of the mammalian target of rapamycin (mTor) due to a reduction of BCAAs might play a crucial unrecognised factor in the etiology of depression and may evoke depressive symptomatology and lower energy metabolism in patients with major depression. In the future, mTor and its up- and down-stream signalling partners might be important targets for the development of novel antidepressants.	[Baranyi, Andreas; Rothenhaeusler, Hans-Bernd; Theokas, Simon] Med Univ Graz, Dept Psychiat & Psychotherapeut Med, Graz, Austria; [Baranyi, Andreas] ARU Cambridge, Inst Int Management Practice, Cambridge, England; [Amouzadeh-Ghadikolai, Omid; Robier, Christoph; Reicht, Gerhard; Hlade, Peter] Hosp Bros St John God, Graz, Austria; [von Lewinski, Dirk] Med Univ Graz, Div Cardiol, Dept Internal Med, Graz, Austria; [Robier, Christoph; Mangge, Harald; Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	von Lewinski, D (corresponding author), Med Univ Graz, Div Cardiol, Dept Internal Med, Graz, Austria.	dirk.von-lewinski@medunigraz.at		Mangge, Harald/0000-0003-4067-247X; Baranyi, Andreas/0000-0003-2389-1945; Rothenhausler, Hans-Bernd/0000-0002-8857-8557				Abelaira HM, 2014, LIFE SCI, V101, P10, DOI 10.1016/j.lfs.2014.02.014; Aquilani R, 2008, ARCH PHYS MED REHAB, V89, P1642, DOI 10.1016/j.apmr.2008.02.023; Baranyi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143397; Baranyi A, 2014, PSYCHOTHER PSYCHOSOM, V83, P312, DOI 10.1159/000362765; Baranyi A, 2013, PSYCHOTHER PSYCHOSOM, V82, P332, DOI 10.1159/000348587; Batch BC, 2014, CURR OPIN CLIN NUTR, V17, P86, DOI 10.1097/MCO.0000000000000010; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Blomstrand E, 2006, J NUTR, V136, p269S, DOI 10.1093/jn/136.1.269S; Capuron L, 2002, MOL PSYCHIATR, V7, P468, DOI 10.1038/sj.mp.4000995; Chandran A, 2013, PROG NEURO-PSYCHOPH, V40, P240, DOI 10.1016/j.pnpbp.2012.08.001; DiazGranados N, 2010, J CLIN PSYCHIAT, V71, P1605, DOI 10.4088/JCP.09m05327blu; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Gluud LL, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001939.pub2; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hirota K, 1996, BRIT J ANAESTH, V77, P441, DOI 10.1093/bja/77.4.441; Jernigan CS, 2011, PROG NEURO-PSYCHOPH, V35, P1774, DOI 10.1016/j.pnpbp.2011.05.010; Kumar MA, 2012, SAUDI J KIDNEY DIS T, V23, P1202, DOI 10.4103/1319-2442.103560; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; LUCCA A, 1994, NEUROPSYCHOBIOLOGY, V29, P108, DOI 10.1159/000119071; Melnik BC, 2012, WORLD J DIABETES, V3, P38, DOI 10.4239/wjd.v3.i3.38; Michaliszyn SF, 2012, J CLIN ENDOCR METAB, V97; Murin R, 2009, NEUROCHEM RES, V34, P1195, DOI 10.1007/s11064-008-9895-2; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Schwarz EL, 2005, CLIN CHIM ACTA, V354, P83, DOI 10.1016/j.cccn.2004.11.016; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Warren BL, 2011, J NEUROSCI, V31, P10347, DOI 10.1523/JNEUROSCI.1470-11.2011; Webhofer C, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.56; Wichers MC, 2005, MOL PSYCHIATR, V10, P538, DOI 10.1038/sj.mp.4001600; Xu QW, 2011, J BIOMOL NMR, V49, P207, DOI 10.1007/s10858-011-9482-8; Yang C, 2013, BIOL PSYCHIAT, V73, pE35, DOI 10.1016/j.biopsych.2012.07.022; Yu JJ, 2013, PSYCHOPHARMACOLOGY, V225, P361, DOI 10.1007/s00213-012-2823-9	32	38	39	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160542	10.1371/journal.pone.0160542	http://dx.doi.org/10.1371/journal.pone.0160542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490818	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900066
J	Blaya, J; Marhuenda, FC; Pascual, JA; Ros, M				Blaya, Josefa; Marhuenda, Frutos C.; Pascual, Jose A.; Ros, Margarita			Microbiota Characterization of Compost Using Omics Approaches Opens New Perspectives for Phytophthora Root Rot Control	PLOS ONE			English	Article							ANTIFUNGAL ACTIVITY; CONTAINER MEDIA; FUSARIUM-WILT; DAMPING-OFF; C-13 NMR; SOIL; SUPPRESSION; METABOLOMICS; COMMUNITY; PEPPER	Phytophthora root rot caused by Phytophthora nicotianae is an economically important disease in pepper crops. The use of suppressive composts is a low environmental impact method for its control. Although attempts have been made to reveal the relationship between microbiota and compost suppressiveness, little is known about the microorganisms associated with disease suppression. Here, an Ion Torrent platform was used to assess the microbial composition of composts made of different agro-industrial waste and with different levels of suppressiveness against P. nicotianae. Both bacterial and fungal populations responded differently depending on the chemical heterogeneity of materials used during the composting process. High proportions (67-75%) of vineyard pruning waste were used in the most suppressive composts, COM-A and COM-B. This material may have promoted the presence of higher relative abundance of Ascomycota as well as higher microbial activity, which have proved to be essential for controlling the disease. Although no unique fungi or bacteria have been detected in neither suppressive nor conducive composts, relatively high abundance of Fusarium and Zopfiella were found in compost COM-B and COM-A, respectively. To the best of our knowledge, this is the first work that studies compost metabolome. Surprisingly, composts and peat clustered together in principal component analysis of the metabolic data according to their levels of suppressiveness achieved. This study demonstrated the need for combining the information provided by different techniques, including metagenomics and metametabolomics, to better understand the ability of compost to control plant diseases.	[Blaya, Josefa; Pascual, Jose A.; Ros, Margarita] Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Soil & Water Conservat & Organ Wastes Manage, Murcia, Spain; [Marhuenda, Frutos C.] Univ Alicante, Dept Agrochem & Biochem, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); Universitat d'Alacant	Blaya, J (corresponding author), Ctr Edafol & Biol Aplicada Segura CEBAS CSIC, Dept Soil & Water Conservat & Organ Wastes Manage, Murcia, Spain.	pepabf@gmail.com	pascual, Jose/I-9021-2012; Ros, Margarita M/L-7081-2014; Marhuenda-Egea, Frutos Carlos/B-3412-2018	pascual, Jose/0000-0001-7485-1092; Ros, Margarita M/0000-0002-0375-7004; Marhuenda-Egea, Frutos Carlos/0000-0002-0402-9770	LIFE project AGROWASTE [LIFE10/ENV/ES/469]	LIFE project AGROWASTE	This work was supported by LIFE project AGROWASTE (LIFE10/ENV/ES/469) http://ec.europa.eu/environment/life/.	Almendros G, 2000, SOIL BIOL BIOCHEM, V32, P793, DOI 10.1016/S0038-0717(99)00202-3; Andres JL, 2003, J PLANT PATHOL, V85, P91; [Anonymous], 1993, P 11 INT S ENV BIOG; Aviles M., 2011, Dynamic Soil, Dynamic Plant, V5, P1; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004; Blaya J, 2015, J SCI FOOD AGR, V95, P1482, DOI 10.1002/jsfa.6847; Blaya J, 2015, J SCI FOOD AGR, V95, P1243, DOI 10.1002/jsfa.6813; Boehm MJ, 1997, APPL ENVIRON MICROB, V63, P162, DOI 10.1128/AEM.63.1.162-168.1997; Bonanomi G, 2010, SOIL BIOL BIOCHEM, V42, P136, DOI 10.1016/j.soilbio.2009.10.012; Borrero C, 2004, PHYTOPATHOLOGY, V94, P1094, DOI 10.1094/PHYTO.2004.94.10.1094; Castano R, 2011, BIOL CONTROL, V58, P286, DOI 10.1016/j.biocontrol.2011.05.011; CHEN W, 1988, PHYTOPATHOLOGY, V78, P1447, DOI 10.1094/Phyto-78-1447; Cline E.T., 2008, PLANT HLTH PROG, V9, DOI [10.1094/PHP-2008-0318-01-RV, DOI 10.1094/PHP-2008-0318-01-RS, DOI 10.1094/PHP-2008-0318-01-RV]; Cuesta G, 2012, J ENVIRON MANAGE, V95, pS280, DOI 10.1016/j.jenvman.2010.11.023; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; Darine T, 2007, PHYSIOL MOL PLANT P, V70, P142, DOI 10.1016/j.pmpp.2007.08.002; De Gannes V, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00164; de Gannes V, 2013, BIORESOURCE TECHNOL, V133, P573, DOI 10.1016/j.biortech.2013.01.138; Erwin DC, 1986, PHYTOPHTHORA DIS WOR, P391; Forte C, 2006, SOLID STATE NUCL MAG, V30, P81, DOI 10.1016/j.ssnmr.2006.03.001; FUSHIMI S, 1989, J ANTIBIOT, V42, P1019, DOI 10.7164/antibiotics.42.1019; Futagawa M, 2002, PESTIC BIOCHEM PHYS, V73, P87, DOI 10.1016/S0048-3575(02)00023-8; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gu Y, 2009, EUR J SOIL BIOL, V45, P436, DOI 10.1016/j.ejsobi.2009.06.003; Hadar Y, 2012, ANNU REV PHYTOPATHOL, V50, P133, DOI 10.1146/annurev-phyto-081211-172914; HARDY GES, 1995, SOIL BIOL BIOCHEM, V27, P243, DOI 10.1016/0038-0717(94)00172-W; Hayes MA, 2012, BIOSCIENCE, V62, P819, DOI 10.1525/bio.2012.62.9.7; Hernandez-Soriano MC, 2014, ENVIRONMENTAL RISK ASSESSMENT OF SOIL CONTAMINATION, P459, DOI 10.5772/58294; Hoitink HAJ, 1999, ANNU REV PHYTOPATHOL, V37, P427, DOI 10.1146/annurev.phyto.37.1.427; Hoitink HAJ, 1997, HORTSCIENCE, V32, P184, DOI 10.21273/HORTSCI.32.2.184; HWANG BK, 1994, CAN J BOT, V72, P480, DOI 10.1139/b94-064; Insam H, 2007, WASTE MANAG SER, V8, P25; Jones OAH, 2014, ENVIRON TOXICOL CHEM, V33, P61, DOI 10.1002/etc.2418; Jones OAH, 2013, AUSTRAL ECOL, V38, P713, DOI 10.1111/aec.12019; Kim HY, 2007, LETT APPL MICROBIOL, V44, P332, DOI 10.1111/j.1472-765X.2006.02093.x; Klammer S, 2008, WASTE MANAGE RES, V26, P173, DOI 10.1177/0734242X07084113; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Lopez-Gonzalez JA, 2015, BIORESOURCE TECHNOL, V175, P406, DOI 10.1016/j.biortech.2014.10.123; Lopez-Mondejar R, 2010, BIORESOURCE TECHNOL, V101, P3718, DOI 10.1016/j.biortech.2009.12.102; Milner JL, 1996, APPL ENVIRON MICROB, V62, P3061, DOI 10.1128/AEM.62.8.3061-3065.1996; Morales-Rodriguez C, 2014, PLANT DIS, V98, P77, DOI 10.1094/PDIS-04-13-0393-RE; Musso L, 2012, CHEM BIOL DRUG DES, V79, P780, DOI 10.1111/j.1747-0285.2012.01343.x; Neher DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079512; NELSON EB, 1983, PHYTOPATHOLOGY, V73, P1457, DOI 10.1094/Phyto-73-1457; Ntougias S, 2008, BIOL FERT SOILS, V44, P1081, DOI 10.1007/s00374-008-0295-1; Pane C, 2011, BIOL CONTROL, V56, P115, DOI 10.1016/j.biocontrol.2010.10.002; Penton CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093893; Quilchano C, 2002, BIOL FERT SOILS, V35, P102, DOI 10.1007/s00374-002-0446-8; Rastogi G, 2011, MICROBES AND MICROBIAL TECHNOLOGY: AGRICULTURAL AND ENVIRONMENTAL APPLICATIONS, P29, DOI 10.1007/978-1-4419-7931-5_2; Reuben S, 2008, SECONDARY METABOLITE, P1; Rochfort S, 2015, MAGN RESON CHEM, V53, P719, DOI 10.1002/mrc.4187; Salazar S, 2011, ECOL ENG, V37, P1123, DOI 10.1016/j.ecoleng.2011.02.007; Shekhar N, 2006, CAN J MICROBIOL, V52, P805, DOI 10.1139/W06-035; SILOSUH LA, 1994, APPL ENVIRON MICROB, V60, P2023, DOI 10.1128/AEM.60.6.2023-2030.1994; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Swenson TL, 2015, SOIL BIOL BIOCHEM, V80, P189, DOI 10.1016/j.soilbio.2014.10.007; Tiquia SM, 2005, ENVIRON TECHNOL, V26, P1101, DOI 10.1080/09593332608618482; Tittarelli F, 2002, MICROBIOLOGY OF COMPOSTING, P397; Tuitert G, 1998, PHYTOPATHOLOGY, V88, P764, DOI 10.1094/PHYTO.1998.88.8.764; Vaidyanathan S, 2005, METABOLOMICS, V1, P17, DOI 10.1007/s11306-005-1104-6; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Warren CR, 2015, SOIL BIOL BIOCHEM, V81, P67, DOI 10.1016/j.soilbio.2014.11.005; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilmes P, 2006, TRENDS MICROBIOL, V14, P92, DOI 10.1016/j.tim.2005.12.006; Wilson MA, 2008, NMR TECHNIQUES APPL; Woo S.L., 2014, OPEN MYCOL J, V8, P71, DOI [10.2174/1874437001408010071, DOI 10.2174/1874437001408010071]; YOU MP, 1995, APPL SOIL ECOL, V2, P33, DOI 10.1016/0929-1393(95)98123-C; Yu D, 2015, APPL SOIL ECOL, V92, P47, DOI 10.1016/j.apsoil.2015.03.005; Yuan BC, 2012, PEDOSPHERE, V22, P1, DOI 10.1016/S1002-0160(11)60186-0	71	32	32	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0158048	10.1371/journal.pone.0158048	http://dx.doi.org/10.1371/journal.pone.0158048			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490955	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900004
J	Christianson, S; Grierson, W; Kein, D; Tyler, AD; Wolfe, J; Sharma, MK				Christianson, Sara; Grierson, William; Kein, Daniel; Tyler, Andrea D.; Wolfe, Joyce; Sharma, Meenu K.			Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar	PLOS ONE			English	Article							CLARITHROMYCIN RESISTANCE; GENE; MASSILIENSE; BOLLETII; CHELONAE	Mutations in the erm(41) gene of M. abscessus group organisms are associated with differences in inducible macrolide resistance, with current recommendations being to hold rapidly growing isolates for up to 14 days in order to ensure that resistance which develops more slowly can be detected. This study aimed to determine the ideal incubation time for accurate identification of inducible macrolide resistance as well as to determine if there was an association between the time taken to detect inducible resistance in M. abscessus group organisms and their erm(41) sequevar. We amplified and sequenced the erm(41) genes of a total of 104 M. abscessus group isolates and determined their sequevars. The isolates were tested for phenotypic clarithromycin resistance at days 7, 10, 14 and 21, using Trek Diagnostics Sensititre RAPMYCO microbroth dilution plates. Associations between erm(41) gene sequevars and time to detection of resistance were evaluated using Fisher's exact test in R. The samples included in this study fell into 14 sequevars, with the majority of samples falling into Sequevar02 (16), Sequevar06 (15), Sequevar08 (7) and Sequvar 15 (31), and several isolates that were in small clusters, or unique. The majority (82.7%) of samples exhibiting inducible macrolide resistance were interpreted as resistant by day 7. Two isolates in Sequevar02, which has a T28C mutation that is associated with sensitivity, showed intermediate resistance at day 14, though the majority (13) were sensitive at day 14. The majority of isolates with inducible macrolide resistance fell into Sequevars 06,08 and 15, none of which contain the T28C mutation. These sequevars were analyzed to determine if there was any correlation between sequevar and time to detection of resistance. None was found. Based on these findings, we recommend the addition of a day 7 read to the CLSI guidelines to improve turn-around-times for these isolates. It is also recommended that erm (41) gene sequencing be added to routine phenotypic testing for the resolution of cases with difficult-to-interpret phenotypic results.	[Christianson, Sara; Grierson, William; Kein, Daniel; Tyler, Andrea D.; Wolfe, Joyce; Sharma, Meenu K.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl Reference Ctr Mycobacteriol, Winnipeg, MB R3E 3R2, Canada; [Sharma, Meenu K.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada	Public Health Agency of Canada; University of Manitoba	Sharma, MK (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Natl Reference Ctr Mycobacteriol, 1015 Arlington St, Winnipeg, MB R3E 3R2, Canada.	meenu.sharma@phac-aspc.gc.ca	Sharma, Meenu/GWM-5030-2022; Sharma, Meenu/AAE-2536-2022	Sharma, Meenu/0000-0002-6020-9995; Kein, Daniel/0000-0002-3188-5732				Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; [Anonymous], 2011, M24A2 CLSI; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Brown-Elliott BA, 2015, J CLIN MICROBIOL, V53, P1211, DOI 10.1128/JCM.02950-14; Choi GE, 2012, AM J RESP CRIT CARE, V186, P917, DOI 10.1164/rccm.201111-2005OC; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Griffith DE, 2015, ANN AM THORAC SOC, V12, P436, DOI 10.1513/AnnalsATS.201501-015OI; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Nash KA, 2006, ANTIMICROB AGENTS CH, V50, P3476, DOI 10.1128/AAC.00402-06; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Sassi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-359; Shallom SJ, 2013, J CLIN MICROBIOL, V51, P2943, DOI 10.1128/JCM.01132-13; Tan JL, 2015, J CLIN MICROBIOL, V53, P3042, DOI 10.1128/JCM.00541-15; Wallace RJ, 1997, AM J RESP CRIT CARE, V156, pS1, DOI 10.1164/ajrccm.156.2.atsstatement; Wallace RJ, 1996, ANTIMICROB AGENTS CH, V40, P1676, DOI 10.1128/AAC.40.7.1676	16	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0158723	10.1371/journal.pone.0158723	http://dx.doi.org/10.1371/journal.pone.0158723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490181	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900007
J	Cortegiani, A; Russotto, V; Graziano, G; Geraci, D; Saporito, L; Cocorullo, G; Raineri, SM; Mammina, C; Giarratano, A				Cortegiani, Andrea; Russotto, Vincenzo; Graziano, Giorgio; Geraci, Daniela; Saporito, Laura; Cocorullo, Gianfranco; Raineri, Santi Maurizio; Mammina, Caterina; Giarratano, Antonino			Use of Cepheid Xpert Carba-R (R) for Rapid Detection of Carbapenemase-Producing Bacteria in Abdominal Septic Patients Admitted to Intensive Care Unit	PLOS ONE			English	Article							COMPLICATED INTRAABDOMINAL INFECTIONS; ANTIMICROBIAL THERAPY; ENTEROBACTERIACEAE; EPIDEMIOLOGY; SPREAD; ERA	Early institution of effective antibiotic therapy and source control are pivotal to improve survival of abdominal septic patients. Xpert (R) Carba-R is a real time polymerase chain reaction assay for rapid detection and differentiation of five genes (bla(KPC), bla(VIM), bla(OXA-48), bla(IMP-1), bla(NDM)) responsible for carbapenem resistance. We performed an observational study investigating the clinical usefulness and applicability of Xpert (R) Carba-R to detect carbapenem resistance in abdominal septic patients admitted to intensive care unit. We compared the results of Xpert (R) Carba-R with standard microbiological culture. We collected a set of two rectal/stomia swabs and two swabs from abdominal drainage fluid for each patient. We included 20 patients for a total of 45 comparisons between the two methods. In our clinical setting, the overall performance of Xpert (R) Carba-R for detection of carbapenem resistance in the presence of genes detectable and non-detectable by the method was: sensitivity 50% (95% CI 24.6-75.3); specificity 93.1% (95% CI 77.2-99.1); positive predictive value (PPV) 80% (95% CI 44.4-97.5); negative predictive value (NPV) 77.1%(95% CI 56.9-89.6). The inter-rater agreement was 0.47 (SE 0.14; 95% CI 0.20-0.74). When considering the only 5 mechanisms of resistance detected by both methods, the overall diagnostic performance was: sensitivity 100% (95% CI 69.1-100), specificity 94.2 (95% CI 80.8-99.3), PPV 83.3 (95% CI 59.6-97.9) and NPV 100% (95% CI 89.4-100). The inter-rater agreement was 0.88 (SE 0.08; 95% CI 0.71-1). Xpert (R) Carba-R may be considered an additional diagnostic tool for early diagnosis of carbapenem resistance in abdominal septic patients. Clinicians should be aware of their epidemiology before its introduction in the diagnostic protocol of their intensive care units.	[Cortegiani, Andrea; Russotto, Vincenzo; Raineri, Santi Maurizio; Giarratano, Antonino] Univ Palermo, Dept Biopathol & Med Biotechnol DIBIMED, Sect Anesthesia Analgesia Intens Care & Emergency, Policlin P Giaccone, Via Vespro 129, I-90127 Palermo, Italy; [Graziano, Giorgio; Geraci, Daniela; Saporito, Laura; Mammina, Caterina] Univ Palermo, Dept Sci Hlth Promot & Mother Child Care, Palermo, Italy; [Cocorullo, Gianfranco] Univ Palermo, Dept Gen Surg Urgency & Organ Transplantat, I-90133 Palermo, Italy	University of Palermo; University of Palermo; University of Palermo	Cortegiani, A (corresponding author), Univ Palermo, Dept Biopathol & Med Biotechnol DIBIMED, Sect Anesthesia Analgesia Intens Care & Emergency, Policlin P Giaccone, Via Vespro 129, I-90127 Palermo, Italy.	andrea.cortegiani@unipa.it	Cortegiani, Andrea/H-4902-2016; Russotto, Vincenzo/AAC-2388-2022; Russotto, Vincenzo/AAM-3265-2020; Cocorullo, Gianfranco/L-3744-2016	Cortegiani, Andrea/0000-0003-1416-9993; Cocorullo, Gianfranco/0000-0003-2660-6724; Russotto, Vincenzo/0000-0003-1411-9099				Al Enizi T, 2015, ANTIMICROBIAL RESIST, V4, P117; Bonura C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132936; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Cortegiani A, 2015, CRITICAL CARE SUPPL, V19, pP108; Dallenne C, 2010, J ANTIMICROB CHEMOTH; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Di Carlo P, 2014, CURRENT INFECT DIS R, V16, P1; DiNubile MJ, 2005, EUR J CLIN MICROBIOL, V24, P443, DOI 10.1007/s10096-005-1356-0; Eckmann C, 2011, EUR J MED RES, V16, P115, DOI 10.1186/2047-783X-16-3-115; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Herzog T, 2010, EUR J MED RES, V15, P525, DOI 10.1186/2047-783X-15-12-525; Kim DK, 2016, ANN LAB MED, V36, P162, DOI 10.3343/alm.2016.36.2.162; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Mammina Caterina, 2012, BMC Res Notes, V5, P365, DOI 10.1186/1756-0500-5-365; Mancini N, 2010, CLIN MICROBIOL REV, V23, P235, DOI 10.1128/CMR.00043-09; Matuschek E, 2014, CLIN MICROBIOL INFEC, V20, pO255, DOI 10.1111/1469-0691.12373; Pfaller MA, 2013, CLIN INFECT DIS; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Sahuquillo-Arce JM, 2014, CARBAPENEMASES WORLD; Savard P, 2014, CLIN MICROBIOL INFEC, V20, P854, DOI 10.1111/1469-0691.12748; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392; Zavascki AP, 2013, COMBINATION THERAPY	24	34	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160643	10.1371/journal.pone.0160643	http://dx.doi.org/10.1371/journal.pone.0160643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490684	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900074
J	Woodgate, JL; Makinson, JC; Lim, KS; Reynolds, AM; Chittka, L				Woodgate, Joseph L.; Makinson, James C.; Lim, Ka S.; Reynolds, Andrew M.; Chittka, Lars			Life-Long Radar Tracking of Bumblebees	PLOS ONE			English	Article							HONEY-BEES; ONTOGENY; ECOLOGY; SPEED	Insect pollinators such as bumblebees play a vital role in many ecosystems, so it is important to understand their foraging movements on a landscape scale. We used harmonic radar to record the natural foraging behaviour of Bombus terrestris audax workers over their entire foraging career. Every flight ever made outside the nest by four foragers was recorded. Our data reveal where the bees flew and how their behaviour changed with experience, at an unprecedented level of detail. We identified how each bee's flights fit into two categories-which we named exploration and exploitation flights-examining the differences between the two types of flight and how their occurrence changed over the course of the bees' foraging careers. Exploitation of learned resources takes place during efficient, straight trips, usually to a single foraging location, and is seldom combined with exploration of other areas. Exploration of the landscape typically occurs in the first few flights made by each bee, but our data show that further exploration flights can be made throughout the bee's foraging career. Bees showed striking levels of variation in how they explored their environment, their fidelity to particular patches, ratio of exploration to exploitation, duration and frequency of their foraging bouts. One bee developed a straight route to a forage patch within four flights and followed this route exclusively for six days before abandoning it entirely for a closer location; this second location had not been visited since her first exploratory flight nine days prior. Another bee made only rare exploitation flights and continued to explore widely throughout its life; two other bees showed more frequent switches between exploration and exploitation. Our data shed light on the way bumblebees balance exploration of the environment with exploitation of resources and reveal extreme levels of variation between individuals.	[Woodgate, Joseph L.; Makinson, James C.; Chittka, Lars] Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, London, England; [Woodgate, Joseph L.; Makinson, James C.; Lim, Ka S.; Reynolds, Andrew M.] Rothamsted Res, Dept Agroecol, Harpenden, Herts, England	University of London; Queen Mary University London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Makinson, JC (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Dept Biol & Expt Psychol, London, England.	j.woodgate@qmul.ac.uk; j.makinson@qmul.ac.uk	Chittka, Lars/C-3110-2012; Lim, Ka Sing/B-4480-2012	Chittka, Lars/0000-0001-8153-1732; Lim, Ka Sing/0000-0002-9166-2928; Makinson, James/0000-0001-9772-0802; Woodgate, Joseph/0000-0001-8176-7024	European Research Council [339347]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Advanced Grant no. 339347: RadarSpacePollinator. https://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Charlton NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012186; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Comba L, 1999, ETHOL ECOL EVOL, V11, P243, DOI 10.1080/08927014.1999.9522826; Couvillon M, 2015, APIDOLOGIE, V46, P61, DOI 10.1007/s13592-014-0302-5; Darwin C., 1876, EFFECTS CROSSAND SEL, P1; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Flack A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500931; Foster DJ, 2011, BEHAV ECOL, V22, P52, DOI 10.1093/beheco/arq160; Heinrich B, 1979, BUMBLEBEE EC, P1; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Klaassen RHG, 2014, J ANIM ECOL, V83, P176, DOI 10.1111/1365-2656.12135; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; MANNING AUBREY, 1956, BEHAVIOUR, V9, P164, DOI 10.1163/156853956X00291; Mitchell RJ, 2009, ANN BOT-LONDON, V103, P1355, DOI 10.1093/aob/mcp122; Muller H, 2010, ANIM BEHAV, V80, P1065, DOI 10.1016/j.anbehav.2010.09.016; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Ohashi K, 2008, BEHAV ECOL, V19, P936, DOI 10.1093/beheco/arn048; Ohashi K, 2009, ANN BOT-LONDON, V103, P1365, DOI 10.1093/aob/mcp088; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078681; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PYKE GH, 1980, THEOR POPUL BIOL, V17, P232, DOI 10.1016/0040-5809(80)90008-8; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; RIBBANDS CR, 1949, J ANIM ECOL, V18, P47, DOI 10.2307/1581; Riley JR, 1999, NATURE, V400, P126, DOI 10.1038/22029; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Schmid-Hempel P, 1998, ANIM BEHAV, V55, P819, DOI 10.1006/anbe.1997.0661; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Sergio F, 2014, NATURE, V515, P410, DOI 10.1038/nature13696; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Singh S, 1950, MEM CORNELL U AGR EX, V288, P1; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Thomson JD, 1996, BEHAV ECOL, V7, P158, DOI 10.1093/beheco/7.2.158; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; von Frisch K, 1967, DANCE LANGUAGE ORIEN, P1	39	64	64	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160333	10.1371/journal.pone.0160333	http://dx.doi.org/10.1371/journal.pone.0160333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490662	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900047
J	Pereira, TBD; Thomaz, EBAF; do Nascimento, FRF; dos Santos, APSD; Batista, RLF; Bettiol, H; Cavalli, RDC; Barbieri, MA; da Silva, AAM				de Brito Pereira, Thais Basso; Abreu Fonseca Thomaz, Erika Barbara; Fernandes do Nascimento, Flavia Raquel; Silva de Azevedo dos Santos, Ana Paula; Fernandes Batista, Rosangela Lucena; Bettiol, Heloisa; Cavalli, Ricardo de Carvalho; Barbieri, Marco Antonio; Moura da Silva, Antonio Augusto			Regulatory Cytokine Expression and Preterm Birth: Case-Control Study Nested in a Cohort	PLOS ONE			English	Article							BLOOD IMMUNE BIOMARKERS; BACTERIAL VAGINOSIS; GESTATIONAL-AGE; RISK-FACTORS; PREGNANCY; WOMEN; INFLAMMATION; INFECTION; PLASMA; IL-10	Background Currently known risk factors explain only a small fraction of preterm birth (PTB). Previous PTB is one of the most important predictors. However, this information is not available in primiparous women. Few studies have looked at associations between regulatory cytokine expression (RCE) and PTB and the results are conflicting. Objective To investigate the association of RCE-Interleukin 10 (IL-10) and Transforming Growth Factor beta (TGF-beta)-with PTB, and to assess whether bacterial vaginosis (BV) is involved in this relationship. Methods This was a case-control study nested in a prospective cohort-called BRISA. Women with singleton pregnancies were interviewed from 22 to 25 weeks of gestational age (GA). Women were recruited from health services in Sao Luis, Brazil. A blood sample was collected and gynecological examination was performed. Serum IL-10 and TGF-beta were determined using cytometric bead array. Nugent score > 7 and/or the presence of clue cells were used for BV diagnosis. All PTB estimated by ultrasound dating performed before 20 weeks of gestational age were considered cases. Controls were selected by simple random sampling from the rest of the cohort, at a 2:1 ratio. Different models were tested, according to the main independent variable. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated by regression analyses. Results The study included 327 pregnant women, 109 cases and 218 controls. No associations were found between BV and PTB (P = 1.44; 95% CI: 0.51-3.77). Low levels of IL-10 (OR = 2.92 95% CI: 1.38-6.16) or TGF-beta (OR = 16.90 95% CI: 6.42-44.51) or both simultaneously (OR = 77.16 95% CI: 7.99-744.88) were associated with increasing odds of PTB, even after adjustment for confounding. Conclusion Decreased RCE is a risk factor for PTB. This relationship, however, is not triggered by the presence of BV. Low IL-10/TGF-beta levels from 22 to 25 weeks of GA could be used as early predictors of PTB. We suggest monitoring of these RCE, especially among primiparous women, for whom history of previous PTB is not available.	[de Brito Pereira, Thais Basso] Univ Fed Maranhao, Grad Program Publ Hlth, Sao Luis, Maranhao, Brazil; [Abreu Fonseca Thomaz, Erika Barbara; Fernandes Batista, Rosangela Lucena; Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Grad Program Publ Hlth, Dept Publ Hlth, Sao Luis, Maranhao, Brazil; [Fernandes do Nascimento, Flavia Raquel; Silva de Azevedo dos Santos, Ana Paula] Univ Fed Maranhao, Grad Program Publ Hlth, Dept Pathol, Sao Luis, Maranhao, Brazil; [Bettiol, Heloisa; Barbieri, Marco Antonio] Univ Sao Paulo, Grad Program Child & Adolescent Hlth, Dept Puericulture & Pediat, Ribeirao Preto, SP, Brazil; [Cavalli, Ricardo de Carvalho] Univ Sao Paulo, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade de Sao Paulo; Universidade de Sao Paulo	Thomaz, EBAF (corresponding author), Univ Fed Maranhao, Grad Program Publ Hlth, Dept Publ Hlth, Sao Luis, Maranhao, Brazil.	ebthomaz@globo.com	Silva, Antonio A M/B-5410-2009; THOMAZ, ERIKA/AAU-7762-2021; Bettiol, Heloisa/B-4190-2013; THOMAZ, ERIKA/AAU-7752-2021; Barbieri, Marco/J-2597-2014; Batista, Rosangela Fernandes Lucena/G-6808-2016; Cavalli, Ricardo C/G-2405-2012	Silva, Antonio A M/0000-0003-4968-5138; Bettiol, Heloisa/0000-0001-8744-4373; THOMAZ, ERIKA/0000-0003-4156-4067; Batista, Rosangela Fernandes Lucena/0000-0002-1529-0165; Azevedo-Santos, Ana Paula/0000-0002-6404-0103; Cavalli, Ricardo/0000-0001-5010-4914	Foundation for Research and Scientific Development of Maranhao (FAPEMA, PRONEX) [001/2007]; National Counsel of Technological and Scientific Development (CNPq); Foundation for Research and Scientific Development of Maranhao (FAPEMA) [BEPP-03728/15, 003/2016]	Foundation for Research and Scientific Development of Maranhao (FAPEMA, PRONEX); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research and Scientific Development of Maranhao (FAPEMA)	This work was supported by the Foundation for Research and Scientific Development of Maranhao (FAPEMA, PRONEX number 001/2007; Productivity grant BEPP-03728/15; and Support for publishing articles, grant number 003/2016) and National Counsel of Technological and Scientific Development (CNPq), by productivity grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Associacao Brasileira de Empresas de Pesquisa, 2009, COD GUIAS CCEB CRIT; Bao SH, 2011, EUR J OBSTET GYN R B, V155, P94, DOI 10.1016/j.ejogrb.2010.11.007; Bastek JA, 2011, CLIN PERINATOL, V38, P385, DOI 10.1016/j.clp.2011.06.003; Beigi RH, 2007, J INFECT DIS, V196, P1355, DOI 10.1086/521628; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Choi SJ, 2012, ANN LAB MED, V32, P194, DOI 10.3343/alm.2012.32.3.194; Denney JM, 2011, CYTOKINE, V53, P170, DOI 10.1016/j.cyto.2010.11.005; Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298; Gargano JW, 2008, J REPROD IMMUNOL, V79, P100, DOI 10.1016/j.jri.2008.08.006; Gomez LM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.042; Hanna N, 2000, J IMMUNOL, V164, P5721, DOI 10.4049/jimmunol.164.11.5721; Harper M, 2013, OBSTET GYNECOL, V121, P805, DOI 10.1097/AOG.0b013e3182878a80; Iyoke CA, 2015, NIGER J CLIN PRACT, V18, P744, DOI 10.4103/1119-3077.158141; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Kumar P, 2011, EARLY HUM DEV, V87, P559, DOI 10.1016/j.earlhumdev.2011.04.013; Matoba N, 2009, PEDIATRICS, V123, P1320, DOI 10.1542/peds.2008-1222; Morris M, 2001, BRIT J OBSTET GYNAEC, V108, P439; da Silva AAM, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-79; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Paganoti CD, 2015, REV BRAS GINECOL OBS, V37, P10, DOI 10.1590/SO100-720320140005202; Porta D, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-60; Rodts-Palenik S, 2004, AM J OBSTET GYNECOL, V191, P1387, DOI 10.1016/j.ajog.2004.06.093; Romaniuk H, 2014, AM J EPIDEMIOL, V180, P920, DOI 10.1093/aje/kwu224; Ruiz RJ, 2012, J PERINATOL, V32, P483, DOI 10.1038/jp.2011.193; Shigeru S, 2008, J REPROD IMMUNOL, V77, P14, DOI 10.1016/j.jri.2007.04.007; Shiozaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111374; Tsiartas P, 2012, BJOG-INT J OBSTET GY, V119, P866, DOI 10.1111/j.1471-0528.2012.03328.x; Wei SQ, 2012, OBSTET GYNECOLOGY, V116, P393; Yang Q, 2009, AM J REPROD IMMUNOL, V62, P339, DOI 10.1111/j.1600-0897.2009.00743.x; Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4	31	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0158380	10.1371/journal.pone.0158380	http://dx.doi.org/10.1371/journal.pone.0158380			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486805	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800010
J	Lindstrom, B; Selbing, I; Olsson, A				Lindstrom, Bjorn; Selbing, Ida; Olsson, Andreas			Co-Evolution of Social Learning and Evolutionary Preparedness in Dangerous Environments	PLOS ONE			English	Article							DECISION-MAKING; FEAR-RELEVANT; ASSOCIATIONS; PHOBIAS; NEUROBIOLOGY; RECOGNITION; CONSTRAINTS; MISBEHAVIOR; MECHANISMS; EMERGENCE	Danger is a fundamental aspect of the lives of most animals. Adaptive behavior therefore requires avoiding actions, objects, and environments associated with danger. Previous research has shown that humans and non-human animals can avoid such dangers through two types of behavioral adaptions, (i) genetic preparedness to avoid certain stimuli or actions, and (ii) social learning. These adaptive mechanisms reduce the fitness costs associated with danger but still allow flexible behavior. Despite the empirical prevalence and importance of both these mechanisms, it is unclear when they evolve and how they interact. We used evolutionary agent-based simulations, incorporating empirically based learning mechanisms, to clarify if preparedness and social learning typically both evolve in dangerous environments, and if these mechanisms generally interact synergistically or antagonistically. Our simulations showed that preparedness and social learning often co-evolve because they provide complimentary benefits: genetic preparedness reduced foraging efficiency, but resulted in a higher rate of survival in dangerous environments, while social learning generally came to dominate the population, especially when the environment was stochastic. However, even in this case, genetic preparedness reliably evolved. Broadly, our results indicate that the relationship between preparedness and social learning is important as it can result in trade-offs between behavioral flexibility and safety, which can lead to seemingly suboptimal behavior if the evolutionary environment of the organism is not taken into account.	[Lindstrom, Bjorn; Selbing, Ida; Olsson, Andreas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lindstrom, Bjorn] Univ Zurich, Dept Econ, Zurich, Switzerland	Karolinska Institutet; University of Zurich	Lindstrom, B (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Lindstrom, B (corresponding author), Univ Zurich, Dept Econ, Zurich, Switzerland.	bjorn.lindstrom@ki.se			Swedish Science Council (Vetenskapsradet) [421-2010-2084]; Independent Starting Grant (Emotional Learning in Social Interaction project) from the European Research Council [284366]; Forte [COFAS2: 2014-2785 FOIP]	Swedish Science Council (Vetenskapsradet)(Swedish Research Council); Independent Starting Grant (Emotional Learning in Social Interaction project) from the European Research Council; Forte(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This research was supported by a grant from the Swedish Science Council (Vetenskapsradet; 421-2010-2084), and an Independent Starting Grant (284366; Emotional Learning in Social Interaction project) from the European Research Council to Andreas Olsson. Bjorn Lindstrom was partially supported by Forte (COFAS2: 2014-2785 FOIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2005, CURR ANTHROPOL, V46, P334, DOI 10.1086/428791; Arbilly M, 2014, THEOR POPUL BIOL; Arbilly M, 2011, EVOLUTION OF SOCIAL; Arbilly M, 2011, J R SOC INTERFACE, V8, P1604, DOI 10.1098/rsif.2011.0138; Askew C, 2008, CLIN PSYCHOL REV, V28, P1249, DOI 10.1016/j.cpr.2008.05.003; Askew C, 2007, BEHAV RES THER, V45, P2616, DOI 10.1016/j.brat.2007.06.008; Barrett HC, 2012, EVOL HUM BEHAV, V33, P499, DOI 10.1016/j.evolhumbehav.2012.01.003; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Bouton M. E., 2007, LEARNING AND BEHAVIO; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; BRELAND K, 1961, AM PSYCHOL, V16, P681, DOI 10.1037/h0040090; Broesch J, 2014, HUM NATURE-INT BIOS, V25, P181, DOI 10.1007/s12110-014-9196-1; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; COOK M, 1989, J ABNORM PSYCHOL, V98, P448, DOI 10.1037/0021-843X.98.4.448; COOK M, 1990, J EXP PSYCHOL ANIM B, V16, P372, DOI 10.1037/0097-7403.16.4.372; CURIO E, 1978, SCIENCE, V202, P899, DOI 10.1126/science.202.4370.899; DAVEY GCL, 1995, BEHAV BRAIN SCI, V18, P289, DOI 10.1017/S0140525X00038498; Daw N. D., 2011, DECISION MAKING AFFE, V23, P1, DOI 10. 1093/acprof:oso/9780199600434.003.0001; Dawson EH, 2013, CURR BIOL, V23, P727, DOI 10.1016/j.cub.2013.03.035; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; Dayan P, 2012, STRUNGMANN FORUM REP, P151; Dayan P, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P175, DOI 10.1016/B978-0-12-374176-9.00012-9; Dayan P, 2008, COGN AFFECT BEHAV NE, V8, P429, DOI 10.3758/CABN.8.4.429; Denrell J, 2005, PSYCHOL REV, V112, P951, DOI 10.1037/0033-295X.112.4.951; Denrell J, 2007, PSYCHOL REV; Denrell J, 2008, SCIENCE, V321, P47, DOI 10.1126/science.1157667; Domjan M, 2005, ANNU REV PSYCHOL, V56, P179, DOI 10.1146/annurev.psych.55.090902.141409; DOMJAN M, 1983, ANIM LEARN BEHAV, V11, P151, DOI 10.3758/BF03199643; Dunlap AS, 2014, P NATL ACAD SCI USA, V111, P11750, DOI 10.1073/pnas.1404176111; Dunlap AS, 2009, P ROY SOC B-BIOL SCI, V276, P3201, DOI 10.1098/rspb.2009.0602; Fawcett TW, 2014, TRENDS COGN SCI, V18, P153, DOI 10.1016/j.tics.2013.12.012; Fawcett TW, 2013, BEHAV ECOL, V24, P2, DOI 10.1093/beheco/ars085; Field AP, 2008, J ABNORM PSYCHOL, V117, P214, DOI 10.1037/0021-843X.117.1.214; Field AP, 2006, CLIN PSYCHOL REV, V26, P857, DOI 10.1016/j.cpr.2005.05.010; Foster KR, 2009, P ROY SOC B-BIOL SCI, V276, P31, DOI 10.1098/rspb.2008.0981; Gall B, 2010, ETHOLOGY; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Griffin A., 2004, ANIM LEARN BEHAV; Haselton MG, 2006, PERS SOC PSYCHOL REV, V10, P47, DOI 10.1207/s15327957pspr1001_3; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; Heyes C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1709; Heyes C, 2012, J COMP PSYCHOL, V126, P193, DOI 10.1037/a0025180; HIRSCH SM, 1980, Z TIERPSYCHOL, V54, P71; Hoppitt W, 2013, SOCIAL LEARNING AN I; Huys QJM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002028; HYGGE S, 1978, J PERS SOC PSYCHOL, V36, P271, DOI 10.1037/0022-3514.36.3.271; Isbell LA, 2006, J HUM EVOL, V51, P1, DOI 10.1016/j.jhevol.2005.12.012; Johnson DDP, 2013, TRENDS ECOL EVOL, V28, P474, DOI 10.1016/j.tree.2013.05.014; Kavaliers M, 2001, NEUROSCI BIOBEHAV R, V25, P577, DOI 10.1016/S0149-7634(01)00042-2; Laland KN, 2004, LEARN BEHAV, V32, P4; Leadbeater E, 2015, J ZOOL, V295, P4, DOI 10.1111/jzo.12197; Liljeholm M, 2012, J NEUROSCI, V32, P9878, DOI 10.1523/JNEUROSCI.0548-12.2012; Lima S, 1990, CAN J ZOOL; Lindstrom B, 2015, EMOTION, DOI [10.1037/emo0000075, DOI 10.1037/EM00000075]; Lindstrom B, 2015, J EXP PSYCHOL GEN, V144, P688, DOI 10.1037/xge0000071; MAGURRAN AE, 1990, ANIM BEHAV, V39, P834, DOI 10.1016/S0003-3472(05)80947-9; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; MILLER RR, 1995, PSYCHOL BULL, V117, P363, DOI 10.1037/0033-2909.117.3.363; Mobbs D, 2009, SCIENCE, V324, P900, DOI 10.1126/science.1170539; Nonacs Peter, 2010, P207; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Pittig A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01050; Pittig A, 2014, J ANXIETY DISORD, V28, P326, DOI 10.1016/j.janxdis.2014.03.001; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rescorla RA, 1972, CLASS COND II CURR R; Rescorla RA, 2008, J EXP PSYCHOL-ANIM B, V34, P315, DOI 10.1037/0097-7403.34.3.315; Rieucau G, 2011, EXPLORING THE COSTS; ROGERS AR, 1988, AM ANTHROPOL, V90, P819, DOI 10.1525/aa.1988.90.4.02a00030; Ruff CC, 2014, NAT REV NEUROSCI, V15, P549, DOI 10.1038/nrn3776; Selbing I, 2014, COGNITION, V133, P128, DOI 10.1016/j.cognition.2014.06.010; SELIGMAN ME, 1971, BEHAV THER, V2, P307, DOI 10.1016/S0005-7894(71)80064-3; Shettleworth S.J., 1972, Advances Study Behav, V4, P1, DOI 10.1016/S0065-3454(08)60006-6; Smith S., 1975, SCIENCE; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; Stephens DW, 1991, BEHAV ECOL, V2, P77, DOI 10.1093/beheco/2.1.77; Trimmer PC, 2012, J THEOR BIOL, V302, P39, DOI 10.1016/j.jtbi.2012.02.014; van der Post DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117027; Veen T, 2000, P ROY SOC B-BIOL SCI, V267, P2253, DOI 10.1098/rspb.2000.1276; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Webster M, 2008, PROC R SOC B BIOL SC	85	17	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160245	10.1371/journal.pone.0160245	http://dx.doi.org/10.1371/journal.pone.0160245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487079	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800064
J	Nosal, AP; Keenan, EA; Hastings, PA; Gneezy, A				Nosal, Andrew P.; Keenan, Elizabeth A.; Hastings, Philip A.; Gneezy, Ayelet			The Effect of Background Music in Shark Documentaries on Viewers' Perceptions of Sharks	PLOS ONE			English	Article								Despite the ongoing need for shark conservation and management, prevailing negative sentiments marginalize these animals and legitimize permissive exploitation. These negative attitudes arise from an instinctive, yet exaggerated fear, which is validated and reinforced by disproportionate and sensationalistic news coverage of shark 'attacks' and by highlighting shark-on-human violence in popular movies and documentaries. In this study, we investigate another subtler, yet powerful factor that contributes to this fear: the ominous background music that often accompanies shark footage in documentaries. Using three experiments, we show that participants rated sharks more negatively and less positively after viewing a 60-second video clip of swimming sharks set to ominous background music, compared to participants who watched the same video clip set to uplifting background music, or silence. This finding was not an artifact of soundtrack alone because attitudes toward sharks did not differ among participants assigned to audio-only control treatments. This is the first study to demonstrate empirically that the connotative attributes of background music accompanying shark footage affect viewers' attitudes toward sharks. Given that nature documentaries are often regarded as objective and authoritative sources of information, it is critical that documentary filmmakers and viewers are aware of how the soundtrack can affect the interpretation of the educational content.	[Nosal, Andrew P.; Keenan, Elizabeth A.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Keenan, Elizabeth A.] Harvard Univ, Harvard Business Sch, Boston, MA 02115 USA; [Hastings, Philip A.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Gneezy, Ayelet] Univ Calif San Diego, Rady Sch Management, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Harvard University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Nosal, AP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA.	anosal@ucsd.edu		Keenan, Elizabeth/0000-0003-2111-3656; Hastings, Philip/0000-0002-9867-6601	DeLaCour Postdoctoral Fellowship - Birch Aquarium at Scripps Institution of Oceanography; Save Our Seas Foundation; National Science Foundation (NSF) Integrative Graduate Education and Research Traineeship (IGERT) award [0903551]	DeLaCour Postdoctoral Fellowship - Birch Aquarium at Scripps Institution of Oceanography; Save Our Seas Foundation; National Science Foundation (NSF) Integrative Graduate Education and Research Traineeship (IGERT) award(National Science Foundation (NSF))	AN was supported by a DeLaCour Postdoctoral Fellowship awarded by the Birch Aquarium at Scripps Institution of Oceanography and a small grant from Save Our Seas Foundation. EK was supported by a mini grant through National Science Foundation (NSF) Integrative Graduate Education and Research Traineeship (IGERT) award #0903551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancorosso G, 2010, MUSIC ANAL, V29, P306, DOI 10.1111/j.1468-2249.2011.00331.x; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cantor J, 2004, POETICS TODAY, V25, P283, DOI 10.1215/03335372-25-2-283; Cardenas SA, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00060; Cohen A.J., 2001, MUSIC EMOTION THEORY, P878, DOI [10.1093/acprof:oso/9780199230143.003.0031, DOI 10.1093/ACPROF:OSO/9780199230143.003.0031]; Crisinel AS, 2012, FOOD QUAL PREFER, V24, P201, DOI 10.1016/j.foodqual.2011.08.009; Crossley Roxanne, 2014, Human Dimensions of Wildlife, V19, P154; Dingwall R, 2006, PUBLIC UNDERST SCI, V15, P131, DOI 10.1177/0963662506060588; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Eladhari M, 2006, PROCEEDINGS OF THE 2, DOI [10.1145/1178823.1178887, DOI 10.1145/1178823.1178887]; Ellis RJ., 2005, PSYCHOMUSICOLOGY J R, V19, P15, DOI DOI 10.1037/H0094042; Evans S, 2015, COMMUN RES REP, V32, P265, DOI 10.1080/08824096.2015.1052903; Ferguson Kathryn, 2006, ATENEA-CONCEPC, V26, P115; Friedrich LA, 2014, MAR POLICY, V47, P1, DOI 10.1016/j.marpol.2014.02.003; Harrison L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00790; Jacques PJ, 2010, PROG OCEANOGR, V86, P192, DOI 10.1016/j.pocean.2010.04.001; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST AND SL; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kennedy JB, 2007, THE CONCISE OXFORD D; Kreutz G, 2008, PSYCHOL MUSIC, V36, P101, DOI 10.1177/0305735607082623; LICHTENSTEIN S, 1978, J EXP PSYCHOL-HUM L, V4, P551, DOI 10.1037/0278-7393.4.6.551; MARSHALL SK, 1988, MUSIC PERCEPT, V6, P95; Moore JE, 2009, MAR POLICY, V33, P435, DOI 10.1016/j.marpol.2008.09.003; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; Myrick JG, 2014, SCI COMMUN, V36, P544, DOI 10.1177/1075547014547159; Neff C., 2013, J ENVIRON STUD SCI, V3, P65, DOI [10.1007/s13412-013-0107-2, DOI 10.1007/S13412-013-0107-2]; North AC, 2012, BRIT J PSYCHOL, V103, P293, DOI 10.1111/j.2044-8295.2011.02072.x; O'Bryhim JR, 2015, MAR POLICY, V56, P43, DOI 10.1016/j.marpol.2015.02.007; Roman J, 2013, ANN NY ACAD SCI, V1286, P29, DOI 10.1111/nyas.12040; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Thompson TL, 2002, INT J SCI EDUC, V24, P645, DOI 10.1080/09500690110110115; Tversky Amos., 1975, UTILITY PROBABILITY, P141, DOI [10.1007/978-94-010-1834-0_8, DOI 10.1017/CBO9780511809477.002, DOI 10.1007/978-94-010-1834-0_8]	34	15	15	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159279	10.1371/journal.pone.0159279	http://dx.doi.org/10.1371/journal.pone.0159279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487003	Green Published, gold			2022-12-27	WOS:000381367800023
J	Stanford, K; Johnson, RP; Alexander, TW; McAllister, TA; Reuter, T				Stanford, Kim; Johnson, Roger P.; Alexander, Trevor W.; McAllister, Tim A.; Reuter, Tim			Influence of Season and Feedlot Location on Prevalence and Virulence Factors of Seven Serogroups of Escherichia coli in Feces of Western-Canadian Slaughter Cattle	PLOS ONE			English	Article							MULTIPLEX PCR; RISK-FACTORS; O157; O145; O26; O111; O103; GENES; STEC; BEEF	Pooled feces collected over two years from 1749 transport trailers hauling western-Canadian slaughter cattle were analysed by PCR for detection of Escherichia coli serogroups O26, O45, O103, O111, O121, O145, and O157. Sequential immunomagnetic separation was then used to collect bacterial isolates (n = 1035) from feces positive for target serogroups. Isolated bacteria were tested by PCR to confirm serogroup and the presence of eae, ehxA, stx(1), and stx(2) virulence genes. Based on PCR screening, serogroup prevalence in feces ranged from 7.0% (O145) to 94.4% (O103) with at least 3 serogroups present in 79.5% of samples. Origin of cattle affected serogroup PCR prevalence and O157 was most prevalent in feces from south-west Alberta (P < 0.001). All serogroups demonstrated seasonal variations in PCR prevalence, with O26, O45, O103, O121, and O157 least prevalent (P < 0.001) in cooler winter months, while uncommon serogroups O111 and O145 increased in prevalence during winter (P < 0.001). However, isolates collected during winter were predominantly from serogroups O103 and O45. No seasonal variation was noted in proportion of isolates which were Shiga toxin containing E. coli (STEC; P = 0.18) or positive for Shiga toxin and eae (enterohemorrhagic E. coli; EHEC; P = 0.29). Isolates of serogroups O111, O145, and O157 were more frequently EHEC than were others, although 37.6-54.3% of isolates from other serogroups were also EHEC. Shiga-toxin genes present also varied by geographic origin of cattle (P < 0.05) in all serogroups except O157. As cattle within feedlots are sourced from multiple regions, locational differences in serogroup prevalence and virulence genes imply existence of selection pressures for E. coli and their virulence in western-Canadian cattle. Factors which reduce carriage or expression of virulence genes, particularly in non-O157 serogroups, should be investigated.	[Stanford, Kim; Reuter, Tim] Alberta Agr & Forestry, Lethbridge, AB, Canada; [Johnson, Roger P.] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Alexander, Trevor W.; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge, AB, Canada	Public Health Agency of Canada; Agriculture & Agri Food Canada	Stanford, K (corresponding author), Alberta Agr & Forestry, Lethbridge, AB, Canada.	kim.stanford@gov.ab.ca	Reuter, Tim/AAA-6443-2020; McAllister, Tim A./R-9201-2017	Reuter, Tim/0000-0002-0593-3163; Stanford, Kim/0000-0001-8784-0042; McAllister, Tim A./0000-0002-8266-6513	Alberta Innovates Biosolutions [BIOFS005]; Alberta Livestock and Meat Agency [BIOFS005]	Alberta Innovates Biosolutions; Alberta Livestock and Meat Agency	This work was supported by Alberta Innovates Biosolutions and Alberta Livestock and Meat Agency, joint grant BIOFS005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, USDA TAKES NEW STEPS; [Anonymous], HPSC ANN EP REP 2014, P68; Arthur TM, 2013, APPL ENVIRON MICROB, V79, P4294, DOI 10.1128/AEM.00846-13; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Baker CA, 2016, FOOD CONTROL, V59, P407, DOI 10.1016/j.foodcont.2015.06.011; Baltasar P, 2014, J FOOD PROTECT, V77, P722, DOI 10.4315/0362-028X.JFP-13-420; Barkocy-Gallagher GA, 2004, J FOOD PROTECT, V67, P993, DOI 10.4315/0362-028X-67.5.993; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; Bielaszewska M, 2007, APPL ENVIRON MICROB, V73, P3144, DOI 10.1128/AEM.02937-06; Bifolchi N, 2014, EPIDEMIOL INFECT, V142, P2302, DOI 10.1017/S0950268813002781; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Buvens G, 2012, FOODBORNE PATHOG DIS, V9, P530, DOI 10.1089/fpd.2011.1073; Canfax, 2016, CATTL FEED BUNK CAP; Carter MQ, 2016, APPL ENVIRON MICROB, V82, P1090, DOI 10.1128/AEM.03172-15; Cernicchiaro N, 2013, FOODBORNE PATHOG DIS, V10, P835, DOI 10.1089/fpd.2013.1526; Conrad CC, 2014, J MICROBIOL METH, V105, P22, DOI 10.1016/j.mimet.2014.06.020; Cooley MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065716; Cooper KK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-17; Creuzburg K, 2005, MICROBIOL-SGM, V151, P941, DOI 10.1099/mic.0.27632-0; Dallman TJ, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000029; Dargatz DA, 2013, FOODBORNE PATH DIS, V10, P1; Delannoy S, 2013, J CLIN MICROBIOL, V51, P1083, DOI 10.1128/JCM.02864-12; Dewsbury DM, 2015, FOODBORNE PATHOG DIS, V12, P726, DOI 10.1089/fpd.2015.1987; Diodati ME, 2015, FOODBORNE PATHOG DIS, V12, P235, DOI 10.1089/fpd.2014.1887; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Eichhorn I, 2015, APPL ENVIRON MICROB, V81, P7041, DOI 10.1128/AEM.01921-15; Ekiri AB, 2014, J FOOD PROTECT, V77, P1052, DOI 10.4315/0362-028X.JFP-13-373; Ennis C, 2012, J APPL MICROBIOL, V113, P1238, DOI 10.1111/j.1365-2672.2012.05421.x; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Garvey P, 2016, EMERG INFECT DIS, V22, P742, DOI 10.3201/eid2204.151160; Gonzalez LA, 2012, J ANIM SCI, V90, P3606, DOI 10.2527/jas.2011-4770; Gould LH, 2013, FOODBORNE PATHOG DIS, V10, P453, DOI 10.1089/fpd.2012.1401; KARMALI MA, 1989, CLIN MICROBIOL REV, V2, P15, DOI 10.1128/CMR.2.1.15-38.1989; Miller JJ, 2004, J ENVIRON QUAL, V33, P1088, DOI 10.2134/jeq2004.1088; Monaghan I, 2011, APPL ENVIRON MICROB, V77, P8662, DOI 10.1128/AEM.06190-11; Money P, 2010, ENVIRON MICROBIOL, V12, P2633, DOI 10.1111/j.1462-2920.2010.02293.x; Paddock Z, 2012, VET MICROBIOL, V156, P381, DOI 10.1016/j.vetmic.2011.11.017; Park D, 2013, APPL ENVIRON MICROB, V79, P1563, DOI 10.1128/AEM.03158-12; Pearce MC, 2006, APPL ENVIRON MICROB, V72, P653, DOI 10.1128/AEM.72.1.653-659.2006; Renter DG, 2007, CAN J VET RES, V71, P230; Renter DG, 2005, J FOOD PROTECT, V68, P1556, DOI 10.4315/0362-028X-68.8.1556; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rivero MA, 2012, EUR J CLIN MICROBIOL, V31, P1131, DOI 10.1007/s10096-011-1418-4; Smith DL, 2007, J BACTERIOL, V189, P7223, DOI 10.1128/JB.00824-07; Stephens TP, 2009, J ANIM SCI, V87, P4151, DOI 10.2527/jas.2009-1967; Stromberg ZR, 2015, FOODBORNE PATHOG DIS, V12, P631, DOI 10.1089/fpd.2015.1945; Thomas KM, 2012, INT J FOOD MICROBIOL, V153, P288, DOI 10.1016/j.ijfoodmicro.2011.11.012; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Vimont A, 2007, VET MICROBIOL, V123, P274, DOI 10.1016/j.vetmic.2007.02.003; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Williams MS, 2010, FOODBORNE PATHOG DIS, V7, P1247, DOI 10.1089/fpd.2010.0576	51	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159866	10.1371/journal.pone.0159866	http://dx.doi.org/10.1371/journal.pone.0159866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482711	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110700016
J	Yan, C; Lang, Q; Liao, HJ; Jiang, X; Ming, Y; Sun, HQ; Xu, WM				Yan, Chen; Lang, Qin; Liao Huijuan; Jiang, Xie; Ming, Yang; Sun Huaqin; Xu Wenming			CFTR Deletion in Mouse Testis Induces VDAC1 Mediated Inflammatory Pathway Critical for Spermatogenesis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CONGENITAL BILATERAL ABSENCE; CYSTIC-FIBROSIS; INFERTILE MEN; VAS-DEFERENS; GENE; MUTATIONS; POLYMORPHISMS; AZOOSPERMIA; PROTEOMICS	Cystic fibrosis is the most common genetic disease among Caucasians and affects tissues including lung, pancreas and reproductive tracts. It has been shown that Endoplasmic Reticulum (ER) stress and heat shock response are two major deregulated functional modules related to CFTR dysfunction. To identify the impact of CFTR deletion during spermatogenesis, we examined the expression of spermiogenesis-related genes in the testis of CFTR mutant mice (CF mice). We confirmed expression changes of MSY2, a germ cell specific RNA binding protein, resulting from deletion of CFTR in testis. Furthermore, real time PCR and Western blot results showed that an inflammatory response was activated in CF mice testis, as reflected by the altered expression of cytokines. We demonstrate for the first time that expression of MSY2 is decreased in CF mice. Our results suggest that CFTR deletion in testis influences inflammatory responses and these features are likely to be due to the unique environment of the seminiferous tubule during the spermatogenesis process. The current study also suggests avenues to understand the pathophysiology of CFTR during spermatogenesis and provides targets for the possible treatment of CFTR-related infertility.	[Yan, Chen; Lang, Qin; Liao Huijuan; Jiang, Xie; Ming, Yang; Sun Huaqin; Xu Wenming] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610041, Sichuan, Peoples R China; [Yan, Chen; Liao Huijuan; Ming, Yang; Sun Huaqin; Xu Wenming] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu 610041, Sichuan, Peoples R China; [Yan, Chen; Liao Huijuan; Ming, Yang; Sun Huaqin; Xu Wenming] Sichuan Univ, West China Univ Hosp 2, SCU CUHK Joint Lab Reprod Med, Chengdu 610041, Sichuan, Peoples R China; [Jiang, Xie] Chongqing Med Univ, Affiliated Hosp Chengdu 2, Peoples Hosp Chengdu 3, Chengdu 610031, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University; Chongqing Medical University	Xu, WM (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610041, Sichuan, Peoples R China.; Xu, WM (corresponding author), Sichuan Univ, West China Univ Hosp 2, Minist Educ, Key Lab Birth Defects & Related Dis Women & Child, Chengdu 610041, Sichuan, Peoples R China.; Xu, WM (corresponding author), Sichuan Univ, West China Univ Hosp 2, SCU CUHK Joint Lab Reprod Med, Chengdu 610041, Sichuan, Peoples R China.	Xuwenming1973@163.com		Xu, wenming/0000-0002-3686-229X	National Basic Research Program of China [2012CB944903]	National Basic Research Program of China(National Basic Research Program of China)	The National Basic Research Program of China (2012CB944903).; We thank all the members of Joint Laboratory for Reproductive Medicine, Sichuan UniversityThe Chinese University of Hong Kong (SCU-CUHK), West China Second University Hospital for their invaluable help with all the studies. We would like to thank Wang Ke for his suggestion for the mechnistic study. This work was supported by the National Basic Research Program of China (2012CB944903).	Ahmad A, 2013, CURR OPIN OBSTET GYN, V25, P167, DOI 10.1097/GCO.0b013e32835f1745; Balch WE, 2011, METHODS MOL BIOL, V742, P227, DOI 10.1007/978-1-61779-120-8_14; Balch WE, 2011, METHODS MOL BIOL, V742, P189, DOI 10.1007/978-1-61779-120-8_11; Boudaya M, 2012, ANN HUM BIOL, V39, P76, DOI 10.3109/03014460.2011.642892; Chan HC, 2009, J PHYSIOL-LONDON, V587, P2187, DOI 10.1113/jphysiol.2008.164970; Chen H, 2012, HUM REPROD UPDATE, V18, P703, DOI 10.1093/humupd/dms027; Collawn JF, 2010, EXPERT REV PROTEOMIC, V7, P495, DOI [10.1586/epr.10.45, 10.1586/EPR.10.45]; Costa C, 2008, CLIN CHEM, V54, P1564, DOI 10.1373/clinchem.2008.103259; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; EGAN ME, 1995, AM J PHYSIOL-CELL PH, V268, pC243, DOI 10.1152/ajpcell.1995.268.1.C243; Elia J, 2014, ARCH ITAL UROL ANDRO, V86, P171, DOI 10.4081/aiua.2014.3.171; Ghorbel M, 2012, ANDROLOGIA, V44, P376, DOI 10.1111/j.1439-0272.2011.01193.x; Gomes-Alves P, 2010, BBA-PROTEINS PROTEOM, V1804, P856, DOI 10.1016/j.bbapap.2009.12.013; Gomes-Alves P, 2009, J PROTEOMICS, V73, P218, DOI 10.1016/j.jprot.2009.09.001; Guerrera IC, 2011, METHODS MOL BIOL, V742, P213, DOI 10.1007/978-1-61779-120-8_13; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; Lee NPY, 2005, BIOL REPROD, V73, P458, DOI 10.1095/biolreprod.105.040766; Li HJ, 2012, J CYST FIBROS, V11, P316, DOI 10.1016/j.jcf.2012.01.005; Lobna HL, 2012, ANDROLOGIA, V44, P848, DOI 10.1111/j.1439-0272.2011.01250.x; Mitra A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.114; Najafipour R, 2016, ANDROLOGIA, V48, P956, DOI 10.1111/and.12537; Nichols DP, 2009, AM J PHYSIOL-LUNG C, V297, pL828, DOI 10.1152/ajplung.00171.2009; Okada SF, 2004, J GEN PHYSIOL, V124, P513, DOI 10.1085/jgp.200409154; Ostedgaard LS, 2011, P NATL ACAD SCI USA, V108, P2921, DOI 10.1073/pnas.1019752108; Pohl K, 2014, BLOOD, V124, P999, DOI 10.1182/blood-2014-02-555268; Sharma H, 2014, GENE, V548, P43, DOI 10.1016/j.gene.2014.07.005; Stahl PJ, 2012, CURR OPIN OBSTET GYN, V24, P221, DOI 10.1097/GCO.0b013e3283558560; Teixeira S, 2013, SYST BIOL REPROD MED, V59, P53, DOI 10.3109/19396368.2012.718851; Teng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040173; Tomaiuolo R, 2011, CLIN CHEM LAB MED, V49, P1289, DOI 10.1515/CCLM.2011.637; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu W, MICRORNAS CYSTIC FIB; Xu WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019120; Xu WM, 2011, CELL BIOL INT, V35, P463, DOI 10.1042/CBI20100664; Yang JX, 2007, BIOL REPROD, V76, P48, DOI 10.1095/biolreprod.106.055095	36	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0158994	10.1371/journal.pone.0158994	http://dx.doi.org/10.1371/journal.pone.0158994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483469	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700008
J	Qiao, F; Luo, LL; Peng, H; Luo, SJ; Huang, WK; Cui, JK; Li, X; Kong, LG; Jiang, DH; Chitwood, DJ; Peng, DL				Qiao, Fen; Luo, Lilian; Peng, Huan; Luo, Shujie; Huang, Wenkun; Cui, Jiangkuan; Li, Xin; Kong, Lingan; Jiang, Daohong; Chitwood, David J.; Peng, Deliang			Characterization of Three Novel Fatty Acid- and Retinoid-Binding Protein Genes (Ha-far-1, Ha-far-2 and Hf-far-1) from the Cereal Cyst Nematodes Heterodera avenae and H. filipjevi	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ONCHOCERCA-VOLVULUS; FILARIAL NEMATODES; FAR PROTEINS; IDENTIFICATION; INFECTION; FAMILY; ROOTS; WHEAT; PCR	Heterodera avenae and H. filipjevi are major parasites of wheat, reducing production worldwide. Both are sedentary endoparasitic nematodes, and their development and parasitism depend strongly on nutrients obtained from hosts. Secreted fatty acid-and retinol-binding (FAR) proteins are nematode-specific lipid carrier proteins used for nutrient acquisition as well as suppression of plant defenses. In this study, we obtained three novel FAR genes Ha-far-1 (KU877266), Ha-far-2 (KU877267), Hf-far-1 (KU877268). Ha-far-1 and Ha-far-2 were cloned from H. avenae, encoding proteins of 191 and 280 amino acids with molecular masses about 17 and 30 kDa, respectively and sequence identity of 28%. Protein Blast in NCBI revealed that Ha-FAR-1 sequence is 78% similar to the Gp-FAR-1 protein from Globodera pallida, while Ha-FAR-2 is 30% similar to Rs-FAR-1 from Radopholus similis. Only one FAR protein Hf-FAR-1was identified in H. filipjevi; it had 96% sequence identity to HaFAR-1. The three proteins are alpha-helix-rich and contain the conserved domain of GpFAR-1, but Ha-FAR-2 had a remarkable peptide at the C-terminus which was random-coilrich. Both Ha-FAR-1 and Hf-FAR-1 had casein kinase II phosphorylation sites, while HaFAR-2 had predicted N-glycosylation sites. Phylogenetic analysis showed that the three proteins clustered together, though Ha-FAR-1 and Hf-FAR-1 adjoined each other in a plantparasitic nematode branch, but Ha-FAR-2 was distinct from the other proteins in the group. Fluorescence-based ligand binding analysis showed the three FAR proteins bound to a fluorescent fatty acid derivative and retinol and with dissociation constants similar to FARs from other species, though Ha-FAR-2 binding ability was weaker than that of the two others. In situ hybridization detected mRNAs of Ha-far-1 and Ha-far-2 in the hypodermis. The qRTPCR results showed that the Ha-far-1and Ha-far-2 were expressed in all developmental	[Qiao, Fen; Luo, Lilian; Peng, Huan; Luo, Shujie; Huang, Wenkun; Cui, Jiangkuan; Li, Xin; Kong, Lingan; Peng, Deliang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Insect Pests & Plant Dis, Beijing 100193, Peoples R China; [Luo, Lilian; Jiang, Daohong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Hubei Province, Peoples R China; [Chitwood, David J.] USDA ARS, Nematol Lab, Bldg 011A,BARC West, Beltsville, MD 20705 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Huazhong Agricultural University; United States Department of Agriculture (USDA)	Peng, DL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Insect Pests & Plant Dis, Beijing 100193, Peoples R China.	dlpeng@ippcaas.cn	Abbas, Aqleem/M-9403-2016	Abbas, Aqleem/0000-0001-9174-9700	National Natural Science Foundation of China [31571988]; National Key Basic Research Program of China (973 Program) [2013CB127502]; Special Fund for Agro-scientific Research in the Public Interest [201503114]; ARS [ARS-0423103] Funding Source: Federal RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research work was supported by the National Natural Science Foundation of China (31571988), the National Key Basic Research Program of China (973 Program, 2013CB127502) and the Special Fund for Agro-scientific Research in the Public Interest (No. 201503114).	Basavaraju S, 2003, MOL BIOCHEM PARASIT, V126, P63, DOI 10.1016/S0166-6851(02)00253-0; Bath JL, 2009, J NEMATOL, V41, P228; Bird J, 2012, THE STRUCTURE OF NEM, V2, P96; BLEVEZACHEO T, 1995, NEMATOLOGICA, V41, P80, DOI 10.1163/003925995X00062; Bradley J E, 2010, TRENDS PARASITOL, V17, P471; Chen CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122256; Chen Pinsan, 1992, Acta Phytopathologica Sinica, V22, P339; Cheng X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066011; Dababat AA, 2015, EUPHYTICA, V202, P173, DOI 10.1007/s10681-014-1269-z; Duarte A, 2014, EUR J PLANT PATHOL, V139, P825, DOI 10.1007/s10658-014-0436-3; Fairfax KC, 2009, INT J PARASITOL, V39, P1561, DOI 10.1016/j.ijpara.2009.06.005; Flower DR, 1996, BIOCHEM J, V318, P1; Gabrielsen M, 2012, ACTA CRYSTALLOGR F, V68, P835, DOI 10.1107/S1744309112023597; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Garofalo A, 2002, MOL BIOCHEM PARASIT, V122, P161, DOI 10.1016/S0166-6851(02)00097-X; Iberkleid I, 2015, EUR J PLANT PATHOL, V143, P133, DOI 10.1007/s10658-015-0671-2; Iberkleid I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1426-3; Iberkleid I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064586; Jordanova R, 2009, J BIOL CHEM, V284, P35818, DOI 10.1074/jbc.M109.022731; Kennedy MW, 2013, PARASITIC NEMATODES: MOLECULAR BIOLOGY, BIOCHEMISTRY AND IMMUNOLOGY, 2ND EDITION, P397, DOI 10.1079/9781845937591.0397; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; Kennedy MW, 1997, J BIOL CHEM, V272, P29442, DOI 10.1074/jbc.272.47.29442; Kuang L, 2009, MOL BIOCHEM PARASIT, V168, P84, DOI 10.1016/j.molbiopara.2009.07.001; Kyndt T, 2013, PLANTA, V238, P807, DOI 10.1007/s00425-013-1923-z; Li HL, 2010, PLANT DIS, V94, P1505, DOI 10.1094/PDIS-04-10-0301; Long HB, 2012, EUR J PLANT PATHOL, V134, P391, DOI 10.1007/s10658-012-9997-1; McDermott L, 1999, MOL CELL BIOCHEM, V192, P69, DOI 10.1023/A:1006822321081; Nicol J M, 2007, Commun Agric Appl Biol Sci, V72, P677; NICOL JM, 2006, PHYTOPATHOLOGY S, V96, pS169; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Ou SQ, 2008, NEMATOLOGY, V10, P397, DOI 10.1163/156854108783900212; Peng DL, 2010, PLANT DIS, V94, P1262, DOI 10.1094/PDIS-04-10-0309; Peng D L, 2012, NEMATOLOGY RES CHINA, V4, P162; Peng DeLiang, 2009, Cereal cyst nematodes: status, research and outlook. Proceedings of the First Workshop of the International Cereal Cyst Nematode Initiative, Antalya, Turkey, 21-23 October 2009, P29; Peng H, 2013, PLANT DIS, V97, P1288, DOI 10.1094/PDIS-02-13-0132-RE; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; STURCHLER D, 1981, T ROY SOC TROP MED H, V75, P617, DOI 10.1016/0035-9203(81)90230-3; Subbotin SA, 2003, NEMATOLOGY, V5, P515, DOI 10.1163/156854103322683247; Subbotin SA, 2010, NEMATOL MONOGR PERSP, V8B, P35; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TREE TIM, 1995, MOL BIOCHEM PARASIT, V69, P185, DOI 10.1016/0166-6851(94)00204-Z; Wu HY, 2014, PLANT DIS, V98, P1654, DOI 10.1094/PDIS-08-13-0830-RE; Yan GP, 2013, PLANT DIS, V97, P1611, DOI 10.1094/PDIS-01-13-0064-RE; Yan GP, 2010, PHYTOPATHOLOGY, V100, P216, DOI 10.1094/PHYTO-100-3-0216; Zhang CL, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/918305	46	23	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160003	10.1371/journal.pone.0160003	http://dx.doi.org/10.1371/journal.pone.0160003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479008	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110300021
J	Haunschild, R; Bornmann, L; Marx, W				Haunschild, Robin; Bornmann, Lutz; Marx, Werner			Climate Change Research in View of Bibliometrics	PLOS ONE			English	Article							SCIENCE; WEB	This bibliometric study of a large publication set dealing with research on climate change aims at mapping the relevant literature from a bibliometric perspective and presents a multitude of quantitative data: (1) The growth of the overall publication output as well as (2) of some major subfields, (3) the contributing journals and countries as well as their citation impact, and (4) a title word analysis aiming to illustrate the time evolution and relative importance of specific research topics. The study is based on 222,060 papers (articles and reviews only) published between 1980 and 2014. The total number of papers shows a strong increase with a doubling every 5-6 years. Continental biomass related research is the major subfield, closely followed by climate modeling. Research dealing with adaptation, mitigation, risks, and vulnerability of global warming is comparatively small, but their share of papers increased exponentially since 2005. Research on vulnerability and on adaptation published the largest proportion of very important papers (in terms of citation impact). Climate change research has become an issue also for disciplines beyond the natural sciences. The categories Engineering and Social Sciences show the strongest field-specific relative increase. The Journal of Geophysical Research, the Journal of Climate, the Geophysical Research Letters, and Climatic Change appear at the top positions in terms of the total number of papers published. Research on climate change is quantitatively dominated by the USA, followed by the UK, Germany, and Canada. The citation-based indicators exhibit consistently that the UK has produced the largest proportion of high impact papers compared to the other countries (having published more than 10,000 papers). Also, Switzerland, Denmark and also The Netherlands (with a publication output between around 3,000 and 6,000 papers) perform top-the impact of their contributions is on a high level. The title word analysis shows that the term climate change comes forward with time. Furthermore, the term impact arises and points to research dealing with the various effects of climate change. The discussion of the question of human induced climate change towards a clear fact (for the majority of the scientific community) stimulated research on future pathways for adaptation and mitigation. Finally, the term model and related terms prominently appear independent of time, indicating the high relevance of climate modeling.	[Haunschild, Robin; Marx, Werner] Max Planck Inst Solid State Res, Stuttgart, Germany; [Bornmann, Lutz] Adm Headquarters Max Planck Soc, Div Sci & Innovat Studies, Munich, Germany	Max Planck Society; Max Planck Society	Haunschild, R (corresponding author), Max Planck Inst Solid State Res, Stuttgart, Germany.	r.haunschild@fkf.mpg.de	Bornmann, Lutz/A-3926-2008; Haunschild, Robin/I-9486-2019; Marx, Werner/G-6801-2012; Haunschild, Robin/A-9925-2010	Bornmann, Lutz/0000-0003-0810-7091; Marx, Werner/0000-0002-1763-5753; Haunschild, Robin/0000-0001-7025-7256				Allen L., 2015, THE METRIC TIDE REPO, DOI 10.13140/RG.2.1.4929.1363.2015; Bjurstrom A, 2011, SCIENTOMETRICS, V87, P525, DOI 10.1007/s11192-011-0356-3; Bjurstrom A, 2011, CLIMATIC CHANGE, V108, P1, DOI 10.1007/s10584-011-0018-8; Bornmann L, 2015, J ASSOC INF SCI TECH, V66, P2215, DOI 10.1002/asi.23329; Bornmann L, 2015, J INFORMETR, V9, P408, DOI 10.1016/j.joi.2015.01.006; BUCKLAND M, 1994, J AM SOC INFORM SCI, V45, P12, DOI 10.1002/(SICI)1097-4571(199401)45:1<12::AID-ASI2>3.0.CO;2-L; Grieneisen ML, 2011, NAT CLIM CHANGE, V1, P72, DOI 10.1038/nclimate1093; Hellsten I, 2016, J ASSOC INF SCI TECH, V67, P2181, DOI 10.1002/asi.23528; Janko F, 2014, GEOFORUM, V56, P17, DOI 10.1016/j.geoforum.2014.06.004; Ji Q, 2014, SCIENTOMETRICS, V101, P1925, DOI 10.1007/s11192-014-1332-5; Li JF, 2011, GLOBAL PLANET CHANGE, V77, P13, DOI 10.1016/j.gloplacha.2011.02.005; Li W, 2015, ENVIRON IMPACT ASSES, V50, P158, DOI 10.1016/j.eiar.2014.09.012; Marx W, 2015, SCIENTOMETRICS, V102, P1823, DOI 10.1007/s11192-014-1499-9; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Pasgaard M, 2013, GLOBAL ENVIRON CHANG, V23, P1684, DOI 10.1016/j.gloenvcha.2013.08.013; Pfister C, 2007, MEDIEV HIST J, V10, P33, DOI 10.1177/097194580701000202; Schwechheimer H, 1999, SCIENTOMETRICS, V44, P547, DOI 10.1007/BF02458495; Stanhill G, 2001, CLIMATIC CHANGE, V48, P515, DOI 10.1023/A:1010721600896; van Eck N.J., 2014, MEASURING SCHOLARLY, DOI [10.1007/978-3-319-10377-8_13(InEng.), 10.1007/978-3-319-10377-8_13, DOI 10.1007/978-3-319-10377-8_13]; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; Vasileiadou E, 2011, ENVIRON SCI POLICY, V14, P1052, DOI 10.1016/j.envsci.2011.07.002; Wacholder N, 2011, ANNU REV INFORM SCI, V45, P157, DOI 10.1002/aris.2011.1440450111; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Waltman L, 2013, J AM SOC INF SCI TEC, V64, P372, DOI 10.1002/asi.22775; Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002; Wang B, 2014, NAT HAZARDS, V74, P1649, DOI 10.1007/s11069-014-1260-y; Weingart P, 2000, PUBLIC UNDERST SCI, V9, P261, DOI 10.1088/0963-6625/9/3/304; Wouters P, 2015, METRIC TIDE LIT REV	29	134	137	31	175	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160393	10.1371/journal.pone.0160393	http://dx.doi.org/10.1371/journal.pone.0160393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27472663	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300048
J	Hsu, CW; Huang, CC; Sheu, JH; Lin, CW; Lin, LF; Jin, JS; Chau, LK; Chen, WL				Hsu, Chih-Wei; Huang, Chia-Chi; Sheu, Jeng-Horng; Lin, Chia-Wen; Lin, Lien-Fu; Jin, Jong-Shiaw; Chau, Lai-Kwan; Chen, Wenlung			Novel Method for Differentiating Histological Types of Gastric Adenocarcinoma by Using Confocal Raman Microspectroscopy	PLOS ONE			English	Article							RING CELL HISTOLOGY; CLINICOPATHOLOGICAL CHARACTERISTICS; PROGNOSTIC IMPACT; CARCINOMA; CANCER; SPECTROSCOPY; CLASSIFICATION; DIAGNOSIS; STOMACH; TISSUE	Gastric adenocarcinoma, a single heterogeneous disease with multiple epidemiological and histopathological characteristics, accounts for approximately 10% of cancers worldwide. It is categorized into four histological types: papillary adenocarcinoma (PAC), tubular adenocarcinoma (TAC), mucinous adenocarcinoma (MAC), and signet ring cell adenocarcinoma (SRC). Effective differentiation of the four types of adenocarcinoma will greatly improve the treatment of gastric adenocarcinoma to increase its five-year survival rate. We reported here the differentiation of the four histological types of gastric adenocarcinoma from the molecularly structural viewpoint of confocal Raman microspectroscopy. In total, 79 patients underwent laparoscopic or open radical gastrectomy during 2008-2011: 21 for signet ring cell carcinoma, 21 for tubular adenocarcinoma, 14 for papillary adenocarcinoma, 6 for mucinous carcinoma, and 17 for normal gastric mucosas obtained from patients underwent operation for other benign lesions. Clinical data were retrospectively reviewed from medical charts, and Raman data were processed and analyzed by using principal component analysis (PCA) and linear discriminant analysis (LDA). Two-dimensional plots of PCA and LDA clearly demonstrated that the four histological types of gastric adenocarcinoma could be differentiated, and confocal Raman microspectroscopy provides potentially a rapid and effective method for differentiating SRC and MAC from TAC or PAC.	[Hsu, Chih-Wei] Tungs Taichung MetroHarbor Hosp, Dept Surg, Div Gen Surg, Taichung, Taiwan; [Hsu, Chih-Wei; Sheu, Jeng-Horng; Chen, Wenlung] Natl Chiayi Univ, Dept Appl Chem, Chiayi, Taiwan; [Huang, Chia-Chi; Chau, Lai-Kwan] Natl Chung Cheng Univ, Ctr Nano Biodetect, Chiayi, Taiwan; [Lin, Chia-Wen] HungKuang Univ, Dept Appl Cosmetol, 34 Zhongqi Rd, Shalu Township, Taichung County, Taiwan; [Lin, Lien-Fu] Tungs Taichung MetroHarbor Hosp, Dept Internal Med, Div Gastroenterol, Taichung, Taiwan; [Jin, Jong-Shiaw] Tungs Taichung MetroHarbor Hosp, Dept Pathol, Taichung, Taiwan	Tungs' Taichung MetroHarbor Hospital; National Chiayi University; National Chung Cheng University; Hungkuang University; Tungs' Taichung MetroHarbor Hospital; Tungs' Taichung MetroHarbor Hospital	Chen, WL (corresponding author), Natl Chiayi Univ, Dept Appl Chem, Chiayi, Taiwan.	wlchen@mail.ncyu.edu.tw	; Huang, Chia-Chi/K-3810-2016	Chau, Lai-Kwan/0000-0002-1659-6465; Huang, Chia-Chi/0000-0002-5456-4077				Adachi Y, 2001, CANCER-AM CANCER SOC, V91, P698, DOI 10.1002/1097-0142(20010215)91:4<698::AID-CNCR1054>3.3.CO;2-F; [Anonymous], 2004, GLOBOCAN 2002 CANC I; Austin LA, 2016, ANALYST, V141, P476, DOI 10.1039/c5an01786f; Belhumeur PN, 1997, IEEE T PATTERN ANAL, V19, P711, DOI 10.1109/34.598228; Bergholt MS, 2011, BIOSENS BIOELECTRON, V26, P4104, DOI 10.1016/j.bios.2011.04.005; Bruno M, 2009, J CLIN GASTROENTEROL, V43, P821, DOI 10.1097/MCG.0b013e31818f50b8; Bu ZD, 2013, CHINESE J CANCER RES, V25, P32, DOI 10.3978/j.issn.1000-9604.2013.01.05; Desroches J, 2015, BIOMED OPT EXPRESS, V6, P2380, DOI 10.1364/BOE.6.002380; GOSEKI N, 1992, GUT, V33, P606, DOI 10.1136/gut.33.5.606; GRAHAM DY, 1982, GASTROENTEROLOGY, V82, P228; Gronnier C, 2013, SURGERY, V154, P1093, DOI 10.1016/j.surg.2013.05.020; Ha TK, 2008, ANN SURG ONCOL, V15, P508, DOI 10.1245/s10434-007-9660-9; Haka AS, 2006, CANCER RES, V66, P3317, DOI 10.1158/0008-5472.CAn-05-2815; Horsnell JD, 2012, SURG-J R COLL SURG E, V10, P123, DOI 10.1016/j.surge.2011.02.004; Hu YG, 2008, SPECTROCHIM ACTA A, V69, P378, DOI 10.1016/j.saa.2007.04.009; Huang ZW, 2010, BIOSENS BIOELECTRON, V26, P383, DOI 10.1016/j.bios.2010.07.125; Huang ZW, 2003, INT J CANCER, V107, P1047, DOI 10.1002/ijc.11500; Karabeber H, 2014, ACS NANO, V8, P9755, DOI 10.1021/nn503948b; Kawabata T, 2008, J GASTROENTEROL, V43, P283, DOI 10.1007/s00535-008-2160-2; Kawamura H, 2001, Gastric Cancer, V4, P83, DOI 10.1007/PL00011728; Keller MD, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600708; Kim BS, 2014, SURGERY, V155, P1030, DOI 10.1016/j.surg.2013.08.016; Kong K, 2014, PHYS MED BIOL, V59, P6141, DOI 10.1088/0031-9155/59/20/6141; Kunisaki C, 2006, ANN SURG ONCOL, V13, P836, DOI 10.1245/ASO.2006.03.077; Lee HH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-254; Li C, 2007, ONCOLOGY-BASEL, V72, P64, DOI 10.1159/000111096; Matsubara Y, 2004, HEPATO-GASTROENTEROL, V51, P285; Meyer T, 2013, HEAD NECK-J SCI SPEC, V35, pE280, DOI 10.1002/hed.23139; National Comprehensive Cancer Network, 2015, CLIN PRACT GUID ONC; Piessen G, 2009, ANN SURG, V250, P878, DOI 10.1097/SLA.0b013e3181b21c7b; Schie IW, 2013, APPL SPECTROSC, V67, P813, DOI 10.1366/12-06971; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Shen AG, 2005, VIB SPECTROSC, V37, P225, DOI 10.1016/j.vibspec.2004.10.001; Spicer J, 2014, ANN SURG ONCOL, V21, P2580, DOI 10.1245/s10434-014-3669-7; Taghavi S, 2012, J CLIN ONCOL, V30, P3493, DOI 10.1200/JCO.2012.42.6635; Teh SK, 2008, BRIT J CANCER, V98, P457, DOI 10.1038/sj.bjc.6604176; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Watanabe H., 1990, HISTOLOGICAL TYPING; Woo LS, 2002, DIGEST SURG, V19, P286, DOI 10.1159/000064583; Yang XF, 2004, WORLD J GASTROENTERO, V10, P750, DOI 10.3748/wjg.v10.i5.750; Yasuda K, 2004, J CLIN GASTROENTEROL, V38, P507, DOI 10.1097/01.mcg.0000128991.59549.9a; Yasuda K, 2001, J SURG ONCOL, V76, P272, DOI 10.1002/jso.1045; Yin CM, 2012, MED ONCOL, V29, P864, DOI 10.1007/s12032-011-9825-z; Zhang M, 2010, J SURG ONCOL, V102, P64, DOI 10.1002/jso.21533; Zheng HC, 2010, HISTOL HISTOPATHOL, V25, P445, DOI 10.14670/HH-25.445	45	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159829	10.1371/journal.pone.0159829	http://dx.doi.org/10.1371/journal.pone.0159829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472385	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300022
J	Curti, A; Schwarz, A; Trachsler, J; Tomonaga, Y; Ambuhl, PM				Curti, Adriano; Schwarz, Albin; Trachsler, Johannes; Tomonaga, Yuki; Ambuehl, Patrice M.			Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy	PLOS ONE			English	Article							DIAGNOSED MULTIPLE-MYELOMA; ACUTE-RENAL-FAILURE; FREE LIGHT-CHAINS; PLASMA-EXCHANGE; HEMODIALYSIS; CHEMOTHERAPY; IMPAIRMENT; SURVIVAL; KIDNEY; IMPACT	Background High Cut-Off (HCO) dialysis membranes efficiently reduce serum free light chain (FLC) concentrations and may improve renal recovery and survival from multiple myeloma (MM) associated renal failure with cast nephropathy. However, clinical trials comparing dialysis with HCO versus conventional filters are lacking. The aim of this study was to assess clinical outcomes and economic impact of HCO dialyzers compared to conventional hemodialysis membranes in cast nephropathy. Methods Multicenter retrospective analysis of 19 patients treated for renal failure from FLC associated cast nephropathy with standard induction chemotherapy (bortezomib/dexamethasone). We compared hemodialysis treatment with High Cut-Off (n = 12) versus conventional dialyzers (n = 7). Primary endpoint was survival; secondary endpoints were renal recovery, renal function and treatment costs. Results At 12 months, patient survival was 25% in the HCO group versus 0% in controls (p = NS). A tendency towards faster renal recovery (p = 0.066) and better renal function at 3, 6 and 12 months (p = 0.109) after diagnosis of MM was noted in the HCO group. Complete renal response rate was achieved in 10.5 and 0% of HCO and control patients, respectively, partial renal response in 15.8 and 5.3%, and minor renal response in 26.3 and 15.8%, respectively. Both patient survival and renal recovery were significantly correlated with the extent of free light chain (FLC) reduction in serum. Median treatment costs were CHF 230'000 and 223'000 (p = NS) in the HCO and control group, respectively. Conclusions Hemodialysis treatment with HCO membranes for cast nephropathy tended towards better survival as well as faster and better recovery of renal function versus conventional dialyzers. Moreover, total medical costs were comparable between groups. In the absence of results from randomized prospective trials on this topic, the use of HCO dialyzers in patients with renal failure from cast nephropathy may be recommended. Prospective randomized trials are required.	[Curti, Adriano; Schwarz, Albin; Trachsler, Johannes; Ambuehl, Patrice M.] Stadtspital Waid Zurich, Div Renal, Zurich, Switzerland; [Tomonaga, Yuki] Univ Zurich, Epidemiol Biostat & Prevent Inst, Med Econ, Zurich, Switzerland	University of Zurich	Ambuhl, PM (corresponding author), Stadtspital Waid Zurich, Div Renal, Zurich, Switzerland.	patrice.ambuehl@waid.zuerich.ch						Basnayake K, 2011, KIDNEY INT, V79, P1289, DOI 10.1038/ki.2011.94; Blade J, 1998, ARCH INTERN MED, V158, P1889, DOI 10.1001/archinte.158.17.1889; Clark WF, 2005, ANN INTERN MED, V143, P777, DOI 10.7326/0003-4819-143-11-200512060-00005; Decourt A, 2016, CLIN J AM SOC NEPHRO, V11, P431, DOI 10.2215/CJN.06290615; Dimopoulos MA, 2014, ANN ONCOL, V25, P195, DOI 10.1093/annonc/mdt483; Dimopoulos MA, 2010, J CLIN ONCOL, V28, P4976, DOI 10.1200/JCO.2010.30.8791; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Ecotiere L, 2016, NEPHROL DIAL TRANSPL, V31, P64, DOI 10.1093/ndt/gfv283; Gonsalves WI, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.20; Heher EC, 2013, CLIN J AM SOC NEPHRO, V8, P2007, DOI 10.2215/CJN.12231212; Hutchison CA, 2007, J AM SOC NEPHROL, V18, P886, DOI 10.1681/ASN.2006080821; Hutchison CA, 2012, NEPHROL DIAL TRANSPL, V27, P3823, DOI 10.1093/ndt/gfr773; Hutchison CA, 2009, CLIN J AM SOC NEPHRO, V4, P745, DOI 10.2215/CJN.04590908; Hutchison CA, 2008, ARTIF ORGANS, V32, P910, DOI 10.1111/j.1525-1594.2008.00653.x; JOHNSON WJ, 1990, ARCH INTERN MED, V150, P863, DOI 10.1001/archinte.150.4.863; Knudsen LM, 2000, EUR J HAEMATOL, V65, P175, DOI 10.1034/j.1600-0609.2000.90221.x; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Ludwig H, 2014, ONCOLOGIST, V19, P829, DOI 10.1634/theoncologist.2014-0042; Peters NO, 2011, HEMODIAL INT, V15, P538, DOI 10.1111/j.1542-4758.2011.00587.x; Scheid C, 2014, HAEMATOLOGICA, V99, P148, DOI 10.3324/haematol.2013.087585; Statistik Bf, 2005, BRUTT DAT IND; Zannetti BA, 2015, AM J HEMATOL, V90, P647, DOI 10.1002/ajh.24035; ZUCCHELLI P, 1988, KIDNEY INT, V33, P1175, DOI 10.1038/ki.1988.127	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159942	10.1371/journal.pone.0159942	http://dx.doi.org/10.1371/journal.pone.0159942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467401	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100077
J	Sardelis, S; Drew, JA				Sardelis, Stephanie; Drew, Joshua A.			Not "Pulling up the Ladder": Women Who Organize Conference Symposia Provide Greater Opportunities for Women to Speak at Conservation Conferences	PLOS ONE			English	Article							GENDER; SCIENCE	The scientific community faces numerous challenges in achieving gender equality among its participants. One method of highlighting the contributions made by female scientists is through their selection as featured speakers in symposia held at the conferences of professional societies. Because they are specially invited, symposia speakers obtain a prestigious platform from which to display their scientific research, which can elevate the recognition of female scientists. We investigated the number of female symposium speakers in two professional societies (the Society of Conservation Biology (SCB) from 1999 to 2015, and the American Society of Ichthyologists and Herpetologists (ASIH) from 2005 to 2015), in relation to the number of female symposium organizers. Overall, we found that 36.4% of symposia organizers and 31.7% of symposia speakers were women at the Society of Conservation Biology conferences, while 19.1% of organizers and 28% of speakers were women at the American Society of Ichthyologists and Herpetologists conferences. For each additional female organizer at the SCB and ASIH conferences, there was an average increase of 95% and 70% female speakers, respectively. As such, we found a significant positive relationship between the number of women organizing a symposium and the number of women speaking in that symposium. We did not, however, find a significant increase in the number of women speakers or organizers per symposium over time at either conference, suggesting a need for revitalized efforts to diversify our scientific societies. To further those ends, we suggest facilitating gender equality in professional societies by removing barriers to participation, including assisting with travel, making conferences child-friendly, and developing thorough, mandatory Codes of Conduct for all conferences.	[Sardelis, Stephanie; Drew, Joshua A.] Columbia Univ, Dept Ecol Evolut & Environm Biol, 1200 Amsterdam Ave, New York, NY 10027 USA	Columbia University	Sardelis, S (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, 1200 Amsterdam Ave, New York, NY 10027 USA.	stephanie.sardelis@columbia.edu						Addessi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030458; [Anonymous], 2014, EARLY ACAD CAREER PA; Appel M, 2011, EUR J SOC PSYCHOL, V41, P904, DOI 10.1002/ejsp.835; Bardolph DN, 2014, AM ANTIQUITY, V79, P522, DOI 10.7183/0002-7316.79.3.522; Blickenstaff JC, 2005, GENDER EDUC, V17, P369, DOI 10.1080/09540250500145072; BUTLER J, 1988, THEATRE J, V40, P519, DOI 10.2307/3207893; Casadevall A, 2014, MBIO, V5, DOI [10.1128/mBio.00846-13, 10.1128/mBio.01730-14, 10.1128/mBio.01342-14, 10.1128/mBio.00064-14]; Ceci SJ, 2015, DO WOMEN EARN LESS M; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Chachra D, 2016, BITCH PLANET, V1; Charyton C, 2011, J CREATIVE BEHAV, V45, P203, DOI 10.1002/j.2162-6057.2011.tb01427.x; Conley D, 2012, NATURE, V488, P590, DOI 10.1038/488590a; Correll SJ, 2007, AM J SOCIOL, V112, P1297, DOI 10.1086/511799; Dasgupta N., 2014, POLICY INSIGHTS BEH, V1, P21, DOI [https://doi.org/10.1177/2372732214549471, DOI 10.1177/2372732214549471, 10.1177/2372732214549471]; Diekman AB, 2015, SOC ISS POLICY REV, V9, P52, DOI 10.1111/sipr.12010; Ecklund EH, 2012, GENDER SOC, V26, P693, DOI 10.1177/0891243212451904; Etzkowitz H., 2000, ATHENA UNBOUND ADV W; Favaro B, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00103; Fox MF, 2005, SOC STUD SCI, V35, P131, DOI 10.1177/0306312705046630; Goulden M, 2011, ANN AM ACAD POLIT SS, V638, P141, DOI 10.1177/0002716211416925; Hedin M, 2014, GEND HIST, V26, P52, DOI 10.1111/1468-0424.12051; Henley MM, 2015, SOCIOL COMPASS, V9, P668, DOI 10.1111/soc4.12291; Holleran SE, 2011, SOC PSYCHOL PERS SCI, V2, P65, DOI 10.1177/1948550610379921; Isbell LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049682; Jones TM, 2014, PEERJ, V2, DOI 10.7717/peerj.627; Karpowitz CF, 2012, AM POLIT SCI REV, V106, P533, DOI 10.1017/S0003055412000329; Kelly K, 2012, SOC STUD SCI, V42, P869, DOI 10.1177/0306312712457111; Knobloch-Westerwick S, 2013, SCI COMMUN, V35, P603, DOI 10.1177/1075547012472684; Lincoln AE, 2012, SOC STUD SCI, V42, P307, DOI 10.1177/0306312711435830; Martin JL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003903; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; R Development Core Team, 2012, R LANG ENV STAT COMP; Redden E., 2007, INSIDE HIGHER ED; Rosser S., 2004, SCI GLASS CEILING AC; Schroeder J, 2013, J EVOLUTION BIOL, V26, P2063, DOI 10.1111/jeb.12198; Sege R, 2015, JAMA-J AM MED ASSOC, V314, P1175, DOI 10.1001/jama.2015.8517; SICB Awards & Scholarships, 2016, AW SCHOL STUD; Stout JG, 2011, J PERS SOC PSYCHOL, V100, P255, DOI 10.1037/a0021385; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; West M, 2006, TECHNICAL REPORT; Wyer Mary, 2013, WOMEN SCI TECHNOLOGY; Yentsch CM, 2003, WOMAN SCI M CHALLENG	43	52	54	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160015	10.1371/journal.pone.0160015	http://dx.doi.org/10.1371/journal.pone.0160015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IL	27467580	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100089
J	Zorman, J; Susjan, P; Hafner-Bratkovic, I				Zorman, Jernej; Susjan, Petra; Hafner-Bratkovic, Iva			Shikonin Suppresses NLRP3 and AIM2 Inflammasomes by Direct Inhibition of Caspase-1	PLOS ONE			English	Article							NF-KAPPA-B; NALP3 INFLAMMASOME; ACTIVATION; RELEASE; CELLS; TOXINS; HMGB1; NEUROINFLAMMATION; IL-1-BETA; APOPTOSIS	Shikonin is a highly lipophilic naphtoquinone found in the roots of Lithospermum erythrorhizon used for its pleiotropic effects in traditional Chinese medicine. Based on its reported antipyretic and anti-inflammatory properties, we investigated whether shikonin suppresses the activation of NLRP3 inflammasome. Inflammasomes are cytosolic protein complexes that serve as scaffolds for recruitment and activation of caspase-1, which, in turn, results in cleavage and secretion of proinflammatory cytokines IL-1 beta and IL-18. NLRP3 inflammasome activation involves two steps: priming, i.e. the activation of NF-kappa B pathway, and inflammasome assembly. While shikonin has previously been reported to suppress the priming step, we demonstrated that shikonin also inhibits the second step of inflammasome activation induced by soluble and particulate NLRP3 instigators in primed immortalized murine bone marrow-derived macrophages. Shikonin decreased NLRP3 inflammasome activation in response to nigericin more potently than acetylshikonin. Our results showed that shikonin also inhibits AIM2 inflammasome activation by double stranded DNA. Shikonin inhibited ASC speck formation and caspase-1 activation in murine macrophages and suppressed the activity of isolated caspase-1, demonstrating that it directly targets caspase-1. Complexing shikonin with beta-lactoglobulin reduced its toxicity while preserving the inhibitory effect on NLRP3 inflammasome activation, suggesting that shikonin with improved bioavailability might be interesting for therapeutic applications in inflammasome-mediated conditions.	[Zorman, Jernej; Susjan, Petra; Hafner-Bratkovic, Iva] Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia; [Susjan, Petra] Univ Ljubljana, Grad Sch Biomed, Ljubljana 1000, Slovenia; [Hafner-Bratkovic, Iva] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Zorman, Jernej] Univ Oxford, Queens Coll, Oxford, England	National Institute of Chemistry - Slovenia; University of Ljubljana; University of Oxford	Hafner-Bratkovic, I (corresponding author), Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia.; Hafner-Bratkovic, I (corresponding author), EN FIST Ctr Excellence, Ljubljana, Slovenia.	iva.hafner@ki.si		Hafner Bratkovic, Iva/0000-0001-5635-931X; Susjan, Petra/0000-0002-0133-9896	Slovenian Research Agency [J3-5503, J3-6791]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was funded by Slovenian Research Agency (www.arrs.gov.si; grants J3-5503 and J3-6791 to IH-B). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Albreht A, 2012, J AGR FOOD CHEM, V60, P10834, DOI 10.1021/jf303153d; Andujar I, 2013, CURR MED CHEM, V20, P2892, DOI 10.2174/09298673113209990008; Andujar I, 2010, BRIT J PHARMACOL, V160, P376, DOI 10.1111/j.1476-5381.2010.00696.x; Andujar I, 2013, PLANTA MED, V79, P1685, DOI 10.1055/s-0033-1350934; Assimopoulou AN, 2004, BIOMED CHROMATOGR, V18, P240, DOI 10.1002/bmc.310; Assimopoulou AN, 2003, J MICROENCAPSUL, V20, P581, DOI 10.3109/02652040309178348; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Cheng YW, 2008, J ETHNOPHARMACOL, V120, P264, DOI 10.1016/j.jep.2008.09.002; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coll RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029539; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Gao D, 2002, BIOL PHARM BULL, V25, P827, DOI 10.1248/bpb.25.827; Gao DY, 2000, BIOORGAN MED CHEM, V8, P2561, DOI 10.1016/S0968-0896(00)00191-7; Gong ZZ, 2015, MOL NUTR FOOD RES, V59, P2132, DOI 10.1002/mnfr.201500316; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Gwon SY, 2012, J AGR FOOD CHEM, V60, P9089, DOI 10.1021/jf3017404; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Han J, 2009, INT J PHARMACEUT, V382, P215, DOI 10.1016/j.ijpharm.2009.07.027; Han WD, 2009, APOPTOSIS, V14, P674, DOI 10.1007/s10495-009-0334-x; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang WR, 2014, MOLECULES, V19, P7785, DOI 10.3390/molecules19067785; Huang YI, 2007, COLLOID SURFACE B, V58, P290, DOI 10.1016/j.colsurfb.2007.04.013; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kontogiannopoulos KN, 2011, INT J PHARMACEUT, V409, P216, DOI 10.1016/j.ijpharm.2011.02.004; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Li Y, 2015, TOXICOL APPL PHARM, V286, P53, DOI 10.1016/j.taap.2015.03.010; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; OLLINGER K, 1989, ARCH BIOCHEM BIOPHYS, V275, P514, DOI 10.1016/0003-9861(89)90398-6; Papageorgiou VP, 1999, ANGEW CHEM INT EDIT, V38, P270, DOI 10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Rossol M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2339; Shi JQ, 2013, CNS NEUROSCI THER, V19, P262, DOI 10.1111/cns.12066; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Ting JPY, 2005, CLIN IMMUNOL, V115, P33, DOI 10.1016/j.clim.2005.02.007; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Xia HM, 2013, BIOSCIENCE REP, V33, P207, DOI 10.1042/BSR20120065; Yang JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094180; Yang L.X., 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1186/S13568-014-0054-7; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yang Y, 2014, INT IMMUNOPHARMACOL, V19, P81, DOI 10.1016/j.intimp.2014.01.003; YOSHIMI N, 1992, JPN J CANCER RES, V83, P1273, DOI 10.1111/j.1349-7006.1992.tb02758.x; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zhu TT, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/819053	56	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159826	10.1371/journal.pone.0159826	http://dx.doi.org/10.1371/journal.pone.0159826			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467658	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100060
J	Kovalenko, I; Glasauer, A; Schockel, L; Sauter, DRP; Ehrmann, A; Sohler, F; Hagebarth, A; Novak, I; Christian, S				Kovalenko, Ilya; Glasauer, Andrea; Schoeckel, Laura; Sauter, Daniel R. P.; Ehrmann, Alexander; Sohler, Florian; Haegebarth, Andrea; Novak, Ivana; Christian, Sven			Identification of K(Ca)3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNELS; CANCER; CALCIUM; KRAS; P53; TRANSPORTERS; HYPOXIA; KCA3.1; TRANSCRIPTION	Pancreatic ductal adenocarcinoma (PDAC) represents the most common form of pancreatic cancer with rising incidence in developing countries and overall 5-year survival rates of less than 5%. The most frequent mutations in PDAC are gain-of-function mutations in KRAS as well as loss-of-function mutations in p53. Both mutations have severe impacts on the metabolism of tumor cells. Many of these metabolic changes are mediated by transporters or channels that regulate the exchange of metabolites and ions between the intracellular compartment and the tumor microenvironment. In the study presented here, our goal was to identify novel transporters or channels that regulate oxidative phosphorylation (OxPhos) in PDAC in order to characterize novel potential drug targets for the treatment of these cancers. We set up a Seahorse Analyzer XF based siRNA screen and identified previously described as well as novel regulators of OxPhos. The siRNA that resulted in the greatest change in cellular oxygen consumption was targeting the KCNN4 gene, which encodes for the Ca2+-sensitive K+ channel K(Ca)3.1. This channel has not previously been reported to regulate OxPhos. Knock-down experiments as well as the use of a small molecule inhibitor confirmed its role in regulating oxygen consumption, ATP production and cellular proliferation. Furthermore, PDAC cell lines sensitive to K(Ca)3.1 inhibition were shown to express the channel protein in the plasma membrane as well as in the mitochondria. These differences in the localization of K(Ca)3.1 channels as well as differences in the regulation of cellular metabolism might offer opportunities for targeted therapy in subsets of PDAC.	[Kovalenko, Ilya; Glasauer, Andrea; Schoeckel, Laura; Haegebarth, Andrea; Christian, Sven] Bayer Pharma AG, Drug Discovery, Therapeut Res Grp, Berlin, Germany; [Kovalenko, Ilya; Glasauer, Andrea; Schoeckel, Laura; Haegebarth, Andrea; Christian, Sven] Bayer Pharma AG, Drug Discovery, Grp Onc 2, Berlin, Germany; [Kovalenko, Ilya] Tech Univ Berlin, Dept Bioanalyt, Inst Biotechnol, Berlin, Germany; [Sauter, Daniel R. P.; Novak, Ivana] Univ Copenhagen, Dept Biol, Sect Cell Biol & Physiol, Copenhagen, Denmark; [Ehrmann, Alexander] Bayer Pharma AG, Drug Discovery, Lead Discovery Cell Biol, Berlin, Germany; [Sohler, Florian] Bayer Pharma AG, Drug Discovery, Therapeut Res Grp, Leverkusen, Germany; [Sohler, Florian] Bayer Pharma AG, Drug Discovery, Grp Bioinformat, Leverkusen, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Technical University of Berlin; University of Copenhagen; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Christian, S (corresponding author), Bayer Pharma AG, Drug Discovery, Therapeut Res Grp, Berlin, Germany.; Christian, S (corresponding author), Bayer Pharma AG, Drug Discovery, Grp Onc 2, Berlin, Germany.	sven.christian@bayer.com	Novak, Ivana/M-2791-2014	Novak, Ivana/0000-0002-8917-8010; Kovalenko, Ilya/0000-0001-9615-3738; Kovalenko, Ilya/0000-0003-4764-9117; Sohler, Florian/0000-0003-4276-0238; Schockel, Laura/0000-0002-8887-9958	FP7 IonTrac Marie Curie Fellowships	FP7 IonTrac Marie Curie Fellowships	This work was supported by FP7 IonTrac Marie Curie Fellowships (IK and DRPS). The funder provided support in the form of salaries for authors IK and DRPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen AP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0098; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Bulk E, 2015, INT J CANCER, V137, P1306, DOI 10.1002/ijc.29490; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cavadas MAS, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-42; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Cowley MJ, 2013, J HEPATO-BIL-PAN SCI, V20, P549, DOI 10.1007/s00534-013-0610-6; De Marchi U, 2009, CELL CALCIUM, V45, P509, DOI 10.1016/j.ceca.2009.03.014; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Eser S, 2014, BRIT J CANCER, V111, P817, DOI 10.1038/bjc.2014.215; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haren N, 2010, HISTOL HISTOPATHOL, V25, P1247, DOI 10.14670/HH-25.1247; Hayashi M, 2013, CHANNELS, V7, P432, DOI 10.4161/chan.26100; Hayashi M, 2012, AM J PHYSIOL-CELL PH, V303, pC151, DOI 10.1152/ajpcell.00089.2012; Hidalgo M, 2012, CLIN CANCER RES, V18, P4249, DOI 10.1158/1078-0432.CCR-12-1327; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kulawiec Mariola, 2009, J Carcinog, V8, P8, DOI 10.4103/1477-3163.50893; Leanza L, 2014, ONCOGENE, V33, P5569, DOI 10.1038/onc.2013.578; Lebedeva MA, 2009, BBA-BIOENERGETICS, V1787, P328, DOI 10.1016/j.bbabio.2009.01.004; Ledoux J, 2008, J GEN PHYSIOL, V131, P125, DOI 10.1085/jgp.200709875; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; McCracken AN, 2013, TRENDS ENDOCRIN MET, V24, P200, DOI 10.1016/j.tem.2013.01.002; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; Munaron L, 2015, BBA-BIOMEMBRANES, V1848, P2647, DOI 10.1016/j.bbamem.2014.10.031; Pertega-Gomes N, 2014, INT J MOL SCI, V15, P18333, DOI 10.3390/ijms151018333; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Samuel N, 2012, NAT REV GASTRO HEPAT, V9, P77, DOI 10.1038/nrgastro.2011.215; Sassi N, 2010, BBA-BIOENERGETICS, V1797, P1260, DOI 10.1016/j.bbabio.2009.12.015; Schwab A, 2012, J CELL PHYSIOL, V227, P686, DOI 10.1002/jcp.22776; Schwartzenberg-Bar-Yoseph F, 2004, CANCER RES, V64, P2627, DOI 10.1158/0008-5472.CAN-03-0846; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Turner KL, 2014, GLIA, V62, P971, DOI 10.1002/glia.22655; Urbahns K, 2005, BIOORG MED CHEM LETT, V15, P401, DOI 10.1016/j.bmcl.2004.10.063; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; WARBURG O, 1956, SCIENCE, V124, P269; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Wojtkowiak JW, 2015, CANCER METAB, V3, DOI 10.1186/s40170-014-0026-z; Yang XW, 2013, J HUAZHONG U SCI-MED, V33, P86, DOI 10.1007/s11596-013-1076-0	55	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160658	10.1371/journal.pone.0160658	http://dx.doi.org/10.1371/journal.pone.0160658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494181	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500069
J	Downie, JM; Tashi, T; Lorenzo, FR; Feusier, JE; Mir, H; Prchal, JT; Jorde, LB; Koul, PA				Downie, Jonathan M.; Tashi, Tsewang; Lorenzo, Felipe Ramos; Feusier, Julie Ellen; Mir, Hyder; Prchal, Josef T.; Jorde, Lynn B.; Koul, Parvaiz A.			A Genome-Wide Search for Greek and Jewish Admixture in the Kashmiri Population	PLOS ONE			English	Article							HIGH-ALTITUDE ADAPTATION; GENETIC-EVIDENCE; PLINK	The Kashmiri population is an ethno-linguistic group that resides in the Kashmir Valley in northern India. A longstanding hypothesis is that this population derives ancestry from Jewish and/or Greek sources. There is historical and archaeological evidence of ancient Greek presence in India and Kashmir. Further, some historical accounts suggest ancient Hebrew ancestry as well. To date, it has not been determined whether signatures of Greek or Jewish admixture can be detected in the Kashmiri population. Using genome-wide genotyping and admixture detection methods, we determined there are no significant or substantial signs of Greek or Jewish admixture in modern-day Kashmiris. The ancestry of Kashmiri Tibetans was also determined, which showed signs of admixture with populations from northern India and west Eurasia. These results contribute to our understanding of the existing population structure in northern India and its surrounding geographical areas.	[Downie, Jonathan M.; Feusier, Julie Ellen; Jorde, Lynn B.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA; [Tashi, Tsewang; Lorenzo, Felipe Ramos; Prchal, Josef T.] Univ Utah, Sch Med, Dept Internal Med, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA; [Mir, Hyder; Koul, Parvaiz A.] Sherikashmir Inst Med Sci, Dept Internal & Pulm Med, Srinagar, Jammu & Kashmir, India	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Sher-i-Kashmir Institute of Medical Sciences	Downie, JM (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84132 USA.	jonathan.downie@hsc.utah.edu	Downie, Jonathan/GPK-5981-2022; Mir, Hyder/AAP-8777-2020; Koul, Parvaiz/B-1666-2017	Downie, Jonathan/0000-0002-5424-4401; Koul, Parvaiz/0000-0002-1700-9285	National Institute of General Medical Sciences [GM059290]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences (GM059290; https://www.nigms.nih.gov/Pages/default.aspx), who funded LBJ. The funder of this project had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2011, ANCIENT GREEKS KASHM; Ahmad KN, 1952, JESUS HEAVEN EARTH; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Ataullah Siddiqui, 1991, TIBET J, V14, P71; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Bellew HW, 1891, 9 INT C OR LOND SEPT; Benfey Theodor, 1866, SANSKRIT ENGLISH DIC; Biddulph John, 1880, TRIBES HINDOO KOOSH; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Caroe Olaf., 1960, J ROY SOC ARTS, V108, P920; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Ge RL, 2012, MOL GENET METAB, V106, P244, DOI 10.1016/j.ymgme.2012.03.003; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Muhammad F, 2010, MYSTERY 10 LOST TRIB; Narain AK, 1957, THE INDO GREEKS; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Robertson GS, 1896, KAFIRS HINDU KUSH; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; van Dorp L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005397; Xing JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003634; Xing JC, 2010, GENOMICS, V96, P199, DOI 10.1016/j.ygeno.2010.07.004; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	33	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160614	10.1371/journal.pone.0160614	http://dx.doi.org/10.1371/journal.pone.0160614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490348	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900072
J	Mannige, RV; Kundu, J; Whitelam, S				Mannige, Ranjan V.; Kundu, Joyjit; Whitelam, Stephen			The Ramachandran Number: An Order Parameter for Protein Geometry	PLOS ONE			English	Article							INTRINSICALLY DISORDERED PROTEINS; STRUCTURAL-CHARACTERIZATION; SECONDARY-STRUCTURE; ALPHA-SHEET; NMR; CRYSTALS; BETA	Three-dimensional protein structures usually contain regions of local order, called secondary structure, such as alpha-helices and beta-sheets. Secondary structure is characterized by the local rotational state of the protein backbone, quantified by two dihedral angles called phi and psi Particular types of secondary structure can generally be described by a single ( diffuse) location on a two-dimensional plot drawn in the space of the angles phi and psi, called a Ramachandran plot. By contrast, a recently-discovered nanomaterial made from peptoids, structural isomers of peptides, displays a secondary-structure motif corresponding to two regions on the Ramachandran plot [Mannige et al., Nature 526, 415 (2015)]. In order to describe such 'higher-order' secondary structure in a compact way we introduce here a means of describing regions on the Ramachandran plot in terms of a single Ramachandran number, R, which is a structurally meaningful combination of phi and psi We show that the potential applications of R are numerous: it can be used to describe the geometric content of protein structures, and can be used to draw diagrams that reveal, at a glance, the frequency of occurrence of regular secondary structures and disordered regions in large protein datasets. We propose that R might be used as an order parameter for protein geometry for a wide range of applications.	[Mannige, Ranjan V.; Kundu, Joyjit; Whitelam, Stephen] Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Whitelam, S (corresponding author), Lawrence Berkeley Natl Lab, Mol Foundry, 1 Cyclotron Rd, Berkeley, CA USA.	rvmannige@lbl.gov; swhitelam@lbl.gov			Defense Threat Reduction Agency [IACRO-B0845281]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	RVM and SW were supported by the Defense Threat Reduction Agency under contract no. IACRO-B0845281. This work was done at the Molecular Foundry at Lawrence Berkeley National Laboratory (LBNL), supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.; The authors thank Ronald N. Zuckermann for important discussions. RVM thanks Alana Canfield Mannige for input. This work, RVM and SW were supported by the Defense Threat Reduction Agency under contract no. IACRO-B0845281. This work was done at the Molecular Foundry at Lawrence Berkeley National Laboratory (LBNL), supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Alberts B., 2002, MOL BIOL CELL, V4th; ANDERSON JM, 1995, SIGPLAN NOTICES, V30, P166, DOI 10.1145/209937.209954; Armen RS, 2004, P NATL ACAD SCI USA, V101, P11622, DOI 10.1073/pnas.0401781101; Babin V, 2011, PROTEINS, V79, P937, DOI 10.1002/prot.22935; Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011; Baruah A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11740; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Berg JM, 2010, BIOCHEMISTRY INTERNA; BRAGG L, 1950, PROC R SOC LON SER-A, V203, P321, DOI 10.1098/rspa.1950.0142; Branden CI, 1999, INTRODUCTION TO PROT; Chebrek R, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau102; Chong SH, 2013, J PHYS CHEM B, V117, P5503, DOI 10.1021/jp401049h; Chothia C, 1997, ANNU REV BIOPH BIOM, V26, P597, DOI 10.1146/annurev.biophys.26.1.597; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cooper G. M., 2013, THE CELL A MOLECULAR; Daggett V, 2006, ACCOUNTS CHEM RES, V39, P594, DOI 10.1021/ar0500719; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Dunker A Keith, 2013, Intrinsically Disord Proteins, V1, pe24157, DOI 10.4161/idp.24157; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eisenberg D, 2003, P NATL ACAD SCI USA, V100, P11207, DOI 10.1073/pnas.2034522100; Geist L, 2013, PROTEIN SCI, V22, P1196, DOI 10.1002/pro.2304; Hayward S, 2008, PROTEINS, V71, P415, DOI 10.1002/prot.21717; Hayward S, 2014, PROTEINS, V82, P230, DOI 10.1002/prot.24357; Hooft RWW, 1997, COMPUT APPL BIOSCI, V13, P425; Hung LW, 1998, ACTA CRYSTALLOGR D, V54, P494, DOI 10.1107/S0907444997012225; Jensen MR, 2013, CURR OPIN STRUC BIOL, V23, P426, DOI 10.1016/j.sbi.2013.02.007; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Konrat R, 2014, J MAGN RESON, V241, P74, DOI 10.1016/j.jmr.2013.11.011; Kosol S, 2013, MOLECULES, V18, P10802, DOI 10.3390/molecules180910802; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski Roman A, 2003, Methods Biochem Anal, V44, P273; Linderstrom-Lang KU, 1952, LANE MEDICAL LECTURE, V6; Mannige RV, 2014, PROTEOMES, V2, DOI 10.3390/proteomes2010128; Mannige RV, 2015, NATURE, V526, P415, DOI 10.1038/nature15363; Mittal A, 2014, J CHEM THEORY COMPUT, V10, P3550, DOI 10.1021/ct5002297; Nam KT, 2010, NAT MATER, V9, P454, DOI [10.1038/nmat2742, 10.1038/NMAT2742]; PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0; RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0; Sibille N, 2012, BIOCHEM SOC T, V40, P955, DOI 10.1042/BST20120149; Staneva I, 2012, BINDING OF TWO INTRI; Subramanian E, 2001, NAT STRUCT BIOL, V8, P489, DOI 10.1038/88544; Tien MZ, 2013, PEERJ, V1, DOI 10.7717/peerj.80; Wu H, 2010, J COMPUT CHEM, V31, P1216, DOI 10.1002/jcc.21408; ZAWADZKE LE, 1993, PROTEINS, V16, P301, DOI 10.1002/prot.340160308	54	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160023	10.1371/journal.pone.0160023	http://dx.doi.org/10.1371/journal.pone.0160023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490241	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900026
J	Morgan, SL; Seggio, JA; Nascimento, NF; Huh, DD; Hicks, JA; Sharp, KA; Axelrod, JD; Wang, KC				Morgan, Stefanie L.; Seggio, Joseph A.; Nascimento, Nara F.; Huh, Dana D.; Hicks, Jasmin A.; Sharp, Katherine A.; Axelrod, Jeffrey D.; Wang, Kevin C.			The Phenotypic Effects of Royal Jelly on Wild-Type D. melanogaster Are Strain-Specific	PLOS ONE			English	Article							LIFE-SPAN; ELEGANS	The role for royal jelly (RJ) in promoting caste differentiation of honeybee larvae into queens rather than workers is well characterized. A recent study demonstrated that this poorly understood complex nutrition drives strikingly similar phenotypic effects in Drosophila melanogaster, such as increased body size and reduced developmental time, making possible the use of D. melanogaster as a model system for the genetic analysis of the cellular mechanisms underlying RJ and caste differentiation. We demonstrate here that RJ increases the body size of some wild-type strains of D. melanogaster but not others, and report significant delays in developmental time in all flies reared on RJ. These findings suggest that cryptic genetic variation may be a factor in the D. melanogaster response to RJ, and should be considered when attempting to elucidate response mechanisms to environmental changes in non-honeybee species.	[Morgan, Stefanie L.; Huh, Dana D.; Wang, Kevin C.] Stanford Univ, Sch Med, Program Epithelial Biol, Dept Dermatol, Stanford, CA 94305 USA; [Morgan, Stefanie L.; Wang, Kevin C.] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA; [Seggio, Joseph A.; Nascimento, Nara F.; Hicks, Jasmin A.] Bridgewater State Univ, Dept Biol Sci, Bridgewater, MA 02325 USA; [Sharp, Katherine A.; Axelrod, Jeffrey D.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Sharp, Katherine A.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Wang, Kevin C.] Vet Affairs Healthcare Syst, Palo Alto, CA 94304 USA; [Nascimento, Nara F.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02467 USA; [Hicks, Jasmin A.] Colorado State Univ, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA	Stanford University; Stanford University; Massachusetts System of Public Higher Education; Bridgewater State College; Stanford University; Stanford University; Boston College; Colorado State University	Wang, KC (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Dept Dermatol, Stanford, CA 94305 USA.; Wang, KC (corresponding author), Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA 94305 USA.; Wang, KC (corresponding author), Vet Affairs Healthcare Syst, Palo Alto, CA 94304 USA.	kevwang@stanford.edu		Wang, Kevin/0000-0002-5305-6791; Seggio, Joseph/0000-0002-7315-1462	Burroughs Wellcome Fund; National Science Foundation [DGE-114747]; Department of Defense National Defense Science & Engineering Graduate Fellowship Program [FA9550-11-C-0028]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, P50GM107615] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); Department of Defense National Defense Science & Engineering Graduate Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K.C.W. is supported in part by a Career Award for Medical Scientists from the Burroughs Wellcome Fund. S.L.M. is supported in part by the National Science Foundation Graduate Research Fellowship (grant #DGE-114747), and by the Department of Defense National Defense Science & Engineering Graduate Fellowship Program (grant #FA9550-11-C-0028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atallah J, 2004, EVOL DEV, V6, P114, DOI 10.1111/j.1525-142X.2004.04017.x; Brembs B, 2014, F1000RES, V3; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chandler CH, 2010, HEREDITY, V105, P473, DOI 10.1038/hdy.2010.62; Chandler CH, 2014, GENETICS, V196, P1321, DOI 10.1534/genetics.113.159426; Chari S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003661; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Honda Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023527; Inoue S, 2003, EXP GERONTOL, V38, P965, DOI 10.1016/S0531-5565(03)00165-7; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; MCKENZIE JA, 1982, HEREDITY, V49, P1, DOI 10.1038/hdy.1982.60; Milloz J, 2008, GENE DEV, V22, P3064, DOI 10.1101/gad.495308; Miyashita A, 2016, BIOL OPEN, P1; RIBBANDS R, 1953, BEHAV SOCIAL LIFE HO; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Shorter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134612; Shuel R. W., 1960, APIS MELLIFERA L INS, V7, P265, DOI [10.1007/BF02224497, DOI 10.1007/BF02224497]; Tarpy DR, 2004, BEHAV ECOL SOCIOBIOL, V55, P513, DOI 10.1007/s00265-003-0738-5; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084	22	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159456	10.1371/journal.pone.0159456	http://dx.doi.org/10.1371/journal.pone.0159456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486863	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800031
J	Del Coso, J; Valero, M; Lara, B; Salinero, JJ; Gallo-Salazar, C; Areces, F				Del Coso, Juan; Valero, Marjorie; Lara, Beatriz; Jose Salinero, Juan; Gallo-Salazar, Cesar; Areces, Francisco			Myosin Light Chain Kinase (MLCK) Gene Influences Exercise Induced Muscle Damage during a Competitive Marathon	PLOS ONE			English	Article							ACUTE EXERTIONAL RHABDOMYOLYSIS; SKELETAL-MUSCLE; PHOSPHORYLATION; CONTRACTION	Myosin light chain kinase (MLCK) phosphorylates the regulatory light chain (RLC) of myosin producing increases in force development during skeletal muscle contraction. It has been suggested that MLCK gene polymorphisms might alter RLC phosphorylation thereby decreasing the ability to produce force and to resist strain during voluntary muscle contractions. Thus, the genetic variations in the MLCK gene might predispose some individuals to higher values of muscle damage during exercise, especially during endurance competitions. The aim of this investigation was to determine the influence of MLCK genetic variants on exercise-induced muscle damage produced during a marathon. Sixty-seven experienced runners competed in a marathon race. The MLCK genotype (C37885A) of these marathoners was determined. Before and after the race, a sample of venous blood was obtained to assess changes in serum myoglobin concentrations and leg muscle power changes were measured during a countermovement jump. Self-reported leg muscle pain and fatigue were determined by questionnaires. A total of 59 marathoners (88.1%) were CC homozygotes and 8 marathoners (11.9%) were CA heterozygotes. The two groups of participants completed the race with a similar time (228 +/- 33 vs 234 +/- 39 min; P = 0.30) and similar self-reported values for fatigue (15 +/- 2 vs 16 +/- 2 A. U.; P = 0.21) and lower-limb muscle pain (6.2 +/- 1.7 vs 6.6 +/- 1.8 cm; P = 0.29). However, CC marathoners presented higher serum myoglobin concentrations (739 +/- 792 vs 348 +/- 144 mu g.mL(-1); P = 0.03) and greater pre-to-post-race leg muscle power reduction (-32.7 +/- 15.7 vs -21.2 +/- 21.6%; P = 0.05) than CA marathoners. CA heterozygotes for MLCK C37885A might present higher exerciseinduced muscle damage after a marathon competition than CC counterparts.	[Del Coso, Juan; Valero, Marjorie; Lara, Beatriz; Jose Salinero, Juan; Gallo-Salazar, Cesar; Areces, Francisco] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain	Camilo Jose Cela University	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdelcoso@ucjc.edu	Del Coso, Juan/AAC-7117-2020; Areces, Francisco/ABH-3023-2020; Lara, Beatriz/AAQ-5269-2021; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012; GALLO, CESAR/O-4823-2019; Salinero, Juan J./GLT-1243-2022	Del Coso, Juan/0000-0002-5785-984X; Areces, Francisco/0000-0003-2996-4156; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; GALLO, CESAR/0000-0001-8676-4658; Salinero, Juan J./0000-0003-4153-5100; Lara, Beatriz/0000-0001-5516-4852	Camilo Jose Cela University	Camilo Jose Cela University	The study was supported by a Grant-in-aid from the Vice-Rectorate of Research and Science, at the Camilo Jose Cela University. This in an internal grant given by the university to the scientists of the own university (2014/003) (http://www.ucjc.edu/launiversidad/estructura-academica/vicerrectorados/vicerrectorado-de-innovacion/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areces F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138376; Areces F, 2015, J ORTHOP SPORT PHYS, V45, P462, DOI 10.2519/jospt.2015.5863; Areces F, 2014, AMINO ACIDS, V46, P1169, DOI 10.1007/s00726-014-1677-3; Baxter RE, 2003, J ORTHOP SPORT PHYS, V33, P104, DOI 10.2519/jospt.2003.33.3.104; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Childers MK, 2004, MUSCLE NERVE, V29, P313, DOI 10.1002/mus.10517; Cho J, 2013, J ORTHOP SPORT PHYS, V43, P932, DOI 10.2519/jospt.2013.0420; Clarkson PM, 2005, J APPL PHYSIOL, V99, P564, DOI 10.1152/japplphysiol.00130.2005; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; Clarkson PM, 2007, SPORTS MED, V37, P361, DOI 10.2165/00007256-200737040-00022; Del Coso J, 2013, APPL PHYSIOL NUTR ME, V38, P286, DOI 10.1139/apnm-2012-0241; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Deuster PA, 2013, EUR J APPL PHYSIOL, V113, P1997, DOI 10.1007/s00421-013-2622-y; Gittings W, 2011, J MUSCLE RES CELL M, V31, P337, DOI 10.1007/s10974-011-9239-8; Hill JA, 2014, J STRENGTH COND RES, V28, P2228, DOI 10.1519/JSC.0000000000000469; SWEENEY HL, 1990, P NATL ACAD SCI USA, V87, P414, DOI 10.1073/pnas.87.1.414; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; Yamin C, 2014, PEDIATR ENDOCR REV P, V11, P400	18	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160053	10.1371/journal.pone.0160053	http://dx.doi.org/10.1371/journal.pone.0160053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483374	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700020
J	Kim, CH; Wheatley, CM; Behnia, M; Johnson, BD				Kim, Chul-Ho; Wheatley, Courtney M.; Behnia, Mehrdad; Johnson, Bruce D.			The Effect of Aging on Relationships between Lean Body Mass and VO(2)max in Rowers	PLOS ONE			English	Article							MAXIMAL AEROBIC CAPACITY; CARDIOVASCULAR-DISEASE ENTERPRISES; AGE-ASSOCIATED CHANGES; MAJOR SHAREHOLDERS; OXYGEN-CONSUMPTION; SEDENTARY MEN; OLDER MEN; EXERCISE; DECLINE; MUSCLE	Aging is associated with a fall in maximal aerobic capacity as well as with a decline in lean body mass. The purpose of the study was to investigate the influence of aging on the relationship between aerobic capacity and lean body mass in subjects that chronically train both their upper and lower bodies. Eleven older rowers (58 +/- 5 yrs) and 11 younger rowers (27 +/- 4 yrs) participated in the study. Prior to the VO(2)max testing, subjects underwent a dual energy X-ray absorptiometry scan to estimate total lean body mass. Subsequently, VO(2)max was quantified during a maximal exercise test on a rowing ergometer as well as a semi-recumbent cycle ergometer. The test protocol included a pre-exercise stage followed by incremental exercise until VO(2)max was reached. The order of exercise modes was randomized and there was a wash-out period between the two tests. Oxygen uptake was obtained via a breath-by-breath metabolic cart (Vmax (TM) Encore, San Diego, CA). Rowing VO(2)max was higher than cycling VO(2)max in both groups (p<0.05). Older subjects had less of an increase in VO(2)max from cycling to rowing (p<0.05). There was a significant relationship between muscle mass and VO(2)max for both groups (p<0.05). After correcting for muscle mass, the difference in cycling VO(2)max between groups disappeared (p>0.05), however, older subjects still demonstrated a lower rowing VO(2)max relative to younger subjects (p<0.05). Muscle mass is associated with the VO(2)max obtained, however, it appears that VO(2)max in older subjects may be less influenced by muscle mass than in younger subjects.	[Kim, Chul-Ho; Wheatley, Courtney M.; Johnson, Bruce D.] Mayo Clin, Human Integrat & Environm Physiol Lab, Rochester, MN 55902 USA; [Behnia, Mehrdad] Doctors Hosp, Cardiopulm Lab, Augusta, GA USA	Mayo Clinic	Kim, CH (corresponding author), Mayo Clin, Human Integrat & Environm Physiol Lab, Rochester, MN 55902 USA.	kim.chulho@mayo.edu			Doctors Hospital, Augusta, GA	Doctors Hospital, Augusta, GA	Doctors Hospital, Augusta, GA, funded the present study.	ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1; Betik AC, 2008, APPL PHYSIOL NUTR ME, V33, P130, DOI 10.1139/H07-174; Brown SJ, 2007, J SPORT SCI MED, V6, P477; Cosgrove MJ, 1999, J SPORT SCI, V17, P845, DOI 10.1080/026404199365407; Deschenes MR, 2004, SPORTS MED, V34, P809, DOI 10.2165/00007256-200434120-00002; Eskurza I, 2002, J APPL PHYSIOL, V92, P2303, DOI 10.1152/japplphysiol.01124.2001; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Fitzgerald MD, 1997, J APPL PHYSIOL, V83, P160, DOI 10.1152/jappl.1997.83.1.160; FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147; FRONTERA WR, 1990, J APPL PHYSIOL, V68, P329, DOI 10.1152/jappl.1990.68.1.329; FUCHI T, 1989, EUR J APPL PHYSIOL, V58, P884, DOI 10.1007/BF02332223; HAGBERG JM, 1985, J APPL PHYSIOL, V58, P2041, DOI 10.1152/jappl.1985.58.6.2041; Hawkins SA, 2003, SPORTS MED, V33, P877, DOI 10.2165/00007256-200333120-00002; HEATH GW, 1981, J APPL PHYSIOL, V51, P634, DOI 10.1152/jappl.1981.51.3.634; Ladyga M, 2008, BIOL SPORT, V25, P245; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Mazzeo RS, 2014, ACSM CURRENT COMMENT; MCELVANEY GN, 1989, MED SCI SPORT EXER, V21, P293; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Pimentel AE, 2003, J APPL PHYSIOL, V94, P2406, DOI 10.1152/japplphysiol.00774.2002; Proctor DN, 1997, J APPL PHYSIOL, V82, P1411, DOI 10.1152/jappl.1997.82.5.1411; RIVERA AM, 1989, J APPL PHYSIOL, V66, P949; Robinson S, 1938, ARBEITSPHYSIOLOGIE, V10, P251, DOI [DOI 10.1007/BF02011412, 10.1007/bf02011412]; ROGERS MA, 1990, J APPL PHYSIOL, V68, P2195, DOI 10.1152/jappl.1990.68.5.2195; SEALS DR, 1984, J APPL PHYSIOL, V57, P1024, DOI 10.1152/jappl.1984.57.4.1024; SECHER NH, 1974, J APPL PHYSIOL, V36, P515, DOI 10.1152/jappl.1974.36.5.515; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Wilson TM, 2000, AM J PHYSIOL-HEART C, V278, pH829, DOI 10.1152/ajpheart.2000.278.3.H829	30	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160275	10.1371/journal.pone.0160275	http://dx.doi.org/10.1371/journal.pone.0160275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479009	gold, Green Published			2022-12-27	WOS:000381110300039
J	Murakami, T; Uji, A; Suzuma, K; Dodo, Y; Yoshitake, S; Ghashut, R; Yoza, R; Fujimoto, M; Yoshimura, N				Murakami, Tomoaki; Uji, Akihito; Suzuma, Kiyoshi; Dodo, Yoko; Yoshitake, Shin; Ghashut, Rima; Yoza, Rina; Fujimoto, Masahiro; Yoshimura, Nagahisa			In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography	PLOS ONE			English	Article							GROWTH-FACTOR THERAPY; MACULAR-EDEMA; RISK-FACTORS; RETINOPATHY; THICKNESS; TYPE-2; CHOROIDOPATHY; EYES; DEGENERATION; PREVALENCE	Diabetes induces microvascular diseases including diabetic retinopathy and choroidopathy which reciprocally promote the pathogenesis, although optical coherence tomography images of diabetic choroidopathy remains to be documented. Here we evaluated the qualitative characteristics of choroidal vascular lesions in patients with diabetes and their association with diabetic retinopathy on swept-source optical coherence tomography (SS-OCT) images. We retrospectively reviewed 110 consecutive eyes of 110 patients with diabetes and 35 eyes of 35 healthy subjects for whom SS-OCT images (6x6-mm scans centered on the fovea) of sufficient quality were acquired. The curve of chorioretinal sections was flattened using Bruch's membrane as a reference surface, followed by generation of en-face images. We characterized choroidal vascular lesions and evaluated their association with the logarithm of the minimum angle of resolution visual acuity (logMAR VA), retinal and choroidal thicknesses, and diabetic retinopathy severity. En-face SS-OCT images showed unvisualized vessels in Sattler's layer in 33 eyes (30.0%). Focal narrowing was seen in choroidal vessels in Haller's layer in 56 eyes (50.9%). The choroidal vessels ended in the superficial or middle portion of Haller's layer, referred to as vascular stumps, in 20 eyes (18.2%). Diabetic eyes had these findings more frequently than nondiabetic eyes. The sub-foveal choroid was thicker in eyes with focal vascular narrowing and vascular stumps than in eyes without such lesions. Vascular stumps in Haller's layer were significantly related to diabetic retinopathy severity, logMAR VA, and central retinal and choroidal thicknesses. These novel findings on SS-OCT images would promote the better understanding of complicated pathogenesis in diabetic retinopathy and choroidopathy.	[Murakami, Tomoaki; Uji, Akihito; Suzuma, Kiyoshi; Dodo, Yoko; Yoshitake, Shin; Ghashut, Rima; Yoza, Rina; Fujimoto, Masahiro; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan	Kyoto University	Murakami, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	mutomo@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science.	Adhi M, 2013, JAMA OPHTHALMOL, V131, P1267, DOI 10.1001/jamaophthalmol.2013.4321; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; Branchini LA, 2013, OPHTHALMOLOGY, V120, P1901, DOI 10.1016/j.ophtha.2013.01.066; Cao JT, 1998, ARCH OPHTHALMOL-CHIC, V116, P589, DOI 10.1001/archopht.116.5.589; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Esmaeelpour M, 2011, INVEST OPHTH VIS SCI, V52, P5311, DOI 10.1167/iovs.10-6875; Ferrara D, 2015, PROG RETIN EYE RES; Flores-Moreno I, 2015, BRIT J OPHTHALMOL, V99, P1260, DOI 10.1136/bjophthalmol-2014-306422; FREYLER H, 1986, KLIN MONATSBL AUGENH, V189, P144, DOI 10.1055/s-2008-1050772; FRYCZKOWSKI AW, 1989, INT OPHTHALMOL, V13, P269, DOI 10.1007/BF02280087; Fukushima I, 1997, AM J OPHTHALMOL, V124, P473, DOI 10.1016/S0002-9394(14)70863-3; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gerendas BS, 2014, AM J OPHTHALMOL, V158, P1039, DOI 10.1016/j.ajo.2014.08.001; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Hua R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083494; Jo Y, 2014, RETINA-J RET VIT DIS, V34, P1190, DOI 10.1097/IAE.0000000000000051; Kim JT, 2013, INVEST OPHTH VIS SCI, V54, P3378, DOI 10.1167/iovs.12-11503; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Motaghiannezam R, 2012, INVEST OPHTH VIS SCI, V53, P2337, DOI 10.1167/iovs.11-7823; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Muraoka Y, 2013, OPHTHALMOLOGY, V120, P91, DOI 10.1016/j.ophtha.2012.06.054; Nagaoka T, 2004, BRIT J OPHTHALMOL, V88, P1060, DOI 10.1136/bjo.2003.035345; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P6017, DOI 10.1167/iovs.12-9692; Rayess N, 2015, AM J OPHTHALMOL, V159, P85, DOI 10.1016/j.ajo.2014.09.033; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; SARACCO JB, 1982, J FR OPHTALMOL, V5, P231; Shiragami C, 2002, GRAEF ARCH CLIN EXP, V240, P436, DOI 10.1007/s00417-002-0451-5; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3979, DOI 10.1167/iovs.14-14188; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Wong IY, 2013, RETINA-J RET VIT DIS, V33, P423, DOI 10.1097/IAE.0b013e3182753b5a; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009; Yang SJ, 2013, CLIN EXP OPTOM, V96, P494, DOI 10.1111/cxo.12056; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yiu G, 2014, AM J OPHTHALMOL, V158, P745, DOI 10.1016/j.ajo.2014.06.006	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160317	10.1371/journal.pone.0160317	http://dx.doi.org/10.1371/journal.pone.0160317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479070	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300040
J	Sammons, JD; Weiss, MS; Escanilla, OD; Fooden, AF; Victor, JD; Di Lorenzo, PM				Sammons, Joshua D.; Weiss, Michael S.; Escanilla, Olga D.; Fooden, Andrew F.; Victor, Jonathan D.; Di Lorenzo, Patricia M.			Spontaneous Changes in Taste Sensitivity of Single Units Recorded over Consecutive Days in the Brainstem of the Awake Rat	PLOS ONE			English	Article							SOLITARY TRACT; NUCLEUS	A neuron's sensitivity profile is fundamental to functional classification of cell types, and underlies theories of sensory coding. Here we show that gustatory neurons in the nucleus of the solitary tract (NTS) and parabrachial nucleus of the pons (PbN) of awake rats spontaneously change their tuning properties across days. Rats were surgically implanted with a chronic microwire assembly into the NTS or PbN. Following recovery, water-deprived rats had free access to a lick spout that delivered taste stimuli while cellular activity was recorded. In 12 rats for the NTS and 8 rats for the PbN, single units could be isolated at the same electrode on consecutive days (NTS, 14 units for 2-5 consecutive days, median = 2 days; PbN, 23 units for 2-7 days, median = 2.5 days). Waveforms were highly similar (waveform template correlation > 0.99) across days in 13 units in NTS and 13 units in PbN. This degree of similarity was rare (0.3% of pairs in NTS, 1.5% of pairs in PbN) when the waveforms were from presumed-different neurons (units recorded on nonconsecutive days with at least one intervening day in which there were no spikes, or from different wires or rats). Analyses of multi-day recordings that met this criterion for "same unit" showed that responses to taste stimuli appeared, disappeared, or shifted in magnitude across days, resulting in changes in tuning. These data imply, generally, that frameworks for cell classification and, specifically, that theories of taste coding, need to consider plasticity of response profiles.	[Sammons, Joshua D.; Weiss, Michael S.; Escanilla, Olga D.; Fooden, Andrew F.; Di Lorenzo, Patricia M.] Binghamton Univ, Dept Psychol, Binghamton, NY 13902 USA; [Victor, Jonathan D.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Victor, Jonathan D.] Weill Cornell Med Coll, Dept Neurol, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Cornell University; Cornell University	Di Lorenzo, PM (corresponding author), Binghamton Univ, Dept Psychol, Binghamton, NY 13902 USA.	diloren@binghamton.edu		Di Lorenzo, Patricia/0000-0003-3935-1089	National Institute on Deafness and Other Communicative Disorders [RO1 DC006914]	National Institute on Deafness and Other Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communicative Disorders (https://www.nidcd.nih.gov) grant RO1 DC006914 to PMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accolla R, 2007, J NEUROSCI, V27, P1396, DOI 10.1523/JNEUROSCI.5188-06.2007; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chen XK, 2011, SCIENCE, V333, P1262, DOI 10.1126/science.1204076; Di Lorenzo PM, 2003, J NEUROSCI, V23, P8893; Di Lorenzo PM, 2000, BRAIN RES, V852, P383, DOI 10.1016/S0006-8993(99)02187-3; Hirata S, 2005, EXP BRAIN RES, V165, P435, DOI 10.1007/s00221-005-2321-y; Roussin AT, 2012, J NEUROSCI, V32, P10494, DOI 10.1523/JNEUROSCI.1856-12.2012; Shimatani Y, 2003, PHYSIOL BEHAV, V80, P309, DOI 10.1016/j.physbeh.2003.08.009; Shimatani Y, 2002, PHYSIOL BEHAV, V76, P143, DOI 10.1016/S0031-9384(02)00684-4; Spector Alan C, 2005, Behav Cogn Neurosci Rev, V4, P143, DOI 10.1177/1534582305280031; Sugita M, 2005, SCIENCE, V309, P781, DOI 10.1126/science.1110787; Weiss MS, 2014, J NEUROPHYSIOL, V111, P1655, DOI 10.1152/jn.00643.2013; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001	13	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160143	10.1371/journal.pone.0160143	http://dx.doi.org/10.1371/journal.pone.0160143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479490	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300027
J	Conceicao, EL; Nascimento-Sampaio, FS; Schwingel, PA; Oliveira, ES; Rocha, MS; Vieira, I; Mendes, CMC; Souza-Machado, A; Oliveira, MM; Barral-Netto, M; Marinho, JM; Barbosa, T				Conceicao, Elisabete L.; Nascimento-Sampaio, Francisco S.; Schwingel, Paulo A.; Oliveira, Evelin S.; Rocha, Michael S.; Vieira, Igor; Mendes, Carlos M. C.; Souza-Machado, Adelmir; Oliveira, Martha M.; Barral-Netto, Manoel; Marinho, Jamocyr M.; Barbosa, Theolis			Revisiting the Heterogeneous IFN-gamma Response of Bacille of Calmette-Guerin (BCG)Revaccinated Healthy Volunteers in a Randomized Controlled Trial: Effect of the Body Mass Index and of the IFNG+874 A/T Polymorphism	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; CYTOKINE GENE POLYMORPHISMS; INTERFERON-GAMMA; BCG VACCINATION; TUBERCULOSIS; PROTECTION; MALNUTRITION; ASSOCIATION; POPULATION; MALAWI	In trials evaluating the immune responses to Bacille of Calmette-Guerin (BCG), the genetic background and the nutritional status are host-related factors that could affect the heterogeneity in these parameters. The IFNG+874 A/T (rs 62559044) polymorphism has been reported to influence the IFN-gamma production by BCG-vaccinated individuals challenged in vitro with mycobacterial antigens. The body mass index (BMI) is a proxy for the nutritional status and has been associated both with the susceptibility to tuberculosis and with the IFN-gamma response. We show that although the IFNG+874 A/T polymorphism was not associated with the heterogeneity of IFN-gamma production in a randomized controlled trial that evaluated long-term immune responses to BCG revaccination previously conducted in Salvador, Bahia, Brazil, the effect of this polymorphism on the observed increase in IFN-gamma production among revaccinated subjects was adjusted in individuals with a low BMI.	[Conceicao, Elisabete L.; Nascimento-Sampaio, Francisco S.; Schwingel, Paulo A.; Oliveira, Evelin S.; Mendes, Carlos M. C.; Souza-Machado, Adelmir; Barral-Netto, Manoel; Barbosa, Theolis] Univ Fed Bahia, Salvador, BA, Brazil; [Conceicao, Elisabete L.; Oliveira, Evelin S.; Rocha, Michael S.; Vieira, Igor; Barral-Netto, Manoel; Barbosa, Theolis] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Vieira, Igor; Marinho, Jamocyr M.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil; [Oliveira, Martha M.] Univ Fed Rio de Janeiro, Fac Med, Rio De Janeiro, RJ, Brazil; [Marinho, Jamocyr M.] Hosp Santa Izabel, Salvador, BA, Brazil; [Schwingel, Paulo A.] Univ Pernambuco, Campus Petrolina, Petrolina, PE, Brazil	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Escola Bahiana de Medicina e Saude Publica; Universidade Federal do Rio de Janeiro; Universidade de Pernambuco (UPE)	Barbosa, T (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.; Barbosa, T (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.	theolis@bahia.fiocruz.br	de Souza Machado, Adelmir/F-7822-2012; Schwingel, Paulo/N-8507-2019; Mendes, Carlos Mauricio Cardeal/AAC-1635-2019; Mendes, Carlos Maurício Cardeal/R-3688-2017; Bessa, Theolis Costa Barbosa/A-1855-2010; Souza-Machado, Adelmir/S-3244-2019; Barral-Netto, Manoel/B-3904-2009	Schwingel, Paulo/0000-0002-2935-3403; Mendes, Carlos Mauricio Cardeal/0000-0003-2089-5668; Mendes, Carlos Maurício Cardeal/0000-0003-2089-5668; Bessa, Theolis Costa Barbosa/0000-0003-1928-0404; Souza-Machado, Adelmir/0000-0002-1475-2663; Barral-Netto, Manoel/0000-0002-5823-7903; Rocha, Michael/0000-0002-0781-2453; Lopes Conceicao, Elisabete/0000-0002-4986-5887; Marinho, Jamocyr/0000-0003-1032-3260	Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB [002/03-PPP]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES; FAPESB	Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia-FAPESB (002/03-PPP). ELC received a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES. ESO and MSR received scholarships from FAPESB. TB was a senior investigator from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Muller BLA, 2013, J BRAS PNEUMOL, V39, P719, DOI 10.1590/S1806-37132013000600011; Amim L, 2008, MOL BIOL REP, V35, P563, DOI 10.1007/s11033-007-9123-1; Andersen P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018523; Ansari A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004778; Anuradha B, 2008, PEDIATR INFECT DIS J, V27, P325, DOI 10.1097/INF.0b013e31816099e6; Anuradha R, 2016, CLIN VACCINE IMMUNOL, V23, P339, DOI 10.1128/CVI.00009-16; Barreto ML, 2011, VACCINE, V29, P4875, DOI 10.1016/j.vaccine.2011.05.023; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bhatt K, 2015, CLIN VACCINE IMMUNOL, V22, P258, DOI 10.1128/CVI.00721-14; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Bream JH, 2002, GENES IMMUN, V3, P165, DOI 10.1038/sj.gene.6363870; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chen YT, 2011, BLOOD, V117, P585, DOI 10.1182/blood-2010-07-295097; Cruz A, 2015, VACCINE, V33, P85, DOI 10.1016/j.vaccine.2014.11.013; de Albuquerque AC, 2012, EUR J CLIN MICROBIOL, V31, P2887, DOI 10.1007/s10096-012-1660-4; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Hur YG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-184; Jabot-Hanin F, 2016, J INFECT DIS, V213, P1173, DOI 10.1093/infdis/jiv757; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; Leandro ACCS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/901740; Lio D, 2002, EUR J IMMUNOGENET, V29, P371, DOI 10.1046/j.1365-2370.2002.00327.x; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Oliveira ES, 2013, VACCINE, V31, P3778, DOI 10.1016/j.vaccine.2013.04.079; R Core Team, 2016, R FDN STAT COMP; Sallakci N, 2007, TUBERCULOSIS, V87, P225, DOI 10.1016/j.tube.2006.10.002; Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011; Shaviya Nathan, 2016, Interdiscip Perspect Infect Dis, V2016, P9415364, DOI 10.1155/2016/9415364; Vidyarani M, 2006, INDIAN J MED RES, V124, P403; World Health Organization, 1995, PHYS STAT US INT ANT; Yen YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002300; Zheng YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054527; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160149	10.1371/journal.pone.0160149	http://dx.doi.org/10.1371/journal.pone.0160149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472280	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300029
J	Tranchant, P; Vuvan, DT; Peretz, I				Tranchant, Pauline; Vuvan, Dominique T.; Peretz, Isabelle			Keeping the Beat: A Large Sample Study of Bouncing and Clapping to Music	PLOS ONE			English	Article							MATLAB TOOLBOX; SYNCHRONIZATION; MOVEMENTS; PERCEPTION; CONSISTENCY; FEEDBACK; DISTINCT; CONTEXT; CORTEX; TASKS	The vast majority of humans move in time with a musical beat. This behaviour has been mostly studied through finger-tapping synchronization. Here, we evaluate naturalistic synchronization responses to music-bouncing and clapping-in 100 university students. Their ability to match the period of their bounces and claps to those of a metronome and musical clips varying in beat saliency was assessed. In general, clapping was better synchronized with the beat than bouncing, suggesting that the choice of a specific movement type is an important factor to consider in the study of sensorimotor synchronization processes. Performance improved as a function of beat saliency, indicating that beat abstraction plays a significant role in synchronization. Fourteen percent of the population exhibited marked difficulties with matching the beat. Yet, at a group level, poor synchronizers showed similar sensitivity to movement type and beat saliency as normal synchronizers. These results suggest the presence of quantitative rather than qualitative variations when losing the beat.	[Tranchant, Pauline; Vuvan, Dominique T.; Peretz, Isabelle] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Tranchant, Pauline; Vuvan, Dominique T.; Peretz, Isabelle] Univ Montreal, Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Peretz, I (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Peretz, I (corresponding author), Univ Montreal, Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada.	isabelle.peretz@umontreal.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [2014-04068]; Center of Research on Brain, Language and Music (CRBLM); Canada Research Chair Program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Center of Research on Brain, Language and Music (CRBLM); Canada Research Chair Program(Canada Research Chairs)	This work was funded by grant # 2014-04068 from the Natural Sciences and Engineering Research Council of Canada (NSERC) [http://www.nserc-crsng.gc.ca/index_eng.asp] to IP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Preparation of this paper was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC), from the Center of Research on Brain, Language and Music (CRBLM) and a Canada Research Chair Program. We thank Petri Toiviainen for help during the data analysis process, Benjamin Schultz in setting up hardwares, and Benjamin Zendel for helpful comments during manuscript preparation.	Aschersleben G, 2002, BRAIN COGNITION, V48, P66, DOI 10.1006/brcg.2001.1304; Bates D., 2013, LME4 LINEAR MIXED EF; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Burger B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00183; Carson RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005248; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Dauvergne C, 2015, ANN PHYS REHABIL MED, V58, pe72; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Elliott MT, 2009, EXP BRAIN RES, V192, P731, DOI 10.1007/s00221-008-1646-8; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fitch WT, 2007, MUSIC PERCEPT, V25, P43, DOI 10.1525/mp.2007.25.1.43; Fujii S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00771; Grahn JA, 2012, PSYCHOMUSICOLOGY MUS, V22, P105, DOI [10.1037/a0031188, DOI 10.1037/A0031188]; Huys R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000061; Iversen J.R., 2008, P 10 INT C MUSIC PER, P465, DOI DOI 10.1016/J.HEARES.2007.10.007; Janata P, 2012, J EXP PSYCHOL GEN, V141, P54, DOI 10.1037/a0024208; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Lartillot O, 2008, ST CLASS DAT ANAL, P261, DOI 10.1007/978-3-540-78246-9_31; Leow LA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00811; Loras H, 2012, EXP BRAIN RES, V220, P335, DOI 10.1007/s00221-012-3142-4; Madison G, 2006, MUSIC PERCEPT, V24, P201, DOI 10.1525/mp.2006.24.2.201; Madison G, 2013, ACTA PSYCHOL, V143, P119, DOI 10.1016/j.actpsy.2013.02.010; Madison G, 2011, J EXP PSYCHOL HUMAN, V37, P1578, DOI 10.1037/a0024323; Miura A, 2013, NEUROSCI LETT, V544, P157, DOI 10.1016/j.neulet.2013.04.005; Moelants D, 2002, P 7 INT C MUSIC PERC, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Nettl B, 2000, ORIGINS OF MUSIC, P463; Palmer C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0405; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2008, MUSIC PERCEPT, V25, P331, DOI 10.1525/MP.2008.25.4.331; Phillips-Silver J, 2005, SCIENCE, V308, P1430, DOI 10.1126/science.1110922; Phillips-Silver J, 2008, BRAIN COGNITION, V67, P94, DOI 10.1016/j.bandc.2007.11.007; Phillips-Silver J, 2007, COGNITION, V105, P533, DOI 10.1016/j.cognition.2006.11.006; Phillips-Silver J, 2011, NEUROPSYCHOLOGIA, V49, P961, DOI 10.1016/j.neuropsychologia.2011.02.002; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Repp BH, 2010, J MOTOR BEHAV, V42, P111, DOI 10.1080/00222890903566418; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; Salimpoor VN, 2011, NAT NEUROSCI, V14, P257, DOI 10.1038/nn.2726; Sowinski J, 2013, NEUROPSYCHOLOGIA, V51, P1952, DOI 10.1016/j.neuropsychologia.2013.06.027; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Stenneken P, 2006, BRAIN RES, V1084, P123, DOI 10.1016/j.brainres.2006.02.057; Studenka BE, 2012, Q J EXP PSYCHOL, V65, P1086, DOI 10.1080/17470218.2011.640404; Stupacher J, 2013, BRAIN COGNITION, V82, P127, DOI 10.1016/j.bandc.2013.03.003; Styns F, 2007, HUM MOVEMENT SCI, V31, P26; Su YH, 2012, PSYCHOL RES-PSYCH FO, V76, P373, DOI 10.1007/s00426-011-0346-3; Toiviainen P, 2010, MUSIC PERCEPT, V28, P59, DOI 10.1525/MP.2010.28.1.59; Torre K, 2008, ACTA PSYCHOL, V129, P284, DOI 10.1016/j.actpsy.2008.08.003; Torre K, 2009, EXP BRAIN RES, V199, P157, DOI 10.1007/s00221-009-1991-2; Van Dyck E, 2013, MUSIC PERCEPT, V30, P349, DOI 10.1525/MP.2013.30.4.349; van Mier H, 2006, HUM MOVEMENT SCI, V25, P657, DOI 10.1016/j.humov.2006.06.004; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; Velasco MJ, 2011, P 12 ANN C INT SOC M; Witek MAG, 2014, MUSIC PERCEPT, V32, P201, DOI 10.1525/MP.2014.32.2.201; Witek MAG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094446; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110; Zelaznik HN, 2000, J MOTOR BEHAV, V32, P193, DOI 10.1080/00222890009601370; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107	62	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160178	10.1371/journal.pone.0160178	http://dx.doi.org/10.1371/journal.pone.0160178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27471854	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516300034
J	Das, S; Chadwick, BP				Das, Sunny; Chadwick, Brian P.			Influence of Repressive Histone and DNA Methylation upon D4Z4 Transcription in Non-Myogenic Cells	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; INACTIVE X-CHROMOSOME; HUMAN CANCER-CELLS; HUMAN GENOME; IMMUNODEFICIENCY SYNDROME; METHYLTRANSFERASE GENE; MACROSATELLITE DXZ4; REPEATED ELEMENTS; MUSCLE-CELLS; DUX4 GENE	We looked at a disease-associated macrosatellite array D4Z4 and focused on epigenetic factors influencing its chromatin state outside of the disease-context. We used the HCT116 cell line that contains the non-canonical polyadenylation (poly-A) signal required to stabilize somatic transcripts of the human double homeobox gene DUX4, encoded from D4Z4. In HCT116, D4Z4 is packaged into constitutive heterochromatin, characterized by DNA methylation and histone H3 tri-methylation at lysine 9 (H3K9me3), resulting in low basal levels of D4Z4-derived transcripts. However, a double knockout (DKO) of DNA methyltransferase genes, DNMT1 and DNMT3B, but not either alone, results in significant loss of DNA and H3K9 methylation. This is coupled with upregulation of transcript levels from the array, including DUX4 isoforms (DUX4-fl) that are abnormally expressed in somatic muscle in the disease Facioscapulohumeral muscular dystrophy (FSHD) along with DUX4 protein, as indicated indirectly by upregulation of bondafide targets of DUX4 in DKO but not HCT116 cells. Results from treatment with a chemical inhibitor of histone methylation in HCT116 suggest that in the absence of DNA hypomethylation, H3K9me3 loss alone is sufficient to facilitate DUX4-fl transcription. Additionally, characterization of a cell line from a patient with Immunodeficiency, Centromeric instability and Facial anomalies syndrome 1 (ICF1) possessing a non-canonical poly-A signal and DNA hypomethylation at D4Z4 showed DUX4 target gene upregulation in the patient when compared to controls in spite of retention of H3K9me3. Taken together, these data suggest that both DNA methylation and H3K9me3 are determinants of D4Z4 silencing. Moreover, we show that in addition to testis, there is appreciable expression of spliced and polyadenylated D4Z4 derived transcripts that contain the complete DUX4 open reading frame (ORF) along with DUX4 target gene expression in the thymus, suggesting that DUX4 may provide normal function in this somatic tissue.	[Das, Sunny; Chadwick, Brian P.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Chadwick, BP (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	chadwick@bio.fsu.edu	Das, Sunny/X-1732-2019	Das, Sunny/0000-0003-1154-3441; Chadwick, Brian/0000-0001-5272-8384	National Institutes of Health [R21NS080779]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health (R21NS080779) for Dr. Brian P. Chadwick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Alvarez JD, 2005, J BIOL RHYTHM, V20, P111, DOI 10.1177/0748730404274078; Bakker E, 1995, MUSCLE NERVE S; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Bruce HA, 2009, PSYCHIAT GENET, V19, P64, DOI 10.1097/YPG.0b013e3283207ff6; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Cacurri S, 1998, AM J HUM GENET, V63, P181, DOI 10.1086/301906; Cherblanc FL, 2013, NAT CHEM BIOL, V9, P136, DOI 10.1038/nchembio.1187; CONSTANTINIDES PG, 1977, NATURE, V267, P364, DOI 10.1038/267364a0; de Greef JC, 2007, NEUROLOGY, V69, P1018, DOI 10.1212/01.wnl.0000271391.44352.fe; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Ferreboeuf M, 2014, HUM MOL GENET, V23, P171, DOI 10.1093/hmg/ddt409; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gaillard MC, 2014, NEUROLOGY, V83, P733, DOI 10.1212/WNL.0000000000000708; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Geng LN, 2011, HYBRIDOMA, V30, P125, DOI 10.1089/hyb.2010.0094; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Greiner D, 2005, NAT CHEM BIOL, V1, P143, DOI 10.1038/nchembio721; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Himeda CL, 2014, MOL CELL BIOL, V34, P1942, DOI 10.1128/MCB.00149-14; Horakova AH, 2012, HUM MOL GENET, V21, P4367, DOI 10.1093/hmg/dds270; Hupkes M, 2011, FASEB J, V25, P3861, DOI 10.1096/fj.11-186122; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; LINDGREN V, 1985, NATURE, V314, P115, DOI 10.1038/314115a0; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Moseley SC, 2012, NUCLEIC ACIDS RES, V40, P1596, DOI 10.1093/nar/gkr964; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Roschke AV, 2002, NEOPLASIA, V4, P19, DOI 10.1038/sj.neo.7900197; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Stadler G, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-12; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tassin A, 2013, J CELL MOL MED, V17, P76, DOI 10.1111/j.1582-4934.2012.01647.x; Thomas NST, 2007, J MED GENET, V44, P215, DOI 10.1136/jmg.2006.042804; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Twigg SRF, 1998, HUM MOL GENET, V7, P685, DOI 10.1093/hmg/7.4.685; van den Boogaard ML, 2016, AM J HUM GENET, V98, P1020, DOI 10.1016/j.ajhg.2016.03.013; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; Weiss A, 1999, P NATL ACAD SCI USA, V96, P2958, DOI 10.1073/pnas.96.6.2958; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yao ZZ, 2014, HUM MOL GENET, V23, P5342, DOI 10.1093/hmg/ddu251; Zeng WH, 2014, HUM MUTAT, V35, P998, DOI 10.1002/humu.22593; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	68	37	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160022	10.1371/journal.pone.0160022	http://dx.doi.org/10.1371/journal.pone.0160022			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467759	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100091
J	Garbe, JR; Prakapenka, D; Tan, C; Da, Y				Garbe, John R.; Prakapenka, Dzianis; Tan, Cheng; Da, Yang			Genomic Inbreeding and Relatedness in Wild Panda Populations	PLOS ONE			English	Article							GIANT PANDAS; RELATIONSHIP MATRIX; ACCURACY; SEQUENCE; PREDICTION; SELECTION; IMPACT; CHINA	Inbreeding and relatedness in wild panda populations are important parameters for panda conservation. Habitat loss and fragmentation are expected to increase inbreeding but the actual inbreeding levels in natural panda habitats were unknown. Using 150,025 SNPs and 14,926 SNPs selected from published whole-genome sequences, we estimated genomic inbreeding coefficients and relatedness of 49 pandas including 34 wild pandas sampled from six habitats. Qinling and Liangshan pandas had the highest levels of inbreeding and relatedness measured by genomic inbreeding and coancestry coefficients, whereas the inbreeding levels in Qionglai and Minshan were 28-45% of those in Qinling and Liangshan. Genomic coancestry coefficients between pandas from different habitats showed that panda populations from the four largest habitats, Minshan, Qionglai, Qinling and Liangshan, were genetically unrelated. Pandas between these four habitats on average shared 66.0-69.1% common alleles and 45.6-48.6% common genotypes, whereas pandas within each habitat shared 71.8-77.0% common alleles and 51.7-60.4% common genotypes. Pandas in the smaller populations of Qinling and Liangshan were more similarly to each other than pandas in the larger populations of Qionglai and Minshan according to three genomic similarity measures. Panda genetic differentiation between these habitats was positively related to their geographical distances. Most pandas separated by 200 kilometers or more shared no common ancestral alleles. The results provided a genomic quantification of the actual levels of inbreeding and relatedness among pandas in their natural habitats, provided genomic confirmation of the relationship between genetic diversity and geographical distances, and provided genomic evidence to the urgency of habitat protection.	[Garbe, John R.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN USA; [Prakapenka, Dzianis; Tan, Cheng; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Tan, Cheng] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; China Agricultural University	Da, Y (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	yda@umn.edu			Agricultural Experiment Station at the University of Minnesota [MN-16-043]; USDA National Institute of Food and Agriculture [2011-67015-30333]	Agricultural Experiment Station at the University of Minnesota(University of Minnesota System); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was supported by project MN-16-043 of the Agricultural Experiment Station at the University of Minnesota, and by Grant no. 2011-67015-30333 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou JD, 2006, GIANT PANDAS: BIOLOGY, VETERINARY MEDICINE AND MANAGEMENT, P495, DOI 10.1017/CBO9780511542244.022; Bolger AM, 2014, BIOINFORMATICS; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Da Y, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0301-1; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; Eynard SE, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0185-0; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fan Juntao, 2011, Acta Ecologica Sinica, V31, P145; Feng TT, 2009, J WILDLIFE MANAGE, V73, P852, DOI 10.2193/2008-186; FRANKHAM R, 1995, CONSERV BIOL, V9, P792, DOI 10.1046/j.1523-1739.1995.09040792.x; Garber RA, 1983, GEN EQUATIONS AVERAG, P277; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Loucks CJ, 2003, CONSERV BIOL, V17, P558, DOI 10.1046/j.1523-1739.2003.01494.x; Munoz PR, 2014, CROP SCI, V54, P1115, DOI 10.2135/cropsci2012.12.0673; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu J, 2015, NATURE NEWS; SAS, 2012, SAS 9 4; Shan L, 2014, MOL BIOL EVOL, V31, P2663, DOI 10.1093/molbev/msu210; Shen FJ, 2009, MOL ECOL, V18, P1061, DOI 10.1111/j.1365-294X.2009.04086.x; State Forestry Administration, 2006, 3 NAT SURV REP GIANT, P24; Traylor-Holzer K, 2015, BREEDING MANAGEMENT; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; Wang CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114484; Wang CK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-270; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wientjes YCJ, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0124-6; Xie Z, 2014, 2014 INT STUDBOOK GI; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zapata-Valenzuela J, 2013, G3-GENES GENOM GENET, V3, P909, DOI 10.1534/g3.113.005975; Zhao SC, 2013, NAT GENET, V45, P67, DOI 10.1038/ng.2494; Zhu LF, 2013, ECOLOGY, V94, P2346, DOI 10.1890/12-1451.1; Zhu Y, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-227	36	11	11	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160496	10.1371/journal.pone.0160496	http://dx.doi.org/10.1371/journal.pone.0160496			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494031	Green Published, gold, Green Submitted			2022-12-27	WOS:000381369500049
J	Sun, P; Zheng, L; Li, L; Guo, XY; Zhang, WD; Zheng, YJ				Sun, Peng; Zheng, Li; Li, Lin; Guo, Xiuyan; Zhang, Weidong; Zheng, Yijie			The Neural Responses to Social Cooperation in Gain and Loss Context	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; INTRANASAL OXYTOCIN; HUMAN BRAIN; REWARD; TRUST; SELF; ENFORCEMENT; PREFERENCES; VASOPRESSIN; CIRCUITRY	Cooperation is pervasive and constitutes the core behavioral principle of human social life. Previous studies have revealed that mutual cooperation was reliably correlated with two reward-related brain regions, the ventral striatum and the orbitofrontal cortex. Using functional magnetic resonance imaging (fMRI), this study sought to investigate how the loss and gain contexts modulated the neural responses to mutual cooperation. Twenty-five female participants were scanned when they played a series of one-shot prisoner's dilemma games in the loss and gain contexts. Specifically, participants and partners independently chose to either cooperate with each other or not, and each was awarded or deprived of (in the gain context or the loss context, respectively) a sum of money which depended upon the interaction of their choices. Behavioral results indicated that participants cooperated in nearly half of the experiment trials and reported higher level of positive emotions for mutual cooperation in both contexts, but they cooperated more in the gain than in the loss context. At the neural level, stronger activities in the orbitofrontal cortex were observed for mutual cooperation compared with the other three outcomes in both contexts, while stronger activation in ventral striatum associated with mutual cooperation was observed in the gain context only. Together, our data indicated that, even in the one-shot interaction under loss context, participants still exhibited preference for cooperation and the rewarding experience from a mutually cooperative social interaction activated the ventral striatum and the orbitofrontal cortex, but the loss context weakened the association between the ventral striatum activation and mutual cooperation.	[Sun, Peng; Li, Lin; Zhang, Weidong] East China Normal Univ, Sch Psychol & Cognit Sci, Shanghai, Peoples R China; [Zheng, Li] East China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Brain Funct Genom, Sch Psychol & Cognit Sci,Minist Educ, Shanghai, Peoples R China; [Guo, Xiuyan] East China Normal Univ, Shanghai Key Lab Magnet Resonance, Sch Psychol & Cognit Sci, Shanghai, Peoples R China; [Guo, Xiuyan] East China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Brain Funct Genom, Minist Educ, Shanghai, Peoples R China; [Zheng, Yijie] East China Normal Univ, Shanghai Key Lab Magnet Resonance, Dept Phys, Shanghai, Peoples R China	East China Normal University; East China Normal University; East China Normal University; East China Normal University; East China Normal University	Zhang, WD (corresponding author), East China Normal Univ, Sch Psychol & Cognit Sci, Shanghai, Peoples R China.; Guo, XY (corresponding author), East China Normal Univ, Shanghai Key Lab Magnet Resonance, Sch Psychol & Cognit Sci, Shanghai, Peoples R China.; Guo, XY (corresponding author), East China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Brain Funct Genom, Minist Educ, Shanghai, Peoples R China.	wlkc_xyguo@126.com; wdzhang@psy.ecnu.edu.cn			National Natural Science Foundation of China [31271090, 71371180]; Key Program of the National Social Science Foundation of China [14AZD106]; Shanghai Leading talent Plan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of the National Social Science Foundation of China; Shanghai Leading talent Plan	This research was supported by the National Natural Science Foundation of China (31271090; 71371180; http://www.nsfc.gov.cn/); the Key Program of the National Social Science Foundation of China (14AZD106; http://www.npopss-cn.gov.cn/); and the Shanghai Leading talent Plan (www.shrcw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Camerer C.F., 2003, BEHAV GAME THEORY, V19, P7; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Emonds G, 2014, SOC NEUROSCI-UK, V9, P10, DOI 10.1080/17470919.2013.858080; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Grabenhorst F, 2010, NEUROIMAGE, V51, P1265, DOI 10.1016/j.neuroimage.2010.03.043; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Han SH, 2010, SOC COGN AFFECT NEUR, V5, P332, DOI 10.1093/scan/nsp027; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hsu M, 2008, SCIENCE, V320, P1092, DOI 10.1126/science.1153651; Jian L, 2009, P NATL ACAD SCI USA, V106, P16835, DOI [10.1073/pnas.0908855106, DOI 10.1073/PNAS.0908855106]; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Korn CW, 2012, J NEUROSCI, V32, P16832, DOI 10.1523/JNEUROSCI.3016-12.2012; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Rilling JK, 2012, PSYCHONEUROENDOCRINO, V37, P447, DOI 10.1016/j.psyneuen.2011.07.013; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Tsukiura T, 2011, SOC COGN AFFECT NEUR, V6, P138, DOI 10.1093/scan/nsq025; Wang TT, 2015, SOC COGN AFFECT NEUR, V10, P814, DOI 10.1093/scan/nsu123; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wu Y, 2014, SOC COGN AFFECT NEUR, V9, P1862, DOI 10.1093/scan/nst187	35	6	6	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160503	10.1371/journal.pone.0160503	http://dx.doi.org/10.1371/journal.pone.0160503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494142	Green Submitted, gold, Green Published			2022-12-27	WOS:000381369500050
J	Araniti, F; Grana, E; Krasuska, U; Bogatek, R; Reigosa, MJ; Abenavoli, MR; Sanchez-Moreiras, AM				Araniti, Fabrizio; Grana, Elisa; Krasuska, Urszula; Bogatek, Renata; Reigosa, Manuel J.; Abenavoli, Maria Rosa; Sanchez-Moreiras, Adela M.			Loss of Gravitropism in Farnesene-Treated Arabidopsis Is Due to Microtubule Malformations Related to Hormonal and ROS Unbalance	PLOS ONE			English	Article							LATERAL ROOT DEVELOPMENT; NITRIC-OXIDE; MORPHOGENIC RESPONSES; HYDROGEN-PEROXIDE; GLAND SECRETIONS; AUXIN; ETHYLENE; GROWTH; TRANSPORT; HERBICIDE	Mode of action of farnesene, a volatile sesquiterpene commonly found in the essential oils of several plants, was deeply studied on the model species Arabidopsis thaliana. The effects of farnesene on the Arabidopsis root morphology were evaluated by different microscopic techniques. As well, microtubules immunolabeling, phytohormone measurements and ROS staining helped us to elucidate the single or multi-modes of action of this sesquiterpene on plant metabolism. Farnesene-treated roots showed a strong growth inhibition and marked modifications on morphology, important tissue alterations, cellular damages and anisotropic growth. Left-handed growth of farnesene-treated roots, reverted by taxol (a known microtubule stabilizer), was related to microtubule condensation and disorganization. As well, the inhibition of primary root growth, lateral root number, lateral root length, and both root hairs length and density could be explained by the strong increment in ethylene production and auxin content detected in farnesene-treated seedlings. Microtubule alteration and hormonal unbalance appear as important components in the mode of action of farnesene and confirm the strong phytotoxic potential of this sesquiterpene.	[Araniti, Fabrizio] Univ Mediterranea Reggio Calabria, Dipartimento AGR, Fac Agr Salita Melissari, I-89124 Lotto D, Reggio Calabria, Italy; [Grana, Elisa; Reigosa, Manuel J.; Sanchez-Moreiras, Adela M.] Univ Vigo, Dept Plant Biol & Soil Sci, Campus Lagoas Marcosende S-N, E-36310 Vigo, Spain; [Krasuska, Urszula; Bogatek, Renata] Warsaw Univ Life Sci SGGW, Dept Plant Physiol, Nowoursynowska 159, PL-02776 Warsaw, Poland	Universita Mediterranea di Reggio Calabria; Universidade de Vigo; Warsaw University of Life Sciences	Araniti, F (corresponding author), Univ Mediterranea Reggio Calabria, Dipartimento AGR, Fac Agr Salita Melissari, I-89124 Lotto D, Reggio Calabria, Italy.; Sanchez-Moreiras, AM (corresponding author), Univ Vigo, Dept Plant Biol & Soil Sci, Campus Lagoas Marcosende S-N, E-36310 Vigo, Spain.	fabrizio.araniti@unirc.it; adela@uvigo.es	Sánchez-Moreiras, Adela M/A-8222-2011; Reigosa, Manuel J/K-3551-2013; Roger, Manuel Joaquín Reigosa/O-4438-2019; Araniti, Fabrizio/F-9925-2016; Sunseri, Francesco/O-8013-2015	Sánchez-Moreiras, Adela M/0000-0002-0771-9259; Reigosa, Manuel J/0000-0003-0527-1849; Roger, Manuel Joaquín Reigosa/0000-0003-0527-1849; Araniti, Fabrizio/0000-0002-4983-4116; Grana, Elisa/0000-0003-3306-2155; Abenavoli, Maria Rosa/0000-0001-5926-9985; Krasuska, Urszula/0000-0001-8373-4509; Sunseri, Francesco/0000-0001-5201-5413	Ministerio de Economia y Competitividad (ES) [AGL2013-41281-R]; Italian Ministry of Education, University and Research (MIUR) [RBSI14L9CE]	Ministerio de Economia y Competitividad (ES); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministerio de Economia y Competitividad (ES) AGL2013-41281-R (to AMSM and MJR); and Italian Ministry of Education, University and Research (MIUR), project SIR-2014 cod. RBSI14L9CE (MEDANAT) (to FA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI MF, 1987, Z NATURFORSCH C, V42, P955; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], [No title captured]; Araniti F, 2016, PLANT BIOL IN PRESS; Araniti F, 2015, MOLECULES, V20, P17883, DOI 10.3390/molecules201017883; Araniti F, 2013, NAT PROD RES, V27, P2297, DOI 10.1080/14786419.2013.827193; Baskin TI, 2004, PLANT PHYSIOL, V135, P2279, DOI 10.1104/pp.104.040493; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Causin HF, 2012, PLANT SCI, V183, P197, DOI 10.1016/j.plantsci.2011.08.012; Chaimovitsh D, 2012, PLANT BIOLOGY, V14, P354, DOI 10.1111/j.1438-8677.2011.00511.x; CLEARY AL, 1988, CAN J BOT, V66, P2353, DOI 10.1139/b88-320; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; CORTESE F, 1977, J BIOL CHEM, V252, P1134; Deysson G, 1975, MICROTUBULES ANTIMIT; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Duke SO, 2012, PEST MANAG SCI, V68, P505, DOI 10.1002/ps.2333; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; ELLIS JR, 1994, PLANT PHYSIOL, V105, P15, DOI 10.1104/pp.105.1.15; FERNANDES A, 1981, J CHEM ECOL, V7, P453, DOI 10.1007/BF00995768; Fernandez-Marcos M, 2011, P NATL ACAD SCI USA, V108, P18506, DOI 10.1073/pnas.1108644108; Fisher DD, 1998, PLANT PHYSIOL, V116, P1043, DOI 10.1104/pp.116.3.1043; Furutani I, 2000, DEVELOPMENT, V127, P4443; Galindo JCG, 1999, PHYTOCHEMISTRY, V52, P805, DOI 10.1016/S0031-9422(99)00303-9; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gniazdowska A., 2015, REACTIVE OXYGEN NITR, P155, DOI [10.1007/978-3-319-10079-1_8, DOI 10.1007/978-3-319-10079-1_8]; Gniazdowska A, 2010, PLANTA, V232, P1397, DOI 10.1007/s00425-010-1262-2; Grana E, 2013, J CHEM ECOL, V39, P271, DOI 10.1007/s10886-013-0250-y; Grana E, 2012, PLANT BIOL C FREIB, P768; Grossmann K, 1996, PHYSIOL PLANTARUM, V97, P772, DOI 10.1111/j.1399-3054.1996.tb00543.x; Guan YL, 2014, PHYSIOL PLANTARUM, V152, P275, DOI 10.1111/ppl.12164; Hashimoto T, 2002, PHILOS T ROY SOC B, V357, P799, DOI 10.1098/rstb.2002.1088; Heap I, 1997, INT SURVEY HERBICIDE; HILLMANN G, 1982, PLANTA, V155, P124, DOI 10.1007/BF00392542; HOFFMAN JC, 1994, PROTOPLASMA, V179, P16, DOI 10.1007/BF01360733; Holzinger A, 2007, PLANT BIOLOGY, V9, P400, DOI 10.1055/s-2006-924727; HONDA K, 1990, INSECT BIOCHEM, V20, P245, DOI 10.1016/0020-1790(90)90041-R; Idris EE, 2004, Z PFLANZENK PFLANZEN, V111, P583; Ishida T, 2007, J PLANT RES, V120, P61, DOI 10.1007/s10265-006-0039-y; Ivanchenko MG, 2008, PLANT J, V55, P335, DOI 10.1111/j.1365-313X.2008.03528.x; JACKSON BD, 1990, NATURWISSENSCHAFTEN, V77, P187, DOI 10.1007/BF01131165; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kasprowicz A, 2009, J EXP BOT, V60, P1605, DOI 10.1093/jxb/erp033; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kunert Grit, 2010, BMC Ecology, V10, P23, DOI 10.1186/1472-6785-10-23; LEE JS, 1990, PLANT PHYSIOL, V94, P1770, DOI 10.1104/pp.94.4.1770; Lewis DR, 2011, DEVELOPMENT, V138, P3485, DOI 10.1242/dev.065102; Li X, 2011, J CHEM ECOL, V37, P880, DOI 10.1007/s10886-011-9987-3; Lupini A, 2014, PLANT GROWTH REGUL, V74, P23, DOI 10.1007/s10725-014-9893-0; MOREJOHN LC, 1987, PLANTA, V172, P252, DOI 10.1007/BF00394595; Morejohn LC., 1991, CYTOSKELETAL BASIS P, P29; Muday GK, 2012, TRENDS PLANT SCI, V17, P181, DOI 10.1016/j.tplants.2012.02.001; Nakamura M, 2004, PLANT CELL PHYSIOL, V45, P1330, DOI 10.1093/pcp/pch300; Oliva A, 2002, PESTIC BIOCHEM PHYS, V72, P45, DOI 10.1006/pest.2002.2582; Potters G, 2009, PLANT CELL ENVIRON, V32, P158, DOI 10.1111/j.1365-3040.2008.01908.x; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Rahman A, 2002, PLANT PHYSIOL, V130, P1908, DOI 10.1104/pp.010546; Reichheld JP, 1999, PLANT J, V17, P647, DOI 10.1046/j.1365-313X.1999.00413.x; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1135, DOI 10.1111/j.1365-3040.2004.01219.x; RYAN GF, 1970, WEED SCI, V18, P614, DOI 10.1017/S0043174500034330; Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x; Schwarzerova K, 2002, PLANT CELL PHYSIOL, V43, P207, DOI 10.1093/pcp/pcf028; Sedbrook JC, 2004, PLANT CELL, V16, P1506, DOI 10.1105/tpc.020644; Segel L, 1982, HERBICIDE RESISTANCE, V215, P245; Selker J, 1991, MUTUAL ALIGNMENTS CE, P303; Soltys D, 2014, J PLANT PHYSIOL, V171, P565, DOI 10.1016/j.jplph.2014.01.004; Soltys D, 2012, PLANTA, V236, P1629, DOI 10.1007/s00425-012-1722-y; Soltys D, 2011, PLANTA, V234, P609, DOI 10.1007/s00425-011-1429-5; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; Swarup R, 2002, PLANT MOL BIOL, V49, P411; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; TITTLE FL, 1990, PLANT PHYSIOL, V94, P1143, DOI 10.1104/pp.94.3.1143; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Uddin MR, 2012, WEED RES, V52, P25, DOI 10.1111/j.1365-3180.2011.00894.x; van Acker FAA, 2000, FEBS LETT, V473, P145, DOI 10.1016/S0014-5793(00)01517-9; Vaughan MA, 1988, ACS S SERIES AM CHEM; VAUGHN KC, 1987, PLANT PHYSIOL, V83, P956, DOI 10.1104/pp.83.4.956; Vuorinen T, 2004, ATMOS ENVIRON, V38, P675, DOI 10.1016/j.atmosenv.2003.10.029; WALNE PL, 1975, AM J BOT, V62, P58, DOI 10.2307/2442078; Yu MD, 2014, NEW PHYTOL, V202, P1142, DOI 10.1111/nph.12739	80	31	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160202	10.1371/journal.pone.0160202	http://dx.doi.org/10.1371/journal.pone.0160202			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490179	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900034
J	Fredrickson, BL				Fredrickson, Barbara L.			Selective Data Analysis in Brown et al.'s Continued Critical Reanalysis	PLOS ONE			English	Editorial Material									[Fredrickson, Barbara L.] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Fredrickson, BL (corresponding author), Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC 27599 USA.	blf@unc.edu			NIH HHS [R01NR012899] Funding Source: Medline; NINR NIH HHS [R01 NR012899] Funding Source: Medline	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Brown NJL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156415; Brown NJL, 2014, P NATL ACAD SCI USA, V111, P12705, DOI 10.1073/pnas.1407057111; Fredrickson BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121839; Fredrickson BL, 2013, P NATL ACAD SCI USA, V110, P13684, DOI 10.1073/pnas.1305419110; McCulloch C. E., 2008, GEN LINEAR MIXED MOD	5	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160565	10.1371/journal.pone.0160565	http://dx.doi.org/10.1371/journal.pone.0160565			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490104	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900069
J	Vandoni, M; Codrons, E; Marin, L; Correale, L; Bigliassi, M; Buzzachera, CF				Vandoni, Matteo; Codrons, Erwan; Marin, Luca; Correale, Luca; Bigliassi, Marcelo; Buzzachera, Cosme Franklim			Psychophysiological Responses to Group Exercise Training Sessions: Does Exercise Intensity Matter?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; POWER ANALYSIS; HEART-RATE; RELIABILITY; VALIDATION; PREFERENCE; VALIDITY; MODERATE; SCALE; MUSIC	Group exercise training programs were introduced as a strategy for improving health and fitness and potentially reducing dropout rates. This study examined the psychophysiological responses to group exercise training sessions. Twenty-seven adults completed two group exercise training sessions of moderate and vigorous exercise intensities in a random and counterbalanced order. The %HRR and the exertional and arousal responses to vigorous session were higher than those during the moderate session (p<0.05). Consequently, the affective responses to vigorous session were less pleasant than those during moderate session (p<0.05). These results suggest that the psychophysiological responses to group exercise training sessions are intensity-dependent. From an adherence perspective, interventionists are encouraged to emphasize group exercise training sessions at a moderate intensity to maximize affective responses and to minimize exertional responses, which in turn may positively affect future exercise behavior.	[Vandoni, Matteo; Codrons, Erwan; Marin, Luca; Correale, Luca] Univ Pavia, Dept Publ Hlth Expt Med & Forens Sci, Pavia, Italy; [Codrons, Erwan] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Bigliassi, Marcelo] State Univ Parana, Dept Phys Educ, Londrina, Brazil; [Buzzachera, Cosme Franklim] North Univ Parana, Dept Phys Educ, Londrina, Brazil	University of Pavia; University of Pavia	Buzzachera, CF (corresponding author), North Univ Parana, Dept Phys Educ, Londrina, Brazil.	cosme.buzzachera@unopar.br	vandoni, matteo/AAS-7299-2021; Bigliassi, Marcelo/J-8285-2016; Marin, Luca/T-2302-2019; Buzzachera, Cosme Franklim/W-8076-2019; Bigliassi, Marcelo/AAH-6795-2020; Marin, Luca/K-2992-2018	vandoni, matteo/0000-0002-3405-9364; Bigliassi, Marcelo/0000-0001-6940-9849; Buzzachera, Cosme Franklim/0000-0002-7827-4656; Bigliassi, Marcelo/0000-0001-6940-9849; CORREALE, LUCA/0000-0003-0452-4015; Marin, Luca/0000-0002-4185-7428				American College of Sports Medicine, 2006, ACSMS GUIDELINES EXE; Bandura A., 1997, SELF EFFICACY EXERCI; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; CAIOZZO VJ, 1982, J APPL PHYSIOL, V53, P1184, DOI 10.1152/jappl.1982.53.5.1184; Cohen J.E., 1988, STAT POWER ANAL BEHA; D'Amico EJ, 2001, BEHAV RES METH INS C, V33, P479, DOI 10.3758/BF03195405; Dasilva SG, 2011, MED SCI SPORT EXER, V43, P1114, DOI 10.1249/MSS.0b013e318205874c; Dishman RK, 1996, MED SCI SPORT EXER, V28, P706, DOI 10.1097/00005768-199606000-00010; Ekkekakis P, 2006, RES Q EXERCISE SPORT, V77, P81; Ekkekakis P, 2005, J SPORT EXERCISE PSY, V27, P350, DOI 10.1123/jsep.27.3.350; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P, 2002, PSYCHOL SPORT EXERC, V3, P35, DOI 10.1016/S1469-0292(01)00028-0; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; Greco CC, 2011, J STRENGTH COND RES, V25, P3422, DOI 10.1519/JSC.0b013e3182160053; Hall EE, 2005, MED SCI SPORT EXER, V37, P1365, DOI 10.1249/01.mss.0000174897.25739.3c; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Karageorghis CI, 2006, RES Q EXERCISE SPORT, V77, P240; Kilpatrick M, 2007, MED SCI SPORT EXER, V39, P1417, DOI 10.1249/mss.0b013e31806ad73c; MCAULEY E, 1983, J SPORT PSYCHOL, V5, P410, DOI 10.1123/jsp.5.4.410; Noble B., 1996, PERCEIVED EXERTION; Oliveira AS, 2009, J STRENGTH COND RES, V23, P579, DOI 10.1519/JSC.0b013e318196b757; Perri MG, 2002, HEALTH PSYCHOL, V21, P452, DOI 10.1037//0278-6133.21.5.452; Rose EA, 2008, MED SCI SPORT EXER, V40, P1852, DOI 10.1249/MSS.0b013e31817a8aea; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; RYCKMAN RM, 1982, J PERS SOC PSYCHOL, V42, P891, DOI 10.1037/0022-3514.42.5.891; SALLIS JF, 1986, PREV MED, V15, P331, DOI 10.1016/0091-7435(86)90001-0; Simpson SD, 2006, J SPORT SCI, V24, P1095, DOI 10.1080/02640410500432789; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Swain DP, 1998, MED SCI SPORT EXER, V30, P318, DOI 10.1097/00005768-199802000-00022; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; World Health Organization, 2004, GLOB STRAT DIET PHYS	33	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0149997	10.1371/journal.pone.0149997	http://dx.doi.org/10.1371/journal.pone.0149997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490493	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900001
J	Anema, A; Fielden, SJ; Shurgold, S; Ding, E; Messina, J; Jones, JE; Chittock, B; Monteith, K; Globerman, J; Rourke, SB; Hogg, RS				Anema, Aranka; Fielden, Sarah J.; Shurgold, Susan; Ding, Erin; Messina, Jennifer; Jones, Jennifer E.; Chittock, Brian; Monteith, Ken; Globerman, Jason; Rourke, Sean B.; Hogg, Robert S.		Canada Food Security Study Team	Association between Food Insecurity and Procurement Methods among People Living with HIV in a High Resource Setting	PLOS ONE			English	Article							MARGINALLY-HOUSED INDIVIDUALS; COMMUNITY-BASED RESEARCH; VITAMIN-A-DEFICIENCY; INFECTED INDIVIDUALS; HIV/AIDS; MORTALITY; HOMELESS; HEALTH; INSUFFICIENCY; SYMPTOMS	Objective People living with HIV in high-resource settings suffer severe levels of food insecurity; however, limited evidence exists regarding dietary intake and sub-components that characterize food insecurity (i.e. food quantity, quality, safety or procurement) in this population. We examined the prevalence and characteristics of food insecurity among people living with HIV across British Columbia, Canada. Design This cross-sectional analysis was conducted within a national community-based research initiative. Methods Food security was measured using the Health Canada Household Food Security Scale Module. Logistic regression was used to determine key independent predictors of food insecurity, controlling for potential confounders. Results Of 262 participants, 192 (73%) reported food insecurity. Sub-components associated with food insecurity in bivariate analysis included: < RDI consumption of protein (p = 0.046); being sick from spoiled/unsafe food in the past six months (p = 0.010); and procurement of food using non-traditional methods (p <0.05). In multivariable analyses, factors significantly associated with food insecurity included: procurement of food using non-traditional methods [AOR = 11.11, 95% CI: 4.79-25.68, p = <0.001]; younger age [AOR = 0.92, 95% CI: 0.86-0.96, p = <0.001]; unstable housing [AOR = 4.46, 95% CI: 1.15-17.36, p = 0.031]; household gross annual income [AOR = 4.49, 95% CI: 1.74-11.60, p = 0.002]; and symptoms of depression [AOR = 2.73, 95% CI: 1.25-5.96, p = 0.012]. Conclusions Food insecurity among people living with HIV in British Columbia is characterized by poor dietary quality and food procurement methods. Notably, participants who reported procuring in non-traditional manners were over 10 times more likely to be food insecure. These findings suggest a need for tailored food security and social support interventions in this setting.	[Anema, Aranka] Harvard Univ, Dept Pediat, Harvard Med Sch, Boston, MA 02115 USA; [Anema, Aranka] Boston Childrens Hosp, Dept Med, Div Emergency Med, Boston, MA USA; [Anema, Aranka] Univ British Columbia, Fac Land & Food Syst, Dept Food Nutr & Hlth, Div Int Nutr, Vancouver, BC, Canada; [Fielden, Sarah J.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Shurgold, Susan; Ding, Erin; Hogg, Robert S.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, HIV AIDS Drug Treatment Program, Vancouver, BC, Canada; [Messina, Jennifer] St Pauls Hosp, Immune Deficiency Clin, Vancouver, BC, Canada; [Jones, Jennifer E.] Pacific AIDS Network, Vancouver, BC, Canada; [Chittock, Brian] AIDS Vancouver, Vancouver, BC, Canada; [Monteith, Ken] Coalit Organismes Communautaires Quebecois Lutte, Montreal, PQ, Canada; [Globerman, Jason; Rourke, Sean B.] Ontario HIV Treatment Network, Toronto, ON, Canada; [Rourke, Sean B.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada; [Rourke, Sean B.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of British Columbia; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Simon Fraser University	Anema, A (corresponding author), Harvard Univ, Dept Pediat, Harvard Med Sch, Boston, MA 02115 USA.; Anema, A (corresponding author), Boston Childrens Hosp, Dept Med, Div Emergency Med, Boston, MA USA.; Anema, A (corresponding author), Univ British Columbia, Fac Land & Food Syst, Dept Food Nutr & Hlth, Div Int Nutr, Vancouver, BC, Canada.	aranka.anema@childrens.harvard.edu		Klein, Marina/0000-0002-3063-8430	Canadian Institutes of Health Research (CIHR) [CBR-99148]; CIHR Postdoctoral Banting Fellowship; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Postdoctoral Banting Fellowship(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR) (#CBR-99148). AA was supported by CIHR Postdoctoral Banting Fellowship, and SJF was supported by a CIHR postdoctoral award.	[AIDS (UNAIDS) Joint United Nations Programme on HIV], UNAIDS POL BRIEF GRE; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; Allison P., 1999, LOGISTIC REGRESSION, P167; ANDERSON SA, 1990, J NUTR, V120, P1559, DOI 10.1093/jn/120.suppl_11.1555; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Anema A, 2014, AIDS BEHAV, V18, pS476, DOI 10.1007/s10461-013-0659-x; Anema A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061277; Baum MK, 1997, J ACQ IMMUN DEF SYND, V15, P370, DOI 10.1097/00042560-199708150-00007; BAUM MK, 1995, AIDS, V9, P1051, DOI 10.1097/00002030-199509000-00010; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Boothroyd RA, 2006, ADM POLICY MENT HLTH, V33, P172, DOI 10.1007/s10488-006-0030-x; [Canadian Community Health Survey (CCHS) Canada Health], 2009, HOUS FOOD INS SEL PR; CELUM CL, 1987, J INFECT DIS, V156, P998, DOI 10.1093/infdis/156.6.998; Coyne-Meyers Kristen, 2004, Nutr Clin Pract, V19, P340, DOI 10.1177/0115426504019004340; Csizmadi I, 2007, PUBLIC HEALTH NUTR, V10, P88, DOI 10.1017/S1368980007184287; Cutler-Triggs C, 2008, ARCH PEDIAT ADOL MED, V162, P1056, DOI 10.1001/archpediatrics.2008.2; FAO (Food and Agriculture Organization of the United Nations), 2009, DECL WORLD SUMM FOOD; Fielden SOJ, 2010, 18 INT AIDS C VIENN; Flicker S, 2009, AIDS CARE, V21, P94, DOI 10.1080/09540120802032650; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Harris GE, 2006, AIDS CARE, V18, P731, DOI 10.1080/09540120500307735; Health Canada Office of Nutrition Policy and Promotion, H164422007E HLTH CAN; [Healthy Eating Index (HEI) National Cancer Institute (NCI)], 2013, HLTH EAT IND HEI COM; Holmes B, 2008, Proc Nutr Soc, V67, pE88, DOI 10.1017/S0029665108007209; HOSMER DW, 2000, WILEY PS TX, P1; Isaac R, 2008, PUBLIC HEALTH NUTR, V11, P124, DOI 10.1017/S1368980007000067; Kaiser L, 2007, PUBLIC HEALTH NUTR, V10, P574, DOI 10.1017/S1368980007382542; Kalichman SC, 2010, J URBAN HEALTH, V87, P631, DOI 10.1007/s11524-010-9446-4; Lachin J. M., 2000, WILEY SER PROB STAT; McClelland A, GOOD PRACTICE GUIDE; Mikolajczyk RT, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-31; National Cancer Institute (NCI), HLTH EAT IND TOOLS R; National Cancer Institute (NCI), ASA24 AUT SELF ADM 2; Normen L, 2005, J NUTR, V135, P820, DOI 10.1093/jn/135.4.820; Obi CL, 2002, J HEALTH POPUL NUTR, V20, P230; Olson CM, 1999, J NUTR, V129, p521S, DOI 10.1093/jn/129.2.521S; Palar K, 2015, AIDS BEHAV, V19, P1527, DOI 10.1007/s10461-014-0922-9; RADIMER KL, 1992, J NUTR EDUC, V24, pS36; Rose D, 1999, J NUTR, V129, p517S, DOI 10.1093/jn/129.2.517S; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SEMBA RD, 1993, ARCH INTERN MED, V153, P2149, DOI 10.1001/archinte.153.18.2149; SEMBA RD, 1995, J INFECT DIS, V171, P1196, DOI 10.1093/infdis/171.5.1196; Shannon K, 2011, AIDS, V25, P2037, DOI 10.1097/QAD.0b013e32834b35c9; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Siefert K, 2004, J HEALTH SOC BEHAV, V45, P171, DOI 10.1177/002214650404500204; Steward WT, 2008, SOC SCI MED, V67, P1225, DOI 10.1016/j.socscimed.2008.05.032; Tang AM, 1997, AIDS, V11, P613, DOI 10.1097/00002030-199705000-00009; Tang AM, 1997, J NUTR, V127, P345, DOI 10.1093/jn/127.2.345; Torres R, 2014, P R HEALTH SCI J, V33, P14; Travers R, 2008, AIDS CARE, V20, P615, DOI 10.1080/09540120701661690; Tsai AC, 2011, SOC SCI MED, V73, P1717, DOI 10.1016/j.socscimed.2011.09.026; United States Department of Agriculture (USDA), USDA AUT MULT PASS M; United States Department of Agriculture (USDA), 2002, HLTH EAT IND 1999 20; Weiser SD, 2009, 5 INT AIDS SOC C HIV; Weiser SD, 2013, J GEN INTERN MED, V28, P91, DOI 10.1007/s11606-012-2176-4; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, AIDS BEHAV, V13, P841, DOI 10.1007/s10461-009-9597-z; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239	60	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0157630	10.1371/journal.pone.0157630	http://dx.doi.org/10.1371/journal.pone.0157630			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487041	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800004
J	Knowles, RL; Tadic, V; Hogan, A; Bull, C; Rahi, JS; Dezateux, C				Knowles, Rachel Louise; Tadic, Valerija; Hogan, Ailbhe; Bull, Catherine; Rahi, Jugnoo Sangeeta; Dezateux, Carol		UK Collaborative Study Congenital	Self-Reported Health Experiences of Children Living with Congenital Heart Defects: Including Patient-Reported Outcomes in a National Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOLOGICAL ADJUSTMENT; YOUNG-PEOPLE; DISEASE; ADOLESCENTS; ADULTS; TERM; PREVALENCE; ILLNESS; FAMILY	Background Understanding children's views about living with congenital heart defects (CHDs) is fundamental to supporting their successful participation in daily life, school and peer relationships. As an adjunct to a health and quality of life outcomes questionnaire, we asked school-age children who survived infant heart procedures to describe their experiences of living with CHDs. Methods In a UK-wide cohort study, children aged 10 to 14 years with CHDs self-completed postal questionnaires that included an open question about having a 'heart problem'. We compared the characteristics of children with more and less severe cardiac diagnoses and, through collaborative inductive content analysis, investigated the subjective experiences and coping strategies described by children in both clinical severity groups. Results Text and/or drawings were returned by 436 children (246 boys [56%], mean age 12.1 years [SD 1.0; range 10-14]); 313 had less severe (LS) and 123 more severe (MS) cardiac diagnoses. At the most recent hospital visit, a higher proportion of the MS group were underweight (more than two standard deviations below the mean for age) or cyanosed (underweight: MS 20.0%, LS 9.9%; cyanosed: MS 26.2%, LS 3.5%). Children in the MS group described concerns about social isolation and feeling 'different', whereas children with less severe diagnoses often characterised their CHD as 'not a big thing'. Some coping strategies were common to both severity groups, including managing health information to avoid social exclusion, however only children in the LS group considered their CHD 'in the past' or experienced a sense of survivorship. Conclusions Children's reported experiences were not dependent on their cardiac diagnosis, although there were clear qualitative differences by clinical severity group. Children's concerns emphasised social participation and our findings imply a need to shift the clinical focus from monitoring cardiac function to optimising participation. We highlight the potential for informing and evaluating clinical practice and service provision through seeking patient-reported outcomes in paediatric care.	[Knowles, Rachel Louise; Tadic, Valerija; Hogan, Ailbhe; Rahi, Jugnoo Sangeeta; Dezateux, Carol] UCL, Life Course Epidemiol & Biostat Sect, Populat Policy & Practice Programme, UCL Inst Child Hlth, London, England; [Bull, Catherine] Great Ormond St Hosp Sick Children, Cardiac Unit, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Knowles, RL (corresponding author), UCL, Life Course Epidemiol & Biostat Sect, Populat Policy & Practice Programme, UCL Inst Child Hlth, London, England.	rachel.knowles@ucl.ac.uk	Tadic, Val/AAL-3304-2020; Knowles, Rachel/L-3236-2018	Tadic, Val/0000-0003-3982-0340; Rahi, Jugnoo/0000-0002-5718-9209; Knowles, Rachel/0000-0002-5490-7682; Dezateux, Carol/0000-0001-9787-6276	British Heart Foundation [PG/02/065/13934]; MRC Special Training Fellowship in Health of the Public and Health Services Research [G106/1083]; Medical Research Council [G04005546]; UCL Institute of Ophthalmology/Moorfields Eye Hospital NHS Trust; Great Ormond St Hospital for Children NHS FoundationTrust; UCL Institute of Child Health from the Department of Health's NIHR Biomedical Research Centres scheme; MRC [G106/1083, G0400546] Funding Source: UKRI; Medical Research Council [G106/1083, G0400546] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); MRC Special Training Fellowship in Health of the Public and Health Services Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL Institute of Ophthalmology/Moorfields Eye Hospital NHS Trust; Great Ormond St Hospital for Children NHS FoundationTrust; UCL Institute of Child Health from the Department of Health's NIHR Biomedical Research Centres scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a British Heart Foundation project grant (reference PG/02/065/13934; www.bhf.org.uk). RK was awarded an MRC Special Training Fellowship in Health of the Public and Health Services Research (reference G106/1083; www.mrc.ac.uk). The Life Course Epidemiology and Biostatistics Section of the Population Policy and Practice Programme benefited from funding support from the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health (reference G04005546). Members of the team are supported by UCL Institute of Ophthalmology/Moorfields Eye Hospital NHS Trust, Great Ormond St Hospital for Children NHS FoundationTrust and the UCL Institute of Child Health, which receive a proportion of funding from the Department of Health's NIHR Biomedical Research Centres scheme. The funders had no role in the study design, data analysis and interpretation, writing or publication of this paper.	Abdullah A., 1994, Journal of Burn Care and Rehabilitation, V15, P164, DOI 10.1097/00004630-199403000-00011; Apers S, 2013, EUR J CARDIOVASC NUR, V12, P475, DOI 10.1177/1474515113477955; Bertoletti J, 2014, ARQ BRAS CARDIOL, V102, P192, DOI 10.5935/abc.20130244; Birks Y, 2007, HEALTH EXPECT, V10, P16, DOI 10.1111/j.1369-7625.2006.00412.x; Brown BC, 2010, J PLAST RECONSTR AES, V63, P1022, DOI 10.1016/j.bjps.2009.03.019; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Burstrom A, 2015, J CARDIOVASC NURS; Christie D, 2012, CLIN CHILD PSYCHOL P, V17, P5, DOI 10.1177/1359104510392309; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Ferguson MK, 2013, CURR OPIN CARDIOL, V28, P115, DOI 10.1097/HCO.0b013e32835d7eba; Hirschberg M, 2012, REINVENTION A JOURNA; Ingerski LM, 2010, J PEDIATR-US, V156, P639, DOI 10.1016/j.jpeds.2009.11.008; Jamieson N, 2014, PEDIATRICS, V133, pE1683, DOI 10.1542/peds.2014-0009; Kendall L, 2001, CARDIOL YOUNG, V11, P431, DOI 10.1017/S1047951101000555; Kinahan KE, 2012, J CLIN ONCOL, V30, P2466, DOI 10.1200/JCO.2011.39.3611; Knowles RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106806; Knowles RL, 2014, ARCH DIS CHILD, V99, P413, DOI 10.1136/archdischild-2013-305130; Knowles RL, 2011, ARCH DIS CHILD, V96, P14, DOI 10.1136/adc.2008.152975; Latal B, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-6; Lazarus R. S., 1984, STRESS APPRAISAL AND; Lightfoot J, 1999, CHILD CARE HLTH DEV, V25, P267, DOI 10.1046/j.1365-2214.1999.00112.x; McCrindle BW, 2010, CIRCULATION, V121, P34, DOI 10.1161/CIRCULATIONAHA.109.869396; McMurray R, 2001, CORON HLTH CARE, V5, P51, DOI DOI 10.1054/CHEC.2001.0112; Moceri P, 2015, EUR J PEDIATR, V174, P847, DOI 10.1007/s00431-015-2557-x; Moola F, 2011, ADAPT PHYS ACT Q, V28, P56, DOI 10.1123/apaq.28.1.56; Moons P, 2009, J ADOLESCENT HEALTH, V44, P316, DOI 10.1016/j.jadohealth.2008.11.007; Mussatto K, 2006, CARDIOL YOUNG, V16, P110, DOI 10.1017/S104795110600103X; Noronha DO, 2007, J PEDIATR PSYCHOL, V32, P380, DOI 10.1093/jpepsy/jsl014; OLSON AL, 1993, J DEV BEHAV PEDIATR, V14, P217; Ricciardelli LA, 2001, CLIN PSYCHOL REV, V21, P325, DOI 10.1016/S0272-7358(99)00051-3; Rivlin Elise, 2007, Dev Neurorehabil, V10, P173, DOI 10.1080/17518420701309667; Scott J, 2009, 21 CENTURY SOC, V4, P123; Silva AM, 2011, CARDIOL YOUNG, V21, P670, DOI 10.1017/S1047951111000576; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; Taylor RM, 2008, J CLIN NURS, V17, P3083, DOI 10.1111/j.1365-2702.2008.02629.x; Taylor RM, 2008, J CLIN NURS, V17, P1823, DOI 10.1111/j.1365-2702.2008.02379.x; Tong EM, 1998, CARDIOL YOUNG, V8, P303, DOI 10.1017/S1047951100006806; Uzark K, 2008, PEDIATRICS, V121, pE1060, DOI 10.1542/peds.2006-3778; Uzark K, 2015, J PEDIATR-US, V167, P1233, DOI 10.1016/j.jpeds.2015.07.043; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2007, HEALTH QUAL LIFE OUT, DOI DOI 10.1186/1477-7525-5-43; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1111/1469-7610.00302; Wallander JL, 2001, QUALITY OF LIFE IN C; White-Koning M, 2007, PEDIATRICS, V120, pE804, DOI 10.1542/peds.2006-3272; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414	46	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159326	10.1371/journal.pone.0159326	http://dx.doi.org/10.1371/journal.pone.0159326			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487183	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000381367800026
J	Stammler, A; Luftner, BU; Kliesch, S; Weidner, W; Bergmann, M; Middendorff, R; Konrad, L				Stammler, Angelika; Lueftner, Benjamin Udo; Kliesch, Sabine; Weidner, Wolfgang; Bergmann, Martin; Middendorff, Ralf; Konrad, Lutz			Highly Conserved Testicular Localization of Claudin-11 in Normal and Impaired Spermatogenesis	PLOS ONE			English	Article							BLOOD-TESTIS BARRIER; CELL TIGHT JUNCTION; SERTOLI-CELLS; RAT TESTIS; EXPRESSION; MICE; GERM; MEN; OSP/CLAUDIN-11; SPERMATOCYTES	In this study we tested expression of tight junction proteins in human, mouse and rat and analyzed the localization of claudin-11 in testis of patients with normal and impaired spermatogenesis. Recent concepts generated in mice suggest that the stage-specifically expressed claudin-3 acts as a basal barrier, sealing the seminiferous epithelium during migration of spermatocytes. Corresponding mechanisms have never been demonstrated in humans. Testicular biopsies (n = 103) from five distinct groups were analyzed: normal spermatogenesis (NSP, n = 28), hypospermatogenesis (Hyp, n = 24), maturation arrest at the level of primary spermatocytes (MA, n = 24), Sertoli cell only syndrome (SCO, n = 19), and spermatogonial arrest (SGA, n = 8). Protein expression of claudin-3, -11 and occludin was analyzed. Human, mice and rat testis robustly express claudin-11 protein. Occludin was detected in mouse and rat and claudin-3 was found only in mice. Thus, we selected claudin-11 for further analysis of localization. In NSP, claudin-11 is located at Sertoli-Sertoli junctions and in Sertoli cell contacts towards spermatogonia. Typically, claudin-11 patches do not reach the basal membrane, unless flanked by the Sertoli cell body or patches between two Sertoli cell bodies. The amount of basal claudin-11 patches was found to be increased in impaired spermatogenesis. Only claudin-11 is expressed in all three species examined. The claudin-11 pattern is robust in man with impaired spermatogenesis, but the proportion of localization is altered in SCO and MA. We conclude that claudin-11 might represent the essential component of the BTB in human.	[Stammler, Angelika; Middendorff, Ralf] Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany; [Stammler, Angelika; Lueftner, Benjamin Udo; Konrad, Lutz] Univ Giessen, Dept Obstet & Gynecol, Feulgenstr 12, D-35392 Giessen, Germany; [Kliesch, Sabine] Univ Hosp Munster, Dept Clin Androl, Ctr Reprod Med & Androl, Domagkstr 11, D-48129 Munster, Germany; [Weidner, Wolfgang] Univ Giessen, UKGM Giessen, Dept Urol Pediat Urol & Androl, D-35392 Giessen, Germany; [Bergmann, Martin] Univ Giessen, Inst Vet Anat Histol & Embryol, Frankfurter Str 98, D-35392 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Munster; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; Justus Liebig University Giessen	Stammler, A (corresponding author), Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany.; Stammler, A (corresponding author), Univ Giessen, Dept Obstet & Gynecol, Feulgenstr 12, D-35392 Giessen, Germany.	angelika.stammler@anatomie.med.uni-giessen.de			State of Hessen, grant LOEWE-MIBIE; Deutsche Forschungsgemeinschaft [KFO 181]	State of Hessen, grant LOEWE-MIBIE; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by State of Hessen, grant LOEWE-MIBIE, project A3, https://wissenschaft.hessen.de/loewe, Grant was awarded to RM & LK; Deutsche Forschungsgemeinschaft, grant KFO 181, project P2, http://www.dfg.de, Grant was awarded to LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMANN M, 1983, ANAT EMBRYOL, V168, P269, DOI 10.1007/BF00315821; BERGMANN M, 1989, CELL TISSUE RES, V256, P183; Bergmann M, 1998, ANDROLOGIE, P66; Blasig IE, 2006, CELL MOL LIFE SCI, V63, P505, DOI 10.1007/s00018-005-5472-x; Bronstein JM, 2000, J NEUROSCI RES, V60, P284, DOI 10.1002/(SICI)1097-4547(20000501)60:3<284::AID-JNR2>3.0.CO;2-T; Cavicchia JC, 1996, ULTRASTRUCT PATHOL, V20, P211, DOI 10.3109/01913129609016317; Chakraborty P, 2014, MOL ENDOCRINOL, V28, P1055, DOI 10.1210/me.2013-1134; Chiba K, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.06.036; Chihara M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.107847; Chihara M, 2010, MOL REPROD DEV, V77, P630, DOI 10.1002/mrd.21200; Dietze R, 2015, MOL CELL ENDOCRINOL, V405, P1, DOI 10.1016/j.mce.2015.02.004; Fawcett D W, 1970, J Reprod Fertil Suppl, V10, P105; Fink C, 2009, HISTOCHEM CELL BIOL, V131, P755, DOI 10.1007/s00418-009-0576-2; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Haverfield JT, 2014, ENDOCRINOLOGY, V155, P1131, DOI 10.1210/en.2013-1878; Haverfield JT, 2013, FERTIL STERIL, V100, P658, DOI 10.1016/j.fertnstert.2013.04.034; Hentrich A, 2011, MODERN PATHOL, V24, P1380, DOI 10.1038/modpathol.2011.97; Ilani N, 2012, HUM REPROD, V27, P3403, DOI 10.1093/humrep/des340; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Koval M, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24518; Mazaud-Guittot S, 2010, BIOL REPROD, V82, P202, DOI 10.1095/biolreprod.109.078907; McCabe MJ, 2016, HUM REPROD, V31, P875, DOI 10.1093/humrep/dew009; McCabe MJ, 2015, ASIAN J ANDROL, DOI [10.4103/1008-682X, DOI 10.4103/1008-682X]; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Moroi S, 1998, AM J PHYSIOL-CELL PH, V274, pC1708, DOI 10.1152/ajpcell.1998.274.6.C1708; Morrow CMK, 2009, BIOL REPROD, V81, P871, DOI 10.1095/biolreprod.109.077040; Nah WH, 2011, FERTIL STERIL, V95, P385, DOI 10.1016/j.fertnstert.2010.08.023; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Smith B., 2012, THESIS; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969	33	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160349	10.1371/journal.pone.0160349	http://dx.doi.org/10.1371/journal.pone.0160349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486954	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800072
J	Ohnishi, T; Sudo, H; Iwasaki, K; Tsujimoto, T; Ito, YM; Iwasaki, N				Ohnishi, Takashi; Sudo, Hideki; Iwasaki, Koji; Tsujimoto, Takeru; Ito, Yoichi M.; Iwasaki, Norimasa			In Vivo Mouse Intervertebral Disc Degeneration Model Based on a New Histological Classification	PLOS ONE			English	Article							NEEDLE-PUNCTURE; LUMBAR DISC; NUCLEUS PULPOSUS; ANIMAL-MODEL; CASPASE 3; DEFICIENCY; INJECTION; INJURY; CELLS; RAT	Although human intervertebral disc degeneration can lead to several spinal diseases, its pathogenesis remains unclear. This study aimed to create a new histological classification applicable to an in vivo mouse intervertebral disc degeneration model induced by needle puncture. One hundred six mice were operated and the L4/5 intervertebral disc was punctured with a 35- or 33-gauge needle. Micro-computed tomography scanning was performed, and the punctured region was confirmed. Evaluation was performed by using magnetic resonance imaging and histology by employing our classification scoring system. Our histological classification scores correlated well with the findings of magnetic resonance imaging and could detect degenerative progression, irrespective of the punctured region. However, the magnetic resonance imaging analysis revealed that there was no significant degenerative intervertebral disc change between the ventrally punctured and non-punctured control groups. To induce significant degeneration in the lumbar intervertebral discs, the central or dorsal region should be punctured instead of the ventral region.	[Ohnishi, Takashi; Iwasaki, Koji; Tsujimoto, Takeru; Iwasaki, Norimasa] Hokkaido Univ, Grad Sch Med, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Sudo, Hideki] Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan; [Ito, Yoichi M.] Hokkaido Univ, Grad Sch Med, Dept Biostat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Sudo, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Adv Med Spine & Spinal Cord Disorders, Sapporo, Hokkaido, Japan.	hidekisudo@yahoo.co.jp	Sudo, Hideki/G-2748-2012	Ito, Yoichi M./0000-0001-5073-0827; Iwasaki, Koji/0000-0002-4525-9150	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26670651]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported partly by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (a Grant-in-Aid for Challenging Exploratory Research, 26670651) (to H. Sudo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chien WM, 2007, CELL CYCLE, V6, P750, DOI 10.4161/cc.6.6.3986; Dower A, 2016, J CLIN NEUROSCI, V23, P44, DOI 10.1016/j.jocn.2015.04.024; Elliott DM, 2008, SPINE, V33, P588, DOI 10.1097/BRS.0b013e318166e0a2; Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA; Hsieh AH, 2009, SPINE, V34, P998, DOI 10.1097/BRS.0b013e31819c09c4; Issy AC, 2013, BRAZ J MED BIOL RES, V46, P235, DOI 10.1590/1414-431X20122429; Iwasaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109851; KEY JA, 1948, J BONE JOINT SURG AM, V30-A, P621, DOI 10.2106/00004623-194830030-00009; Liang HX, 2010, SPINE J, V10, P32, DOI 10.1016/j.spinee.2009.10.006; Martin JT, 2013, J ORTHOP RES, V31, P1276, DOI 10.1002/jor.22355; Masuda K, 2006, SPINE, V31, P742, DOI 10.1097/01.brs.0000206358.66412.7b; Masuda K, 2005, SPINE, V30, P5, DOI 10.1097/01.brs.0000148152.04401.20; Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006; OSTI OL, 1990, SPINE, V15, P762, DOI 10.1097/00007632-199008010-00005; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rousseau MAA, 2007, SPINE, V32, P17, DOI 10.1097/01.brs.0000251013.07656.45; Seki S, 2014, BIOCHEM BIOPH RES CO, V446, P876, DOI 10.1016/j.bbrc.2014.03.025; Seki S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2851; Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346; Sobajima S, 2005, SPINE, V30, P15, DOI 10.1097/01.brs.0000148048.15348.9b; Sudo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058806; Sudo H, 2011, ARTHRITIS RHEUM-US, V63, P1648, DOI 10.1002/art.30251; Sudo H, 2010, J ORTHOP RES, V28, P1608, DOI 10.1002/jor.21185; Yamada K, 2014, AM J PATHOL, V184, P753, DOI 10.1016/j.ajpath.2013.11.010; Yang F, 2009, MOL THER, V17, P1959, DOI 10.1038/mt.2009.146; Zhao CQ, 2006, APOPTOSIS, V11, P2079, DOI 10.1007/s10495-006-0290-7; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343	27	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160486	10.1371/journal.pone.0160486	http://dx.doi.org/10.1371/journal.pone.0160486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482708	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700051
J	Dong, XF; Du, XM; Qi, B				Dong, Xiaofei; Du, Xiumin; Qi, Bing			Conceptual Knowledge Influences Decision Making Differently in Individuals with High or Low Cognitive Flexibility: An ERP Study	PLOS ONE			English	Article							CARD SORTING TEST; FEEDBACK-RELATED NEGATIVITY; SOMATIC MARKER HYPOTHESIS; MEDIAL FRONTAL-CORTEX; IOWA GAMBLING TASK; PREFRONTAL CORTEX; WORKING-MEMORY; EXECUTIVE FUNCTIONS; SCHIZOPHRENIA; SENSITIVITY	Objective Studies using the Iowa Gambling Task (IGT) have distinguished between good and bad decision makers and have provided an explanation for deficits in decision making. Previous studies have demonstrated a link between Wisconsin Card Sorting Test (WCST) performance and IGT performance, but the results were not consistent and failed to explain why WCST performance can predict IGT performance. The present study aimed to demonstrate that WCST performance can predict IGT performance and to identify the cognitive component of the WCST that affects IGT performance using event-related potentials (ERPs). Methods In this study, 39 healthy subjects (5 subjects were excluded) were divided into a high group and a low group based on their global score on the WCST. A single-choice version of the IGT was used to eliminate the impact of retrieval strategies on the choice evaluation process and interference due to uncorrelated decks. Differences in the underlying neural mechanisms and explicit knowledge between the two groups during the three stages of the decision-making process were described. Results Based on the information processing perspective, we divided the decision-making process into three stages: choice evaluation, response selection, and feedback processing. The behavioral results showed that the highly cognitively flexible participants performed better on the IGT and acquired more knowledge of the task. The ERP results showed that during the choice evaluation stage, the P300 recorded from central and parietal regions when a bad deck appeared was larger in the high group participants than in the low group participants. During the response selection stage, the effect of choice type was significant only in the frontal region in the high group, with a larger effect for passing. During the feedback evaluation stage, a larger FRN was evoked for a loss than for a win in the high group, whereas the FRN effect was absent in the low group. Conclusion Compared with the participants with low cognitive flexibility, the participants with high cognitive flexibility performed better on the IGT, acquired more knowledge of the task, and displayed more obvious somatic markers. The low group participants showed reduced working memory abilities during the choice evaluation stage. The appropriate somatic markers reflected by the DPN is formed only when conceptual knowledge is gained in the response selection stage. The absence of an FRN effect in the subjects who performed poorly on the WCST suggests a significant deficit in feedback learning and reward prediction.	[Dong, Xiaofei; Du, Xiumin; Qi, Bing] Hebei Univ, Coll Educ, Baoding, Peoples R China	Hebei University	Du, XM; Qi, B (corresponding author), Hebei Univ, Coll Educ, Baoding, Peoples R China.	duxiumin-312@126.com; hdqibing@126.com	dong, xiaofei/R-2809-2016	dong, xiaofei/0000-0002-9629-4888	Project of Chinese National Education Science "12th five Year" plan [BBA130013, BBA150044]; Project of Philosophy and Social Science Research in Hebei Province of China [HB15JY078, HB16JY016]; Humanities-Society Scientific Foundation of Hebei Education Department of China [SD151092]	Project of Chinese National Education Science "12th five Year" plan; Project of Philosophy and Social Science Research in Hebei Province of China; Humanities-Society Scientific Foundation of Hebei Education Department of China	This work was supported by Project of Chinese National Education Science "12th five Year" plan (BBA130013; BBA150044) [http://onsgep.moe.edu.cn/edoas2/website7/index.jsp], Project of Philosophy and Social Science Research in Hebei Province of China (HB15JY078; HB16JY016) and Humanities-Society Scientific Foundation of Hebei Education Department of China (SD151092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson R.R., 1985, HDB SOCIAL PSYCHOL, P231; Asp E, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00086; Balconi M, 2015, J NEUROPSYCH CLIN N, V27, P219, DOI 10.1176/appi.neuropsych.14070165; Barcelo F, 2003, BRAIN RES PROTOC, V11, P27, DOI 10.1016/S1385-299X(03)00013-8; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bianchin M, 2011, BRAIN COGNITION, V75, P273, DOI 10.1016/j.bandc.2011.01.005; BIRBAUMER N, 1990, PHYSIOL REV, V70, P1, DOI 10.1152/physrev.1990.70.1.1; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Cui JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00776; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Delpero C, 2015, J COGN PSYCHOL, V27, P882, DOI 10.1080/20445911.2015.1036759; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; [方平 Fang Ping], 2009, [心理科学, Psychological Science], V32, P640; Fernie G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00687; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Giustiniani J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130871; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hinson JM, 2002, COGN AFFECT BEHAV NE, V2, P341, DOI 10.3758/CABN.2.4.341; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Horowitz-Kraus T, 2014, J LEARN DISABIL-US, V47, P208, DOI 10.1177/0022219412453084; Jameson TL, 2004, PSYCHON B REV, V11, P515, DOI 10.3758/BF03196604; Kaladjian A, 2011, PSYCHOL MED, V41, P291, DOI 10.1017/S0033291710000796; Lehto JE, 2003, APPL NEUROPSYCHOL, V10, P234, DOI 10.1207/s15324826an1004_5; Loh M, 2005, EUR J NEUROSCI, V22, P2927, DOI 10.1111/j.1460-9568.2005.04505.x; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Maurage P, 2007, CLIN NEUROPHYSIOL, V118, P633, DOI 10.1016/j.clinph.2006.11.007; Mellentin AI, 2013, SCAND J PSYCHOL, V54, P292, DOI 10.1111/sjop.12054; Perianez JA, 2009, NEUROPSYCHOLOGIA, V47, P1160, DOI 10.1016/j.neuropsychologia.2009.01.014; Petit L, 1998, J NEUROSCI, V18, P9429; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ritter LM, 2004, SCHIZOPHR RES, V68, P65, DOI 10.1016/S0920-9964(03)00086-0; Sawa T, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-31; SIMON HA, 1986, J BUS, V59, pS209, DOI 10.1086/296363; Starcke K, 2011, COGN PROCESS, V12, P177, DOI 10.1007/s10339-010-0387-3; Toyomaki A, 2005, INT CONGR SER, V1278, P381, DOI 10.1016/j.ics.2004.11.032; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Yip SW, 2009, SCHIZOPHR RES, V110, P156, DOI 10.1016/j.schres.2009.01.012	42	10	11	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0158875	10.1371/journal.pone.0158875	http://dx.doi.org/10.1371/journal.pone.0158875			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27479484	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300008
J	Limm, K; Dettmer, K; Reinders, J; Oefner, PJ; Bosserhoff, AK				Limm, Katharina; Dettmer, Katja; Reinders, Joerg; Oefner, Peter J.; Bosserhoff, Anja-Katrin			Characterization of the Methylthioadenosine Phosphorylase Polymorphism rs7023954-Incidence and Effects on Enzymatic Function in Malignant Melanoma	PLOS ONE			English	Article							CUTANEOUS MELANOMA; CELL-PROLIFERATION; EXPRESSION; MTAP; PROGRESSION; SURVIVAL; RISK; 5'-DEOXY-5'-METHYLTHIOADENOSINE; MECHANISMS; VARIANTS	Deficiency of methylthioadenosine phosphorylase (MTAP) supports melanoma development and progression through accumulation of its substrate 5'-methylthioadenosine (MTA), which leads amongst others to a constitutive inhibition of protein arginine methyltransferases (PRMTs) and activation of the transcription factor AP-1 via the receptor ADORA2B. Genetic association studies have also suggested that genetic polymorphism in MTAP may modulate the risk of melanoma. Here, we investigated the only globally common non-synonymous single nucleotide polymorphism (SNP) reported to date for MTAP. The SNP rs7023954 is located in exon 3 (c. 166G>A), and leads to the conservative substitution of one branched-chain amino acid residue (valine) for another (isoleucine) at position 56 (p. Val56lle). Whereas genotype frequencies in normal and primary melanoma tissues or cell lines were in Hardy-Weinberg equilibrium based on cDNA amplicon sequencing, a marked (P = 0.00019) deviation was observed in metastatic melanoma tissues and cell lines due to a deficit of heterozygotes. Enzyme assays conducted on the co-dominantly expressed alleles revealed no difference in the conversion rate of MTA to adenine and 5-methylthioribose-1-phosphate, indicating that this known enzymatic activity does not modulate the tumor suppressive function of MTAP.	[Limm, Katharina; Bosserhoff, Anja-Katrin] Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany; [Dettmer, Katja; Reinders, Joerg; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, Regensburg, Germany; [Bosserhoff, Anja-Katrin] Univ Erlangen Nurnberg, CCC Erlangen EMN, Comprehens Canc Ctr Erlangen, Erlangen, Germany	University of Erlangen Nuremberg; University of Regensburg; University of Erlangen Nuremberg	Bosserhoff, AK (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany.; Bosserhoff, AK (corresponding author), Univ Erlangen Nurnberg, CCC Erlangen EMN, Comprehens Canc Ctr Erlangen, Erlangen, Germany.	anja.bosserhoff@fau.de	Bosserhoff, Anja/GNH-4801-2022; Dettmer, Katja/D-6218-2018; Dettmer, Katja/N-4562-2016	Dettmer, Katja/0000-0001-7337-2380; Dettmer, Katja/0000-0001-7337-2380; Reinders, Joerg/0000-0003-1025-7849; Bosserhoff, Anja/0000-0001-8147-394X	Medical Faculty of the University of Regensburg (ReForM); German Research Foundation [DFG BO1573, KFO 262]; BioSysNet; German Cancer Aid	Medical Faculty of the University of Regensburg (ReForM); German Research Foundation(German Research Foundation (DFG)); BioSysNet; German Cancer Aid(Deutsche Krebshilfe)	This work was supported by grants from the Medical Faculty of the University of Regensburg (ReForM) and the German Research Foundation (DFG BO1573, KFO 262), further by BioSysNet and the German Cancer Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Perez P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001936; Andreu-Perez P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-265; Behrmann I, 2003, AM J PATHOL, V163, P683, DOI 10.1016/S0002-9440(10)63695-4; Bluemlein K, 2011, NAT PROTOC, V6, P859, DOI 10.1038/nprot.2011.333; Braig S, 2011, BRIT J CANCER, V105, P231, DOI 10.1038/bjc.2011.226; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Camacho-Vanegas O, 2012, AM J HUM GENET, V90, P614, DOI 10.1016/j.ajhg.2012.02.024; Canady J, 2013, J INVEST DERMATOL, V133, P647, DOI 10.1038/jid.2012.389; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Congrains A, 2013, INT J MOL SCI, V14, P1278, DOI 10.3390/ijms14011278; Godar DE, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/858425; Hohenauer T, 2013, EMBO MOL MED, V5, P919, DOI 10.1002/emmm.201201862; Houslay MD, 2011, CANCER CELL, V19, P3, DOI 10.1016/j.ccr.2011.01.004; Jacob K, 1998, MELANOMA RES, V8, P211, DOI 10.1097/00008390-199806000-00003; Kirovski G, 2011, AM J PATHOL, V178, P1145, DOI 10.1016/j.ajpath.2010.11.059; Kvaskoff M, 2011, TWIN RES HUM GENET, V14, P422, DOI 10.1375/twin.14.5.422; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Limm K, 2014, EUR J CANCER, V50, P2714, DOI 10.1016/j.ejca.2014.07.005; Limm K, 2013, EUR J CANCER, V49, P1305, DOI 10.1016/j.ejca.2012.11.026; Maccioni L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-325; Miller DM, 2014, PIGM CELL MELANOMA R, V27, P351, DOI 10.1111/pcmr.12211; Newton-Bishop JA, 2010, CANCER EPIDEM BIOMAR, V19, P2043, DOI 10.1158/1055-9965.EPI-10-0233; Niebler S, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0648-8; Ogbah Z, 2012, ANTICANCER RES, V32, P1245; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Spangler B, 2012, INT J CANCER, V130, P2801, DOI 10.1002/ijc.26277; Stevens AP, 2010, J CHROMATOGR A, V1217, P3282, DOI 10.1016/j.chroma.2010.01.025; Stevens AP, 2009, J CELL BIOCHEM, V106, P210, DOI 10.1002/jcb.21984; Stevens AP, 2008, J CHROMATOGR B, V876, P123, DOI 10.1016/j.jchromb.2008.10.038; Tang BQ, 2015, G3-GENES GENOM GENET, V5, P35, DOI 10.1534/g3.114.014555; Villanueva J, 2011, CANCER RES, V71, P7137, DOI 10.1158/0008-5472.CAN-11-1243; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yang XR, 2010, FAM CANCER, V9, P625, DOI 10.1007/s10689-010-9356-3	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160348	10.1371/journal.pone.0160348	http://dx.doi.org/10.1371/journal.pone.0160348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479139	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110300043
J	Zigler, JS; Hodgkinson, CA; Wright, M; Klise, A; Sundin, O; Broman, KW; Hejtmancik, F; Huang, H; Patek, B; Sergeev, Y; Hose, S; Brayton, C; Jiao, XD; Vasquez, D; Maragakis, N; Mori, S; Goldman, D; Hoke, A; Sinha, D				Zigler, J. Samuel, Jr.; Hodgkinson, Colin A.; Wright, Megan; Klise, Andrew; Sundin, Olof; Broman, Karl W.; Hejtmancik, Fielding; Huang, Hao; Patek, Bonnie; Sergeev, Yuri; Hose, Stacey; Brayton, Cory; Jiao Xaiodong; Vasquez, David; Maragakis, Nicholas; Mori, Susumu; Goldman, David; Hoke, Ahmet; Sinha, Debasish			A Spontaneous Missense Mutation in Branched Chain Keto Acid Dehydrogenase Kinase in the Rat Affects Both the Central and Peripheral Nervous Systems	PLOS ONE			English	Article							MICE; BETA-A3/A1-CRYSTALLIN; PROTEIN	A novel mutation, causing a phenotype we named frogleg because its most obvious characteristic is a severe splaying of the hind limbs, arose spontaneously in a colony of Sprague-Dawley rats. Frogleg is a complex phenotype that includes abnormalities in hind limb function, reduced brain weight with dilated ventricles and infertility. Using micro-satellite markers spanning the entire rat genome, the mutation was mapped to a region of rat chromosome 1 between D1Rat131 and D1Rat287. Analysis of whole genome sequencing data within the linkage interval, identified a missense mutation in the branched-chain alpha-keto dehydrogenase kinase (Bckdk) gene. The protein encoded by Bckdk is an integral part of an enzyme complex located in the mitochondrial matrix of many tissues which regulates the levels of the branched-chain amino acids (BCAAs), leucine, isoleucine and valine. BCAAs are essential amino acids (not synthesized by the body), and circulating levels must be tightly regulated; levels that are too high or too low are both deleterious. BCKDK phosphorylates Ser293 of the E1a subunit of the BCKDH protein, which catalyzes the rate-limiting step in the catabolism of the BCAAs, inhibiting BCKDH and thereby, limiting breakdown of the BCAAs. In contrast, when Ser293 is not phosphorylated, BCKDH activity is unchecked and the levels of the BCAAs will decrease dramatically. The mutation is located within the kinase domain of Bckdk and is predicted to be damaging. Consistent with this, we show that in rats homozygous for the mutation, phosphorylation of BCKDH in the brain is markedly decreased relative to wild type or heterozygous littermates. Further, circulating levels of the BCAAs are reduced by 70-80% in animals homozygous for the mutation. The frogleg phenotype shares important characteristics with a previously described Bckdk knockout mouse and with human subjects with Bckdk mutations. In addition, we report novel data regarding peripheral neuropathy of the hind limbs.	[Zigler, J. Samuel, Jr.; Klise, Andrew; Patek, Bonnie; Hose, Stacey; Sinha, Debasish] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Hodgkinson, Colin A.; Goldman, David] NIAAA, NIH, Rockville, MD 20852 USA; [Wright, Megan; Maragakis, Nicholas; Hoke, Ahmet] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Sundin, Olof] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, El Paso, TX USA; [Broman, Karl W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Informat, Madison, WI USA; [Huang, Hao; Sergeev, Yuri; Jiao Xaiodong] NEI, NIH, Bethesda, MD 20892 USA; [Huang, Hao] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Brayton, Cory] Johns Hopkins Univ, Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Vasquez, David] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Mori, Susumu] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Johns Hopkins University; Texas Tech University System; Texas Tech University; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sinha, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	Debasish@jhmi.edu	Goldman, David/F-9772-2010; Brayton, Cory/AAW-4681-2021	Goldman, David/0000-0002-1724-5405; Brayton, Cory/0000-0002-6666-6548; Klise, Andrew/0000-0002-5078-5577; Broman, Karl/0000-0002-4914-6671; Hodgkinson, Colin/0000-0002-5365-8119; Hejtmancik, James/0000-0002-4788-0362	National Institutes of Health, National Institutes of Child Health and Human Disease [R21HD059008]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL EYE INSTITUTE [ZIAEY000476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000301] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Child Health and Human Disease; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	DS received support from National Institutes of Health, National Institutes of Child Health and Human Disease, R21HD059008, https://www.nichd.nih.gov/Pages/index.aspx. AH received support from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, http://www.adelsonfoundation.org/amrfphil.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brayton C, 2001, VET PATHOL, V38, P1, DOI 10.1354/vp.38-1-1; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; COOK KG, 1984, EUR J BIOCHEM, V145, P587, DOI 10.1111/j.1432-1033.1984.tb08597.x; Garcia-Cazorla A, 2014, HUM MUTAT, V35, P470, DOI 10.1002/humu.22513; Gietzen DW, 1996, AM J PHYSIOL-REG I, V271, pR18, DOI 10.1152/ajpregu.1996.271.1.R18; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; HARRIS RA, 1990, ADV ENZYME REGUL, V30, P245; Hutson Susan M, 2006, Biochem J, V400, pe1; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; POPOV KM, 1992, J BIOL CHEM, V267, P13127; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Sinha D, 2005, EXP EYE RES, V80, P323, DOI 10.1016/j.exer.2004.09.014; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Wright MC, 2007, EXP NEUROL, V205, P437, DOI 10.1016/j.expneurol.2007.03.011; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Zigler JS, 2015, PROG RETIN EYE RES, V44, P62, DOI 10.1016/j.preteyeres.2014.11.002	19	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160447	10.1371/journal.pone.0160447	http://dx.doi.org/10.1371/journal.pone.0160447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472223	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516300052
J	Dore, MP; Marras, G; Rocchi, C; Soro, S; Pes, GM				Dore, Maria Pina; Marras, Giuseppina; Rocchi, Chiara; Soro, Sara; Pes, Giovanni Mario			G6PD Deficiency Does Not Enhance Susceptibility for Acquiring Helicobacter pylori Infection in Sardinian Patients	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; BENZO(A)PYRENE METABOLISM; BACTERICIDAL ACTIVITY; SOCIOECONOMIC-STATUS; HUMAN FIBROBLASTS; OXIDATIVE STRESS; EPIDEMIOLOGY; INDIVIDUALS; POPULATION	Background Subjects with glucose-6-phosphate dehydrogenase (G6PD) deficiency may be more susceptible to infections due to impaired leukocyte bactericidal activity. The disorder is common in the Mediterranean area. The aim of this study was to investigate whether G6PD deficiency may be a risk factor for acquiring H. pylori infection. Methods We performed a retrospective study. Data from clinical records of 6565 patients (2278 men and 4287 women, median age 51, range 7-94) who underwent upper endoscopy between 2002 and 2014 were collected. H. pylori status, assessed by histology plus rapid urease test or C-13-urea breath test, and G6PD status were also reported. A multiple logistic regression model was used to investigate the association between G6PD deficiency and H. pylori infection. Results Enzyme deficiency was detected in 12% (789/6565) of the entire cohort, and more specifically in 8.3% of men and in 14.0% of women. Overall, the proportion of patients positive for H. pylori was 50.6% and 51.5% among G6PD deficient and non-deficient patients (chi(2) = 0.271; p = 0.315). Moreover, among G6PD-deficient and normal patients the frequency of previous H. pylori infection was similar. After adjustment for age and gender the risk for acquiring H. pylori infection was similar in G6PD-deficient and normal patients. Only age was a strong statistically significant risk predictor. Conclusions These results demonstrate for the first time that G6PD deficiency does not enhance patients' susceptibility to acquire H. pylori infection in Sardinia.	[Dore, Maria Pina; Marras, Giuseppina; Rocchi, Chiara; Soro, Sara; Pes, Giovanni Mario] Univ Sassari, Dipartimento Med Clin & Sperimentale, Sassari, Italy; [Dore, Maria Pina] Baylor Coll Med, Houston, TX 77030 USA; [Pes, Giovanni Mario] Ist Nazl Biostrutture & Biosistemi, Sassari, Italy	University of Sassari; Baylor College of Medicine	Pes, GM (corresponding author), Univ Sassari, Dipartimento Med Clin & Sperimentale, Sassari, Italy.; Pes, GM (corresponding author), Ist Nazl Biostrutture & Biosistemi, Sassari, Italy.	gmpes@uniss.it	DORE, Maria Pina/AAV-7918-2021; Pes, Giovanni Mario/AAH-3340-2019; Dore, Maria P/K-8391-2012	DORE, Maria Pina/0000-0001-7305-3531; Pes, Giovanni Mario/0000-0003-3265-2823; 				Agudelo-Florez P, 2004, AM J HEMATOL, V75, P151, DOI 10.1002/ajh.10477; Algood HMS, 2006, CLIN MICROBIOL REV, V19, P597, DOI 10.1128/CMR.00006-06; Allen LAH, 2005, J IMMUNOL, V174, P3658, DOI 10.4049/jimmunol.174.6.3658; BAEHNER RL, 1980, PEDIATR CLIN N AM, V27, P377; BAEHNER RL, 1972, J RETICULOENDOTH SOC, V12, P150; Batetta B, 1999, CANCER LETT, V140, P53, DOI 10.1016/S0304-3835(99)00052-X; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; Blanchard TG, 2003, J INFECT DIS, V187, P1609, DOI 10.1086/374780; CLARK M, 1979, YALE J BIOL MED, V52, P169; COOPER MR, 1972, J CLIN INVEST, V51, P769, DOI 10.1172/JCI106871; Dore MP, 2015, INTERN EMERG MED, V10, P787, DOI 10.1007/s11739-015-1218-4; Dore MP, 2002, CLIN INFECT DIS, V35, P240, DOI 10.1086/341415; Felix K, 2002, FREE RADICAL BIO MED, V32, P663, DOI 10.1016/S0891-5849(02)00756-6; FEO F, 1987, INT J CANCER, V39, P560, DOI 10.1002/ijc.2910390504; Fiorelli G, 1990, Gene Geogr, V4, P139; GRAHAM DY, 1991, DIGEST DIS SCI, V36, P1084, DOI 10.1007/BF01297451; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; Ho HY, 2014, FREE RADICAL RES, V48, P1028, DOI 10.3109/10715762.2014.913788; Ho HY, 2000, FREE RADICAL BIO MED, V29, P156, DOI 10.1016/S0891-5849(00)00331-2; Hsieh YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079566; Kikuchi S, 2005, HELICOBACTER, V10, P1, DOI 10.1111/j.1523-5378.2005.00335.x; Luzzatto L, 2001, SCIENCE, V293, P442, DOI 10.1126/science.1063292; Luzzatto L, 2001, HEMATOLOGYONCOLOGY C, P4517, DOI [DOI 10.1016/J.HOC.2015.11.006, 10.1016/j.hoc.2015.11.006]; MALATY HM, 1994, GUT, V35, P742, DOI 10.1136/gut.35.6.742; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; PASCALE R, 1990, RES COMMUN CHEM PATH, V69, P361; RINALDI A, 1976, AM J HUM GENET, V28, P496; Sanna E, 1997, ADAPTATION MALARIA I, P293; Sanna F, 2007, J VASC RES, V44, P253, DOI 10.1159/000100903; SINISCALCO M, 1961, NATURE, V190, P1179, DOI 10.1038/1901179a0; SZABO P, 1984, P NATL ACAD SCI-BIOL, V81, P7855, DOI 10.1073/pnas.81.24.7855; Tsai KJ, 1998, FEBS LETT, V436, P411, DOI 10.1016/S0014-5793(98)01174-0; Vives CJ, 1982, BLOOD, V59, P428; Wolach B, 2004, PEDIATR RES, V55, P807, DOI 10.1203/01.PDR.0000120680.47846.47	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160032	10.1371/journal.pone.0160032	http://dx.doi.org/10.1371/journal.pone.0160032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467818	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100092
J	Ning, HC; Lin, CN; Chiu, DTY; Chang, YT; Wen, CN; Peng, SY; Chu, TL; Yu, HM; Wu, TL				Ning, Hsiao-Chen; Lin, Chia-Ni; Chiu, Daniel Tsun-Yee; Chang, Yung-Ta; Wen, Chiao-Ni; Peng, Shu-Yu; Chu, Tsung-Lan; Yu, Hsin-Ming; Wu, Tsu-Lan			Reduction in Hospital-Wide Clinical Laboratory Specimen Identification Errors following Process Interventions: A 10-Year Retrospective Observational Study	PLOS ONE			English	Article							Q-PROBES ANALYSIS; LABELING ERRORS; PATIENT SAFETY; WRONG BLOOD; SYSTEM; IMPLEMENTATION; REJECTION; PATHOLOGY; TUBE	Background Accurate patient identification and specimen labeling at the time of collection are crucial steps in the prevention of medical errors, thereby improving patient safety. Methods All patient specimen identification errors that occurred in the outpatient department (OPD), emergency department (ED), and inpatient department (IPD) of a 3,800-bed academic medical center in Taiwan were documented and analyzed retrospectively from 2005 to 2014. To reduce such errors, the following series of strategies were implemented: a restrictive specimen acceptance policy for the ED and IPD in 2006; a computer-assisted barcode positive patient identification system for the ED and IPD in 2007 and 2010, and automated sample labeling combined with electronic identification systems introduced to the OPD in 2009. Results Of the 2000345 specimens collected in 2005, 1023 (0.0511%) were identified as having patient identification errors, compared with 58 errors (0.0015%) among 3761238 specimens collected in 2014, after serial interventions; this represents a 97% relative reduction. The total number (rate) of institutional identification errors contributed from the ED, IPD, and OPD over a 10-year period were 423 (0.1058%), 556 (0.0587%), and 44 (0.0067%) errors before the interventions, and 3 (0.0007%), 52 (0.0045%) and 3 (0.0001%) after interventions, representing relative 99%, 92% and 98% reductions, respectively. Conclusions Accurate patient identification is a challenge of patient safety in different health settings. The data collected in our study indicate that a restrictive specimen acceptance policy, computer-generated positive identification systems, and interdisciplinary cooperation can significantly reduce patient identification errors.	[Ning, Hsiao-Chen; Lin, Chia-Ni; Chiu, Daniel Tsun-Yee; Chang, Yung-Ta; Wen, Chiao-Ni; Peng, Shu-Yu] Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Ning, Hsiao-Chen; Lin, Chia-Ni; Chiu, Daniel Tsun-Yee; Chang, Yung-Ta; Wen, Chiao-Ni; Peng, Shu-Yu; Wu, Tsu-Lan] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Chu, Tsung-Lan] Linkou Chang Gung Mem Hosp, Dept Nursing, Taoyuan, Taiwan; [Chu, Tsung-Lan] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [Yu, Hsin-Ming] Chang Gung Med Fdn, Dept Management Informat Syst, Taipei, Taiwan; [Wu, Tsu-Lan] Chang Gung Med Fdn, Dept Med Labs Adm Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, CN (corresponding author), Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan.	chianilin@cgmh.org.tw						Askeland RW, 2008, TRANSFUSION, V48, P1308, DOI 10.1111/j.1537-2995.2008.01668.x; Astion M., 2004, ERROR REDUCTION RISK; Atay A, 2014, BIOCHEM MEDICA, V24, P376, DOI 10.11613/BM.2014.040; Bolton-Maggs PHB, 2015, BRIT J HAEMATOL, V168, P3, DOI 10.1111/bjh.13137; Bonini P, 2002, CLIN CHEM, V48, P691; Brown JE, 2011, J NURS CARE QUAL, V26, P13, DOI 10.1097/NCQ.0b013e3181e4e6dd; Clinical and Laboratory Standards Institute (CLSI), 2010, GP33A CLSI; College of American Pathologists, ROS IS NOT ROS PROBL; Da Rin G, 2009, CLIN CHIM ACTA, V404, P68, DOI 10.1016/j.cca.2009.03.024; Dhatt GS, 2011, CLIN CHEM LAB MED, V49, P927, DOI 10.1515/CCLM.2011.129; Dock Bobbi, 2005, Clin Lab Sci, V18, P210; Galvin L, 2007, CIN-COMPUT INFORM NU, V25, P86, DOI 10.1097/01.NCN.0000263978.54048.cc; Grimm E, 2010, ARCH PATHOL LAB MED, V134, P1108, DOI 10.1043/2009-0674-CP.1; Hawker CD, 2014, CLIN CHEM, V60, P463, DOI 10.1373/clinchem.2013.215434; Hayden RT, 2008, J PEDIATR-US, V152, P219, DOI 10.1016/j.jpeds.2007.08.021; Hill PM, 2010, ANN EMERG MED, V56, P630, DOI 10.1016/j.annemergmed.2010.05.028; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Lippi G, 2006, CLIN LAB, V52, P217; Lippi G, 2011, CLIN CHEM LAB MED, V49, P1921, DOI 10.1515/CCLM.2011.736; Lippi G, 2009, CLIN CHEM LAB MED, V47, P143, DOI 10.1515/CCLM.2009.045; Morrison AP, 2010, AM J CLIN PATHOL, V133, P870, DOI 10.1309/AJCPC95YYMSLLRCX; Plebani M, 1997, CLIN CHEM, V43, P1348; Plebani M, 2006, CLIN CHEM LAB MED, V44, P750, DOI 10.1515/CCLM.2006.123; Snyder SR, 2012, CLIN BIOCHEM, V45, P988, DOI 10.1016/j.clinbiochem.2012.06.019; Stark A, 2007, ARCH PATHOL LAB MED, V131, P588; The Joint Commission International, INT PAT SAF GOALS; Valenstein PN, 2006, ARCH PATHOL LAB MED, V130, P1106; Valenstein PN, 2004, CLIN LAB MED, V24, P979, DOI 10.1016/j.cll.2004.05.013; Wagar EA, 2008, ARCH PATHOL LAB MED, V132, P1617, DOI 10.1043/1543-2165(2008)132[1617:SLEAQA]2.0.CO;2; Wagar EA, 2006, ARCH PATHOL LAB MED, V130, P1662; Wright AA, 2005, NEW ENGL J MED, V353, P329, DOI 10.1056/NEJMp058101; Zarbo RJ, 2009, AM J CLIN PATHOL, V131, P468, DOI 10.1309/AJCPPTJ3XJY6ZXDB	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160821	10.1371/journal.pone.0160821	http://dx.doi.org/10.1371/journal.pone.0160821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494020	Green Submitted, gold, Green Published			2022-12-27	WOS:000381369500085
J	Arias, P; Corral-Bergantinos, Y; Robles-Garcia, V; Madrid, A; Oliviero, A; Cudeiro, J				Arias, Pablo; Corral-Bergantinos, Yoanna; Robles-Garcia, Veronica; Madrid, Antonio; Oliviero, Antonio; Cudeiro, Javier			Bilateral tDCS on Primary Motor Cortex: Effects on Fast Arm Reaching Tasks	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; SPINAL NETWORK EXCITABILITY; HEALTHY-SUBJECTS; BRAIN-STIMULATION; CORTICAL STIMULATION; VOLUNTARY MOVEMENT; CHRONIC STROKE; HUMANS; INHIBITION	Background The effects produced by transcranial direct current stimulation (tDCS) applied to the motor system have been widely studied in the past, chiefly focused on primary motor cortex (M1) excitability. However, the effects on functional tasks are less well documented. Objective This study aims to evaluate the effect of tDCS-M1 on goal-oriented actions (i.e., arm-reaching movements; ARM), in a reaction-time protocol. Methods 13 healthy subjects executed dominant ARM as fast as possible to one of two targets in front of them while surface EMG was recorded. Participants performed three different sessions. In each session they first executed ARM (Pre), then received tDCS, and finally executed Post, similar to Pre. Subjects received three different types of tDCS, one per session: In one session the anode was on right-M1 (AR), and the cathode on the left-M1 (CL), thus termed AR-CL; AL-CR reversed the montage; and Sham session was applied likewise. Real stimulation was 1mA-10min while subjects at rest. Three different variables and their coefficients of variation (CV) were analyzed: Premotor times (PMT), reaction-times (RT) and movement-times (MT). Results triceps-PMT were significantly increased at Post-Sham, suggesting fatigue. Results obtained with real tDCS were not different depending on the montage used, in both cases PMT were significantly reduced in all recorded muscles. RT and MT did not change for real or sham stimulation. RT-CV and PMT-CV were reduced after all stimulation protocols. Conclusion tDCS reduces premotor time and fatigability during the execution of fast motor tasks. Possible underlying mechanisms are discussed.	[Arias, Pablo; Corral-Bergantinos, Yoanna; Robles-Garcia, Veronica; Madrid, Antonio; Cudeiro, Javier] Univ A Coruna, INEF Galicia, Dept Med, Neurosci & Motor Control Grp NEUROcom, La Coruna, Spain; [Arias, Pablo; Corral-Bergantinos, Yoanna; Robles-Garcia, Veronica; Madrid, Antonio; Cudeiro, Javier] Univ A Coruna, Biomed Res Inst A Coruna INIBIC, Dept Med, Neurosci & Motor Control Grp NEUROcom, La Coruna, Spain; [Oliviero, Antonio] SESCAM, Hosp Nacl Paraplej, FENNSI Grp, Toledo, Spain; [Cudeiro, Javier] Ctr Estimulac Cerebral Galicia, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Hospital Nacional de Paraplejicos	Arias, P (corresponding author), Univ A Coruna, INEF Galicia, Dept Med, Neurosci & Motor Control Grp NEUROcom, La Coruna, Spain.	pabloarias.neurocom@udc.es	Arias, Pablo/C-7926-2015; Oliviero, Antonio/ABH-4485-2020; Madrid, Antonio/AAS-5777-2020; Arias, Pablo/AAP-9721-2021	Oliviero, Antonio/0000-0001-7723-0478; Madrid, Antonio/0000-0001-8564-6502; Arias, Pablo/0000-0002-9029-5310	Xunta de Galicia, Ayudas Grupos Consolidados (Conselleria de Educacion), Spain; FPU-MECD Spain [AP2010-2774, AP2010-2775]	Xunta de Galicia, Ayudas Grupos Consolidados (Conselleria de Educacion), Spain(Xunta de Galicia); FPU-MECD Spain	This work was supported by Xunta de Galicia, Ayudas Grupos Consolidados (Conselleria de Educacion, 2014), Spain. VRG and YCB are granted by FPU-MECD AP2010-2774 and AP2010-2775 Spain.	Andrews RK, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-51; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Cantello R, 2011, CLIN NEUROPHYSIOL, V122, P1622, DOI 10.1016/j.clinph.2011.01.008; Cengiz B, 2013, EXP BRAIN RES, V225, P321, DOI 10.1007/s00221-012-3369-0; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; COLEBATCH JG, 1989, BRAIN, V112, P749, DOI 10.1093/brain/112.3.749; d'Avella A, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00042; Dean C, 1999, GAIT POSTURE, V10, P135, DOI 10.1016/S0966-6362(99)00026-0; Derakhshan I, 2003, NEUROL RES, V25, P538, DOI 10.1179/016164103101201797; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; EICHENBERGER A, 1984, J PHYSIOL-LONDON, V347, P545, DOI 10.1113/jphysiol.1984.sp015082; Faber LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048073; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; FLANDERS M, 1991, J NEUROSCI, V11, P2680; Flanders M, 1996, EXP BRAIN RES, V110, P67; FRANK JS, 1986, ELECTROEN CLIN NEURO, V63, P361, DOI 10.1016/0013-4694(86)90021-0; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; GEORGOPOULOS AP, 1995, TRENDS NEUROSCI, V18, P506, DOI 10.1016/0166-2236(95)92775-L; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Glover S, 2012, EUR J NEUROSCI, V35, P909, DOI 10.1111/j.1460-9568.2012.08018.x; Gorsler A, 2003, CLIN NEUROPHYSIOL, V114, P1800, DOI 10.1016/S1388-2457(03)00157-3; Goto K, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3658757; GOTTSDANKER R, 1985, J EXP PSYCHOL HUMAN, V11, P765, DOI 10.1037/0096-1523.11.6.765; Hanakawa T, 2011, NEUROSCI RES, V70, P144, DOI 10.1016/j.neures.2011.02.010; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KALASKA JF, 1983, EXP BRAIN RES, V51, P247; Katsuki F, 2014, EUR J NEUROSCI; Kidgell DJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-64; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Lindenberg R, 2010, NEUROLOGY, V75, P2176, DOI 10.1212/WNL.0b013e318202013a; Lomond KV, 2010, EXP BRAIN RES, V206, P271, DOI 10.1007/s00221-010-2405-1; Marquez J, 2015, RESTOR NEUROL NEUROS, V33, P509, DOI 10.3233/RNN-140490; Mattia M, 2012, Front Neuroeng, V5, P12, DOI 10.3389/fneng.2012.00012; Mattia M, 2013, J NEUROSCI, V33, P11155, DOI 10.1523/JNEUROSCI.4664-12.2013; MELLAH S, 1990, EXP BRAIN RES, V82, P178; Mirabella G, 2012, CEREB CORTEX, V22, P1124, DOI 10.1093/cercor/bhr187; Mirabella G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00206; Mirabella G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062793; Mirabella G, 2008, COGN NEUROPSYCHOL, V25, P996, DOI 10.1080/02643290802003216; Mordillo-Mateos L, 2012, BRAIN STIMUL, V5, P214, DOI 10.1016/j.brs.2011.05.001; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; NETZ J, 1995, EXP BRAIN RES, V104, P527; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reynolds C, 1999, NEUROLOGY, V53, P730, DOI 10.1212/WNL.53.4.730; RIEDO R, 1988, J PHYSIOL-LONDON, V397, P371, DOI 10.1113/jphysiol.1988.sp017006; Roche N, 2011, J PHYSIOL-LONDON, V589, P2813, DOI 10.1113/jphysiol.2011.205161; Roche N, 2009, J PHYSIOL-LONDON, V587, P5653, DOI 10.1113/jphysiol.2009.177550; Saiote C, 2014, RESTOR NEUROL NEUROS, V32, P423, DOI 10.3233/RNN-130372; Schieppati M, 1996, J PHYSIOL-LONDON, V491, P551, DOI 10.1113/jphysiol.1996.sp021239; Schlaug G, 2008, ARCH NEUROL-CHICAGO, V65, P1571, DOI 10.1001/archneur.65.12.1571; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Strigaro G, 2015, J PHYSIOL-LONDON, V593, P2365, DOI 10.1113/JP270135; Tanaka M, 2014, BRAIN RES, V1561, P60, DOI 10.1016/j.brainres.2014.03.009; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Vicario CM, 2013, NEUROSCIENCE, V245, P121, DOI 10.1016/j.neuroscience.2013.04.041; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Waters-Metenier S, 2014, J NEUROSCI, V34, P1037, DOI 10.1523/JNEUROSCI.2282-13.2014; Zhang J, 1997, J NEUROSCI, V17, P2227; Ziemann U, 1999, J PHYSIOL-LONDON, V518, P895, DOI 10.1111/j.1469-7793.1999.0895p.x	72	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160063	10.1371/journal.pone.0160063	http://dx.doi.org/10.1371/journal.pone.0160063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490752	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900030
J	Cao, HJ; Mu, YJ; Li, X; Wang, YY; Chen, S; Liu, JP				Cao, Huijuan; Mu, Yujie; Li, Xun; Wang, Yuyi; Chen, Shiuan; Liu, Jian-ping			A Systematic Review of Randomized Controlled Trials on Oral Chinese Herbal Medicine for Prostate Cancer	PLOS ONE			English	Review							MULTICENTER; GUIDELINES	Background Prostate cancer is the most common malignant tumor associated with male reproductive system. Objective The existing eligible randomized controlled trials (RCTs) were critically appraised for the safety and effectiveness of CHM for prostate cancer. Methods A literature search was conducted by using PubMed, CENTRAL, CNKI, CBM, VIP and Wanfang databases until August 2015. RCTs of CHM or CHM plus conventional medicine for prostate cancer patients were included. The primary outcomes appraised were survival time, time to progression and quality of life. The risk of bias assessment according to the Cochrane Handbook was used to evaluate the methodological quality of the included trials. Revman 5.3 software was used for data analyses. Risk ratio and mean difference (MD) with a 95% confidence interval (CI) were used as effect measures. Meta-analysis was to be used if sufficient trials without obvious clinical or statistical heterogeneity were available. Results A total of 17 RCTs involving 1224 participants were analyzed. One trial was about CHM comparing to no treatment. The remaining 16 trials used CHMs as adjunctive treatment for endocrine therapy. Due to the poor quality of methodologies of most trials, only limited evidence showed that a combination of CHM and endocrine therapy might be more effective in restraining the development of the disease (MD 10.37 months, 95% CI 9.10 to 11.63 months), increasing patients' survival time (7-15 months) or improving patients' performance status, when compared to endocrine therapy alone (Karnofsky performance scale average changed 15 scores between groups). No severe adverse event was reported related to CHM. Conclusion Due to the insufficient quality of trials that were analyzed, it is not appropriate to recommend any kind of CHMs in treating prostate cancer at the present time. Well-designed trials with high methodological quality are needed to validate the effect of CHMs for patients with prostate cancer.	[Cao, Huijuan; Li, Xun; Liu, Jian-ping] Beijing Univ Chinese Med, Beijing, Peoples R China; [Mu, Yujie] Beijing Aerosp Gen Hosp, Beijing, Peoples R China; [Wang, Yuyi] Chongqing Tradit Chinese Hosp, Chongqing, Peoples R China; [Chen, Shiuan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA USA	Beijing University of Chinese Medicine; City of Hope; Beckman Research Institute of City of Hope	Liu, JP (corresponding author), Beijing Univ Chinese Med, Beijing, Peoples R China.	Liujp@bucm.edu.cn		Li, Xun/0000-0002-3513-5904; Liu, Jianping/0000-0002-0320-061X	State Administration of Traditional Chinese Medicine [201207012]; Beijing Municipal Organization Department talents project [2015000020124G083]; Beijing University of Chinese Medicine [2015-JYB-JSMS037]	State Administration of Traditional Chinese Medicine; Beijing Municipal Organization Department talents project; Beijing University of Chinese Medicine	Jian-Ping Liu is supported by the Research Capacity Establishment Grant (No. 201207012) from the State Administration of Traditional Chinese Medicine. Hui-Juan Cao is supported by the Beijing Municipal Organization Department talents project (Grant No. 2015000020124G083) and the Research Capacity Establishment Grant (No. 2015-JYB-JSMS037) from the Beijing University of Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jian-Ping Liu is supported by the Research Capacity Establishment Grant ( No. 201207012) from the State Administration of Traditional Chinese Medicine. Huijuan Cao is supported by the Beijing Municipal Organization Department talents project(Grant No. 2015000020124G083) and the Research Capacity Establishment Grant (No. 2015-JYB-JSMS037) from the Beijing University of Chinese Medicine.	BRENDLER C B, 1988, Keio Journal of Medicine, V37, P10; Chen YY, 2007, SCI TECHNOLOGY INFOR, P194; Chen ZF., 2013, JILIN J MED, V34, P4450; Dong SM., 2007, CHIN J CLIN MED RES, V13, P533; Gu ZM, 2007, J GUANGDONG COLL PHA, P92; Guns E S, 2002, Can J Urol, V9, P1684; Guo W. H., 2010, THESIS; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu F.F., 2006, THESIS; Huang GJ, 2010, JIANGSU J TRADITIONA, P18; Huang GQ, 2014, MED FORUM, V18, P1; Jia Ying-Jie, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P448; Klempner SJ, 2012, ONCOLOGIST, V17, P830, DOI 10.1634/theoncologist.2012-0094; Liu H., 2012, CHIN J INF TRADIT CH, V19, P61; Liu SJ, 2012, INFORM TRADITIONAL C, P50; Lu J. X., 2012, THESIS; Oh WK, 2004, J CLIN ONCOL, V22, P3705, DOI 10.1200/JCO.2004.10.195; Pang R, 2013, J SURG INTEGRATIVE T, V19, P374; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng Y, 2010, CHINESE J ANDROLOGY, P53; Peng Y, 2010, CHINESE J ANDROLOGY, P44; Peyromaure M, 2005, J UROLOGY, V174, P1794, DOI 10.1097/01.ju.0000176817.46279.93; Schmitt B, 1999, COCHRANE DB SYST REV, DOI 001510.001002/14651858; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Tang JW, 2014, FORUM TRADITIONAL CH, V29, P15; Twardowski P, 2015, CANCER-AM CANCER SOC, V121, P2942, DOI 10.1002/cncr.29421; Wang Q, 2011, SHIYONG YIYAO ZAZHI, V51, P69; Wang Q., 2009, THESIS; [王宇翎 Wang Yuling], 2005, [中国药理学通报, Chinese Pharmacological Bulletin], V21, P444; Woolam GL, 2000, CA-CANCER J CLIN, V50, P6, DOI 10.3322/canjclin.50.1.6; Yang L, 2015, CHINESE J CANCER RES, V27, P13, DOI 10.3978/j.issn.1000-9604.2015.01.07; Zhang P, 2014, JIANGSU J TRADITIONA, V46, P39; Zheng W., 2014, THESIS; Zhou H, 2013, J SICHUAN TRADITIONA, V31, P95	36	12	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160253	10.1371/journal.pone.0160253	http://dx.doi.org/10.1371/journal.pone.0160253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490098	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900042
J	Comar, JF; de Oliveira, DS; Bracht, L; Kemmelmeier, FS; Peralta, RM; Bracht, A				Comar, Jurandir Fernando; de Oliveira, Denise Silva; Bracht, Livia; Kemmelmeier, Fumie Suzuki; Peralta, Rosane Marina; Bracht, Adelar			The Metabolic Responses to L-Glutamine of Livers from Rats with Diabetes Types 1 and 2	PLOS ONE			English	Article							PHOSPHATE-DEPENDENT GLUTAMINASE; GLUCAGON-LIKE PEPTIDE-1; INSULIN SENSITIVITY; ALANINE METABOLISM; PERFUSED LIVER; AMINO-ACIDS; STREPTOZOTOCIN; GLUCONEOGENESIS; AMMONIA; GLUCOSE	There are several claims about the beneficial effects of supplementing L-glutamine to both type 1 and type 2 diabetes. The purpose of the present study was to provide detailed knowledge about the fate of this amino acid in the liver, the first organ that receives the compound when ingested orally. The study was done using the isolated perfused rat liver, an experimental system that preserves the microcirculation of the organ and that allows to measured several parameters during steady-state and pre steady-state conditions. L-Glutamine was infused in the portal vein (5 mM) and several parameters were monitored. Livers from type 1 diabetic rats showed an accelerated response to L-glutamine infusion. In consequence of this accelerated response livers from type 1 diabetic rats presented higher rates of ammonia, urea, glucose and lactate output during the first 25-30 minutes following L-glutamine infusion. As steady-state conditions approached, however, the difference between type 1 diabetes and control livers tended to disappear. Measurement of the glycogen content over a period of 100 minutes revealed that, excepting the initial phase of the L-glutamine infusion, the increased glucose output in livers from type 1 diabetic rats was mainly due to accelerated glycogenolysis. Livers from type 2 diabetic rats behaved similarly to control livers with no accelerated glucose output but with increased L-alanine production. L-Alanine is important for the pancreatic beta-cells and from this point of view the oral intake of L-glutamine can be regarded as beneficial. Furthermore, the lack of increased glucose output in livers from type 2 diabetic rats is consistent with observations that even daily L-glutamine doses of 30 g do not increase the glycemic levels in well controlled type 2 diabetes patients.	[Comar, Jurandir Fernando; de Oliveira, Denise Silva; Bracht, Livia; Kemmelmeier, Fumie Suzuki; Peralta, Rosane Marina; Bracht, Adelar] Univ Maringa, Lab Liver Metab, BR-87020900 Maringa, Parana, Brazil		Bracht, A (corresponding author), Univ Maringa, Lab Liver Metab, BR-87020900 Maringa, Parana, Brazil.	adebracht@uol.com.br	PERALTA, ROSANE MARINA/J-3912-2016; Comar, Jurandir F./I-7285-2013; Comar, Jurandir Fernando/D-8160-2019; Bracht, Adelar/A-9700-2011	PERALTA, ROSANE MARINA/0000-0001-5749-0723; Comar, Jurandir Fernando/0000-0002-9518-7589; 	CNPq [302615/2001-3]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the CNPq grant n. 302615/2001-3 to AB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto LS, 2000, RES COMMUN MOL PATH, V107, P65; Bakalar B, 2006, CRIT CARE MED, V34, P381, DOI 10.1097/01.CCM.0000196829.30741.D4; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P1205; Bernt E., 1974, METHODS ENZYMATIC AN, P1704, DOI [10.1016/B978-0-12-091304-6.50017-3, DOI 10.1016/B978-0-12-091304-6.50017-3]; Botini FF, 2005, LIVER INT, V25, P861, DOI 10.1111/j.1478-3231.2005.01093.x; BROSNAN JT, 1983, AM J PHYSIOL, V244, pE151, DOI 10.1152/ajpendo.1983.244.2.E151; Carvalho-Martini, 2010, HEALTH, V2, P477; Chang JC, 2005, HORM METAB RES, V37, P610, DOI 10.1055/s-2005-870528; CLARK LC, 1956, T AM SOC ART INT ORG, V2, P41; Comar JF, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-1; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; DELPRATO S, 1980, ACTA DIABETOL LAT, V17, P111, DOI 10.1007/BF02580992; Dixon G, 2003, J ENDOCRINOL, V179, P447, DOI 10.1677/joe.0.1790447; Donatelli M, 1992, DIABETES RES, V20, P212; Ferraz M, 1997, RES COMMUN MOL PATH, V95, P147; Gannon MC, 1997, DIABETOLOGIA, V40, P758, DOI 10.1007/s001250050746; Garcia RF, 2007, AMINO ACIDS, V33, P151, DOI 10.1007/s00726-006-0397-8; GIROIX MH, 1984, DIABETES METAB, V10, P12; Goyal BR, 2011, PHARMACOL REP, V63, P956, DOI 10.1016/S1734-1140(11)70611-9; Greenfield JR, 2009, AM J CLIN NUTR, V89, P106, DOI 10.3945/ajcn.2008.26362; Gutmann J, 1974, METHOD ENZYMAT AN, P1794; Gutmann J, 1974, METHOD ENZYMAT AN; HAUSSINGER D, 1983, EUR J BIOCHEM, V133, P269, DOI 10.1111/j.1432-1033.1983.tb07458.x; Kashinath RT, 2014, GLOB J MED RES, V14, P1; Kearney EB, 1974, METHOD ENZYMAT AN; KEPLER D, 1974, METHOD ENZYMAT AN, P1126; KLECKNER NW, 1987, BIOCHEM J, V246, P417, DOI 10.1042/bj2460417; Krause MD, 2008, CELL BIOCHEM FUNCT, V26, P406, DOI 10.1002/cbf.1470; Labow BI, 2001, J NUTR, V131, p2467S, DOI 10.1093/jn/131.9.2467S; LACEY JH, 1981, BIOCHEM J, V194, P29, DOI 10.1042/bj1940029; LOW SY, 1993, BIOCHEM J, V295, P617, DOI 10.1042/bj2950617; LOW SY, 1992, BIOCHEM J, V284, P333, DOI 10.1042/bj2840333; Masola B, 2010, ARCH BIOCHEM BIOPHYS, V504, P197, DOI 10.1016/j.abb.2010.09.002; Mauras N, 2010, DIABETES CARE, V33, P1951, DOI 10.2337/dc10-0275; MCGIVAN J, 1985, EUR J BIOCHEM, V148, P323, DOI 10.1111/j.1432-1033.1985.tb08842.x; Molfino A, 2010, NUTR THER METAB, V28, P7; Newsholme P, 2006, DIABETES, V55, pS39, DOI 10.2337/db06-S006; Patil MA, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/463264; Pereira SRC, 2004, BBA-MOL BASIS DIS, V1688, P187, DOI 10.1016/j.bbadis.2003.12.001; PORTHA B, 1974, DIABETES, V23, P889, DOI 10.2337/diab.23.11.889; Rosa CV, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0143005, DOI 10.1371/JOURNAL.PONE.0143005]; Samocha-Bonet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113366; Samocha-Bonet D, 2011, J NUTR, V141, P1233, DOI 10.3945/jn.111.139824; SCHOLZ ROLAND, 1965, P393; Silva de Oliveira D, 2007, BRAZ ARCH BIOL TECHN, V50, P785, DOI 10.1590/S1516-89132007000500006; Souza HM, 2011, RES COMMUN MOL PATH, V110, P264; Squires SA, 1997, DIABETES, V46, P1945, DOI 10.2337/diabetes.46.12.1945; Stumvoll M, 1996, DIABETES, V45, P863, DOI 10.2337/diabetes.45.7.863; VERHOEVEN AJ, 1983, EUR J BIOCHEM, V133, P241, DOI 10.1111/j.1432-1033.1983.tb07454.x; WAGLE SR, 1975, ACTA DIABETOL LAT, V12, P185, DOI 10.1007/BF02581299; Watford M, 2002, NUTRITION, V18, P301, DOI 10.1016/S0899-9007(02)00739-6; WATFORD M, 1984, BIOCHEM J, V224, P207, DOI 10.1042/bj2240207; Watford M, 2000, J NUTR, V130, p983S, DOI 10.1093/jn/130.4.983S; WIDMAIER EP, 1991, REGUL PEPTIDES, V34, P235, DOI 10.1016/0167-0115(91)90182-G; WILLIAMSON DH, 1974, METHOD ENZYMAT AN, P1679; ZALESKI J, 1978, BIOCHEM J, V176, P563, DOI 10.1042/bj1760563; Zwiebel FM, 1990, THESIS	57	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160067	10.1371/journal.pone.0160067	http://dx.doi.org/10.1371/journal.pone.0160067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490892	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900031
J	Ngo, MH; Borowska-Fielding, J; Heathcote, G; Nejat, S; Kelly, ME; McMaster, CR; Robitaille, JM				Ngo, Michael H.; Borowska-Fielding, Joanna; Heathcote, Godfrey; Nejat, Sara; Kelly, Melanie E.; McMaster, Christopher R.; Robitaille, Johane M.			Fzd4 Haploinsufficiency Delays Retinal Revascularization in the Mouse Model of Oxygen Induced Retinopathy	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; NORRIE-DISEASE GENE; FLUORESCEIN-ANGIOGRAPHIC-FINDINGS; INTRAVITREAL BEVACIZUMAB; VASCULAR DEVELOPMENT; VISUAL-ACUITY; KIF11 MUTATIONS; FRIZZLED-4 GENE; CANDIDATE GENE; PREMATURITY	Mutations in genes that code for components of the Norrin-FZD4 ligand-receptor complex cause the inherited childhood blinding disorder familial exudative vitreoretinopathy (FEVR). Statistical evidence from studies of patients at risk for the acquired disease retinopathy of prematurity (ROP) suggest that rare polymorphisms in these same genes increase the risk of developing severe ROP, implying that decreased Norrin-FZD4 activity predisposes patients to more severe ROP. To test this hypothesis, we measured the development and recovery of retinopathy in wild type and Fzd4 heterozygous mice in the absence or presence of ocular ischemic retinopathy (OIR) treatment. Avascular and total retinal vascular areas and patterning were determined, and vessel number and caliber were quantified. In room air, there was a small delay in retinal vascularization in Fzd4 heterozygous mice that resolved as mice reached maturity suggestive of a slight defect in retinal vascular development. Subsequent to OIR treatment there was no difference between wild type and Fzd4 heterozygous mice in the vaso-obliterated area following exposure to high oxygen. Importantly, after return of Fzd4 heterozygous mice to room air subsequent to OIR treatment, there was a substantial delay in retinal revascularization of the avascular area surrounding the optic nerve, as well as delayed vascularization toward the periphery of the retina. Our study demonstrates that a small decrease in Norrin-Fzd4 dependent retinal vascular development lengthens the period during which complications from OIR could occur.	[Ngo, Michael H.; Borowska-Fielding, Joanna; Kelly, Melanie E.; McMaster, Christopher R.] Dalhousie Univ, Dept Pharmacol, Halifax, NS, Canada; [Heathcote, Godfrey; Robitaille, Johane M.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Heathcote, Godfrey; Kelly, Melanie E.; Robitaille, Johane M.] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Heathcote, Godfrey; Kelly, Melanie E.; Robitaille, Johane M.] IWK Hlth Ctr, Halifax, NS, Canada; [Nejat, Sara] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; McMaster University	Robitaille, JM (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.; Robitaille, JM (corresponding author), Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada.; Robitaille, JM (corresponding author), IWK Hlth Ctr, Halifax, NS, Canada.	jrobitai@dal.ca		McMaster, Christopher/0000-0003-0822-5776	Genome Canada; Nova Scotia Research and Innovation Trust; Dalhousie Medical Research Foundation; Canadian Institutes for Health Research; IWK Health Centre; Capital Health Research Fund, Innovacorp; Genome Atlantic	Genome Canada(Genome Canada); Nova Scotia Research and Innovation Trust; Dalhousie Medical Research Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); IWK Health Centre; Capital Health Research Fund, Innovacorp; Genome Atlantic	Funding support: Genome Canada, Genome Atlantic, the Nova Scotia Research and Innovation Trust, the Dalhousie Medical Research Foundation, the Canadian Institutes for Health Research, the IWK Health Centre and the Capital Health Research Fund, Innovacorp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CC, 2000, THE COCHRANE DATABAS, DOI [doi: 10.1002/ 14651858.CD001693, DOI 10.1002/14651858.CD001693]; Avery RL, 2012, J AAPOS, V16, P2, DOI 10.1016/j.jaapos.2011.11.002; BERGER W, 1992, HUM MOL GENET, V1, P461, DOI 10.1093/hmg/1.7.461; Blencowe H, 2013, PEDIATR RES, V74, P35, DOI 10.1038/pr.2013.205; CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; Chang-Godinich A, 1999, AM J OPHTHALMOL, V127, P469, DOI 10.1016/S0002-9394(99)00003-3; Chen J, 2013, ANGIOGENESIS, V16, P985, DOI 10.1007/s10456-013-9374-5; Chen W, 2014, J AAPOS, V18, P402, DOI 10.1016/j.jaapos.2014.03.011; CHEN ZY, 1992, NAT GENET, V1, P204, DOI 10.1038/ng0692-204; Collin RWJ, 2013, P NATL ACAD SCI USA, V110, P9856, DOI 10.1073/pnas.1220864110; Darlow BA, 2013, ARCH DIS CHILD-FETAL, V98, pF170, DOI 10.1136/archdischild-2011-301148; Dickinson JL, 2006, CLIN EXP OPHTHALMOL, V34, P682, DOI 10.1111/j.1442-9071.2006.01314.x; Ells A, 2010, OPHTHALMIC GENET, V31, P37, DOI 10.3109/13816810903479834; FLYNN JT, 1992, EYE, V6, P161, DOI 10.1038/eye.1992.32; Good WV, 2010, ARCH OPHTHALMOL-CHIC, V128, P663, DOI 10.1001/archophthalmol.2010.72; GOW J, 1971, ARCH OPHTHALMOL-CHIC, V86, P150, DOI 10.1001/archopht.1971.01000010152007; Haider MZ, 2002, J BIOMED SCI, V9, P365; Haider MZ, 2001, PEDIATR INT, V43, P120, DOI 10.1046/j.1442-200x.2001.01361.x; Henaine-Berra A, 2014, J AAPOS, V18, P120, DOI 10.1016/j.jaapos.2013.12.009; Hiraoka M, 2001, J HUM GENET, V46, P178, DOI 10.1007/s100380170085; Hiraoka M, 2010, MOL VIS, V16, P2572; Holmes JM, 1996, CURR EYE RES, V15, P403, DOI 10.3109/02713689608995831; Hu H, 2016, BRIT J OPHTHALMOL, V100, P278, DOI 10.1136/bjophthalmol-2015-306878; Hutcheson KA, 2005, MOL VIS, V11, P501; Ittiara S, 2013, J AAPOS, V17, P323, DOI 10.1016/j.jaapos.2013.01.004; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kondo H, 2013, MOL VIS, V19, P476; Kong LK, 2015, INVEST OPHTH VIS SCI, V56, P956, DOI 10.1167/iovs.14-15842; Lepore D, 2014, OPHTHALMOLOGY, V121, P2212, DOI 10.1016/j.ophtha.2014.05.015; MacDonald MLE, 2005, CLIN GENET, V67, P363, DOI 10.1111/j.1399-0004.2005.00408.x; Mehta Sonia, 2013, Retin Cases Brief Rep, V7, P206, DOI 10.1097/ICB.0b013e318285238e; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; NISHIMURA M, 1983, JPN J OPHTHALMOL, V27, P40; OBER RR, 1980, BRIT J OPHTHALMOL, V64, P112, DOI 10.1136/bjo.64.2.112; Ohlmann A, 2010, J NEUROSCI, V30, P183, DOI 10.1523/JNEUROSCI.3210-09.2010; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Qin MH, 2005, HUM MUTAT, V26, P104, DOI 10.1002/humu.20191; Quinn GE, 2011, ARCH OPHTHALMOL-CHIC, V129, P127, DOI 10.1001/archophthalmol.2010.360; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Robitaille JM, 2014, JAMA OPHTHALMOL, V132, P1393, DOI 10.1001/jamaophthalmol.2014.2814; Robitaille JM, 2011, BRIT J OPHTHALMOL, V95, P574, DOI 10.1136/bjo.2010.190116; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Shastry BS, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-69; Shastry BS, 1997, ARCH OPHTHALMOL-CHIC, V115, P651, DOI 10.1001/archopht.1997.01100150653015; Shubert A, 1997, GRAEF ARCH CLIN EXP, V235, P490, DOI 10.1007/BF00947005; Siatkowski RM, 2013, J AAPOS, V17, P129, DOI 10.1016/j.jaapos.2012.10.022; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Spandau U, 2013, ACTA OPHTHALMOL, V91, P170, DOI 10.1111/j.1755-3768.2011.02351.x; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tahija SG, 2014, BRIT J OPHTHALMOL, V98, P507, DOI 10.1136/bjophthalmol-2013-304109; Talks S J, 2001, J Med Genet, V38, pE46, DOI 10.1136/jmg.38.12.e46; Tokunaga CC, 2013, INVEST OPHTH VIS SCI, V54, P222, DOI 10.1167/iovs.12-10127; van Nouhuys C E, 1989, Fortschr Ophthalmol, V86, P221; Vanhaesebrouck S, 2009, PEDIATR RES, V65, P307, DOI 10.1203/PDR.0b013e3181973dc8; VANNOUHUYS CE, 1982, DOC OPHTHALMOL, V54, P1; VANNOUHUYS CE, 1991, AM J OPHTHALMOL, V111, P34, DOI 10.1016/S0002-9394(14)76893-X; Wallace DK, 2012, ARCH OPHTHALMOL-CHIC, V130, P1512, DOI [10.1001/archophthalmol.2012.2118, 10.1001/archopht.130.12.1510]; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	64	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0158320	10.1371/journal.pone.0158320	http://dx.doi.org/10.1371/journal.pone.0158320			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27489958	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900005
J	Avin, KG; Chen, NX; Organ, JM; Zarse, C; O'Neill, K; Conway, RG; Konrad, RJ; Bacallao, RL; Allen, MR; Moe, SM				Avin, Keith G.; Chen, Neal X.; Organ, Jason M.; Zarse, Chad; O'Neill, Kalisha; Conway, Richard G.; Konrad, Robert J.; Bacallao, Robert L.; Allen, Matthew R.; Moe, Sharon M.			Skeletal Muscle Regeneration and Oxidative Stress Are Altered in Chronic Kidney Disease	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM; NOX4 EXPRESSION; MESSENGER-RNA; SMOOTH-MUSCLE; MYOSTATIN; INFLAMMATION; MECHANISMS; SARCOPENIA; EXERCISE; OXIDASE	Skeletal muscle atrophy and impaired muscle function are associated with lower health-related quality of life, and greater disability and mortality risk in those with chronic kidney disease (CKD). However, the pathogenesis of skeletal dysfunction in CKD is unknown. We used a slow progressing, naturally occurring, CKD rat model (Cy/+rat) with hormonal abnormalities consistent with clinical presentations of CKD to study skeletal muscle signaling. The CKD rats demonstrated augmented skeletal muscle regeneration with higher activation and differentiation signals in muscle cells (i.e. lower Pax-7; higher MyoD and myogenin RNA expression). However, there was also higher expression of proteolytic markers (Atrogin-1 and MuRF-1) in CKD muscle relative to normal. CKD animals had higher indices of oxidative stress compared to normal, evident by elevated plasma levels of an oxidative stress marker, 8-hydroxy-2'-deoxyguanosine (8-OHdG), increased muscle expression of succinate dehydrogenase (SDH) and Nox4 and altered mitochondria morphology. Furthermore, we show significantly higher serum levels of myostatin and expression of myostatin in skeletal muscle of CKD animals compared to normal. Taken together, these data show aberrant regeneration and proteolytic signaling that is associated with oxidative stress and high levels of myostatin in the setting of CKD. These changes likely play a role in the compromised skeletal muscle function that exists in CKD.	[Avin, Keith G.] Indiana Univ, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Indianapolis, IN 46204 USA; [Avin, Keith G.; Chen, Neal X.; Zarse, Chad; O'Neill, Kalisha; Bacallao, Robert L.; Moe, Sharon M.] Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46202 USA; [Organ, Jason M.; Allen, Matthew R.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Conway, Richard G.; Konrad, Robert J.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Eli Lilly	Avin, KG (corresponding author), Indiana Univ, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Indianapolis, IN 46204 USA.; Avin, KG (corresponding author), Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46202 USA.	keigavin@iu.edu	Organ, Jason M./I-1548-2019	Organ, Jason M./0000-0001-8462-0271	National Institutes of Health [R01AR058005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK110429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01AR058005), http://www.nih.gov/.	Acharya S, 2013, PFLUG ARCH EUR J PHY, V465, P1181, DOI 10.1007/s00424-013-1241-0; Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Brown JH, 2005, J AM SOC NEPHROL, V16, P3517, DOI 10.1681/ASN.2005060601; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Cheung WW, 2012, AM J PHYSIOL-RENAL, V303, pF1315, DOI 10.1152/ajprenal.00341.2012; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Fried LF, 2006, J AM GERIATR SOC, V54, P750, DOI 10.1111/j.1532-5415.2006.00727.x; Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF92, DOI 10.1152/ajprenal.00184.2006; Gattone VH, 2009, J AM SOC NEPHROL, V20, P1527, DOI 10.1681/ASN.2008090927; GOLLNICK PD, 1991, ACTA PHYSIOL SCAND, V142, P135, DOI 10.1111/j.1748-1716.1991.tb09139.x; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Han DS, 2011, CLIN ENDOCRINOL, V75, P857, DOI 10.1111/j.1365-2265.2011.04120.x; Ju CR, 2012, RESP MED, V106, P102, DOI 10.1016/j.rmed.2011.07.016; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Moe SM, 2015, J BONE MINER RES, V30, P539, DOI 10.1002/jbmr.2372; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Moe SM, 2003, KIDNEY INT, V63, P1003, DOI 10.1046/j.1523-1755.2003.00820.x; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Nishikawa M, 2015, NEPHROL DIAL TRANSPL, V30, P934, DOI 10.1093/ndt/gfv103; Organ JM, 2016, NEPHROL DIAL TRANSPL, V31, P223, DOI 10.1093/ndt/gfv352; Pagels AA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-71; Pedone C, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.01.009; Peshavariya H, 2009, ANTIOXID REDOX SIGN, V11, P2399, DOI [10.1089/ars.2009.2579, 10.1089/ARS.2009.2579]; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Stack AG, 2005, CARDIOL CLIN, V23, P285, DOI 10.1016/j.ccl.2005.04.003; Steinbacher P, 2015, BIOMOLECULES, V5, P356, DOI 10.3390/biom5020356; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Suzuki N, 2007, J CLIN INVEST, V117, P2468, DOI 10.1172/JCI30654; Tong XY, 2010, CIRC RES, V107, P975, DOI 10.1161/CIRCRESAHA.110.221242; Turner NJ, 2012, CELL TISSUE RES, V347, P759, DOI 10.1007/s00441-011-1185-7; Verzola D, 2011, KIDNEY INT, V79, P773, DOI 10.1038/ki.2010.494; Wang H, 2009, CELL CYCLE, V8, P1833, DOI 10.4161/cc.8.12.8851; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B; Xia RH, 2003, AM J PHYSIOL-CELL PH, V285, pC215, DOI 10.1152/ajpcell.00034.2002; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571	47	43	43	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159411	10.1371/journal.pone.0159411	http://dx.doi.org/10.1371/journal.pone.0159411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486747	Green Published, gold			2022-12-27	WOS:000381367800029
J	Iwahashi, H; Yoshimura, N; Hashizume, H; Yamada, H; Oka, H; Matsudaira, K; Shinto, K; Ishimoto, Y; Nagata, K; Teraguchi, M; Kagotani, R; Muraki, S; Akune, T; Tanaka, S; Kawaguchi, H; Nakamura, K; Minamide, A; Nakagawa, Y; Yoshida, M				Iwahashi, Hiroki; Yoshimura, Noriko; Hashizume, Hiroshi; Yamada, Hiroshi; Oka, Hiroyuki; Matsudaira, Ko; Shinto, Kazunori; Ishimoto, Yuyu; Nagata, Keiji; Teraguchi, Masatoshi; Kagotani, Ryohei; Muraki, Shigeyuki; Akune, Toru; Tanaka, Sakae; Kawaguchi, Hiroshi; Nakamura, Kozo; Minamide, Akihito; Nakagawa, Yukihiro; Yoshida, Munehito			The Association between the Cross-Sectional Area of the Dural Sac and Low Back Pain in a Large Population: The Wakayama Spine Study	PLOS ONE			English	Article							RADIOGRAPHIC LUMBAR SPONDYLOSIS; QUALITY-OF-LIFE; DISC DEGENERATION; JAPANESE MEN; STENOSIS; PREVALENCE; COHORT; OSTEOARTHRITIS; DECOMPRESSION; SYMPTOMS	Objective The purpose of this study was to evaluate the relations between the degree of encroachment, measured as the cross-sectional area of the dural sac, and low back pain in a large population. Methods In this cross-sectional study, data from 802 participants (247 men, 555 women; mean age, 63.5 years) were analyzed. The measurement of the cross-sectional area of the dural sac from the level of L1/2 to L4/5 was taken using axial T2-weighted images. The minimum cross-sectional area was defined as the cross-sectional area of the dural sac at the most constricted level in the examined spine. Participants were divided into three groups according to minimum cross-sectional area measurement quartiles (less than the first quartile, between the first and third quartiles, and greater than the third quartile). A multivariate logistic regression analysis was used to estimate the association between the minimum cross-sectional area and the prevalence of low back pain. Results The mean minimum cross-sectional area was 117.3 mm(2) (men: 114.4 mm(2); women: 118.6 mm(2)). A logistic regression analysis adjusted for age, sex, body mass index, and other confounding factors, including disc degeneration, showed that a narrow minimum cross-sectional area (smaller than the first quartile) was significantly associated with low back pain (odds ratio, 1.78; 95% confidence interval, 1.13-2.80 compared to the wide minimum cross-sectional area group: minimum cross-sectional area greater than the third quartile measured). Conclusion This study showed that a narrow dural sac cross-sectional area was significantly associated with the presence of low back pain after adjustment for age, sex, and body mass index. Further investigations that include additional radiographic findings and psychological factors will continue to elucidate the causes of low back pain.	[Iwahashi, Hiroki; Hashizume, Hiroshi; Yamada, Hiroshi; Shinto, Kazunori; Ishimoto, Yuyu; Nagata, Keiji; Teraguchi, Masatoshi; Kagotani, Ryohei; Minamide, Akihito; Nakagawa, Yukihiro; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama, Wakayama 6418510, Japan; [Yoshimura, Noriko; Muraki, Shigeyuki] Univ Tokyo, Dept Joint Dis Res, Fac Med, 22nd Century Med & Res Ctr,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Akune, Toru; Nakamura, Kozo] Natl Rehabil Ctr Persons Disabil, Rehabil Serv Bur, 1 Namiki 4 Chome, Tokorozawa, Saitama 3598555, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan; [Kawaguchi, Hiroshi] Tokyo Shinjuku Med Ctr, Japan Community Hlth Care Org, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan	Wakayama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Hashizume, H (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, 811-1 Kimiidera, Wakayama, Wakayama 6418510, Japan.	hashizum@wakayama-med.ac.jp	Tanaka, Sakae/Y-3061-2019; Hashizume, Hiroshi/V-6888-2019	Tanaka, Sakae/0000-0001-9210-9414; Hashizume, Hiroshi/0000-0002-9064-0284; Nagata, Keiji/0000-0002-9251-672X	Ministry of Health, Labour and Welfare [201417014A, H23-Choujyu-002, H-25-Choujyu-007, H25-Nanchitou (Men)-005, H22-Choujyu-Wakate-007]; JSPS KAKENHI [B26293139, B23390172, B2629333, C20591774, C26462249, C25462305, B25860448, B26861286, B26860419, B15K20013, 15K15219, 26670307, 24659666, 25670293]; Japanese Orthopaedics and Traumatology Foundation, Inc. [287]; Ministry of Education, Culture, Sports, Science and Technology in Japan [NSF 08033011-00262]; Japan Osteoporosis Society; JA Kyosai Research Institute; Mitsui Sumitomo Insurance Welfare Foundation; Japanese Orthopaedic Association (JOA-Subsidized Science Project Research) [2006-1, 2010-2]; Japan Society for the Promotion of Science [C26462249]; Grants-in-Aid for Scientific Research [26462249] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Orthopaedics and Traumatology Foundation, Inc.; Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Osteoporosis Society(Japan Osteoporosis Society); JA Kyosai Research Institute; Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); Japanese Orthopaedic Association (JOA-Subsidized Science Project Research); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by H23-Choujyu-002 (Director, TA), H-25-Choujyu-007 (Director, NY), H25-Nanchitou (Men)-005 (Director, ST), 201417014A (Director, NY), and H22-Choujyu-Wakate-007 (Director, SM) from the Ministry of Health, Labour and Welfare, [URL: http://www.mhlw.go.jp/]; a Grant-in-Aid for Scientific Research (B26293139, B23390172 to NY, B2629333, C20591774 to SM, C26462249 to HH, C25462305 to HY) and a Grant-in-Aid for Young Researcher (B25860448 to YI, B26861286 to MT, B26860419 to RK, B15K20013 to HI); and Grant-in-Aid for Challenging Exploratory Research (15K15219 to NY, 26670307 to SM, 24659666 to HO, 25670293 to TA) of JSPS KAKENHI grant, [URL: https://www.jsps.go.jp/j-grantsinaid/]; a Grant from the Japanese Orthopaedics and Traumatology Foundation, Inc. (No. 287) to MT, [URL: http://jotf.jp/invitation.html]; and Collaborating Research with NSF 08033011-00262 (Director, NY) from the Ministry of Education, Culture, Sports, Science and Technology in Japan, [URL: http://www.mext.go.jp/english/]. This study also was supported by grants from the Japan Osteoporosis Society (NY, SM, HO, and TA), [URL: http://www. josteo.com/ja/index.html]; a grant from JA Kyosai Research Institute (HO), [URL: http://www.jkri.or.jp/]; grants from Mitsui Sumitomo Insurance Welfare Foundation (SM), [URL: http://www.ms-ins.com/welfare/index.htm]; research aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1 & 2010-2; Director, HK), [URL: https://www.joa.or.jp/english/english_frame.html]; and Japan Society for the Promotion of Science a Grant-in-Aid for Scientific Research (C26462249) to Hiroshi Hashizume. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMUNDSEN T, 1995, SPINE, V20, P1178, DOI 10.1097/00007632-199505150-00013; Amundsen T, 2000, SPINE, V25, P1424, DOI 10.1097/00007632-200006010-00016; ARNOLDI CC, 1976, CLIN ORTHOP RELAT R, P4; BOLENDER NF, 1985, J BONE JOINT SURG AM, V67A, P240, DOI 10.2106/00004623-198567020-00009; Coulier B, 2000, JBR-BTR, V83, P61; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; GANZ JC, 1990, J NEUROSURG, V72, P71, DOI 10.3171/jns.1990.72.1.0071; Hagen KB, 2005, SPINE, V30, P542, DOI 10.1097/01.brs.0000154625.02586.95; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Jones ADR, 2014, EUR SPINE J, V23, P135, DOI 10.1007/s00586-013-2964-5; Konnai Y, 2000, SPINE, V25, P776, DOI 10.1097/00007632-200004010-00004; Kreiner DS, 2011, EVIDENCE BASED CLIN; Macfarlane GJ, 2012, PAIN, V153, P27, DOI 10.1016/j.pain.2011.08.005; Ministry of Health Labour and Welfare, REP NAT HLTH NUTR SU; Miyakoshi N, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/340629; Muraki S, 2012, OSTEOARTHR CARTILAGE, V20, P712, DOI 10.1016/j.joca.2012.03.009; Muraki S, 2009, ANN RHEUM DIS, V68, P1401, DOI 10.1136/ard.2007.087296; Muraki S, 2011, SPINE, V36, P1312, DOI 10.1097/BRS.0b013e3181fa60d1; Muraki S, 2010, MOD RHEUMATOL, V20, P444, DOI 10.1007/s10165-010-0307-5; Nagata K, 2014, SPINE J, V14, P2811, DOI 10.1016/j.spinee.2014.03.051; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; Ogikubo O, 2007, SPINE, V32, P1423, DOI 10.1097/BRS.0b013e318060a5f5; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Porter RW, 1996, SPINE, V21, P2046, DOI 10.1097/00007632-199609010-00024; SCHONSTROM NSR, 1985, SPINE, V10, P806, DOI 10.1097/00007632-198511000-00005; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Teraguchi M, 2015, SPINE J, V15, P622, DOI 10.1016/j.spinee.2014.11.012; Thome C, 2005, J NEUROSURG-SPINE, V3, P129, DOI 10.3171/spi.2005.3.2.0129; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8	30	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160002	10.1371/journal.pone.0160002	http://dx.doi.org/10.1371/journal.pone.0160002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486899	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800052
J	Pinceti, E; Shults, CL; Rao, YS; Pak, TR				Pinceti, Elena; Shults, Cody L.; Rao, Yathindar S.; Pak, Toni R.			Differential Effects of E2 on MAPK Activity in the Brain and Heart of Aged Female Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-BETA; ACTIVATED PROTEIN-KINASE; HORMONE REPLACEMENT THERAPY; POSTMENOPAUSAL WOMEN; ER-BETA; CARDIAC-HYPERTROPHY; REPERFUSION INJURY; COGNITIVE FUNCTION; ESTRADIOL; 17-BETA-ESTRADIOL	Aging and the coincident loss of circulating estrogens at menopause lead to increased risks for neurological and cardiovascular pathologies. Clinical studies show that estrogen therapy (ET) can be beneficial in mitigating these negative effects, in both the brain and heart, when it is initiated shortly after the perimenopausal transition. However, this same therapy is detrimental when initiated > 10 years postmenopause. Importantly, the molecular mechanisms underlying this age-related switch in ET efficacy are unknown. Estrogen receptors (ERs) mediate the neuroprotective and cardioprotective functions of estrogens by modulating gene transcription or, non-genomically, by activating second messenger signaling pathways, such as mitogen activated protein kinases (MAPK). These kinases are critical regulators of cell signaling pathways and have widespread downstream effects. Our hypothesis is that age and estrogen deprivation following menopause alters the expression and activation of the MAPK family members p38 and ERK in the brain and heart. To test this hypothesis, we used a surgically induced model of menopause in 18 month old rats through bilateral ovariectomy (OVX) followed by an acute dose of 17 beta-estradiol (E2) administered at varying time points post-OVX (1 week, 4 weeks, 8 weeks, or 12 weeks). Age and E2 treatment differentially regulated kinase activity in both the brain and heart, and the effects were also brain region specific. MAPK signaling plays an integral role in aging, and the aberrant regulation of those signaling pathways might be involved in age-related disorders. Clinical studies show benefits of ET during early menopause but detrimental effects later, which might be reflective of changes in kinase expression and activation status.	[Pinceti, Elena; Shults, Cody L.; Rao, Yathindar S.; Pak, Toni R.] Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Pak, TR (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	tpak@luc.edu		Pinceti, Elena/0000-0002-4188-4434	NIH [R01AG033605]; NATIONAL INSTITUTE ON AGING [R01AG033605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIH, grant # R01AG033605 (http://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi P, 2008, AGING CELL, V7, P168, DOI 10.1111/j.1474-9726.2007.00364.x; Arai K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060716, DOI 10.1371/JOURNAL.PONE.0060716]; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bal UA, 2015, ANATOL J CARDIOL, V15, P480, DOI 10.5152/akd.2014.5473; Barrick CJ, 2012, J MOL CELL CARDIOL, V52, P165, DOI 10.1016/j.yjmcc.2011.10.021; Benmansour S, 2016, NEUROENDOCRINOLOGY, V103, P269, DOI 10.1159/000437268; Benmansour S, 2014, INT J NEUROPSYCHOPH, V17, P765, DOI 10.1017/S146114571300165X; Chi JH, 2011, J REPROD DEVELOP, V57, P365, DOI 10.1262/jrd.10-189E; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Do Rego JL, 2009, FRONT NEUROENDOCRIN, V30, P259, DOI 10.1016/j.yfrne.2009.05.006; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gabel Scott A, 2005, J Mol Cell Cardiol, V38, P289, DOI 10.1016/j.yjmcc.2004.11.013; George S, 2013, ACS CHEM NEUROSCI, V4, P1537, DOI 10.1021/cn400133s; GOULD E, 1990, J NEUROSCI, V10, P1286; Hausenloy DJ, 2007, HEART FAIL REV, V12, P217, DOI 10.1007/s10741-007-9026-1; Hershberger PA, 2009, J STEROID BIOCHEM, V116, P102, DOI 10.1016/j.jsbmb.2009.05.004; Hodis HN, 2012, CLIMACTERIC, V15, P217, DOI 10.3109/13697137.2012.656401; Hodis HN, 2011, BRAIN RES, V1379, P244, DOI 10.1016/j.brainres.2010.10.076; Hunter DHK., 2005, MECHANISM OF AGEING; Jazbutyte V, 2008, CARDIOVASC RES, V77, P774, DOI 10.1093/cvr/cvm081; Kitamura N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005159; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Laredo SA, 2014, FRONT NEUROENDOCRIN, V35, P447, DOI 10.1016/j.yfrne.2014.03.005; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; LEFEVRE J, 1988, BIOL REPROD, V38, P780, DOI 10.1095/biolreprod38.4.780; Li ZL, 2011, EXP GERONTOL, V46, P694, DOI 10.1016/j.exger.2011.04.005; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund TD, 2005, ENDOCRINOLOGY, V146, P797, DOI 10.1210/en.2004-1158; Lundeen SG, 1997, ENDOCRINOLOGY, V138, P1552, DOI 10.1210/en.138.4.1552; Markowska AL, 2002, J NEUROSCI, V22, P10985; McGregor C, 2014, ENDOCRINOLOGY, V155, P2480, DOI 10.1210/en.2013-1976; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687; Nguyen LK, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-52; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Nuedling S, 2001, FEBS LETT, V502, P103, DOI 10.1016/S0014-5793(01)02675-8; Oyola MG, 2012, ENDOCRINOLOGY, V153, P837, DOI 10.1210/en.2011-1674; Pak TR, 2003, AM J PHYSIOL-ENDOC M, V284, pE206, DOI 10.1152/ajpendo.00352.2002; Parmar MS, 2014, NEUROBIOL AGING, V35, P669, DOI 10.1016/j.neurobiolaging.2013.09.031; Pedram A, 2008, ENDOCRINOLOGY, V149, P3361, DOI 10.1210/en.2008-0133; Queiros AM, 2013, INT J CARDIOL, V169, P331, DOI 10.1016/j.ijcard.2013.09.002; Rao YS, 2015, ONCOTARGET, V6, P36965, DOI 10.18632/oncotarget.5433; Rao YS, 2013, ENDOCRINOLOGY, V154, P2795, DOI 10.1210/en.2013-1230; Resnick Susan M, 2004, Clin Trials, V1, P440, DOI 10.1191/1740774504cn040oa; Rocca WA, 2011, BRAIN RES, V1379, P188, DOI 10.1016/j.brainres.2010.10.031; Rocca WA, 2010, NEURODEGENER DIS, V7, P163, DOI 10.1159/000289229; Rosario ER, 2011, NEUROBIOL AGING, V32, P604, DOI 10.1016/j.neurobiolaging.2009.04.008; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sandberg K, 2013, HYPERTENSION, V61, P1153, DOI 10.1161/HYPERTENSIONAHA.113.01191; Savonenko AV, 2003, NEUROSCIENCE, V119, P821, DOI 10.1016/S0306-4522(03)00213-6; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; SCHMIDT G, 1994, GYNECOL OBSTET INVES, V38, P253, DOI 10.1159/000292492; Seval Y, 2006, J CLIN ENDOCR METAB, V91, P2349, DOI 10.1210/jc.2005-2132; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Shults CL, 2015, ENDOCRINOLOGY, V156, P4187, DOI 10.1210/en.2015-1514; Simone Nuedling SKa, 1999, FEBS LETT, V454, P271; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Song GY, 2007, PHARMACOL RES, V56, P295, DOI 10.1016/j.phrs.2007.07.005; Spencer-Segal JL, 2012, NEUROSCIENCE, V202, P131, DOI 10.1016/j.neuroscience.2011.11.035; Suh YS, 2001, MECH AGEING DEV, V122, P1797, DOI 10.1016/S0047-6374(01)00301-3; Suzuki T, 2006, SURGERY, V140, P141, DOI 10.1016/j.surg.2006.02.014; Taguchi K, 2012, PFLUG ARCH EUR J PHY, V464, P205, DOI 10.1007/s00424-012-1131-x; Talboom JS, 2008, NEUROBIOL LEARN MEM, V90, P155, DOI 10.1016/j.nlm.2008.04.002; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Turcotte JC, 2005, HORM BEHAV, V47, P178, DOI 10.1016/j.yhbeh.2004.09.005; Tuscher JJ, 2016, J NEUROSCI, V36, P1483, DOI 10.1523/JNEUROSCI.3135-15.2016; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Varas-Lorenzo C, 2000, CIRCULATION, V101, P2572, DOI 10.1161/01.CIR.101.22.2572; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wade CB, 2001, ENDOCRINOLOGY, V142, P2336, DOI 10.1210/en.142.6.2336; Wang MJ, 2006, J MOL CELL CARDIOL, V40, P205, DOI 10.1016/j.yjmcc.2005.06.019; Westberry JM, 2008, NEUROSCIENCE, V152, P982, DOI 10.1016/j.neuroscience.2008.01.048; Wetzel-Strong SE, 2016, AM J PHYSIOL-REG I, V310, pR209, DOI 10.1152/ajpregu.00305.2014; Williamson D, 2003, J PHYSIOL-LONDON, V547, P977, DOI 10.1113/jphysiol.2002.036673; Wilson ME, 2013, PFLUG ARCH EUR J PHY, V465, P595, DOI 10.1007/s00424-013-1260-x; Witty CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051385; Xu XH, 2014, CHEMOSPHERE, V96, P129, DOI 10.1016/j.chemosphere.2013.09.063; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Yamaguchi T, 2007, J GERONTOL A-BIOL, V62, P481, DOI 10.1093/gerona/62.5.481; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072985; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092; Znamensky V, 2003, J NEUROSCI, V23, P2340	86	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160276	10.1371/journal.pone.0160276	http://dx.doi.org/10.1371/journal.pone.0160276			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487271	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800067
J	Xu, L; Wang, JB; Lei, M; Li, L; Fu, YL; Wang, ZNA; Ao, MF; Li, ZY				Xu, Li; Wang, Jiabin; Lei, Ming; Li, Li; Fu, Yunliu; Wang, Zhunian; Ao, Mengfei; Li, Zhiying			Transcriptome Analysis of Storage Roots and Fibrous Roots of the Traditional Medicinal Herb Callerya speciosa (Champ.) ScHot	PLOS ONE			English	Article							MADS-BOX GENES; IPOMOEA-BATATAS; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; PHOTOPERIODIC TUBERIZATION; STARCH ACCUMULATION; SOLANUM-TUBEROSUM; SUCROSE SYNTHASE; ANALYSIS REVEALS; FLOWERING TIME	Callerya speciosa (Champ.) ScHot is a woody perennial plant in Fabaceae, the roots of which are used medicinally. The storage roots of C. speciosa are derived from fibrous roots, but not all fibrous roots can develop into storage roots. To detect key genes involved in storage roots formation, we performed Illumina sequencing of the C. speciosa storage roots and fibrous roots. De novo assembly resulted in 161,926 unigenes, which were subsequently annotated by BLAST, GO and KEGG analyses. After expression profiling, 4538 differentially expressed genes were identified. The KEGG pathway enrichment analysis revealed changes in the biosynthesis of cytokinin, phenylpropanoid, starch, sucrose, flavone and other secondary metabolites. Transcription factor-related differentially expressed genes (DEGs) were also identified, including such gene families as GRAS, COL, MIKC, ERF, LBD, and NAC. The DEGs related to light signaling, starch, sugar, photohormones and cell wall-loosening might be involved in the formation of storage roots. This study provides the first transcriptome profiling of C. speciosa roots, data that will facilitate future research of root development and metabolites with medicinal value as well as the breeding of C. speciosa.	[Xu, Li; Wang, Jiabin; Lei, Ming; Li, Li; Fu, Yunliu; Wang, Zhunian; Ao, Mengfei; Li, Zhiying] Chinese Acad Trop Agr Sci, Inst Trop Crop Genet Resources, Danzhou 571737, Hainan, Peoples R China; [Xu, Li; Wang, Jiabin; Lei, Ming; Li, Li; Fu, Yunliu; Wang, Zhunian; Ao, Mengfei; Li, Zhiying] Chinese Acad Trop Agr Sci, Inst Trop Crop Genet Resources, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Danzhou 571737, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Li, ZY (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Crop Genet Resources, Danzhou 571737, Hainan, Peoples R China.; Li, ZY (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Crop Genet Resources, Key Lab Crop Gene Resources & Germplasm Enhanceme, Minist Agr, Danzhou 571737, Hainan, Peoples R China.	xllizhiying@vip.163.com			Ministry of Agriculture Species Resource Production Project [15RZZY-29]; Fundamental Scientific Research Funds for CATAS-TCGRI [1630032013012]; Special Fund for AGRO-Scientific Research in The Public Interest [201303117]	Ministry of Agriculture Species Resource Production Project; Fundamental Scientific Research Funds for CATAS-TCGRI; Special Fund for AGRO-Scientific Research in The Public Interest	This work was funded by The Ministry of Agriculture Species Resource Production Project (15RZZY-29), The Fundamental Scientific Research Funds for CATAS-TCGRI (1630032013012), and The Special Fund for AGRO-Scientific Research in The Public Interest (201303117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenova NP, 2014, BULBOUS PLANTS: BIOTECHNOLOGY, P3; [Anonymous], 2015, MODERN CHINESE MEDIC, V17, P808; Balasubramanian R, 2008, PLANT SIGNAL BEHAV, V3, P322, DOI 10.4161/psb.3.5.5319; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792; Bhogale S, 2014, PLANT PHYSIOL, V164, P1011, DOI 10.1104/pp.113.230714; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Chikano H, 2001, MOL GEN GENET, V264, P674, DOI 10.1007/s004380000354; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Faivre-Rampant O, 2004, J EXP BOT, V55, P613, DOI 10.1093/jxb/erh075; Firon N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-460; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Gonzalez-Schain ND, 2012, PLANT J, V70, P678, DOI 10.1111/j.1365-313X.2012.04909.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guivarc'h A, 2002, J EXP BOT, V53, P621, DOI 10.1093/jexbot/53.369.621; Guo JL, 2010, PLANT CELL TISS ORG, V103, P103, DOI 10.1007/s11240-010-9759-8; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hassidim M, 2009, PLANTA, V230, P481, DOI 10.1007/s00425-009-0958-7; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Hur YS, 2015, NEW PHYTOL, V205, P316, DOI 10.1111/nph.12998; Husbands AY, 2007, MOLECULAR AND BIOCHE; Iseli C., 1999, ESTSCAN A PROGRAM FO; Jin J, 2013, NUCLEIC ACIDS RES; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim SH, 2005, J PLANT BIOL, V48, P387, DOI 10.1007/BF03030580; Kim SH, 2002, PLANT CELL PHYSIOL, V43, P314, DOI 10.1093/pcp/pcf043; Kloosterman B, 2007, PLANT J, V52, P362, DOI 10.1111/j.1365-313X.2007.03245.x; Kloosterman B, 2013, NATURE, V495, P246, DOI 10.1038/nature11912; Kopriva S, 2016, PLANT CELL; KRAUSS A, 1982, POTATO RES, V25, P13, DOI 10.1007/BF02357269; Ku AT, 2008, ANN BOT-LONDON, V102, P57, DOI 10.1093/aob/mcn067; Ledger S, 2001, PLANT J, V26, P14; Lee R, 2013, NATURE COMMUNICATION, V4; Li C, 2011, SOCIAL NETW ANAL MIN, V1, DOI DOI 10.1007/S13278-011-0037-5; Li L, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200345; Li M, 2015, JOURNAL OF EXPERIMEN; Li XQ, 2003, PLANT CELL PHYSIOL, V44, P630, DOI 10.1093/pcp/pcg080; Li ZY, 2013, PROPAG ORNAM PLANTS, V13, P189; Lin T, 2013, PLANT PHYSIOL, V161, P760, DOI 10.1104/pp.112.209429; Mahajan A, 2012, PLANT MOL BIOL, V79, P595, DOI 10.1007/s11103-012-9931-0; Martin A, 2009, DEVELOPMENT, V136, P2873, DOI 10.1242/dev.031658; Masuda JI, 2006, ANN BOT-LONDON, V97, P39, DOI 10.1093/aob/mcj008; MATSUO T, 1983, PLANT CELL PHYSIOL, V24, P1305; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; NAKATANI M, 1991, JPN J CROP SCI, V60, P91, DOI 10.1626/jcs.60.91; NAKATANI M, 1988, JPN J CROP SCI, V57, P544, DOI 10.1626/jcs.57.544; Navarro C, 2015, CURR OPIN PLANT BIOL, V23, P45, DOI 10.1016/j.pbi.2014.10.008; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Noh SA, 2010, J EXP BOT, V61, P1337, DOI 10.1093/jxb/erp399; Orman-Ligeza B, 2013, TRENDS PLANT SCI, V18, P464, DOI 10.1016/j.tplants.2013.04.010; Ovono PO, 2009, PLANT CELL TISS ORG, V99, P55, DOI 10.1007/s11240-009-9575-1; PERL A, 1991, PLANT SCI, V73, P87, DOI 10.1016/0168-9452(91)90129-V; Ravi V., 2009, J ROOT CROPS, V35, P1; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Roumeliotis E, 2012, J EXP BOT, V63, P4539, DOI 10.1093/jxb/ers132; Schmidt R, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27540; Shan JW, 2013, GENOMICS, V102, P388, DOI 10.1016/j.ygeno.2013.07.001; Sojikul P, 2015, PLANT MOL BIOL, V88, P531, DOI 10.1007/s11103-015-0340-z; Sun P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00396; Tanaka M, 2008, J PLANT PHYSIOL, V165, P1726, DOI 10.1016/j.jplph.2007.11.009; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thieme CJ, 2015, NATURE PLANTS, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villordon AQ, 2014, TRENDS PLANT SCI, V19, P419, DOI 10.1016/j.tplants.2014.02.002; WANG F, 1993, PLANT PHYSIOL, V101, P321, DOI 10.1104/pp.101.1.321; Wang XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19643; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; [王祝年 Wang Zhunian], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P2378; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Xue Jian-ping, 2002, Zhongguo Zhongyao Zazhi, V27, P824; Yang J, 2011, J INTEGR PLANT BIOL, V53, P193, DOI 10.1111/j.1744-7909.2010.01018.x; You MK, 2003, FEBS LETT, V536, P101, DOI 10.1016/S0014-5793(03)00035-8; Zhong RQ, 2007, PLANTA, V225, P1603, DOI 10.1007/s00425-007-0498-y; Zong Xin-Kai, 2009, Zhong Yao Cai, V32, P520	84	9	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160338	10.1371/journal.pone.0160338	http://dx.doi.org/10.1371/journal.pone.0160338			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486800	gold, Green Submitted, Green Published			2022-12-27	WOS:000381367800070
J	Li, Y; Wei, J; Mao, X; Gao, QP; Liu, LL; Cheng, P; Liu, LM; Zhang, XH; Zhang, K; Wang, J; Zhu, L; Zhou, JF; Zhang, YC; Meng, L; Sun, HY; Li, DJ; Huang, M; Huang, W; Deng, JN; Zhang, DH				Li, Yi; Wei, Jia; Mao, Xia; Gao, Qingping; Liu, Longlong; Cheng, Ping; Liu, Limei; Zhang, Xinhua; Zhang, Ke; Wang, Jin; Zhu, Li; Zhou, Jianfeng; Zhang, Yicheng; Meng, Li; Sun, Hanying; Li, Dengju; Huang, Mei; Huang, Wei; Deng, Jinniu; Zhang, Donghua			Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis	PLOS ONE			English	Article							OF-THE-LITERATURE; GRANULAR LYMPHOCYTIC-LEUKEMIA; IMMUNOGLOBULIN-LIKE RECEPTORS; NK CELLS; LYMPHOPROLIFERATIVE DISEASE; CYTOMEGALOVIRUS-INFECTION; ACTIVATING KIRS; NEOPLASMS; LYMPHOMA; TRANSPLANTATION	Aggressive natural killer cell leukemia (ANKL) is a fatal hematological neoplasm characterized by a fulminating clinical course and extremely high mortality. Current diagnosis of this disease is not effective during the early stages and it is easily misdiagnosed as other NK cell disorders. We retrospectively analyzed the clinical characteristics and flow cytometric immunophenotype of 47 patients with ANKL. Patients with extranodal NK/T cell lymphoma, nasal type (ENKTL) and chronic lymphoproliferative disorder of NK cell (CLPD-NK), who were diagnosed during the same time period were used for comparisons. Abnormal NK cells in ANKL were found to have a distinctiveCD56bright/CD16dim immunophenotype and markedly increased Ki-67 expression, whereas CD57 negativity and reduced expression of killer immunoglobulin-like receptor (KIR), CD161, CD7, CD8 and perforin were exhibited compared with other NK cell proliferative disorders (p<0.05). The positive rates of flow cytometry detection (97.4%) was higher than those of cytomorphological (89.5%), immunohistochemical (90%), cytogenetic (56.5%) and F-18 fluorodeoxyglucose positron emission tomography/computer tomography (18-FDG-PET/CT) examinations (50%) (p<0.05). ANKL is a highly aggressive leukemia with high mortality. Flow cytometry detection is sensitive for the early and differential diagnosis of ANKL with high	[Li, Yi; Wei, Jia; Mao, Xia; Zhang, Ke; Wang, Jin; Zhu, Li; Zhou, Jianfeng; Zhang, Yicheng; Meng, Li; Sun, Hanying; Li, Dengju; Huang, Mei; Huang, Wei; Deng, Jinniu; Zhang, Donghua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Peoples R China; [Gao, Qingping; Liu, Limei] Wuhan Univ, Renmin Hosp, Dept Hematol, Wuhan, Peoples R China; [Liu, Longlong; Zhang, Xinhua] Wuhan Gen Hosp Guangzhou Mil, Dept Hematol, Wuhan, Peoples R China; [Cheng, Ping] Wuhan Integrated Tradit China Med & Western Med H, Dept Hematol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Zhang, DH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan, Peoples R China.	zdh_62@126.com	meng, li/GVT-2063-2022	Zhang, Donghua/0000-0003-2959-9638; Li, Yi/0000-0002-8287-5999	National Natural Science Foundation of China [NSFC 81300390]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC 81300390).; This study was supported by the National Natural Science Foundation of China (NSFC 81300390). The authors thank their collaborators from the following institutions for providing patient information and samples: Tongji Hospital, Renmin Hospital of Wuhan University, Wuhan General Hospital of Guangzhou Military and Wuhan Integrated Traditional China Medicine and Western Medicine Hospital. The authors are also grateful for the technical assistance provided by the technicians at the Hematology Laboratory and PET/CT Center of Tongji Hospital.	Au WY, 2004, BLOOD, V104, P243, DOI 10.1182/blood-2003-12-4197; Au WY, 2005, ANN ONCOL, V16, P206, DOI 10.1093/annonc/mdi037; Azzi T, 2014, BLOOD, V124, P2533, DOI 10.1182/blood-2014-01-553024; Beziat V, 2013, BLOOD, V121, P4703, DOI 10.1182/blood-2012-10-461442; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Cassidy SA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00133; Chan J., 2008, WHO CLASSIFICATION T, P276; Chan JC, 2008, WHO CLASSIFICATION T, P285; Chan JKC, 1997, BLOOD, V89, P4501, DOI 10.1182/blood.V89.12.4501; Derlin T, 2011, CLIN NUCL MED, V36, P932, DOI 10.1097/RLU.0b013e318219b38f; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Felices M, 2014, J IMMUNOL, V193, P3344, DOI 10.4049/jimmunol.1400534; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Fernandez L, 1986, BLOOD REV, V67, P697; Gao LM, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-43; Ghez D, 2006, CLIN LYMPHOMA MYELOM, V6, P417, DOI 10.3816/CLM.2006.n.022; Ichikawa S, 2010, INTERNAL MED, V49, P1907, DOI 10.2169/internalmedicine.49.3814; Ishida F, 2012, CANCER SCI, V103, P1079, DOI 10.1111/j.1349-7006.2012.02251.x; Ito T, 2008, EUR J HAEMATOL, V81, P107, DOI 10.1111/j.1600-0609.2008.01090.x; Jiang NG, 2013, ANN HEMATOL, V92, P89, DOI 10.1007/s00277-012-1574-3; Ko YH, 2008, ACTA HAEMATOL-BASEL, V120, P199, DOI 10.1159/000193225; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kwong YL, 2011, J CLIN EXP HEMATOP, V51, P21; Li CR, 2014, TRANSL RES, V163, P565, DOI 10.1016/j.trsl.2014.01.010; Lima M, 2015, LEUKEMIA LYMPHOMA, V56, P103, DOI 10.3109/10428194.2014.905772; Lima M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-95; Liu JH, 2002, BLOOD, V100, P1449, DOI 10.1182/blood.V100.4.1449.h81602001449_1449_1453; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Luetke-Eversloh M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00499; Makishima H, 2005, LEUKEMIA, V19, P1169, DOI 10.1038/sj.leu.2403732; Makishima H, 2007, LEUKEMIA RES, V31, P1237, DOI 10.1016/j.leukres.2006.10.020; Moretta L, 2014, INT ARCH ALLERGY IMM, V164, P253, DOI 10.1159/000365632; Morice WG, 2007, AM J CLIN PATHOL, V127, P881, DOI 10.1309/Q49CRJ030L22MHLF; Okuno Y, 2012, J CLIN EXP HEMATOP, V52, P101, DOI 10.3960/jslrt.52.101; Oshimi K, 2005, HEMATOLOGY, V10, P237, DOI 10.1080/10245330400026162; Pascal V, 2004, EUR J IMMUNOL, V34, P2930, DOI 10.1002/eji.200425146; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Rajala HLM, 2014, ANN MED, V46, P114, DOI 10.3109/07853890.2014.882105; Romagnani C, 2007, J IMMUNOL, V178, P4947, DOI 10.4049/jimmunol.178.8.4947; Ruskova AK, 2004, LEUKEMIA LYMPHOMA, V45, P2427, DOI 10.1080/10428190400004513; Ryder J, 2007, INT J HEMATOL, V85, P18, DOI 10.1532/IJH97.A10612; Sawada A, 2006, AM J HEMATOL, V81, P576, DOI 10.1002/ajh.20659; Scquizzato E, 2007, LEUKEMIA, V21, P1060, DOI 10.1038/sj.leu.2404634; Song SY, 2002, HAEMATOLOGICA, V87, P1343; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Steinway SN, 2014, BLOOD REV, V28, P87, DOI 10.1016/j.blre.2014.02.001; Suzuki R, 2004, LEUKEMIA, V18, P763, DOI 10.1038/sj.leu.2403262; Suzuki R, 2010, ANN ONCOL, V21, P1032, DOI 10.1093/annonc/mdp418; Villamor N., 2008, WHO CLASSIFICATION T, P274, DOI DOI 10.3109/07853890.2014.882105; Yoo EH, 2009, KOREAN J LAB MED, V29, P491, DOI 10.3343/kjlm.2009.29.6.491; Zambello R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00072; Zhang HY, 2013, AM J MED SCI, V346, P56, DOI 10.1097/MAJ.0b013e3182764b59; Zhang QG, 2014, INT J CLIN EXP PATHO, V7, P3423	56	6	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0158827	10.1371/journal.pone.0158827	http://dx.doi.org/10.1371/journal.pone.0158827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483437	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700007
J	Anand, R; Strecker, V; Urbach, J; Wittig, I; Reichert, AS				Anand, Ruchika; Strecker, Valentina; Urbach, Jennifer; Wittig, Ilka; Reichert, Andreas S.			Mic13 Is Essential for Formation of Crista Junctions in Mammalian Cells	PLOS ONE			English	Article							MITOCHONDRIAL CONTACT SITE; INNER MEMBRANE; ORGANIZING SYSTEM; APOLIPOPROTEIN O; MICOS COMPLEX; CYTOCHROME-C; MITOFILIN; ORGANIZATION; ARCHITECTURE; MORPHOLOGY	Mitochondrial cristae are connected to the inner boundary membrane via crista junctions which are implicated in the regulation of oxidative phosphorylation, apoptosis, and import of lipids and proteins. The MICOS complex determines formation of crista junctions. We performed complexome profiling and identified Mic13, also termed Qil1, as a subunit of the MICOS complex. We show that MIC13 is an inner membrane protein physically interacting with MIC60, a central subunit of the MICOS complex. Using the CRISPR/Cas method we generated the first cell line deleted for MIC13. These knockout cells show a complete loss of crista junctions demonstrating that MIC13 is strictly required for the formation of crista junctions. MIC13 is required for the assembly of MIC10, MIC26, and MIC27 into the MICOS complex. However, it is not needed for the formation of the MIC60/MIC19/MIC25 subcomplex suggesting that the latter is not sufficient for crista junction formation. MIC13 is also dispensable for assembly of respiratory chain complexes and for maintaining mitochondrial network morphology. Still, lack of MIC13 resulted in a moderate reduction of mitochondrial respiration. In summary, we show that MIC13 has a fundamental role in crista junction formation and that assembly of respiratory chain supercomplexes is independent of mitochondrial cristae shape.	[Anand, Ruchika; Urbach, Jennifer; Reichert, Andreas S.] Heinrich Heine Univ, Fac Med, Inst Biochem & Mol Biol 1, Univ Str 1, D-40225 Dusseldorf, Germany; [Strecker, Valentina; Wittig, Ilka] Goethe Univ Frankfurt, Fac Med, SFB Core Unit 815, Funct Prote, Frankfurt, Germany; [Wittig, Ilka] Goethe Univ Frankfurt, Cluster Excellence Macromol Complexes, Frankfurt, Germany; [Wittig, Ilka] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Frankfurt, Germany	Heinrich Heine University Dusseldorf; Goethe University Frankfurt; Goethe University Frankfurt; German Centre for Cardiovascular Research	Reichert, AS (corresponding author), Heinrich Heine Univ, Fac Med, Inst Biochem & Mol Biol 1, Univ Str 1, D-40225 Dusseldorf, Germany.	reichert@hhu.de	Reichert, Andreas/A-4090-2012	Anand, Ruchika/0000-0001-7337-6007; Reichert, Andreas/0000-0001-9340-3113	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 815]; Heinrich Heine University, Medical Faculty, Forschungskommission	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinrich Heine University, Medical Faculty, Forschungskommission	This work was supported by Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 815, (www.dfg.de) and Heinrich Heine University, Medical Faculty, Forschungskommission, (http://www.medizin.hhu.de/forschung.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Barbot M, 2015, CELL METAB, V21, P756, DOI 10.1016/j.cmet.2015.04.006; Bohnert M, 2015, CELL METAB, V21, P747, DOI 10.1016/j.cmet.2015.04.007; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Ding CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16064; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Genin EC, 2016, EMBO MOL MED, V8, P58, DOI 10.15252/emmm.201505496; Giese H, 2015, BIOINFORMATICS, V31, P440, DOI 10.1093/bioinformatics/btu623; Guarani V, 2015, ELIFE, V4, DOI 10.7554/eLife.06265; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Heide H, 2012, CELL METAB, V16, P538, DOI 10.1016/j.cmet.2012.08.009; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Huynen MA, 2016, BBA-MOL CELL RES, V1863, P91, DOI 10.1016/j.bbamcr.2015.10.009; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Koob S, 2015, DATA BRIEF, V4, P135, DOI 10.1016/j.dib.2015.04.014; Koob S, 2015, BBA-MOL CELL RES, V1853, P1551, DOI 10.1016/j.bbamcr.2015.03.004; Koob S, 2014, BIOL CHEM, V395, P285, DOI 10.1515/hsz-2013-0274; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; MANNELLA CA, 1994, MICROSC RES TECHNIQ, V27, P278, DOI 10.1002/jemt.1070270403; Mannella CA, 2001, IUBMB LIFE, V52, P93, DOI 10.1080/15216540152845885; Munoz-Gomez Sergio A, 2015, Commun Integr Biol, V8, pe1094593, DOI 10.1080/19420889.2015.1094593; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pfanner N, 2014, J CELL BIOL, V204, P1083, DOI 10.1083/jcb.201401006; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Thapa D, 2015, J MOL CELL CARDIOL, V79, P212, DOI 10.1016/j.yjmcc.2014.11.008; Turkieh A, 2014, J CLIN INVEST, V124, P2277, DOI 10.1172/JCI74668; van der Laan M, 2016, CURR OPIN CELL BIOL, V41, P33, DOI 10.1016/j.ceb.2016.03.013; Vogel F, 2006, J CELL BIOL, V175, P237, DOI 10.1083/jcb.200605138; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683; Wurm CA, 2006, FEBS LETT, V580, P5628, DOI 10.1016/j.febslet.2006.09.012; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yang RF, 2012, BIOCHEM BIOPH RES CO, V428, P93, DOI 10.1016/j.bbrc.2012.10.012; Yu BL, 2012, J LIPID RES, V53, P1952, DOI 10.1194/jlr.P023028; Zerbes RM, 2016, J MOL BIOL, V428, P1485, DOI 10.1016/j.jmb.2016.02.031; Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	46	51	51	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160258	10.1371/journal.pone.0160258	http://dx.doi.org/10.1371/journal.pone.0160258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479602	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300036
J	Cabiati, M; Svezia, B; Matteucci, M; Botta, L; Pucci, A; Rinaldi, M; Caselli, C; Lionetti, V; Del Ry, S				Cabiati, Manuela; Svezia, Benedetta; Matteucci, Marco; Botta, Luca; Pucci, Angela; Rinaldi, Mauro; Caselli, Chiara; Lionetti, Vincenzo; Del Ry, Silvia			Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; INFLAMMATION; DISEASE; ALPHA(9)BETA(1); MECHANISMS; INTEGRINS; BINDING; CANCER; GENE	Osteopontin (OPN) is a phosphoglycoprotein of cardiac extracellular matrix and it is still poorly defined whether its expression changes in failing heart of different origin. The fulllength OPN-a and its isoforms (OPN-b, OPN-c) transcriptomic profile were evaluated in myocardium of patients with dilated or ischemic cardiomyopathy (DCM n = 8; LVEF% = 17.5 +/- 3; ICM n = 8; LVEF% = 19.5 +/- 5.2) and in auricle of valvular patients (VLP n = 5; LVEF % +/- 50), by Real-time PCR analysis. OPN-a and thrombin mRNA levels resulted significantly higher in DCM compared to ICM patients (DCM: 31.3 +/- 7.4, ICM: 2.7 +/- 1.1, p = 0.0002; DCM: 19.1 +/- 4.9, ICM: 5.4 +/- 2.2, p = 0.007, respectively). Although both genes' mRNA levels increased in patients with LVEF< 50% (DCM+ ICM) with respect to VLP with LVEF> 50%, a significant increase in OPN (p = 0.0004) and thrombin (p = 0.001) expression was observed only in DCM. In addition, a correlation between OPN-a and thrombin was found in patients with LVEF< 50% (r = 0.6; p = 0.003). The mRNA pattern was confirmed by OPN-a cardiac protein concentration (VLP: 1.127 +/- 0.26; DCM: 1.29 +/- 0.22; ICM: 1.00 +/- 0.077 ng/ml). The OPN splice variants expression were detectable only in ICM (OPN-b: 0.357 +/- 0.273; OPN-c: 0.091 +/- 0.033) and not in DCM patients. A significant correlation was observed between collagen type I, evaluated by immunohistochemistry analysis, and both OPN-a mRNA expression (r = 0.87, p = 0.002) and OPN protein concentrations (r = 0.77, p = 0.016). Concluding, OPN-a and thrombin mRNA resulted dependent on the origin of heart failure while OPN-b and OPN-c highlighted a different expression for DCM and ICM patients, suggesting their correlation with different clinical-pathophysiological setting.	[Cabiati, Manuela; Svezia, Benedetta; Caselli, Chiara; Del Ry, Silvia] CNR, Inst Clin Physiol, Pisa, Italy; [Svezia, Benedetta; Matteucci, Marco; Lionetti, Vincenzo] Scuola Super Sant Anna, Inst Life Sci, Lab Translat Crit Care Med, Pisa, Italy; [Botta, Luca] Osped Niguarda Ca Granda, Dept Cardiac Surg, Milan, Italy; [Pucci, Angela] Univ Hosp Pisa, Dept Pathol, Pisa, Italy; [Rinaldi, Mauro] AOU Citta Salute & Sci Torino, Dept Cardiac Surg, Cardiothorac Dept, Presidio Molinette, Turin, Italy; [Rinaldi, Mauro] Univ Turin, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University of Pisa; Azienda Ospedaliero Universitaria Pisana; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Del Ry, S (corresponding author), CNR, Inst Clin Physiol, Pisa, Italy.; Lionetti, V (corresponding author), Scuola Super Sant Anna, Inst Life Sci, Lab Translat Crit Care Med, Pisa, Italy.	v.lionetti@sssup.it; delry@ifc.cnr.it	Caselli, Chiara/AAN-6227-2021; Cabiati, Manuela/K-1306-2014; Lionetti, Vincenzo/G-9528-2014; Pucci, Angela/A-6509-2013; Lionetti, Vincenzo/AAH-9503-2020; Del Ry, Silvia/C-1149-2015; Lionetti, Vincenzo/AAN-1994-2020; Botta, Luca/A-1090-2015; MATTEUCCI, MARCO/G-3566-2014	Caselli, Chiara/0000-0001-6705-2460; Cabiati, Manuela/0000-0002-0811-6257; Pucci, Angela/0000-0001-8110-4458; Del Ry, Silvia/0000-0001-7163-245X; Lionetti, Vincenzo/0000-0002-0640-8651; Botta, Luca/0000-0002-5674-3861; MATTEUCCI, MARCO/0000-0002-7224-2522	Pastificio Attilio Mastromauro Granoro s.r.l., Corato, Italy	Pastificio Attilio Mastromauro Granoro s.r.l., Corato, Italy	This work was supported by institutional funding (S.D.) and in part by a grant of Pastificio Attilio Mastromauro Granoro s.r.l., Corato, Italy (V.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anborgh PH, 2011, J CELL COMMUN SIGNAL, V5, P111, DOI 10.1007/s12079-011-0130-6; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Asp J, 2012, PHYSIOL GENOMICS, V44, P89, DOI 10.1152/physiolgenomics.00137.2011; Behnes M, 2013, EUR J HEART FAIL, V15, P1390, DOI 10.1093/eurjhf/hft112; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Breyne J, 2010, ATHEROSCLEROSIS, V213, P369, DOI 10.1016/j.atherosclerosis.2010.07.047; Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Dashkevich A, 2010, LYMPHOLOGY, V43, P110; Del Ry S, 2013, INT J CARDIOL, V168, P2426, DOI 10.1016/j.ijcard.2013.03.015; Del Ry S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047011; Del Ry S, 2010, CYTOKINE, V49, P325, DOI 10.1016/j.cyto.2009.11.018; Del Ry S, 2008, PEPTIDES, V29, P2208, DOI 10.1016/j.peptides.2008.09.005; Erlich JH, 2000, AM J PATHOL, V157, P1849, DOI 10.1016/S0002-9440(10)64824-9; Francis GS, 2010, J AM COLL CARDIOL, V56, P424, DOI 10.1016/j.jacc.2010.04.014; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Grau JB, 2012, ANN THORAC SURG, V93, P79, DOI 10.1016/j.athoracsur.2011.08.036; HARE JM, 1992, J AM COLL CARDIOL, V20, P1318, DOI 10.1016/0735-1097(92)90243-G; Helm PA, 2006, CIRC RES, V98, P125, DOI 10.1161/01.RES.0000199396.30688.eb; Herpel E, 2006, HISTOPATHOLOGY, V48, P736, DOI 10.1111/j.1365-2559.2006.02398.x; HIJIYA N, 1994, BIOCHEM J, V303, P255, DOI 10.1042/bj3030255; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Lin D, 2011, J CARD FAIL, V17, P867, DOI 10.1016/j.cardfail.2011.07.001; Lionetti V, 2014, J CELL MOL MED, V18, P396, DOI 10.1111/jcmm.12198; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Psarras S, 2012, EUR HEART J, V33, P1954, DOI 10.1093/eurheartj/ehr119; Renault MA, 2010, CIRC-HEART FAIL, V3, P431, DOI 10.1161/CIRCHEARTFAILURE.109.898114; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Sarosiek K, 2015, J GASTROINTEST SURG, V19, P639, DOI 10.1007/s11605-014-2735-6; Satoh M, 2005, EUR J HEART FAIL, V7, P755, DOI 10.1016/j.ejheart.2004.10.019; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schechter MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104157; Schipper MEI, 2011, J HEART LUNG TRANSPL, V30, P805, DOI 10.1016/j.healun.2011.03.015; Singh K, 1999, HYPERTENSION, V33, P663, DOI 10.1161/01.HYP.33.2.663; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Soejima H, 2007, CIRC J, V71, P1879, DOI 10.1253/circj.71.1879; Stoka V, 2005, IUBMB LIFE, V57, P347, DOI 10.1080/15216540500154920; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wolak T, 2013, AM J HYPERTENS, V26, P326, DOI 10.1093/ajh/hps043; Xie ZL, 2004, HYPERTENSION, V44, P826, DOI 10.1161/01.HYP.0000148458.03202.48	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160110	10.1371/journal.pone.0160110	http://dx.doi.org/10.1371/journal.pone.0160110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479215	Green Published, gold			2022-12-27	WOS:000381110300025
J	Selvakumar, G; Krishnamoorthy, R; Kim, K; Sa, TM				Selvakumar, Gopal; Krishnamoorthy, Ramasamy; Kim, Kiyoon; Sa, Tong-Min			Genetic Diversity and Association Characters of Bacteria Isolated from Arbuscular Mycorrhizal Fungal Spore Walls	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; GIGASPORA-MARGARITA; SOIL-MICROORGANISMS; MYCELIUM; GROWTH; STRAIN; CHITIN; CARBON	Association between arbuscular mycorrhizal fungi (AMF) and bacteria has long been studied. However, the factors influencing their association in the natural environment is still unknown. This study aimed to isolate bacteria associated with spore walls of AMF and identify their potential characters for association. Spores collected from coastal reclamation land were differentiated based on their morphology and identified by 18S rDNA sequencing as Funneliformis caledonium, Racocetra alborosea and Funneliformis mosseae. Bacteria associated with AMF spore walls were isolated after treating them with disinfection solution at different time intervals. After 0, 10 and 20 min of spore disinfection, 86, 24 and 10 spore associated bacteria (SAB) were isolated, respectively. BOX-PCR fingerprinting analysis showed that diverse bacterial communities were associated to AMF spores. Bacteria belonging to the same genera could associate with different AMF spores. Gram positive bacteria were more closely associated with AMF spores. Isolated SAB were characterized and tested for spore association characters such as chitinase, protease, cellulase enzymes and exopolysaccharide production (EPS). Among the 120 SAB, 113 SAB were able to show one or more characters for association and seven SAB did not show any association characters. The 16S rDNA sequence of SAB revealed that bacteria belonging to the phyla Firmicutes, Proteobacteria, Actinobacteria and Bactereiodes were associated with AMF spore walls.	[Selvakumar, Gopal; Krishnamoorthy, Ramasamy; Kim, Kiyoon; Sa, Tong-Min] Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju, Chungbuk, South Korea; [Selvakumar, Gopal] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Hort & Herbal Crop Environm Div, Wonju, South Korea; [Krishnamoorthy, Ramasamy] Tamil Nadu Agr Univ, Agr Coll & Res Inst, Dept Agr Microbiol, Madurai, Tamil Nadu, India	Chungbuk National University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Tamil Nadu Agricultural University	Sa, TM (corresponding author), Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju, Chungbuk, South Korea.	tomsa@chungbuk.ac.kr		Gopal, Selvakumar/0000-0001-7575-7022	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science and Technology [2015R1A2A1A05001885]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science and Technology(National Research Foundation of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2015R1A2A1A05001885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolucci M, 2015, BIOL FERT SOILS, V51, P379, DOI 10.1007/s00374-014-0989-5; Albalasmeh AA, 2013, CARBOHYD POLYM, V97, P253, DOI 10.1016/j.carbpol.2013.04.072; Albertsen A, 2006, SOIL BIOL BIOCHEM, V38, P1008, DOI 10.1016/j.soilbio.2005.08.015; AMES RN, 1989, NEW PHYTOL, V111, P67, DOI 10.1111/j.1469-8137.1989.tb04219.x; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Artursson V, 2003, APPL ENVIRON MICROB, V69, P6208, DOI 10.1128/AEM.69.10.6208-6215.2003; Awasthi A, 2011, APPL SOIL ECOL, V49, P125, DOI 10.1016/j.apsoil.2011.06.005; Battini F, 2016, MICROBIOL RES, V183, P68, DOI 10.1016/j.micres.2015.11.012; Bharadwaj DP, 2008, FEMS MICROBIOL ECOL, V65, P310, DOI 10.1111/j.1574-6941.2008.00515.x; Bianciotto V, 2001, EUR J HISTOCHEM, V45, P39; BONFANTEFASOLO P, 1984, PROTOPLASMA, V120, P51, DOI 10.1007/BF01287617; BONFANTEFASOLO P, 1984, PROTOPLASMA, V123, P140, DOI 10.1007/BF01283584; Budi SW, 1999, APPL ENVIRON MICROB, V65, P5148; Budi SW, 2012, MICROBIOLOGY, V6, P180, DOI DOI 10.5454/MI.6.4.6; Cruz AF, 2008, J APPL MICROBIOL, V104, P1711, DOI 10.1111/j.1365-2672.2007.03695.x; Cruz AF, 2012, BIOL OPEN, V1, P52, DOI 10.1242/bio.2011014; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; Daniels B. A., 1982, Methods and principles of mycorrhizal research., P29; Desiro A, 2014, ISME J, V8, P257, DOI 10.1038/ismej.2013.151; Filippi C, 1998, SYMBIOSIS, V24, P1; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Horii S, 2006, SYMBIOSIS, V41, P135; Iffis B, 2014, FEMS MICROBIOL LETT, V358, P44, DOI 10.1111/1574-6968.12533; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; Jin LA, 2010, SYMBIOSIS, V50, P157, DOI 10.1007/s13199-010-0058-2; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; Kobae Y, 2015, MYCORRHIZA, V25, P411, DOI 10.1007/s00572-014-0623-2; Krishnamoorthy R, 2014, SOIL BIOL BIOCHEM, V72, P1, DOI 10.1016/j.soilbio.2014.01.017; Lecomte J, 2011, FEMS MICROBIOL LETT, V317, P43, DOI 10.1111/j.1574-6968.2011.02209.x; Levy A, 2003, APPL ENVIRON MICROB, V69, P6250, DOI 10.1128/AEM.69.10.6250-6256.2003; Liu M, 2002, J APPL MICROBIOL, V93, P374, DOI 10.1046/j.1365-2672.2002.01693.x; Long LK, 2008, PLANT SOIL, V310, P1, DOI 10.1007/s11104-008-9611-7; Lumini E, 2007, CELL MICROBIOL, V9, P1716, DOI 10.1111/j.1462-5822.2007.00907.x; Mansfeld-Giese K, 2002, FEMS MICROBIOL ECOL, V41, P133, DOI 10.1111/j.1574-6941.2002.tb00974.x; MAYO K, 1986, MYCOLOGIA, V78, P426, DOI 10.2307/3793046; Miransari M, 2011, APPL MICROBIOL BIOT, V89, P917, DOI 10.1007/s00253-010-3004-6; MOSSE B, 1973, ANNU REV PHYTOPATHOL, V11, P171, DOI 10.1146/annurev.py.11.090173.001131; Naik PR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-230; Naumann M, 2010, ISME J, V4, P862, DOI 10.1038/ismej.2010.21; Redecker D, 2013, MYCORRHIZA, V23, P515, DOI 10.1007/s00572-013-0486-y; Roesti D, 2005, APPL ENVIRON MICROB, V71, P6673, DOI 10.1128/AEM.71.11.6673-6679.2005; Rojas-Avelizapa LI, 1999, WORLD J MICROB BIOT, V15, P299, DOI 10.1023/A:1008947029713; Scheublin TR, 2010, ISME J, V4, P752, DOI 10.1038/ismej.2010.5; Selvakumar G, 2017, PLANT GROWTH REGUL, V81, P159, DOI 10.1007/s10725-016-0184-9; Sharma A, 2007, ARCH MICROBIOL, V188, P483, DOI 10.1007/s00203-007-0270-5; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toljander JF, 2006, FEMS MICROBIOL LETT, V254, P34, DOI 10.1111/j.1574-6968.2005.00003.x; Toljander JF, 2007, FEMS MICROBIOL ECOL, V61, P295, DOI 10.1111/j.1574-6941.2007.00337.x; Utobo E.B., 2011, LIBYAN AGR RES CTR J, P68; Walley FL, 1996, MYCORRHIZA, V6, P43, DOI 10.1007/s005720050104; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Welc M, 2010, SOIL BIOL BIOCHEM, V42, P1534, DOI 10.1016/j.soilbio.2010.05.024; Xavier LJC, 2003, SOIL BIOL BIOCHEM, V35, P471, DOI 10.1016/S0038-0717(03)00003-8; Yang C., 2009, SOIL MICROBIOL, V59, P724; Zhang L, 2016, NEW PHYTOL, V210, P1022, DOI 10.1111/nph.13838; Zhang L, 2014, SOIL BIOL BIOCHEM, V74, P177, DOI 10.1016/j.soilbio.2014.03.004	58	20	21	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160356	10.1371/journal.pone.0160356	http://dx.doi.org/10.1371/journal.pone.0160356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479250	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300044
J	Dhurga, DB; Suresh, K; Tan, TC				Dhurga, Devi Balkrishnan; Suresh, Kumar; Tan, Tian Chye			Granular Formation during Apoptosis in Blastocystis sp Exposed to Metronidazole (MTZ)	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HOMINIS; PARASITE; YEAST; ULTRASTRUCTURE; ACCUMULATION; EXCYSTATION; PROTOZOAN; ORIGIN; LIGHT	The role and function of the granular life cycle stage in Blastocystis sp, remains uncertain despite suggestions being made that the granules are metabolic, reproductive and lipid in nature. This present study aims to understand granular formation by triggering apoptosis in Blastocystis sp. by treating them with metronidazole (MTZ). Blastocystis sp. cultures of 4 sub-types namely 1, 2, 3 and 5 when treated with 0.01 and 0.0001 mg/ml of metronidazole (MTZ) respectively showed many of the parasites to be both viable and apoptotic (VA). Treated subtype 3 isolates exhibited the highest number of granular forms i.e. 88% (p<0.001) (0.0001 mg/ml) and 69% (p< 0.01) (0.01 mg/ml) respectively at the 72 h in in vitro culture compared to other subtypes. These VA forms showed distinct granules using acridine orange (AO) and 4', 6-diamino-2-phenylindole (DAPI) staining with a mean per cell ranging from 5 in ST 5 to as high as 16 in ST 3. These forms showed intact mitochondria in both viable apoptotic (VA) and viable non-apoptotic (VNA) cells with a pattern of accumulation of lipid droplets corresponding to viable cells. Granular VA forms looked ultra-structurally different with prominent presence of mitochondria-like organelle (MLO) and a changed mitochondrial trans-membrane potential with thicker membrane and a highly convoluted inner membrane than the less dense non-viable apoptotic (NVA) cells. This suggests that granular formation during apoptosis is a self-regulatory mechanism to produce higher number of viable cells in response to treatment. This study directs the need to search novel chemotherapeutic approaches by incorporating these findings when developing drugs against the emerging Blastocystis sp. infections.	[Dhurga, Devi Balkrishnan; Suresh, Kumar; Tan, Tian Chye] Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Suresh, K (corresponding author), Univ Malaya, Dept Parasitol, Fac Med, Kuala Lumpur 50603, Malaysia.	suresh@um.edu.my	TAN, TIAN CHYE/B-9920-2010		University of Malaya [PG101-2013 B];  [UM.C/HIR/MOHE/MED/44]	University of Malaya(Universiti Malaya); 	Funding for this study was provided by a High Impact Research Grant UM.C/HIR/MOHE/MED/44 and by the University of Malaya (grant PG101-2013 B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; Balakrishnan DD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-219; Barcinski MA, 1999, BRAZ J MED BIOL RES, V32, P395, DOI 10.1590/S0100-879X1999000400003; BOREHAM PFL, 1993, ADV PARASIT, V32, P1, DOI 10.1016/S0065-308X(08)60206-7; Chen XQ, 1999, PARASITOLOGY, V118, P151, DOI 10.1017/S0031182098003667; den Hartigh LJ, 2010, J IMMUNOL, V184, P3927, DOI 10.4049/jimmunol.0903475; Dhurga DB, 2012, T ROY SOC TROP MED H, V106, P725, DOI 10.1016/j.trstmh.2012.08.005; DUNN LA, 1989, INT J PARASITOL, V19, P43, DOI 10.1016/0020-7519(89)90020-9; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Freshney R, 2004, CULTURE ANIMAL CELLS, V4th; Frohlich KU, 2000, FEBS LETT, V473, P6, DOI 10.1016/S0014-5793(00)01474-5; Gaythri T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095608; Ghaffar A, 2010, PARASITOLOGY CHAPTER; Haresh K, 1999, TROP MED INT HEALTH, V4, P274, DOI 10.1046/j.1365-3156.1999.00398.x; Hetsko ML, 1998, EXP PARASITOL, V88, P172, DOI 10.1006/expr.1998.4246; Humason G., 1962, ANIMAL TISSUE TECHNI; Ithoi Init, 2011, Journal of Parasitology Research, V2011; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Johnston G., 1842, HIST BRIT SPONGELI; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; Moe KT, 1996, PARASITOL RES, V82, P439, DOI 10.1007/s004360050142; Nagel R, 2014, GUT PATHOG, V6, DOI 10.1186/s13099-014-0034-0; Nasirudeen A. M. A., 2005, Current Issues in Intestinal Microbiology, V6, P77; Nasirudeen AMA, 2004, MICROBIOL-SGM, V150, P33, DOI 10.1099/mic.0.26496-0; Nasirudeen AMA, 2001, PARASITOLOGY, V123, P235, DOI 10.1017/S0031182001008332; OHYAMA H, 1985, RADIAT RES, V101, P123, DOI 10.2307/3576309; RUSTIA M, 1979, JNCI-J NATL CANCER I, V63, P863, DOI 10.1093/jnci/63.3.863; Sekar U, 2015, JMR, V1, P33; Silard R, 1979, Arch Roum Pathol Exp Microbiol, V38, P105; Stenzel DJ, 1996, CLIN MICROBIOL REV, V9, P563, DOI 10.1128/CMR.9.4.563; STENZEL DJ, 1991, INT J PARASITOL, V21, P807, DOI 10.1016/0020-7519(91)90149-2; Sumiyoshi E, 2002, J CELL SCI, V115, P1403; SUN T, 1989, AM J GASTROENTEROL, V84, P1543; SURESH K, 1994, PARASITOL RES, V80, P327, DOI 10.1007/BF02351875; SURESH K, 1995, INT J PARASITOL, V25, P123, DOI 10.1016/0020-7519(94)00074-X; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tan KSW, 2003, TRENDS PARASITOL, V19, P290, DOI 10.1016/S1471-4922(03)00119-3; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tan TC, 2009, PARASITOL RES, V105, P1283, DOI 10.1007/s00436-009-1551-5; Taylor-Brown E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-108; Vdovenko AA, 2000, PARASITOL RES, V86, P8, DOI 10.1007/PL00008506; Yoshikawa H, 2004, PARASITOL RES, V92, P22, DOI 10.1007/s00436-003-0995-2; YOSHIKAWA H, 1995, J ELECTRON MICROSC, V44, P100; YOSHIKAWA H, 1988, J PROTOZOOL, V35, P522, DOI 10.1111/j.1550-7408.1988.tb04143.x; ZIERDT CH, 1973, J PROTOZOOL, V20, P114, DOI 10.1111/j.1550-7408.1973.tb06013.x; ZIERDT CH, 1988, PARASITOL TODAY, V4, P15, DOI 10.1016/0169-4758(88)90049-X; ZIERDT CH, 1991, CLIN MICROBIOL REV, V4, P61, DOI 10.1128/CMR.4.1.61-79.1991; ZIERDT CH, 1986, J PROTOZOOL, V33, P67, DOI 10.1111/j.1550-7408.1986.tb05559.x; ZIERDT CH, 1974, EXP PARASITOL, V36, P233, DOI 10.1016/0014-4894(74)90062-9; ZIERDT CH, 1976, Z PARASITENKD, V50, P277, DOI 10.1007/BF02462972	51	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0155390	10.1371/journal.pone.0155390	http://dx.doi.org/10.1371/journal.pone.0155390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27471855	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516300002
J	Lurgi, M; Wells, K; Kennedy, M; Campbell, S; Fordham, DA				Lurgi, Miguel; Wells, Konstans; Kennedy, Malcolm; Campbell, Susan; Fordham, Damien A.			A Landscape Approach to Invasive Species Management	PLOS ONE			English	Article							ORYCTOLAGUS-CUNICULUS; RIPPING PROGRAMS; POPULATION; CONSERVATION; RABBITS; PATTERNS; DETERMINANTS; DISPERSAL; STABILITY; EVOLUTION	Biological invasions are not only a major threat to biodiversity, they also have major impacts on local economies and agricultural production systems. Once established, the connection of local populations into metapopulation networks facilitates dispersal at landscape scales, generating spatial dynamics that can impact the outcome of pest-management actions. Much planning goes into landscape-scale invasive species management. However, effective management requires knowledge on the interplay between metapopulation network topology and management actions. We address this knowledge gap using simulation models to explore the effectiveness of two common management strategies, applied across different extents and according to different rules for selecting target localities in metapopulations with different network topologies. These management actions are: (i) general population reduction, and (ii) reduction of an obligate resource. The reduction of an obligate resource was generally more efficient than population reduction for depleting populations at landscape scales. However, the way in which local populations are selected for management is important when the topology of the metapopulation is heterogeneous in terms of the distribution of connections among local populations. We tested these broad findings using real-world scenarios of European rabbits (Oryctolagus cuniculus) infesting agricultural landscapes in Western Australia. Although management strategies targeting central populations were more effective in simulated heterogeneous metapopulation structures, no difference was observed in real-world metapopulation structures that are highly homogeneous. In large metapopulations with high proximity and connectivity of neighbouring populations, different spatial management strategies yield similar outcomes. Directly considering spatial attributes in pest-management actions will be most important for metapopulation networks with heterogeneously distributed links. Our modelling framework provides a simple approach for identifying the best possible management strategy for invasive species based on metapopulation structure and control capacity. This information can be used by managers trying to devise efficient landscape-oriented management strategies for invasive species and can also generate insights for conservation purposes.	[Lurgi, Miguel; Wells, Konstans; Fordham, Damien A.] Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia; [Lurgi, Miguel; Wells, Konstans; Fordham, Damien A.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Wells, Konstans] Griffith Univ, Environm Futures Res Inst, Brisbane, Qld 4111, Australia; [Kennedy, Malcolm] Western Australia, Dept Agr & Food, 3 Baron Hay Ct, S Perth, WA 6151, Australia; [Campbell, Susan] Western Australia, Dept Agr & Food, 444 Albany Hwy, Albany, WA 6330, Australia	University of Adelaide; University of Adelaide; Griffith University; Government of Western Australia; Department of Agriculture & Food - Western Australia; Government of Western Australia; Department of Agriculture & Food - Western Australia	Lurgi, M (corresponding author), Univ Adelaide, Inst Environm, Adelaide, SA 5005, Australia.; Lurgi, M (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia.	miguel.lurgi@icloud.com	Wells, Konstans/A-7232-2010; Fordham, Damien/E-9255-2013	Wells, Konstans/0000-0003-0377-2463; Lurgi, Miguel/0000-0001-9891-895X; Fordham, Damien/0000-0003-2137-5592	Australian Research Council [LP110200805, FT140101192]	Australian Research Council(Australian Research Council)	The Australian Research Council (http://www.arc.gov.au) funded this work. Grant numbers: LP110200805 and FT140101192. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Australian Research Council (ARC) supported M.L., K.W. and D.A.F. (LP110200805 and FT140101192). We thank current and previous DAFWA staff involved with rabbit monitoring and research, specifically Andrew Woolnough and Garry Gray, previously DAFWA Vertebrate Pest Research Section, for access to rabbit demographic data from Western Australia. We also thank Phill Cassey, Greg Mutze and Brian Cooke for their constructive and insightful comments and support.	[Anonymous], 1991, RANGELAND J, DOI DOI 10.1071/RJ9910096; Avery ML, 2002, P 20 VERT PEST C MAR; Azman AS, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1341; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Berman D, 2011, WILDLIFE RES, V38, P77, DOI 10.1071/WR09178; Caplat P, 2012, ECOLOGY, V93, P368, DOI 10.1890/11-0820.1; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cassey P, 2014, OECOLOGIA, V175, P417, DOI 10.1007/s00442-014-2902-1; Clark F, 2010, METHODS ECOL EVOL, V1, P253, DOI 10.1111/j.2041-210X.2010.00029.x; Cooke BD, 2014, WILDLIFE RES, V41, P141, DOI 10.1071/WR14003; Cooke B, 2013, AUST ECON HIST REV, V53, P91, DOI 10.1111/aehr.12000; Cooke B, 2010, WILDLIFE RES, V37, P558, DOI 10.1071/WR09154; Cox T, 2013, BENEFITS RABBIT BIOC; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fordham D., 2012, WILDLIFE CONSERVATIO, P86; Glen AS, 2013, BIOL INVASIONS, V15, P2127, DOI 10.1007/s10530-013-0439-6; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hone J, 1999, J APPL ECOL, V36, P709, DOI 10.1046/j.1365-2664.1999.00439.x; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Jeschke JM, 2006, GLOBAL CHANGE BIOL, V12, P1608, DOI 10.1111/j.1365-2486.2006.01213.x; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Le Corre N, 2015, ECOLOGY, V96, P2245, DOI 10.1890/14-2126.1; Leventhal GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7101; Lurgi M, 2015, METHODS ECOL EVOL, V6, P247, DOI 10.1111/2041-210X.12315; McPhee SR, 2010, WILDLIFE RES, V37, P68, DOI 10.1071/WR09103; Moilanen A, 2007, BIOL CONSERV, V134, P571, DOI 10.1016/j.biocon.2006.09.008; Murray JV, 2014, BIOL INVASIONS, V16, P2403, DOI 10.1007/s10530-014-0673-6; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ramsey DSL, 2014, WILDLIFE RES, V41, P46, DOI 10.1071/WR13195; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rix MG, 2015, BIOL REV, V90, P762, DOI 10.1111/brv.12132; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Savage D, 2014, ECOL MODEL, V272, P394, DOI 10.1016/j.ecolmodel.2013.10.001; Soh MCK, 2002, LANDSCAPE URBAN PLAN, V59, P217, DOI 10.1016/S0169-2046(02)00047-6; Spencer PBS, 2012, J WILDLIFE MANAGE, V76, P1254, DOI 10.1002/jwmg.381; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tablado Z, 2009, ECOGRAPHY, V32, P310, DOI 10.1111/j.1600-0587.2008.05532.x; Thompson HV., 1994, EUROPEAN RABBIT HIST; Tingley R, 2013, J APPL ECOL, V50, P129, DOI 10.1111/1365-2664.12021; Twigg LE, 1998, WILDLIFE RES, V25, P97, DOI 10.1071/WR97066; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Vitousek PM, 1996, AM SCI, V84, P468; Wells K, 2016, J WILDLIFE MANAGE, V80, P990, DOI 10.1002/jwmg.21093; Wells K, 2016, OECOLOGIA, V181, P853, DOI 10.1007/s00442-016-3617-2; Wells K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1184; Williams K, 1995, MANAGING VERTEBRATE; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Ziska LH, 2013, INVASIVE SPECIES GLO; [No title captured]	56	13	14	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160417	10.1371/journal.pone.0160417	http://dx.doi.org/10.1371/journal.pone.0160417			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27471853	gold, Green Published			2022-12-27	WOS:000381516300050
J	Schattenkerk, DWE; van Gorp, J; Snijder, MB; Zwinderman, AH; Agyemang, CO; Peters, RJG; van den Born, BJH				Schattenkerk, Daan W. Eeftinck; van Gorp, Jacqueline; Snijder, Marieke B.; Zwinderman, Aeilko H.; Agyemang, Charles O.; Peters, Ron J. G.; van den Born, Bert-Jan H.			Ethnic Differences in Arterial Wave Reflection Are Mostly Explained by Differences in Body Height - Cross-Sectional Analysis of the HELIUS Study	PLOS ONE			English	Article							CENTRAL BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; AUGMENTATION INDEX; HEART-RATE; STIFFNESS; IMPACT; RISK; HEMODYNAMICS; ARTERIOGRAPH; DETERMINANTS	Background Differences in arterial wave reflection and central blood pressure (BP) have been associated with cardiovascular disease (CVD) in various populations and may contribute to ethnic differences in CVD. Whether ethnic differences in wave reflection and central BP can be explained by conventional risk factors for CVD or may result from physiological differences remains undetermined. Methods We examined ethnic differences in augmentation index (AIx) and central systolic BP and their determinants in a large multi-ethnic cohort study in Amsterdam, the Netherlands. A total of 8812 (46% male) participants aged 18-70 years of Dutch, South-Asian Surinamese, African Surinamese and Ghanaian origin were included. AIx and central BP were measured in duplicate using the Arteriograph system. Results AIx and central systolic BP were significantly higher in South-Asian Surinamese (35+/-17%, 126+/-22 mmHg), African Surinamese (33+/-17%, 129+/-23 mmHg) and Ghanaian (33+/-16%, 135+/-24 mmHg) as compared with Dutch (27+/-17%, 118+/-20 mmHg, all p<0.001). Correction for cardiovascular risk factors only slightly reduced the difference in AIx, whereas correction for body height attenuated age and gender corrected ethnic differences in AIx the most. Differences in central systolic BP were primarily determined by differences in AIx for South-Asian Surinamese and by differences in peripheral systolic BP for subjects of African origin. Conclusions Substantial differences in AIx and central BP exist across different ethnic groups that cannot be explained by differences in conventional risk factors for CVD. These findings may explain part of the underestimation of cardiovascular risk observed in populations of African and South-Asian descent.	[Schattenkerk, Daan W. Eeftinck; van Gorp, Jacqueline; van den Born, Bert-Jan H.] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Snijder, Marieke B.; Agyemang, Charles O.] Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Acad Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; [Peters, Ron J. G.] Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Schattenkerk, DWE (corresponding author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	d.w.schattenkerk@amc.nl	van den Born, Bert-Jan/E-4263-2017; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; van den Born, Bert-Jan H. (BJH)/0000-0003-0943-4393	Dutch Heart Foundation [2010T084]; Netherlands Organization for Health Research and Development (ZonMw) [200500003]; European Union (FP-7) [278901]	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union (FP-7)	The HELIUS study is conducted by the Academic Medical Center, Amsterdam and the Public Health Service (GGD) of Amsterdam. Both organisations provided core support for HELIUS. The HELIUS study is also funded by the Dutch Heart Foundation (grant number 2010T084), the Netherlands Organization for Health Research and Development (ZonMw) (grant number 200500003), and the European Union (FP-7) (grant number 278901).	Adamopoulos D, 2010, J HYPERTENS, V28, P903, DOI 10.1097/HJH.0b013e3283369f67; Agyemang C, 2014, STROKE, V45, P3236, DOI 10.1161/STROKEAHA.114.006462; Baulmann J, 2008, J HYPERTENS, V26, P523, DOI 10.1097/HJH.0b013e3282f314f7; Bhopal R, 2000, HEART, V83, P495, DOI 10.1136/heart.83.5.495; Bogert LWJ, 2010, ANAESTHESIA, V65, P1119, DOI 10.1111/j.1365-2044.2010.06511.x; Chirinos JA, 2012, J AM COLL CARDIOL, V60, P2170, DOI 10.1016/j.jacc.2012.07.054; Chirinos JA, 2011, HYPERTENSION, V57, P1108, DOI 10.1161/HYPERTENSIONAHA.110.166348; Chirinos JA, 2009, HYPERTENSION, V54, P558, DOI 10.1161/HYPERTENSIONAHA.109.131870; Din JN, 2006, J HUM HYPERTENS, V20, P163, DOI 10.1038/sj.jhh.1001961; Fok H, 2014, HYPERTENSION; Gu QP, 2008, ANN EPIDEMIOL, V18, P302, DOI 10.1016/j.annepidem.2007.11.013; Guelen I, 2008, J HYPERTENS, V26, P1321, DOI 10.1097/HJH.0b013e3282fe1d28; Heffernan KS, 2008, AM J PHYSIOL-HEART C, V295, pH2380, DOI 10.1152/ajpheart.00902.2008; Horvath IG, 2010, J HYPERTENS, V28, P2068, DOI 10.1097/HJH.0b013e32833c8a1a; Jatoi NA, 2009, J HYPERTENS, V27, P2186, DOI 10.1097/HJH.0b013e32833057e8; Kelly RP, 2001, HYPERTENSION, V37, P1429, DOI 10.1161/01.HYP.37.6.1429; Kock N, 2012, J ASSOC INF SYST, V13, P546, DOI 10.17705/1jais.00302; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; LONDON GM, 1995, HYPERTENSION, V26, P514, DOI 10.1161/01.HYP.26.3.514; Martina JR, 2012, ANESTHESIOLOGY, V116, P1092, DOI 10.1097/ALN.0b013e31824f94ed; McEniery CM, 2010, HYPERTENSION, V56, P591, DOI 10.1161/HYPERTENSIONAHA.110.156950; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; McEniery CM, 2014, EUR HEART J; Mitchell GF, 2008, J APPL PHYSIOL, V105, P1652, DOI 10.1152/japplphysiol.90549.2008; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Morris AA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.002154; Nelson CP, 2015, NEW ENGL J MED, V372, P1608, DOI 10.1056/NEJMoa1404881; Pini R, 2008, J AM COLL CARDIOL, V51, P2432, DOI 10.1016/j.jacc.2008.03.031; Rezai MR, 2013, BLOOD PRESS MONIT, V18, P111, DOI 10.1097/MBP.0b013e32835d3663; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Schattenkerk DWE, 2009, AM J HYPERTENS, V22, P378, DOI 10.1038/ajh.2008.368; Starmans-Kool MJ, 2011, J APPL PHYSIOL, V110, P468, DOI 10.1152/japplphysiol.00917.2010; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Teixido-Tura G, 2015, HYPERTENSION, V66, P23, DOI 10.1161/HYPERTENSIONAHA.115.05156; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Wesseling KH, 1996, Z KARDIOL, V85, P38; Westerhof BE, 2007, AM J PHYSIOL-HEART C, V292, pH800, DOI 10.1152/ajpheart.00443.2006; Westerhof BE, 2012, J HYPERTENS, V30, P932, DOI 10.1097/HJH.0b013e3283524932; Wilkinson IB, 2000, J PHYSIOL-LONDON, V525, P263, DOI 10.1111/j.1469-7793.2000.t01-1-00263.x; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Williams B, 2009, J AM COLL CARDIOL, V54, P705, DOI [10.1016/j.jacc.2009.02.088, 10.1016/j.jacc.2009.06.043]; Wormser D, 2012, INT J EPIDEMIOL, V41, P1419, DOI 10.1093/ije/dys086	42	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160243	10.1371/journal.pone.0160243	http://dx.doi.org/10.1371/journal.pone.0160243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472397	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516300038
J	Fraszczak, J; Helness, A; Chen, R; Vadnais, C; Robert, F; Khandanpour, C; Moroy, T				Fraszczak, Jennifer; Helness, Anne; Chen, Riyan; Vadnais, Charles; Robert, Francois; Khandanpour, Cyrus; Moroy, Tarik			Threshold Levels of Gfi1 Maintain E2A Activity for B Cell Commitment via Repression of Id1	PLOS ONE			English	Article							COMMON LYMPHOID PROGENITORS; GENE REGULATORY NETWORKS; HEMATOPOIETIC STEM-CELLS; BONE-MARROW; TRANSCRIPTION FACTORS; DIFFERENTIAL EXPRESSION; MULTIPOTENT PROGENITORS; MICE LACKING; FACTOR EBF; E PROTEINS	A regulatory circuit that controls myeloid versus B lymphoid cell fate in hematopoietic progenitors has been proposed, in which a network of the transcription factors Egr1/2, Nab, Gfi1 and PU.1 forms the core element. Here we show that a direct link between Gfi1, the transcription factor E2A and its inhibitor Id1 is a critical element of this regulatory circuit. Our data suggest that a certain threshold of Gfi1 is required to gauge E2A activity by adjusting levels of Id1 in multipotent progenitors, which are the first bipotential myeloid/lymphoidrestricted progeny of hematopoietic stem cells. If Gfi1 levels are high, Id1 is repressed enabling E2A to activate a specific set of B lineage genes by binding to regulatory elements for example the IL7 receptor gene. If Gfi1 levels fall below a threshold, Id1 expression increases and renders E2A unable to function, which prevents hematopoietic progenitors from engaging along the B lymphoid lineage.	[Fraszczak, Jennifer; Helness, Anne; Chen, Riyan; Vadnais, Charles; Robert, Francois; Moroy, Tarik] IRCM, Montreal, PQ, Canada; [Fraszczak, Jennifer; Vadnais, Charles; Moroy, Tarik] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Helness, Anne; Moroy, Tarik] McGill Univ, Div Expt Med, Montreal, PQ, Canada; [Robert, Francois] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Khandanpour, Cyrus] Univ Hosp, Dept Hematol, Essen, Germany	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; University of Duisburg Essen	Moroy, T (corresponding author), IRCM, Montreal, PQ, Canada.; Moroy, T (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.; Moroy, T (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ, Canada.	Tarik.Moroy@ircm.qc.ca	Robert, Francois/D-2316-2012	Khandanpour, Cyrus/0000-0003-4655-6269	Fonds recherche Quebec-Sante; Canadian Institute for Health Research (CIHR); Deutsche Krebshilfe; Jakstadt-foundation; CIHR [MOP - 111011, MOP-106427]	Fonds recherche Quebec-Sante; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Deutsche Krebshilfe(Deutsche Krebshilfe); Jakstadt-foundation; CIHR(Canadian Institutes of Health Research (CIHR))	JF was supported by a fellowship from the Fonds recherche Quebec-Sante. CV was supported by a fellowship from the Canadian Institute for Health Research (CIHR). CK is supported by funds of the Deutsche Krebshilfe and the Jakstadt-foundation. TM holds a Canada Research Chair (Tier 1). This work was supported by CIHR grants to TM (MOP - 111011) and FR/TM (MOP-106427).	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; BAIN G, 1994, CELL, V79, P885, DOI 10.1016/0092-8674(94)90077-9; Batliner J, 2011, MOL IMMUNOL, V48, P714, DOI 10.1016/j.molimm.2010.10.016; Bonadies N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016330; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cochrane SW, 2011, CELL MOL IMMUNOL, V8, P41, DOI 10.1038/cmi.2010.58; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Dias S, 2008, IMMUNITY, V29, P217, DOI 10.1016/j.immuni.2008.05.015; Dolence JJ, 2011, EUR J IMMUNOL, V41, P324, DOI 10.1002/eji.201040710; Duan ZJ, 2005, MOL CELL BIOL, V25, P10338, DOI 10.1128/MCB.25.23.10338-10351.2005; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hones JM, 2016, LEUKEMIA, V30, P1237, DOI 10.1038/leu.2016.11; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kee BL, 1998, J EXP MED, V188, P699, DOI 10.1084/jem.188.4.699; Kee BL, 2000, IMMUNOL REV, V175, P138, DOI 10.1111/j.1600-065X.2000.imr017514.x; Khandanpour C, 2013, CANCER CELL, V23, P200, DOI 10.1016/j.ccr.2013.01.011; Khandanpour C, 2012, BLOOD, V120, P4006, DOI 10.1182/blood-2011-02-334722; Khandanpour C, 2011, STEM CELLS, V29, P376, DOI 10.1002/stem.575; Kim W, 2014, BLOOD, V124, P1586, DOI 10.1182/blood-2014-02-556522; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Li HJ, 2010, BLOOD, V116, P1060, DOI 10.1182/blood-2009-11-255075; Ligons DL, 2012, J BIOL CHEM, V287, P34386, DOI 10.1074/jbc.M112.378687; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Perry SS, 2007, BLOOD, V110, P2351, DOI 10.1182/blood-2007-01-069914; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Welinder E, 2011, P NATL ACAD SCI USA, V108, P17402, DOI 10.1073/pnas.1111766108; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zarebski A, 2008, IMMUNITY, V28, P370, DOI 10.1016/j.immuni.2007.12.020; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Zou GM, 2005, P NATL ACAD SCI USA, V102, P13236, DOI 10.1073/pnas.0506218102	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160344	10.1371/journal.pone.0160344	http://dx.doi.org/10.1371/journal.pone.0160344			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467586	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100149
J	Hodzic, A; Kriechbaum, M; Schrank, S; Reiter, F				Hodzic, Aden; Kriechbaum, Manfred; Schrank, Simone; Reiter, Franz			Monitoring of Pentoxifylline Thermal Behavior by Novel Simultaneous Laboratory Small and Wide X-Ray Scattering (SWAXS) and Differential Scanning Calorimetry (DSC)	PLOS ONE			English	Article							THERAPEUTIC EFFICACY; DIFFRACTION	The thermal and structural evolutions associated to active pharmaceutical ingredient (API) purity are monitored using a laboratory instrument (S3-MicroCaliX) allowing simultaneous time-resolved X-ray scattering at both wide and small angles (SWAXS) as a function of temperature. This is performed simultaneously with differential scanning calorimetric (DSC) that is carried out in the same apparatus at scanning rate of 2 K/min on the same sample in the range from 20 degrees to 200 degrees C. We have studied simultaneous thermal and structural properties of pentoxifylline, as an active pharmaceutical ingredient (API), for its purity quality control. We have found a satisfying API purity, due to obtained melting temperature and enthalpy values, which are in a well agreement with literature. We have also found that the combination of these techniques allows the thermal monitoring of scanning rates of 2 K/min, continuously without the need for static thermal equilibration, particularly for X-ray spectra. Hence, DSC and SWAXS allowing better identification of the structural thermal events recorded by following of the phase transitions simultaneously. This interpretation is much better possible when X-ray scattering at small and wide angles is coupled with DSC from the same sample. Hence, as a laboratory tool, the method presents a reproducible thermal and crystallographic API purity quality control of non-complex samples, as crucial information for pharmaceutical technology.	[Hodzic, Aden] Cent European Res Infrastruct Consortium CERIC ER, Trieste, Italy; [Kriechbaum, Manfred] Graz Univ Technol, Inst Inorgan Chem, Graz, Austria; [Hodzic, Aden] Res Ctr Pharmaceut Engn GmbH, Graz, Austria; [Reiter, Franz] GL Pharma GmbH, Lannach, Austria; [Schrank, Simone] Graz Univ, Inst Pharmaceut Sci, Graz, Austria	Graz University of Technology; Research Center for Pharmaceutical Engineering (RCPE); University of Graz	Hodzic, A (corresponding author), Cent European Res Infrastruct Consortium CERIC ER, Trieste, Italy.; Hodzic, A (corresponding author), Res Ctr Pharmaceut Engn GmbH, Graz, Austria.	aden.hodzic@ceric-eric.eu		Kriechbaum, Manfred/0000-0002-3852-4198; Eder, Simone/0000-0002-2894-2193	Research Center Pharmaceutical Engineering GmbH and G.L. Pharma GmbH	Research Center Pharmaceutical Engineering GmbH and G.L. Pharma GmbH	The funders Research Center Pharmaceutical Engineering GmbH and G.L. Pharma GmbH provided support in the form of salaries for authors AH and FR. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2006, MERCK INDEX ENCY CHE; BRAS W, 1993, J PHYS IV, V3, P447, DOI 10.1051/jp4:1993892; Domanska U, 2009, J PHYS CHEM B, V113, P8941, DOI 10.1021/jp900468w; FRAMPTON JE, 1995, DRUG AGING, V7, P480, DOI 10.2165/00002512-199507060-00007; Giron D, 2002, J THERM ANAL CALORIM, V68, P335, DOI 10.1023/A:1016015113795; GIRON D, 1995, J THERM ANAL, V44, P217, DOI 10.1007/BF02547150; Glatter O., 1982, SMALL ANGLE X RAY SC; Heigl N, 2012, J PHARM INNOV, V7, P76, DOI 10.1007/s12247-012-9129-7; Hodzic A, 2012, INT J PHARMACEUT, V428, P91, DOI 10.1016/j.ijpharm.2012.02.048; Hodzic A, 2008, BIOPHYS J, V94, P3935, DOI 10.1529/biophysj.107.123224; Jednacak T, 2014, ACTA PHARMACEUT, V64, P1, DOI 10.2478/acph-2014-0009; Kalnin D, 2002, FOOD RES INT, V35, P927, DOI 10.1016/S0963-9969(02)00155-2; Mathkar S, 2009, J PHARMACEUT BIOMED, V49, P627, DOI 10.1016/j.jpba.2008.12.030; Ollivon M, 2006, J THERM ANAL CALORIM, V85, P219, DOI 10.1007/s10973-005-7351-y; PLATO C, 1972, ANAL CHEM, V44, P1531, DOI 10.1021/ac60316a049; Porod G, 1982, SMALL ANGLE XRAY SCA; PORTER JM, 1982, AM HEART J, V104, P66, DOI 10.1016/0002-8703(82)90642-1; Vitez IM, 2004, J THERM ANAL CALORIM, V78, P33, DOI 10.1023/B:JTAN.0000042151.60566.0f; WARD A, 1987, DRUGS, V34, P50, DOI 10.2165/00003495-198734010-00003	19	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159840	10.1371/journal.pone.0159840	http://dx.doi.org/10.1371/journal.pone.0159840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467972	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100062
J	Nauta, TD; Duyndam, MCA; Weijers, EM; van Hinsbergh, VMW; Koolwijk, P				Nauta, Tessa D.; Duyndam, Monique C. A.; Weijers, Ester M.; van Hinsbergh, Victor M. W.; Koolwijk, Pieter			HIF-2 alpha Expression Regulates Sprout Formation into 3D Fibrin Matrices in Prolonged Hypoxia in Human Microvascular Endothelial Cells	PLOS ONE			English	Article							PAS DOMAIN PROTEIN; GROWTH-FACTOR; UROKINASE RECEPTOR; OXYGEN GRADIENTS; GENE-EXPRESSION; IN-VITRO; RETINAL NEOVASCULARIZATION; TUMOR ANGIOGENESIS; INDUCIBLE FACTOR-1; TUBE FORMATION	Background During short-term hypoxia, Hypoxia Inducible Factors (particular their subunits HIF-1 alpha and HIF-2 alpha) regulate the expression of many genes including the potent angiogenesis stimulator VEGF. However, in some pathological conditions chronic hypoxia occurs and is accompanied by reduced angiogenesis. Objectives We investigated the effect of prolonged hypoxia on the proliferation and sprouting ability of human microvascular endothelial cells and the involvement of the HIFs and DII4/Notch signaling. Methods and Results Human microvascular endothelial cells (hMVECs), cultured at 20% oxygen for 14 days and seeded on top of 3D fibrin matrices, formed sprouts when stimulated with VEGF-A/TNF alpha . In contrast, hMVECs precultured at 1% oxygen for 14 days were viable and proliferative, but did not form sprouts into fibrin upon VEGF-A/TNF alpha stimulation at 1% oxygen. Silencing of HIF-2 alpha with si-RNA partially restored the inhibition of endothelial sprouting, whereas HIF-1 alpha or HIF-3 alpha by si-RNA had no effect. No involvement of DII4/Notch pathway in the inhibitory effect on endothelial sprouting by prolonged hypoxia was found. In addition, hypoxia decreased the production of urokinase-type plasminogen activator (uPA), needed for migration and invasion, without a significant effect on its inhibitor PAI-1. This was independent of HIF-2 alpha, as si-HIF-2 alpha did not counteract uPA reduction. Conclusion Prolonged culturing of hMVECs at 1% oxygen inhibited endothelial sprouting into fibrin. Two independent mechanisms contribute. Silencing of HIF-2 alpha with si-RNA partially restored the inhibition of endothelial sprouting pointing to a HIF-2 alpha-dependent mechanism. In addition, reduction of uPA contributed to reduced endothelial tube formation in a fibrin matrix during prolonged hypoxia.	[Nauta, Tessa D.; Duyndam, Monique C. A.; Weijers, Ester M.; van Hinsbergh, Victor M. W.; Koolwijk, Pieter] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Physiol, De Boelelaan 1118, NL-1081 HV Amsterdam, Netherlands; [Nauta, Tessa D.; Weijers, Ester M.] A Skin Nederland BV, De Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Koolwijk, P (corresponding author), Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Physiol, De Boelelaan 1118, NL-1081 HV Amsterdam, Netherlands.	p.koolwijk@vumc.nl			Netherlands Institute for Regenerative Medicine (NIRM) [WP 1.6]; ASkin B.V.	Netherlands Institute for Regenerative Medicine (NIRM); ASkin B.V.	This work was supported by a grant (nr. WP 1.6) of the Netherlands Institute for Regenerative Medicine (NIRM) to both the department of Physiology of the VU university Medical Center (VUMC) and the company ASkin B.V. ASkin B.V. provided support in the form of salaries for authors [TDN, EMW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The help of Dr. Marten Engelse in designing the hypoxic workstation is gratefully acknowledged. Moreover, we kindly acknowledge Dr. Robert Szulcek (our laboratory) for providing us with lung microvascular endothelial cells. This work was supported by a grant of the Netherlands Institute for Regenerative Medicine (NIRM).	Albina JE, 2001, AM J PHYSIOL-CELL PH, V281, pC1971, DOI 10.1152/ajpcell.2001.281.6.C1971; Alizadeh N, 2007, WOUND REPAIR REGEN, V15, P809, DOI 10.1111/j.1524-475X.2007.00312.x; Augstein A, 2011, CELL MOL LIFE SCI, V68, P2627, DOI 10.1007/s00018-010-0575-4; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950; Cowburn AS, 2014, J INVEST DERMATOL, V134, P801, DOI 10.1038/jid.2013.395; Davis GE, 2006, J INVEST DERM SYMP P, V11, P44, DOI 10.1038/sj.jidsymp.5650008; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Garcia-Pascual CM, 2013, FERTIL STERIL, V100, P1768, DOI 10.1016/j.fertnstert.2013.08.034; Gawlitta D, 2012, TISSUE ENG PT A, V18, P208, DOI [10.1089/ten.tea.2010.0731, 10.1089/ten.TEA.2010.0731]; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Gong HX, 2015, J CLIN INVEST, V125, P652, DOI 10.1172/JCI77701; Griffith CK, 2009, TISSUE ENG PT A, V15, P2423, DOI 10.1089/ten.tea.2008.0267; Hara S, 2001, BIOCHEM BIOPH RES CO, V287, P808, DOI 10.1006/bbrc.2001.5659; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352; Kobayashi S, 2015, GENES CELLS, V20, P224, DOI 10.1111/gtc.12215; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; Kroon ME, 2000, BLOOD, V96, P2775; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Lafleur MA, 2002, J CELL SCI, V115, P3427; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Makino Y, 2007, J BIOL CHEM, V282, P14073, DOI 10.1074/jbc.M700732200; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; MOSCATELLI D, 1988, BIOCHIM BIOPHYS ACTA, V948, P67, DOI 10.1016/0304-419X(88)90005-4; Nunez-O'Mara A, 2015, J CELL SCI, V128, P40, DOI 10.1242/jcs.151514; Ozaki H, 1997, EXP EYE RES, V64, P505, DOI 10.1006/exer.1996.0239; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; PEPPER MS, 1990, J CELL BIOL, V111, P743, DOI 10.1083/jcb.111.2.743; PHILLIPS PG, 1995, AM J PHYSIOL-LUNG C, V268, pL789, DOI 10.1152/ajplung.1995.268.5.L789; Poitz DM, 2014, MOL IMMUNOL, V57, P226, DOI 10.1016/j.molimm.2013.10.001; Prager GW, 2004, CIRC RES, V94, P1562, DOI 10.1161/01.RES.0000131498.36194.6b; Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rissanen TT, 2002, AM J PATHOL, V160, P1393, DOI 10.1016/S0002-9440(10)62566-7; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tasev D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129935; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; van der Heijden M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023448; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P1426, DOI 10.1161/ATVBAHA.107.139642; VANHINSBERGH VWM, 1987, THROMB HAEMOSTASIS, V57, P148; Wei YH, 2013, P NATL ACAD SCI USA, V110, pE3910, DOI 10.1073/pnas.1309276110; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7	61	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160700	10.1371/journal.pone.0160700	http://dx.doi.org/10.1371/journal.pone.0160700			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490118	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900078
J	Hart, PS; Feldman, L				Hart, P. Sol; Feldman, Lauren			The Influence of Climate Change Efficacy Messages and Efficacy Beliefs on Intended Political Participation	PLOS ONE			English	Article							FEAR APPEALS; MEDIA USE; MITIGATION; IMPACTS; HEALTH; COMMUNICATION; BARRIERS; SCIENCE; THREAT; FRAMES	Using an online survey experiment with a national sample, this study examined how changing the type and valence of efficacy information in news stories discussing global climate change may impact intended political participation through the mediators of perceived internal, external, and response efficacy. Overall, the results revealed that after a single exposure to a news story, stories including positive internal efficacy content increased perceived internal efficacy, while stories including negative external efficacy content lowered perceived external efficacy. There were limited impacts of other types of efficacy content on perceived efficacy. Perceived internal, external, and response efficacy all offered unique, positive associations with intentions to engage in climate change-related political participation. The results suggest that news stories including positive internal efficacy information in particular have the potential to increase public engagement around climate change. The implications for science communication are discussed.	[Hart, P. Sol] Univ Michigan, Dept Commun Studies, Ann Arbor, MI 48109 USA; [Feldman, Lauren] Rutgers State Univ, Sch Commun & Informat, New Brunswick, NJ USA	University of Michigan System; University of Michigan; Rutgers State University New Brunswick	Hart, PS (corresponding author), Univ Michigan, Dept Commun Studies, Ann Arbor, MI 48109 USA.	solhart@umich.edu	Feldman, Lauren/AAL-5195-2020		University of Michigan; Rutgers University; National Science Foundation [SES-1419604]; Divn Of Social and Economic Sciences [1419604] Funding Source: National Science Foundation	University of Michigan(University of Michigan System); Rutgers University; National Science Foundation(National Science Foundation (NSF)); Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by the University of Michigan, Rutgers University, and the National Science Foundation Grant (SES-1419604). Although this research was supported by these organizations, any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of this organization.; The University of Michigan, Rutgers University, and the National Science Foundation Grant (SES-1419604) supported this research. Although these organizations supported this research, any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of this organization.	Aarts K, 2003, J POLIT, V65, P759, DOI 10.1111/1468-2508.00211; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Balch G. I., 1974, POLITICAL METHODOLOG, P1; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Campbell Angus., 1954, VOTER DECIDES; CRAIG SC, 1990, POLITICAL BEHAV, V0012; Feldman L, 2015, COMMUN RES; Feldman L, 2015, PUBLIC UNDERST SCI; Feldman L, 2016, SCI COMMUN, V38, P99, DOI 10.1177/1075547015617941; FINKEL SE, 1985, AM J POLIT SCI, V29, P891, DOI 10.2307/2111186; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Green MC, 2003, NARRATIVE IMPACT SOC; Haines A, 2006, PUBLIC HEALTH, V120, P585, DOI 10.1016/j.puhe.2006.01.002; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hart PS, 2015, NAT CLIM CHANGE, V5, P541, DOI 10.1038/nclimate2577; Hart PS, 2014, SCI COMMUN, V36, P325, DOI 10.1177/1075547013520239; Hart PS, 2013, PUBLIC UNDERST SCI, V22, P785, DOI 10.1177/0963662513482268; Hart PS, 2012, COMMUN RES, V39, P701, DOI 10.1177/0093650211416646; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Jang SM, 2015, GLOBAL ENVIRON CHANG, V32, P11, DOI 10.1016/j.gloenvcha.2015.02.010; Kenski K, 2006, J BROADCAST ELECTRON, V50, P173, DOI 10.1207/s15506878jobem5002_1; Kim S, 2012, SCI COMMUN; Leiserowitz A., 2014, AM ACTIONS LIMIT GLO; Lubell M, 2003, POLIT RES QUART, V56, P309, DOI 10.2307/3219791; Lubell M, 2002, ENVIRON BEHAV, V34, P431, DOI 10.1177/00116502034004002; Lutsey N, 2008, ENERG POLICY, V36, P673, DOI 10.1016/j.enpol.2007.10.018; Maibach E, 2009, SCI COMMUN, V30, P299, DOI 10.1177/1075547008329202; McCluskey MR, 2004, INT J PUBLIC OPIN R, V16, P437, DOI 10.1093/ijpor/edh038; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McCright AM, 2003, SOC PROBL, V50, P348, DOI 10.1525/sp.2003.50.3.348; McKay DL, 2004, HEALTH EDUC BEHAV, V31, P355, DOI 10.1177/1090198104263353; Morman MT, 2000, J APPL COMMUN RES, V28, P91, DOI 10.1080/00909880009365558; Morrell ME, 2003, PUBLIC OPIN QUART, V67, P589, DOI 10.1086/378965; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; NIEMI RG, 1991, AM POLIT SCI REV, V85, P1407, DOI 10.2307/1963953; Nisbet MC, 2009, ENVIRONMENT, V51, P12, DOI 10.3200/ENVT.51.2.12-23; O'Neill SJ, 2013, GEOFORUM, V49, P10, DOI 10.1016/j.geoforum.2013.04.030; Ockwell D, 2009, SCI COMMUN, V30, P305, DOI 10.1177/1075547008328969; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pinkleton BE, 1998, J BROADCAST ELECTRON, V42, P34; POLLOCK PH, 1983, WESTERN POLIT QUART, V36, P400; Rosenstone S. J., 2003, MOBILIZATION PARTICI; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Smalec JL, 2000, J BEHAV MED, V23, P37, DOI 10.1023/A:1005468220077; Stedman RC, 2004, RISK ANAL, V24, P1395, DOI 10.1111/j.0272-4332.2004.00534.x; Sunstein CR, 2003, U CHICAGO LAW REV, V70, P1159, DOI 10.2307/1600573; Tewksbury D, 2008, JOURNALISM MASS COMM, V85, P257, DOI 10.1177/107769900808500203; Thaler RH, 2003, AM ECON REV, V93, P175, DOI 10.1257/000282803321947001; Verba S., 1987, PARTICIPATION AM POL; Whitmarsh L, 2011, GLOBAL ENVIRON CHANG, V21, P56, DOI 10.1016/j.gloenvcha.2010.07.011; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328	57	41	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0157658	10.1371/journal.pone.0157658	http://dx.doi.org/10.1371/journal.pone.0157658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27487117	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800005
J	Mohammad, DK; Ali, RH; Turunen, JJ; Nore, BF; Smith, CIE				Mohammad, Dara K.; Ali, Raja H.; Turunen, Janne J.; Nore, Beston F.; Smith, C. I. Edvard			B Cell Receptor Activation Predominantly Regulates AKT-mTORC1/2 Substrates Functionally Related to RNA Processing	PLOS ONE			English	Article							PROTEIN-KINASE-B; PHOSPHORYLATION; AKT; SURVIVAL; AKT/PKB; MECHANISMS; PKB/AKT; PATHWAY; GROWTH; DOMAIN	Protein kinase B (AKT) phosphorylates numerous substrates on the consensus motif RXRXXpS/T, a docking site for 14-3-3 interactions. To identify novel AKT-induced phosphorylation events following B cell receptor (BCR) activation, we performed proteomics, biochemical and bioinformatics analyses. Phosphorylated consensus motif-specific antibody enrichment, followed by tandem mass spectrometry, identified 446 proteins, containing 186 novel phosphorylation events. Moreover, we found 85 proteins with up regulated phosphorylation, while in 277 it was down regulated following stimulation. Up regulation was mainly in proteins involved in ribosomal and translational regulation, DNA binding and transcription regulation. Conversely, down regulation was preferentially in RNA binding, mRNA splicing and mRNP export proteins. Immunoblotting of two identified RNA regulatory proteins, RBM25 and MEF-2D, confirmed the proteomics data. Consistent with these findings, the AKT-inhibitor (MK-2206) dramatically reduced, while the mTORC-inhibitor PP242 totally blocked phosphorylation on the RXRXXpS/T motif. This demonstrates that this motif, previously suggested as an AKT target sequence, also is a substrate for mTORC1/2. Proteins with PDZ, PH and/or SH3 domains contained the consensus motif, whereas in those with an HMG-box, H15 domains and/or NF-X1-zinc-fingers, the motif was absent. Proteins carrying the consensus motif were found in all eukaryotic clades indicating that they regulate a phylogenetically conserved set of proteins.	[Mohammad, Dara K.; Turunen, Janne J.; Nore, Beston F.; Smith, C. I. Edvard] Karolinska Inst, Karolinska Hosp Huddinge, Dept Lab Med, Clin Res Ctr, SE-14186 Huddinge, Sweden; [Mohammad, Dara K.] Univ Salahaddin, Coll Sci, Dept Biol, Erbil 44002, Kurdistan Regio, Iraq; [Ali, Raja H.] KTH Royal Inst Technol, Swedish E Sci Res Ctr, Sci Life Lab, Sch Comp Sci & Commun, SE-17177 Solna, Sweden; [Nore, Beston F.] Univ Sulaimani, Sch Med, Dept Biochem, Sulaimaniyah, Kurdistan Regio, Iraq	Karolinska Institutet; Karolinska University Hospital; Salahaddin University; Royal Institute of Technology; University of Sulimanyah	Mohammad, DK; Smith, CIE (corresponding author), Karolinska Inst, Karolinska Hosp Huddinge, Dept Lab Med, Clin Res Ctr, SE-14186 Huddinge, Sweden.; Mohammad, DK (corresponding author), Univ Salahaddin, Coll Sci, Dept Biol, Erbil 44002, Kurdistan Regio, Iraq.	dara.mohammad@ki.se; edvard.smith@ki.se	Nore, Beston F./N-9288-2016	Nore, Beston F./0000-0003-3865-2920; Turunen, Janne/0000-0003-0013-0246; SMITH, C. I. Edvard/0000-0003-1907-3392; Mohammad, Dara K./0000-0001-9201-0991; Ali, Raja Hashim/0000-0002-9068-2337	Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government (ERBIL-Iraq); Sigrid Juselius Foundation; Osk. Huttunen Foundation; Swedish Cancer Society; Swedish Research Council; Stockholm County Council (research grant ALF); European Council FP7 grant EURO-PADnet; Erik Edith Fernstrom Stiftelse; CRDF Global (USA); Mount Sinai Hospital, Toronto, Canada	Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government (ERBIL-Iraq); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Osk. Huttunen Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (research grant ALF); European Council FP7 grant EURO-PADnet; Erik Edith Fernstrom Stiftelse; CRDF Global (USA); Mount Sinai Hospital, Toronto, Canada	D.K.M. thanks the Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government (ERBIL-Iraq) for the financial support. J.J.T. has been supported by postdoctoral grants from Sigrid Juselius Foundation and Osk. Huttunen Foundation. The Swedish Cancer Society, the Swedish Research Council, the Stockholm County Council (research grant ALF) and the European Council FP7 grant EURO-PADnet further supported this work. B.F.N. thanks the Erik Edith Fernstrom Stiftelse for providing funding for travel and cooperation with the Mount Sinai Hospital, Toronto, Canada. Additional support to B.F.N. was from CRDF Global (USA).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ali RH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S12; Aman MJ, 1998, J BIOL CHEM, V273, P33922, DOI 10.1074/jbc.273.51.33922; Bauman J, 2009, OLIGONUCLEOTIDES, V19, P1, DOI 10.1089/oli.2008.0161; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blomberg KEM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-233; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonetta L, 2010, NATURE, V468, P851, DOI [10.1038/468851a, 10.1038/468854a, 10.1038/468852a]; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Cheng Y, 2012, MOL CANCER THER, V11, P154, DOI 10.1158/1535-7163.MCT-11-0606; Choi SJ, 2001, NUCLEIC ACIDS RES, V29, P2836, DOI 10.1093/nar/29.13.2836; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cox D M, 2000, Exerc Sport Sci Rev, V28, P33; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; GALSKI H, 1983, BIOCHIM BIOPHYS ACTA, V761, P284, DOI 10.1016/0304-4165(83)90078-8; Gao G, 2013, TRENDS CARDIOVAS MED, V23, P5, DOI 10.1016/j.tcm.2012.08.003; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gong DS, 2013, BIOCHEM J, V450, P85, DOI 10.1042/BJ20121382; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Hyun T, 2000, BLOOD, V96, P3560, DOI 10.1182/blood.V96.10.3560.h8003560_3560_3568; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jiang K, 2009, ENDOCRINOLOGY, V150, P2087, DOI 10.1210/en.2008-0818; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Lamond AI, 1997, TRENDS CELL BIOL, V7, P139, DOI 10.1016/S0962-8924(97)01031-3; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lindsley CW, 2010, CURR TOP MED CHEM, V10, P458, DOI 10.2174/156802610790980602; Liu XF, 2003, J VIROL, V77, P2105, DOI 10.1128/JVI.77.3.2105-2115.2003; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mohammad DK, 2013, MOL CELL BIOL, V33, P3214, DOI 10.1128/MCB.00247-13; Nam SY, 2010, J BIOL CHEM, V285, P31157, DOI 10.1074/jbc.M110.122044; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Okada M, 2008, P NATL ACAD SCI USA, V105, P8649, DOI 10.1073/pnas.0802533105; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Scheid MP, 2001, NAT REV MOL CELL BIO, V2, P760, DOI 10.1038/35096067; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Smith AJ, 2011, PHYSIOLOGY, V26, P181, DOI 10.1152/physiol.00042.2010; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vasudevan KM, 2011, CURR TOP MICROBIOL, V347, P105, DOI 10.1007/82_2010_66; Vu NT, 2013, J BIOL CHEM, V288, P8575, DOI 10.1074/jbc.M112.443333; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Zeng ZH, 2012, BLOOD, V120, P2679, DOI 10.1182/blood-2011-11-393934; Zhang ML, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-150; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9; Zou HF, 2013, J BIOL CHEM, V288, P28824, DOI 10.1074/jbc.M113.505370	67	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160255	10.1371/journal.pone.0160255	http://dx.doi.org/10.1371/journal.pone.0160255			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487157	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800065
J	Zhang, SQ; Chen, Y				Zhang, Shaoqiang; Chen, Yong			CLIMP: Clustering Motifs via Maximal Cliques with Parallel Computing Design	PLOS ONE			English	Article							FACTOR-BINDING SITES; TRANSCRIPTIONAL REGULATORY ELEMENTS; POSITION FREQUENCY MATRICES; DE-NOVO PREDICTION; CHIP-SEQ DATA; SACCHAROMYCES-CEREVISIAE; COREGULATED GENES; GENOME; DATABASE; DROSOPHILA	A set of conserved binding sites recognized by a transcription factor is called a motif, which can be found by many applications of comparative genomics for identifying over-represented segments. Moreover, when numerous putative motifs are predicted from a collection of genome-wide data, their similarity data can be represented as a large graph, where these motifs are connected to one another. However, an efficient clustering algorithm is desired for clustering the motifs that belong to the same groups and separating the motifs that belong to different groups, or even deleting an amount of spurious ones. In this work, a new motif clustering algorithm, CLIMP, is proposed by using maximal cliques and sped up by parallelizing its program. When a synthetic motif dataset from the database JASPAR, a set of putative motifs from a phylogenetic foot-printing dataset, and a set of putative motifs from a ChIP dataset are used to compare the performances of CLIMP and two other high-performance algorithms, the results demonstrate that CLIMP mostly outperforms the two algorithms on the three datasets for motif clustering, so that it can be a useful complement of the clustering procedures in some genome-wide motif prediction pipelines. CLIMP is available at http://sqzhang.cn/climp.html.	[Zhang, Shaoqiang] Tianjin Normal Univ, Coll Comp & Informat Engn, Tianjin, Peoples R China; [Chen, Yong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Chen, Yong] Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Richardson, TX 75083 USA	Tianjin Normal University; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Texas System; University of Texas Dallas	Zhang, SQ (corresponding author), Tianjin Normal Univ, Coll Comp & Informat Engn, Tianjin, Peoples R China.; Chen, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Chen, Y (corresponding author), Univ Texas Dallas, Ctr Syst Biol, Dept Biol Sci, Richardson, TX 75083 USA.	zhangshaoqiang@mail.tjnu.edu.cn; yongchenutd@gmail.com	Zhang, Shaoqiang/M-6802-2019; Zhang, Shaoqiang/E-5367-2010	Zhang, Shaoqiang/0000-0002-4127-0539; Zhang, Shaoqiang/0000-0002-4127-0539	National Natural Science Foundation of China [61572358, 61273228]; Natural Science Foundation of Tianjin [15JCYBJC46600, 16JCYBJC23600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	The publication of this article has been funded by two grants (61572358 to SZ, 61273228 to YC) from the National Natural Science Foundation of China and two grants (15JCYBJC46600 and 16JCYBJC23600 to SZ) from Natural Science Foundation of Tianjin.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Elo LL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr839; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Karp RM, 1972, COMPLEXITY COMPUTER, P85, DOI [10.1126/science.1140748, DOI 10.1126/SCIENCE.1140748]; Kim Hyunmin, 2011, Human Genomics, V5, P117; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liu X, 2001, PAC S BIOCOMPUT; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; MacQueen J, 1967, THE FIFTH BERKELEY S; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MATULA DW, 1990, DISCRETE APPL MATH, V27, P113, DOI 10.1016/0166-218X(90)90133-W; MULLER RU, 1987, J NEUROSCI, V7, P1951; Niu M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1047; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Pietrokovski S, 1996, NUCLEIC ACIDS RES, V24, P3836, DOI 10.1093/nar/24.19.3836; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Qin ZHS, 2003, NAT BIOTECHNOL, V21, P435, DOI 10.1038/nbt802; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SOKAL RR, 1958, U KANSAS SCI B, V38, P1409; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Van Dongen S., 2000, THESIS; van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Vlasblom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-99; Wang T, 2005, P NATL ACAD SCI USA, V102, P17400, DOI 10.1073/pnas.0505147102; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Xu ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008797; Zhang SQ, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S14; Zhang SQ, 2011, BMC BIOINFORMATICS, V12, DOI [10.1186/1471-2105-12-238, 10.1186/1471-2105-12-450]; Zhang SQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-397; Zhang SQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp248; Zhu LHJ, 2011, NUCLEIC ACIDS RES, V39, pD111, DOI 10.1093/nar/gkq858	57	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160435	10.1371/journal.pone.0160435	http://dx.doi.org/10.1371/journal.pone.0160435			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487245	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800077
J	Eom, BW; Joo, J; Park, B; Jo, MJ; Choi, SH; Cho, SJ; Ryu, KW; Kim, YW; Kook, MC				Eom, Bang Wool; Joo, Jungnam; Park, Boram; Jo, Min Jung; Choi, Seung Ho; Cho, Soo-Jeong; Ryu, Keun Won; Kim, Young-Woo; Kook, Myeong-Cherl			Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer	PLOS ONE			English	Article							BETA-CATENIN; E-CADHERIN; EXPRESSION; MARKER; PROTEIN	Background Treatment strategy for early gastric cancer depends on the probability of lymph node metastasis. The aim of this study is to develop a nomogram predicting lymph node metastasis in early gastric cancer using clinicopathological factors and biomarkers. Methods A literature review was performed to identify biomarkers related to lymph node metastasis in gastric cancer. Seven markers were selected and immunohistochemistry was performed in 336 early gastric cancer tissues. Based on the multivariable analysis, a prediction model including clinicopatholgical factors and biomarkers was developed, and benefit of adding biomarkers was evaluated using the area under the receiver operating curve and net reclassification improvement. Functional study in gastric cancer cell line was performed to evaluate mechanism of biomarker. Results Of the seven biomarkers studied, alpha 1 catenin and CD44v6 were significantly associated with lymph node metastasis. A conventional prediction model, including tumor size, histological type, lymphatic blood vessel invasion, and depth of invasion, was developed. Then, a new prediction model including both clinicopathological factors and CD44v6 was developed. Net reclassification improvement analysis revealed a significant improvement of predictive performance by the addition of CD44v6, and a similar result was shown in the internal validation using bootstrapping. Prediction nomograms were then constructed based on these models. In the functional study, CD44v6 was revealed to affect cell proliferation, migration and invasion. Conclusions Overexpression of CD44v6 was a significant predictor of lymph node metastasis in early gastric cancer. The prediction nomograms incorporating CD44v6 can be useful to determine treatment plans in patients with early gastric cancer.	[Eom, Bang Wool; Choi, Seung Ho] Yonsei Univ, Grad Sch Med, Dept Med, Seoul, South Korea; [Eom, Bang Wool; Jo, Min Jung; Cho, Soo-Jeong; Ryu, Keun Won; Kim, Young-Woo; Kook, Myeong-Cherl] Natl Canc Ctr, Res Inst & Hosp, Gastr Canc Branch, Goyang, Gyeonggi Do, South Korea; [Joo, Jungnam; Park, Boram] Natl Canc Ctr, Res Inst Natl Canc Control & Evaluat, Canc Biostat Branch, Goyang, Gyeonggi Do, South Korea	Yonsei University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Kook, MC (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Gastr Canc Branch, Goyang, Gyeonggi Do, South Korea.	mckook@ncc.re.kr	Eom, Bang Wool/K-4412-2016	Eom, Bang Wool/0000-0002-0332-2051; Park, Boram/0000-0003-2683-8795; Kim, Young-Woo/0000-0002-1559-9672; CHO, SOO-JEONG/0000-0001-7144-0589	National Cancer Center, South Korea [1341060-1, 1210060-3]	National Cancer Center, South Korea	This study was supported by grant no. 1341060-1 and 1210060-3 from the National Cancer Center, South Korea.	Castella EM, 1998, J CLIN PATHOL, V51, P134, DOI 10.1136/jcp.51.2.134; Che XM, 1999, ONCOLOGY-BASEL, V57, P131, DOI 10.1159/000012020; Chen JW, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/786543; Edge SB, 2010, AJCC CANC STAGING MA; Fenoglio-Reiser C C F, 2000, PATHOLOGY GENETICS T, P39; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; Gupta A, 2013, SCI WORLD J, DOI 10.1155/2013/493689; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; He LJ, 2012, ASIAN PAC J CANCER P, V13, P3173, DOI 10.7314/APJCP.2012.13.7.3173; HOFMANN M, 1991, CANCER RES, V51, P5292; HONG RL, 1995, ONCOLOGY-BASEL, V52, P334; Huang S, 2013, EUR J HISTOCHEM, V57, P1, DOI 10.4081/ejh.2013.e1; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jee YS, 2009, BRIT J SURG, V96, P1157, DOI 10.1002/bjs.6686; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Joo M, 2003, ANTICANCER RES, V23, P1581; Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285; Kang HJ, 2010, GASTROINTEST ENDOSC, V72, P508, DOI 10.1016/j.gie.2010.03.1077; Kim JH, 2012, ANN SURG ONCOL, V19, P779, DOI 10.1245/s10434-011-2081-9; Kurozumi K, 1998, WORLD J SURG, V22, P853, DOI 10.1007/s002689900481; Lee JH, 2014, J GASTRIC CANCER, V14, P87, DOI [10.5230/jgc.2014.14.2.87, 10.7583/JKGS.2014.14.5.87]; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Muller W, 1997, J PATHOL, V183, P222, DOI 10.1002/(SICI)1096-9896(199710)183:2<222::AID-PATH923>3.0.CO;2-C; Okayama H, 2009, ONCOL REP, V22, P745, DOI 10.3892/or_00000496; Ooki A, 2009, ONCOL REP, V21, P1467, DOI 10.3892/or_00000376; Pan WS, 2003, J SURG ONCOL, V82, P104, DOI 10.1002/jso.10204; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ramesh S, 1999, BRIT J CANCER, V81, P1392, DOI 10.1038/sj.bjc.6693437; Xin Y, 2001, APPL IMMUNOHISTO M M, V9, P138, DOI 10.1097/00022744-200106000-00006; YONEMURA Y, 1992, ONCOLOGY, V49, P363; Yoshii T, 2013, TUMORI, V99, P234, DOI 10.1700/1283.14198; Zhang Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-103	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159424	10.1371/journal.pone.0159424	http://dx.doi.org/10.1371/journal.pone.0159424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482895	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700010
J	Frances, A; Hildur, K; Barbera, JA; Rodriguez-Trigo, G; Zock, JP; Giraldo, J; Monyarch, G; Rodriguez-Rodriguez, E; Reis, FD; Souto, A; Gomez, FP; Pozo-Rodriguez, F; Templado, C; Fuster, C				Frances, Alexandra; Hildur, Kristin; Albert Barbera, Joan; Rodriguez-Trigo, Gema; Zock, Jan-Paul; Giraldo, Jesus; Monyarch, Gemma; Rodriguez-Rodriguez, Emma; de Castro Reis, Fernanda; Souto, Ana; Gomez, Federico P.; Pozo-Rodriguez, Francisco; Templado, Cristina; Fuster, Carme			Persistence of Breakage in Specific Chromosome Bands 6 Years after Acute Exposure to Oil	PLOS ONE			English	Article							COMMON FRAGILE SITES; PRESTIGE OIL; OCCUPATIONAL-EXPOSURE; RESPIRATORY SYMPTOMS; REPAIR CAPACITY; CLEANUP WORKERS; BENZENE; CANCER; DNA; LYMPHOCYTES	Background The identification of breakpoints involved in chromosomal damage could help to detect genes involved in genetic disorders, most notably cancer. Until now, only one published study, carried out by our group, has identified chromosome bands affected by exposure to oil from an oil spill. In that study, which was performed two years after the initial oil exposure in individuals who had participated in clean-up tasks following the wreck of the Prestige, three chromosomal bands (2q21, 3q27, 5q31) were found to be especially prone to breakage. A recent follow-up study, performed on the same individuals, revealed that the genotoxic damage had persisted six years after oil exposure. Objectives To determine whether there exist chromosome bands which are especially prone to breakages and to know if there is some correlation with those detected in the previous study. In addition, to investigate if the DNA repair problems detected previously persist in the present study. Design Follow-up study performed six years after the Prestige oil spill. Setting Fishermen cooperatives in coastal villages. Participants Fishermen highly exposed to oil spill who participated in previous genotoxic study six years after the oil. Measurements Chromosome damage in peripheral lymphocytes. For accurate identification of the breakpoints involved in chromosome damage of circulating lymphocytes, a sequential stain/Gbanding technique was employed. To determine the most break-prone chromosome bands, two statistical methods, the Fragile Site Multinomial and the chi-square tests ( where the bands were corrected by their length) were used. To compare the chromosome lesions, structural chromosome alterations and gaps/breaks between two groups of individuals we used the GEE test which takes into account a possible within-individual correlation. Dysfunctions in DNA repair mechanisms, expressed as chromosome damage, were assessed in cultures with aphidicolin by the GEE test. Results Cytogenetic analyses were performed in 47 exposed individuals. A total of 251 breakpoints in exposed individuals) were identified, showing a non-uniform distribution in the human ideogram. Ten chromosome bands were found to be especially prone to breakage through both statistical methods. By comparing these bands with those observed in certain exposed individuals who had already participated the previous study, it was found in both studies that four bands (2q21, 3q27, 5q31 and 17p11.2) are particularly sensitive to breakage. Additionally, the dysfunction in DNA repair mechanisms was not significantly higher in oil-exposed individuals than in non-exposed individuals. Limitations The sample size and the possibility of some kind of selection bias should be considered. Genotoxic results cannot be extrapolated to the high number of individuals who participated occasionally in clean-up tasks. Conclusion Our findings show the existence of at least four target bands (2q21, 3q27, 5q31 and 17p11.2) with a greater propensity to break over time after an acute exposure to oil. The breaks in these bands, which are commonly involved in hematological cancer, may explain the increase of cancer risk reported in chronically benzene-exposed individuals. In addition, a more efficiency of the DNA repair mechanisms has been detected six years after in fishermen who were highly exposed to the oil spill. To date, only this study, performed by our group on the previous and present genotoxic effects, has analyzed the chromosomal regions affected by breakage after an acute oil exposure.	[Frances, Alexandra; Hildur, Kristin; Monyarch, Gemma; de Castro Reis, Fernanda; Templado, Cristina; Fuster, Carme] UAM, Fac Med, Unitat Biol Cellular & Genet Med, Bellaterra, Spain; [Albert Barbera, Joan; Rodriguez-Trigo, Gema; Gomez, Federico P.; Pozo-Rodriguez, Francisco] CIBERES, Bunyola, Mallorca, Spain; [Albert Barbera, Joan; Gomez, Federico P.] Hosp Clin Inst Invest Biomed August Pi & Sunyer I, Dept Resp Med, Barcelona, Spain; [Rodriguez-Trigo, Gema] Hosp Clin San Carlos, Dept Resp Med, Madrid, Spain; [Zock, Jan-Paul] Ctr Recerca Epidemiol Ambiental CREAL, Barcelona, Spain; [Zock, Jan-Paul] Hosp del Mar, Inst Recerca Med, Barcelona, Spain; [Zock, Jan-Paul] CIBERESP, Barcelona, Spain; [Giraldo, Jesus] UAB, Fac Med, Inst Neurociencies, Bellaterra, Spain; [Giraldo, Jesus] UAB, Fac Med, Unitat Bioestadist, Bellaterra, Spain; [Rodriguez-Rodriguez, Emma; Souto, Ana] Complexo Hosp Univ A Coruna, Dept Resp Med, La Coruna, Spain; [Pozo-Rodriguez, Francisco] Hosp 12 Octubre, Dept Resp Med, Unidad Epidemiol Clin, Madrid, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Clinico San Carlos; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; Autonomous University of Barcelona; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Universitario 12 de Octubre	Fuster, C (corresponding author), UAM, Fac Med, Unitat Biol Cellular & Genet Med, Bellaterra, Spain.	carme.fuster@uab.es	Zock, Jan-Paul/P-5034-2018; Giraldo, Jesus/F-9881-2011	Zock, Jan-Paul/0000-0002-2941-6259; Giraldo, Jesus/0000-0001-7082-4695	Health Institute Carlos III FEDER/ERDF [PI03/1685, PI07/0086]; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Comissionat per a Universitats i Recerca from Generalitat de Catalunya [SGR14-903, FI-00312]; Centro de Investigacion en Red de Enfermedades Respiratorias; Universidad Autonoma de Barcelona [PS-456-01/08]	Health Institute Carlos III FEDER/ERDF; Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR); Comissionat per a Universitats i Recerca from Generalitat de Catalunya; Centro de Investigacion en Red de Enfermedades Respiratorias; Universidad Autonoma de Barcelona	This work was supported by Health Institute Carlos III FEDER/ERDF (PI03/1685; PI07/0086), Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR), Comissionat per a Universitats i Recerca from Generalitat de Catalunya (SGR14-903; FI-00312), Centro de Investigacion en Red de Enfermedades Respiratorias and Universidad Autonoma de Barcelona (PS-456-01/08). The different sponsors were not involved in the design of the study, sample collection, cytogenetic analysis, interpretation of the data, or preparation and revision of the manuscript.	Aguilera F, 2010, J APPL TOXICOL, V30, P291, DOI 10.1002/jat.1521; AKSOY M, 1985, AM J IND MED, V7, P395, DOI 10.1002/ajim.4700070506; Aqeilan RI, 2014, CELL MOL LIFE SCI, V71, P4487, DOI 10.1007/s00018-014-1716-y; Au WW, 2007, INT J HYG ENVIR HEAL, V210, P239, DOI 10.1016/j.ijheh.2006.11.001; Barregard L, 2009, ENVIRON RES, V109, P985, DOI 10.1016/j.envres.2009.09.001; Biern G, 2015, J MAR SCI ENG, V3, P1334, DOI 10.3390/jmse3041334; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Chanvaivit S, 2007, MUTAT RES-GEN TOX EN, V626, P79, DOI 10.1016/j.mrgentox.2006.09.007; CLARE MG, 1984, BRIT J IND MED, V41, P249; Cole J, 1997, ENVIRON MOL MUTAGEN, V30, P97; D'Andrea MA, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.04.035; De Braekeleer E, 2014, LEUKEMIA LYMPHOMA, V55, P1189, DOI 10.3109/10428194.2013.820292; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; Douet-Guilbert N, 2014, CANCER GENET-NY, V207, P83, DOI 10.1016/j.cancergen.2014.02.009; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Fu XJ, 2015, INT J HYG ENVIR HEAL, V218, P313, DOI 10.1016/j.ijheh.2015.01.001; Georgakilas AG, 2014, CELL MOL LIFE SCI, V71, P4519, DOI 10.1007/s00018-014-1717-x; Goldstein BD, 2011, NEW ENGL J MED, V364, P1334, DOI 10.1056/NEJMra1007197; Greenbaum IF, 1997, HUM GENET, V101, P109, DOI 10.1007/s004390050596; Hallberg LM, 1997, MUTAT RES-DNA REPAIR, V383, P213, DOI 10.1016/S0921-8777(97)00004-9; Hildur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132413; IARC International Agency for Research on Cancer, 1998, IRAC MONOGRAPHS CARC; Kim SY, 2004, PHARMACOGENETICS, V14, P453, DOI 10.1097/01.fpc.0000114751.08559.7b; Laffon B, 2006, FOOD CHEM TOXICOL, V44, P1714, DOI 10.1016/j.fct.2006.05.010; Laffon B, 2014, MUTAT RES-GEN TOX EN, V760, P10, DOI 10.1016/j.mrgentox.2013.09.013; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marcon F, 2002, MUTAGENESIS, V17, P157, DOI 10.1093/mutage/17.2.157; Monyarch G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081276; Mrasek K, 2010, INT J ONCOL, V36, P929, DOI 10.3892/ijo_00000572; Navasumrit P, 2005, CHEM-BIOL INTERACT, V153, P75, DOI 10.1016/j.cbi.2005.03.010; Norppa H, 2006, MUTAT RES-FUND MOL M, V600, P37, DOI 10.1016/j.mrfmmm.2006.05.030; Perez-Cadahia B, 2008, MUTAT RES-GEN TOX EN, V653, P117, DOI 10.1016/j.mrgentox.2008.04.002; Perez-Cadahia B, 2008, CHEMOSPHERE, V71, P447, DOI 10.1016/j.chemosphere.2007.10.053; Perez-Cadahia B, 2007, ENVIRON INT, V33, P176, DOI 10.1016/j.envint.2006.09.006; Perez-Cadahia B, 2006, THESCIENTIFICWORLDJO, V6, P1221, DOI 10.1100/tsw.2006.206; Perez-Cadahia B, 2008, ENVIRON HEALTH INSIG, V2, P83; Rodriguez-Trigo G, 2010, ANN INTERN MED, V153, P489, DOI 10.7326/0003-4819-153-8-201010190-00279; Salerno C, 2013, INT J ENVIRON HEAL R, V23, P342, DOI 10.1080/09603123.2012.733938; SASIADEK M, 1989, MUTAT RES, V224, P235; Schnatter AR, 2012, J NATL CANCER I, V104, P1724, DOI 10.1093/jnci/djs411; Shaffer L.G., 2013, INT SYSTEM HUMAN CYT; Slyskova J, 2011, ENVIRON MOL MUTAGEN, V52, P511, DOI 10.1002/em.20650; Speit G, 2013, MUTAGENESIS, V28, P145, DOI 10.1093/mutage/ges063; Stillman WS, 2000, EXP HEMATOL, V28, P169, DOI 10.1016/S0301-472X(99)00144-7; Zhang L, 2012, JOVE-J VIS EXP, V60, DOI [10.3791/3619.10.3791/36192015.01.001, DOI 10.3791/36192015.01.001]; Zhang LP, 1998, LEUKEMIA RES, V22, P105, DOI 10.1016/S0145-2126(97)00157-4; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC; Zock JP, 2012, OCCUP ENVIRON MED, V69, P508, DOI 10.1136/oemed-2011-100614; Zusman M, 2012, SCI TOTAL ENVIRON, V441, P265, DOI 10.1016/j.scitotenv.2012.09.054	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159404	10.1371/journal.pone.0159404	http://dx.doi.org/10.1371/journal.pone.0159404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479010	Green Published, gold			2022-12-27	WOS:000381110300012
J	Zhu, FY; Xu, S; Zhang, YS; Chen, FM; Ji, JJ; Xie, GQ				Zhu, Feiye; Xu, Shan; Zhang, Yongsheng; Chen, Fangming; Ji, Jinjun; Xie, Guanqun			Total Glucosides of Paeony Promote Intestinal Motility in Slow Transit Constipation Rats through Amelioration of Interstitial Cells of Cajal	PLOS ONE			English	Article							SIGMOID COLON; KIT; NERVES	Objectives Using an atropine-diphenoxylate-induced slow transit constipation (STC) model, this study explored the effects of the total glucosides of paeony (TGP) in the treatment of STC and the possible mechanisms. Study Design A prospective experimental animal study. Methods The constipation model was set up in rats with an oral gavage of atropine-diphenoxylate and then treated with the TGP. The volume and moisture content of the faeces were observed and the intestinal kinetic power was evaluated. Meanwhile, the colorimetric method and enzyme linked immunosorbent assay (ELISA) were employed to determine the changes of nitric oxide (NO), nitric oxide synthase (NOS), vasoative intestinal peptide (VIP) and the P substance (SP) in the serum, respectively. The protein expressions of c-kit and stem cell factor (SCF) were assessed by immunohistochemical analysis and western blot, respectively, and the mRNA level of c-kit was measured by a reverse transcription polymerase chain reaction (RT-PCR). Results The TGP attenuated STC responses in terms of an increase in the fecal volume and moisture content, an enhancement of intestinal transit rate and the reduction of NO, NOS and VIP in the serum. In addition, the c-kit, a labeling of interstitial cells of Cajal (ICC) increased at both protein and mRNA levels. SCF, which serves as a ligand of c-kit also increased at protein level. Conclusion The analysis of our data indicated that the TGP could obviously attenuate STC through improving the function of ICC and blocking the inhibitory neurotransmitters such as NO, NOS and VIP.	[Zhu, Feiye] Zhejiang Chinese Med Univ, Ctr Anal & Testing, Hangzhou, Zhejiang, Peoples R China; [Xu, Shan; Ji, Jinjun; Xie, Guanqun] Zhejiang Chinese Med Univ, Coll Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yongsheng] Lib Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China; [Chen, Fangming] Zhejiang Chinese Med Univ, Lab Anim Ctr, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Xie, GQ (corresponding author), Zhejiang Chinese Med Univ, Coll Basic Med Sci, Hangzhou, Zhejiang, Peoples R China.	xieguanqun@163.com			National Key Basic Research Program of China (973 Plan) [2014CB543001]; Scientific Research Fund of Zhejiang Provincial Education Department [Y201017092]	National Key Basic Research Program of China (973 Plan)(National Basic Research Program of China); Scientific Research Fund of Zhejiang Provincial Education Department	This study was supported by National Key Basic Research Program of China (973 Plan) (2014CB543001) and Scientific Research Fund of Zhejiang Provincial Education Department (No: Y201017092). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Bassotti G, 2003, ARCH SURG-CHICAGO, V138, P1302, DOI 10.1001/archsurg.138.12.1302; Bassotti G, 2006, WORLD J GASTROENTERO, V12, P4609, DOI 10.3748/wjg.v12.i29.4609; Bassotti G, 2005, WORLD J GASTROENTERO, V11, P2691, DOI 10.3748/wjg.v11.i18.2691; Bharucha AE, 2001, GASTROENTEROL CLIN N, V30, P77, DOI 10.1016/S0889-8553(05)70168-0; Faussone-Pellegrini MS, 2006, J CELL MOL MED, V10, P20, DOI 10.1111/j.1582-4934.2006.tb00288.x; He DY, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00010; Hutson JM, 2001, J PAEDIATR CHILD H, V37, P426, DOI 10.1046/j.1440-1754.2001.00692.x; King SK, 2010, NEUROGASTROENT MOTIL, V22, P883, DOI 10.1111/j.1365-2982.2010.01524.x; Lee JI, 2005, J GASTROEN HEPATOL, V20, P1292, DOI 10.1111/j.1440-1746.2005.03809.x; Li J, 1991, CHINESE PHARMACOL B, V1, P53; Long JW, 2010, CHIN J INTEGR MED, V16, P353, DOI 10.1007/s11655-010-0504-2; Lyford GL, 2002, GUT, V51, P496, DOI 10.1136/gut.51.4.496; Mostafa RM, 2010, WORLD J GASTROENTERO, V16, P3239, DOI 10.3748/wjg.v16.i26.3239; Sanders KM, 2007, J PHYSIOL-LONDON, V578, P33, DOI 10.1113/jphysiol.2006.122473; Schiller Lawrence R, 2004, Rev Gastroenterol Disord, V4 Suppl 2, pS43; Shan JJ, 2010, PHYTOTHER RES, V24, P1734, DOI 10.1002/ptr.3212; Takaki Miyako, 2003, Journal of Smooth Muscle Research, V39, P137, DOI 10.1540/jsmr.39.137; Tong WD, 2005, INT J COLORECTAL DIS, V20, P363, DOI 10.1007/s00384-004-0679-0; Tong WD, 2004, INT J COLORECTAL DIS, V19, P467, DOI 10.1007/s00384-003-0577-x; Wang JP, 2013, CELL TISSUE RES, V352, P479, DOI 10.1007/s00441-013-1572-3; Wedel T, 2002, GASTROENTEROLOGY, V123, P1459, DOI 10.1053/gast.2002.36600; Wu YG, 2009, J PHARMACOL SCI, V109, P78, DOI 10.1254/jphs.08112FP; Xu HM, 2007, J ETHNOPHARMACOL, V109, P442, DOI 10.1016/j.jep.2006.08.019; Xu J, 2012, BMC COMPLEM ALTERN M, V9, P12; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055	26	32	37	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160398	10.1371/journal.pone.0160398	http://dx.doi.org/10.1371/journal.pone.0160398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27478893	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300047
J	Debes, JD; Wassaf, MM; Pisano, MB; Isa, MB; Lotto, M; Marianelli, LG; Frassone, N; Ballari, E; Bohjanen, PR; Hansen, BE; Re, V				Debes, Jose D.; Martinez Wassaf, Maribel; Belen Pisano, Maria; Beatriz Isa, Maria; Lotto, Martin; Marianelli, Leonardo G.; Frassone, Natalia; Ballari, Estefania; Bohjanen, Paul R.; Hansen, Bettina E.; Re, Viviana			Increased Hepatitis E Virus Seroprevalence Correlates with Lower CD4+Cell Counts in HIV-Infected Persons in Argentina	PLOS ONE			English	Article							ORGAN-TRANSPLANT RECIPIENTS; LIVER	Hepatitis E virus (HEV) is a single-stranded RNA virus that can cause hepatitis in an epidemic fashion. HEV usually causes asymptomatic or limited acute infections in immunocompetent individuals, whereas in immunosuppressed individuals such as transplant recipients, HEV can cause chronic infections. The risks and outcomes of HEV co-infection in patients infected with human immunodeficiency virus (HIV) are poorly characterized. We used a third generation immunoassay to measure serum IgG antibodies specific for HEV in 204 HIV-infected individuals from Argentina and a control group of 433 HIV-negative individuals. We found 15 of 204 (7.3%, 95% CI 3.74-10.96%) individuals in the HIV-positive group to have positive HEV IgG levels suggestive of previous infection, compared to 19 of 433 (4.4%, 95% CI 2.5-6.3%) individuals in the HIV-negative control group (p = 0.12). Among HIV-positive individuals, those with HEV seropositivity had lower CD4 counts compared to those that were HEV seronegative (average CD4 count of 234 vs 422 mm(3), p = 0.01), indicating that patients with lower CD4 counts were more likely to be HEV IgG positive. Moreover, HEV seropositivity in patients with CD4 counts <200 mm(3) was 16%, compared to 4.5% in those with CD4 counts >200 mm(3) (p = 0.012). We found a positive PCR result for HEV in one individual. Our study found that increased seroprevalence of HEV IgG correlated with lower CD4 counts in HIV-infected patients in Argentina.	[Debes, Jose D.; Bohjanen, Paul R.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Martinez Wassaf, Maribel] LACE, Dept Virol, Cordoba, Argentina; [Belen Pisano, Maria; Beatriz Isa, Maria; Lotto, Martin; Re, Viviana] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Cordoba, Argentina; [Marianelli, Leonardo G.; Frassone, Natalia; Ballari, Estefania] Hosp Rawson, Cordoba, Argentina; [Hansen, Bettina E.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; National University of Cordoba; Erasmus University Rotterdam; Erasmus MC	Debes, JD (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	debes003@umn.edu	Debes, Jose/Q-9794-2016	Lotto, Martin/0000-0002-9437-5270	Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba [PID 2012 MINCyT-Cba]; Agencia Nacional de Promocion Cientifica y Tecnologica-Foncyt [PICT-2014 2537]; American College of Gastroenterology CRA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI096925] Funding Source: NIH RePORTER	Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia Nacional de Promocion Cientifica y Tecnologica-Foncyt(ANPCyTFONCyT); American College of Gastroenterology CRA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from Ministerio de Ciencia y Tecnologia, Gobierno de la Provincia de Cordoba to VR (PID 2012 MINCyT-Cba), Agencia Nacional de Promocion Cientifica y Tecnologica-Foncyt to MBP (PICT-2014 2537), and American College of Gastroenterology CRA to JD; MBP and VER are members of the researcher career from Consejo Nacional de Investigaciones Cientificas - CONICET - Argentina.	Abravanel F, 2014, J INFECT DIS, V209, P1900, DOI 10.1093/infdis/jiu032; Brochot E, 2014, NEW ENGL J MED, V370, P2446, DOI 10.1056/NEJMc1405191; Fujiwara S, 2014, J VIRAL HEPATITIS, V21, P78, DOI 10.1111/jvh.12156; Haagsma EB, 2009, LIVER TRANSPLANT, V15, P1225, DOI 10.1002/lt.21819; Hering T, 2014, J MED VIROL, V86, P948, DOI 10.1002/jmv.23915; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Isa MB, 2014, EPIDEMIOL INFECT, V142, P1708, DOI 10.1017/S0950268813002628; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kenfak-Foguena A, 2011, EMERG INFECT DIS, V17, P1074, DOI [10.3201/eid1706.101067, 10.3201/eid/1706.101067]; Martinez Wassaf MG, 2014, J CLIN VIROL; Pas SD, 2013, J CLIN VIROL, V58, P629, DOI 10.1016/j.jcv.2013.10.010; Pineda JA, 2014, AIDS, V28, P1931, DOI 10.1097/QAD.0000000000000378; Pischke S, 2010, Minerva Gastroenterol Dietol, V56, P121; Sherman KE, 2014, J VIRAL HEPATITIS, V21, pE74, DOI 10.1111/jvh.12233	15	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160082	10.1371/journal.pone.0160082	http://dx.doi.org/10.1371/journal.pone.0160082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467394	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100107
J	He, SM; Wang, MW; Yang, ZY; Zhang, JP; Zhang, YP; Luo, JM; Zhang, YJ				He, Simin; Wang, MingWei; Yang, ZhongYi; Zhang, JianPing; Zhang, YongPing; Luo, JianMin; Zhang, YingJian			Comparison of F-18-FES, F-18-FDG, and F-18-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTORS; RESISTANCE; F-18-FLUOROMISONIDAZOLE; TAMOXIFEN; TOOL	Background There is an increasing need to characterize biological processes for early prediction and monitoring of response to endocrine therapy in breast cancer using multiple positron emission tomography (PET) imaging probes. However, use of more than two PET tracers in a single clinical trial is quite challenging. In this study we carried out a longitudinal investigation of F-18-FES, F-18-FDG, and F-18-FMISO PET imaging probes for early prediction and monitoring of response to endocrine therapy in a mouse xenograft model of estrogen receptor (ER)-positive breast cancer. Method ER+ human breast cancer ZR-75-1 models were established in female mice that were then randomly assigned to a treatment (fulvestrant, 5.0 mg/ week for 21 days) or vehicle group. Micro-PET/CT imaging with F-18-FES, F-18-FDG, and F-18-FMISO was performed on days 0, 3, 14, and 21 after treatment. The uptake value (percentage injected dose per gram, % ID/g) for each probe in tumor (T) tissue and contralateral muscle (M) was measured for quantitative analysis and T/M calculation. Tumor volume was measured to record tumor growth at each time point. Tumor tissues were sampled for immunohistochemical staining of ER expression. Correlations for tumor volume and ER alpha levels with uptake data for the probe were tested. Results Uptake data for F-18-FES in ZR-75-1 tumor tissues corresponded well with tumor response to endocrine therapy, but not for F-18-FDG and F-18-FMISO, according to longitudinal micro-PET/CT imaging and quantitative correlation analysis. There was a significant positive correlation between F-18-FES uptake and ER levels (%ID/g(max) r(2) = 0.76, P< 0.05; T/M r(2) = 0.82, P< 0.05). Notably, F-18-FES uptake on day 3 was significantly correlated with the day 21/baseline tumor volume ratio (%ID/g(max) r(2) = 0.74, P< 0.05; T/M r(2) = 0.78, P < 0.05). Conclusions Comparison of F-18-FES, F-18-FDG, and F-18-FMISO probes revealed that F-18-FES PET/CT molecular imaging can provide a precise early prediction of tumor response to endocrine therapy in ER+ breast cancer in a ZR-75-1 xenograft model. This molecular imaging strategy with F-18-FES PET/CT will be useful in evaluating the efficacy of endocrine therapies and in developing new endocrine drugs.	[He, Simin; Wang, MingWei; Yang, ZhongYi; Zhang, JianPing; Zhang, YongPing; Luo, JianMin; Zhang, YingJian] Fudan Univ, Shanghai Canc Ctr, Dept Nucl Med, Shanghai, Peoples R China; [He, Simin; Wang, MingWei; Yang, ZhongYi; Zhang, JianPing; Zhang, YongPing; Luo, JianMin; Zhang, YingJian] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [He, Simin; Wang, MingWei; Yang, ZhongYi; Zhang, JianPing; Zhang, YongPing; Luo, JianMin; Zhang, YingJian] Fudan Univ, Ctr Biomed Imaging, Shanghai, Peoples R China; [He, Simin; Wang, MingWei; Yang, ZhongYi; Zhang, JianPing; Zhang, YongPing; Luo, JianMin; Zhang, YingJian] Shanghai Engn Res Ctr Mol Imaging Probes, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, YJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Nucl Med, Shanghai, Peoples R China.; Zhang, YJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.; Zhang, YJ (corresponding author), Fudan Univ, Ctr Biomed Imaging, Shanghai, Peoples R China.; Zhang, YJ (corresponding author), Shanghai Engn Res Ctr Mol Imaging Probes, Shanghai, Peoples R China.	yjzhang111@aliyun.com	Luo, jian/HGE-7331-2022	Wang, Ming-Wei/0000-0003-0020-4700	Science and Technology Commission of Shanghai Municipality of China [12431900208, 15ZR1407600, 14DZ2251400]; National Natural Science Foundation of China [11275050]	Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Science and Technology Commission of Shanghai Municipality of China (12431900208, 15ZR1407600, 14DZ2251400) and partly by National Natural Science Foundation of China (11275050).	Blamey RW, 2010, EUR J CANCER, V46, P56, DOI 10.1016/j.ejca.2009.09.009; Blasberg Ronald G, 2002, Mol Imaging, V1, P280; Campanile C, 2013, J NUCL MED, V54, P1362, DOI 10.2967/jnumed.112.115527; Cheng JY, 2013, J NUCL MED, V54, P333, DOI 10.2967/jnumed.112.111963; Chitneni SK, 2013, J NUCL MED, V54, P1339, DOI 10.2967/jnumed.112.116293; Chodosh LA, 2006, J MAMMARY GLAND BIOL, V11, P101, DOI 10.1007/s10911-006-9016-2; Curran S D, 2006, Cancer Imaging, V6, pS126, DOI 10.1102/1470-7330.2006.9039; Fowler AM, 2012, J NUCL MED, V53, P1119, DOI 10.2967/jnumed.112.103465; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Heidari P, 2015, CLIN CANCER RES, V21, P1340, DOI 10.1158/1078-0432.CCR-14-1178; Howell A, 2006, CRIT REV ONCOL HEMAT, V57, P265, DOI 10.1016/j.critrevonc.2005.08.001; Jia XQ, 2015, ONCOTARGET, V6, P8648, DOI 10.18632/oncotarget.3257; Lee ST, 2007, SEMIN NUCL MED, V37, P451, DOI 10.1053/j.semnuclmed.2007.07.001; MCGUIRE AH, 1991, J NUCL MED, V32, P1526; MINTUN MA, 1988, RADIOLOGY, V169, P45, DOI 10.1148/radiology.169.1.3262228; Mortimer JE, 2001, J CLIN ONCOL, V19, P2797, DOI 10.1200/JCO.2001.19.11.2797; Mouridsen H, 2001, J CLIN ONCOL, V19, P2596, DOI 10.1200/JCO.2001.19.10.2596; Peterson LM, 2008, J NUCL MED, V49, P367, DOI 10.2967/jnumed.107.047506; Peterson LM, 2014, MOL IMAGING BIOL, V16, P431, DOI 10.1007/s11307-013-0699-7; RASEY JS, 1990, RADIAT RES, V122, P301, DOI 10.2307/3577760; Specht JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3094; Sun YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116341; Tsujikawa T, 2008, ANN NUCL MED, V22, P73, DOI 10.1007/s12149-007-0075-2; van Kruchten M, 2013, LANCET ONCOL, V14, pE465, DOI 10.1016/S1470-2045(13)70292-4; van Kruchten M, 2012, J NUCL MED, V53, P182, DOI 10.2967/jnumed.111.092734; Wahl RL, 2001, J NUCL MED S1, p122S; Wang Mingwei, 2008, Nuclear Techniques, V31, P460; Yang M, 2011, MOL PHARMACEUT, V8, P621, DOI 10.1021/mp100446t; Yang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078192; Zhang YP, 2011, CHIN J NUCL MED, V3, P196	30	14	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159916	10.1371/journal.pone.0159916	http://dx.doi.org/10.1371/journal.pone.0159916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467716	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100071
J	Bourque, PR; Pringle, CE; Cameron, W; Cowan, J; Chardon, JW				Bourque, P. R.; Pringle, C. E.; Cameron, W.; Cowan, J.; Chardon, J. Warman			Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study	PLOS ONE			English	Article							PRIMARY ANTIBODY DEFICIENCIES; MULTIFOCAL MOTOR NEUROPATHY; QUALITY-OF-LIFE; INTRAVENOUS IMMUNOGLOBULIN; OPEN-LABEL; IGG; INFUSION; POLYMYOSITIS; REPLACEMENT	Background Immunoglobulin therapy has become a major treatment option in several autoimmune neuromuscular disorders. For patients with Myasthenia Gravis (MG), intravenous immunoglobulin (IVIg) has been used for both crisis and chronic management. Subcutaneous Immunoglobulins (SCIg), which offer the advantage of home administration, may be a practical and effective option in chronic management of MG. We analyzed clinical outcomes and patient satisfaction in nine cases of chronic disabling MG who were either transitioned to, or started de novo on SCIg. Methods and Findings This was a retrospective cohort study for the period of 2015-2016, with a mean follow-up period of 6.8 months after initiation of SCIg. All patients with MG treated with SCIg at the Ottawa Hospital, a large Canadian tertiary hospital with subspecialty expertise in neuromuscular disorders were included, regardless of MG severity, clinical subtype and antibody status. The primary outcome was MG disease activity after SCIg initiation. This outcome was measured by 1) the Myasthenia Gravis Foundation of America (MGFA) clinical classification, and 2) subjective scales of disease activity including the Myasthenia Gravis activities of daily living profile (MG-ADL), Myasthenia Gravis Quality-of-life (MG-QOL 15), Visual Analog (VA) satisfaction scale. We also assessed any requirement for emergency department visits or hospitalizations. Safety outcomes included any SCIg related complication. All patients were stable or improved for MGFA class after SCIg initiation. Statistically significant improvements were documented in the MG-ADL, MG-QOL and VAS scales. There were no exacerbations after switching therapy and no severe SCIg related complications. Conclusions SCIg may be a beneficial therapy in the chronic management of MG, with favorable clinical outcome and patient satisfaction results.	[Bourque, P. R.; Pringle, C. E.; Chardon, J. Warman] Ottawa Hosp, Dept Med, Div Neurol, Ottawa, ON, Canada; [Bourque, P. R.; Pringle, C. E.; Cameron, W.; Cowan, J.; Chardon, J. Warman] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Cameron, W.; Cowan, J.] Ottawa Hosp, Dept Med, Div Infect Dis, Ottawa, ON, Canada; [Cameron, W.; Chardon, J. Warman] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Chardon, J. Warman] Childrens Hosp Eastern Ontario, Div Genet, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario	Bourque, PR (corresponding author), Ottawa Hosp, Dept Med, Div Neurol, Ottawa, ON, Canada.; Bourque, PR (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.	pbourque@toh.ca	Cameron, Bill/E-9180-2010; Warman, Jodi/B-6062-2016	Cameron, Bill/0000-0002-0090-3539; Warman, Jodi/0000-0002-0187-2199; Cowan, Juthaporn/0000-0001-6648-5109				Abolhassani H, 2012, J CLIN IMMUNOL, V32, P1180, DOI 10.1007/s10875-012-9720-1; Achiron A, 2000, MUSCLE NERVE, V23, P551, DOI 10.1002/(SICI)1097-4598(200004)23:4<551::AID-MUS14>3.3.CO;2-F; Alabdali M, 2014, EXPERT REV CLIN IMMU, V10, P1659, DOI 10.1586/1744666X.2014.971757; Baggi F, 2013, NEUROLOGY, V80, P188, DOI 10.1212/WNL.0b013e31827b907b; Barth D, 2011, NEUROLOGY, V76, P2017, DOI 10.1212/WNL.0b013e31821e5505; Bedlack RS, 2005, NEUROLOGY, V64, P1968, DOI 10.1212/01.WNL.0000163988.28892.79; Berger M, 2004, CLIN IMMUNOL, V112, P1, DOI 10.1016/j.clim.2004.02.002; Berger M, 2014, IMMUNOTHERAPY-UK, V6, P71, DOI 10.2217/imt.13.146; Berger M, 2008, IMMUNOL ALLERGY CLIN, V28, P779, DOI 10.1016/j.iac.2008.07.002; Burns TM, 2008, MUSCLE NERVE, V38, P957, DOI 10.1002/mus.21053; Cherin P, 2015, AUTOIMMUN REV; Cherin P, 2016, AUTOIMMUN REV, V15, P281, DOI 10.1016/j.autrev.2015.12.003; Cowan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142205; Dalakas MC, 2015, THER ADV NEUROL DISO, V8, P316, DOI 10.1177/1756285615605700; Danieli MG, 2014, CLIN RHEUMATOL, V33, P531, DOI 10.1007/s10067-013-2478-x; Danieli MG, 2011, AUTOIMMUN REV, V10, P144, DOI 10.1016/j.autrev.2010.09.004; Eftimov F, 2009, J PERIPHER NERV SYST, V14, P93, DOI 10.1111/j.1529-8027.2009.00218.x; Eienbroker C, 2014, MUSCLE NERVE, V50, P999, DOI 10.1002/mus.24259; Elovaara I, 2008, EUR J NEUROL, V15, P893, DOI 10.1111/j.1468-1331.2008.02246.x; Gajdos P, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1007/S10067-013-2478-X; GARDULF A, 1995, LANCET, V345, P365; Haddad E, 2012, J CLIN IMMUNOL, V32, P281, DOI 10.1007/s10875-011-9631-6; Harbo T, 2009, EUR J NEUROL, V16, P631, DOI 10.1111/j.1468-1331.2009.02568.x; Harbo T, 2010, NEUROLOGY, V75, P1377, DOI 10.1212/WNL.0b013e3181f735ce; Lee DH, 2008, MUSCLE NERVE, V37, P406, DOI 10.1002/mus.20909; Liew WKM, 2014, JAMA NEUROL, V71, P575, DOI 10.1001/jamaneurol.2014.17; Markvardsen LH, 2013, EUR J NEUROL, V20, P836, DOI 10.1111/ene.12080; Martin A, 2013, TRANSFUSION MED, V23, P55, DOI 10.1111/j.1365-3148.2012.01201.x; Misbah SA, 2011, J PERIPHER NERV SYST, V16, P92, DOI 10.1111/j.1529-8027.2011.00330.x; Nicolay U, 2006, J CLIN IMMUNOL, V26, P65, DOI 10.1007/s10875-006-8905-x; Sanders DB, 2010, AUTOIMMUNITY, V43, P428, DOI 10.3109/08916930903518107; Schleinitz N, 2008, CLIN RHEUMATOL, V27, P1067, DOI 10.1007/s10067-008-0892-2; Silvestri NJ, 2012, SEMIN NEUROL, V32, P215, DOI 10.1055/s-0032-1329200; Wasserman RL, 2011, CLIN PHARMACOKINET, V50, P405, DOI 10.2165/11587030-000000000-00000; Wolfe GI, 1999, NEUROLOGY, V52, P1487, DOI 10.1212/WNL.52.7.1487; Yoon MS, 2015, THER ADV NEUROL DISO, V8, P153, DOI 10.1177/1756285615584739	36	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159993	10.1371/journal.pone.0159993	http://dx.doi.org/10.1371/journal.pone.0159993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490101	gold, Green Submitted, Green Published			2022-12-27	WOS:000381368900024
J	Wang, NN; Wu, YP; Zeng, N; Wang, HP; Deng, P; Xu, Y; Feng, YP; Zeng, H; Yang, HX; Hou, K; Wang, A; Parthasarathy, K; Goyal, S; Qin, GJ; Wu, M				Wang, Ningning; Wu, Yiping; Zeng, Ning; Wang, Haiping; Deng, Pei; Xu, Yi; Feng, Youping; Zeng, Hong; Yang, Hongxia; Hou, Kai; Wang, Andrew; Parthasarathy, Keshav; Goyal, Samaksh; Qin, Gangjian; Wu, Min			E2F1 Hinders Skin Wound Healing by Repressing Vascular Endothelial Growth Factor (VEGF) Expression, Neovascularization, and Macrophage Recruitment	PLOS ONE			English	Article							CELLS; ANGIOGENESIS; MECHANISMS; THERAPY; DISEASE; REPAIR	Background Refractory surface of wound and dermal chronic ulcer are largely attributed to poor neovascularization. We have previously shown that E2F1 suppresses VEGF expression in the ischemic heart, and that genetic deletion of E2F1 leads to better cardiac recovery. However, whether E2F1 has a role in dermal wound healing is currently not known. Methods and Results Skin wounds were surgically induced in E2F1-null (E2F1(-/-)) mice and WT littermates. E2F1(-/-) displayed an accelerated wound healing including wound closure, dermal thickening and collagen deposition, which was associated with an increased endothelial cell proliferation and greater vessel density in the border zone of the wound. Furthermore, more macrophages were recruited to the skin lesions and the level of VEGF expression was markedly higher in E2F1(-/-) than in WT mice. Conclusions E2F1 hinders skin wound healing by suppressing VEGF expression, neovascularization, and macrophage recruitment. Strategies that target E2F1 may enhance wound healing.	[Wang, Ningning; Wu, Yiping; Zeng, Ning; Wang, Haiping; Deng, Pei; Xu, Yi; Feng, Youping; Zeng, Hong; Yang, Hongxia; Hou, Kai; Wu, Min] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China; [Wang, Andrew] Univ Illinois, Coll Liberal Arts & Sci, Champaign, IL USA; [Parthasarathy, Keshav; Goyal, Samaksh; Qin, Gangjian] Northwestern Univ, Dept Med Cardiol, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Qin, Gangjian] Univ Alabama Birmingham, Dept Biomed Engn, Sch Med, Birmingham, AL 35294 USA; [Qin, Gangjian] Sch Engn, Birmingham, AL USA	Huazhong University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Feinberg School of Medicine; University of Alabama System; University of Alabama Birmingham	Wu, M (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Plast Surg, Wuhan, Hubei, Peoples R China.	wumin82@hotmail.com			National Natural Science Foundation of China [81201472]; National Institute of Health [HL093439, HL113541, HL131110]; American Diabetes Association [1-15-BS-148]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093439, R01HL131110, R01HL113541] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Natural Science Foundation of China (grant # 81201472 to MW. URLs: http://www.nsfc.gov.cn); the National Institute of Health (Grants# HL093439, HL113541, and HL131110 to GQ URLs: http://www.nih.gov); and the American Diabetes Association (Grant# 1-15-BS-148 to GQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelis E, 2011, J MOL CELL CARDIOL, V51, P919, DOI 10.1016/j.yjmcc.2011.09.012; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chang ShuFang, 2009, Chongqing Medicine, V38, P641; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cordon CR, 2009, ANN PLAS SURG, V62, P707, DOI 10.1097/SAP.0b013e3181828141; Delavary BM, 2011, IMMUNOBIOLOGY, V216, P753, DOI 10.1016/j.imbio.2011.01.001; Eming SA, 2007, CLIN DERMATOL, V25, P79, DOI 10.1016/j.clindermatol.2006.09.011; Garbedian S, 2011, ORTHOPEDICS, V34, pE516, DOI 10.3928/01477447-20110714-42; Howangyin KY, 2014, ARTERIOSCL THROM VAS, V34, P1126, DOI 10.1161/ATVBAHA.114.303090; Jiang YF, 2011, WOUND REPAIR REGEN, V19, P181, DOI 10.1111/j.1524-475X.2010.00666.x; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Mohandas A, 2015, COLLOID SURFACE B, V127, P105, DOI 10.1016/j.colsurfb.2015.01.024; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Qin GJ, 2006, P NATL ACAD SCI USA, V103, P11015, DOI 10.1073/pnas.0509533103; Qin GJ, 2006, J EXP MED, V203, P153, DOI 10.1084/jem.20050459; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037; Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340; Tanaka C, 2010, ARTHRITIS RHEUM-US, V62, P1723, DOI 10.1002/art.27428; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu M, 2014, CARDIOVASC RES, V104, P412, DOI 10.1093/cvr/cvu222; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhou J, 2015, J ENDOCRINO IN PRESS	27	7	9	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160411	10.1371/journal.pone.0160411	http://dx.doi.org/10.1371/journal.pone.0160411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490344	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900054
J	Xie, ZQ; Shao, X; Xin, Y				Xie, Zhiqiang; Shao, Xia; Xin, Yu			A Scheduling Algorithm for Cloud Computing System Based on the Driver of Dynamic Essential Path	PLOS ONE			English	Article								To solve the problem of task scheduling in the cloud computing system, this paper proposes a scheduling algorithm for cloud computing based on the driver of dynamic essential path (DDEP). This algorithm applies a predecessor-task layer priority strategy to solve the problem of constraint relations among task nodes. The strategy assigns different priority values to every task node based on the scheduling order of task node as affected by the constraint relations among task nodes, and the task node list is generated by the different priority value. To address the scheduling order problem in which task nodes have the same priority value, the dynamic essential long path strategy is proposed. This strategy computes the dynamic essential path of the pre-scheduling task nodes based on the actual computation cost and communication cost of task node in the scheduling process. The task node that has the longest dynamic essential path is scheduled first as the completion time of task graph is indirectly influenced by the finishing time of task nodes in the longest dynamic essential path. Finally, we demonstrate the proposed algorithm via simulation experiments using Matlab tools. The experimental results indicate that the proposed algorithm can effectively reduce the task Makespan in most cases and meet a high quality performance objective.	[Xie, Zhiqiang; Shao, Xia; Xin, Yu] Harbin Univ Sci & Technol, Coll Comp & Technol, Harbin, Heilongjiang, Peoples R China	Harbin University of Science & Technology	Shao, X (corresponding author), Harbin Univ Sci & Technol, Coll Comp & Technol, Harbin, Heilongjiang, Peoples R China.	shaoxia.723@126.com			National Natural Science Foundation of China [61370086]; Science and Technology Research Foundation of Heilongjiang Province Education Department [12531105]; Heilongjiang Province Postdoctoral Science Foundation [LBHQ13092]; National University of Computer Education Research Association [ER2014018]; Heilongjiang Postdoctoral Science Foundation [LBH-Z15096]; China Postdoctoral Science Foundation [2016M591541]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Foundation of Heilongjiang Province Education Department; Heilongjiang Province Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National University of Computer Education Research Association; Heilongjiang Postdoctoral Science Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors acknowledge the support of Supported by National Natural Science Foundation of China (No. 61370086), Science and Technology Research Foundation of Heilongjiang Province Education Department (No. 12531105), Heilongjiang Province Postdoctoral Science Foundation (No. LBHQ13092), National University of Computer Education Research Association (No. ER2014018), the Heilongjiang Postdoctoral Science Foundation (LBH-Z15096).; We acknowledge the support of Supported by National Natural Science Foundation of China (No. 61370086), Science and Technology Research Foundation of Heilongjiang Province Education Department (No. 12531105), Heilongjiang Province Postdoctoral Science Foundation (No. LBHQ13092), National University of Computer Education Research Association (No. ER2014018), the Heilongjiang Postdoctoral Science Foundation(LBH-Z15096), China Postdoctoral Science Foundation(No. 2016M591541).	Adabi S, 2014, J SUPERCOMPUT, V67, P175, DOI 10.1007/s11227-013-0994-8; Ahmad I, 2010, IEEE T PARALL DISTR, V7, P506; Al Badawia A, 2013, COMPUT OPER RES, V40, P2322, DOI 10.1016/j.cor.2013.03.015; Armbrust M., 2009, TECH REP UCB EECS 20; Armbrust M, 2010, COMMUN ACM, V53, P50, DOI 10.1145/1721654.1721672; Bittencourt Luiz F, PAR DISTR NETW BAS P, P27; Bittencourt LF, 2010, J GRID COMPUT, V8, P419, DOI 10.1007/s10723-009-9144-1; Chen Rang, 2009, Journal of Software, V20, P1337, DOI 10.3724/SP.J.1001.2009.03493; Dai M, 2013, ROBOT CIM-INT MANUF, V29, P418, DOI 10.1016/j.rcim.2013.04.001; Foster I., 2008, P 2008 GRID COMP ENV, P1, DOI [10.1109/GCE.2008.4738445, DOI 10.1109/GCE.2008.4738445]; Guo FY, 2015, INT J COMMUN SYST, V28, P1053, DOI 10.1002/dac.2743; HOU ESH, 1994, IEEE T PARALL DISTR, V5, P113, DOI 10.1109/71.265940; Khan MA, 2012, PARALLEL COMPUT, V38, P175, DOI 10.1016/j.parco.2012.01.001; Kokilavani T., 2011, INT J COMPUTER APPL, V20, P43, DOI DOI 10.5120/2403-3197; Luo Hai-Bin, 2000, Journal of Software, V11, P899; Maheswaran M, 1998, SEVENTH HETEROGENEOUS COMPUTING WORKSHOP (HCW '98), P57, DOI 10.1109/HCW.1998.666545; Rimal BP, 2012, INT J COMMUN SYST, V25, P796, DOI 10.1002/dac.1279; SIH GC, 1993, IEEE T PARALL DISTR, V4, P175, DOI 10.1109/71.207593; Singh J., 2014, P HIGH PERF COMP S, P22; Topcuoglu H, 2002, IEEE T PARALL DISTR, V13, P260, DOI 10.1109/71.993206; Xie GQ, 2014, INT CON ADV INFO NET, P1011, DOI 10.1109/AINA.2014.123; Zhang JX, 2011, APPL RES COMPUTERS, V27, P429; Zhang Q, 2010, J INTERNET SERV APPL, V1, P7, DOI 10.1007/s13174-010-0007-6; Zong ZL, 2011, IEEE T COMPUT, V60, P360, DOI 10.1109/TC.2010.216	24	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159932	10.1371/journal.pone.0159932	http://dx.doi.org/10.1371/journal.pone.0159932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490901	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900022
J	Zhang, YL; Huang, JC; Yu, L; Wang, S				Zhang, Yali; Huang, Junchang; Yu, Lin; Wang, Song			Quantitatively Verifying the Results' Rationality for Farmland Quality Evaluation with Crop Yield, a Case Study in the Northwest Henan Province, China	PLOS ONE			English	Article							SOIL-QUALITY; PRODUCTION SYSTEMS; COMPOST; FERTILIZATION; INDICATORS; FIELD	Evaluating the assessing results' rationality for farmland quality (FQ) is usually qualitative and based on farmers and experts' perceptions of soil quality and crop yield. Its quantitative checking still remains difficult and is likely ignored. In this paper, FQ in Xiuwu County, the Northwest Henan Province, China was evaluated by the gray relational analysis (GRA) method and the traditional analytic hierarchy process (AHP) method. The consistency rate of two results was analysed. Research focused on proposing one method of testing the evaluation results' rationality for FQ based on the crop yield. Firstly generating a grade map of crop yield and overlying it with the FQ evaluation maps. Then analysing their consistency rate for each grade in the same spatial position. Finally examining the consistency effects and allowing for a decision on adopting the results. The results showed that the area rate consistency and matching evaluation unit numbers between the two methods were 84.68% and 87.29%, respectively, and the space distribution was approximately equal. The area consistency rates between crop yield level and FQ evaluation levels by GRA and AHP were 78.15% and 74.29%, respectively. Therefore, the verifying effects of GRA and AHP were near, good and acceptable, and the FQ results from both could reflect the crop yield levels. The evaluation results by GCA, as a whole, were slightly more rational than that by AHP.	[Zhang, Yali; Huang, Junchang; Yu, Lin; Wang, Song] Henan Agr Univ, Coll Resources & Environm, Zhengzhou, Peoples R China; [Zhang, Yali; Huang, Junchang; Yu, Lin; Wang, Song] Coll & Univ Henan Prov, Engn Res Ctr Agr Resources & Environm, Zhengzhou, Peoples R China	Henan Agricultural University	Zhang, YL (corresponding author), Henan Agr Univ, Coll Resources & Environm, Zhengzhou, Peoples R China.; Zhang, YL (corresponding author), Coll & Univ Henan Prov, Engn Res Ctr Agr Resources & Environm, Zhengzhou, Peoples R China.	skyali@163.com			key project of three major on the philosophy and social science of higher education in Henan Province [2014-szzd-27]; Education Department of Henan Province; National Nature Science Fund of China [40801102]	key project of three major on the philosophy and social science of higher education in Henan Province; Education Department of Henan Province; National Nature Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the key project of three major on the philosophy and social science of higher education in Henan Province (2014-szzd-27); Funding institution: Education Department of Henan Province; YLZ received the funding. This work was also supported by the National Nature Science Fund of China (40801102); Funding institution: National Natural Science Foundation of China; YLZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2002, AGR ECOSYST ENVIRON, V90, P25, DOI 10.1016/S0167-8809(01)00174-8; Armenise E, 2013, SOIL TILL RES, V130, P91, DOI 10.1016/j.still.2013.02.013; Baja S, 2002, ENVIRON MANAGE, V29, P647, DOI 10.1007/s00267-001-0053-8; Bhardwaj AK, 2011, AGR ECOSYST ENVIRON, V140, P419, DOI 10.1016/j.agee.2011.01.005; Bonanomi G, 2014, AGR ECOSYST ENVIRON, V192, P1, DOI 10.1016/j.agee.2014.03.029; Cheng JJ, 2016, SOIL TILL RES, V155, P225, DOI 10.1016/j.still.2015.08.015; D'Hose T, 2014, APPL SOIL ECOL, V75, P189, DOI 10.1016/j.apsoil.2013.11.013; Ditzler CA, 2002, AGRON J, V94, P33, DOI 10.2134/agronj2002.0033; Doran J.W., 1996, METHODS ASSESSING SO, P25, DOI [10.2136/sssaspecpub49.c2, DOI 10.2136/SSSASPECPUB49.C2]; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; DORAN JW, 1994, SSSA SPEC PUBL, P3; Editorial board of Xiuwu County annals, 2002, XIUW COUNT ANN, P47; FAO, 1976, FRAM LAND EV SOILS B; Giacometti C, 2013, APPL SOIL ECOL, V64, P32, DOI 10.1016/j.apsoil.2012.10.002; He B, 2014, FORESTRY SCI TECHNOL, V39, P52; Huang YY, 2013, J AGR RESOURCES REGI, V34, P32; Jiang JP, 2007, ARID LAND RES MANAG, V21, P287, DOI 10.1080/15324980701603524; Kalu S., 2015, INT J ENV PROTECT, V5, P38, DOI [10.5963/ijep0501006, DOI 10.5963/IJEP0501006]; Karlen D.L., 2008, J INTEGR BIOSCI, V6, P3; Karlen DL, 2003, J SOIL WATER CONSERV, V58, P171; Kong XiangBin, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P237; Kwansoo K, 2011, AGR EC, V25, P13; Lashari MS, 2013, FIELD CROP RES, V144, P113, DOI 10.1016/j.fcr.2012.11.015; Lentzsch P, 2005, SOIL BIOL BIOCHEM, V37, P1577, DOI 10.1016/j.soilbio.2005.01.017; Li P, 2013, SOIL TILL RES, V126, P112, DOI 10.1016/j.still.2012.07.011; Lima ACR, 2013, APPL SOIL ECOL, V64, P194, DOI 10.1016/j.apsoil.2012.12.009; Liu SF, 2008, GREY SYSTEM THEORY I, P185; Liu ZG, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0140839, 10.1371/journal.pone.0128274]; Lu Mingxing, 2006, AGR ENG, V22, P96; Marks EAN, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2503-6; Masto RE, 2008, ENVIRON MONIT ASSESS, V136, P419, DOI 10.1007/s10661-007-9697-z; Ministry of agriculture of the peoples Republic of China, 1996, 3091996 NYT MIN AGR; Ministry of agriculture of the peoples Republic of China, 2008, 16342008 NYT MIN AGR; Mueller L, 2013, SOIL TILL RES, V127, P74, DOI 10.1016/j.still.2012.03.002; National Agricultural Technology Extension and Service Center, 2005, FARML INV QUAL EV; Qi YB, 2009, GEODERMA, V149, P325, DOI 10.1016/j.geoderma.2008.12.015; Shukla MK, 2006, SOIL TILL RES, V87, P194, DOI 10.1016/j.still.2005.03.011; Tesfahunegn GB, 2011, GEODERMA, V163, P209, DOI 10.1016/j.geoderma.2011.04.016; Tian YG, 2006, FARMLAND FERTILITY E, P25; Wang L, 2009, J ANHUI AGR SCI, V37, P7594; Wang XJ, 1998, GEODERMA, V81, P339, DOI 10.1016/S0016-7061(97)00109-2; Willekens K, 2014, APPL SOIL ECOL, V82, P61, DOI 10.1016/j.apsoil.2014.05.009	42	2	2	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160204	10.1371/journal.pone.0160204	http://dx.doi.org/10.1371/journal.pone.0160204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490247	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900035
J	Le Ven, F; Alavi, Z; Jobic, Y; Etienne, Y; Didier, R; Porcher, R				Le Ven, Florent; Alavi, Zarrin; Jobic, Yannick; Etienne, Yves; Didier, Romain; Porcher, Raphael			Drug-Induced- or Rheumatic-Valvular Heart Disease in Patients Exposed to Benfluorex?	PLOS ONE			English	Article							DIABETES-MELLITUS; MULTICENTER; FEVER	There is a risk of misdiagnosis between benfluorex-induced VHD and acute rheumatic fever (ARF)-related VHD due to common characteristics of both etiologies. We aimed at estimating the probability for a patient exposed to benfluorex presenting with VHD to have, at the same time, a history of ARF-related VHD. Such epidemiological approach could help at reducing the risk of misdiagnosis. We used INSEE data and related literature as well as various modeling hypotheses to drive and test a formula for calculating the probability of a patient presenting with VHD and a history of benfluorex intake to have a prior history of ARF-related VHD. Different scenarios were estimated by a Markov model on the life course of people born in France between 1940 and 1960. Sensitivity analyses were performed under these scenarios. According to the different scenarios and gender, the probability that a patient born between 1940 and 1960 presenting with VHD and a history of benfluorex intake would have had a prior history of ARF-related VHD varied from 0.2% to 2.7%. The probabilities by the year of birth were as follows: 0.8%-2.7% for a patient born in 1940, <0.5% in all scenarios for patients born after 1955, and <0.2% in all scenarios for patients, born in 1960. Our results indicate that the burden of ARF-related VHD is low in the patient population exposed to benfluorex. The probability of ARF related VHD should not be over-estimated in the diagnostic procedure of VHD.	[Le Ven, Florent; Jobic, Yannick; Etienne, Yves; Didier, Romain] CHRU Brest, Hop Cavale Blanche, Serv Cardiol, Brest, France; [Alavi, Zarrin] Univ Brest, Univ Europeenne Bretagne, INSERM, CIC 1412,CHRU Brest, Brest, France; [Porcher, Raphael] Univ Paris 05, Ctr Epidemiol Clin, AP HP, Hotel Dieu,Inserm,U1153, Paris, France	CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Jobic, Y (corresponding author), CHRU Brest, Hop Cavale Blanche, Serv Cardiol, Brest, France.	yannick.jobic@chu-brest.fr		Le Ven, Florent/0000-0003-0555-1816; Porcher, Raphael/0000-0002-5277-4679; DIDIER, Romain/0000-0001-6214-7612				ACHESON RM, 1965, J CHRON DIS, V18, P723, DOI 10.1016/0021-9681(65)90016-0; Afssaps PL, 2010, PROPRIETES PHARMACOL, P12; benfluorex. Cde, 2015, ARCH MALADIES COEUR, V243, P23; Boudoulas KD, 2013, CARDIOLOGY, V126, P139, DOI 10.1159/000354221; Derumeaux G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038273; Frachon I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010128; Khan MA, 1998, NEW ENGL J MED, V339, P713, DOI 10.1056/NEJM199809103391101; LEFF S, 1956, Klin Med (Mosk), V34, P27; Maganti K, 2010, MAYO CLIN PROC, V85, P483, DOI 10.4065/mcp.2009.0706; MISCH KA, 1974, BRIT MED J, V2, P365, DOI 10.1136/bmj.2.5915.365; Olivier C, 2000, J ANTIMICROB CHEMOTH, V45, P13, DOI 10.1093/jac/45.suppl_1.13; Szymanski C, 2014, PHARMACOEPIDEM DR S, V23, P679, DOI 10.1002/pds.3642; Tribouilloy C, 2013, EUR HEART J, V34, P3580, DOI 10.1093/eurheartj/eht266; Tribouilloy C, 2012, CIRCULATION, V126, P2852, DOI 10.1161/CIRCULATIONAHA.112.111260; Weill A, 2010, PHARMACOEPIDEM DR S, V19, P1256, DOI 10.1002/pds.2044	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160011	10.1371/journal.pone.0160011	http://dx.doi.org/10.1371/journal.pone.0160011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487042	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800054
J	O'Connor, B; Pollner, F; Fugh-Berman, A				O'Connor, Bonnie; Pollner, Fran; Fugh-Berman, Adriane			Salespeople in the Surgical Suite: Relationships between Surgeons and Medical Device Representatives	PLOS ONE			English	Article							ORTHOPEDIC SURGEONS; INDUSTRY; STRATEGIES; PAYMENTS	Background Industry payments to surgeons have received public attention, but little is known about the relationships between surgeons and medical device representatives. Medical device representatives ("device reps") have become an integral part of operating room personnel. The effect of their presence on patient care deserves discussion. Study Design We conducted a qualitative, ethnographic study to explore relationships between surgeons and medical device representatives, and characterize industry involvement in the training of surgeons. We used group and individual open-ended interviews to gain insight into the beliefs, values, and perspectives of surgeons and device reps. We conducted two focus groups, one with ear, nose, and throat surgeons, and one with hospital-based attending orthopedic surgeons. We also conducted individual interviews with three former or current medical device representatives, a director of a surgical residency program at an academic medical center, and a medical assistant for a multi-physician orthopedic practice. Results While surgeons view themselves as indisputably in charge, device reps work hard to make themselves unobtrusively indispensable in order to establish and maintain influence, and to imbue the products they provide with personalized services that foster a surgeon's loyalty to the reps and their companies. Surgeons view industry-funded training opportunities as a necessary service. Device reps and some surgeons believe that reps benefit patient care, by increasing efficiency and mitigating deficiencies among operating room personnel (including the surgeons themselves). Conclusions Our study raises ethical questions about the reliance of surgeons on device reps and device companies for education and surgical assistance and practical concerns regarding existing levels of competence among OR personnel.	[O'Connor, Bonnie] Brown Univ, Alpert Sch Med, Providence, RI 02912 USA; [Fugh-Berman, Adriane] Georgetown Univ, Med Ctr, Washington, DC 20007 USA	Brown University; Georgetown University	Fugh-Berman, A (corresponding author), Georgetown Univ, Med Ctr, Washington, DC 20007 USA.	ajf29@georgetown.edu		Fugh-Berman, Adriane/0000-0002-1717-7617	Georgetown University Complex Moral Issues program	Georgetown University Complex Moral Issues program	This study was funded by a grant from Georgetown University Complex Moral Issues program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, 5 ANN SURG SAL SAL R; Bedard Jeffrey, 2014, J Clin Ethics, V25, P238; Burns LR, 2009, HEALTH CARE MANAGE R, V34, P2, DOI 10.1097/01.HMR.0000342984.22426.ac; Cvetanovich GL, 2015, J BONE JOINT SURG AM, V97A, P1288, DOI 10.2106/JBJS.N.01093; Datta A, 2017, HEALTH ECON, V26, P450, DOI 10.1002/hec.3323; FDA Office of Device Evaluation, 2016, P FDA ORTH REH DEV P; Hockenberry JM, 2011, ARCH INTERN MED, V171, P1759, DOI 10.1001/archinternmed.2011.454; Iyer S, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.O.00343; Korenstein D, 2010, ARCH SURG-CHICAGO, V145, P570, DOI 10.1001/archsurg.2010.75; Mintzes B, 2013, J GEN INTERN MED, V28, P1368, DOI 10.1007/s11606-013-2411-7; Montgomery K, 2007, MILBANK Q, V85, P307, DOI 10.1111/j.1468-0009.2007.00489.x; Rathi VK, 2015, OTOLAYRYNGOL HE 0316; Riessman C.K., 2008, NARRATIVE METHODS HU, P21; Sah S, 2013, J LAW MED ETHICS, V41, P665, DOI 10.1111/jlme.12076; Samuel AM, 2015, CLIN ORTHOP RELAT R, V473, P3297, DOI 10.1007/s11999-015-4413-8; Smieliauskas F, 2016, HEALTH ECON, V25, P723, DOI 10.1002/hec.3177; Sudarsky D, 2013, AM HEART J, V166, P258, DOI 10.1016/j.ahj.2013.05.011	17	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0158510	10.1371/journal.pone.0158510	http://dx.doi.org/10.1371/journal.pone.0158510			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486992	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800012
J	Timm, ES; Pardo, LH; Coello, RP; Navarrete, TC; Villegas, ON; Ordonez, ES				Sanchez Timm, Eduardo; Hidalgo Pardo, Lisette; Pacheco Coello, Ricardo; Chavez Navarrete, Tatiana; Navarrete Villegas, Oscar; Santos Ordonez, Efren			Identification of Differentially-Expressed Genes in Response to Mycosphaerella fijiensis in the Resistant Musa Accession 'Calcutta-4' Using Suppression Subtractive Hybridization	PLOS ONE			English	Article							DISEASE RESISTANCE; DROUGHT STRESS; DNA MICROARRAY; BANANA; TRANSCRIPTOME; FAMILY; INFECTION; ACUMINATA; PLANTAIN; ROOTS	Bananas and plantains are considered an important crop around the world. Banana production is affected by several constraints, of which Black Sigatoka Disease, caused by the fungus Mycosphaerella fijiensis, is considered one of the most important diseases in banana plantations. The banana accession 'Calcutta-4' has a natural resistance to Black Sigatoka; however, the fruit is not valuable for commercialization. Gene identification and expression studies in 'Calcutta-4' might reveal possible gene candidates for resistant to the disease and elucidate mechanisms for resistance. A subtracted cDNA library was generated from leaves after 6, 9 and 12 days inoculated with M. fijiensis conidia on greenhouse banana plants of the accession 'Calcutta-4'. Bioinformatic analysis revealed 99 good quality sequences. Blast2go analysis revealed that 31% of the sequences could not be categorized and, according to the Biological Process Category, 32 and 28 ESTs are related to general metabolic and cellular processes, respectively; while 10 ESTs response to stimulus. Seven sequences were redundant and one was similar to genes that may be involved in pathogen resistance including the putative disease resistance protein RGA1. Genes encoding zinc finger domains were identified and may play an important role in pathogen resistance by inducing the expression of downstream genes. Expression analysis of four selected genes was performed using RT-qPCR during the early stage of the disease development at 6, 9, 12 and 15 days post inoculation showing a peak of up regulation at 9 or 12 days post inoculation. Three of the four genes showed an up-regulation of expression in 'Calcutta-4' when compared to 'Williams' after inoculation with M. fijiensis, suggesting a fine regulation of specific gene candidates that may lead to a resistance response. The genes identified in early responses in a plant-pathogen interaction may be relevant for the resistance response of 'Calcutta-4' to Black Sigatoka. Genes with different functions may play a role in plant response to the disease. The present study suggests a fine up regulation of these genes that might be needed to perform an incompatible interaction. Further gene functional studies need to be performed to validate their use as candidate resistance genes in susceptible banana cultivars.	[Sanchez Timm, Eduardo; Hidalgo Pardo, Lisette; Pacheco Coello, Ricardo; Chavez Navarrete, Tatiana; Navarrete Villegas, Oscar; Santos Ordonez, Efren] Escuela Super Politecn Litoral, ESPOL, Ctr Invest Biotecnol Ecuador, Campus Gustavo Galindo,Km 30-5,Via Perimetral, Guayaquil, Ecuador; [Santos Ordonez, Efren] Escuela Super Politecn Litoral, ESPOL, Fac Ciencias Vida, Campus Gustavo Galindo,Km 30-5,Via Perimetral, Guayaquil, Ecuador	Escuela Superior Politecnica del Litoral; Escuela Superior Politecnica del Litoral	Ordonez, ES (corresponding author), Escuela Super Politecn Litoral, ESPOL, Ctr Invest Biotecnol Ecuador, Campus Gustavo Galindo,Km 30-5,Via Perimetral, Guayaquil, Ecuador.; Ordonez, ES (corresponding author), Escuela Super Politecn Litoral, ESPOL, Fac Ciencias Vida, Campus Gustavo Galindo,Km 30-5,Via Perimetral, Guayaquil, Ecuador.	gsantos@espol.edu.ec	Sanchez, Eduardo/AAE-8651-2019; Santos, Efrén/ABF-7110-2020	Sanchez, Eduardo/0000-0001-7712-3605; Santos, Efrén/0000-0002-0749-6024; CHAVEZ NAVARRETE, TATIANA PAOLA/0000-0001-8394-1735; Pacheco Coello, Ricardo Humberto/0000-0002-7260-0641	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion project [PIC-08-0000300, SENACYT-FWO-10-005]	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion project	The author ESO received all the funding for this research from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion projects: PIC-08-0000300; and SENACYT-FWO-10-005; http://www.educacionsuperior.gob.ec/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto-Tomiyama C, 2003, PLANT MOL BIOL, V52, P537, DOI 10.1023/A:1024890601888; Alvarado Capo Y., 2003, Mycosphaerella leaf spot diseases of bananas: present status and outlook. Proceedings of the 2nd International Workshop on Mycosphaerella leaf spot diseases held in San Jose, Costa Rica on 20-23 May 2002, P169; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BEVERAGGI A, 1995, CAN J BOT, V73, P1328, DOI 10.1139/b95-144; Boddu J, 2007, MOL PLANT MICROBE IN, V20, P1364, DOI 10.1094/MPMI-20-11-1364; Cavalcante M. de J. B., 2011, Tropical Plant Biology, V4, P134, DOI 10.1007/s12042-011-9071-8; Chen J, 2012, GENE, V496, P110, DOI 10.1016/j.gene.2012.01.008; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; de Bellaire LD, 2010, FRUITS, V65, P327, DOI 10.1051/fruits/2010034; Dias MC, 2014, ENVIRON EXP BOT, V100, P64, DOI 10.1016/j.envexpbot.2013.12.013; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Hirao T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-13; Hoss R, 2000, J PHYTOPATHOL, V148, P387, DOI 10.1046/j.1439-0434.2000.00530.x; Ibrahim HMM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-220; Ji W, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-12; Jimenez M, 2007, RENEW AGR FOOD SYST, V22, P297, DOI 10.1017/S1742170507001895; Jones AME, 2006, PLANT PHYSIOL, V142, P1603, DOI 10.1104/pp.106.086231; Kumar S, 2014, MOL BREEDING, V34, P127, DOI 10.1007/s11032-014-0022-6; Lepoivre P., 2003, Mycosphaerella leaf spot diseases of bananas: present status and outlook. Proceedings of the 2nd International Workshop on Mycosphaerella leaf spot diseases held in San Jose, Costa Rica on 20-23 May 2002, P151; Li Chun-Yu, 2012, BMC Genomics, V13, P374, DOI 10.1186/1471-2164-13-374; Meng M, 2007, GENE, V389, P186, DOI 10.1016/j.gene.2006.11.006; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Miller RNG, 2009, ACTA HORTIC, V828, P255; Miller RNG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-15; ORTIZ R, 1994, THEOR APPL GENET, V89, P146, DOI 10.1007/BF00225134; Passos MAN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-78; Passos MAN, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls030; Ploetz R., 2000, Pesticide Outlook, V11, P19, DOI 10.1039/b006308h; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Portal O, 2011, PLANT CELL REP, V30, P913, DOI 10.1007/s00299-011-1008-z; Quinones W, 2000, MOLECULES, V5, P974, DOI 10.3390/50700974; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Rojas CM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00017; Sreedharan S, 2012, PLANT MOL BIOL, V80, P503, DOI 10.1007/s11103-012-9964-4; Swarupa V, 2013, PHYSIOL MOL PLANT P, V83, P1, DOI 10.1016/j.pmpp.2013.02.003; UNCTAD, SPEC UN COMM UNCTAD; van den Berg N, 2004, BIOTECHNIQUES, V37, P818, DOI 10.2144/04375RR02; van den Berg N, 2009, ACTA HORTIC, V828, P273; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-650; Wiame I, 2000, BIOTECHNIQUES, V29, P252, DOI 10.2144/00292bm11; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Zhou T, 2014, PLANT MOL BIOL, V85, P163, DOI 10.1007/s11103-014-0175-z	44	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160083	10.1371/journal.pone.0160083	http://dx.doi.org/10.1371/journal.pone.0160083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487237	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800057
J	Tahmasbi, F; Maleki, S; Shariati, M; Sulong, NHR; Tahir, MM				Tahmasbi, Farzad; Maleki, Shervin; Shariati, Mahdi; Sulong, N. H. Ramli; Tahir, M. M.			Shear Capacity of C-Shaped and L-Shaped Angle Shear Connectors	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; BEHAVIOR; CONCRETE; CHANNEL; STEEL	This paper investigates the behaviour of C-shaped and L-shaped angle shear connectors embedded in solid concrete slabs. An effective finite element model is proposed to simulate the push out tests of these shear connectors that encompass nonlinear material behaviour, large displacement and damage plasticity. The finite element models are validated against test results. Parametric studies using this nonlinear model are performed to investigate the variations in concrete strength and connector dimensions. The finite element analyses also confirm the test results that increasing the length of shear connector increases their shear strength proportionately. It is observed that the maximum stress in L-shaped angle connectors takes place in the weld attachment to the beam, whereas in the C-shaped angle connectors, it is in the attached leg. The location of maximum concrete compressive damage is rendered in each case. Finally, a new equation for prediction of the shear capacity of C-shaped angle connectors is proposed.	[Tahmasbi, Farzad; Maleki, Shervin] Sharif Univ Technol, Dept Civil Engn, Tehran, Iran; [Shariati, Mahdi; Sulong, N. H. Ramli] Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia; [Tahir, M. M.] UTM, Inst Smart Infrastruct & Innovat Construct, Fac Civil Engn, UTM Construct Res Ctr, Johor Baharu 81310, Johor, Malaysia	Sharif University of Technology; Universiti Malaya; Universiti Teknologi Malaysia	Shariati, M (corresponding author), Univ Malaya, Dept Civil Engn, Kuala Lumpur 50603, Malaysia.	shariati@um.edu.my	Shariati, Mahdi/C-9626-2019; SULONG, NOR HAFIZAH RAMLI/B-9311-2010	Shariati, Mahdi/0000-0002-0440-7612; SULONG, NOR HAFIZAH RAMLI/0000-0001-8209-313X; maleki, shervin/0000-0002-3574-2106	University of Malaya Higher Impact Research (HIR) [UM.C/HIR/MOHE/ENG/57]; University of Malaya Research Grant (UMRG) [RP004C-13AET]	University of Malaya Higher Impact Research (HIR); University of Malaya Research Grant (UMRG)	The study presented herein was made possible by the University of Malaya Higher Impact Research (HIR) Grant: UM.C/HIR/MOHE/ENG/57 and University of Malaya Research Grant (UMRG): RP004C-13AET. The authors would like to acknowledge the support.; The study presented herein was made possible by the University of Malaya Higher Impact Research (HIR) Grant: UM.C/HIR/MOHE/ENG/57 and University of Malaya Research Grant (UMRG): RP004C-13AET. The authors would like to acknowledge the support.	[Anonymous], 2010, MAN ASU VERS 6 10; Association CS. Design of Concrete Structures, 2010, CANCSAA23304 ASS CS; Chen A, 2015, ENG STRUCT, V98, P95, DOI 10.1016/j.engstruct.2015.04.022; Cornelissen H.A.W., 1986, HERON, V31; Hillerborg A., 1976, CEMENT CONCRETE RES, V6, P773, DOI [10.1016/0008-8846(76)90007-7, DOI 10.1016/0008-8846(76)90007-7]; Khalilian M., 2013, ASSESSMENT SHEAR CAP; Khorramian K, 2015, PLOS ONE IN PRESS; Majdi Y, 2014, ENG STRUCT, V77, P65, DOI 10.1016/j.engstruct.2014.07.030; Maleki S, 2008, J CONSTR STEEL RES, V64, P1333, DOI 10.1016/j.jcsr.2008.01.010; Maleki S, 2008, J CONSTR STEEL RES, V64, P1341, DOI 10.1016/j.jcsr.2008.01.006; Maleki S, 2009, J CONSTR STEEL RES, V65, P1787, DOI 10.1016/j.jcsr.2009.04.008; Nguyen HT, 2009, J CONSTR STEEL RES, V65, P1909, DOI 10.1016/j.jcsr.2009.06.010; Qureshi J, 2011, J CONSTR STEEL RES, V67, P706, DOI 10.1016/j.jcsr.2010.11.009; Shah SNR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139422; Shariati A, 2014, CONSTR BUILD MATER, V52, P276, DOI 10.1016/j.conbuildmat.2013.11.036; Shariati M, ENG FAILURE ANAL; Shariati M, 2013, CONSTR BUILD MATER, V38, P582, DOI 10.1016/j.conbuildmat.2012.07.050; Shariati M, 2012, MATER DESIGN, V41, P67, DOI 10.1016/j.matdes.2012.04.039; Soty R, 2013, ENG STRUCT, V46, P581, DOI 10.1016/j.engstruct.2012.09.003; Wang AJ, 2008, ENG STRUCT, V30, P2724, DOI 10.1016/j.engstruct.2008.03.001	20	92	92	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0156989	10.1371/journal.pone.0156989	http://dx.doi.org/10.1371/journal.pone.0156989			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27478894	Green Published, gold			2022-12-27	WOS:000381110300002
J	Theil, G; Fischer, K; Weber, E; Medek, R; Hoda, R; Lucke, K; Fornara, P				Theil, Gerit; Fischer, Kersten; Weber, Ekkehard; Medek, Rita; Hoda, Raschid; Luecke, Klaus; Fornara, Paolo			The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study	PLOS ONE			English	Article							PERIPHERAL-BLOOD; PREDICT SURVIVAL; CTC; ABIRATERONE; EXPERIENCE; CARCINOMA; DISEASES	Background and Methods Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. Nevertheless, the isolation of these cells remains very challenging because they rarely circulate in the blood. Another current problem is the cancer-specific characterization of these cells, which requires a method that allows for the molecular and immunocytochemical profiling of all captured cells. The purpose of our proof of concept study was to investigate the use of a medical wire (CellCollector, GILUPI) to isolate CTCs in the blood of prostate cancer (PCa) patients, which allowed CTCs to be counted and molecularly characterized. Forty-three PCa patients in different stages and 11 control subjects were studied. Some randomized samples were used to detect tumor-associated transcripts, such as prostate-specific membrane antigen (PSMA), prostate-specific antigen (PSA) and epidermal growth factor receptor (EGFR), in the isolated CTCs. Results The mean CTC counts were 4.6 CTCs [range, 0-8] in patients with localized PCa, 16.8 CTCs [range, 10-25] in patients with locally advanced PCa, and 26.8 CTCs [range, 0-98] in patients with metastatic PCa. The median follow-up time was 24 months, and there was a significant difference in the cancer-specific survival rates. Patients with CTC counts under 5 CTCs lived significantly longer (p = 0.035) than patients with more than 5 CTCs. We also demonstrated that the captured CTCs could be molecularly characterized. We detected tumor-associated transcripts of EGFR and PSMA in patients with metastatic PCa in 42.8% and 14.3% of the analyzed samples, respectively. Conclusion Our results indicate that the sensitive isolation and molecular characterization of CTCs can be achieved ex vivo using the wire. Patients with more than 5 CTCs had a mortality risk that was 7.0 times greater that of those with fewer than 5 CTCs (hazard ratio 7.0 95%, CI 1.1-29.39). This proof of concept was required for the approval of the use of the CellCollector in a clinical study for the in vivo isolation of CTCs from the blood stream of PCa patients by the Federal Institute for Drugs and Medical devices (Germany, BfArM).	[Theil, Gerit; Fischer, Kersten; Hoda, Raschid; Fornara, Paolo] Univ Halle Wittenberg, Clin Urol & Transplantat, Ernst Grube Str 40, D-06120 Halle, Germany; [Weber, Ekkehard; Luecke, Klaus] GILUPI GmbH, Muhlenberg 11, Potsdam, Germany; [Medek, Rita] Univ Halle Wittenberg, Inst Physiol Chem, Hollystr 1, D-06120 Halle, Germany; [Hoda, Raschid] Univ Klinikum Schleswig Holstein, Urol Clin, Ratzburger Allee 160, D-23538 Lubeck, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Kiel; Schleswig Holstein University Hospital	Theil, G (corresponding author), Univ Halle Wittenberg, Clin Urol & Transplantat, Ernst Grube Str 40, D-06120 Halle, Germany.	Gerit.Theil@uk-halle.de	Theil, Gerit/AGQ-2625-2022	Weber, Ekkehard/0000-0002-4014-4303	GILUPI GmbH	GILUPI GmbH	EW and KL are paid employees of the GILUPI GmbH. The employees of the GILUPI GmBH had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Bitting RL, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.002; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; Danila DC, 2011, EUR UROL, V60, P897, DOI 10.1016/j.eururo.2011.07.011; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm477; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hu Brian, 2013, Cancers (Basel), V5, P1676, DOI 10.3390/cancers5041676; Kirby BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035976; Minner S, 2011, PROSTATE, V71, P281, DOI 10.1002/pros.21241; Miyamoto DT, 2014, NAT REV CLIN ONCOL, V11, P401, DOI 10.1038/nrclinonc.2014.82; Moreno JG, 2005, UROLOGY, V65, P713, DOI 10.1016/j.urology.2004.11.006; Moreno JG, 2001, UROLOGY, V58, P386, DOI 10.1016/S0090-4295(01)01191-8; Olmos D, 2009, ANN ONCOL, V20, P27, DOI 10.1093/annonc/mdn544; Pantel K, 2012, CLIN CHEM, V58, P936, DOI 10.1373/clinchem.2011.175570; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Polzer B, 2014, EMBO MOL MED, V6, P1371, DOI 10.15252/emmm.201404033; Saucedo-Zeni N, 2012, INT J ONCOL, V41, P1241, DOI 10.3892/ijo.2012.1557; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Scher HI, 2013, NAT REV CLIN ONCOL, V10, P225, DOI 10.1038/nrclinonc.2013.30; Scher HI, 2009, LANCET ONCOL, V10, P233, DOI 10.1016/S1470-2045(08)70340-1; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Todenhofer T, 2012, ANTICANCER RES, V32, P3507; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533	29	43	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0158354	10.1371/journal.pone.0158354	http://dx.doi.org/10.1371/journal.pone.0158354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479125	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110300005
J	Zheng, YL; Zhang, X; Fu, HX; Guo, M; Shukla, V; Amin, ND; Jing, E; Bao, L; Luo, HY; Li, B; Lu, XH; Gao, YC				Zheng, Ya-Li; Zhang, Xia; Fu, Hai-Xia; Guo, Mei; Shukla, Varsha; Amin, Niranjana D.; Jing, E.; Bao, Li; Luo, Hong-Yan; Li, Bo; Lu, Xiao-Hua; Gao, Yong-Cai			Knockdown of Expression of Cdk5 or p35 (a Cdk5 Activator) Results in Podocyte Apoptosis	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; GLOMERULOSCLEROSIS; DIFFERENTIATION; CELLS; NEURODEGENERATION; GLOMERULI; REGULATOR; DEPLETION; PEPTIDE; NEURONS	Podocytes are terminally differentiated glomerular epithelial cells. Podocyte loss has been found in many renal diseases. Cdk5 is a cyclin-dependent protein kinase which is predominantly regulated by p35. To study the role of Cdk5/p35 in podocyte survival, we first applied western blotting (WB) analysis to confirm the time-course expression of Cdk5 and p35 during kidney development and in cultured immortalized mouse podocytes. We also demonstrated that p35 plays an important role in promoting podocyte differentiation by overexpression of p35 in podocytes. To deregulate the expression of Cdk5 or p35 in mouse podocytes, we used RNAi and analyzed cell function and apoptosis assaying for podocyte specific marker Wilms Tumor 1 (WT1) and cleaved caspase 3, respectively. We also counted viable cells using cell counting kit-8. We found that depletion of Cdk5 causes decreased expression of WT1 and apoptosis. It is noteworthy, however, that downregulation of p35 reduced Cdk5 activity, but had no effect on cleaved caspase 3 expression. It did, however, reduce expression of WT1, a transcription factor, and produced podocyte dysmorphism. On the other hand increased apoptosis could be detected in p35-deregulated podocytes using the TUNEL analysis and immunofluorescent staining with cleaved caspase3 antibody. Viability of podocytes was decreased in both Cdk5 and p35 knockdown cells. Knocking down Cdk5 or p35 gene by RNAi does not affect the cycline I expression, another Cdk5 activator in podocyes. We conclude that Cdk5 and p35 play a crucial role in maintaining podocyte differentiation and survival, and suggest these proteins as targets for therapeutic intervention in podocyte-damaged kidney diseases.	[Zheng, Ya-Li; Zhang, Xia; Jing, E.; Bao, Li; Luo, Hong-Yan; Li, Bo; Lu, Xiao-Hua; Gao, Yong-Cai] Northwest Univ Nationalities, Coll Med, Affiliated Hosp 1, Dept Nephrol,Ningxia Peoples Hosp, Yinchuan 750002, Ningxia, Peoples R China; [Fu, Hai-Xia] Cent Hosp Rizhao City, Ctr Blood Purificat, Rizhao 276800, Shangdong, Peoples R China; [Shukla, Varsha; Amin, Niranjana D.] NINDS, Lab Neurochem, Bethesda, MD 20814 USA; [Guo, Mei] Fudan Univ, Zhongshan Xuhui Hosp, Shanghai 200031, Peoples R China	Northwest Minzu University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Fudan University	Zheng, YL (corresponding author), Northwest Univ Nationalities, Coll Med, Affiliated Hosp 1, Dept Nephrol,Ningxia Peoples Hosp, Yinchuan 750002, Ningxia, Peoples R China.	yalinew@yahoo.com			National Natural Science Foundation of China [81160093, 81460161]; Natural Science Foundation of Ningxia Province [NZ14160]; Department of Science and Technology of Ningxia Province [2011ZYH169, 2013ZYS103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ningxia Province; Department of Science and Technology of Ningxia Province	This work was supported by the following grant sponsors: National Natural Science Foundation of China, grant no. 81160093 and 81460161; Natural Science Foundation of Ningxia Province, grant no. NZ14160; and Department of Science and Technology of Ningxia Province, grant no. 2013ZYS103 and 2011ZYH169 (international collaboration with the intramural funds of NIH/NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binukumar BK, 2014, J ALZHEIMERS DIS, V39, P899, DOI 10.3233/JAD-131784; Brinkkoetter PT, 2010, KIDNEY INT, V77, P690, DOI 10.1038/ki.2009.548; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen F, 2001, BLOOD, V97, P3763, DOI 10.1182/blood.V97.12.3763; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Gao CY, 1997, DEV GENET, V20, P267; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Hagmann H, 2015, AM J PHYSIOL-CELL PH, V308, pC339, DOI 10.1152/ajpcell.00168.2014; Ichii O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110383; Kanungo J, 2009, CELL MOL NEUROBIOL, V29, P1073, DOI 10.1007/s10571-009-9410-6; Ko J, 2001, J NEUROSCI, V21, P6758; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Lazaro JB, 1997, J CELL SCI, V110, P1251; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lopes JP, 2009, CELL CYCLE, V8, P97, DOI 10.4161/cc.8.1.7506; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; Michaud JLR, 2007, CLIN SCI, V112, P325, DOI 10.1042/CS20060143; MISRA RP, 1972, AM J CLIN PATHOL, V58, P135; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Shukla V, 2013, FASEB J, V27, P174, DOI 10.1096/fj.12-217497; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; Taniguchi Y, 2012, AM J PHYSIOL-RENAL, V302, pF1161, DOI 10.1152/ajprenal.00614.2011; Trunova S, 2012, DIS MODEL MECH, V5, P210, DOI 10.1242/dmm.008847; Veeranna, 1998, J NEUROSCI, V18, P4008; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins JE, 2007, J AM GERIATR SOC, V55, pS212; Zhang Y, 2014, EXP CELL RES, V326, P219, DOI 10.1016/j.yexcr.2014.04.014; Zheng YL, 2010, J NEUROL SCI, V299, P101, DOI 10.1016/j.jns.2010.08.067; Zheng YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054527	37	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160252	10.1371/journal.pone.0160252	http://dx.doi.org/10.1371/journal.pone.0160252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479491	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300035
J	Zinellu, A; Fois, AG; Sotgia, S; Sotgiu, E; Zinellu, E; Bifulco, F; Mangoni, AA; Pirina, P; Carru, C				Zinellu, Angelo; Fois, Alessandro Giuseppe; Sotgia, Salvatore; Sotgiu, Elisabetta; Zinellu, Elisabetta; Bifulco, Fabiana; Mangoni, Arduino A.; Pirina, Pietro; Carru, Ciriaco			Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ASYMMETRIC DIMETHYLARGININE; LIPID-PEROXIDATION; ASTHMA; DIMETHYLAMINOHYDROLASE; MITOCHONDRIA; INFLAMMATION; EMPHYSEMA; SMOKERS; MARKERS	Background Elevated plasma concentrations of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) have been observed in respiratory conditions such as asthma and cystic fibrosis. Since oxidative stress has been shown to increase the activity of arginine methylating enzymes, hence increased ADMA synthesis, and to reduce ADMA degrading enzymes, hence increased ADMA concentrations, we assessed methylated arginines concentrations in chronic obstructive pulmonary disease (COPD), a disease characterized by increased oxidative stress. Methods Plasma arginine, ADMA and symmetric dimethylarginine (SDMA), oxidative stress markers (thiobarbituric acid reactive substances, TBARS, and plasma proteins SH, PSH) and antioxidants (taurine and paraoxonase 1, PON1, activity) were measured in 43 COPD patients with mild (n = 29) or moderate (n = 14) disease and 43 age-and sex-matched controls. Results TBARS significantly increased with COPD presence and severity (median 2.93 vs 3.18 vs 3.64 mu mol/L, respectively in controls, mild and moderate group, p < 0.0001 by ANOVA) whereas PSH decreased (6.69 +/- 1.15 vs 6.04 +/- 0.85 vs 5.33 +/- 0.96 mu mol/gr prot, p < 0.0001 by ANOVA). Increased ADMA/arginine ratio, primarily due to reduced arginine concentrations, was also observed with COPD presence and severity (median 0.0067 vs 0.0075 vs 0.0100, p < 0.0001 by ANOVA). In multiple logistic regression analysis, only TBARS (OR 0.44, 95% CI 0.25-0.77; p = 0.0045) and ADMA/Arginine ratio (OR 1.72, 95% CI 2.27-13.05; p = 0.02) were independently associated with COPD severity. Conclusion COPD presence and severity are associated with increased oxidative stress and alterations in arginine metabolism. The reduced arginine concentrations in COPD may offer a new target for therapeutic interventions increasing arginine availability.	[Zinellu, Angelo; Sotgia, Salvatore; Sotgiu, Elisabetta; Carru, Ciriaco] Univ Sassari, Dept Biomed Sci, Sassari, Italy; [Fois, Alessandro Giuseppe; Zinellu, Elisabetta; Bifulco, Fabiana; Pirina, Pietro] Univ Sassari, Dept Clin & Expt Med, Sassari, Italy; [Mangoni, Arduino A.] Flinders Univ S Australia, Sch Med, Dept Clin Pharmacol, Adelaide, SA, Australia; [Carru, Ciriaco] Univ Hosp Sassari AOU, Qual Control Unit, Sassari, Italy	University of Sassari; University of Sassari; Flinders University South Australia	Zinellu, A; Carru, C (corresponding author), Univ Sassari, Dept Biomed Sci, Sassari, Italy.; Carru, C (corresponding author), Univ Hosp Sassari AOU, Qual Control Unit, Sassari, Italy.	azinellu@uniss.it; carru@uniss.it	Mangoni, Arduino Aleksander/I-5109-2019; Sotgia, Salvatore/T-6598-2019; Carru, Ciriaco/AAI-9996-2021	Mangoni, Arduino Aleksander/0000-0001-8699-1412; Carru, Ciriaco/0000-0002-6985-4907; Sotgia, Salvatore/0000-0002-3717-3437; Zinellu, Angelo/0000-0002-8396-0968; Sotgiu, Elisabetta/0000-0001-8053-1247; Zinellu, Elisabetta/0000-0001-8707-2098	Fondazione Banco di Sardegna - Sassari - Italy; "Ministero dell'Universita e della Ricerca" Italy	Fondazione Banco di Sardegna - Sassari - Italy(Fondazione Banco di Sardegna); "Ministero dell'Universita e della Ricerca" Italy(Ministry of Education, Universities and Research (MIUR))	This research was funded by the "Fondazione Banco di Sardegna - Sassari - Italy" and by the "Ministero dell'Universita e della Ricerca" Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin M, 2017, CLIN RESPIR J, V11, P318, DOI 10.1111/crj.12337; Barnes PJ, 2004, LANCET, V364, P564, DOI 10.1016/S0140-6736(04)16866-9; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Boger RH, 2009, PHARMACOL RES, V60, P481, DOI 10.1016/j.phrs.2009.07.001; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Bulau P, 2007, AM J PHYSIOL-LUNG C, V292, pL18, DOI 10.1152/ajplung.00076.2006; Caldwell RB, 2015, TRENDS PHARMACOL SCI, V36, P395, DOI 10.1016/j.tips.2015.03.006; Carraro S, 2013, CHEST, V144, P405, DOI 10.1378/chest.12-2379; Chandel NS, 2000, J APPL PHYSIOL, V88, P1880, DOI 10.1152/jappl.2000.88.5.1880; Chen YH, 2009, EXP EYE RES, V89, P1028, DOI 10.1016/j.exer.2009.09.004; Deponte M, 2015, BIOL CHEM, V396, P401, DOI 10.1515/hsz-2014-0280; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; Grasemann H, 2011, AM J RESP CRIT CARE, V183, P1363, DOI 10.1164/rccm.201012-1995OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513; Jiang JL, 2006, CARDIOVASC DRUG THER, V20, P281, DOI 10.1007/s10557-006-9065-1; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P449, DOI 10.1164/ajrccm.155.2.9032177; Kiml V, 2013, AM J RESP CRIT CARE, V187, P228, DOI 10.1164/rccm.201210-1843CI; Koechlin C, 2005, THORAX, V60, P834, DOI 10.1136/thx.2004.037531; Kurz K, 2009, PHARMACOL RES, V60, P508, DOI 10.1016/j.phrs.2009.07.009; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; McEvoy MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058390; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; Morrison D, 1999, AM J RESP CRIT CARE, V159, P473, DOI 10.1164/ajrccm.159.2.9804080; Paredi P, 2000, AM J RESP CRIT CARE, V162, P369, DOI 10.1164/ajrccm.162.2.9909025; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; RENKEMA TEJ, 1991, EUR RESPIR J, V4, P1237; Retamales I, 2001, AM J RESP CRIT CARE, V164, P469, DOI 10.1164/ajrccm.164.3.2007149; Rossi R, 2009, J CELL MOL MED, V13, P3131, DOI 10.1111/j.1582-4934.2008.00417.x; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Scott JA, 2014, INT J MOL SCI, V15, P6062, DOI 10.3390/ijms15046062; Scott JA, 2013, CHEST, V144, P367, DOI 10.1378/chest.13-0480; Scott JA, 2011, AM J RESP CRIT CARE, V184, P779, DOI 10.1164/rccm.201011-1810OC; Teerlink T, 2005, CLIN CHEM LAB MED, V43, P1130, DOI 10.1515/CCLM.2005.197; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; VALLANCE P, 1992, LANCET, V339, P572; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Zinellu A, 2009, AMINO ACIDS, V36, P35, DOI 10.1007/s00726-007-0022-5; Zinellu A, 2011, ANAL BIOANAL CHEM, V399, P1815, DOI 10.1007/s00216-010-4580-0	44	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160237	10.1371/journal.pone.0160237	http://dx.doi.org/10.1371/journal.pone.0160237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479314	Green Published, gold			2022-12-27	WOS:000381110300034
J	Tucker, MA; Nguyen, N; Stickgold, R				Tucker, Matthew A.; Nguyen, Nam; Stickgold, Robert			Experience Playing a Musical Instrument and Overnight Sleep Enhance Performance on a Sequential Typing Task	PLOS ONE			English	Article							MOTOR MEMORY CONSOLIDATION; DEPENDENT CONSOLIDATION; TIME-COURSE; SKILLS; SPINDLES	The smooth, coordinated fine motor movements required to play a musical instrument are not only highly valued in our society; they also predict academic success in areas that generalize beyond the motor domain, including reading and math readiness, and verbal abilities. Interestingly, motor skills that overlap with those required to play a musical instrument (e.g., sequential finger tapping) markedly improve (get faster) over a night of sleep, but not after a day spent awake. Here we studied whether individuals who play musical instruments that require fine finger motor skill are better able to learn and consolidate a simple motor skill task compared to those who do not play an instrument, and whether sleep-specific motor skill benefits interact with those imparted by musical experience. We used the motor sequence task (MST), which taps into a core skill learned and used by musicians, namely, the repetition of learned sequences of key presses. Not surprisingly, we found that musicians were faster than non-musicians throughout the learning session, typing more correct sequences per 30-sec trial. In the 12hrs that followed learning we found that sleep and musical experience both led to greater improvement in performance. Surprisingly, musicians retested after a day of wake performed slightly better than non-musicians who had slept between training and retest, suggesting that musicians have the capacity to consolidate a motor skill across waking hours, while non-musicians appear to lack this capacity. These findings suggest that the musically trained brain is optimized for motor skill consolidation across both wake and sleep, and that sleep may simply promote a more effective use of this machinery. In sum, there may be something special about musicians, perhaps a neurophysiological advantage, that leads to both the expected-greater motor speed at learning -and the surprising-greater motor skill improvement over time.	[Tucker, Matthew A.; Nguyen, Nam; Stickgold, Robert] Beth Israel Deaconess Med Ctr, Ctr Sleep & Cognit, Boston, MA 02215 USA; [Stickgold, Robert] Harvard Univ, Cambridge, MA 02138 USA; [Tucker, Matthew A.] Univ South Carolina, Sch Med, Dept Biomed Sci, Greenville, SC 29208 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University	Tucker, MA (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Sleep & Cognit, Boston, MA 02215 USA.; Tucker, MA (corresponding author), Univ South Carolina, Sch Med, Dept Biomed Sci, Greenville, SC 29208 USA.	matucker@greenvillemed.sc.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048832] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH048832] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allen SE, 2013, PSYCHOL MUSIC, V41, P794, DOI 10.1177/0305735612463947; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Cameron CE, 2012, CHILD DEV, V83, P1229, DOI 10.1111/j.1467-8624.2012.01768.x; Doyon J, 2009, EXP BRAIN RES, V195, P15, DOI 10.1007/s00221-009-1748-y; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Forgeard Marie, 2008, PLoS One, V3, pe3566, DOI 10.1371/journal.pone.0003566; Gaser C, 2003, J NEUROSCI, V23, P9240; Grissmer D, 2010, DEV PSYCHOL, V46, P1008, DOI 10.1037/a0020104; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Klein C, 2016, HUM BRAIN MAPP, V37, P536, DOI 10.1002/hbm.23045; Korman M, 2007, NAT NEUROSCI, V10, P1206, DOI 10.1038/nn1959; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Landau SM, 2006, COGN AFFECT BEHAV NE, V6, P246, DOI 10.3758/CABN.6.3.246; Laventure S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002429; Manoach DS, 2010, J PSYCHIATR RES, V44, P112, DOI 10.1016/j.jpsychires.2009.06.011; Nishida M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000341; Spencer RMC, 2007, LEARN MEMORY, V14, P480, DOI 10.1101/lm.569407; Spencer RMC, 2006, CURR BIOL, V16, P1001, DOI 10.1016/j.cub.2006.03.094; Tamaki M, 2009, CLIN NEUROPHYSIOL, V120, P878, DOI 10.1016/j.clinph.2009.03.006; Tucker MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021737; Tucker MA, 2009, J SLEEP RES, V18, P304, DOI 10.1111/j.1365-2869.2009.00740.x; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8	27	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159608	10.1371/journal.pone.0159608	http://dx.doi.org/10.1371/journal.pone.0159608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27472398	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516300014
J	Wemhoff, S; Klassen, R; Beetz, A; Meinhardt, F				Wemhoff, Sabrina; Klassen, Roland; Beetz, Anja; Meinhardt, Friedhelm			DNA Damage Responses Are Induced by tRNA Anticodon Nucleases and Hygromycin B	PLOS ONE			English	Article							KLUYVEROMYCES-LACTIS TOXIN; SACCHAROMYCES-CEREVISIAE; PICHIA-ACACIAE; KILLER TOXIN; POSTREPLICATION REPAIR; ESCHERICHIA-COLI; ABASIC SITES; AMINOGLYCOSIDE ANTIBIOTICS; HOMOLOGOUS RECOMBINATION; S-PHASE	Previous studies revealed DNA damage to occur during the toxic action of PaT, a fungal anticodon ribonuclease (ACNase) targeting the translation machinery via tRNA cleavage. Here, we demonstrate that other translational stressors induce DNA damage-like responses in yeast as well: not only zymocin, another ACNase from the dairy yeast Kluyveromyces lactis, but also translational antibiotics, most pronouncedly hygromycin B (HygB). Specifically, DNA repair mechanisms BER (base excision repair), HR (homologous recombination) and PRR (post replication repair) provided protection, whereas NHEJ (non-homologous end-joining) aggravated toxicity of all translational inhibitors. Analysis of specific BER mutants disclosed a strong HygB, zymocin and PaT protective effect of the endonucleases acting on apurinic sites. In cells defective in AP endonucleases, inactivation of the DNA glycosylase Ung1 increased tolerance to ACNases and HygB. In addition, Mag1 specifically contributes to the repair of DNA lesions caused by HygB. Consistent with DNA damage provoked by translation inhibitors, mutation frequencies were elevated upon exposure to both fungal ACNases and HygB. Since polymerase. contributed to toxicity in all instances, error-prone lesion-bypass probably accounts for the mutagenic effects. The finding that differently acting inhibitors of protein biosynthesis induce alike cellular responses in DNA repair mutants is novel and suggests the dependency of genome stability on translational fidelity.	[Wemhoff, Sabrina; Beetz, Anja; Meinhardt, Friedhelm] Univ Munster, Inst Mol Mikrobiol & Biotechnol, Munster, Germany; [Klassen, Roland] Univ Kassel, Fachgebiet Mikrobiol, Inst Biol, Kassel, Germany	University of Munster; Universitat Kassel	Meinhardt, F (corresponding author), Univ Munster, Inst Mol Mikrobiol & Biotechnol, Munster, Germany.	meinhar@uni-muenster.de			Deutsche Forschungsgemeinschaft; Open Access Publication Fund of University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of University of Muenster	The authors acknowledge support by the Deutsche Forschungsgemeinschaft and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Alseth I, 1999, MOL CELL BIOL, V19, P3779; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; BAKKER EP, 1992, J GEN MICROBIOL, V138, P563, DOI 10.1099/00221287-138-3-563; Bennett RAO, 1999, MOL CELL BIOL, V19, P1800; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Borovinskaya MA, 2008, RNA, V14, P1590, DOI 10.1261/rna.1076908; Branzei D, 2011, FEBS LETT, V585, P2810, DOI 10.1016/j.febslet.2011.04.053; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; BUTLER AR, 1991, EUR J BIOCHEM, V199, P483, DOI 10.1111/j.1432-1033.1991.tb16147.x; BUTLER AR, 1991, J GEN MICROBIOL, V137, P1749, DOI 10.1099/00221287-137-7-1749; CABANAS MJ, 1978, BIOCHEM BIOPH RES CO, V83, P991; CABANAS MJ, 1978, EUR J BIOCHEM, V87, P21, DOI 10.1111/j.1432-1033.1978.tb12347.x; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; EUSTICE DC, 1984, BIOCHEMISTRY-US, V23, P1462, DOI 10.1021/bi00302a019; EUSTICE DC, 1984, ANTIMICROB AGENTS CH, V26, P53, DOI 10.1128/AAC.26.1.53; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; GONZALEZ A, 1978, BIOCHIM BIOPHYS ACTA, V521, P459, DOI 10.1016/0005-2787(78)90287-3; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guillet M, 2003, MOL CELL BIOL, V23, P8386, DOI 10.1128/MCB.23.22.8386-8394.2003; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; GUNGE N, 1981, J BACTERIOL, V145, P382, DOI 10.1128/JB.145.1.382-390.1981; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoskins J, 2007, YEAST, V24, P861, DOI 10.1002/yea.1516; Jablonowski D, 2001, YEAST, V18, P1285, DOI 10.1002/yea.776; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; KAMPER J, 1991, CURR GENET, V19, P109, DOI 10.1007/BF00326291; Kast A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005005; Klassen R, 2005, CELL MICROBIOL, V7, P393, DOI 10.1111/j.1462-5822.2004.00469.x; Klassen R, 2004, MOL MICROBIOL, V53, P263, DOI 10.1111/j.1365-2958.2004.04119.x; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; Klassen R, 2007, DNA REPAIR, V6, P1864, DOI 10.1016/j.dnarep.2007.07.010; Klassen R, 2014, CURR GENET, V60, P213, DOI 10.1007/s00294-014-0426-1; Klassen R, 2011, MOL GENET GENOMICS, V285, P185, DOI 10.1007/s00438-010-0597-5; Lee KY, 2008, MOL CELLS, V26, P5; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Merrill BJ, 1999, GENETICS, V153, P595; Muccilli S, 2013, YEAST, V30, P33, DOI 10.1002/yea.2935; Nash HM, 1996, CURR BIOL, V6, P968, DOI 10.1016/S0960-9822(02)00641-3; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Paluszynski JP, 2007, APPL ENVIRON MICROB, V73, P4373, DOI 10.1128/AEM.00271-07; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Patil A, 2012, RNA BIOL, V9, P990, DOI 10.4161/rna.20531; PERCIVAL KJ, 1989, J BIOL CHEM, V264, P2593; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PITTENGER RC, 1953, ANTIBIOT CHEMOTHER, V3, P1268; Plant EP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000517; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Satwika D, 2012, APPL MICROBIOL BIOT, V96, P345, DOI 10.1007/s00253-012-4349-9; Scheller J, 2000, GENETICS, V155, P1069; Schmitt F, 1997, J BIOL CHEM, V272, P1534, DOI 10.1074/jbc.272.3.1534; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Smirnova M, 2003, MUTAT RES-FUND MOL M, V532, P117, DOI 10.1016/j.mrfmmm.2003.08.026; STARK MJR, 1990, YEAST, V6, P1, DOI 10.1002/yea.320060102; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tinkelenberg BA, 2002, CANCER RES, V62, P4909; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; vanderKemp PA, 1996, P NATL ACAD SCI USA, V93, P5197, DOI 10.1073/pnas.93.11.5197; Wardle J, 2008, NUCLEIC ACIDS RES, V36, P705, DOI 10.1093/nar/gkm1023; Wemhoff S, 2016, CELL MICROBIOL, V18, P211, DOI 10.1111/cmi.12496; Wemhoff S, 2014, APPL ENVIRON MICROB, V80, P6549, DOI 10.1128/AEM.02197-14; WORSHAM PL, 1990, CURR GENET, V18, P77, DOI 10.1007/BF00321119; Xiao W, 1998, CURR GENET, V33, P92, DOI 10.1007/s002940050313; Xiao W, 2001, MUTAT RES-DNA REPAIR, V487, P137, DOI 10.1016/S0921-8777(01)00113-6	77	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0157611	10.1371/journal.pone.0157611	http://dx.doi.org/10.1371/journal.pone.0157611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472060	Green Published, gold			2022-12-27	WOS:000381516300003
J	Zhang, L; Ma, XM; Xuan, JL; Wang, HH; Yuan, ZH; Wu, MM; Liu, RZ; Zhu, CY; Wei, CH; Zhao, FP; Du, LX				Zhang, Li; Ma, Xiaomeng; Xuan, Junli; Wang, Huihua; Yuan, Zehu; Wu, Mingming; Liu, Ruizao; Zhu, Caiye; Wei, Caihong; Zhao, Fuping; Du, Lixin			Identification of MEF2B and TRHDE Gene Polymorphisms Related to Growth Traits in a New Ujumqin Sheep Population	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTORS; QUANTITATIVE TRAIT; EXPRESSION; DIFFERENTIATION; MUTATIONS; PHENOTYPE; ASSOCIATION; MYOGENESIS; SNPS	2 SNPs were discovered in our previous genome-wide association study (GWAS): s58995.1 (rs420767326 A>G) in MEF2B gene and OAR3_115712045.1 (rs401775061 A>C) in TRHDE gene, which were significantly associated with post-weaning gain in sheep. Herein, we performed a replication experiment to investigate single nucleotide polymorphisms (SNPs) within the MEF2B and TRHDE gene exons, the 5' untranslated regions (within 1000bp), the 3' untranslated regions (within 1000bp) and their associations with Ujumqin sheep growth traits in 4-month age and 6-month age, respectively. Finally, 3 SNPs were selected to be investigated including 1 SNP in 3' untranslated regions in MEF2B gene (rs417014745 A>G) and 2 SNPs in TRHDE gene (rs426980328 T>C and rs430810656 G>A). The chi(2) test showed all the 3 variations were in Hardy-Weinberg equilibrium (P>0.05) status. Association analysis suggested that rs426980328 T>C was significantly associated with body weight and chest girth in 4-month age (P<0.05). rs430810656 G>A exhibited extremely significant association with body weight and chest girth in 4-month age (P<0.01). rs417014745 A>G was extremely significantly associated with body weight and chest girth in 4-month age and chest girth in 6-month age (P<0.01), and it was also significantly associated with body weight in 6-month age (P<0.05). Combined effect analysis indicated significant associations between the combinations of rs426980328-rs417014745, rs430810656-rs417014745 and several growth traits (P<0.05). These results suggested MEF2B and TRHDE genes affected growth traits in Ujumqin sheep and the combination effect of the two genes also played a significant effective role. These SNPs might have potential value as genetic markers for growth traits and it could be used in Ujumqin sheep breeding in future. Further studies are necessary to confirm our findings.	[Zhang, Li; Ma, Xiaomeng; Xuan, Junli; Wang, Huihua; Yuan, Zehu; Wu, Mingming; Liu, Ruizao; Zhu, Caiye; Wei, Caihong; Zhao, Fuping; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhang, L; Du, LX (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	zhangli07@caas.cn; lxdu@263.net	wu, mingming/GXN-1864-2022; Wang, Huihua/AGY-6668-2022		National Natural Science Foundation of China [U1503285]; 863 project of China "Genome-wide association study on meat traits in sheep" [2011AA100307-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 project of China "Genome-wide association study on meat traits in sheep"	This study was supported by the National Natural Science Foundation of China "Studies on the Characteristics and Molecular Mechanisms of Formation of Sheep Skeletal Muscle" (U1503285) and the 863 project of China "Genome-wide association study on meat traits in sheep" (2011AA100307-02).	Bo HE, 2006, ACTA VET ZOOTECHNICA, P555; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Cavanagh CR, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-36; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen L, 2015, GENE, V555, P223, DOI 10.1016/j.gene.2014.11.007; Chu MX, 2007, J ANIM SCI, V85, P598, DOI 10.2527/jas.2006-324; Daw EW, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S32; Dumortier O, 2012, DIABETES OBES METAB, V14, P22, DOI 10.1111/j.1463-1326.2012.01656.x; Estrella NL, 2015, J BIOL CHEM, V290, P1256, DOI 10.1074/jbc.M114.589838; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Freudenberg J, 2011, ARTHRITIS RHEUM-US, V63, P884, DOI 10.1002/art.30235; Iida K, 1999, TOHOKU J EXP MED, V187, P15, DOI 10.1620/tjem.187.15; Kim ES, 2016, HEREDITY, V116, P255, DOI 10.1038/hdy.2015.94; Komar AA, 2007, PHARMACOGENOMICS, V8, P1075, DOI 10.2217/14622416.8.8.1075; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu YB, 2010, NUCLEIC ACIDS RES, V38, P6857, DOI 10.1093/nar/gkq585; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nagy V, 2015, CELL CYCLE, V14, P1797, DOI 10.1080/15384101.2015.1036209; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Orozco G, 2009, HUM MOL GENET, V18, P2693, DOI 10.1093/hmg/ddp193; Pon JR, 2016, ONCOTARGET, V7, P2297, DOI 10.18632/oncotarget.6223; Reamon-Buettner SM, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-38; Rodriguez AI, 2015, ARTERIOSCL THROM VAS, V35, P430, DOI 10.1161/ATVBAHA.114.304936; Schomburg L, 1999, EUR J BIOCHEM, V265, P415, DOI 10.1046/j.1432-1327.1999.00753.x; Sun Q, 2012, EXP BIOL MED, V237, P178, DOI 10.1258/ebm.2011.011261; Yajima H, 2010, EXP CELL RES, V316, P2932, DOI 10.1016/j.yexcr.2010.08.001; Zhang L, 2014, STUD BIG DATA, V1, P1, DOI 10.1007/978-3-642-40837-3_1; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066569; Zuo BY, 2014, MOL BIOL REP, V41, P6967, DOI 10.1007/s11033-014-3583-x	30	17	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159504	10.1371/journal.pone.0159504	http://dx.doi.org/10.1371/journal.pone.0159504			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472808	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516300009
J	Furihata, S; Matsumura, T; Hirata, M; Mizutani, T; Nagata, N; Kataoka, M; Katayama, Y; Omatsu, T; Matsumoto, H; Hayakawa, Y				Furihata, Shunsuke; Matsumura, Takashi; Hirata, Makiko; Mizutani, Tetsuya; Nagata, Noriyo; Kataoka, Michiyo; Katayama, Yukie; Omatsu, Tsutomu; Matsumoto, Hitoshi; Hayakawa, Yoichi			Characterization of Venom and Oviduct Components of Parasitoid Wasp Asobara japonica	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; GLYPTAPANTELES-INDIENSIS POLYDNAVIRUS; DIADROMUS PULCHELLUS ASCOVIRUS; ACROLEPIOPSIS-ASSECTELLA; DROSOPHILA-MELANOGASTER; ENDOPARASITOID WASP; MOLECULAR-BIOLOGY; LEPIDOPTERAN HOST; COTESIA-KARIYAI; IMMUNE-RESPONSE	During natural parasitization, Asobara japonica wasps introduce lateral oviduct (LO) components into their Drosophila hosts soon after the venom injection to neutralize its strong toxicity; otherwise, the host will die. Although the orchestrated relationship between the venom and LO components necessary for successful parasitism has attracted the attention of many researchers in this field, the molecular natures of both factors remain ambiguous. We here showed that precipitation of the venom components by ultracentrifugation yielded a toxic fraction that was inactivated by ultraviolet light irradiation, boiling, and sonication, suggesting that it is a virus-like entity. Morphological observation of the precipitate after ultracentrifugation showed small spherical heterogeneous virus-like particles 20-40 nm in diameter. The venom's detrimental effect on D. melanogaster larvae was not directly neutralized by the LO components but blocked by a hemolymphal neutralizing factor activated by the LO factor. Furthermore, we found that A. japonica venom and LO components acted similarly on the larvae of the common cutworm Spodoptera litura: the venom injection caused mortality but coinjection of the LO factor protected S. litura larvae from the venom's toxicity. In contrast, D. ficusphila and D. bipectinata, which are closely related to D. melanogaster but non-habitual host species of A. japonica, were not negatively affected by A. japonica venom due to an intrinsic neutralizing activity in their hemolymph, indicating that these species must have acquired a neutralizer of A. japonica venom during evolution. These results give new insights into the characteristics of both the venom and LO components: A. japonica females have utilized the virus-like toxic venom factor to exploit a wider range of host species after the evolutionary process enabled them to use the LO factor for activation of the host hemolymph neutralizer precursor, although the non-habitual host Drosophila species possess an active intrinsic neutralizer in their hemolymph.	[Furihata, Shunsuke; Matsumura, Takashi; Hirata, Makiko; Matsumoto, Hitoshi; Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan; [Mizutani, Tetsuya; Katayama, Yukie; Omatsu, Tsutomu] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo 1838509, Japan; [Nagata, Noriyo; Kataoka, Michiyo] Natl Inst Infect Dis, Dept Virol 2, Tokyo 2800011, Japan	Saga University; Tokyo University of Agriculture & Technology; National Institute of Infectious Diseases (NIID)	Hayakawa, Y (corresponding author), Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan.	hayakayo@cc.saga-u.ac.jp	Furihata, Shunsuke/O-8571-2019; Omatsu, Tsutomu/C-8344-2013; MIZUTANI, Tetsuya/G-1086-2013	Omatsu, Tsutomu/0000-0001-7860-7409; MIZUTANI, Tetsuya/0000-0003-2570-0452; Matsumura, Takashi/0000-0002-5817-8819	Grants-in-Aid for Scientific Research [16K14777] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ARIF BM, 1995, J GEN VIROL, V76, P1, DOI 10.1099/0022-1317-76-1-1; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Barratt BIP, 1999, J INVERTEBR PATHOL, V73, P182, DOI 10.1006/jipa.1998.4826; Bergoin M, 2000, CONTRIB MICROBIOL, V4, P12; Bigot Y, 2000, J GEN VIROL, V81, P3073, DOI 10.1099/0022-1317-81-12-3073; Bigot Y, 1997, J GEN VIROL, V78, P1149, DOI 10.1099/0022-1317-78-5-1149; Bigot Y, 1997, J GEN VIROL, V78, P1139, DOI 10.1099/0022-1317-78-5-1139; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke Gaelen R., 2012, Insects, V3, P91, DOI 10.3390/insects3010091; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Chen YP, 2003, INSECT MOL BIOL, V12, P271, DOI 10.1046/j.1365-2583.2003.00411.x; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; Doremus T, 2013, J INSECT PHYSIOL, V59, P500, DOI 10.1016/j.jinsphys.2013.02.010; EDSON KM, 1982, TOXICON, V20, P553, DOI 10.1016/0041-0101(82)90049-6; Fath-Goodin A, 2009, INSECT MOL BIOL, V18, P497, DOI 10.1111/j.1365-2583.2009.00892.x; FLEMING JAGW, 1992, ANNU REV ENTOMOL, V37, P401, DOI 10.1146/annurev.en.37.010192.002153; Furihata S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140914; Furihata S, 2014, J INVERTEBR PATHOL, V115, P26, DOI 10.1016/j.jip.2013.10.013; Furihata SX, 2013, ARCH INSECT BIOCHEM, V83, P86, DOI 10.1002/arch.21093; Furihata SX, 2009, PHYSIOL ENTOMOL, V34, P292, DOI 10.1111/j.1365-3032.2009.00676.x; Goldsmith CS, 2009, CLIN MICROBIOL REV, V22, P552, DOI 10.1128/CMR.00027-09; Gundersen-Rindal DE, 2006, J GEN VIROL, V87, P311, DOI 10.1099/vir.0.81326-0; HAYAKAWA Y, 1994, J BIOL CHEM, V269, P14536; Hayakawa Yoichi, 1994, Insect Molecular Biology, V3, P97, DOI 10.1111/j.1365-2583.1994.tb00156.x; Ideo S, 2008, ENTOMOL SCI, V11, P1, DOI 10.1111/j.1479-8298.2007.00244.x; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; KRELL PJ, 1987, J GEN VIROL, V68, P1477, DOI 10.1099/0022-1317-68-5-1477; Lawrence PO, 2005, J INSECT PHYSIOL, V51, P221, DOI 10.1016/j.jinsphys.2004.12.003; LAWRENCE PO, 1990, CAN J ZOOL, V68, P539, DOI 10.1139/z90-079; Morales J, 2005, J INSECT PHYSIOL, V51, P181, DOI 10.1016/j.jinsphys.2004.11.002; Moreau SJM, 2003, DEV COMP IMMUNOL, V27, P273, DOI 10.1016/S0145-305X(02)00101-5; MORITA T, 1977, J BIOCHEM-TOKYO, V82, P1495, DOI 10.1093/oxfordjournals.jbchem.a131840; Nakashima N, 2009, VIRUS RES, V139, P137, DOI 10.1016/j.virusres.2008.06.006; Ohnishi A, 1995, INSECT BIOCHEM MOLEC, V25, P1121, DOI 10.1016/0965-1748(95)00054-2; ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067; Renault S, 2003, J GEN VIROL, V84, P1799, DOI 10.1099/vir.0.19038-0; Rossmann MG, 1999, NAT STRUCT BIOL, V6, P717, DOI 10.1038/11477; Ryuda M, 2008, APPL ENTOMOL ZOOL, V43, P563, DOI 10.1303/aez.2008.563; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmidt O, 1989, Subcell Biochem, V15, P91; Schmidt O, 2008, INSECT IMMUNOLOGY, P271, DOI 10.1016/B978-012373976-6.50013-6; Shia M, 2008, VIROLOGY, V375, P374, DOI 10.1016/j.virol.2008.02.027; Stasiak K, 2005, J INSECT PHYSIOL, V51, P103, DOI 10.1016/j.jinsphys.2004.07.004; STOLTZ DB, 1984, INTERVIROLOGY, V21, P1, DOI 10.1159/000149497; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Suderman RJ, 2008, J GEN VIROL, V89, P1411, DOI 10.1099/vir.0.2008/000307-0; Tanaka K, 2002, EUR J BIOCHEM, V269, P2557, DOI 10.1046/j.1432-1033.2002.02922.x; Tanaka K, 2002, APPL ENTOMOL ZOOL, V37, P323, DOI 10.1303/aez.2002.323; VINSON SB, 1980, Q REV BIOL, V55, P143, DOI 10.1086/411731; Vinson SB, 1998, J INSECT PHYSIOL, V44, P701; WEBB BA, 2004, COMPREHENSIVE MOL IN, V6, P323	53	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160210	10.1371/journal.pone.0160210	http://dx.doi.org/10.1371/journal.pone.0160210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467595	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516100130
J	Gadahi, JA; Wang, S; Bo, G; Ehsan, M; Yan, RF; Song, XK; Xu, L; Li, XR				Gadahi, Javaid Ali; Wang, Shuai; Bo, Gao; Ehsan, Muhammad; Yan, RuoFeng; Song, XiaoKai; Xu, Lixin; Li, XiangRui			Proteomic Analysis of the Excretory and Secretory Proteins of Haemonchus contortus (HcESP) Binding to Goat PBMCs In Vivo Revealed Stage-Specific Binding Profiles	PLOS ONE			English	Article							EXCRETORY/SECRETORY PRODUCTS; MOLECULAR CHARACTERIZATION; ELONGATION FACTOR-1-ALPHA; SCHISTOSOMA-MANSONI; EXPRESSION ANALYSIS; GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; CLONORCHIS-SINENSIS; AKT PHOSPHORYLATION; PROTECTIVE IMMUNITY	Haemonchus contortus is a parasitic gastrointestinal nematode, and its excretory and secretory products (HcESPs) interact extensively with the host cells. In this study, we report the interaction of proteins from HcESPs at different developmental stages to goat peripheral blood mononuclear cells (PBMCs) in vivo using liquid chromatography-tandem mass spectrometry. A total of 407 HcESPs that interacted with goat PBMCs at different time points were identified from a H. contortus protein database using SEQUEST searches. The L-4 and L-5 stages of H. contortus represented a higher proportion of the identified proteins compared with the early and late adult stages. Both stage-specific interacting proteins and proteins that were common to multiple stages were identified. Forty-seven interacting proteins were shared among all stages. The gene ontology (GO) distributions of the identified goat PBMC-interacting proteins were nearly identical among all developmental stages, with high representation of binding and catalytic activity. Cellular, metabolic and single-organism processes were also annotated as major biological processes, but interestingly, more proteins were annotated as localization processes at the L5 stage than at the L4 and adult stages. Based on the clustering of homologous proteins, we improved the functional annotations of un-annotated proteins identified at different developmental stages. Some unnamed H. contortus ATP-binding cassette proteins, including ADP-ribosylation factor and P-glycoprotein-9, were identified by STRING protein clustering analysis.	[Gadahi, Javaid Ali; Wang, Shuai; Bo, Gao; Ehsan, Muhammad; Yan, RuoFeng; Song, XiaoKai; Xu, Lixin; Li, XiangRui] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Li, XR (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China.	lixiangrui@njau.edu.cn	Ehsan, Muhammad/ABB-9122-2020; Ehsan, Muhammad/AAK-8086-2021; Gadahi, Javaid Ali/ABE-1857-2020	Ehsan, Muhammad/0000-0001-5314-5869; Ehsan, Muhammad/0000-0001-5314-5869; Gadahi, Javaid Ali/0000-0001-6006-1954	National Key Basic Research Program (973 program) of China [2015CB150300]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program (973 program) of China(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The project was supported by the "National Key Basic Research Program (973 program) of China" (Grant No. 2015CB150300) and by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Ackema KB, 2014, EMBO J, V33, P2659, DOI 10.15252/embj.201489039; Aghazadeh Y, 2014, J BIOL CHEM, V289, P26542, DOI 10.1074/jbc.M114.569079; Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Anbu KA, 2008, PARASITE IMMUNOL, V30, P23, DOI 10.1111/j.1365-3024.2007.00995.x; Barteneva NS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00049; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Berndt Norbert, 2003, Prog Cell Cycle Res, V5, P497; BLACKBURN HD, 1992, VET PARASITOL, V44, P183, DOI 10.1016/0304-4017(92)90116-Q; Blanch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066436; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Breugelmans B, 2014, INT J PARASITOL, V44, P827, DOI 10.1016/j.ijpara.2014.06.005; Buck AH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6488; Campbell BE, 2011, BIOTECHNOL ADV, V29, P28, DOI 10.1016/j.biotechadv.2010.08.008; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; COX GN, 1990, MOL BIOCHEM PARASIT, V41, P25, DOI 10.1016/0166-6851(90)90093-2; Craig H, 2006, PARASITOLOGY, V132, P535, DOI 10.1017/S0031182005009510; DeLoof A, 1996, INT REV CYTOL, V166, P1; Doerks T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034302; El Ridi R, 2013, J PARASITOL, V99, P194, DOI 10.1645/GE-3186.1; Estrada-Reyes ZM, 2015, PARASITE IMMUNOL, V37, P446, DOI 10.1111/pim.12211; Fang L, 2014, VACCINE, V32, P4412, DOI 10.1016/j.vaccine.2014.06.055; Ferrell J E Jr, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.52.pe1; Gadahi JA, 2016, ONCOTARGET, V7, P35670, DOI 10.18632/oncotarget.9589; Geering B, 2015, INT J BIOCHEM CELL B, V65, P151, DOI 10.1016/j.biocel.2015.06.001; Geldhof P, 2005, INT J PARASITOL, V35, P513, DOI 10.1016/j.ijpara.2005.02.009; Gilleard JS, 2013, PARASITOLOGY, V140, P1506, DOI 10.1017/S0031182013001145; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; GITT MA, 1995, J BIOL CHEM, V270, P5032, DOI 10.1074/jbc.270.10.5032; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Han K, 2011, J HELMINTHOL, V85, P421, DOI 10.1017/S0022149X10000763; Han KK, 2012, RES VET SCI, V92, P259, DOI 10.1016/j.rvsc.2011.03.008; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hartman D, 2001, INT J PARASITOL, V31, P1236, DOI 10.1016/S0020-7519(01)00248-X; Hartmann W, 2014, PARASITE IMMUNOL, V36, P141, DOI 10.1111/pim.12093; Heusden G.P.H.V., 1995, EUR J BIOCHEM, V229, P45, DOI DOI 10.1111/J.1432-1033.1995.0045L.X; Hewitson JP, 2011, J PROTEOMICS, V74, P1573, DOI 10.1016/j.jprot.2011.06.002; Hoekstra R, 2000, MOL BIOCHEM PARASIT, V110, P53, DOI 10.1016/S0166-6851(00)00255-3; Hu M, 2007, EXP PARASITOL, V117, P22, DOI 10.1016/j.exppara.2007.03.008; Hu Y, 2014, PARASITOL RES, V113, P4543, DOI 10.1007/s00436-014-4144-x; Huber A, 2005, PARASITOL RES, V96, P290, DOI 10.1007/s00436-005-1321-y; Issouf M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087802; Jacobs JR, 2016, PARASITE IMMUNOL, V38, P333, DOI 10.1111/pim.12321; Jasmer DP, 2007, PARASITE IMMUNOL, V29, P139, DOI 10.1111/j.1365-3024.2006.00928.x; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jeon YH, 2013, BBA-MOL CELL RES, V1833, P2135, DOI 10.1016/j.bbamcr.2013.05.005; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; KAUR KJ, 1994, J BIOL CHEM, V269, P23045; Kim TY, 2007, PARASITOL RES, V101, P1557, DOI 10.1007/s00436-007-0676-7; Kiss JE, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-21; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Knox D, 2011, ADV EXP MED BIOL, V712, P155, DOI 10.1007/978-1-4419-8414-2_10; Knox DP, 2000, PARASITOLOGY, V120, pS43, DOI 10.1017/S0031182099005764; Kovaleva ES, 2005, COMP PARASITOL, V72, P39, DOI 10.1654/4138; Koyama T, 2001, VET PARASITOL, V96, P65, DOI 10.1016/S0304-4017(00)00424-6; Kutuzov MA, 2008, MOL BIOCHEM PARASIT, V161, P81, DOI 10.1016/j.molbiopara.2008.06.008; Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Ma GX, 2014, EXP PARASITOL, V141, P55, DOI 10.1016/j.exppara.2014.03.019; Mangiola S, 2013, BIOTECHNOL ADV, V31, P1109, DOI 10.1016/j.biotechadv.2012.12.004; Marcilla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045974; Matsubayashi M, 2013, J BIOL CHEM, V288, P34111, DOI 10.1074/jbc.M113.515544; McGonigle S, 2001, FEBS LETT, V490, P65, DOI 10.1016/S0014-5793(01)02133-0; Merkelbach P, 2002, VET PARASITOL, V104, P217, DOI 10.1016/S0304-4017(01)00635-5; Morassutti AL, 2012, EXP PARASITOL, V130, P26, DOI 10.1016/j.exppara.2011.10.003; Moreno Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001370; Morphew RM, 2007, MOL CELL PROTEOMICS, V6, P963, DOI 10.1074/mcp.M600375-MCP200; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Nikolaou S, 2006, INT J PARASITOL, V36, P859, DOI 10.1016/j.ijpara.2006.04.007; Nikolaou S, 2004, GENE, V343, P313, DOI 10.1016/j.gene.2004.09.017; Nowacki FC, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28665; Przemeck S, 2005, PARASITOL RES, V95, P213, DOI 10.1007/s00436-004-1280-8; Ransom-Hodgkins WD, 2009, MOL GENET GENOMICS, V281, P391, DOI 10.1007/s00438-008-0418-2; Rathore DK, 2006, VET PARASITOL, V138, P291, DOI 10.1016/j.vetpar.2006.01.055; Ravooru N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00291; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Redman E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002534; Rehman A, 1998, MOL BIOCHEM PARASIT, V97, P55, DOI 10.1016/S0166-6851(98)00132-7; Reinhardt S, 2011, PARASITOL RES, V109, P627, DOI 10.1007/s00436-011-2305-8; Rhoads Robert E, 2006, WormBook, P1; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; Sahoo S, 2013, PARASITE IMMUNOL, V35, P457, DOI 10.1111/pim.12058; Salavati R, 2010, TRENDS PARASITOL, V26, P225, DOI 10.1016/j.pt.2010.02.001; Sarmiento M, 1998, J BIOL CHEM, V273, P26368, DOI 10.1074/jbc.273.41.26368; Saverwyns H, 2008, PARASITOLOGY, V135, P63, DOI 10.1017/S0031182007003666; Schallig HDFH, 1997, PARASITE IMMUNOL, V19, P447, DOI 10.1046/j.1365-3024.1997.d01-148.x; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Siles-Lucas MD, 2003, TRENDS PARASITOL, V19, P575, DOI 10.1016/j.pt.2003.10.003; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Singhvi A, 2011, CURR BIOL, V21, P948, DOI 10.1016/j.cub.2011.04.025; Sotillo J, 2015, INT J PARASITOL, V45, P505, DOI 10.1016/j.ijpara.2015.03.004; Sotillo J, 2014, MOL CELL PROTEOMICS, V13, P2736, DOI 10.1074/mcp.M114.038950; Srivastava S, 2010, VACCINE, V28, P1429, DOI 10.1016/j.vaccine.2009.06.044; Stoll NR, 1929, AM J HYG, V10, P0384, DOI 10.1093/oxfordjournals.aje.a112760; Sun YM, 2007, INT J PEPT RES THER, V13, P387, DOI 10.1007/s10989-006-9045-0; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Toueille M, 2007, PLANT PHYSIOL BIOCH, V45, P113, DOI 10.1016/j.plaphy.2007.01.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VANLEEUWEN MAW, 1995, PARASITOL RES, V81, P706, DOI 10.1007/BF00931852; Verpelli C, 2012, ADV EXP MED BIOL, V970, P29, DOI 10.1007/978-3-7091-0932-8_2; Vinkenoog R, 1998, MOL BIOCHEM PARASIT, V94, P1, DOI 10.1016/S0166-6851(98)00035-8; Wang W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-342; Wang W, 2014, J PROTEOMICS, V98, P123, DOI 10.1016/j.jprot.2013.12.017; Wang WF, 1996, J MOL EVOL, V43, P384; Wang YF, 2014, INT J PARASITOL, V44, P515, DOI 10.1016/j.ijpara.2014.03.003; Williamson SM, 2012, J HELMINTHOL, V86, P202, DOI 10.1017/S0022149X11000216; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yan FB, 2010, VET J, V185, P174, DOI 10.1016/j.tvjl.2009.05.021; Yan RF, 2014, ACTA PARASITOL, V59, P698, DOI 10.2478/s11686-014-0298-z; Yatsuda AP, 2003, J BIOL CHEM, V278, P16941, DOI 10.1074/jbc.M212453200; Yatsuda AP, 2002, RES VET SCI, V73, P297, DOI 10.1016/S0034-5288(02)00125-X; Yoshino TP, 2014, INT J PARASITOL, V44, P551, DOI 10.1016/j.ijpara.2014.04.002; Yuan C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0816-3; Yuan W, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003062; Zamanian M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004069; Zhang HL, 2013, PARASITOLOGY, V140, P683, DOI 10.1017/S0031182012002168	119	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159796	10.1371/journal.pone.0159796	http://dx.doi.org/10.1371/journal.pone.0159796			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467391	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100057
J	Tercek, M; Rodman, A				Tercek, Michael; Rodman, Ann			Forecasts of 21st Century Snowpack and Implications for Snowmobile and Snowcoach Use in Yellowstone National Park	PLOS ONE			English	Article							20-1ST-CENTURY PROJECTIONS; CLIMATE-CHANGE; TRENDS; VARIABILITY; COVER	Climate models project a general decline in western US snowpack throughout the 21st century, but long-term, spatially fine-grained, management-relevant projections of snowpack are not available for Yellowstone National Park. We focus on the implications that future snow declines may have for oversnow vehicle (snowmobile and snowcoach) use because oversnow tourism is critical to the local economy and has been a contentious issue in the park for more than 30 years. Using temperature-indexed snow melt and accumulation equations with temperature and precipitation data from downscaled global climate models, we forecast the number of days that will be suitable for oversnow travel on each Yellowstone road segment during the mid-and late-21st century. The west entrance road was forecast to be the least suitable for oversnow use in the future while the south entrance road was forecast to remain at near historical levels of driveability. The greatest snow losses were forecast for the west entrance road where as little as 29% of the December-March oversnow season was forecast to be driveable by late century. The climatic conditions that allow oversnow vehicle use in Yellowstone are forecast by our methods to deteriorate significantly in the future. At some point it may be prudent to consider plowing the roads that experience the greatest snow losses.	[Tercek, Michael; Rodman, Ann] Natl Pk Serv, Yellowstone Ctr Resources, POB 168, Yellowstone Natl Pk, WY 82190 USA; [Tercek, Michael] Walking Shadow Ecol, POB 1085, Gardiner, MT 59030 USA	United States Department of the Interior	Tercek, M (corresponding author), Natl Pk Serv, Yellowstone Ctr Resources, POB 168, Yellowstone Natl Pk, WY 82190 USA.; Tercek, M (corresponding author), Walking Shadow Ecol, POB 1085, Gardiner, MT 59030 USA.	Tercek@YellowstoneEcology.com			Canon USA, Inc.	Canon USA, Inc.	The grant funding this work was administered by the Yellowstone Park Foundation "Eyes on Yellowstone Program." The funding provided to the Yellowstone Park Foundation came from Canon USA, Inc., web URL: http://www.ypf.org/site/PageServer?pagename=WHAT_visitors_Canon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chokhachy R, 2013, GLOBAL CHANGE BIOL, V19, DOI 10.1111/gcb.12262; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; Bavay M, 2009, HYDROL PROCESS, V23, P95, DOI 10.1002/hyp.7195; Callaghan TV, 2011, AMBIO, V40, P17, DOI 10.1007/s13280-011-0212-y; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Copeland JP, 2010, CAN J ZOOL, V88, P233, DOI 10.1139/Z09-136; Dingman S., 2002, PHYS HYDROLOGY; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fisichelli NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128226; HALFPENNY J. C., 1989, WINTER ECOLOGICAL HD; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hock R, 2003, J HYDROL, V282, P104, DOI 10.1016/S0022-1694(03)00257-9; Jylha K, 2008, CLIMATIC CHANGE, V86, P441, DOI 10.1007/s10584-007-9310-z; Kapnick S, 2012, CLIM DYNAM, V38, P1885, DOI 10.1007/s00382-011-1089-y; Li HB, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012882; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; MAKRIDAKIS S, 1993, INT J FORECASTING, V9, P527, DOI 10.1016/0169-2070(93)90079-3; Maloney ED, 2014, J CLIMATE, V27, P2230, DOI 10.1175/JCLI-D-13-00273.1; Mansfield C, 2015, LAND ECON, V84, P282; McBoyle G., 2007, Managing Leisure, V12, P237, DOI 10.1080/13606710701546868; Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36; Monahan WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101302; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Nagler M, 2012, 2011 2012 WYOM UNPUB; National Operational Hydrologic Remote Sensing Center, 2004, SNOW DAT ASS SYST SN; Notaro M, 2014, J CLIMATE, V27, P6526, DOI 10.1175/JCLI-D-13-00520.1; Notaro M, 2011, INT J CLIMATOL, V31, P1615, DOI 10.1002/joc.2179; Oyler JW, 2015, INT J CLIMATOL, V35, P2258, DOI 10.1002/joc.4127; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Pederson GT, 2011, J CLIMATE, V24, P1666, DOI 10.1175/2010JCLI3729.1; Rupp DE, 2013, J GEOPHYS RES-ATMOS, V118, P10884, DOI 10.1002/jgrd.50843; Rutty M, 2015, J OUTDO RECREAT TOUR, V11, P13, DOI 10.1016/j.jort.2015.07.002; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sepulveda AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145060; Tercek M., 2015, YELLOWSTONE SCI, V23, P20; Tercek MT, 2012, ENVIRON MANAGE, V49, P1076, DOI 10.1007/s00267-012-9827-4; Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Yochim Michael J., 2009, YELLOWSTONE SNOWMOBI	41	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159218	10.1371/journal.pone.0159218	http://dx.doi.org/10.1371/journal.pone.0159218			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467778	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100022
J	Parizek, A; Hill, M; Duskova, M; Vitek, L; Velikova, M; Kancheva, R; Simjak, P; Koucky, M; Kokrdova, Z; Adamcova, K; Cerny, A; Hajek, Z; Starka, L				Parizek, Antonin; Hill, Martin; Duskova, Michaela; Vitek, Libor; Velikova, Marta; Kancheva, Radmila; Simjak, Patrik; Koucky, Michal; Kokrdova, Zuzana; Adamcova, Karolina; Cerny, Andrej; Hajek, Zdenek; Starka, Luboslav			A Comprehensive Evaluation of Steroid Metabolism in Women with Intrahepatic Cholestasis of Pregnancy	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; SALT EXPORT PUMP; BILE-ACIDS; PROGESTERONE METABOLITES; X RECEPTOR; DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE; SUBSTRATE-SPECIFICITY; URSODEOXYCHOLIC ACID; POTENTIAL BIOMARKERS; BACKDOOR PATHWAY	Intrahepatic cholestasis of pregnancy (ICP) is a common liver disorder, mostly occurring in the third trimester. ICP is defined as an elevation of serum bile acids, typically accompanied by pruritus and elevated activities of liver aminotransferases. ICP is caused by impaired biliary lipid secretion, in which endogenous steroids may play a key role. Although ICP is benign for the pregnant woman, it may be harmful for the fetus. We evaluated the differences between maternal circulating steroids measured by RIA (17-hydroxypregnenolone and its sulfate, 17-hydroxyprogesterone, and cortisol) and GC-MS (additional steroids), hepatic aminotransferases and bilirubin in women with ICP (n = 15, total bile acids (TBA) > 8 mu M) and corresponding controls (n = 17). An age-adjusted linear model, receiver-operating characteristics (ROC), and multivariate regression (a method of orthogonal projections to latent structure, OPLS) were used for data evaluation. While aminotransferases, conjugates of pregnanediols, 17-hydroxypregnenolone and 5 beta-androstane-3 alpha, 17 beta-diol were higher in ICP patients, 20 alpha-dihydropregnenolone, 16 alpha-hydroxy-steroids, sulfated 17-oxo-C19-steroids, and 5 beta-reduced steroids were lower. The OPLS model including steroids measured by GC-MS and RIA showed 93.3% sensitivity and 100% specificity, while the model including steroids measured by GC-MS in a single sample aliquot showed 93.3% sensitivity and 94.1% specificity. A composite index including ratios of sulfated 3 alpha/beta-hydroxy-5 alpha/beta-androstane-17-ones to conjugated 5 alpha/beta-pregnane-3 alpha/beta, 20 alpha-diols discriminated with 93.3% specificity and 81.3% sensitivity (ROC analysis). These new data demonstrating altered steroidogenesis in ICP patients offer more detailed pathophysiological insights into the role of steroids in the development of ICP.	[Parizek, Antonin; Simjak, Patrik; Koucky, Michal; Kokrdova, Zuzana; Adamcova, Karolina; Cerny, Andrej; Hajek, Zdenek] Gen Univ Hosp, Dept Obstet & Gynecol, Prague, Czech Republic; [Parizek, Antonin; Vitek, Libor; Simjak, Patrik; Koucky, Michal; Kokrdova, Zuzana; Adamcova, Karolina; Cerny, Andrej; Hajek, Zdenek] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Hill, Martin; Duskova, Michaela; Velikova, Marta; Kancheva, Radmila; Starka, Luboslav] Inst Endocrinol, Prague, Czech Republic; [Vitek, Libor] Gen Univ Hosp, Inst Med Biochem & Lab Diagnost, Prague, Czech Republic; [Vitek, Libor] Gen Univ Hosp, Dept Internal Med 4, Prague, Czech Republic	General University Hospital Prague; Charles University Prague; Institute of Endocrinology - Prague; General University Hospital Prague; General University Hospital Prague	Hill, M (corresponding author), Inst Endocrinol, Prague, Czech Republic.	mhill@endo.cz	Dušková, Michaela/H-5472-2016; Hill, Martin/G-7699-2019; Koucký, Michal/J-3300-2017; Hajek, Zdenek/O-1777-2017; Kokrdova, Zuzana/Q-4488-2017; Šimják, Patrik/D-3124-2017; Vitek, Libor/A-2645-2008; Parizek, Antonin/N-2824-2017; Černý, Andrej/M-9562-2017	Dušková, Michaela/0000-0002-4781-1447; Koucký, Michal/0000-0003-2807-7635; Hajek, Zdenek/0000-0003-2003-9431; Kokrdova, Zuzana/0000-0001-8879-4164; Šimják, Patrik/0000-0003-0811-2085; Vitek, Libor/0000-0002-5318-0151; Parizek, Antonin/0000-0002-8068-9041; Černý, Andrej/0000-0001-9230-9184; Hill, Martin/0000-0002-1705-0835; Starka, Luboslav/0000-0003-4589-6050	Internal Grant Agency of the Czech Ministry of Health [IGA NT/12211]	Internal Grant Agency of the Czech Ministry of Health	Grant IGA NT/12211 from the Internal Grant Agency of the Czech Ministry of Health supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hayyeh S, 2015, HEPATOLOGY; Abu-Hayyeh S, 2013, HEPATOLOGY, V57, P716, DOI 10.1002/hep.26055; BROCHU M, 1987, J STEROID BIOCHEM, V28, P619, DOI 10.1016/0022-4731(87)90388-8; BROCHU M, 1987, PROSTATE, V11, P33, DOI 10.1002/pros.2990110105; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Chen JB, 2013, INT J GYNECOL OBSTET, V122, P5, DOI 10.1016/j.ijgo.2013.02.015; Chen JZ, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2013.03.02; Chen M, 2015, BIOCHEMISTRY-US, V54, P6343, DOI 10.1021/acs.biochem.5b00816; Chen M, 2011, STEROIDS, V76, P484, DOI 10.1016/j.steroids.2011.01.003; Cheng J, 2011, BRIT J PHARMACOL, V163, P461, DOI 10.1111/j.1476-5381.2010.01129.x; Czech C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031501; Dehennin L, 1996, INT J SPORTS MED, V17, P315, DOI 10.1055/s-2007-972853; Escobar-Morreale HF, 2001, EUR J ENDOCRINOL, V145, P619, DOI 10.1530/eje.0.1450619; Fukami M, 2013, DEV DYNAM, V242, P320, DOI 10.1002/dvdy.23892; Glantz A, 2008, HEPATOLOGY, V47, P544, DOI 10.1002/hep.21987; Gonzales E, 2004, J HEPATOL, V40, P716, DOI 10.1016/j.jhep.2003.12.024; Hill M, 1999, STEROIDS, V64, P341, DOI 10.1016/S0039-128X(99)00017-3; Hill M, 2007, J STEROID BIOCHEM, V105, P166, DOI 10.1016/j.jsbmb.2006.10.010; Hill M, 2014, J STEROID BIOCHEM, V139, P201, DOI 10.1016/j.jsbmb.2013.03.008; Hill M, 2011, STEROIDS, V76, P1351, DOI 10.1016/j.steroids.2011.07.002; Hill M, 2010, J STEROID BIOCHEM, V122, P239, DOI 10.1016/j.jsbmb.2010.06.003; Hill M, 2010, J STEROID BIOCHEM, V122, P114, DOI 10.1016/j.jsbmb.2010.05.007; Hill M, 2010, J STEROID BIOCHEM, V121, P594, DOI 10.1016/j.jsbmb.2009.10.012; Hirst JJ, 2014, J STEROID BIOCHEM, V139, P144, DOI 10.1016/j.jsbmb.2013.04.002; Homma K, 2006, J CLIN ENDOCR METAB, V91, P2643, DOI 10.1210/jc.2005-2460; Huang WM, 2009, AM J PERINAT, V26, P291, DOI 10.1055/s-0028-1103158; IMAI K, 1970, JPN J PHARMACOL, V20, P473, DOI 10.1254/jjp.20.473; Kamrath C, 2013, HORM METAB RES, V45, P86, DOI 10.1055/s-0032-1331751; Kremer AE, 2015, J HEPATOL, V62, P897, DOI 10.1016/j.jhep.2014.10.041; LAATIKAINEN TJ, 1974, J CLIN INVEST, V53, P1709, DOI 10.1172/JCI107722; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Lammert F, 2000, J HEPATOL, V33, P1012, DOI 10.1016/S0168-8278(00)80139-7; Lemonde HA, 2003, GUT, V52, P1494, DOI 10.1136/gut.52.10.1494; Leslie KK, 2000, OBSTET GYNECOL, V95, P372, DOI 10.1016/S0029-7844(99)00533-5; Li TG, 2013, DRUG METAB REV, V45, P145, DOI 10.3109/03602532.2012.740048; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Martineau M, 2014, PLACENTA, V35, P37, DOI 10.1016/j.placenta.2013.10.019; Meloun M, 2000, CLIN CHEM LAB MED, V38, P553, DOI 10.1515/CCLM.2000.081; Meloun M, 2004, CLIN CHEM LAB MED, V42, P311, DOI 10.1515/CCLM.2004.057; Meloun M, 2002, ANALYST, V127, P433, DOI 10.1039/b110779h; Meng LJ, 1997, J HEPATOL, V27, P346, DOI 10.1016/S0168-8278(97)80181-X; Meng LJ, 1997, HEPATOLOGY, V26, P1573; Meng LJ, 1997, J HEPATOL, V27, P1029, DOI 10.1016/S0168-8278(97)80147-X; Milona A, 2010, HEPATOLOGY, V52, P1341, DOI 10.1002/hep.23849; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Neunzig J, 2014, J STEROID BIOCHEM, V144, P324, DOI 10.1016/j.jsbmb.2014.07.005; Pascual MJ, 2002, CLIN SCI, V102, P587, DOI 10.1042/CS20010258; Perez MJ, 2006, PLACENTA, V27, P34, DOI 10.1016/j.placenta.2004.10.020; Pusl T, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-26; Reyes H, 2000, ANN MED, V32, P94, DOI 10.3109/07853890009011758; Reyes H, 2008, HEPATOLOGY, V47, P376, DOI 10.1002/hep.22139; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Sanchez-Guijo A, 2015, J LIPID RES, V56, P1843, DOI 10.1194/jlr.D061499; Simjak P, 2015, J PERINAT MED, V43, P133, DOI 10.1515/jpm-2014-0089; Sirianni R, 2005, J CLIN ENDOCR METAB, V90, P5393, DOI 10.1210/jc.2005-0680; Sirianni R, 2005, J CLIN ENDOCR METAB, V90, P279, DOI 10.1210/jc.2004-0865; Smith R, 2007, FRONT BIOSCI, V12, P912, DOI 10.2741/2113; Smith R, 2009, J CLIN ENDOCR METAB, V94, P2066, DOI 10.1210/jc.2008-2257; Storbeck KH, 2013, MOL CELL ENDOCRINOL, V371, P87, DOI 10.1016/j.mce.2012.11.020; Tokushige K, 2013, J GASTROENTEROL, V48, P1392, DOI 10.1007/s00535-013-0766-5; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vallejo M, 2006, J HEPATOL, V44, P1150, DOI 10.1016/j.jhep.2005.09.017; Vcelakova H, 2007, STEROIDS, V72, P323, DOI 10.1016/j.steroids.2006.11.026; Wang CF, 2011, MED SCI MONITOR, V17, pCR265, DOI 10.12659/MSM.881766; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhou F, 2013, PLACENTA, V34, P401, DOI 10.1016/j.placenta.2013.02.006	67	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0159203	10.1371/journal.pone.0159203	http://dx.doi.org/10.1371/journal.pone.0159203			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494119	Green Submitted, Green Published, gold			2022-12-27	WOS:000381369500005
J	Wang, LN; Wang, PY; Ren, Y; Du, JY; Jiang, JJ; Jia, XS; Chen, CF; Wang, YZ				Wang, Lina; Wang, Pengyan; Ren, Yan; Du, Jingyun; Jiang, Jianjun; Jia, Xuesong; Chen, Chuangfu; Wang, Yuanzhi			Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China	PLOS ONE			English	Article							CANCER; WOMEN; SAMPLES; DNA	Multiple human papillomavirus (HPV) genotypes often coexist within the cervical epithelia and are frequently detected together in various grades of the cervical neoplasia. To date, only a few reports exist on multiple HPV infections of HPV in Xinjiang Uygur Autonomous Region (XUAR). In the present study, we investigated the prevalence of High-Risk HPV (HR-HPV) genotypes and multiple infections. Cervical cytology samples were collected from 428 women who presented cervical abnormalities. Genotyping of HPV was performed by polymerase chain reaction-sequencing based typing (PCR-SBT) using consensus primers and specific primers. Of them, 166 samples were positive for HPV according to PCR results using the consensus primers. These samples contained cervical abnormalities enriched with inflammation (n = 107), cervical intraepithelial neoplasia (CIN) I (n = 19), CINII-III (n = 9) and cervical cancer (n = 31). Of the 166 HPV positive samples as determined by PCR analysis, 151 were further typed by PCR-SBT using 19 pairs of genotype-specific primers. Using this method, 17 different HR-HPV genotypes were identified. The most frequently observed HPV genotypes were HPV16 (44.0%, 73/166), 53 (28.9%, 48/166), 52 (25.3%, 42/166), 58 (22.3%, 37/166) and 35 (17.5%, 29/166). The proportions of single and multiple infections in the HPV-positive specimens were 34.9% and 65.1%, respectively. Multiple HPV types were most prevalent in the inflammatory state (63.0%), followed by cervical cancer (24.1%), CINI (11.1%), and CINII-III (1.9%). The results of our data analyses suggested that i) multiple HPV infection is not necessarily correlated with the severity of cervical abnormalities; and ii) among the multiple HPV infections, double infections combined with HPV16 is the most common. In addition, L1 full-length sequences of the top five high-risk HPV genotypes were amplified and sequenced. According to the L1 sequence of the epidemic genotypes that were amplified, we found that these genotypes contained the sequence point mutation, and that some of these genotypes further showed amino acid modifications. These results provide a basis for the construction of a polyvalent vaccine that is suitable for use in the XUAR, even in economically challenged communities located in China.	[Wang, Lina; Wang, Pengyan; Jiang, Jianjun; Chen, Chuangfu] Shihezi Univ, Sch Anim Sci & Technol, Shihezi, Peoples R China; [Ren, Yan; Wang, Yuanzhi] Shihezi Univ, Sch Med, Shihezi, Peoples R China; [Jia, Xuesong] Shihezi Univ, Sch Med, Affiliated Hosp 1, Shihezi, Peoples R China; [Du, Jingyun] Maternal & Child Hlth Hosp, Baoding, Hebei Province, Peoples R China	Shihezi University; Shihezi University; Shihezi University	Wang, YZ (corresponding author), Shihezi Univ, Sch Med, Shihezi, Peoples R China.	wangyuanzhi621@126.com			National Natural Science Foundation of China [81560338, U1503283]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	A grant was provided by the National Natural Science Foundation of China (CN) to Yuanzhi Wang (Grant No: 81560338 and U1503283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2009, J WOMENS HEALTH, V18, P1341, DOI 10.1089/jwh.2008.1223; Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091761; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Chen LY, 2006, ZHEJIANG PREV MED, V18, P6; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Dickson EL, 2013, INT J GYNECOL CANCER, V23, P1295, DOI 10.1097/IGC.0b013e31829e9fb4; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Feller L, 2010, HEAD FACE MED, V6, DOI 10.1186/1746-160X-6-15; Gargiulo F, 2007, VIRUS RES, V125, P176, DOI 10.1016/j.virusres.2006.12.017; Gheit T, 2011, METHODS MOL BIOL, V665, P195, DOI 10.1007/978-1-60761-817-1_12; IWASAKA T, 1992, ACTA OBSTET GYN SCAN, V71, P219, DOI 10.3109/00016349209009922; Kay P, 2003, J MED VIROL, V71, P265, DOI 10.1002/jmv.10479; Kim YT, 2009, J GYNECOL ONCOL, V20, P1, DOI 10.3802/jgo.2009.20.1.1; Kjaer SK, 2000, SEX TRANSM DIS, V27, P438, DOI 10.1097/00007435-200009000-00003; Lee GY, 2005, INT J GYNECOL CANCER, V15, P81, DOI 10.1111/j.1048-891x.2005.14417.x; Levi JE, 2002, J CLIN MICROBIOL, V40, P3341, DOI 10.1128/JCM.40.9.3341-3345.2002; Liu HQ, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-147; D'Ottaviano MGL, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/328909; Luxembourg A, 2015, HUM VACC IMMUNOTHER, V11, P1313, DOI 10.1080/21645515.2015.1012010; Mayineur N., 2011, Chinese Clinical Oncology, V16, P322; Muhanmad YLK, 2009, DETECTION SIGNIFICAN, P18; Munagala R, 2009, INT J ONCOL, V34, P263, DOI 10.3892/ijo_00000148; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nayar Ritu, 2004, Cytojournal, V1, P4, DOI 10.1186/1742-6413-1-4; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Shi YY, 2011, RELATIONSHIP HIGH RI, P7; Sun B, 2012, PROGR ANATOMICAL SCI, V18, P435; Tao Guihua, 2009, MED J CHINESE PEOPLE, V21, P1427; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; Venceslau Emanuella Meneses, 2014, J. Bras. Patol. Med. Lab., V50, P280, DOI 10.5935/1676-2444.20140028; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HN, 2014, J GUANGXI MED U, V31, P220; Xia JiRong, 2012, Chongqing Medicine, V41, P892; Yip YC, 2010, J MED VIROL, V82, P1724, DOI 10.1002/jmv.21826; Yu XD, 2014, CHIN J HLTH LAB TEC, V24, P3425; 吴意, 2009, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V29, P191	39	16	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160698	10.1371/journal.pone.0160698	http://dx.doi.org/10.1371/journal.pone.0160698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494179	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500078
J	Wei, W; Wang, Y; Wang, Z; Han, RM; Li, SY; Wei, ZG; Zhang, Y				Wei, Wei; Wang, Yu; Wang, Zheng; Han, Ruiming; Li, Shiyin; Wei, Zhenggui; Zhang, Yong			Stability of Chloropyromorphite in Ryegrass Rhizosphere as Affected by Root-Secreted Low Molecular Weight Organic Acids	PLOS ONE			English	Article							CONTAMINATED SOIL; BRASSICA-JUNCEA; MEDICAGO-SATIVA; PHOSPHATE ROCK; LUPINUS-ALBUS; LEAD; HYDROXYAPATITE; PYROMORPHITE; PHOSPHORUS; PB	Understanding the stability of chloropyromorphite (CPY) is of considerable benefit for improving risk assessment and remediation strategies in contaminated water and soil. The stability of CPY in the rhizosphere of phosphorus-deficient ryegrass was evaluated to elucidate the role of root-secreted low molecular weight organic acids (LMWOAs) on the dissolution of CPY. Results showed that CPY treatments significantly reduced the ryegrass biomass and rhizosphere pH. The presence of calcium nitrate extractable lead (Pb) and phosphorus (P) suggested that CPY in the rhizosphere could be bioavailable, because P and Pb uptake by ryegrass potentially provided a significant concentration gradient that would promote CPY dissolution. Pb accumulation and translocation in ryegrass was found to be significantly higher in P-sufficient conditions than in P-deficient conditions. CPY treatments significantly enhanced root exudation of LMWOAs irrigated with P-nutrient solution or P-free nutrient solution. Oxalic acid was the dominant species in root-secreted LMWOAs of ryegrass under P-free nutrient solution treatments, suggesting that root-secreted oxalic acid may be the driving force of root-induced dissolution of CPY. Hence, our work, provides clarifying hints on the role of LMWOAs in controlling the stability of CPY in the rhizosphere.	[Wei, Wei; Wang, Zheng; Han, Ruiming; Li, Shiyin; Wei, Zhenggui] Nanjing Normal Univ, Sch Environm, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing 210023, Jiangsu, Peoples R China; [Wei, Wei; Wei, Zhenggui] Nanjing Normal Univ, Minist Educ, Key Lab Virtual Geog Environm, Nanjing 210023, Jiangsu, Peoples R China; [Wei, Wei; Wei, Zhenggui] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Wang, Yu] Anqing Normal Univ, Sch Resources & Environm, Anqing 246011, Peoples R China; [Zhang, Yong] Univ Alabama, Dept Geog Sci, Tuscaloosa, AL 35487 USA	Nanjing Normal University; Nanjing Normal University; Anqing Normal University; University of Alabama System; University of Alabama Tuscaloosa	Wei, ZG (corresponding author), Nanjing Normal Univ, Sch Environm, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing 210023, Jiangsu, Peoples R China.; Wei, ZG (corresponding author), Nanjing Normal Univ, Minist Educ, Key Lab Virtual Geog Environm, Nanjing 210023, Jiangsu, Peoples R China.; Wei, ZG (corresponding author), Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China.	weizhenggui@gmail.com	Wei, Wei/AAH-4521-2020	Wei, Wei/0000-0003-2918-7107	National Natural Science Foundation of China [41303081, 41373111, 21307002]; Natural Science Foundation of Jiangsu Province [BK20161557]; Research Fund for the Doctoral Program of Higher Education [20113207110014, 20133207120019]; Foundation for Talent Recommendation Program of Nanjing Normal University [2009103XGQ0063, 2011105XGQ0247]; PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions [164320H101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Foundation for Talent Recommendation Program of Nanjing Normal University; PAPD (Priority Academic Program Development of Jiangsu Higher Education Institutions	This work is supported by the National Natural Science Foundation of China (Nos. 41303081, 41373111 and 21307002), the Natural Science Foundation of Jiangsu Province (No. BK20161557), the Research Fund for the Doctoral Program of Higher Education (Nos. 20113207110014 and 20133207120019), the Foundation for Talent Recommendation Program of Nanjing Normal University (Nos. 2009103XGQ0063 and 2011105XGQ0247), and PAPD (a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, No. 164320H101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour A, 2012, INT J PHYTOREMEDIAT, V14, P531, DOI 10.1080/15226514.2010.499918; Abbaspour A, 2012, J ENVIRON QUAL, V41, P1525, DOI 10.2134/jeq2012.0062; BAKER WE, 1964, AM MINERAL, V49, P607; BOLAN NS, 1994, BIOL FERT SOILS, V18, P311, DOI 10.1007/BF00570634; Butkus MA, 2011, SOIL SEDIMENT CONTAM, V20, P172, DOI 10.1080/15320383.2011.546444; Chen MC, 2001, PLANT SOIL, V231, P37, DOI 10.1023/A:1010347421351; Christophe C, 2013, GEOCHIM COSMOCHIM AC, V106, P287, DOI 10.1016/j.gca.2012.12.014; COTTERHOWELLS JD, 1994, EUR J SOIL SCI, V45, P393, DOI 10.1111/j.1365-2389.1994.tb00524.x; CUNNINGHAM JE, 1992, APPL ENVIRON MICROB, V58, P1451, DOI 10.1128/AEM.58.5.1451-1458.1992; Debela F, 2013, J ENVIRON MANAGE, V116, P156, DOI 10.1016/j.jenvman.2012.11.037; Debela F, 2010, CHEMOSPHERE, V80, P450, DOI 10.1016/j.chemosphere.2010.04.025; Fomina M, 2004, GEOMICROBIOL J, V21, P351, DOI 10.1080/01490450490462066; Gadd GM, 1999, ADV MICROB PHYSIOL, V41, P47, DOI 10.1016/S0065-2911(08)60165-4; GRINSTED MJ, 1982, NEW PHYTOL, V91, P19, DOI 10.1111/j.1469-8137.1982.tb03289.x; Gunawardana B, 2010, PLANT SOIL, V329, P283, DOI 10.1007/s11104-009-0153-4; Hashimoto Y, 2009, CHEMOSPHERE, V76, P616, DOI 10.1016/j.chemosphere.2009.04.049; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; HINSINGER P, 1995, AUST J SOIL RES, V33, P477, DOI 10.1071/SR9950477; HOFFLAND E, 1992, PLANT SOIL, V140, P279, DOI 10.1007/BF00010605; Hou LY, 2011, BIOL TRACE ELEM RES, V139, P228, DOI 10.1007/s12011-010-8657-6; Islam E, 2007, J HAZARD MATER, V147, P806, DOI 10.1016/j.jhazmat.2007.01.117; Johnson JF, 1996, PLANT PHYSIOL, V112, P19, DOI 10.1104/pp.112.1.31; Jones DL, 2003, PLANT SOIL, V248, P31, DOI 10.1023/A:1022304332313; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kosobrukhov A, 2004, PLANT GROWTH REGUL, V42, P145, DOI 10.1023/B:GROW.0000017490.59607.6b; Laperche V, 1996, ENVIRON SCI TECHNOL, V30, P3321, DOI 10.1021/es960141u; Laperche V, 1997, ENVIRON SCI TECHNOL, V31, P2745, DOI 10.1021/es961011o; Li LP, 2013, J HAZARD MATER, V262, P250, DOI 10.1016/j.jhazmat.2013.08.058; Lu HL, 2007, ENVIRON EXP BOT, V61, P159, DOI 10.1016/j.envexpbot.2007.05.007; Magdziak Z, 2013, TREES-STRUCT FUNCT, V27, P663, DOI 10.1007/s00468-012-0821-5; Martinez CE, 2004, ENVIRON SCI TECHNOL, V38, P5584, DOI 10.1021/es049617x; Neumann G, 1999, PLANT SOIL, V211, P121, DOI 10.1023/A:1004380832118; NRIAGU JO, 1973, GEOCHIM COSMOCHIM AC, V37, P367, DOI 10.1016/0016-7037(73)90206-8; Panich-Pat T, 2004, WATER AIR SOIL POLL, V155, P159, DOI 10.1023/B:WATE.0000026523.96599.6b; Park JH, 2013, J HAZARD MATER, V261, P777, DOI 10.1016/j.jhazmat.2013.02.010; Qiao DongMei, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P195; RUBY MV, 1994, ENVIRON SCI TECHNOL, V28, P646, DOI 10.1021/es00053a018; Ryan JA, 2001, ENVIRON SCI TECHNOL, V35, P3798, DOI 10.1021/es010634l; Sas L, 2001, PLANT SCI, V160, P1191, DOI 10.1016/S0168-9452(01)00373-9; Sayer JA, 1999, CURR BIOL, V9, P691, DOI 10.1016/S0960-9822(99)80309-1; Scheckel KG, 2002, ENVIRON SCI TECHNOL, V36, P2198, DOI 10.1021/es015803g; Scheckel KG, 2013, J TOXICOL ENV HEAL B, V16, P337, DOI 10.1080/10937404.2013.825216; Shen H, 2002, ENVIRON EXP BOT, V48, P1, DOI 10.1016/S0098-8472(02)00009-6; Wang HO, 2011, BIOL TRACE ELEM RES, V143, P489, DOI 10.1007/s12011-010-8850-7; Wei W, 2014, CHEMOSPHERE, V105, P14, DOI 10.1016/j.chemosphere.2013.09.121; Wei W, 2010, J LIQ CHROMATOGR R T, V33, P1335, DOI 10.1080/10826076.2010.489430; Wei W, 2009, BIOL TRACE ELEM RES, V131, P165, DOI 10.1007/s12011-009-8360-7; Xie L, 2007, ENVIRON SCI TECHNOL, V41, P8050, DOI 10.1021/es071517e; Yang YY, 2000, PLANT PHYSIOL, V124, P1019, DOI 10.1104/pp.124.3.1019; YOUSSEF RA, 1988, SOIL SCI PLANT NUTR, V34, P461, DOI 10.1080/00380768.1988.10415701; Zhang MK, 2010, COMMUN SOIL SCI PLAN, V41, P820, DOI 10.1080/00103621003592341; Zhang PC, 1999, ENVIRON SCI TECHNOL, V33, P625, DOI 10.1021/es980268e; Zhang PC, 1999, ENVIRON SCI TECHNOL, V33, P618, DOI 10.1021/es980314a; Zhang PC, 1998, ENVIRON SCI TECHNOL, V32, P3318, DOI 10.1021/es980232m; Zheng LJ, 2012, ENVIRON EXP BOT, V77, P196, DOI 10.1016/j.envexpbot.2011.11.018	55	5	5	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160628	10.1371/journal.pone.0160628	http://dx.doi.org/10.1371/journal.pone.0160628			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494023	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500067
J	Tao, W; Li, PS; Yang, LQ; Ma, YB				Tao, Wei; Li, Ping-Song; Yang, Liu-Qing; Ma, Yong-Bo			Effects of a Soluble Epoxide Hydrolase Inhibitor on Lipopolysaccharide-Induced Acute Lung Injury in Mice	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATION; METABOLISM; IMPACT; TARGET	Objectives Inflammation plays a key role in the pathogenesis of acute lung injury (ALI). Soluble epoxide hydrolase (sEH) is suggested as a vital pharmacologic target for inflammation. In this study, we determined whether a sEH inhibitor, AUDA, exerts lung protection in lipopolysaccharide (LPS)-induced ALI in mice. Methods Male BALB/c mice were randomized to receive AUDA or vehicle intraperitoneal injection 4 h after LPS or phosphate buffered saline (PBS) intratracheal instillation. Samples were harvested 24 h post LPS or PBS administration. Results AUDA administration decreased the pulmonary levels of monocyte chemoattractant protein (MCP)-1 and tumor necrosis factor (TNF)-alpha. Improvement of oxygenation and lung edema were observed in AUDA treated group. AUDA significantly inhibited sEH activity, and elevated epoxyeicosatrienoic acids (EETs) levels in lung tissues. Moreover, LPS induced the activation of nuclear factor (NF)-kappa B was markedly dampened in AUDA treated group. Conclusion Administration of AUDA after the onset of LPS-induced ALI increased pulmonary levels of EETs, and ameliorated lung injury. sEH is a potential pharmacologic target for ALI.	[Tao, Wei; Li, Ping-Song] Subei Peoples Hosp Jiangsu Prov, Dept Burn & Plast Surg, Yangzhou, Jiangsu, Peoples R China; [Yang, Liu-Qing] Subei Peoples Hosp Jiangsu Prov, Dept Anesthesiol, Yangzhou, Jiangsu, Peoples R China; [Ma, Yong-Bo] Subei Peoples Hosp Jiangsu Prov, Dept Outpatient, Yangzhou, Jiangsu, Peoples R China		Ma, YB (corresponding author), Subei Peoples Hosp Jiangsu Prov, Dept Burn & Plast Surg, Yangzhou, Jiangsu, Peoples R China.	yzzxmrlps@qq.com; mayongbo@163.com						Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Blackwell TS, 1997, AM J RESP CELL MOL, V17, P3, DOI 10.1165/ajrcmb.17.1.f132; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Fan J, 2001, AM J PHYSIOL-LUNG C, V281, pL1037, DOI 10.1152/ajplung.2001.281.5.L1037; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Larsen BT, 2006, EUR J CLIN INVEST, V36, P293, DOI 10.1111/j.1365-2362.2006.01634.x; Lin WC, 2011, J PHARMACOL EXP THER, V339, P45, DOI 10.1124/jpet.111.181560; Liu SF, 2006, AM J PHYSIOL-LUNG C, V290, pL622, DOI 10.1152/ajplung.00477.2005; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Roche C, 2015, PROSTAG OTH LIPID M, V120, P148, DOI 10.1016/j.prostaglandins.2015.04.011; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Shu YS, 2014, J TRAUMA ACUTE CARE, V76, P1417, DOI 10.1097/TA.0000000000000229; Tao W, 2012, PULM PHARMACOL THER, V25, P99, DOI 10.1016/j.pupt.2011.12.006; Wang LF, 2012, SHOCK, V37, P539, DOI 10.1097/SHK.0b013e31824dcb5a; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; Zhou Y, 2016, CELL TISSUE RES, V363, P399, DOI 10.1007/s00441-015-2262-0	23	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160359	10.1371/journal.pone.0160359	http://dx.doi.org/10.1371/journal.pone.0160359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490848	gold, Green Submitted, Green Published			2022-12-27	WOS:000381368900049
J	Hsieh, FI; Jeng, JS; Chern, CM; Lee, TH; Tang, SC; Tsai, LK; Liao, HH; Chang, H; LaBresh, KA; Lin, HJ; Chiou, HY; Chiu, HC; Lien, LM				Hsieh, Fang-I; Jeng, Jiann-Shing; Chern, Chang-Ming; Lee, Tsong-Hai; Tang, Sung-Chun; Tsai, Li-Kai; Liao, Hsun-Hsiang; Chang, Hang; LaBresh, Kenneth A.; Lin, Hung-Jung; Chiou, Hung-Yi; Chiu, Hou-Chang; Lien, Li-Ming		BTS-Stroke Investigators	Quality Improvement in Acute Ischemic Stroke Care in Taiwan: The Breakthrough Collaborative in Stroke	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; GUIDELINES-STROKE; HEALTH-CARE; PERFORMANCE-MEASURES; ATRIAL-FIBRILLATION; OF-CARE; ATTACK; ASSOCIATION; MANAGEMENT; RISK	In the management of acute ischemic stroke, guideline adherence is often suboptimal, particularly for intravenous thrombolysis or anticoagulation for atrial fibrillation. We sought to improve stroke care quality via a collaborative model, the Breakthrough Series (BTS)Stroke activity, in a nationwide, multi-center activity in Taiwan. A BTS Collaborative, a short-term learning system for a large number of multidisciplinary teams from hospitals, was applied to enhance acute ischemic stroke care quality. Twenty-four hospitals participated in and submitted data for this stroke quality improvement campaign in 2010-2011. Totally, 14 stroke quality measures, adopted from the Get With The Guideline (GWTG)-Stroke program, were used to evaluate the performance and outcome of the ischemic stroke patients. Data for a one-year period from 24 hospitals with 13,181 acute ischemic stroke patients were analyzed. In 14 hospitals, most stroke quality measures improved significantly during the BTS-activity compared with a pre-BTS-Stroke activity period (2006-08). The rate of intravenous thrombolysis increased from 1.2% to 4.6%, door-to-needle time <= 60 minutes improved from 7.1% to 50.8%, symptomatic hemorrhage after intravenous thrombolysis decreased from 11.0% to 5.6%, and anticoagulation therapy for atrial fibrillation increased from 32.1% to 64.1%. The yearly composite measures of five stroke quality measures revealed significant improvements from 2006 to 2011 (75% to 86.3%, p< 0.001). The quarterly composite measures also improved significantly during the BTS-Stroke activity. In conclusion, a BTS collaborative model is associated with improved guideline adherence for patients with acute ischemic stroke. GWTG-Stroke recommendations can be successfully applied in countries besides the United States.	[Hsieh, Fang-I; Chiou, Hung-Yi] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Jeng, Jiann-Shing; Tang, Sung-Chun; Tsai, Li-Kai] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Jeng, Jiann-Shing; Tang, Sung-Chun; Tsai, Li-Kai] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chern, Chang-Ming] Taipei Vet Gen Hosp, Neurol Inst, Taipei, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurol, Linkou, Taiwan; [Lee, Tsong-Hai] Chang Gung Univ, Coll Med, Linkou, Taiwan; [Liao, Hsun-Hsiang; Chang, Hang; Lin, Hung-Jung] Taiwan Joint Commiss Hosp Accreditat, Taipei, Taiwan; [LaBresh, Kenneth A.] RTI Int, Waltham, MA USA; [Lin, Hung-Jung] Chi Mei Med Ctr, Dept Emergency Med, Tainan, Taiwan; [Lin, Hung-Jung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Chiu, Hou-Chang; Lien, Li-Ming] Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, 95 Wen Chang Rd, Taipei, Taiwan; [Chiu, Hou-Chang] Fu Jen Catholic Univ, Coll Med, Taipei, Taiwan; [Lien, Li-Ming] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Research Triangle Institute; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Medical University	Lien, LM (corresponding author), Shin Kong Wu Ho Su Mem Hosp, Dept Neurol, 95 Wen Chang Rd, Taipei, Taiwan.; Lien, LM (corresponding author), Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan.	limingmd@ms28.hinet.net	LaBresh, Kenneth A/A-6995-2017	LaBresh, Kenneth A/0000-0001-9040-1956; JENG, JIANN-SHING/0000-0002-1456-3686; Chiou, Hung Yi/0000-0002-4545-9697; Tang, Sung-Chun/0000-0003-3731-5973; Tsai, Li-Kai/0000-0001-8420-6951				Abilleira S, 2012, INT J STROKE, V7, P19, DOI 10.1111/j.1747-4949.2011.00638.x; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; [Anonymous], 2003, IHI INNO VATION SERI; Asch SM, 2006, NEW ENGL J MED, V354, P1147, DOI 10.1056/NEJMsa044464; Carnaby G, 2006, LANCET NEUROL, V5, P31, DOI 10.1016/S1474-4422(05)70252-0; de Carvalho FA, 2012, CEREBROVASC DIS EXTR, V2, P26, DOI 10.1159/000339578; Dippel DWJ, 2009, CIRCULATION, V119, P16, DOI 10.1161/CIRCULATIONAHA.108.821470; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; George Mary G., 2009, Morbidity and Mortality Weekly Report, V58, P1; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heo JH, 2010, STROKE, V41, P1978, DOI 10.1161/STROKEAHA.110.583591; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Ingeman A, 2008, MED CARE, V46, P63, DOI 10.1097/MLR.0b013e3181484b91; Institute for Healthcare Improvement, 2004, DIABETES SPECTRUM, V17, P97, DOI DOI 10.2337/DIASPECT.17.2.97; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnston SC, 2006, ANN NEUROL, V60, P301, DOI 10.1002/ana.20942; Keenan CR, 2007, CURR OPIN PULM MED, V13, P377, DOI 10.1097/MCP.0b013e3281eb8ef0; Kim AS, 2011, CIRCULATION, V124, P314, DOI 10.1161/CIRCULATIONAHA.111.018820; LaBresh KA, 2008, ARCH INTERN MED, V168, P411, DOI 10.1001/archinternmed.2007.101; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Leifer D, 2011, STROKE, V42, P849, DOI 10.1161/STR.0b013e318208eb99; Lin CB, 2012, CIRC-CARDIOVASC QUAL, V5, P514, DOI 10.1161/CIRCOUTCOMES.112.965210; Lin LJ, 2008, CLIN THER, V30, P1726, DOI 10.1016/j.clinthera.2008.09.010; Lingsma HF, 2008, J NEUROL NEUROSUR PS, V79, P888, DOI 10.1136/jnnp.2007.137059; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Parker C, 2012, STROKE, V43, P155, DOI 10.1161/STROKEAHA.111.635011; Reeves MJ, 2010, STROKE, V41, P1573, DOI 10.1161/STROKEAHA.109.577171; Reimer WJMSO, 2006, STROKE, V37, P1844, DOI 10.1161/01.STR.0000226463.17988.a3; Rizos T, 2009, STROKE, V40, P3547, DOI 10.1161/STROKEAHA.109.562769; Saposnik G, 2009, STROKE, V40, P1417, DOI 10.1161/STROKEAHA.108.533018; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS31, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.004; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Yeh SJ, 2011, J NEUROL SCI, V306, P38, DOI 10.1016/j.jns.2011.04.001	38	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160426	10.1371/journal.pone.0160426	http://dx.doi.org/10.1371/journal.pone.0160426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487190	Green Submitted, gold, Green Published			2022-12-27	WOS:000381367800076
J	Li, N; Wang, LC; Zeng, CF; Wang, D; Liu, DF; Wu, XT				Li, Na; Wang, Lachun; Zeng, Chunfen; Wang, Dong; Liu, Dengfeng; Wu, Xutong			Variations of Runoff and Sediment Load in the Middle and Lower Reaches of the Yangtze River, China (1950-2013)	PLOS ONE			English	Article							3 GORGES RESERVOIRS; YELLOW-RIVER; PEARL RIVER; CHANGJIANG RIVER; FLOW REGIME; IMPACTS; DELTA; BASIN; DISCHARGE; WATER	On the basis of monthly runoff series obtained in 1950-2013 and annual sediment load measured in 1956--2013 at five key hydrological stations in the middle and lower reaches of the Yangtze River basin, this study used the Mann-Kendall methods to identify trend and abrupt changes of runoff and sediment load in relation to human activities. The results were as follows: (1) The annual and flood season runoffs showed significant decreasing trends at Yichang station, and showed slight downward trends at Hankou and Datong stations, while the abrupt changes of dry season runoff at Yichang, Hankou and Datong stations occurred in about 2007 and the change points were followed by significant increasing trends. The construction of the Three Gorges Dam, which began to operate in 2003, influenced the variations of runoff in the mainstream of Yangtze River, but the effect weakened with the distance along the downstream direction from TGD. (2) Since the 1990s, annual sediment loads at Yichang, Hankou, and Datong stations have been decreasing significantly, and after 2002, the annual sediment load at Yichang dropped below that of Hankou and Datong. The dams and deforestation/ forestation contributed to the significant decreasing trend of the sediment load. In addition, the Three Gorges Dam aggravated the downward trend and caused the erosion of the riverbed and riverbanks in the middle and lower reaches. (3) The runoff and sediment load flowing from Dongting Lake into the mainstream of the Yangtze River showed significant decreasing trends at Chenglingji station after 1970s, and in contrast, slight increase in the sediment flow from Poyang Lake to the mainstream of the Yangtze River at Hukou station were detected over the post-TGD period (2003-2013). The result of the study will be an important foundation for watershed sustainable development of the Yangtze River under the human activities.	[Li, Na; Wang, Lachun; Zeng, Chunfen; Wu, Xutong] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Dong; Liu, Dengfeng] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Dept Hydrosci,Sch Earth Sci & Engn,Key Lab Surfic, Collaborat Innovat Ctr South China Sea Studies,Mi, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Wang, LC (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.; Wang, D (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Dept Hydrosci,Sch Earth Sci & Engn,Key Lab Surfic, Collaborat Innovat Ctr South China Sea Studies,Mi, Nanjing, Jiangsu, Peoples R China.	wang6312@263.net.cn; wangdong@nju.edu.cn		Wu, Xutong/0000-0001-6124-0436	National Key Basic Research Program of China [2013CB956503]; National Natural Science Funds of China [41571017, 51190091, 41071018, 41401021]; program B for Outstanding PhD candidate of Nanjing University	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); program B for Outstanding PhD candidate of Nanjing University	This work is supported by the National Key Basic Research Program of China (2013CB956503) to LW, the National Natural Science Funds of China (41571017, 51190091, 41071018) to DW, the National Natural Science Funds of China (41401021) to CZ, the National Natural Science Funds of Jiangsu (BK20130567) to CZ, and the program B for Outstanding PhD candidate of Nanjing University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abam T.K.S., 1999, B ENG GEOL ENVIRON, V57, P239, DOI DOI 10.1007/S100640050041; Batalla RJ, 2004, J HYDROL, V290, P117, DOI 10.1016/j.jhydrol.2003.12.002; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; Burn DH, 2002, J HYDROL, V255, P107, DOI 10.1016/S0022-1694(01)00514-5; Carriquiry JD, 2001, SEDIMENT GEOL, V144, P37, DOI 10.1016/S0037-0738(01)00134-8; Changjiang Water Resources Commission of the Ministry of Water Resources (CWRC), 2000, CHANGJ SED BULLT; Changjiang Water Resources Commission of the Ministry of Water Resources (CWRC), 2013, CHANGJ SW RIV WAT RE; Chen J, 2014, J HYDROL, V513, P403, DOI 10.1016/j.jhydrol.2014.03.044; Chen XQ, 2008, QUATERN INT, V186, P55, DOI 10.1016/j.quaint.2007.10.003; Chen XQ, 2001, GEOMORPHOLOGY, V41, P111, DOI 10.1016/S0169-555X(01)00109-X; Chen YQD, 2010, QUATERN INT, V226, P44, DOI 10.1016/j.quaint.2009.08.014; Chen ZY, 2001, GEOMORPHOLOGY, V41, P77, DOI 10.1016/S0169-555X(01)00106-4; China Institute of Water Resources and Hydropower Research (IWHR), 2002, IMP WAT SAND 3 OUTL; Chu ZX, 2006, MAR GEOL, V227, P13, DOI 10.1016/j.margeo.2005.11.013; Dai SB, 2008, CATENA, V76, P36, DOI 10.1016/j.catena.2008.08.004; Dai ZJ, 2012, NAT HAZARDS REV, V13, P310, DOI 10.1061/(ASCE)NH.1527-6996.0000081; FANOS AM, 1995, J COASTAL RES, V11, P821; Gao B, 2013, QUATERN INT, V304, P43, DOI 10.1016/j.quaint.2012.11.023; Gao JH, 2014, SCI TOTAL ENVIRON, V481, P542, DOI 10.1016/j.scitotenv.2014.02.087; Gao S, 2008, CONT SHELF RES, V28, P1490, DOI 10.1016/j.csr.2007.02.010; Gerstengarbe FW, 1999, CLIMATE RES, V11, P97, DOI 10.3354/cr011097; Hipel KW, 1994, TIME SERIES MODELLIN; Horrevoets AC, 2004, J HYDROL, V294, P213, DOI 10.1016/j.jhydrol.2004.02.012; Humborg C, 1997, NATURE, V386, P385, DOI 10.1038/386385a0; Jian Hua Gao, 2018, Quaternary International, V493, P187, DOI 10.1016/j.quaint.2015.03.015; Kahya E, 2004, J HYDROL, V289, P128, DOI 10.1016/j.jhydrol.2003.11.006; Khaliq MN, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006132; Li N., 2015, J WATER RESOURCES WA, V26, P139; Li QF, 2011, J HYDROL, V403, P224, DOI 10.1016/j.jhydrol.2011.03.043; Lu XX, 1999, EARTH SURF PROC LAND, V24, P1077, DOI 10.1002/(SICI)1096-9837(199911)24:12&lt;1077::AID-ESP36&gt;3.0.CO;2-M; Ma XX, 2015, QUATERN INT, V380, P334, DOI 10.1016/j.quaint.2015.02.012; Malini BH, 2004, CURR SCI INDIA, V87, P1232; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Meade RH, 2010, HYDROL PROCESS, V24, P35, DOI 10.1002/hyp.7477; Mikhailova M.V., 2003, WATER RESOUR, V30, P370, DOI [DOI 10.1023/A:1024963911893, 10.1023/A:1024963911893]; Milliman J. D., 2011, RIVER DISCHARGE COAS, DOI 10.1017/CBO9780511781247; Milliman JD, 1997, NATURE, V386, P325, DOI 10.1038/386325a0; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Pan J.G., 1999, J SEDIMENT RES, V2, P46; Ran LS, 2013, GLOBAL PLANET CHANGE, V100, P308, DOI 10.1016/j.gloplacha.2012.11.001; Rao KN, 2010, EARTH SURF PROC LAND, V35, P817, DOI 10.1002/esp.1977; Satio Y, 2003, GEOPHYS RES ABSTR, V5, P9143; Sivakumar B, 2005, EARTH SURF PROC LAND, V30, P665, DOI 10.1002/esp.1167; Song W, 2015, QUATERN INT, V1, P1; Syvitski JPM, 2007, GLOBAL PLANET CHANGE, V57, P261, DOI 10.1016/j.gloplacha.2006.12.001; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Syvitski JPM, 2003, GLOBAL PLANET CHANGE, V39, P1, DOI 10.1016/S0921-8181(03)00008-0; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Topping DJ, 2000, WATER RESOUR RES, V36, P515, DOI 10.1029/1999WR900285; Vorosmarty CJ, 2003, GLOBAL PLANET CHANGE, V39, P169, DOI 10.1016/S0921-8181(03)00023-7; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wang SA, 2016, NAT GEOSCI, V9, P38, DOI [10.1038/ngeo2602, 10.1038/NGEO2602]; [王延贵 Wang Yangui], 2014, [水科学进展, Advances in Water Science], V25, P467; Wei W, 2014, QUATERN INT, V336, P98, DOI 10.1016/j.quaint.2013.10.064; Wiegel RL, 1996, SCIENCE, V272, P337; Wu CS, 2012, J HYDROL, V452, P190, DOI 10.1016/j.jhydrol.2012.05.064; Wu GF, 2007, WATER RES, V41, P3271, DOI 10.1016/j.watres.2007.05.018; Wu L, 2011, 3 INT C ENV SCI IN B, V10, P1496, DOI DOI 10.1016/J.PR0ENV.2011.09.238; Xu HX, 2003, HYDROL PROCESS, V17, P3359, DOI 10.1002/hyp.1392; Xu JJ, 2008, QUATERN INT, V186, P32, DOI 10.1016/j.quaint.2007.10.014; [许炯心 XU Jiongxin], 2009, [地理学报, Acta Geographica Sinica], V64, P515; Yang SL, 2011, GLOBAL PLANET CHANGE, V75, P14, DOI 10.1016/j.gloplacha.2010.09.006; Yang SL, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008589; Yang SL, 2005, HYDROLOG SCI J, V50, P825, DOI 10.1623/hysj.2005.50.5.825; Yang SL, 2003, ESTUAR COAST SHELF S, V57, P689, DOI 10.1016/S0272-7714(02)00409-2; Yang Z, 1998, EOS T AM GEOPHYS UN, V79, P589, DOI DOI 10.1029/98E000428; Yu MX, 2013, J HYDROL ENG, V18, P1098, DOI 10.1061/(ASCE)HE.1943-5584.0000545; Zamora HA, 2013, ECOL ENG, V59, P134, DOI 10.1016/j.ecoleng.2012.11.012; Zhang Q, 2013, HYDROL PROCESS, V27, P444, DOI 10.1002/hyp.9278; Zhang Q, 2012, HYDROL PROCESS, V26, P1495, DOI 10.1002/hyp.8269; Zhang Q, 2006, J HYDROL, V331, P511, DOI 10.1016/j.jhydrol.2006.05.036	72	17	17	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160154	10.1371/journal.pone.0160154	http://dx.doi.org/10.1371/journal.pone.0160154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479591	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300028
J	Lingren, T; Chen, P; Bochenek, J; Doshi-Velez, F; Manning-Courtney, P; Bickel, J; Welchons, LW; Reinhold, J; Bing, N; Ni, YZ; Barbaresi, W; Mentch, F; Basford, M; Denny, J; Vazquez, L; Perry, C; Namjou, B; Qiu, HJ; Connolly, J; Abrams, D; Holm, IA; Cobb, BA; Lingren, N; Solti, I; Hakonarson, H; Kohane, IS; Harley, J; Savova, G				Lingren, Todd; Chen, Pei; Bochenek, Joseph; Doshi-Velez, Finale; Manning-Courtney, Patty; Bickel, Julie; Welchons, Leah Wildenger; Reinhold, Judy; Bing, Nicole; Ni, Yizhao; Barbaresi, William; Mentch, Frank; Basford, Melissa; Denny, Joshua; Vazquez, Lyam; Perry, Cassandra; Namjou, Bahram; Qiu, Haijun; Connolly, John; Abrams, Debra; Holm, Ingrid A.; Cobb, Beth A.; Lingren, Nataline; Solti, Imre; Hakonarson, Hakon; Kohane, Isaac S.; Harley, John; Savova, Guergana			Electronic Health Record Based Algorithm to Identify Patients with Autism Spectrum Disorder	PLOS ONE			English	Article							MEDICAL-RECORD; INFORMATICS; COMORBIDITY; SELECTION; CHILDREN; CLUSTERS; SUPPORT; DISEASE	Objective Cohort selection is challenging for large-scale electronic health record (EHR) analyses, as International Classification of Diseases 9th edition (ICD-9) diagnostic codes are notoriously unreliable disease predictors. Our objective was to develop, evaluate, and validate an automated algorithm for determining an Autism Spectrum Disorder (ASD) patient cohort from EHR. We demonstrate its utility via the largest investigation to date of the co-occurrence patterns of medical comorbidities in ASD. Methods We extracted ICD-9 codes and concepts derived from the clinical notes. A gold standard patient set was labeled by clinicians at Boston Children's Hospital (BCH) (N = 150) and Cincinnati Children's Hospital and Medical Center (CCHMC) (N = 152). Two algorithms were created: (1) rule-based implementing the ASD criteria from Diagnostic and Statistical Manual of Mental Diseases 4th edition, (2) predictive classifier. The positive predictive values (PPV) achieved by these algorithms were compared to an ICD-9 code baseline. We clustered the patients based on grouped ICD-9 codes and evaluated subgroups. Results The rule-based algorithm produced the best PPV: (a) BCH: 0.885 vs. 0.273 (baseline); (b) CCHMC: 0.840 vs. 0.645 (baseline); (c) combined: 0.864 vs. 0.460 (baseline). A validation at Children's Hospital of Philadelphia yielded 0.848 (PPV). Clustering analyses of comorbidities on the three-site large cohort (N = 20,658 ASD patients) identified psychiatric, developmental, and seizure disorder clusters. Conclusions In a large cross-institutional cohort, co-occurrence patterns of comorbidities in ASDs provide further hypothetical evidence for distinct courses in ASD. The proposed automated algorithms for cohort selection open avenues for other large-scale EHR studies and individualized treatment of ASD.	[Lingren, Todd; Ni, Yizhao; Solti, Imre] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Chen, Pei] Boston Childrens Hosp, Ctr Syst Biol, Boston, MA USA; [Bochenek, Joseph; Denny, Joshua] Vanderbilt Univ, Sch Med, Biomed Informat, Nashville, TN 37212 USA; [Doshi-Velez, Finale] Harvard Med Sch, Ctr Biomed Informat, Boston, MA USA; [Manning-Courtney, Patty; Reinhold, Judy; Bing, Nicole; Harley, John] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Manning-Courtney, Patty; Reinhold, Judy; Bing, Nicole] Cincinnati Childrens Hosp Med Ctr, Div Dev & Behav Pediat, Cincinnati, OH 45229 USA; [Bickel, Julie; Welchons, Leah Wildenger] Boston Childrens Hosp, Pediat, Boston, MA USA; [Bickel, Julie; Welchons, Leah Wildenger] Boston Childrens Hosp, Dev Med, Boston, MA USA; [Welchons, Leah Wildenger] Boston Childrens Hosp, Neurol, Boston, MA USA; [Welchons, Leah Wildenger] Boston Childrens Hosp, Ctr Commun Enhancement, Boston, MA USA; [Barbaresi, William; Holm, Ingrid A.] Childrens Hosp, Div Med, 300 Longwood Ave, Boston, MA 02115 USA; [Mentch, Frank; Vazquez, Lyam; Qiu, Haijun; Connolly, John; Abrams, Debra; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Basford, Melissa] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Clin & Translat Res, Nashville, TN USA; [Perry, Cassandra; Holm, Ingrid A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Namjou, Bahram; Cobb, Beth A.; Harley, John] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Namjou, Bahram; Solti, Imre] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Holm, Ingrid A.; Kohane, Isaac S.; Savova, Guergana] Harvard Med Sch, Pediat, Boston, MA USA; [Holm, Ingrid A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Lingren, Nataline] Cincinnati Childrens Hosp Med Ctr, Emergency Med, Cincinnati, OH 45229 USA; [Hakonarson, Hakon] Perelman Sch Med, Pediat, Philadelphia, PA USA; [Kohane, Isaac S.; Savova, Guergana] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Harley, John] US Dept Vet Affairs, Med Ctr, Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Harvard University; Boston Children's Hospital; Vanderbilt University; Harvard University; Harvard Medical School; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Vanderbilt University; Harvard University; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Lingren, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA.	todd.lingren@cchmc.org	Denny, Josh/AAL-3359-2021	Denny, Josh/0000-0002-3049-7332; Holm, Ingrid/0000-0003-4712-8821; Lingren, Todd/0000-0003-0311-7100; Holloway, Courtney Jean/0000-0003-3661-1957; Connolly, John/0000-0003-4396-1226; Ni, Yizhao/0000-0001-8599-454X	collaborative sites in the eMERGE Network; National Human Genome Research Institute (NHGRI) [U01HG006828, U01HG006830, U01HG006378, U01HG008666]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006830, U01HG008684, U01HG006828, U01HG008666, U01HG008701, U01HG006378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	collaborative sites in the eMERGE Network; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by collaborative sites in the eMERGE Network and funded by National Human Genome Research Institute (NHGRI) through the following grants: U01HG006828 (Cincinnati Children's Hospital Medical Center/Boston Children's Hospital); U01HG006830 (Children's Hospital of Philadelphia); U01HG006378 (Vanderbilt University Medical Center) and U01HG008666 (Cincinnati Children's Hospital Medical Center).	Ananthakrishnan AN, 2013, INFLAMM BOWEL DIS, V19, P1411, DOI 10.1097/MIB.0b013e31828133fd; [Anonymous], 2010, ARTHRITIS CARE RES H, V62, P1120, DOI [10.1002/acr.20184, DOI 10.1002/ACR.20184]; Barbaresi WJ, 2005, ARCH PEDIAT ADOL MED, V159, P37, DOI 10.1001/archpedi.159.1.37; Ben-Sasson A, 2008, J CHILD PSYCHOL PSYC, V49, P817, DOI 10.1111/j.1469-7610.2008.01899.x; Bitsika V, 2008, J INTELL DISABIL RES, V52, P973, DOI 10.1111/j.1365-2788.2008.01123.x; Boland MR, 2013, J AM MED INFORM ASSN, V20, pE232, DOI 10.1136/amiajnl-2013-001932; Chen H, 2010, MEDICAL INFORMATICS; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Denny JC, 2013, NATURE BIOTECHNOLOGY; Denny JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002823; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Ester M, 1996, THE PROCEEDINGS OF 2; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Held FP, 2015, THE JOURNALS OF GERO; Hu VW, 2009, AUTISM RES, V2, P67, DOI 10.1002/aur.72; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Kohane IS, 2011, NAT REV GENET, V12, P417, DOI 10.1038/nrg2999; Kullo IJ, 2010, J AM MED INFORM ASSN, V17, P568, DOI 10.1136/jamia.2010.004366; Lin C, 2013, PLOS ONE, DOI [10.1371/journal.pone.0069932, DOI 10.1371/J0URNAL.P0NE.0069932]; Manning Christopher D., 2008, INTRO INFORM RE; Newton KM, 2013, J AM MED INFORM ASSN, V20, pE147, DOI 10.1136/amiajnl-2012-000896; Newton KM, 2013, J AM MED INFORM ASSO; Nguyen MH, 2010, PATTERN RECOGN, V43, P584, DOI 10.1016/j.patcog.2009.09.003; Nierenberg AA, 2013, CLIN TRIALS; Ortiz AE, 2016, EUR ARCH PSY CLIN N, V266, P199, DOI 10.1007/s00406-015-0642-9; Pathak J, 2013, J AM MED INFORM ASSN, V20, pE206, DOI 10.1136/amiajnl-2013-002428; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peissig PL, 2012, J AM MED INFORM ASSN, V19, P225, DOI 10.1136/amiajnl-2011-000456; Sarkar IN., 2013, METHODS IN BIOMEDICA; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Schildcrout JS, 2010, J BIOMED INFORM, V43, P914, DOI 10.1016/j.jbi.2010.07.011; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weston J, 2001, ADV NEUR IN, V13, P668; Wiggins LD, 2012, J AUTISM DEV DISORD, V42, P191, DOI 10.1007/s10803-011-1230-0; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Wingate M, 2014, MMWR SURVEILL SUMM, V63	40	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159621	10.1371/journal.pone.0159621	http://dx.doi.org/10.1371/journal.pone.0159621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27472449	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516300015
J	Subharat, S; Shu, DR; Zheng, T; Buddle, BM; Kaneko, K; Hook, S; Janssen, PH; Wedlock, DN				Subharat, Supatsak; Shu, Dairu; Zheng, Tao; Buddle, Bryce M.; Kaneko, Kan; Hook, Sarah; Janssen, Peter H.; Wedlock, D. Neil			Vaccination of Sheep with a Methanogen Protein Provides Insight into Levels of Antibody in Saliva Needed to Target Ruminal Methanogens	PLOS ONE			English	Article							STREPTOCOCCUS-BOVIS; RUMEN METHANOGENS; LACTIC-ACIDOSIS; IMMUNIZATION; CATTLE; LACTOBACILLUS; ADJUVANTS; ANTIGENS; CHITOSAN; CORE	Methane is produced in the rumen of ruminant livestock by methanogens and is a major contributor to agricultural greenhouse gases. Vaccination against ruminal methanogens could reduce methane emissions by inducing antibodies in saliva which enter the rumen and impair ability of methanogens to produce methane. Presently, it is not known if vaccination can induce sufficient amounts of antibody in the saliva to target methanogen populations in the rumen and little is known about how long antibody in the rumen remains active. In the current study, sheep were vaccinated twice at a 3-week interval with a model methanogen antigen, recombinant glycosyl transferase protein (rGT2) formulated with one of four adjuvants: saponin, Montanide ISA61, a chitosan thermogel, or a lipid nanoparticle/cationic liposome adjuvant (n = 6/formulation). A control group of sheep (n = 6) was not vaccinated. The highest antigen-specific IgA and IgG responses in both saliva and serum were observed with Montanide ISA61, which promoted levels of salivary antibodies that were five-fold higher than the second most potent adjuvant, saponin. A rGT2-specific IgG standard was used to determine the level of rGT2-specific IgG in serum and saliva. Vaccination with GT2/Montanide ISA61 produced a peak antibody concentration of 7 x 10(16) molecules of antigen-specific IgG per litre of saliva, and it was estimated that in the rumen there would be more than 10(4) molecules of antigen-specific IgG for each methanogen cell. Both IgG and IgA in saliva were shown to be relatively stable in the rumen. Salivary antibody exposed for 1-2 hours to an in vitro simulated rumen environment retained approximately 50% of antigen- binding activity. Collectively, the results from measuring antibody levels and stablility suggest a vaccination-based mitigation strategy for livestock generated methane is in theory feasible.	[Subharat, Supatsak; Shu, Dairu; Zheng, Tao; Buddle, Bryce M.; Janssen, Peter H.; Wedlock, D. Neil] AgResearch, Hopkirk Res Inst, Grasslands Res Ctr, Palmerston North, New Zealand; [Kaneko, Kan; Hook, Sarah] Univ Otago, Sch Pharm, Dunedin, New Zealand	AgResearch - New Zealand; University of Otago	Subharat, S (corresponding author), AgResearch, Hopkirk Res Inst, Grasslands Res Ctr, Palmerston North, New Zealand.	art.subharat@agresearch.co.nz		Subharat, Supatsak/0000-0003-2181-5797; Hook, Sarah/0000-0001-9634-8594	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Agricultural Greenhouse Gas Research Centre (NZAGRC); Ministry for Primary Industries	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Agricultural Greenhouse Gas Research Centre (NZAGRC); Ministry for Primary Industries	These studies were carried out under contract by the Pastoral Greenhouse Gas Research Consortium (PGgRc) and through funding from New Zealand Agricultural Greenhouse Gas Research Centre (NZAGRC) and the Ministry for Primary Industries as part of its support for the Global Research Alliance on Agricultural Greenhouse Gases (GRA).	Arca HC, 2009, EXPERT REV VACCINES, V8, P937, DOI [10.1586/erv.09.47, 10.1586/ERV.09.47]; Beatty DT, 2008, J THERM BIOL, V33, P437, DOI 10.1016/j.jtherbio.2008.07.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buddle BM, 2011, VET J, V188, P11, DOI 10.1016/j.tvjl.2010.02.019; Gill HS, 2000, VACCINE, V18, P2541, DOI 10.1016/S0264-410X(00)00017-7; Gordon S, 2010, EUR J PHARM SCI, V41, P360, DOI 10.1016/j.ejps.2010.07.004; KAY RNB, 1960, J PHYSIOL-LONDON, V150, P515, DOI 10.1113/jphysiol.1960.sp006402; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; Pinheiro J, 2020, R PACKAGE VERSION 31; PURSER DB, 1966, J ANIM SCI, V25, P509, DOI 10.2527/jas1966.252509x; R Core Team, 2013, R A LANGUAGE AND ENV; Ranilla MJ, 1995, ANN ZOOTECHNIE S, V44, P172; Scherliess R, 2013, VACCINE, V31, P4812, DOI 10.1016/j.vaccine.2013.07.081; Seedorf H, 2015, APPL ENVIRON MICROB, V81, P986, DOI 10.1128/AEM.03018-14; Shu Q, 2000, AM J VET RES, V61, P839, DOI 10.2460/ajvr.2000.61.839; Shu Q, 1999, FEMS IMMUNOL MED MIC, V26, P153, DOI 10.1111/j.1574-695X.1999.tb01383.x; Shu Q, 1999, RES VET SCI, V67, P65, DOI 10.1053/rvsc.1998.0284; Shu Q, 2000, VET J, V159, P262, DOI 10.1053/tvjl.1999.0400; Shu Q, 2001, VET RES COMMUN, V25, P43, DOI 10.1023/A:1026757917968; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; Subharat S, 2015, VET IMMUNOL IMMUNOP, V164, P201, DOI 10.1016/j.vetimm.2015.02.008; Tizard IR, 2009, VETERINARY IMMUNOLOG; Wedlock DN, 2013, ANIMAL, V7, P244, DOI 10.1017/S1751731113000682; Wedlock DN, 1999, VET IMMUNOL IMMUNOP, V67, P359, DOI 10.1016/S0165-2427(99)00004-5; White K, 2006, PHARM RES, V23, P1473, DOI 10.1007/s11095-006-0272-z; Williams YJ, 2008, BRIT J NUTR, V99, P100, DOI 10.1017/S0007114507801553; Williams YJ, 2009, APPL ENVIRON MICROB, V75, P1860, DOI 10.1128/AEM.02453-08; Wright ADG, 2004, VACCINE, V22, P3976, DOI 10.1016/j.vaccine.2004.03.053; Zhao SG, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0409-6	29	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159861	10.1371/journal.pone.0159861	http://dx.doi.org/10.1371/journal.pone.0159861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472482	Green Submitted, gold, Green Published			2022-12-27	WOS:000381516300023
J	Huetter, FK; Bachmann, HS; Reinders, A; Siffert, D; Stelmach, P; Knop, D; Horn, PA; Siffert, W				Huetter, Franz Korbinian; Bachmann, Hagen Sjard; Reinders, Anette; Siffert, Doris; Stelmach, Patrick; Knop, Dietmar; Horn, Peter Alexander; Siffert, Winfried			Association of a Common Oxytocin Receptor Gene Polymorphism with Self-Reported 'Empathic Concern' in a Large Population of Healthy Volunteers	PLOS ONE			English	Article							ASPERGER-SYNDROME; OXTR; STRESS; AFFILIATION; REACTIVITY; INTERACT; BEHAVIOR; HUMANS	Background Previous research has linked genomic variations of the oxytocin receptor (OXTR) gene with individual differences in empathy. The impact of these variations on specific cognitive and emotional aspects of empathy, however, remains to be clarified. Methods We analysed associations of a common OXTR polymorphism (rs53576) with trait empathy in a sample of 421 blood donors (231 M, 190 F; age 18-74) using the Interpersonal Reactivity Index (IRI) as an established multidimensional self-report measure of empathy. Results Female sex was significantly associated with higher empathy scores in all IRI scales (p<0.001) with the exception of the cognitive perspective taking scale (p = 0.09). The overall trait empathy score was significantly associated with rs53576 (p = 0.01), with mean scores increasing from AA to GG genotypes. An analysis of the IRI subscores revealed that the polymorphism was especially associated with the emotional empathic concern scale (p = 0.02). Separate analysis of the male and female subgroup revealed a significant association of the polymorphism with female (p = 0.04), but not with male (p = 0.20) empathic concern. A comparison of effect sizes between the groups showed greater effects for women compared to men although effect size differences did not become significant in our sample. Conclusions Our findings suggest a significant association of the rs53576 OXTR gene polymorphism with trait empathy and especially with emotional aspects of empathy. This association is possibly weaker or absent in men compared to women.	[Huetter, Franz Korbinian; Bachmann, Hagen Sjard; Reinders, Anette; Siffert, Doris; Stelmach, Patrick; Siffert, Winfried] Univ Duisburg Essen, Univ Klinikum Essen, Inst Pharmakogenet, D-45122 Essen, Germany; [Knop, Dietmar; Horn, Peter Alexander] Univ Duisburg Essen, Univ Klinikum Essen, Inst Transfus Med, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Siffert, W (corresponding author), Univ Duisburg Essen, Univ Klinikum Essen, Inst Pharmakogenet, D-45122 Essen, Germany.	winfried.siffert@uk-essen.de	Huetter, Franz/AAA-6497-2022	Huetter, Franz/0000-0002-3333-4571				1000 Genomes, DEEP CAT HUM GEN VAR; Abizaid A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00199; Bakermans-Kranenburg MJ, 2008, SOC COGN AFFECT NEUR, V3, P128, DOI 10.1093/scan/nsn004; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; Brune M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-38; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Choi D, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-4; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis MH, 1980, JSAS CAT SEL DOCS PS, V10, P85; Devroye L., 1986, NONUNIFORM RANDOM VA; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Feldman R, 2016, BIOL PSYCHIAT, V79, P174, DOI 10.1016/j.biopsych.2015.08.008; Feldman R, 2012, HORM BEHAV, V61, P380, DOI 10.1016/j.yhbeh.2012.01.008; Fisher R. A., 1921, METRON, V1, P3; Flandre P, 2005, ANTIVIR THER, V10, P479; Haas BW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00801; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; Tello FP, 2013, CHILD PSYCHIAT HUM D, V44, P320, DOI 10.1007/s10578-012-0327-9; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Keysers C, 2014, UNSER EMPATHISCHES G; Kim HS, 2010, P NATL ACAD SCI USA, V107, P15717, DOI 10.1073/pnas.1010830107; Klahr AM, 2015, J FAM PSYCHOL, V29, P91, DOI 10.1037/fam0000034; Li JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131820; LitvackMiller W, 1997, GENET SOC GEN PSYCH, V123, P303; MacDonald KS, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00194; Maoz H, 2014, J PSYCHOPHARMACOL, V28, P212, DOI 10.1177/0269881113492030; Montag C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051882; Moons WG, 2014, EMOTION, V14, P562, DOI 10.1037/a0035503; Motomura Y, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0053-7; O'Brien E, 2013, J GERONTOL B-PSYCHOL, V68, P168, DOI 10.1093/geronb/gbs055; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Sauer C, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00045; Seidel EM, 2013, PSYCHIAT RES, V210, P1168, DOI 10.1016/j.psychres.2013.08.027; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGY, V21, P431, DOI 10.1037/0894-4105.21.4.431; Smith KE, 2014, SOC NEUROSCI-UK, V9, P1, DOI 10.1080/17470919.2013.863223; Soper D., SIGNIFICANCE DIFFERE; Stankova T, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-17; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Uzefovsky F, 2015, HORM BEHAV, V67, P60, DOI 10.1016/j.yhbeh.2014.11.007; Wang JP, 2013, NEUROIMAGE, V81, P199, DOI 10.1016/j.neuroimage.2013.05.029; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Zak PJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00211	43	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160059	10.1371/journal.pone.0160059	http://dx.doi.org/10.1371/journal.pone.0160059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467763	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100101
J	Gajewski, PA; Turecki, G; Robison, AJ				Gajewski, Paula A.; Turecki, Gustavo; Robison, Alfred J.			Differential Expression of FosB Proteins and Potential Target Genes in Select Brain Regions of Addiction and Depression Patients	PLOS ONE			English	Article							CHRONIC ELECTROCONVULSIVE SEIZURES; DELTA-FOSB; NUCLEUS-ACCUMBENS; CHRONIC COCAINE; EPIGENETIC MECHANISMS; CHRONIC STRESS; INDUCTION; CDK5; STABILITY; PHOSPHORYLATION	Chronic exposure to stress or drugs of abuse has been linked to altered gene expression throughout the body, and changes in gene expression in discrete brain regions are thought to underlie many psychiatric diseases, including major depressive disorder and drug addiction. Preclinical models of these disorders have provided evidence for mechanisms of this altered gene expression, including transcription factors, but evidence supporting a role for these factors in human patients has been slow to emerge. The transcription factor.FosB is induced in the prefrontal cortex (PFC) and hippocampus (HPC) of rodents in response to stress or cocaine, and its expression in these regions is thought to regulate their "top down" control of reward circuitry, including the nucleus accumbens (NAc). Here, we use biochemistry to examine the expression of the FosB family of transcription factors and their potential gene targets in PFC and HPC postmortem samples from depressed patients and cocaine addicts. We demonstrate that Delta FosB and other FosB isoforms are downregulated in the HPC but not the PFC in the brains of both depressed and addicted individuals. Further, we show that potential Delta FosB transcriptional targets, including GluA2, are also downregulated in the HPC but not PFC of cocaine addicts. Thus, we provide the first evidence of FosB gene expression in human HPC and PFC in these psychiatric disorders, and in light of recent findings demonstrating the critical role of HPC Delta FosB in rodent models of learning and memory, these data suggest that reduced Delta FosB in HPC could potentially underlie cognitive deficits accompanying chronic cocaine abuse or depression.	[Gajewski, Paula A.; Robison, Alfred J.] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Turecki, Gustavo] McGill Univ, Montreal, PQ, Canada; [Robison, Alfred J.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA	Michigan State University; McGill University; McGill University; Michigan State University	Robison, AJ (corresponding author), Michigan State Univ, Genet Program, E Lansing, MI 48824 USA.; Robison, AJ (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	robiso45@msu.edu	Robison, Alfred J/P-8521-2018	Robison, Alfred J/0000-0002-4150-9570; Turecki, Gustavo/0000-0003-4075-2736	Whitehall Foundation	Whitehall Foundation	Author PAG received some salary support from a grant to author AJR from the Whitehall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COMORBIDITY ADDICTIO; Bignante EA, 2008, EUR NEUROPSYCHOPHARM, V18, P578, DOI 10.1016/j.euroneuro.2008.02.007; Blier P, 2003, EUR NEUROPSYCHOPHARM, V13, P57, DOI 10.1016/S0924-977X(02)00173-6; Buchta WC, 2015, BRAIN RES, V1628, P88, DOI 10.1016/j.brainres.2015.02.003; Cadet Jean Lud, 2015, Front Psychiatry, V6, P189, DOI 10.3389/fpsyt.2015.00189; Carle TL, 2007, EUR J NEUROSCI, V25, P3009, DOI 10.1111/j.1460-9568.2007.05575.x; Mlewski EC, 2008, ANN NY ACAD SCI, V1139, P89, DOI 10.1196/annals.1432.039; Chen JS, 2000, J NEUROSCI, V20, P8965; Chen JS, 1997, J NEUROSCI, V17, P4933; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Culpepper Larry, 2015, J Clin Psychiatry, V76, pe901, DOI 10.4088/JCP.13086tx4c; Davis L, 2008, CURR OPIN PSYCHIATR, V21, P14, DOI 10.1097/YCO.0b013e3282f32408; Duman RS, 2014, DIALOGUES CLIN NEURO, V16, P11; Eagle AL, 2015, J NEUROSCI, V35, P13773, DOI 10.1523/JNEUROSCI.2083-15.2015; Evans VC, 2014, J CLIN PSYCHIAT, V75, P1359, DOI 10.4088/JCP.13r08939; Fass DM, 2014, NEUROSCIENCE, V264, P112, DOI 10.1016/j.neuroscience.2013.01.041; Graybeal Carolyn, 2012, Curr Top Behav Neurosci, V12, P189; Hiroi N, 1998, J NEUROSCI, V18, P6952; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Januar V, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.114; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Keralapurath MM, 2017, ADDICT BIOL, V22, P446, DOI 10.1111/adb.12345; Loureiro M, 2016, BIOL PSYCHIAT, V80, P216, DOI 10.1016/j.biopsych.2015.10.016; Loweth JA, 2014, NEUROPHARMACOLOGY, V76, P287, DOI 10.1016/j.neuropharm.2013.04.061; Luscher C, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012013; Massart R, 2015, J NEUROSCI, V35, P8042, DOI 10.1523/JNEUROSCI.3053-14.2015; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Menard C, 2016, NEUROSCIENCE, V321, P138, DOI 10.1016/j.neuroscience.2015.05.053; Nestler EJ, 2015, EUR J PHARMACOL, V753, P66, DOI [10.1016/j.ejphar.2014.1.0.034, 10.1016/j.ejphar.2014.10.034]; Nye HE, 1995, J PHARMACOL EXP THER, V275, P1671; Papakostas GI, 2015, J CLIN PSYCHIAT, V76, P456, DOI [10.4088/JCP.14r09297, 10.4088/JCP.13086tx5c, 10.4088/JCP.13086ah1c]; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Pierce RC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012021; QUIRION R, 1987, SYNAPSE, V1, P446, DOI 10.1002/syn.890010508; Robison AJ, 2014, TRENDS NEUROSCI, V37, P653, DOI 10.1016/j.tins.2014.07.001; Robison AJ, 2014, NEUROPSYCHOPHARMACOL, V39, P1178, DOI 10.1038/npp.2013.319; Robison AJ, 2013, J NEUROSCI, V33, P4295, DOI 10.1523/JNEUROSCI.5192-12.2013; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Ruffle JK, 2014, AM J DRUG ALCOHOL AB, V40, P428, DOI 10.3109/00952990.2014.933840; Seiwell AP, 2007, NEUROSCI LETT, V417, P100, DOI 10.1016/j.neulet.2007.02.043; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Tafet GE, 2016, J NEUROPSYCH CLIN N, V28, P77, DOI 10.1176/appi.neuropsych.15030053; Taylor JR, 2007, P NATL ACAD SCI USA, V104, P4147, DOI 10.1073/pnas.0610288104; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; Ulery-Reynolds PG, 2009, NEUROSCIENCE, V158, P369, DOI 10.1016/j.neuroscience.2008.10.059; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Vialou V, 2015, NEUROPHARMACOLOGY, V99, P28, DOI 10.1016/j.neuropharm.2015.07.005; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Wood S, 2014, PHARMACOL REV, V66, P193, DOI 10.1124/pr.112.007054; Zarate C, 2013, ANN NY ACAD SCI, V1292, P21, DOI 10.1111/nyas.12223	51	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160355	10.1371/journal.pone.0160355	http://dx.doi.org/10.1371/journal.pone.0160355			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494187	Green Submitted, gold, Green Published			2022-12-27	WOS:000381369500033
J	Jeong, JH; Choi, YJ; Park, KH; Kim, DM; Jeoung, JW				Jeong, Jae Hoon; Choi, Yun Jeong; Park, Ki Ho; Kim, Dong Myung; Jeoung, Jin Wook			Macular Ganglion Cell Imaging Study: Covariate Effects on the Spectral Domain Optical Coherence Tomography for Glaucoma Diagnosis	PLOS ONE			English	Article							NERVE-FIBER LAYER; SCANNING LASER OPHTHALMOSCOPY; HIGH MYOPIA; DETECT GLAUCOMA; THICKNESS; OCT; HEAD; AGE; SIZE; PERFORMANCE	Purpose To evaluate the effect of multiple covariates on the diagnostic performance of the Cirrus high-definition optical coherence tomography (HD-OCT) for glaucoma detection. Methods A prospective case-control study was performed and included 173 recently diagnosed glaucoma patients and 63 unaffected individuals from the Macular Ganglion Cell Imaging Study. Regression analysis of receiver operating characteristic were conducted to evaluate the influence of age, spherical equivalent, axial length, optic disc size, and visual field index on the macular ganglion cell-inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (RNFL) measurements. Results Disease severity, as measured by visual field index, had a significant effect on the diagnostic performance of all Cirrus HD-OCT parameters. Age, axial length and optic disc size were significantly associated with diagnostic accuracy of average peripapillary RNFL thickness, whereas axial length had a significant effect on the diagnostic accuracy of average GCIPL thickness. Conclusions Diagnostic performance of the Cirrus HD-OCT may be more accurate in the advanced stages of glaucoma than at earlier stages. A smaller optic disc size was significantly associated with improved the diagnostic ability of average RNFL thickness measurements; however, GCIPL thickness may be less affected by age and optic disc size.	[Jeong, Jae Hoon] Konyang Univ Hosp, Dept Ophthalmol, Daejeon, South Korea; [Jeong, Jae Hoon] Chung Ang Univ, Grad Sch, Seoul, South Korea; [Choi, Yun Jeong; Park, Ki Ho; Kim, Dong Myung; Jeoung, Jin Wook] Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea; [Choi, Yun Jeong; Park, Ki Ho; Kim, Dong Myung; Jeoung, Jin Wook] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Konyang University; Konyang University Hospital; Chung Ang University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Jeoung, JW (corresponding author), Seoul Natl Univ Hosp, Dept Ophthalmol, Seoul, South Korea.; Jeoung, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	neuroprotect@gmail.com	Jeong, Jae Hoon/K-6334-2015	Jeong, Jae Hoon/0000-0001-7311-7080	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C1499]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant of the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [Grant Number: HI12C1499]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo TA, 2002, BIOSTATISTICS, V3, P421, DOI 10.1093/biostatistics/3.3.421; BALAZSI AG, 1984, AM J OPHTHALMOL, V97, P760, DOI 10.1016/0002-9394(84)90509-9; Bayraktar S, 2001, J GLAUCOMA, V10, P163; Bendschneider D, 2010, J GLAUCOMA, V19, P475, DOI 10.1097/IJG.0b013e3181c4b0c7; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Choi YJ, 2013, INVEST OPHTH VIS SCI, V54, P2296, DOI 10.1167/iovs.12-10530; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Eriksson U, 2009, BRIT J OPHTHALMOL, V93, P1448, DOI 10.1136/bjo.2007.131094; Hariri A, 2012, INVEST OPHTH VIS SCI, V53, P5287, DOI 10.1167/iovs.12-9767; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Jaffe GJ, 2004, AM J OPHTHALMOL, V137, P156, DOI 10.1016/S0002-9394(03)00792-X; Janes H, 2009, STATA J, V9, P17, DOI 10.1177/1536867X0900900102; Jeoung JW, 2013, INVEST OPHTH VIS SCI, V54, P4422, DOI 10.1167/iovs.12-11273; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P587, DOI 10.1007/BF02169209; Kanamori A, 2003, OPHTHALMOLOGICA, V217, P273, DOI 10.1159/000070634; Kim NR, 2011, BRIT J OPHTHALMOL, V95, P1115, DOI 10.1136/bjo.2010.182493; Leite MT, 2010, INVEST OPHTH VIS SCI, V51, P4104, DOI 10.1167/iovs.09-4716; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P3178, DOI 10.1167/iovs.06-1315; Leung CKS, 2006, INVEST OPHTH VIS SCI, V47, P5171, DOI 10.1167/iovs.06-0545; Medeiros FA, 2005, AM J OPHTHALMOL, V139, P44, DOI 10.1016/j.ajo.2004.08.069; MIKELBERG FS, 1989, OPHTHALMOLOGY, V96, P1325; Moghimi S, 2012, INVEST OPHTH VIS SCI, V53, P4519, DOI 10.1167/iovs.11-8362; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nakano N, 2013, AM J OPHTHALMOL, V156, P511, DOI 10.1016/j.ajo.2013.04.028; Nukada M, 2011, OPHTHALMOLOGY, V118, P1038, DOI 10.1016/j.ophtha.2010.10.025; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Rao HL, 2011, INVEST OPHTH VIS SCI, V52, P1103, DOI 10.1167/iovs.10-5997; REPKA MX, 1989, OPHTHALMOLOGY, V96, P26; Savini G, 2005, BRIT J OPHTHALMOL, V89, P489, DOI 10.1136/bjo.2004.052498; Savini G, 2011, CURR OPIN OPHTHALMOL, V22, P115, DOI 10.1097/ICU.0b013e3283437222; Shoji T, 2012, GRAEF ARCH CLIN EXP, V250, P1843, DOI 10.1007/s00417-012-1994-8; Shoji T, 2011, INVEST OPHTH VIS SCI, V52, P1098, DOI 10.1167/iovs.10-5922; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Takayama K, 2012, INVEST OPHTH VIS SCI, V53, P6904, DOI 10.1167/iovs.12-10210; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Varma R, 1996, OPHTHALMOLOGY, V103, P2114, DOI 10.1016/S0161-6420(96)30381-3; Vemon SA, 2008, BRIT J OPHTHALMOL, V92, P1076, DOI 10.1136/bjo.2007.127571; Wollstein G, 2005, AM J OPHTHALMOL, V139, P39, DOI 10.1016/j.ajo.2004.08.036	41	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160448	10.1371/journal.pone.0160448	http://dx.doi.org/10.1371/journal.pone.0160448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490718	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900057
J	Pino, MC; Mazza, M				Pino, Maria Chiara; Mazza, Monica			The Use of "Literary Fiction" to Promote Mentalizing Ability	PLOS ONE			English	Article							SOCIAL COGNITION; ASPERGER-SYNDROME; SYSTEMATIZING QUOTIENT; FUNCTIONING AUTISM; EMOTIONAL EMPATHY; NORMAL ADULTS; VERSION; MIND; DISSOCIATION; RELIABILITY	Empathy is a multidimensional process that incorporates both mentalizing and emotional sharing dimensions. Empathic competencies are important for creating interpersonal relationships with other people and developing adequate social behaviour. The lack of these social components also leads to isolation and exclusion in healthy populations. However, few studies have investigated how to improve these social skills. In a recent study, Kidd and Castano (2013) found that reading literary fiction increases mentalizing ability and may change how people think about other people's emotions and mental states. The aim of our study was to evaluate the effects of reading literary fiction, compared to nonfiction and science fiction, on empathic abilities. Compared to previous studies, we used a larger variety of empathy measures and utilized a pre and post-test design. In all, 214 healthy participants were randomly assigned to read a book representative of one of three literary genres (literary fiction, nonfiction, science fiction). Participants were assessed before and after the reading phase using mentalizing and emotional sharing tests, according to Zaki and Ochsner's (2012) model. Comparisons of sociodemographic, mentalizing, and emotional sharing variables across conditions were conducted using ANOVA. Our results showed that after the reading phase, the literary fiction group showed improvement in mentalizing abilities, but there was no discernible effect on emotional sharing abilities. Our study showed that the reading processes can promote mentalizing abilities. These results may set important goals for future low-cost rehabilitation protocols for several disorders in which the mentalizing deficit is considered central to the disease, such as Autism Spectrum Disorders and Schizophrenia.	[Pino, Maria Chiara] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Mazza, Monica] Univ Aquila, Dept Appl Clin Sci & Biotechnol, Laquila, Italy	University of L'Aquila; University of L'Aquila	Pino, MC (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy.	mariachiara.pino@graduate.univaq.it		Pino, Maria Chiara/0000-0003-2657-2122; Mazza, Monica/0000-0003-4050-2243				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Albiero P, 2009, J ADOLESCENCE, V32, P393, DOI 10.1016/j.adolescence.2008.01.001; Bal PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055341; Barnes JL, 2012, POETICS, V40, P299, DOI 10.1016/j.poetic.2012.05.001; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Black JE, 2015, POETICS, V52, P32, DOI 10.1016/j.poetic.2015.07.001; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Bradbury R., 1951, FAHRENHEIT 451; Brandley MM, 1994, JOURNAL OF BEHAVIOR, V25, P49, DOI DOI 10.1016/0005-7916(94)90063-9; Charon R, 2001, JAMA-J AM MED ASSOC, V286, P1897, DOI 10.1001/jama.286.15.1897; Coman L, 2006, CAN J AGING, V25, P253, DOI 10.1353/cja.2007.0001; D'Orazio DM, 2004, SEX ABUSE-J RES TR, V16, P173, DOI 10.1023/B:SEBU.0000023169.51421.76; Davidson JH, 2015, RAMBAM MAIMONIDES ME, V6, pe0014, DOI [10.5041/AMMJ.10198, DOI 10.5041/AMMJ]; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Deraniyagala S., 2013, WAVE; Djikic M, 2013, SCI STUDY LIT, V3, P28, DOI [10.1075/ssol.3.1.06dji, DOI 10.1075/SSOL.3.1.06DJI]; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Dziobek I, 2011, NEUROIMAGE, V57, P539, DOI 10.1016/j.neuroimage.2011.05.005; Fallaci O., 2010, ORIANA FALLACI INTER; Farrington DP, 2006, J ADOLESC; Fontenelle LF, 2009, J PSYCHIATR RES, V43, P455, DOI 10.1016/j.jpsychires.2008.05.007; Groen Y, 2015, J AUTISM DEV DISORD, V45, P2848, DOI 10.1007/s10803-015-2448-z; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hooker CI, 2008, SOC COGN AFFECT NEUR, V3, P204, DOI 10.1093/scan/nsn019; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kim J, 2010, PSYCHIAT INVEST, V7, P24, DOI 10.4306/pi.2010.7.1.24; Kumschick IR, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01448; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lehne M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124550; Ling J, 2009, BRIT J PSYCHOL, V100, P539, DOI 10.1348/000712608X368261; Mar RA, 2006, J RES PERS, V40, P694, DOI 10.1016/j.jrp.2005.08.002; Mar RA, 2010, COGNITIVE DEV, V25, P69, DOI 10.1016/j.cogdev.2009.11.002; Mariano M, 2016, SOC NEUROSCI; Mazza M, 2007, EUR ARCH PSY CLIN N, V257, P12, DOI 10.1007/s00406-006-0676-0; Mazza M, 2015, BEHAV BRAIN RES, V282, P37, DOI 10.1016/j.bbr.2014.12.049; Mazza M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00791; Mazza M, 2010, NEUROPSYCHOL REHABIL, V20, P675, DOI 10.1080/09602011.2010.486284; Pino MC, 2016, REV BRAS PSIQUIATR; Reynolds A, 2011, TROIKA; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Sarfati Y, 1997, SCHIZOPHR RES, V25, P199, DOI 10.1016/S0920-9964(97)00025-X; Schultz D, 2001, DEV PSYCHOPATHOL, V13, P53, DOI 10.1017/S0954579401001043; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2005, NAT NEUROSCI, V8, P845, DOI 10.1038/nn0705-845; Zaki J, 2012, NAT NEUROSCI, V15, P675, DOI 10.1038/nn.3085	50	54	55	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160254	10.1371/journal.pone.0160254	http://dx.doi.org/10.1371/journal.pone.0160254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490164	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900043
J	Bourgeois, A; Neveu, R; Vuilleumier, P				Bourgeois, Alexia; Neveu, Remi; Vuilleumier, Patrik			How Does Awareness Modulate Goal-Directed and Stimulus-Driven Shifts of Attention Triggered by Value Learning?	PLOS ONE			English	Article							NEURAL MECHANISMS; REWARD SIGNALS; BIAS; RESPONSES; SALIENCE; NEGLECT; DORSAL	In order to behave adaptively, attention can be directed in space either voluntarily (i.e., endogenously) according to strategic goals, or involuntarily (i.e., exogenously) through reflexive capture by salient or novel events. The emotional or motivational value of stimuli can also strongly influence attentional orienting. However, little is known about how reward-related effects compete or interact with endogenous and exogenous attention mechanisms, particularly outside of awareness. Here we developed a visual search paradigm to study subliminal value-based attentional orienting. We systematically manipulated goal-directed or stimulus-driven attentional orienting and examined whether an irrelevant, but previously rewarded stimulus could compete with both types of spatial attention during search. Critically, reward was learned without conscious awareness in a preceding phase where one among several visual symbols was consistently paired with a subliminal monetary reinforcement cue. Our results demonstrated that symbols previously associated with a monetary reward received higher attentional priority in the subsequent visual search task, even though these stimuli and reward were no longer task-relevant, and despite reward being unconsciously acquired. Thus, motivational processes operating independent of conscious awareness may provide powerful influences on mechanisms of attentional selection, which could mitigate both stimulus-driven and goal-directed shifts of attention.	[Bourgeois, Alexia; Neveu, Remi; Vuilleumier, Patrik] Univ Geneva, Lab Behav Neurol & Imaging Cognit, Dept Neurosci, Geneva, Switzerland	University of Geneva	Bourgeois, A (corresponding author), Univ Geneva, Lab Behav Neurol & Imaging Cognit, Dept Neurosci, Geneva, Switzerland.	alx.bourgeois@gmail.com	Vuilleumier, Patrik/AAJ-1839-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Bourgeois, Alexia/0000-0002-7397-6835	Fondation Fyssen; Marie-Curie CoFund BRIDGE program from the European Union Seventh Framework Programme (FP7) [267171]; National Center of Competence in Research (NCCR) for the Affective Sciences - Swiss National Science Foundation (SNF) [51NF40-104897]; Geneva Academic Society	Fondation Fyssen; Marie-Curie CoFund BRIDGE program from the European Union Seventh Framework Programme (FP7); National Center of Competence in Research (NCCR) for the Affective Sciences - Swiss National Science Foundation (SNF); Geneva Academic Society	This work was supported by grants from the Fondation Fyssen (AB); the Marie-Curie CoFund BRIDGE program (AB) from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 267171; the National Center of Competence in Research (NCCR) for the Affective Sciences financed by the Swiss National Science Foundation (SNF No 51NF40-104897) and hosted by the University of Geneva; and an award from the Geneva Academic Society (Foremane Fund to PV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2008, SCIENCE, V319, P1639, DOI 10.1126/science.1150432; Allport D. A., 1989, FDN COGNITIVE SCI, P631; Anderson BA, 2014, BRAIN RES, V1587, P88, DOI 10.1016/j.brainres.2014.08.062; Anderson BA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00262; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Arsenault JT, 2013, NEURON, V77, P1174, DOI 10.1016/j.neuron.2013.01.008; Bartolomeo P, 2001, EXP BRAIN RES, V137, P432; Bijleveld E, 2014, HUM BRAIN MAPP, V35, P5578, DOI 10.1002/hbm.22571; Bijleveld E, 2010, COGNITION, V115, P330, DOI 10.1016/j.cognition.2009.12.012; Bourgeois A, 2017, COGNITION EMOTION, V31, P109, DOI 10.1080/02699931.2015.1085366; Bourgeois A, 2013, CORTEX, V49, P2229, DOI 10.1016/j.cortex.2012.10.017; Chelazzi L, 2014, J NEUROSCI, V34, P8594, DOI 10.1523/JNEUROSCI.0277-14.2014; Chica AB, 2013, BEHAV BRAIN RES, V237, P107, DOI 10.1016/j.bbr.2012.09.027; Chica AB, 2011, J NEUROSCI, V31, P8143, DOI 10.1523/JNEUROSCI.5463-10.2010; Cojan Y, 2015, NEUROIMAGE, V117, P367, DOI 10.1016/j.neuroimage.2015.05.076; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Ding L, 2006, J NEUROSCI, V26, P6695, DOI 10.1523/JNEUROSCI.0836-06.2006; Ding L, 2007, J NEUROPHYSIOL, V97, P57, DOI 10.1152/jn.00902.2006; Driver J, 2001, NEUROPSYCHOLOGIA, V39, P1257, DOI 10.1016/S0028-3932(01)00115-4; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Hickey C, 2015, NEURON, V85, P512, DOI 10.1016/j.neuron.2014.12.049; Hickey C, 2013, VISION RES, V92, P67, DOI 10.1016/j.visres.2013.09.008; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Ikeda T, 2007, J NEUROPHYSIOL, V98, P3163, DOI 10.1152/jn.00975.2007; Krebs RM, 2012, CEREB CORTEX, V22, P607, DOI 10.1093/cercor/bhr134; Lee J, 2014, PSYCHOL SCI, V25, P466, DOI 10.1177/0956797613509284; Lucas N, 2013, CORTEX, V49, P2616, DOI 10.1016/j.cortex.2013.06.004; Maunsell JHR, 2004, TRENDS COGN SCI, V8, P261, DOI 10.1016/j.tics.2004.04.003; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Pourtois G, 2012, BIOL PSYCHOL; Schneider W., 2002, E PRIME USERS GUIDE; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Serences JT, 2008, NEURON, V60, P1169, DOI 10.1016/j.neuron.2008.10.051; Tachibana Y, 2012, NEURON, V76, P826, DOI 10.1016/j.neuron.2012.09.030; Tosoni A, 2013, CORTEX, V49, P1733, DOI 10.1016/j.cortex.2012.03.022; Vaidya AR, 2015, J NEUROSCI, V35, P12813, DOI 10.1523/JNEUROSCI.1607-15.2015; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2015, CURR OPIN NEUROL, V28, P29, DOI 10.1097/WCO.0000000000000159; Zedelius CM, 2014, COGN AFFECT BEHAV NE, V14, P493, DOI 10.3758/s13415-013-0241-z; Zedelius CM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00219; Zedelius CM, 2011, CONSCIOUS COGN, V20, P355, DOI 10.1016/j.concog.2010.05.001	47	16	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160469	10.1371/journal.pone.0160469	http://dx.doi.org/10.1371/journal.pone.0160469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NS	27483371	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700048
J	Kim, MH; Kim, YJ; Kim, HR; Jeon, TJ; Choi, JB; Chung, KY; Kim, MK				Kim, Min Hyeok; Kim, Young Jin; Kim, Hee Ryung; Jeon, Tae-Joon; Choi, Jae Boong; Chung, Ka Young; Kim, Moon Ki			Computational Simulation of the Activation Cycle of G alpha Subunit in the G Protein Cycle Using an Elastic Network Model	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; BETA(2) ADRENERGIC-RECEPTOR; GTP-GAMMA-S; CRYSTAL-STRUCTURE; NUCLEOTIDE EXCHANGE; STRUCTURAL BASIS; CONFORMATIONAL TRANSITIONS; G-ALPHA(I) SUBUNITS; COUPLED RECEPTOR; DOMAIN MOTIONS	Agonist-activated G protein-coupled receptors (GPCRs) interact with GDP-bound G protein heterotrimers (G alpha beta gamma) promoting GDP/GTP exchange, which results in dissociation of G alpha from the receptor and G beta gamma. The GTPase activity of G alpha hydrolyzes GTP to GDP, and the GDP-bound Ga interacts with G beta gamma, forming a GDP-bound G protein heterotrimer. The G protein cycle is allosterically modulated by conformational changes of the G alpha subunit. Although biochemical and biophysical methods have elucidated the structure and dynamics of G alpha, the precise conformational mechanisms underlying the G protein cycle are not fully understood yet. Simulation methods could help to provide additional details to gain further insight into G protein signal transduction mechanisms. In this study, using the available X-ray crystal structures of G alpha, we simulated the entire G protein cycle and described not only the steric features of the G alpha structure, but also conformational changes at each step. Each reference structure in the G protein cycle was modeled as an elastic network model and subjected to normal mode analysis. Our simulation data suggests that activated receptors trigger conformational changes of the G alpha subunit that are thermodynamically favorable for opening of the nucleotide-binding pocket and GDP release. Furthermore, the effects of GTP binding and hydrolysis on mobility changes of the C and N termini and switch regions are elucidated. In summary, our simulation results enabled us to provide detailed descriptions of the structural and dynamic features of the G protein cycle.	[Kim, Min Hyeok] Korea Inst Adv Study, Seoul, South Korea; [Kim, Young Jin; Choi, Jae Boong; Kim, Moon Ki] Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea; [Kim, Hee Ryung; Chung, Ka Young] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Jeon, Tae-Joon] Inha Univ, Dept Biol Engn, Inchon, South Korea	Korea Institute for Advanced Study (KIAS); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Inha University	Kim, MK (corresponding author), Sungkyunkwan Univ, Sch Mech Engn, Suwon, South Korea.; Chung, KY (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea.	kychung2@skku.edu; mkkim@me.skku.ac.kr	Kim, Young-jin/GSD-3168-2022; Chung, Ka Young/AAO-7984-2020; Jeon, Tae-Joon/D-4725-2013	Jeon, Tae-Joon/0000-0002-4882-9040; Chung, Ka Young/0000-0001-9038-9571; Kim, Hee Ryung/0000-0002-3356-713X	Pioneer Research Center Program through the National Research Foundation of Korea - the Ministry of Science, ICT & Future Planning [2012-0009579]; Basic Science Research Program through the National Research Foundation of Korea - the Ministry of Science, ICT & Future Planning [2015R1D1A1A01057280]; Ministry of Education	Pioneer Research Center Program through the National Research Foundation of Korea - the Ministry of Science, ICT & Future Planning; Basic Science Research Program through the National Research Foundation of Korea - the Ministry of Science, ICT & Future Planning; Ministry of Education	This research was supported by Pioneer Research Center Program (2012-0009579) and Basic Science Research Program (2015R1D1A1A01057280) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning and by the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Pioneer Research Center Program (2012-0009579) and Basic Science Research Program (2015R1D1A1A01057280) through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning and by the Ministry of Education. None of the authors has any conflicts of interest with respect to the material contained in this manuscript.	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Ayoub Mohammed Akli, 2012, Front Endocrinol (Lausanne), V3, P82, DOI 10.3389/fendo.2012.00082; Baltoumas FA, 2013, J STRUCT BIOL, V182, P209, DOI 10.1016/j.jsb.2013.03.004; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DEGTYAREV MY, 1994, J BIOL CHEM, V269, P30898; Dohlman HG, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003013; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Franco M, 1996, J BIOL CHEM, V271, P1573, DOI 10.1074/jbc.271.3.1573; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 2013, J STRUCT BIOL, V184, P63, DOI 10.1016/j.jsb.2013.02.016; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Hinsen K, 1998, PROTEINS, V33, P417, DOI 10.1002/(SICI)1097-0134(19981115)33:3<417::AID-PROT10>3.0.CO;2-8; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Jeong JI, 2006, J MOL GRAPH MODEL, V24, P296, DOI 10.1016/j.jmgm.2005.09.006; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kim MH, 2013, PROTEIN SCI, V22, P605, DOI 10.1002/pro.2244; Kim MK, 2006, INT J CONTROL AUTOM, V4, P382; Kim MK, 2002, BIOPHYS J, V83, P1620, DOI 10.1016/S0006-3495(02)73931-3; Kim MK, 2002, J MOL GRAPH MODEL, V21, P151, DOI 10.1016/S1093-3263(02)00143-2; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Louet M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002595; Louet M, 2011, J MOL BIOL, V411, P298, DOI 10.1016/j.jmb.2011.05.034; Lundstrom K, 2009, VIRUSES-BASEL, V1, P13, DOI 10.3390/v1010013; Marques O, 1995, PROTEINS, V23, P557, DOI 10.1002/prot.340230410; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Mnpotra JS, 2014, J BIOL CHEM, V289, P20259, DOI 10.1074/jbc.M113.539916; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Orban T, 2012, STRUCTURE, V20, P826, DOI 10.1016/j.str.2012.03.017; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ridge KD, 2006, J BIOL CHEM, V281, P7635, DOI 10.1074/jbc.M509851200; Rose AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143399; Seo S, 2012, NUCLEIC ACIDS RES, V40, pW531, DOI 10.1093/nar/gks525; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Song G, 2006, PROTEINS, V63, P197, DOI 10.1002/prot.20836; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Yao XQ, 2016, J BIOL CHEM, V291, P4742, DOI 10.1074/jbc.M115.702605	60	65	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0159528	10.1371/journal.pone.0159528	http://dx.doi.org/10.1371/journal.pone.0159528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483005	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110700011
J	Lin, ZJ; Chen, X; Li, ZF; Luo, YM; Fang, ZH; Xu, B; Han, MZ				Lin, Zhijuan; Chen, Xing; Li, Zhifeng; Luo, Yiming; Fang, Zhihong; Xu, Bing; Han, Mingzhe			PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ANTI-PD-1 ANTIBODY; MULTIPLE-MYELOMA; NIVOLUMAB; IPILIMUMAB; MELANOGENESIS; EXPRESSION; B7-H1; PEMBROLIZUMAB; CHEMOTHERAPY; DOCETAXEL	Antibodies targeting programmed death 1 (PD-1) help prevent tumor cells from escaping immune-mediated destruction. We conducted this systematic review and meta-analysis to gain insight into the efficacy of PD-1 antibodies for the treatment of melanoma. Five trials involving 2,828 adult patients were included in this meta-analysis. In patients with previously untreated or refractory melanoma, treatment with PD-1 antibodies significantly improved the six-month progression-free survival (PFS) (HR 0.55, 95% CI 0.50-0.60, P < 0.00001) and the overall response rate (OR 3.89, 95% CI 3.12-4.83, P < 0.00001). This meta-analysis indicated that anti-PD-1 treatment might provide a significant survival benefit in patients with melanoma. In addition, we found that patients treated with nivolumab reported significantly fewer treatment-related adverse events (OR 0.74, 95% CI 0.57-0.97, P = 0.03) than those treated with other agents, but there was a dose-dependent increase in the frequency of adverse events in patients treated with pembrolizumab.	[Lin, Zhijuan; Li, Zhifeng; Luo, Yiming; Fang, Zhihong; Xu, Bing; Han, Mingzhe] Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Peoples R China; [Chen, Xing] Xiamen Univ, Affiliated Hosp 1, Dept Nephrol, Xiamen, Peoples R China; [Han, Mingzhe] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Han, Mingzhe] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Han, Mingzhe] Peking Union Med Coll, Tianjin, Peoples R China; [Han, Mingzhe] Chinese Acad Med Sci, Ctr Stem Cell Med, Tianjin, Peoples R China; [Han, Mingzhe] Peking Union Med Coll, Dept Stem Cells & Regenerat Med, Tianjin, Peoples R China	Xiamen University; Xiamen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, B; Han, MZ (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Peoples R China.; Han, MZ (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.; Han, MZ (corresponding author), Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China.; Han, MZ (corresponding author), Peking Union Med Coll, Tianjin, Peoples R China.; Han, MZ (corresponding author), Chinese Acad Med Sci, Ctr Stem Cell Med, Tianjin, Peoples R China.; Han, MZ (corresponding author), Peking Union Med Coll, Dept Stem Cells & Regenerat Med, Tianjin, Peoples R China.	xubingzhangjian@126.com; mzhan@medmail.com.cn						Ancuceanu R, 2016, INDIAN J MED RES, V143, P135, DOI 10.4103/0971-5916.180197; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2016, ONCOTARGET, V7, P17844, DOI 10.18632/oncotarget.7528; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Caers J, 2016, ONCOLOGIST, V21, P333, DOI 10.1634/theoncologist.2015-0303; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Francisco LM, 2009, J EXP MED, V206, P3015, DOI 10.1084/jem.20090847; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gandini S, 2016, CRIT REV ONCOL HEMAT, V100, P88, DOI 10.1016/j.critrevonc.2016.02.001; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Ribas A, 2015, LANCET ONCOL, V16, P908, DOI 10.1016/S1470-2045(15)00083-2; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Salem MR, 2015, J THERM SCI ENG APPL, V7, DOI 10.1115/1.4030635; Schadendorf D, 2015, J CLIN ONCOL, V33, P1889, DOI 10.1200/JCO.2014.56.2736; SHINOHARA T, 1994, GENOMICS, V23, P704, DOI 10.1006/geno.1994.1562; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Tarhini AA, 2015, ONCOLOGY-NY, V29, P501; Tarhini AA, 2015, ONCOLOGY-NY, V29, P94; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8	37	23	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160485	10.1371/journal.pone.0160485	http://dx.doi.org/10.1371/journal.pone.0160485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483468	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700050
J	Cai, CG; Jiang, H; Li, L; Liu, TM; Song, XJ; Liu, B				Cai, Chenggu; Jiang, Hua; Li, Lei; Liu, Tianming; Song, Xuejie; Liu, Bo			Characterization of the Sweet Taste Receptor Tas1r2 from an Old World Monkey Species Rhesus Monkey and Species-Dependent Activation of the Monomeric Receptor by an Intense Sweetener Perillartine	PLOS ONE			English	Article							PROTEIN; T1R3; SUBUNITS	Sweet state is a basic physiological sensation of humans and other mammals which is mediated by the broadly acting sweet taste receptor-the heterodimer of Tas1r2 (taste receptor type 1 member 2) and Tas1r3 (taste receptor type 1 member 3). Various sweeteners interact with either Tas1r2 or Tas1r3 and then activate the receptor. In this study, we cloned, expressed and functionally characterized the taste receptor Tas1r2 from a species of Old World monkeys, the rhesus monkey. Paired with the human TAS1R3, it was shown that the rhesus monkey Tas1r2 could respond to natural sugars, amino acids and their derivates. Furthermore, similar to human TAS1R2, rhesus monkey Tas1r2 could respond to artificial sweeteners and sweet-tasting proteins. However, the responses induced by rhesus monkey Tas1r2 could not be inhibited by the sweet inhibitor amiloride. Moreover, we found a species-dependent activation of the Tas1r2 monomeric receptors of human, rhesus monkey and squirrel monkey but not mouse by an intense sweetener perillartine. Molecular modeling and sequence analysis indicate that the receptor has the conserved domains and ligand-specific interactive residues, which have been identified in the characterized sweet taste receptors up to now. This is the first report of the functional characterization of sweet taste receptors from an Old World monkey species.	[Cai, Chenggu; Li, Lei; Liu, Tianming; Song, Xuejie] Qilu Univ Technol, Dept Bioengn, Jinan 250353, Shandong, Peoples R China; [Jiang, Hua; Liu, Bo] Qilu Univ Technol, Dept Food Sci & Engn, Jinan 250353, Shandong, Peoples R China; [Liu, Bo] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China	Qilu University of Technology; Qilu University of Technology; Shandong University	Liu, B (corresponding author), Qilu Univ Technol, Dept Food Sci & Engn, Jinan 250353, Shandong, Peoples R China.; Liu, B (corresponding author), Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan 250012, Shandong, Peoples R China.	ertrdfgg@qlu.edu.cn	Liu, Tianming/AAA-4602-2022		Natural Science Foundation of China [31271118]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (31271118 to BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; Imada T, 2010, BIOCHEM BIOPH RES CO, V397, P220, DOI 10.1016/j.bbrc.2010.05.088; Jiang PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093043; Jiang PH, 2004, J BIOL CHEM, V279, P45068, DOI 10.1074/jbc.M406779200; Kim UK, 2004, J DENT RES, V83, P448, DOI 10.1177/154405910408300603; Li X, 2011, CHEM SENSES, V36, P453, DOI 10.1093/chemse/bjq145; Liu B, 2012, BIOCHEM BIOPH RES CO, V427, P431, DOI 10.1016/j.bbrc.2012.09.083; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Masuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035380; Masuda T, 2013, BIOCHIMIE, V95, P1502, DOI 10.1016/j.biochi.2013.01.010; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Ueda T, 2003, J NEUROSCI, V23, P7376; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	16	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160079	10.1371/journal.pone.0160079	http://dx.doi.org/10.1371/journal.pone.0160079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479072	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300022
J	Zhang, Z; Tang, RX; Bian, L; Mei, M; Li, CH; Ma, XD; Yi, L; Ma, LX				Zhang, Zhen; Tang, Rongxin; Bian, Lu; Mei, Meng; Li, Chunhua; Ma, Xiangdong; Yi, Li; Ma, Lixin			Surface Immobilization of Human Arginase-1 with an Engineered Ice Nucleation Protein Display System in E-coli	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE; ORGANOPHOSPHORUS HYDROLASE; TAT PATHWAY; EXPRESSION; BACTERIA; ARGININE; CHANNEL; COMPLEX	Ice nucleation protein (INP) is frequently used as a surface anchor for protein display in gram-negative bacteria. Here, MalE and TorA signal peptides, and three charged polypeptides, 6xLys, 6xGlu and 6xAsp, were anchored to the N-terminus of truncated INP (InaK-N) to improve its surface display efficiency for human Arginase1 (ARG1). Our results indicated that the TorA signal peptide increased the surface translocation of non-protein fused InaK-N and human ARG1 fused InaK-N (InaK-N/ARG1) by 80.7% and 122.4%, respectively. Comparably, the MalE signal peptide decreased the display efficiencies of both the non-protein fused InaK-N and InaK-N/ARG1. Our results also suggested that the 6xLys polypeptide significantly increased the surface display efficiency of K-6-InaK-N/ARG1 by almost 2-fold, while also practically abolishing the surface translocation of non-protein fused InaK-N, indicating the interesting roles of charged polypeptides in bacteria surface display systems. Cell surface-immobilized K-6-InaK-N/ARG1 presented an arginase activity of 10.7 U/OD600 under the optimized conditions of 40 degrees C, pH 10.0 and 1 mM Mn2+, which could convert more than 95% of L-Arginine (L-Arg) to L-Ornithine (L-Orn) in 16 hours. The engineered InaK-Ns expanded the INP surface display system, which aided in the surface immobilization of human ARG1 in E. coli cells.	[Zhang, Zhen; Tang, Rongxin; Mei, Meng; Li, Chunhua; Ma, Xiangdong; Yi, Li; Ma, Lixin] Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Hubei Key Lab Ind Biotechnol, Wuhan, Peoples R China; [Bian, Lu] Beihai Blood Ctr, Guang Xi, Peoples R China	Hubei University	Yi, L; Ma, LX (corresponding author), Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Hubei Key Lab Ind Biotechnol, Wuhan, Peoples R China.	malixing@hubu.edu.cn; liyi@hubu.edu.cn			Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department [2014070504020239]; Nature Science Foundation of HuBei Province of China [2015CFA088]; National Natural Science Foundation of China [31540068, 31100124]; National key Basic Research Program of China (973 Program) [2013CB91080]; Nature Science Found for creative Research Group of Hubei Province of China [2012FFA034]	Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department; Nature Science Foundation of HuBei Province of China(Natural Science Foundation of Hubei Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key Basic Research Program of China (973 Program)(National Basic Research Program of China); Nature Science Found for creative Research Group of Hubei Province of China	This work was supported by the following: 1. Lizin Ma, Foundation for High and New Technology Industrial Innovative Research Groups of the Wuhan Science and technology Bureau's department. Grant Number: 2014070504020239. Website URL: http://www.whst.gov.cn/. Authors: Zhen Zhang, Rongxin Tang, Lu Bian, and Meng Mei received the funding. 2. Li Yi, Nature Science Foundation of HuBei Province of China. Grant Number: 2015CFA088. Website URL: http://www.hbstd.gov.cn/. Authors: Zhen Zhang, Rongxin Tang, Lu Bian, and Meng Mei received the funding. 3. LI Yi, National Natural Science Foundation of China (CN). Grant Number: 31540068. Website URL: http://www.Nsfc.gov.cn/. Authors: Zhen Zhang, Rongxin Tang, Lu Bian, and Meng Mei received the funding. 4. Chunhua Li, National Natural Science Foundation of China (CN). Grant Number: 31100124. Website URL: http://www.Nsfc.gov.cn/. Authors: Zhen Zhang, Rongxin Tang, Lu Bian, and Meng Mei received the funding. 5. Lixin Ma, National key Basic Research Program of China (973 Program). Grant Number: 2013CB91080. Website URL: http://program.most.gov.cn/. Authors: Zhen Zhang, Rongxin Tang, Lu Bian, and Meng Mei received the funding. 6. Lixin Ma, Nature Science Found for creative Research Group of Hubei Province of China. Grant Number: 2012FFA034. Website URL: http://www.hbstd.gov.cn/. Authors: Zhen Zhang, Rongxin Tang, Lu Bian, and Meng Mei received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrage LC, 2015, HUM MOL GENET, V24, P6417, DOI 10.1093/hmg/ddv352; CHEN GQ, 1994, J AM CHEM SOC, V116, P8799, DOI 10.1021/ja00098a045; Cochet N, 2000, APPL MICROBIOL BIOT, V54, P153, DOI 10.1007/s002530000377; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; Jung HC, 1998, NAT BIOTECHNOL, V16, P576, DOI 10.1038/nbt0698-576; Kawahara H, 2002, J BIOSCI BIOENG, V94, P492, DOI 10.1016/S1389-1723(02)80185-2; Lee SJ, 2011, MOL CELLS, V32, P349, DOI 10.1007/s10059-011-0088-5; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Li L, 2004, BIOTECHNOL BIOENG, V85, P214, DOI 10.1002/bit.10892; Li QQ, 2012, INT J BIOL SCI, V8, P1097, DOI 10.7150/ijbs.4524; Li YB, 2016, TUMOR BIOL, V37, P6627, DOI 10.1007/s13277-015-4253-x; LINDOW SE, 1989, MOL PLANT MICROBE IN, V2, P262, DOI 10.1094/MPMI-2-262; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; PATCHETT ML, 1991, BIOCHIM BIOPHYS ACTA, V1077, P291, DOI 10.1016/0167-4838(91)90543-9; Richins RD, 1997, NAT BIOTECHNOL, V15, P984, DOI 10.1038/nbt1097-984; Samuelson P, 2002, J BIOTECHNOL, V96, P129, DOI 10.1016/S0168-1656(02)00043-3; Sargent F, 2002, ARCH MICROBIOL, V178, P77, DOI 10.1007/s00203-002-0434-2; Shimazu M, 2001, BIOTECHNOL PROGR, V17, P76, DOI 10.1021/bp0001563; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Zhang X, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0184-2; Zhong Xing, 2013, Sheng Wu Gong Cheng Xue Bao, V29, P510	24	4	4	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160367	10.1371/journal.pone.0160367	http://dx.doi.org/10.1371/journal.pone.0160367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479442	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300045
J	Harrison, RL; Rowley, DL; Funk, CJ				Harrison, Robert L.; Rowley, Daniel L.; Funk, C. Joel			The Complete Genome Sequence of Plodia Interpunctella Granulovirus: Evidence for Horizontal Gene Transfer and Discovery of an Unusual Inhibitor-of-Apoptosis Gene	PLOS ONE			English	Article							INDIAN MEAL MOTH; GRANULOSIS-VIRUS; HUBNER LEPIDOPTERA; DNA-REPLICATION; BASIC-PROTEIN; INSECT; NUCLEOPOLYHEDROVIRUS; PYRALIDAE; TRANSMISSION; RESISTANCE	The Indianmeal moth, Plodia interpunctella (Lepidoptera: Pyralidae), is a common pest of stored goods with a worldwide distribution. The complete genome sequence for a larval pathogen of this moth, the baculovirus Plodia interpunctella granulovirus (PiGV), was determined by next-generation sequencing. The PiGV genome was found to be 112, 536 bp in length with a 44.2% G+C nucleotide distribution. A total of 123 open reading frames (ORFs) and seven homologous regions (hrs) were identified and annotated. Phylogenetic inference using concatenated alignments of 36 baculovirus core genes placed PiGV in the "b" clade of viruses from genus Betabaculovirus with a branch length suggesting that PiGV represents a distinct betabaculovirus species. In addition to the baculovirus core genes and orthologues of other genes found in other betabaculovirus genomes, the PiGV genome sequence contained orthologues of the bidensovirus NS3 gene, as well as ORFs that occur in alphabaculoviruses but not betabaculoviruses. While PiGV contained an orthologue of inhibitor of apoptosis-5 (iap-5), an orthologue of inhibitor of apoptosis-3 (iap-3) was not present. Instead, the PiGV sequence contained an ORF (PiGV ORF81) encoding an IAP homologue with sequence similarity to insect cellular IAPs, but not to viral IAPs. Phylogenetic analysis of baculovirus and insect IAP amino acid sequences suggested that the baculovirus IAP-3 genes and the PiGV ORF81 IAP homologue represent different lineages arising from more than one acquisition event. The presence of genes from other sources in the PiGV genome highlights the extent to which baculovirus gene content is shaped by horizontal gene transfer.	[Harrison, Robert L.; Rowley, Daniel L.] USDA ARS, Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Funk, C. Joel] John Brown Univ, Dept Biol, Siloam Springs, AR USA	United States Department of Agriculture (USDA)	Harrison, RL (corresponding author), USDA ARS, Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.	Robert.L.Harrison@ars.usda.gov		Rowley, Daniel/0000-0002-1255-8330; Harrison, Robert/0000-0002-8348-3874	National Institute of General Medical Sciences [P20 GM103429]; Arkansas INBRE program; National Institute of General Medical Sciences, (NIGMS) [P20 GM103429]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Arkansas INBRE program; National Institute of General Medical Sciences, (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institute of General Medical Sciences (https://www.nigms.nih.gov), grant number P20 GM103429, awarded to CJF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank Jeff Lord (USDA-ARS) for providing a sample of PiGV and William McGaughey and Lee Bulla for information on the source of the PiGV isolate sequenced in this study. Equipment used for purification of the virus and viral DNA isolation was made possible from support by the Arkansas INBRE program, with a grant from the National Institute of General Medical Sciences, (NIGMS), P20 GM103429. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Abd-Alla A, 2004, J VIROL, V78, P790, DOI 10.1128/JVI.78.2.790-797.2004; Ardisson-Araujo DMP, 2016, SCI REP-UK, V6, DOI 10.1038/srep24612; ARNOTT HJ, 1967, J ULTRA MOL STRUCT R, V21, P251, DOI 10.1016/S0022-5320(67)80095-9; Bao YY, 2013, FEBS J, V280, P939, DOI 10.1111/febs.12088; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Bonsall MB, 2005, J ANIM ECOL, V74, P937, DOI 10.1111/j.1365-2656.2005.00991.x; Boots M, 1998, ECOL ENTOMOL, V23, P118, DOI 10.1046/j.1365-2311.1998.00115.x; BOOTS M, 1995, RES POPUL ECOL, V37, P37, DOI 10.1007/BF02515759; Boots M, 2007, SCIENCE, V315, P1284, DOI 10.1126/science.1137126; Boots M, 2012, P ROY SOC B-BIOL SCI, V279, P4009, DOI 10.1098/rspb.2012.1073; Boots M, 2011, AM NAT, V178, P214, DOI 10.1086/660833; Budhidarmo R, 2015, SEMIN CELL DEV BIOL, V39, P80, DOI 10.1016/j.semcdb.2014.12.002; Burden JP, 2002, MOL ECOL, V11, P547, DOI 10.1046/j.0962-1083.2001.01439.x; Byers NM, 2016, J VIROL, V90, P533, DOI 10.1128/JVI.02320-15; Clem RJ, 2015, SEMIN CELL DEV BIOL, V39, P72, DOI 10.1016/j.semcdb.2015.01.011; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Dennehy JJ, 2014, ANNU REV MICROBIOL, V68, P117, DOI 10.1146/annurev-micro-091313-103436; Environmental Protection Agency, 2004, BIOP REG ACT DOC IND; Estornes Y, 2015, SEMIN CELL DEV BIOL, V39, P106, DOI 10.1016/j.semcdb.2014.03.035; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; FUNK CJ, 1993, VIROLOGY, V193, P396, DOI 10.1006/viro.1993.1136; Gasmi L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005470; Gilbert C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4348; Guo FB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-9; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrison R, 2012, INSECT PATHOLOGY, 2ND EDITION, P73, DOI 10.1016/B978-0-12-384984-7.00004-X; Harrison RL, 2008, VIRUS GENES, V36, P565, DOI 10.1007/s11262-008-0218-0; Harrison RL, 2007, VIRUS GENES, V35, P857, DOI 10.1007/s11262-007-0136-6; Harrison RL, 2014, J INVERTEBR PATHOL, V116, P27, DOI 10.1016/j.jip.2013.12.005; Hashimoto Y, 2000, VIROLOGY, V275, P358, DOI 10.1006/viro.2000.0530; Hayakawa T, 1999, VIROLOGY, V262, P277, DOI 10.1006/viro.1999.9894; Herniou EA, 2012, VIRUS TAXONOMY, P163; Hilton S, 2008, ARCH VIROL, V153, P1527, DOI 10.1007/s00705-008-0148-0; Hilton S, 2007, J GEN VIROL, V88, P1496, DOI 10.1099/vir.0.82760-0; Hu ZH, 1998, J GEN VIROL, V79, P2841, DOI 10.1099/0022-1317-79-11-2841; Hu ZY, 2013, CHINESE SCI BULL, V58, P4528, DOI 10.1007/s11434-013-5876-1; Hughes AL, 2002, INFECT GENET EVOL, V2, P3, DOI 10.1016/S1567-1348(02)00040-0; HUNTER DK, 1973, J INVERTEBR PATHOL, V22, P481, DOI 10.1016/0022-2011(73)90185-7; HUNTER DK, 1979, J STORED PROD RES, V15, P65, DOI 10.1016/0022-474X(79)90014-6; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Johnson JA, 2002, J ECON ENTOMOL, V95, P190, DOI 10.1603/0022-0493-95.1.190; Knell RJ, 1998, J ANIM ECOL, V67, P592, DOI 10.1046/j.1365-2656.1998.00219.x; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lange M, 2003, VIROLOGY, V317, P220, DOI 10.1016/S0042-6822(03)00515-4; Liang ZP, 2011, ARCH VIROL, V156, P1185, DOI 10.1007/s00705-011-0977-0; Luque T, 2001, J GEN VIROL, V82, P2531, DOI 10.1099/0022-1317-82-10-2531; MATTHEWS REF, 1982, INTERVIROLOGY, V17, P4, DOI 10.1159/000149278; MCGAUGHEY WH, 1975, J ECON ENTOMOL, V68, P346, DOI 10.1093/jee/68.3.346; MCTAGGART SJ, 2015, BMC GENOMICS, V16, DOI DOI 10.1186/S12864-015-; McVean RIK, 2002, BIOL CONTROL, V25, P81, DOI 10.1016/S1049-9644(02)00048-8; Mealor MA, 2006, J EVOLUTION BIOL, V19, P326, DOI 10.1111/j.1420-9101.2005.01031.x; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Ardisson-Araujo DMP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-856; Rowley DL, 2011, J INVERTEBR PATHOL, V107, P112, DOI 10.1016/j.jip.2011.03.007; Saejeng A, 2011, J INSECT PHYSIOL, V57, P246, DOI 10.1016/j.jinsphys.2010.10.005; Saejeng A, 2010, J INSECT PHYSIOL, V56, P1232, DOI 10.1016/j.jinsphys.2010.03.025; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao XY, 2015, J VIROL, V89, P373, DOI 10.1128/JVI.01742-14; Tenev T, 2007, CELL DEATH DIFFER, V14, P1191, DOI 10.1038/sj.cdd.4402118; Theze J, 2015, VIRUSES-BASEL, V7, P1960, DOI 10.3390/v7041960; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517; TWEETEN KA, 1980, J VIROL, V33, P866, DOI 10.1128/JVI.33.2.866-876.1980; TWEETEN KA, 1977, APPL ENVIRON MICROB, V34, P320, DOI 10.1128/AEM.34.3.320-327.1977; TWEETEN KA, 1977, P NATL ACAD SCI USA, V74, P3574, DOI 10.1073/pnas.74.8.3574; VAIL PV, 1993, J STORED PROD RES, V29, P71, DOI 10.1016/0022-474X(93)90024-X; van Oers MM, 2015, J GEN VIROL, V96, P6, DOI 10.1099/vir.0.067108-0; Vanarsdall AL, 2007, VIROLOGY, V367, P187, DOI 10.1016/j.virol.2007.05.003; Vandergaast R, 2015, J VIROL, V89, P4481, DOI 10.1128/JVI.03659-14; WILSON ME, 1985, VIROLOGY, V143, P526, DOI 10.1016/0042-6822(85)90391-5; WINSTANLEY D, 1993, J GEN VIROL, V74, P1599, DOI 10.1099/0022-1317-74-8-1599; Wright CW, 2005, VIROLOGY, V335, P61, DOI 10.1016/j.virol.2005.02.007; Yang ZN, 2008, VIRUS RES, V135, P220, DOI 10.1016/j.virusres.2008.03.016; Yutin N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-161; Zhang BQ, 2012, J VIROL, V86, P9544, DOI 10.1128/JVI.01431-12	78	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160389	10.1371/journal.pone.0160389	http://dx.doi.org/10.1371/journal.pone.0160389			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472489	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516300047
J	Papadodima, O; Moulos, P; Koryllou, A; Piroti, G; Kolisis, F; Chatziioannou, A; Pletsa, V				Papadodima, Olga; Moulos, Panagiotis; Koryllou, Aggeliki; Piroti, Georgia; Kolisis, Fragiskos; Chatziioannou, Aristotelis; Pletsa, Vasiliki			Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to S(N)1 Methylating Agents Treatment	PLOS ONE			English	Article							WHOLE-BRAIN RADIOTHERAPY; PRETREATED PATIENTS; BREAST-CANCER; TEMOZOLOMIDE; EXPRESSION; REPAIR; TRIAL; CHEMOTHERAPY; METASTASES; CASPASE-1		[Papadodima, Olga; Koryllou, Aggeliki; Piroti, Georgia; Chatziioannou, Aristotelis; Pletsa, Vasiliki] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, GR-11635 Athens, Greece; [Moulos, Panagiotis] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Vari 16672, Greece; [Kolisis, Fragiskos] Natl Tech Univ Athens, Sch Chem Engn, Biotechnol Lab, Athens 15780, Greece; [Chatziioannou, Aristotelis] Enios Applicat Private Co, 25 Al Pantou Str, Athens 17671, Greece	National Hellenic Research Foundation; Alexander Fleming Biomedical Sciences Research Center; National Technical University of Athens	Chatziioannou, A; Pletsa, V (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, GR-11635 Athens, Greece.; Chatziioannou, A (corresponding author), Enios Applicat Private Co, 25 Al Pantou Str, Athens 17671, Greece.	achatzi@eie.gr; vpletsa@eie.gr	Papadodima, Olga/AAU-6664-2021; KOLISIS, FRAGKISKOS/GSN-7219-2022; Pletsa, Vassiliki/AHD-0104-2022; Moulos, Panagiotis/E-2335-2018	Moulos, Panagiotis/0000-0002-4199-0333; Papadodima, Olga/0000-0003-3896-4270; Kolisis, Frangiskos/0000-0001-7656-3975; Pletsa, Vasiliki/0000-0003-0245-0083	E.U.-European Social Fund; General Secretariat for Research and Technology; PENED [03/EDelta/322]; PROMISE [12CHN 204]	E.U.-European Social Fund(European Social Fund (ESF)); General Secretariat for Research and Technology(Greek Ministry of Development-GSRT); PENED(Greek Ministry of Development-GSRT); PROMISE	This project was co-financed by E.U.-European Social Fund (75%) and the General Secretariat for Research and Technology (www.gsrt.gr), Greece (25%); PENED 03/E Delta/322 and PROMISE, 12CHN 204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addeo R, 2008, CANCER, V113, P2524, DOI 10.1002/cncr.23859; Adema AD, 2009, J CHEMOTHERAPY, V21, P338, DOI 10.1179/joc.2009.21.3.338; Aguilera-Aguirre L, 2014, J IMMUNOL, V193, P4643, DOI 10.4049/jimmunol.1401625; Aki T, 2015, TOXICOLOGY, V333, P118, DOI 10.1016/j.tox.2015.04.003; Almeida GM, 2008, INT J CANCER, V122, P1810, DOI 10.1002/ijc.23188; Ashwell S, 2008, CLIN CANCER RES, V14, P4032, DOI 10.1158/1078-0432.CCR-07-5138; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Carter CA, 2014, POSTGRAD MED, V126, DOI 10.3810/pgm.2014.11.2842; Chatziioannou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-354; Chatziioannou AA, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00008; Cho EC, 2014, ONCOTARGET, V5, P4834, DOI 10.18632/oncotarget.2044; Cortot AB, 2006, ANN ONCOL, V17, P1412, DOI 10.1093/annonc/mdl146; De Backer O, 1999, CANCER RES, V59, P3157; De Smet C, 1997, BIOCHEM BIOPH RES CO, V241, P653, DOI 10.1006/bbrc.1997.7868; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Eilebrecht S, 2011, RNA BIOL, V8, P1084, DOI 10.4161/rna.8.6.17015; Eilebrecht S, 2011, RNA BIOL, V8, P143, DOI 10.4161/rna.8.1.14261; Fiori V, 2012, ANN I SUPER SANITA, V48, P161, DOI [10.4415/ANN_12_02.09, 10.4415/ANN_12_02_09]; Han Y, 2014, GENET MOL RES, V13, P8913, DOI 10.4238/2014.October.31.6; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Koryllou A, 2009, APOPTOSIS, V14, P1121, DOI 10.1007/s10495-009-0379-x; Kouroussis C, 2009, ONCOLOGY-BASEL, V76, P112, DOI 10.1159/000192586; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Li SQ, 2015, J SURG RES, V193, P255, DOI 10.1016/j.jss.2014.06.055; Lilenbaum RC, 2008, J THORAC ONCOL, V3, pS171, DOI 10.1097/JTO.0b013e318174e942; Lombardi G, 2014, CANCER TREAT REV, V40, P951, DOI 10.1016/j.ctrv.2014.05.007; Martin-Duque P, 2006, INT J MOL MED, V17, P841; Miciak J, 2016, BBA-REV CANCER, V1865, P220, DOI 10.1016/j.bbcan.2016.03.001; Mirzoeva OK, 2006, MOL CANCER THER, V5, P2757, DOI 10.1158/1535-7163.MCT-06-0183; Mostafa AA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00288; Nittka S, 2008, ONCOGENE, V27, P3721, DOI 10.1038/sj.onc.1211033; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; Papadaki C, 2012, J THORAC ONCOL, V7, P663, DOI 10.1097/JTO.0b013e318244bdd4; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Qiu MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077005; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Ryu JS, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2013.12.01; Sculier JP, 2007, EUR RESPIR J, V30, P1186, DOI 10.1183/09031936.00034507; Shen XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069553; Sollberger G, 2014, INNATE IMMUN-LONDON, V20, P115, DOI 10.1177/1753425913484374; Stahel R, 2013, LUNG CANCER, V82, P375, DOI 10.1016/j.lungcan.2013.08.025; Su YL, 2015, CELL PHYSIOL BIOCHEM, V36, P1419, DOI 10.1159/000430307; Surova O, 2013, ONCOGENE, V32, P3789, DOI 10.1038/onc.2012.556; Taguchi A, 2014, CANCER RES, V74, P4694, DOI 10.1158/0008-5472.CAN-13-3725; Tamaskar I, 2008, INVEST NEW DRUG, V26, P553, DOI 10.1007/s10637-008-9153-0; Tolcher AW, 2003, BRIT J CANCER, V88, P1004, DOI 10.1038/sj.bjc.6600827; Tuominen R, 2015, INT J CANCER, V136, P2844, DOI 10.1002/ijc.29332; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Yang Y, 2015, MILITARY MED RES, V2, DOI 10.1186/s40779-015-0039-0; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhou MQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-359; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	54	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160248	10.1371/journal.pone.0160248	http://dx.doi.org/10.1371/journal.pone.0160248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467507	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100138
J	Hongoh, V; Campagna, C; Panic, M; Samuel, O; Gosselin, P; Waaub, JP; Ravel, A; Samoura, K; Michel, P				Hongoh, Valerie; Campagna, Celine; Panic, Mirna; Samuel, Onil; Gosselin, Pierre; Waaub, Jean-Philippe; Ravel, Andre; Samoura, Karim; Michel, Pascal			Assessing Interventions to Manage West Nile Virus Using Multi-Criteria Decision Analysis with Risk Scenarios	PLOS ONE			English	Article							CLIMATE-CHANGE; CULEX-QUINQUEFASCIATUS; NORTH-AMERICA; VECTOR-BORNE; EPIDEMIOLOGY; DYNAMICS; DISEASE; INFECTION; OUTBREAK; FEATURES	The recent emergence of West Nile virus (WNV) in North America highlights vulnerability to climate sensitive diseases and stresses the importance of preventive efforts to reduce their public health impact. Effective prevention involves reducing environmental risk of exposure and increasing adoption of preventive behaviours, both of which depend on knowledge and acceptance of such measures. When making operational decisions about disease prevention and control, public health must take into account a wide range of operational, environmental, social and economic considerations in addition to intervention effectiveness. The current study aimed to identify, assess and rank possible risk reduction measures taking into account a broad set of criteria and perspectives applicable to the management of WNV in Quebec under increasing transmission risk scenarios, some of which may be related to ongoing warming in higher-latitude regions. A participatory approach was used to collect information on categories of concern to relevant stakeholders with respect to WNV prevention and control. Multi-criteria decision analysis was applied to examine stakeholder perspectives and their effect on strategy rankings under increasing transmission risk scenarios. Twenty-three preventive interventions were retained for evaluation using eighteen criteria identified by stakeholders. Combined evaluations revealed that, at an individual-level, inspecting window screen integrity, wearing light colored, long clothing, eliminating peridomestic larval sites and reducing outdoor activities at peak times were top interventions under six WNV transmission scenarios. At a regional-level, the use of larvicides was a preferred strategy in five out of six scenarios, while use of adulticides and dissemination of sterile male mosquitoes were found to be among the least favoured interventions in almost all scenarios. Our findings suggest that continued public health efforts aimed at reinforcing individual-level preventive behaviours combined with the application of larvicides to manage the risk of WNV infection are the interventions most acceptable and effective at reaching current management objectives now and under future theoretical transmission risk.	[Hongoh, Valerie; Samoura, Karim; Michel, Pascal] Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada; [Campagna, Celine; Panic, Mirna; Samuel, Onil; Gosselin, Pierre] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Campagna, Celine] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada; [Panic, Mirna] Publ Hlth Agcy Canada, Canadian Field Epidemiol Program, Ottawa, ON, Canada; [Gosselin, Pierre] Consortium Reg Climatol & Adaptat Climate Change, Ouranos, Montreal, PQ, Canada; [Waaub, Jean-Philippe] Grp Res Decis Anal, Montreal, PQ, Canada; [Hongoh, Valerie; Ravel, Andre] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [Samoura, Karim] Univ Aube Nouvelle, Ouagadougou, Burkina Faso; [Michel, Pascal] Publ Hlth Agcy Canada, Natl Microbiol Lab St Hyacinthe, St Hyacinthe, PQ, Canada	Universite de Montreal; Institut national de sante publique du Quebec (INSPQ); Laval University; Public Health Agency of Canada; Ouranos Consortium; Universite de Montreal; Public Health Agency of Canada	Hongoh, V (corresponding author), Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada.; Hongoh, V (corresponding author), Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada.	valerie.hongoh@umontreal.ca			Canadian Institutes of Health Research; Ouranos Consortium for research in climatology and adaptation to climate change; Strategic Training Program in Global Health Research, CIHR; Quebec Population Health Research Network; Public Health Agency of Canada; Canadian Institutes of Health Research (CIHR); Quebec Population Health Research Network (RRSPQ); IDRC from Canada; CIHR from Canada; NSERC from Canada; SSHRC from Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ouranos Consortium for research in climatology and adaptation to climate change; Strategic Training Program in Global Health Research, CIHR(Canadian Institutes of Health Research (CIHR)); Quebec Population Health Research Network; Public Health Agency of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Quebec Population Health Research Network (RRSPQ); IDRC from Canada; CIHR from Canada(Canadian Institutes of Health Research (CIHR)); NSERC from Canada; SSHRC from Canada	This work was supported by Canadian Institutes of Health Research: Doctoral grant for VH (http://www.cihr-irsc.gc.ca/); Ouranos Consortium for research in climatology and adaptation to climate change: Doctoral grant for VH (http://www.ouranos.ca/); Strategic Training Program in Global Health Research, a partnership of CIHR and the Quebec Population Health Research Network: Doctoral grant for VH (http://www.pifrsm-ghrcaps.org/program.html); and Public Health Agency of Canada funded the project (http://www.phac-aspc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to sincerely thank all stakeholders and experts consulted during this project for their participation and contribution. The authors would also like to thank the Public Health Agency of Canada for funding the project and the Quebec National Institute of Public Health for its collaboration in this project. VH is funded by the Canadian Institutes of Health Research (CIHR), Ouranos Consortium for research in climatology and adaptation to climate change and the Strategic Training Program in Global Health Research, a partnership of CIHR and the Quebec Population Health Research Network (RRSPQ). This project is also nested within the IRIACC-FACE program funded by IDRC, CIHR, NSERC and SSHRC from Canada. The funding sources had no involvement in the actual research or preparation of the paper.	Aenishaenslin C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-897; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309; Tran A, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-26; Bellini R, 2014, PARASITE VECTOR, V7; Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384; Brans JP, 2005, INT SER OPER RES MAN, V78, P163, DOI 10.1007/0-387-23081-5_5; BRANS JP, 1985, MANAGE SCI, V31, P647, DOI 10.1287/mnsc.31.6.647; Bunning ML, 2007, AVIAN DIS, V51, P573, DOI 10.1637/0005-2086(2007)51[573:DVOTAC]2.0.CO;2; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Centers for Disease Control and Prevention, 2015, WEST NIL VIR FEAT CD; Centers For Disease Control and Prevention (CDC), 2015, W NIL VIR; Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1; De Smet Y, 2013, LECT NOTES BUS INF P, V138, P150; El Adlouni S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-40; Gouvernement du Quebec, 2015, PORT SANT MIEUX ETR; Government of Canada, 2015, SURV W NIL VIR; Government of Canada, 2015, PREV W NIL VIR; Greco S, 2000, APPL OPTIM, V45, P295; Grondin J, 2003, VIRUS NIL OCCIDENTAL; Gubler DJ., 2008, VECTOR BORNE DIS UND, P43; Harbison JE, 2010, J MED ENTOMOL, V47, P67, DOI 10.1603/033.047.0109; Harrigan RJ, 2014, GLOBAL CHANGE BIOL, V20, P2417, DOI 10.1111/gcb.12534; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418; Hribar LJ, 2011, J AM MOSQUITO CONTR, V27, P408, DOI 10.2987/11-6171.1; Huang IB, 2011, SCI TOTAL ENVIRON, V409, P3578, DOI 10.1016/j.scitotenv.2011.06.022; Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kilpatrick AM, 2010, VECTOR-BORNE ZOONOT, V10, P377, DOI 10.1089/vbz.2009.0029; Labbe Y, 2006, REV MESURES PREVENTI, P173; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lowe A-M, 2014, RISK LINKED W NILE V, P83; Lund A, 2014, ENVIRON RES, V129, P20, DOI 10.1016/j.envres.2013.12.008; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Ministere de la Sante et des Services sociaux, 2014, PLAN INT GOUV 2013 2; Morestin F, 2011, METHOD FOR SYNTHESIZ; Nasci RS, 2013, W NILE VIRUS US GUID; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Plummer DA, 2006, J CLIMATE, V19, P3112, DOI 10.1175/JCLI3769.1; Rabinowitz P, 2013, ANNU REV PUBL HEALTH, V34, P189, DOI 10.1146/annurev-publhealth-031912-114426; Reisen W, 2007, PEST MANAG SCI, V63, P641, DOI 10.1002/ps.1325; Ricard S, 2003, QUEBEC NATL SANTE PU; Ross W, 2000, HLTH CANADA DECISION; Sawford K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-182; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Stockwell PJ, 2006, J AM MOSQUITO CONTR, V22, P666, DOI 10.2987/8756-971X(2006)22[666:AFEOFL]2.0.CO;2; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; Vazquez-Prokopec GM, 2010, ENVIRON HEALTH PERSP, V118, P1382, DOI 10.1289/ehp.1001939; Venter A, 2001, TRENDS MICROBIOL, V9, P469; Young JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067137	55	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160651	10.1371/journal.pone.0160651	http://dx.doi.org/10.1371/journal.pone.0160651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494136	Green Published, gold, Green Submitted			2022-12-27	WOS:000381369500068
J	Uhl, L; Dukan, S				Uhl, Lionel; Dukan, Sam			Hydrogen Peroxide Induced Cell Death: The Major Defences Relative Roles and Consequences in E-coli	PLOS ONE			English	Article							COUPLED CHEMICAL-REACTIONS; HABER-WEISS CYCLE; DNA DAMAGE; SIMULATION; REPAIR	We recently developed a mathematical model for predicting reactive oxygen species (ROS) concentration and macromolecules oxidation in vivo. We constructed such a model using Escherichia coli as a model organism and a set of ordinary differential equations. In order to evaluate the major defences relative roles against hydrogen peroxide (H2O2), we investigated the relative contributions of the various reactions to the dynamic system and searched for approximate analytical solutions for the explicit expression of changes in H2O2 internal or external concentrations. Although the key actors in cell defence are enzymes and membrane, a detailed analysis shows that their involvement depends on the H2O2 concentration level. Actually, the impact of the membrane upon the H2O2 stress felt by the cell is greater when micromolar H2O2 is present (9-fold less H2O2 in the cell than out of the cell) than when millimolar H2O2 is present (about 2-fold less H2O2 in the cell than out of the cell). The ratio between maximal external H2O2 and internal H2O2 concentration also changes, reducing from 8 to 2 while external H2O2 concentration increases from micromolar to millimolar. This non-linear behaviour mainly occurs because of the switch in the predominant scavenger from Ahp (Alkyl Hydroperoxide Reductase) to Cat (catalase). The phenomenon changes the internal H2O2 maximal concentration, which surprisingly does not depend on cell density. The external H2O2 half-life and the cumulative internal H2O2 exposure do depend upon cell density. Based on these analyses and in order to introduce a concept of dose response relationship for H2O2-induced cell death, we developed the concepts of "maximal internal H2O2 concentration" and "cumulative internal H2O2 concentration" (e.g. the total amount of H2O2). We predict that cumulative internal H2O2 concentration is responsible for the H2O2-mediated death of bacterial cells.	[Uhl, Lionel; Dukan, Sam] Univ Aix Marseille, Inst Microbiol Mediterranee, Lab Chim Bacterienne, CNRS UMR7283, 31 Chemin Joseph Aiguier, F-13009 Marseille, France; [Dukan, Sam] Click4Tag SAS, Grand Luminy Technopole, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Dukan, S (corresponding author), Univ Aix Marseille, Inst Microbiol Mediterranee, Lab Chim Bacterienne, CNRS UMR7283, 31 Chemin Joseph Aiguier, F-13009 Marseille, France.; Dukan, S (corresponding author), Click4Tag SAS, Grand Luminy Technopole, F-13288 Marseille 09, France.	sdukan@imm.cnrs.fr		UHL, Lionel/0000-0003-0201-6367	ANR (Agence National de la Recherchegrant) [ANR-12-BS07-0022 ROSAS]	ANR (Agence National de la Recherchegrant)(French National Research Agency (ANR))	This work was supported by ANR (Agence National de la Recherchegrant) (ANR-12-BS07-0022 ROSAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Dart RC, 2006, CLIN TOXICOL, V44, P1, DOI 10.1080/15563650500394571; DEMPLE B, 1983, NATURE, V304, P466, DOI 10.1038/304466a0; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Harrison J, 2007, J RADIOL PROT, V27, P17, DOI 10.1088/0952-4746/27/1/001; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; IMLAY JA, 1991, J BIOL CHEM, V266, P6957; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; Koppenol WH, 2001, REDOX REP, V6, P229, DOI 10.1179/135100001101536373; Lin K, 2011, AM J PHARM EDUC, V75, DOI 10.5688/ajpe7510209; Liochev SI, 2002, REDOX REP, V7, P55, DOI 10.1179/135100002125000190; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Polynikis A, 2009, J THEOR BIOL, V261, P511, DOI 10.1016/j.jtbi.2009.07.040; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Uhl L, 2015, HELIYON, V1, DOI 10.1016/j.heliyon.2015.e00049; Verhulst P., 1845, ACAD R SCI METR BR 2, V18, P1; Verhulst P.F., 1847, MEMOIRES ACAD ROYALE, V20, P1	22	17	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0159706	10.1371/journal.pone.0159706	http://dx.doi.org/10.1371/journal.pone.0159706			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494019	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500013
J	Dondzillo, A; Thompson, JA; Klug, A				Dondzillo, Anna; Thompson, John A.; Klug, Achim			Recurrent Inhibition to the Medial Nucleus of the Trapezoid Body in the Mongolian Gerbil (Meriones Unguiculatus)	PLOS ONE			English	Article							SUPERIOR OLIVARY COMPLEX; GLYCINE RECEPTOR COMPLEX; VENTRAL COCHLEAR NUCLEUS; BUSHY CELL AXONS; PRINCIPAL CELLS; BRAIN-STEM; POSTNATAL-DEVELOPMENT; AFFERENT-PROJECTIONS; AUDITORY SYNAPSE; HELD SYNAPSE	Principal neurons in the medial nucleus of the trapezoid body (MNTB) receive strong and temporally precise excitatory input from globular bushy cells in the cochlear nucleus through the calyx of Held. The extremely large synaptic currents produced by the calyx have sometimes led to the view of the MNTB as a simple relay synapse which converts incoming excitation to outgoing inhibition. However, electrophysiological and anatomical studies have shown the additional presence of inhibitory glycinergic currents that are large enough to suppress action potentials in MNTB neurons at least in some cases. The source(s) of glycinergic inhibition to MNTB are not fully understood. One major extrinsic source of glycinergic inhibitory input to MNTB is the ventral nucleus of the trapezoid body. However, it has been suggested that MNTB neurons receive additional inhibitory inputs via intrinsic connections (collaterals of glycinergic projections of MNTB neurons). While several authors have postulated their presence, these collaterals have never been examined in detail. Here we test the hypothesis that collaterals of MNTB principal cells provide glycinergic inhibition to the MNTB. We injected dye into single principal neurons in the MNTB, traced their projections, and immunohistochemically identified their synapses. We found that collaterals terminate within the MNTB and provide an additional source of inhibition to other principal cells, creating an inhibitory microcircuit within the MNTB. Only about a quarter to a third of MNTB neurons receive such collateral inputs. This microcircuit could produce side band inhibition and enhance frequency tuning of MNTB neurons, consistent with physiological observations.	[Dondzillo, Anna; Klug, Achim] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA; [Thompson, John A.] Univ Colorado, Sch Med, Dept Neurosurg, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Dondzillo, A (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA.	anna.dondzillo@ucdenver.edu	Klug, Achim/N-6956-2014; Thompson, John A/T-6194-2019	Klug, Achim/0000-0002-3383-850X; Thompson, John A/0000-0003-2991-5194	NIH/NIDCD [R01 DC 011582]; Rocky Mountain Neurological Disorders Core Center Grant NIH [P30NS048154]; NIH/NCRR Colorado CTSI [UL1 RR025780]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011582] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Rocky Mountain Neurological Disorders Core Center Grant NIH; NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH/NIDCD R01 DC 011582 to A.K., and in part by the Rocky Mountain Neurological Disorders Core Center Grant NIH P30NS048154. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advanced Light Microscopy Core supported in part by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780.; Supported by NIH/NIDCD R01 DC 011582 to A.K., and in part by the Rocky Mountain Neurological Disorders Core Center Grant NIH P30NS048154. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advanced Light Microscopy Core supported in part by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780. We would also like to thank Dr. Tom Finger for many helpful discussions, and Dr. Jennifer Stratford for sharing her expertise in neuroanatomical tracing and immunohistochemical techniques. Drs. Elizabeth McCullagh and Daniel Tollin provided helpful suggestions for improving earlier versions of this manuscript.	Albrecht O, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00083; ALTSCHULER RA, 1986, BRAIN RES, V369, P316, DOI 10.1016/0006-8993(86)90542-1; Ashida G, 2011, CURR OPIN NEUROBIOL, V21, P745, DOI 10.1016/j.conb.2011.05.008; Awatramani GB, 2005, J NEUROPHYSIOL, V93, P819, DOI 10.1152/jn.00798.2004; Awatramani GB, 2004, J NEUROSCI, V24, P2643, DOI 10.1523/JNEUROSCI.5144-03.2004; Baer K, 2003, NEUROSCIENCE, V122, P773, DOI 10.1016/S0306-4522(03)00543-8; BANKS MI, 1992, J NEUROSCI, V12, P2819; BECKER CM, 1989, J NEUROCHEM, V53, P124, DOI 10.1111/j.1471-4159.1989.tb07303.x; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Borst JGG, 2012, ANNU REV PHYSIOL, V74, P199, DOI 10.1146/annurev-physiol-020911-153236; CASEY MA, 1985, J COMP NEUROL, V232, P401, DOI 10.1002/cne.902320311; ELVERLAND HH, 1978, EXP BRAIN RES, V32, P117; Fischer F, 2000, J COMP NEUROL, V427, P634, DOI 10.1002/1096-9861(20001127)427:4<634::AID-CNE10>3.0.CO;2-X; FRIAUF E, 1988, EXP BRAIN RES, V73, P263; Green JS, 2005, J NEUROPHYSIOL, V94, P3826, DOI 10.1152/jn.00601.2005; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; HARRISON JM, 1962, J COMP NEUROL, V119, P341, DOI 10.1002/cne.901190306; Held H, 1893, ARCH ANAT PHYSL ANAT; HELFERT RH, 1989, BRAIN RES, V501, P269, DOI 10.1016/0006-8993(89)90644-6; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Hoffpauir BK, 2009, BRAIN RES, V1277, P115, DOI 10.1016/j.brainres.2009.02.050; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; KIRSCH J, 1993, BRAIN RES, V621, P301, DOI 10.1016/0006-8993(93)90120-C; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V157, P432, DOI 10.1016/j.neuroscience.2008.08.068; Kota K, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00144; KUWABARA N, 1991, J COMP NEUROL, V314, P684, DOI 10.1002/cne.903140405; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Lu T, 2008, NEURON, V57, P524, DOI 10.1016/j.neuron.2007.12.010; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; Maklad A, 2003, BRAIN RES BULL, V60, P497, DOI 10.1016/S0361-9230(03)00054-6; Mayer F, 2014, J NEUROPHYSIOL, V112, P2901, DOI 10.1152/jn.00864.2013; MOREST D. KENT, 1968, BRAIN RES, V9, P288, DOI 10.1016/0006-8993(68)90235-7; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Rodriguez-Contreras A, 2006, J COMP NEUROL, V496, P214, DOI 10.1002/cne.20918; SANES DH, 1991, J NEUROBIOL, V22, P837, DOI 10.1002/neu.480220805; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; SOMMER I, 1993, EXP BRAIN RES, V95, P223; SPANGLER KM, 1985, J COMP NEUROL, V238, P249, DOI 10.1002/cne.902380302; SPIROU GA, 1990, J NEUROPHYSIOL, V63, P1169, DOI 10.1152/jn.1990.63.5.1169; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Thompson AM, 2000, MICROSC RES TECHNIQ, V51, P330, DOI 10.1002/1097-0029(20001115)51:4<330::AID-JEMT4>3.0.CO;2-X; Tollin DJ, 2005, J NEUROSCI, V25, P10648, DOI 10.1523/JNEUROSCI.1609-05.2005; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; Turecek R, 2002, P NATL ACAD SCI USA, V99, P13884, DOI 10.1073/pnas.212419699; WARR WB, 1972, BRAIN RES, V40, P247	53	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160241	10.1371/journal.pone.0160241	http://dx.doi.org/10.1371/journal.pone.0160241			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27489949	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900041
J	Huang, CX; Cao, J; Wen, FH; Yang, XG				Huang, Chuangxia; Cao, Jie; Wen, Fenghua; Yang, Xiaoguang			Stability Analysis of SIR Model with Distributed Delay on Complex Networks	PLOS ONE			English	Article							BASIC REPRODUCTION NUMBER; EPIDEMIC MODEL; GLOBAL STABILITY; INFECTIVE VECTOR; TIME-DELAY; TRANSMISSION; OUTBREAKS	In this paper, by taking full consideration of distributed delay, demographics and contact heterogeneity of the individuals, we present a detailed analytical study of the Susceptible-Infected- Removed (SIR) epidemic model on complex population networks. The basic reproduction number R-0 of the model is dominated by the topology of the underlying network, the properties of individuals which include birth rate, death rate, removed rate and infected rate, and continuously distributed time delay. By constructing suitable Lyapunov functional and employing Kirchhoff's matrix tree theorem, we investigate the globally asymptotical stability of the disease-free and endemic equilibrium points. Specifically, the system shows threshold behaviors: if R-0 <= 1, then the disease-free equilibrium is globally asymptotically stable, otherwise the endemic equilibrium is globally asymptotically stable. Furthermore, the obtained results show that SIR models with different types of delays have different converge time in the process of contagion: if R-0 > 1, then the system with distributed time delay stabilizes fastest; while R-0 <= 1, the system with distributed time delay converges most slowly. The validness and effectiveness of these results are demonstrated through numerical simulations.	[Huang, Chuangxia; Cao, Jie] Changsha Univ Sci & Technol, Sch Math & Stat, Changsha 410114, Hunan, Peoples R China; [Huang, Chuangxia; Yang, Xiaoguang] Chinese Acad Sci, Acad Math & Syst Sci, Beijing 10090, Peoples R China; [Wen, Fenghua] Cent South Univ, Sch Business, Changsha 410083, Hunan, Peoples R China	Changsha University of Science & Technology; Chinese Academy of Sciences; Central South University	Wen, FH (corresponding author), Cent South Univ, Sch Business, Changsha 410083, Hunan, Peoples R China.	mailtowfh@126.com	Wen, Fenghua/ABD-5745-2021	WEN, Fenghua/0000-0003-2991-3981	National Natural Science Foundation of China [11101053, 71371195, 71431008, 71471020, 71532013]; China Postdoctoral Science Foundation [2014M550097, 2015T80144]; Hunan Provincial Natural Science Foundation of China [PLOS 17/20, 2016JJ1001]; Scientific Research Fund of Hunan Provincial Education Department [15A003]; Hunan Provincial Innovation Foundation for Postgraduate [CX2015B373]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Hunan Provincial Innovation Foundation for Postgraduate	The work is partially supported by the National Natural Science Foundation of China (Nos. 11101053, 71371195, 71431008, 71471020, and 71532013); China Postdoctoral Science Foundation (Nos. 2014M550097 and 2015T80144); Hunan Provincial Natural Science Foundation of China (No. PLOS 17/20, 2016JJ1001); Scientific Research Fund of Hunan Provincial Education Department (No. 15A003); and Hunan Provincial Innovation Foundation for Postgraduate (No. CX2015B373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178701; BERETTA E, 1995, J MATH BIOL, V33, P250, DOI 10.1007/BF00169563; Castren O, 2014, J BANK FINANC, V46, P43, DOI 10.1016/j.jbankfin.2014.04.027; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cooke K. L., 1979, ROCKY MT J MATH, V9, P31, DOI [10.1216/RMJ-1979-9-1-31, DOI 10.1216/RMJ-1979-9-1-31]; Cui A X, 2014, CHAOS, V24, P5880; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Guo HB, 2008, P AM MATH SOC, V136, P2793, DOI 10.1090/S0002-9939-08-09341-6; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Huang CX, 2014, J DIFFER EQUATIONS, V256, P2101, DOI 10.1016/j.jde.2013.12.015; Huang CX, 2011, IEEE T NEURAL NETWOR, V22, P561, DOI 10.1109/TNN.2011.2109012; Kang HY, 2015, COMMUN NONLINEAR SCI, V27, P30, DOI 10.1016/j.cnsns.2015.02.018; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Li MY, 2010, J MATH ANAL APPL, V361, P38, DOI 10.1016/j.jmaa.2009.09.017; Li MY, 2010, J DIFFER EQUATIONS, V248, P1, DOI 10.1016/j.jde.2009.09.003; Liu QM, 2014, PHYSICA A, V410, P79, DOI 10.1016/j.physa.2014.05.010; Ma WB, 2002, TOHOKU MATH J, V54, P581, DOI 10.2748/tmj/1113247650; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; McCluskey CC, 2010, MATH BIOSCI ENG, V7, P837, DOI 10.3934/mbe.2010.7.837; McCluskey CC, 2010, NONLINEAR ANAL-REAL, V11, P55, DOI 10.1016/j.nonrwa.2008.10.014; Mei S, 2015, APPL SOFT COMPUT, V37, P311, DOI 10.1016/j.asoc.2015.08.010; Moon JW, 1970, CANADIAN MATHEMATICA; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Muroya Y, 2015, J MATH ANAL APPL, V425, P415, DOI 10.1016/j.jmaa.2014.12.019; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Schimit PHT, 2009, ECOL MODEL, V220, P1034, DOI 10.1016/j.ecolmodel.2009.01.014; Small M, 2005, INT J BIFURCAT CHAOS, V15, P1745, DOI 10.1142/S0218127405012776; Small M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.188702; Strickland C, 2015, ECOL MODEL, V309, P1, DOI 10.1016/j.ecolmodel.2015.04.010; Wang JR, 2014, PHYSICA A, V410, P268, DOI 10.1016/j.physa.2014.05.011; Wang Y, 2015, PHYSICA A, V437, P75, DOI 10.1016/j.physa.2015.05.103; Wang Y, 2012, NONLINEAR ANAL-REAL, V13, P543, DOI 10.1016/j.nonrwa.2011.07.033; Xia Cheng-yi, 2009, Journal of China Universities of Posts and Telecommunications, V16, P27, DOI 10.1016/S1005-8885(08)60173-9; Yang HM, 2014, BIOSYSTEMS, V126, P52, DOI 10.1016/j.biosystems.2014.10.002; Yorke J.-A., 1967, MATH SYST THEORY, V1, P353, DOI DOI 10.1007/BF01695169; Zhang JP, 2011, APPL MATH COMPUT, V217, P7053, DOI 10.1016/j.amc.2010.09.063; Zhang RX, 2015, APPL MATH COMPUT, V263, P342, DOI 10.1016/j.amc.2015.04.074; Zhao ZD, 2012, CHAOS, V22, DOI 10.1063/1.4730750; Zhu GH, 2015, COMMUN NONLINEAR SCI, V20, P240, DOI 10.1016/j.cnsns.2014.04.023	43	51	53	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0158813	10.1371/journal.pone.0158813	http://dx.doi.org/10.1371/journal.pone.0158813			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490363	Green Submitted, gold, Green Published			2022-12-27	WOS:000381368900009
J	Khan, HH; Ahmad, RB; Gee, CS				Khan, Habib Hussain; Ahmad, Rubi Binit; Gee, Chan Sok			Market Structure, Financial Dependence and Industrial Growth: Evidence from the Banking Industry in Emerging Asian Economies	PLOS ONE			English	Article							LENDING CHANNEL; RISK-TAKING; COMPETITION; EFFICIENCY; ENTRY; TRANSMISSION; INTEGRATION; STABILITY; BEHAVIOR; SECTOR	In this study, we examine the role of market structure for growth in financially dependent industries from 10 emerging Asian economies over the period of 1995-2011. Our approach departs from existing studies in that we apply four alternative measures of market structure based on structural and non-structural approaches and compare their outcomes. Results indicate that higher bank concentration may slow down the growth of financially dependent industries. Bank competition on the other hand, allows financially dependent industries to grow faster. These findings are consistent across a number of sensitivity checks such as alternative measures of financial dependence, institutional factors (including property rights, quality of accounting standards and bank ownership), and endogeneity consideration. In sum, our study suggests that financially dependent industries grow more in more competitive/less concentrated banking systems. Therefore, regulatory authorities need to be careful while pursuing a consolidation policy for banking sector in emerging Asian economies.	[Khan, Habib Hussain; Ahmad, Rubi Binit; Gee, Chan Sok] Univ Malaya, Fac Business & Accountancy, Dept Finance & Banking, Kuala Lumpur, Malaysia	Universiti Malaya	Khan, HH (corresponding author), Univ Malaya, Fac Business & Accountancy, Dept Finance & Banking, Kuala Lumpur, Malaysia.	habib.suduzai@gmail.com	Khan, Habib Hussain/AET-0812-2022; Khan, Habib Hussain/AAF-6995-2022	Khan, Habib Hussain/0000-0002-9407-9797; Khan, Habib Hussain/0000-0002-9407-9797				Agenor PR, 2003, WORLD ECON, V26, P1089, DOI 10.1111/1467-9701.00564; Allen F, 2004, J MONEY CREDIT BANK, V36, P453, DOI 10.1353/mcb.2004.0038; Allen F., 2000, COMP FINANCIAL SYSTE; Ariff M, 2008, CHINA ECON REV, V19, P260, DOI 10.1016/j.chieco.2007.04.001; Baharumshah AZ, 2006, CHINA ECON REV, V17, P70, DOI 10.1016/j.chieco.2005.09.001; Beck T, 2006, J BANK FINANC, V30, P1581, DOI 10.1016/j.jbankfin.2005.05.010; Beck T, 2003, J FINANC ECON, V70, P137, DOI 10.1016/S0304-405X(03)00144-2; Beck T, 2004, J MONEY CREDIT BANK, V36, P627, DOI 10.1353/mcb.2004.0039; Berger A.N., 2004, J FINANC SERV RES, V25, P169, DOI [10.1023/B:FINA.0000020659.33510.b7, DOI 10.1023/B:FINA.0000020659.33510.B7]; Berger AN, 2009, J FINANC SERV RES, V35, P99, DOI 10.1007/s10693-008-0050-7; Berger AN, 2004, J MONEY CREDIT BANK, V36, P433, DOI 10.1353/mcb.2004.0040; Bikker JA, 2002, J BANK FINANC, V26, P2191, DOI 10.1016/S0378-4266(02)00205-4; Blackburn K, 1998, ECONOMICA, V65, P107, DOI 10.1111/1468-0335.00116; Boone J, 2008, ECON J, V118, P1245, DOI 10.1111/j.1468-0297.2008.02168.x; Boyd JH, 2005, J FINANC, V60, P1329, DOI 10.1111/j.1540-6261.2005.00763.x; Carbo S, 2009, J INT MONEY FINANC, V28, P115, DOI 10.1016/j.jimonfin.2008.06.005; Cetorelli N, 2001, J FINANC, V56, P617, DOI 10.1111/0022-1082.00339; Cetorelli N, 2006, J FINANC, V61, P437, DOI 10.1111/j.1540-6261.2006.00841.x; Chan KS, 2012, CHINA ECON REV, V23, P482, DOI 10.1016/j.chieco.2012.03.009; Chen XG, 2005, CHINA ECON REV, V16, P229, DOI 10.1016/j.chieco.2005.02.001; Claessens S, 2005, J EUR ECON ASSOC, V3, P179, DOI 10.1162/1542476053295322; Clerides S., 2015, FINANCIAL MARKETS I, V24, P267, DOI [10.1111/fmii.12030, DOI 10.1111/FMII.12030]; de Blas B, 2013, INT REV ECON FINANC, V26, P4, DOI 10.1016/j.iref.2012.08.005; De Haas R, 2013, REV FINANC STUD, V26, P244, DOI 10.1093/rfs/hhs113; Deidda L, 2005, MACROECON DYN, V9, P198, DOI 10.1017/S1365100505040174; delaFuente A, 1996, J MONETARY ECON, V38, P269, DOI 10.1016/S0304-3932(96)01277-9; Dell'Ariccia G, 2000, 0010 CTR FIN I WHART; Di Patti EB, 2004, J MONEY CREDIT BANK, V36, P225, DOI 10.1353/mcb.2004.0011; Fisman R, 2007, J EUR ECON ASSOC, V5, P470, DOI 10.1162/jeea.2007.5.2-3.470; Fu XQ, 2007, CHINA ECON REV, V18, P35, DOI 10.1016/j.chieco.2006.10.002; Fu XQ, 2014, J BANK FINANC, V38, P64, DOI 10.1016/j.jbankfin.2013.09.012; Fungacova Z, 2013, CHINA ECON REV, V27, P121, DOI 10.1016/j.chieco.2013.09.004; Giannetti M, 2009, REV FINANC, V13, P181, DOI 10.1093/rof/rfm019; Gormley TA, 2010, J FINANC INTERMED, V19, P26, DOI 10.1016/j.jfi.2009.01.003; Guzman MG, 2000, ECON THEOR, V16, P421, DOI 10.1007/PL00004091; Hao C, 2006, CHINA ECON REV, V17, P347, DOI 10.1016/j.chieco.2006.01.001; Hoxha I, 2013, INT REV ECON FINANC, V27, P432, DOI 10.1016/j.iref.2013.01.004; Hsiao C, 2015, CHINA ECON REV, V35, P70, DOI 10.1016/j.chieco.2015.05.006; Ivashina Victoria, 2010, J FINANC ECON, V97, P319, DOI DOI 10.1016/J.JFINEC0.2009.12.001; Kawana T, 2007, FINANCIAL RES TRAINI; Khan HH, 2016, INT REV ECON FINANC, V44, P19, DOI 10.1016/j.iref.2016.03.003; KING RG, 1993, J MONETARY ECON, V32, P513, DOI 10.1016/0304-3932(93)90028-E; Lensink R, 2004, J BANK FINANC, V28, P553, DOI 10.1016/S0378-4266(02)00393-X; Leon F., 2015, ETUDES DOCUMENTS; Lerner AP, 1933, REV ECON STUD, V1, P157; Levine R, 1998, AM ECON REV, V88, P537; Li Q, 2013, CHINA ECON REV, V24, P26, DOI 10.1016/j.chieco.2012.10.002; Liang Q, 2006, CHINA ECON REV, V17, P395, DOI 10.1016/j.chieco.2005.09.003; Liu G, 2014, ECON LETT, V124, P60, DOI 10.1016/j.econlet.2014.04.016; Love I, 2006, Q REV ECON FINANC, V46, P190, DOI 10.1016/j.qref.2005.11.007; Marquez R, 2002, REV FINANC STUD, V15, P901, DOI 10.1093/rfs/15.3.901; MAYER C, 1988, EUR ECON REV, V32, P1167, DOI 10.1016/0014-2921(88)90077-3; Mirzaei A, 2013, J BANK FINANC, V37, P2920, DOI 10.1016/j.jbankfin.2013.04.031; Mitchener KJ, 2013, EXPLOR ECON HIST, V50, P161, DOI 10.1016/j.eeh.2012.09.004; Naz I., 2016, J INT FINANCIAL MARK; Northcott C. A., 2004, WORKING PAPER, P2004; Olivero MP, 2011, J INT MONEY FINANC, V30, P1034, DOI 10.1016/j.jimonfin.2011.06.006; Olivero MP, 2011, J BANK FINANC, V35, P560, DOI 10.1016/j.jbankfin.2010.08.004; PAGANO M, 1993, EUR ECON REV, V37, P613, DOI 10.1016/0014-2921(93)90051-B; PANZAR JC, 1987, J IND ECON, V35, P443, DOI 10.2307/2098582; PETERSEN MA, 1995, THE QUARTERLY JOURNA, P407; Rajan RG, 1998, AM ECON REV, V88, P559; Rice T, 2010, J FINANC, V65, P861, DOI 10.1111/j.1540-6261.2010.01555.x; Rustomjee Zavareh, SSRN ELECT J, DOI [10.2139/ssrn.3269724, DOI 10.2139/SSRN.1032162]; Schaeck K, 2014, FINANC MANAGE, V43, P215, DOI 10.1111/fima.12010; Windmeijer F, 2005, J ECONOMETRICS, V126, P25, DOI 10.1016/j.jeconom.2004.02.005; Zarutskie R, 2006, J FINANC ECON, V81, P503, DOI 10.1016/j.jfineco.2005.07.008; Zhang JH, 2012, CHINA ECON REV, V23, P284, DOI 10.1016/j.chieco.2011.12.001; Zhang J, 2012, J COMP ECON, V40, P393, DOI 10.1016/j.jce.2012.01.001	69	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160452	10.1371/journal.pone.0160452	http://dx.doi.org/10.1371/journal.pone.0160452			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490847	gold, Green Published			2022-12-27	WOS:000381368900058
J	Naylor, JM; Descallar, J; Grootemaat, M; Badge, H; Harris, IA; Simpson, G; Jenkin, D				Naylor, Justine M.; Descallar, Joseph; Grootemaat, Mechteld; Badge, Helen; Harris, Ian A.; Simpson, Grahame; Jenkin, Deanne			Is Satisfaction with the Acute-Care Experience Higher amongst Consumers Treated in the Private Sector? A Survey of Public and Private Sector Arthroplasty Recipients	PLOS ONE			English	Article							PATIENT-SATISFACTION; HEALTH-CARE; MEDICAL-CARE; TOTAL HIP; KNEE ARTHROPLASTY; REPLACEMENT; AGREEMENT; KAPPA; HOSPITALS	Background Consumer satisfaction with the acute-care experience could reasonably be expected to be higher amongst those treated in the private sector compared to those treated in the public sector given the former relies on high-level satisfaction of its consumers and their subsequent recommendations to thrive. The primary aims of this study were to determine, in a knee or hip arthroplasty cohort, if surgery in the private sector predicts greater overall satisfaction with the acute-care experience and greater likelihood to recommend the same hospital. A secondary aim was to determine whether satisfaction across a range of service domains is also higher in the private sector. Methods A telephone survey was conducted 35 days post-surgery. The hospital cohort comprised eight public and seven private high-volume arthroplasty providers. Consumers rated overall satisfaction with care out of 100 and likeliness to recommend their hospital on a 5-point Likert scale. Additional Likert-style questions were asked covering specific service domains. Generalized estimating equation models were used to analyse overall satisfaction (dichotomised as >= 90 or < 90) and future recommendations for care (dichotomised as 'definitely recommend' or 'other'), whilst controlling for covariates. The proportions of consumers in each sector reporting the best Likert response for each individual domain were compared using non-parametric tests. Results 457 survey respondents (n = 210 private) were included. Less patient-reported joint impairment pre-surgery [OR 1.03 (95% CI 1.01-1.05)] and absence of an acute complication (OR 2.13 95% CI 1.41-3.23) significantly predicted higher overall satisfaction. Hip arthroplasty [OR 1.84 (1.1-2.96)] and an absence of an acute complication [OR 2.31 (1.28-4.17] significantly predicted greater likelihood for recommending the hospital. The only care domains where the private out-performed the public sector were hospitality (46.7 vs 35.6%, p <0.01) and frequency of surgeon visitation (76.4 vs 65.8%, p = 0.03). Conclusions Arthroplasty consumers treated in the private sector are not more satisfied with their acute-care experience nor are they more likely to recommend their hospital provider. Rather, avoidance of complications in either sector appears to result in improved satisfaction as well as a greater likelihood that patients would recommend their hospital provider.	[Naylor, Justine M.; Badge, Helen; Harris, Ian A.; Jenkin, Deanne] Liverpool Hosp, Dept Orthopaed, Liverpool, NSW, Australia; [Naylor, Justine M.; Descallar, Joseph; Badge, Helen; Harris, Ian A.; Jenkin, Deanne] UNSW, South West Clin Sch, Randwick, NSW, Australia; [Naylor, Justine M.; Descallar, Joseph; Badge, Helen; Harris, Ian A.; Simpson, Grahame; Jenkin, Deanne] Ingham Inst Appl Med Hlth Res, Liverpool, NSW, Australia; [Grootemaat, Mechteld] Univ Amsterdam, Amsterdam, Netherlands; [Simpson, Grahame] Liverpool Hosp, Brain Injury Rehabil Unit, Liverpool, NSW, Australia; [Simpson, Grahame] Griffith Univ, Sch Human Serv & Social Work, Gold Coast, Qld, Australia; [Simpson, Grahame] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia	Liverpool Hospital; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; University of Amsterdam; Liverpool Hospital; Griffith University; University of Sydney	Naylor, JM (corresponding author), Liverpool Hosp, Dept Orthopaed, Liverpool, NSW, Australia.	Justine.Naylor@sswahs.nsw.gov.au	Naylor, Justine/R-8459-2019; Simpson, Grahame K/W-1074-2019	Naylor, Justine/0000-0002-9147-1312; Simpson, Grahame K/0000-0001-8156-9060; Badge, Helen/0000-0002-5351-393X; Jenkin, Deanne/0000-0002-5541-9015	HCF Research Foundation [IHIIAMR2012073043]	HCF Research Foundation	This work was supported by HCF Research Foundation IHIIAMR2012073043 (JN, IH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 1301 0 YB AUSTR 2009; Adie S, 2012, ANZ J SURG, V82, P616, DOI 10.1111/j.1445-2197.2012.06113.x; Altman DG., 1999, PRACTICAL STAT MED R; Australian Commission on Safety and Quality in Health Care, 2012, REV PAT EXP SAT SURV; Australian Orthopaedic Association National Joint Replacement Registry, 2013, ANN REPORT; Bannigan K, 2009, J CLIN NURS, V18, P3237, DOI 10.1111/j.1365-2702.2009.02939.x; Baumann C, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-150; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Bourne RB, 2010, CLIN ORTHOP RELAT R, V468, P57, DOI 10.1007/s11999-009-1119-9; Bradbury KJ, 2013, J HEALTH PSYCHOL, V18, P1307, DOI 10.1177/1359105312465101; Brokelman RBG, 2003, J BONE JOINT SURG BR, V85B, P495, DOI 10.1302/0301-620X.85B4.13411; Bullens PHJ, 2001, J ARTHROPLASTY, V16, P740, DOI 10.1054/arth.2001.23922; Cheung K, 2009, USER GUIDE BASIC INF; Clavien PA, 2009, ANN SURG, V250, P197, DOI 10.1097/SLA.0b013e3181b6dcab; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Davis K, 2002, HLTH AFF MILLWOOD S; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Draper M, 2001, INT J QUAL HEALTH C, V13, P463, DOI 10.1093/intqhc/13.6.463; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; HALL JA, 1990, SOC SCI MED, V30, P811, DOI 10.1016/0277-9536(90)90205-7; HALL JA, 1988, SOC SCI MED, V27, P935, DOI 10.1016/0277-9536(88)90284-5; Hamilton DF, 2014, BONE JOINT J, V96B, P622, DOI 10.1302/0301-620X.96B5.32434; Hamilton DF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002525; Huynh HP, 2014, J SURG RES, V192, P339, DOI 10.1016/j.jss.2014.05.086; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Katz JN, 2003, ARTHRITIS RHEUM, V48, P560, DOI 10.1002/art.10754; Katz MH, 1997, J ACQ IMMUN DEF SYND, V14, P35, DOI 10.1097/00042560-199701010-00007; Kennedy GD, 2014, ANN SURG, V260, P592, DOI 10.1097/SLA.0000000000000932; Khattak A, 2012, INT J COLLAB RES INT, V4, P713; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Murray DW, 2007, J BONE JOINT SURG BR, V89B, P1010, DOI 10.1302/0301-620X.89B8; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pager CK, 2004, CLIN EXP OPHTHALMOL, V32, P482, DOI 10.1111/j.1442-9071.2004.00868.x; Robertsson O, 2000, ACTA ORTHOP SCAND, V71, P262, DOI 10.1080/000164700317411852; Suki NM, 2011, INT J HEALTH CARE Q, V24, P42, DOI 10.1108/09526861111098238; Tateke T, 2012, AFRICAN J PRIMARY HL, V4; Thompson LA, 2009, PEDIATRICS S, V24, pS420; Tolley E, 1997, PUBLIC PRIVATE SECTO; Tooth LR, 2004, ARCH PHYS MED REHAB, V85, P1371, DOI 10.1016/j.apmr.2003.12.002; Tsai TC, 2015, ANN SURG, V261, P2, DOI 10.1097/SLA.0000000000000765; Viera AJ, 2005, FAM MED, V37, P360	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159799	10.1371/journal.pone.0159799	http://dx.doi.org/10.1371/journal.pone.0159799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490358	Green Published, Green Submitted, gold			2022-12-27	WOS:000381368900018
J	Lu, J; Guo, JH; Tu, XL; Zhang, C; Zhao, M; Zhang, QW; Gao, FH				Lu, Jing; Guo, Jia-Hui; Tu, Xue-Liang; Zhang, Chao; Zhao, Mei; Zhang, Quan-Wu; Gao, Feng-Hou			Tiron Inhibits UVB-Induced AP-1 Binding Sites Transcriptional Activation on MMP-1 and MMP-3 Promoters by MAPK Signaling Pathway in Human Dermal Fibroblasts	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN SKIN; C-JUN; SODIUM 4,5-DIHYDROXYBENZENE-1,3-DISULFONATE; PROTEIN-KINASES; EXPRESSION; INDUCTION; MECHANISMS; PREVENTION; TOXICITY	Recent research found that Tiron was an effective antioxidant that could act as the intracellular reactive oxygen species (ROS) scavenger or alleviate the acute toxic metal overload in vivo. In this study, we investigated the inhibitory effect of Tiron on matrix metalloproteinase (MMP)-1 and MMP-3 expression in human dermal fibroblast cells. Western blot and ELISA analysis revealed that Tiron inhibited ultraviolet B (UVB)-induced protein expression of MMP-1 and MMP-3. Real-time quantitative PCR confirmed that Tiron could inhibit UVB-induced mRNA expression of MMP-1 and MMP-3. Furthermore, Tiron significantly blocked UVB-induced activation of the MAPK signaling pathway and activator protein (AP)-1 in the downstream of this transduction pathway in fibroblasts. Through the AP-1 binding site mutation, it was found that Tiron could inhibit AP-1-induced upregulation of MMP-1 and MMP-3 expression through blocking AP-1 binding to the AP-1 binding sites in the MMP-1 and MMP-3 promoter region. In conclusion, Tiron may be a novel antioxidant for preventing and treating skin photoaging UV-induced.	[Lu, Jing; Guo, Jia-Hui; Zhang, Chao; Gao, Feng-Hou] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst Oncol, Shanghai, Peoples R China; [Tu, Xue-Liang] Attached Henan Univ Sci & Technol, Yellow River Hosp, Sanmeixia, Peoples R China; [Zhao, Mei] Tongji Univ, Sch Med, Shanghai Matern & Infant Hosp 1, Dept Reprod Med, Shanghai, Peoples R China; [Zhang, Quan-Wu] Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Pathol, Zhengzhou, Peoples R China	Shanghai Jiao Tong University; Tongji University; Zhengzhou University	Gao, FH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Inst Oncol, Shanghai, Peoples R China.; Zhang, QW (corresponding author), Zhengzhou Univ, Zhengzhou Cent Hosp, Dept Pathol, Zhengzhou, Peoples R China.	zxyyzqw@163.com; fenghougao@163.com			National Natural Science Foundation of China [81172322, 81302006]; Shanghai Municipal Education Committee [13ZZ089]; Science and Technology Committee of Shanghai [14401901500]; Science and Technology Committee of Baoshan District [12-E-2]; People's Hospital affiliated to Shanghai Jiao-Tong University School of Medicine [sy2013-008]; Science and Technology of Henan province fund [142102310461]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Committee; Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee); Science and Technology Committee of Baoshan District; People's Hospital affiliated to Shanghai Jiao-Tong University School of Medicine; Science and Technology of Henan province fund	This work was supported in part by the National Natural Science Foundation of China (81172322, 81302006), Shanghai Municipal Education Committee (13ZZ089), Science and Technology Committee of Shanghai (14401901500), Science and Technology Committee of Baoshan District (12-E-2), NO.3 People's Hospital affiliated to Shanghai Jiao-Tong University School of Medicine (sy2013-008), Project supported by the Science and Technology of Henan province fund (142102310461).	Abeyama K, 2000, J CLIN INVEST, V105, P1751, DOI 10.1172/JCI9745; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bode Ann M, 2003, Sci STKE, V2003, pRE2, DOI 10.1126/stke.2003.167.re2; Brenneisen P, 1998, J BIOL CHEM, V273, P5279, DOI 10.1074/jbc.273.9.5279; Burke KE, 2010, GIORN ITAL DERMAT V, V145, P445; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DOMINGO JL, 1993, TERATOLOGY, V48, P133, DOI 10.1002/tera.1420480207; Emerit I, 1992, EXS, V62, P328; Eyden B., 2005, Journal of Submicroscopic Cytology and Pathology, V37, P109; Fang Y, 2012, AUSTRALAS J DERMATOL, V53, P172, DOI 10.1111/j.1440-0960.2012.00912.x; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Han YH, 2009, ONCOL REP, V21, P253, DOI 10.3892/or_00000216; Inarrea P, 2011, FREE RADICAL BIO MED, V50, P1575, DOI 10.1016/j.freeradbiomed.2011.03.003; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kim J, 2011, J ETHNOPHARMACOL, V137, P427, DOI 10.1016/j.jep.2011.04.072; LEWIN I, 1993, BLOOD, V82, P3745; LIN CW, 1993, AGENTS ACTIONS, V39, pC215, DOI 10.1007/BF01972770; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Luff SA, 2016, J BIOL CHEM, V291, P7831, DOI 10.1074/jbc.M115.707174; Ma W, 2001, CLIN EXP DERMATOL, V26, P592, DOI 10.1046/j.1365-2230.2001.00905.x; MAUVIEL A, 1993, J CELL BIOCHEM, V53, P288, DOI 10.1002/jcb.240530404; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; MIYACHI Y, 1995, J DERMATOL SCI, V9, P79, DOI 10.1016/0923-1811(94)00363-J; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; Nishimori Y, 2001, J INVEST DERMATOL, V117, P1458; Palmer DM, 2010, J DRUGS DERMATOL, V9, P11; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PETERSEN MJ, 1992, J INVEST DERMATOL, V99, P440, DOI 10.1111/1523-1747.ep12616142; Pillai S., 2005, International Journal of Cosmetic Science, V27, P17, DOI 10.1111/j.1467-2494.2004.00241.x; Quan TH, 2005, J BIOL CHEM, V280, P8079, DOI 10.1074/jbc.M409647200; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Sanchez DJ, 1999, BIOL TRACE ELEM RES, V69, P249, DOI 10.1007/BF02783877; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; TREMBLE P, 1995, J CELL BIOL, V129, P1707, DOI 10.1083/jcb.129.6.1707; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; WILHELM D, 1995, IMMUNOBIOLOGY, V193, P143, DOI 10.1016/S0171-2985(11)80537-1	44	38	42	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159998	10.1371/journal.pone.0159998	http://dx.doi.org/10.1371/journal.pone.0159998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486852	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800051
J	Mao, CT; Wang, JL; Chen, DY; Tsai, ML; Lin, YS; Cherng, WJ; Wang, CH; Wen, MS; Hsieh, IC; Hung, MJ; Chen, CC; Chen, TH				Mao, Chun-Tai; Wang, Jian-Liang; Chen, Dong-Yi; Tsai, Ming-Lung; Lin, Yu-Sheng; Cherng, Wen-Jin; Wang, Chao-Hung; Wen, Ming-Shien; Hsieh, I-Chang; Hung, Ming-Jui; Chen, Chun-Chi; Chen, Tien-Hsing			Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; VENTRICULAR ASSIST DEVICES; CEREBRAL-BLOOD-FLOW; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; COUNTERPULSATION; IABP; MANAGEMENT; AUGMENTATION; ANGIOPLASTY	Background Prior studies have suggested intraaortic balloon pump (IABP) have a neutral effect on acute myocardial infarction (AMI) patients with cardiogenic shock (CS). However, the effects of IABP on patients with severe CS remain unclear. We therefore investigated the benefits of IABP in AMI patients with severe CS undergoing coronary revascularization. Methods and Results This study identified 14,088 adult patients with AMI and severe CS undergoing coronary revascularization from Taiwan's National Health Insurance Research Database between January 1, 1997 and December 31, 2011, dividing them into the IABP group (n = 7044) and the Nonusers group (n = 7044) after propensity score matching to equalize confounding variables. The primary outcomes included myocardial infarction(MI), cerebrovascular accidents or cardiovascular death. In-hospital events including dialysis, stroke, pneumonia and sepsis were secondary outcomes. Primary outcomes were worse in the IABP group than in the Nonusers group in 1 month (Hazard ratio (HR) = 1.97, 95% confidence interval (CI) = 1.84-2.12). The MI rate was higher in the IABP group (HR = 1.44, 95% CI = 1.16-1.79), and the cardiovascular death was much higher in the IABP group (HR = 2.07, 95% CI = 1.92-2.23). The IABP users had lower incidence of dialysis (8.5% and 9.5%, P = 0.04), stroke (2.6% and 3.8%, P < 0.001), pneumonia (13.9% and 16.5%, P < 0.001) and sepsis (13.2% and 16%, P < 0.001) during hospitalization than Nonusers. Conclusion The use of IABP in patients with myocardial infarction and severe cardiogenic shock undergoing coronary revascularization did not improve the outcomes of recurrent myocardial infarction and cardiovascular death. However, it did reduce the incidence of dialysis, stroke, pneumonia and sepsis during hospitalization.	[Mao, Chun-Tai; Cherng, Wen-Jin; Wang, Chao-Hung; Hung, Ming-Jui; Chen, Tien-Hsing] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Keelung, Taiwan; [Mao, Chun-Tai; Lin, Yu-Sheng; Cherng, Wen-Jin; Wang, Chao-Hung; Hung, Ming-Jui; Chen, Tien-Hsing] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wang, Jian-Liang] Landseed Hosp, Div Cardiol, Pingzhen City, Taiwan; [Chen, Dong-Yi; Tsai, Ming-Lung; Wen, Ming-Shien; Hsieh, I-Chang; Chen, Chun-Chi] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Div Cardiol,Dept Internal Med, Taoyuan, Taiwan; [Lin, Yu-Sheng] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, TH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Keelung, Taiwan.; Chen, TH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	skyheart0826@gmail.com	Wang, Chao/GXF-8353-2022					Administration FaD, 2010, STAND DEF POINT EV C, P37; American Regent Laboratories Inc S NY, 2001, DOP HYDR INJ DOP HYD; Babaev A, 2005, JAMA-J AM MED ASSOC, V294, P448, DOI 10.1001/jama.294.4.448; Barron HV, 2001, AM HEART J, V141, P933, DOI 10.1067/mhj.2001.115295; Brunkhorst FM, 1999, INT J CARDIOL, V72, P3, DOI 10.1016/S0167-5273(99)00118-7; Chen DY, 2016, INT J CARDIOL, V215, P98, DOI 10.1016/j.ijcard.2016.04.014; Chen DY, 2015, INT J CARDIOL, V181, P200, DOI 10.1016/j.ijcard.2014.12.029; Cheng JM, 2009, EUR HEART J, V30, P2102, DOI 10.1093/eurheartj/ehp292; Gass A, 2014, CARDIOLOGY, V129, P137, DOI 10.1159/000365138; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; Hasin T, 2012, J AM COLL CARDIOL, V59, P26, DOI 10.1016/j.jacc.2011.09.038; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; KANTROWITZ A, 1968, J AMER MED ASSOC, V203, P113, DOI 10.1001/jama.203.2.113; KERN MJ, 1993, CIRCULATION, V87, P500, DOI 10.1161/01.CIR.87.2.500; Kohsaka S, 2005, ARCH INTERN MED, V165, P1643, DOI 10.1001/archinte.165.14.1643; Lauten A, 2013, CIRC-HEART FAIL, V6, P23, DOI 10.1161/CIRCHEARTFAILURE.112.967224; Ma PY, 2014, HEART LUNG CIRC, V23, P363, DOI 10.1016/j.hlc.2013.10.081; Madershahian N, 2011, J CARDIOVASC SURG, V52, P411; NANAS JN, 1994, CARDIOLOGY, V84, P156, DOI 10.1159/000176394; Nussbaum ES, 1998, NEUROSURGERY, V42, P206, DOI 10.1097/00006123-199801000-00048; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Onorati F, 2007, AM J KIDNEY DIS, V50, P229, DOI 10.1053/j.ajkd.2007.05.017; Patel H, 2014, AM HEART J, V168, P363, DOI 10.1016/j.ahj.2014.02.015; Patel MR, 2011, JAMA-J AM MED ASSOC, V306, P1329, DOI 10.1001/jama.2011.1280; Prondzinsky R, 2010, CRIT CARE MED, V38, P152, DOI 10.1097/CCM.0b013e3181b78671; Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596; SCHEIDT S, 1973, NEW ENGL J MED, V288, P979, DOI 10.1056/NEJM197305102881901; Seyfarth M, 2008, J AM COLL CARDIOL, V52, P1584, DOI 10.1016/j.jacc.2008.05.065; Sheu JJ, 2010, CRIT CARE MED, V38, P1810, DOI 10.1097/CCM.0b013e3181e8acf7; Sjauw KD, 2009, EUR HEART J, V30, P459, DOI 10.1093/eurheartj/ehn602; Spann RG, 2001, ACTA NEUROCHIR, V143, P115, DOI 10.1007/s007010170115; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Takeuchi M, 2004, J AM COLL CARDIOL, V43, P368, DOI 10.1016/j.jacc.2003.08.047; Theroux P, 2005, EUR HEART J, V26, P1964, DOI 10.1093/eurheartj/ehi292; Thiele H, 2013, LANCET, V382, P1638, DOI 10.1016/S0140-6736(13)61783-3; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Unverzagt S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007398.pub2; van Nunen LX, 2014, EUROINTERVENTION J E, DOI [10.4244/eijy14m09_10, DOI 10.4244/EIJY14M09_10]; Werdan K, 2014, EUR HEART J, V35, P156, DOI 10.1093/eurheartj/eht248; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	41	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160070	10.1371/journal.pone.0160070	http://dx.doi.org/10.1371/journal.pone.0160070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483439	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700021
J	Olatunji, BO; Puncochar, BD; Cox, R				Olatunji, Bunmi O.; Puncochar, Bieke David; Cox, Rebecca			Effects of Experienced Disgust on Morally-Relevant Judgments	PLOS ONE			English	Article							BAD TASTE; EMOTIONS; MOOD; SENSITIVITY; PUNISHMENT; DIVINITY; PURITY; MEMORY; SCALE; GROSS	Although disgust has been implicated in moral judgments, the extent to which the influence of disgust on moral judgment is distinct from other negative affective states remains unclear. To address this gap in knowledge, participants in Study 1 were randomized to a disgust (hand submersion in imitation vomit), discomfort (hand submersion in ice water), or neutral (hand submersion in room temperature water) affect condition while moral judgments of offenses were simultaneously assessed. The results showed that participants in the discomfort condition made the most severe moral judgments, particularly for moderate offenses. To examine if disgust may have more of an effect on some moral violations than others, participants in Study 2 were randomized to similar affect inductions while judgments of purity and non-purity offenses were simultaneously assessed. The results showed that those who had their hand submerged in imitation vomit recommended harsher punishment for purity violations relative to moral violations unrelated to purity. The opposite was true for those who submerged their hands in ice water, whereas punishment ratings for purity and non-purity violations did not significantly differ for those who submerged their hands in room temperature water. The implications of these findings for further delineating the specific role of experienced disgust in moral decision-making are discussed.	[Olatunji, Bunmi O.; Puncochar, Bieke David; Cox, Rebecca] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Olatunji, BO (corresponding author), Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.	olubunmi.o.olatunji@vanderbilt.edu	Cox, Rebecca C/ABE-7485-2021	Cox, Rebecca C/0000-0001-8964-4360				ALICKE MD, 1992, J PERS SOC PSYCHOL, V63, P368, DOI 10.1037/0022-3514.63.3.368; BERKOWITZ L, 1993, MOTIV EMOTION, V17, P277, DOI 10.1007/BF00992223; Bodenhausen GV, 2000, PSYCHOL SCI, V11, P320, DOI 10.1111/1467-9280.00263; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Buhle JT, 2013, SOC COGN AFFECT NEUR, V8, P609, DOI 10.1093/scan/nss038; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Chapman HA, 2014, EMOTION, V14, P341, DOI 10.1037/a0035120; Chapman HA, 2013, PSYCHOL BULL, V139, P300, DOI 10.1037/a0030964; Chepenik LG, 2007, EMOTION, V7, P802, DOI 10.1037/1528-3542.7.4.802; Eskine KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041159; Eskine KJ, 2011, PSYCHOL SCI, V22, P295, DOI 10.1177/0956797611398497; Fiedler K, 2001, J EXP SOC PSYCHOL, V37, P201, DOI 10.1006/jesp.2000.1442; Gilboa E, 1997, COGNITION EMOTION, V11, P65, DOI 10.1080/026999397380032; Gross JJ, 1995, EMOT, V9, P87, DOI DOI 10.1080/02699939508408966; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J, 2001, J APPL SOC PSYCHOL, V31, P191, DOI 10.1111/j.1559-1816.2001.tb02489.x; HAIDT J, 1993, J PERS SOC PSYCHOL, V65, P613, DOI 10.1037/0022-3514.65.4.613; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Helsen K, 2011, J PAIN, V12, P1230, DOI 10.1016/j.jpain.2011.07.002; Herz RS, 2014, BEHAV NEUROSCI, V128, P20, DOI 10.1037/a0035468; Horberg EJ, 2009, J PERS SOC PSYCHOL, V97, P963, DOI 10.1037/a0017423; Horberg EJ, 2011, EMOT REV, V3, P237, DOI 10.1177/1754073911402384; Hutcherson CA, 2011, J PERS SOC PSYCHOL, V100, P719, DOI 10.1037/a0022408; Inbar Y, 2012, EMOTION, V12, P23, DOI 10.1037/a0023984; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Lieberman D, 2007, EVOL PSYCHOL, V5, P291; Lindquist K., 2008, HDB EMOTIONS, P513; May J, 2014, AUSTRALAS J PHILOS, V92, P125, DOI 10.1080/00048402.2013.797476; Miller William Ian, 1997, ANATOMY DISGUST; Moretti L, 2010, EMOTION, V10, P169, DOI 10.1037/a0017826; Olatunji BO, REV GEN PSY IN PRESS; Olatunji BO, 2007, PSYCHOL ASSESSMENT, V19, P281, DOI 10.1037/1040-3590.19.3.281; Olatunji BO, 2007, J ANXIETY DISORD, V21, P820, DOI 10.1016/j.janxdis.2006.11.004; Peters E, 2006, J BEHAV DECIS MAKING, V19, P79, DOI 10.1002/bdm.528; Royzman E, 2014, EMOTION, V14, P892, DOI 10.1037/a0036829; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Rozin P., 2000, HDB EMOTIONS, P637; SCHERER KR, 1994, J PERS SOC PSYCHOL, V66, P310, DOI 10.1037/0022-3514.66.2.310; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Tsao SD, 2004, BEHAV RES THER, V42, P207, DOI 10.1016/S0005-7967(03)00119-0; Tybur JM, 2013, PSYCHOL REV, V120, P65, DOI 10.1037/a0030778; Ugazio G, 2012, EMOTION, V12, P579, DOI 10.1037/a0024611; Wheatley T, 2005, PSYCHOL SCI, V16, P780, DOI 10.1111/j.1467-9280.2005.01614.x; Zhong CB, 2010, J EXP SOC PSYCHOL, V46, P859, DOI 10.1016/j.jesp.2010.04.003	48	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160357	10.1371/journal.pone.0160357	http://dx.doi.org/10.1371/journal.pone.0160357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NS	27482909	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700038
J	Tang, YC; Zhou, DY; Jiang, W				Tang, Yongchuan; Zhou, Deyun; Jiang, Wen			A New Fuzzy-Evidential Controller for Stabilization of the Planar Inverted Pendulum System	PLOS ONE			English	Article							REASONING APPROACH; FAULT-DIAGNOSIS; SIMILARITY MEASURE; TRACKING CONTROL; FAILURE MODE; DEFUZZIFICATION; PROBABILITY; DESIGN	order to realize the stability control of the planar inverted pendulum system, which is a typical multi-variable and strong coupling system, a new fuzzy-evidential controller based on fuzzy inference and evidential reasoning is proposed. Firstly, for each axis, a fuzzy ninepoint controller for the rod and a fuzzy nine-point controller for the cart are designed. Then, in order to coordinate these two controllers of each axis, a fuzzy-evidential coordinator is proposed. In this new fuzzy-evidential controller, the empirical knowledge for stabilization of the planar inverted pendulum system is expressed by fuzzy rules, while the coordinator of different control variables in each axis is built incorporated with the dynamic basic probability assignment (BPA) in the frame of fuzzy inference. The fuzzy-evidential coordinator makes the output of the control variable smoother, and the control effect of the new controller is better compared with some other work. The experiment in MATLAB shows the effectiveness and merit of the proposed method.	[Tang, Yongchuan; Zhou, Deyun; Jiang, Wen] Northwest Polytech Univ, Sch Elect & Informat, Xian 710072, Shaanxi, Peoples R China	Northwestern Polytechnical University	Jiang, W (corresponding author), Northwest Polytech Univ, Sch Elect & Informat, Xian 710072, Shaanxi, Peoples R China.	jiangwen@nwpu.edu.cn	Tang, Yongchuan/G-8970-2019	Tang, Yongchuan/0000-0003-2568-9628; jiang, wen/0000-0001-5429-2748	National Natural Science Foundation of China [60904099]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM6018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China	The work is partially supported by National Natural Science Foundation of China (Grant No. 60904099) and Natural Science Basic Research Plan in Shaanxi Province of China (Grant No. 2016JM6018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyar H, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/3080679; Azadi M, 2015, COMPUT OPER RES, V54, P274, DOI 10.1016/j.cor.2014.03.002; Binaghi E, 1999, INT J INTELL SYST, V14, P559, DOI 10.1002/(SICI)1098-111X(199906)14:6<559::AID-INT2>3.0.CO;2-#; CHANG SSL, 1972, IEEE T SYST MAN CYB, VSMC2, P30, DOI 10.1109/TSMC.1972.5408553; Chin KS, 2015, COMPUT IND ENG, V87, P150, DOI 10.1016/j.cie.2015.04.016; Chou CC, 2016, J INTELL FUZZY SYST, V30, P1147, DOI 10.3233/IFS-151838; DEMPSTER AP, 1967, ANN MATH STAT, V38, P325, DOI 10.1214/aoms/1177698950; Deng Y, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/878024; Deng Y, 2017, J COMPUT ANAL APPL, V22, P201; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; FILEV DP, 1991, INT J INTELL SYST, V6, P687, DOI 10.1002/int.4550060702; Fu C, 2015, EUR J OPER RES, V246, P886, DOI 10.1016/j.ejor.2015.05.042; Geng T, 2015, J COMPUT THEOR NANOS, V12, P1287, DOI 10.1166/jctn.2015.3888; GORDON J, 1985, ARTIF INTELL, V26, P323, DOI 10.1016/0004-3702(85)90064-5; GRAHAM JH, 1995, INT J HUM FACTOR MAN, V5, P447, DOI 10.1002/hfm.4530050407; Guo J, 2016, J INTELL FUZZY SYST, V30, P869, DOI 10.3233/IFS-151809; Gutierrez-Estrada JC, 2005, AQUACULT ENG, V33, P110, DOI 10.1016/j.aquaeng.2004.12.003; Howimanporn S, 2015, INT J ROBOT AUTOM, V30, P310, DOI 10.2316/Journal.206.2015.4.206-4075; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641820; Jiang W, 2017, J INTELL FUZZY SYST, V32, P1931, DOI 10.3233/JIFS-16139; Jiang W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/5769061; Jiang W, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/3878634; Jiang W, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016644579; Jiang W, 2015, J INTELL FUZZY SYST, V28, P2343, DOI 10.3233/IFS-151639; JOHNSON C, 1990, PHYS MED BIOL, V35, P781, DOI 10.1088/0031-9155/35/6/007; Li NJ, 2015, NEUROCOMPUTING, V167, P488, DOI 10.1016/j.neucom.2015.04.045; Liu Feng, 2011, Proceedings of the 2011 IEEE International Conference on Automation and Logistics (ICAL), P238, DOI 10.1109/ICAL.2011.6024720; Liu HC, 2015, APPL SOFT COMPUT, V28, P579, DOI 10.1016/j.asoc.2014.11.036; Liu HC, 2013, COMPUT IND ENG, V66, P899, DOI 10.1016/j.cie.2013.09.004; Liu HC, 2013, IEEE T RELIAB, V62, P23, DOI 10.1109/TR.2013.2241251; Liu ZG, 2016, PATTERN RECOGN, V52, P85, DOI 10.1016/j.patcog.2015.10.001; Liu ZG, 2015, IEEE T CYBERNETICS, V45, P635, DOI 10.1109/TCYB.2014.2332037; Muskinja N, 2006, IEEE T IND ELECTRON, V53, P631, DOI 10.1109/TIE.2006.870667; Qi Q, 2008, C IND ELECT APPL, P645, DOI 10.1109/ICIEA.2008.4582594; Sabahi F, 2014, INT J APPROX REASON, V55, P1383, DOI 10.1016/j.ijar.2013.12.003; Sabahi F, 2013, INFORM SCIENCES, V244, P60, DOI 10.1016/j.ins.2013.03.020; Shafer G.A., 1976, MATH THEORY EVIDENCE; Shen JL, 2004, IEEE DECIS CONTR P, P323, DOI 10.1109/CDC.2004.1428650; Shin HK, 2014, IEEE T ROBOT, V30, P986, DOI 10.1109/TRO.2014.2305792; SMETS P, 1994, ARTIF INTELL, V66, P191, DOI 10.1016/0004-3702(94)90026-4; Su XY, 2016, APPL INTELL, V44, P634, DOI 10.1007/s10489-015-0723-5; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; SUH DY, 1993, IEEE T MED IMAGING, V12, P65, DOI 10.1109/42.222668; Sun XB, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814015624834; Tang Yong-chuan, 2014, IAES TELKOMNIKA Indonesian Journal of Electrical Engineering, V12, P422; Velagic J, 2006, ROBOT AUTON SYST, V54, P989, DOI 10.1016/j.robot.2006.05.006; Wai RJ, 2006, IEEE T IND ELECTRON, V53, P674, DOI 10.1109/TIE.2006.870680; Wai RJ, 2006, IEEE T FUZZY SYST, V14, P145, DOI 10.1109/TFUZZ.2005.859305; Wai RJ, 2008, IEEE T FUZZY SYST, V16, P1232, DOI 10.1109/TFUZZ.2008.924277; Wai RJ, 2008, IEEE T SYST MAN CY B, V38, P439, DOI 10.1109/TSMCB.2007.913600; Wang LX, 1996, IEEE T SYST MAN CY B, V26, P677, DOI 10.1109/3477.537311; WANG LX, 1992, IEEE T NEURAL NETWOR, V3, P807, DOI 10.1109/72.159070; Wang YM, 2006, EUR J OPER RES, V174, P1885, DOI 10.1016/j.ejor.2004.09.059; Wen CL, 2008, LECT NOTES COMPUT SC, V5264, P506; YAGER RR, 1995, IEEE T SYST MAN CYB, V25, P1221, DOI 10.1109/21.398683; YAGER RR, 1993, FUZZY SET SYST, V55, P255, DOI 10.1016/0165-0114(93)90252-D; YANG JB, 1994, IEEE T SYST MAN CYB, V24, P1, DOI 10.1109/21.259681; Yang JB, 2013, ARTIF INTELL, V205, P1, DOI 10.1016/j.artint.2013.09.003; Zadeh LA, 1997, FUZZY SET SYST, V90, P111, DOI 10.1016/S0165-0114(97)00077-8; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang JL, 2012, PHYSCS PROC, V24, P1669, DOI 10.1016/j.phpro.2012.02.246	61	26	26	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160416	10.1371/journal.pone.0160416	http://dx.doi.org/10.1371/journal.pone.0160416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482707	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110700044
J	Allen, HA; Chambers, A; Blissett, J; Chechlacz, M; Barrett, T; Higgs, S; Nouwen, A				Allen, Harriet A.; Chambers, Alison; Blissett, Jacqueline; Chechlacz, Magdalena; Barrett, Timothy; Higgs, Suzanne; Nouwen, Arie			Relationship between Parental Feeding Practices and Neural Responses to Food Cues in Adolescents	PLOS ONE			English	Article							REWARD-SYSTEM ACTIVATION; DIETARY SELF-CARE; BODY-MASS INDEX; BRAIN RESPONSES; RECEPTOR ACTIVATION; DIABETES-MELLITUS; EATING BEHAVIORS; CALORIE FOODS; WEIGHT STATUS; SOCIAL NORMS	Social context, specifically within the family, influences adolescent eating behaviours and thus their health. Little is known about the specific mechanisms underlying the effects of parental feeding practices on eating. We explored relationships between parental feeding practices and adolescent eating habits and brain activity in response to viewing food images. Fifty-seven adolescents (15 with type 2 diabetes mellitus, 21 obese and 21 healthy weight controls) underwent fMRI scanning whilst viewing images of food or matched control images. Participants completed the Kids Child Feeding Questionnaire, the Childrens' Dutch Eating Behaviour Questionnaire (DEBQ) and took part in an observed meal. Parents completed the Comprehensive Feeding Practices Questionniare and the DEBQ. We were particularly interested in brain activity in response to food cues that was modulated by different feeding and eating styles. Healthy-weight participants increased activation (compared to the other groups) to food in proportion to the level of parental restriction in visual areas of the brain such as right lateral occipital cortex (LOC), right temporal occipital cortex, left occipital fusiform gyrus, left lateral and superior LOC. Adolescents with type 2 diabetes mellitus had higher activation (compared to the other groups) with increased parental restrictive feeding in areas relating to emotional control, attention and decision-making, such as posterior cingulate, precuneus, frontal operculum and right middle frontal gyrus. Participants with type 2 diabetes mellitus also showed higher activation (compared to the other groups) in the left anterior intraparietal sulcus and angular gyrus when they also reported higher self restraint. Parental restriction did not modulate food responses in obese participants, but there was increased activity in visual (visual cortex, left LOC, left occipital fusiform gyrus) and reward related brain areas (thalamus and parietal operculum) in response to parental teaching and modelling of behaviour. Parental restrictive feeding and parental teaching and modelling affected neural responses to food cues in different ways, depending on motivations and diagnoses, illustrating a social influence on neural responses to food cues.	[Allen, Harriet A.; Chambers, Alison] Univ Nottingham, Sch Psychol, Nottingham, England; [Blissett, Jacqueline; Higgs, Suzanne] Univ Birmingham, Sch Psychol, Nottingham, England; [Chechlacz, Magdalena] Univ Oxford, Dept Expt Psychol, Oxford, England; [Barrett, Timothy] Birmingham Childrens Hosp, NIHR Wellcome Clin Res Facil, Birmingham, W Midlands, England; [Nouwen, Arie] Middlesex Univ, Dept Psychol, London, England	University of Nottingham; University of Birmingham; University of Oxford; University of Birmingham; Middlesex University	Allen, HA (corresponding author), Univ Nottingham, Sch Psychol, Nottingham, England.	H.A.Allen@nottingham.ac.uk	Barrett, Timothy/F-1682-2010; Chechlacz, Magdalena/ABB-6360-2021; Higgs, Suzanne/A-9632-2008	Barrett, Timothy/0000-0002-6873-0750; Chechlacz, Magdalena/0000-0003-1811-3946; Higgs, Suzanne/0000-0002-9225-7692; Allen, Harriet/0000-0002-3447-0137; Blissett, Jacqueline/0000-0002-0275-6413	European Foundation; MRC [G0800661] Funding Source: UKRI	European Foundation(European Science Foundation (ESF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded via a grant from the European Foundation for the Study of Diabetes / Novo Nordisk European Clinical Research Programme in Adolescents with Type 2 diabetes mellitus to AN (with HA, JB, and SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798; ANDERSON BJ, 1990, J PEDIATR PSYCHOL, V15, P477, DOI 10.1093/jpepsy/15.4.477; Austin S, 2013, J PSYCHOSOM RES, V75, P153, DOI 10.1016/j.jpsychores.2013.04.013; Benedict C, 2004, PSYCHONEUROENDOCRINO, V29, P1326, DOI 10.1016/j.psyneuen.2004.04.003; Bevelander KE, 2012, APPETITE, V58, P864, DOI 10.1016/j.appet.2012.02.003; Birch LL, 2003, AM J CLIN NUTR, V78, P215, DOI 10.1093/ajcn/78.2.215; Birch LL, 2001, APPETITE, V36, P201, DOI 10.1006/appe.2001.0398; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Carnell S, 2014, INT J EAT DISORDER, V47, P705, DOI 10.1002/eat.22324; Chechlacz M, 2009, DIABETOLOGIA, V52, P524, DOI 10.1007/s00125-008-1253-z; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 1995, ARCH DIS CHILD, P25; D'Adamo E, 2011, DIABETES CARE, V34, pS161, DOI 10.2337/dc11-s212; Faith MS, 2004, PEDIATRICS, V114, pE429, DOI 10.1542/peds.2003-1075-L; Farrow C, 2006, PEDIATRICS, V118, pE293, DOI 10.1542/peds.2005-2919; Fisher JO, 2002, AM J CLIN NUTR, V76, P226, DOI 10.1093/ajcn/76.1.226; Garcia-Garcia I, 2013, EUR EAT DISORD REV, V21, P89, DOI 10.1002/erv.2216; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Gregory JE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-55; Gubbels JS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-18; HARPER LV, 1975, J EXP CHILD PSYCHOL, V20, P206, DOI 10.1016/0022-0965(75)90098-3; Haycraft E, 2014, J ADOLESCENT HEALTH, V54, P204, DOI 10.1016/j.jadohealth.2013.08.007; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Houldcroft L, 2014, APPETITE, V80, P61, DOI 10.1016/j.appet.2014.05.002; Jastreboff AM, 2014, DIABETES CARE, V37, P3061, DOI 10.2337/dc14-0525; Jastreboff AM, 2013, DIABETES CARE, V36, P394, DOI 10.2337/dc12-1112; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson MK, 2009, SOC COGN AFFECT NEUR, V4, P313, DOI 10.1093/scan/nsp022; Killgore WDS, 2005, DEV PSYCHOBIOL, V47, P377, DOI 10.1002/dev.20099; Kroller K, 2013, APPETITE, V65, P25, DOI 10.1016/j.appet.2012.11.032; Kroemer NB, 2013, HUM BRAIN MAPP, V34, P2367, DOI 10.1002/hbm.22071; Krug A, 2014, BEHAV BRAIN RES, V261, P89, DOI 10.1016/j.bbr.2013.12.013; Kullmann S, 2013, CEREB CORTEX, V23, P1247, DOI 10.1093/cercor/bhs124; Larsen JK, 2015, APPETITE, V89, P246, DOI 10.1016/j.appet.2015.02.012; Loth KA, 2014, INT J EAT DISORDER, V47, P310, DOI 10.1002/eat.22189; Loth KA, 2013, PEDIATRICS, V131, pE1443, DOI 10.1542/peds.2012-3073; Murdaugh DL, 2012, NEUROIMAGE, V59, P2709, DOI 10.1016/j.neuroimage.2011.10.071; Musher-Eizenman D, 2007, J PEDIATR PSYCHOL, V32, P960, DOI 10.1093/jpepsy/jsm037; Nook EC, 2015, J COGNITIVE NEUROSCI, V27, P1412, DOI 10.1162/jocn_a_00795; Nouwen A, 2009, PSYCHOL HEALTH, V24, P1071, DOI 10.1080/08870440802254597; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Perantie DC, 2008, PEDIATR DIABETES, V9, P87, DOI 10.1111/j.1399-5448.2007.00274.x; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Riddoch MJ, 2010, ANN NY ACAD SCI, V1191, P156, DOI 10.1111/j.1749-6632.2010.05448.x; Robinson E, 2014, HEALTH PSYCHOL, V33, P1057, DOI 10.1037/a0034213; Robinson E, 2014, J ACAD NUTR DIET, V114, P414, DOI 10.1016/j.jand.2013.11.009; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Schur EA, 2012, PHYSIOL BEHAV, V105, P560, DOI 10.1016/j.physbeh.2011.09.008; Senecal C, 2006, CONSTRUCTION V UNPUB; Shloim N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01849; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stice E, 2011, J NEUROSCI, V31, P4360, DOI 10.1523/JNEUROSCI.6604-10.2011; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; ten Kulve JS, 2015, DIABETOLOGIA, V58, P2688, DOI 10.1007/s00125-015-3754-x; Timmerman GM, 2003, WESTERN J NURS RES, V25, P405, DOI 10.1177/0193945903025004006; Toobert DJ, 1994, HDB PSYCHOL DIABETES; Towner EK, 2015, APPETITE, V84, P120, DOI 10.1016/j.appet.2014.08.015; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; van Bloemendaal L, 2015, DIABETES OBES METAB, V17, P878, DOI 10.1111/dom.12506; van Bloemendaal L, 2015, OBESITY, V23, P2075, DOI 10.1002/oby.21200; van Bloemendaal L, 2014, DIABETES, V63, P4186, DOI 10.2337/db14-0849; Van Strien T, 2008, APPETITE, V50, P544, DOI 10.1016/j.appet.2007.08.005; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Zaki J, 2011, PSYCHOL SCI, V22, P894, DOI 10.1177/0956797611411057; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	68	9	9	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0157037	10.1371/journal.pone.0157037	http://dx.doi.org/10.1371/journal.pone.0157037			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27479051	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300004
J	Zhang, RF; Tian, XC; Gao, LJ; Li, HH; Yin, XM; Dong, YX; Yang, YZ; Xia, YL				Zhang, Rongfeng; Tian, Xiaochen; Gao, Lianjun; Li, Huihua; Yin, Xiaomeng; Dong, Yingxue; Yang, Yanzong; Xia, Yunlong			Common Variants in the TBX5 Gene Associated with Atrial Fibrillation in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HOLT-ORAM-SYNDROME; PR INTERVAL; ISCHEMIC-STROKE; HEART; MUTATIONS; RISK; EXPRESSION; GATA4	Background PR interval variations have recently been associated with an increased risk of long-term atrial fibrillation (AF), heart block and all-cause mortality. Genome-wide association studies have linked the PR interval with several common variants in the TBX5 gene. Several variants in the TBX5 gene, including rs7312625 and rs883079, have been associated with AF. The purpose of this study was to determine the association of single-nucleotide polymorphisms (SNPs) in the TBX5 gene, rs7312625 and rs883079, with AF in Chinese Han patients. Methodology/Principal Findings In this case-control association study, large cohorts of AF patients (n = 1132) and controls (n = 1206) were recruited from different hospitals. The genotyping was performed using a Rotor-Gene TM 6000 high-resolution melt system. Rs7312625, rs3825214 and rs883079 were analyzed. We found that SNP 3825214 was significantly associated with AF (P-obs = 0.002, odds ratio [OR] = 0.82), and lone AF (P-obs = 6.77x10-5, odds ratio [OR] = 0.71). SNP rs7312625 was significantly associated with lone AF (P-obs = 0.015, odds ratio [OR] = 1.27), although its association with AF was not significant. No significant association of SNP rs883079 with AF or lone AF was observed. Thus, we analyzed the interaction among these three loci. We demonstrated significant interaction among rs3825214, rs7312625 and rs883079. Four-locus risk alleles showed the highest odds ratio in combined rs3825214 and rs7312625 (P-obs<0.0001, odds ratio [OR] = 2.21). Six-locus risk alleles showed the highest odds ratio in combined rs3825214, rs7312625 and rs 883079(P-obs<0.0001, odds ratio [OR] = 2.35). Significance was established with the trend test (P<0.0001). Conclusions For the first time, we report the strong association of SNP rs3825214 in the TBX5 gene with AF and lone AF in a Chinese Han population. Rs7312625 was significantly associated with lone AF, and snp-snp interaction increased the risk of atrial fibrillation. Our data might provide new insights into understanding AF pathogenesis and designing novel genetic therapies for AF patients.	[Zhang, Rongfeng; Tian, Xiaochen; Gao, Lianjun; Li, Huihua; Yin, Xiaomeng; Dong, Yingxue; Yang, Yanzong; Xia, Yunlong] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China	Dalian Medical University	Zhang, RF; Xia, YL (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China.	yyzheart@126.com; yunlong_xia@126.com			International SaeT Cooperation Program of China [2014DFA31930]; National Natural Science Foundation of China [81270247]	International SaeT Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by International SaeT Cooperation Program of China (2014DFA31930), website: http://www.istcp.org.cn; and National Natural Science Foundation of China (81270247), website: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Li QY, 1997, NAT GENET, V15, P21; Linhares VLF, 2004, CARDIOVASC RES, V64, P402, DOI 10.1016/j.cardiores.2004.09.021; Mahida S, 2012, J CARDIOVASC ELECTR, V23, P1400, DOI 10.1111/j.1540-8167.2012.02445.x; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Smith JG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001304; Smith JG, 2009, HEART RHYTHM, V6, P634, DOI 10.1016/j.hrthm.2009.02.022; Soliman EZ, 2009, STROKE, V40, P1204, DOI 10.1161/STROKEAHA.108.534735; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Xu CQ, 2010, STROKE, V41, P1587, DOI 10.1161/STROKEAHA.110.583096; Zang XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064966; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720	19	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160467	10.1371/journal.pone.0160467	http://dx.doi.org/10.1371/journal.pone.0160467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479212	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110300052
J	Lara, J; O'Brien, N; Godfrey, A; Heaven, B; Evans, EH; Lloyd, S; Moffatt, S; Moynihan, PJ; Meyer, TD; Rochester, L; Sniehotta, FF; White, M; Mathers, JC				Lara, Jose; O'Brien, Nicola; Godfrey, Alan; Heaven, Ben; Evans, Elizabeth H.; Lloyd, Scott; Moffatt, Suzanne; Moynihan, Paula J.; Meyer, Thomas D.; Rochester, Lynn; Sniehotta, Falko F.; White, Martin; Mathers, John C.			Pilot Randomised Controlled Trial of a Web-Based Intervention to Promote Healthy Eating, Physical Activity and Meaningful Social Connections Compared with Usual Care Control in People of Retirement Age Recruited from Workplaces	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; DIETARY INTERVENTIONS; PROGRAM; ADULTS; INTERNET; BEHAVIOR; MEN; ACCELEROMETER; METAANALYSIS; ASSOCIATION	Background Lifestyle interventions delivered during the retirement transition might promote healthier ageing. We report a pilot randomised controlled trial (RCT) of a web-based platform (Living, Eating, Activity and Planning through retirement; LEAP) promoting healthy eating (based on a Mediterranean diet (MD)), physical activity (PA) and meaningful social roles. Methods A single blinded, two-arm RCT with individual allocation. Seventy-five adult regular internet users living in Northeast England, within two years of retirement, were recruited via employers and randomised in a 2: 1 ratio to receive LEAP or a 'usual care' control. Intervention arm participants were provided with a pedometer to encourage self-monitoring of PA goals.Feasibility of the trial design and procedures was established by estimating recruitment and retention rates, and of LEAP from usage data. At baseline and 8-week follow-up, adherence to a MD derived from three 24-hour dietary recalls and seven-day PA by accelerometry were assessed. Healthy ageing outcomes (including measures of physiological function, physical capability, cognition, psychological and social wellbeing) were assessed and acceptability established by compliance with measurement protocols and completion rates. Thematically analysed, semi-structured, qualitative interviews assessed acceptability of the intervention, trial design, procedures and outcome measures. Results Seventy participants completed the trial; 48 (96%) participants in the intervention and 22 (88%) in the control arm. Participants had considerable scope for improvement in diet as assessed by MD score. LEAP was visited a median of 11 times (range 1-80) for a mean total time of 2.5 hours (range 5.5 min-8.3 hours). 'Moving more', 'eating well' and 'being social' were the most visited modules. At interview, participants reported that diet and PA modules were important and acceptable within the context of healthy ageing. Participants found both trial procedures and outcome assessments acceptable. Conclusions The trial procedures and the LEAP intervention proved feasible and acceptable. Effectiveness and cost-effectiveness of LEAP to promote healthy lifestyles warrant evaluation in a definitive RCT.	[Lara, Jose; Moynihan, Paula J.; Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Lara, Jose; Mathers, John C.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Lara, Jose; Godfrey, Alan; Moffatt, Suzanne; Moynihan, Paula J.; Rochester, Lynn; Mathers, John C.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England; [Lara, Jose] Northumbria Univ, Fac Hlth & Life Sci, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England; [O'Brien, Nicola; Heaven, Ben; Evans, Elizabeth H.; Moffatt, Suzanne; Sniehotta, Falko F.; White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Godfrey, Alan; Rochester, Lynn] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Lloyd, Scott] People Serv Redcar & Cleveland Borough Council, Redcar, England; [Lloyd, Scott] Univ Durham, Sch Med Pharm & Hlth, Ctr Publ Policy & Hlth, Queens Campus, Stockton On Tees, England; [Lloyd, Scott] Univ Teesside, Sch Hlth & Social Care, Hlth & Social Care Inst, Middlesbrough, Tees Valley, England; [Lloyd, Scott; Sniehotta, Falko F.] UKCRC Ctr Translat Res Publ Hlth, Fuse, Newcastle Upon Tyne, Tyne & Wear, England; [Moynihan, Paula J.] Newcastle Univ, Ctr Oral Hlth Res, Newcastle Upon Tyne, Tyne & Wear, England; [Meyer, Thomas D.] Univ Texas HSC, Dept Psychiat & Behav Sci, Houston, TX USA; [White, Martin] Univ Cambridge, MRC Epidemiol Unit, Ctr Diet & Act Res CEDAR, Cambridge, England; [Mathers, John C.] Newcastle Univ, CAV, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Northumbria University; Newcastle University - UK; Newcastle University - UK; Durham University; University of Teesside; Newcastle University - UK; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Cambridge; Newcastle University - UK	Mathers, JC (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England.; Mathers, JC (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.; Mathers, JC (corresponding author), Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England.; Mathers, JC (corresponding author), Newcastle Univ, CAV, Newcastle Upon Tyne, Tyne & Wear, England.	john.mathers@newcastle.ac.uk	O'Brien, Nicola/G-5987-2010; Moynihan, Paula/AAT-9649-2021; Sniehotta, Falko F/C-5481-2008; Sniehotta, Falko/ABF-7131-2021	Moynihan, Paula/0000-0002-5015-5620; Sniehotta, Falko F/0000-0003-1738-4269; Sniehotta, Falko/0000-0003-1738-4269; Rochester, Lynn/0000-0001-5774-9272; O'Brien, Nicola/0000-0002-7773-6871; Lloyd, Scott/0000-0001-9617-4838; Godfrey, Alan/0000-0003-4049-9291; White, Martin/0000-0002-1861-6757; Lara, Jose/0000-0002-4449-9304; Moffatt, Suzanne/0000-0002-8553-249X; Evans, Elizabeth/0000-0002-3432-3778	Lifelong Health and Wellbeing (LLHW) Cross-Council research initiative; UK Health Departments; Biotechnology and Biological Sciences Research Council (BBSRC) Engineering and Physical Sciences Research Council; Economic and Social Research Council (ESRC); Medical Research Council (MRC); Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research/The Department of Health; Health and Social Care Research & Development of the Public Health Agency (Northern Ireland); Wales Office of Research and Development for Health and Social Care, Welsh Assembly Government [G0900686]; MRC; BBSRC; Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; ESRC; National Institute for Health Research under the UKCRC; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre (BRC) and Unit (BRU) based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1, G0900686, MR/K006312/1, MR/K023187/1] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K006312/1, MR/K023187/1, G0900686] Funding Source: UKRI	Lifelong Health and Wellbeing (LLHW) Cross-Council research initiative; UK Health Departments; Biotechnology and Biological Sciences Research Council (BBSRC) Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates; National Institute for Health Research/The Department of Health(National Institute for Health Research (NIHR)); Health and Social Care Research & Development of the Public Health Agency (Northern Ireland); Wales Office of Research and Development for Health and Social Care, Welsh Assembly Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research under the UKCRC; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre (BRC) and Unit (BRU) based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was undertaken by the LiveWell Programme team which is funded by the Lifelong Health and Wellbeing (LLHW) Cross-Council research initiative in partnership with the UK Health Departments. The LLHW Funding Partners are: Biotechnology and Biological Sciences Research Council (BBSRC) Engineering and Physical Sciences Research Council, Economic and Social Research Council (ESRC), Medical Research Council (MRC), Chief Scientist Office of the Scottish Government Health Directorates, National Institute for Health Research/The Department of Health, The Health and Social Care Research & Development of the Public Health Agency (Northern Ireland), and Wales Office of Research and Development for Health and Social Care, Welsh Assembly Government (Grant no. G0900686). JCM's research through the Centre for Ageing and Vitality is funded by the MRC and BBSRC. During this study, MW was partly funded and FFS was fully funded as members of Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding for Fuse from the British Heart Foundation, Cancer Research UK, ESRC, MRC, and the National Institute for Health Research, under the auspices of the UKCRC, is gratefully acknowledged. LR and AG are supported by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre (BRC) and Unit (BRU) based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are those of the authors and do not necessarily represent those of the funders listed above.	Adamson AJ, 2004, P NUTR SOC, V63, P537, DOI 10.1079/PNS2004395; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Beverley Bates, 2014, NATIONAL DIET AND NU; Braun T, 2015, J PUBLIC HEALTH-UK, V37, P138, DOI 10.1093/pubmed/fdu043; Britain Great, 2011, DIETARY REFERENCE VA; Brouwer W, 2010, HEALTH EDUC RES, V25, P585, DOI 10.1093/her/cyp063; Campbell MK, 2000, AM J HEALTH PROMOT, V14, P306, DOI 10.4278/0890-1171-14.5.306; Celis-Morales C, 2015, P NUTR SOC, V74, P130, DOI 10.1017/S0029665114001633; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Dennison L, 2014, J MED INTERNET RES, V16, P130, DOI 10.2196/jmir.3199; Dobbins TA, 1998, INT J BEHAV MED, V5, P323, DOI 10.1207/s15327558ijbm0504_6; Dzewaltowski DA, 2004, HEALTH PROMOT INT, V19, P235, DOI 10.1093/heapro/dah211; Ebbinghaus B, 2006, REFORMING EARLY RETI; Godfrey A, 2015, PHYSIOL MEAS, V36, pN71, DOI 10.1088/0967-3334/36/5/N71; Godfrey A, 2015, MATURITAS; Godfrey A, 2014, AGE AGEING, V43, P386, DOI 10.1093/ageing/aft168; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Guest G, 2011, APPLIED THEMATIC ANA; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Heaven B., 2015, GERONTOLOGIST; Heaven B, 2013, MILBANK Q, V91, P222, DOI 10.1111/milq.12013; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hobbs N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-75; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Internet World Stats, 2014, INTERNET USER STATIS; Khaw Kay-Tee, 2008, PLoS Med, V5, pe12, DOI 10.1371/journal.pmed.0050012; King K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117015; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Lara J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0177-3; Lara J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-60; Lara J, 2013, MATURITAS, V76, P189, DOI 10.1016/j.maturitas.2013.07.007; Liu B, 2011, PUBLIC HEALTH NUTR, V14, P1998, DOI 10.1017/S1368980011000942; Lloyd S, 2013, LANCET, V382, P62; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; McDonald S, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0186-4; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Morgan PJ, 2011, PREV MED, V52, P317, DOI 10.1016/j.ypmed.2011.01.031; Nicholas D, 2007, DIGITAL HEALTH INFOR; Nooyens ACJ, 2005, PUBLIC HEALTH NUTR, V8, P1266, DOI 10.1079/PHN2005756; NUTTING PA, 1986, PREV MED, V15, P537, DOI 10.1016/0091-7435(86)90029-0; O'Brien N, 2015, HLTH PSYCHOL REV, P1; Ogilvie D, 2011, MILBANK Q, V89, P206, DOI 10.1111/j.1468-0009.2011.00626.x; Papadaki A, 2005, BRIT J NUTR, V94, P290, DOI 10.1079/BJN20051476; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Robbins TW, 1998, J INT NEUROPSYCH SOC, V4, P474, DOI 10.1017/s1355617798455073; Robroek SJW, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-26; Rochester L, 2012, J NEUROL, V259, P1081, DOI 10.1007/s00415-011-6301-9; Schafer M, 2012, J CONSUM POLICY, V35, P65, DOI 10.1007/s10603-011-9181-6; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Schulz DN, 2015, J HEALTH COMMUN, V20, P663, DOI 10.1080/10810730.2015.1012243; Schulz DN, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3094; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SCHWARZER R, 2008, APPL PSYCHOL INT REV, V57, P1; Spittaels H, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-39; Sugden JA, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-169; van Dam RM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1440; Weiss A, 2013, NEUROREHAB NEURAL RE, V27, P742, DOI 10.1177/1545968313491004; Werkman A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-110; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; Wight D, 2015, SIX STEPS IN QUALITY	61	35	35	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159703	10.1371/journal.pone.0159703	http://dx.doi.org/10.1371/journal.pone.0159703			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IM	27472560	gold, Green Published, Green Accepted			2022-12-27	WOS:000381516300016
J	Cho, Y; Lee, YB; Lee, JH; Lee, DH; Cho, EJ; Yu, SJ; Kim, YJ; Kim, JI; Im, JH; Lee, JH; Oh, EJ; Yoon, JH				Cho, Yuri; Lee, Yun Bin; Lee, Jeong-Hoon; Lee, Dong Hyeon; Cho, Eun Ju; Yu, Su Jong; Kim, Yoon Jun; Kim, Jong In; Im, Jong Hun; Lee, Jung Hwan; Oh, Eun Ju; Yoon, Jung-Hwan			Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14	PLOS ONE			English	Article							POOR-PROGNOSIS; CELL-LINES; NUCLEOLIN; CANCER; GROWTH; SORAFENIB	Aptamers are small synthetic oligonucleotides that bind to target proteins with high specificity and affinity. AS1411 is an aptamer that binds to nucleolin, which is overexpressed in the cytoplasm and occurs on the surface of cancer cells. We investigated the therapeutic potential of aptamers in hepatocellular carcinoma (HCC) by evaluating anti-tumor effects and confirming the affinity and specificity of AS1411- and modified AS1411-aptamers in HCC cells. Cell growth was assessed using the MTS assay, and cell death signaling was explored by immunoblot analysis. Fluorescence-activated cell sorting was performed to evaluate the affinity and specificity of AS1411-aptamers in SNU-761 HCC cells. We investigated the in vivo effects of the AS1411-aptamer using BALB/c nude mice in a subcutaneous xenograft model with SNU-761 cells. Treatment with a modified AS1411-aptamer significantly decreased in vitro (under normoxic [P = 0.035] and hypoxic [P = 0.018] conditions) and in vivo (under normoxic conditions, P = 0.041) HCC cell proliferation compared to control aptamers. AS1411-and control aptamers failed to control HCC cell proliferation. However, AS1411-and the modified AS1411-aptamer did not induce caspase activation. Decrease in cell growth by AS1411 or modified AS1411 was not prevented by caspase or necrosis inhibitors. In a microarray, AS1411 significantly enhanced galectin-14 expression. Suppression of HCC cell proliferation by the modified AS1411-aptamer was attenuated by galectin-14 siRNA transfection. Modified AS1411-aptamer suppressed HCC cell growth in vitro and in vivo by up-regulating galectin-14 expressions. Modified AS1411-aptamers may have therapeutic potential as a novel targeted therapy for HCC.	[Cho, Yuri; Lee, Yun Bin; Lee, Jeong-Hoon; Lee, Dong Hyeon; Cho, Eun Ju; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Cho, Yuri; Lee, Yun Bin; Lee, Jeong-Hoon; Lee, Dong Hyeon; Cho, Eun Ju; Yu, Su Jong; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea; [Cho, Yuri] CHA Univ, CHA Gangnam Med Ctr, Dept Internal Med, Seoul, South Korea; [Lee, Yun Bin] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongnam, South Korea; [Kim, Jong In; Im, Jong Hun; Lee, Jung Hwan; Oh, Eun Ju] Pohang Univ Sci & Technol, POSTECH Biotech Ctr, Aptamer Initiat, Pohang, South Korea; [Lee, Dong Hyeon] Seoul Natl 26 Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pochon Cha University; Pochon Cha University; Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Seoul National University Hospital	Yoon, JH (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	pindra@empal.com; yoonjh@snu.ac.kr	Lee, Jeong-Hoon/Q-1055-2018	Lee, Jeong-Hoon/0000-0002-0315-2080; Lee, Yun Bin/0000-0002-3193-9745; Kim, Yoon Jun/0000-0001-9141-7773; Yoon, Jung-Hwan/0000-0002-9128-3610; Yu, Su Jong/0000-0001-8888-7977; Cho, Eun Ju/0000-0002-2677-3189	National R & D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1420050]	National R & D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This study was supported by a grant from the National R & D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1420050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Cho Y, 2016, DIGEST DIS SCI, V61, P2568, DOI 10.1007/s10620-016-4158-6; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; Eaton BE, 1997, BIOORGAN MED CHEM, V5, P1087, DOI 10.1016/S0968-0896(97)00044-8; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Fujita K, 2015, INT J ONCOL, V46, P2419, DOI 10.3892/ijo.2015.2941; Gu HR, 2015, CLIN MOL HEPATOL, V21, P49, DOI 10.3350/cmh.2015.21.1.49; Guo XD, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0175-y; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Lee JH, 1999, WORLD J GASTROENTERO, V5, P289; Lee JS, 2015, CLIN MOL HEPATOL, V21, P220, DOI 10.3350/cmh.2015.21.3.220; Lee KY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/168306; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Micklefield J, 2001, CURR MED CHEM, V8, P1157, DOI 10.2174/0929867013372391; Mongelard F, 2010, CURR OPIN MOL THER, V12, P107; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakatsura T, 2003, BIOCHEM BIOPH RES CO, V306, P16, DOI 10.1016/S0006-291X(03)00908-2; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Qiu W, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0530-1; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Santra S, 2011, J AM CHEM SOC, V133, P16680, DOI 10.1021/ja207463b; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Shen N, 2014, ONCOTARGET, V5, P5494, DOI 10.18632/oncotarget.2131	26	19	19	9	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160822	10.1371/journal.pone.0160822	http://dx.doi.org/10.1371/journal.pone.0160822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494117	Green Published, gold, Green Submitted			2022-12-27	WOS:000381369500086
J	Mayhugh, RE; Moussa, MN; Simpson, SL; Lyday, RG; Burdette, JH; Porrino, LJ; Laurienti, PJ				Mayhugh, Rhiannon E.; Moussa, Malaak N.; Simpson, Sean L.; Lyday, Robert G.; Burdette, Jonathan H.; Porrino, Linda J.; Laurienti, Paul J.			Moderate-Heavy Alcohol Consumption Lifestyle in Older Adults Is Associated with Altered Central Executive Network Community Structure during Cognitive Task	PLOS ONE			English	Article							BODY-MASS INDEX; FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; AGING BRAIN; AGE; SYSTEMS; MEMORY; VOLUME	Older adults today consume more alcohol than previous generations, the majority being social drinkers. The effects of heavy alcohol use on brain functioning closely resemble age-related changes, but it is not known if moderate-heavy alcohol consumption intensifies brain aging. Whether a lifestyle of moderate-heavy alcohol use in older adults increased age-related brain changes was examined. Forty-one older adults (65-80 years) that consumed light (< 2 drinks/week and >= 1 drink/month, n = 20) or moderate-heavy (7-21 drinks/week, non-bingers, n = 21) amounts of alcohol were enrolled. Twenty-two young adults (24-35 years) were also enrolled (light, n = 11 and moderate-heavy, n = 11). Functional brain networks based on magnetic resonance imaging data were generated for resting state and during a working memory task. Whole-brain, Central Executive Network (CEN), and Default Mode Network (DMN) connectivity were assessed in light and moderate-heavy alcohol consuming older adults with comparisons to young adults. The older adults had significantly lower whole brain connectivity (global efficiency) and lower regional connectivity (community structure) in the CEN during task and in the DMN at rest. Moderate-heavy older drinkers did not exhibit whole brain connectivity differences compared to the low drinkers. However, decreased CEN connectivity was observed during the task. There were no differences in the DMN connectivity between drinking groups. Taken together, a lifestyle including moderate-heavy alcohol consumption may be associated with further decreases in brain network connectivity within task-related networks in older adults. Further research is required to determine if this decrease is compensatory or an early sign of decline.	[Mayhugh, Rhiannon E.; Moussa, Malaak N.; Simpson, Sean L.; Lyday, Robert G.; Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA; [Mayhugh, Rhiannon E.; Moussa, Malaak N.] Wake Forest Sch Med, Neurosci Program, Winston Salem, NC USA; [Simpson, Sean L.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC USA; [Lyday, Robert G.; Burdette, Jonathan H.; Laurienti, Paul J.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27101 USA; [Porrino, Linda J.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University	Laurienti, PJ (corresponding author), Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA.; Laurienti, PJ (corresponding author), Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27101 USA.	plaurien@wakehealth.edu			National Institute on Alcohol Abuse and Alcoholism [AA021639, AA007565, AA021099]; National Institute of Biomedical Imaging and Bioengineering [EB012236]; Wake Forest Older Americans Independence Center [P30 21332]; Sticht Center on Aging at Wake Forest School of Medicine; Translational Science Center at Wake Forest University; Wake Forest University School of Medicine Venture Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K25EB012236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F31AA021639, P01AA021099, T32AA007565] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Wake Forest Older Americans Independence Center; Sticht Center on Aging at Wake Forest School of Medicine; Translational Science Center at Wake Forest University; Wake Forest University School of Medicine Venture Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the following: National Institute on Alcohol Abuse and Alcoholism, http://www.niaaa.nih.gov/ under awards (MNM, AA021639), (REM, AA007565), and (PJL, AA021099), National Institute of Biomedical Imaging and Bioengineering, https:// www.nibib.nih.gov/ (SLS, EB012236), Wake Forest Older Americans Independence Center, http://www.wakehealth.edu/Pepper/(PJL, P30 21332), Sticht Center on Aging at Wake Forest School of Medicine http://www.wakehealth.edu/agingresearch/(PJL), Translational Science Center at Wake Forest University, http://tsc.wfu.edu/(PJL), and the Wake Forest University School of Medicine Venture Fund, http://www.wakehealth.edu/TSI/(PJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Antonenko D, 2014, GERONTOLOGY, V60, P3, DOI 10.1159/000354376; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brayne C, 2007, NAT REV NEUROSCI, V8, P233, DOI 10.1038/nrn2091; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Camchong J, 2013, ALCOHOL CLIN EXP RES, V37, P75, DOI 10.1111/j.1530-0277.2012.01859.x; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Fist MB, 2002, STRUCTURED CLIN INTE; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Geerligs L, 2014, HUM BRAIN MAPP, V35, P3788, DOI 10.1002/hbm.22437; Geerligs L, 2014, HUM BRAIN MAPP, V35, P319, DOI 10.1002/hbm.22175; Gunstad J, 2008, INT J NEUROSCI, V118, P1582, DOI 10.1080/00207450701392282; Han JW, 2015, ADDICT BEHAV, V41, P12, DOI 10.1016/j.addbeh.2014.09.006; Hayasaka S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00880; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Marioni RE, 2012, J ALZHEIMERS DIS, V28, P223, DOI 10.3233/JAD-2011-110377; Matthaus F, 2012, BRAIN CONNECT, V2, P113, DOI 10.1089/brain.2012.0077; Maurage P, 2013, CORTEX, V49, P1610, DOI 10.1016/j.cortex.2012.04.012; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Moussa MN, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00341; Moussa MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044428; Moussa MN, 2014, BRAIN CONNECT, V4, P193, DOI 10.1089/brain.2013.0184; Muller-Oehring Eva M, 2015, Cereb Cortex, V25, P4155, DOI 10.1093/cercor/bhu134; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA NEWSLETTER, V3, P3; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; NIAAA, 2006, US ALCOHOL EPIDEMIOL; NIAAA, 1998, NIAAA PUBL; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rzucidlo JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070275; Sala-Llonch R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00663; Sobell L.C., 1992, TIMELINE FOLLOW BACK; Stanley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00954; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Steen M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016111; Substance Abuse and Mental Health Services Administration (SAMHSA), 2013, NSDUH SER H, V46; Telesford QK, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00067; Thayer RE, 2014, CURR HIV RES, V12, P293, DOI 10.2174/1570162X12666140721124441; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; WANG MQ, 1992, PHARMACOL BIOCHEM BE, V43, P641; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weiland BJ, 2014, ALCOHOL CLIN EXP RES, V38, P2445, DOI 10.1111/acer.12505	58	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160214	10.1371/journal.pone.0160214	http://dx.doi.org/10.1371/journal.pone.0160214			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494180	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500024
J	Bjorck, L; Rosengren, A; Winkvist, A; Capewell, S; Adiels, M; Bandosz, P; Critchley, J; Boman, K; Guzman-Castillo, M; O'Flaherty, M; Johansson, I				Bjorck, Lena; Rosengren, Annika; Winkvist, Anna; Capewell, Simon; Adiels, Martin; Bandosz, Piotr; Critchley, Julia; Boman, Kurt; Guzman-Castillo, Maria; O'Flaherty, Martin; Johansson, Ingegerd			Changes in Dietary Fat Intake and Projections for Coronary Heart Disease Mortality in Sweden: A Simulation Study	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; VASCULAR MORTALITY; INDIVIDUAL DATA; RISK-FACTORS; METAANALYSIS; CHOLESTEROL; TRENDS; DECLINE; WOMEN	Objective In Sweden, previous favourable trends in blood cholesterol levels have recently levelled off or even increased in some age groups since 2003, potentially reflecting changing fashions and attitudes towards dietary saturated fatty acids (SFA). We aimed to examine the potential effect of different SFA intake on future coronary heart disease (CHD) mortality in 2025. Methods We compared the effect on future CHD mortality of two different scenarios for fat intake a) daily SFA intake decreasing to 10 energy percent (E%), and b) daily SFA intake rising to 20 E %. We assumed that there would be moderate improvements in smoking (5%), salt intake (1g/day) and physical inactivity (5% decrease) to continue recent, positive trends. Results In the baseline scenario which assumed that recent mortality declines continue, approximately 5,975 CHD deaths might occur in year 2025. Anticipated improvements in smoking, dietary salt intake and physical activity, would result in some 380 (-6.4%) fewer deaths (235 in men and 145 in women). In combination with a mean SFA daily intake of 10 E%, a total of 810 (-14%) fewer deaths would occur in 2025 (535 in men and 275 in women). If the overall consumption of SFA rose to 20 E%, the expected mortality decline would be wiped out and approximately 20 (0.3%) additional deaths might occur. Conclusion CHD mortality may increase as a result of unfavourable trends in diets rich in saturated fats resulting in increases in blood cholesterol levels. These could cancel out the favourable trends in salt intake, smoking and physical activity.	[Bjorck, Lena; Rosengren, Annika; Adiels, Martin] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Bjorck, Lena] Gothenburg Univ, Inst Hlth & Care Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Winkvist, Anna] Univ Gothenburg, Dept Internal Med & Clin Nutr, Sahlgrenska Acad, Gothenburg, Sweden; [Capewell, Simon; Bandosz, Piotr; Guzman-Castillo, Maria; O'Flaherty, Martin] Univ Liverpool, Div Publ Hlth, Liverpool, Merseyside, England; [Adiels, Martin] Univ Gothenburg, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden; [Critchley, Julia] St Georges Univ London, Populat Hlth Res Inst, Cranmer Terrace, London, England; [Boman, Kurt] Umea Univ, Res Unit, Dept Publ Hlth & Clin Med, Med Geriatr, Umea, Sweden; [Johansson, Ingegerd] Umea Univ, Dept Odontol, Umea, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Liverpool; University of Gothenburg; St Georges University London; Umea University; Umea University	Bjorck, L (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden.; Bjorck, L (corresponding author), Gothenburg Univ, Inst Hlth & Care Sci, Sahlgrenska Acad, Gothenburg, Sweden.	Lena.bjorck@gu.se	Winkvist, Anna/AAC-6178-2021; Bandosz, Piotr/E-4964-2017	Winkvist, Anna/0000-0001-9122-7240; Critchley, Julia/0000-0002-5248-4188; O'Flaherty, Martin/0000-0001-8944-4131; Bjorck, Lena/0000-0002-4827-4559	Swedish Research Council (SIMSAM) [2013-5187, 2013-4236]; Swedish Council for Health, Working Life and welfare (EpiLife); Swedish Heart and Lung Foundation; Swedish government; European Union Health Programme (Executive Agency for Health & Consumers), "EuroHeart II" (European Heart Health Strategy 2; ADONIS code) [A/100946]; National Institute for Health Research's School for Public Health Research (NIHR SPHR); ALF	Swedish Research Council (SIMSAM)(Swedish Research Council); Swedish Council for Health, Working Life and welfare (EpiLife); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish government; European Union Health Programme (Executive Agency for Health & Consumers), "EuroHeart II" (European Heart Health Strategy 2; ADONIS code); National Institute for Health Research's School for Public Health Research (NIHR SPHR); ALF	The Swedish Research Council, www.vr.se, (SIMSAM; grants 2013-5187 and 2013-4236), the Swedish Council for Health, Working Life and welfare, www.forte.se, (EpiLife), and the Swedish Heart and Lung Foundation, www.hjart-lungfonden.se, supported this research. The Swedish state also provided funding under the agreement between the Swedish government and the county councils concerning economic support of research and education of doctors (ALF-agreement). The European Union Health Programme (Executive Agency for Health & Consumers), "EuroHeart II" (European Heart Health Strategy 2; ADONIS code A/100946) provided additional funding for the study methodology. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MCG and PB also received support from the National Institute for Health Research's School for Public Health Research (NIHR SPHR).	Amcoff E, 2010, RIKSMATEN VUXNA 2010; [Anonymous], 2008, PHYS ACT ENV; Aspelund T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013957; BENGTSSON C, 1993, BMJ-BRIT MED J, V307, P1385, DOI 10.1136/bmj.307.6916.1385; Berg CM, 2005, EUR J CARDIOV PREV R, V12, P115, DOI 10.1097/00149831-200504000-00005; Berg J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-9; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2000, CIRCULATION, P102; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Hughes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138044; Johansson I, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-40; Jordbruksverket, 2013, STATISTIK FRAN JORDB; KEYS A, 1950, SCIENCE, V112, P79, DOI 10.1126/science.112.2899.79; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; LAW MR, 1994, BMJ-BRIT MED J, V308, P363, DOI 10.1136/bmj.308.6925.363; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mann J, 2009, LANCET, V374, P767, DOI 10.1016/S0140-6736(09)61575-0; MIETTINEN M, 1983, INT J EPIDEMIOL, V12, P17, DOI 10.1093/ije/12.1.17; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; National Institute for Health Care and Excellence (NICE), 2008, PROM PHYS ACT WORKPL; NICE, 2009, PROM PHYS ACT CHILDR; NICE, 2010, PREV CARD DIS POP LE; Nichols M, 2013, EUR HEART J, V34, P3028, DOI 10.1093/eurheartj/eht356; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Keeffe C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002837; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Rad N, 2005, NORDIC NUTRITION REC; Rosengren A, 2009, J INTERN MED, V266, P268, DOI 10.1111/j.1365-2796.2009.02116.x; SBU, 2007, MATT FORH BLODT UPPD; TURPEINEN O, 1979, INT J EPIDEMIOL, V8, P99, DOI 10.1093/ije/8.2.99; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	42	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160474	10.1371/journal.pone.0160474	http://dx.doi.org/10.1371/journal.pone.0160474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490257	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000381368900062
J	Chen, QY; Zobel, J; Zhang, XZ; Verspoor, K				Chen, Qingyu; Zobel, Justin; Zhang, Xiuzhen; Verspoor, Karin			Supervised Learning for Detection of Duplicates in Genomic Sequence Databases	PLOS ONE			English	Article							CD-HIT; PROTEIN	Motivation First identified as an issue in 1996, duplication in biological databases introduces redundancy and even leads to inconsistency when contradictory information appears. The amount of data makes purely manual de-duplication impractical, and existing automatic systems cannot detect duplicates as precisely as can experts. Supervised learning has the potential to address such problems by building automatic systems that learn from expert curation to detect duplicates precisely and efficiently. While machine learning is a mature approach in other duplicate detection contexts, it has seen only preliminary application in genomic sequence databases. Results We developed and evaluated a supervised duplicate detection method based on an expert curated dataset of duplicates, containing over one million pairs across five organisms derived from genomic sequence databases. We selected 22 features to represent distinct attributes of the database records, and developed a binary model and a multi-class model. Both models achieve promising performance; under cross-validation, the binary model had over 90% accuracy in each of the five organisms, while the multi-class model maintains high accuracy and is more robust in generalisation. We performed an ablation study to quantify the impact of different sequence record features, finding that features derived from metadata, sequence identity, and alignment quality impact performance most strongly. The study demonstrates machine learning can be an effective additional tool for de-duplication of genomic sequence databases. All Data are available as described in the supplementary material.	[Chen, Qingyu; Zobel, Justin; Verspoor, Karin] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia; [Zhang, Xiuzhen] RMIT Univ, Sch Sci, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Institute of Technology (RMIT)	Verspoor, K (corresponding author), Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic, Australia.	karin.verspoor@unimelb.edu.au	Verspoor, Karin/G-6034-2016; Chen, Qingyu/Q-8343-2019	Verspoor, Karin/0000-0002-8661-1544; Chen, Qingyu/0000-0002-6036-1516; Zhang, Xiuzhen (Jenny)/0000-0001-5558-3790	Australian Research Council [DP150101550]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council Discovery program, grant number DP150101550.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Bilenko M, 2003, IEEE INTELL SYST, V18, P16, DOI 10.1109/MIS.2003.1234765; Bilenko M., 2003, P ACM INTCONF KNOWLE, P39; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chaudhuri S., 2003, SIGMOD C, P313, DOI [10.1145/872757.872796, DOI 10.1145/872757.872796]; Chen Q, 2015, ACM 9 INT WORKSH DAT; Christen P, 2007, QUALITY MEASURES DAT, P127, DOI DOI 10.1007/978-3-540-44918-8_6; Consortium UniProt, 2015, NUCLEIC ACIDS RES; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Elmagarmid AK, 2007, IEEE T KNOWL DATA EN, V19, P1, DOI 10.1109/TKDE.2007.250581; Fitzgerald J, 2014, UNDERSTANDING FRAUD; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Holm L, 1998, BIOINFORMATICS, V14, P423, DOI 10.1093/bioinformatics/14.5.423; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Huang HZ, 2011, BIOINFORMATICS, V27, P1190, DOI 10.1093/bioinformatics/btr101; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Joffe Erel, 2013, AMIA Annu Symp Proc, V2013, P721; Joffe E, 2014, J AM MED INFORM ASSN, V21, P97, DOI 10.1136/amiajnl-2013-001744; Koh JL, 2004, LOCUS, V501; Korf I., 2003, BLAST; Korning PG, 1996, NUCLEIC ACIDS RES, V24, P316, DOI 10.1093/nar/24.2.316; Kpcke H., 2012, P 15 INT C EXT DAT T, P545, DOI DOI 10.1145/2247596.2247662; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liang Feng, 2013, Web Technologies and Applications. 15th Asia-Pacific Web Conference, APWeb 2013. Proceedings, P709, DOI 10.1007/978-3-642-37401-2_69; Lin YS, 2013, EXPERT SYST APPL, V40, P1467, DOI 10.1016/j.eswa.2012.08.045; Martins B, 2011, LECT NOTES COMPUT SC, V6631, P34, DOI 10.1007/978-3-642-20630-6_3; Percudani R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat071; Poux S, 2014, J BIOL DATABASES CUR, V2014, P10; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Roy RS, 2015, WWW'15 COMPANION: PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P103, DOI 10.1145/2740908.2742750; Rudniy A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-187; Rudniy A, 2010, INT J DATA MIN BIOIN, V4, P395, DOI 10.1504/IJDMB.2010.034196; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Smith TF, 1997, NAT BIOTECHNOL, V15, P1222, DOI 10.1038/nbt1197-1222; Song M, 2010, KNOWL INF SYST, V25, P371, DOI 10.1007/s10115-009-0254-7; Suhara Y, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P1157; Wenfei Fan, 2012, Web-Age Information Management. Proceedings of the 13th International Conference, WAIM 2012, P1, DOI 10.1007/978-3-642-32281-5_1; Zorita E, 2015, BIOINFORMATICS, V31, P1913, DOI 10.1093/bioinformatics/btv053	40	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159644	10.1371/journal.pone.0159644	http://dx.doi.org/10.1371/journal.pone.0159644			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27489953	Green Submitted, gold, Green Published			2022-12-27	WOS:000381368900014
J	Ho, D; Jensen, P; Gutierrez-Zamora, ML; Beckmann, S; Manefield, M; Batstone, D				Ho, Dang; Jensen, Paul; Gutierrez-Zamora, Maria-Luisa; Beckmann, Sabrina; Manefield, Mike; Batstone, Damien			High-rate, High Temperature Acetotrophic Methanogenesis Governed by a Three Population Consortium in Anaerobic Bioreactors	PLOS ONE			English	Article							ACETATE-OXIDIZING BACTERIUM; SP NOV.; COPROTHERMOBACTER-PROTEOLYTICUS; COMMUNITY STRUCTURE; GEN. NOV.; SP. NOV.; DIGESTION; SLUDGE; PATHWAYS; SAMPLES	A combination of acetate oxidation and acetoclastic methanogenesis has been previously identified to enable high-rate methanogenesis at high temperatures (55 to 65 degrees C), but this capability had not been linked to any key organisms. This study combined RNA-stable isotope probing on C-13-labelled acetate and 16S amplicon sequencing to identify the active micro-organisms involved in high-rate methanogenesis. Active biomass was harvested from three bench-scale thermophilic bioreactors treating waste activated sludge at 55, 60 and 65 degrees C, and fed with C-13- labelled and C-12-unlabelled acetate. Acetate uptake and cumulative methane production were determined and kinetic parameters were estimated using model-based analysis. Pyrosequencing performed on C-13-enriched samples indicated that organisms accumulating labelled carbon were Coprothermobacter (all temperatures between 55 and 65 degrees C), acetoclastic Methanosarcina (55 to 60 degrees C) and hydrogenotrophic Methanothermobacter (60 to 65 degrees C). The increased relative abundance of Coprothermobacter with increased temperature corresponding with a shift to syntrophic acetate oxidation identified this as a potentially key oxidiser. Methanosarcina likely acts as both a hydrogen utilising and acetoclastic methanogen at 55 degrees C, and is replaced by Methanothermobacter as a hydrogen utiliser at higher temperatures.	[Ho, Dang; Jensen, Paul; Batstone, Damien] Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia; [Gutierrez-Zamora, Maria-Luisa; Beckmann, Sabrina; Manefield, Mike] Univ New South Wales, Ctr Marine BioInnovat, Sch Biotechnol & Biomol Sci, Kensington, NSW, Australia	University of Queensland; University of New South Wales Sydney	Batstone, D (corresponding author), Univ Queensland, Adv Water Management Ctr, St Lucia, Qld, Australia.	d.batstone@awmc.uq.edu.au	; Batstone, Damien/N-1896-2014	Beckmann, Sabrina/0000-0001-8882-9400; Jensen, Paul/0000-0002-9819-1516; Batstone, Damien/0000-0002-4294-3942				Amani T, 2010, ENVIRON REV, V18, P255, DOI 10.1139/A10-011; Angelidaki I, 2009, WATER SCI TECHNOL, V59, P927, DOI 10.2166/wst.2009.040; Appels L, 2010, BIORESOURCE TECHNOL, V101, P5743, DOI 10.1016/j.biortech.2010.02.068; Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Barret M, 2013, APPL ENVIRON MICROB, V79, P424, DOI 10.1128/AEM.02268-12; Batstone DJ, 2011, TREATISE ON WATER SCIENCE, VOL 4: WATER-QUALITY ENGINEERING, P615; Beckmann S, 2011, APPL ENVIRON MICROB, V77, P3749, DOI 10.1128/AEM.02818-10; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Etchebehere C, 1998, INT J SYST BACTERIOL, V48, P1297, DOI 10.1099/00207713-48-4-1297; Ferry J.G, 2012, METHANOGENESIS ECOLO; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Goberna M, 2009, APPL ENVIRON MICROB, V75, P2566, DOI 10.1128/AEM.02260-08; Godwin S, 2014, ISME J; Hattori S, 2000, INT J SYST EVOL MICR, V50, P1601, DOI 10.1099/00207713-50-4-1601; Ho D, 2014, ENVIRON SCI TECHNOL, V48, P6468, DOI 10.1021/es500074j; Ho DP, 2013, APPL ENVIRON MICROB, V79, P6491, DOI 10.1128/AEM.01730-13; Horz HP, 2005, J CLIN MICROBIOL, V43, P5332, DOI 10.1128/JCM.43.10.5332-5337.2005; Kamagata Y., 1989, DIVERSITY ACETOTROPH; Karakashev D, 2005, APPL ENVIRON MICROB, V71, P331, DOI 10.1128/AEM.71.1.331-338.2005; KERSTERS I, 1994, SYST APPL MICROBIOL, V17, P289, DOI 10.1016/S0723-2020(11)80021-4; Krakat N, 2010, APPL ENVIRON MICROB, V76, P1842, DOI 10.1128/AEM.02397-09; Lu F, 2013, WATER RES, V47, P2297, DOI 10.1016/j.watres.2013.01.049; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Pervin HM, 2013, WATER RES, V47, P7098, DOI 10.1016/j.watres.2013.07.053; Regueiro L, 2012, MICROBIOL RES, V167, P581, DOI 10.1016/j.micres.2012.06.002; REICHERT P, 1994, WATER SCI TECHNOL, V30, P21, DOI 10.2166/wst.1994.0025; Sasaki D, 2011, J BIOSCI BIOENG, V111, P41, DOI 10.1016/j.jbiosc.2010.08.011; Sasaki K, 2011, J BIOSCI BIOENG, V112, P469, DOI 10.1016/j.jbiosc.2011.07.003; Schnurer A, 1996, INT J SYST BACTERIOL, V46, P1145, DOI 10.1099/00207713-46-4-1145; VanLier JB, 1996, WATER RES, V30, P199, DOI 10.1016/0043-1354(95)00107-V; Vanwonterghem I, 2015, SCI REP, V5; Westerholm M, 2011, SYST APPL MICROBIOL, V34, P260, DOI 10.1016/j.syapm.2010.11.018; Westerholm M, 2010, FEMS MICROBIOL LETT, V309, P100, DOI 10.1111/j.1574-6968.2010.02023.x; Whiteley AS, 2007, NAT PROTOC, V2, P838, DOI 10.1038/nprot.2007.115; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; ZINDER SH, 1979, APPL ENVIRON MICROB, V38, P996, DOI 10.1128/AEM.38.5.996-1008.1979; [No title captured], DOI DOI 10.1016/0273-1177(89)90215-9	38	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159760	10.1371/journal.pone.0159760	http://dx.doi.org/10.1371/journal.pone.0159760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490246	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900017
J	Oberbeckmann, S; Osborn, AM; Duhaime, MB				Oberbeckmann, Sonja; Osborn, A. Mark; Duhaime, Melissa B.			Microbes on a Bottle: Substrate, Season and Geography Influence Community Composition of Microbes Colonizing Marine Plastic Debris	PLOS ONE			English	Article							SURFACE WATERS; PHYLOGENETIC DIVERSITY; MICROPLASTIC POLLUTION; BACTERIAL COMMUNITIES; GENOME SEQUENCE; SP-NOV; INGESTION; BIOFILMS; LIFE; BIODEGRADATION	Plastic debris pervades in our oceans and freshwater systems and the potential ecosystem-level impacts of this anthropogenic litter require urgent evaluation. Microbes readily colonize aquatic plastic debris and members of these biofilm communities are speculated to include pathogenic, toxic, invasive or plastic degrading-species. The influence of plastic-colonizing microorganisms on the fate of plastic debris is largely unknown, as is the role of plastic in selecting for unique microbial communities. This work aimed to characterize microbial biofilm communities colonizing single-use poly(ethylene terephthalate) (PET) drinking bottles, determine their plastic-specificity in contrast with seawater and glass-colonizing communities, and identify seasonal and geographical influences on the communities. A substrate recruitment experiment was established in which PET bottles were deployed for 5-6 weeks at three stations in the North Sea in three different seasons. The structure and composition of the PET-colonizing bacterial/archaeal and eukaryotic communities varied with season and station. Abundant PET-colonizing taxa belonged to the phylum Bacteroidetes (e.g. Flavobacteriaceae, Cryomorphaceae, Saprospiraceae-all known to degrade complex carbon substrates) and diatoms (e.g. Coscinodiscophytina, Bacillariophytina). The PET-colonizing microbial communities differed significantly from free-living communities, but from particleassociated (>3 mu m) communities or those inhabiting glass substrates. These data suggest that microbial community assembly on plastics is driven by conventional marine biofilm processes, with the plastic surface serving as raft for attachment, rather than selecting for recruitment of plastic-specific microbial colonizers. A small proportion of taxa, notably, members of the Cryomorphaceae and Alcanivoraceae, were significantly discriminant of PET but not glass surfaces, conjuring the possibility that these groups may directly interact	[Oberbeckmann, Sonja; Osborn, A. Mark] Univ Hull, Dept Biol Sci, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England; [Oberbeckmann, Sonja; Osborn, A. Mark] Lincoln Univ, Sch Life Sci, Brayford Pool LN6 7TS, Lincs, England; [Oberbeckmann, Sonja] Leibniz Inst Balt Sea Res, Environm Microbiol Working Grp, Warnemunde, Germany; [Osborn, A. Mark] RMIT Univ, Sch Appl Sci, POB 77, Bundoora, Vic 3083, Australia; [Duhaime, Melissa B.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Hull; University of Lincoln; Leibniz Institut fur Ostseeforschung Warnemunde; Royal Melbourne Institute of Technology (RMIT); University of Michigan System; University of Michigan	Duhaime, MB (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	duhaimem@umich.edu	Osborn, Andrew M/F-5466-2015	Osborn, Andrew M/0000-0002-6433-0581; Oberbeckmann, Sonja/0000-0001-9709-0783	Society for General Microbiology [PFRV12/20]; Elizabeth C. Crosby Research Award (University of Michigan ADVANCE); University of Hull; University of Lincoln; Department for Environment, Food and Rural Affairs (DEFRA)	Society for General Microbiology; Elizabeth C. Crosby Research Award (University of Michigan ADVANCE); University of Hull; University of Lincoln; Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by a President's Fund for Research Visit Grants by the Society for General Microbiology (http://www.sgm.ac.uk/) to S.O. (Grant number PFRV12/20) and an Elizabeth C. Crosby Research Award (University of Michigan ADVANCE: http://sitemaker.umich.edu/advance/crosby_research_fund) to M.B.D. The Universities of Hull and Lincoln supported the work of S.O. and A.M.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Centre for Environment, Fisheries & Aquaculture Science (CEFAS) for operating and allowing access to the SmartBuoys and their collected environmental data, in particular Naomi Greenwood, the SmartBuoy team and the crew of RV Endeavour. The contribution of CEFAS took place within the SmartBuoy and Wavenet programs funded by the Department for Environment, Food and Rural Affairs (DEFRA). Gunnar Gerdts for advice on concept and experimental design, Leonie Elie for guidance on the scanning electron microscope, the Denef, Dick, and Schloss Labs at the University of Michigan for technical support regarding sequence library prep and analysis, and Thomas Jenkinson for providing Saccharomyces cerevisiae positive control DNA.	Abell GCJ, 2005, FEMS MICROBIOL ECOL, V53, P379, DOI 10.1016/j.femsec.2005.01.008; Amaral-Zettler LA, 2015, FRONT ECOL ENVIRON, V13, P541, DOI 10.1890/150017; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Artham T, 2009, INT BIODETER BIODEGR, V63, P884, DOI 10.1016/j.ibiod.2009.03.003; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Becker RA, 2014, MAPS DRAW GEOGRAPHIC; Briand JF, 2012, BIOFOULING, V28, P453, DOI 10.1080/08927014.2012.688957; Brinkhoff T, 2012, ISME J, V6, P1260, DOI 10.1038/ismej.2011.190; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Chronopoulou PM, 2015, MICROB BIOTECHNOL, V8, P434, DOI 10.1111/1751-7915.12176; Clarke KR, 2006, PRIMER V 6 USER MANU; COLTON JB, 1974, SCIENCE, V185, P491, DOI 10.1126/science.185.4150.491; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Crespo BG, 2013, MICROBIOLOGYOPEN, V2, P541, DOI 10.1002/mbo3.92; Danovaro R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007006; Deguchi T, 1998, APPL ENVIRON MICROB, V64, P1366; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Denner EBM, 2001, INT J SYST EVOL MICR, V51, P827, DOI 10.1099/00207713-51-3-827; Dubinsky EA, 2013, ENVIRON SCI TECHNOL, V47, P10860, DOI 10.1021/es401676y; Duhaime MB, 2011, ISME J, V5, P107, DOI 10.1038/ismej.2010.94; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Eich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137201; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Foekema EM, 2013, ENVIRON SCI TECHNOL, V47, P8818, DOI 10.1021/es400931b; Free CM, 2014, MAR POLLUT BULL, V85, P156, DOI 10.1016/j.marpolbul.2014.06.001; Freitas S, 2012, ISME J, V6, P1499, DOI 10.1038/ismej.2012.3; Ghiglione JF, 2007, MICROB ECOL, V54, P217, DOI 10.1007/s00248-006-9189-7; Gilan I, 2004, APPL MICROBIOL BIOT, V65, P97, DOI 10.1007/s00253-004-1584-8; GIOVANNONI SJ, 1988, J BACTERIOL, V170, P720, DOI 10.1128/jb.170.2.720-726.1988; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Hankett JM, 2016, ENVIRON SCI TECHNOL, V50, P1304, DOI 10.1021/acs.est.5b05598; Harrison JP, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0232-4; Harrison JP, 2011, MAR TECHNOL SOC J, V45, P12, DOI 10.4031/MTSJ.45.2.2; Hirai H, 2011, MAR POLLUT BULL, V62, P1683, DOI 10.1016/j.marpolbul.2011.06.004; Hoellein T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098485; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Khandeparker L, 2014, MAR ECOL-EVOL PERSP, V35, P233, DOI 10.1111/maec.12077; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lee OO, 2014, SCI REP-UK, V4, DOI 10.1038/srep03587; Leefmann T, 2015, GEOMICROBIOL J, V32, P197, DOI 10.1080/01490451.2014.910570; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Lopez-Perez M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00696; Mackinson S, 2007, ECOSYSTEM MODEL N SE, V142, P196; Maso M, 2003, SCI MAR, V67, P107, DOI 10.3989/scimar.2003.67n1107; Matsuyama H, 2008, INT J SYST EVOL MICR, V58, P1576, DOI 10.1099/ijs.0.65791-0; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; McIlroy S. J., 2014, PROKARYOTES, P863, DOI [10.1007/978-3-642-38954-2_138, DOI 10.1007/978-3-642-38954-2_138]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Michelou VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067480; Mills DK, 2003, ELSEV OCEANOGR SERIE, V69, P311; Miranda LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058269; Mohit V, 2014, APPL ENVIRON MICROB, V80, P2071, DOI 10.1128/AEM.02916-13; Oberbeckmann S, 2015, ENV CHEM; Oberbeckmann S, 2014, FEMS MICROBIOL ECOL, V90, P478, DOI 10.1111/1574-6941.12409; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ortega-Retuerta E, 2013, BIOGEOSCIENCES, V10, P2747, DOI 10.5194/bg-10-2747-2013; Palinska KA, 2008, ARCH MICROBIOL, V189, P325, DOI 10.1007/s00203-007-0323-9; Pham CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095839; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Reisser J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100289; Riedel T, 2012, STAND GENOMIC SCI, V7, P120, DOI 10.4056/sigs.3296896; Robards AW, 1993, PROCEDURES ELECT MIC; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Russell JR, 2011, APPL ENVIRON MICROB, V77, P6076, DOI 10.1128/AEM.00521-11; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Salta M, 2013, ENVIRON MICROBIOL, V15, P2879, DOI 10.1111/1462-2920.12186; Sapp M, 2007, FEMS MICROBIOL ECOL, V59, P622, DOI 10.1111/j.1574-6941.2006.00238.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneiker S, 2006, NAT BIOTECHNOL, V24, P997, DOI 10.1038/nbt1232; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Setala O, 2014, ENVIRON POLLUT, V185, P77, DOI 10.1016/j.envpol.2013.10.013; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Sinha V, 2010, J POLYM ENVIRON, V18, P8, DOI 10.1007/s10924-008-0106-7; Sivan A, 2006, APPL MICROBIOL BIOT, V72, P346, DOI 10.1007/s00253-005-0259-4; Suzuki M, 2001, INT J SYST EVOL MICR, V51, P1639, DOI 10.1099/00207713-51-5-1639; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053; TORGERSON W, 1958, THEORY METHODS SCALI; Witt V, 2011, FEMS MICROBIOL LETT, V323, P188, DOI 10.1111/j.1574-6968.2011.02374.x; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Xia Y, 2008, APPL ENVIRON MICROB, V74, P2229, DOI 10.1128/AEM.02502-07; Yang J, 2014, ENVIRON SCI TECHNOL, V48, P13776, DOI 10.1021/es504038a; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zbyszewski M, 2014, J GREAT LAKES RES, V40, P288, DOI 10.1016/j.jglr.2014.02.012; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x; Zobell CE, 1943, J BACTERIOL, V46, P39, DOI 10.1128/JB.46.1.39-56.1943	104	245	250	26	272	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159289	10.1371/journal.pone.0159289	http://dx.doi.org/10.1371/journal.pone.0159289			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487037	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000381367800024
J	Sun, PG; Miao, HX; Yu, XM; Jia, CH; Liu, JH; Zhang, JB; Wang, JY; Wang, Z; Wang, AB; Xu, BY; Jin, ZQ				Sun, Peiguang; Miao, Hongxia; Yu, Xiaomeng; Jia, Caihong; Liu, Juhua; Zhang, Jianbin; Wang, Jingyi; Wang, Zhuo; Wang, Anbang; Xu, Biyu; Jin, Zhiqiang			A Novel Role for Banana MaASR in the Regulation of Flowering Time in Transgenic Arabidopsis	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; GENE-EXPRESSION; CIRCADIAN CLOCK; LOCUS-C; VERNALIZATION; PROTEIN; DESICCATION; CONSTANS; HOMOLOG; TARGETS	The abscisic acid (ABA)-, stress-, and ripening-induced (ASR) protein is a plant-specific hydrophilic transcriptional factor involved in fruit ripening and the abiotic stress response. To date, there have been no studies on the role of ASR genes in delayed flowering time. Here, we found that the ASR from banana, designated as MaASR, was preferentially expressed in the banana female flowers from the eighth, fourth, and first cluster of the inflorescence. MaASR transgenic lines (L14 and L38) had a clear delayed-flowering phenotype. The number of rosette leaves, sepals, and pedicel trichomes in L14 and L38 was greater than in the wild type (WT) under long day (LD) conditions. The period of buds, mid-flowers, and full bloom of L14 and L38 appeared later than the WT. cDNA microarray and quantitative real-time PCR (qRT-PCR) analyses revealed that overexpression of MaASR delays flowering through reduced expression of several genes, including photoperiod pathway genes, vernalization pathway genes, gibberellic acid pathway genes, and floral integrator genes, under short days (SD) for 28 d (from vegetative to reproductive transition stage); however, the expression of the autonomous pathway genes was not affected. This study provides the first evidence of a role for ASR genes in delayed flowering time in plants.	[Sun, Peiguang; Wang, Anbang; Jin, Zhiqiang] Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou 570102, Peoples R China; [Miao, Hongxia; Yu, Xiaomeng; Jia, Caihong; Liu, Juhua; Zhang, Jianbin; Wang, Jingyi; Wang, Zhuo; Xu, Biyu; Jin, Zhiqiang] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou 571101, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Jin, ZQ (corresponding author), Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou 570102, Peoples R China.; Xu, BY; Jin, ZQ (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou 571101, Peoples R China.	biyuxu@126.com; 18689846976@163.com	WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China (NSFC) [31401843]; Modern Agroindustry Technology Research System [CARS32]; Natural Science Foundation of Hainan Province [314100]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Modern Agroindustry Technology Research System; Natural Science Foundation of Hainan Province	The authors would like to acknowledge funding from the National Natural Science Foundation of China (NSFC, No. 31401843), the Modern Agroindustry Technology Research System (No. CARS32), and the Natural Science Foundation of Hainan Province (No. 314100).	Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Ayre BG, 2004, PLANT PHYSIOL, V135, P2271, DOI 10.1104/pp.104.040592; Castede S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143250; Castillejo C, 2005, PLANT J, V43, P586, DOI 10.1111/j.1365-313X.2005.02476.x; Cheng XF, 2005, PLANT J, V43, P758, DOI 10.1111/j.1365-313X.2005.02491.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Diallo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008690; Ding F, 2015, J NANOMATER, V2015, DOI 10.1155/2015/791529; Fourquin C, 2014, NEW PHYTOL, V202, P1001, DOI 10.1111/nph.12703; Frankel N, 2007, PLANT MOL BIOL, V63, P719, DOI 10.1007/s11103-006-9120-0; Golan I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107117; Golembeski GS, 2014, ADV BOT RES, V72, P1, DOI 10.1016/B978-0-12-417162-6.00001-8; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Dominguez PG, 2013, PLANT PHYSIOL, V161, P1486, DOI 10.1104/pp.112.208199; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hanano S, 2011, PLANT CELL, V23, P3172, DOI 10.1105/tpc.111.088641; Henderson IR, 2003, ANNU REV GENET, V37, P371, DOI 10.1146/annurev.genet.37.110801.142640; Hu Q, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0263-x; Jang YH, 2009, PLANT CELL PHYSIOL, V50, P1479, DOI 10.1093/pcp/pcp093; Johansson M, 2015, J EXP BOT, V66, P719, DOI 10.1093/jxb/eru441; Kim Y, 2012, MOL PLANT, V5, P678, DOI 10.1093/mp/sss005; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li WX, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003937; Liu WY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096051, 10.1371/journal.pone.0088077]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0602-6; Marquardt S, 2006, J EXP BOT, V57, P3379, DOI 10.1093/jxb/erl073; Matias-Hernandez L, 2016, J EXP BOT, V67, P1209, DOI 10.1093/jxb/erv534; Miao HX, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0204-x; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Poduska B, 2003, GENETICS, V163, P1457; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Ricardi MM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-29; Rosas U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4651; Shu K, 2016, J EXP BOT, V67, P195, DOI 10.1093/jxb/erv459; TIWARI V, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0131567; Wada T, 2015, PLANT SCI, V241, P260, DOI 10.1016/j.plantsci.2015.10.015; Wang CS, 1998, PLANT CELL PHYSIOL, V39, P1307, DOI 10.1093/oxfordjournals.pcp.a029335; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Xu BY, 2007, PLANTA, V226, P529, DOI 10.1007/s00425-007-0502-6; Yang CY, 2008, PROTOPLASMA, V233, P241, DOI 10.1007/s00709-008-0016-5; Zhang LL, 2015, FUNCT INTEGR GENOMIC, V15, P247, DOI 10.1007/s10142-014-0415-y; Zhang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124108	49	5	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160690	10.1371/journal.pone.0160690	http://dx.doi.org/10.1371/journal.pone.0160690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486844	Green Submitted, gold, Green Published			2022-12-27	WOS:000381367800091
J	Tian, YL; Zhang, HX				Tian, Yuling; Zhang, Hongxian			Research on B Cell Algorithm for Learning to Rank Method Based on Parallel Strategy	PLOS ONE			English	Article								For the purposes of information retrieval, users must find highly relevant documents from within a system (and often a quite large one comprised of many individual documents) based on input query. Ranking the documents according to their relevance within the system to meet user needs is a challenging endeavor, and a hot research topic-there already exist several rank-learning methods based on machine learning techniques which can generate ranking functions automatically. This paper proposes a parallel B cell algorithm, RankBCA, for rank learning which utilizes a clonal selection mechanism based on biological immunity. The novel algorithm is compared with traditional rank-learning algorithms through experimentation and shown to outperform the others in respect to accuracy, learning time, and convergence rate; taken together, the experimental results show that the proposed algorithm indeed effectively and rapidly identifies optimal ranking functions.	[Tian, Yuling; Zhang, Hongxian] Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan, Peoples R China	Taiyuan University of Technology	Tian, YL (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan, Peoples R China.	tianyuling@tyut.edu.cn			National Natural Science Foundation Project "Research on immune intelligent method of abnormal tracking detection and diagnosis for large-scale mining equipment" [61472271]; Shanxi Province Natural Science Foundation Project "Study of early fault diagnosis model" [2013011018-1]	National Natural Science Foundation Project "Research on immune intelligent method of abnormal tracking detection and diagnosis for large-scale mining equipment"; Shanxi Province Natural Science Foundation Project "Study of early fault diagnosis model"	Support as provided by National Natural Science Foundation Project "Research on immune intelligent method of abnormal tracking detection and diagnosis for large-scale mining equipment" (61472271); Shanxi Province Natural Science Foundation Project "Study of early fault diagnosis model" (2013011018-1).	Chen JS, 2015, IEEE SIGNAL PROC LET, V22, P90, DOI 10.1109/LSP.2014.2347419; Clark E, 2005, LECT NOTES COMPUT SC, V3627, P318; De Almeida HM, 2007, P 30 ANN INT ACM SIG, P399; He Q., 2010, P 19 ACM INT C INF K, P1449; Lin JY, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND CYBERNETICS (CYBERNETICSCOM), P45, DOI 10.1109/CyberneticsCom.2012.6381614; Liu B, 2015, BIOINFORMATICS, V31, P3492, DOI 10.1093/bioinformatics/btv413; Musilek P, 2006, INFORM SCIENCES, V176, P972, DOI 10.1016/j.ins.2005.03.009; Qin T, 2010, INFORM RETRIEVAL, V13, P346, DOI 10.1007/s10791-009-9123-y; Tie-Yan Liu, 2009, Foundations and Trends in Information Retrieval, V3, P225, DOI 10.1561/1500000016; Timmis J, 2003, GENETIC EVOLUTIONARY; Wang SQ, 2015, IEEE T KNOWL DATA EN, V27, P3152, DOI 10.1109/TKDE.2015.2453952; Wang SAQ, 2010, EXPERT SYST APPL, V37, P5863, DOI 10.1016/j.eswa.2010.02.019; Xia Fen, 2008, P 25 INT C MACH LEAR, P1192, DOI DOI 10.1145/1390156.1390306; Xu J., 2008, P 31 ANN INT ACM SIG, P107, DOI DOI 10.1145/1390334.1390355; Yang XX, 2015, IEEE T RELIAB, V64, P234, DOI 10.1109/TR.2014.2370891; Yu J, 2015, IEEE T CYBERNETICS, V45, P767, DOI 10.1109/TCYB.2014.2336697; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	18	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0157994	10.1371/journal.pone.0157994	http://dx.doi.org/10.1371/journal.pone.0157994			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487242	Green Submitted, Green Published, gold			2022-12-27	WOS:000381367800007
J	Verma, RK; Abela, E; Schindler, K; Krestel, H; Springer, E; Huber, A; Weisstanner, C; Hauf, M; Gralla, J; Wiest, R				Verma, Rajeev Kumar; Abela, Eugenio; Schindler, Kaspar; Krestel, Heinz; Springer, Elisabeth; Huber, Adrian; Weisstanner, Christian; Hauf, Martinus; Gralla, Jan; Wiest, Roland			Focal and Generalized Patterns of Cerebral Cortical Veins Due to Non-Convulsive Status Epilepticus or Prolonged Seizure Episode after Convulsive Status Epilepticus - A MRI Study Using Susceptibility Weighted Imaging	PLOS ONE			English	Article							BRAIN PERFUSION CT; EPILEPSY; ABNORMALITIES; FREQUENCY; ADULTS	Objective The aim of this study was to investigate variant patterns of cortical venous oxygenation during status epilepticus (SE) using susceptibility-weighted imaging (SWI). Methods We analyzed magnetic resonance imaging (MRI) scans of 26 patients with clinically witnessed prolonged seizures and/or EEG-confirmed SE. All MRI exams encompassed SWI, dynamic susceptibility contrast perfusion MRI (MRI-DSC) and diffusion-weighted imaging (DWI). We aimed to identify distinct patterns of SWI signal alterations that revealed regional or global increases of cerebral blood flow (CBF) and DWI restrictions. We hypothesized that SWI-related oxygenation patterns reflect ictal or postictal patterns that resemble SE or sequelae of seizures. Results Sixteen patients were examined during nonconvulsive status epilepticus (NCSE) as confirmed by EEG, a further ten patients suffered from witnessed and prolonged seizure episode ahead of imaging without initial EEG. MRI patterns of 15 of the 26 patients revealed generalized hyperoxygenation by SWI in keeping with either global or multifocal cortical hyperperfusion. Eight patients revealed a focal hyperoxygenation pattern related to focal CBF increase and three patients showed a focal deoxygenation pattern related to focal CBF decrease. Conclusions SWI-related hyper- and deoxygenation patterns resemble ictal and postictal CBF changes within a range from globally increased to focally decreased perfusion. In all 26 patients the SWI patterns were in keeping with ictal hyperperfusion (hyperoxygenation patterns) or postictal hypoperfusion (deoxygenation patterns) respectively. A new finding of this study is that cortical venous patterns in SWI can be not only focally, but globally attenuated. SWI may thus be considered as an alternative contrast-free MR sequence to identify perfusion changes related to ictal or postictal conditions.	[Verma, Rajeev Kumar; Springer, Elisabeth; Weisstanner, Christian; Hauf, Martinus; Gralla, Jan; Wiest, Roland] Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland; [Verma, Rajeev Kumar] Tiefenau Hosp, Inst Radiol & Neuroradiol, Bern, Switzerland; [Abela, Eugenio; Schindler, Kaspar; Krestel, Heinz] Univ Bern, Dept Neurol, Inselspital, Bern, Switzerland; [Huber, Adrian] Univ Bern, Univ Inst Diagnost & Intervent Radiol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern	Verma, RK (corresponding author), Univ Bern, Inselspital, Univ Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland.; Verma, RK (corresponding author), Tiefenau Hosp, Inst Radiol & Neuroradiol, Bern, Switzerland.	rajeev.verma@insel.ch	Huber, Adrian/N-5713-2016; Schindler, Kaspar/L-7115-2013; Huber, Adrian/ABA-2766-2020	Huber, Adrian/0000-0001-6146-8238; Schindler, Kaspar/0000-0002-2387-7767; Abela, Eugenio/0000-0002-9356-1450; Weisstanner, Christian/0000-0003-2830-1000; Krestel, Heinz Eric/0000-0001-8742-0232	Swiss National Foundation (SNF) [140332]	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF))	This study was supported be the Swiss National Foundation (SNF) Grant No. 140332 "Imaging large scale neuronal networks in epilepsy". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aellen J, 2014, EUR RADIOL, V24, P2980, DOI 10.1007/s00330-014-3284-9; Alroughani R, 2009, SEIZURE-EUR J EPILEP, V18, P38, DOI 10.1016/j.seizure.2008.06.013; Assal F, 2001, SEIZURE-EUR J EPILEP, V10, P260, DOI 10.1053/seiz.2000.0506; Cianfoni A, 2013, EUR J RADIOL, V82, P1964, DOI 10.1016/j.ejrad.2013.05.020; Engelhorn T, 2007, AM J NEURORADIOL, V28, P321; Gelfand JM, 2010, EUR J NEUROL, V17, P594, DOI 10.1111/j.1468-1331.2009.02869.x; Grand S, 2013, Diagn Interv Imaging, V94, P1241, DOI 10.1016/j.diii.2013.06.009; Hauf M, 2009, AM J NEURORADIOL, V30, P693, DOI 10.3174/ajnr.A1456; Hauf M, 2013, PSYCHIAT RES-NEUROIM, V211, P268, DOI 10.1016/j.pscychresns.2012.06.007; Kaplan PW, 2006, J CLIN NEUROPHYSIOL, V23, P221, DOI 10.1097/01.wnp.0000220837.99490.66; Kiefer C, 2016, RADIOLOGY, V280, P237, DOI 10.1148/radiol.2016150368; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; la Fougere C, 2009, EPILEPSY BEHAV, V15, P50, DOI 10.1016/j.yebeh.2009.02.025; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Meierkord H, 2007, LANCET NEUROL, V6, P329, DOI 10.1016/S1474-4422(07)70074-1; Mendes A, 2016, SEIZURE-EUR J EPILEP, V38, P63, DOI 10.1016/j.seizure.2016.04.007; Milligan TA, 2009, SEIZURE-EUR J EPILEP, V18, P104, DOI 10.1016/j.seizure.2008.07.004; Niquet J., 2012, JASPERS BASIC MECH E; Nixon J, 2001, SEIZURE-EUR J EPILEP, V10, P588, DOI 10.1053/seiz.2001.0553; Pizzini FB, 2013, MAGN RESON IMAGING, V31, P1001, DOI 10.1016/j.mri.2013.03.023; Power KN, 2015, SEIZURE-EUR J EPILEP, V24, P102, DOI 10.1016/j.seizure.2014.09.007; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; ROWE CC, 1989, ANN NEUROL, V26, P660, DOI 10.1002/ana.410260512; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; STEFAN H, 1990, ANN NEUROL, V27, P162, DOI 10.1002/ana.410270211; Storti SF, 2014, NEUROIMAGE, V102, P49, DOI 10.1016/j.neuroimage.2013.06.028; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; Wiest R, 2006, EPILEPSY RES, V72, P102, DOI 10.1016/j.eplepsyres.2006.07.017	28	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160495	10.1371/journal.pone.0160495	http://dx.doi.org/10.1371/journal.pone.0160495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486662	gold, Green Published			2022-12-27	WOS:000381367800078
J	Davies, BM; McHugh, M; Elgheriani, A; Kolias, AG; Tetreault, LA; Hutchinson, PJA; Fehlings, MG; Kotter, MRN				Davies, Benjamin M.; McHugh, Maire; Elgheriani, Ali; Kolias, Angelos G.; Tetreault, Lindsay A.; Hutchinson, Peter J. A.; Fehlings, Michael G.; Kotter, Mark R. N.			Reported Outcome Measures in Degenerative Cervical Myelopathy: A Systematic Review	PLOS ONE			English	Review							SPONDYLOTIC MYELOPATHY; TRIALS; SET	Objective Degenerative cervical myelopathy [DCM] is a disabling and increasingly prevalent group of diseases. Heterogeneous reporting of trial outcomes limits effective inter-study comparison and optimisation of treatment. This is recognised in many fields of healthcare research. The present study aims to assess the heterogeneity of outcome reporting in DCM as the premise for the development of a standardised reporting set. Methods A systematic review of MEDLINE and EMBASE databases, registered with PROSPERO (CRD42015025497) was conducted in accordance with PRISMA guidelines. Full text articles in English, with >50 patients (prospective) or >200 patients (retrospective), reporting outcomes of DCM were eligible. Results 108 studies, assessing 23,876 patients, conducted world-wide, were identified. Reported outcome themes included function (reported by 97, 90% of studies), complications (reported by 56, 52% of studies), quality of life (reported by 31, 29% of studies), pain (reported by 29, 27% of studies) and imaging (reported by 59, 55% of studies). Only 7 (6%) studies considered all of domains in a single publication. All domains showed variability in reporting. Conclusions Significant heterogeneity exists in the reporting of outcomes in DCM. The development of a consensus minimum dataset will facilitate future research synthesis.	[Davies, Benjamin M.; McHugh, Maire; Kolias, Angelos G.; Hutchinson, Peter J. A.; Kotter, Mark R. N.] Univ Cambridge, Dept Clin Neurosurg, Acad Neurosurg Unit, Cambridge, England; [Kotter, Mark R. N.] Univ Cambridge, Anne McLaren Lab, WT MRC Cambridge Stem Cell Inst, Cambridge, England; [Elgheriani, Ali; Tetreault, Lindsay A.; Fehlings, Michael G.; Kotter, Mark R. N.] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada; [Elgheriani, Ali; Tetreault, Lindsay A.; Fehlings, Michael G.; Kotter, Mark R. N.] Univ Toronto, Toronto, ON, Canada; [Hutchinson, Peter J. A.; Kotter, Mark R. N.] Univ Cambridge, John van Geest Brain Repair Ctr, Cambridge, England	University of Cambridge; University of Cambridge; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Cambridge	Kotter, MRN (corresponding author), Univ Cambridge, Dept Clin Neurosurg, Acad Neurosurg Unit, Cambridge, England.; Kotter, MRN (corresponding author), Univ Cambridge, Anne McLaren Lab, WT MRC Cambridge Stem Cell Inst, Cambridge, England.; Kotter, MRN (corresponding author), Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada.; Kotter, MRN (corresponding author), Univ Toronto, Toronto, ON, Canada.; Kotter, MRN (corresponding author), Univ Cambridge, John van Geest Brain Repair Ctr, Cambridge, England.	Mrk25@cam.ac.uk	Davies, Benjamin/AAB-6000-2019	Davies, Benjamin/0000-0003-0591-5069; Kotter, Mark/0000-0001-5145-7199; Kolias, Angelos/0000-0003-3992-0587; Fehlings, Michael/0000-0002-5722-6364	NIHR [National Institute Health Research] Clinician Scientist Award; NIHR research professorship; Medical Research Council [MC_PC_12009] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-013, ACF-2015-14-009, CS-2015-15-023] Funding Source: researchfish	NIHR [National Institute Health Research] Clinician Scientist Award; NIHR research professorship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the corresponding author (MRNK) NIHR [National Institute Health Research] Clinician Scientist Award. PJAH holds a NIHR research professorship.	Abma TA, 2005, QUAL HEALTH RES, V15, P1310, DOI 10.1177/1049732305282382; Boers M, 2014, J CLIN EPIDEMIOL, V67, P745, DOI 10.1016/j.jclinepi.2013.11.013; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chari A, 2016, J NEUROTRAUM, V33, P1212, DOI 10.1089/neu.2015.3983; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Fukui M, 2007, J ORTHOP SCI, V12, P227, DOI 10.1007/s00776-007-1118-1; Gargon E, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1038-x; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Hawthorne G, 2008, QUAL LIFE RES, V17, P1183, DOI 10.1007/s11136-008-9395-5; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Kalsi-Ryan S, 2013, SPINE, V38, pS111, DOI 10.1097/BRS.0b013e3182a7f499; Karadimas SK, 2015, EUR SPINE J, V24, pS132, DOI 10.1007/s00586-014-3264-4; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-21; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Longworth L, 2013, VALUE HEALTH, V16, P202, DOI 10.1016/j.jval.2012.10.010; Norvell DC, 2015, GLOB SPINE J, V5, P455, DOI 10.1055/s-0035-1566228; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Shiban E, 2014, NEUROLOGY CLIN PRACT; Singh A, 2005, ACTA NEUROCHIR, V147, P1235, DOI 10.1007/s00701-005-0639-7; Singh A, 2015, EUR SPINE J, V24, pS209, DOI 10.1007/s00586-013-2935-x; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Wu HL, 2012, SPINE, V37, P1958, DOI 10.1097/BRS.0b013e31825bfb85	25	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0157263	10.1371/journal.pone.0157263	http://dx.doi.org/10.1371/journal.pone.0157263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482710	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000381110700002
J	Dhamad, AE; Zhou, ZQ; Zhou, JH; Du, YC				Dhamad, Ahmed E.; Zhou, Zhenqi; Zhou, Jianhong; Du, Yuchun			Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ER alpha) and Biochemical Characterization of the ER alpha-Hsp70 Interaction	PLOS ONE			English	Article							BREAST-CANCER-CELLS; MITOCHONDRIAL LOCALIZATION; GLUCOCORTICOID-RECEPTOR; STEROID-RECEPTORS; NUCLEAR RECEPTORS; BINDING; EXPRESSION; HORMONE; DNA; PROTEASOME	Heat shock proteins (Hsps) are known to associate with estrogen receptors (ER) and regulate ER-mediated cell proliferation. Historically, the studies in this area have focused on Hsp90. However, some critical aspects of the Hsp-ER alpha interactions remain unclear. For example, we do not know which Hsps are the major or minor ER alpha interactants and whether or not different Hsp isoforms associate equally with ER alpha. In the present study, through a quantitative proteomic method we found that 21 Hsps and 3 Hsp cochaperones were associated with ER alpha in human 293T cells that were cultured in a medium containing necessary elements for cell proliferation. Four Hsp70s (Hsp70-1, Hsc70, Grp75, and Grp78) were the most abundant Hsps identified to associate with ER alpha, followed by two Hsp90s (Hsp90 alpha and Hsp90 beta) and three Hsp110s (Hsp105, HspA4, and HspA4L). Hsp90 alpha was found to be 2-3 times more abundant than Hsp90 beta in the ER alpha-containing complexes. Among the reported Hsp cochaperones, we detected prostaglandin E synthase 3 (p23), peptidyl-prolyl cis-trans isomerase FKBP5 (FKBP51), and E3 ubiquitin-protein ligase CHIP (CHIP). Studies with the two most abundant ER alpha-associated Hsps, Hsp70-1 and Hsc70, using human breast cancer MCF7 cells demonstrate that the two Hsps interacted with ER alpha in both the cytoplasm and nucleus when the cells were cultured in a medium supplemented with fetal bovine serum and phenol red. Interestingly, the ER alpha-Hsp70-1/Hsc70 interactions were detected only in the cytoplasm but not in the nucleus under hormone starvation conditions, and stimulation of the starved cells with 17 beta-estradiol (E2) did not change this. In addition, E2-treatment weakened the ER alpha-Hsc70 interaction but had no effect on the ER alpha-Hsp70-1 interaction. Further studies showed that significant portions of Hsp70-1 and Hsc70 were associated with transcriptionally active chromatin and inactive chromatin, and the two Hsps interacted with ER alpha in both forms of the chromatins in MCF7 cells.	[Dhamad, Ahmed E.; Zhou, Zhenqi; Zhou, Jianhong; Du, Yuchun] Univ Arkansas, Dept Biol Sci, Fayetteville, AR USA; [Zhou, Zhenqi] UCLA, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA USA	University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Du, YC (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR USA.		Dhamad, Ahmed E./H-2336-2018	Dhamad, Ahmed E./0000-0002-1846-5768	National Institutes of Health (NIH) [P30 GM103450, R03 CA169692]; Arkansas Biosciences Institute	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Biosciences Institute	This work was supported by National Institutes of Health (NIH) grants P30 GM103450 and R03 CA169692, and a grant from the Arkansas Biosciences Institute (YD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; BLAUSTEIN JD, 1992, ENDOCRINOLOGY, V131, P281, DOI 10.1210/en.131.1.281; Carrello A, 2004, CELL STRESS CHAPERON, V9, P167, DOI 10.1379/CSC-26R.1; CHAMBRAUD B, 1990, J BIOL CHEM, V265, P20686; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; Cheung J, 2000, MOL ENDOCRINOL, V14, P939, DOI 10.1210/me.14.7.939; DARBRE P, 1983, CANCER RES, V43, P349; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Demonacos CV, 1996, STEROIDS, V61, P226, DOI 10.1016/0039-128X(96)00019-0; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; Du YC, 2009, J PROTEOME RES, V8, P2211, DOI 10.1021/pr800662x; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; Echeverria PC, 2016, MOL CELL BIOL; ECKERT RL, 1984, ENDOCRINOLOGY, V114, P629, DOI 10.1210/endo-114-2-629; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; FATHALLAH DM, 1993, J IMMUNOL, V151, P810; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Gonzalez M, 2008, GEN COMP ENDOCR, V155, P857, DOI 10.1016/j.ygcen.2007.10.007; Govind AP, 2003, MOL CELL BIOCHEM, V253, P233, DOI 10.1023/A:1026068017309; Grad I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015770; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; HATTORI H, 1993, J CELL SCI, V104, P629; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; HICKEY E, 1989, MOL CELL BIOL, V9, P2615, DOI 10.1128/MCB.9.6.2615; Howe MK, 2014, CHEM BIOL, V21, P1648, DOI 10.1016/j.chembiol.2014.10.016; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; INANO K, 1994, J BIOCHEM-TOKYO, V116, P759, DOI 10.1093/oxfordjournals.jbchem.a124593; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kaneko Y, 1997, GENE, V189, P19, DOI 10.1016/S0378-1119(96)00807-4; Klinge CM, 1997, J STEROID BIOCHEM, V63, P283, DOI 10.1016/S0960-0760(97)00091-5; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; LANDEL CC, 1994, MOL ENDOCRINOL, V8, P1407, DOI 10.1210/me.8.10.1407; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Liu L, 2012, J PROTEOME RES, V11, P4091, DOI 10.1021/pr3001332; Messaoudi S, 2008, ANTI-CANCER AGENT ME, V8, P761, DOI 10.2174/187152008785914824; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Picard D, 2006, TRENDS ENDOCRIN MET, V17, P229, DOI 10.1016/j.tem.2006.06.003; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Powell E, 2010, J BIOL CHEM, V285, P16125, DOI 10.1074/jbc.M110.104356; Pratt WB, 2004, ESSAYS BIOCHEM, V40, P41, DOI 10.1042/bse0400041; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Ratajczak T, 1996, J BIOL CHEM, V271, P2961, DOI 10.1074/jbc.271.6.2961; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sanchez ER, 2012, BBA-MOL CELL RES, V1823, P722, DOI 10.1016/j.bbamcr.2011.11.006; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6986; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; SEGNITZ B, 1995, P NATL ACAD SCI USA, V92, P2179, DOI 10.1073/pnas.92.6.2179; SMITH DF, 1990, J BIOL CHEM, V265, P3996; SOLER AP, 1989, HISTOCHEMISTRY, V91, P351, DOI 10.1007/BF00493012; Sreedhar AS, 2004, FEBS LETT, V562, P11; SRINIVASAN G, 1994, MOL ENDOCRINOL, V8, P189, DOI 10.1210/me.8.2.189; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Voss AK, 2000, DEVELOPMENT, V127, P1; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Yager JD, 2007, TRENDS ENDOCRIN MET, V18, P89, DOI 10.1016/j.tem.2007.02.006; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Yang LQ, 2014, P NATL ACAD SCI USA, V111, P17809, DOI 10.1073/pnas.1414004111; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zaarur N, 2006, CANCER RES, V66, P1783, DOI 10.1158/0008-5472.CAN-05-3692; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhou JH, 2012, MOL CANCER RES, V10, P768, DOI 10.1158/1541-7786.MCR-11-0378; Zhou ZQ, 2012, BIOCHEM BIOPH RES CO, V427, P305, DOI 10.1016/j.bbrc.2012.09.047; Zhou ZQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011056; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	83	36	37	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160312	10.1371/journal.pone.0160312	http://dx.doi.org/10.1371/journal.pone.0160312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483141	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110700033
J	Kumakech, E; Berggren, V; Wabinga, H; Lillsunde-Larsson, G; Helenius, G; Kaliff, M; Karlsson, M; Kirimunda, S; Musubika, C; Andersson, S				Kumakech, Edward; Berggren, Vanja; Wabinga, Henry; Lillsunde-Larsson, Gabriella; Helenius, Gisela; Kaliff, Malin; Karlsson, Mats; Kirimunda, Samuel; Musubika, Caroline; Andersson, Soren			Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix (R)) Pilot Project in Uganda	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; VISUAL INSPECTION; CERVICAL-CANCER; HIGH COVERAGE; ACETIC-ACID; HPV; KAMPALA; PREVALENCE; HIV; EFFICACY	The objective of this study was to determine the prevalence and some predictors for vaccine and non-vaccine types of HPV infections among bivalent HPV vaccinated and non-vaccinated young women in Uganda. This was a comparative cross sectional study 5.5 years after a bivalent HPV 16/18 vaccination (Cervarix (R), GlaxoSmithKline, Belgium) pilot project in western Uganda. Cervical swabs were collected between July 2014-August 2014 and analyzed with a HPV genotyping test, CLART (R) HPV2 assay (Genomica, Madrid Spain) which is based on PCR followed by microarray for determination of genotype. Blood samples were also tested for HIV and syphilis infections as well as CD4 and CD8 lymphocyte levels. The age range of the participants was 15-24 years and mean age was 18.6(SD 1.4). Vaccine-type HPV-16/18 strains were significantly less prevalent among vaccinated women compared to non-vaccinated women (0.5% vs 5.6%, p 0.006, OR 95% CI 0.08 (0.01-0.64). At type-specific level, significant difference was observed for HPV16 only. Other STIs (HIV/syphilis) were important risk factors for HPV infections including both vaccine types and non-vaccine types. In addition, for non-vaccine HPV types, living in an urban area, having a low BMI, low CD4 count and having had a high number of life time sexual partners were also significant risk factors. Our data concurs with the existing literature from other parts of the world regarding the effectiveness of bivalent HPV-16/18 vaccine in reducing the prevalence of HPV infections particularly vaccine HPV-16/18 strains among vaccinated women. This study reinforces the recommendation to vaccinate young girls before sexual debut and integrate other STI particularly HIV and syphilis interventions into HPV vaccination packages.	[Kumakech, Edward; Lillsunde-Larsson, Gabriella; Helenius, Gisela; Karlsson, Mats; Andersson, Soren] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Kumakech, Edward; Wabinga, Henry; Kirimunda, Samuel; Musubika, Caroline] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Pathol, Kampala, Uganda; [Berggren, Vanja] Lund Univ, Fac Med, Lund, Sweden; [Berggren, Vanja] Karolinska Inst, Dept Publ Hlth, Global Hlth IHCAR, Stockholm, Sweden; [Lillsunde-Larsson, Gabriella; Helenius, Gisela; Kaliff, Malin; Karlsson, Mats; Andersson, Soren] Orebro Univ Hosp, Fac Med & Hlth, Dept Lab Med, Orebro, Sweden; [Lillsunde-Larsson, Gabriella; Helenius, Gisela; Kaliff, Malin; Karlsson, Mats; Andersson, Soren] Univ Orebro, Orebro, Sweden	Orebro University; Makerere University; Lund University; Karolinska Institutet; Orebro University; Orebro University	Kumakech, E (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden.; Kumakech, E (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Pathol, Kampala, Uganda.	Edward.kumakech@oru.se	Karlsson, Mats G/AAV-7542-2021; Berggren, Vanja/AAM-6526-2020	Karlsson, Mats G/0000-0001-6881-237X; Lillsunde Larsson, Gabriella/0000-0001-9992-266X; kirimunda, Samuel/0000-0002-8769-5516; Kumakech, Edward/0000-0002-7237-7734	Swedish International Development Cooperation Agency (SIDA) [SWE-2010-146/348-2013-6172]	Swedish International Development Cooperation Agency (SIDA)	This work was supported by project research grant Dnr: SWE-2010-146/348-2013-6172 from Swedish International Development Cooperation Agency (SIDA) to Dr. Vanja Berggren (PhD), the second author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1991, PRACTICAL STATISTIC; Banura C, 2008, INT J CANCER, V123, P2180, DOI 10.1002/ijc.23762; Banura C, 2008, J INFECT DIS, V197, P555, DOI 10.1086/526792; Banura C, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-11; Banura Cecily, 2010, Infect Agent Cancer, V5, P7, DOI 10.1186/1750-9378-5-7; Beck, 2008, NURSING RES GENERATI; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Chranioti A, 2012, ANAL QUANT CYTOL, V34, P257; Delere Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-87; Downing RG, 1998, J ACQ IMMUN DEF SYND, V18, P384, DOI 10.1097/00042560-199808010-00011; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038; Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940; IARC, 2012, GLOBOCAN 2012 EST CA; International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISKS HU, V100; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; JOHNSON D, 1995, J ACQ IMMUN DEF SYND, V10, P522, DOI 10.1097/00042560-199510050-00005; Kavanagh K, 2014, BRIT J CANCER, V110, P2804, DOI 10.1038/bjc.2014.198; LaMontagne DS, 2011, B WORLD HEALTH ORGAN, V89, P821, DOI [10.2471/BLT.11.089862, 10.2471/BLT.11.08986]; Lu BB, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-13; Luger A, 1983, WIEN KLIN WOCHENSCHR, V95, P440; Mesher D, 2013, VACCINE, V32, P26, DOI 10.1016/j.vaccine.2013.10.085; Moses E, 2015, TROP MED INT HEALTH, V20, P1355, DOI 10.1111/tmi.12549; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Odida M, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-8; Odida M, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-85; Palmroth J, 2012, INT J CANCER, V131, P2832, DOI 10.1002/ijc.27586; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pista A, 2011, J MED VIROL, V83, P272, DOI 10.1002/jmv.21952; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Wabinga HR, 2014, INT J CANCER, V135, P432, DOI 10.1002/ijc.28661; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	35	4	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160099	10.1371/journal.pone.0160099	http://dx.doi.org/10.1371/journal.pone.0160099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27482705	gold, Green Published			2022-12-27	WOS:000381110700023
J	Madhwani, T; McBain, AJ				Madhwani, Tejal; McBain, Andrew J.			The Application of Magnetic Bead Selection to Investigate Interactions between the Oral Microbiota and Salivary Immunoglobulins	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS; HUMORAL IMMUNITY; RIBOSOMAL DNA; DENTAL PLAQUE; HUMAN INFANTS; INDIVIDUALS; COMMUNITIES; ANTIBODIES; RESPONSES; CHILDREN	The effect of humoral immunity on the composition of the oral microbiota is less intensively investigated than hygiene and diet, in part due to a lack of simple and robust systems for investigating interactions between salivary immunoglobulins and oral bacteria. Here we report the application of an ex situ method to investigate the specificity of salivary immunoglobulins for salivary bacteria. Saliva collected from six volunteers was separated into immunoglobulin and microbial fractions, and the microbial fractions were then directly exposed to salivary immunoglobulins of "self" and "non-self" origin. Antibody-selected bacteria were separated from their congeners using a magnetic bead system, selective for IgA or IgG isotypes. The positively selected fractions were then characterized using gel-based eubacterial-specific DNA profiling. The eubacterial profiles of positively selected fractions diverged significantly from profiles of whole salivary consortia based on volunteer (P <= 0.001%) and immunoglobulin origin (P <= 0.001%), but not immunoglobulin isotype (P = 0.2). DNA profiles of separated microbial fractions were significantly (p <= 0.05) less diverse than whole salivary consortia and included oral and environmental bacteria. Consortia selected using self immunoglobulins were generally less diverse than those selected with immunoglobulins of non-self origin. Magnetic bead separation facilitated the testing of interactions between salivary antibodies and oral bacteria, showing that these interactions are specific and may reflect differences in recognition by self and non-self immunoglobulins. Further development of this system could improve understanding of the relationship between the oral microbiota and the host immune system and of mechanisms underlying the compositional stability of the oral microbiota.	[Madhwani, Tejal; McBain, Andrew J.] Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England	University of Manchester	McBain, AJ (corresponding author), Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England.	andrew.mcbain@manchester.ac.uk		McBain, Andrew/0000-0002-5255-5425	British Council (UK); Indian Government under the UK-India Education and research initiative (UK-IERI) postgraduate funding scheme	British Council (UK); Indian Government under the UK-India Education and research initiative (UK-IERI) postgraduate funding scheme	This work was funded jointly by British Council (UK) and the Indian Government under the UK-India Education and research initiative (UK-IERI) postgraduate funding scheme.	Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Cauci S, 2002, AM J OBSTET GYNECOL, V187, P877, DOI 10.1067/mob.2002.127454; Celenligil H, 1998, J PERIODONTOL, V69, P571, DOI 10.1902/jop.1998.69.5.571; Cole MF, 2004, CLIN DIAGN LAB IMMUN, V11, P473, DOI 10.1128/CDLI.11.3.473-482.2004; Cole MF, 1999, INFECT IMMUN, V67, P1878; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; Drisko CL, 2013, PERIODONTOL 2000, V62, P243, DOI 10.1111/prd.12012; Gafan GP, 2004, J CLIN MICROBIOL, V42, P4141, DOI 10.1128/JCM.42.9.4141-4146.2004; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; Hocini H, 2000, J IMMUNOL METHODS, V235, P53, DOI 10.1016/S0022-1759(99)00214-8; Kampoo K, 2014, APPL ENVIRON MICROB, V80, P662, DOI 10.1128/AEM.02821-13; Kilian M, 2002, MOL MICROBIOL, V46, P1367, DOI 10.1046/j.1365-2958.2002.03254.x; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Ledder RG, 2007, APPL ENVIRON MICROB, V73, P516, DOI 10.1128/AEM.01419-06; Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068157, 10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057, 10.1371/journal.pone.0067018, 10.1371/journal.pone.0063139]; Ling ZX, 2013, MICROB ECOL, V65, P487, DOI 10.1007/s00248-012-0123-x; MEDAGLINI D, 1995, P NATL ACAD SCI USA, V92, P6868, DOI 10.1073/pnas.92.15.6868; Monteiro-da-Silva F, 2014, MED MYCOL, V52, P496, DOI 10.1093/mmy/myu027; NIEMINEN A, 1993, SCAND J DENT RES, V101, P196; Nogueira RD, 2005, INFECT IMMUN, V73, P5675, DOI 10.1128/IAI.73.9.5675-5684.2005; NORHAGEN G, 1989, J CLIN IMMUNOL, V9, P279, DOI 10.1007/BF00918659; PEARCE C, 1995, J MED MICROBIOL, V42, P67, DOI 10.1099/00222615-42-1-67; Plombas M, 2002, J PERIODONTOL, V73, P1507, DOI 10.1902/jop.2002.73.12.1507; Rasiah IA, 2005, ARCH ORAL BIOL, V50, P779, DOI 10.1016/j.archoralbio.2005.02.001; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WILLIAMS RC, 1972, SCIENCE, V177, P697, DOI 10.1126/science.177.4050.697; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Wright CJ, 2013, MOL ORAL MICROBIOL, V28, P83, DOI 10.1111/omi.12012	32	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0158288	10.1371/journal.pone.0158288	http://dx.doi.org/10.1371/journal.pone.0158288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483159	Green Published, gold, Green Submitted			2022-12-27	WOS:000381110700005
J	Norling, M; Karlsson-Lindsjo, OE; Gourle, H; Bongcam-Rudloff, E; Hayer, J				Norling, Martin; Karlsson-Lindsjo, Oskar E.; Gourle, Hadrien; Bongcam-Rudloff, Erik; Hayer, Juliette			MetLab: An In Silico Experimental Design, Simulation and Analysis Tool for Viral Metagenomics Studies	PLOS ONE			English	Article							PHYLOGENETIC CLASSIFICATION; COVERAGE; ALIGNMENT	Metagenomics, the sequence characterization of all genomes within a sample, is widely used as a virus discovery tool as well as a tool to study viral diversity of animals. Metagenomics can be considered to have three main steps; sample collection and preparation, sequencing and finally bioinformatics. Bioinformatic analysis of metagenomic datasets is in itself a complex process, involving few standardized methodologies, thereby hampering comparison of metagenomics studies between research groups. In this publication the new bioinformatics framework MetLab is presented, aimed at providing scientists with an integrated tool for experimental design and analysis of viral metagenomes. MetLab provides support in designing the metagenomics experiment by estimating the sequencing depth needed for the complete coverage of a species. This is achieved by applying a methodology to calculate the probability of coverage using an adaptation of Stevens' theorem. It also provides scientists with several pipelines aimed at simplifying the analysis of viral metagenomes, including; quality control, assembly and taxonomic binning. We also implement a tool for simulating metagenomics datasets from several sequencing platforms. The overall aim is to provide virologists with an easy to use tool for designing, simulating and analyzing viral metagenomes. The results presented here include a benchmark towards other existing software, with emphasis on detection of viruses as well as speed of applications. This is packaged, as comprehensive software, readily available for Linux and OSX users at https://github.com/norling/metlab.	[Norling, Martin] Uppsala Univ, NBIS, Uppsala, Sweden; [Karlsson-Lindsjo, Oskar E.; Gourle, Hadrien; Bongcam-Rudloff, Erik; Hayer, Juliette] Swedish Univ Agr Sci SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden; [Karlsson-Lindsjo, Oskar E.] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth BVF, Uppsala, Sweden; [Karlsson-Lindsjo, Oskar E.] OIE Collaborating Ctr Biotechnol Based Diag Infec, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Hayer, J (corresponding author), Swedish Univ Agr Sci SLU, Dept Anim Breeding & Genet HGEN, SLU Global Bioinformat Ctr, Uppsala, Sweden.	juliette.hayer@slu.se	Gourlé, Hadrien/U-5711-2019; Hayer, Juliette/ABG-5814-2021	Gourlé, Hadrien/0000-0001-9807-1082; Hayer, Juliette/0000-0003-4899-9637; Karlsson Lindsjo, Oskar/0000-0003-1068-981X	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas [221-2012-586]; EU project AniBioThreat [Home/2009/ISEC/AG/191]; Prevention of and Fight against Crime Programme of the European Union; European Commission-Directorate General Home Affairs; EU FP7 [612583]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas(Swedish Research Council Formas); EU project AniBioThreat; Prevention of and Fight against Crime Programme of the European Union; European Commission-Directorate General Home Affairs; EU FP7(European Commission)	Financial support was obtained from The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, Formas (221-2012-586), http://www.formas.se/. This work has been supported by grants from the framework of the EU project AniBioThreat (grant agreement: Home/2009/ISEC/AG/191) with financial support from the Prevention of and Fight against Crime Programme of the European Union, European Commission-Directorate General Home Affairs. This publication reflects views only of the authors, and the European Commission cannot be held responsible for any use that may be made of the information contained therein http://ec.europa.eu/dgs/home-affairs/index_en.htm). The authors would like to express special thanks to the EU FP7 Project reference: 612583: "Developing an European American NGS Network" (DEANN).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S, 2010, BABRAHAM BIOINFORMAT; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Byrd AL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-262; Charuvaka A, 2010, IEEE INT C BIOINFORM, P171, DOI 10.1109/BIBM.2010.5706558; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Fousse L, 2007, ACM T MATH SOFTWARE, V33, DOI 10.1145/1236463.1236468; Ghosh TS, 2011, BIOINFORMATION, V6, P91, DOI 10.6026/97320630006091; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Hoff KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-520; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Karlsson OE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151481; Karlsson OE, 2013, BIOSECUR BIOTERROR, V11, pS146, DOI 10.1089/bsp.2012.0077; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/bfgp/elr035; Mande SS, 2012, BRIEF BIOINFORM, V13, P669, DOI 10.1093/bib/bbs054; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Mokili JL, 2012, CURR OPIN VIROL, V2, P63, DOI 10.1016/j.coviro.2011.12.004; Mrazek J, 2009, MOL BIOL EVOL, V26, P1163, DOI 10.1093/molbev/msp032; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Nalbantoglu OU, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-41; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rodriguez-R LM, 2014, ISME J, V8, P2349, DOI 10.1038/ismej.2014.76; Rodriguez-R LM, 2014, BIOINFORMATICS, V30, P629, DOI 10.1093/bioinformatics/btt584; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; Stanhope SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011652; Suzuki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036060; Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644; Wendl MC, 2013, J MATH BIOL, V67, P1141, DOI 10.1007/s00285-012-0586-x; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	61	8	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160334	10.1371/journal.pone.0160334	http://dx.doi.org/10.1371/journal.pone.0160334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479078	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000381110300041
J	Rosen, DL; Grodensky, CA; Holley, TK				Rosen, David L.; Grodensky, Catherine A.; Holley, Tara K.			Federally-Assisted Healthcare Coverage among Male State Prisoners with Chronic Health Problems	PLOS ONE			English	Article								Prisoners have higher rates of chronic diseases such as substance dependence, mental health conditions and infectious disease, as compared to the general population. We projected the number of male state prisoners with a chronic health condition who at release would be eligible or ineligible for healthcare coverage under the Affordable Care Act (ACA). We used ACA income guidelines in conjunction with reported pre-arrest social security benefits and income from a nationally representative sample of prisoners to estimate the number eligible for healthcare coverage at release. There were 643,290 US male prisoners aged 18-64 with a chronic health condition. At release, 73% in Medicaid-expansion states would qualify for Medicaid or tax credits. In non-expansion states, 54% would qualify for tax credits, but 22% (n = 69,827) had incomes of <= 100% the federal poverty limit and thus would be ineligible for ACA-mediated healthcare coverage. These prisoners comprise 11% of all male prisoners with a chronic condition. The ACA was projected to provide coverage to most male state prisoners with a chronic health condition; however, roughly 70,000 fall in the "coverage gap" and may require non-routine care at emergency departments. Mechanisms are needed to secure coverage for this at risk group and address barriers to routine utilization of health services.	[Rosen, David L.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Rosen, David L.; Grodensky, Catherine A.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Holley, Tara K.] Duke Univ, Dept Behav Med, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Rosen, DL (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC USA.; Rosen, DL (corresponding author), Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA.	drosen@med.unc.edu			National Institutes of Health [R21 MH099162]; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health [P30 AI50410]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD069204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by the National Institutes of Health (http://nih.gov/). This project was supported by the National Institutes of Health grant R21 MH099162 (DR). This publication also resulted (in part) from research supported by the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an National Institutes of Health funded program P30 AI50410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PRISONERS IN 2013; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Blair P, 2011, INCREASING ACCESS HL; Cuellar AE, 2012, HEALTH AFFAIR, V31, P931, DOI 10.1377/hlthaff.2011.0501; Frank Joseph W, 2014, Health Justice, V2, P6; Frank JW, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-16; Galarraga JE, 2015, ACAD EMERG MED; Garfield R, 2014, KAISER COMMISSION ME; Harrison Paige M, 2005, PRISONERS IN 2004; Kaiser Family Foundation, 2014, STAT ACT EXP MED AFF; Mallik-Kane K, 2008, HLTH PRISONER REENTR, P1; Maruschak L.M., 2015, MED PROBLEMS STATE F; Meyer JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042416; Mulako-Wangota J, 2015, COUNT TOTAL RELEASES; Office of Inspector General, 2014, ACC CAR PROV AV MED; Rich JD, 2014, HEALTH AFFAIR, V33, P462, DOI 10.1377/hlthaff.2013.1133; Rosen DL, 2014, AM J PUBLIC HEALTH, V104, P418, DOI 10.2105/AJPH.2013.301563; Rudowitz R, 2013, APPENDIX B WAIVERS C; United States Department of Justice. Bureau of Justice Statistics, 2007, ICPSR04572V1 US DEP; US Bureau of Labor Statistics, 2015, CONT OCC IND SER, VV, P1; Wang Emily A, 2012, Am J Public Health, V102, pe22, DOI 10.2105/AJPH.2012.300894; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P666, DOI 10.2105/AJPH.2008.144279	22	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0160085	10.1371/journal.pone.0160085	http://dx.doi.org/10.1371/journal.pone.0160085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27479089	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110300023
J	Staab, E; Thiele, GM; Clarey, D; Wyatt, TA; Romberger, DJ; Wells, AD; Dusad, A; Wang, D; Klassen, LW; Mikuls, TR; Duryee, MJ; Poole, JA				Staab, Elizabeth; Thiele, Geoffrey M.; Clarey, Dillon; Wyatt, Todd A.; Romberger, Debra J.; Wells, Adam D.; Dusad, Anand; Wang, Dong; Klassen, Lynell W.; Mikuls, Ted R.; Duryee, Michael J.; Poole, Jill A.			Toll-Like Receptor 4 Signaling Pathway Mediates Inhalant Organic Dust-Induced Bone Loss	PLOS ONE			English	Article							MUSCULOSKELETAL DISORDERS; LUNG INFLAMMATION; RISK-FACTORS; EXPOSURE; LIPOPOLYSACCHARIDE; ENDOTOXIN; DISEASE; WORKERS; COPD; METABOLISM	Agriculture workers have increased rates of airway and skeletal disease. Inhalant exposure to agricultural organic dust extract (ODE) induces bone deterioration in mice; yet, mechanisms underlying lung-bone crosstalk remain unclear. Because Toll-like receptor 2 (TLR2) and TLR4 are important in mediating the airway consequences of ODE, this study investigated their role in regulating bone responses. First, swine facility ODE stimulated wild-type (WT) bone marrow macrophages to form osteoclasts, and this finding was inhibited in TLR4 knock-out (KO), but not TLR2 KO cells. Next, using an established intranasal inhalation exposure model, WT, TLR2 KO and TLR4 KO mice were treated daily with ODE or saline for 3 weeks. ODE-induced airway neutrophil influx and cytokine/chemokine release were similarly reduced in TLR2 and TLR4 KO animals as compared to WT mice. Utilizing micro-computed tomography (CT), analysis of tibia showed loss of bone mineral density, volume and deterioration of bone micro-architecture and mechanical strength induced by ODE in WT mice were significantly reduced in TLR4 but not TLR2 KO animals. Bone marrow osteoclast precursor cell populations were analyzed by flow cytometry from exposed animals. In WT animals, exposure to inhalant ODE increased osteoclast precursor cell populations as compared to saline, an effect that was reduced in TLR4 but not TLR2 KO mice. These results show that TLR2 and TLR4 pathways mediate ODE-induced airway inflammation, but bone deterioration consequences following inhalant ODE treatment is strongly dependent upon TLR4. Thus, the TLR4 signaling pathway appears critical in regulating the lung-bone inflammatory axis to microbial component-enriched organic dust exposures.	[Staab, Elizabeth; Clarey, Dillon; Wyatt, Todd A.; Romberger, Debra J.; Wells, Adam D.; Poole, Jill A.] Univ Nebraska Med Ctr, Dept Internal Med, Pulm Crit Care Sleep & Allergy Div, Omaha, NE 68198 USA; [Thiele, Geoffrey M.; Wyatt, Todd A.; Romberger, Debra J.; Klassen, Lynell W.; Mikuls, Ted R.; Duryee, Michael J.] Vet Affairs Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA; [Thiele, Geoffrey M.; Dusad, Anand; Wang, Dong; Klassen, Lynell W.; Mikuls, Ted R.; Duryee, Michael J.] Univ Nebraska Med Ctr, Div Rheumatol, Dept Internal Med, Omaha, NE USA; [Wyatt, Todd A.] Univ Nebraska Med Ctr, Dept Environm Agr & Occupat Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Poole, JA (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Pulm Crit Care Sleep & Allergy Div, Omaha, NE 68198 USA.	japoole@unmc.edu		Duryee, Michael/0000-0001-9104-2238	National Institute of Environmental Health Sciences [R01ES019325]; National Institute of Occupational Safety and Health [U54OH010162, R01OH008539]; Central States Center for Agricultural Safety and Health (CS-CASH); Nebraska Tobacco Settlement Biomedical Research Development Fund; Eugene Kenney Memorial Research UNMC Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019325] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Central States Center for Agricultural Safety and Health (CS-CASH); Nebraska Tobacco Settlement Biomedical Research Development Fund; Eugene Kenney Memorial Research UNMC Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences (R01ES019325 to JAP) http://www.niehs.nih.gov/, National Institute of Occupational Safety and Health (U54OH010162 to JAP and TAW and R01OH008539 to DJR) http://www.cdc.gov/niosh/, Central States Center for Agricultural Safety and Health (CS-CASH) in partnership with Nebraska Tobacco Settlement Biomedical Research Development Fund (JAP), and Eugene Kenney Memorial Research UNMC Fund (JAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469; Bauer C, 2013, AM J RESP CELL MOL, V48, P781, DOI 10.1165/rcmb.2012-0479OC; Bellido M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3103; Boissy RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095578; Charavaryamath C, 2008, EXP LUNG RES, V34, P19, DOI 10.1080/01902140701807779; Chauhan V, 2012, POSTGRAD MED, V124, P80, DOI 10.3810/pgm.2012.05.2551; Dosman JA, 2004, EUR RESPIR J, V24, P698, DOI 10.1183/09031936.04.00112102; Dusad A, 2015, IMMUNOL RES, V62, P46, DOI 10.1007/s12026-015-8634-4; Dusad A, 2013, AM J RESP CELL MOL, V49, P829, DOI 10.1165/rcmb.2013-0178OC; Eduard W, 2009, CHEST, V136, P716, DOI 10.1378/chest.08-2192; Gao ZW, 2013, ANN ALLERG ASTHMA IM, V110, P44, DOI 10.1016/j.anai.2012.11.003; Graat-Verboom L, 2012, BONE, V50, P1234, DOI 10.1016/j.bone.2012.02.638; Halleen JM, 2006, CLIN LAB, V52, P499; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Jacome-Galarza C, 2014, J CELL BIOCH; Jacome-Galarza CE, 2011, J BONE MINER RES, V26, P1207, DOI 10.1002/jbmr.324; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Jung JW, 2014, ANN ALLERG ASTHMA IM, V112, P426, DOI 10.1016/j.anai.2014.02.013; Kobara M, 2010, CARDIOVASC RES, V87, P424, DOI 10.1093/cvr/cvq078; Koide M, 2010, PERIODONTOL 2000, V54, P235, DOI 10.1111/j.1600-0757.2010.00355.x; Lehouck A, 2011, CHEST, V139, P648, DOI 10.1378/chest.10-1427; Leon ME, 2011, INT J ENV RES PUB HE, V8, P1341, DOI 10.3390/ijerph8051341; Liang BL, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-10; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Man JP, 2012, CHEST, V141, P837, DOI 10.1378/chest.11-2483; May S, 2012, J TOXICOL ENV HEAL B, V15, P524, DOI 10.1080/10937404.2012.744288; Merchant JA, 2005, ENVIRON HEALTH PERSP, V113, P350, DOI 10.1289/ehp.7240; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Osborne A, 2012, AM J IND MED, V55, P376, DOI 10.1002/ajim.22001; Osborne A, 2012, AM J IND MED, V55, P143, DOI 10.1002/ajim.21033; Poole JA, 2015, J TOXICOL ENV HEAL A, V78, P1201, DOI 10.1080/15287394.2015.1075165; Poole JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0272-9; Poole JA, 2015, J IMMUNOTOXICOL, V12, P64, DOI 10.3109/1547691X.2014.882449; Poole JA, 2011, AM J RESP CELL MOL, V45, P711, DOI 10.1165/rcmb.2010-0427OC; Poole JA, 2010, J TOXICOL ENV HEAL A, V73, P684, DOI 10.1080/15287390903578539; Poole JA, 2009, AM J PHYSIOL-LUNG C, V296, pL1085, DOI 10.1152/ajplung.90622.2008; RASKANDERSEN A, 1989, BRIT J IND MED, V46, P412; Robertson Julie, 2010, Br J Nurs, V19, P636; Schett G, 2008, AUTOIMMUNITY, V41, P224, DOI 10.1080/08916930701694717; SCHWARTZ DA, 1995, AM J RESP CRIT CARE, V152, P603, DOI 10.1164/ajrccm.152.2.7633714; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Sundblad BM, 2009, EUR RESPIR J, V34, P80, DOI 10.1183/09031936.00105308; Takahashi Naoyuki, 2007, V135, P285; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Xiao YL, 2013, P NATL ACAD SCI USA, V110, P12385, DOI 10.1073/pnas.1216082110; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206	47	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0158735	10.1371/journal.pone.0158735	http://dx.doi.org/10.1371/journal.pone.0158735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479208	gold, Green Submitted, Green Published			2022-12-27	WOS:000381110300006
J	Sala, A; Herrmann, B; De Carlo, F; Lucchetti, A; Brcic, J				Sala, Antonello; Herrmann, Bent; De Carlo, Francesco; Lucchetti, Alessandro; Brcic, Jure			Effect of Codend Circumference on the Size Selection of Square-Mesh Codends in Trawl Fisheries	PLOS ONE			English	Article							HAKE MERLUCCIUS-MERLUCCIUS; MULLET MULLUS-BARBATUS; DIAMOND-MESH; MEDITERRANEAN TRAWL; END SELECTIVITY; TWINE THICKNESS; GADUS-MORHUA; CATCH SIZE; HADDOCK; SEA	It is well established that increasing mesh number in the circumference of a diamond-mesh trawl codend can reduce size selection for round fish, whereas selection for flat fish species is unaffected. This effect has also been documented in Mediterranean trawl fisheries. In contrast, no information is available with regard to the effect of increasing mesh number in the circumference of square-mesh codends on the size selection of round fish and flat fish species. A field study was devised to bridge this gap and formulate proposals aimed at improving trawl fishery management. Size selection data were collected for a round fish species, red mullet (Mullus barbatus), and two flat fish species, Mediterranean scaldfish (Arnoglossus laterna) and solenette (Buglossidium luteum). Fishing trials were conducted in the Adriatic Sea (Central Mediterranean) using three square-mesh codends that differed only in mesh number around the circumference. Results demonstrated that increasing the number of meshes from 107 to 213 reduced the 50% retention length (L50) for red mullet by 2.5 cm but did not affect size selection for the two flat fish species. In some fisheries, regulatory provisions regarding the number of meshes in the circumference should therefore be carefully considered both for diamond- and square-mesh codends.	[Sala, Antonello; De Carlo, Francesco; Lucchetti, Alessandro] Italian Natl Res Council CNR, Inst Marine Sci ISMAR, Ancona, Italy; [Brcic, Jure] Univ Split, Dept Marine Studies, Split, Croatia; [Herrmann, Bent] SINTEF Fisheries & Aquaculture, Fishing Gear Technol, North Sea Sci Pk, Hirtshals, Denmark; [Herrmann, Bent] Univ Tromso, Tromso, Norway	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Split; SINTEF; UiT The Arctic University of Tromso	Sala, A (corresponding author), Italian Natl Res Council CNR, Inst Marine Sci ISMAR, Ancona, Italy.	a.sala@ismar.cnr.it	Sala, Antonello/B-8517-2016; Brčić, Jure/D-4337-2017; Lucchetti, Alessandro/AAV-7188-2020; lucchetti, alessandro/K-7264-2012	Sala, Antonello/0000-0001-7066-1152; Lucchetti, Alessandro/0000-0001-8418-9848; Herrmann, Bent/0000-0003-1325-6198; Brcic, Jure/0000-0003-3181-1749	European project "BENTHIS: Benthic ecosystem fisheries impact study" - EC Commission through the Seventh Framework Programme [KBBE 2012.1.2-09, 312088]; Flagship Project RITMARE "The Italian Research for the Sea"; Italian Ministry of Education, University and Research within the National Research Programme	European project "BENTHIS: Benthic ecosystem fisheries impact study" - EC Commission through the Seventh Framework Programme; Flagship Project RITMARE "The Italian Research for the Sea"; Italian Ministry of Education, University and Research within the National Research Programme	This work was partially funded by the European project "BENTHIS: Benthic ecosystem fisheries impact study" (KBBE 2012.1.2-09, Grant Agreement No. 312088), financed by the EC Commission through the Seventh Framework Programme and by the Flagship Project RITMARE "The Italian Research for the Sea", coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the 2011-2013 National Research Programme.; This work was partially funded by the European project "BENTHIS: Benthic ecosystem fisheries impact study" (KBBE 2012.1.2-09, Grant Agreement No. 312088), financed by the EC Commission through the Seventh Framework Programme and by the Flagship Project RITMARE "The Italian Research for the Sea", coordinated by the Italian National Research Council and funded by the Italian Ministry of Education, University and Research within the 20112013 National Research Programme. We are very grateful to Silvia Modena (Word Designs sas) for the final revision of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bahamon N, 2006, FISH RES, V81, P15, DOI 10.1016/j.fishres.2006.05.020; Brcic J, 2015, FISH RES, V172, P352, DOI 10.1016/j.fishres.2015.07.035; Brcic J, 2014, SCI MAR, V78, P135, DOI 10.3989/scimar.03819.24A; FRYER RJ, 1991, ICES J MAR SCI, V48, P281, DOI 10.1093/icesjms/48.3.281; GALBRAITH RD, 1994, FISH RES, V20, P13, DOI 10.1016/0165-7836(94)90003-5; Graham N, 2007, ICES J MAR SCI, V64, P744, DOI 10.1093/icesjms/fsm059; Guijarro B, 2006, ICES J MAR SCI, V63, P52, DOI 10.1016/j.icesjms.2005.08.011; Herrmann B, 2005, FISH RES, V71, P15, DOI 10.1016/j.fishres.2004.08.021; Herrmann B, 2016, FISHERIES R IN PRESS; Herrmann B, 2007, FISH RES, V84, P222, DOI 10.1016/j.fishres.2006.10.020; Herrmann B, 2006, FISH RES, V80, P221, DOI 10.1016/j.fishres.2006.04.008; Herrmann B, 2015, FISH RES, V167, P82, DOI 10.1016/j.fishres.2015.01.014; Herrmann B, 2013, FISH RES, V146, P59, DOI 10.1016/j.fishres.2013.04.004; Herrmann B, 2013, FISH RES, V145, P22, DOI 10.1016/j.fishres.2013.03.002; Herrmann B, 2009, FISH RES, V97, P59, DOI 10.1016/j.fishres.2009.01.002; Krag LA, 2011, FISH RES, V110, P225, DOI 10.1016/j.fishres.2011.03.009; Krag LA, 2008, FISH RES, V91, P175, DOI 10.1016/j.fishres.2007.11.022; Lok A, 1997, FISH RES, V32, P149, DOI 10.1016/S0165-7836(97)00048-9; Lucchetti A, 2008, SCI MAR, V72, P451; Notti E, 2013, TECHNICAL SPECIFICAT, P310; O'Neill FG, 2007, ICES J MAR SCI, V64, P1558, DOI 10.1093/icesjms/fsm101; O'Neill FG, 2008, FISH RES, V94, P175, DOI 10.1016/j.fishres.2008.06.007; ONeill FG, 1996, FISH RES, V28, P291, DOI 10.1016/0165-7836(96)00501-2; Ozbilgin H, 2005, TURK J VET ANIM SCI, V29, P967; Petrakis G, 1997, ICES J MAR SCI, V54, P13, DOI 10.1006/jmsc.1996.0172; REEVES SA, 1992, ICES J MAR SCI, V49, P279, DOI 10.1093/icesjms/49.3.279; Sala A, 2013, MARE200905LOT1; Sala A, 2008, FISH RES, V93, P8, DOI 10.1016/j.fishres.2008.02.003; Sala A, 2006, AQUAT LIVING RESOUR, V19, P317, DOI 10.1051/alr:2007002; Sala A, 2015, FISH RES, V161, P182, DOI 10.1016/j.fishres.2014.07.011; Sala A, 2011, FISH RES, V110, P252, DOI 10.1016/j.fishres.2011.04.012; Sistiaga M, 2011, CAN J FISH AQUAT SCI, V68, P927, DOI 10.1139/F2011-017; Stewart PAM, 1985, SCOTT FISH RES REP, V32, P1; Tokac A, 2016, FISH RES, V174, P81, DOI 10.1016/j.fishres.2015.09.002; Wienbeck H, 2014, FISH RES, V150, P28, DOI 10.1016/j.fishres.2013.10.007; Wienbeck H, 2011, FISH RES, V109, P80, DOI 10.1016/j.fishres.2011.01.019; Wileman D.A., 1996, ICES COOP RES REP, V132, P126	38	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160354	10.1371/journal.pone.0160354	http://dx.doi.org/10.1371/journal.pone.0160354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472058	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516300043
J	Deng, LL; Wang, ZX; Yang, S; Song, JM; Que, F; Zhang, H; Feng, FQ				Deng, Lingli; Wang, Zhaoxia; Yang, Sheng; Song, Junmei; Que, Fei; Zhang, Hui; Feng, Fengqin			Improvement of Functional Properties of Wheat Gluten Using Acid Protease from Aspergillus usamii	PLOS ONE			English	Article							EMULSION-STABILIZING PROPERTIES; EMULSIFYING PROPERTIES; ENZYMATIC-HYDROLYSIS; FOAMING PROPERTIES; PROTEINS; PEPTIDES; TRANSGLUTAMINASE; ULTRAFILTRATION; OPTIMIZATION; VIBRATIONS	Hydrolysis parameters (temperature, E/S ratio, pH, and time) for acid protease (from Aspergillus usamii) hydrolysis of wheat gluten were optimized by response surface methodology (RSM) using emulsifying activity index (EAI) as the response factor. A temperature of 48.9 degrees C, E/S ratio of 1.60%, pH 3.0, hydrolysis time of 2.5 h was found to be the optimum condition to obtain wheat gluten hydrolysate with higher EAI. The solubility of wheat gluten was greatly improved by hydrolysis and became independent of pH over the studied range. Enzymatic hydrolysis resulted in dramatically increase in EAI, water and oil holding capacity. Molecular weight distribution results showed that most of the peptides above 10 kDa have been hydrolyzed into smaller peptides. The results of FTIR spectra and disulfide bond (SS) and sulfhydryl (SH) content suggested that a more extensional conformation was formed after hydrolysis, which could account for the improved functional properties.	[Deng, Lingli; Yang, Sheng; Zhang, Hui; Feng, Fengqin] Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci, Fuli Inst Food Sci,Zhejiang Key Lab Agrofood Proc, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Zhaoxia] Shanghe Comprehens Testing Ctr, Jinan 251600, Peoples R China; [Wang, Zhaoxia; Song, Junmei] Qilu Univ Technol, Sch Food & Bioengn, Jinan 250353, Peoples R China; [Que, Fei] Zhejiang Econ & Trade Polytech, Dept Appl Engn, Hangzhou 310018, Peoples R China	Zhejiang University; Qilu University of Technology	Zhang, H; Feng, FQ (corresponding author), Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Coll Biosyst Engn & Food Sci, Fuli Inst Food Sci,Zhejiang Key Lab Agrofood Proc, Hangzhou 310058, Zhejiang, Peoples R China.	hubert0513@zju.edu.cn; fengfq@zju.edu.cn	张, 辉/ABF-4186-2020; , 张辉/ABE-8532-2020; lingli, deng/M-4549-2019	lingli, deng/0000-0003-3105-9104	National High Technology Research and Development Project of China (863 project) [2013AA102207]; National Natural Science Foundation of China [31471622]; Zhejiang Province Natural Science Foundation of China [LY14C200010]; Fund of Fuli Institute of Food Science Zhejiang University [KY201401]	National High Technology Research and Development Project of China (863 project)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Fund of Fuli Institute of Food Science Zhejiang University	This work was supported by the National High Technology Research and Development Project of China (863 project) (Grant No. 2013AA102207), National Natural Science Foundation of China (Grant No. 31471622), Zhejiang Province Natural Science Foundation of China (Grant No. LY14C200010), and Fund of Fuli Institute of Food Science Zhejiang University (KY201401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebowale KO, 2002, NAHRUNG, V46, P311, DOI 10.1002/1521-3803(20020901)46:5&lt;311::AID-FOOD311&gt;3.0.CO;2-Z; Agyare KK, 2009, FOOD HYDROCOLLOID, V23, P72, DOI 10.1016/j.foodhyd.2007.11.012; Apichartsrangkoon A, 1998, FOOD CHEM, V63, P215, DOI 10.1016/S0308-8146(98)00004-1; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Berti C, 2007, J AGR FOOD CHEM, V55, P2482, DOI 10.1021/jf062623n; Bhaskar N, 2008, BIORESOURCE TECHNOL, V99, P4105, DOI 10.1016/j.biortech.2007.09.006; Caessens PWJR, 1999, J AGR FOOD CHEM, V47, P1856, DOI 10.1021/jf9809479; Chen LY, 2009, BIOMACROMOLECULES, V10, P3327, DOI 10.1021/bm900989y; Cui C, 2011, J FOOD PROCESS ENG, V34, P187, DOI 10.1111/j.1745-4530.2008.00348.x; Dadzie RG, 2013, FOOD SCI BIOTECHNOL, V22, P1531, DOI 10.1007/s10068-013-0248-9; DAVIDSON J, 1970, ANALYST, V95, P181, DOI 10.1039/an9709500181; Joye IJ, 2014, J AGR FOOD CHEM, V62, P2623, DOI 10.1021/jf5001343; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; Kong XZ, 2007, FOOD CHEM, V101, P615, DOI 10.1016/j.foodchem.2006.01.057; Larre C, 2000, CEREAL CHEM, V77, P121, DOI 10.1094/CCHEM.2000.77.2.121; Linares E, 2000, CEREAL CHEM, V77, P414, DOI 10.1094/CCHEM.2000.77.4.414; Lindsay MP, 1999, TRENDS FOOD SCI TECH, V10, P247, DOI 10.1016/S0924-2244(00)00004-2; Micard V, 2000, J AGR FOOD CHEM, V48, P2948, DOI 10.1021/jf0001785; Mimouni B, 1999, J SCI FOOD AGR, V79, P1048, DOI 10.1002/(SICI)1097-0010(19990515)79:7<1048::AID-JSFA327>3.3.CO;2-P; NEVSKAYA NA, 1976, BIOPOLYMERS, V15, P637, DOI 10.1002/bip.1976.360150404; PEARCE KN, 1978, J AGR FOOD CHEM, V26, P716, DOI 10.1021/jf60217a041; Popineau Y, 2002, J CEREAL SCI, V35, P327, DOI 10.1006/jcrs.2001.0437; Saberi AH, 2008, J AGRIC SCI TECHNOL, V10, P243; Shewry PR, 1997, J CEREAL SCI, V25, P207, DOI 10.1006/jcrs.1996.0100; Surowka K, 2004, TRENDS FOOD SCI TECH, V15, P153, DOI 10.1016/j.tifs.2003.09.013; SUSI H, 1988, APPL SPECTROSC, V42, P819, DOI 10.1366/0003702884428905; TORII H, 1992, J CHEM PHYS, V97, P92, DOI 10.1063/1.463528; Wang JS, 2006, J CEREAL SCI, V44, P93, DOI 10.1016/j.jcs.2006.04.002; Yamazaki E, 2005, PLANT FOOD HUM NUTR, V60, P17, DOI 10.1007/s11130-005-2537-9; Zhao J, 2011, FOOD CHEM, V128, P1029, DOI 10.1016/j.foodchem.2011.04.009	30	21	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160101	10.1371/journal.pone.0160101	http://dx.doi.org/10.1371/journal.pone.0160101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467884	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100111
J	Loffler-Wirth, H; Willscher, E; Ahnert, P; Wirkner, K; Engel, C; Loeffler, M; Binder, H				Loeffler-Wirth, Henry; Willscher, Edith; Ahnert, Peter; Wirkner, Kerstin; Engel, Christoph; Loeffler, Markus; Binder, Hans			Novel Anthropometry Based on 3D-Bodyscans Applied to a Large Population Based Cohort	PLOS ONE			English	Article							BODY SCANNER; CARDIOVASCULAR-DISEASE; EXPRESSION LANDSCAPES; ADIPOSE-TISSUE; RISK; OBESITY; WAIST; PARTICIPANTS; PREVALENCE; VALIDATION	Three-dimensional (3D) whole body scanners are increasingly used as precise measuring tools for the rapid quantification of anthropometric measures in epidemiological studies. We analyzed 3D whole body scanning data of nearly 10,000 participants of a cohort collected from the adult population of Leipzig, one of the largest cities in Eastern Germany. We present a novel approach for the systematic analysis of this data which aims at identifying distinguishable clusters of body shapes called body types. In the first step, our method aggregates body measures provided by the scanner into meta-measures, each representing one relevant dimension of the body shape. In a next step, we stratified the cohort into body types and assessed their stability and dependence on the size of the underlying cohort. Using self-organizing maps (SOM) we identified thirteen robust meta-measures and fifteen body types comprising between 1 and 18 percent of the total cohort size. Thirteen of them are virtually gender specific (six for women and seven for men) and thus reflect most abundant body shapes of women and men. Two body types include both women and men, and describe androgynous body shapes that lack typical gender specific features. The body types disentangle a large variability of body shapes enabling distinctions which go beyond the traditional indices such as body mass index, the waist-to-height ratio, the waist-to-hip ratio and the mortality-hazard ABSI-index. In a next step, we will link the identified body types with disease predispositions to study how size and shape of the human body impact health and disease.	[Loeffler-Wirth, Henry; Willscher, Edith; Loeffler, Markus; Binder, Hans] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Hartelstr 16-18, D-04107 Leipzig, Germany; [Loeffler-Wirth, Henry; Willscher, Edith; Ahnert, Peter; Wirkner, Kerstin; Engel, Christoph; Loeffler, Markus; Binder, Hans] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, LIFE, Philipp Rosenthal Str 27, D-04103 Leipzig, Germany; [Ahnert, Peter; Engel, Christoph; Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Hartelstr 16-18, D-04107 Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Loffler-Wirth, H (corresponding author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, Hartelstr 16-18, D-04107 Leipzig, Germany.; Loffler-Wirth, H (corresponding author), Univ Leipzig, Leipzig Res Ctr Civilizat Dis, LIFE, Philipp Rosenthal Str 27, D-04103 Leipzig, Germany.	wirth@izbi.uni-leipzig.de	Ahnert, Peter/I-8150-2015; Binder, Hans/U-5519-2018	Ahnert, Peter/0000-0002-1771-0856; Engel, Christoph/0000-0002-7247-282X; Loeffler-Wirth, Henry/0000-0001-8239-440X; Binder, Hans/0000-0002-2242-4678	LIFE-Leipzig Research Center for Civilization Diseases, Leipzig University; European Union; European Regional Development Fund (ERDF); European Social Fund (ESF); Free State of Saxony; German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	LIFE-Leipzig Research Center for Civilization Diseases, Leipzig University; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); European Social Fund (ESF)(European Social Fund (ESF)); Free State of Saxony; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	This publication is supported by LIFE-Leipzig Research Center for Civilization Diseases, Leipzig University. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF), by the European Social Fund (ESF) and by means of the Free State of Saxony within the framework of the excellence initiative. We acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.; This publication is supported by LIFE-Leipzig Research Center for Civilization Diseases, Leipzig University. LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF), by the European Social Fund (ESF) and by means of the Free State of Saxony within the framework of the excellence initiative. We acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. We thank all participants who were willing to take part in the study and the entire study team for their commitment.	Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 2011, NUTR TODAY, V46, P85, DOI DOI 10.1097/NT.0B013E3182118779; Ashwell M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103483; Binder H., 2013, SYST BIOMED, V1, P99, DOI [10.4161/sysb.25897, DOI 10.4161/SYSB.25897]; Bretschneider T, 2009, SKIN RES TECHNOL, V15, P364, DOI 10.1111/j.1600-0846.2009.00374.x; Cakir MV, 2014, METHODS MOL BIOL, V1107, P279, DOI 10.1007/978-1-62703-748-8_17; Cerney M. M., 2004, SAE T J AEROSPCE, V113, P208; Fagherazzi G, 2013, INT J CANCER, V133, P740, DOI 10.1002/ijc.28069; Hirshberg D, 2011, PROC 2ND INT CONF 3D, DOI DOI 10.1.1.225.5101; Hopp Lydia, 2013, Biology (Basel), V2, P1411, DOI 10.3390/biology2041411; Jaeschke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119430; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Kohonen T, 1995, SELF ORGANIZING MAPS; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Lin JD, 2004, CLIN NUTR, V23, P1313, DOI 10.1016/j.clnu.2004.04.005; Loeffler M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1983-z; Olds T, 2004, J SPORT SCI, V22, P319, DOI 10.1080/02640410310001641593; Olds T, 2013, J SPORT SCI, V31, P936, DOI 10.1080/02640414.2012.759660; Patrick J, 2010, PROC NAECON IEEE NAT, P149, DOI 10.1109/NAECON.2010.5712939; Pepper MR, 2010, J AM COLL NUTR, V29, P179, DOI 10.1080/07315724.2010.10719832; Price GM, 2006, AM J CLIN NUTR, V84, P449; Robinette K, 2002, CIVILIAN AMERICAN AN; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Suikerbuik R., 2004, 2004012193 SAE INT U, DOI [10.4271/2004-01-2193, DOI 10.4271/2004-01-2193]; Treleaven P, 2007, COMPUTER, V40, P28, DOI 10.1109/MC.2007.225; Vesanto J., 1999, Intelligent Data Analysis, V3, P111, DOI 10.1016/S1088-467X(99)00013-X; Weller M, 2015, ACTA NEUROPATHOL, V129, P679, DOI 10.1007/s00401-015-1409-0; Wells JCK, 2008, INT J OBESITY, V32, P232, DOI 10.1038/sj.ijo.0803727; Wirth H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-306; Yamaji T, 2009, AM J EPIDEMIOL, V170, P1502, DOI 10.1093/aje/kwp311	33	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159887	10.1371/journal.pone.0159887	http://dx.doi.org/10.1371/journal.pone.0159887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467550	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100069
J	Maruko, I; Arakawa, H; Koizumi, H; Izumi, R; Sunagawa, H; Iida, T				Maruko, Ichiro; Arakawa, Hisaya; Koizumi, Hideki; Izumi, Reiko; Sunagawa, Hiromi; Iida, Tomohiro			Age-Dependent Morphologic Alterations in the Outer Retinal and Choroidal Thicknesses Using Swept Source Optical Coherence Tomography	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; HEALTHY JAPANESE SUBJECTS; OCCULT MACULAR DYSTROPHY; DEGENERATION; ABNORMALITY; THERAPY	Purpose To evaluate the age-dependent morphologic alterations in the outer retina and choroid at the macula using swept-source optical coherence tomography (OCT). Methods Thirty eyes (30 normal subjects; average age, 49 years) were examined; five (age range, third-eighth decades of life) had refractive errors of +/- 2 diopters or less and no fundus abnormalities. An Early Treatment Diabetic Retinopathy Study (ETDRS) map of the outer retinal and choroidal thickness was constructed using swept-source OCT. The outer retinal and choroidal segmentation lines were drawn automatically, partially manually, within 6 millimeters of the macula. Results The mean outer retinal and choroidal thicknesses in the 6-millimeter-diameter circle were 145 +/- 13 and 236 +/- 68 microns, respectively. The choroidal thickness and age were negatively (r = -0.66, P<0.01) correlated; the outer retinal thickness and age were not correlated (r = -0.16, P = 0.39). The outer retinal and choroidal thicknesses in the ETDRS map were not correlated (r = -0.13, P = 0.49) within 1 millimeter but correlated (r = 0.32, P<0.01) within 6 millimeters. Conclusions The choroid thins with aging. The outer retina remains stable. Outer retina and choroid are correlated in the entire macula except for the center. ETDRS map can be useful for evaluation of the morphologic relationship between the outer retina and choroid.	[Maruko, Ichiro; Arakawa, Hisaya; Koizumi, Hideki; Izumi, Reiko; Sunagawa, Hiromi; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Maruko, I (corresponding author), Tokyo Womens Med Univ, Dept Ophthalmol, Sch Med, Shinjuku Ku, Tokyo, Japan.	imaruko@twmu.ac.jp	Maruko, Ichiro/AFP-1311-2022	Maruko, Ichiro/0000-0001-5647-6372				Agawa T, 2011, GRAEF ARCH CLIN EXP, V249, P1485, DOI 10.1007/s00417-011-1708-7; Alm A., 1992, ADLERS PHYSL EYE, P198; Fischer MD, 2008, INVEST OPHTH VIS SCI, V49, P3617, DOI 10.1167/iovs.08-2003; Grunwald JE, 1999, AGE RELATED MACULAR, P167; Hayashi H, 2009, AM J OPHTHALMOL, V148, P83, DOI 10.1016/j.ajo.2009.01.017; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Karahan E, 2013, OSLI RETINA, V44, P544, DOI 10.3928/23258160-20131015-01; Lupo S, 2011, AM J OPHTHALMOL, V151, P106, DOI 10.1016/j.ajo.2010.07.026; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Matsumoto H, 2009, AM J OPHTHALMOL, V148, P105, DOI 10.1016/j.ajo.2009.01.018; Miyake Y, 2015, JPN J OPHTHALMOL, V59, P71, DOI 10.1007/s10384-015-0371-7; Oishi A, 2013, GRAEF ARCH CLIN EXP, V251, P435, DOI 10.1007/s00417-012-2034-4; Ojima Y, 2007, OPHTHALMOLOGY, V114, P2197, DOI 10.1016/j.ophtha.2007.02.015; Park SJ, 2010, INVEST OPHTH VIS SCI, V51, P3673, DOI 10.1167/iovs.09-4169; PARVER LM, 1980, AM J OPHTHALMOL, V89, P641, DOI 10.1016/0002-9394(80)90280-9; Puche N, 2010, BRIT J OPHTHALMOL, V94, P1190, DOI 10.1136/bjo.2009.175075; Sayanagi K, 2009, BRIT J OPHTHALMOL, V93, P622, DOI 10.1136/bjo.2008.151977; Spaide RF, 2015, RETINA, V31, P1609; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tsunoda K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1099, DOI 10.1001/archophthalmol.2011.217; Wakabayashi T, 2009, OPHTHALMOLOGY, V116, P519, DOI 10.1016/j.ophtha.2008.10.001; Wolsley CJ, 2009, EYE, V23, P1524, DOI 10.1038/eye.2008.318	26	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159439	10.1371/journal.pone.0159439	http://dx.doi.org/10.1371/journal.pone.0159439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467879	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516100032
J	Pabinger, S; Ernst, K; Pulverer, W; Kallmeyer, R; Valdes, AM; Metrustry, S; Katic, D; Nuzzo, A; Kriegner, A; Vierlinger, K; Weinhaeusel, A				Pabinger, Stephan; Ernst, Karina; Pulverer, Walter; Kallmeyer, Rainer; Valdes, Ana M.; Metrustry, Sarah; Katic, Denis; Nuzzo, Angelo; Kriegner, Albert; Vierlinger, Klemens; Weinhaeusel, Andreas			Analysis and Visualization Tool for Targeted Amplicon Bisulfite Sequencing on Ion Torrent Sequencers	PLOS ONE			English	Article							DNA METHYLATION; ALIGNMENT; WIDE; PERFORMANCE; SOFTWARE	Targeted sequencing of PCR amplicons generated from bisulfite deaminated DNA is a flexible, cost-effective way to study methylation of a sample at single CpG resolution and perform subsequent multi-target, multi-sample comparisons. Currently, no platform specific protocol, support, or analysis solution is provided to perform targeted bisulfite sequencing on a Personal Genome Machine (PGM). Here, we present a novel tool, called TABSAT, for analyzing targeted bisulfite sequencing data generated on Ion Torrent sequencers. The workflow starts with raw sequencing data, performs quality assessment, and uses a tailored version of Bismark to map the reads to a reference genome. The pipeline visualizes results as lollipop plots and is able to deduce specific methylation-patterns present in a sample. The obtained profiles are then summarized and compared between samples. In order to assess the performance of the targeted bisulfite sequencing workflow, 48 samples were used to generate 53 different Bisulfite-Sequencing PCR amplicons from each sample, resulting in 2,544 amplicon targets. We obtained a mean coverage of 282X using 1,196,822 aligned reads. Next, we compared the sequencing results of these targets to the methylation level of the corresponding sites on an Illumina 450k methylation chip. The calculated average Pearson correlation coefficient of 0.91 confirms the sequencing results with one of the industry-leading CpG methylation platforms and shows that targeted amplicon bisulfite sequencing provides an accurate and cost-efficient method for DNA methylation studies, e.g., to provide platform-independent confirmation of Illumina Infinium 450k methylation data. TABSAT offers a novel way to analyze data generated by Ion Torrent instruments and can also be used with data from the Illumina MiSeq platform. It can be easily accessed via the Platomics platform, which offers a web-based graphical user interface along with sample and parameter storage. TABSAT is freely available under a GNU General Public License version 3.0 (GPLv3) at https://github.com/tadkeys/tabsat/andhttp://demo.platomics.com/.	[Pabinger, Stephan; Ernst, Karina; Pulverer, Walter; Kallmeyer, Rainer; Vierlinger, Klemens; Weinhaeusel, Andreas] AIT, Hlth & Environm Dept, Mol Diagnost, Vienna, Austria; [Valdes, Ana M.; Metrustry, Sarah] Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Campus, London, England; [Katic, Denis; Nuzzo, Angelo; Kriegner, Albert] Platomics GmbH, Vienna, Austria	Austrian Institute of Technology (AIT); University of London; King's College London	Pabinger, S (corresponding author), AIT, Hlth & Environm Dept, Mol Diagnost, Vienna, Austria.	stephan.pabinger@ait.ac.at	Weinhaeusel, Andreas/A-7644-2018	Valdes, Ana M./0000-0003-1141-4471; Pabinger, Stephan/0000-0001-9876-5965; Vierlinger, Klemens/0000-0001-6038-5895	European Union, FP7 small medium focused project [277849]; Platomics GmbH	European Union, FP7 small medium focused project; Platomics GmbH	This work was supported by the European Union, FP7 small medium focused project 277849 EurHEALTHAgeing (http://eurhealth.org/). Platomics GmbH provided support in the form of salaries for authors [DK, AN, AK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Becker D, 2014, NUCLEIC ACIDS RES, V42, pW501, DOI 10.1093/nar/gku457; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Chatterjee A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks150; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Corley MJ, 2015, EPIGENETICS-US, V10, P153, DOI 10.1080/15592294.2014.1003747; Di Tommaso P, 2015, PEERJ, V3, DOI 10.7717/peerj.1273; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jones PA, 1997, P NATL ACAD SCI USA, V94, P2103, DOI 10.1073/pnas.94.6.2103; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Kunde-Ramamoorthy G, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1325; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Muers M, 2013, NAT REV GENET, V14, P3535, DOI 10.1038/nrg3535; Noehammer C, 2014, EPIGENOMICS-UK, V6, P603, DOI [10.2217/EPI.14.43, 10.2217/epi.14.43]; Pandey RV, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0190-9; Paulsen M, 2001, J PATHOL, V195, P97, DOI 10.1002/path.890; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rahmann Sven, 2013, AMPLIKYZER AUTOMATED, DOI [10.7287/peerj.preprints.122v2, DOI 10.7287/PEERJ.PREPRINTS.122V2]; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Tran Hong, 2014, Advances in Bioinformatics, V2014, P472045, DOI 10.1155/2014/472045; Wagner JR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r37; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]	36	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160227	10.1371/journal.pone.0160227	http://dx.doi.org/10.1371/journal.pone.0160227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467908	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100132
J	Reinhart, KO; Vermeire, LT				Reinhart, Kurt O.; Vermeire, Lance T.			Soil Aggregate Stability and Grassland Productivity Associations in a Northern Mixed-Grass Prairie	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SPATIAL AUTOCORRELATION; ORGANIC-MATTER; GREAT-PLAINS; PLANT; CARBON; SITES; STABILIZATION; DEGRADATION; INDICATORS	Soil aggregate stability data are often predicted to be positively associated with measures of plant productivity, rangeland health, and ecosystem functioning. Here we revisit the hypothesis that soil aggregate stability is positively associated with plant productivity. We measured local (plot-to-plot) variation in grassland community composition, plant (above-ground) biomass, root biomass,% water-stable soil aggregates, and topography. After accounting for spatial autocorrelation, we observed a negative association between % water-stable soil aggregates (0.25-1 and 1-2 mm size classes of macroaggregates) and dominant graminoid biomass, and negative associations between the % water-stable aggregates and the root biomass of a dominant sedge (Carex filifolia). However, variation in total root biomass (0-10 or 0-30 cm depths) was either negatively or not appreciably associated with soil aggregate stabilities. Overall, regression slope coefficients were consistently negative thereby indicating the general absence of a positive association between measures of plant productivity and soil aggregate stability for the study area. The predicted positive association between factors was likely confounded by variation in plant species composition. Specifically, sampling spanned a local gradient in plant community composition which was likely driven by niche partitioning along a subtle gradient in elevation. Our results suggest an apparent trade-off between some measures of plant biomass production and soil aggregate stability, both known to affect the land's capacity to resist erosion. These findings further highlight the uncertainty of plant biomass-soil stability associations.	[Reinhart, Kurt O.; Vermeire, Lance T.] USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA	United States Department of Agriculture (USDA)	Reinhart, KO (corresponding author), USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA.	kurt.reinhart@ars.usda.gov	Reinhart, Kurt/GZH-0417-2022	Reinhart, Kurt/0000-0002-7985-6738; Vermeire, Lance/0000-0001-9147-0099	United States Department of Agriculture appropriated funds (Current Research Information System) [5434-21630-003-00D]; ARS [ARS-0424156] Funding Source: Federal RePORTER	United States Department of Agriculture appropriated funds (Current Research Information System); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was funded by United States Department of Agriculture appropriated funds (Current Research Information System #5434-21630-003-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BW, 2003, RANGE HLTH ASSESSMEN; Barto EK, 2010, SOIL BIOL BIOCHEM, V42, P2316, DOI 10.1016/j.soilbio.2010.09.008; Batten KM, 2005, SOIL BIOL BIOCHEM, V37, P2277, DOI 10.1016/j.soilbio.2005.04.005; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Beever EA, 2006, DIVERS DISTRIB, V12, P258, DOI 10.1111/j.1366-9516.2006.00253.x; Bird SB, 2007, GEODERMA, V140, P106, DOI 10.1016/j.geoderma.2007.03.010; Boix-Fayos C, 2001, CATENA, V44, P47, DOI 10.1016/S0341-8162(00)00176-4; Chaudhary VB, 2009, ECOL APPL, V19, P110, DOI 10.1890/07-2076.1; COUPLAND RT, 1961, J ECOL, V49, P135, DOI 10.2307/2257431; Coupland RT, 1968, NPP GRASSLAND MATADO, pR1; Daynes CN, 2013, SOIL BIOL BIOCHEM, V57, P683, DOI 10.1016/j.soilbio.2012.09.020; Don A, 2007, GEODERMA, V141, P272, DOI 10.1016/j.geoderma.2007.06.003; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Herrick JE, 2010, FRONT ECOL ENVIRON, V8, P403, DOI 10.1890/100017; Jastrow JD, 1998, SOIL BIOL BIOCHEM, V30, P905, DOI 10.1016/S0038-0717(97)00207-1; Karl Jason W., 2010, Rangelands, V32, P60, DOI 10.2111/RANGELANDS-D-10-00082.1; Kemper W. D., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P425; Koorem K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091998; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; Letey J., 1985, Advances in soil science. Volume I, P277; LETEY J, 1991, AUST J SOIL RES, V29, P699, DOI 10.1071/SR9910699; Martin B.S., 1998, NATURAL COMMUNITY IN; Miller RM, 1999, AM J BOT, V86, P547, DOI 10.2307/2656816; Nichols KA, 2011, SOIL TILL RES, V111, P99, DOI 10.1016/j.still.2010.08.014; O'Dea ME, 2007, GEODERMA, V138, P79, DOI 10.1016/j.geoderma.2006.10.017; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pellant M., 2005, 17346 US DEP INT BUR; Peres G, 2013, PLANT SOIL, V373, P285, DOI 10.1007/s11104-013-1791-0; Piotrowski JS, 2004, NEW PHYTOL, V164, P365, DOI 10.1111/j.1469-8137.2004.01181.x; POWELL CL, 1975, PLANT SOIL, V42, P481, DOI 10.1007/BF00010023; Pyke DA, 2002, J RANGE MANAGE, V55, P584, DOI 10.2307/4004002; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reinhart KO, 2016, PLANT SOIL, V409, P203, DOI 10.1007/s11104-016-2957-3; Reinhart KO, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00056.1; Reinhart KO, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu051; Reinhart KO, 2012, ECOL LETT, V15, P689, DOI 10.1111/j.1461-0248.2012.01786.x; Rezaei SA, 2006, GEODERMA, V136, P229, DOI 10.1016/j.geoderma.2006.03.021; Rillig MC, 2002, PLANT SOIL, V238, P325, DOI 10.1023/A:1014483303813; Six J, 2014, SOIL BIOL BIOCHEM, V68, pA4, DOI 10.1016/j.soilbio.2013.06.014; Snedecor G. W., 1989, FAILURES ASSUMPTIONS, P273; STUBBENDIECK J, 1978, J RANGE MANAGE, V31, P290, DOI 10.2307/3897604; Stubbendieck J., 1997, N AM RANGE PLANTS, V5th ed.; Tichota Gina R., 2002, Transactions of the Nebraska Academy of Sciences, V28, P15; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Vermeire LT, 2011, RANGELAND ECOL MANAG, V64, P37, DOI 10.2111/REM-D-10-00049.1; Vermeire LT, 2009, RANGELAND ECOL MANAG, V62, P230, DOI 10.2111/07-140R2.1; Wang G. C., 2010, THESIS; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x	51	12	12	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160262	10.1371/journal.pone.0160262	http://dx.doi.org/10.1371/journal.pone.0160262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467598	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100140
J	Biosca, EG; Flores, R; Santander, RD; Diez-Gil, JL; Barreno, E				Biosca, Elena G.; Flores, Raquel; Santander, Ricardo D.; Luis Diez-Gil, Jose; Barreno, Eva			Innovative Approaches Using Lichen Enriched Media to Improve Isolation and Culturability of Lichen Associated Bacteria	PLOS ONE			English	Article							ERWINIA-AMYLOVORA; SOIL BACTERIA; NONCULTURABLE STATE; DIVERSITY; COMMUNITIES; SURVIVAL; CULTIVATION; COEXISTENCE; PHOSPHATE; REVEALS	Lichens, self-supporting mutualistic associations between a fungal partner and one or more photosynthetic partners, also harbor non-photosynthetic bacteria. The diversity and contribution of these bacteria to the functioning of lichen symbiosis have recently begun to be studied, often by culture-independent techniques due to difficulties in their isolation and culture. However, culturing as yet unculturable lichenic bacteria is critical to unravel their potential functional roles in lichen symbiogenesis, to explore and exploit their biotechnological potential and for the description of new taxa. Our objective was to improve the recovery of lichen associated bacteria by developing novel isolation and culture approaches, initially using the lichen Pseudevernia furfuracea. We evaluated the effect of newly developed media enriched with novel lichen extracts, as well as the influence of thalli washing time and different disinfection and processing protocols of thalli. The developed methodology included: i) the use of lichen enriched media to mimic lichen nutrients, supplemented with the fungicide natamycin; ii) an extended washing of thalli to increase the recovery of ectolichenic bacteria, thus allowing the disinfection of thalli to be discarded, hence enhancing endolichenic bacteria recovery; and iii) the use of an antioxidant buffer to prevent or reduce oxidative stress during thalli disruption. The optimized methodology allowed significant increases in the number and diversity of culturable bacteria associated with P. furfuracea, and it was also successfully applied to the lichens Ramalina farinacea and Parmotrema pseudotinctorum. Furthermore, we provide, for the first time, data on the abundance of culturable ecto- and endolichenic bacteria that naturally colonize P. furfuracea, R. farinacea and P. pseudotinctorum, some of which were only able to grow on lichen enriched media. This innovative methodology is also applicable to other microorganisms inhabiting these and other lichen species.	[Biosca, Elena G.; Flores, Raquel; Santander, Ricardo D.] Univ Valencia, Fac Ciencias Biol, Dept Microbiol & Ecol, Avda Doctor Moliner 50, E-46100 Valencia, Spain; [Flores, Raquel; Barreno, Eva] Univ Valencia, Fac Ciencias Biol, Dept Bot, Avda Doctor Moliner 50, E-46100 Valencia, Spain; [Flores, Raquel; Barreno, Eva] Univ Valencia, Fac Ciencias Biol, ICBIBE Inst Cavanilles Biodiversidad & Biol Evolu, Avda Doctor Moliner 50, E-46100 Valencia, Spain; [Luis Diez-Gil, Jose] Hosp Univ & Politecn La Fe, Grp RETRACAR, Inst Invest Sanitaria La Fe, Ave Fernando Abril Martorell 106, Valencia 46026, Spain	University of Valencia; University of Valencia; University of Valencia; Hospital Universitari i Politecnic La Fe	Biosca, EG (corresponding author), Univ Valencia, Fac Ciencias Biol, Dept Microbiol & Ecol, Avda Doctor Moliner 50, E-46100 Valencia, Spain.	elena.biosca@uv.es	Santander, Ricardo Delgado/AAG-6067-2019; González Biosca, Elena/F-4979-2016; Rodríguez, Eva Barreno/M-2525-2014	Santander, Ricardo Delgado/0000-0002-1309-2632; González Biosca, Elena/0000-0002-8590-6180; Rodríguez, Eva Barreno/0000-0002-2622-4550	Excellence in Research, Generalitat Valenciana, Spain [PrometeoII-2013/021]; Ministerio de Economia y Competitividad, Spain [MINECO CGL2012-40058-C02-01]; University of Valencia [UV-INV-AE 112-66196]	Excellence in Research, Generalitat Valenciana, Spain; Ministerio de Economia y Competitividad, Spain; University of Valencia	This work was funded by the research projects PrometeoII-2013/021 (Excellence in Research, Generalitat Valenciana, Spain), EGB EB; MINECO CGL2012-40058-C02-01 (Ministerio de Economia y Competitividad, Spain), EB and UV-INV-AE 112-66196 of University of Valencia, EGB, as well as the University of Valencia-Research Support, EGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagot N, 2001, APPL ENVIRON MICROB, V67, P5233, DOI 10.1128/AEM.67.11.5233-5239.2001; Alvarez R, 2015, MICROB ECOL, V69, P698, DOI 10.1007/s00248-014-0524-0; Aschenbrenner IA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00180; Aschenbrenner IA, 2014, ENVIRON MICROBIOL, V16, P3743, DOI 10.1111/1462-2920.12658; Barreno E., 2013, ONCE TIME LYNN MARGU, P56; Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Beckett RP, 2005, LICHENOLOGIST, V37, P397, DOI 10.1017/S0024282905014921; Berg G, 2016, BIOSPEKTRUM, V22, P12, DOI [10.1007/s12268-016-0648-5, DOI 10.1007/S12268-016-0648-5]; Biosca EG, 2003, PHYTOPATHOLOGY, V93, P485, DOI 10.1094/PHYTO.2003.93.4.485; Bischoff H, 1963, PHYCOLOGICAL STUDIES, V6318, P1; Cardinale M, 2008, FEMS MICROBIOL ECOL, V66, P63, DOI 10.1111/j.1574-6941.2008.00546.x; Cardinale M, 2006, FEMS MICROBIOL ECOL, V57, P484, DOI 10.1111/j.1574-6941.2006.00133.x; Cardinale M, 2012, ENV MICROBIOL REP, V4, P23, DOI 10.1111/j.1758-2229.2011.00272.x; Casano LM, 2011, ENVIRON MICROBIOL, V13, P806, DOI 10.1111/j.1462-2920.2010.02386.x; Catala S, 2016, MOL PHYLOGENET EVOL, V94, P765, DOI 10.1016/j.ympev.2015.10.021; Cernava T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00620; Cernava Tomislav, 2015, Front Microbiol, V6, P398, DOI 10.3389/fmicb.2015.00398; Chapman M J, 1998, Int Microbiol, V1, P319; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Davis KER, 2005, APPL ENVIRON MICROB, V71, P826, DOI 10.1128/AEM.71.2.826-834.2005; Erlacher A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00053; Gorris M. T., 1996, Acta Horticulturae, P41; Green PN, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P257, DOI 10.1007/0-387-30745-1_14; Grube M, 2007, MYCOL RES, V111, P1116, DOI 10.1016/j.mycres.2007.04.008; Grube M, 2015, ISME J, V9, P412, DOI 10.1038/ismej.2014.138; Grube Martin, 2009, Fungal Biology Reviews, V23, P72, DOI 10.1016/j.fbr.2009.10.001; Grube M, 2009, ISME J, V3, P1105, DOI 10.1038/ismej.2009.63; Hamaki T, 2005, J BIOSCI BIOENG, V99, P485, DOI 10.1263/jbb.99.485; HATTORI R, 1980, J GEN APPL MICROBIOL, V26, P1, DOI 10.2323/jgam.26.1; Hodkinson BP, 2012, ENVIRON MICROBIOL, V14, P147, DOI 10.1111/j.1462-2920.2011.02560.x; Hodkinson BP, 2009, SYMBIOSIS, V49, P163, DOI 10.1007/s13199-009-0049-3; ISHIMARU C, 1984, PHYTOPATHOLOGY, V74, P1342, DOI 10.1094/Phyto-74-1342; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; KING EO, 1954, J LAB CLIN MED, V44, P301; Kong IS, 2004, FEMS MICROBIOL ECOL, V50, P133, DOI 10.1016/j.femsec.2004.06.004; Liba CM, 2006, J APPL MICROBIOL, V101, P1076, DOI 10.1111/j.1365-2672.2006.03010.x; Margulis L, 2003, BIOSCIENCE, V53, P776, DOI DOI 10.1641/0006-3568(2003)053[0776:LAL]2.0.CO;2; Molins Arantxa, 2013, Vieraea, V41, P349; Morita RY, 1997, BACTERIA IN OLIGOTRO; Mushegian AA, 2011, APPL ENVIRON MICROB, V77, P4249, DOI 10.1128/AEM.02850-10; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Ordax M, 2009, J APPL MICROBIOL, V107, P106, DOI 10.1111/j.1365-2672.2009.04187.x; Ordax M, 2006, APPL ENVIRON MICROB, V72, P3482, DOI 10.1128/AEM.72.5.3482-3488.2006; Ordax M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127560; Ordax M, 2010, RES MICROBIOL, V161, P549, DOI 10.1016/j.resmic.2010.05.003; Parrot D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15839; PEDERSEN JC, 1992, APPL ENVIRON MICROB, V58, P1064, DOI 10.1128/AEM.58.3.1064-1066.1992; Puspita ID, 2012, MICROBES ENVIRON, V27, P356, DOI 10.1264/jsme2.ME12092; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Sait M, 2002, ENVIRON MICROBIOL, V4, P654, DOI 10.1046/j.1462-2920.2002.00352.x; Sancho LG, 2007, ASTROBIOLOGY, V7, P443, DOI 10.1089/ast.2006.0046; Santander RD, 2012, TREES-STRUCT FUNCT, V26, P75, DOI 10.1007/s00468-011-0653-8; Santander RD, 2014, FEMS MICROBIOL ECOL, V90, P895, DOI 10.1111/1574-6941.12444; Santander RD, 2014, FEMS MICROBIOL ECOL, V88, P258, DOI 10.1111/1574-6941.12290; SCHAAD NW, 1990, METHODS PHYTOBACTERI, P153; Selbmann L, 2010, POLAR BIOL, V33, P71, DOI 10.1007/s00300-009-0686-2; Sigurbjornsdottir MA, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2019-2; Sigurbjornsdottir MA, 2015, MICROBIOL-SGM, V161, P989, DOI 10.1099/mic.0.000069; Sigurbjornsdottir MA, 2014, CAN J MICROBIOL, V60, P307, DOI 10.1139/cjm-2013-0888; Smith CW, 2009, THE LICHENS OF GREAT; Suzuki MT, 2016, APPL MICROBIOL BIOT, V100, P583, DOI 10.1007/s00253-015-7114-z; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x	64	24	25	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160328	10.1371/journal.pone.0160328	http://dx.doi.org/10.1371/journal.pone.0160328			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494030	Green Published, gold, Green Submitted			2022-12-27	WOS:000381369500031
J	Goette, NP; Glembotsky, AC; Lev, PR; Grodzielski, M; Contrufo, G; Pierdominici, MS; Espasandin, YR; Riveros, D; Garcia, AJ; Molinas, FC; Heller, PG; Marta, RF				Goette, Nora P.; Glembotsky, Ana C.; Lev, Paola R.; Grodzielski, Matias; Contrufo, Geraldine; Pierdominici, Marta S.; Espasandin, Yesica R.; Riveros, Dardo; Garcia, Alejandro J.; Molinas, Felisa C.; Heller, Paula G.; Marta, Rosana F.			Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-Antibodies	PLOS ONE			English	Article							MEDIATED CYTOTOXICITY; PURPURA ITP; IN-VITRO; ACTIVATION; PROFILE; CELLS	Mechanisms leading to decreased platelet count in immune thrombocytopenia (ITP) are heterogeneous. This study describes increased platelet apoptosis involving loss of mitochondrial membrane potential (Delta psi m), caspase 3 activation (aCasp3) and phosphatidylserine (PS) externalization in a cohort of adult ITP patients. Apoptosis was not related to platelet activation, as PAC-1 binding, P-selectin exposure and GPIb-IX internalization were not increased. Besides, ITP platelets were more sensitive to apoptotic stimulus in terms of aCasp3. Incubation of normal platelets with ITP plasma induced loss of Delta psi m, while PS exposure and aCasp3 remained unaltered. The increase in PS exposure observed in ITP platelets could be reproduced in normal platelets incubated with ITP plasma by adding normal CD3(+) lymphocytes to the system as effector cells. Addition of leupeptin -a cathepsin B inhibitor-to this system protected platelets from apoptosis. Increased PS exposure was also observed when normal platelets and CD3+ lymphocytes were incubated with purified IgG from ITP patients and was absent when ITP plasma was depleted of auto-antibodies, pointing to the latter as responsible for platelet damage. Apoptosis was present in platelets from all patients carrying anti-GPIIb-IIIa and anti-GPIb auto-antibodies but was absent in the patient with anti-GPIa-IIa auto-antibodies. Platelet damage inversely correlated with platelet count and decreased during treatment with a thrombopoietin receptor agonist. These results point to a key role for auto-antibodies in platelet apoptosis and suggest that antibody-dependent cell cytotoxicity is the mechanism underlying this phenomenon.	[Goette, Nora P.; Glembotsky, Ana C.; Lev, Paola R.; Grodzielski, Matias; Contrufo, Geraldine; Espasandin, Yesica R.; Molinas, Felisa C.; Heller, Paula G.; Marta, Rosana F.] Univ Buenos Aires, CONICET, Inst Invest Med A Lanari IDIM, Dept Hematol Invest, Buenos Aires, DF, Argentina; [Pierdominici, Marta S.] Hosp Ramos Mejia, Dept Hematol, Buenos Aires, DF, Argentina; [Riveros, Dardo] Ctr Educ Med & Invest Clin Norberto Quirno CEMIC, Dept Hematol, Buenos Aires, DF, Argentina; [Garcia, Alejandro J.] Ctr Educ Med & Invest Clin Norberto Quirno CEMIC, Lab Citometria Flujo, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Hospital Ramos Mejia; University of Buenos Aires; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Centro de Educacion Medica e Investigaciones Clinicas (CEMIC)	Marta, RF (corresponding author), Univ Buenos Aires, CONICET, Inst Invest Med A Lanari IDIM, Dept Hematol Invest, Buenos Aires, DF, Argentina.	rfmarta2005@gmail.com		Heller, Paula G./0000-0002-6829-1313	Agencia Nacional de Promocion Cientifica y Tecnologica [1860]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica www.agencia.mincyt.gob.ar/ Prestamo BID, PICT2010, no 1860. Author responsible for receiving the funding: RFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Roman MTA, 2014, THROMB HAEMOSTASIS, V112, P65, DOI 10.1160/TH13-10-0873; Beigier-Bompadre M, 2003, SCAND J IMMUNOL, V57, P221, DOI 10.1046/j.1365-3083.2003.01219.x; Catani L, 2006, EXP HEMATOL, V34, P879, DOI 10.1016/j.exphem.2006.03.009; Couzi L, 2012, BLOOD, V119, P1418, DOI 10.1182/blood-2011-06-363655; Glembotsky AC, 2014, J THROMB HAEMOST, V12, P761, DOI 10.1111/jth.12550; HE RY, 1994, BLOOD, V83, P1024; Hulkower KI, 2000, EUR J BIOCHEM, V267, P4165, DOI 10.1046/j.1432-1327.2000.01458.x; Kile BT, 2014, BRIT J HAEMATOL, V165, P217, DOI 10.1111/bjh.12757; Lev PR, 2014, BRIT J HAEMATOL, V165, P854, DOI 10.1111/bjh.12832; Leytin V, 2006, BRIT J HAEMATOL, V133, P78, DOI 10.1111/j.1365-2141.2006.05981.x; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; McKenzie CGJ, 2013, BRIT J HAEMATOL, V163, P10, DOI 10.1111/bjh.12480; McMillan R, 2004, BLOOD, V103, P1364, DOI 10.1182/blood-2003-08-2672; McMillan R, 2000, SEMIN HEMATOL, V37, P239, DOI 10.1016/S0037-1963(00)90102-1; McMillan R, 2007, SEMIN HEMATOL, V44, pS3, DOI 10.1053/j.seminhematol.2007.11.002; Mitchell WB, 2014, AM J HEMATOL, V89, pE228, DOI 10.1002/ajh.23832; Mutlu A, 2012, BRIT J HAEMATOL, V159, P565, DOI 10.1111/bjh.12066; Najaoui A, 2012, EUR J HAEMATOL, V88, P167, DOI 10.1111/j.1600-0609.2011.01718.x; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Page LK, 2007, BRIT J HAEMATOL, V138, P245, DOI 10.1111/j.1365-2141.2007.06635.x; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Winkler J, 2012, BRIT J HAEMATOL, V156, P508, DOI 10.1111/j.1365-2141.2011.08973.x; WOODS VL, 1984, BLOOD, V63, P368; WOODS VL, 1984, BLOOD, V64, P156; Zhan YX, 2014, IMMUNOL LETT, V160, P33, DOI 10.1016/j.imlet.2014.03.002; Zhao CH, 2008, HAEMATOL-HEMATOL J, V93, P1428, DOI 10.3324/haematol.12889	26	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160563	10.1371/journal.pone.0160563	http://dx.doi.org/10.1371/journal.pone.0160563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494140	Green Submitted, Green Published, gold			2022-12-27	WOS:000381369500059
J	Kamada, R; Tano, F; Kudoh, F; Kimura, N; Chuman, Y; Osawa, A; Namba, K; Tanino, K; Sakaguchi, K				Kamada, Rui; Tano, Fumi; Kudoh, Fuki; Kimura, Nozomi; Chuman, Yoshiro; Osawa, Ayumi; Namba, Kosuke; Tanino, Keiji; Sakaguchi, Kazuyasu			Effective Cellular Morphology Analysis for Differentiation Processes by a Fluorescent 1,3a,6a-Triazapentalene Derivative Probe in Live Cells	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; LIVING CELLS; COMPLEXES	Nuclear and cytoplasmic morphological changes provide important information about cell differentiation processes, cell functions, and signal responses. There is a strong desire to develop a rapid and simple method for visualizing cytoplasmic and nuclear morphology. Here, we developed a novel and rapid method for probing cellular morphological changes of live cell differentiation process by a fluorescent probe, TAP-4PH, a 1,3a, 6a-triazapentalene derivative. TAP-4PH showed high fluorescence in cytoplasmic area, and visualized cytoplasmic and nuclear morphological changes of live cells during differentiation. We demonstrated that TAP-4PH visualized dendritic axon and spine formation in neuronal differentiation, and nuclear structural changes during neutrophilic differentiation. We also showed that the utility of TAP-4PH for visualization of cytoplasmic and nuclear morphologies of various type of live cells. Our visualizing method has no toxicity and no influence on the cellular differentiation and function. The cell morphology can be rapidly observed after addition of TAP-4PH and can continue to be observed in the presence of TAP-4PH in cell culture medium. Moreover, TAP-4PH can be easily removed after observation by washing for subsequent biological assay. Taken together, these results demonstrate that our visualization method is a powerful tool to probe differentiation processes before subsequent biological assay in live cells.	[Kamada, Rui; Tano, Fumi; Kudoh, Fuki; Kimura, Nozomi; Chuman, Yoshiro; Sakaguchi, Kazuyasu] Hokkaido Univ, Fac Sci, Dept Chem, Biol Chem Lab, Sapporo, Hokkaido, Japan; [Osawa, Ayumi; Tanino, Keiji] Hokkaido Univ, Fac Sci, Dept Chem, Lab Organ Chem 2, Sapporo, Hokkaido, Japan; [Namba, Kosuke] Univ Tokushima, Grad Sch Pharmaceut Sci, Tokushima, Japan	Hokkaido University; Hokkaido University; Tokushima University	Sakaguchi, K (corresponding author), Hokkaido Univ, Fac Sci, Dept Chem, Biol Chem Lab, Sapporo, Hokkaido, Japan.	kazuyasu@sci.hokudai.ac.jp	Tanino, Keiji/M-3564-2019; Chuman, Yoshiro/AAM-4267-2021; Kamada, Rui/P-9714-2019; Tanino, Keiji/D-8399-2012	Tanino, Keiji/0000-0002-0580-0125; Tanino, Keiji/0000-0002-0580-0125; Chuman, Yoshiro/0000-0003-4995-3542; Osawa, Ayumi/0000-0002-5459-3660	JSPS [26560449]; Grants-in-Aid for Scientific Research [16H01156, 16H03292] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (No. 26560449) from JSPS (to K.N.) (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belitsky JM, 2002, BIOORGAN MED CHEM, V10, P3313, DOI 10.1016/S0968-0896(02)00204-3; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; COLLINS SJ, 1987, BLOOD, V70, P1233; dOnofrio G, 1998, MORPHOLOGY BLOOD; Er JC, 2015, ANGEW CHEM INT EDIT, V54, P2442, DOI 10.1002/anie.201408614; Horobin RW, 2013, BIOTECH HISTOCHEM, V88, P440, DOI 10.3109/10520295.2013.780634; HUBERMAN E, 1979, P NATL ACAD SCI USA, V76, P1293, DOI 10.1073/pnas.76.3.1293; Hughes CC, 2009, ANGEW CHEM INT EDIT, V48, P728, DOI 10.1002/anie.200804107; Li QL, 2014, COMPUT MED IMAG GRAP, V38, P171, DOI 10.1016/j.compmedimag.2013.12.008; Meinig JM, 2015, ANGEW CHEM INT EDIT, V54, P9696, DOI 10.1002/anie.201504156; Namba K, 2015, CHEM SCI, V6, P1083, DOI 10.1039/c4sc02780a; Namba K, 2012, ORG LETT, V14, P5554, DOI 10.1021/ol302668y; Namba K, 2011, J AM CHEM SOC, V133, P11466, DOI 10.1021/ja203917r; Okabe S, 2013, MICROSCOPY-JPN, V62, P51, DOI 10.1093/jmicro/dfs083; Rao A, 2012, FASEB J, V26, P1921, DOI 10.1096/fj.11-196113; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; Sakaguchi T, 2015, CHEM LETT, V44, P327, DOI 10.1246/cl.141085; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Verkhratsky A, 2014, CELL TISSUE RES, V357, P493, DOI 10.1007/s00441-014-1814-z; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yu MX, 2008, CHEM COMMUN, P2115, DOI 10.1039/b800939b; Yuan YJ, 2013, CHEMSUSCHEM, V6, P1357, DOI 10.1002/cssc.201300451; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	24	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160625	10.1371/journal.pone.0160625	http://dx.doi.org/10.1371/journal.pone.0160625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490470	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900073
J	Shao, M; Li, GX; Sarvottam, K; Wang, SY; Thongprayoon, C; Dong, Y; Gajic, O; Kashani, K				Shao, Min; Li, Guangxi; Sarvottam, Kumar; Wang, Shengyu; Thongprayoon, Charat; Dong, Yue; Gajic, Ognjen; Kashani, Kianoush			Dyschloremia Is a Risk Factor for the Development of Acute Kidney Injury in Critically Ill Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; 0.9-PERCENT SALINE; HOSPITAL MORTALITY; HEALTHY-VOLUNTEERS; ASSOCIATION; HYPERCHLOREMIA; HYPONATREMIA; SURVEILLANCE; PROGNOSIS; INFUSIONS	Introduction Dyschloremia is common in critically ill patients, although its impact has not been well studied. We investigated the epidemiology of dyschloremia and its associations with the incidence of acute kidney injury and other intensive care unit outcomes. Material and Methods This is a single-center, retrospective cohort study at Mayo Clinic Hospital-Rochester. All adult patients admitted to intensive care units from January 1st, 2006, through December 30th, 2012 were included. Patients with known acute kidney injury and chronic kidney disease stage 5 before intensive care unit admission were excluded. We evaluated the association of dyschloremia with ICU outcomes, after adjustments for the effect of age, gender, Charlson comorbidity index and severity of illness score. Results A total of 6,025 patients were enrolled in the final analysis following the implementation of eligibility criteria. From the cohort, 1,970 patients (33%) developed acute kidney injury. Of the total patients enrolled, 4,174 had a baseline serum chloride. In this group, 1,530 (37%) had hypochloremia, and 257 (6%) were hyperchloremic. The incidence of acute kidney injury was higher in hypochloremic and hyperchloremic patients compared to those with a normal serum chloride level (43% vs. 30% and 34% vs. 30%, respectively; P < .001). Baseline serum chloride was lower in the acute kidney injury group vs. the non-acute kidney injury group [100 mmol/L (96-104) vs. 102 mmol/L (98-105), P < .0001]. In a multivariable logistic regression model, baseline serum chloride of <= 94 mmol/L found to be independently associated with the risk of acute kidney injury (OR 1.7, 95% CI 1.1-2.6; P =.01). Discussion Dyschloremia is common in critically ill patients, and severe hypochloremia is independently associated with an increased risk of development of acute kidney injury.	[Shao, Min; Sarvottam, Kumar; Kashani, Kianoush] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55902 USA; [Shao, Min; Li, Guangxi; Sarvottam, Kumar; Wang, Shengyu; Thongprayoon, Charat; Dong, Yue; Gajic, Ognjen; Kashani, Kianoush] Mayo Clin, Multidisciplinary Epidemiol & Translat Res Intens, Rochester, MN 55902 USA; [Shao, Min] Anhui Med Univ, Anhui Prov Hosp, Dept Crit Care Med, Hefei, Anhui, Peoples R China; [Li, Guangxi] China Acad Chinese Med Sci, GuangAnmen Hosp, Dept Pulm Med, Beijing, Peoples R China; [Wang, Shengyu] Xian Med Univ, Affiliated Hosp 1, Dept Pulm Med, Xian, Shaanxi, Peoples R China; [Gajic, Ognjen; Kashani, Kianoush] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic; Anhui Medical University; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Xi'an Medical University; Mayo Clinic	Kashani, K (corresponding author), Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN 55902 USA.	kashani.kianoush@mayo.edu	Thongprayoon, Charat/J-4184-2019; Dong, Yue/B-7597-2008; Li, Guangxi/AAB-3946-2019	Thongprayoon, Charat/0000-0002-8313-3604; Dong, Yue/0000-0002-1737-6536; Kashani, Kianoush/0000-0003-2184-3683; Li, Guangxi/0000-0002-2234-9188				Ahmed A, 2015, J CRIT CARE, V30, P988, DOI 10.1016/j.jcrc.2015.05.007; Callahan MA, 2009, POSTGRAD MED, V121, P186, DOI 10.3810/pgm.2009.03.1991; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Cildir E, 2013, INTERN EMERG MED, V8, P255, DOI 10.1007/s11739-012-0890-x; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; Funk GC, 2010, INTENS CARE MED, V36, P304, DOI 10.1007/s00134-009-1692-0; Hansen PB, 1998, HYPERTENSION, V32, P1066, DOI 10.1161/01.HYP.32.6.1066; Herasevich V, 2007, AMIA Annu Symp Proc, P972; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Lobo DN, 2010, CRIT CARE MED, V38, P464, DOI 10.1097/CCM.0b013e3181bc80f1; McCluskey SA, 2013, ANESTH ANALG, V117, P412, DOI 10.1213/ANE.0b013e318293d81e; Neyra JA, 2015, CRIT CARE MED, V43, P1938, DOI 10.1097/CCM.0000000000001161; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Rehm M, 2004, ANAESTHESIST, V53, P347, DOI 10.1007/s00101-004-0660-x; Sakr Y, 2013, CRIT CARE MED, V41, P133, DOI 10.1097/CCM.0b013e318265f576; Shaw AD, 2014, INTENS CARE MED, V40, P1897, DOI 10.1007/s00134-014-3505-3; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Tani M, 2012, THESCIENTIFICWORLDJO, V2012, DOI [doi: 10.1100/ 2012/ 474185, DOI 10.1100/2012/474185]; Terzano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035245; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vandergheynst F, 2013, EUR J CLIN INVEST, V43, P933, DOI 10.1111/eci.12123; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	27	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160322	10.1371/journal.pone.0160322	http://dx.doi.org/10.1371/journal.pone.0160322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490461	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900046
J	Sharma, S; Tyagi, JS				Sharma, Saurabh; Tyagi, Jaya Sivaswami			Mycobacterium tuberculosis DevR/DosR Dormancy Regulator Activation Mechanism: Dispensability of Phosphorylation, Cooperativity and Essentiality of alpha 10 Helix	PLOS ONE			English	Article							DEVR DOSR; RESPONSE REGULATOR; HYPOXIC RESPONSE; DNA-BINDING; TRANSCRIPTION; DIMERIZATION; ADAPTATION; SURVIVAL; INSIGHTS; SYSTEMS	DevR/DosR is a well-characterized regulator in Mycobacterium tuberculosis which is implicated in various processes ranging from dormancy/persistence to drug tolerance. DevR induces the expression of an similar to 48-gene dormancy regulon in response to gaseous stresses, including hypoxia. Strains of the Beijing lineage constitutively express this regulon, which may confer upon them a significant advantage, since they would be 'pre-adapted' to the environmental stresses that predominate during infection. Aerobic DevR regulon expression in laboratory-manipulated overexpression strains is also reported. In both instances, the need for an inducing signal is bypassed. While a phosphorylation-mediated conformational change in DevR was proposed as the activation mechanism under hypoxia, the mechanism underlying constitutive expression is not understood. Because DevR is implicated in bacterial dormancy/persistence and is a promising drug target, it is relevant to resolve the mechanistic puzzle of hypoxic activation on one hand and constitutive expression under 'non-inducing' conditions on the other. Here, an overexpression strategy was employed to elucidate the DevR activation mechanism. Using a panel of kinase and transcription factor mutants, we establish that DevR, upon overexpression, circumvents DevS/DosT sensor kinase-mediated or small molecule phosphodonor-dependent activation, and also cooperativity-mediated effects, which are key aspects of hypoxic activation mechanism. However, overexpression failed to rescue the defect of C-terminal-truncated DevR lacking the alpha 10 helix, establishing the alpha 10 helix as an indispensable component of DevR activation mechanism. We propose that aerobic overexpression of DevR likely increases the concentration of alpha 10 helix-mediated active dimer species to above the threshold level, as during hypoxia, and enables regulon expression. This advance in the understanding of DevR activation mechanism clarifies a long standing question as to the mechanism of DevR overexpression-mediated induction of the regulon in the absence of the normal environmental cue and establishes the alpha 10 helix as an universal and pivotal targeting interface for DevR inhibitor development.	[Sharma, Saurabh; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Tyagi, JS (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi, India.	jayatyagi.aiims@gmail.com			Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	JST is thankful to the Department of Science and Technology, Government of India for funding support and J.C. Bose National Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Kohinoor Kaur for RKO-P<INF>Operon</INF>DevR strain as well as present and past members of the JST lab, especially Dr. Atul Vashist for useful discussions. JST is thankful to Department of Science and Technology, Government of India for funding support and J.C. Bose National Fellowship. The BSL-3 facility at University of Delhi South Campus is duly acknowledged for providing access to perform some of experiments involving M. tuberculosis culture.	Flores-Valdez MA, 2015, ANN MICROBIOL, V65, P713, DOI 10.1007/s13213-014-0910-3; Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Boyd JM, 1996, J BACTERIOL, V178, P831, DOI 10.1128/jb.178.3.831-839.1996; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Chan K, 2002, P NATL ACAD SCI USA, V99, P3920, DOI 10.1073/pnas.002024599; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Da Re S, 1999, MOL MICROBIOL, V34, P504, DOI 10.1046/j.1365-2958.1999.01614.x; Dahl JL, 1997, J BIOL CHEM, V272, P1910, DOI 10.1074/jbc.272.3.1910; Dhingra S, 2012, FEMS MICROBIOL LETT, V330, P66, DOI 10.1111/j.1574-6968.2012.02534.x; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gautam US, 2014, J BACTERIOL, V196, P790, DOI 10.1128/JB.01270-13; Gautam US, 2011, J BACTERIOL, V193, P4849, DOI 10.1128/JB.05051-11; Gautam US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016500; Gupta RK, 2009, J MED CHEM, V52, P6324, DOI 10.1021/jm900358q; HERTIG C, 1989, J BACTERIOL, V171, P1736, DOI 10.1128/jb.171.3.1736-1738.1989; Kaur K, 2016, FEBS J, V283, P2949, DOI 10.1111/febs.13787; Kaur K, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-195; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Lejona S, 2004, J BACTERIOL, V186, P2476, DOI 10.1128/JB.186.8.2476-2480.2004; Leoni L, 2003, BIOCHEM BIOPH RES CO, V303, P926, DOI 10.1016/S0006-291X(03)00450-9; Majumdar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035847; Martin B, 2013, MOL MICROBIOL, V87, P394, DOI 10.1111/mmi.12104; Mehra S, 2015, AM J RESP CRIT CARE, V191, P1185, DOI 10.1164/rccm.201408-1502OC; Minch K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035935; Okkotsu Y, 2013, J BACTERIOL, V195, P5499, DOI 10.1128/JB.00726-13; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Vashist A, 2016, FEBS J, V283, P1286, DOI 10.1111/febs.13664; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160723	10.1371/journal.pone.0160723	http://dx.doi.org/10.1371/journal.pone.0160723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490491	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900082
J	Marusic, F; Zaucer, R; Plesnicar, V; Razborsek, T; Sullivan, J; Barner, D				Marusic, Franc; Zaucer, Rok; Plesnicar, Vesna; Razborsek, Tina; Sullivan, Jessica; Barner, David			Does Grammatical Structure Accelerate Number Word Learning? Evidence from Learners of Dual and Non-Dual Dialects of Slovenian	PLOS ONE			English	Article							CHILDRENS ACQUISITION; AMERICAN CHILDREN; LANGUAGE; CHINESE; COGNITION; MEANINGS	How does linguistic structure affect children's acquisition of early number word meanings? Previous studies have tested this question by comparing how children learning languages with different grammatical representations of number learn the meanings of labels for small numbers, like 1, 2, and 3. For example, children who acquire a language with singular-plural marking, like English, are faster to learn the word for 1 than children learning a language that lacks the singular-plural distinction, perhaps because the word for 1 is always used in singular contexts, highlighting its meaning. These studies are problematic, however, because reported differences in number word learning may be due to unmeasured cross-cultural differences rather than specific linguistic differences. To address this problem, we investigated number word learning in four groups of children from a single culture who spoke different dialects of the same language that differed chiefly with respect to how they grammatically mark number. We found that learning a dialect which features "dual" morphology (marking of pairs) accelerated children's acquisition of the number word two relative to learning a "non-dual" dialect of the same language.	[Marusic, Franc; Zaucer, Rok; Plesnicar, Vesna; Razborsek, Tina] Univ Nova Gorica, Ctr Cognit Sci Language, Nova Gorica, Slovenia; [Sullivan, Jessica] Skidmore Coll, Dept Psychol, Saratoga Springs, NY 12866 USA; [Barner, David] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; [Barner, David] Univ Calif San Diego, Dept Linguist, La Jolla, CA 92093 USA	University of Nova Gorica; Skidmore College; University of California System; University of California San Diego; University of California System; University of California San Diego	Marusic, F (corresponding author), Univ Nova Gorica, Ctr Cognit Sci Language, Nova Gorica, Slovenia.	franc.marusic@ung.si	Marušič, Franc/AAA-5406-2019	Marušič, Franc/0000-0002-0667-3236	Slovenian Research Agency [P6-0382, J7-5569]; National Science Foundation [1420249]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from the Slovenian Research Agency (http://www.arrs.gov.si/): P6-0382 & J7-5569 to FM and RZ and a National Science Foundation (http://www.nsf.gov/) grant 1420249 to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almoammer A, 2013, P NATL ACAD SCI USA, V110, P18448, DOI 10.1073/pnas.1313652110; Bale A, 2014, LINGUIST INQ, V45, P1, DOI 10.1162/LING_a_00147; Barner D, 2006, J CHILD LAN IN PRESS; Barner D, 2012, LANG LEARN DEV, V8, P177, DOI 10.1080/15475441.2012.635541; Barner D, 2009, COGNITIVE PSYCHOL, V58, P195, DOI 10.1016/j.cogpsych.2008.07.001; Barner D, 2009, J EXP CHILD PSYCHOL, V103, P421, DOI 10.1016/j.jecp.2008.12.001; Bloom P, 1997, J CHILD LANG, V24, P511, DOI 10.1017/S0305000997003188; Briars D.J., 1988, CHILDRENS COUNTING C, P63; Carey S., 2009, ORIGIN CONCEPTS; Carey S, 2004, DAEDALUS-US, V133, P59, DOI 10.1162/001152604772746701; Casasanto D, 2008, LANG LEARN, V58, P63, DOI 10.1111/j.1467-9922.2008.00462.x; Corbett G., 2000, NUMBER; Davidson K, 2012, COGNITION, V123, P162, DOI 10.1016/j.cognition.2011.12.013; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; Derganc A., 2003, SPRACHTYPOLOGIE UNIV, P165; Everett C, 2012, COGNITIVE SCI, V36, P130, DOI 10.1111/j.1551-6709.2011.01209.x; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Frank MC, 2008, COGNITION, V108, P819, DOI 10.1016/j.cognition.2008.04.007; GEARY DC, 1993, COGNITIVE DEV, V8, P517, DOI 10.1016/S0885-2014(05)80007-3; Geary DC, 1996, CHILD DEV, V67, P2022, DOI 10.2307/1131607; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; Hurford J. R., 1987, LANGUAGE NUMBER EMER; Hutchisson D, 1986, CONTINUUM, P217; Jakop Tjaa, 2008, DUAL SLOVENE DIALECT; Li P, 2010, J EAST ASIAN LINGUIS, V19, P207, DOI 10.1007/s10831-010-9060-1; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; MILLER KF, 1987, COGNITIVE DEV, V2, P279, DOI 10.1016/S0885-2014(87)90091-8; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Rutkowski P, 2003, J UNIVERSAL LANGUAGE, V4, P147; Sarnecka BW, 2007, COGNITIVE PSYCHOL, V55, P136, DOI 10.1016/j.cogpsych.2006.09.001; SIMON HA, 1954, J AM STAT ASSOC, V49, P467, DOI 10.2307/2281124; Vogel EK, 2001, J EXP PSYCHOL HUMAN, V27, P92, DOI 10.1037/0096-1523.27.1.92; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P; WYNN K, 1990, COGNITION, V36, P155, DOI 10.1016/0010-0277(90)90003-3	36	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159208	10.1371/journal.pone.0159208	http://dx.doi.org/10.1371/journal.pone.0159208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GA	27486802	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800020
J	McCourt, AC; Jakobsson, L; Larsson, S; Holm, C; Piel, S; Elmer, E; Bjorkqvist, M				McCourt, Andrew C.; Jakobsson, Lovisa; Larsson, Sara; Holm, Cecilia; Piel, Sarah; Elmer, Eskil; Bjorkqvist, Maria			White Adipose Tissue Browning in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; INSULIN-RESISTANCE; TRANSGENIC MOUSE; WEIGHT-LOSS; CAG REPEAT; WHOLE-BODY; FAT-CELL; ADIPOCYTES; MICE	Huntington's disease (HD) is a fatal, autosomal dominantly inherited neurodegenerative disorder, characterised not only by progressive cognitive, motor and psychiatric impairments, but also of peripheral pathology. In both human HD and in mouse models of HD there is evidence of increased energy expenditure and weight loss, alongside altered body composition. Unlike white adipose tissue (WAT), brown adipose tissue (BAT), as well as brown-like cells within WAT, expresses the mitochondrial protein, uncoupling protein 1 (UCP1). UCP1 enables dissociation of cellular respiration from ATP utilization, resulting in the release of stored energy as heat. Hyperplasia of brown/beige cells in WAT has been suggested to enhance energy expenditure. In this study, we therefore investigated the gene expression profile, histological appearance, response to cold challenge and functional aspects of WAT in the R6/2 HD mouse model and selected WAT gene expression in the full-length Q175 mouse model of HD. WAT from R6/2 mice contained significantly more brown-like adipocyte regions and had a gene profile suggestive of the presence of brown-like adipocytes, such as higher Ucp1 expression. Cold exposure induced Ucp1 expression in R6/2 inguinal WAT to a markedly higher degree as compared to the thermogenic response in WT WAT. Alongside this, gene expression of transcription factors (Zfp516 and Ppar alpha), important inducers of WAT browning, were increased in R6/2 inguinal WAT, and Creb1 was highlighted as a key transcription factor in HD. In addition to increased WAT Ucp1 expression, a trend towards increased mitochondrial oxygen consumption due to enhanced uncoupling activity was found in inguinal R6/2 WAT. Key gene expressional changes (increased expression of (Zfp516 and Ppar alpha)) were replicated in inguinal WAT obtained from Q175 mice. In summary, for the first time, we here show that HD mouse WAT undergoes a process of browning, resulting in molecular and functional alterations that may contribute to the weight loss and altered metabolism observed with disease progression.	[McCourt, Andrew C.; Jakobsson, Lovisa; Bjorkqvist, Maria] Lund Univ, Dept Expt Med Sci, Brain Dis Biomarker Unit, BMC A10, S-22184 Lund, Sweden; [Larsson, Sara; Holm, Cecilia] Lund Univ, Sect Diabet Metab & Endocrinol, Dept Expt Med Sci, BMC C11, S-22184 Lund, Sweden; [Piel, Sarah; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Med, BMC A13, S-22184 Lund, Sweden	Lund University; Lund University; Lund University	Bjorkqvist, M (corresponding author), Lund Univ, Dept Expt Med Sci, Brain Dis Biomarker Unit, BMC A10, S-22184 Lund, Sweden.	maria.bjorkqvist@med.lu.se	Elmér, Eskil/F-9341-2014	Elmér, Eskil/0000-0001-7901-1826; Jakobsson, Lovisa/0000-0001-6179-5327; Piel, Sarah/0000-0002-1779-3532; Bjorkqvist, Maria/0000-0001-8550-0431	Swedish Research Council [521-2014-3911]; Royal Physiographic Society of Lund; Per Westling's memorial fund; Bagadilico (Swedish research Council)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society of Lund; Per Westling's memorial fund; Bagadilico (Swedish research Council)(Swedish Research Council)	MB was supported by grants from the Swedish Research Council (521-2014-3911; www.vr.se) and Bagadilico (Linnaeus Environments funded by Swedish research Council). ACMcC was funded by the Royal Physiographic Society of Lund (www.fysiografen.se) and Per Westling's memorial fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida S, 2004, NEUROBIOL DIS, V17, P435, DOI 10.1016/j.nbd.2004.07.002; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brunetto MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110782; Bugrim A, 2004, DRUG DISCOV TODAY, V9, P127, DOI 10.1016/S1359-6446(03)02971-4; Carroll JB, 2015, LANCET NEUROL, V14, P1135, DOI 10.1016/S1474-4422(15)00177-5; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965; Dempersmier J, 2015, MOL CELL, V57, P235, DOI 10.1016/j.molcel.2014.12.005; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; FARRER LA, 1985, AM J MED GENET, V21, P307, DOI 10.1002/ajmg.1320210213; FARRER LA, 1985, AM J PHYS ANTHROPOL, V67, P185, DOI 10.1002/ajpa.1330670304; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LANSKA DJ, 1988, NEUROLOGY, V38, P769, DOI 10.1212/WNL.38.5.769; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Lindenberg KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105556; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marder K, 2009, NEUROLOGY, V73, P385, DOI 10.1212/WNL.0b013e3181b04aa2; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; McCourt AC, 2015, J HUNTINGTONS DIS, V4, P371, DOI 10.3233/JHD-150172; Mihm MJ, 2007, NEUROBIOL DIS, V25, P297, DOI 10.1016/j.nbd.2006.09.016; Mochel F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000647; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Piel S, 2015, ACTA PHYSIOL, V213, P171, DOI 10.1111/apha.12311; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosen ED, 2000, GENE DEV, V14, P1293; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Sun L, 2014, METABOLISM, V63, P272, DOI 10.1016/j.metabol.2013.10.004; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Burg JMM, 2008, NEUROBIOL DIS, V29, P41, DOI 10.1016/j.nbd.2007.07.029; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vogler O, 2008, INT J OBESITY, V32, P464, DOI 10.1038/sj.ijo.0803768; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4	57	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159870	10.1371/journal.pone.0159870	http://dx.doi.org/10.1371/journal.pone.0159870			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486903	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800042
J	Pronobis, MI; Deuitch, N; Peifer, M				Pronobis, Mira I.; Deuitch, Natalie; Peifer, Mark			The Miraprep: A Protocol that Uses a Miniprep Kit and Provides Maxiprep Yields	PLOS ONE			English	Article							ALKALINE EXTRACTION; PLASMID DNA; PURIFICATION; COMPLEX	Plasmid purification is a basic tool of molecular biologists. Although the development of plasmid isolation kits utilizing silica spin columns reduced the time and labor spent on plasmid purification, achieving large plasmid DNA yields still requires significant time and effort. Here we introduce the Miraprep, a rapid protocol that allows isolation of plasmid DNA using commercial Miniprep kits, but with DNA yields comparable to commercial Maxiprep plasmid purifications. Combining ethanol precipitation with spin column purification, we created a DNA isolation protocol that yields highly concentrated plasmid DNA samples in less than 30 minutes. We show that Miraprep isolated plasmids are as stable as plasmids isolated by standard procedures, can be used for standard molecular biology procedures including DNA sequencing, and can be efficiently transfected into mammalian cells. This new plasmid DNA isolation protocol will significantly reduce time and labor without increasing costs.	[Pronobis, Mira I.; Peifer, Mark] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Deuitch, Natalie; Peifer, Mark] Univ North Carolina Chapel Hill, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Peifer, M (corresponding author), Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Peifer, M (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	peifer@unc.edu		Pronobis, Mira/0000-0002-9861-6596; Peifer, Mark/0000-0003-1412-3987; Deuitch, Natalie/0000-0002-0146-1162	NIH [RO1 GM67236, R35 GM118096]; Howard Hughes Medical Institute International Student Research Fellowship; William W. and Ida W. Taylor Summer Undergraduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067236, R35GM118096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); William W. and Ida W. Taylor Summer Undergraduate Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH RO1 GM67236 and R35 GM118096 to M.P. M.I.P. was supported by a Howard Hughes Medical Institute International Student Research Fellowship and N.D. by a William W. and Ida W. Taylor Summer Undergraduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, QIAPREP MINIPREP HDB; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CLEWELL DB, 1969, P NATL ACAD SCI USA, V62, P1159, DOI 10.1073/pnas.62.4.1159; COLMAN A, 1978, EUR J BIOCHEM, V91, P303, DOI 10.1111/j.1432-1033.1978.tb20966.x; GLASEL JA, 1995, BIOTECHNIQUES, V18, P62; MARKO MA, 1982, ANAL BIOCHEM, V121, P382, DOI 10.1016/0003-2697(82)90497-3; Nakamura Y, 1991, Princess Takamatsu Symp, V22, P285; Pronobis MI, 2015, ELIFE, V4, DOI 10.7554/eLife.08022; Roberts DM, 2011, MOL BIOL CELL, V22, P1845, DOI 10.1091/mbc.E10-11-0871; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615	11	22	22	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160509	10.1371/journal.pone.0160509	http://dx.doi.org/10.1371/journal.pone.0160509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486871	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800081
J	Zeigler-Johnson, C; Morales, KH; Lal, P; Feldman, M				Zeigler-Johnson, Charnita; Morales, Knashawn H.; Lal, Priti; Feldman, Michael			The Relationship between Obesity, Prostate Tumor Infiltrating Lymphocytes and Macrophages, and Biochemical Failure	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; BREAST-CANCER; ADIPOSE-TISSUE; IMMUNE INFILTRATION; AFRICAN-AMERICAN; INFLAMMATION; MICROENVIRONMENT; CELLS; MECHANISMS; MEN	Background Obesity reflects a chronic inflammatory environment that may contribute to prostate cancer progression and poor treatment outcomes. However, it is not clear which mechanisms drive this association within the tumor microenvironment. The aim of this pilot study was to examine prostatic inflammation via tumor infiltrating lymphocytes and macrophages characterized by obesity and cancer severity. Methods We studied paraffin-embedded prostatectomy tissue from 99 participants (63 non-obese and 36 obese) from the Study of Clinical Outcomes, Risk and Ethnicity (University of Pennsylvania). Pathologists analyzed the tissue for type and count of lymphocytes and macrophages, including CD3, CD8, FOXP3, and CD68. Pathology data were linked to clinical and demographic variables. Statistical analyses included frequency tables, Kruskal-Wallis tests, Spearman correlations, and multivariable models. Results We observed positive univariate associations between the number of CD68 cells and tumor grade (p = 0.019). In multivariable analysis, CD8 counts were associated with time to biochemical failure (HR = 1.09, 95% CI = 1.004-1.192, p-value = 0.041.) There were no differences in lymphocytes or macrophages by obesity status or BMI. Conclusions The number of lymphocytes and macrophages in the tumor microenvironment did not differ by obesity status. However, these inflammation markers were associated with poor prostate cancer outcomes. Further examination of underlying mechanisms that influence obesity-related effects on prostate cancer outcomes is warranted. Such research will guide immunotherapy protocols and weight management as they apply to diverse patient populations and phenotypes.	[Zeigler-Johnson, Charnita] Thomas Jefferson Univ, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA; [Morales, Knashawn H.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Lal, Priti; Feldman, Michael] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA	Jefferson University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Zeigler-Johnson, C (corresponding author), Thomas Jefferson Univ, Dept Med Oncol, Div Populat Sci, Philadelphia, PA 19107 USA.	charnita.zeigler-johnson@jefferson.edu			Department of Defense [W81XWH-14-1-0064]	Department of Defense(United States Department of Defense)	Funding for this study was awarded to Dr. Zeigler-Johnson from the Department of Defense (W81XWH-14-1-0064). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amling CL, 2004, J CLIN ONCOL, V22, P439, DOI 10.1200/JCO.2004.03.132; Blando J, 2011, CANCER PREV RES, V4, P2002, DOI 10.1158/1940-6207.CAPR-11-0182; Block KI, 2015, SEMIN CANCER BIOL, V35, pS276, DOI 10.1016/j.semcancer.2015.09.007; Briganti A, 2009, INT J UROL, V16, P676, DOI 10.1111/j.1442-2042.2009.02330.x; Buschemeyer WC, 2007, EUR UROL, V52, P331, DOI 10.1016/j.eururo.2007.04.069; Byers T, 2015, ENDOCR-RELAT CANCER, V22, pR125, DOI 10.1530/ERC-14-0580; Casbas-Hernandez P, 2015, CANCER EPIDEM BIOMAR, V24, P406, DOI 10.1158/1055-9965.EPI-14-0934; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; De Ridder J, 2016, CANCER CAUSE CONTROL, V27, P291, DOI 10.1007/s10552-015-0709-y; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Ebelt K, 2008, PROSTATE, V68, P1, DOI 10.1002/pros.20661; Freedland SJ, 2009, PROSTATE CANCER P D, V12, P259, DOI 10.1038/pcan.2009.11; Galustian C, 2011, BIOCHEM SOC T, V39, P1433, DOI 10.1042/BST0391433; Gannot G, 2011, AM J CANCER RES, V1, P120; Gollapudi K, 2013, AM J CANCER RES, V3, P523; Gross M, 2009, PROSTATE, V69, P520, DOI 10.1002/pros.20901; Hardaway AL, 2014, CANCER METAST REV, V33, P527, DOI 10.1007/s10555-013-9484-y; Jacobsen MJ, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8539057; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Khani F, 2014, CLIN CANCER RES, V20, P4925, DOI 10.1158/1078-0432.CCR-13-2265; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Kmiecik J, 2013, J NEUROIMMUNOL, V264, P71, DOI 10.1016/j.jneuroim.2013.08.013; Kruger JM, 2013, J PATHOL, V229, P569, DOI 10.1002/path.4150; Lundholm M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15651; Lysaght J, 2011, CANCER LETT, V312, P62, DOI 10.1016/j.canlet.2011.07.034; Miyahira AK, 2015, PROSTATE, V75, P337, DOI 10.1002/pros.22920; Motamedinia P, 2008, UROLOGY, V72, P1106, DOI 10.1016/j.urology.2008.04.021; Mukhtar RA, 2012, ANN SURG ONCOL, V19, P3979, DOI 10.1245/s10434-012-2415-2; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Perez-Hernandez AI, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00065; Preston CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080063; Rebbeck TR, 2010, CANCER EPIDEM BIOMAR, V19, P2115, DOI 10.1158/1055-9965.EPI-10-0173; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Rodriguez C, 2007, NUTR COHORT CANC EPI, V161, P63; Rose DP, 2015, CANCERS, V7, P2147, DOI 10.3390/cancers7040883; Santoni M, 2015, CANCER METAST REV, V34, P765, DOI 10.1007/s10555-015-9597-6; Spangler E, 2007, J UROLOGY, V178, P1939, DOI 10.1016/j.juro.2007.07.021; Strasner A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00128; Strong AL, 2015, STEM CELLS, V33, P318, DOI 10.1002/stem.1857; Sun XZ, 2012, BREAST CANCER RES TR, V131, P1003, DOI 10.1007/s10549-011-1789-3; Taverna G, 2015, INFLAMM RES, V64, P275, DOI 10.1007/s00011-015-0812-2; Tiainen S, 2015, HISTOPATHOLOGY, V66, P873, DOI 10.1111/his.12607; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ungefroren H, 2015, HORM MOL BIOL CLIN I, V21, P5, DOI 10.1515/hmbci-2014-0046; Valdman A, 2010, APMIS, V118, P360, DOI 10.1111/j.1600-0463.2010.02604.x; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Vral A, 2012, INT J ONCOL, V41, P1950, DOI 10.3892/ijo.2012.1646; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Womack J, 2007, METABOLISM, V56, P998, DOI 10.1016/j.metabol.2007.03.008; Zeigler-Johnson C, 2013, CANCER EPIDEM BIOMAR, V22, P589, DOI 10.1158/1055-9965.EPI-12-0944; Zlobec I, 2011, HISTOPATHOLOGY, V59, P482, DOI 10.1111/j.1365-2559.2011.03975.x	51	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159109	10.1371/journal.pone.0159109	http://dx.doi.org/10.1371/journal.pone.0159109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487262	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800017
J	Jung, YH; Ha, TM; Oh, CY; Lee, US; Jang, JH; Kim, J; Park, JO; Kang, DH				Jung, Ye-Ha; Ha, Tae Min; Oh, Chang Young; Lee, Ui Soon; Jang, Joon Hwan; Kim, Jungwon; Park, Jae-Oh; Kang, Do-Hyung			The Effects of an Online Mind-Body Training Program on Stress, Coping Strategies, Emotional Intelligence, Resilience and Psychological State	PLOS ONE			English	Article							MINDFULNESS; MEDITATION; REDUCTION; PERSONALITY; SYMPTOMS	The goal of this study was to evaluate the effects of an online mind-body training (MBT) program on participants' stress, anger, coping strategies, emotional intelligence, resilience, and positive and negative affect. Forty-two healthy women participated in an online MBT program for approximately 8-10 minutes a day for 8 weeks; a control group of 45 healthy women did not participate in the program. Self-report psychological questionnaires were administered before the beginning of the program and at 4 and 8 weeks following its onset. Data from the MBT group and the control group were compared using repeated measures ANOVA and Student's t-tests. Significant time x group interaction effects were found with respect to stress, coping strategies, anger, emotional intelligence, negative affect and resilience. These results demonstrate beneficial effects of the online MBT program and significant improvements in the psychological capabilities of participants compared with the control group. The effects of online MBT program were similar with those of the previous offline MBT in psychological aspects, suggesting further studies for neuroscientific evidence related stress and emotion of online MBT effects.	[Jung, Ye-Ha; Jang, Joon Hwan; Kang, Do-Hyung] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul, South Korea; [Kang, Do-Hyung] Seoul Natl Univ, Dept Psychiat, Coll Med, Seoul, South Korea; [Oh, Chang Young; Lee, Ui Soon] Global Cyber Univ, Dept Brain Educ, Cheonan, South Korea; [Kim, Jungwon] Kosin Univ, Dept Occupat & Environm Med, Coll Med, Busan, South Korea; [Park, Jae-Oh] Occupat Safety & Hlth Res Inst, Dept Occupat Hlth Res, Ulsan, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kang, DH (corresponding author), Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul, South Korea.; Kang, DH (corresponding author), Seoul Natl Univ, Dept Psychiat, Coll Med, Seoul, South Korea.	basuare@daum.net			Occupational Safety and Health Research Institute [2015-research institute-961]; Korea Occupational Safety and Health Research Institute	Occupational Safety and Health Research Institute; Korea Occupational Safety and Health Research Institute	This work was supported by the Occupational Safety and Health Research Institute, grant number: 2015-research institute-961 (http://oshri.kosha.or.kr/main) to DHK, TMH, CYO, JHJ, YHJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge Ministry of Employment and Labor. This study was planned and supported by Korea Occupational Safety and Health Research Institute.	AMIRKHAN JH, 1990, J PERS SOC PSYCHOL, V59, P1066, DOI 10.1037/0022-3514.59.5.1066; Amutio A, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01572; Brackett MA, 2003, PERS SOC PSYCHOL B, V29, P1147, DOI 10.1177/0146167203254596; Cavanagh K, 2013, BEHAV RES THER, V51, P573, DOI 10.1016/j.brat.2013.06.003; Chang Sei-Jin, 2005, Annals of Occupational and Environmental Medicine, V17, P297; Cho HS, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-12; Coleman A. M., 2008, DICT PSYCHOL; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; de Azevedo FB, 2010, ARQ NEURO-PSIQUIAT, V68, P231, DOI 10.1590/S0004-282X2010000200015; Deible Stephanie, 2015, Glob Adv Health Med, V4, P28, DOI 10.7453/gahmj.2014.057; DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x; Garland SN, 2007, SUPPORT CARE CANCER, V15, P949, DOI 10.1007/s00520-007-0280-5; Griffin KH, 2015, J ALTERN COMPLEM MED, V21, P628, DOI 10.1089/acm.2015.0130; Gupta Nidhi, 2006, Indian J Physiol Pharmacol, V50, P41; Hochschild A. R., 1983, J POLICY ANAL MANAG, DOI DOI 10.1002/PAM.4050030365; Iyenger BKS, 1995, LIGHT ON PRANAYAMA; Jang JH, 2011, NEUROSCI LETT, V487, P358, DOI 10.1016/j.neulet.2010.10.056; Jung YH, 2012, STRESS, V15, P97, DOI 10.3109/10253890.2011.592880; Jung YH, 2010, NEUROSCI LETT, V479, P138, DOI 10.1016/j.neulet.2010.05.048; Kang DH, 2013, SOC COGN AFFECT NEUR, V8, P27, DOI 10.1093/scan/nss056; Kemper KJ, 2015, J EVID-BASED INTEGR, V20, P247, DOI 10.1177/2156587215575816; Kemper KJ, 2015, J EVID-BASED INTEGR, V20, P275, DOI 10.1177/2156587215580882; Koh KB, 2001, PSYCHOSOM MED, V63, P668, DOI 10.1097/00006842-200107000-00020; Lane JD, 2007, ALTERN THER HEALTH M, V13, P38; Lee KH, 2015, ANN OCCUP ENVIRON ME, V27, DOI 10.1186/s40557-015-0075-y; Lieberman HR, 2015, PSYCHOPHARMACOLOGY, V232, P943, DOI 10.1007/s00213-014-3727-7; Mann S, 2005, J Psychiatr Ment Health Nurs, V12, P154, DOI 10.1111/j.1365-2850.2004.00807.x; Mather AS, 2002, BRIT J PSYCHIAT, V180, P411, DOI 10.1192/bjp.180.5.411; Matthews G, 2006, J EXP PSYCHOL-APPL, V12, P96, DOI 10.1037/1076-898X.12.2.96; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; McEwen BS, 2016, ANN NY ACAD SCI, V1373, P56, DOI 10.1111/nyas.13020; Moon Y., 1999, REPORT SAEHAN MEDIA; Patel C., 1999, PRINCIPLES PRACTICE, P72; Pert C, 1995, Altern Ther Health Med, V1, P70; Pidgeon AM, 2014, PSYCHOL HEALTH MED, V19, P355, DOI 10.1080/13548506.2013.806815; Por J, 2011, NURS EDUC TODAY, V31, P855, DOI 10.1016/j.nedt.2010.12.023; Robins CJ, 2012, J CLIN PSYCHOL, V68, P117, DOI 10.1002/jclp.20857; Roth R., 1994, TRANSCENDENTAL MEDIT; Ruiz-Aranda D, 2011, J PAIN, V12, P1190, DOI 10.1016/j.jpain.2011.06.008; Sahin NH, 2009, TURK PSIKIYATR DERG, V20, P243; Sharma J, 2016, APPL NURS RES, V30, P268, DOI 10.1016/j.apnr.2015.01.010; Spielberger C., 1988, MANUAL STATE TRAIT A; Tajvar Abdolhamid, 2015, Electron Physician, V7, P1108, DOI 10.14661/2015.1108-1113; Tang YY, 2011, NEUROSCI BULL, V27, P383, DOI 10.1007/s12264-011-1141-2; Tarantino B, 2013, EXPLORE-NY, V9, P44, DOI 10.1016/j.explore.2012.10.002; Valderas MT, 2015, IEEE ENG MED BIO, P6134, DOI 10.1109/EMBC.2015.7319792; Walpole P, 2008, EPILEPSIA, V49, P1470, DOI 10.1111/j.1528-1167.2008.01655.x; Wang Huey-Fen, 2005, J Nurs Res, V13, P106; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weller S., 1995, YOGA THERAPY; Xiong GL, 2009, ANN NY ACAD SCI, V1172, P63, DOI 10.1196/annals.1393.002	51	19	20	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0159841	10.1371/journal.pone.0159841	http://dx.doi.org/10.1371/journal.pone.0159841			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NO	27479499	Green Published, Green Submitted, gold			2022-12-27	WOS:000381110300019
J	Fahad, S; Hussain, S; Saud, S; Hassan, S; Chauhan, BS; Khan, F; Ihsan, MZ; Ullah, A; Wu, C; Bajwa, AA; Alharby, H; Amanullah; Nasim, W; Shahzad, B; Tanveer, M; Huang, JL				Fahad, Shah; Hussain, Saddam; Saud, Shah; Hassan, Shah; Chauhan, Bhagirath Singh; Khan, Fahad; Ihsan, Muhammad Zahid; Ullah, Abid; Wu, Chao; Bajwa, Ali Ahsan; Alharby, Hesham; Amanullah; Nasim, Wajid; Shahzad, Babar; Tanveer, Mohsin; Huang, Jianliang			Responses of Rapid Viscoanalyzer Profile and Other Rice Grain Qualities to Exogenously Applied Plant Growth Regulators under High Day and High Night Temperatures	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENE-EXPRESSION; CLIMATE-CHANGE; YIELD; WHEAT; ACID; ACCUMULATION; CHALKINESS; PHOTOSYNTHESIS; PACLOBUTRAZOL	High-temperature stress degrades the grain quality of rice; nevertheless, the exogenous application of plant growth regulators (PGRs) might alleviate the negative effects of high temperatures. In the present study, we investigated the responses of rice grain quality to exogenously applied PGRs under high day temperatures (HDT) and high night temperatures (HNT) under controlled conditions. Four different combinations of ascorbic acid (Vc), alpha-tocopherol (Ve), brassinosteroids (Br), methyl jasmonates (MeJA) and triazoles (Tr) were exogenously applied to two rice cultivars (IR-64 and Huanghuazhan) prior to the high-temperature treatment. A Nothing applied Control (NAC) was included for comparison. The results demonstrated that high-temperature stress was detrimental for grain appearance and milling qualities and that both HDT and HNT reduced the grain length, grain width, grain area, head rice percentage and milled rice percentage but increased the chalkiness percentage and percent area of endosperm chalkiness in both cultivars compared with ambient temperature (AT). Significantly higher grain breakdown, set back, consistence viscosity and gelatinization temperature, and significantly lower peak, trough and final viscosities were observed under high-temperature stress compared with AT. Thus, HNT was more devastating for grain quality than HDT. The exogenous application of PGRs ameliorated the adverse effects of high temperature in both rice cultivars, and Vc+Ve+MejA+Br was the best combination for both cultivars under high temperature stress.	[Fahad, Shah; Hussain, Saddam; Khan, Fahad; Ullah, Abid; Wu, Chao; Tanveer, Mohsin; Huang, Jianliang] Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, MOA Key Lab Crop Ecophysiol & Farming Syst, Wuhan 430070, Hubei, Peoples R China; [Hussain, Saddam; Khan, Fahad] Huazhong Agr Univ, Coll Resources & Environm, Wuhan 430070, Hubei, Peoples R China; [Saud, Shah] Northeast Agr Univ, Dept Hort, Harbin 150030, Peoples R China; [Hassan, Shah] Agr Univ Peshawar, Dept Extens, Khyber Pakhtunkhwa 25130, Pakistan; [Chauhan, Bhagirath Singh; Bajwa, Ali Ahsan] Univ Queensland, Queensland Alliance Agr & Food Innovat, Toowoomba, Qld 4350, Australia; [Ihsan, Muhammad Zahid] King Abdulaziz Univ, Fac Meteorol Environm & Arid Land Agr, Dept Arid Land Agr, POB 80208, Jeddah 21589, Saudi Arabia; [Bajwa, Ali Ahsan] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld 4343, Australia; [Alharby, Hesham] King Abdulaziz Univ, Dept Biol Sci, Fac Sci, Jeddah 21589, Saudi Arabia; [Amanullah] Univ Agr, Dept Agron, Fac Crop Prod Sci, Peshawar 25000, Pakistan; [Nasim, Wajid] COMSATS Inst Informat Technol, Dept Environm Sci, Vehari 61100, Pakistan; [Shahzad, Babar] Univ Agr Faisalabad, Faisalabad 38000, Pakistan; [Huang, Jianliang] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Northeast Agricultural University - China; University of Queensland; King Abdulaziz University; University of Queensland; King Abdulaziz University; Agricultural University Peshawar; University of Agriculture Faisalabad; COMSATS University Islamabad (CUI); University of Agriculture Faisalabad; Yangtze University	Huang, JL (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Natl Key Lab Crop Genet Improvement, MOA Key Lab Crop Ecophysiol & Farming Syst, Wuhan 430070, Hubei, Peoples R China.; Huang, JL (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China.	jhuang@mail.hzau.edu.cn	Bajwa, Ali/B-9948-2016; Fahad, Shah/J-7265-2019; Fahad, Shah/GZM-2604-2022; Shahzad, Babar/J-3204-2019; Saud, Shah/AEA-9474-2022; Amanullah/U-7782-2019; Tanveer, Mohsin/I-2577-2019; Hussain, Saddam/H-3489-2019; Ullah, Abid/AAD-1241-2020; Nasim, Dr Wajid/A-2112-2014; Chauhan, Bhagirath/G-8892-2014	Bajwa, Ali/0000-0002-7171-3118; Fahad, Shah/0000-0002-7525-0296; Shahzad, Babar/0000-0002-4358-3539; Saud, Shah/0000-0002-3761-2858; Amanullah/0000-0003-2289-7755; Tanveer, Mohsin/0000-0003-4560-6439; Hussain, Saddam/0000-0002-0895-1287; Ullah, Abid/0000-0003-2389-3916; Nasim, Dr Wajid/0000-0001-6221-7318; Chauhan, Bhagirath/0000-0003-1540-4668	Key Technology Program R D of China [2012BAD04B12]; MOA Special Fund for Agro-scientific Research in the Public Interest of China [201103003]; Major International Joint Research Project of NSFC [31361140368]	Key Technology Program R D of China; MOA Special Fund for Agro-scientific Research in the Public Interest of China; Major International Joint Research Project of NSFC	The authors thank the funding provided by the Key Technology Program R & D of China (Project No. 2012BAD04B12) and MOA Special Fund for Agro-scientific Research in the Public Interest of China (No. 201103003).; We thank the funding provided by the Major International Joint Research Project of NSFC (No.31361140368).	Ashida K, 2009, CEREAL CHEM, V86, P225, DOI 10.1094/CCHEM-86-2-0225; Bao JS, 2002, THEOR APPL GENET, V104, P408, DOI 10.1007/s001220100688; Beltagi M., 2008, AFR J PLANT SCI, V2, P118; Ceccarelli S, 2010, J AGR SCI-CAMBRIDGE, V148, P627, DOI 10.1017/S0021859610000651; Chanvrier H, 2013, FOOD RES INT, V53, P73, DOI 10.1016/j.foodres.2013.03.040; Chen C, 2013, FIELD CROP RES, V151, P85, DOI 10.1016/j.fcr.2013.07.016; Cheong JJ, 2003, TRENDS GENET, V19, P409, DOI 10.1016/S0168-9525(03)00138-0; Clarke SM, 2009, NEW PHYTOL, V182, P175, DOI 10.1111/j.1469-8137.2008.02735.x; Cooper NTW, 2008, CEREAL CHEM, V85, P276, DOI 10.1094/CCHEM-85-3-0276; Counce PA, 2005, CEREAL CHEM, V82, P645, DOI 10.1094/CC-82-0645; Ebata, 1975, JPN J CROP SCI, V44, P205, DOI [DOI 10.1626/JCS.44.205, 10.1626/jcs.44.205]; Eitzinger J, 2010, J AGR SCI-CAMBRIDGE, V148, P499, DOI 10.1017/S0021859610000481; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Fletcher R. A., 2000, Horticultural Reviews, V24, P55, DOI 10.1002/9780470650776.ch3; Gaiser T, 2011, AGR FOREST METEOROL, V151, P1120, DOI 10.1016/j.agrformet.2011.03.015; Gang W, 2007, COLLOID SURFACE B, V59, P113, DOI 10.1016/j.colsurfb.2007.05.003; Gonzalez-Olmedo J. L., 2005, Infomusa, V14, P18; Hajihashemi S, 2007, PLANT GROWTH REGUL, V53, P117, DOI 10.1007/s10725-007-9209-8; Hall AE, 2001, CROP RESPONSES ENV; Han YP, 2004, PLANT SCI, V166, P357, DOI 10.1016/j.plantsci.2003.09.023; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Igamberdiev AU, 2004, J EXP BOT, V55, P2473, DOI 10.1093/jxb/erh272; Igamberdiev AU, 2004, PLANTA, V219, P95, DOI 10.1007/s00425-003-1192-3; Ishimaru T, 2009, J CEREAL SCI, V50, P166, DOI 10.1016/j.jcs.2009.04.011; Ivanov B, 2003, ANTIOXID REDOX SIGN, V5, P43, DOI 10.1089/152308603321223531; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Khush GS, 1979, P WORKSH CHEM ASP RI; Kiddle G, 2003, ANTIOXID REDOX SIGN, V5, P23, DOI 10.1089/152308603321223513; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Koutroubas SD, 2004, FIELD CROP RES, V86, P115, DOI 10.1016/S0378-4290(03)00117-5; Krishnan P, 2007, AGR ECOSYST ENVIRON, V122, P233, DOI 10.1016/j.agee.2007.01.019; Lanning SB, 2011, FIELD CROP RES, V124, P132, DOI 10.1016/j.fcr.2011.06.012; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Lyman NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072157; MACKAY CE, 1990, PESTIC BIOCHEM PHYS, V37, P74, DOI 10.1016/0048-3575(90)90110-N; Maclean J.L., 2002, RICE ALMANAC SOURCE, V3, P253, DOI [10.1079/9780851996363.0000, DOI 10.1079/9780851996363.0000]; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; Mohammed AR, 2011, CAN J PLANT SCI, V91, P283, DOI 10.4141/CJPS10038; Nagai T, 2009, PLANT CELL PHYSIOL, V50, P744, DOI 10.1093/pcp/pcp029; Pedranzani H, 2003, PLANT GROWTH REGUL, V41, P149, DOI 10.1023/A:1027311319940; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Perrotta C, 1998, J CEREAL SCI, V27, P127, DOI 10.1006/jcrs.1997.0153; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; PINHERO RG, 1994, PLANT GROWTH REGUL, V15, P47, DOI 10.1007/BF00024676; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Rehmani MIA, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-41; RYU GH, 1993, J FOOD SCI, V58, P567, DOI 10.1111/j.1365-2621.1993.tb04325.x; Shao HB, 2005, ACTA ECOL SIN, V25, P1871; Shi WJ, 2016, FIELD CROP RES, V190, P18, DOI 10.1016/j.fcr.2015.10.006; Song XY, 2013, CEREAL CHEM, V90, P114, DOI 10.1094/CCHEM-01-12-0010-R; Umemoto T, 2002, FUNCT PLANT BIOL, V29, P1121, DOI 10.1071/PP01145; Wardlaw I, 1989, CROP PASTURE SCI, V40, P15; Wardlaw IF, 2002, FUNCT PLANT BIOL, V29, P25, DOI 10.1071/PP00147; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; Yoshioka Y, 2007, CROP SCI, V47, P2113, DOI 10.2135/cropsci2006.10.0631sc; Zakaria S, 2002, PLANT PROD SCI, V5, P160, DOI 10.1626/pps.5.160; Zhang S, 2007, AUST J AGR RES, V58, P811, DOI 10.1071/AR06253; Zheng X, 2008, THEOR APPL GENET, V116, P335, DOI 10.1007/s00122-007-0671-5; Zhu LiYang, 2013, Australian Journal of Crop Science, V7, P543	60	84	86	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159590	10.1371/journal.pone.0159590	http://dx.doi.org/10.1371/journal.pone.0159590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472200	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300012
J	Kopechek, JA; Carson, AR; McTiernan, CF; Chen, XC; Klein, EC; Villanueva, FS				Kopechek, Jonathan A.; Carson, Andrew R.; McTiernan, Charles F.; Chen, Xucai; Klein, Edwin C.; Villanueva, Flordeliza S.			Cardiac Gene Expression Knockdown Using Small Inhibitory RNA-Loaded Microbubbles and Ultrasound	PLOS ONE			English	Article							MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; RED-BLOOD-CELLS; SIRNA DELIVERY; DESTRUCTION; INFARCTION; HEART; KINETICS; THERAPY; TISSUE	RNA interference has potential therapeutic value for cardiac disease, but targeted delivery of interfering RNA is a challenge. Custom designed microbubbles, in conjunction with ultrasound, can deliver small inhibitory RNA to target tissues in vivo. The efficacy of cardiac RNA interference using a microbubble-ultrasound theranostic platform has not been demonstrated in vivo. Therefore, our objective was to test the hypothesis that custom designed microbubbles and ultrasound can mediate effective delivery of small inhibitory RNA to the heart. Microbubble and ultrasound mediated cardiac RNA interference was tested in transgenic mice displaying cardiac-restricted luciferase expression. Luciferase expression was assayed in select tissues of untreated mice (n = 14). Mice received intravenous infusion of cationic microbubbles bearing small inhibitory RNA directed against luciferase (n = 9) or control RNA (n = 8) during intermittent cardiac-directed ultrasound at mechanical index of 1.6. Simultaneous echocardiography in a separate group of mice (n = 3) confirmed microbubble destruction and replenishment during treatment. Three days post treatment, cardiac luciferase messenger RNA and protein levels were significantly lower in ultrasound-treated mice receiving microbubbles loaded with small inhibitory RNA directed against luciferase compared to mice receiving microbubbles bearing control RNA (23+/-7% and 33+/-7% of control mice, p<0.01 and p = 0.03, respectively). Passive cavitation detection focused on the heart confirmed that insonification resulted in inertial cavitation. In conclusion, small inhibitory RNA-loaded microbubbles and ultrasound directed at the heart significantly reduced the expression of a reporter gene. Ultrasound-targeted destruction of RNA-loaded microbubbles may be an effective image-guided strategy for therapeutic RNA interference in cardiac disease.	[Kopechek, Jonathan A.; Carson, Andrew R.; McTiernan, Charles F.; Chen, Xucai; Villanueva, Flordeliza S.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Kopechek, Jonathan A.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Klein, Edwin C.] Univ Pittsburgh, Dept Lab Anim Resources, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Louisville; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Villanueva, FS (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	villanuevafs@upmc.edu			Center for Ultrasound Molecular Imaging and Therapeutics; University of Pittsburgh Medical Center; University of Pittsburgh; National Institutes of Health [R01EB016516, R21CA167373, F32HL126421]; NATIONAL CANCER INSTITUTE [R21CA167373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL126421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016516] Funding Source: NIH RePORTER	Center for Ultrasound Molecular Imaging and Therapeutics; University of Pittsburgh Medical Center; University of Pittsburgh(University of Pittsburgh); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by the Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh Medical Center and University of Pittsburgh and by the National Institutes of Health (R01EB016516, R21CA167373, and F32HL126421).	Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bekeredjian R, 2003, CIRCULATION, V108, P1022, DOI 10.1161/01.CIR.0000084535.35435.AE; Carson AR, 2012, CANCER RES, V72, P6191, DOI 10.1158/0008-5472.CAN-11-4079; Carson AR, 2011, ULTRASOUND MED BIOL, V37, P393, DOI 10.1016/j.ultrasmedbio.2010.11.011; Chen S, 2010, GENE THER, V17, P1411, DOI 10.1038/gt.2010.85; Chen SY, 2002, ECHOCARDIOGR-J CARD, V19, P495, DOI 10.1046/j.1540-8175.2002.00495.x; CHILD SZ, 1990, ULTRASOUND MED BIOL, V16, P817, DOI 10.1016/0301-5629(90)90046-F; Christiansen JP, 2003, ULTRASOUND MED BIOL, V29, P1759, DOI 10.1016/S0301-5629(03)00976-1; de Jong N, 2002, ECHOCARDIOGR-J CARD, V19, P229, DOI 10.1046/j.1540-8175.2002.00229.x; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; Feinstein SB, 2010, J NUCL CARDIOL, V17, P106, DOI 10.1007/s12350-009-9165-y; Fujii H, 2009, JACC-CARDIOVASC IMAG, V2, P869, DOI 10.1016/j.jcmg.2009.04.008; Hegde V, 2014, J CONTROL RELEASE, V196, P355, DOI 10.1016/j.jconrel.2014.10.022; JAYAWEERA AR, 1994, CIRC RES, V74, P1157, DOI 10.1161/01.RES.74.6.1157; Kaul S, 2008, CIRCULATION, V118, P291, DOI 10.1161/CIRCULATIONAHA.107.747303; Kubota T, 1997, J Card Fail, V3, P117, DOI 10.1016/S1071-9164(97)90045-2; Mannell H, 2012, PHARM RES-DORDR, V29, P1282, DOI 10.1007/s11095-012-0678-8; McTiernan CF, 1999, J MOL CELL CARDIOL, V31, P679, DOI 10.1006/jmcc.1998.0904; McTiernan CF, 1999, J MOL CELL CARDIOL, V31, P2137, DOI 10.1006/jmcc.1999.1042; Meijering BDM, 2009, CIRC RES, V104, P679, DOI 10.1161/CIRCRESAHA.108.183806; Mulvagh SL, 2000, J AM SOC ECHOCARDIOG, V13, P331, DOI 10.1067/mje.2000.105462; Natarajan R, 2006, CIRC RES, V98, P133, DOI 10.1161/01.RES.0000197816.63513.27; Price RJ, 1998, CIRCULATION, V98, P1264, DOI 10.1161/01.CIR.98.13.1264; Qin P, 2014, ULTRASOUND MED BIOL, V40, P979, DOI 10.1016/j.ultrasmedbio.2013.11.024; Raghunathan S, 2013, FUND CLIN PHARMACOL, V27, P1, DOI 10.1111/j.1472-8206.2012.01051.x; Somasuntharam I, 2013, BIOMATERIALS, V34, P7790, DOI 10.1016/j.biomaterials.2013.06.051; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Tsunoda S, 2005, BIOCHEM BIOPH RES CO, V336, P118, DOI 10.1016/j.bbrc.2005.08.052; Videira M, 2014, NANOMED-NANOTECHNOL, V10, P689, DOI 10.1016/j.nano.2013.11.018; Villanueva FS, 2009, JACC-CARDIOVASC IMAG, V2, P880, DOI 10.1016/j.jcmg.2009.05.006; Wu HQ, 2014, CARDIOLOGY, V127, P236, DOI 10.1159/000356471; Zhao SK, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061872; Zhou Y, 2009, ULTRASOUND MED BIOL, V35, P1756, DOI 10.1016/j.ultrasmedbio.2009.05.012	33	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0159751	10.1371/journal.pone.0159751	http://dx.doi.org/10.1371/journal.pone.0159751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27471848	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516300018
J	Morimoto, C; Manabe, S; Kawaguchi, T; Kawai, C; Fujimoto, S; Hamano, Y; Yamada, R; Matsuda, F; Tamaki, K				Morimoto, Chie; Manabe, Sho; Kawaguchi, Takahisa; Kawai, Chihiro; Fujimoto, Shuntaro; Hamano, Yuya; Yamada, Ryo; Matsuda, Fumihiko; Tamaki, Keiji			Pairwise Kinship Analysis by the Index of Chromosome Sharing Using High-Density Single Nucleotide Polymorphisms	PLOS ONE			English	Article							IDENTIFICATION; IDENTITY; DESCENT; MARKERS; SNPS; TOOL; HAPMAP; LOCI	We developed a new approach for pairwise kinship analysis in forensic genetics based on chromosomal sharing between two individuals. Here, we defined "index of chromosome sharing" (ICS) calculated using 174,254 single nucleotide polymorphism (SNP) loci typed by SNP microarray and genetic length of the shared segments from the genotypes of two individuals. To investigate the expected ICS distributions from first-to fifth-degree relatives and unrelated pairs, we used computationally generated genotypes to consider the effect of linkage disequilibrium and recombination. The distributions were used for probabilistic evaluation of the pairwise kinship analysis, such as likelihood ratio (LR) or posterior probability, without allele frequencies and haplotype frequencies. Using our method, all actual sample pairs from volunteers showed significantly high LR values (i.e., >= 10(8)); therefore, we can distinguish distant relationships (up to the fifth-degree) from unrelated pairs based on LR. Moreover, we can determine accurate degrees of kinship in up to third-degree relationships with a probability of > 80% using the criterion of posterior probability >= 0.90, even if the kinship of the pair is totally unpredictable. This approach greatly improves pairwise kinship analysis of distant relationships, specifically in cases involving identification of disaster victims or missing persons.	[Morimoto, Chie; Manabe, Sho; Kawai, Chihiro; Fujimoto, Shuntaro; Hamano, Yuya; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan; [Kawaguchi, Takahisa; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Unit Human Dis Genom, Kyoto, Japan; [Hamano, Yuya] Kyoto Prefectural Police Headquarters, Forens Sci Lab, Kyoto, Japan; [Yamada, Ryo] Kyoto Univ, Grad Sch Med, Unit Stat Genet, Ctr Genom Med, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University	Tamaki, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan.	ktamaki@fp.med.kyoto-u.ac.jp		Yamada, Ryo/0000-0002-1587-630X				Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning SR, 2012, ANNU REV GENET, V46, P617, DOI 10.1146/annurev-genet-110711-155534; Delaneau O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-540; Gao Xiaoyi, 2012, Frontiers in Genetics, V3, P117, DOI 10.3389/fgene.2012.00117; Grandell I, 2016, INT J LEGAL MED; Han LD, 2013, EUR J HUM GENET, V21, P205, DOI 10.1038/ejhg.2012.148; Hill WG, 2013, G3-GENES GENOM GENET, V3, P1553, DOI 10.1534/g3.113.007500; Hummel K., 1971, BIOSTATISTICAL OPINI; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kling D, 2012, FORENSIC SCI INT-GEN, V6, P322, DOI 10.1016/j.fsigen.2011.07.007; Lareu MV, 2012, FORENSIC SCI INT-GEN, V6, P350, DOI 10.1016/j.fsigen.2011.07.011; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; Lindner I, 2014, TRANSFUS MED HEMOTH, V41, P117, DOI 10.1159/000357989; Pontes ML, 2015, TRANSFUS MED HEMOTH, V42, P385, DOI 10.1159/000440832; Morimoto C, 2015, DNA POLYMORPHISM, V23, P151; Narahara M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-72; Phillips C, 2012, TRANSFUS MED HEMOTH, V39, P202, DOI 10.1159/000338857; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2006, R LANG ENV STAT COMP; Sun M, 2016, THEOR POPUL BIOL, V107, P14, DOI 10.1016/j.tpb.2015.10.002; Tamaki K, 2009, TRANSFUSION, V49, P578, DOI 10.1111/j.1537-2995.2008.02024.x; Wang H, 2015, FORENS SCI INT-GEN S, V5, pE233, DOI 10.1016/j.fsigss.2015.09.093	22	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160287	10.1371/journal.pone.0160287	http://dx.doi.org/10.1371/journal.pone.0160287			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27472558	gold, Green Published			2022-12-27	WOS:000381516300040
J	Ahmad, N; Javaid, A; Sulaiman, SAS; Basit, A; Afridi, AK; Jaber, AAS; Khan, AH				Ahmad, Nafees; Javaid, Arshad; Sulaiman, Syed Azhar Syed; Basit, Anila; Afridi, Afsar Khan; Jaber, Ammar Ali Saleh; Khan, Amer Hayat			Effects of Multidrug Resistant Tuberculosis Treatment on Patients' Health Related Quality of Life: Results from a Follow Up Study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; RISK-FACTORS; DEPRESSION; GENDER; EXPERIENCES; PREVALENCE; IMPACT; UK	Background At present, within the management of multidrug resistant tuberculosis (MDR-TB) much attention is being paid to the traditional microbiological and clinical indicators. Evaluation of the impact of MDR-TB treatment on patients' Health Related Quality of Life (HRQoL) has remained a neglected area. Objective To evaluate the impact of MDR-TB treatment on patients HRQoL, and determine the predictors of variability in HRQoL along the course of treatment Methods A prospective follow up study was conducted at the programmatic management unit for drug resistant TB of Lady Reading Hospital Peshawar. Culture confirmed eligible MDR-TB patients were asked to self complete SF-36v2 at the baseline visit, and subsequently after the completion of 12 months of treatment and at the end of treatment. A score of <47 norm-based scoring (NBS) points on component summary measures and health domain scales was considered indicative of function impairment. General linear model repeated measures ANOVA was used examine the change and predictors of change in physical component summary (PCS) and mental component summary (MCS) scores over the time. Results A total of 68 out of enrolled 81 eligible MDR-TB patients completed SF-36v2 questionnaire at the three time points. Patients' mean PCS scores at the three time points were, 38.2 +/- 4.7, 38.6 +/- 4.4 and 42.2 +/- 5.2 respectively, and mean MCS were 33.7 +/- 7.0, 35.5 +/- 6.9 and 40.0 +/- 6.9 respectively. Length of sickness prior to the diagnosis of MDR-TB was predictive of difference in PCS scores (F = 4.988, Df = 1, 66), whereas patients' gender (F = 5.638, Df = 1, 66) and length of sickness prior to the diagnosis of MDR-TB (F = 4.400, Df = 1, 66) were predictive of difference in MCS scores. Conclusion Despite the positive impact of MDR-TB treatment on patients' HRQoL, the scores on component summary measures suggested compromised physical and mental health even at the end of treatment. A large multicenter study is suggested to confirm the present findings.	[Ahmad, Nafees; Sulaiman, Syed Azhar Syed; Jaber, Ammar Ali Saleh; Khan, Amer Hayat] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia; [Javaid, Arshad; Basit, Anila] Postgrad Med Inst Peshawar, Dept Pulmonol, Peshawar, Pakistan; [Afridi, Afsar Khan] Lady Reading Hosp Peshawar, PMDT, Peshawar, Pakistan	Universiti Sains Malaysia	Khan, AH (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Clin Pharm, George Town, Malaysia.	dramer2006@gmail.com	Khan, Amer Hayat/O-5310-2018	Khan, Amer Hayat/0000-0003-4802-6181; Jaber, Ammar/0000-0003-0411-1923; Basit, Anila/0000-0003-1166-1632; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X				Aggarwal AN, 2013, INT J TUBERC LUNG D, V17, P947, DOI 10.5588/ijtld.12.0299; Ahmad N, 2015, INT J TUBERC LUNG D, V19, P1109, DOI 10.5588/ijtld.15.0167; Ahmad N, 2018, AM J THER, V25, pE533, DOI 10.1097/MJT.0000000000000421; Ahmad N, 2016, BRAZ J INFECT DIS, V20, P41, DOI 10.1016/j.bjid.2015.09.011; Al-Qahtani MF, 2014, J TAIBAH UNIV MED SC, V9, P311, DOI 10.1016/j.jtumed.2014.04.005; Ambaw F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007653; Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19; Avong YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120161; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Basit A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093206; Bloss E, 2010, INT J TUBERC LUNG D, V14, P275; Breslau N, 1997, ARCH GEN PSYCHIAT, V54, P1044; CASSILETH BR, 1984, NEW ENGL J MED, V311, P506, DOI 10.1056/NEJM198408233110805; Chamla D, 2004, INT J TUBERC LUNG D, V8, P1100; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dhuria M., 2009, ASIA PACIFIC J PUBLI; Dujaili JA, 2015, INT J INFECT DIS, V31, P4, DOI 10.1016/j.ijid.2014.12.004; Duko B, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0598-3; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Furin J, 2014, INT J TUBERC LUNG D, V18, P1479, DOI 10.5588/ijtld.14.0277; Furin J, 2012, B WORLD HEALTH ORGAN, V90, P63, DOI 10.2471/BLT.11.092320; Godoy MDP, 2012, RESP CARE, V57, P1949, DOI 10.4187/respcare.01532; Guo N, 2010, EUR RESPIR J, V36, P206, DOI 10.1183/09031936.00159409; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Hansel NN, 2004, QUAL LIFE RES, V13, P639, DOI 10.1023/B:QURE.0000021317.12945.f0; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; Jenkinson C, 1999, J PUBLIC HEALTH MED, V21, P372, DOI 10.1093/pubmed/21.4.372; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Kittikraisak W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029775; Kruijshaar ME, 2010, INT J TUBERC LUNG D, V14, P296; Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008; Leidy N K, 1999, Value Health, V2, P113, DOI 10.1046/j.1524-4733.1999.02210.x; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P887; Nan HR, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-198; Nasrullah M, 2012, JCPSP-J COLL PHYSICI, V22, P273, DOI 05.2012/JCPSP.273274; Natani GD., 1985, INDIAN J TUBERC, V32, P195; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Nunnally IH, 1994, NUNNALLY IH BERNSTEI; Pachas AMC, 2004, INT J TUBERC LUNG D, V8, P52; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Shah AR, 2002, INT J TUBERC LUNG D, V6, P1098; Sharma Raman, 2014, Acta Med Iran, V52, P448; Sherbourne CD, 1999, J GEN INTERN MED, V14, P357, DOI 10.1046/j.1525-1497.1999.00354.x; Tandon AK, 1980, J TUBER, V27, P172; Thomas BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147397; Vega F, 2004, INT J TUBERC LUNG D, V8, P749; Ware JE, 2007, USERS MANUAL SF 36V2; Weiss EL, 1999, AM J PSYCHIAT, V156, P816, DOI 10.1176/ajp.156.6.816; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Williams K, 2003, J HEALTH SOC BEHAV, V44, P470, DOI 10.2307/1519794; World Health Organization, 2006, WHOEMTDR009E; World Health Organization, 2010, WHOHTMTB2009420, P420; World Health Organization, 2011, WHO PROGRESS REPORT	56	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159560	10.1371/journal.pone.0159560	http://dx.doi.org/10.1371/journal.pone.0159560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IL	27467560	gold, Green Submitted, Green Published			2022-12-27	WOS:000381516100039
J	Beck, HJ; Fleming, IMC; Janssen, GR				Beck, Heather J.; Fleming, Ian M. C.; Janssen, Gary R.			5 '-Terminal AUGs in Escherichia coli mRNAs with Shine-Dalgarno Sequences: Identification and Analysis of Their Roles in Non-Canonical Translation Initiation	PLOS ONE			English	Article							OPEN READING FRAMES; PROTEIN-SYNTHESIS; RIBOSOME-BINDING; 70S RIBOSOMES; SITES; EXPRESSION; REPRESSOR; BACTERIA; CODON; SUBUNITS	Analysis of the Escherichia coli transcriptome identified a unique subset of messenger RNAs (mRNAs) that contain a conventional untranslated leader and Shine-Dalgarno (SD) sequence upstream of the gene's start codon while also containing an AUG triplet at the mRNA's 5'-terminus (5'-uAUG). Fusion of the coding sequence specified by the 5'-terminal putative AUG start codon to a lacZ reporter gene, as well as primer extension inhibition assays, reveal that the majority of the 5'-terminal upstream open reading frames (5'-uORFs) tested support some level of lacZ translation, indicating that these mRNAs can function both as leaderless and canonical SD-leadered mRNAs. Although some of the uORFs were expressed at low levels, others were expressed at levels close to that of the respective downstream genes and as high as the naturally leaderless cI mRNA of bacteriophage.. These 5'-terminal uORFs potentially encode peptides of varying lengths, but their functions, if any, are unknown. In an effort to determine whether expression from the 5'-terminal uORFs impact expression of the immediately downstream cistron, we examined expression from the downstream coding sequence after mutations were introduced that inhibit efficient 5'-uORF translation. These mutations were found to affect expression from the downstream cistrons to varying degrees, suggesting that some 5'-uORFs may play roles in downstream regulation. Since the 5'-uAUGs found on these conventionally leadered mRNAs can function to bind ribosomes and initiate translation, this indicates that canonical mRNAs containing 5'-uAUGs should be examined for their potential to function also as leaderless mRNAs.	[Beck, Heather J.; Fleming, Ian M. C.; Janssen, Gary R.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	Miami University	Beck, HJ (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	beckhj@miamioh.edu			nih.gov, National Institutes of Health [GM065120]	nih.gov, National Institutes of Health	The work was supported by GM065120 (GRJ), nih.gov, National Institutes of Health.	Brock JE, 2008, RNA, V14, P2159, DOI 10.1261/rna.1089208; Chang B, 2006, GENE, V373, P90, DOI 10.1016/j.gene.2006.01.033; CONE KC, 1985, J MOL BIOL, V186, P733, DOI 10.1016/0022-2836(85)90393-6; de Smit MH, 2003, J MOL BIOL, V331, P737, DOI 10.1016/S0022-2836(03)00809-X; Delgado-Olivares L, 2006, BIOCHIMIE, V88, P793, DOI 10.1016/j.biochi.2006.01.007; Dincbas V, 1999, J MOL BIOL, V291, P745, DOI 10.1006/jmbi.1999.3028; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gualerzi CO, 2015, CELL MOL LIFE SCI, V72, P4341, DOI 10.1007/s00018-015-2010-3; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; Hobbs EC, 2011, CURR OPIN MICROBIOL, V14, P167, DOI 10.1016/j.mib.2011.01.007; Islam MS, 2012, BIOCHEM J, V441, P247, DOI 10.1042/BJ20110912; JANSSEN GR, 1993, GENE, V124, P133, DOI 10.1016/0378-1119(93)90774-W; Janssen GR, IND MICROORGANISMS B, P59; KLOCK G, 1986, J MOL BIOL, V189, P633, DOI 10.1016/0022-2836(86)90493-6; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Krishnan KM, 2010, J BACTERIOL, V192, P6482, DOI 10.1128/JB.00756-10; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Martin-Farmer J, 1999, MOL MICROBIOL, V31, P1025, DOI 10.1046/j.1365-2958.1999.01228.x; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Miller J., 1992, LAB MANUAL ESCHERICH, V1, P72; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Moll I, 2002, MOL MICROBIOL, V43, P239, DOI 10.1046/j.1365-2958.2002.02739.x; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; O'Donnell SA, 2002, J BACTERIOL, V184, P6730, DOI 10.1128/JB.184.23.6730-6733.2002; PTASHNE M, 1976, SCIENCE, V194, P156, DOI 10.1126/science.959843; REX G, 1994, J BIOL CHEM, V269, P18118; RINGQUIST S, 1993, BIOCHEMISTRY-US, V32, P10254, DOI 10.1021/bi00089a048; SARABHAI A, 1967, J MOL BIOL, V27, P145, DOI 10.1016/0022-2836(67)90357-9; SCHLEIF R, 1972, P NATL ACAD SCI USA, V69, P3479, DOI 10.1073/pnas.69.11.3479; Sharma P, 2012, NUCLEIC ACIDS RES, V40, P3143, DOI 10.1093/nar/gkr1176; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Udagawa T, 2004, J BIOL CHEM, V279, P8539, DOI 10.1074/jbc.M308784200; Van Etten WJ, 1998, MOL MICROBIOL, V27, P987, DOI 10.1046/j.1365-2958.1998.00744.x; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160144	10.1371/journal.pone.0160144	http://dx.doi.org/10.1371/journal.pone.0160144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467758	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100121
J	Ostad, M; Shirian, S; Pishro, F; Abbasi, T; Ai, A; Azimi, F				Ostad, Mojdeh; Shirian, Sadegh; Pishro, Fatemeh; Abbasi, Tahereh; Ai, Armin; Azimi, Farideh			Control of Cutaneous Leishmaniasis Using Geographic Information Systems from 2010 to 2014 in Khuzestan Province, Iran	PLOS ONE			English	Article							MUCOSAL LEISHMANIASIS; DIAGNOSIS; DIVERSITY; TROPICA; IMPACT	Background Cutaneous leishmanisis (CL) is found worldwide and is considered to be endemic in 88 countries such as Iran. Geographic information system (GIS) is a method that can create, archive, analyze traditional map and place data of the disease distribution. The aim of this study was to produce distributional maps of CL over five years and evaluate the role of GIS in control of CL in Khuzestan province where an endemic area of CL in Iran is. Methods CL epidemiological data on the District and village levels for the period 2010-2013 were provided as census by health surveillance system in all counties and in control diseases center (CDC) of Khuzestan province. After collection of CL data, the collected data of CL from 2010 to 2013 were analyzed using GIS. The collected data of CL from 2010 to 2013 was analyzed using GIS. The endemic areas of CL during 2010-2013 were recognized using GIS maps and the control programs of CL were done in these regions based on epidemiological situation and the stratification of risk areas. Results During the study period, there were 4672 recorded cases of clinical cases of CL by Khuzestan Health Center. Data of GIS referring to CL patients showed that center and eastern districts of Khuzestan had a significant number of cases. In 2014 that control program was done, ten distinct of Khuzestan Province didn't show any cases of the disease. Conclusion In conclusion, analyses of data distributed in the geographic spaces are increasingly appreciated in leishmaniasis control management. GIS tools promoted greater efficiency in making decisions and planning activities in the control of vector born disease such as leishmaniasis.	[Ostad, Mojdeh; Pishro, Fatemeh; Azimi, Farideh] Ahvaz Islamic Azad Univ, Dept Geog, Ahvaz, Iran; [Shirian, Sadegh] Shahrekord Univ, Sch Vet Med, Dept Pathol, Shahrekord, Iran; [Shirian, Sadegh] Univ Tehran Med Sci, Inst Neurosci, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran; [Shirian, Sadegh; Abbasi, Tahereh] Shiraz Mol Pathol Res Ctr, Dr Daneshbod Lab, Shiraz, Iran; [Abbasi, Tahereh] Shiraz Islam Azad Univ, Dept Water Resource Engn, Shiraz, Iran; [Ai, Armin] Univ Tehran Med Sci, Tehran, Iran	Islamic Azad University; Shahrekord University; Tehran University of Medical Sciences; Islamic Azad University; Tehran University of Medical Sciences	Azimi, F (corresponding author), Ahvaz Islamic Azad Univ, Dept Geog, Ahvaz, Iran.; Shirian, S (corresponding author), Shahrekord Univ, Sch Vet Med, Dept Pathol, Shahrekord, Iran.; Shirian, S (corresponding author), Univ Tehran Med Sci, Inst Neurosci, Brain & Spinal Cord Injury Res Ctr, Tehran, Iran.; Shirian, S (corresponding author), Shiraz Mol Pathol Res Ctr, Dr Daneshbod Lab, Shiraz, Iran.	s-shirian@razi.tums.ac.ir; ahvazuniversity@yahoo.com	Shirian, Sadegh/ABA-6006-2021					Ali-Akbarpour Mohsen, 2012, J Cutan Aesthet Surg, V5, P30, DOI 10.4103/0974-2077.94338; Asgari Q, 2007, J RES MED SCI, V12, P7; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Beiranvand R., 2014, Tehran University Medical Journal, V72, P417; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Cardenas R, 2006, AM J TROP MED HYG, V75, P273, DOI 10.4269/ajtmh.2006.75.273; Antonialli SAC, 2007, J INFECTION, V54, P509, DOI 10.1016/j.jinf.2006.08.004; Cross ER, 1996, ENVIRON HEALTH PERSP, V104, P724, DOI 10.2307/3433217; Daneshbod Y, 2011, ARCH PATHOL LAB MED, V135, P478, DOI 10.1043/2010-0069-OA.1; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x; Gomez-Barroso D, 2015, EUROSURVEILLANCE, V20, P11, DOI 10.2807/1560-7917.ES2015.20.7.21037; Malone JB, 1998, VET PARASITOL, V78, P87, DOI 10.1016/S0304-4017(98)00137-X; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Oryan A, 2013, INFECT GENET EVOL, V19, P226, DOI 10.1016/j.meegid.2013.07.021; Ready PD, 2008, REV SCI TECH OIE, V27, P399, DOI 10.20506/rst.27.2.1803; Rodríguez-Morales Alfonso J., 2005, Rev. perú. med. exp. salud publica, V22, P54; Saraiva L, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/254361; Shirian S, 2014, ARCH PATHOL LAB MED, V138, P235, DOI 10.5858/arpa.2013-0098-OA; Shirian S, 2013, PATHOG GLOB HEALTH, V107, P267, DOI 10.1179/2047773213Y.0000000098; Shirian S, 2012, J CLIN MICROBIOL, V50, P3805, DOI 10.1128/JCM.01469-12; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Spotin Adel, 2015, Iranian Biomedical Journal, V19, P149, DOI 10.7508/ibj.2015.03.004; Vazquez-Pineiro T, 1998, ORAL SURG ORAL MED O, V86, P179, DOI 10.1016/S1079-2104(98)90122-6; WHO-TDR-World Health Organization, 2007, TROP DIS RES; Zimmermann S, 2009, PROTIST, V160, P151, DOI 10.1016/j.protis.2008.12.001	28	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159546	10.1371/journal.pone.0159546	http://dx.doi.org/10.1371/journal.pone.0159546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467509	Green Published, Green Submitted, gold			2022-12-27	WOS:000381516100038
J	Seo, YG; Choi, HC; Cho, B				Seo, Young-Gyun; Choi, Ho-Chun; Cho, Belong			The Relationship between Metabolically Obese Non-Obese Weight and Stroke: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; JAPANESE POPULATION; ISCHEMIC-STROKE; HIP RATIO; RISK; COMPONENTS; IMPACT; ASSOCIATION	Objective Both metabolic syndrome (MetS) and obesity increase the risk of stroke. However, few studies have compared the risks of stroke associated with metabolically obese non-obese weight (MONW) and metabolically healthy obesity (MHO). This study aimed to compare the prevalence of stroke in MONW and MHO individuals. Methods A total of 25,744 subjects aged >= 40 years were selected from the 2007-2014 Korean National Health and Nutrition Examination Survey. MetS was defined using 2001 National Cholesterol Education Program/Adult Treatment Panel III and 2005 American Heart Association/National Heart, Lung, and Blood Institute criteria. Non-obese weight and obesity were defined as a body mass index (BMI) < 25 kg/m(2) and >= 25 kg/m(2), respectively. MONW was defined as meeting the MetS criteria with a BMI < 25 kg/m(2) and MHO was defined as not meeting the MetS criteria with a BMI >= 25 kg/m(2). Results Women with MONW had a higher prevalence of stroke than those with MHO (odds ratio [OR] = 2.27, 95% confidence interval [CI]: 1.45-3.57). The prevalence of stroke increased as the number of MetS components increased. The ORs for MONW with 3, 4, and 5 MetS components were 1.95 (95% CI: 1.19-3.21), 2.49 (95% CI: 1.46-4.24) and 2.74 (95% CI: 1.39-5.40), respectively. Conclusions Our study findings may better emphasize the risk of stroke among more lean but unhealthy individuals, who appear healthy but may be suffering from MetS. These findings also highlight the need for stroke risk factor assessment in non-obese weight individuals.	[Seo, Young-Gyun] Hallym Univ, Dept Family Med, Sacred Heart Hosp, Anyang, Gyeonggi Do, South Korea; [Choi, Ho-Chun] Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Cho, Belong] Seoul Natl Univ Hosp, Hlth Promot Ctr Canc Survivor, Dept Family Med, Ctr Hlth Promot & Optimal Aging, Seoul, South Korea; [Cho, Belong] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, Gyeonggi Do, South Korea; [Cho, Belong] Seoul Natl Univ, Coll Med, Inst Aging, Seoul, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Choi, HC (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.	skyho331@gmail.com	Cho, Belong/GLU-3443-2022; Seo, Young-Gyun/AAV-3487-2020	Cho, Belong/0000-0001-9558-689X; Seo, Young-Gyun/0000-0001-8294-1741				Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Choi KM, 2013, CLIN ENDOCRINOL, V79, P364, DOI 10.1111/cen.12154; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Federation ID, 2006, IDF CONS WORLDW DEF; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hanchaiphiboolkul S, 2013, J STROKE CEREBROVASC, V22, pE264, DOI 10.1016/j.jstrokecerebrovasdis.2012.05.013; Hu G, 2007, ARCH INTERN MED, V167, P1420, DOI 10.1001/archinte.167.13.1420; International Physical Activity Questionnaire (IPAQ), 2005, GUID DAT PROC AN IPA; Kojima S, 2007, ATHEROSCLEROSIS, V194, P204, DOI 10.1016/j.atherosclerosis.2006.07.028; Kokubo Y, 2008, HYPERTENS RES, V31, P2027, DOI 10.1291/hypres.31.2027; Kuk JL, 2009, DIABETES CARE, V32, P2297, DOI 10.2337/dc09-0574; Kwon BJ, 2013, METABOLISM, V62, P952, DOI 10.1016/j.metabol.2013.01.006; Mak KH, 2007, AM J CARDIOL, V100, P227, DOI 10.1016/j.amjcard.2007.02.090; Maruyama K, 2009, J STROKE CEREBROVASC, V18, P173, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.008; Mitchell AB, 2015, STROKE, V46, P1690, DOI 10.1161/STROKEAHA.115.008940; [National Academy of Agricultural Science Rural Development Administration], 2011, STAND FOOD COMP TABL; Niwa Y, 2010, J EPIDEMIOL, V20, P62, DOI 10.2188/jea.JE20081041; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Takahashi K, 2007, INTERNAL MED, V46, P643, DOI 10.2169/internalmedicine.46.6094; Twig G, 2015, EUR J ENDOCRINOL, V173, P305, DOI 10.1530/EJE-15-0284; [World Health Organization the International Association for the Study of Obesity and the International Obesity Task Force The Regional Office for the Western Pacific], 2000, AS PAC PERSP RED OB; Yen YF, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000956; Yoo HJ, 2014, ATHEROSCLEROSIS, V234, P218, DOI 10.1016/j.atherosclerosis.2014.02.033; Zhang WW, 2009, J NEUROL, V256, P1493, DOI 10.1007/s00415-009-5150-2	26	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160846	10.1371/journal.pone.0160846	http://dx.doi.org/10.1371/journal.pone.0160846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494241	Green Published, Green Submitted, gold			2022-12-27	WOS:000381369500088
J	Gill, MJ; Mendes, DM				Gill, Michael J.; Mendes, Dana M.			When the Minority Thinks "Essentially" Like the Majority: Blacks Distinguish Bio-Somatic from Bio-Behavioral Essentialism in Their Conceptions of Whites, and Only the Latter Predicts Prejudice	PLOS ONE			English	Article							SOCIAL CATEGORIES; PSYCHOLOGICAL ESSENTIALISM; RACE DIFFERENCES; LAY THEORIES; STEREOTYPES; ATTITUDES; PERCEPTION; EXPERIENCE; COGNITION; BELIEFS	Essentialist beliefs about social groups can contribute to prejudice and intergroup distancing. To date, little data have been gathered regarding minority group members' essentialistic thinking about the White majority in the U.S. Do essentialist beliefs show a similar structure when minority group members are thinking about the majority as when the majority group is thinking about the minority group? Do minority group essentialist beliefs predict affective prejudice and diminished desire for intergroup contact as they do among White respondents? We sought answers to these questions in a study that included 248 African American participants. We found clear evidence that the structure of Blacks' essentialist thinking about Whites matches the structure of Whites' essentialist thinking about Blacks. Specifically, Black respondents made a distinction between bio-somatic and bio-behavioral essentialism, and reported stronger endorsement of the former as compared to the latter. Also replicating prior studies of Whites' essentialist thinking, only bio-behavioral essentialist beliefs were predictive of negative attitudes. This suggests that essentialism can be linked to prejudice even in contexts that do not involve a dominant group rationalizing its social advantages. Discussion centers on implications of this work for prejudice reduction.	[Gill, Michael J.; Mendes, Dana M.] Lehigh Univ, Dept Psychol, Bethlehem, PA 18015 USA	Lehigh University	Gill, MJ (corresponding author), Lehigh Univ, Dept Psychol, Bethlehem, PA 18015 USA.	m.gill@lehigh.edu			Lehigh University College of Arts and Sciences	Lehigh University College of Arts and Sciences	This work was supported by an Undergraduate Research Grant to Dana M. Mendes from the Lehigh University College of Arts and Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreychik MR, 2015, GROUP PROCESS INTERG, V18, P454, DOI 10.1177/1368430214550341; Astuti R, 2004, MONOGR SOC RES CHILD, V69, P153; Bastian B, 2008, ASIAN J SOC PSYCHOL, V11, P127, DOI 10.1111/j.1467-839X.2008.00250.x; Bloch M., 2001, J COGN CULT, V1, P43, DOI [10.1163/156853701300063570, DOI 10.1163/156853701300063570]; BRIGHAM JC, 1993, J APPL SOC PSYCHOL, V23, P1933, DOI 10.1111/j.1559-1816.1993.tb01074.x; BRIGHAM JC, 1978, J APPL SOC PSYCHOL, V8, P306, DOI 10.1111/j.1559-1816.1978.tb00786.x; Bukach CM, 2012, COGNITION, V123, P319, DOI 10.1016/j.cognition.2012.02.007; Cacioppo J T, 1997, Pers Soc Psychol Rev, V1, P3, DOI 10.1207/s15327957pspr0101_2; Caspari R, 2003, AM ANTHROPOL, V105, P65, DOI 10.1525/aa.2003.105.1.65; Conley TD, 2010, ANAL SOC ISS PUB POL, V10, P69, DOI 10.1111/j.1530-2415.2010.01209.x; Demoulin S, 2006, GROUP PROCESS INTERG, V9, P25, DOI 10.1177/1368430206059856; Gil-White FJ, 2001, CURR ANTHROPOL, V42, P515, DOI 10.1086/321802; Gill MJ, 2013, PERS SOC PSYCHOL B, V39, P73, DOI 10.1177/0146167212460281; Hamilton DL, 2007, EUR J SOC PSYCHOL, V37, P1077, DOI 10.1002/ejsp.436; Haslam N, 2002, BRIT J SOC PSYCHOL, V41, P87, DOI 10.1348/014466602165072; Haslam N, 2000, BRIT J SOC PSYCHOL, V39, P113, DOI 10.1348/014466600164363; Hirschfeld L.A., 1996, RACE MAKING COGNITIO; HOFFMAN C, 1990, J PERS SOC PSYCHOL, V58, P197, DOI 10.1037/0022-3514.58.2.197; Jayaratne TE, 2006, GROUP PROCESS INTERG, V9, P77, DOI 10.1177/1368430206059863; Johnson JD, 2003, PERS SOC PSYCHOL B, V29, P299, DOI 10.1177/0146167202250041; Keller J, 2005, J PERS SOC PSYCHOL, V88, P686, DOI 10.1037/0022-3514.88.4.686; Litman L., 2016, BEHAV RES METHODS, DOI 10.3758/s13428-016-0727-z; Mahalingam Ramaswami, 1998, THESIS; MARTIN CL, 1995, PERS SOC PSYCHOL B, V21, P45, DOI 10.1177/0146167295211006; MEDIN DL, 1989, AM PSYCHOL, V44, P1469, DOI 10.1037/0003-066X.44.12.1469; Morton TA, 2009, PERS SOC PSYCHOL B, V35, P656, DOI 10.1177/0146167208331254; Morton TA, 2009, J PERS SOC PSYCHOL, V96, P653, DOI 10.1037/a0012966; No S, 2008, J PERS SOC PSYCHOL, V95, P991, DOI 10.1037/a0012978; Phinney, 1992, J ADOLESCENT RES, V7, P156, DOI [10.1177/074355489272003, DOI 10.1177/074355489272003]; Plaks JE, 2009, SOC PERSONAL PSYCHOL, V3, P1069, DOI 10.1111/j.1751-9004.2009.00222.x; Rangel U, 2011, J PERS SOC PSYCHOL, V100, P1056, DOI 10.1037/a0022401; Rhodes M, 2009, COGNITIVE PSYCHOL, V59, P244, DOI 10.1016/j.cogpsych.2009.05.001; Rosch E., 1978, COGNITION CATEGORIZA, P189; Rothbart M., 1992, LANGUAGE INTERACTION, P11; Royal CDM, 2004, NAT GENET, V36, pS5, DOI 10.1038/ng1454; Solomon GEA, 1996, CHILD DEV, V67, P151, DOI 10.1111/j.1467-8624.1996.tb01726.x; Springer K, 1996, CHILD DEV, V67, P2841, DOI 10.2307/1131755; Verkuyten M, 2004, EUR J SOC PSYCHOL, V34, P647, DOI 10.1002/ejsp.222; Verkuyten M, 2003, BRIT J SOC PSYCHOL, V42, P371, DOI 10.1348/014466603322438215; Williams MJ, 2008, J PERS SOC PSYCHOL, V94, P1033, DOI 10.1037/0022-3514.94.6.1033; Yzerbyt V, 2001, PERS SOC PSYCHOL REV, V5, P141, DOI 10.1207/S15327957PSPR0502_5; Yzerbyt V., 1997, SOCIAL PSYCHOL STERE, P20	42	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160086	10.1371/journal.pone.0160086	http://dx.doi.org/10.1371/journal.pone.0160086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27489948	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900032
J	Jeong, B; Lee, W; Kim, DS; Shin, H				Jeong, Byungduk; Lee, Wonjoon; Kim, Deok-Soo; Shin, Hayong			Copula-Based Approach to Synthetic Population Generation	PLOS ONE			English	Article								Generating synthetic baseline populations is a fundamental step of agent-based modeling and simulation, which is growing fast in a wide range of socio-economic areas including transportation planning research. Traditionally, in many commercial and non-commercial microsimulation systems, the iterative proportional fitting (IPF) procedure has been used for creating the joint distribution of individuals when combining a reference joint distribution with target marginal distributions. Although IPF is simple, computationally efficient, and rigorously founded, it is unclear whether IPF well preserves the dependence structure of the reference joint table sufficiently when fitting it to target margins. In this paper, a novel method is proposed based on the copula concept in order to provide an alternative approach to the problem that IPF resolves. The dependency characteristic measures were computed and the results from the proposed method and IPF were compared. In most test cases, the proposed method outperformed IPF in preserving the dependence structure of the reference joint distribution.	[Jeong, Byungduk; Lee, Wonjoon; Shin, Hayong] Korea Adv Inst Sci & Technol, Dept Ind & Syst Engn, Daejeon, South Korea; [Kim, Deok-Soo] Hanyang Univ, Dept Mech Engn, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Hanyang University	Shin, H (corresponding author), Korea Adv Inst Sci & Technol, Dept Ind & Syst Engn, Daejeon, South Korea.	hyshin@kaist.ac.kr	Shin, Hayong/C-1586-2011; Kim, Deok-Soo/K-8661-2015	Shin, Hayong/0000-0002-5161-661X	Agency for Defense Development [UD110006MD]; National Research Foundation of Korea [2011-0029881]; Defense Acquisition Program Administration [UD110006MD]	Agency for Defense Development(Agency of Defense Development (ADD), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Defense Acquisition Program Administration	This research was jointly supported by Defense Acquisition Program Administration and Agency for Defense Development under the contract UD110006MD and National Research Foundation of Korea (contract No. 2011-0029881).	[Anonymous], 1996, LECT NOTES MONOGR SE; Barthelemy J, 2013, TRANSPORT SCI, V47, P266, DOI 10.1287/trsc.1120.0408; Beckman RJ, 1996, TRANSPORT RES A-POL, V30, P415, DOI 10.1016/0965-8564(96)00004-3; Borgomeo E, 2015, WATER RESOUR RES, V51, P8927, DOI 10.1002/2015WR017324; Bowman J. L, 2009, TRAFFIC ENG CONTROL, V49, P342; DARSOW WF, 1992, ILLINOIS J MATH, V36, P600, DOI 10.1215/ijm/1255987328; Deming WE, 1940, ANN MATH STAT, V11, P427, DOI 10.1214/aoms/1177731829; Gargiulo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008828; Gilboy N, 2011, AHRQ PUBLICATION NO; IRELAND CT, 1968, BIOMETRIKA, V55, P179; Kalantari B, 2008, MATH PROGRAM, V112, P371, DOI 10.1007/s10107-006-0021-4; Kao SC, 2012, TRANSPORT RES REC, P192, DOI 10.3141/2302-21; Lenormand M, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2319; MATSim-T, 2010, MULT AG TRANSP SIM T; Muller K, 2011, P 90 ANN M TRANSP RE; Nelsen R. B, 2006, INTRO COPULAS; Pinjari AR, 2009, TRANSPORT RES B-METH, V43, P729, DOI 10.1016/j.trb.2009.02.002; Pukelsheim F, 2009, PREPRINT; Rana TA, 2010, TRANSPORT RES REC, P75, DOI 10.3141/2147-10; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Sklar A., 1959, PUBLICATIONS I STAT, V8, P229, DOI DOI 10.1007/BF01544178; Statistics Korea, 2016, FUT POP PRED S KOR 2; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Tsitsiklis JN, INTRO LINEAR OPTIMIZ, P17; UrbanSim, 2010, OP PLATF URB SIM; WONG DWS, 1992, PROF GEOGR, V44, P340, DOI 10.1111/j.0033-0124.1992.00340.x	27	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159496	10.1371/journal.pone.0159496	http://dx.doi.org/10.1371/journal.pone.0159496			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490692	Green Submitted, gold, Green Published			2022-12-27	WOS:000381368900011
J	Visschedijk, MC; Alberts, R; Mucha, S; Deelen, P; de Jong, DJ; Pierik, M; Spekhorst, LM; Imhann, F; van der Meulen-de Jong, AE; van der Woude, CJ; van Bodegraven, AA; Oldenburg, B; Lowenberg, M; Dijkstra, G; Ellinghaus, D; Schreiber, S; Wijmenga, C; Rivas, MA; Franke, A; van Diemen, CC; Weersma, RK				Visschedijk, Marijn C.; Alberts, Rudi; Mucha, Soren; Deelen, Patrick; de Jong, Dirk J.; Pierik, Marieke; Spekhorst, Lieke M.; Imhann, Floris; van der Meulen-de Jong, Andrea E.; van der Woude, C. Janneke; van Bodegraven, Adriaan A.; Oldenburg, Bas; Lowenberg, Mark; Dijkstra, Gerard; Ellinghaus, David; Schreiber, Stefan; Wijmenga, Cisca; Rivas, Manuel A.; Franke, Andre; van Diemen, Cleo C.; Weersma, Rinse K.		Initiative Crohn Colitis	Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME; RISK; LOCI	Genome-wide association studies have revealed several common genetic risk variants for ulcerative colitis (UC). However, little is known about the contribution of rare, large effect genetic variants to UC susceptibility. In this study, we performed a deep targeted re-sequencing of 122 genes in Dutch UC patients in order to investigate the contribution of rare variants to the genetic susceptibility to UC. The selection of genes consists of 111 established human UC susceptibility genes and 11 genes that lead to spontaneous colitis when knocked-out in mice. In addition, we sequenced the promoter regions of 45 genes where known variants exert cis-eQTL-effects. Targeted pooled re-sequencing was performed on DNA of 790 Dutch UC cases. The Genome of the Netherlands project provided sequence data of 500 healthy controls. After quality control and prioritization based on allele frequency and pathogenicity probability, follow-up genotyping of 171 rare variants was performed on 1021 Dutch UC cases and 1166 Dutch controls. Single-variant association and gene-based analyses identified an association of rare variants in the MUC2 gene with UC. The associated variants in the Dutch population could not be replicated in a German replication cohort (1026 UC cases, 3532 controls). In conclusion, this study has identified a putative role for MUC2 on UC susceptibility in the Dutch population and suggests a population-specific contribution of rare variants to UC.	[Visschedijk, Marijn C.; Alberts, Rudi; Spekhorst, Lieke M.; Imhann, Floris; Dijkstra, Gerard; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [Visschedijk, Marijn C.; Deelen, Patrick; Wijmenga, Cisca; van Diemen, Cleo C.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Mucha, Soren; Ellinghaus, David; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [de Jong, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 GA Nijmegen, Netherlands; [Pierik, Marieke] Maastricht Univ, Med Ctr, Div Gastroenterol & Hepatol, NL-6229 HX Maastricht, Netherlands; [van der Meulen-de Jong, Andrea E.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-2333 ZA Leiden, Netherlands; [van der Woude, C. Janneke] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [van Bodegraven, Adriaan A.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, NL-1081 HZ Amsterdam, Netherlands; [Oldenburg, Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, NL-3584 CX Utrecht, Netherlands; [Lowenberg, Mark] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Schreiber, Stefan] Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Rivas, Manuel A.] Broad Inst, Ctr Study IBD SCIBD Genet, Cambridge, MA USA	University of Groningen; University of Groningen; University of Kiel; Radboud University Nijmegen; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Kiel; Schleswig Holstein University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	van Diemen, CC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands.	c.c.van.diemen@umcg.nl	van Bodegraven, Ad/ABG-4367-2020; Rivas, Manuel/ABE-8173-2020; Deelen, Patrick/B-3566-2013; Ellinghaus, David/G-4467-2012; Weersma, Rinse/ABE-3807-2021; van Bodegraven, Ad A/L-3180-2013; Franke, Andre/B-2151-2010; Wijmenga, Cisca/D-2173-2009; van der Meulen, Andrea/AAU-9430-2020; Ellinghaus, David/ABC-3610-2020; Wijmenga, Cisca/AAE-7719-2019	Rivas, Manuel/0000-0003-1457-9925; Deelen, Patrick/0000-0002-5654-3966; Franke, Andre/0000-0003-1530-5811; van der Meulen, Andrea/0000-0001-9353-5431; Ellinghaus, David/0000-0002-4332-6110; Wijmenga, Cisca/0000-0002-5635-1614; Lowenberg, Mark/0000-0002-4975-9945; Mucha, Soren/0000-0002-1647-2526; /0000-0003-4563-7462; van Diemen, Cleo/0000-0001-9283-2207	AGIKO grant from the Netherlands Organization for Scientific Research (NWO) [92.003.577]; grant Unraveling Genetics Driving PSC Subphenotypes - An IPSCSG Study from PSC Partners Seeking a Cure; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [2012-322698]; NWO [016.136.308]; Dutch Digestive foundation [CW011-72]; BigGrid/eBioGrid project	AGIKO grant from the Netherlands Organization for Scientific Research (NWO); grant Unraveling Genetics Driving PSC Subphenotypes - An IPSCSG Study from PSC Partners Seeking a Cure; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); NWO(Netherlands Organization for Scientific Research (NWO)); Dutch Digestive foundation; BigGrid/eBioGrid project	MC Visschedijk is supported by an AGIKO grant (92.003.577) from the Netherlands Organization for Scientific Research (NWO). R Alberts is supported by grant Unraveling Genetics Driving PSC Subphenotypes - An IPSCSG Study from PSC Partners Seeking a Cure. C Wijmenga is supported by funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Advanced grant agreement 2012-322698). RK Weersma is supported by a VIDI grant (016.136.308) from NWO and a grant from the Dutch Digestive foundation (CW011-72).; We thank The Target project (http://www.rug.nl/target) for providing the computational infrastructure and the BigGrid/eBioGrid project (http://www.ebiogrid.nl) for sponsoring the imputation pipeline implementation.	Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Berglund EC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-856; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Fransen K, 2011, GENOME MED, V3, DOI 10.1186/gm227; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Hong S., 2015, GUT, V1, DOI [10.1109/GLOCOM.2015.7417771, DOI 10.1136/GUTJNL-2014-308617, 10.1136/gutjnl-2014-308617]; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mizoguchi A, 2010, CURR OPIN PHARMACOL, V10, P578, DOI 10.1016/j.coph.2010.05.007; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Prescott NJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004955; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Spekhorst LM, 2015, EXPERT REV CLIN IMMU, V11, P33, DOI 10.1586/1744666X.2015.990439; Swallow DM, 1999, J MED GENET, V36, P859; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wenzel UA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100217; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; 2004, SCIENCE, V306, P636, DOI DOI 10.1126/SCIENCE.1105136	26	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159609	10.1371/journal.pone.0159609	http://dx.doi.org/10.1371/journal.pone.0159609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490946	Green Published, gold			2022-12-27	WOS:000381368900013
J	Wierzchon, M; Wronka, E; Paulewicz, B; Szczepanowski, R				Wierzchon, Michal; Wronka, Eligiusz; Paulewicz, Boryslaw; Szczepanowski, Remigiusz			Post-Decision Wagering Affects Metacognitive Awareness of Emotional Stimuli: An Event Related Potential Study	PLOS ONE			English	Article							VISUAL AWARENESS; CONSCIOUS PERCEPTION; SUBJECTIVE AWARENESS; FACE; P3; MODULATION; ATTENTION; CORRELATE; VIEW	The present research investigated metacognitive awareness of emotional stimuli and its psychophysiological correlates. We used a backward masking task presenting participants with fearful or neutral faces. We asked participants for face discrimination and then probed their metacognitive awareness with confidence rating (CR) and post-decision wagering (PDW) scales. We also analysed psychophysiological correlates of awareness with event-related potential (ERP) components: P1, N170, early posterior negativity (EPN), and P3. We have not observed any differences between PDW and CR conditions in the emotion identification task. However, the "aware" ratings were associated with increased accuracy performance. This effect was more pronounced in PDW, especially for fearful faces, suggesting that emotional stimuli awareness may be enhanced by monetary incentives. EEG analysis showed larger N170, EPN and P3 amplitudes in aware compared to unaware trials. It also appeared that both EPN and P3 ERP components were more pronounced in the PDW condition, especially when emotional faces were presented. Taken together, our ERP findings suggest that metacognitive awareness of emotional stimuli depends on the effectiveness of both early and late visual information processing. Our study also indicates that awareness of emotional stimuli can be enhanced by the motivation induced by wagering.	[Wierzchon, Michal] Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland; [Wronka, Eligiusz] Jagiellonian Univ, Inst Psychol, Psychophysiol Lab, Krakow, Poland; [Paulewicz, Boryslaw] SWPS Univ Social Sci & Humanities, Fac Katowice, Katowice, Poland; [Szczepanowski, Remigiusz] SWPS Univ Social Sci & Humanities, Fac Wroclaw, Wroclaw, Poland	Jagiellonian University; Jagiellonian University; SWPS University of Social Sciences & Humanities; SWPS University of Social Sciences & Humanities	Wierzchon, M (corresponding author), Jagiellonian Univ, Inst Psychol, Consciousness Lab, Krakow, Poland.	michal.wierzchon@uj.edu.pl	Wierzchon, Michal/B-7207-2012	Wierzchon, Michal/0000-0002-7347-2696; Paulewicz, Boryslaw/0000-0002-1270-2988; Szczepanowski, Remigiusz/0000-0003-2989-2172; Wronka, Eligiusz/0000-0001-9785-8887	National Science Center (Poland);  [DEC-2011/03/B/HS6/01799]	National Science Center (Poland)(National Science Centre, Poland); 	This research has been supported by the National Science Center (Poland), ncn.gov.pl, and funded under the grant's decision DEC-2011/03/B/HS6/01799 to RS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aru J, 2012, NEUROSCI BIOBEHAV R, V36, P737, DOI 10.1016/j.neubiorev.2011.12.003; Block N, 2005, TRENDS COGN SCI, V9, P46, DOI 10.1016/j.tics.2004.12.006; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Zotto M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01691; Eimer M, 2011, OXFORD HDB FACE PERC, P329, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0017; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; Fleming SM, 2010, CONSCIOUS COGN, V19, P352, DOI 10.1016/j.concog.2009.11.002; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Halgren E, 2000, CEREB CORTEX, V10, P69, DOI 10.1093/cercor/10.1.69; Itier RJ, 2006, BRAIN RES, V1115, P108, DOI 10.1016/j.brainres.2006.07.072; Jacques C, 2008, NEUROIMAGE, P39; Junghofer M, 2002, PSYCHOPHYSIOLOGY, V39, pS14; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Koivisto M, 2008, COGN AFFECT BEHAV NE, V8, P195, DOI 10.3758/CABN.8.2.195; Koivisto M, 2008, BRAIN COGNITION, V66, P91, DOI 10.1016/j.bandc.2007.05.010; Koivisto M, 2010, NEUROSCI BIOBEHAV R, V34, P922, DOI 10.1016/j.neubiorev.2009.12.002; Koivisto M, 2009, NEUROPSYCHOLOGIA, V47, P2891, DOI 10.1016/j.neuropsychologia.2009.06.016; Lamme VAF, 2010, COGN NEUROSCI-UK, V1, P204, DOI 10.1080/17588921003731586; Lamy D, 2009, J COGNITIVE NEUROSCI, V21, P1435, DOI 10.1162/jocn.2009.21064; Lau H, 2011, TRENDS COGN SCI, V15, P365, DOI 10.1016/j.tics.2011.05.009; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P142, DOI 10.1016/S0013-4694(97)00117-X; Ojanen V, 2003, PSYCHOPHYSIOLOGY, V40, P192, DOI 10.1111/1469-8986.00021; Overgaard M, 2004, BRAIN COGNITION, V54, P58, DOI 10.1016/S0278-2626(03)00260-4; Pegna AJ, 2008, INT J PSYCHOPHYSIOL, V70, P127, DOI 10.1016/j.ijpsycho.2008.08.007; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pitts MA, 2014, NEUROIMAGE, V101, P337, DOI 10.1016/j.neuroimage.2014.07.024; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; R Core Team, 2013, R LANG ENV STAT COMP; Railo H, 2011, CONSCIOUS COGN, V20, P972, DOI 10.1016/j.concog.2011.03.019; Railo H, 2009, CONSCIOUS COGN, V18, P794, DOI 10.1016/j.concog.2009.01.006; Rausch M, 2014, CONSCIOUS COGN, V28, P126, DOI 10.1016/j.concog.2014.06.012; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rossion B, 1999, CLIN NEUROPHYSIOL, V110, P449, DOI 10.1016/S1388-2457(98)00037-6; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Salti M, 2012, CONSCIOUS COGN, V21, P961, DOI 10.1016/j.concog.2012.01.012; Sandberg K, 2010, CONSCIOUS COGN, V19, P1069, DOI 10.1016/j.concog.2009.12.013; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt K.L., 2001, AM J PHYS ANTHROPOL, V116, P3, DOI DOI 10.1002/AJPA.20001; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schurger A, 2008, TRENDS COGN SCI, V12, P209, DOI 10.1016/j.tics.2008.02.012; Schweinberger S. R, 2011, OXFORD HDB FACE PERC, P345, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0018; Silverstein BH, 2015, CORTEX, V73, P216, DOI 10.1016/j.cortex.2015.09.004; Szczepanowski R, 2007, J VISION, V7, DOI 10.1167/7.4.10; Szczepanowski R, 2013, CONSCIOUS COGN, V22, P212, DOI 10.1016/j.concog.2012.12.003; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Walentowska W, 2012, INT J PSYCHOPHYSIOL, V85, P27, DOI 10.1016/j.ijpsycho.2011.12.004; Wierzchon M, 2014, CONSCIOUS COGN, V27, P109, DOI 10.1016/j.concog.2014.04.009; Wronka E, 2008, ACTA NEUROBIOL EXP, V68, P362; Wronka E, 2014, J PSYCHOPHYSIOL, V28, P32, DOI 10.1027/0269-8803/a000109; Wronka E, 2012, ACTA NEUROBIOL EXP, V72, P51; Wronka E, 2011, PSYCHOPHYSIOLOGY, V48, P1047, DOI 10.1111/j.1469-8986.2011.01180.x	59	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159516	10.1371/journal.pone.0159516	http://dx.doi.org/10.1371/journal.pone.0159516			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3GL	27490816	Green Submitted, Green Published, gold			2022-12-27	WOS:000381368900012
J	Zhao, M; Zhu, RA; Qian, Y; Deng, J; Wang, F; Sun, Y; Dong, HJ; Liu, LY; Jia, LP; Zhao, LQ				Zhao, Min; Zhu, Runan; Qian, Yuan; Deng, Jie; Wang, Fang; Sun, Yu; Dong, Huijin; Liu, Liying; Jia, Liping; Zhao, Linqing			Prevalence and Phylogenetic Analysis of Human Bocaviruses 1-4 in Pediatric Patients with Various Infectious Diseases	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; SAMPLES; RECOMBINATION; ENCEPHALITIS; STOOL	Objectives Viral infections caused by human bocaviruses 1-4 (HBoV1-4) are more complicated than previously believed. A retrospective, large-scale study was undertaken to explore the prevalence of HBoV1-4 in pediatric patients with various infectious diseases and delineate their phylogenetic characteristics. Methods Clinical samples from four specimen types, including 4,941 respiratory, 2,239 cerebrospinal fluid (CSF), 2,619 serum, and 1,121 fecal specimens, collected from pediatric patients with various infectious diseases were screened for HBoV1-4. A 690-nt fragment in each specimen was then amplified and sequenced for phylogenetic analysis. Clinical characteristics of HBoV-positive patients with different specimen types available were evaluated. Results Approximately 1.2% of patients were confirmed as HBoV-positive, with the highest positive rate in patients with gastrointestinal infection (2.2%), followed by respiratory (1.65%), central nervous system (0.8%), and hematological infections (0.2%). A single genetic lineage of HBoV1 circulated among children over the 8-year period, while a new cluster of HBoV2, via intra-genotype recombination between HBoV2A and HBoV2B, was prevalent. Some patients had HBoV1-positive respiratory and serum specimens or fecal specimens. Several cases became HBoV1-positive following the appearance of respiratory infection, while several cases were positive for HBoV2 only in CSF and serum specimens, rather than respiratory specimens. Conclusions A single genetic lineage of HBoV1 is speculated as a viral pathogen of respiratory infection and causes both comorbid infection and acute gastroenteritis. Additionally, a new cluster of HBoV2 is prevalent in China, which may infect the host through sites other than the respiratory tract.	[Zhao, Min; Zhu, Runan; Qian, Yuan; Deng, Jie; Wang, Fang; Sun, Yu; Dong, Huijin; Liu, Liying; Jia, Liping; Zhao, Linqing] Capital Inst Pediat, Virol Lab, Key Beijing Lab Viral Dis Etiol, Beijing, Peoples R China	Capital Institute of Pediatrics (CIP)	Zhao, LQ (corresponding author), Capital Inst Pediat, Virol Lab, Key Beijing Lab Viral Dis Etiol, Beijing, Peoples R China.	linqingz525@163.com	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022; wang, fang/GYD-4295-2022		Beijing Municipal Commission of Health and Family "The Special Fund for Capital Health Research and Development'' [2014-2-1132]; Beijing Natural Science Foundation of China [7152026]	Beijing Municipal Commission of Health and Family "The Special Fund for Capital Health Research and Development''; Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by grants from the Beijing Municipal Commission of Health and Family "The Special Fund for Capital Health Research and Development'' (No. 2014-2-1132) and Beijing Natural Science Foundation of China (No. 7152026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; BELAK S, 1993, MOL CELL PROBE, V7, P241, DOI 10.1006/mcpr.1993.1035; Brebion A, 2014, J CLIN MICROBIOL, V52, P1006, DOI 10.1128/JCM.03013-13; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Kantola K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139096; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Korner RW, 2011, EMERG INFECT DIS, V17, P2303, DOI 10.3201/eid1712.110574; Koseki N, 2012, J CLIN MICROBIOL, V50, P2118, DOI 10.1128/JCM.00098-12; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Mitui MT, 2012, CLIN INFECT DIS, V54, P964, DOI 10.1093/cid/cir957; Mori D, 2013, EMERG INFECT DIS, V19, P1859, DOI 10.3201/eid1911.121548; Ong DSY, 2016, J CLIN VIROL, V74, P45, DOI 10.1016/j.jcv.2015.11.027; Paloniemi M, 2014, EUR J PEDIATR, V173, P1051, DOI 10.1007/s00431-014-2290-x; Schildgen O, 2016, CLIN INFECT DIS, V62, DOI 10.1093/cid/civ759; Simon Arne, 2007, J Infect, V54, pe125, DOI 10.1016/j.jinf.2006.08.001; Tozer SJ, 2009, J MED VIROL, V81, P488, DOI 10.1002/jmv.21409; Ursic T, 2015, PEDIATR INFECT DIS J, V34, P111, DOI 10.1097/INF.0000000000000509; Zhao Lin-qing, 2006, Zhonghua Weishengwuxue He Mianyixue Zazhi, V26, P385; Zhao M, 2014, INFECT GENET EVOL, V27, P382, DOI 10.1016/j.meegid.2014.08.022	24	2	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0160603	10.1371/journal.pone.0160603	http://dx.doi.org/10.1371/journal.pone.0160603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490242	Green Published, gold, Green Submitted			2022-12-27	WOS:000381368900071
J	Galambos, C; Minic, AD; Bush, D; Nguyen, D; Dodson, B; Seedorf, G; Abman, SH				Galambos, Csaba; Minic, Angela D.; Bush, Douglas; Nguyen, Dominique; Dodson, Blair; Seedorf, Gregory; Abman, Steven H.			Increased Lung Expression of Anti-Angiogenic Factors in Down Syndrome: Potential Role in Abnormal Lung Vascular Growth and the Risk for Pulmonary Hypertension	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; ARTERIAL-HYPERTENSION; SERUM ENDOSTATIN; TUMOR-GROWTH; INHIBITOR; ALVEOLARIZATION; ALPHA-V-BETA-3; PATHOGENESIS; PREVALENCE; TUMSTATIN	Background and Aims Infants with Down syndrome (DS) or Trisomy 21, are at high risk for developing pulmonary arterial hypertension (PAH), but mechanisms that increase susceptibility are poorly understood. Laboratory studies have shown that early disruption of angiogenesis during development impairs vascular and alveolar growth and causes PAH. Human chromosome 21 encodes known anti-angiogenic factors, including collagen18a1 (endostatin, ES), beta-amyloid peptide (BAP) and Down Syndrome Critical Region 1 (DSCR-1). Therefore, we hypothesized that fetal lungs from subjects with DS are characterized by early over-expression of anti-angiogenic factors and have abnormal lung vascular growth in utero. Methods Human fetal lung tissue from DS and non-DS subjects were obtained from a biorepository. Quantitative reverse transcriptase PCR (qRT-PCR) was performed to assay 84 angiogenesis-associated genes and individual qRT-PCR was performed for ES, amyloid protein precursor (APP) and DSCR1. Western blot analysis (WBA) was used to assay lung ES, APP and DSCR-1 protein contents. Lung vessel density and wall thickness were determined by morphometric analysis. Results The angiogenesis array identified up-regulation of three anti-angiogenic genes: COL18A1 (ES), COL4A3 (tumstatin) and TIMP3 (tissue inhibitor of metallopeptidase 3) in DS lungs. Single qRT-PCR and WBA showed striking elevations of ES and APP mRNA (p = 0.022 and p = 0.001) and protein (p = 0.040 and p = 0.002; respectively). Vessel density was reduced (p = 0.041) and vessel wall thickness was increased in DS lung tissue (p = 0.033) when compared to non-DS subjects. Conclusions We conclude that lung anti-angiogenic factors, including COL18A1 (ES), COL4A3, TIMP3 and APP are over-expressed and fetal lung vessel growth is decreased in subjects with DS. We speculate that increased fetal lung anti-angiogenic factor expression due to trisomy 21 impairs lung vascular growth and signaling, which impairs alveolarization and contributes to high risk for PAH during infancy.	[Galambos, Csaba; Minic, Angela D.] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO 80045 USA; [Galambos, Csaba; Minic, Angela D.] Univ Colorado, Dept Lab Med, Sch Med, Aurora, CO 80045 USA; [Galambos, Csaba; Minic, Angela D.; Bush, Douglas; Dodson, Blair; Seedorf, Gregory; Abman, Steven H.] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Dodson, Blair] Univ Colorado, Sch Med, Pediat Surg, Aurora, CO USA; [Bush, Douglas; Abman, Steven H.] Univ Colorado, Sch Med, Pediat, Aurora, CO USA; [Galambos, Csaba; Minic, Angela D.; Bush, Douglas; Dodson, Blair; Seedorf, Gregory; Abman, Steven H.] Univ Colorado, Sch Med, Pediat Heart Lung Ctr, Aurora, CO 80045 USA; [Nguyen, Dominique] Univ Notre Dame, South Bend, IN USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Notre Dame	Galambos, C (corresponding author), Univ Colorado, Dept Pathol, Sch Med, Aurora, CO 80045 USA.; Galambos, C (corresponding author), Univ Colorado, Dept Lab Med, Sch Med, Aurora, CO 80045 USA.; Galambos, C (corresponding author), Childrens Hosp Colorado, Aurora, CO 80045 USA.; Galambos, C (corresponding author), Univ Colorado, Sch Med, Pediat Heart Lung Ctr, Aurora, CO 80045 USA.	csaba.galambos@childrenscolorado.org		Minic, Angela/0000-0001-5395-0032	National Institutes of Health [HL085703, HL68702]; Jerome Lejeune Foundation Grant for Down syndrome; Children's Hospital Colorado Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068702, T32HL007670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jerome Lejeune Foundation Grant for Down syndrome; Children's Hospital Colorado Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health [HL085703 (SHA); HL68702 (SHA)]; the Jerome Lejeune Foundation Grant for Down syndrome (https://lejeuneusa.org/research/grant-application#.VrUL91I-WpU); and the Children's Hospital Colorado Research Institute (https://research.childrenscolorado.org/).	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Abman SH, 2010, ADV EXP MED BIOL, V661, P323, DOI 10.1007/978-1-60761-500-2_21; Ayeni TI, 1998, J ROY SOC MED, V91, P321, DOI 10.1177/014107689809100612; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Betsy L, 1990, HUM PATHOL, V22, P919; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Biko DM, 2008, PEDIATR RADIOL, V38, P280, DOI 10.1007/s00247-007-0699-3; COONEY TP, 1982, NEW ENGL J MED, V307, P1170, DOI 10.1056/NEJM198211043071902; Cua CL, 2007, PEDIATR CARDIOL, V28, P250, DOI 10.1007/s00246-006-0011-6; D'Alto M, 2012, EUR RESPIR REV, V21, P328, DOI 10.1183/09059180.00004712; Damico R, 2015, AM J RESP CRIT CARE, V191, P208, DOI 10.1164/rccm.201409-1742OC; Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981; Greene AK, 2008, PEDIATRICS, V121, pE135, DOI 10.1542/peds.2007-1316; Grover TR, 2005, AM J PHYSIOL-LUNG C, V288, pL648, DOI 10.1152/ajplung.00288.2004; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; Jakkula M, 2000, AM J PHYSIOL-LUNG C, V279, pL600, DOI 10.1152/ajplung.2000.279.3.L600; Kim YM, 2002, J BIOL CHEM, V277, P27872, DOI 10.1074/jbc.M202771200; Le Cras TD, 2000, AM J PHYSIOL-LUNG C, V279, pL283, DOI 10.1152/ajplung.2000.279.2.L283; Le Cras TD, 2002, AM J PHYSIOL-LUNG C, V283, pL555, DOI 10.1152/ajplung.00408.2001; McDowell KM, 2011, J PEDIATR-US, V158, P319, DOI 10.1016/j.jpeds.2010.07.023; Mehta PD, 2007, J NEUROL SCI, V254, P22, DOI 10.1016/j.jns.2006.12.010; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Park J, 2009, BMB REP, V42, P6, DOI 10.5483/BMBRep.2009.42.1.006; Patel NS, 2010, J NEUROCHEM, V112, P66, DOI 10.1111/j.1471-4159.2009.06426.x; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Ryeom S, 2009, J CRANIOFAC SURG, V20, P595, DOI 10.1097/SCS.0b013e3181927f47; Saji T, 2014, PEDIATR INT, V56, P297, DOI 10.1111/ped.12349; Salinas M, 2013, FETAL PEDIATR PATHOL, V32, P38, DOI 10.3109/15513815.2012.659415; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Watts R, 2013, ARCH DIS CHILD, V98, P812, DOI 10.1136/archdischild-2013-304611; Weijerman ME, 2010, EUR J PEDIATR, V169, P1195, DOI 10.1007/s00431-010-1200-0; Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3; Zorick TS, 2001, EUR J HUM GENET, V9, P811, DOI 10.1038/sj.ejhg.5200721	37	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159005	10.1371/journal.pone.0159005	http://dx.doi.org/10.1371/journal.pone.0159005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487163	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800015
J	Lee, H; Yoon, YE; Park, JB; Kim, HL; Park, HE; Lee, SP; Kim, HK; Choi, Y; Kim, YJ; Cho, GY; Zo, JH; Sohn, DW				Lee, Heesun; Yoon, Yeonyee E.; Park, Jun-Bean; Kim, Hack-Lyoung; Park, Hyo Eun; Lee, Seung-Pyo; Kim, Hyung-Kwan; Choi, Yeon; Kim, Yong-Jin; Cho, Goo-Yeong; Zo, Joo-Hee; Sohn, Dae-Won			The Incremental Prognostic Value of Cardiac Computed Tomography in Comparison with Single-Photon Emission Computed Tomography in Patients with Suspected Coronary Artery Disease	PLOS ONE			English	Article							ACUTE CHEST-PAIN; CT ANGIOGRAPHY; MYOCARDIAL-ISCHEMIA; CULPRIT LESIONS; CALCIUM SCORE; TASK-FORCE; PLAQUE; PERFUSION; STENOSIS; ASSOCIATION	Background Coronary computed tomographic angiography (CCTA) facilitates comprehensive evaluation of coronary artery disease (CAD), including plaque characterization, and can provide additive diagnostic value to single-photon emission computed tomography (SPECT). However, data regarding the incremental prognostic value of CCTA to SPECT remain sparse. We evaluated the independent and incremental prognostic value of CCTA, as compared with clinical risk factors and SPECT. Materials and methods A total of 1,077 patients with suspected CAD who underwent both SPECT and cardiac CT between 2004 and 2012 were enrolled retrospectively. Presence of reversible or fixed perfusion defect (PD) and summed stress score were evaluated on SPECT. Presence, extent of coronary atherosclerosis and diameter stenosis (DS) were evaluated on CCTA. Plaque composition was categorized as non-calcified, mixed, or calcified according to the volume of calcified component (>130 Hounsfield Units). Patients were followed up for the occurrence of adverse cardiac events including cardiac death, non-fatal myocardial infarction, unstable angina, and late revascularization (>90 days after imaging studies). Results During follow-up (median 23 months), adverse cardiac events were observed in 71 patients (6.6%). When adjusted for clinical risk factors and SPECT findings, the presence of any coronary plaque, any plaque in >= 3 segments, coronary artery calcium score (CACS) >= 400, a plaque >= 50% DS, presence of non-calcified plaque (NCP) or mixed plaque (MP), and NCP/ MP in >= 2 segments were independent predictors of adverse cardiac events; however, the presence of calcified plaque (CP) was not. Conventional CCTA findings, including CACS >= 400 and a plaque >= 50% DS, demonstrated incremental prognostic value over clinical risk factors and SPECT (chi(2) 54.19 to 101.03; p < 0.001). Addition of NCP/ MP in >= 2 segments resulted in further significantly improved prediction (chi(2) 101.03 to 113.29; p < 0.001). Conclusion Comprehensive CCTA evaluation of coronary atherosclerosis provides independent and incremental prognostic value in relation to SPECT evaluation of myocardial ischemia. Specifically, segmentally-analyzed plaque composition with CCTA provides further risk stratification in addition to CACS and DS.	[Lee, Heesun; Yoon, Yeonyee E.; Park, Jun-Bean; Kim, Hack-Lyoung; Park, Hyo Eun; Lee, Seung-Pyo; Kim, Hyung-Kwan; Choi, Yeon; Kim, Yong-Jin; Cho, Goo-Yeong; Zo, Joo-Hee; Sohn, Dae-Won] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Heesun; Park, Hyo Eun; Choi, Yeon] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Seoul, South Korea; [Yoon, Yeonyee E.; Cho, Goo-Yeong] Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Ctr Cardiovasc, Songnam, South Korea; [Park, Jun-Bean; Lee, Seung-Pyo; Kim, Hyung-Kwan; Kim, Yong-Jin; Sohn, Dae-Won] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul, South Korea; [Kim, Hack-Lyoung; Zo, Joo-Hee] Seoul Natl Univ, Boramae Med Ctr, Div Cardiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Yoon, YE (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Yoon, YE (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Cardiol, Ctr Cardiovasc, Songnam, South Korea.	yeonyeeyoon@gmail.com	Kim, Hack-Lyoung/AAL-5038-2020; Kim, Hyung-Kwan/R-8375-2019; Park, Jun-Bean/AAN-3026-2021	Kim, Hack-Lyoung/0000-0002-6703-1472; Park, Jun-Bean/0000-0003-4053-8713; Kim, Hyung-Kwan/0000-0001-7950-2131	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI13C1961]	Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI13C1961) to YJK (https://www.htdream.kr/index.do). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI13C1961). We would like to acknowledge Seoul National University Bundang Hospital medical research collaborating center for their contribution to this study.	Achenbach S, 2004, CIRCULATION, V109, P14, DOI 10.1161/01.CIR.0000111517.69230.0F; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; BERMAN DS, 1993, J AM COLL CARDIOL, V22, P1455, DOI 10.1016/0735-1097(93)90557-H; Cannon CP, 2013, J AM COLL CARDIOL, V61, P992, DOI 10.1016/j.jacc.2012.10.005; Chang SM, 2009, J AM COLL CARDIOL, V54, P1872, DOI 10.1016/j.jacc.2009.05.071; Choi EK, 2009, AM J CARDIOL, V104, P890, DOI 10.1016/j.amjcard.2009.05.026; Choi JH, 2011, JACC-CARDIOVASC IMAG, V4, P1149, DOI 10.1016/j.jcmg.2011.09.006; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ferencik M, 2012, AM J CARDIOL, V110, P183, DOI 10.1016/j.amjcard.2012.02.066; Ferencik M, 2010, HEART, V96, P575, DOI 10.1136/hrt.2009.187815; Gaemperli O, 2008, RADIOLOGY, V248, P414, DOI 10.1148/radiol.2482071307; George RT, 2014, RADIOLOGY, V272, P407, DOI 10.1148/radiol.14140806; Hansen CL, 2007, J NUCL CARDIOL, V14, P134, DOI 10.1016/j.nuclcard.2006.11.009; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Hou ZH, 2012, JACC-CARDIOVASC IMAG, V5, P990, DOI 10.1016/j.jcmg.2012.06.006; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Kitagawa T, 2009, JACC-CARDIOVASC IMAG, V2, P153, DOI 10.1016/j.jcmg.2008.09.015; Lee HS, 2015, J ATHEROSCLER THROMB, V22, P1040, DOI 10.5551/jat.29918; Lee H, 2015, INT J CARDIOVAS IMAG, V31, P1469, DOI 10.1007/s10554-015-0709-8; Lin F, 2008, ATHEROSCLEROSIS, V197, P700, DOI 10.1016/j.atherosclerosis.2007.07.002; Maurovich-Horvat P, 2014, NAT REV CARDIOL, V11, P390, DOI 10.1038/nrcardio.2014.60; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P636, DOI 10.1016/j.jacc.2008.05.024; Min JK, 2011, ATHEROSCLEROSIS, V219, P573, DOI 10.1016/j.atherosclerosis.2011.05.032; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Pflederer T, 2010, ATHEROSCLEROSIS, V211, P437, DOI 10.1016/j.atherosclerosis.2010.02.001; Puchner SB, 2014, J AM COLL CARDIOL, V64, P684, DOI 10.1016/j.jacc.2014.05.039; Pursnani A, 2014, ATHEROSCLEROSIS, V237, P314, DOI 10.1016/j.atherosclerosis.2014.09.023; Rochitte CE, 2014, EUR HEART J, V35, P1120, DOI 10.1093/eurheartj/eht488; Schenker MP, 2008, CIRCULATION, V117, P1693, DOI 10.1161/CIRCULATIONAHA.107.717512; Schuijf JD, 2006, J AM COLL CARDIOL, V48, P2508, DOI 10.1016/j.jacc.2006.05.080; Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Smith SC, 2014, J AM COLL CARDIOL, V64, P601, DOI 10.1016/j.jacc.2014.06.1159; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; van Werkhoven JM, 2009, J AM COLL CARDIOL, V53, P623, DOI 10.1016/j.jacc.2008.10.043	35	34	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160188	10.1371/journal.pone.0160188	http://dx.doi.org/10.1371/journal.pone.0160188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486804	Green Published, gold, Green Submitted			2022-12-27	WOS:000381367800060
J	Meyer, FW; Schubert, N; Diele, K; Teichberg, M; Wild, C; Enriquez, S				Meyer, Friedrich W.; Schubert, Nadine; Diele, Karen; Teichberg, Mirta; Wild, Christian; Enriquez, Susana			Effect of Inorganic and Organic Carbon Enrichments (DIC and DOC) on the Photosynthesis and Calcification Rates of Two Calcifying Green Algae from a Caribbean Reef Lagoon	PLOS ONE			English	Article							SEAGRASS THALASSIA-TESTUDINUM; OCEAN ACIDIFICATION; CORAL-REEF; CALCAREOUS ALGAE; MARINE ORGANISMS; PHASE-SHIFTS; HALIMEDA; MACROALGAE; BACTERIA; CO2	Coral reefs worldwide are affected by increasing dissolved inorganic carbon (DIC) and organic carbon (DOC) concentrations due to ocean acidification (OA) and coastal eutrophication. These two stressors can occur simultaneously, particularly in near-shore reef environments with increasing anthropogenic pressure. However, experimental studies on how elevated DIC and DOC interact are scarce and fundamental to understanding potential synergistic effects and foreseeing future changes in coral reef function. Using an open mesocosm experiment, the present study investigated the impact of elevated DIC (pH(NBS): 8.2 and 7.8; pCO(2): 377 and 1076 mu atm) and DOC (added as 833 mu mol L-1 of glucose) on calcification and photosynthesis rates of two common calcifying green algae, Halimeda incrassata and Udotea flabellum, in a shallow reef environment. Our results revealed that under elevated DIC, algal photosynthesis decreased similarly for both species, but calcification was more affected in H. incrassata, which also showed carbonate dissolution rates. Elevated DOC reduced photosynthesis and calcification rates in H. incrassata, while in U. flabellum photosynthesis was unaffected and thalus calcification was severely impaired. The combined treatment showed an antagonistic effect of elevated DIC and DOC on the photosynthesis and calcification rates of H. incrassata, and an additive effect in U. flabellum. We conclude that the dominant sand dweller H. incrassata is more negatively affected by both DIC and DOC enrichments, but that their impact could be mitigated when they occur simultaneously. In contrast, U. flabellum can be less affected in coastal eutrophic waters by elevated DIC, but its contribution to reef carbonate sediment production could be further reduced. Accordingly, while the capacity of environmental eutrophication to exacerbate the impact of OA on algal-derived carbonate sand production seems to be species-specific, significant reductions can be expected under future OA scenarios, with important consequences for beach erosion and coastal sediment dynamics.	[Meyer, Friedrich W.; Teichberg, Mirta; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany; [Schubert, Nadine; Enriquez, Susana] UNAM, Unidad Acad Sistemas Arrecifales Puerto Morelos I, Lab Photobiol, Cancun, Mexico; [Diele, Karen] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh EH11 4BN, Midlothian, Scotland; [Wild, Christian] Univ Bremen, Fac Biol & Chem, Bibliothekstr 1, Bremen, Germany; [Diele, Karen] St Abbs Marine Stn, St Abbs TD14 5QF, Berwick, Scotland; [Schubert, Nadine] Univ Fed Santa Catarina, Dept Geociencias, Florianopolis, SC, Brazil	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Universidad Nacional Autonoma de Mexico; Edinburgh Napier University; University of Bremen; Universidade Federal de Santa Catarina (UFSC)	Enriquez, S (corresponding author), UNAM, Unidad Acad Sistemas Arrecifales Puerto Morelos I, Lab Photobiol, Cancun, Mexico.	enriquez@cmarl.unam.mx	Schubert, Nadine/C-6179-2009	Schubert, Nadine/0000-0001-7161-7882; Teichberg, Mirta/0000-0003-1586-738X; Enriquez, Susana/0000-0001-5776-902X	DGAPA [IN206710]; SEP-CONACYT [129880]; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) [HR09011]; UNAM-DGAPA; Scottish Funding Council [HR09011]; Mexican permit: "Permiso de Pesca de Fomento" [DGOPA.07342.010810.4121]; Leibniz Association	DGAPA; SEP-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); UNAM-DGAPA(Universidad Nacional Autonoma de Mexico); Scottish Funding Council; Mexican permit: "Permiso de Pesca de Fomento"; Leibniz Association	This study was funded by two research projects DGAPA (IN206710) and a SEP-CONACYT (129880) to SE and also by the Leibniz Association to CW. The MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) with the grant reference HR09011 to KD is also gratefully acknowledged. Support to NS was provided through two post-doctoral fellowships: UNAM-DGAPA and SEP-CONACYT (129880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff of UNAM, Puerto Morelos, especially Roman Vasquez Elizondo and Tim Scheufen, for field and laboratory support. In addition, we would like to thank Matthias Birkicht for the support in TA and TOC analysis. This study was funded by two research projects DGAPA (IN206710) and a SEP-CONACYT (129880) to SE and also by the Leibniz Association to CW. The MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) with the grant reference HR09011 to KD is also gratefully acknowledged. Support to NS was provided through two post-doctoral fellowships: UNAM-DGAPA and SEP-CONACYT (129880). We thank Roberto Iglesias-Prieto for his valuable support and J.E. Escalante Mancera and F.G. Ruiz Renteria for providing SST data from the Oceanographically and Meteorological Monitoring Academic Service (UASA, ICMyL, UNAM). KD received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) and its support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions.; The experiments performed in this work comply with the current laws of Mexico. The study was supported by the Mexican permit: "Permiso de Pesca de Fomento" No DGOPA.07342.010810.4121, to SE, issued by the Secretaria de Agricultura, Ganaderia, Desarrollo rural, Pesca y Alimentacion of the United States of Mexico, to support the development of the project: "Evaluacion del efecto de la limitacion de carbono sobre diferentes productores primarios de la laguna arrecifal de Puerto Morelos: Importancia de la calcificacion".	[Anonymous], 2012, P 12 INT COR REEF S; [Anonymous], 2001, ELSEVIER SCI; BACH SD, 1979, B MAR SCI, V29, P191; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Barry SC, 2013, J EXP MAR BIOL ECOL, V444, P73, DOI 10.1016/j.jembe.2013.03.012; BOHM L, 1978, J PHYCOL, V14, P486, DOI 10.1111/j.1529-8817.1978.tb02474.x; BOROWITZKA MA, 1976, J EXP BOT, V27, P894, DOI 10.1093/jxb/27.5.894; Buddemeier RW, 2004, POTENTIAL CONTRIBUTI; Campbell JE, 2016, CORAL REEFS, V35, P357, DOI 10.1007/s00338-015-1377-9; Campbell JE, 2014, MAR ECOL PROG SER, V514, P43, DOI 10.3354/meps10981; Cardenas A, 2015, MAR CHEM, V175, P47, DOI 10.1016/j.marchem.2015.04.002; Carruthers TJB, 2005, ESTUAR COAST SHELF S, V64, P191, DOI 10.1016/j.ecss.2005.01.015; Cayabyab NM, 2007, NEW PHYTOL, V176, P108, DOI 10.1111/j.1469-8137.2007.02147.x; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Collado-Vides L, 2005, J PHYCOL, V41, P742, DOI 10.1111/j.1529-8817.2005.00099.x; Comeau S, 2014, LIMNOL OCEANOGR, V59, P1081, DOI 10.4319/lo.2014.59.3.1081; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Cruz-Palacios V, 2005, J EXP MAR BIOL ECOL, V324, P44, DOI 10.1016/j.jembe.2005.04.002; DELGADO O, 1994, CORAL REEFS, V13, P151, DOI 10.1007/BF00301191; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DREW EA, 1990, BOT MAR, V33, P31, DOI 10.1515/botm.1990.33.1.31; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; ELZENGA JTM, 1989, PLANT PHYSIOL, V91, P62, DOI 10.1104/pp.91.1.62; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; Enriquez S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4835; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Gregg AK, 2013, PEERJ, V1, DOI 10.7717/peerj.107; Haas A, 2009, J EXP MAR BIOL ECOL, V380, P99, DOI 10.1016/j.jembe.2009.09.005; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, AQUAT BIOL, V10, P131, DOI 10.3354/ab00271; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hendriks IE, 2014, BIOGEOSCIENCES, V11, P333, DOI 10.5194/bg-11-333-2014; Hillis L.W., 1997, P 8 INT COR REEF S, P761; Hofmann LC, 2015, OECOLOGIA, V177, P1157, DOI 10.1007/s00442-015-3242-5; Hofmann LC, 2014, PLANTA, V239, P231, DOI 10.1007/s00425-013-1982-1; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jensen PR, 1996, MAR BIOL, V126, P1, DOI 10.1007/BF00571371; Johnson MD, 2014, PEERJ, V2, DOI 10.7717/peerj.411; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; LITTLER MM, 1988, CORAL REEFS, V6, P219, DOI 10.1007/BF00302018; Vasquez-Elizondo RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19030; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; Meyer FW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133596; MIEDEMA H, 1991, CAN J BOT, V69, P1116, DOI 10.1139/b91-143; Mumby P., 2014, REEF RESILIENCE SUST; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Naumann MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082923; Nelson CE, 2013, ISME J, V7, P962, DOI 10.1038/ismej.2012.161; NEUMANN AC, 1975, J SEDIMENT PETROL, V45, P763; Null KA, 2014, CONT SHELF RES, V77, P38, DOI 10.1016/j.csr.2014.01.011; Orr J. C., 2014, BIOGEOSCIENCES DISCU, V11, P5327, DOI [10.5194/bgd-11-5327-2014, DOI 10.5194/BGD-11-5327-2014]; Peach KE, 2016, MAR ECOL PROG SER, V544, P143, DOI 10.3354/meps11591; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Price NN, 2011, MAR ECOL PROG SER, V440, P67, DOI 10.3354/meps09309; PRINS HBA, 1982, PLANT CELL ENVIRON, V5, P207, DOI 10.1111/1365-3040.ep11571916; Ries JB, 2009, TERRA NOVA, V21, P323, DOI 10.1111/j.1365-3121.2009.00899.x; Robbins L. L., 2009, BIOGEOSCI DISCUSS, V6, P4895, DOI DOI 10.5194/bgd-6-4895-2009; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; Semesi IS, 2009, MAR ECOL PROG SER, V382, P41, DOI 10.3354/meps07973; Singh RP, 2014, FEMS MICROBIOL ECOL, V88, P213, DOI 10.1111/1574-6941.12297; Sinutok S, 2012, CORAL REEFS, V31, P1201, DOI 10.1007/s00338-012-0952-6; Sinutok S, 2011, LIMNOL OCEANOGR, V56, P1200, DOI 10.4319/lo.2011.56.4.1200; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; SMITH SV, 1978, CORAL REEFS RES METH, P469; Stocker T.F., 2013, WORKING GROUP I CONT; van Tussenbroek BI, 2007, J PHYCOL, V43, P69, DOI 10.1111/j.1529-8817.2006.00307.x; VANTUSSENBROEK BI, 1995, MAR BIOL, V122, P33, DOI 10.1007/BF00349275; Verbruggen H, 2005, J PHYCOL, V41, P126, DOI 10.1111/j.1529-8817.2005.04080.x; Vogel N, 2015, MAR ECOL PROG SER, V521, P49, DOI 10.3354/meps11088; Wild C, 2008, 11 INT COR REEF S, P7; Wizemann A, 2015, CORAL REEFS, V34, P941, DOI 10.1007/s00338-015-1288-9; Yao WS, 1998, DEEP-SEA RES PT I, V45, P1383, DOI 10.1016/S0967-0637(98)00018-1	77	8	8	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160268	10.1371/journal.pone.0160268	http://dx.doi.org/10.1371/journal.pone.0160268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487195	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800066
J	Rodrigo, T; Casals, M; Caminero, JA; Garcia-Garcia, JM; Jimenez-Fuentes, MA; Medina, JF; Millet, JP; Ruiz-Manzano, J; Cayla, J				Rodrigo, T.; Casals, M.; Caminero, J. A.; Garcia-Garcia, J. M.; Jimenez-Fuentes, M. A.; Medina, J. F.; Millet, J. P.; Ruiz-Manzano, J.; Cayla, J.		Working Grp Integrated Programme T	Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; RISK-FACTORS; PULMONARY TUBERCULOSIS; RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; MORTALITY; OUTCOMES; THERAPY; DEATH; CARE	Objective To determine the case-fatality rate (CFR) at the end of the intensive phase of tuberculosis (TB) treatment, and factors associated with fatality. Methods TB patients diagnosed between 2006 and 2013 were followed-up during treatment. We computed the CFR at the end of the intensive phase of TB treatment, and the incidence of death per 100 person-days (pd) of follow-up. We performed survival analysis using the Kaplan-Meier method and Cox regression, and calculate hazard ratios (HR) and 95% confidence intervals (CI). Results A total of 5,182 patients were included, of whom 180 (3.5%) died; 87 of these deaths (48.3%) occurred during the intensive phase of treatment, with a CFR of 1.7%. The incidence of death was 0.028/100 pd. The following factors were associated with death during the intensive phase: being >50 years (HR = 36.9; CI: 4.8-283.4); being retired (HR = 2.4; CI: 1.1-5.1); having visited the emergency department (HR = 3.1; CI: 1.2-7.7); HIV infection standard treatments (HR = 2.68; CI: 1.36-5.25); comprehension difficulties (HR = 2.8; CI: 1.3-6.1); and smear-positive sputum (HR = 2.3-CI: 1.0-4.8). Conclusion There is a non-negligible CFR during the intensive phase of TB, whose reduction should be prioritised. The CFR could be a useful indicator for evaluating TB programs.	[Rodrigo, T.; Caminero, J. A.; Garcia-Garcia, J. M.; Jimenez-Fuentes, M. A.; Medina, J. F.; Millet, J. P.; Ruiz-Manzano, J.; Cayla, J.] Fdn Resp Soc Espanola Neumol & Cirugia, Programa Integrado Invest TB PII TB, Barcelona, Spain; [Rodrigo, T.; Casals, M.; Cayla, J.] Minist Econ & Competitividad, Inst Salud Carlos III, Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain; [Caminero, J. A.] Hosp Gen Univ Gran Canaria Dr, Serv Neumol, Negrin, Canary Islands, Spain; [Garcia-Garcia, J. M.] Hosp San Agustin Aviles, Serv Neumol, Asturias, Spain; [Jimenez-Fuentes, M. A.] Hosp Univ Valle de Hebron, Unidad TB, Barcelona, Spain; [Medina, J. F.] Hosp Univ Virgen del Rocio, Serv Neumol, Seville, Spain; [Ruiz-Manzano, J.] Hosp Badalona Germans Trias & Pujol, Serv Neumol, Badalona, Spain; [Ruiz-Manzano, J.] Minist Econ & Competitividad, Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [Caminero, J. A.] Int Union TB & Lung Dis, Paris, France; [Rodrigo, T.; Casals, M.; Millet, J. P.; Cayla, J.] Agencia Salud Publ Barcelona, Serv Epidemiol, Unidad Invest TB, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Spanish Ministry of Economy & Competitiveness; Hospital San Agustin; Hospital Universitari Vall d'Hebron; Virgen del Rocio University Hospital; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Spanish Ministry of Economy & Competitiveness; Public Health Agency of Barcelona	Rodrigo, T (corresponding author), Fdn Resp Soc Espanola Neumol & Cirugia, Programa Integrado Invest TB PII TB, Barcelona, Spain.; Rodrigo, T (corresponding author), Minist Econ & Competitividad, Inst Salud Carlos III, Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain.; Rodrigo, T (corresponding author), Agencia Salud Publ Barcelona, Serv Epidemiol, Unidad Invest TB, Barcelona, Spain.	pii_tb_teresa_rodrigo@separ.es	Casals, Martí/M-8388-2019; Anibarro, Luis/A-3959-2009	Casals, Martí/0000-0002-1775-8331; Anibarro, Luis/0000-0001-8790-6320; Garcia-Garcia, Jose-Maria/0000-0002-2809-6230; Gullon, Jose Antonio/0000-0002-3007-0873; Casas, Francisco/0000-0002-8007-9323; RODRIGO, TERESA/0000-0003-3663-5828; Valencia, Eulalia/0000-0001-6902-0120; Cayla, Joan A./0000-0003-3891-111X; Villanueva, Manuel Angel/0000-0003-3256-9579; Millet, Joan Pau/0000-0003-0200-2459; MEDINA GALLARDO, JUAN FRANCISCO/0000-0001-5400-1592	SEPAR that is the Spanish Society of Pneumology ("Sociedad Espanola de Pneumologia y Cirugia Toracica") [207/2011]; International Union Against Tuberculosis and Lung Disease; SEPAR	SEPAR that is the Spanish Society of Pneumology ("Sociedad Espanola de Pneumologia y Cirugia Toracica"); International Union Against Tuberculosis and Lung Disease; SEPAR	This study was funded by SEPAR that is the Spanish Society of Pneumology ("Sociedad Espanola de Pneumologia y Cirugia Toracica") Grant Number: 207/2011 (URL: http://www.separ.es). Authors TR, JAC, JMG-G, MAJ-F, JFM, JPM, JR-M and JC are affiliated to, but do not receive a salary from SEPAR. JAC is also affiliated to, but does not receive a salary from the International Union Against Tuberculosis and Lung Disease. SEPAR and the International Union Against Tuberculosis and Lung Disease did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahamd N, 2012, REV GLOBAL MED HEALT, V3; All-Party Parliamentary Group on Global Tuberculosis, 2013, DRUG RES TUB OLD DIS; [Anonymous], 2015, ENN EP REC RESP TRAC; Blanquer R, 2015, ARCH BRONCONEUMOL, V51, P24, DOI 10.1016/j.arbres.2014.06.001; Caminero JA, 2011, TUBERCULOSIS, p[36, 347], DOI [10.1016/j.tube.2010.11.00821147037, DOI 10.1016/J.TUBE.2010.11.008]; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Crofts JR, 2008, INT J TUBERC LUNG D, V12, P308; Dheda K, 2004, J INFECT DIS, V190, P1670, DOI 10.1086/424676; Feng JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023715; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Gadkowski LB, 2009, AIDS PATIENT CARE ST, V23, P845, DOI 10.1089/apc.2009.0030; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P561, DOI 10.1164/rccm.200401-095OC; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-921; Kayigamba FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073501; Kwon YS, 2014, CURR OPIN PULM MED, V20, P280, DOI 10.1097/MCP.0000000000000045; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025315; Nahid P, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-1; Najera-Ortiz JC, 2008, INT J EPIDEMIOL, V37, P786, DOI 10.1093/ije/dyn089; Ordobás María, 2003, Rev. Esp. Salud Publica, V77, P189, DOI [10.1590/S1135-57272003000200002, 10.1590/s1135-57272003000200002]; Pardeshi Geeta, 2009, Indian J Med Sci, V63, P180, DOI 10.4103/0019-5359.53163; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; RUTSTEIN DD, 1976, NEW ENGL J MED, V294, P582, DOI 10.1056/NEJM197603112941104; Ryu YJ, 2011, INT J TUBERC LUNG D, V15, P246; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; Silva DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-54; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; THEMEAU T, 2009, SURVIVAL SURVIVAL AN; WHO, 2009, 2 WHO; World Health Organization, 2015, GLOB TUB REP 2015	33	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0159925	10.1371/journal.pone.0159925	http://dx.doi.org/10.1371/journal.pone.0159925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27487189	Green Published, Green Submitted, gold			2022-12-27	WOS:000381367800046
J	Frazier, M; Longo, C; Halpern, BS				Frazier, Melanie; Longo, Catherine; Halpern, Benjamin S.			Mapping Uncertainty Due to Missing Data in the Global Ocean Health Index	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; COMPOSITE INDICATORS; HUMAN APPROPRIATION; SENSITIVITY	Indicators are increasingly used to measure environmental systems; however, they are often criticized for failing to measure and describe uncertainty. Uncertainty is particularly difficult to evaluate and communicate in the case of composite indicators which aggregate many indicators of ecosystem condition. One of the ongoing goals of the Ocean Health Index (OHI) has been to improve our approach to dealing with missing data, which is a major source of uncertainty. Here we: (1) quantify the potential influence of gapfilled data on index scores from the 2015 global OHI assessment; (2) develop effective methods of tracking, quantifying, and communicating this information; and (3) provide general guidance for implementing gapfilling procedures for existing and emerging indicators, including regional OHI assessments. For the overall OHI global index score, the percent contribution of gapfilled data was relatively small (18.5%); however, it varied substantially among regions and goals. In general, smaller territorial jurisdictions and the food provision and tourism and recreation goals required the most gapfilling. We found the best approach for managing gapfilled data was to mirror the general framework used to organize, calculate, and communicate the Index data and scores. Quantifying gapfilling provides a measure of the reliability of the scores for different regions and components of an indicator. Importantly, this information highlights the importance of the underlying datasets used to calculate composite indicators and can inform and incentivize future data collection.	[Frazier, Melanie; Halpern, Benjamin S.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Longo, Catherine] Marine Stewardship Council, 1 Snow Hill, London EC1A 2DH, England; [Halpern, Benjamin S.] Imperial Coll London, Silwood Pk Campus, Ascot, West Berkshire, England; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; University of California System; University of California Santa Barbara	Frazier, M (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	frazier@nceas.ucsb.edu	Frazier, Melanie R/A-2367-2012		Pacific Life Foundation	Pacific Life Foundation	This work was possible with the generous funding from the Pacific Life Foundation to the Moore Center for Science and Oceans at Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2005, EC HUM WELL BEING WE; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Armon R.H., 2015, ENV INDICATORS; Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Bohringer C, 2007, ECOL ECON, V63, P1, DOI 10.1016/j.ecolecon.2007.03.008; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Convention on Biological Diversity, LIST OF PART; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Dobbie MJ, 2015, MAR FRESHWATER RES, V66, P95, DOI 10.1071/MF13065; Dobbie MJ, 2013, ECOL INDIC, V29, P270, DOI 10.1016/j.ecolind.2012.12.025; European Commission, 2008, HDB CONSTRUCTING COM; Foley JA, 2007, P NATL ACAD SCI USA, V104, P12585, DOI 10.1073/pnas.0705190104; Frederiksen P, 2013, ECOL INDIC, V35, P1, DOI 10.1016/j.ecolind.2013.05.016; Guan N. C., 2011, EMJ, V3; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117863; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Joppa LN, 2016, SCIENCE, V352, P416, DOI 10.1126/science.aaf3565; Jorgensen SE, 2013, ECOL INDIC, V28, P4, DOI 10.1016/j.ecolind.2012.12.018; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Lowndes JSS, 2015, PEERJ, V3, DOI 10.7717/peerj.1503; McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641; Muller F, 2013, ECOL INDIC, V28, P1, DOI 10.1016/j.ecolind.2012.12.007; Munda G, 2009, INT J ENVIRON TECHNO, V11, P7, DOI 10.1504/IJETM.2009.027185; Nardo M, 2005, 21682 EUR EN; Nations United, FAO FISH AQ FISH STA; Nations United, FAO STAT DIV INP; Niemi GJ, 2004, ANNU REV ECOL EVOL S, V35, P89, DOI 10.1146/annurev.ecolsys.35.112202.130132; Parris TM, 2003, ANNU REV ENV RESOUR, V28, P559, DOI 10.1146/annurev.energy.28.050302.105551; Pauly D., 2015, SEA US CONCEPTS DESI; R Core Team, 2013, R LANG ENV STAT COMP; Saisana M, 2005, J ROY STAT SOC A STA, V168, P307, DOI 10.1111/j.1467-985X.2005.00350.x; Saisana M., 2010, UNCERTAINTY SENSITIV; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A, 2007, SOC INDIC RES, V81, P65, DOI 10.1007/s11205-006-0024-9; Selig ER, 2015, ECOSYST SERV, V16, P403, DOI 10.1016/j.ecoser.2014.11.007; Selig ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060284; Singh RK, 2012, ECOL INDIC, V15, P281, DOI 10.1016/j.ecolind.2011.01.007; Storlie C., 2014, SDMTOOLS SPECIES DIS; Trujillo P, 2008, FISHERIES CTR RES RE; United Nations Statistics Division, STAND COUNTR AR COD; World Economic Forum, 2015, TRAV TOUR COMP REP	47	16	16	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160377	10.1371/journal.pone.0160377	http://dx.doi.org/10.1371/journal.pone.0160377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483378	Green Submitted, gold, Green Published			2022-12-27	WOS:000381110700041
J	Golay, P; Basterrechea, L; Conus, P; Bonsack, C				Golay, Philippe; Basterrechea, Louis; Conus, Philippe; Bonsack, Charles			Internal and Predictive Validity of the French Health of the Nation Outcome Scales: Need for Future Directions	PLOS ONE			English	Article							HONOS; UTILITY; VERSION	The Health of the Nation Outcome Scales (HoNOS) is a widely used measure of health and social functioning of people with mental illness. The goals of this study were to verify the internal validity of the one factor and several four-factor scoring structures and to evaluate the predictive validity of HoNOS items with regards to duration of hospitalization, probability of readmission in the following year and time before readmission. 6175 hospital stays at the department of psychiatry of Lausanne University Hospital were screened and the first HoNOS of each patient was taken into account (N = 2722). Data were analyzed through Confirmatory Factor Analysis (CFA) and the predictive validity of HoNOS items was evaluated with two approaches: item level regressions and latent class analysis (LCA). CFA indicated that the suggested factor structures were not supported by the data. Predictive validity of the 12 items was weak but LCA revealed five distinct and meaningful profiles that were related to length of stay or readmission. HoNOS may be more adapted to the evaluation of patients case-mix rather than to the individual level and concepts such as predictive validity may be more appropriate than internal validity to guide its use.	[Golay, Philippe; Basterrechea, Louis; Conus, Philippe; Bonsack, Charles] Lausanne Univ Hosp CHUV, Dept Psychiat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Golay, P (corresponding author), Lausanne Univ Hosp CHUV, Dept Psychiat, Lausanne, Switzerland.	Philippe.golay@chuv.ch	Golay, Philippe/GMX-4576-2022; Golay, Philippe/L-6973-2016	Golay, Philippe/0000-0002-2273-6241; Golay, Philippe/0000-0002-2273-6241; Conus, Philippe/0000-0002-5832-1910				Andreas S, 2010, INT J METH PSYCH RES, V19, P50, DOI 10.1002/mpr.305; Asparouhov T, 2014, STRUCT EQU MODELING, V21, P329, DOI 10.1080/10705511.2014.915181; Bech P, 2006, ACTA PSYCHIAT SCAND, V113, P485, DOI 10.1111/j.1600-0447.2005.00693.x; Bisson J, 2004, RAPPORT DE RECHERCHE, P1; Bonsack C, 2002, HEALTH OF NATION OUT, P483; Boot B, 1997, BRIT J PSYCHIAT, V171, P242, DOI 10.1192/bjp.171.3.242; Burns A, 1999, BRIT J PSYCHIAT, V174, P424, DOI 10.1192/bjp.174.5.424; Chin W.W., 1998, MIS QUART, V22, P7, DOI DOI 10.2307/249674; Cieza A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132410; Eagar K, 2005, AUST NZ J PSYCHIAT, V39, P713, DOI 10.1111/j.1440-1614.2005.01655.x; Furr RM, 2013, PSYCHOMETRICS AN INT; Gavin H, 2008, UNDERSTANDING RESEAR; Goldney RD, 1998, AUST NZ J PSYCHIAT, V32, P199, DOI 10.3109/00048679809062729; Gowers SG, 1999, BRIT J PSYCHIAT, V174, P413, DOI 10.1192/bjp.174.5.413; HAYWOOD TW, 1995, AM J PSYCHIAT, V152, P856; Hope JD, 1998, SCHIZOPHR RES, V29, P9, DOI 10.1016/S0920-9964(97)88307-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Lanza ST, 2013, STRUCT EQU MODELING, V20, P361, DOI 10.1080/10705511.2013.797816; Lauzon S, 2001, CAN J PSYCHIAT, V46, P841, DOI 10.1177/070674370104600908; Lovaglio PG, 2012, QUAL LIFE RES, V21, P1643, DOI 10.1007/s11136-011-0071-9; Muncer S, 2016, AUSTRALAS PSYCHIATRY; Muncer SJ, 2016, PERS INDIV DIFFER, V94, P272, DOI 10.1016/j.paid.2016.01.051; Muthen B.O., 2004, MPLUS TECHNICAL APPE; Newnham EA, 2009, J MENT HEALTH, V18, P326, DOI 10.1080/09638230802522486; Parker G, 2002, INT J SOC PSYCHIATR, V48, P11, DOI 10.1177/002076402128783046; Pirkis Jane, 2005, Aust New Zealand Health Policy, V2, P8, DOI 10.1186/1743-8462-2-8; Pirkis Jane E, 2005, Health Qual Life Outcomes, V3, P76, DOI 10.1186/1477-7525-3-76; Prowse L, 2009, AUST HEALTH REV, V33, P13, DOI 10.1071/AH090013; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Speak B, 2012, FINAL REPORT; Speak BL, 2015, INT J HEALTH CARE Q, V28, P115, DOI 10.1108/IJHCQA-08-2013-0096; Speak BL, 2016, INTERNATIONAL JOURNA; Trauer T., 1999, J MENTAL HLTH, V8, P499, DOI [DOI 10.1080/09638239917193, 10.1080/09638239917193]; Veerbeek MA, 2013, INT J NURS STUD, V50, P1711, DOI 10.1016/j.ijnurstu.2013.05.004; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11; Wolff J, 2015, BMC PSYCHIATRY, V15, P1; Yu CY, 2002, EVALUATING CUTOFF CR	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160360	10.1371/journal.pone.0160360	http://dx.doi.org/10.1371/journal.pone.0160360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS9NS	27483015	Green Published, gold			2022-12-27	WOS:000381110700039
J	Saetang, J; Puseenam, A; Roongsawang, N; Voravuthikunchai, SP; Sangkhathat, S; Tipmanee, V				Saetang, Jirakrit; Puseenam, Aekkachai; Roongsawang, Niran; Voravuthikunchai, Supayang Piyawan; Sangkhathat, Surasak; Tipmanee, Varomyalin			Immunologic Function and Molecular Insight of Recombinant Interleukin-18	PLOS ONE			English	Article							BINDING-PROTEIN; BIOLOGICAL-ACTIVITY; HUMAN IL-18; CELLS; CANCER; DYNAMICS; GROWTH	In recent years, cytokine-mediated therapy has emerged as further advance alternative in cancer therapy. Interleukin-18 (IL-18) has exhibited interesting anti-cancer properties especially when combined with IL-12. We engineered IL-18 in order to improve its activity using single point mutagenesis. IL-18 mutants were constructed according to binding residues and polarity which we tried to increase polarity in M33Q and M60Q, enhanced cationicity in E6K, and flexibility in T63A. All IL-18 proteins were expressed in Pichia pastoris, purified, and then measured the activity by treating with the NK-92MI cell line to evaluate interferon-gamma (IFN-gamma) stimulation. The E6K and T63A mutant forms showed higher activity with respect to native proteins at the concentration of 200 ng mL(-1) by inducing the expression of IFN-gamma, about factors of 9 and 4, respectively. Meanwhile, M33Q and M60Q had no significant activity to induce IFN-gamma. Interestingly, the combination of E6K and T63A mutations could synergize the induction activity of IL-18 to be 16 times at 200 ng mL(-1). Furthermore, molecular dynamics studies have elucidated the effect due to mutation on conformation of the binding site of IL-18. The results turn out that E6K provides structural perseverance against mutation, while M33Q and M60Q promote vivid overall change in protein conformation, especially at the binding site. For T63A, mutation yields small difference in structure but clearly increases structural flexibility. However, a small structural change was observed when T63A was combined with E6K. Our research resulted in a novel version of IL-18 which could be a new key candidate for cytokine-mediated therapy.	[Saetang, Jirakrit; Sangkhathat, Surasak; Tipmanee, Varomyalin] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai 90110, Thailand; [Saetang, Jirakrit] Prince Songkla Univ, Grad Sch, Hat Yai 90110, Thailand; [Puseenam, Aekkachai; Roongsawang, Niran] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Microbial Cell Factory Lab, Bioresources Technol Unit, 113 Thailand Sci Pk,Phahonyothin Rd, Pathum Thani 12120, Thailand; [Voravuthikunchai, Supayang Piyawan] Prince Songkla Univ, Fac Sci, Dept Microbiol, Hat Yai 90110, Thailand; [Voravuthikunchai, Supayang Piyawan] Prince Songkla Univ, Fac Sci, Nat Prod Res Ctr Excellence, Hat Yai 90110, Thailand; [Sangkhathat, Surasak] Prince Songkla Univ, Fac Med, Dept Surg, Hat Yai 90110, Thailand	Prince of Songkla University; Prince of Songkla University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Tipmanee, V (corresponding author), Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai 90110, Thailand.	tvaromya@medicine.psu.ac.th	Saetang, Jirakrit/AHE-7398-2022; Sangkhathat, Surasak/F-6397-2010; Tipmanee, Varomyalin/AAG-6784-2021; Sangkhathat, Surasak/AAP-5157-2021; Sangkhathat, Surasak/AAE-3816-2020	Saetang, Jirakrit/0000-0003-2769-8149; Sangkhathat, Surasak/0000-0003-3622-3233; Roongsawang, Niran/0000-0002-2114-5052; Tipmanee, Varomyalin/0000-0001-6017-7519	Higher Education Research Promotion and National Research University Project of Thailand, Office of Higher Education Commission [MED570579S]; Faculty of Medicine, Prince of Songkla University	Higher Education Research Promotion and National Research University Project of Thailand, Office of Higher Education Commission; Faculty of Medicine, Prince of Songkla University	This work was supported by the Higher Education Research Promotion and National Research University Project of Thailand, Office of Higher Education Commission (grant no. MED570579S). In addition, this research was partially supported by Faculty of Medicine, Prince of Songkla University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Cao RH, 1999, FASEB J, V13, P2195, DOI 10.1096/fasebj.13.15.2195; Case D., 2012, AMBER 12, P142; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Dalgleish AG, 2001, J CLIN PATHOL, V54, P675, DOI 10.1136/jcp.54.9.675; Du GY, 2012, J CANCER RES CLIN, V138, P1727, DOI 10.1007/s00432-012-1248-5; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gatti S, 2002, AM J PHYSIOL-REG I, V282, pR702, DOI 10.1152/ajpregu.00393.2001; Huang CJ, 2011, APPL MICROBIOL BIOT, V90, P235, DOI 10.1007/s00253-011-3118-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kim SH, 2000, P NATL ACAD SCI USA, V97, P1190, DOI 10.1073/pnas.97.3.1190; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Ma Xiaomei, 2006, Yale J Biol Med, V79, P85; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nagai H, 2002, J INVEST DERMATOL, V119, P541, DOI 10.1046/j.1523-1747.2002.01866.x; Nakamura Y, 2006, CANCER IMMUNOL IMMUN, V55, P1151, DOI 10.1007/s00262-005-0097-3; Nelson D, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/789069; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Novick D, 2001, CYTOKINE, V14, P334, DOI 10.1006/cyto.2001.0914; Okamoto I, 1999, J IMMUNOL, V162, P3202; Robertson MJ, 2008, CLIN CANCER RES, V14, P3462, DOI 10.1158/1078-0432.CCR-07-4740; Robertson MJ, 2006, CLIN CANCER RES, V12, P4265, DOI 10.1158/1078-0432.CCR-06-0121; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Swencki-Underwood B, 2006, CYTOKINE, V34, P114, DOI 10.1016/j.cyto.2006.04.004; Tse BWC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024241; Tsutsumi N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6340; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Yamashita K, 2002, ONCOL REP, V9, P1237	33	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2016	11	8							e0160321	10.1371/journal.pone.0160321	http://dx.doi.org/10.1371/journal.pone.0160321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NS	27483370	gold, Green Published, Green Submitted			2022-12-27	WOS:000381110700034
J	Wahl, J; Barleon, L; Morfeld, P; Lichtmess, A; Haas-Brahler, S; Pfeiffer, N				Wahl, Jochen; Barleon, Lorenz; Morfeld, Peter; Lichtmess, Andrea; Haas-Braehler, Sibylle; Pfeiffer, Norbert			The Evonik-Mainz Eye Care-Study (EMECS): Development of an Expert System for Glaucoma Risk Detection in a Working Population	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; OPTIC DISC; PREVALENCE; DEFINITIONS; SENSITIVITY; NUMBER; RATIO	Purpose To develop an expert system for glaucoma screening in a working population based on a human expert procedure using images of optic nerve head (ONH), visual field (frequency doubling technology, FDT) and intraocular pressure (IOP). Methods 4167 of 13037 (32%) employees between 40 and 65 years of Evonik Industries were screened. An experienced glaucoma expert (JW) assessed papilla parameters and evaluated all individual screening results. His classification into "no glaucoma", "possible glaucoma" and "probable glaucoma" was defined as "gold standard". A screening model was developed which was tested versus the gold-standard. This model took into account the assessment of the ONH. Values and relationships of CDR and IOP and the FDT were considered additionally and a glaucoma score was generated. The structure of the screening model was specified a priori whereas values of the parameters were chosen post-hoc to optimize sensitivity and specificity of the algorithm. Simple screening models based on IOP and / or FDT were investigated for comparison. Results 111 persons (2.66%) were classified as glaucoma suspects, thereof 13 (0.31%) as probable and 98 (2.35%) as possible glaucoma suspects by the expert. Re-evaluation by the screening model revealed a sensitivity of 83.8% and a specificity of 99.6% for all glaucoma suspects. The positive predictive value of the model was 80.2%, the negative predictive value 99.6%. Simple screening models showed insufficient diagnostic accuracy. Conclusion Adjustment of ONH and symmetry parameters with respect to excavation and IOP in an expert system produced sufficiently satisfying diagnostic accuracy. This screening model seems to be applicable in such a working population with relatively low age and low glaucoma prevalence. Different experts should validate the model in different populations.	[Wahl, Jochen] Helios Dr Horst Schmidt Kliniken, Dept Ophthalmol, Wiesbaden, Germany; [Wahl, Jochen; Barleon, Lorenz; Pfeiffer, Norbert] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany; [Barleon, Lorenz] Diakonissen Hosp, Dept Ophthalmol, Karlsruhe, Germany; [Morfeld, Peter] Univ Cologne, Inst Occupat Med, Cologne, Germany; [Morfeld, Peter] Inst Occupat Epidemiol & Risk Assessment Evonik I, Essen, Germany; [Lichtmess, Andrea] Bundeswehrzent Krankenhaus Koblenz, Abt Anasthesie Intens Med Notfallmed Schmertz 10, Koblenz, Germany; [Haas-Braehler, Sibylle] Evon Ind, Occupat Hlth, Hanau, Germany	Johannes Gutenberg University of Mainz; University of Cologne; Evonik Industries	Wahl, J (corresponding author), Helios Dr Horst Schmidt Kliniken, Dept Ophthalmol, Wiesbaden, Germany.; Wahl, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Ophthalmol, Mainz, Germany.	jochenwahl@freenet.de	Pfeiffer, Norbert/AAO-7586-2020		Evonik Industries	Evonik Industries	Evonik Industries provided an unrestricted grant for this study. Evonik Industries provided some of the equipment, qualified personnel, transportation and accommodation. The funder provided support in the form of salaries for authors [PM, SH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.; The authors wish to thank the workers of Evonik Industries who attended the study. This investigation was sponsored by a grant from Evonik Industries.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Anton A, 2004, J GLAUCOMA, V13, P371; Barleon L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098538; Bishop Y.M., 2007, DISCRETE MULTIVARIAT; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Cedrone C, 1997, Ophthalmic Epidemiol, V4, P59; Checkoway H, 2004, OCCUP ENVIRON MED, V61, P953, DOI 10.1136/oem.2004.014886; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Ervin A-M, 2012, AHRQ PUBLICATION; European Glaucoma Society, 2014, CLASS TERM TERM GUID, P93; Foster Paul J, 2002, Semin Ophthalmol, V17, P50; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P1118, DOI 10.1136/bjo.82.10.1118; GIUFFRE G, 1995, ACTA OPHTHALMOL SCAN, V73, P222; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Hitzil W, 2006, KLIN MONATSBL AUGENH, V223, P970, DOI 10.1055/s-2006-927102; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; KAHN HA, 1980, ARCH OPHTHALMOL-CHIC, V98, P2172, DOI 10.1001/archopht.1980.01020041024003; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; Lopes FSS, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-72; McGinn T, 2004, CAN MED ASSOC J, V171, P1369, DOI 10.1503/cmaj.1031981; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mowatt G, 2008, INVEST OPHTH VIS SCI, V49, P5373, DOI 10.1167/iovs.07-1501; Nuovo J, 2002, JAMA-J AM MED ASSOC, V287, P2813, DOI 10.1001/jama.287.21.2813; Pfeiffer N, 2002, J GLAUCOMA, V11, P458, DOI 10.1097/00061198-200210000-00016; Powell C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005020.pub3; QUIGLEY HA, 1982, ANN OPHTHALMOL, V14, P611; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Saito H, 2009, OPHTHALMOLOGY, V116, P1854, DOI 10.1016/j.ophtha.2009.03.048; Sakata K, 2007, INVEST OPHTH VIS SCI, V48, P4974, DOI 10.1167/iovs.07-0342; Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211; Susanna R, 2007, CURR OPIN OPHTHALMOL, V18, P122, DOI 10.1097/ICU.0b013e328040bfe0; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; TIELSCH JM, 1991, AM J EPIDEMIOL, V134, P1102, DOI 10.1093/oxfordjournals.aje.a116013; Tuck M W, 1998, Ophthalmic Epidemiol, V5, P173, DOI 10.1076/opep.5.4.173.4192; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309; Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992	47	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2016	11	8							e0158824	10.1371/journal.pone.0158824	http://dx.doi.org/10.1371/journal.pone.0158824			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS9NO	27479301	Green Submitted, Green Published, gold			2022-12-27	WOS:000381110300007
J	Catalan, A; de Artaza, MG; Bustamante, S; Orgaz, P; Osa, L; Angosto, V; Valverde, C; Bilbao, A; Madrazo, A; van Os, J; Gonzalez-Torres, MA				Catalan, Ana; Gonzalez de Artaza, Maider; Bustamante, Sonia; Orgaz, Pablo; Osa, Luis; Angosto, Virxinia; Valverde, Cristina; Bilbao, Amaia; Madrazo, Arantza; van Os, Jim; Angel Gonzalez-Torres, Miguel			Differences in Facial Emotion Recognition between First Episode Psychosis, Borderline Personality Disorder and Healthy Controls	PLOS ONE			English	Article							1ST-EPISODE SCHIZOPHRENIA; EXPRESSION RECOGNITION; VOCAL AFFECT; EARLY-ONSET; HIGH-RISK; PERCEPTION; PEOPLE; SYMPTOMATOLOGY; METAANALYSIS; ASSOCIATION	Background Facial emotion recognition (FER) is essential to guide social functioning and behaviour for interpersonal communication. FER may be altered in severe mental illness such as in psychosis and in borderline personality disorder patients. However, it is unclear if these FER alterations are specifically related to psychosis. Awareness of FER alterations may be useful in clinical settings to improve treatment strategies. The aim of our study was to examine FER in patients with severe mental disorder and their relation with psychotic symptomatology. Materials and Methods Socio-demographic and clinical variables were collected. Alterations on emotion recognition were assessed in 3 groups: patients with first episode psychosis (FEP) (n = 64), borderline personality patients (BPD) (n = 37) and healthy controls (n = 137), using the Degraded Facial Affect Recognition Task. The Positive and Negative Syndrome Scale, Structured Interview for Schizotypy Revised and Community Assessment of Psychic Experiences scales were used to assess positive psychotic symptoms. WAIS III subtests were used to assess IQ. Results Kruskal-Wallis analysis showed a significant difference between groups on the FER of neutral faces score between FEP, BPD patients and controls and between FEP patients and controls in angry face recognition. No significant differences were found between groups in the fear or happy conditions. There was a significant difference between groups in the attribution of negative emotion to happy faces. BPD and FEP groups had a much higher tendency to recognize happy faces as negatives. There was no association with the different symptom domains in either group. Conclusions FEP and BPD patients have problems in recognizing neutral faces more frequently than controls. Moreover, patients tend to over-report negative emotions in recognition of happy faces. Although no relation between psychotic symptoms and FER alterations was found, these deficits could contribute to a patient's misinterpretations in daily life.	[Catalan, Ana; Gonzalez de Artaza, Maider; Bustamante, Sonia; Angel Gonzalez-Torres, Miguel] Univ Basque Country, Dept Neurosci, Leioa, Basque Country, Spain; [Catalan, Ana; Bustamante, Sonia; Orgaz, Pablo; Osa, Luis; Angosto, Virxinia; Valverde, Cristina; Madrazo, Arantza; Angel Gonzalez-Torres, Miguel] Basurto Univ Hosp, Dept Psychiat, Bilbao, Spain; [Bilbao, Amaia] Basurto Univ Hosp, Res Unit, Red Invest Serv Salud Enfermedades Cron REDISSEC, Bilbao, Vizcaya, Spain; [van Os, Jim] Maastricht Univ, Med Ctr, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England	University of Basque Country; Basurto Hospital; Basurto Hospital; Maastricht University; University of London; King's College London	Catalan, A (corresponding author), Univ Basque Country, Dept Neurosci, Leioa, Basque Country, Spain.; Catalan, A (corresponding author), Basurto Univ Hosp, Dept Psychiat, Bilbao, Spain.	ana.catalanalcantara@osakidetza.eus	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; Catalan, Ana/AAL-2224-2020; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; Catalan, Ana/0000-0002-0418-7904; Madrazo, Arantza/0000-0002-5142-7245; Gonzalez-Torres, Miguel Angel/0000-0002-4017-2785; Bustamante, Sonia/0000-0002-7226-2910				Addington J, 2006, SCHIZOPHR RES, V85, P142, DOI 10.1016/j.schres.2006.03.028; Addington J, 2012, SCHIZOPHR RES, V140, P87, DOI 10.1016/j.schres.2012.06.012; Amminger GP, 2012, EARLY INTERV PSYCHIA, V6, P450, DOI 10.1111/j.1751-7893.2012.00362.x; Amminger GP, 2012, SCHIZOPHRENIA BULL, V38, P1030, DOI 10.1093/schbul/sbr015; Barkl SJ, 2014, SCHIZOPHR RES, V159, P62, DOI 10.1016/j.schres.2014.07.049; Bertrand MC, 2007, SCHIZOPHR RES, V95, P124, DOI 10.1016/j.schres.2007.05.033; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Bland EB, 2004, ISSUES MENT HEALTH N, V25, P655; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Brune M, 2011, PSYCHIAT RES, V190, P9, DOI 10.1016/j.psychres.2010.03.015; Catalan A, 2015, PLOS ONE, V10, P13; Comparelli A, 2013, SCHIZOPHR RES, V143, P65, DOI 10.1016/j.schres.2012.11.005; Daros AR, 2014, SCHIZOPHR RES, V153, P32, DOI 10.1016/j.schres.2014.01.009; Derntl B, 2009, SCHIZOPHR RES, V108, P197, DOI 10.1016/j.schres.2008.11.009; Edwards J, 2001, SCHIZOPHR RES, V48, P235, DOI 10.1016/S0920-9964(00)00099-2; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fett AKJ, 2013, SCHIZOPHRENIA BULL, V39, P77, DOI 10.1093/schbul/sbr058; Fu CHY, 2007, AM J PSYCHIAT, V164, P599, DOI 10.1176/appi.ajp.164.4.599; Hardy-Bayle MC, 2003, SCHIZOPHRENIA BULL, V29, P459, DOI 10.1093/oxfordjournals.schbul.a007019; Hempel RJ, 2010, PSYCHIAT RES, V178, P1, DOI 10.1016/j.psychres.2008.07.025; Janssen I, 2003, ACTA PSYCHIAT SCAND, V108, P110, DOI 10.1034/j.1600-0447.2003.00092.x; Janssens M, 2012, SCHIZOPHR RES, V142, P116, DOI 10.1016/j.schres.2012.10.003; Kee KS, 2003, SCHIZOPHRENIA BULL, V29, P487, DOI 10.1093/oxfordjournals.schbul.a007021; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Kornreich C, 2003, PSYCHIAT RES, V119, P251, DOI 10.1016/S0165-1781(03)00130-6; Kucharska-Pietura K, 2005, BRIT J PSYCHIAT, V187, P523, DOI 10.1192/bjp.187.6.523; Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Marwick K, 2008, BRIT MED BULL, V88, P43, DOI 10.1093/bmb/ldn035; Minzenberg MJ, 2006, COMPR PSYCHIAT, V47, P468, DOI 10.1016/j.comppsych.2006.03.005; Mitchell AE, 2014, NEUROPSYCHOL REV, V24, P166, DOI 10.1007/s11065-014-9254-9; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Nicol K, 2014, PSYCHIAT RES, V218, P256, DOI 10.1016/j.psychres.2014.04.017; Penn DL, 1997, PSYCHIATRY, V60, P281, DOI 10.1080/00332747.1997.11024806; Peralta Martin V, 1994, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V22, P171; PERSAD SM, 1993, J ABNORM PSYCHOL, V102, P358, DOI 10.1037/0021-843X.102.3.358; Pinkham AE, 2006, PSYCHIAT RES, V143, P167, DOI 10.1016/j.psychres.2005.09.005; Pinkham Amy E, 2007, Cogn Neuropsychiatry, V12, P198; Sab Benton A.L., 1983, BENTONS TEST FACIAL; Schroeder K, 2013, CURR OPIN PSYCHIATR, V26, P113, DOI 10.1097/YCO.0b013e32835a2ae7; Schulze L, 2013, PSYCHOPATHOLOGY, V46, P217, DOI 10.1159/000341730; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; Tranter R, 2009, J AFFECT DISORDERS, V118, P87, DOI 10.1016/j.jad.2009.01.028; Unoka Z, 2011, PSYCHIAT RES, V189, P419, DOI 10.1016/j.psychres.2011.02.010; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; van't Wout M, 2004, SCHIZOPHR RES, V68, P271, DOI 10.1016/j.schres.2003.09.006; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482; Wagner AW, 1999, J PERS DISORD, V13, P329, DOI 10.1521/pedi.1999.13.4.329; Wozniak JR, 2008, EARLY INTERV PSYCHIA, V2, P169, DOI 10.1111/j.1751-7893.2008.00075.x; Zanarini MC, 2004, AM J PSYCHIAT, V161, P2108, DOI 10.1176/appi.ajp.161.11.2108	54	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0160056	10.1371/journal.pone.0160056	http://dx.doi.org/10.1371/journal.pone.0160056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5IL	27467692	gold, Green Published, Green Submitted			2022-12-27	WOS:000381516100100
J	Jimenez, S; Gascon, S; Luquin, A; Laguna, M; Ancin-Azpilicueta, C; Rodriguez-Yoldi, MJ				Jimenez, Sandra; Gascon, Sonia; Luquin, Asuncion; Laguna, Mariano; Ancin-Azpilicueta, Carmen; Rodriguez-Yoldi, Maria Jesus			Rosa canina Extracts Have Antiproliferative and Antioxidant Effects on Caco-2 Human Colon Cancer	PLOS ONE			English	Article							PLANT POLYPHENOLS; FREE-RADICALS; CELL-CYCLE; IN-VITRO; APOPTOSIS; L.; DISEASE; CYTOTOXICITY; DERIVATIVES; MECHANISMS	The in vitro antiproliferative and antioxidant effects of different fractions of Rosa canina hips on human colon cancer cell lines (Caco-2) was studied. The compounds tested were total extract (fraction 1), vitamin C (fraction 2), neutral polyphenols (fraction 3) and acidic polyphenols (fraction 4). All the extracts showed high cytotoxicity after 72 h, both low and high concentrations. The flow cytometric analysis revealed that all the fractions produce disturbances in the cell cycle resulting in a concomitant cell death by an apoptotic pathway. Changes in the redox status of Caco-2 cells in response to Rosa canina hips were determined. Cells were exposed to hydrogen peroxide in presence of plant fractions and the production of Reactive Oxygen Species (ROS) was significantly decreased. Therefore, our data demonstrate that rosehip extracts are a powerful antioxidant that produces an antiproliferative effect in Caco-2 cells. Therefore, these results predict a promising future for Rosa canina as a therapeutic agent. Thus, this natural plant could be an effective component of functional foods addressed towards colorectal carcinoma.	[Jimenez, Sandra; Luquin, Asuncion; Ancin-Azpilicueta, Carmen] Univ Publ Navarra, Dept Appl Chem, Pamplona, Spain; [Gascon, Sonia; Rodriguez-Yoldi, Maria Jesus] Univ Zaragoza, Dept Physiol & Pharmacol, CIBERobn, IA2,IIS Aragon,Vet Fac, Zaragoza, Spain; [Laguna, Mariano] Univ Zaragoza, CSIC, Dept Inorgan Chem, Inst Chem Syntheses & Homogeneous Catalysis, Zaragoza, Spain	Universidad Publica de Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza	Ancin-Azpilicueta, C (corresponding author), Univ Publ Navarra, Dept Appl Chem, Pamplona, Spain.; Rodriguez-Yoldi, MJ (corresponding author), Univ Zaragoza, Dept Physiol & Pharmacol, CIBERobn, IA2,IIS Aragon,Vet Fac, Zaragoza, Spain.	ancin@unavarra.es; mjrodyol@unizar.es	Ancín-Azpilicueta, Carmen/M-5632-2018	Ancín-Azpilicueta, Carmen/0000-0001-7690-3204; Luquin, Asuncion/0000-0002-2264-5956	Ministry of Science and Innovation [SAF2013-41651]; CIBER (Centros de Investigacion Biomedica en Red) Sub-program (CIBERobn) by the Instituto de Salud Carlos III [CB06/03/1012]; Proyecto ELENA [EFA 220/11 ELENA]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER (Centros de Investigacion Biomedica en Red) Sub-program (CIBERobn) by the Instituto de Salud Carlos III; Proyecto ELENA	This study was supported by the projects: the Ministry of Science and Innovation (SAF2013-41651), founds from Aragon Regional Government (A-32) and CIBER (Centros de Investigacion Biomedica en Red) Sub-program (CIBERobn, CB06/03/1012,) by the Instituto de Salud Carlos III and Proyecto ELENA, EFA 220/11 ELENA. Authors would like also to acknowledge AVANZARE for their collaboration in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULLO G, 1994, CANCER LETT, V87, P55, DOI 10.1016/0304-3835(94)90409-X; Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; Alshikh N, 2015, J FUNCT FOODS, V18, P1022, DOI 10.1016/j.jff.2015.05.018; Beattie J, 2005, CURR NUTR FOOD SCI, V1, P71, DOI 10.2174/1573401052953294; Cano A, 1998, PHYTOCHEM ANALYSIS, V9, P196, DOI 10.1002/(SICI)1099-1565(199807/08)9:4&lt;196::AID-PCA395&gt;3.0.CO;2-W; Carocho M, 2016, FOOD CHEM, V207, P51, DOI 10.1016/j.foodchem.2016.03.085; CHANTRET I, 1994, J CELL SCI, V107, P213; Charles DJ, 2013, ANTIOXIDANT PROPERTI, P39; Chrubasik JE, 2007, PHYTOTHER RES, V21, P675, DOI 10.1002/ptr.2142; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Demir N, 2014, LWT-FOOD SCI TECHNOL, V57, P126, DOI 10.1016/j.lwt.2013.12.038; Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016; Dzialo M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020160; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; Gallaher DD, 2013, NUTR PREVENTION TREA, P697; Garcia-Alonso J, 2006, FOOD RES INT, V39, P982, DOI 10.1016/j.foodres.2006.07.001; Garcia-Moreno E, 2013, ORGANOMETALLICS, V32, P3710, DOI 10.1021/om400340a; Guimaraes R, 2010, J AGR FOOD CHEM, V58, P6277, DOI 10.1021/jf101394w; Guo XD, 2013, MOL NUTR FOOD RES, V57, P1037, DOI 10.1002/mnfr.201200569; Hu XL, 2010, BIOCHEM BIOPH RES CO, V398, P62, DOI 10.1016/j.bbrc.2010.06.033; Jain SK, 2013, J NAT PROD, V76, P1724, DOI 10.1021/np400433g; Janeiro P, 2004, ANAL CHIM ACTA, V518, P109, DOI 10.1016/j.aca.2004.05.038; Larsen E, 2003, J NAT PROD, V66, P994, DOI 10.1021/np0300636; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Li Q, 2014, MOLECULES, V19, P19036, DOI 10.3390/molecules191119036; Li Y., 2012, FOOD SCI HUM WELL, V1, P19, DOI [10.1016/j.fshw.2012.08.002, DOI 10.1016/J.FSHW.2012.08.002]; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Lopez V, 2010, PHYTOTHER RES, V24, P869, DOI 10.1002/ptr.3037; Montero P, 2016, LWT-FOOD SCI TECHNOL, V70, P229, DOI 10.1016/j.lwt.2016.02.040; Nybom H, 2015, ACTA HORTIC, V1064, P137; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Piazzon A, 2012, J AGR FOOD CHEM, V60, P12312, DOI 10.1021/jf304076z; Rechner AR, 2002, FREE RADICAL BIO MED, V33, P220, DOI 10.1016/S0891-5849(02)00877-8; Ruiz-Leal M, 2004, MAR ENVIRON RES, V58, P631, DOI 10.1016/j.marenvres.2004.03.054; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Schieber A, 2003, J AGR FOOD CHEM, V51, P5006, DOI 10.1021/jf030218f; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Serrano J, 2007, FOOD RES INT, V40, P15, DOI 10.1016/j.foodres.2006.07.010; Shahidi F, 2015, J FUNCT FOODS, V18, P820, DOI 10.1016/j.jff.2015.06.018; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Stralsjo L, 2003, J AGR FOOD CHEM, V51, P4291, DOI 10.1021/jf034208q; Taleb-Senouci D, 2009, PHYTOMEDICINE, V16, P623, DOI 10.1016/j.phymed.2008.12.004; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tumbas VT, 2012, J SCI FOOD AGR, V92, P1273, DOI 10.1002/jsfa.4695; Turkben C, 2010, J FOOD AGRIC ENVIRON, V8, P26; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wenzel H, 2000, CANCER RES, V60, P3823; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1101, DOI 10.1177/002215549904700901; Yang J, 2009, J AGR FOOD CHEM, V57, P8581, DOI 10.1021/jf8039796; Zaletok S., 2015, Experimental Oncology, V37, P262	51	60	60	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159136	10.1371/journal.pone.0159136	http://dx.doi.org/10.1371/journal.pone.0159136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467555	Green Published, gold			2022-12-27	WOS:000381516100019
J	Staudacher, DL; Biever, PM; Benk, C; Ahrens, I; Bode, C; Wengenmayer, T				Staudacher, Dawid L.; Biever, Paul M.; Benk, Christoph; Ahrens, Ingo; Bode, Christoph; Wengenmayer, Tobias			Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation	PLOS ONE			English	Article							2010 INTERNATIONAL CONSENSUS; CARDIOVASCULAR CARE SCIENCE; ACUTE CORONARY SYNDROMES; LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; TREATMENT RECOMMENDATIONS; PLATELET DYSFUNCTION; ADULT PATIENTS; ANTICOAGULATION; COMPLICATIONS	Aims Bleeding is a frequent complication in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO). An indication for dual antiplatelet therapy due to coronary stent implantation is present in a considerable number of these patients. The objective of this retrospective study was to evaluate if dual antiplatelet therapy ( DAPT) significantly increases the high intrinsic bleeding risk in patients on VA-ECMO. Methods and Results A total of 93 patients were treated with VA-ECMO between October 2010 and October 2013. Average time on VA-ECMO was 58.9 +/- 1.7 hours. Dual antiplatelet therapy was given to 51.6% of all patients. Any bleeding was recorded in 60.2% of all patients. There was no difference in bleeding incidence in patients on DAPT when compared to those without any antiplatelet therapy including any bleeding (66.7% vs. 57.1%, p = 0.35), BARC3 bleeding (43.8% vs. 33.3%, p = 0.31) or pulmonary bleeding (16.7% vs. 19.0%, p = 0.77). This holds true after adjustment for confounders. Rate of transfusion of red blood cells were similar in patients with or without DAPT (35.4% vs. 28.6%, p = 0.488). Conclusions Bleeding on VA-ECMO is frequent. This registry recorded no statistical difference in bleeding in patients on dual antiplatelet therapy when compared to no antiplatelet therapy. When indicated, DAPT should not be withheld from VA ECMO patients.	[Staudacher, Dawid L.; Biever, Paul M.; Ahrens, Ingo; Bode, Christoph; Wengenmayer, Tobias] Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol 1, Freiburg, Germany; [Benk, Christoph] Univ Freiburg, Ctr Heart, Dept Cardiovasc Surg, Freiburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Staudacher, DL (corresponding author), Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol 1, Freiburg, Germany.	dawid.staudacher@universitaets-herzzenrum.de	Staudacher, Dawid L./AAF-5263-2021; Wengenmayer, Tobias/ABD-7064-2020	Staudacher, Dawid L./0000-0002-9423-9682; Wengenmayer, Tobias/0000-0002-3659-0407	German Research Foundation (DFG); University of Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.; The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Abrams D, 2014, J AM COLL CARDIOL, V63, P2769, DOI 10.1016/j.jacc.2014.03.046; Ang AL, 2009, VOX SANG, V96, P34, DOI 10.1111/j.1423-0410.2008.01110.x; Annich GM, 2015, J THROMB HAEMOST, V13, pS336, DOI 10.1111/jth.12963; Aubron C, 2013, CRIT CARE, V17, DOI 10.1186/cc12681; Bein T, 2011, ASAIO J, V57, P164, DOI 10.1097/MAT.0b013e318213f9e0; Bossaert L, 2010, RESUSCITATION, V81, pE175, DOI 10.1016/j.resuscitation.2010.09.001; Brown DJA, 2012, NEW ENGL J MED, V367, P1930, DOI 10.1056/NEJMra1114208; Cheng R, 2014, ANN THORAC SURG, V97, P610, DOI 10.1016/j.athoracsur.2013.09.008; Cheung PY, 2000, CRIT CARE MED, V28, P2584, DOI 10.1097/00003246-200007000-00067; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Heilmann C, 2012, INTENS CARE MED, V38, P62, DOI 10.1007/s00134-011-2370-6; Hou G, 2015, MINERVA CARDIOANGIOL; Kalbhenn J, 2015, PERFUSION-UK, V30, P675, DOI 10.1177/0267659115579714; Kane DA, 2010, CIRCULATION, V122, pS241, DOI 10.1161/CIRCULATIONAHA.109.928390; Lequier L, 2014, ELSO ANTICOAGULATION; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Raja SG, 2006, J CARDIAC SURG, V21, P35, DOI 10.1111/j.1540-8191.2006.00164.x; Rubboli A, 2014, J INVASIVE CARDIOL, V26, P563; Sousa-Uva M, 2014, EUR HEART J, V35, P1510, DOI 10.1093/eurheartj/ehu158; Staudacher DL, 2015, SCIENTIFICA, V2015, P1, DOI 10.1155/2015/435878; Staudacher DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140101; Steinlechner B, 2009, ANN THORAC SURG, V87, P131, DOI 10.1016/j.athoracsur.2008.10.027; StephanWindecker, 2015, Rev Esp Cardiol (Engl Ed), V68, P144, DOI 10.1016/j.rec.2014.12.006; Werho DK, 2015, PEDIATR CRIT CARE ME, V16, P276, DOI 10.1097/PCC.0000000000000345; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	26	14	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2016	11	7							e0159973	10.1371/journal.pone.0159973	http://dx.doi.org/10.1371/journal.pone.0159973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IL	27467697	Green Submitted, Green Published, gold			2022-12-27	WOS:000381516100080
J	Tania, S; Behr, S; Thone, K; Bricout, H; Garbe, E				Schink, Tania; Behr, Sigrid; Thoene, Kathrin; Bricout, Helene; Garbe, Edeltraut			Risk of Stroke after Herpes Zoster - Evidence from a German Self-Controlled Case-Series Study	PLOS ONE			English	Article							ASSOCIATION; VACCINATION; HEMORRHAGE; DATABASE	Background Herpes zoster (HZ) is caused by reactivation of the latent varicella-zoster virus (VZV). A severe complication of HZ is VZV vasculopathy which can result in ischemic or hemorrhagic stroke. The aims of our study were to assess the risk of stroke after the onset of HZ and to investigate the roles of stroke subtype, HZ location and the time interval between HZ onset and stroke. Methods A self-controlled case-series study was performed on a cohort of patients with incident stroke recorded in the German Pharmacoepidemiological Research Database (GePaRD), which covers about 20 million persons throughout Germany. We estimated adjusted incidence rate ratios (IRR) by comparing the rate of stroke in risk periods (i.e., periods following HZ) with the rate of stroke in control periods (i.e., periods without HZ) in the same individuals, controlling for both time-invariant and major potentially time-variant confounders. Results The cohort included 124,462 stroke patients, of whom 6,035 (5%) had at least one HZ diagnosis identified in GePaRD either as main hospital discharge diagnosis or as HZ treated with antivirals. The risk of stroke was about 1.3 times higher in the risk periods 3 months after HZ onset, than in the control periods (IRR: 1.29; 95% confidence interval: 1.16-1.44). An elevated risk of similar magnitude was observed for ischemic and unspecified stroke, but a 1.5-fold higher risk was observed for hemorrhagic stroke. A slightly stronger effect on the risk of stroke was also observed during the 3 months after HZ ophthalmicus (HZO) onset (1.59; 1.10-2.32). The risk was highest 3 and 4 weeks after HZ onset and decreased thereafter. Conclusions Our study corroborates an increased risk of stroke after HZ, which is highest 3 to 4 weeks after HZ onset. The results suggest that the risk is more pronounced after HZO and is numerically higher for hemorrhagic than for ischemic stroke.	[Schink, Tania; Behr, Sigrid; Thoene, Kathrin; Garbe, Edeltraut] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Thoene, Kathrin] Univ Canc Ctr Hamburg, Univ Med Ctr Hamburg Eppendorf UKE, Hamburg, Germany; [Bricout, Helene] Sanofi Pasteur MSD, Dept Epidemiol, Lyon, France	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Hamburg; University Medical Center Hamburg-Eppendorf; Sanofi-Aventis; Sanofi France	Tania, S (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	schink@bips.uni-bremen.de	Marcus, Ulrich/AAF-3085-2020; Schink, Susanne Barbara/F-7758-2015; Schink, Tania/A-4585-2017; Schink, Susanne Barbara/A-2669-2017	Marcus, Ulrich/0000-0002-3143-2717; Schink, Tania/0000-0002-0224-1866; Schink, Susanne Barbara/0000-0001-7542-9416; Helene, BRICOUT/0000-0002-5439-8064	Sanofi Pasteur MSD; Sanofi Pasteur	Sanofi Pasteur MSD; Sanofi Pasteur	The study was funded by Sanofi Pasteur MSD and by BIPS own resources. In collaboration with Sanofi Pasteur MSD, TS, SB, and EG designed the study, analyzed and interpreted the data. SB and TS drafted the manuscript and KT, HB and EG critically reviewed the manuscript. All authors approved the final version for submission. All BIPS authors had full access to the data and final responsibility for the decision to submit for publication. HB is employed by Sanofi Pasteur. Sanofi Pasteur provided support in the form of salary for author HB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Breuer J, 2014, NEUROLOGY, V83, pE27, DOI 10.1212/WNL.0000000000000584; Garbe E, 2013, STROKE, V44, P2422, DOI 10.1161/STROKEAHA.111.000811; Garbe E, 2011, PHARMACOEPIDEM DR S, V20, P258, DOI 10.1002/pds.2038; Hillebrand K, 2015, J INFECTION, V70, P178, DOI 10.1016/j.jinf.2014.08.018; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Langan SM, 2014, CLIN INFECT DIS, V58, P1497, DOI 10.1093/cid/ciu098; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; Minassian C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001919; Nagel MA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0534-4; Nagel MA, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0407-z; Ohlmeier C, 2014, BUNDESGESUNDHEITSBLA, V57, P464, DOI 10.1007/s00103-013-1912-1; Ohlmeier C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1943-7; Ohlmeier C, 2013, PHARMACOEPIDEM DR S, V22, P306; Pigeot I, 2008, PHARMACOEPIDEM DR S, V17, P215, DOI 10.1002/pds.1545; Powell DR, 2015, AM J MED SCI, V350, P243, DOI 10.1097/MAJ.0000000000000327; Schink T, 2014, VACCINE, V32, P645, DOI 10.1016/j.vaccine.2013.12.011; Schmedt N, 2016, INT CLIN PSYCHOPHARM, V31, P159, DOI 10.1097/YIC.0000000000000119; Schmedt N, 2013, J CLIN PSYCHOPHARM, V33, P753, DOI 10.1097/JCP.0b013e3182a412d5; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Sreenivasan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069156; Sundstrom K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1170-y; Whitaker HJ, 2009, STAT METHODS MED RES, V18, P7, DOI 10.1177/0962280208092342; Whitaker HJ, 2006, USING SAS SELF CONTR; Yawn BP, 2016, MAYO CLIN PROC, V91, P33, DOI 10.1016/j.mayocp.2015.09.015; Zhang J, 2012, JAMA-J AM MED ASSOC, V308, P43, DOI 10.1001/jama.2012.7304	26	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2016	11	11							e0166554	10.1371/journal.pone.0166554	http://dx.doi.org/10.1371/journal.pone.0166554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5KB	27486669	gold, Green Submitted, Green Published			2022-12-27	WOS:000388889500025
J	Wang, F; Chen, W; Bruening, KS; Raj, S; Larsen, DA				Wang, Fang; Chen, Wei; Bruening, Kay Stearns; Raj, Sudha; Larsen, David A.			Nutrition Screening Tools and the Prediction of Clinical Outcomes among Chinese Hospitalized Gastrointestinal Disease Patients	PLOS ONE			English	Article							MALNUTRITION; RISK; PREVALENCE; UNDERNUTRITION; SUPPORT; IDENTIFICATION; POPULATION; ADMISSION	Nutrition risk Screening 2002 (NRS-2002) and Subjective Global Assessment (SGA) are widely used screening tools but have not been compared in a Chinese population. We conducted secondary data analysis of a cross-sectional study which included 332 hospitalized gastrointestinal disease patients, collected by the Gastrointestinal department of Peking Union Medical College Hospital (PUMCH) in 2008. Results of NRS-2002 and SGA screening tools, complications, length of stay (LOS), cost, and death were measured. The agreement between the tools was assessed via Kappa (kappa) statistics. The performance of NRS-2002 and SGA in predicting LOS and cost was assessed via linear regression. The complications and death prediction of tools was assessed using receiver operating characteristic (ROC) curves. NRS-2002 and SGA identified nutrition risk at 59.0% and 45.2% respectively. Moderate agreement (kappa > 0.50) between the two tools was found among all age groups except individuals aged <= 20, which only slight agreement was found (kappa = 0.087). NRS-2002 (R square 0.130) and SGA (R square 0.140) did not perform differently in LOS prediction. The cost prediction of NRS-2002 (R square 0.198) and SGA (R square 0.190) were not significantly different. There was no difference between NRS-2002 (infectious complications: area under ROC (AUROC) = 0.615, death: AUROC = 0.810) and SGA (infectious complications: AUROC = 0.600, death: AUROC = 0.846) in predicting infectious complication and death, but NRS-2002 (0.738) seemed to perform better than SGA (0.552) in predicting non-infectious complications. The risk of malnutrition among patients was high. NRS-2002 and SGA have similar capacity to predict LOS, cost, infectious complications and death, but NRS-2002 performed better in predicting non-infectious complications.	[Wang, Fang] Peking Union Med Coll Hosp, Dept Nutr, Beijing, Peoples R China; [Chen, Wei] Peking Union Med Coll Hosp, Parenteral & Enteral Dept, Beijing, Peoples R China; [Bruening, Kay Stearns; Raj, Sudha; Larsen, David A.] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Syracuse University	Larsen, DA (corresponding author), Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, Syracuse, NY 13244 USA.	dalarsen@syr.edu	Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536; Raj, Sudha/0000-0002-3409-5920				Baldwin C, 2004, CLIN NUTR, V23, P1267, DOI 10.1016/j.clnu.2004.07.018; Bruun LI, 1999, CLIN NUTR, V18, P141, DOI 10.1016/S0261-5614(99)80003-X; Christensson L, 2002, EUR J CLIN NUTR, V56, P810, DOI 10.1038/sj.ejcn.1601394; Edington J, 2000, CLIN NUTR, V19, P191, DOI 10.1054/clnu.1999.0121; Gout BS, 2009, NUTR DIET, V66, P206, DOI 10.1111/j.1747-0080.2009.01372.x; Jensen GL, 2010, CLIN NUTR, V29, P151, DOI 10.1016/j.clnu.2009.11.010; Jensen GL, 2009, JPEN-PARENTER ENTER, V33, P710, DOI 10.1177/0148607109344724; Kubrak C, 2007, INT J NURS STUD, V44, P1036, DOI 10.1016/j.ijnurstu.2006.07.015; Kyle UG, 2005, CURR OPIN CLIN NUTR, V8, P397, DOI 10.1097/01.mco.0000172579.94513.db; Kyle UG, 2003, CLIN NUTR, V22, P473, DOI 10.1016/S0261-5614(03)00049-9; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liang XK, 2008, NUTRITION, V24, P969, DOI 10.1016/j.nut.2008.05.001; Liang XK, 2009, ASIA PAC J CLIN NUTR, V18, P54; Marshall JA, 1999, J AM DIET ASSOC, V99, P315, DOI 10.1016/S0002-8223(99)00081-4; Mason P., 2006, HOSP PHARM, V13, P353, DOI [10.7748/ns2003, DOI 10.7748/NS2003.]; Natl Alliance Infusion Therapy, 2010, NUTR CLIN PRACT, V25, P548, DOI 10.1177/0884533610378524; Pirlich M, 2006, CLIN NUTR, V25, P563, DOI 10.1016/j.clnu.2006.03.005; Putwatana P, 2005, NUTRITION, V21, P691, DOI 10.1016/j.nut.2004.10.015; Raslan M, 2010, NUTRITION, V26, P721, DOI 10.1016/j.nut.2009.07.010; Rasmussen HH, 2004, CLIN NUTR, V23, P1009, DOI 10.1016/j.clnu.2004.01.001; Sherein A.I., 2003, EGYPT J NUTR, V18, P95; Sullivan DH, 1999, JAMA-J AM MED ASSOC, V281, P2013, DOI 10.1001/jama.281.21.2013; Valero M.ª A., 2005, Nutr. Hosp., V20, P259; van Bokhorst-de van der Schueren MAE, 2005, EUR J CLIN NUTR, V59, P1129, DOI 10.1038/sj.ejcn.1602222; Velasco C, 2011, EUR J CLIN NUTR, V65, P269, DOI 10.1038/ejcn.2010.243; Waitzberg DL, 2001, NUTRITION, V17, P573, DOI 10.1016/S0899-9007(01)00573-1; Wei C, 2005, CHINESE J CLIN NUTR, V3; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Winter TA, 2000, EUR J GASTROEN HEPAT, V12, P191, DOI 10.1097/00042737-200012020-00010; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929; ZWEIG MH, 1993, CLIN CHEM, V39, P561	31	228	272	15	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2016	11	8							e0159436	10.1371/journal.pone.0159436	http://dx.doi.org/10.1371/journal.pone.0159436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GL	27490480	gold, Green Published, Green Submitted			2022-12-27	WOS:000381368900010
J	Seva, AP; Ovallos, FG; Amaku, M; Carrillo, E; Moreno, J; Galati, EAB; Lopes, EG; Soares, RM; Ferreira, F				Seva, Anaia P.; Ovallos, Fredy G.; Amaku, Marcus; Carrillo, Eugenia; Moreno, Javier; Galati, Eunice A. B.; Lopes, Estela G.; Soares, Rodrigo M.; Ferreira, Fernando			Canine-Based Strategies for Prevention and Control of Visceral Leishmaniasis in Brazil	PLOS ONE			English	Article							IMPREGNATED DOG COLLARS; CVL RAPID TEST; INFANTUM INFECTION; RISK-FACTORS; AREA; TRANSMISSION; IMPACT; SEROPREVALENCE; SERODIAGNOSIS; EPIDEMIOLOGY	Visceral leishmaniasis (VL) is a zoonosis found worldwide. Its incidence has increased in Brazil in recent years, representing a serious public and animal health problem. The strategies applied in Brazil are questionable and are not sufficient to control the disease. Thus, we have compared the efficacy of some of the currently available strategies focused on dogs to prevent and control zoonotic VL in endemic areas by optimizing a mathematical model. The simulations showed that the elimination of seropositive dogs, the use of insecticide-impregnated dog collars, and the vaccination of dogs significantly contribute to reducing the prevalence of infection in both canines and humans. The use of insecticide-impregnated collars presented the highest level of efficacy mainly because it directly affected the force of infection and vector-dog contact. In addition, when used at a coverage rate of 90%, insecticide-impregnated collar was able to decrease the prevalence of seropositive dogs and humans to zero; moreover, because of the easy application and acceptance by the targeted population, these collars may be considered the most feasible for inclusion in public policies among the three simulated measures. Vaccination and euthanasia were efficacious, but the latter method is strongly criticized on ethical grounds, and both methods present difficulties for inclusion in public policies. When we compared the use of euthanasia and vaccination at coverages of 70 and 90%, respectively, the proportion of infected populations were similar. However, on evaluating the implications of both of these methods, particularly the negative aspects of culling dogs and the proportion of animals protected by vaccination, the latter measure appears to be the better option if the total cost is not significantly higher. The comparison of complications and advantages of different control strategies allows us to analyze the optimal measure and offer strategies to veterinary and public health authorities for making decisions to prevent and control zoonotic VL. Hence, improvements in both public and animal health can be achieved in regions with scenarios similar to that considered in the present study; such scenarios are characteristically found in some areas of Brazil and other countries.	[Seva, Anaia P.; Amaku, Marcus; Lopes, Estela G.; Soares, Rodrigo M.; Ferreira, Fernando] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil; [Ovallos, Fredy G.; Galati, Eunice A. B.] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [Amaku, Marcus] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Carrillo, Eugenia; Moreno, Javier] Inst Salud Carlos III, Ctr Nacl Microbiol, WHO Collaborating Ctr Leishmaniasis, Majadahonda, Spain	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Seva, AP (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil.	anaiaps@usp.br	Galvis-Ovallos, Fredy/AAM-3621-2021; Moreno, Javier/AAB-5386-2021; Soares, Rodrigo M/E-8747-2015; Amaku, Marcos/D-5252-2012; Ferreira, Fernando/C-9038-2013; Carrillo, Eugenia/F-2058-2018; Sevá, Anaiá Paixão/J-4538-2013; Sevá, Anaiá P/E-9762-2015	Galvis-Ovallos, Fredy/0000-0002-2105-7941; Soares, Rodrigo M/0000-0002-7736-7914; Amaku, Marcos/0000-0003-4752-6774; Ferreira, Fernando/0000-0002-9160-7355; Carrillo, Eugenia/0000-0002-7869-7915; Sevá, Anaiá Paixão/0000-0001-5203-012X; Sevá, Anaiá P/0000-0001-5203-012X; Moreno, Javier/0000-0003-0087-4659	National Council for Scientific and Technological Development - Brazil (CNPq) [142612/2010-3]; Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) [BEX 9803/11-4]; Sao Paulo Research Foundation - Brazil (FAPESP) [2012/01442-4]	National Council for Scientific and Technological Development - Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation - Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the National Council for Scientific and Technological Development - Brazil (CNPq, 142612/2010-3), the Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES, Fellowship BEX 9803/11-4), and the Sao Paulo Research Foundation - Brazil (FAPESP, 2012/01442-4). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar DM, 2010, REV BRAS PARASITOL V, V19, P71, DOI 10.1590/S1984-29612010000100015; Akhavan D., 1996, Revista de Patologia Tropical, V25, P203; Alvar J., 2001, LAS LEISHMANIASIS DE; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrade AM, 2007, REV SOC BRAS MED TRO, V40, P594, DOI 10.1590/S0037-86822007000500021; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; BADARO R, 1986, J INFECT DIS, V154, P1003, DOI 10.1093/infdis/154.6.1003; Bentubo Henri Donnarumma Levy, 2007, Cienc. Rural, V37, P1021, DOI 10.1590/S0103-84782007000400016; Berg C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4075; Bortoletto DV, 2011, INFLUENCIA DA ESTERI; Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001; Brasil M da S, 2015, SINAN SISTEMA DE INF; Buratti M, 1998, J COMB DES, V6, P337, DOI 10.1002/(SICI)1520-6610(1998)6:5<337::AID-JCD3>3.3.CO;2-O; Camargo-Neves V. L. F. de, 2001, Cadernos de Saude Publica, V17, P1263, DOI 10.1590/S0102-311X2001000500026; Camargo-Neves VLF, 2004, B EPIDEMIOLOGICO PAU, V12, P7; Cameron MM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1309-8; CARVALHO EM, 1992, J INFECT DIS, V165, P535, DOI 10.1093/infdis/165.3.535; Costa C H, 2001, Rev Soc Bras Med Trop, V34, P223; Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795; Costa CHN, 2013, FIFTH WORLD CONGRESS, P1116; Costa DNCC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002355; Costa J.M.L., 2005, GAZETA MED BAHIA, V75, P3; Coura-Vital W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001291; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; da Saude Ministerio, 2006, LEISHMANIOSE VISCERA, P122; Dantas-Torres Filipe, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P151, DOI 10.1590/S0036-46652006000300007; David JR, 2001, MEM I OSWALDO CRUZ, V96, P839, DOI 10.1590/S0074-02762001000600018; Marzochi MCD, 2009, REV SOC BRAS MED TRO, V42, P570, DOI 10.1590/S0037-86822009000500017; de Oliveira JM, 2010, REV SOC BRAS MED TRO, V43, P188, DOI 10.1590/S0037-86822010000200016; Dye C, 1996, AM J TROP MED HYG, V55, P125, DOI 10.4269/ajtmh.1996.55.125; Fernandes AP, 2012, CURR OPIN MICROBIOL, V15, P476, DOI 10.1016/j.mib.2012.05.002; Fernandes CB, 2014, VACCINE, V32, P1287, DOI 10.1016/j.vaccine.2013.12.046; Ferroglio E, 2008, ZOONOSES PUBLIC HLTH, V55, P145, DOI 10.1111/j.1863-2378.2007.01092.x; Fisa R, 1999, VET PARASITOL, V83, P87, DOI 10.1016/S0304-4017(99)00074-6; Foroughi-Parvar Faeze, 2014, Adv Prev Med, V2014, P569193, DOI 10.1155/2014/569193; Garcia AM., 2009, GAZETA M DICA BAHIA, V79, P147; Gavgani ASM, 2002, LANCET, V360, P374, DOI 10.1016/S0140-6736(02)09609-5; Gradoni L, 2015, VET PARASITOL, V208, P94, DOI 10.1016/j.vetpar.2015.01.003; Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001; Hermont VJ, 2008, LEISHTEC MANUAL TECN; IBGE, 2011, BRASIL TABUA COMPLET; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; KillickKendrick R, 1997, MED VET ENTOMOL, V11, P105, DOI 10.1111/j.1365-2915.1997.tb00298.x; Laurenti MD, 2014, VET PARASITOL, V205, P444, DOI 10.1016/j.vetpar.2014.09.002; Laurenti MD, 2013, VET PARASITOL, V196, P296, DOI 10.1016/j.vetpar.2013.03.017; Laz D, 2009, J VENOM ANIM TOXINS, V15, P305; Lima ID, 2012, AM J TROP MED HYG, V86, P99, DOI 10.4269/ajtmh.2012.10-0492; Luz PM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000761; Maia C, 2010, ACTA TROP, V116, P193, DOI 10.1016/j.actatropica.2010.08.001; Maroli M, 2001, MED VET ENTOMOL, V15, P358, DOI 10.1046/j.0269-283x.2001.00321.x; Martinez E, 2013, CIENC RURAL, V43, P1998, DOI 10.1590/S0103-84782013001100013; Michel G, 2011, ACTA TROP, V119, P69, DOI 10.1016/j.actatropica.2011.05.012; Moreira ED, 2004, VET PARASITOL, V122, P245, DOI 10.1016/j.vetpar.2004.05.019; Moreira ED, 2003, AM J TROP MED HYG, V69, P393, DOI 10.4269/ajtmh.2003.69.393; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Nunes CM, 2008, VET PARASITOL, V153, P19, DOI 10.1016/j.vetpar.2008.01.005; Nunes CM, 2010, VET PARASITOL, V170, P131, DOI 10.1016/j.vetpar.2010.01.044; Oliveira-Lima JW, 2002, PRELIMINARY RESULTS, P7; Ovallos FG, 2011, ESTUDO DA CAPACIDADE; Palatnik-de-Sousa CB, 2001, AM J TROP MED HYG, V65, P510, DOI 10.4269/ajtmh.2001.65.510; Palatnik-De-Sousa CB, 2009, VACCINE, V27, P3505, DOI 10.1016/j.vaccine.2009.03.045; ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39; de Almeida ADPF, 2012, REV BRAS PARASITOL V, V21, P359, DOI 10.1590/S1984-29612012005000005; POZIO E, 1981, ACTA TROP, V38, P383; Queiroz Márcia J. A., 2004, J. Pediatr. (Rio J.), V80, P141, DOI 10.1590/S0021-75572004000200012; Quinnell RJ, 2009, PARASITOLOGY, V136, P1915, DOI 10.1017/S0031182009991156; Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005; Reithinger R, 2004, INT J PARASITOL, V34, P55, DOI 10.1016/j.ijpara.2003.09.006; Rogers ME, 2007, PLOS PATHOG, V3, P818, DOI 10.1371/journal.ppat.0030091; Rollin BE, 2011, VET CLIN N AM-SMALL, V41, P651, DOI 10.1016/j.cvsm.2011.03.005; Silva FS., 2007, REV TROP CIENC AGRAR, V1, P20; Silva LD, 2006, AM J TROP MED HYG, V75, P739, DOI 10.4269/ajtmh.2006.75.739; Silveira FT, 2010, T ROY SOC TROP MED H, V104, P529, DOI 10.1016/j.trstmh.2010.05.002; TESH RB, 1995, AM J TROP MED HYG, V52, P287, DOI 10.4269/ajtmh.1995.52.287; Vieira J B, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P85; Werneck GL, 2007, EPIDEMIOL INFECT, V135, P195, DOI 10.1017/S0950268806006881; Werneck Guilherme L., 2002, Cad. Saúde Pública, V18, P633, DOI [10.1590/S0102-311X2002000300012, 10.1590/S0102-311X2002000300007]; Werneck GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003172; Yang HM, 2001, EPIDEMIOLOGIA MATEMA	79	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2016	11	7							e0160058	10.1371/journal.pone.0160058	http://dx.doi.org/10.1371/journal.pone.0160058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5IM	27606898	Green Published, gold, Green Submitted			2022-12-27	WOS:000381516300026
J	Hellenbrand, W; Claus, H; Schink, S; Marcus, U; Wichmann, O; Vogel, U				Hellenbrand, Wiebke; Claus, Heike; Schink, Susanne; Marcus, Ulrich; Wichmann, Ole; Vogel, Ulrich			Risk of Invasive Meningococcal Disease in Men Who Have Sex with Men: Lessons Learned from an Outbreak in Germany, 2012-2013	PLOS ONE			English	Article							NEW-YORK-CITY; NEISSERIA-MENINGITIDIS; HOMOSEXUAL MEN; SEROGROUP-B; VACCINATION; COMMUNITY; GONORRHEA; CHILDREN; USA	Background We undertook investigations in response to an invasive meningococcal disease (IMD) outbreak in men who have sex with men (MSM) in Berlin 2012-2013 to better understand meningococcal transmission and IMD risk in MSM. Methods We retrospectively searched for further IMD cases in MSM in Germany through local health departments and undertook exploratory interviews. We performed antigen sequence typing, characterized fHbp and aniA genes of strains with the outbreak finetype and reviewed epidemiologically or spatiotemporally linked cases from 2002-2014. Results Among the 148 IMD-cases notified from 01.01.2012-30.09.2013 in 18-59 year-old men we identified 13 MSM in 6 federal states: 11 serogroup C (MenC, all finetype C: P1.5-1,10-8: F3-6), 2 MenB. Interviews with 7 MSM revealed frequent meeting of multiple partners online or via mobile apps and illicit drug use as potential risk factors. MenC incidence was 13-fold higher in MSM than non-MSM. MenC isolates from 9/11 MSM had a novel fHbp allele 766. All C: P1.5-1,10-8: F3-6 strains from MSM versus 16/23 from non-MSM had intact aniA genes (p = 0.04). Although definitive evidence for transmission among MSM in epidemiological or spatiotemporal clusters in 2002-2014 was lacking, clusters were more frequent in men aged 20-49 years. Molecular analysis of C: P1.5-1,10-8: F3-6 strains revealed cases with intact aniA since 2007, mainly associated with fHbp361, fHbp766 and fHbp813, all involving one or more MSM. Conclusions MenC incidence was elevated in MSM during the study period. Multiple casual sexual contacts and illicit drug use were common in affected MSM. In all strains from MSM we detected an intact aniA gene coding for a nitrite reductase, which permits survival in microanaerobic environments and could play a role in meningococcal transmission in MSM through urogenital colonization. Furthermore, meningococcal transmission among MSM may be sustained over large areas and thus require modified spatiotemporal scanning algorithms for timely detection and control.	[Hellenbrand, Wiebke; Wichmann, Ole] Robert Koch Inst, Immunizat Unit, Seestr 10, D-13353 Berlin, Germany; [Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Reference Lab Meningococci & Haemophilus Influenz, Wurzburg, Germany; [Schink, Susanne; Marcus, Ulrich] Robert Koch Inst, Unit HIV AIDS STI & Blood Borne Infect, Seestr 10, D-13353 Berlin, Germany; [Schink, Susanne] Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany; [Schink, Susanne] ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden; [Schink, Susanne] Charite, Augustenburger Pl 1, D-13353 Berlin, Germany	Robert Koch Institute; University of Wurzburg; Robert Koch Institute; Robert Koch Institute; European Centre for Disease Prevention & Control; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hellenbrand, W (corresponding author), Robert Koch Inst, Immunizat Unit, Seestr 10, D-13353 Berlin, Germany.	hellenbrandw@rki.de	Marcus, Ulrich/AAF-3085-2020; Schink, Susanne Barbara/F-7758-2015; Schink, Tania/A-4585-2017; Schink, Susanne Barbara/A-2669-2017	Marcus, Ulrich/0000-0002-3143-2717; Schink, Tania/0000-0002-0224-1866; Schink, Susanne Barbara/0000-0001-7542-9416; Helene, BRICOUT/0000-0002-5439-8064	German Federal Ministry of Health [1369-237]	German Federal Ministry of Health	WH, SS, UM and OW received no specific funding for this work. The National Reference Laboratory for Meningococci and Haemophilus influenzae (HC and UV) received funding from the German Federal Ministry of Health (http://www.bmg.bund.de/ministerium.html), funding code 1369-237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert L, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.3.21016; Barth KR, 2009, MICROBIOL-SGM, V155, P4093, DOI 10.1099/mic.0.032961-0; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; Bijlsma MW, 2014, J INFECTION, V68, P296, DOI 10.1016/j.jinf.2013.10.008; BISAILLON JG, 1984, SEX TRANSM DIS, V11, P296, DOI 10.1097/00007435-198410000-00006; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Elias J, 2006, EMERG INFECT DIS, V12, P1689, DOI 10.3201/eid1211.060682; FAUR YC, 1981, AM J PUBLIC HEALTH, V71, P53, DOI 10.2105/AJPH.71.1.53; Hellenbrand W, 2015, BUNDESGESUNDHEITSBLA, V58, P1314, DOI 10.1007/s00103-015-2253-z; Hellenbrand W, 2013, J INFECTION, V66, P48, DOI 10.1016/j.jinf.2012.09.008; JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060; Kamiya H, 2015, MMWR-MORBID MORTAL W, V64, P1256, DOI 10.15585/mmwr.mm6444a6; Koch J, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.5.30122; Kratz MM, 2015, EMERG INFECT DIS, V21, P1379, DOI 10.3201/eid2108.141837; Lucidarme J, 2015, J INFECTION, V71, P544, DOI 10.1016/j.jinf.2015.07.007; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marcus U., 2013, Eurosurveillance, V18, P20523, DOI 10.2807/1560-7917.ES2013.18.28.20523; Marcus U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-180; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Moir JW, 2011, BIOCHEM SOC T, V39, P1890, DOI 10.1042/BST20110735; Ridpath A, 2015, EMERG INFECT DIS, V21, P1458, DOI 10.3201/eid2108.141932; Robert Koch Institute, 2012, EPIDEMIOLOGISCHES B, V39, P389; Robert Koch-Institut, 2012, MEN INV ERKR INF JB, P150; Robert Koch-Institut, HIV AIDS DEUTSCHL EC; Robert Koch-Institut, 2007, FALL R KOCH I UB ERK; Robert Koch-Institut, 2003, EPIDEMIOLOGISCHES B, V50, P415; Schmink S, 2007, J CLIN MICROBIOL, V45, P3768, DOI 10.1128/JCM.01190-07; Seib KL, 2015, EXPERT REV VACCINES, V14, P841, DOI 10.1586/14760584.2015.1016915; Senatsverwaltung fur Gesundheit und Soziales, 2014, AMTSBL BERL, V3, P60; Simmons RD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0538-6; Simon MS, 2013, ANN INTERN MED, V159, P300, DOI 10.7326/0003-4819-159-4-201308200-00674; Snape MD, 2005, PEDIATR INFECT DIS J, V24, P128, DOI 10.1097/01.inf.0000151029.58752.27; Stefanelli P, 2008, IUBMB LIFE, V60, P629, DOI 10.1002/iub.95; STIKO, 2006, EPID B, V31, P255; Taha MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154047; Tsang RSW, 2003, J CLIN MICROBIOL, V41, P4411, DOI 10.1128/JCM.41.9.4411-4414.2003; Vu DM, 2012, INFECT IMMUN, V80, P643, DOI 10.1128/IAI.05604-11; Weiss D, 2013, MMWR-MORBID MORTAL W, V61, P1048; Weiss D, 2009, CLIN INFECT DIS, V48, P894, DOI 10.1086/597257	39	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2016	11	8							e0160126	10.1371/journal.pone.0160126	http://dx.doi.org/10.1371/journal.pone.0160126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GA	27486669	gold, Green Published, Green Submitted			2022-12-27	WOS:000381367800058
J	Wang, FJ; Wang, CL; Liu, PQ; Lei, CL; Hao, W; Gao, Y; Liu, YG; Zhao, KJ				Wang, Fujun; Wang, Chunlian; Liu, Piqing; Lei, Cailin; Hao, Wei; Gao, Ying; Liu, Yao-Guang; Zhao, Kaijun			Enhanced Rice Blast Resistance by CRISPR/Cas9-Targeted Mutagenesis of the ERF Transcription Factor Gene OsERF922	PLOS ONE			English	Article							CRISPR-CAS SYSTEM; NEGATIVELY REGULATES RESISTANCE; EFFICIENT TARGETED MUTAGENESIS; TAL EFFECTOR NUCLEASES; DISEASE RESISTANCE; SALT TOLERANCE; TRANSGENIC RICE; GUIDE RNA; GENOME MODIFICATION; MAGNAPORTHE-GRISEA	Rice blast is one of the most destructive diseases affecting rice worldwide. The adoption of host resistance has proven to be the most economical and effective approach to control rice blast. In recent years, sequence-specific nucleases (SSNs) have been demonstrated to be powerful tools for the improvement of crops via gene-specific genome editing, and CRISPR/Cas9 is thought to be the most effective SSN. Here, we report the improvement of rice blast resistance by engineering a CRISPR/Cas9 SSN (C-ERF922) targeting the OsERF922 gene in rice. Twenty-one C-ERF922-induced mutant plants (42.0%) were identified from 50 T-0 transgenic plants. Sanger sequencing revealed that these plants harbored various insertion or deletion (InDel) mutations at the target site. We showed that all of the C-ERF922-induced allele mutations were transmitted to subsequent generations. Mutant plants harboring the desired gene modification but not containing the transferred DNA were obtained by segregation in the T-1 and T-2 generations. Six T-2 homozygous mutant lines were further examined for a blast resistance phenotype and agronomic traits, such as plant height, flag leaf length and width, number of productive panicles, panicle length, number of grains per panicle, seed setting percentage and thousand seed weight. The results revealed that the number of blast lesions formed following pathogen infection was significantly decreased in all 6 mutant lines compared with wild-type plants at both the seedling and tillering stages. Furthermore, there were no significant differences between any of the 6 T2 mutant lines and the wild-type plants with regard to the agronomic traits tested. We also simultaneously targeted multiple sites within OsERF922 by using Cas9/Multi-target-sgRNAs (C-ERF922S1S2 and C-ERF922S1S2S3) to obtain plants harboring mutations at two or three sites. Our results indicate that gene modification via CRISPR/Cas9 is a useful approach for enhancing blast resistance in rice.	[Wang, Fujun; Liu, Piqing] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Wang, Fujun; Wang, Chunlian; Lei, Cailin; Hao, Wei; Gao, Ying; Zhao, Kaijun] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Liu, Yao-Guang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Guangxi University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; South China Agricultural University	Zhao, KJ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	zhaokaijun@caas.cn	Larsen, David/D-4027-2016	Larsen, David/0000-0002-1876-6536; Raj, Sudha/0000-0002-3409-5920	Major Science and Technology Project [2014ZX0801001B]	Major Science and Technology Project	This research was supported by a grant from the Major Science and Technology Project to Create New Crop Cultivars using Gene Transfer Technology (grant number 2014ZX0801001B.	Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Bundo M, 2016, PLANT BIOTECHNOL J, V14, P1357, DOI 10.1111/pbi.12500; Cao YF, 2006, J PLANT PHYSIOL, V163, P1167, DOI 10.1016/j.jplph.2005.11.004; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen XJ, 2008, INT J MOL SCI, V9, P2601, DOI 10.3390/ijms9122601; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clasen BM, 2016, PLANT BIOTECHNOL J, V14, P169, DOI 10.1111/pbi.12370; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Du HY, 2016, J BIOTECHNOL, V217, P90, DOI 10.1016/j.jbiotec.2015.11.005; Endo M, 2015, PLANT CELL PHYSIOL, V56, P41, DOI 10.1093/pcp/pcu154; Feng C, 2016, J GENET GENOMICS, V43, P37, DOI 10.1016/j.jgg.2015.10.002; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Ikeda T, 2015, GENES GENET SYST, V90, P231, DOI 10.1266/ggs.15-00030; Ito Y, 2015, BIOCHEM BIOPH RES CO, V467, P76, DOI 10.1016/j.bbrc.2015.09.117; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jia Y. L., 2003, Pesticide Outlook, V14, P150, DOI 10.1039/b308503c; Jiang CJ, 2009, MOL PLANT MICROBE IN, V22, P820, DOI 10.1094/MPMI-22-7-0820; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kobayashi N., 2007, WORK REP, V53, P17; Lai Y, 2013, PLANT PHYSIOL BIOCH, V62, P70, DOI 10.1016/j.plaphy.2012.10.010; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Li W, 2008, MOL BREEDING, V22, P141, DOI 10.1007/s11032-008-9163-9; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Liu DF, 2012, J EXP BOT, V63, P3899, DOI 10.1093/jxb/ers079; Liu WZ, 2015, MOL PLANT, V8, P1431, DOI 10.1016/j.molp.2015.05.009; Liu WD, 2014, ANNU REV PHYTOPATHOL, V52, P213, DOI 10.1146/annurev-phyto-102313-045926; Lowder LG, 2015, PLANT PHYSIOL, V169, P971, DOI 10.1104/pp.15.00636; Ma J, 2015, MOL PLANT MICROBE IN, V28, P558, DOI 10.1094/MPMI-11-14-0367-R; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Ma XL, 2015, MOL PLANT, V8, P1285, DOI 10.1016/j.molp.2015.02.012; McGinnis KM, 2010, BRIEF FUNCT GENOMICS, V9, P111, DOI 10.1093/bfgp/elp052; Miah G, 2013, MOL BIOL REP, V40, P2369, DOI 10.1007/s11033-012-2318-0; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Muller M, 2015, PLANT PHYSIOL, V169, P32, DOI 10.1104/pp.15.00677; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Rojo E, 2003, J PLANT GROWTH REGUL, V22, P82, DOI 10.1007/s00344-003-0027-6; Shan QW, 2015, PLANT BIOTECHNOL J, V13, P791, DOI 10.1111/pbi.12312; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Sherif S, 2013, PLANT CELL REP, V32, P1111, DOI 10.1007/s00299-013-1405-6; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tian ZD, 2015, PLANT CELL PHYSIOL, V56, P992, DOI 10.1093/pcp/pcv025; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Vogel MO, 2014, PLANT CELL, V26, P1151, DOI 10.1105/tpc.113.121061; Wang C, 2015, J GENET GENOMICS, V42, P703, DOI 10.1016/j.jgg.2015.09.011; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang SH, 2015, PLANT CELL REP, V34, P1473, DOI 10.1007/s00299-015-1816-7; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Weeks DP, 2016, PLANT BIOTECHNOL J, V14, P483, DOI 10.1111/pbi.12448; Wendt T, 2013, PLANT MOL BIOL, V83, P279, DOI 10.1007/s11103-013-0078-4; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11491; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yara A, 2008, BIOCHEM BIOPH RES CO, V376, P460, DOI 10.1016/j.bbrc.2008.08.157; Yara A, 2007, PLANT CELL PHYSIOL, V48, P1263, DOI 10.1093/pcp/pcm107; Zhang H, 2016, PLANT BIOTECHNOL J, V14, P186, DOI 10.1111/pbi.12372; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806; Zhu JJ, 2016, J GENET GENOMICS, V43, P25, DOI 10.1016/j.jgg.2015.10.006	83	228	272	15	212	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2016	11	4							e0154027	10.1371/journal.pone.0154027	http://dx.doi.org/10.1371/journal.pone.0154027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK5QB	27490480	Green Submitted, Green Published, gold			2022-12-27	WOS:000374973600037
J	Xin, Y; Jiang, X; Wang, YS; Su, XJ; Sun, MY; Zhang, LH; Tan, Y; Wintergerst, KA; Li, Y; Li, YL				Xin, Ying; Jiang, Xin; Wang, Yishu; Su, Xuejin; Sun, Meiyu; Zhang, Lihong; Tan, Yi; Wintergerst, Kupper A.; Li, Yan; Li, Yulin			Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; TRANSPLANTATION; GENERATION; RAT; MANIPULATION; MECHANISM; PATHWAYS	Background The two major obstacles in the successful transplantation of islets for diabetes treatment are inadequate supply of insulin-producing tissue and immune rejection. Induction of the differentiation of human bone marrow-derived mesenchymal stem cells (hMSCs) into insulinproducing cells (IPCs) for autologous transplantation may alleviate those limitations. Methods hMSCs were isolated and induced to differentiate into IPCs through a three-stage differentiation protocol in a defined media with high glucose, nicotinamide, and exendin-4. The physiological characteristics and functions of IPCs were then evaluated. Next, about 3 x 10(6) differentiated cells were transplanted into the renal sub-capsular space of streptozotocin (STZ)-induced diabetic nude mice. Graft survival and function were assessed by immunohistochemistry, TUNEL staining and measurements of blood glucose levels in the mice. Results The differentiated IPCs were characterized by Dithizone (DTZ) positive staining, expression of pancreatic beta-cell markers, and human insulin secretion in response to glucose stimulation. Moreover, 43% of the IPCs showed L-type Ca2+ channel activity and similar changes in intracellular Ca2+ in response to glucose stimulation as that seen in pancreatic beta-cells in the process of glucose-stimulated insulin secretion. Transplantation of functional IPCs into the renal subcapsular space of STZ-induced diabetic nude mice ameliorated the hypergly-cemia. Immunofluorescence staining revealed that transplanted IPCs sustainably expressed insulin, c-peptide, and PDX-1 without apparent apoptosis in vivo. Conclusions IPCs derived from hMSCs in vitro can ameliorate STZ-induced diabetic hyperglycemia, which indicates that these hMSCs may be a promising approach to overcome the limitations of islet transplantation.	[Xin, Ying; Wang, Yishu; Su, Xuejin; Sun, Meiyu; Zhang, Lihong; Li, Yulin] Jilin Univ, Minist Educ, Key Lab Pathobiol, Changchun 130023, Peoples R China; [Jiang, Xin] Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130023, Peoples R China; [Xin, Ying; Tan, Yi; Wintergerst, Kupper A.] Univ Louisville, Dept Pediat, Div Endocrinol, Wendy L Novak Diabet Care Ctr, Louisville, KY 40292 USA; [Li, Yan] Karolinska Univ Hosp, Dept Orthoped Surg, Stockholm, Sweden	Jilin University; Jilin University; University of Louisville; Karolinska Institutet; Karolinska University Hospital	Li, Y (corresponding author), Karolinska Univ Hosp, Dept Orthoped Surg, Stockholm, Sweden.	Yan.Li@ki.se; ylli_jlu@126.com	Jiang, Xin/AHA-9454-2022	Jiang, Xin/0000-0002-4613-7438; Lin, Fu-Cheng/0000-0002-4127-8143	National Science Foundation of China [981201218]; Jilin Provincial Science & Technology Foundation [20130413032GH, 20110465, 20130522038JH, 20140414035GH]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Provincial Science & Technology Foundation	This study was supported in part by Young Scientist Award from National Science Foundation of China (981201218, to YX), and the funds from Jilin Provincial Science & Technology Foundation (20130413032GH and 20110465, to YX; 20130522038JH and 20140414035GH, to XJ). The funders had roles in data collection and analysis, decision to publish, and preparation of the manuscript.	Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Calne RY, 2010, NAT REV ENDOCRINOL, V6, P173, DOI 10.1038/nrendo.2009.276; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; De Miguel MP, 2012, CURR MOL MED, V12, P574; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Francese R, 2010, CLIN IMMUNOL, V136, P309, DOI 10.1016/j.clim.2010.04.010; Gabr MM, 2013, CELL TRANSPLANT, V22, P133, DOI 10.3727/096368912X647162; Ham DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079076; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; He X, 2005, CHINESE MED J-PEKING, V118, P1728; Jiang X, 2013, TOXICOL LETT, V219, P65, DOI 10.1016/j.toxlet.2013.02.022; Karaoz E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.14; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kawano S, 2002, CELL CALCIUM, V32, P165, DOI 10.1016/S0143416002001240; Kazantseva J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074799; Kolb H, 1999, DIABETES CARE, V22, pB16; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Li GR, 2005, STEM CELLS, V23, P371, DOI 10.1634/stemcells.2004-0213; Limbert C, 2009, PEDIATR DIABETES, V10, P413, DOI 10.1111/j.1399-5448.2009.00502.x; Mhanna R, 2014, TISSUE ENG PT A, V20, P1165, DOI [10.1089/ten.tea.2013.0519, 10.1089/ten.TEA.2013.0519]; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prabakar KR, 2012, CELL TRANSPLANT, V21, P1321, DOI 10.3727/096368911X612530; Rahmati S, 2013, BIOCHEM BIOPH RES CO, V437, P413, DOI 10.1016/j.bbrc.2013.06.092; Rajagopal J, 2003, SCIENCE, V299, P363; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Shi Y, 2005, STEM CELLS, V23, P656, DOI 10.1634/stemcells.2004-0241; Sun Y, 2007, CHINESE MED J-PEKING, V120, P771, DOI 10.1097/00029330-200705010-00007; Takemitsu H, 2013, GEN COMP ENDOCR, V189, P1, DOI 10.1016/j.ygcen.2013.04.009; Ueyama H, 2012, J CELL MOL MED, V16, P72, DOI 10.1111/j.1582-4934.2011.01303.x; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; Wu XH, 2007, WORLD J GASTROENTERO, V13, P3342, DOI 10.3748/wjg.v13.i24.3342; Xie HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076056; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Yang XF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-59; Zahanich I, 2005, J BONE MINER RES, V20, P1637, DOI 10.1359/JBMR.050521; Zhang H, 2003, ACTA PHARMACOL SIN, V24, P790; Zhang WJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt352	40	106	114	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2016	11	1							e0145838	10.1371/journal.pone.0145838	http://dx.doi.org/10.1371/journal.pone.0145838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA6CG	26756576	Green Submitted, gold, Green Published			2022-12-27	WOS:000367888800005
